Class ID,Preferred Label,Synonyms,Definitions,Obsolete,CUI,Semantic Types,Parents,Accepted_Therapeutic_Use_For,ALT_DEFINITION,alternative term,axiom_lost_from_external_ontology,BFO CLIF specification label,BFO OWL specification label,CAS_Registry,CHEBI_ID,Chemical_Formula,chromosome ID of gene,code,Concept_Status,consider,Contributing_Source,contributor,created_by,creation_date,creator,curator notes,database cross reference,definition,definition,definition source,definition_citation,depicted by,DesignNote,Display_Name,dubious_for_taxon,editor note,editor preferred term~editor preferred label,editor preferred term~editor preferred label,elucidation,example,example of usage,external_definition,external_ontology_notes,FDA_Table,FDA_UNII_Code,fma_set_term,full name from nomenclature authority,function_notes,gene map location,has associated axiom(fol),has associated axiom(nl),has curation status,has GO association,has PubMed association,has_alternative_id,has_broad_synonym,Has_CDRH_Parent,Has_CTCAE_5_Parent,has_exact_synonym,Has_Free_Acid_Or_Base_Form,has_MedDRA_id,has_narrow_synonym,Has_NICHD_Parent,has_obo_namespace,has_rank,has_related_synonym,has_relational_adjective,has_RxCUI,Has_Salt_Form,Has_Target,homology_notes,http://data.bioontology.org/metadata/prefixIRI,http://ontofox.hegroup.org/vkdjgd5o.owl#oboInOwl:hasDefinition,http://protege.stanford.edu/plugins/owl/protege#readOnly,http://purl.obolibrary.org/obo/chebi/charge,http://purl.obolibrary.org/obo/chebi/formula,http://purl.obolibrary.org/obo/chebi/inchi,http://purl.obolibrary.org/obo/chebi/inchikey,http://purl.obolibrary.org/obo/chebi/mass,http://purl.obolibrary.org/obo/chebi/monoisotopicmass,http://purl.obolibrary.org/obo/chebi/smiles,http://purl.obolibrary.org/obo/created_by,http://purl.obolibrary.org/obo/creation_date,http://purl.obolibrary.org/obo/def,http://purl.obolibrary.org/obo/IAO_0010000,http://purl.obolibrary.org/obo/mondo#closeMatch,http://purl.obolibrary.org/obo/mondo#exactMatch,http://purl.obolibrary.org/obo/namespace,http://purl.obolibrary.org/obo/RO_0002161,http://purl.org/dc/elements/1.1/date,http://purl.org/dc/elements/1.1/description,http://purl.org/dc/terms/license,http://www.ebi.ac.uk/efo/branch_class,http://www.ebi.ac.uk/efo/gwas_trait,http://www.geneontology.org/formats/oboInOWL#hasExactSynonym,http://www.geneontology.org/formats/oboInOWL#hasRelatedSynonym,http://www.geneontology.org/formats/oboInOwl#is_class_level,http://www.geneontology.org/formats/oboInOwl#is_metadata_tag,http://www.geneontology.org/formats/oboInOwl#xref,http://www.w3.org/1999/02/22-rdf-syntax-ns#type,http://www.w3.org/2000/01/rdf-schema#comment,http://www.w3.org/2000/01/rdf-schema#isDefinedBy,http://www.w3.org/2000/01/rdf-schema#subClassOf,http://www.w3.org/2002/07/owl#deprecated,http://www.w3.org/2004/02/skos/core#closeMatch,http://www.w3.org/2004/02/skos/core#exactMatch,http://www.w3.org/2004/02/skos/core#notation,https://bio.scai.fraunhofer.de/ontology/covid#CommentonDefinition,https://bio.scai.fraunhofer.de/ontology/covid#CommentOnDefinition,https://bio.scai.fraunhofer.de/ontology/covid#CommentonDefintion,https://bio.scai.fraunhofer.de/ontology/covid#CommentonHierarchy,https://bio.scai.fraunhofer.de/ontology/covid#DrugsinVirtualScreening,https://bio.scai.fraunhofer.de/ontology/covid#fromArticle,https://bio.scai.fraunhofer.de/ontology/covid#fromBEL,https://bio.scai.fraunhofer.de/ontology/covid#fromNCBIBook,https://bio.scai.fraunhofer.de/ontology/covid#fromPubMed,https://bio.scai.fraunhofer.de/ontology/covid#fromSciBite,https://bio.scai.fraunhofer.de/ontology/covid#oboInOwl:hasDbXRef,https://bio.scai.fraunhofer.de/ontology/covid#oboInOwl:hasDefinition,https://bio.scai.fraunhofer.de/ontology/covid#oboInOwl:hasExactSynonym,https://bio.scai.fraunhofer.de/ontology/covid#oboInOwl:hasRelatedSynonym,id,IEDB alternative term,imported from,in subset,ISA alternative term,isClinicalAspectFor,isClinicalTrialFor,isModelFor,isPreventionAndControlFor,isRiskFactorFor,isSignsAndSymptomsFor,isTransmissionProcessFor,isVirologyFor,label,Legacy_Concept_Name,Maps_To,modification date,NCBI GeneID,NCBI LocusTag,NCBI_Taxon_ID,NCI_META_CUI,NICHD_Hierarchy_Term,nomenclature status,NSC_Code,OBO foundry unique label,OLD_CHILD,OLD_KIND,ontology term requester,organism NCBITaxon ID,PDQ_Closed_Trial_Search_ID,PDQ_Open_Trial_Search_ID,preferred label,Preferred_Name,present_in_taxon,PubMedID_Primary_Reference,seeAlso,Semantic_Type,shorthand,structure_notes,symbol from nomenclature authority,taxon_notes,term editor,term tracker item,type of gene,UMLS_CUI,Unique Apollo Label
http://purl.obolibrary.org/obo/OGMS_0000096,health care process,,"A planned process with the objective to improve the health status of a patient that directly involves the treatment, diagnosis, or prevention of disease or injury of a patient",false,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,"creation date: 2011-02-21T09:57:44Z
editor date: 2017-04-18
",,"A planned process with the objective to improve the health status of a patient that directly involves the treatment, diagnosis, or prevention of disease or injury of a patient",,http://groups.google.com/group/ogms-discuss/browse_thread/thread/a2dbc2ed1dff99d6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000096,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,health care process,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Albert Goldfain
Sagar Jain",,,,
http://purl.obolibrary.org/obo/GO_0048839,inner ear development,,"The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0048839,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048839,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,inner ear development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051988,regulation of attachment of spindle microtubules to kinetochore,regulation of kinetochore-microtubule attachment,"Any process that modulates the frequency, rate or extent of the attachment of spindle microtubules to the kinetochore.",false,,,http://purl.obolibrary.org/obo/GO_0051983,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the attachment of spindle microtubules to the kinetochore.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of kinetochore-microtubule attachment,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051983,,,,GO:0051988,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051988,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of attachment of spindle microtubules to kinetochore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_235173,SARS coronavirus Shanhgai LY,SARS coronavirus Hong Kong ZY-2003,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus Hong Kong ZY-2003,,,,,,NCBITaxon:235173,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Shanhgai LY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_33281,antimicrobial agent,microbicides|Antibiotika|antimicrobials|antibiotic|Antibiotikum|antibiotique|antimicrobial|microbicide|antimicrobial agents|antibiotics,"A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:12964249|PMID:22849268|PMID:22439833|PMID:22958833|PMID:22849276|PMID:22117953,"A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:22582,,,,,,,,,chebi_ontology,,microbicides|Antibiotika|antimicrobials|antibiotic|Antibiotikum|antibiotique|antimicrobial|microbicide|antimicrobial agents|antibiotics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:33281,,,,,,true,,,,,,,Antimicrobials,,CHEBI:33281,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,antimicrobial agent,,,,,,,,,,,,,,,,,,,,,,https://www.asm.org/Articles/2020/March/Antimicrobials-and-COVID-19-Treatment-Strategies-f,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034774,secretory granule lumen,,The volume enclosed by the membrane of a secretory granule.,false,,,http://purl.obolibrary.org/obo/GO_0060205,,,,,,,,,,,,,,,,,,,,,The volume enclosed by the membrane of a secretory granule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0060205,,,,GO:0034774,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034774,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,secretory granule lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000010,apicidin,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Apicidin is a cyclic tetrapeptide fungal metabolite which is used as a histone deacetylase 2 (HDAC2) inhibitor.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,true,,,,,,,,,,,,,,,,,,,,,,apicidin,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full|https://www.sigmaaldrich.com/catalog/product/sigma/a8851,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000079,cough etiquette,,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,Intervention,,true,,,,,,"Cough etiquette is a series of actions to take if you are coughing or sneezing, which are designed
to reduce the spread of respiratory illness to others.",,,,,,,,,,,,,,,,cough etiquette,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/docs/default-source/searo/thailand/20200318-tha-sitrep-25-covid19-final.pdf?sfvrsn=e7813cf4_0,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002171,FABP5,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,E-FABP|PAFABP|PA-FABP|EFABP|KFABP,,,,,,,8,,,,,,,,,,Ensembl:ENSG00000164687|Vega:OTTHUMG00000134313|HPRD:05524|MIM:605168|HGNC:3560,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,fatty acid binding protein 5 (psoriasis-associated),,8q21.13,,,,"GO_0005215 (EC: IEA); GO_0005504 (EC: IEA); GO_0005515 (EC: IPI, PMID: 12839573); GO_0005737 (EC: TAS, PMID: 16130169); GO_0006006 (EC: IEA); GO_0006629 (EC: TAS, PMID: 8092987); GO_0006656 (EC: IEA); GO_0008289 (EC: TAS, PMID: 1512466); GO_0008544 (EC: TAS, PMID: 1512466); GO_0009611 (EC: IEA); GO_0015758 (EC: IEA); GO_0070062 (EC: IDA)",PMID: 1286667; 1512466; 8092987; 8125298; 8427590; 8726632; 8947466; 9285630; 9438903; 10191275; 10331666; 10493790; 11113456; 12049637; 12477932; 12665801; 12839573; 15146197; 15335354; 15489334; 15592455; 16130169; 16759896; 16806233; 17353931; 17428383; 18360704; 18729184; 19156129; 19337991; 19339807; 19434059; 19554614; 19861119; 20040021; 20057506; 20424164; 20452069; 20563994; 20833513; 21139048; 21288588; 21356353; 21492859; 21890473; 21906983; 22010213; 22505724; 22761399; 22825302; 23000965; 23039948; 23327868; 23528210; 23535730; 23722546; 24457600,,,,,,,,,,,,,,,,,,OGG:3000002171,,,,,,,,,,,,,,,,,,,fatty acid binding protein 5 (psoriasis-associated),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FABP5,,,20140408,2171,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,FABP5,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/DOID_225,syndrome,,A disease characterized by a group of signs and symptoms that occur together and characterize a particular abnormality.,false,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,,,,,,,,,,,,,,,,,NCI:C28193|SNOMEDCT_US_2018_03_01:64572001|MESH:D013577|UMLS_CUI:C0039082,A disease characterized by a group of signs and symptoms that occur together and characterize a particular abnormality.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,DOID:225,,,,,,,,,,,,,,,DOID:225,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001653,DDX1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,DBP-RB|UKVH5d,,,,,,,2,,,,,,,,,,HGNC:2734|Ensembl:ENSG00000079785|Vega:OTTHUMG00000090593|MIM:601257|HPRD:03158,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,DEAD (Asp-Glu-Ala-Asp) box helicase 1,,2p24,,,,"GO_0000245 (EC: NAS, PMID: 7689221); GO_0003677 (EC: IEA); GO_0003682 (EC: IDA, PMID: 19058135); GO_0003712 (EC: IDA, PMID: 19058135); GO_0003724 (EC: TAS, PMID: 7689221); GO_0003725 (EC: IEA); GO_0004518 (EC: IDA, PMID: 18710941); GO_0004527 (EC: IEA); GO_0005515 (EC: IPI, PMID: 11598190); GO_0005524 (EC: IEA); GO_0005634 (EC: IDA); GO_0005730 (EC: IDA, Qualifier: NOT); GO_0005737 (EC: IDA); GO_0006200 (EC: IDA, PMID: 12183465); GO_0006302 (EC: IDA, PMID: 18710941); GO_0006351 (EC: IEA); GO_0006355 (EC: IEA); GO_0006446 (EC: NAS, PMID: 7689221); GO_0007275 (EC: IEP, PMID: 7689221); GO_0008026 (EC: IDA, PMID: 12183465); GO_0008143 (EC: IDA, PMID: 12183465); GO_0009615 (EC: IEA); GO_0010494 (EC: IDA, PMID: 18335541); GO_0030529 (EC: IDA, PMID: 18809582); GO_0032508 (EC: IDA, PMID: 18710941); GO_0033677 (EC: IDA, PMID: 18710941); GO_0043330 (EC: IEA); GO_0044822 (EC: IDA); GO_0071920 (EC: IDA, PMID: 11598190); GO_0072669 (EC: IDA); GO_0090305 (EC: IDA, PMID: 18710941)",PMID: 1552844; 7689221; 8135819; 10319407; 10834319; 11598190; 11790298; 12183465; 12477932; 15161933; 15489334; 15567440; 15588285; 15635413; 15892970; 16159877; 16230076; 16335966; 16354571; 17028906; 17220478; 17314511; 17380053; 17380054; 17611020; 17620599; 17661632; 18029348; 18335541; 18508616; 18710941; 18809582; 19058135; 19135240; 19149558; 19240061; 19398953; 19738201; 20499159; 20573827; 21081666; 21139048; 21145461; 21252943; 21319273; 21358275; 21697133; 21763499; 21832049; 21890473; 21907836; 21946350; 21963094; 21988832; 22051512; 22053931; 22079093; 22174317; 22446626; 22479191; 22544364; 22623428; 22751105; 22863883; 22939629; 23000965; 23284291; 23703321; 23797032; 23862649; 24130170,,,,,,,,,,,,,,,,,,OGG:3000001653,,,,,,,,,,,,,,,,,,,DEAD (Asp-Glu-Ala-Asp) box helicase 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/20573827,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,DDX1,,,20140408,1653,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,DDX1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0002285,lymphocyte activation involved in immune response,lymphocyte activation during immune response,"A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,lymphocyte activation during immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0002285,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002285,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lymphocyte activation involved in immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0040224,Abnormality of fibrinolysis,Abnormality of the fibrinolytic system,Clincial phenotype characterized by delayed bleeding accelerated break down of blood clot (fibrinolysis)|requested and created by members of the BRIDGE consortium,false,,,http://purl.obolibrary.org/obo/HP_0001928,,,,,,,,,,,,,,,,,,,,UMLS:C4280719,Clincial phenotype characterized by delayed bleeding accelerated break down of blood clot (fibrinolysis),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of the fibrinolytic system,,,,,,,,,,,,,HP:0040224,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,requested and created by members of the BRIDGE consortium,,http://purl.obolibrary.org/obo/HP_0001928,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of fibrinolysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_253435,SARS coronavirus PUMC03,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:253435,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PUMC03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000146,ORF3b,,,false,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Open Reading Frame 3b in SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,modified definition,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,true,,,,,https://pubmed.ncbi.nlm.nih.gov/32167180/,,,,,,,,,,,,,,,,,ORF3b,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00017633,Interferon Alfa-2b,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5880,,,,DRON:00017633,"A non-glycosylated recombinant interferon with antiviral and antineoplastic activities. Alfa interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32275914,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,Interferon Alfa-2b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_94484,1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester,carbetapentane citrate|carbetapentane|pentoxyverine citrate|pentoxiverine,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LINCS:LSM-5240|Drug_Central:494|CAS:77-23-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,carbetapentane citrate|carbetapentane|pentoxyverine citrate|pentoxiverine,,,,,,,,,0,C20H31NO3,"InChI=1S/C20H31NO3/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3",CFJMRBQWBDQYMK-UHFFFAOYSA-N,333.466,333.23039,CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:94484,,,,,true,true,,,,,,,,,CHEBI:94484,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000041,analysis of SARS-CoV-2 host interacting proteins,,,false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,Assay,,true,,,,,,Global analysis of SARS-CoV-2 host interacting proteins.,,,,,,,,,,,,,,,,analysis of SARS-CoV-2 host interacting proteins,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v1.full.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305406,SARS coronavirus B012,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305406,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus B012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010743,regulation of macrophage derived foam cell differentiation,,"Any process that modulates the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0010743,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010743,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of macrophage derived foam cell differentiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_9606,Homo sapiens,man|human|Homo sampiens|Homo sapients|Homo sapien|Homo sapiense|Homo sapeins|Homo sapians|Homo spiens|Home sapiens|Homo sapian|Homo sapience|Humo sapiens|Homo spaiens|Homo sapines,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_9443,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,man|human,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Homo sampiens|Homo sapients|Homo sapien|Homo sapiense|Homo sapeins|Homo sapians|Homo spiens|Home sapiens|Homo sapian|Homo sapience|Humo sapiens|Homo spaiens|Homo sapines,,,,,,NCBITaxon:9606,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_9443,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32290293,The primate species of mammal to which modern humans belong.,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Homo sapiens,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051303,establishment of chromosome localization,chromosome positioning|establishment of chromosome localisation,The directed movement of a chromosome to a specific location.,false,,,http://purl.obolibrary.org/obo/GO_0050000,,,,,,,,,,,,,,,,,,,,,The directed movement of a chromosome to a specific location.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chromosome positioning|establishment of chromosome localisation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050000,,,,GO:0051303,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051303,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,establishment of chromosome localization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0038095,Fc-epsilon receptor signaling pathway,Fc-epsilon receptor signalling pathway,"A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.",false,,,http://purl.obolibrary.org/obo/GO_0038093,,,,,,,,,,,,,,,,rfoulger,2012-02-16T05:23:51Z,,,,"A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fc-epsilon receptor signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0038093,,,,GO:0038095,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0038095,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,Fc-epsilon receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258963,SARS coronavirus TW10,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258963,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034502,protein localization to chromosome,protein localisation to chromosome|condensin localization to chromosome,"Any process in which a protein is transported to, or maintained at, a specific location on a chromosome.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"Any process in which a protein is transported to, or maintained at, a specific location on a chromosome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein localisation to chromosome,,,condensin localization to chromosome,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0034502,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034502,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein localization to chromosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_784,chronic kidney disease,chronic renal failure syndrome|CKD|chronic kidney failure|CRF|renal failure - chronic|chronic renal disease,,false,,,http://purl.obolibrary.org/obo/DOID_1074,,,,,,,,,,,,,,,,,,,,EFO:0003884|NCI:C9438|MESH:D007676|ICD9CM:585.6|SNOMEDCT_US_2019_09_01:46177005|ICD10CM:N18.9|UMLS_CUI:C0022661,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chronic renal failure syndrome|CKD|chronic kidney failure|CRF|renal failure - chronic|chronic renal disease,,,,,disease_ontology,,,,,,,,,Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1074,,,,DOID:784,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217650/|https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,DOID:784,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,chronic kidney disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_134504,tenofovir(1-),hydrogen ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate|tenofovir (1-)|tenofovir,A phosphorus oxoanion resulting from the removal of one proton from the phosphonic acid group of tenofovir. The major microspecies at pH 7.3.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:15914676,A phosphorus oxoanion resulting from the removal of one proton from the phosphonic acid group of tenofovir. The major microspecies at pH 7.3.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hydrogen ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate,,,,,chebi_ontology,,tenofovir (1-)|tenofovir,,,,,,,,,-1,C9H13N5O4P,"InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/p-1/t6-/m1/s1",SGOIRFVFHAKUTI-ZCFIWIBFSA-M,286.205,286.07106,N1(C=2C(=C(N)N=CN2)N=C1)C[C@H](OCP(O)(=O)[O-])C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:134504,,,,,,,,,,,,,,,CHEBI:134504,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tenofovir(1-),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006915,apoptotic process,cell suicide|cellular suicide|apoptotic programmed cell death|apoptotic cell death|programmed cell death by apoptosis|activation of apoptosis|apoptosis|type I programmed cell death|apoptosis signaling|apoptotic program|signaling (initiator) caspase activity|induction of apoptosis by p53|induction of apoptosis|apoptosis activator activity|caspase-dependent programmed cell death|commitment to apoptosis,"A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Apoptosis,"A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008632|GO:0006917,cell suicide|cellular suicide,,,apoptotic programmed cell death|apoptotic cell death|programmed cell death by apoptosis,,,activation of apoptosis|apoptosis|type I programmed cell death|apoptosis signaling|apoptotic program,,biological_process,,signaling (initiator) caspase activity|induction of apoptosis by p53|induction of apoptosis|apoptosis activator activity|caspase-dependent programmed cell death|commitment to apoptosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006915,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006915,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,apoptotic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C25269,Symptomatic,Symptomatic|symptomatic,Exhibiting the symptoms of a particular disease.,false,,,http://purl.obolibrary.org/obo/OGMS_0000073,,"Having to do with symptoms, which are signs of a condition or disease.",,,,,,,,,C25269,,,,,,,,,,Exhibiting the symptoms of a particular disease.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Symptomatic|symptomatic,,,,,,,,,,,,,NCIT:C25269,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Symptomatic,Symptomatic,,,,,,,,,,,,,,,,,,Symptomatic,,,https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-glossary-of-terms/,Sign or Symptom,,,,,,,,C0231220,
http://purl.obolibrary.org/obo/NCBITaxon_464095,Picornavirales,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_order,,,,,,,NCBITaxon:464095,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Picornavirales,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039699,viral mRNA cap methylation,IFIT mRNA restriction evasion by virus,"Methylation of the 2'-O-ribose of the first or second transcribed nucleotide of a viral mRNA. Methylation allows evasion of the host innate immune response, which degrades cap0 (non-methylated) mRNAs.",false,,,http://purl.obolibrary.org/obo/GO_0075528|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-11-06T14:39:17Z,,,,"Methylation of the 2'-O-ribose of the first or second transcribed nucleotide of a viral mRNA. Methylation allows evasion of the host innate immune response, which degrades cap0 (non-methylated) mRNAs.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IFIT mRNA restriction evasion by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0075528|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039699,,,,,,true,,,,true,,,,,GO:0039699,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral mRNA cap methylation,,,,,,,,,,,,,,,,,,,,,,https://zhanglab.ccmb.med.umich.edu/COVID-19/,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0005173,abdominal segment element,abdominal segment organ,An organ or element that is part of the adbominal segment of the organism. This region can be further subdivided into the abdominal cavity and the pelvic region.,false,,,http://purl.obolibrary.org/obo/UBERON_0005177,,,,,,,,,,,,,,,,,,,,MA:0000529|EMAPA:37062,An organ or element that is part of the adbominal segment of the organism. This region can be further subdivided into the abdominal cavity and the pelvic region.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,abdominal segment organ,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0005177,,,,UBERON:0005173,,,,,,,,,,,,,,,UBERON:0005173,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,abdominal segment element,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000007,sanglifehrin A,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"sanglifehrin A is a novel immunosuppressive drug. This natural product binds to immunophilins, cyclosporin A (CsA),2 FK506, and rapamycin, have not only revolutionized the field of organ transplantation but also offered useful molecular tools for dissecting intracellular signal transduction pathways involved in T cell activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,Modified Definition,,,,true,,,,,https://pubmed.ncbi.nlm.nih.gov/11313401/,,,,,,,,,,,,,,,,,sanglifehrin A,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0019176,malaise,,Malaise is a neurological and physiological symptom characterized as an indefinite feeling of debility or lack of health often indicative of or accompanying the onset of an illness.,false,,,http://purl.obolibrary.org/obo/SYMP_0000410,,,,,,,,,,,,,,,,,,,,,Malaise is a neurological and physiological symptom characterized as an indefinite feeling of debility or lack of health often indicative of or accompanying the onset of an illness.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000410,,,,SYMP:0019176,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,SYMP:0019176,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,malaise,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072073,kidney epithelium development,,"The process whose specific outcome is the progression of an epithelium in the kidney over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,midori,2010-01-25T04:37:42Z,,,,"The process whose specific outcome is the progression of an epithelium in the kidney over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0072073,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072073,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,kidney epithelium development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019083,viral transcription,,"The process by which a viral genome, or part of a viral genome, is transcribed within the host cell.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"The process by which a viral genome, or part of a viral genome, is transcribed within the host cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019083,,,,,,,true,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226/|https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,GO:0019083,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral transcription,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007435,salivary gland morphogenesis,,The process in which the anatomical structures of the salivary gland are generated and organized.,false,,,http://purl.obolibrary.org/obo/GO_0022612,,,,,,,,,,,,,,,,,,,,,The process in which the anatomical structures of the salivary gland are generated and organized.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0022612,,,,GO:0007435,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007435,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,salivary gland morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_15939,glycyrrhizinic acid,"30-hydroxy-11,30-dioxoolean-12-en-3beta-yl (2-O-beta-D-glucopyranosyluronic acid)-alpha-D-glucopyranosiduronic acid|(3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|glycyrrhizic acid|Glycyrrhizin|Glycyrrhizic acid",A  triterpenoid saponin that is the  glucosiduronide derivative of 3beta-hydroxy-11-oxoolean-12-en-30-oic acid.,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,Beilstein:77922|MetaCyc:GLYCYRRHIZINATE|PMID:11282481|PMID:15013279|Drug_Central:1325|HMDB:HMDB0029843|PMID:24497916|Reaxys:77922|CAS:1405-86-3|KEGG:C02284|LIPID_MAPS_instance:LMPR0106150013|Wikipedia:Glycyrrhizin,A  triterpenoid saponin that is the  glucosiduronide derivative of 3beta-hydroxy-11-oxoolean-12-en-30-oic acid.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:24418|CHEBI:5508,,,,"30-hydroxy-11,30-dioxoolean-12-en-3beta-yl (2-O-beta-D-glucopyranosyluronic acid)-alpha-D-glucopyranosiduronic acid",,,,,chebi_ontology,,"(3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|glycyrrhizic acid|Glycyrrhizin|Glycyrrhizic acid",,,,,,,,,0,C42H62O16,"InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1",LPLVUJXQOOQHMX-QWBHMCJMSA-N,822.93210,822.40379,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:15939,,,,,true,true,,,,,,,,,CHEBI:15939,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,glycyrrhizinic acid,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000025,dry cough,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000614,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000614,,,,SYMP:0000025,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,A dry cough refers to a cough that does not produce mucus (also known as phlegm or sputum).,,,SYMP:0000025,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,dry cough,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_742001,Bat SARS coronavirus HKU3-4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:742001,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_237639,SARS coronavirus Taiwan TC1,SARS coronavirus TC1,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus TC1,,,,,,NCBITaxon:237639,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Taiwan TC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043583,ear development,hearing organ development,"The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hearing organ development,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0043583,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043583,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ear development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_385684,SARS coronavirus CS24,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:385684,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CS24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0080599,Coronavirus infectious disease,,A viral infectious disease that has_material_basis_in Coronavirus.,false,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,,,,,,,,,,A viral infectious disease that has_material_basis_in Coronavirus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934,,,,DOID:0080599,,,,,,,,,,,,,,,DOID:0080599,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,Coronavirus infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000213,ALB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PRO0883|PRO1341|PRO0903,,,,,,,4,,,,,,,,,,Vega:OTTHUMG00000129919|HGNC:399|MIM:103600|Ensembl:ENSG00000163631|HPRD:00062,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,albumin,,4q13.3,,,,"GO_0001895 (EC: IEP); GO_0002576 (EC: TAS); GO_0003677 (EC: IDA, PMID: 16405401); GO_0005504 (EC: IDA, PMID: 16289007); GO_0005504 (EC: NAS, PMID: 9731778); GO_0005507 (EC: NAS, PMID: 14726550); GO_0005515 (EC: IPI, PMID: 16099937); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0005604 (EC: IEA); GO_0005615 (EC: IDA, PMID: 19996109); GO_0006810 (EC: TAS, PMID: 12617161); GO_0007584 (EC: IEA); GO_0007596 (EC: TAS); GO_0008144 (EC: IDA, PMID: 16169013); GO_0008144 (EC: NAS, PMID: 10940303); GO_0008206 (EC: TAS); GO_0008270 (EC: IEA); GO_0009267 (EC: IDA, PMID: 16245148); GO_0010033 (EC: IEA); GO_0015643 (EC: IDA, PMID: 16169013); GO_0015721 (EC: TAS); GO_0016209 (EC: NAS, PMID: 14726550); GO_0019825 (EC: IDA, Qualifier: contributes_to, PMID: 16283771); GO_0019836 (EC: IDA, PMID: 16394536); GO_0019899 (EC: IEA); GO_0030168 (EC: TAS); GO_0030170 (EC: IDA, PMID: 16201370); GO_0031093 (EC: TAS); GO_0042157 (EC: TAS); GO_0043066 (EC: IDA, PMID: 16153637); GO_0043069 (EC: NAS, PMID: 14726550); GO_0043234 (EC: IDA, PMID: 16283771); GO_0043252 (EC: TAS); GO_0044281 (EC: TAS); GO_0046010 (EC: IEA); GO_0046689 (EC: IEA); GO_0051087 (EC: IPI, PMID: 19996109); GO_0051659 (EC: IDA, PMID: 16153637); GO_0055085 (EC: TAS); GO_0070062 (EC: IDA, PMID: 19056867); GO_0070541 (EC: IEA); GO_0072562 (EC: IDA)",PMID: 325004; 571335; 656055; 683332; 955075; 1225573; 1347703; 1390939; 1518850; 1602151; 1630489; 1810199; 1819460; 1859851; 1946412; 2068071; 2104980; 2247440; 2339130; 2374930; 2404284; 2419329; 2437111; 2460858; 2564675; 2727704; 2762316; 2792379; 2898383; 2901102; 2911589; 2914956; 3009475; 3081519; 3087352; 3353369; 3474609; 3479777; 3759977; 3795040; 3828358; 4027254; 4062880; 6171778; 6173750; 6192711; 6275391; 6292049; 6324579; 6457647; 6864486; 6933567; 7297678; 7557095; 7576927; 7578225; 7852505; 7882997; 7895732; 7902134; 8022807; 8048949; 8063017; 8064810; 8132774; 8134387; 8312056; 8347685; 8513793; 8605586; 8889549; 8898021; 9168236; 9183005; 9329347; 9589637; 9618718; 9731778; 10086322; 10388840; 10580404; 10780709; 10811843; 10940303; 11140838; 11145723; 11158855; 11159893; 11168369; 11483580; 11680902; 11689002; 11734007; 11743520; 11743713; 11781148; 11810025; 11847277; 11906609; 11931649; 12007569; 12009306; 12118010; 12477932; 12480711; 12566415; 12601813; 12617161; 12665801; 12732844; 12815038; 12969171; 12970360; 12975309; 13677478; 14520007; 14579113; 14687905; 14718574; 14726550; 14759223; 14983239; 15137089; 15149953; 15174051; 15210122; 15324660; 15353599; 15489334; 15502818; 15604093; 15616580; 15646839; 15716124; 15740590; 15832324; 15837789; 15890566; 15913893; 15942949; 15952740; 15996651; 16037246; 16054887; 16099937; 16153637; 16156788; 16159939; 16169013; 16169070; 16201370; 16213467; 16245148; 16253963; 16283771; 16289007; 16307046; 16324740; 16329499; 16337614; 16344560; 16394536; 16405401; 16413734; 16413740; 16413837; 16454580; 16608438; 16703327; 16705651; 16721655; 16843720; 16892178; 16916777; 16939204; 16979183; 17002873; 17048273; 17048876; 17054386; 17058928; 17064838; 17067818; 17109502; 17184834; 17200780; 17301560; 17347578; 17438360; 17460892; 17467280; 17499233; 17575979; 17587712; 17603933; 17940721; 17987802; 18028874; 18029235; 18054940; 18068661; 18178096; 18192916; 18200582; 18200583; 18256067; 18287254; 18323672; 18337751; 18346470; 18386863; 18459107; 18464274; 18474236; 18513410; 18579803; 18791744; 18958405; 18979581; 19011736; 19056867; 19139584; 19212124; 19298387; 19318029; 19339807; 19375269; 19377253; 19404566; 19450464; 19484197; 19505594; 19520864; 19572666; 19588173; 19601929; 19615354; 19615732; 19664386; 19707690; 19711930; 19733855; 19734142; 19785033; 19883602; 19884191; 19955769; 19996109; 20006594; 20018394; 20018855; 20025859; 20160662; 20171595; 20211614; 20215742; 20306030; 20346571; 20381621; 20471030; 20473970; 20603593; 20692819; 20705604; 20716240; 20818804; 20828817; 20835227; 21139048; 21190025; 21190670; 21193536; 21228463; 21271345; 21326965; 21357544; 21439346; 21456469; 21488149; 21494773; 21521316; 21539799; 21565611; 21635915; 21832049; 21843484; 21890473; 21900206; 21950461; 21997768; 22079093; 22120732; 22209935; 22244477; 22286219; 22306656; 22351593; 22437883; 22440250; 22450170; 22513409; 22549788; 22613267; 22630368; 22642562; 22675238; 22685563; 22718756; 22797925; 22815976; 22832880; 22870899; 22878801; 22905377; 22968245; 22982313; 23099538; 23103397; 23104623; 23176518; 23182422; 23215783; 23285146; 23351092; 23360066; 23398456; 23455922; 23473402; 23531836; 23535732; 23538348; 23592780; 23673386; 23724004; 23732484; 23862649; 23888317; 23958299; 24076337; 24244333; 24627724,,,,,,,,,,,,,,,,,,OGG:3000000213,,,,,,,,,,,,,,,,,,,albumin,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ALB,,,20140408,213,GIG20,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,ALB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_2509511,Sarbecovirus,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694002,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_subgenus,,,,,,,NCBITaxon:2509511,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694002,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Sarbecovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000043,acute brain injury,,,false,,,http://purl.obolibrary.org/obo/HP_0000707,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000707,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,"Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.",Brain Injuries,,,,,,,,,,,,,,,acute brain injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249063,SARS coronavirus GZ-B,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249063,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051304,chromosome separation,rDNA separation|chromatid release,"The cell cycle process in which paired chromosomes are detached from each other. Chromosome separation begins with the release of cohesin complexes from chromosomes; in budding yeast, this includes the cleavage of cohesin complexes along the chromosome arms, followed by the separation of the centromeric regions. Chromosome separation also includes formation of chromatid axes mediated by condensins, and ends with the disentangling of inter-sister catenation catalyzed by topoisomerase II (topo II).",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The cell cycle process in which paired chromosomes are detached from each other. Chromosome separation begins with the release of cohesin complexes from chromosomes; in budding yeast, this includes the cleavage of cohesin complexes along the chromosome arms, followed by the separation of the centromeric regions. Chromosome separation also includes formation of chromatid axes mediated by condensins, and ends with the disentangling of inter-sister catenation catalyzed by topoisomerase II (topo II).",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0034500,,,,,,,rDNA separation,,biological_process,,chromatid release,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0051304,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051304,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,chromosome separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032169,Severe infection,Unusual course of infection,A type of infection that is regarded as a sign of a pathological susceptibility to infection because of unusual severity or intensity of the infection.,false,,,http://purl.obolibrary.org/obo/HP_0032101,,,,,,,,,,,,,,,,peter,,,,,A type of infection that is regarded as a sign of a pathological susceptibility to infection because of unusual severity or intensity of the infection.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Unusual course of infection,,,,,,,,,,,,,HP:0032169,,,,,,,,,,,,,,,,,,2018-12-16T15:11:20Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0032101,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Severe infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010744,positive regulation of macrophage derived foam cell differentiation,,"Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.",false,,,http://purl.obolibrary.org/obo/GO_0010743,,,,,,,,,,,,,,,,,,,,,"Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0010743,,,,GO:0010744,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010744,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of macrophage derived foam cell differentiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012638,Abnormal nervous system physiology,Abnormality of nervous system physiology,A functional anomaly of the nervous system.,false,,,http://purl.obolibrary.org/obo/HP_0000707,,,,,,,,,,,,,,,,peter,2014-01-19T08:02:46Z,,,UMLS:C4022811,A functional anomaly of the nervous system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of nervous system physiology,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000707,,,,HP:0012638,,,,,,,,,,,,,,,HP:0012638,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal nervous system physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045177,apical part of cell,apical region of cell,"The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,apical region of cell,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0045177,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045177,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,apical part of cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002455,humoral immune response mediated by circulating immunoglobulin,humoral immune response mediated by circulating antibody|circulating antibody mediated immune response|circulating immunoglobulin mediated immune response|humoral defence mechanism,An immune response dependent upon secreted immunoglobulin. An example of this process is found in Mus musculus.,false,,,http://purl.obolibrary.org/obo/GO_0016064|http://purl.obolibrary.org/obo/GO_0006959,,,,,,,,,,,,,,,,,,,,,An immune response dependent upon secreted immunoglobulin. An example of this process is found in Mus musculus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,humoral immune response mediated by circulating antibody|circulating antibody mediated immune response|circulating immunoglobulin mediated immune response,,,,,biological_process,,humoral defence mechanism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016064|http://purl.obolibrary.org/obo/GO_0006959,,,,GO:0002455,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002455,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,humoral immune response mediated by circulating immunoglobulin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003002,GZMB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CGL-1|CTSGL1|CTLA1|CSPB|HLP|CGL1|SECT|CCPI|CSP-B,,,,,,,14,,,,,,,,,,MIM:123910|HPRD:00476|Ensembl:ENSG00000100453|HGNC:4709|Vega:OTTHUMG00000029369,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)",,14q11.2,,,,"GO_0001772 (EC: TAS, PMID: 12524539); GO_0004252 (EC: IDA, PMID: 11331782); GO_0004252 (EC: TAS, PMID: 12524539); GO_0005515 (EC: IPI, PMID: 11911826); GO_0005634 (EC: TAS, PMID: 11909973); GO_0005737 (EC: IDA); GO_0005829 (EC: TAS); GO_0006508 (EC: IBA); GO_0006915 (EC: TAS, PMID: 12524539); GO_0007219 (EC: TAS); GO_0008236 (EC: TAS, PMID: 2402757); GO_0008626 (EC: IBA); GO_0019835 (EC: IEA); GO_0030141 (EC: IBA); GO_0043231 (EC: IDA); GO_0097193 (EC: TAS); GO_1900740 (EC: TAS)",PMID: 1067155; 1985927; 2049336; 2193684; 2300587; 2323780; 2332171; 2365998; 2402757; 2788607; 2953813; 3258865; 3261871; 3262682; 3263427; 8156655; 8631895; 8760815; 8770355; 8900201; 8910377; 9233763; 9337844; 9464839; 9586635; 9642276; 9651578; 9694885; 9727491; 9852092; 10228010; 11050075; 11081635; 11085743; 11114298; 11160179; 11209755; 11266473; 11325591; 11331782; 11406587; 11665980; 11802788; 11909973; 11911826; 12009596; 12135665; 12200377; 12218164; 12384430; 12388539; 12477932; 12483306; 12524539; 12645627; 12648450; 12648453; 12721789; 12874291; 12913938; 12919092; 14499262; 14512315; 14635036; 14696402; 14697980; 14739229; 14752093; 14967307; 14996347; 15014070; 15069086; 15238416; 15302935; 15340161; 15489334; 15494398; 15528317; 15569669; 15641052; 15650747; 15673968; 15699075; 15788411; 15818305; 15843372; 15880044; 15911377; 15998831; 16107729; 16166746; 16336214; 16415351; 16524880; 16547231; 16547254; 16611405; 16794249; 16798735; 16908262; 16952444; 17008916; 17015688; 17055354; 17077322; 17116752; 17198275; 17202328; 17224449; 17258890; 17283187; 17437484; 17485116; 17493234; 17568588; 17620340; 17703412; 17785818; 17825804; 17869012; 17976318; 17996944; 18024321; 18029348; 18275349; 18311812; 18317234; 18523274; 18568772; 18580471; 18675462; 18772390; 18785318; 18814951; 18836177; 19079360; 19141320; 19141860; 19145036; 19157637; 19175398; 19258923; 19343046; 19446661; 19458908; 19543056; 19592644; 19759420; 19796544; 19801510; 19956856; 20027633; 20035050; 20038786; 20087581; 20194725; 20371822; 20388708; 20394077; 20410501; 20449762; 20497195; 20503287; 20536562; 20618609; 20633650; 20800603; 20825413; 20959405; 21042704; 21156847; 21203542; 21301799; 21326808; 21349256; 21458778; 21548883; 21709155; 21884199; 21886827; 21919028; 21948366; 21960590; 21964027; 22050094; 22084442; 22089193; 22142046; 22172867; 22194691; 22387007; 22430249; 22438997; 22476618; 22479366; 22547705; 22759804; 23172556; 23228447; 23321919; 23321921; 23326234; 23377437; 23382885; 23407551; 23440692; 23528102; 23555267; 23598339; 23607435; 23892923; 24101526; 24113190; 24114594,,,,,,,,,,,,,,,,,,OGG:3000003002,,,,,,,,,,,,,,,,,,,"granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GZMB,,,20140408,3002,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,GZMB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_29235,hydrogen(.),monohydrogen|hydrogen(.)|H(.),,false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,monohydrogen|hydrogen(.),,,,,chebi_ontology,,H(.),,,,,,,,,0,H,InChI=1S/H,YZCKVEUIGOORGS-UHFFFAOYSA-N,1.00794,1.00783,[H],,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,CHEBI:29235,,,,,,true,,,,,,,hydrogen,,CHEBI:29235,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,hydrogen(.),,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_22587,antiviral agent,antivirals|anti-viral agents|antiviral agents|antiviral|anti-viral agent,A substance that destroys or inhibits replication of viruses.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,A substance that destroys or inhibits replication of viruses.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,antivirals|anti-viral agents|antiviral agents|antiviral|anti-viral agent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:22587,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32293834,,,,CHEBI:22587,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,antiviral agent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C155835,Oropharyngeal Swab Specimen,Throat Swab|Oropharyngeal Swab Specimen|THRT|Oropharyngeal Swab,A biospecimen collected from the oropharynx by swabbing.,false,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,C155835,,,,,,,,,,A biospecimen collected from the oropharynx by swabbing.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Throat Swab|Oropharyngeal Swab Specimen|THRT|Oropharyngeal Swab,,,,,,,,,,,,,NCIT:C155835,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Oropharyngeal Swab Specimen,,,,,,,,,,,,,,,,,,,Oropharyngeal Swab Specimen,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144858/,Body Substance,,,,,,,,C0439056,
https://bio.scai.fraunhofer.de/ontology/COVID_0000009,interstitial edema,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142773,Edema caused by the accumulation of fluid in the extracellular spaces of a tissue.,"edema, interstitial",,,,,,,,,,,,,,,interstitial edema,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0014065,phosphatidylinositol 3-kinase signaling,phosphoinositide 3-kinase cascade|PI3K cascade|phosphatidylinositol 3-kinase signal transduction|PI 3-kinase cascade|PI3K signaling|PI3K signal transduction|phosphatidylinositol 3-kinase cascade,"A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,,"A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phosphoinositide 3-kinase cascade|PI3K cascade|phosphatidylinositol 3-kinase signal transduction|PI 3-kinase cascade|PI3K signaling|PI3K signal transduction,,,,,biological_process,,phosphatidylinositol 3-kinase cascade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0014065,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0014065,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,phosphatidylinositol 3-kinase signaling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0050013,carbohydrate metabolism disease,,An acquired metabolic disease that is characterized by abnormal carbohydrate metabolism.,false,,,http://purl.obolibrary.org/obo/DOID_0060158,,,,,,,,,,,,,,,,,,,,,An acquired metabolic disease that is characterized by abnormal carbohydrate metabolism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0060158,,,,DOID:0050013,,,,,,,,,,,,,,,DOID:0050013,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim,,,,,,,,,,carbohydrate metabolism disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_28674,tetryzoline,"Tetryzoline|2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole|Tetrahydrozoline|2-Tetralin-1-yl-4,5-dihydro-1H-imidazole|tetryzolinum|tetryzoline|2-(1,2,3,4-Tetrahydro-1-naphthyl)-2-imidazoline|teetryzoline|4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazole|tetryzolina",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LINCS:LSM-1430|Wikipedia:Tetrahydrozoline|Beilstein:11442|Drug_Central:3591|CAS:84-22-0|KEGG:D08578|KEGG:C07912,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:26927|CHEBI:9491,,,,"Tetryzoline|2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole",,,,,chebi_ontology,,"Tetrahydrozoline|2-Tetralin-1-yl-4,5-dihydro-1H-imidazole|tetryzolinum|tetryzoline|2-(1,2,3,4-Tetrahydro-1-naphthyl)-2-imidazoline|teetryzoline|4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazole|tetryzolina",,,,,,,,,0,C13H16N2,"InChI=1S/C13H16N2/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13/h1-2,4,6,12H,3,5,7-9H2,(H,14,15)",BYJAVTDNIXVSPW-UHFFFAOYSA-N,200.27962,200.13135,C1CC(C2=NCCN2)c2ccccc2C1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:28674,,,,,true,true,,,,,,,,,CHEBI:28674,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tetryzoline,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039656,modulation by virus of host gene expression,regulation by virus of host gene expression,The process in which a virus effects a change in gene expression in its host organism. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-06-20T15:28:26Z,,,,The process in which a virus effects a change in gene expression in its host organism. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,regulation by virus of host gene expression,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039656,,,,,,true,,,,true,,,,,GO:0039656,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host gene expression,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.04.20.048066v4,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035579,specific granule membrane,secondary granule membrane,"The lipid bilayer surrounding a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.",false,,,http://purl.obolibrary.org/obo/GO_0030667,,,,,,,,,,,,,,,,rfoulger,2010-10-05T01:32:47Z,,,,"The lipid bilayer surrounding a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,secondary granule membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030667,,,,GO:0035579,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035579,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,specific granule membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002219,FCN1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,FCNM,,,,,,,9,,,,,,,,,,HGNC:3623|MIM:601252|HPRD:03153|Ensembl:ENSG00000085265|Vega:OTTHUMG00000020895,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,ficolin (collagen/fibrinogen domain containing) 1,,9q34,,,,"GO_0001867 (EC: TAS); GO_0003823 (EC: TAS, PMID: 8576206); GO_0005509 (EC: TAS, PMID: 8576206); GO_0005515 (EC: IPI, PMID: 17581635); GO_0005576 (EC: TAS); GO_0005581 (EC: IEA); GO_0006956 (EC: TAS); GO_0008228 (EC: TAS, PMID: 8576206); GO_0030246 (EC: TAS, PMID: 8576206); GO_0045087 (EC: TAS)",PMID: 7686157; 8573080; 8576206; 8884275; 8947836; 9202708; 9777405; 10679061; 12477932; 12624729; 15117939; 15340161; 15489334; 16305643; 17148457; 17581635; 17928056; 17938215; 18029348; 18032536; 18343499; 19539995; 19741154; 19853918; 20032467; 20237496; 20375634; 20400674; 21037097; 21112665; 21490156; 21689722; 21974696; 22236007; 22391637; 22673311; 22941510; 23182717; 23184524; 23209787; 23817411; 24022747; 24161415,,,,,,,,,,,,,,,,,,OGG:3000002219,,,,,,,,,,,,,,,,,,,ficolin (collagen/fibrinogen domain containing) 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FCN1,,,20140408,2219,RP11-447M12.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,FCN1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_17224,4-methylumbelliferone,7-hydroxy-4-methyl-2H-chromen-2-one|4-Methylumbelliferone|4-methylumbelliferone|Hymecromone|himecromona|4-MU|7-Hydroxy-4-methyl-2-oxo-2H-1-benzopyran|7-Hydroxy-4-methyl-2-oxo-3-chromene|Imecromone|7-Hydroxy-4-methylcoumarin|hymecromonum|7-Hydroxy-4-methyl-2H-1-benzopyran-2-one|hymecromone|beta-Methylumbelliferone|4-Methyl-7-hydroxycoumarin,A hydroxycoumarin that is umbelliferone substituted by a methyl group at position 4.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:90-33-5|PMID:17470403|KEGG:D00170|PMID:23228386|PDBeChem:4MU|PMID:26548718|MetaCyc:CPD-182|Drug_Central:1401|Beilstein:142217|LINCS:LSM-3025|Wikipedia:Hymecromone|HMDB:HMDB0059622|PMID:12419303|PMID:24080584|Gmelin:165817|Reaxys:142217|PMID:23124556|PMID:1650428|KEGG:C03081|PMID:20332231,A hydroxycoumarin that is umbelliferone substituted by a methyl group at position 4.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:110550|CHEBI:20452|CHEBI:12030|CHEBI:1903,,,,7-hydroxy-4-methyl-2H-chromen-2-one|4-Methylumbelliferone|4-methylumbelliferone,,,,,chebi_ontology,,Hymecromone|himecromona|4-MU|7-Hydroxy-4-methyl-2-oxo-2H-1-benzopyran|7-Hydroxy-4-methyl-2-oxo-3-chromene|Imecromone|7-Hydroxy-4-methylcoumarin|hymecromonum|7-Hydroxy-4-methyl-2H-1-benzopyran-2-one|hymecromone|beta-Methylumbelliferone|4-Methyl-7-hydroxycoumarin,,,,,,,,,0,C10H8O3,"InChI=1S/C10H8O3/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5,11H,1H3",HSHNITRMYYLLCV-UHFFFAOYSA-N,176.16870|176.169,176.04734,C1=2OC(=O)C=C(C1=CC=C(C2)O)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:17224,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32205856,,,,CHEBI:17224,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,4-methylumbelliferone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267392,SARS coronavirus SinP3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267392,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SinP3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_285946,SARS coronavirus civet010,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:285946,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus civet010,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039657,suppression by virus of host gene expression,host gene expression shutoff by virus,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of gene expression in the host organism. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.",false,,,http://purl.obolibrary.org/obo/GO_0039656,,,,,,,,,,,,,,,,rfoulger,2013-06-20T15:29:55Z,,,VZ:1582,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of gene expression in the host organism. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,host gene expression shutoff by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039656,,,,GO:0039657,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/19079579,,,,GO:0039657,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host gene expression,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_23888,drug,drugs|medicine,"Any substance which when absorbed into a living organism may modify one or more of its functions. The term is generally accepted for a substance taken for a therapeutic purpose, but is also commonly used for abused substances.",false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,,"Any substance which when absorbed into a living organism may modify one or more of its functions. The term is generally accepted for a substance taken for a therapeutic purpose, but is also commonly used for abused substances.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,drugs|medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,CHEBI:23888,,,,,,,,,,,,,,,CHEBI:23888,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,drug,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061765,modulation by virus of host NIK/NF-kappaB signaling,,"Any process in which a virus effect a change in the frequency, rate or extent of NIK/NF-kappaB signaling in the host.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,dph,2016-04-19T10:41:22Z,,,,"Any process in which a virus effect a change in the frequency, rate or extent of NIK/NF-kappaB signaling in the host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0061765,,,,,,true,,,,true,,,,,GO:0061765,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host NIK/NF-kappaB signaling,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_8622,measles,morbilli,"A viral infectious disease that results_in infection located_in skin, has_material_basis_in Measles virus, which is transmitted_by contact with oronasal secretions, or semen of an infected person. The infection has_symptom fever, has_symptom cough, has_symptom coryza, has_symptom conjunctivitis, and has_symptom maculopapular, erythematous rash.",false,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:14189004|ICD10CM:B05|NCI:C96406|GARD:3434|ICD9CM:055|MESH:D008457|UMLS_CUI:C0025007,"A viral infectious disease that results_in infection located_in skin, has_material_basis_in Measles virus, which is transmitted_by contact with oronasal secretions, or semen of an infected person. The infection has_symptom fever, has_symptom cough, has_symptom coryza, has_symptom conjunctivitis, and has_symptom maculopapular, erythematous rash.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:9112|DOID:8963|DOID:8621,,,,morbilli,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934,,,,DOID:8622,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,DOID:8622,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,measles,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003669,ISG20,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HEM45|CD25,,,,,,,15,,,,,,,,,,HPRD:05169|HGNC:6130|MIM:604533,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interferon stimulated exonuclease gene 20kDa,,15q26,,,,"GO_0000175 (EC: IDA, PMID: 11401564); GO_0000738 (EC: IDA, PMID: 11401564); GO_0004527 (EC: IMP); GO_0005634 (EC: IDA); GO_0005654 (EC: TAS); GO_0005730 (EC: IDA, PMID: 16514659); GO_0005737 (EC: IDA, PMID: 16514659); GO_0006364 (EC: IEA); GO_0006401 (EC: IDA, PMID: 11401564); GO_0008283 (EC: TAS, PMID: 9569007); GO_0008310 (EC: IDA, PMID: 11401564); GO_0008859 (EC: IEA); GO_0009615 (EC: IDA, PMID: 12594219); GO_0015030 (EC: IDA, PMID: 16514659); GO_0016605 (EC: IDA, PMID: 9235947); GO_0019221 (EC: TAS); GO_0030619 (EC: IDA, PMID: 16514659); GO_0030620 (EC: IDA, PMID: 16514659); GO_0034511 (EC: IDA, PMID: 16514659); GO_0045071 (EC: IMP); GO_0046872 (EC: IEA); GO_0051607 (EC: IMP); GO_0060337 (EC: TAS); GO_0090503 (EC: IDA, PMID: 11401564)",PMID: 9235947; 9569007; 9605874; 11401564; 12477932; 12539042; 12594219; 14702039; 15489334; 15527770; 16514659; 18278447; 21036379; 21732829; 21963094; 22647704; 23251661; 23830076,,,,,,,,,,,,,,,,,,OGG:3000003669,,,,,,,,,,,,,,,,,,,interferon stimulated exonuclease gene 20kDa,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ISG20,,,20140408,3669,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,ISG20,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCIT_C71902,Quarantine,Quarantine,Place into enforced isolation.,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,C71902,,,,,,,,,,Place into enforced isolation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Quarantine,,,,,,,,,,,,,NCIT:C71902,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,,,,Self-Quarantine,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Quarantine,Quarantine,,,,,,,,,,,,,,,,,,Quarantine,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,Activity,,,,,,,,C0034386,
http://purl.obolibrary.org/obo/NCBITaxon_347536,Bat SARS CoV Rm1/2004,Bat SARS-CoV/Rm1/2004|Bat SARS coronavirus Rm1,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat SARS-CoV/Rm1/2004|Bat SARS coronavirus Rm1,,,,,,NCBITaxon:347536,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS CoV Rm1/2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C51946,Erythrocyte Count,Red Blood Cell Count|Erythrocytes|Erythrocyte Count|Red Blood Cells|Red Cell Count|RBC,The determination of the number of erythrocytes in a blood sample.,false,,,http://purl.obolibrary.org/obo/CMO_0000036,,A measurement of the total erythrocytes in a biological specimen.,,,,,,,,,C51946,,,CDISC,,,,,,,The determination of the number of erythrocytes in a blood sample.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Red Blood Cell Count|Erythrocytes|Erythrocyte Count|Red Blood Cells|Red Cell Count|RBC,,,,,,,,,,,,,NCIT:C51946,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000036,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67154|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C65047,,,,,,,,,,Erythrocyte Count,Erythrocyte_Count,,,,,,,,,,,,,,,,,,Erythrocyte Count,,,,Laboratory Procedure,,,,,,,,C0014772,
http://purl.obolibrary.org/obo/GO_0019046,release from viral latency,,The process by which a virus begins to replicate following a latency replication decision (switch).,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,The process by which a virus begins to replicate following a latency replication decision (switch).,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0075717,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019046,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32275181,,,,GO:0019046,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,release from viral latency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000022,SARS-CoV-1 model,,,false,,,http://purl.obolibrary.org/obo/NCIT_C71164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C71164,,,,,Modified definition,,,Animal testing,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/17499378,Animal models manifesting  SARS-CoV infections.,,,,,,,,,,,,,,,,SARS-CoV-1 model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039612,modulation by virus of host protein phosphorylation,,"Any viral process that modulates the frequency, rate or extent of phosphorylation of viral or host proteins in a host.",false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2012-07-06T11:13:59Z,,,,"Any viral process that modulates the frequency, rate or extent of phosphorylation of viral or host proteins in a host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039612,,,,,,true,,,,true,,,,,GO:0039612,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host protein phosphorylation,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046034,ATP metabolic process,ATP metabolism,"The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ATP metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0046034,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046034,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ATP metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003111,Abnormal blood ion concentration,Abnormality of ion homeostasis|Electrolyte disorders,Abnormality of the homeostasis (concentration) of a monoatomic ion.,false,,,http://purl.obolibrary.org/obo/HP_0032180,,,,,,,,,,,,,,,,,,,,UMLS:C1704431|UMLS:C4025654|SNOMEDCT_US:237840007,Abnormality of the homeostasis (concentration) of a monoatomic ion.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0003253,,,,Abnormality of ion homeostasis|Electrolyte disorders,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0032180,,,,HP:0003111,,,,,,,,,,,,,,,HP:0003111,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal blood ion concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035932,aldosterone secretion,,"The regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,rfoulger,2011-07-20T01:06:24Z,,,,"The regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0035932,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215613,,,,GO:0035932,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,aldosterone secretion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0016552,phlegm,,mucus produced in the respiratory tract.,false,,,http://purl.obolibrary.org/obo/UBERON_0000912,,,,,,,,,,,,,,,,,,,,NCIT:C93171|http://linkedlifedata.com/resource/umls/id/C0225378,mucus produced in the respiratory tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000912,,,,UBERON:0016552,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32173576,,,,UBERON:0016552,,http://purl.obolibrary.org/obo/uberon.owl,,,,,,,,,,,phlegm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039557,suppression by virus of host IRF7 activity,suppression by virus of host interferon regulatory factor 7 activity|inhibition of host IRF7 by virus|inhibition of host interferon regulatory factor-7 by virus,"Any process in which a virus stops, prevents, or reduces the activity of host IRF7 (interferon regulatory factor-7), a transcription factor in the RIG-I/MDA-5 signaling pathway. Viral infection triggers phosphorylation of cytoplasmic IRF7, which allows IRF7 to form a homodimer, migrate to the nucleus, and activate transcription of IFN-alpha and IFN-beta genes.|This term is for annotation of viral proteins that counteract the host anti-viral innate immune response.",false,,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2012-03-09T04:17:46Z,,,VZ:653,"Any process in which a virus stops, prevents, or reduces the activity of host IRF7 (interferon regulatory factor-7), a transcription factor in the RIG-I/MDA-5 signaling pathway. Viral infection triggers phosphorylation of cytoplasmic IRF7, which allows IRF7 to form a homodimer, migrate to the nucleus, and activate transcription of IFN-alpha and IFN-beta genes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,suppression by virus of host interferon regulatory factor 7 activity|inhibition of host IRF7 by virus|inhibition of host interferon regulatory factor-7 by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This term is for annotation of viral proteins that counteract the host anti-viral innate immune response.,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039557,,,,,,true,,,,true,,,,,GO:0039557,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host IRF7 activity,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0206/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_77596,Ranitidine bismuth citrate,,"Complex of ranitidine, trivalent bismuth, and citrate. CAS#128345-62-0.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,"Complex of ranitidine, trivalent bismuth, and citrate. CAS#128345-62-0.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:77596,,,,,,true,,,,,,,,,CHEBI:77596,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Ranitidine bismuth citrate,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000153,cytoplasmic ubiquitin ligase complex,,A ubiquitin ligase complex found in the cytoplasm.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,A ubiquitin ligase complex found in the cytoplasm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0000153,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000153,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytoplasmic ubiquitin ligase complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031983,vesicle lumen,,The volume enclosed by the membrane or protein that forms a vesicle.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao797538226,The volume enclosed by the membrane or protein that forms a vesicle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0031983,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031983,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,vesicle lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072599,establishment of protein localization to endoplasmic reticulum,establishment of protein localization to ER|establishment of protein localization in endoplasmic reticulum|establishment of protein localisation to ER|establishment of protein localisation to endoplasmic reticulum,The directed movement of a protein to a specific location in the endoplasmic reticulum.,false,,,http://purl.obolibrary.org/obo/GO_0070972,,,,,,,,,,,,,,,,midori,2011-02-14T02:23:41Z,,,,The directed movement of a protein to a specific location in the endoplasmic reticulum.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,establishment of protein localization to ER|establishment of protein localization in endoplasmic reticulum|establishment of protein localisation to ER|establishment of protein localisation to endoplasmic reticulum,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0070972,,,,GO:0072599,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072599,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,establishment of protein localization to endoplasmic reticulum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016064,immunoglobulin mediated immune response,antibody-mediated immune response,"An immune response mediated by immunoglobulins, whether cell-bound or in solution.",false,,,http://purl.obolibrary.org/obo/GO_0019724,,,,,,,,,,,,,,,,,,,,,"An immune response mediated by immunoglobulins, whether cell-bound or in solution.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,antibody-mediated immune response,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019724,,,,GO:0016064,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016064,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,immunoglobulin mediated immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2945,severe acute respiratory syndrome,SARS-CoV infection|SARS,"A Coronavirus infection that results_in infection located_in respiratory tract, has_material_basis_in SARS coronavirus (SARS-CoV), which is transmitted_by droplet spread of respiratory secretions, transmitted_by ingestion of contaminated food, or transmitted_by fomites. The infection has_symptom fever, has_symptom headache, has_symptom body aches, has_symptom dry cough, and has_symptom hypoxia.",false,,,http://purl.obolibrary.org/obo/DOID_0080599,,,,,,,,,,,,,,,,,,,,ICD9CM:079.82|SNOMEDCT_US_2019_09_01:398447004|UMLS_CUI:C1175175|GARD:9237|NCI:C85064|ICD10CM:J12.81|MESH:D045169,"A Coronavirus infection that results_in infection located_in respiratory tract, has_material_basis_in SARS coronavirus (SARS-CoV), which is transmitted_by droplet spread of respiratory secretions, transmitted_by ingestion of contaminated food, or transmitted_by fomites. The infection has_symptom fever, has_symptom headache, has_symptom body aches, has_symptom dry cough, and has_symptom hypoxia.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SARS-CoV infection|SARS,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0080599,,,,DOID:2945,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32125455,,,,DOID:2945,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#zoonotic_infectious_disease|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,severe acute respiratory syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0011216,organ system subdivision,,A subdivision of an anatomical system.,false,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,,,,,,,,,,,,,,,,,FBbt:00007330|FMA:67509|http://www.snomedbrowser.com/Codes/Details/91690000,A subdivision of an anatomical system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,UBERON:0011216,,,,,,,,,,,,,,,UBERON:0011216,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,organ system subdivision,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031570,DNA integrity checkpoint,,"A cell cycle process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and progresses through signal transduction and ends with cell cycle effector processes.",false,,,http://purl.obolibrary.org/obo/GO_0000075,,,,,,,,,,,,,,,,,,,,,"A cell cycle process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and progresses through signal transduction and ends with cell cycle effector processes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000075,,,,GO:0031570,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031570,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,DNA integrity checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_385686,SARS coronavirus ES260,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:385686,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ES260,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006280,S100A9,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MAC387|CAGB|CFAG|CGLB|MIF|LIAG|60B8AG|MRP14|NIF|P14|L1AG,,,,,,,1,,,,,,,,,,Vega:OTTHUMG00000013125|HGNC:10499|MIM:123886|HPRD:00472|Ensembl:ENSG00000163220,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,S100 calcium binding protein A9,,1q21,,,,"GO_0001816 (EC: TAS); GO_0002523 (EC: IDA, PMID: 12626582); GO_0002544 (EC: IEA); GO_0004871 (EC: TAS, PMID: 3313057); GO_0005509 (EC: TAS); GO_0005515 (EC: IPI, PMID: 17620599); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005829 (EC: TAS); GO_0005856 (EC: TAS); GO_0005886 (EC: TAS); GO_0006914 (EC: IDA, PMID: 19935772); GO_0006919 (EC: IDA, PMID: 19935772); GO_0006954 (EC: TAS, PMID: 3313057); GO_0007165 (EC: TAS, PMID: 3313057); GO_0007267 (EC: TAS, PMID: 3313057); GO_0008017 (EC: TAS); GO_0008270 (EC: TAS); GO_0010043 (EC: IEA); GO_0016209 (EC: IEA); GO_0030307 (EC: TAS); GO_0030593 (EC: IDA, PMID: 12626582); GO_0031532 (EC: IEA); GO_0032119 (EC: TAS); GO_0032496 (EC: IEA); GO_0032602 (EC: TAS); GO_0035662 (EC: TAS); GO_0042742 (EC: TAS); GO_0045087 (EC: IEA); GO_0045113 (EC: IEA); GO_0045471 (EC: IEA); GO_0050544 (EC: TAS); GO_0050729 (EC: IDA, PMID: 12626582); GO_0050786 (EC: TAS); GO_0050832 (EC: TAS); GO_0051092 (EC: TAS); GO_0051493 (EC: TAS); GO_0070062 (EC: IDA, PMID: 19056867); GO_0070488 (EC: IDA, PMID: 12626582); GO_2001244 (EC: IDA, PMID: 19935772)",PMID: 1286667; 1562590; 2149559; 2478889; 2656677; 3313057; 3405210; 7759097; 8341667; 8400238; 8423249; 8701470; 9570563; 9867828; 9920411; 10464253; 10551823; 10612291; 10837826; 11058579; 11564187; 11708798; 11803621; 11851337; 11867565; 12137245; 12167632; 12218151; 12477932; 12489193; 12553726; 12626582; 12645005; 12704215; 12710851; 12719414; 12748056; 12748257; 12833525; 12937135; 13130482; 14654085; 15040889; 15069705; 15075348; 15277376; 15489334; 15598812; 15642721; 15740587; 15905572; 16033829; 16196087; 16216873; 16253391; 16297907; 16573830; 16613612; 16682612; 16690079; 16710414; 16799092; 16806487; 16979015; 17050004; 17090475; 17095618; 17110338; 17126494; 17187679; 17222807; 17237603; 17328050; 17353931; 17429438; 17620599; 17636430; 17787039; 17803295; 17852869; 17895549; 17936757; 18029348; 18030206; 18044712; 18060880; 18339893; 18537548; 18588753; 18689872; 18784990; 18786929; 18803290; 18922970; 18927283; 19056867; 19059406; 19079333; 19087201; 19122197; 19142861; 19156129; 19165585; 19186948; 19201880; 19203362; 19232095; 19248102; 19284577; 19380743; 19440546; 19534726; 19601998; 19608587; 19670424; 19752232; 19755614; 19762566; 19823685; 19935772; 19957061; 20098622; 20103766; 20130364; 20219570; 20226301; 20231196; 20237496; 20422274; 20550547; 20555353; 20594128; 20812987; 20819668; 20936779; 21067798; 21139048; 21145461; 21192933; 21228116; 21239714; 21325622; 21334078; 21369941; 21376380; 21380506; 21472666; 21492422; 21592353; 21738950; 21766173; 21782178; 21791097; 21799753; 21839816; 21912088; 22029973; 22074005; 22093455; 22127564; 22145905; 22209981; 22230807; 22253789; 22282267; 22304731; 22318783; 22363402; 22446997; 22457725; 22505354; 22555971; 22583932; 22622474; 22634002; 22660800; 22683330; 22691358; 22699162; 22804476; 22822112; 22838504; 22864818; 22939629; 22962574; 23018243; 23029420; 23135911; 23165982; 23207880; 23223301; 23248262; 23299480; 23320892; 23340902; 23349634; 23354417; 23378728; 23423260; 23426492; 23431180; 23455922; 23456298; 23483999; 23563247; 23626736; 23637971; 23664529; 23667563; 23806524; 23850136; 23868055; 23874958; 23883959; 23907944; 23915068; 23942785; 23954397; 24054362; 24122301; 24202303,,,,,,,,,,,,,,,,,,OGG:3000006280,,,,,,,,,,,,,,,,,,,S100 calcium binding protein A9,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,S100A9,,,20140408,6280,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,S100A9,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000002805,GOT1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,GIG18|cAspAT|ASTQTL1|cCAT,,,,,,,10,,,,,,,,,,Vega:OTTHUMG00000018882|HPRD:00687|HGNC:4432|Ensembl:ENSG00000120053|MIM:138180,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"glutamic-oxaloacetic transaminase 1, soluble",,10q24.1-q25.1,,,,"GO_0000096 (EC: TAS); GO_0004069 (EC: IDA, PMID: 2182221); GO_0004069 (EC: ISS); GO_0004069 (EC: TAS); GO_0004609 (EC: IEA); GO_0005737 (EC: IDA, PMID: 7060339); GO_0005764 (EC: IEA); GO_0005829 (EC: TAS); GO_0005975 (EC: TAS); GO_0006006 (EC: TAS); GO_0006094 (EC: TAS); GO_0006103 (EC: ISS); GO_0006107 (EC: IEA); GO_0006114 (EC: ISS); GO_0006531 (EC: ISS); GO_0006532 (EC: IEA); GO_0006533 (EC: IDA, PMID: 2241899); GO_0006536 (EC: ISS); GO_0006595 (EC: TAS); GO_0008483 (EC: TAS); GO_0008652 (EC: TAS); GO_0019509 (EC: TAS); GO_0019550 (EC: IEA); GO_0019551 (EC: IEA); GO_0030170 (EC: IEA); GO_0031406 (EC: IEA); GO_0032869 (EC: IEP, PMID: 8396422); GO_0034641 (EC: TAS); GO_0043679 (EC: IEA); GO_0044281 (EC: TAS); GO_0047801 (EC: ISS); GO_0051384 (EC: IEP, PMID: 8396422); GO_0055089 (EC: IEA); GO_0070062 (EC: IDA, PMID: 19056867); GO_0080130 (EC: IEA)",PMID: 225064; 1974457; 2182221; 2225456; 2241899; 2731362; 2777255; 3207426; 6391741; 6397370; 7060339; 8349677; 8396422; 8619474; 9110174; 10360399; 12477932; 12480555; 15164054; 15306699; 15489334; 16169070; 16344560; 16681433; 17623298; 17877759; 17907318; 18242760; 18752324; 19012630; 19056867; 19370784; 19393479; 20029029; 20201926; 20205615; 20499337; 20972737; 21139048; 21750724; 21900944; 21906983; 21963094; 21988832; 22132177; 22242166; 22352690; 22412388; 22863883; 23667618; 24124411,,,,,,,,,,,,,,,,,,OGG:3000002805,,,,,,,,,,,,,,,,,,,"glutamic-oxaloacetic transaminase 1, soluble",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GOT1,,,20140408,2805,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://doi.org/10.1101/2020.02.06.20020974/,,,,GOT1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0044391,ribosomal subunit,,Either of the two subunits of a ribosome: the ribosomal large subunit or the ribosomal small subunit.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,janelomax,2011-12-15T04:47:59Z,,,,Either of the two subunits of a ribosome: the ribosomal large subunit or the ribosomal small subunit.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0044391,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044391,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribosomal subunit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043312,neutrophil degranulation,neutrophil granule exocytosis|heterophil degranulation,"The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.",false,,,http://purl.obolibrary.org/obo/GO_0002283,,,,,,,,,,,,,,,,,,,,,"The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,neutrophil granule exocytosis,,,,,biological_process,,heterophil degranulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002283,,,,GO:0043312,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043312,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neutrophil degranulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C20401,Monoclonal Antibody,Monoclonal Antibody|MoAB|MAb|Monoclonal Antibody Therapy|monoclonal antibody|Monoclonal Antibodies,"An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.",false,,,http://purl.obolibrary.org/obo/PR_000000001,,"A type of protein made in the laboratory that can bind to substances in the body, including tumor cells. There are many kinds of monoclonal antibodies. Each monoclonal antibody is made to find one substance. Monoclonal antibodies are being used to treat some types of cancer and are being studied in the treatment of other types. They can be used alone or to carry drugs, toxins, or radioactive materials directly to a tumor.",,,,,,,,,C20401,,,CTRP,,,,,,,"An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.",,,,,,Monoclonal Antibody,,,,,,,,,,,,,,,,,,,,,,,,,Monoclonal Antibody|MoAB|MAb|Monoclonal Antibody Therapy|monoclonal antibody|Monoclonal Antibodies,,,,,,,,,,,,,NCIT:C20401,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32134278,,passive antibody therapy|monoclonal antibodies,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978,,,,,,,,,,Monoclonal Antibody,Monoclonal_Antibody,,,,,,,,,,,,,,,,,,Monoclonal Antibody,,,,"Amino Acid, Peptide, or Protein",,,,,,,,C0003250,
http://purl.obolibrary.org/obo/CL_0000791,mature alpha-beta T cell,mature alpha-beta T-lymphocyte|mature alpha-beta T lymphocyte|mature alpha-beta T-cell,A alpha-beta T cell that has a mature phenotype.,false,,,http://purl.obolibrary.org/obo/CL_0000789|http://purl.obolibrary.org/obo/CL_0002419,,,,,,,,,,,,,,,,,,,,,A alpha-beta T cell that has a mature phenotype.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mature alpha-beta T-lymphocyte|mature alpha-beta T lymphocyte|mature alpha-beta T-cell,,,,,cell,,,,,,,,CL:0000791,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000789|http://purl.obolibrary.org/obo/CL_0002419,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,mature alpha-beta T cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC6,ORF6 protein (SARS-CoV-2),ORF6 (SARS2)|accessory protein 6 (SARS2)|protein X3 (SARS2)|PRO_0000449653|ns6 (SARS2)|non-structural protein 6 (SARS2)|ORF6|GU280_gp06,A protein that is a translation product of the ORF6 gene in SARS-CoV-2.|Category=organism-gene. Note: 61 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,GenPept:YP_009724394|UniProtKB:P0DTC6,A protein that is a translation product of the ORF6 gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ORF6 (SARS2)|accessory protein 6 (SARS2)|protein X3 (SARS2)|PRO_0000449653|ns6 (SARS2),,,,,protein,,non-structural protein 6 (SARS2)|ORF6|GU280_gp06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 61 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC6,,,,,,true,,,,,,,,,PR:P0DTC6,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,ORF6 protein (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_12067,Coxsackievirus A9,CVA9|Coxsackie virus A9|Coxsackie A virus type 9|Coxsackie A type 9|Human coxsackievirus A9,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_138949,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CVA9,,,,,,,,ncbi_taxonomy,,Coxsackie virus A9|Coxsackie A virus type 9|Coxsackie A type 9|Human coxsackievirus A9,,,,,,NCBITaxon:12067,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_138949,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Coxsackievirus A9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_28545,valinomycin,"(3R,6R,9S,12S,15R,18R,21S,24S,27R,30R,33S,36S)-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone|Valinomycin|Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)|cyclo[-D-O-Val-D-Val-L-O-Ala-L-Val]3",A twelve-membered cyclodepsipeptide composed of three repeating D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl units joined in sequence. An antibiotic found in several Streptomyces strains.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:7590182|Reaxys:78657|PMID:19347893|PMID:18633285|KEGG:C06684|Wikipedia:Valinomycin|PMID:22683555|CAS:2001-95-8|PMID:10603383|Beilstein:78657,A twelve-membered cyclodepsipeptide composed of three repeating D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl units joined in sequence. An antibiotic found in several Streptomyces strains.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:9924|CHEBI:27269|CHEBI:66347,,,,"(3R,6R,9S,12S,15R,18R,21S,24S,27R,30R,33S,36S)-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone|Valinomycin",,,,,chebi_ontology,,Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)|cyclo[-D-O-Val-D-Val-L-O-Ala-L-Val]3,,,,,,,,,0,C54H90N6O18,"InChI=1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/h22-42H,1-21H3,(H,55,61)(H,56,62)(H,57,63)(H,58,64)(H,59,65)(H,60,66)/t31-,32-,33-,34+,35+,36+,37-,38-,39-,40+,41+,42+/m0/s1",FCFNRCROJUBPLU-DNDCDFAISA-N,1111.32180,1110.63116,CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC(=O)[C@@H](NC(=O)[C@H](C)OC(=O)[C@H](NC(=O)[C@H](OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:28545,,,,,true,true,,,,,,,,,CHEBI:28545,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,valinomycin,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/IAO_0000007,action specification,,a directive information entity that describes an action the bearer will take,false,,,http://purl.obolibrary.org/obo/IAO_0000033,,,,,,,,,,,,,,,,,,,,,a directive information entity that describes an action the bearer will take,,OBI Plan and Planned Process branch,,,,,,,,,,,Pour the contents of flask 1 into flask 2,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000123,,,,,,,,,,,,,,,,,,,,IAO:0000007,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000033,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl|http://purl.obolibrary.org/obo/iao.owl,,,,,,,,,,,action specification,,,,,,,,,,,,,,,,,,,,,,,,,,,,Alan Ruttenberg,,,,
http://purl.obolibrary.org/obo/OGG_3000003945,LDHB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LDH-B|TRG-5|HEL-S-281|LDH-H|LDHBD,,,,,,,12,,,,,,,,,,HPRD:01026|HGNC:6541|Ensembl:ENSG00000111716|MIM:150100|Vega:OTTHUMG00000133760,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,lactate dehydrogenase B,,12p12.2-p12.1,,,,"GO_0004459 (EC: IEA); GO_0005737 (EC: IDA); GO_0005737 (EC: TAS, PMID: 16130169); GO_0005739 (EC: IEA); GO_0005829 (EC: TAS); GO_0006089 (EC: IEA); GO_0006090 (EC: TAS); GO_0006096 (EC: IEA); GO_0019674 (EC: IEA); GO_0019900 (EC: IEA); GO_0042802 (EC: IEA); GO_0044237 (EC: TAS); GO_0044262 (EC: IEA); GO_0044281 (EC: TAS); GO_0051287 (EC: IEA); GO_0070062 (EC: IDA, PMID: 19056867)",PMID: 1081369; 1371976; 1587525; 2334429; 2930497; 3435492; 7273846; 7821789; 8314553; 8462975; 8611651; 9929983; 10211631; 10508479; 10509905; 11125887; 11276087; 11509017; 11582518; 12160330; 12477932; 12555229; 15489334; 15492215; 15576338; 15592455; 15710247; 16130169; 16196087; 16236267; 17178662; 18457437; 18593994; 18781797; 19056867; 19135240; 19338310; 19596686; 19738201; 19786724; 20000738; 20499337; 20592382; 20639865; 20877624; 20951115; 21044950; 21139048; 21145461; 21199794; 21319273; 21356207; 21853274; 21858537; 21890473; 21906983; 21963094; 21987572; 21988832; 22027740; 22053931; 22248949; 22304920; 22461886; 22505724; 22623428; 22752059; 22807456; 22863883; 22891270; 22892192; 22939629; 22990118; 23000965; 23139210; 23184937; 23202721; 23224736; 23246001; 23266049; 23349634; 23437403; 23516535; 23697991; 24457600,,,,,,,,,,,,,,,,,,OGG:3000003945,,,,,,,,,,,,,,,,,,,lactate dehydrogenase B,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,LDHB,,,20140408,3945,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,LDHB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_285945,Civet SARS CoV 007/2004,SARS coronavirus civet007|Civet SARS-CoV/007/2004,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus civet007|Civet SARS-CoV/007/2004,,,,,,NCBITaxon:285945,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Civet SARS CoV 007/2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039694,viral RNA genome replication,,The replication of a viral RNA genome.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-10-23T15:24:36Z,,,,The replication of a viral RNA genome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039694,,,,,,true,,true,,true,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,GO:0039694,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral RNA genome replication,,,,,,,,,,,,,,,,,,,,,,https://www.antibodies-online.com/resources/18/5410/sars-cov-2-life-cycle-stages-and-inhibition-targets/,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000891,CCNB1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CCNB,,,,,,,5,,,,,,,,,,Ensembl:ENSG00000134057|HPRD:00454|MIM:123836|HGNC:1579|Vega:OTTHUMG00000097817,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,cyclin B1,,5q12,,,,"GO_0000079 (EC: IEA); GO_0000082 (EC: TAS); GO_0000086 (EC: TAS); GO_0000278 (EC: TAS); GO_0000922 (EC: IDA, PMID: 18195732); GO_0000942 (EC: IDA, PMID: 18195732); GO_0001556 (EC: IEA); GO_0001701 (EC: IEA); GO_0001933 (EC: IEA); GO_0005113 (EC: IPI, PMID: 11331587); GO_0005515 (EC: IPI, PMID: 10373560); GO_0005634 (EC: IDA, PMID: 11331587); GO_0005654 (EC: TAS); GO_0005737 (EC: IDA); GO_0005813 (EC: IDA, PMID: 12524548); GO_0005829 (EC: TAS); GO_0006461 (EC: IEA); GO_0006468 (EC: IEA); GO_0007077 (EC: TAS); GO_0007080 (EC: IMP, PMID: 18195732); GO_0007283 (EC: IEA); GO_0009612 (EC: IEA); GO_0010629 (EC: IEA); GO_0016020 (EC: IEA); GO_0016301 (EC: IEA); GO_0019901 (EC: IPI, PMID: 12524548); GO_0031145 (EC: TAS); GO_0031442 (EC: IEA); GO_0033129 (EC: IEA); GO_0042246 (EC: IEA); GO_0042493 (EC: IEA); GO_0043148 (EC: IMP, PMID: 18195732); GO_0045931 (EC: IMP, PMID: 18195732); GO_0046680 (EC: IEA); GO_0048565 (EC: IEA); GO_0051437 (EC: TAS); GO_0051439 (EC: TAS); GO_0051726 (EC: TAS); GO_0051987 (EC: IMP, PMID: 18195732); GO_0055015 (EC: IEA); GO_0060045 (EC: IEA); GO_0060623 (EC: IEA); GO_0071174 (EC: IMP, PMID: 18195732); GO_0071283 (EC: IEA); GO_0071398 (EC: IEA); GO_0071407 (EC: IEA); GO_0071456 (EC: IEA)",PMID: 1384126; 1386342; 1387877; 1717476; 1828290; 1836978; 2570636; 7474080; 7474100; 7494303; 7666531; 7737117; 7769006; 7799941; 7843284; 7876309; 7903056; 8070405; 8101826; 8397206; 8397207; 8402895; 8463339; 8475101; 8524869; 8662825; 8756624; 8889548; 9001210; 9053846; 9094673; 9244350; 9247342; 9315635; 9499405; 9515786; 9520381; 9560267; 9679058; 9813064; 9885575; 9891079; 9926943; 10339564; 10362260; 10373560; 10395539; 10421840; 10581175; 10716937; 10793135; 10799291; 10864927; 10958988; 10973963; 10995390; 11113184; 11238118; 11242082; 11259605; 11260656; 11278247; 11285280; 11310559; 11331587; 11444800; 11531413; 11559705; 11562349; 11572993; 11598127; 11642719; 11691994; 11732576; 11751633; 11779217; 11809526; 11836499; 11878934; 11960377; 12009577; 12054478; 12068134; 12097298; 12115375; 12124778; 12200597; 12379461; 12397081; 12424202; 12447691; 12468530; 12477932; 12483522; 12515609; 12524548; 12586340; 12612082; 12676926; 12684677; 12738867; 12775724; 12791267; 12839990; 12865421; 14645578; 14701726; 14760118; 14993212; 15016823; 15024056; 15181148; 15215233; 15256223; 15265780; 15489334; 15541388; 15623561; 15635413; 15654331; 15710382; 15749827; 15767402; 15790566; 15916961; 15931389; 15989971; 16009132; 16082198; 16109376; 16142332; 16159883; 16221667; 16226712; 16237118; 16273239; 16275333; 16322753; 16407259; 16474839; 16478538; 16479161; 16557593; 16614707; 16751065; 16784539; 16799550; 16880739; 16921029; 17098733; 17167975; 17242184; 17242210; 17274640; 17327911; 17359284; 17359356; 17360335; 17373649; 17386261; 17388661; 17389604; 17408621; 17431037; 17445807; 17466630; 17472438; 17495531; 17495533; 17513602; 17533373; 17586317; 17598982; 17655707; 17668170; 17679094; 17850284; 17881737; 18048386; 18059335; 18195732; 18281511; 18337751; 18353325; 18372919; 18408012; 18414058; 18445273; 18471975; 18491248; 18591933; 18593994; 18652313; 18671143; 18692784; 18799590; 18820706; 19028417; 19134343; 19162005; 19275580; 19275586; 19293801; 19344781; 19369249; 19458171; 19470724; 19475398; 19505905; 19608149; 19609944; 19614764; 19666607; 19724852; 19738611; 19763267; 19786724; 19820702; 19825974; 19826003; 19855194; 19968870; 20080579; 20095356; 20097574; 20103625; 20126263; 20160477; 20169205; 20171170; 20228808; 20334896; 20360007; 20360068; 20367638; 20368335; 20383333; 20404109; 20412769; 20453000; 20508983; 20526282; 20660152; 20661218; 20733051; 20733055; 20808790; 20810654; 20890132; 20927403; 20937773; 20956543; 20965177; 20974803; 21120602; 21139048; 21145461; 21148318; 21174181; 21241890; 21264543; 21276999; 21336306; 21379580; 21488187; 21489275; 21504622; 21525341; 21569376; 21596315; 21871181; 21890473; 21900495; 21900748; 21906983; 21925791; 21952639; 21963094; 21965721; 22014574; 22024040; 22024133; 22071694; 22137483; 22157815; 22158041; 22163316; 22193957; 22253775; 22266860; 22286100; 22391203; 22482362; 22508987; 22529100; 22532137; 22552851; 22580043; 22682366; 22726437; 22905155; 22939629; 22949227; 22965228; 23007861; 23091007; 23114644; 23239745; 23253261; 23383273; 23455922; 23460259; 23505570; 23602568; 23708605; 23775624; 23791783; 23874748; 23979597; 24145166; 24163370; 24248602; 24250222,,,,,,,,,,,,,,,,,,OGG:3000000891,,,,,,,,,,,,,,,,,,,cyclin B1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCNB1,,,20140408,891,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CCNB1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCIT_C126400,Renal Replacement Therapy,Renal Replacement Therapy|RRT,"Treatments that substitute for the blood-filtering function of the kidneys. It includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration. Kidney transplant may also be considered a renal replacement therapy.",false,,,http://purl.obolibrary.org/obo/OGMS_0000112,,,,,,,,,,,C126400,,,,,,,,,,"Treatments that substitute for the blood-filtering function of the kidneys. It includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration. Kidney transplant may also be considered a renal replacement therapy.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Renal Replacement Therapy|RRT,,,,,,,,,,,,,NCIT:C126400,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000112,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32276031,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Renal Replacement Therapy,,,,,,,,,,,,,,,,,,,Renal Replacement Therapy,,,,Therapeutic or Preventive Procedure,,,,,,,,C0206074,
http://purl.obolibrary.org/obo/NCBITaxon_633140,SARS coronavirus MA15 ExoN1,SARS coronavirus strain MA15 ExoN1,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus strain MA15 ExoN1,,,,,,NCBITaxon:633140,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus MA15 ExoN1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_694002,Betacoronavirus,Coronavirus group 2|Coronavirus|Group 2 species,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2501931,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:156439,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,Coronavirus group 2|Coronavirus|Group 2 species,,,,,,NCBITaxon:694002,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2501931,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Betacoronavirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_850,lung disease,,"A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide.|Updating out dated CUI and removing lung abscess as a synonym.",false,,,http://purl.obolibrary.org/obo/DOID_0050161,,,,,,,,,,,,,,,,,,,,NCI:C3198|ICD10CM:J98.4|UMLS_CUI:C0024115|MESH:D008171|SNOMEDCT_US_2019_09_01:19829001,"A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:11894|DOID:29|DOID:766|DOID:11895,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Updating out dated CUI and removing lung abscess as a synonym.,,http://purl.obolibrary.org/obo/DOID_0050161,,,,DOID:850,,,,,,,,,,,,,,,DOID:850,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_32016,pirfenidone,5-methyl-1-phenylpyridin-2(1H)-one|pirfenidona|AMR 69|AMR-69|Esbriet|pirfenidonum|pirfenidone,A pyridone that is 2-pyridone substituted at positions 1 and 5 by phenyl and methyl groups respectively. An anti-inflammatory drug used for the treatment of idiopathic pulmonary fibrosis.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:25604027|Reaxys:1526549|PMID:25678074|PMID:25459156|Wikipedia:Pirfenidone|PMID:25691376|PMID:25596380|PMID:25726556|LINCS:LSM-4190|KEGG:D01583|CAS:53179-13-8|Beilstein:1526549|PMID:25727967|PMID:25738437|PMID:25432946|PMID:25542603|PMID:25593606|PMID:25639750|PMID:25624597|Drug_Central:4224,A pyridone that is 2-pyridone substituted at positions 1 and 5 by phenyl and methyl groups respectively. An anti-inflammatory drug used for the treatment of idiopathic pulmonary fibrosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5-methyl-1-phenylpyridin-2(1H)-one,,,,,chebi_ontology,,pirfenidona|AMR 69|AMR-69|Esbriet|pirfenidonum|pirfenidone,,,,,,,,,0,C12H11NO,"InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3",ISWRGOKTTBVCFA-UHFFFAOYSA-N,185.22180,185.08406,Cc1ccc(=O)n(c1)-c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:32016,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32256547,,,,CHEBI:32016,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,pirfenidone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IAO_0000030,information content entity,,A generically dependent continuant that is about some thing.|An information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity|an information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity,false,,,http://purl.obolibrary.org/obo/BFO_0000031,,,,,,,,,,,,,,,,,,,,,A generically dependent continuant that is about some thing.|An information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity|an information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity,,OBI_0000142|OBI_0000142,,,,,,"information_content_entity 'is_encoded_in' some digital_entity in obi before split (040907). information_content_entity 'is_encoded_in' some physical_document in obi before split (040907).

Previous. An information content entity is a non-realizable information entity that 'is encoded in' some digital or physical entity.|2014-03-10: The use of ""thing"" is intended to be general enough to include universals and configurations (see https://groups.google.com/d/msg/information-ontology/GBxvYZCk1oc/-L6B5fSBBTQJ).",information content entity,,,,"Examples of information content entites include journal articles, data, graphical layouts, and graphs.",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000125|http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,IAO:0000030,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000031,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl|http://purl.obolibrary.org/obo/apollo_sv.owl|http://purl.obolibrary.org/obo/iao.owl,,,,,,,,,,,information content entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Chris Stoeckert|PERSON: Chris Stoeckert,,,,
http://purl.obolibrary.org/obo/GO_0031532,actin cytoskeleton reorganization,actin cytoskeleton reorganisation|actin cytoskeleton remodeling,A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007012,,,,actin cytoskeleton reorganisation|actin cytoskeleton remodeling,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0031532,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031532,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,actin cytoskeleton reorganization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_388737,SARS coronavirus GDH-BJH01,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:388737,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GDH-BJH01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_742000,Bat SARS coronavirus HKU3-13,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:742000,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258964,SARS coronavirus TW11,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258964,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000075,Wuhan,,,false,,,http://purl.obolibrary.org/obo/BFO_0000029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000029,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113704,"A city that lies at the east of Jianghan Plain, and the intersection of the middle reaches of the Yangtze and Han River. Formed from the conglomeration of three boroughs, Wuchang, Hankou, and Hanyang",,,,,,,,,,,,,,,,Wuhan,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/GAZ_00057851,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_178,vascular disease,vascular tissue disease,"A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart.",false,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:27550009|SNOMEDCT_US_2019_09_01:371029002|UMLS_CUI:C0752130|NCI:C35117|MESH:D020758|UMLS_CUI:C0752127|SNOMEDCT_US_2019_09_01:432119003|MESH:D020760|ICD10CM:I72.9|MESH:D000783|MESH:D014652|UMLS_CUI:C0002940|NCI:C26693|UMLS_CUI:C0042373|SNOMEDCT_US_2019_09_01:85659009|ICD9CM:442.9,"A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:0000405|DOID:45|DOID:325|DOID:2403|DOID:2869|DOID:324,,,,vascular tissue disease,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287,,,,DOID:178,,,,,,,,,,,,,,,DOID:178,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,vascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0019163,eye symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000387,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms manisfested on eyes during every possible eye problems.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000387,,,,SYMP:0019163,,modified definition,,,,,,,,,,,,,SYMP:0019163,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,eye symptom,,,,,,,,,,,,,,,,,,,,,,https://www.allaboutvision.com/en-in/vision-by-age/warning-signs/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098798,mitochondrial protein complex,,"A protein complex that is part of a mitochondrion.|Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,A protein complex that is part of a mitochondrion.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.",,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0098798,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098798,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_manually_annotate,,,,,,,,,,mitochondrial protein complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005874,microtubule,microtubulus|microtubuli|neurotubule,"Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Microtubule|NIF_Subcellular:sao1846835077,"Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,microtubulus|microtubuli,,,neurotubule,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005874,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005874,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics,,,,,,,,,,microtubule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000083,physical examination finding,,TODO: Define.,false,,,http://purl.obolibrary.org/obo/OGMS_0000014,,,,,,,,,,,,,,,,,,,creation date: 2009-11-24T04:51:11Z,,TODO: Define.,,http://code.google.com/p/ogms/issues/detail?id=26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000083,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000014,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl|http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,physical examination finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/NCIT_C2096,Lopinavir/Ritonavir,Lopinavir/Ritonavir|lopinavir/ritonavir|Kaletra,"A fixed combination of two protease inhibitors, lopinavir and ritonavir, used to treat human immunodeficiency virus (HIV) infection. The ritonavir in the combination drug increases the concentration and biological half-life of lopinavir but is not present in sufficient concentration to act as a protease inhibitor.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,A combination of the drugs ritonavir and lopinavir. It is used to treat infection with HIV (the virus that causes AIDS). It is also being studied in the treatment of some types of cancer. Lopinavir/ritonavir blocks the ability of HIV to make copies of itself and may help other anticancer drugs work better or may block the growth of cancer cells. Ritonavir blocks the breakdown of lopinavir. Lopinavir/ritonavir is a type of anti-HIV agent and a type of protease inhibitor.,,,,,,,,,C2096,,,,,,,,,,"A fixed combination of two protease inhibitors, lopinavir and ritonavir, used to treat human immunodeficiency virus (HIV) infection. The ritonavir in the combination drug increases the concentration and biological half-life of lopinavir but is not present in sufficient concentration to act as a protease inhibitor.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lopinavir/Ritonavir|lopinavir/ritonavir|Kaletra,,,,,,,,,,,,,NCIT:C2096,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,Lopinavir + ritonavir,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Lopinavir/Ritonavir,Lopinavir_Ritonavir,,,,,,,,,,,,,,,,,,Lopinavir/Ritonavir,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,Pharmacologic Substance,,,,,,,,C0939237,
http://purl.obolibrary.org/obo/OGG_3000003725,JUN,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,AP-1|c-Jun|AP1,,,,,,,1,,,,,,,,,,Ensembl:ENSG00000177606|Vega:OTTHUMG00000008376|MIM:165160|HGNC:6204|HPRD:01302,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,jun proto-oncogene,,1p32-p31,,,,"GO_0000228 (EC: TAS, PMID: 10918580); GO_0000980 (EC: IDA, PMID: 19861239); GO_0001077 (EC: IEA); GO_0001102 (EC: IPI, PMID: 19861239); GO_0001190 (EC: IC, PMID: 19861239); GO_0001525 (EC: IEA); GO_0001774 (EC: IEA); GO_0001836 (EC: IEA); GO_0001889 (EC: IEA); GO_0001938 (EC: IEA); GO_0002224 (EC: TAS); GO_0002755 (EC: TAS); GO_0002756 (EC: TAS); GO_0003151 (EC: IEA); GO_0003677 (EC: TAS, PMID: 2825349); GO_0003690 (EC: IEA); GO_0003700 (EC: IDA, PMID: 9732876); GO_0003705 (EC: IC, PMID: 19861239); GO_0003705 (EC: IDA, PMID: 2833704); GO_0003713 (EC: IDA, PMID: 2833704); GO_0005100 (EC: IDA, PMID: 11804590); GO_0005515 (EC: IPI, PMID: 10327051); GO_0005654 (EC: TAS); GO_0005667 (EC: IEA); GO_0005719 (EC: IDA, PMID: 19861239); GO_0005829 (EC: IEA); GO_0007179 (EC: IDA, PMID: 9732876); GO_0007184 (EC: IDA, PMID: 9732876); GO_0007568 (EC: IEA); GO_0007612 (EC: IEA); GO_0007623 (EC: IEA); GO_0008134 (EC: IPI, PMID: 16007074); GO_0008285 (EC: IEA); GO_0009314 (EC: IEA); GO_0009612 (EC: IEA); GO_0017053 (EC: IEA); GO_0030224 (EC: IEA); GO_0031103 (EC: IEA); GO_0031953 (EC: IEA); GO_0032321 (EC: IDA, PMID: 11804590); GO_0032496 (EC: IEA); GO_0034097 (EC: IEA); GO_0034134 (EC: TAS); GO_0034138 (EC: TAS); GO_0034142 (EC: TAS); GO_0034146 (EC: TAS); GO_0034162 (EC: TAS); GO_0034166 (EC: TAS); GO_0035026 (EC: IEA); GO_0035497 (EC: IDA, PMID: 19861239); GO_0035666 (EC: TAS); GO_0038095 (EC: TAS); GO_0038123 (EC: TAS); GO_0038124 (EC: TAS); GO_0042493 (EC: IEA); GO_0042542 (EC: IEA); GO_0043392 (EC: IDA, PMID: 14645924); GO_0043524 (EC: IEA); GO_0043525 (EC: IEA); GO_0043922 (EC: IDA, PMID: 2833704); GO_0043923 (EC: IDA, PMID: 2833704); GO_0044212 (EC: IDA, PMID: 14645924); GO_0044822 (EC: IDA); GO_0045087 (EC: TAS); GO_0045657 (EC: IEA); GO_0045740 (EC: IEA); GO_0045892 (EC: IDA, PMID: 2833704); GO_0045893 (EC: IDA, PMID: 2833704); GO_0045944 (EC: IC, PMID: 19861239); GO_0045944 (EC: IDA, PMID: 2833704); GO_0048146 (EC: IEA); GO_0048661 (EC: IEA); GO_0051090 (EC: TAS); GO_0051365 (EC: IEA); GO_0051403 (EC: TAS); GO_0051591 (EC: IEA); GO_0051726 (EC: IEA); GO_0051899 (EC: IEA); GO_0060395 (EC: IDA, PMID: 9732876); GO_0070412 (EC: IPI, PMID: 9732876); GO_0071277 (EC: IEA); GO_0071837 (EC: IEA)",PMID: 1310896; 1448082; 1516134; 1631061; 1651323; 1827203; 1922387; 2138276; 2320002; 2825349; 2833704; 3194415; 7623830; 7642615; 7662174; 7666555; 7690421; 7738014; 7816143; 7823959; 7848298; 7957556; 8001819; 8027667; 8087846; 8108109; 8137421; 8224842; 8302594; 8380166; 8387155; 8397339; 8440710; 8464713; 8480425; 8557686; 8570175; 8586671; 8617242; 8621542; 8621941; 8622660; 8628277; 8649793; 8654373; 8662824; 8663380; 8663478; 8733011; 8763994; 8798722; 8816797; 8816798; 8837781; 8846788; 8945519; 8974016; 8985011; 9020136; 9030721; 9129988; 9154808; 9155018; 9160889; 9207092; 9211894; 9223324; 9235954; 9334186; 9346889; 9374537; 9405416; 9443941; 9445037; 9468519; 9488446; 9510247; 9545246; 9566900; 9575168; 9621077; 9628874; 9642216; 9659924; 9670954; 9671405; 9681824; 9685505; 9692890; 9732876; 9774977; 9786917; 9808624; 9837938; 9872330; 9973222; 10026157; 10027715; 10188588; 10196196; 10207054; 10220381; 10327051; 10330159; 10346818; 10357819; 10388555; 10393177; 10419510; 10421840; 10428834; 10478848; 10488148; 10490605; 10490649; 10497212; 10506225; 10509564; 10523647; 10567391; 10567404; 10581001; 10620019; 10637231; 10644332; 10747973; 10766246; 10777532; 10788439; 10799874; 10847592; 10878360; 10903323; 10903862; 10913197; 10918580; 10962563; 10973489; 11022789; 11053448; 11090181; 11108663; 11254713; 11260070; 11274169; 11278277; 11278395; 11278640; 11278891; 11287617; 11306568; 11316804; 11331419; 11331585; 11371641; 11397794; 11431474; 11432833; 11448159; 11477071; 11479302; 11551904; 11641401; 11689449; 11704680; 11708771; 11738026; 11739718; 11801649; 11804590; 11823437; 11867732; 11877416; 11891228; 11891317; 11903046; 11909859; 11912197; 11914583; 11948398; 11956220; 11980644; 11983170; 12034730; 12052834; 12052862; 12077347; 12080089; 12087103; 12089333; 12091339; 12119282; 12145210; 12165517; 12167088; 12183893; 12185592; 12186939; 12228228; 12324474; 12419228; 12419805; 12437352; 12441106; 12446585; 12477932; 12485413; 12547826; 12554755; 12592382; 12600818; 12615916; 12618758; 12628923; 12676957; 12682910; 12692226; 12697749; 12700665; 12775419; 12788955; 12796506; 12798298; 12799614; 12805554; 12815619; 12853483; 12875982; 12909593; 12949493; 12954631; 12963547; 12963725; 12963995; 13130464; 14500675; 14506227; 14511403; 14517282; 14522952; 14530285; 14532268; 14572659; 14612408; 14630807; 14633987; 14638681; 14645224; 14645924; 14652666; 14654548; 14667575; 14675752; 14701799; 14701856; 14739464; 14973137; 15001576; 15034932; 15044437; 15087451; 15158360; 15175153; 15191540; 15226448; 15240010; 15249231; 15258149; 15262961; 15271374; 15276183; 15299005; 15302867; 15302935; 15314183; 15314185; 15319445; 15333603; 15334056; 15351693; 15378002; 15383523; 15385474; 15469925; 15480426; 15489334; 15507668; 15514030; 15528994; 15530430; 15544846; 15546613; 15550679; 15579469; 15586248; 15590691; 15626733; 15642950; 15654976; 15674337; 15677475; 15688015; 15696159; 15701643; 15702969; 15706351; 15708845; 15718494; 15746191; 15749833; 15806162; 15840658; 15863510; 15867431; 15870692; 15894171; 15897893; 15922298; 15923621; 15923644; 15936718; 15941782; 15944151; 15958389; 15991283; 15994313; 15994960; 16001969; 16007074; 16007099; 16023595; 16023596; 16045761; 16049073; 16055710; 16123044; 16140218; 16157600; 16158054; 16166642; 16179804; 16199533; 16223572; 16236267; 16243842; 16253992; 16266514; 16285957; 16289409; 16291755; 16303762; 16328781; 16341687; 16343055; 16361535; 16380075; 16410250; 16434970; 16478997; 16511568; 16533805; 16549498; 16569633; 16569638; 16571680; 16582099; 16586042; 16611996; 16620772; 16676006; 16690925; 16702224; 16710414; 16714286; 16740711; 16786139; 16824735; 16844113; 16880509; 16887814; 16895791; 16901904; 16905771; 16911523; 16916642; 16928756; 16928824; 16951171; 16980310; 16980615; 16983342; 17009014; 17056544; 17074809; 17082780; 17085440; 17088247; 17097050; 17101801; 17110928; 17121851; 17130130; 17182846; 17189706; 17215518; 17235455; 17237388; 17237407; 17283040; 17283046; 17296604; 17314269; 17317669; 17363973; 17390236; 17401435; 17403042; 17438848; 17440114; 17466952; 17495958; 17506864; 17510314; 17538020; 17588603; 17592138; 17634427; 17636030; 17637753; 17639289; 17651785; 17652081; 17658605; 17672916; 17681951; 17702894; 17703412; 17704768; 17761353; 17804415; 17845581; 17875713; 17908424; 17914574; 17920329; 17940019; 17952113; 17968316; 17978573; 18003900; 18032824; 18062835; 18065414; 18073204; 18097055; 18165900; 18171671; 18172215; 18174157; 18180292; 18180316; 18192274; 18234454; 18239671; 18253836; 18262488; 18281687; 18302882; 18304423; 18316037; 18316603; 18322962; 18347071; 18351441; 18352974; 18384814; 18410487; 18414033; 18429822; 18435914; 18443042; 18443043; 18445313; 18448277; 18467434; 18485515; 18487146; 18494816; 18497564; 18515365; 18543249; 18570890; 18572021; 18597608; 18600430; 18617512; 18619508; 18621151; 18644981; 18646516; 18650425; 18653452; 18653705; 18664273; 18671972; 18692129; 18708361; 18716056; 18725194; 18757369; 18775869; 18805449; 18823944; 18838675; 18844221; 18845538; 18922473; 18923650; 18931081; 18936204; 18940179; 18950845; 18952102; 18957410; 18957422; 18985028; 18992165; 19015316; 19018257; 19020743; 19022561; 19028685; 19035162; 19064921; 19080373; 19105933; 19123467; 19131506; 19156129; 19164581; 19165171; 19166930; 19176525; 19193763; 19206162; 19215067; 19219074; 19231233; 19238531; 19249008; 19258923; 19270716; 19281909; 19306295; 19334540; 19343052; 19357699; 19358752; 19384981; 19433309; 19435822; 19471022; 19495976; 19499154; 19513521; 19527717; 19528235; 19531482; 19578717; 19591174; 19595408; 19616043; 19653276; 19654329; 19656241; 19701800; 19714312; 19723051; 19734233; 19734545; 19738058; 19758340; 19758438; 19782465; 19787273; 19794957; 19795388; 19806201; 19811296; 19818398; 19837979; 19841138; 19859790; 19860880; 19861239; 19874574; 19878434; 19885545; 19898747; 19910471; 19910486; 19913121; 19919900; 19921846; 19937141; 19937979; 19939924; 19944700; 19959471; 19965873; 20012528; 20042607; 20044606; 20051654; 20053993; 20074357; 20093361; 20093369; 20102411; 20133937; 20137127; 20170659; 20185758; 20193273; 20195357; 20198339; 20203690; 20222112; 20225236; 20227498; 20232342; 20304822; 20306472; 20331627; 20331972; 20331980; 20333648; 20353950; 20353996; 20371606; 20376080; 20395206; 20410304; 20430872; 20432452; 20448330; 20459032; 20479273; 20479762; 20482821; 20483790; 20503287; 20505831; 20507572; 20508969; 20510020; 20511396; 20519498; 20531301; 20543003; 20554528; 20557936; 20590529; 20607803; 20619956; 20628086; 20628624; 20665665; 20680410; 20683948; 20688351; 20697347; 20698984; 20732415; 20837772; 20852630; 20936779; 20939893; 20942798; 20943203; 20952681; 20955203; 20976196; 20977688; 21030269; 21034562; 21081043; 21081472; 21106530; 21106746; 21134350; 21139048; 21145111; 21148792; 21196933; 21212516; 21268080; 21289643; 21338584; 21349840; 21350237; 21357535; 21360282; 21364631; 21381700; 21393476; 21397653; 21410405; 21417953; 21439937; 21451046; 21454713; 21496208; 21511059; 21518489; 21526160; 21530485; 21555589; 21559334; 21565167; 21570970; 21607373; 21617575; 21617851; 21640141; 21647439; 21675959; 21685329; 21693764; 21697091; 21699750; 21703547; 21732343; 21739277; 21743958; 21745629; 21799768; 21801875; 21814482; 21822357; 21829441; 21835421; 21835891; 21860413; 21862593; 21872498; 21890473; 21895606; 21937452; 21972703; 21988832; 21989944; 22001392; 22002117; 22051934; 22077140; 22083952; 22092038; 22110360; 22119392; 22132731; 22139817; 22176144; 22189957; 22235337; 22239235; 22265050; 22266871; 22271085; 22271878; 22307329; 22327296; 22328508; 22331067; 22354960; 22384197; 22384232; 22394497; 22399296; 22417306; 22429882; 22438909; 22450687; 22484283; 22508041; 22512945; 22570239; 22597534; 22675553; 22685373; 22688014; 22719067; 22749179; 22771387; 22791811; 22797068; 22801218; 22843696; 22853846; 22860098; 22869147; 22879913; 22911824; 22926518; 22933572; 22966201; 22974165; 22981541; 22988241; 23027969; 23028371; 23041974; 23047699; 23135283; 23153494; 23163821; 23182717; 23223231; 23226410; 23236059; 23269699; 23300800; 23331079; 23339184; 23362975; 23382074; 23437118; 23454483; 23467542; 23523566; 23546882; 23562910; 23580428; 23583295; 23602568; 23608488; 23614275; 23615400; 23624934; 23625009; 23625206; 23661758; 23665382; 23669365; 23671702; 23678002; 23682787; 23686163; 23690655; 23720779; 23747343; 23749999; 23762330; 23770289; 23814048; 23818969; 23832539; 23844083; 23906792; 23929433; 23942796; 24027432; 24113186,,,,,,,,,,,,,,,,,,OGG:3000003725,,,,,,,,,,,,,,,,,,,jun proto-oncogene,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,JUN,,,20140408,3725,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,JUN,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0008151,Prolonged prothrombin time,Increased international normalized ratio|Increased INR|Reduced factor II activity|Prolonged PT|increased international normalised ratio|Reduced prothrombin activity|Low factor II activity,"Increased time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.|The prothrombin time (PT) and the activated partial thromboplastin time (APTT) are the most requested tests to investigate patients with congenital or acquired coagulopathies and drug monitoring. They are defined as the time (seconds) needed to clot platelet-poor plasma upon addition of coagulation triggers, such as tissue factor in complex with phospholipids and calcium chloride (in the PT), or negatively charged phospholipids-activators and calcium chloride (in the APTT). They can hence be considered as global coagulation tests sensitive to deficiencies of many coagulation factors. In brief, they are both sensitive to factor X, V, II and fibrinogen, whereas the PT is only sensitive to factor VII deficiency and the APTT is sensitive to pre-kallikrein, high molecular weight kininogen (HMWK), factor XII, XI, IX and VIII deficiencies. Normal plasma in the PT clots approximately within 10-12 s upon triggering coagulation, and the normal reference range is (usually) narrow. PT results have been reported as clotting time, percentage activity, PT-ratio (patient-to-normal clotting time) and as international normalized ratio (INR). The INR scale has been devised to harmonize results stemming from different thromboplastins from patients on treatment with vitamin K antagonists. Some recommend abandoning the approach of using percentage activity to assess PR.",false,,,http://purl.obolibrary.org/obo/HP_0032199,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:409674002|UMLS:C0151872,"Increased time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.",,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0012201,,,,Increased international normalized ratio|Increased INR|Reduced factor II activity|Prolonged PT|increased international normalised ratio|Reduced prothrombin activity|Low factor II activity,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The prothrombin time (PT) and the activated partial thromboplastin time (APTT) are the most requested tests to investigate patients with congenital or acquired coagulopathies and drug monitoring. They are defined as the time (seconds) needed to clot platelet-poor plasma upon addition of coagulation triggers, such as tissue factor in complex with phospholipids and calcium chloride (in the PT), or negatively charged phospholipids-activators and calcium chloride (in the APTT). They can hence be considered as global coagulation tests sensitive to deficiencies of many coagulation factors. In brief, they are both sensitive to factor X, V, II and fibrinogen, whereas the PT is only sensitive to factor VII deficiency and the APTT is sensitive to pre-kallikrein, high molecular weight kininogen (HMWK), factor XII, XI, IX and VIII deficiencies. Normal plasma in the PT clots approximately within 10-12 s upon triggering coagulation, and the normal reference range is (usually) narrow. PT results have been reported as clotting time, percentage activity, PT-ratio (patient-to-normal clotting time) and as international normalized ratio (INR). The INR scale has been devised to harmonize results stemming from different thromboplastins from patients on treatment with vitamin K antagonists. Some recommend abandoning the approach of using percentage activity to assess PR.",,http://purl.obolibrary.org/obo/HP_0032199,,,,HP:0008151,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076|https://www.ncbi.nlm.nih.gov/pubmed/3221830,,,,HP:0008151,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Prolonged prothrombin time,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0015228,circulatory organ,heart|heart or heart like organ|cardiac pump|circulatory vessel|cardiac structure,"A hollow, muscular organ, which, by contracting rhythmically, contributes to the circulation of lymph, blood or analogs. Examples: a chambered vertebrate heart; the tubular peristaltic heart of ascidians; the dorsal vessel of an insect; the lymoh heart of a reptile.",false,,,http://purl.obolibrary.org/obo/UBERON_0003103,,,,,,,,,,,,,,,,,,,,SPD:0000130,"A hollow, muscular organ, which, by contracting rhythmically, contributes to the circulation of lymph, blood or analogs. Examples: a chambered vertebrate heart; the tubular peristaltic heart of ascidians; the dorsal vessel of an insect; the lymoh heart of a reptile.",,,,,,,,,,,,,,,,,,,,,,,,,,,,heart,,,heart or heart like organ|cardiac pump,,,circulatory vessel,,uberon,,cardiac structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0003103,,,,UBERON:0015228,,,,,,,,,,,,,,,UBERON:0015228,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,circulatory organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000153,vasculitis,,doid/symp duplicate,false,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,doid/symp duplicate,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,SYMP:0000153,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,Vasculitis refers to a large group of diseases that cause inflammation of the blood vessels.,,,SYMP:0000153,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,vasculitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000131,inhalation of droplets,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,behavior process|behaviour process,,true,,,,,,Inhalation of small respiratory droplets.,,,,,,,,,,,,,,,,inhalation of droplets,,,,,,,,,,,,,,,,,,,,,,https://www.sciencealert.com/is-coronavirus-spread-by-talking-and-breathing,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003486,IGFBP3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IBP3|BP-53,,,,,,,7,,,,,,,,,,Ensembl:ENSG00000146674|Vega:OTTHUMG00000023769|HGNC:5472|HPRD:00899|MIM:146732,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,insulin-like growth factor binding protein 3,,7p13-p12,,,,"GO_0001558 (EC: IEA); GO_0001933 (EC: IDA, PMID: 17591901); GO_0001968 (EC: IEA); GO_0005515 (EC: IPI, PMID: 14561895); GO_0005520 (EC: NAS, PMID: 12599210); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 17119061); GO_0005634 (EC: IDA, PMID: 17434920); GO_0006468 (EC: IDA, PMID: 17434920); GO_0006915 (EC: IEA); GO_0008160 (EC: IDA, PMID: 11940579); GO_0008285 (EC: IGI, PMID: 19258508); GO_0009968 (EC: NAS, PMID: 11940579); GO_0010906 (EC: IEA); GO_0014912 (EC: IDA, PMID: 10766744); GO_0016942 (EC: IC, PMID: 10766744); GO_0031994 (EC: IPI, PMID: 10766744); GO_0043065 (EC: IMP, PMID: 11971816); GO_0043085 (EC: IDA, PMID: 11940579); GO_0043410 (EC: IEA); GO_0043568 (EC: IEA); GO_0044267 (EC: TAS); GO_0044342 (EC: IEA); GO_0045663 (EC: IDA, PMID: 12599210); GO_0046872 (EC: NAS, PMID: 14576163); GO_0048662 (EC: IDA, PMID: 10766744)",PMID: 1280211; 1293182; 1373120; 1383255; 1695633; 1697583; 2464130; 7508771; 7523391; 7538844; 7566179; 8550744; 8675597; 8708531; 8843739; 8964576; 9252371; 9275067; 9337997; 9388210; 9389554; 9408744; 9446566; 9497324; 9688635; 10076184; 10218588; 10226805; 10352394; 10407151; 10511594; 10512690; 10650937; 10766744; 10770214; 10811646; 10823924; 10849447; 10874028; 11095942; 11238520; 11264294; 11297622; 11319179; 11344214; 11375929; 11600567; 11749962; 11751851; 11762714; 11784719; 11801256; 11804742; 11886859; 11914023; 11914026; 11940579; 11948969; 11953210; 11959812; 11971816; 11997031; 12006706; 12011225; 12051736; 12054563; 12068000; 12111701; 12122101; 12127836; 12135130; 12150454; 12163384; 12200149; 12210764; 12213898; 12219010; 12220677; 12242693; 12473575; 12477932; 12506097; 12508918; 12519841; 12571183; 12571851; 12575534; 12590636; 12599210; 12690205; 12725526; 12730416; 12735930; 12810533; 12810534; 12853948; 12865482; 12870155; 12907612; 12925957; 12926118; 12937269; 12962157; 14561895; 14576163; 14576164; 14597676; 14598881; 14644829; 14674122; 14693733; 14702039; 14710345; 14718574; 14744783; 14751238; 14760718; 15014034; 15047131; 15059907; 15066922; 15067329; 15069073; 15070968; 15086466; 15126567; 15140235; 15178549; 15198293; 15221971; 15247132; 15247904; 15282325; 15298948; 15302288; 15340161; 15379965; 15448002; 15485880; 15489334; 15517912; 15625284; 15641262; 15641264; 15642160; 15642732; 15651061; 15661050; 15668470; 15681824; 15703779; 15734965; 15769996; 15781645; 15800934; 15802501; 15809062; 15817480; 15844718; 15894673; 15894694; 15927849; 15941947; 15959422; 15986122; 15987847; 16015705; 16030120; 16049980; 16169070; 16181731; 16189247; 16189260; 16210470; 16211216; 16215864; 16275148; 16303743; 16306136; 16322329; 16335952; 16394092; 16404426; 16448675; 16455777; 16489075; 16489531; 16540651; 16541420; 16543235; 16552541; 16614079; 16617154; 16645643; 16723126; 16763062; 16775172; 16776662; 16793770; 16825320; 16887362; 16915540; 16935391; 16965600; 16969385; 17018785; 17035411; 17044098; 17047053; 17051426; 17056474; 17063263; 17070193; 17085968; 17096329; 17113753; 17119061; 17172410; 17187018; 17210081; 17237715; 17264182; 17287408; 17289909; 17293864; 17297462; 17300730; 17350302; 17388800; 17396438; 17434446; 17434920; 17446556; 17447118; 17453001; 17457048; 17546465; 17555512; 17560154; 17566087; 17567756; 17577982; 17591901; 17593323; 17597108; 17624927; 17627014; 17635417; 17655506; 17668637; 17689128; 17719815; 17724372; 17761791; 17763192; 17803702; 17823260; 17827406; 17879951; 17912004; 17952116; 17957164; 17959403; 17972510; 17997337; 18006928; 18031946; 18059035; 18084616; 18162523; 18163429; 18171112; 18177247; 18178497; 18259111; 18287864; 18329388; 18335323; 18375957; 18398029; 18410545; 18450319; 18459102; 18471292; 18481170; 18498652; 18534134; 18562769; 18596909; 18602100; 18615538; 18618736; 18624627; 18636124; 18676680; 18812263; 18818748; 18929499; 18984657; 18992148; 18992263; 19004037; 19019335; 19020726; 19036873; 19064126; 19064572; 19077426; 19121847; 19124506; 19124510; 19127217; 19129715; 19138871; 19158946; 19170196; 19190540; 19194113; 19207313; 19217707; 19223521; 19240240; 19257984; 19258508; 19332270; 19414355; 19449212; 19453261; 19455605; 19477944; 19491931; 19492232; 19509068; 19527514; 19540231; 19551141; 19551864; 19556345; 19568604; 19588500; 19591553; 19596932; 19625176; 19633297; 19634593; 19672706; 19692168; 19734278; 19764562; 19784788; 19786462; 19786971; 19789190; 19800385; 19833751; 19845745; 19846909; 19858071; 19863750; 19913121; 19917654; 19919528; 19938081; 19941883; 19944347; 19948975; 19960406; 20003326; 20023704; 20039319; 20051649; 20084546; 20099974; 20102313; 20119675; 20121533; 20144192; 20145156; 20155489; 20204283; 20215856; 20219400; 20228135; 20302654; 20307522; 20350746; 20357812; 20378848; 20403354; 20416304; 20423985; 20427254; 20453000; 20468064; 20484221; 20501753; 20513670; 20540360; 20580999; 20587610; 20599318; 20613589; 20628086; 20628624; 20634197; 20677014; 20731527; 20734064; 20801067; 20810604; 20848532; 20851879; 20860465; 20884247; 20889360; 20920870; 20921904; 20945273; 21068693; 21076409; 21078522; 21140206; 21195059; 21216879; 21254935; 21347663; 21378090; 21383009; 21388950; 21392749; 21435441; 21447628; 21447640; 21455575; 21471542; 21474793; 21478207; 21520041; 21520165; 21521316; 21525788; 21529443; 21536375; 21536469; 21551235; 21562710; 21585623; 21636299; 21648284; 21697095; 21698457; 21701930; 21737444; 21761353; 21788435; 21823995; 21852217; 21892705; 21898383; 21930730; 21944866; 22001433; 22004906; 22026507; 22032863; 22085490; 22113073; 22128038; 22167391; 22246875; 22253890; 22278433; 22318747; 22328165; 22332214; 22347413; 22363400; 22381038; 22389159; 22415309; 22415807; 22441125; 22442270; 22475139; 22494072; 22500655; 22527168; 22543588; 22554827; 22565227; 22643116; 22739332; 22745191; 22751133; 22778398; 22801219; 22847383; 22879989; 22882716; 22884472; 22892437; 22894543; 22936258; 22951368; 23011725; 23041555; 23158139; 23174226; 23178489; 23185474; 23341348; 23348700; 23377640; 23383064; 23498137; 23527244; 23527725; 23592916; 23611528; 23619263; 23720424; 23748063; 23770368; 23789983; 23792502; 23831640; 23864804; 23962053; 24022308; 24250222,,,,,,,,,,,,,,,,,,OGG:3000003486,,,,,,,,,,,,,,,,,,,insulin-like growth factor binding protein 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IGFBP3,,,20140408,3486,tcag7.703,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IGFBP3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_249062,SARS coronavirus GZ-A,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249062,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ-A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1503303,BtRs-BetaCoV/YN2013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1503303,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,BtRs-BetaCoV/YN2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000920,CD4,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CD4mut,,,,,,,12,,,,,,,,,,Vega:OTTHUMG00000168514|HPRD:01740|MIM:186940|Ensembl:ENSG00000010610|HGNC:1678,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,CD4 molecule,,12p13.31,,,,"GO_0001816 (EC: IEA); GO_0001948 (EC: IPI, PMID: 10922058); GO_0004872 (EC: TAS, PMID: 10413516); GO_0004888 (EC: TAS, PMID: 10358157); GO_0005201 (EC: NAS, PMID: 12444132); GO_0005515 (EC: IPI, PMID: 11113139); GO_0005769 (EC: TAS); GO_0005788 (EC: IEA); GO_0005789 (EC: TAS); GO_0005886 (EC: IDA, PMID: 11390434); GO_0005886 (EC: TAS); GO_0006948 (EC: IDA, PMID: 9166430); GO_0006955 (EC: NAS, PMID: 8512039); GO_0007155 (EC: IEA); GO_0007165 (EC: TAS, PMID: 10358157); GO_0007166 (EC: TAS, PMID: 9780207); GO_0007167 (EC: TAS, PMID: 10358157); GO_0007169 (EC: NAS, PMID: 8512039); GO_0008270 (EC: IDA, PMID: 9668045); GO_0009897 (EC: IDA, PMID: 17213291); GO_0015026 (EC: NAS, PMID: 8512039); GO_0016021 (EC: IEA); GO_0016032 (EC: TAS); GO_0019899 (EC: IPI, PMID: 19333378); GO_0019901 (EC: IPI, PMID: 7486703); GO_0030217 (EC: IDA, PMID: 1533274); GO_0030260 (EC: TAS); GO_0031295 (EC: TAS); GO_0032507 (EC: IDA, PMID: 15128768); GO_0042101 (EC: NAS, PMID: 8512039); GO_0042289 (EC: NAS, PMID: 8512039); GO_0042803 (EC: IDA, PMID: 12444132); GO_0045058 (EC: IDA, PMID: 9551897); GO_0045086 (EC: NAS, PMID: 1901411); GO_0045087 (EC: TAS); GO_0045121 (EC: IEA); GO_0045234 (EC: IDA, PMID: 15128768); GO_0045860 (EC: IDA, PMID: 2118992); GO_0050690 (EC: TAS); GO_0050731 (EC: IEA); GO_0050829 (EC: IEA); GO_0050850 (EC: IEA); GO_0050852 (EC: TAS); GO_0050863 (EC: IDA, PMID: 1533274)",PMID: 153; 200; 237459; 1279195; 1280382; 1281202; 1310988; 1348943; 1352879; 1354681; 1354808; 1356673; 1370558; 1370739; 1373203; 1373549; 1374095; 1376134; 1376135; 1378510; 1380099; 1380260; 1381201; 1381203; 1381399; 1382339; 1388715; 1402655; 1425921; 1433512; 1438278; 1457205; 1457207; 1465431; 1472279; 1489581; 1491632; 1493050; 1500858; 1501286; 1501294; 1503822; 1512692; 1520872; 1527858; 1533274; 1535086; 1535787; 1537337; 1543562; 1546447; 1548744; 1548763; 1548769; 1549584; 1551875; 1563094; 1565858; 1567578; 1569213; 1588493; 1592430; 1599754; 1602552; 1605591; 1614536; 1618861; 1622897; 1627247; 1636088; 1639820; 1674549; 1677023; 1678778; 1685857; 1687500; 1690236; 1690832; 1691226; 1691563; 1693676; 1696539; 1697332; 1698804; 1698911; 1698964; 1701030; 1701782; 1702163; 1702842; 1703212; 1706342; 1708753; 1709701; 1710248; 1711033; 1711118; 1713252; 1713692; 1717587; 1717717; 1720590; 1720627; 1720631; 1721822; 1722676; 1724568; 1727475; 1727486; 1727487; 1727497; 1730924; 1732513; 1736938; 1738091; 1742075; 1757107; 1763044; 1810199; 1832782; 1834739; 1845049; 1851800; 1870202; 1870209; 1871120; 1888898; 1889086; 1896455; 1899141; 1901411; 1910691; 1918997; 1931229; 1931230; 1959561; 1967269; 1967280; 1970124; 1970444; 1971526; 1977427; 1978941; 1979339; 1979910; 1983967; 1984054; 1985197; 1985202; 1991970; 1995942; 2006155; 2007979; 2014052; 2015114; 2018763; 2040625; 2040664; 2045792; 2059359; 2062847; 2068099; 2076345; 2078013; 2078408; 2078409; 2082620; 2103853; 2104682; 2107024; 2109100; 2111957; 2115689; 2118992; 2125484; 2136376; 2171457; 2182910; 2187500; 2190096; 2190604; 2190605; 2198840; 2212945; 2214026; 2243375; 2247146; 2251501; 2261984; 2324685; 2325207; 2335819; 2339113; 2341717; 2363051; 2364018; 2374593; 2402498; 2431105; 2431482; 2432599; 2436231; 2437327; 2438696; 2441727; 2441877; 2446880; 2453925; 2461565; 2462895; 2468713; 2475780; 2479005; 2482055; 2523711; 2536098; 2537355; 2538505; 2538547; 2541915; 2543930; 2545918; 2549633; 2549987; 2550671; 2550679; 2555159; 2558637; 2558687; 2559777; 2571187; 2592374; 2821115; 2829022; 2829023; 2830667; 2833917; 2842778; 2845147; 2846691; 2851650; 2986290; 2986291; 2990682; 2990730; 2995487; 3001934; 3006256; 3016552; 3018753; 3023102; 3027168; 3029227; 3038935; 3086883; 3095663; 3118220; 3257102; 3259291; 3260352; 3261864; 3263213; 3304356; 3466790; 3484980; 3495568; 3497054; 3652531; 3682024; 6096719; 7486703; 7494500; 7504739; 7506554; 7515973; 7521897; 7522245; 7529290; 7529735; 7533854; 7537501; 7539035; 7539755; 7541827; 7543586; 7544051; 7545243; 7545244; 7546903; 7562439; 7576913; 7576930; 7589091; 7589092; 7592573; 7594524; 7615007; 7616571; 7618285; 7636191; 7650480; 7676667; 7678271; 7685405; 7686944; 7687306; 7688299; 7688827; 7689324; 7690418; 7690724; 7692037; 7692087; 7693970; 7707502; 7734186; 7737288; 7754236; 7769669; 7769687; 7774645; 7778293; 7821926; 7831289; 7831801; 7832633; 7853478; 7853484; 7867080; 7871751; 7874384; 7897355; 7897356; 7902127; 7903106; 7903128; 7903479; 7904348; 7904351; 7904656; 7906314; 7906657; 7910967; 7913036; 7914230; 7917519; 7935503; 7961587; 7975260; 7982906; 7983750; 8035515; 8043225; 8057354; 8075984; 8091666; 8091684; 8102473; 8104794; 8105835; 8122371; 8124721; 8125527; 8129620; 8139010; 8139011; 8151300; 8151301; 8151774; 8160267; 8168144; 8178478; 8196669; 8212576; 8230446; 8246987; 8262036; 8280475; 8289353; 8331723; 8331733; 8350411; 8356059; 8361381; 8363802; 8369162; 8409933; 8411350; 8416385; 8417177; 8419649; 8419650; 8437224; 8437228; 8437234; 8438588; 8455141; 8460995; 8464887; 8474162; 8497074; 8497077; 8510207; 8510209; 8512039; 8516299; 8547064; 8551569; 8551601; 8551619; 8552983; 8560759; 8560767; 8568275; 8575195; 8599214; 8599229; 8599760; 8599832; 8605026; 8613144; 8615015; 8615021; 8615032; 8627160; 8627264; 8627711; 8629022; 8635586; 8648738; 8649438; 8659106; 8661396; 8661397; 8663408; 8674119; 8674120; 8707350; 8709227; 8723724; 8726523; 8738430; 8760413; 8801439; 8805353; 8806567; 8806575; 8811198; 8827217; 8827218; 8849450; 8862276; 8871625; 8882662; 8887470; 8887682; 8891109; 8892926; 8896248; 8898753; 8906795; 8906796; 8906988; 8924209; 8948487; 8973529; 8976200; 8977179; 8986758; 8995609; 9000083; 9002959; 9036944; 9037057; 9043947; 9049297; 9049413; 9052838; 9074930; 9123823; 9151836; 9166430; 9168119; 9168885; 9185604; 9186786; 9226175; 9261346; 9263011; 9264287; 9269777; 9334377; 9344703; 9349472; 9360974; 9377118; 9417096; 9420225; 9443108; 9445013; 9451022; 9473011; 9499087; 9499113; 9499115; 9525683; 9525894; 9546790; 9548463; 9551897; 9558100; 9573233; 9576954; 9600078; 9600268; 9601645; 9604776; 9614108; 9621091; 9622505; 9632396; 9632631; 9637477; 9641677; 9653051; 9658072; 9658081; 9660940; 9668045; 9696823; 9721247; 9724097; 9739096; 9770524; 9780207; 9811606; 9811611; 9826718; 9862697; 9870313; 9918507; 9923610; 9989602; 10074122; 10089882; 10199403; 10202115; 10208934; 10213312; 10213313; 10233996; 10329539; 10358157; 10364484; 10371171; 10375525; 10375528; 10393974; 10413516; 10430052; 10438529; 10446313; 10451539; 10482576; 10490978; 10505674; 10508188; 10557278; 10558884; 10559275; 10559349; 10562325; 10581250; 10582593; 10589997; 10590121; 10593874; 10600606; 10606089; 10623731; 10623764; 10644351; 10684310; 10738970; 10758170; 10774549; 10776787; 10779509; 10816381; 10820003; 10873786; 10875613; 10888615; 10922058; 10941932; 11024150; 11024154; 11024464; 11048639; 11069996; 11070895; 11086073; 11106664; 11113139; 11118070; 11140838; 11188697; 11201791; 11238869; 11264367; 11264384; 11264386; 11265761; 11287575; 11290759; 11311058; 11312658; 11327825; 11333905; 11333908; 11352665; 11356961; 11356967; 11390434; 11396948; 11397808; 11413305; 11413335; 11413337; 11413340; 11414813; 11438519; 11453640; 11463741; 11489906; 11504923; 11533181; 11535811; 11578695; 11581379; 11581410; 11602639; 11602785; 11704677; 11711593; 11734627; 11752220; 11756173; 11799176; 11804554; 11827520; 11827988; 11854499; 11861835; 11861874; 11876757; 11877445; 11878912; 11884536; 11893391; 11906183; 11920312; 11922627; 11931835; 11932428; 11959143; 11967288; 11994538; 12007789; 12008044; 12033937; 12055221; 12072528; 12083833; 12091904; 12120995; 12134256; 12145207; 12163558; 12191776; 12208966; 12213222; 12218051; 12218052; 12218108; 12368305; 12368322; 12392548; 12402167; 12406507; 12429712; 12429730; 12438611; 12441808; 12444132; 12462973; 12477840; 12477867; 12477932; 12487827; 12502809; 12502824; 12517957; 12525600; 12525647; 12531788; 12531905; 12584309; 12586555; 12597360; 12608057; 12610158; 12614324; 12629155; 12634405; 12639247; 12646791; 12646921; 12692222; 12695117; 12702212; 12707350; 12713058; 12719560; 12719580; 12734410; 12746459; 12767984; 12768015; 12769725; 12787886; 12816953; 12832058; 12832421; 12836198; 12842621; 12845769; 12857973; 12864967; 12871111; 12873765; 12885233; 12887918; 12893943; 12899833; 12930892; 12943795; 12953261; 12954211; 12960231; 12963807; 12970437; 13679604; 14500983; 14505910; 14505925; 14512572; 14517611; 14557624; 14557639; 14561767; 14570906; 14576059; 14585209; 14585219; 14592765; 14592831; 14624372; 14640682; 14646564; 14659896; 14670336; 14697933; 14705953; 14722266; 14739941; 14747534; 14757743; 14965316; 14967033; 14990703; 15014135; 15016849; 15016894; 15018709; 15033567; 15033690; 15047060; 15051887; 15063762; 15078178; 15090827; 15099523; 15109676; 15113900; 15113923; 15113926; 15128768; 15161081; 15166428; 15166429; 15168796; 15180540; 15180541; 15183057; 15194762; 15194768; 15202998; 15215692; 15258189; 15279588; 15279589; 15308718; 15308751; 15317218; 15321703; 15326605; 15340161; 15371410; 15489307; 15489334; 15489916; 15494497; 15542675; 15572157; 15577644; 15585836; 15611114; 15613479; 15616015; 15638726; 15650196; 15660419; 15665647; 15665762; 15714205; 15719026; 15722538; 15729334; 15731180; 15737612; 15748209; 15748900; 15767435; 15767436; 15778371; 15784911; 15797855; 15807900; 15821887; 15823605; 15854903; 15857992; 15857997; 15890908; 15890935; 15893666; 15929700; 15936090; 15956589; 15956605; 15964018; 15972448; 15975620; 15977243; 15983047; 15990565; 15996703; 16002156; 16046522; 16047221; 16091223; 16103167; 16106369; 16116206; 16148047; 16174727; 16185162; 16188969; 16227248; 16282475; 16284180; 16300985; 16309726; 16310238; 16314494; 16315040; 16331979; 16344560; 16354571; 16365153; 16426633; 16439540; 16454711; 16476977; 16497223; 16507315; 16515489; 16611063; 16616288; 16631599; 16684552; 16702010; 16721558; 16736946; 16753228; 16758122; 16762062; 16775320; 16777164; 16796521; 16817962; 16821115; 16829607; 16855325; 16873261; 16886053; 16886061; 16888650; 16951326; 16955142; 16963439; 16979207; 16987062; 17001685; 17005819; 17010381; 17020785; 17030448; 17035237; 17042973; 17053352; 17065205; 17077296; 17082567; 17083721; 17084877; 17121788; 17121803; 17132727; 17144914; 17151103; 17157668; 17158233; 17170457; 17175221; 17180012; 17187670; 17213291; 17234232; 17235436; 17237241; 17239419; 17251298; 17251303; 17252589; 17267500; 17269928; 17292399; 17304105; 17320923; 17328229; 17329339; 17334223; 17344303; 17346169; 17346946; 17360741; 17363727; 17413690; 17462597; 17485285; 17507486; 17522341; 17526486; 17543960; 17586316; 17586321; 17591854; 17599917; 17628860; 17632197; 17632570; 17645467; 17652306; 17652391; 17653867; 17676933; 17686993; 17712998; 17721546; 17726154; 17728240; 17824250; 17825297; 17855336; 17885647; 17888880; 17904606; 17937819; 17947540; 17956985; 17959679; 17975141; 17980430; 18032634; 18035040; 18045872; 18061610; 18078954; 18089681; 18097956; 18156204; 18162176; 18167642; 18187620; 18197116; 18204854; 18205604; 18205925; 18237398; 18242797; 18261176; 18296630; 18310503; 18353949; 18376303; 18377648; 18390744; 18418773; 18432409; 18438604; 18451325; 18468560; 18473783; 18480458; 18500445; 18508887; 18523251; 18524826; 18541215; 18566427; 18579178; 18579609; 18590744; 18619974; 18624812; 18632854; 18668044; 18672082; 18672260; 18676680; 18691022; 18704932; 18713475; 18715908; 18725938; 18786994; 18789977; 18808677; 18833294; 18837996; 18924611; 18976462; 18976975; 18977142; 18987145; 18991615; 19000821; 19004052; 19018669; 19019953; 19020832; 19064722; 19066282; 19103208; 19129443; 19144136; 19146681; 19149577; 19170196; 19170639; 19180463; 19192224; 19196101; 19275586; 19289577; 19301975; 19324886; 19327048; 19333378; 19366992; 19403684; 19439470; 19449444; 19478876; 19492063; 19493998; 19505389; 19535453; 19553323; 19553524; 19556424; 19572057; 19573080; 19596013; 19625176; 19643141; 19664391; 19667946; 19667950; 19671162; 19692168; 19692474; 19692476; 19692480; 19715524; 19734912; 19751272; 19770068; 19773279; 19777054; 19781555; 19798410; 19812686; 19813706; 19843086; 19851458; 19895210; 19917496; 19926478; 19933330; 19944437; 19965434; 20007245; 20012522; 20012528; 20041213; 20051874; 20078884; 20080564; 20088758; 20132229; 20139419; 20162270; 20166763; 20179761; 20186035; 20195464; 20197275; 20201792; 20213609; 20224778; 20227370; 20237496; 20357769; 20380698; 20388015; 20403730; 20420669; 20442859; 20447038; 20448211; 20458450; 20463063; 20463068; 20463957; 20465832; 20494390; 20501362; 20504833; 20507591; 20530479; 20539016; 20558728; 20562332; 20568250; 20570309; 20594957; 20610714; 20622010; 20631314; 20638642; 20659345; 20724730; 20729906; 20730055; 20739067; 20819778; 20826747; 20835359; 20847001; 20858517; 20860805; 20874088; 20880565; 20881088; 20924289; 20930173; 20943653; 20961591; 20974815; 20974843; 20980513; 21041720; 21048031; 21057376; 21060818; 21068258; 21110955; 21134642; 21142701; 21146497; 21152581; 21165790; 21176220; 21177324; 21179414; 21179576; 21193846; 21209878; 21216423; 21249232; 21249500; 21255440; 21257970; 21284901; 21289125; 21310048; 21324454; 21325401; 21346189; 21351734; 21357438; 21357743; 21376048; 21382342; 21411542; 21430066; 21444771; 21465559; 21482738; 21487012; 21491089; 21543478; 21557772; 21593147; 21600899; 21601230; 21607084; 21612582; 21613393; 21625496; 21626027; 21637819; 21651772; 21660189; 21674066; 21697467; 21709158; 21709254; 21715496; 21738584; 21744325; 21750724; 21757642; 21760891; 21763239; 21769486; 21792088; 21800875; 21827143; 21845735; 21849975; 21851958; 21861776; 21875413; 21880749; 21886150; 21900604; 21902583; 21909273; 21917951; 21922073; 21931551; 21949691; 21957314; 21988832; 21994452; 21994772; 22006924; 22013062; 22017399; 22032685; 22069466; 22083481; 22090097; 22103831; 22103832; 22103833; 22103834; 22103836; 22103838; 22117536; 22158072; 22163292; 22163344; 22171785; 22175768; 22209232; 22222210; 22283893; 22284360; 22291690; 22291921; 22301137; 22301152; 22310634; 22329717; 22337266; 22345473; 22357275; 22378925; 22384114; 22404213; 22419808; 22433250; 22437554; 22446965; 22451932; 22466163; 22479399; 22479639; 22482414; 22497421; 22505724; 22524483; 22545156; 22547820; 22551420; 22553332; 22606344; 22624045; 22640559; 22640659; 22672991; 22674993; 22687513; 22696649; 22751485; 22773820; 22797698; 22808111; 22826297; 22844345; 22846998; 22863293; 22908191; 22933284; 22959895; 22980333; 23077246; 23098499; 23151229; 23158993; 23185351; 23225889; 23282736; 23340699; 23364796; 23426363; 23470050; 23691059; 23692566; 23700441; 23729440; 23807677; 23863698; 23923047; 24006463; 24257748,,,,,,,,,,,,,,,,,,OGG:3000000920,,,,,,,,,,,,,,,,,,,CD4 molecule,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD4,,,20140408,920,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CD4,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/SYMP_0000603,tachypnea,,Tachypnea is a respiratory abnormality characterized by an increased rate of respiration.,false,,,http://purl.obolibrary.org/obo/SYMP_0000598,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0231835|ICD9CM_2005:786.06|UMLS_ICD9CM_2005_AUI:A0465027|SyOID:7246,Tachypnea is a respiratory abnormality characterized by an increased rate of respiration.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000598,,,,SYMP:0000603,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,SYMP:0000603,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,tachypnea,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002698,negative regulation of immune effector process,down regulation of immune effector process|downregulation of immune effector process|down-regulation of immune effector process|inhibition of immune effector process,"Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune effector process.",false,,,http://purl.obolibrary.org/obo/GO_0002683|http://purl.obolibrary.org/obo/GO_0002697,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune effector process.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,down regulation of immune effector process|downregulation of immune effector process|down-regulation of immune effector process,,,inhibition of immune effector process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002683|http://purl.obolibrary.org/obo/GO_0002697,,,,GO:0002698,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002698,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of immune effector process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_385683,SARS coronavirus CS21,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:385683,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CS21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000010410,IFITM3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,DSPA2b|1-8U|IP15,,,,,,,11,,,,,,,,,,Ensembl:ENSG00000142089|HGNC:5414|MIM:605579|HPRD:05719|Vega:OTTHUMG00000165542,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interferon induced transmembrane protein 3,,11p15.5,,,,"GO_0005515 (EC: IPI, PMID: 18486613); GO_0005765 (EC: IEA); GO_0005886 (EC: IDA); GO_0005886 (EC: TAS); GO_0006955 (EC: TAS, PMID: 1906403); GO_0009615 (EC: IDA); GO_0016021 (EC: IEA); GO_0019221 (EC: TAS); GO_0031902 (EC: IEA); GO_0032897 (EC: IDA); GO_0034341 (EC: IDA); GO_0035455 (EC: IDA); GO_0035456 (EC: IDA); GO_0045071 (EC: IDA); GO_0046597 (EC: IDA); GO_0051607 (EC: IEA); GO_0060337 (EC: TAS)",PMID: 1906403; 10950117; 11076863; 11256614; 12477932; 15489334; 15489336; 16326387; 16344560; 16381901; 18029348; 18177740; 18470904; 18486613; 19901966; 19946179; 20534863; 20972266; 21103663; 21139048; 21177806; 21413873; 21531817; 21890473; 21906983; 21914072; 21963094; 22363774; 22446628; 22511783; 23361009; 23376165; 23601107; 23624618; 23649619; 23658454; 23720721; 23864651; 23874452; 24129573; 24367104; 24370119,,,,,,,,,,,,,,,,,,OGG:3000010410,,,,,,,,,,,,,,,,,,,interferon induced transmembrane protein 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IFITM3,,,20140408,10410,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,IFITM3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OMIT_0008054,Hygiene,,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0008054,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,The science dealing with the establishment and maintenance of health in the individual and the group. It includes the conditions and practices conducive to health.,hygienic care,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Hygiene,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/docs/default-source/inaugural-who-partners-forum/who-interim-recommendation-on-obligatory-hand-hygiene-against-transmission-of-covid-19.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C115149,Adenovirus Infection,AdV Infection|Adenovirus Infection|Adenoviral Infection,"An infectious process caused by adenovirus. The virus may cause respiratory illness, conjunctivitis, gastroenteritis, and cystitis.",false,,,http://purl.obolibrary.org/obo/DOID_934,,"An infectious process caused by adenovirus. The virus may cause respiratory illness, conjunctivitis, gastroenteritis, and cystitis.",,,,,,,,,C115149,,,MedDRA|NICHD|CTRP,,,,,,,"An infectious process caused by adenovirus. The virus may cause respiratory illness, conjunctivitis, gastroenteritis, and cystitis.",,,,,,Adenovirus Infection,,,,,,,,,,,,,,,,,,,,,,,,,AdV Infection|Adenovirus Infection|Adenoviral Infection,,,,http://purl.obolibrary.org/obo/NCIT_C3439,,,,,,,,,NCIT:C115149,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,true,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,adenovirus,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118464|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799,,,,,,,,,,Adenovirus Infection,,Adenovirus infection,,,,,,Adenovirus Infection,,,,,,,,,,,Adenovirus Infection,,,,Disease or Syndrome,,,,,,,,C0001486,
http://purl.obolibrary.org/obo/GO_0042133,neurotransmitter metabolic process,neurotransmitter metabolism,"The chemical reactions and pathways involving neurotransmitters, any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell.",false,,,http://purl.obolibrary.org/obo/GO_0001505,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving neurotransmitters, any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,neurotransmitter metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_4895,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0001505,,,,GO:0042133,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042133,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,neurotransmitter metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C20493,Interferon,Human Fibroblast Interferon|Human Lymphoblastoid Interferon|IFN|interferon|Human Leukocyte Interferon|Interferon,"Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570)",false,,,http://purl.obolibrary.org/obo/PR_000000001,,"A biological response modifier (a substance that can improve the body's natural response to infection and disease). Interferons interfere with the division of cancer cells and can slow tumor growth. There are several types of interferons, including interferon-alpha, -beta, and -gamma. These substances are normally produced by the body. They are also made in the laboratory for use in treating cancer and other diseases.",,,,,,,,,C20493,,,CTRP,,,,,,,"Human interferons have been classified into 3 groups: alpha, beta, and gamma. Both alpha- and beta-IFNs, previously designated type I, are acid-stable, but they differ immunologically and in regard to some biologic and physiochemical properties. The IFNs produced by virus-stimulated leukocytes (leukocyte IFNs) are predominantly of the alpha type. Those produced by lymphoblastoid cells are about 90% alpha and 10% beta. Induced fibroblasts produce mainly or exclusively the beta type. The alpha- and beta-IFNs differ widely in amino acid sequence. The gamma or immune IFNs, which are produced by T lymphocytes in response to mitogens or to antigens to which they are sensitized, are acid-labile and serologically distinct from alpha- and beta-IFNs. (from OMIM 147570)",,,,,,Interferon,,,,,,,,,,,,,,,,,,,,,,,,,Human Fibroblast Interferon|Human Lymphoblastoid Interferon|IFN|interferon|Human Leukocyte Interferon|Interferon,,,,,,,,,,,,,NCIT:C20493,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678|https://www.ncbi.nlm.nih.gov/pubmed/32142938,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142800|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799,,,,,,,,,,Interferon,Interferon,,,,,,,,,,,,,,,,,,Interferon,,,,"Immunologic Factor|Amino Acid, Peptide, or Protein",,,,,,,,C0021747,
http://purl.obolibrary.org/obo/GO_0005575,cellular_component,cellular component|cell or subcellular entity|subcellular entity,"A location, relative to cellular compartments and structures, occupied by a macromolecular machine when it carries out a molecular function. There are two ways in which the gene ontology describes locations of gene products: (1) relative to cellular structures (e.g., cytoplasmic side of plasma membrane) or compartments (e.g., mitochondrion), and (2) the stable macromolecular complexes of which they are parts (e.g., the ribosome).|Note that, in addition to forming the root of the cellular component ontology, this term is recommended for use for the annotation of gene products whose cellular component is unknown. When this term is used for annotation, it indicates that no information was available about the cellular component of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this.|Note that, in addition to forming the root of the cellular component ontology, this term is recommended for use for the annotation of gene products whose cellular component is unknown. When this term is used for annotation, it indicates that no information was available about the cellular component of the gene product annotated as of the date the annotation was made; the evidence code ""no data"" (ND), is used to indicate this.",false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1337158144,"A location, relative to cellular compartments and structures, occupied by a macromolecular machine when it carries out a molecular function. There are two ways in which the gene ontology describes locations of gene products: (1) relative to cellular structures (e.g., cytoplasmic side of plasma membrane) or compartments (e.g., mitochondrion), and (2) the stable macromolecular complexes of which they are parts (e.g., the ribosome).",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008372,,,,cellular component|cell or subcellular entity,,,,,cellular_component,,subcellular entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that, in addition to forming the root of the cellular component ontology, this term is recommended for use for the annotation of gene products whose cellular component is unknown. When this term is used for annotation, it indicates that no information was available about the cellular component of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this.|Note that, in addition to forming the root of the cellular component ontology, this term is recommended for use for the annotation of gene products whose cellular component is unknown. When this term is used for annotation, it indicates that no information was available about the cellular component of the gene product annotated as of the date the annotation was made; the evidence code ""no data"" (ND), is used to indicate this.",,http://purl.obolibrary.org/obo/BFO_0000040,,,,GO:0005575,,,,,,,,,,,,,,,GO:0005575,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000792,"CD4-positive, CD25-positive, alpha-beta regulatory T cell","suppressor T-cell|suppressor T cell|Treg|suppressor T lymphocyte|suppressor T-lymphocyte|CD4-positive, CD25-positive, alpha-beta regulatory T-cell|CD4-positive, CD25-positive, alpha-beta regulatory T-lymphocyte|CD4-positive, CD25-positive, alpha-beta regulatory T lymphocyte","A CD4-positive, CD25-positive, alpha-beta T cell that regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.|This cell type is compatible with the HIPC Lyoplate markers for 'Treg'.  The inclusion of CD127lo in the logical definition is compatible with both human and mouse T cells of this subtype.",false,,,http://purl.obolibrary.org/obo/CL_0000815|http://purl.obolibrary.org/obo/CL_0000624,,,,,,,,,,,,,,,,,,,,,"A CD4-positive, CD25-positive, alpha-beta T cell that regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.",,,,,,,,,,,,,,,,,,,,,,,,,,,,suppressor T-cell|suppressor T cell|Treg|suppressor T lymphocyte|suppressor T-lymphocyte,,,"CD4-positive, CD25-positive, alpha-beta regulatory T-cell|CD4-positive, CD25-positive, alpha-beta regulatory T-lymphocyte|CD4-positive, CD25-positive, alpha-beta regulatory T lymphocyte",,,,,cell,,,,,,,,CL:0000792,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This cell type is compatible with the HIPC Lyoplate markers for 'Treg'.  The inclusion of CD127lo in the logical definition is compatible with both human and mouse T cells of this subtype.,,http://purl.obolibrary.org/obo/CL_0000815|http://purl.obolibrary.org/obo/CL_0000624,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,"CD4-positive, CD25-positive, alpha-beta regulatory T cell",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9434,telmisartan,"4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid|Telmisartan|4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid|4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Micardis|telmisartan|4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|BIBR 277",A member of the class of  benzimidazoles  used widely in the treatment of hypertension.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,HMDB:HMDB0015101|Beilstein:6624054|Reaxys:6624054|LINCS:LSM-3657|Drug_Central:2583|PMID:24048485|PMID:18360028|CAS:144701-48-4|Patent:EP502314|PMID:15498586|PMID:11558835|DrugBank:DB00966|PMID:18008027|KEGG:D00627|Wikipedia:Telmisartan|KEGG:C07710,A member of the class of  benzimidazoles  used widely in the treatment of hypertension.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid|Telmisartan",,,,,chebi_ontology,,"4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid|4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Micardis|telmisartan|4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|BIBR 277",,,,,,,,,0,C33H30N4O2,"InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)",RMMXLENWKUUMAY-UHFFFAOYSA-N,514.61690,514.23688,CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9434,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,CHEBI:9434,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,telmisartan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007076,TIMP1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,EPA|TIMP|HCI|CLGI|EPO,,,,,,,X,,,,,,,,,,MIM:305370|Vega:OTTHUMG00000021447|HGNC:11820|HPRD:02371|Ensembl:ENSG00000102265,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,TIMP metallopeptidase inhibitor 1,,Xp11.3-p11.23,,,,"GO_0002020 (EC: IEA); GO_0002576 (EC: TAS); GO_0005515 (EC: IPI, PMID: 16917503); GO_0005576 (EC: NAS, PMID: 1653055); GO_0005576 (EC: TAS); GO_0005604 (EC: IEA); GO_0007568 (EC: IEA); GO_0007596 (EC: TAS); GO_0008191 (EC: IDA, PMID: 12714508); GO_0008284 (EC: TAS, PMID: 3839290); GO_0010951 (EC: IDA, PMID: 12714508); GO_0022617 (EC: TAS); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0031093 (EC: TAS); GO_0034097 (EC: IEA); GO_0043066 (EC: IEA); GO_0043249 (EC: IEA); GO_0043434 (EC: IEA); GO_0046872 (EC: IEA); GO_0051045 (EC: IDA, PMID: 12714508); GO_1901164 (EC: IMP)",PMID: 1420137; 1653055; 1730286; 2163605; 2171551; 2251898; 2921031; 3010309; 3460333; 3688834; 3839290; 3903517; 7507419; 8757599; 9063449; 9286280; 9288970; 9778693; 10071915; 10233411; 10441576; 10623524; 11279011; 11598182; 11606052; 11705862; 11762702; 11796725; 11876751; 11935340; 11940298; 12032189; 12034345; 12063180; 12081564; 12082592; 12147251; 12150976; 12218659; 12376362; 12406369; 12452001; 12475252; 12477932; 12479097; 12496489; 12538453; 12612199; 12614934; 12620441; 12626459; 12634064; 12651627; 12704667; 12714508; 12717827; 12771930; 12791318; 12834347; 12846741; 12861139; 12869573; 12873541; 12904305; 12921631; 12951656; 12970724; 14517716; 14605322; 14622947; 14630798; 14648584; 14652000; 14661256; 14669348; 14688084; 14710472; 14734567; 14871825; 14962256; 14973177; 14983226; 15028476; 15051730; 15073104; 15161657; 15225209; 15248826; 15277439; 15287862; 15313474; 15340161; 15363817; 15363818; 15465038; 15479729; 15485866; 15489334; 15494493; 15515157; 15516987; 15530852; 15557756; 15616792; 15754326; 15754388; 15797648; 15818737; 15841325; 15867221; 15888067; 15890357; 15896974; 15944607; 16005367; 16019435; 16042227; 16061701; 16100012; 16103240; 16107690; 16169070; 16188099; 16191301; 16219294; 16248458; 16263699; 16269968; 16280123; 16288711; 16289162; 16303743; 16335952; 16372907; 16407831; 16410344; 16474379; 16496359; 16555295; 16615041; 16631927; 16740002; 16754484; 16767366; 16772717; 16786122; 16840178; 16864898; 16877361; 16880228; 16917503; 16931892; 16935611; 16940985; 16960901; 16996520; 17008230; 17009408; 17012236; 17045024; 17050530; 17071711; 17072372; 17114213; 17136882; 17162914; 17182940; 17192464; 17202148; 17205957; 17209789; 17222415; 17226791; 17299802; 17301822; 17340613; 17350093; 17380436; 17409012; 17456311; 17478562; 17489740; 17493602; 17543340; 17549663; 17564313; 17572998; 17589947; 17634538; 17660250; 17703334; 17726014; 17763191; 17786346; 17878270; 17893005; 17899257; 17920311; 17928006; 17998244; 18025061; 18034264; 18042068; 18049028; 18063811; 18159069; 18214300; 18217401; 18236174; 18273688; 18291374; 18292822; 18298349; 18385523; 18391843; 18395263; 18474748; 18477480; 18487063; 18502033; 18630499; 18634035; 18636124; 18645261; 18683786; 18692810; 18704317; 18787947; 18850474; 18854176; 18945772; 18984437; 19012952; 19019896; 19020757; 19036126; 19134356; 19141395; 19246282; 19288452; 19331801; 19336475; 19358835; 19383295; 19383343; 19383344; 19387352; 19390929; 19430729; 19464975; 19506087; 19513566; 19524176; 19551542; 19560452; 19596921; 19608737; 19609944; 19629003; 19637058; 19653096; 19717938; 19723139; 19723899; 19728856; 19747478; 19758569; 19766963; 19781774; 19796534; 19814619; 19863693; 19875168; 19887890; 19889076; 19904223; 19911067; 19913121; 19927649; 20021931; 20030715; 20039537; 20041335; 20051489; 20095885; 20111696; 20164040; 20193458; 20215736; 20298300; 20305574; 20361393; 20371206; 20388222; 20423842; 20450704; 20452482; 20459644; 20484597; 20514432; 20533294; 20545111; 20545310; 20556397; 20584750; 20587546; 20595097; 20616161; 20628086; 20628624; 20646231; 20654099; 20655547; 20673868; 20685094; 20707923; 20798956; 20838751; 20853162; 20854182; 20889295; 20921293; 21041986; 21086628; 21094936; 21115936; 21128246; 21139048; 21163810; 21165404; 21167221; 21211402; 21283828; 21427648; 21437624; 21437772; 21454617; 21463121; 21487066; 21506705; 21524282; 21535601; 21547130; 21586274; 21684102; 21709637; 21720458; 21731773; 21745383; 21763297; 21786179; 21858035; 21860087; 21881840; 21882477; 21903858; 21906983; 21928345; 21946941; 21963094; 21963718; 21969093; 21987572; 21993004; 21995626; 22016393; 22020222; 22051851; 22110238; 22122951; 22139647; 22177802; 22199358; 22200256; 22200690; 22200710; 22204652; 22223664; 22257687; 22268729; 22286923; 22289852; 22291969; 22305865; 22364921; 22397869; 22402936; 22427646; 22457727; 22465225; 22516898; 22532131; 22544540; 22547904; 22558080; 22645431; 22667130; 22671570; 22706255; 22712305; 22718114; 22739984; 22788708; 22820628; 22859303; 22883459; 22901654; 22906271; 22957045; 22965799; 22971139; 22975753; 22985578; 23000965; 23016931; 23043898; 23057632; 23060593; 23064462; 23107442; 23122949; 23158994; 23175213; 23179318; 23223421; 23318123; 23388475; 23407481; 23412981; 23457635; 23509357; 23522389; 23525523; 23548070; 23555182; 23557756; 23563628; 23583449; 23592002; 23650722; 23660069; 23673111; 23763354; 23768069; 23815085; 23817219; 23834019; 23881388; 23893334; 23967215; 23993112; 24039251; 24174628; 24330623; 24479343,,,,,,,,,,,,,,,,,,OGG:3000007076,,,,,,,,,,,,,,,,,,,TIMP metallopeptidase inhibitor 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TIMP1,,,20140408,7076,RP1-230G1.3,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TIMP1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000003454,IFNAR1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IFNBR|AVP|IFRC|IFNAR|IFN-alpha-REC,,,,,,,21,,,,,,,,,,Vega:OTTHUMG00000065126|HGNC:5432|MIM:107450|Ensembl:ENSG00000142166|HPRD:00126,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interferon (alpha, beta and omega) receptor 1",,21q22.11,,,,"GO_0004905 (EC: TAS, PMID: 7665574); GO_0005515 (EC: IPI, PMID: 12220192); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 8181059); GO_0007166 (EC: TAS, PMID: 7665574); GO_0007259 (EC: TAS, PMID: 7665574); GO_0009615 (EC: TAS, PMID: 2153461); GO_0019221 (EC: TAS); GO_0032729 (EC: IEA); GO_0042110 (EC: IEA); GO_0045351 (EC: IEA); GO_0051607 (EC: IEA); GO_0060337 (EC: TAS); GO_0060338 (EC: TAS)",PMID: 1350660; 1370833; 1834641; 2148760; 2153461; 7526154; 7559568; 7665574; 7932753; 8125298; 8181059; 8524272; 8605876; 8626489; 9029147; 9121453; 9174595; 9225992; 9403695; 9677371; 9733772; 10490982; 10542297; 10830953; 11167825; 11301323; 11694501; 11786546; 12220192; 12477932; 12554654; 12618863; 12620806; 12697242; 12761564; 14532120; 14647450; 14727154; 15063762; 15337770; 15356134; 15389589; 15449939; 15489334; 15589821; 15885318; 15946680; 15990456; 16171819; 16338279; 16624932; 17001036; 17027223; 17125879; 17310065; 17517919; 17667505; 17703412; 17823081; 17923090; 18056411; 18166147; 18250407; 18338947; 18362156; 18474601; 18535656; 18761606; 18801736; 18937499; 18953482; 19103527; 19124753; 19220955; 19258923; 19299650; 19434718; 19453261; 19501422; 19559055; 19561067; 19730683; 19773451; 19796549; 19805514; 19817957; 19879773; 19913121; 19948722; 19957332; 20020050; 20065083; 20237496; 20331378; 20378664; 20503287; 20565290; 20588308; 20628086; 20811626; 21139048; 21173164; 21540188; 21690295; 21695243; 21716316; 21756311; 21757742; 21821707; 21830897; 21832278; 21865166; 22036215; 22136495; 22156349; 22162633; 22218495; 22258259; 22786773; 22824466; 23128233; 23129613; 23201923; 23209811; 23663046; 24250222,,,,,,,,,,,,,,,,,,OGG:3000003454,,,,,,,,,,,,,,,,,,,"interferon (alpha, beta and omega) receptor 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IFNAR1,,,20140408,3454,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IFNAR1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0099006,viral entry via permeabilization of endosomal membrane,viral penetration via permeabilization of host membrane,"The entry of a non-enveloped virus into a host eukaryotic cell, following endocytosis, via permeabilization of the endosomal membrane by membrane penetration protein(s) associated with the viral capsid.  In some cases, viral membrane-penetration protein require first to be activated to display its membrane penetrating activity. Activation can be due to receptor binding or the acidic pH of the endosomal lumen.",false,,,http://purl.obolibrary.org/obo/GO_0140267,,,,,,,,,,,,,,,,,,,,VZ:985,"The entry of a non-enveloped virus into a host eukaryotic cell, following endocytosis, via permeabilization of the endosomal membrane by membrane penetration protein(s) associated with the viral capsid.  In some cases, viral membrane-penetration protein require first to be activated to display its membrane penetrating activity. Activation can be due to receptor binding or the acidic pH of the endosomal lumen.",,,,,,,,,,,,,,,,,,,,,,,,,,,,viral penetration via permeabilization of host membrane,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0140267,,,,GO:0099006,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32236561,,,,GO:0099006,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral entry via permeabilization of endosomal membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016054,organic acid catabolic process,organic acid degradation|organic acid breakdown|organic acid catabolism,"The chemical reactions and pathways resulting in the breakdown of organic acids, any acidic compound containing carbon in covalent linkage.",false,,,http://purl.obolibrary.org/obo/GO_0044282,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of organic acids, any acidic compound containing carbon in covalent linkage.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,organic acid degradation|organic acid breakdown|organic acid catabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044282,,,,GO:0016054,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016054,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,organic acid catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034399,nuclear periphery,,The portion of the nuclear lumen proximal to the inner nuclear membrane.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The portion of the nuclear lumen proximal to the inner nuclear membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0034399,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034399,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nuclear periphery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_65347,carfilzomib,N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide|carfilzomib|Kyprolis,"A synthetic tetrapeptide consisting of morpholin-4-acetyl, L-2-amino-4-phenylbutanoyl, L-leucyl and L-phenylalanyl residues joined in sequence with the C-terminus connected to the amino group of (2S)-2-amino-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-1-one via an amide linkage. Used for the treatment of patients with multiple myeloma",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:21905015|PMID:22411899|Drug_Central:4483|PMID:22555973|PMID:22763387|PMID:22645181|CAS:868540-17-4|PMID:22734651|PMID:20937826|KEGG:D08880|PMID:22727391|PMID:22726549|PMID:22621161|PMID:22665938|PMID:19348473|PMID:22507799|PMID:22761464|Wikipedia:Carfilzomib|Reaxys:12488950|PMID:22235146|PMID:22507794,"A synthetic tetrapeptide consisting of morpholin-4-acetyl, L-2-amino-4-phenylbutanoyl, L-leucyl and L-phenylalanyl residues joined in sequence with the C-terminus connected to the amino group of (2S)-2-amino-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-1-one via an amide linkage. Used for the treatment of patients with multiple myeloma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide,,,,,chebi_ontology,,carfilzomib|Kyprolis,,,,,,,,,0,C40H57N5O7,"InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1",BLMPQMFVWMYDKT-NZTKNTHTSA-N,719.911,719.42580,C(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C([C@@]1(OC1)C)=O)CC(C)C)=O)CC2=CC=CC=C2)=O)CC(C)C)=O)CCC3=CC=CC=C3)=O)N4CCOCC4,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:65347,,,,,true,true,,,,,,,,,CHEBI:65347,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,carfilzomib,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_12059,Enterovirus,Enteroviruses,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_12058,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:12128,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,Enteroviruses,,,,,,NCBITaxon:12059,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_12058,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Enterovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_50667,mercaptopurine,"1,7-dihydro-6H-purine-6-thione|Mercaptopurine|mercaptopurine|Mercapurin|6-Thioxopurine|Purinethol|6-MP|6-Thiohypoxanthine|Mercaptopurina|6-Mercaptopurine|mercaptopurinum|6 MP|mercaptopurine|Puri-Nethol","A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6. An adenine analogue, it is used in the treatment of acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:28484608|Beilstein:132916|KEGG:C02380|PMID:28574837|PMID:16267626|Reaxys:132916|PMID:28166217|Patent:US2697709|Patent:US2721866|PDBeChem:PM6|KEGG:D04931|CAS:50-44-2|PMID:28406092|PMID:28295989|PMID:28301625|DrugBank:DB01033|PMID:28011186|PMID:28212467|PMID:28418010,"A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6. An adenine analogue, it is used in the treatment of acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1,7-dihydro-6H-purine-6-thione|Mercaptopurine|mercaptopurine",,,,,chebi_ontology,,Mercapurin|6-Thioxopurine|Purinethol|6-MP|6-Thiohypoxanthine|Mercaptopurina|6-Mercaptopurine|mercaptopurinum|6 MP|mercaptopurine|Puri-Nethol,,,,,,,,,0,C5H4N4S,"InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",GLVAUDGFNGKCSF-UHFFFAOYSA-N,152.17822,152.01567,S=c1[nH]cnc2nc[nH]c12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50667,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:50667,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,mercaptopurine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC8,ORF8 protein (SARS-CoV-2),ns8 (SARS2)|ORF8 (SARS2)|non-structural protein 8 (SARS2)|ORF8|GU280_gp09,A protein that is a translation product of the ORF8 gene in SARS-CoV-2.|Category=organism-gene. Note: 121 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,UniProtKB:P0DTC8|GenPept:YP_009724396,A protein that is a translation product of the ORF8 gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ns8 (SARS2)|ORF8 (SARS2),,,,,protein,,non-structural protein 8 (SARS2)|ORF8|GU280_gp09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 121 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC8,,,,,,true,,,,,,,,,PR:P0DTC8,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,ORF8 protein (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035967,cellular response to topologically incorrect protein,cellular response to misfolded or unfolded protein,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure.",false,,,http://purl.obolibrary.org/obo/GO_0033554|http://purl.obolibrary.org/obo/GO_0035966,,,,,,,,,,,,,,,,rfoulger,2011-08-03T11:44:50Z,,,,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,cellular response to misfolded or unfolded protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033554|http://purl.obolibrary.org/obo/GO_0035966,,,,GO:0035967,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035967,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cellular response to topologically incorrect protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003574,IL7,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL-7,,,,,,,8,,,,,,,,,,HGNC:6023|HPRD:00892|MIM:146660|Vega:OTTHUMG00000164620|Ensembl:ENSG00000104432,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 7,,8q12-q13,,,,"GO_0002360 (EC: IEA); GO_0005125 (EC: IEA); GO_0005139 (EC: IEA); GO_0005515 (EC: IPI, PMID: 8266077); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006959 (EC: TAS, PMID: 2643102); GO_0007267 (EC: TAS, PMID: 2643102); GO_0008083 (EC: ISS); GO_0008284 (EC: TAS, PMID: 2643102); GO_0009887 (EC: TAS, PMID: 2643102); GO_0010468 (EC: IEA); GO_0030890 (EC: ISS); GO_0043066 (EC: ISS); GO_0043086 (EC: IEA); GO_0045453 (EC: ISS); GO_0045582 (EC: ISS); GO_0046622 (EC: IEA); GO_0048873 (EC: IEA); GO_2001240 (EC: IEA)",PMID: 2320434; 2329282; 2643102; 2786840; 7686307; 7769137; 8125298; 8266077; 8473051; 8840152; 8862549; 9010926; 9158092; 9200446; 9215626; 9407080; 9475337; 9493287; 9561370; 10390077; 10850801; 11447288; 11564764; 11672535; 11858939; 11927620; 11929775; 12010786; 12027403; 12072494; 12149213; 12427286; 12433286; 12441142; 12477932; 12742982; 12792903; 12816983; 12847229; 12882655; 14530372; 14601648; 14607751; 14978141; 15028279; 15048088; 15133032; 15226432; 15247003; 15353558; 15489334; 15598813; 15630452; 15911446; 15964403; 15993713; 16162475; 16284535; 16322477; 16344560; 16626395; 16709829; 16923550; 16967044; 17053062; 17110377; 17205128; 17284597; 17296584; 17328044; 17373935; 17438097; 17524612; 17584976; 17635814; 17656007; 17665400; 17703412; 17894415; 17909291; 17913246; 17956896; 18158957; 18289383; 18322183; 18390701; 18401975; 18431516; 18441236; 18949045; 18976766; 19001329; 19002156; 19008454; 19092841; 19141282; 19147839; 19155487; 19230961; 19240061; 19248116; 19258923; 19279003; 19299724; 19366834; 19432535; 19675167; 19714586; 19770269; 19796902; 19847194; 19864382; 19889552; 19904747; 19913121; 19923894; 20035760; 20067635; 20089933; 20131250; 20167604; 20190192; 20190194; 20200205; 20226540; 20237496; 20382196; 20386468; 20465565; 20503287; 20505146; 20546594; 20628086; 20660706; 20673240; 20815339; 21048031; 21159243; 21209878; 21239710; 21257970; 21418620; 21455214; 21647866; 21680796; 21711552; 21753149; 21795588; 21832049; 21833088; 21876448; 21912394; 21920046; 21988832; 22027639; 22113713; 22194871; 22247488; 22312161; 22314878; 22384197; 22398700; 22506826; 22618230; 22795293; 22859301; 22897934; 22911005; 22921903; 22949940; 22955921; 23018454; 23053510; 23129754; 23157741; 23160470; 23188693; 23244154; 23325887; 23437070; 23454692; 23454917; 23554911; 23628622; 23963040; 23966629,,,,,,,,,,,,,,,,,,OGG:3000003574,,,,,,,,,,,,,,,,,,,interleukin 7,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32169119,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL7,,,20140408,3574,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL7,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0033046,negative regulation of sister chromatid segregation,,"Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid segregation.",false,,,http://purl.obolibrary.org/obo/GO_2001251|http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_0010948|http://purl.obolibrary.org/obo/GO_0051985,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid segregation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_2001251|http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_0010948|http://purl.obolibrary.org/obo/GO_0051985,,,,GO:0033046,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033046,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of sister chromatid segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031965,nuclear membrane,,Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1687101204,Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0031965,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031965,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nuclear membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072525,pyridine-containing compound biosynthetic process,pyridine-containing compound biosynthesis|pyridine and derivative biosynthetic process|pyridine-containing compound anabolism|pyridine-containing compound synthesis|pyridine-containing compound formation,"The chemical reactions and pathways resulting in the formation of a pyridine-containing compound, i.e. any compound that contains pyridine or a formal derivative thereof.",false,,,http://purl.obolibrary.org/obo/GO_0072524,,,,,,,,,,,,,,,,midori,2011-01-04T03:23:01Z,,,,"The chemical reactions and pathways resulting in the formation of a pyridine-containing compound, i.e. any compound that contains pyridine or a formal derivative thereof.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pyridine-containing compound biosynthesis|pyridine and derivative biosynthetic process|pyridine-containing compound anabolism|pyridine-containing compound synthesis|pyridine-containing compound formation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072524,,,,GO:0072525,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072525,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pyridine-containing compound biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006730,one-carbon metabolic process,one-carbon metabolism|one carbon metabolic process|one carbon metabolism|one-carbon transfer metabolic process|one-carbon transfer metabolism,The chemical reactions and pathways involving the transfer of one-carbon units in various oxidation states.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,UM-BBD_pathwayID:C1cyc,The chemical reactions and pathways involving the transfer of one-carbon units in various oxidation states.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019754|GO:0019753,,,,one-carbon metabolism|one carbon metabolic process|one carbon metabolism|one-carbon transfer metabolic process|one-carbon transfer metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006730,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006730,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,one-carbon metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0004332,Abnormal lymphocyte morphology,Abnormal lymphocytes|Abnormality of cells of the lymphoid lineage,"An abnormality of lymphocytes.|A lymphocyte refers to a cell of the B cell, T cell, or natural killer cell lineage.",false,,,http://purl.obolibrary.org/obo/HP_0001881,,,,,,,,,,,,,,,,peter,2008-02-28T06:46:00Z,,,UMLS:C0427546|SNOMEDCT_US:250284007,An abnormality of lymphocytes.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0012140|HP:0001887,,,,Abnormal lymphocytes|Abnormality of cells of the lymphoid lineage,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"A lymphocyte refers to a cell of the B cell, T cell, or natural killer cell lineage.",,http://purl.obolibrary.org/obo/HP_0001881,,,,HP:0004332,,,,,,,,,,,,,,,HP:0004332,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal lymphocyte morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003456,IFNB1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IFB|IFNB|IFF,,,,,,,9,,,,,,,,,,HGNC:5434|Ensembl:ENSG00000171855|HPRD:00972|Vega:OTTHUMG00000019652|MIM:147640,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interferon, beta 1, fibroblast",,9p21,,,,"GO_0002250 (EC: IEA); GO_0002286 (EC: IBA); GO_0002312 (EC: IMP, PMID: 12932356); GO_0002323 (EC: IBA); GO_0005125 (EC: IBA); GO_0005125 (EC: IDA, PMID: 19008854); GO_0005132 (EC: NAS, PMID: 2414376); GO_0005576 (EC: IC, PMID: 2414376); GO_0005576 (EC: TAS); GO_0005615 (EC: IBA); GO_0006959 (EC: IBA); GO_0007166 (EC: TAS, PMID: 10640778); GO_0007596 (EC: TAS); GO_0009615 (EC: NAS, PMID: 12120696); GO_0019221 (EC: IBA); GO_0019221 (EC: TAS); GO_0030101 (EC: NAS, PMID: 11987821); GO_0030183 (EC: IBA); GO_0033141 (EC: IDA, PMID: 18035482); GO_0042100 (EC: NAS, PMID: 3135963); GO_0042742 (EC: IEA); GO_0043330 (EC: IDA); GO_0045071 (EC: IDA, PMID: 19008854); GO_0045087 (EC: TAS); GO_0045089 (EC: NAS, PMID: 11987821); GO_0045343 (EC: NAS, PMID: 8805651); GO_0045581 (EC: IDA); GO_0045944 (EC: IDA, PMID: 18035482); GO_0051607 (EC: TAS, PMID: 19416887); GO_0060337 (EC: TAS); GO_0060338 (EC: TAS); GO_0071360 (EC: TAS); GO_2000552 (EC: IDA); GO_2001235 (EC: IDA, PMID: 10918594)",PMID: 1708818; 1834641; 2414376; 3135963; 3667593; 3872918; 6157094; 6157601; 6159580; 6159584; 6159597; 6162107; 6164984; 6171735; 6178110; 6183692; 6500557; 6762376; 7532202; 7913356; 8083608; 8107259; 8605876; 8661419; 8805651; 9225992; 9342320; 9713311; 10229237; 10395669; 10482360; 10640778; 10918594; 10963806; 11337497; 11694501; 11781186; 11972054; 11987821; 12050353; 12068083; 12089333; 12096926; 12097388; 12120696; 12184914; 12405292; 12477932; 12581491; 12761564; 12847277; 12932356; 14519761; 14519765; 14727154; 14747551; 15004750; 15107417; 15163707; 15163721; 15280450; 15340234; 15481145; 15489334; 15557158; 15621727; 15652402; 15737993; 15752772; 15767399; 16002711; 16185826; 16338279; 16375755; 16504056; 16504464; 16505900; 16545883; 16593086; 16631220; 16697656; 16873258; 16951313; 16954376; 16984921; 16989575; 17079289; 17142768; 17167270; 17182689; 17215277; 17328045; 17548221; 17560375; 17574024; 17652396; 17675303; 17968925; 17968926; 17985330; 18035482; 18209079; 18272195; 18322185; 18370868; 18381783; 18382694; 18389079; 18420941; 18437017; 18571728; 18581327; 18611945; 18614013; 18614628; 18641315; 18653385; 18653650; 18708672; 18715339; 18771559; 18781139; 18823997; 18989459; 19008854; 19017631; 19017982; 19017994; 19056675; 19201909; 19240061; 19351494; 19353519; 19380831; 19416887; 19449179; 19453261; 19546225; 19564073; 19564411; 19622906; 19667093; 19728309; 19758707; 19795416; 19804729; 19833099; 19846511; 19898481; 19913121; 19934272; 20007272; 20048166; 20127681; 20154210; 20174559; 20181693; 20187765; 20237496; 20331378; 20375222; 20404187; 20518826; 20519382; 20538852; 20554782; 20561040; 20573816; 20574843; 20588308; 20592282; 20628086; 20631305; 20699220; 20711230; 20844191; 20846052; 20850164; 21040977; 21068253; 21071089; 21113677; 21115688; 21129405; 21160051; 21170271; 21170385; 21213104; 21228327; 21276246; 21288362; 21320124; 21321205; 21325029; 21361792; 21368231; 21389130; 21518144; 21652010; 21690236; 21698224; 21764463; 21778165; 21792910; 21829730; 21855056; 21886773; 21886806; 21889215; 21897875; 21952237; 22072748; 22112394; 22149411; 22192711; 22200507; 22222875; 22226324; 22258259; 22278222; 22293894; 22301134; 22344395; 22383950; 22396773; 22396801; 22442431; 22527232; 22531926; 22629479; 22674996; 22698399; 22730532; 22731491; 22738830; 22745372; 22814248; 22842821; 22843696; 22879913; 22889324; 22938469; 22951153; 22970235; 22992810; 23008447; 23056170; 23166786; 23221969; 23284052; 23333334; 23383510; 23396947; 23449998; 23507702; 23518714; 23552410; 23616277; 23631912; 23649622; 23675467; 23685241; 23686695; 23814052; 23824799; 23986588; 23990053; 24049179; 24067967; 24144296; 24227842,,,,,,,,,,,,,,,,,,OGG:3000003456,,,,,,,,,,,,,,,,,,,"interferon, beta 1, fibroblast",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32186952/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IFNB1,,,20140408,3456,RP11-113D19.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IFNB1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/UBERON_0003103,compound organ,organ,Anatomical structure that has as its parts two or more multi-tissue structures of at least two different types and which through specific morphogenetic processes forms a single distinct structural unit demarcated by bona fide boundaries from other distinct anatomical structures of different types.,false,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,,,,,,,,,,,,,,,,"this class was introduced for consistency with CARO. However, in this ontology we typically classify organs directly under 'organ' rather than subdividing into compound and simple organs",CARO:0000024|VHOG:0001723|AAO:0010015|EHDAA2:0003024|ZFA:0000496|BILA:0000024|TADS:0000598|TGMA:0001837|TAO:0000496|HAO:0000024|AEO:0000024|XAO:0003041,Anatomical structure that has as its parts two or more multi-tissue structures of at least two different types and which through specific morphogenetic processes forms a single distinct structural unit demarcated by bona fide boundaries from other distinct anatomical structures of different types.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,UBERON:0003103,,,,,,,,,,,,,,,UBERON:0003103,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim,,,,,,,,,,compound organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1902749,regulation of cell cycle G2/M phase transition,,Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_1901987,,,,,,,,,,,,,,,,jl,2014-03-05T15:38:15Z,,,,Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901987,,,,GO:1902749,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902749,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of cell cycle G2/M phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030261,chromosome condensation,DNA condensation|eukaryotic chromosome condensation|nuclear chromosome condensation,"The progressive compaction of dispersed interphase chromatin into threadlike chromosomes prior to mitotic or meiotic nuclear division, or during apoptosis, in eukaryotic cells.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The progressive compaction of dispersed interphase chromatin into threadlike chromosomes prior to mitotic or meiotic nuclear division, or during apoptosis, in eukaryotic cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000068,DNA condensation,,,eukaryotic chromosome condensation|nuclear chromosome condensation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0030261,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030261,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,chromosome condensation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_557,kidney disease,impaired renal function disease|nephropathy,A urinary system disease that is located_in the kidney.,false,,,http://purl.obolibrary.org/obo/DOID_18,,,,,,,,,,,,,,,,,,,,MESH:D007674|EFO:0003086|ICD10CM:N08|NCI:C3149|SNOMEDCT_US_2019_09_01:90708001|UMLS_CUI:C0022658,A urinary system disease that is located_in the kidney.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:11705,,,,impaired renal function disease|nephropathy,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_18,,,,DOID:557,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,DOID:557,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,kidney disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000027,white blood cell count,,The number of white blood cells in a specified volume of blood.,false,,,http://purl.obolibrary.org/obo/CMO_0000036,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000027,,,,,,,,,,,,The number of white blood cells in a specified volume of blood.,,,,,,,,,,,,white corpuscle count|leukocyte count,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000036,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113704,,leukocyte numbers,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,white blood cell count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTD1-1,replicase polyprotein 1ab (SARS-CoV-2),pp1ab (SARS2)|PRO_0000449618|ORF1ab polyprotein (SARS2)|rep/iso:ORF1ab (SARS2),A rep gene translation product (SARS-CoV-2) that is a translation product of some mRNA giving rise to a protein with the amino acid sequence represented by UniProtKB:P0DTD1-1. Requires ribosomal frameshifting.|Category=organism-sequence. Note: 7096 aa protein. Undergoes additional processing by proteolytic cleavage.,false,,,http://purl.obolibrary.org/obo/PR_000050263,,,,,,,,,,,,,,,,,,,,UniProtKB:P0DTD1|GenPept:YP_009724389,A rep gene translation product (SARS-CoV-2) that is a translation product of some mRNA giving rise to a protein with the amino acid sequence represented by UniProtKB:P0DTD1-1. Requires ribosomal frameshifting.,,,,,,,,,,,,,,,,,,,,,,,,,,,PR:P0DTD1,,,,pp1ab (SARS2)|PRO_0000449618|ORF1ab polyprotein (SARS2)|rep/iso:ORF1ab (SARS2),,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-sequence. Note: 7096 aa protein. Undergoes additional processing by proteolytic cleavage.,,http://purl.obolibrary.org/obo/PR_000050263,,,,PR:P0DTD1-1,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,PR:P0DTD1-1,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,replicase polyprotein 1ab (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016999,antibiotic metabolic process,antibiotic metabolism,"The chemical reactions and pathways involving an antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving an antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,antibiotic metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0016999,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016999,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antibiotic metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000054,fluid management,,,false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,Medical intervention,,true,,,,,,"Fluid management is a critical aspect of patient care, especially in the inpatient medical setting. What makes fluid management both challenging and interesting is that each patient demands careful consideration of their individual fluid needs",,,,,,,,,,,,,,,,fluid management,,,,,,,,,,,,,,,,,,,,,,https://www.mohfw.gov.in/pdf/GuidelinesonClinicalManagementofCOVID1912020.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_4659,disulfiram,"1,1',1'',1'''-[disulfanediylbis(carbonothioylnitrilo)]tetraethane|Disulfiram|bis(diethylthiocarbamoyl) disulfide|Tetraethylthiuram disulfide|Antabuse|tetraethylthioperoxydicarbonic diamide|tetraethylthiuram disulfide|N,N,N',N'-tetraethylthiuram disulfide|tetraethylthiuram disulphide|1,1'-dithiobis(N,N-diethylthioformamide)","An organic disulfide that results from the formal oxidative dimerisation of N,N-diethyldithiocarbamic acid.  A multi-enzyme inhibitor that is used in alcohol aversion therapy and also exhibits anticancer properties.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:26550292|Wikipedia:Disulfiram|PMID:25557293|PMID:21471244|PMID:16661923|PMID:10841824|PMID:25464072|PMID:24496638|PMID:15709459|PMID:11716515|PMID:17667894|PMID:26314552|PMID:25565438|PMID:25777347|PMID:26224731|PMID:26517513|PMID:16426571|PMID:25133664|KEGG:D00131|DrugBank:DB00822|PMID:19720750|Drug_Central:928|PMID:8572926|PMID:25445071|PMID:25495604|PMID:14978246|PMID:11005259|HMDB:HMDB0014960|Reaxys:1712560|PMID:26033731|PMID:15325261|PMID:16880974|PMID:16666414|PMID:25657800|PMID:25476326|PMID:19787200|PMID:26239994|PMID:18579431|PMID:17079463|CAS:97-77-8|KEGG:C01692|PMID:17579916|LINCS:LSM-5467|PMID:8442800|PMID:26235918|PMID:19782464,"An organic disulfide that results from the formal oxidative dimerisation of N,N-diethyldithiocarbamic acid.  A multi-enzyme inhibitor that is used in alcohol aversion therapy and also exhibits anticancer properties.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1,1',1'',1'''-[disulfanediylbis(carbonothioylnitrilo)]tetraethane|Disulfiram",,,,,chebi_ontology,,"bis(diethylthiocarbamoyl) disulfide|Tetraethylthiuram disulfide|Antabuse|tetraethylthioperoxydicarbonic diamide|tetraethylthiuram disulfide|N,N,N',N'-tetraethylthiuram disulfide|tetraethylthiuram disulphide|1,1'-dithiobis(N,N-diethylthioformamide)",,,,,,,,,0,C10H20N2S4,"InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3",AUZONCFQVSMFAP-UHFFFAOYSA-N,296.544,296.05093,S(SC(N(CC)CC)=S)C(N(CC)CC)=S,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:4659,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:4659,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,disulfiram,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PATO_0002146,virulence,,A quality inhering in a bearer by virtue of the severity of infectious disease caused by the bearer in a target organism.,false,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,,,,,,,,,george,2009-10-30T05:04:06Z,,,,A quality inhering in a bearer by virtue of the severity of infectious disease caused by the bearer in a target organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,quality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,PATO:0002146,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142938,,,,PATO:0002146,,http://purl.obolibrary.org/obo/pato.owl,http://purl.oboInOwllibrary.org/oboInOwl/pato#attribute_slim|http://purl.oboInOwllibrary.org/oboInOwl/pato#scalar_slim,,,,,,,,,,virulence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007535,ZAP70,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,ZAP-70|SRK|STD|TZK|STCD,,,,,,,2,,,,,,,,,,Vega:OTTHUMG00000153060|HGNC:12858|HPRD:01495|MIM:176947|Ensembl:ENSG00000115085,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,zeta-chain (TCR) associated protein kinase 70kDa,,2q12,,,,"GO_0001772 (EC: IEA); GO_0001784 (EC: IEA); GO_0002250 (EC: TAS); GO_0004713 (EC: IDA, PMID: 12447358); GO_0004713 (EC: NAS, PMID: 1423621); GO_0004713 (EC: TAS); GO_0004715 (EC: TAS); GO_0005515 (EC: IPI, PMID: 10318843); GO_0005524 (EC: NAS, PMID: 1423621); GO_0005737 (EC: TAS, PMID: 12359715); GO_0005829 (EC: TAS); GO_0005886 (EC: IDA, PMID: 12150984); GO_0005886 (EC: TAS); GO_0006468 (EC: IDA, PMID: 12447358); GO_0006468 (EC: NAS, PMID: 1423621); GO_0006955 (EC: IDA, PMID: 1423621); GO_0018108 (EC: IDA); GO_0030217 (EC: NAS, PMID: 8613493); GO_0035556 (EC: NAS, PMID: 1423621); GO_0042101 (EC: IDA, PMID: 8176201); GO_0042110 (EC: TAS); GO_0042113 (EC: TAS); GO_0043366 (EC: IEA); GO_0045059 (EC: IDA, PMID: 7630421); GO_0045060 (EC: IEA); GO_0045121 (EC: IDA, Qualifier: colocalizes_with, PMID: 12150984); GO_0045582 (EC: IDA, PMID: 7630421); GO_0046638 (EC: IEA); GO_0046641 (EC: IEA); GO_0046777 (EC: IEA); GO_0050850 (EC: IEA); GO_0050852 (EC: TAS); GO_0070489 (EC: TAS); GO_0072678 (EC: TAS)",PMID: 1423621; 7522245; 7528772; 7539035; 7629168; 7630421; 7737297; 7760813; 7761456; 7798261; 7819147; 7961936; 8082894; 8176201; 8202712; 8202713; 8366117; 8530437; 8613493; 8621646; 8638162; 8702662; 8756661; 8761298; 8798643; 8906806; 8943371; 9036949; 9047237; 9169414; 9269777; 9362531; 9378960; 9403695; 9407100; 9464824; 9490415; 9685404; 9698567; 9846481; 9988730; 10037717; 10074432; 10078535; 10209036; 10221598; 10318843; 10419455; 10449770; 10458769; 10660534; 10779765; 10790433; 10867021; 10966114; 10979964; 11048639; 11133830; 11279207; 11353765; 11368773; 11390470; 11412303; 11572860; 11781312; 11855827; 11891219; 11964272; 11976341; 12051764; 12084069; 12150984; 12154360; 12165490; 12186560; 12190313; 12359715; 12387734; 12393534; 12447358; 12450381; 12477932; 12504004; 12522270; 12595313; 12646565; 12648457; 12778467; 12817019; 12847255; 14523017; 14557276; 14560012; 14672952; 14766232; 14985102; 15059847; 15084271; 15100278; 15133473; 15143214; 15144186; 15190462; 15292186; 15358536; 15370248; 15489334; 15514014; 15536084; 15588985; 15592455; 15688026; 15699074; 15735648; 15759031; 15800671; 15856008; 15861514; 15923611; 15972449; 15996927; 16079094; 16079107; 16094384; 16096284; 16219325; 16263570; 16273093; 16291755; 16300468; 16339550; 16406604; 16412387; 16418492; 16461343; 16467082; 16467851; 16503409; 16538501; 16642047; 16823829; 16888650; 16906159; 16932341; 17038529; 17051526; 17192257; 17215865; 17222799; 17375875; 17492476; 17512407; 17534928; 17577788; 17652306; 17702857; 17767948; 17785822; 17926183; 17931624; 17948236; 18005690; 18022252; 18025306; 18029348; 18048647; 18190465; 18203013; 18311544; 18322442; 18333847; 18424730; 18453590; 18519230; 18577710; 18616755; 18683785; 18687687; 18689273; 18757853; 18770822; 18770856; 18818202; 18854088; 19018007; 19021053; 19050243; 19136305; 19230824; 19267204; 19297020; 19298946; 19377082; 19454010; 19575876; 19679010; 19710135; 19727816; 19826250; 19907441; 19920178; 19944462; 20001236; 20014315; 20029467; 20056178; 20132303; 20145264; 20164537; 20228263; 20301777; 20488542; 20534575; 20575031; 20637659; 20657554; 20702582; 20842205; 20864151; 20890395; 21055809; 21079155; 21200022; 21205967; 21344162; 21453975; 21463115; 21607290; 21716207; 21725281; 21832049; 21856938; 21887278; 21945028; 21988832; 22002134; 22151263; 22171799; 22207134; 22266821; 22338471; 22362302; 22505724; 22564988; 22664044; 22802418; 22839722; 22844345; 22888118; 22965421; 22971532; 22984268; 23097993; 23124046; 23245794; 23267066; 23293025; 23406209; 23514740; 23530057; 23572149; 23620790; 23786282; 23916875; 23981382; 24103478; 24219331,,,,,,,,,,,,,,,,,,OGG:3000007535,,,,,,,,,,,,,,,,,,,zeta-chain (TCR) associated protein kinase 70kDa,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ZAP70,,,20140408,7535,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,ZAP70,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0030397,membrane disassembly,membrane catabolism|membrane degradation|membrane breakdown,The controlled breakdown of any cell membrane in the context of a normal process such as autophagy.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The controlled breakdown of any cell membrane in the context of a normal process such as autophagy.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,membrane catabolism|membrane degradation|membrane breakdown,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0030397,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030397,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,membrane disassembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_7772,omeprazole,"rac-5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole|Danlox|Gastrimut|Indurgan|Audazol|Omebeta|Ceprandal|Omapren|OMEP|Ulceral|5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole|Losec|omeprazolum|Gasec|Ultop|Emeproton|Inhibitron|Prazidec|Sanamidol|Elgam|Belmazol|omeprazole|Desec|OMZ|omeprazol|Procelac|OMP|Olit|Antra|Ulcesep",A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:19236757|PMID:19383986|PMID:11459434|PMID:16259581|Wikipedia:Omeprazole|PMID:11304936|PMID:16380990|PMID:19801857|PMID:19937171|PMID:19517893|PMID:17049542|PMID:18498918|PMID:11404722|PMID:15586641|PMID:11807212|PMID:14708212|PMID:15774534|PMID:11210716|PMID:15684503|PMID:11962536|PMID:16129922|PMID:18416943|Beilstein:3628192|PMID:12135028|PMID:17384694|PMID:13680386|PMID:18616070|PMID:16440530|PMID:12235248|PMID:11568514|KEGG:D00455|PMID:15125696|Patent:EP5129|PMID:19470853|PMID:12495367|PMID:19434360|PMID:15707461|PMID:16386527|PMID:11321383|PMID:14616415|DrugBank:DB00338|PMID:11060758|PMID:11851112|PMID:16998872|PMID:19176055|PMID:18520598|PMID:16080278|PMID:18366242|PMID:14725575|KEGG:C07324|PMID:15004262|PMID:19166730|PMID:19746659|PMID:18448060|PMID:18294333|Patent:US5693818|PMID:11395292|PMID:18571645|PMID:18793272|Reaxys:3628192|PMID:19150046|PMID:16397810|PMID:18818790|PMID:15598025|PMID:16276979|PMID:11700946|Patent:US4255431|PMID:12072663|PMID:19327607|VSDB:1827|PMID:12683615|PMID:11208500|CAS:73590-58-6|PMID:11774962|PMID:17532167|PMID:19796313|PMID:11903739,A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"rac-5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole",,,,,chebi_ontology,,"Danlox|Gastrimut|Indurgan|Audazol|Omebeta|Ceprandal|Omapren|OMEP|Ulceral|5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole|Losec|omeprazolum|Gasec|Ultop|Emeproton|Inhibitron|Prazidec|Sanamidol|Elgam|Belmazol|omeprazole|Desec|OMZ|omeprazol|Procelac|OMP|Olit|Antra|Ulcesep",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:7772,,,,,true,true,,,,,,,,,CHEBI:7772,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,omeprazole,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002683,negative regulation of immune system process,down-regulation of immune system process|downregulation of immune system process|down regulation of immune system process|inhibition of immune system process,"Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,down-regulation of immune system process|downregulation of immune system process|down regulation of immune system process,,,inhibition of immune system process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0002683,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002683,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of immune system process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0001836,saliva,salivary gland secretion|sailva normalis|saliva atomaris|saliva molecularis,"A fluid produced in the oral cavity by salivary glands, typically used in predigestion, but also in other functions.",false,,,http://purl.obolibrary.org/obo/UBERON_0006314,,,,,,,,,,,,,,,,,,,,ENVO:02000036|OpenCyc:Mx4rvVjJ95wpEbGdrcN5Y29ycA|MA:0002507|EMAPA:36536|galen:Saliva|UMLS:C0036087|MESH:D012463|NCIT:C13275|BTO:0001202|GAID:1167|FMA:59862|MAT:0000444|CALOHA:TS-0891|http://en.wikipedia.org/wiki/Saliva|http://linkedlifedata.com/resource/umls/id/C0036087,"A fluid produced in the oral cavity by salivary glands, typically used in predigestion, but also in other functions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,salivary gland secretion,,,,,uberon,,sailva normalis|saliva atomaris|saliva molecularis,salivary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0006314,,,,UBERON:0001836,,,,,,,,,yes,,https://pubmed.ncbi.nlm.nih.gov/32094336/,,,,UBERON:0001836,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim,,,,,,,,,,saliva,,,,,,,,,,,,,,,,,,,,,,,,,,,"We classify a wide variety of not necessarily homologous fluids here. In humans, the saliva is a turbid and slightly viscous fluid, generally of an alkaline reaction, and is secreted by the parotid, submaxillary, and sublingual glands. In the mouth the saliva is mixed with the secretion from the buccal glands. In man and many animals, saliva is an important digestive fluid on account of the presence of the peculiar enzyme, ptyalin",,,,,
http://purl.obolibrary.org/obo/NCBITaxon_239243,SARS coronavirus CUHK-AG03,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:239243,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CUHK-AG03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000025,coughing by symptomatic patient,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,Modified definition,,,behaviour process,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32105090|https://www.ncbi.nlm.nih.gov/pubmed/32166607,Coughing by symptomatic patients.,,,,,,,,,,,,,,,,coughing by symptomatic patient,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_17154,nicotinamide,NICOTINAMIDE|nicotinamide|Nicotinamide|pyridine-3-carboxamide|Vitamin PP|Nikotinamid|Nicotinamid|Nikotinsaeureamid|vitamin B3|niacin|beta-pyridinecarboxamide|Nicotinic acid amide|Niacinamide|3-pyridinecarboxamide|Nicotinsaeureamid,A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,CAS:98-92-0|Wikipedia:Nicotinamide|MetaCyc:NIACINAMIDE|PMID:22232263|PMID:25504347|PMID:17129213|PMID:16871361|PMID:22207684|PMID:18930755|PMID:22281243|PDBeChem:NCA|PMID:22407380|PMID:19539713|PMID:17021258|PMID:18234191|PMID:12890690|PMID:12519385|PMID:21503886|PMID:8620561|PMID:23043891|Drug_Central:1906|Patent:US2993051|PMID:12014919|PMID:22763693|PMID:22359146|PMID:25561219|Reaxys:383619|PMID:22699421|PMID:22543086|PMID:18389009|PMID:15780941|PMID:22770225|PMID:21926578|Beilstein:383619|HMDB:HMDB0001406|PMID:22456321|PMID:21918528|DrugBank:DB02701|PMID:18368629|PMID:14729974|PMID:21891976|PMID:15995937|PMID:10884473|PMID:15497767|PMID:11355130|KEGG:D00036|PMID:22160932|PMID:12782109|PMID:18514428|PMID:23028781|PMID:19544437|KNApSAcK:C00000209|PMID:23047329|PMID:24559077|KEGG:C00153|PMID:22536229|PMID:23016598|PMID:22067079|PMID:18987186|PMID:22361740|PMID:22709272|PMID:18316796|Gmelin:3336|Patent:US2904552|PMID:18373238|LINCS:LSM-5428|PMID:14871431|PMID:24635573,A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:7556|CHEBI:14645|CHEBI:25521|CHEBI:44258,,,,NICOTINAMIDE|nicotinamide|Nicotinamide|pyridine-3-carboxamide,,,,,chebi_ontology,,Vitamin PP|Nikotinamid|Nicotinamid|Nikotinsaeureamid|vitamin B3|niacin|beta-pyridinecarboxamide|Nicotinic acid amide|Niacinamide|3-pyridinecarboxamide|Nicotinsaeureamid,,,,,,,,,0,C6H6N2O,"InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)",DFPAKSUCGFBDDF-UHFFFAOYSA-N,122.12472,122.04801,NC(=O)c1cccnc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:17154,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32205856,,,,CHEBI:17154,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,nicotinamide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_358128,Manis tricuspis,Tree pangolin|Phataginus tricuspis,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_7711,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Tree pangolin,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Phataginus tricuspis,,,,,,NCBITaxon:358128,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_7711,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32197085,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Manis tricuspis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005765,lysosomal membrane,lysosome membrane,The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.,false,,,http://purl.obolibrary.org/obo/GO_0098852,,,,,,,,,,,,,,,,,,,,,The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,lysosome membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0098852,,,,GO:0005765,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005765,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lysosomal membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0010929,Abnormal blood cation concentration,Abnormality of cation homeostasis,An abnormality of cation homeostasis.,false,,,http://purl.obolibrary.org/obo/HP_0003111,,,,,,,,,,,,,,,,peter,2011-01-06T10:36:04Z,,,UMLS:C4023646,An abnormality of cation homeostasis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of cation homeostasis,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0003111,,,,HP:0010929,,,,,,,,,,,,,,,HP:0010929,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal blood cation concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0026623,Drug-Induced Liver Injury,,,false,,,http://purl.obolibrary.org/obo/DOID_409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0026623,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_409,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32213337,"A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.",Chemical and Drug Induced Liver Injury,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Drug-Induced Liver Injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0006528,Chronic lung disease,Chronic lung disease,"According to the definitions of the American and British Thoracic Societies, including pulmonary functional tests, X-rays, and CT scans for items such as fibrosis, bronchiectasis, bullae, emphysema, nodular or lymphomatous abnormalities.",false,,,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:413839001|UMLS:C0746102,"According to the definitions of the American and British Thoracic Societies, including pulmonary functional tests, X-rays, and CT scans for items such as fibrosis, bronchiectasis, bullae, emphysema, nodular or lymphomatous abnormalities.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Chronic lung disease,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002088,,,,HP:0006528,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,HP:0006528,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Chronic lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000127,"acute cardiac injury
",,,false,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113704,"Acute myocardial injury is classified where troponin concentrations are elevated with evidence of dynamic change in the absence of overt myocardial ischaemia, whereas in chronic myocardial injury troponin concentrations remain unchanged on serial testing. ",,,,,,,,,,,,,,,,"acute cardiac injury
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000090,virus elimination,,,false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,Process,,true,,,,,,Reduction to zero of the incidence of infection caused by a specific agent in a defined geographical area as a result of deliberate efforts; continued measures to prevent re-establishment of transmission are required.,,,,,,,,,,,,,,,,virus elimination,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/mmwr/preview/mmwrhtml/su48a7.htm,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_228415,SARS coronavirus CUHK-W1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:228415,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CUHK-W1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_314146,Euarchontoglires,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_40674,,,,,,,,,,,,,,,,,,,,PMID:12082125|PMID:11214319|PMID:12878460|GC_ID:1|PMID:15522813,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_superorder,,,,,,,NCBITaxon:314146,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_40674,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Euarchontoglires,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039709,cytoplasmic capsid assembly,,The assembly of a virus capsid that occurs in the cytoplasm.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-11-28T15:12:30Z,,,VZ:1950,The assembly of a virus capsid that occurs in the cytoplasm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039709,,,,,,true,,,,true,,,,,GO:0039709,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytoplasmic capsid assembly,,,,,,,,,,,,,,,,,,,,,,https://www.researchsquare.com/article/rs-21833/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000504,headache,,Headache is a pain characterized by a pain in the head.,false,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,,,,,,,,,,,,,,,,,,Headache is a pain characterized by a pain in the head.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,SYMP:0000504,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,,,SYMP:0000504,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,headache,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_39867,valproic acid,VALPROIC ACID|2-propylpentanoic acid|dipropylacetic acid|valproic acid|acidum valproicum|4-heptanecarboxylic acid|2-PROPYL-PENTANOIC ACID|di-n-propylacetic acid|Depakene|2-propylpentanoic acid|VPA|2-n-propyl-n-valeric acid|Valproinsaeure|DPA|2-propylvaleric acid|Di-n-propylessigsaeure|acide valproique|acido valproico|n-DPA,A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:2803|PMID:17273758|PMID:15124690|KEGG:C07185|PMID:12475192|Beilstein:1750447|PMID:23792104|PMID:19280426|LINCS:LSM-4620|PDBeChem:2PP|HMDB:HMDB0001877|PMID:16496131|PMID:16621443|DrugBank:DB00313|PMID:11716839|PMID:8558327|Wikipedia:Valproic_Acid|PMID:19318486|Reaxys:1750447|PMID:23810771|LIPID_MAPS_instance:LMFA01020291|PMID:24200999|PMID:15578701|PMID:24135375|KEGG:D00399|PMID:17156483|PMID:16759735|PMID:8681902|CAS:99-66-1|PMID:24348849|PMID:15560954|PMID:23949302,A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:39858|CHEBI:115217|CHEBI:9926,,,,VALPROIC ACID|2-propylpentanoic acid,,,,,chebi_ontology,,dipropylacetic acid|valproic acid|acidum valproicum|4-heptanecarboxylic acid|2-PROPYL-PENTANOIC ACID|di-n-propylacetic acid|Depakene|2-propylpentanoic acid|VPA|2-n-propyl-n-valeric acid|Valproinsaeure|DPA|2-propylvaleric acid|Di-n-propylessigsaeure|acide valproique|acido valproico|n-DPA,,,,,,,,,0,C8H16O2,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",NIJJYAXOARWZEE-UHFFFAOYSA-N,144.21140,144.11503,CCCC(CCC)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:39867,,,,,,true,,,,,,,,,CHEBI:39867,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,valproic acid,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_228404,SARS coronavirus HKU-39849,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:228404,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HKU-39849,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098852,lytic vacuole membrane,,The lipid bilayer surrounding a lytic vacuole and separating its contents from the cytoplasm of the cell.,false,,,http://purl.obolibrary.org/obo/GO_0005774,,,,,,,,,,,,,,,,,,,,,The lipid bilayer surrounding a lytic vacuole and separating its contents from the cytoplasm of the cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005774,,,,GO:0098852,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098852,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lytic vacuole membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032465,regulation of cytokinesis,regulation of cell cycle cytokinesis,"Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells.",false,,,http://purl.obolibrary.org/obo/GO_0051302,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0071775,,,,regulation of cell cycle cytokinesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051302,,,,GO:0032465,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032465,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of cytokinesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007015,actin filament organization,actin filament organisation|regulation of actin filament localization,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,actin filament organisation,,,regulation of actin filament localization,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007015,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007015,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,actin filament organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009157,deoxyribonucleoside monophosphate biosynthetic process,deoxyribonucleoside monophosphate anabolism|deoxyribonucleoside monophosphate synthesis|deoxyribonucleoside monophosphate formation|deoxyribonucleoside monophosphate biosynthesis,"The chemical reactions and pathways resulting in the formation of a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009162|http://purl.obolibrary.org/obo/GO_0009124,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,deoxyribonucleoside monophosphate anabolism|deoxyribonucleoside monophosphate synthesis|deoxyribonucleoside monophosphate formation|deoxyribonucleoside monophosphate biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009162|http://purl.obolibrary.org/obo/GO_0009124,,,,GO:0009157,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009157,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,deoxyribonucleoside monophosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1431340,SARS bat coronavirus,Bat SARS coronavirus,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat SARS coronavirus,,,,,,NCBITaxon:1431340,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS bat coronavirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_63621,saquinavir,"N(1)-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide|Fortovase|saquinavir","An aspartic acid derivative obtained by formal condensation of the primary amino group of (2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-ylamine with the carboxy group of N(2)(-quinolin-2-ylcarbonyl)-L-asparagine. An inhibitor of HIV-1 protease.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22024400|PMID:21819645|Reaxys:5469491|Wikipedia:Saquinavir|PMID:21135186|CAS:127779-20-8|PMID:22159894|DrugBank:DB01232|LINCS:LSM-2205|PMID:21819804|PMID:22136805|KEGG:D00429|Patent:EP432695|PMID:22150669|PMID:22104402|PMID:21600016|PMID:21683096|Patent:US5196438,"An aspartic acid derivative obtained by formal condensation of the primary amino group of (2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-ylamine with the carboxy group of N(2)(-quinolin-2-ylcarbonyl)-L-asparagine. An inhibitor of HIV-1 protease.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:9028,,,,"N(1)-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide",,,,,chebi_ontology,,Fortovase|saquinavir,,,,,,,,,0,C38H50N6O5,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,670.84080,670.38427,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc3ccccc3n1)[C@@H](C2)C(=O)NC(C)(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:63621,,,,,true,true,,,,,,,,,CHEBI:63621,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,saquinavir,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000056,fusion peptide (SARS-CoV-2),,,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,modified definition,,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32231345,Fusion peptide is located within the N-terminal 14–685 amino acids of S protein.,,,,,,,,,,,,,,,,fusion peptide (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32231345,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003497,IGHE,,,false,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,IgE,,,,,,,14,,,,,,,,,,IMGT/GENE-DB:IGHE|MIM:147180|HGNC:5522,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,immunoglobulin heavy constant epsilon,,14q32.33,,,,"GO_0003823 (EC: NAS, PMID: 6300763); GO_0005576 (EC: TAS); GO_0006955 (EC: NAS, PMID: 6300763); GO_0038095 (EC: TAS); GO_0045087 (EC: TAS)",PMID: 3796618; 6234164; 6288268; 6299662; 6300763; 6327276; 6407005; 6421489; 6804948; 6815656; 9856836; 12032735; 12897753; 15356573; 15814733; 17220216; 18254319; 18356810; 18631248; 19115948; 19271128; 19331717; 19419945; 19682998; 20304474; 20333376; 20348423; 20364560; 20609172; 20666680; 20808937; 20845638; 20926033; 21039739; 21050946; 21051082; 21106524; 21272988; 21516097; 21526166; 21795592; 21796807; 21898702; 21906983; 22194960; 22289548; 24055037,,,,,,,,,,,,,,,,,,OGG:3000003497,,,,,,,,,,,,,,,,,,,immunoglobulin heavy constant epsilon,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IGHE,,,20140408,3497,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,IGHE,,"Bin Zhao, Yue Liu, Oliver He",,other,,
http://purl.obolibrary.org/obo/GO_0061136,regulation of proteasomal protein catabolic process,,"Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.",false,,,http://purl.obolibrary.org/obo/GO_1903050,,,,,,,,,,,,,,,,dph,2010-05-17T01:33:20Z,,,,"Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1903050,,,,GO:0061136,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061136,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of proteasomal protein catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039604,suppression by virus of host translation,host translation shutoff by virus|viral shutoff of host protein synthesis|viral inhibition of cellular protein synthesis,"Any process in which a virus prevents or reduces the frequency, rate or extent of translation of host mRNA.",false,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2012-07-05T04:25:22Z,,,VZ:1579,"Any process in which a virus prevents or reduces the frequency, rate or extent of translation of host mRNA.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,host translation shutoff by virus|viral shutoff of host protein synthesis|viral inhibition of cellular protein synthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039604,,,,,,true,,,,true,,,,,GO:0039604,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host translation,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C97364,Tideglusib,"TIDEGLUSIB|Tideglusib|Nypta|Zentylor|4-Benzyl-2-(naphthalen-1-yl)-1,2,4-thiadiazolidine-3,5-dione",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,865854-05-3,,C19H14N2O2S,,C97364,,,FDA,,,,,,,,,,,,,,,,,,,,,,,,Q747Y6TT42,,,,,,,,,,,,,,"TIDEGLUSIB|Tideglusib|Nypta|Zentylor|4-Benzyl-2-(naphthalen-1-yl)-1,2,4-thiadiazolidine-3,5-dione",,,,,,,,,,,,,NCIT:C97364,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,"Tideglusib is an orally available, small-molecule drug of the thiadiazolidinone class. It acts as an inhibitor of glycogen synthase kinase 3 (GSK3-β), a widely studied tau kinase. ",,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Tideglusib,,,,,,,,,,,,,,,,,,,Tideglusib,,,,Pharmacologic Substance,,,,,,,,C3273375,
http://purl.obolibrary.org/obo/GO_0098813,nuclear chromosome segregation,,"The process in which genetic material, in the form of nuclear chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. Nuclear chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.",false,,,http://purl.obolibrary.org/obo/GO_0007059,,,,,,,,,,,,,,,,,,,,,"The process in which genetic material, in the form of nuclear chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. Nuclear chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007059,,,,GO:0098813,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098813,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nuclear chromosome segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051591,response to cAMP,"response to adenosine 3',5'-cyclophosphate|response to 3',5' cAMP|response to 3',5'-cAMP|response to cyclic AMP","Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.",false,,,http://purl.obolibrary.org/obo/GO_0014074|http://purl.obolibrary.org/obo/GO_0046683,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"response to adenosine 3',5'-cyclophosphate|response to 3',5' cAMP|response to 3',5'-cAMP|response to cyclic AMP",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0014074|http://purl.obolibrary.org/obo/GO_0046683,,,,GO:0051591,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051591,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to cAMP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_35480,analgesic,,"An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,"An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:35480,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32139372,,,,CHEBI:35480,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,analgesic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003932,LCK,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,p56lck|YT16|pp58lck|LSK,,,,,,,1,,,,,,,,,,HGNC:6524|Vega:OTTHUMG00000007463|Ensembl:ENSG00000182866|HPRD:01080|MIM:153390,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,lymphocyte-specific protein tyrosine kinase,,1p34.3,,,,"GO_0000242 (EC: IDA, PMID: 7513706); GO_0000242 (EC: ISS); GO_0001772 (EC: IDA); GO_0001948 (EC: IPI, PMID: 14625311); GO_0003823 (EC: IEA); GO_0004713 (EC: EXP); GO_0004713 (EC: IDA, PMID: 214242); GO_0004713 (EC: ISS); GO_0004713 (EC: TAS); GO_0004715 (EC: IEA); GO_0004722 (EC: IDA, PMID: 8506364); GO_0004722 (EC: ISS); GO_0005515 (EC: IPI, PMID: 10209036); GO_0005524 (EC: IEA); GO_0005829 (EC: TAS); GO_0005886 (EC: IDA, PMID: 12150984); GO_0005886 (EC: TAS); GO_0006468 (EC: IDA, PMID: 214242); GO_0006882 (EC: IEP, PMID: 11739864); GO_0006882 (EC: ISS); GO_0006919 (EC: IDA, PMID: 16116473); GO_0006919 (EC: ISS); GO_0007173 (EC: TAS); GO_0007568 (EC: IEA); GO_0007596 (EC: TAS); GO_0008022 (EC: IPI, PMID: 16245368); GO_0008543 (EC: TAS); GO_0009612 (EC: IEA); GO_0010043 (EC: IEA); GO_0010628 (EC: IEA); GO_0016032 (EC: TAS); GO_0016311 (EC: IDA, PMID: 8506364); GO_0016311 (EC: ISS); GO_0019901 (EC: IPI, PMID: 8618896); GO_0019903 (EC: IPI); GO_0030097 (EC: NAS, PMID: 12884910); GO_0030139 (EC: IEA); GO_0030168 (EC: TAS); GO_0030217 (EC: IMP, PMID: 1579166); GO_0030217 (EC: ISS); GO_0031295 (EC: TAS); GO_0032403 (EC: IEA); GO_0038095 (EC: TAS); GO_0042169 (EC: IPI, PMID: 7852312); GO_0042169 (EC: ISS); GO_0042493 (EC: IDA, PMID: 16116473); GO_0042493 (EC: ISS); GO_0042523 (EC: IEA); GO_0042542 (EC: IEA); GO_0042609 (EC: IPI, PMID: 7486703); GO_0042610 (EC: IPI, PMID: 2470098); GO_0042802 (EC: IPI, PMID: 17118402); GO_0043548 (EC: IPI, PMID: 7504174); GO_0045087 (EC: TAS); GO_0045121 (EC: IDA, PMID: 12150984); GO_0045121 (EC: ISS); GO_0045588 (EC: IEA); GO_0046777 (EC: IEA); GO_0048011 (EC: TAS); GO_0048015 (EC: TAS); GO_0050690 (EC: TAS); GO_0050852 (EC: TAS); GO_0050853 (EC: IEA); GO_0050862 (EC: NAS, PMID: 12614355); GO_0050870 (EC: IDA, PMID: 8943371); GO_0050870 (EC: ISS); GO_0050900 (EC: TAS); GO_0051117 (EC: IPI, PMID: 15671290); GO_0051209 (EC: ISS); GO_0051249 (EC: NAS, PMID: 7852312); GO_0070062 (EC: IDA); GO_0070474 (EC: IEA); GO_2001244 (EC: IMP, PMID: 16116473); GO_2001244 (EC: ISS)",PMID: 214242; 1351058; 1382070; 1385527; 1491632; 1500851; 1535086; 1535787; 1548763; 1579166; 1622897; 1638019; 1709155; 1850098; 1988541; 2014052; 2040625; 2047859; 2115123; 2470098; 2558056; 2787474; 2835736; 2850479; 3257410; 3265417; 3489486; 3493153; 7486703; 7494315; 7495859; 7504174; 7512963; 7513045; 7513706; 7522245; 7539035; 7539106; 7539724; 7543024; 7545683; 7657660; 7680610; 7682059; 7690989; 7774645; 7831289; 7852312; 7853525; 7859737; 7871751; 7896837; 7961936; 8020561; 8062594; 8077654; 8086341; 8104794; 8114715; 8139546; 8246987; 8258691; 8262984; 8294442; 8405050; 8473339; 8506364; 8551220; 8576115; 8576267; 8618896; 8626429; 8626543; 8626561; 8636141; 8648738; 8650207; 8663450; 8671590; 8692915; 8702662; 8794306; 8797825; 8798643; 8798764; 8864141; 8870842; 8871625; 8879209; 8883579; 8887682; 8900205; 8910285; 8939988; 8943371; 8945479; 8995379; 9020138; 9032261; 9036944; 9038134; 9043947; 9045636; 9047237; 9075929; 9091579; 9092949; 9121430; 9123823; 9169414; 9178760; 9178909; 9195899; 9257837; 9269777; 9312162; 9341123; 9341793; 9344703; 9403695; 9446569; 9461588; 9488700; 9573028; 9621091; 9624175; 9664084; 9685404; 9687533; 9705913; 9710204; 9712716; 9741627; 9751747; 9778343; 9788619; 9790917; 9792645; 9880255; 9973379; 9973453; 9989602; 10208934; 10209036; 10214954; 10229084; 10318843; 10330160; 10358157; 10364375; 10383400; 10422873; 10430626; 10447714; 10449731; 10455176; 10482988; 10488096; 10544125; 10553045; 10574931; 10617656; 10636863; 10642173; 10652356; 10669745; 10733577; 10748115; 10764799; 10790433; 10799545; 10799874; 10799879; 10816433; 10825200; 10858437; 10880360; 10896916; 10918587; 10921922; 10975838; 11048639; 11067948; 11075717; 11278465; 11278738; 11294838; 11294897; 11298344; 11351273; 11369760; 11381116; 11389730; 11431473; 11525746; 11572860; 11591716; 11739864; 11741599; 11741929; 11741956; 11827988; 11839738; 11854499; 11855827; 11904433; 12007789; 12036857; 12055221; 12100025; 12150984; 12171035; 12181444; 12186560; 12237775; 12359715; 12370810; 12401726; 12429743; 12468540; 12477932; 12485116; 12496362; 12527887; 12538589; 12560083; 12565834; 12570875; 12589038; 12614355; 12628756; 12637327; 12645944; 12660731; 12697812; 12732664; 12734017; 12746907; 12755691; 12817007; 12835311; 12837766; 12884910; 12899942; 12923183; 14500983; 14523017; 14534291; 14583609; 14592831; 14610044; 14623872; 14625311; 14688329; 14699120; 14702039; 14757743; 14766232; 14965316; 14993658; 15016553; 15047060; 15078178; 15085197; 15096483; 15144186; 15163734; 15186530; 15199125; 15263807; 15322115; 15331563; 15371598; 15489916; 15536084; 15554700; 15638726; 15641485; 15671290; 15687496; 15696170; 15707590; 15743820; 15751964; 15784897; 15867154; 15870274; 15892963; 15958529; 15967991; 15976924; 15980863; 16099425; 16107303; 16116473; 16185072; 16195219; 16219325; 16245368; 16257509; 16274251; 16293614; 16339550; 16344560; 16354835; 16374509; 16446405; 16461343; 16474166; 16600997; 16740747; 16769579; 16806069; 16818765; 16860758; 16888650; 16899217; 16938345; 17005671; 17008721; 17078813; 17118402; 17266559; 17382937; 17586321; 17632570; 17652306; 17897955; 17897956; 17910071; 17932036; 17998336; 18029348; 18030346; 18067320; 18314490; 18424699; 18473783; 18541536; 18683785; 18714047; 18792408; 18854243; 18991294; 19010391; 19019957; 19050260; 19109140; 19149577; 19167335; 19168706; 19192391; 19201754; 19201869; 19343496; 19439470; 19592652; 19776125; 19850743; 19912576; 20007709; 20012528; 20035083; 20040600; 20056178; 20064523; 20098747; 20237292; 20300113; 20305788; 20360068; 20372794; 20379614; 20421494; 20538612; 20541955; 20555418; 20594957; 20729329; 20835359; 20842205; 20971076; 21152094; 21234523; 21266711; 21453975; 21508261; 21738584; 21757751; 21819973; 21834013; 21900206; 21917715; 21952639; 21983898; 22034844; 22034845; 22123847; 22345475; 22378744; 22422068; 22457183; 22505724; 22537596; 22613726; 22674786; 22802418; 22863785; 22939624; 23202272; 23931554; 23946459; 24227778; 24231767,,,,,,,,,,,,,,,,,,OGG:3000003932,,,,,,,,,,,,,,,,,,,lymphocyte-specific protein tyrosine kinase,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,LCK,,,20140408,3932,RP4-675E8.4,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,LCK,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/BFO_0000140,continuant fiat boundary,,"b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001])",false,,,http://purl.obolibrary.org/obo/BFO_0000141,,,,,ContinuantFiatBoundary,cf-boundary,,,,,,,,,,,,,,,"b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001])",,,,,,,,"BFO 2 Reference: a continuant fiat boundary is a boundary of some material entity (for example: the plane separating the Northern and Southern hemispheres; the North Pole), or it is a boundary of some immaterial entity (for example of some portion of airspace). Three basic kinds of continuant fiat boundary can be distinguished (together with various combination kinds [29|BFO 2 Reference: In BFO 1.1 the assumption was made that the external surface of a material entity such as a cell could be treated as if it were a boundary in the mathematical sense. The new document propounds the view that when we talk about external surfaces of material objects in this way then we are talking about something fiat. To be dealt with in a future version: fiat boundaries at different levels of granularity.More generally, the focus in discussion of boundaries in BFO 2.0 is now on fiat boundaries, which means: boundaries for which there is no assumption that they coincide with physical discontinuities. The ontology of boundaries becomes more closely allied with the ontology of regions.|Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions.",,,,,,,,,,,,,,(iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001] ,Every continuant fiat boundary is located at some spatial region at every time at which it exists,,,,,,,,,,,,,,,,,,,,,BFO:0000140,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000141,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,continuant fiat boundary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C16748,Integrin,"Integrin Receptor|Extracellular Matrix, Integrins|RGD Receptor|Integrin","Integrins are transmembrane glycoprotein receptors that mediate cell-matrix or cell-cell adhesion, and transduce signals that regulate gene expression and cell growth.  They are heterodimeric molecules consisting of noncovalently linked alpha and beta subunits. Different combinations of alpha and beta polypeptides form complexes that vary in their ligand-binding specificities. Both alpha and beta subunits display a cytoplasmic domain that interacts with the cytoskeleton (and possibly signaling molecules), a transmembrane region, and a large extracellular domain that interacts with the extracellular matrix. (from OMIM 147557)",false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,C16748,,,CTRP,,,,,,,"Integrins are transmembrane glycoprotein receptors that mediate cell-matrix or cell-cell adhesion, and transduce signals that regulate gene expression and cell growth.  They are heterodimeric molecules consisting of noncovalently linked alpha and beta subunits. Different combinations of alpha and beta polypeptides form complexes that vary in their ligand-binding specificities. Both alpha and beta subunits display a cytoplasmic domain that interacts with the cytoskeleton (and possibly signaling molecules), a transmembrane region, and a large extracellular domain that interacts with the extracellular matrix. (from OMIM 147557)",,,,,,Integrin,,,,,,,,,,,,,,,,,,,,,,,,,"Integrin Receptor|Extracellular Matrix, Integrins|RGD Receptor|Integrin",,,,,,,,,,,,,NCIT:C16748,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142800|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799,,,,,,,,,,Integrin,RGD_Receptor|Integrin,,,,,,,,,,,,,,,,,,Integrin,,,,"Receptor|Amino Acid, Peptide, or Protein",,,,,,,,C0021701,
http://purl.obolibrary.org/obo/GO_0010324,membrane invagination,single-organism membrane invagination,The infolding of a membrane.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,jl,2013-12-02T13:58:34Z,,,,The infolding of a membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:1902534,,,,,,,,,biological_process,,single-organism membrane invagination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0010324,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010324,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,membrane invagination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_253434,SARS coronavirus PUMC02,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:253434,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PUMC02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0005212,"Diagnosis, Differential",,,false,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0005212,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.,differential diagnosis,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,"Diagnosis, Differential",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC9,nucleoprotein (SARS-CoV-2),PRO_0000449656|N (SARS2)|NC (SARS2)|nucleocapsid protein (SARS2)|protein N (SARS2)|N|ORF9|GU280_gp10,A protein that is a translation product of the N gene in SARS-CoV-2.|Category=organism-gene. Note: 419 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,GenPept:YP_009724397|UniProtKB:P0DTC9,A protein that is a translation product of the N gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PRO_0000449656|N (SARS2)|NC (SARS2)|nucleocapsid protein (SARS2)|protein N (SARS2),,,,,protein,,N|ORF9|GU280_gp10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 419 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC9,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,PR:P0DTC9,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,nucleoprotein (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000613,fever,,Fever is a neurological and physiological symptom characterized by a rise of body temperature above the normal whether a natural response (as to infection) or artificially induced for therapeutic reasons.,false,,,http://purl.obolibrary.org/obo/SYMP_0000410,,,,,,,,,,,,,,,,,,,,,Fever is a neurological and physiological symptom characterized by a rise of body temperature above the normal whether a natural response (as to infection) or artificially induced for therapeutic reasons.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000410,,,,SYMP:0000613,,,,,,true,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,,high fever,SYMP:0000613,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,fever,,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305416,SARS coronavirus C025,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305416,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C025,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/APOLLO_SV_00000298,epidemic,,"A process whose beginning is demarcated by accelerating infection acquisition by one or more host species of a particular pathogen in a particular location and whose end is demarcated by the time when the rate of infection acquisition becomes constant.|An example of multiple host species is foot and mouth disease (such as the 2001 epidemic in the UK, see: http://www.sciencemag.org/content/292/5519/1155.long) and swine flu.  The foot and mouth disease epidemic affected sheep, pigs, and cattle.",false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,epidemic of infection,,,,,,,,,,,,,,,,,,A process whose beginning is demarcated by accelerating infection acquisition by one or more host species of a particular pathogen in a particular location and whose end is demarcated by the time when the rate of infection acquisition becomes constant.,,,,,,,,,,,"A process whose beginning is demarcated by accelerating infection acquisition by one or more host species of a particular pathogen in a particular location and whose end is demarcated by the time when the rate of of infection acquisition becomes constant.

The constant rate may be zero.  The period of an epidemic may be defined using statistical criteria based on incidence rates or causal models based on their fit to incidence data.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,APOLLO_SV:00000298,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"An example of multiple host species is foot and mouth disease (such as the 2001 epidemic in the UK, see: http://www.sciencemag.org/content/292/5519/1155.long) and swine flu.  The foot and mouth disease epidemic affected sheep, pigs, and cattle.",,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,epidemic,,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,William R. Hogan,,,,Epidemic
http://purl.obolibrary.org/obo/GO_0019029,helical viral capsid,,The protein coat that surrounds the infective nucleic acid in some virus particles; the subunits are arranged to form a protein helix with the genetic material contained within. Tobacco mosaic virus has such a capsid structure.,false,,,http://purl.obolibrary.org/obo/GO_0019028,,,,,,,,,,,,,,,,,,,,,The protein coat that surrounds the infective nucleic acid in some virus particles; the subunits are arranged to form a protein helix with the genetic material contained within. Tobacco mosaic virus has such a capsid structure.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019028,,,,GO:0019029,,,,,,true,,,,true,,,,,GO:0019029,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,helical viral capsid,,,,,,,,,,,,,,,,,,,,,,https://geneticeducation.co.in/novel-coronavirus-covid-19-structure-genome-and-testing/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C94624,Oxygen Therapy,Oxygen Therapy|supplemental oxygen therapy|oxygen therapy,"The administration of oxygen to an individual, usually to aid in respiration.",false,,,http://purl.obolibrary.org/obo/OGMS_0000112,,"Treatment in which a storage tank of oxygen or a machine called a compressor is used to give oxygen to people with breathing problems. It may be given through a nose tube, a mask, or a tent. The extra oxygen is breathed in along with normal air.",,,,,,,,,C94624,,,CTRP,,,,,,,"The administration of oxygen to an individual, usually to aid in respiration.",,,,,,Oxygen Therapy,,,,,,,,,,,,,,,,,,,,,,,,,Oxygen Therapy|supplemental oxygen therapy|oxygen therapy,,,,,,,,,,,,,NCIT:C94624,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000112,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32172669,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977,,,,,,,,,,Oxygen Therapy,,,,,,,,,,,,,,,,,,,Oxygen Therapy,,,,Therapeutic or Preventive Procedure,,,,,,,,C0184633,
http://purl.obolibrary.org/obo/APOLLO_SV_00000307,endemic,,,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,APOLLO_SV:00000307,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,true,,,,,,"The baseline, or expected, level of the disease in the community—meaning it always exists, like the common cold and flu, which are usually at low, predictable rates.",,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,endemic,,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035710,"CD4-positive, alpha-beta T cell activation",,"The change in morphology and behavior of a CD4-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",false,,,http://purl.obolibrary.org/obo/GO_0046631,,,,,,,,,,,,,,,,rfoulger,2011-03-02T03:04:11Z,,,,"The change in morphology and behavior of a CD4-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046631,,,,GO:0035710,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186|https://www.ncbi.nlm.nih.gov/pubmed/32215613,,,,GO:0035710,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"CD4-positive, alpha-beta T cell activation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_133009,velpatasvir,"methyl {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-4-yl}-1,11-dihydro[2]benzopyrano[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate|GS 5816|velpatasvir|GS5816|GS-5816",A complex organic heteropentacyclic compound that is a hepatitis C virus nonstructural protein 5A inhibitor used in combination with sofosbuvir (under the brand name Epclusa) for treatment of patients with chronic hepatitis C of all six major genotypes.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:26183611|Reaxys:23709173|Drug_Central:5154|PMID:27353271|PMID:27429714|PMID:26956698|PMID:27240903|PMID:26519191|PMID:27135095|PMID:27015627|Wikipedia:Velpatasvir|PMID:26571066|CAS:1377049-84-7|PMID:27177605|PMID:26551051|PMID:27508349|PMID:26569658|PMID:27486034|PMID:27135094|PMID:26551263|PMID:27444413|PMID:27119242|PMID:27486033|PMID:26575258|PMID:27119243,A complex organic heteropentacyclic compound that is a hepatitis C virus nonstructural protein 5A inhibitor used in combination with sofosbuvir (under the brand name Epclusa) for treatment of patients with chronic hepatitis C of all six major genotypes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"methyl {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-4-yl}-1,11-dihydro[2]benzopyrano[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate",,,,,chebi_ontology,,GS 5816|velpatasvir|GS5816|GS-5816,,,,,,,,,0,C49H54N8O8,"InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1",FHCUMDQMBHQXKK-CDIODLITSA-N,883.004,882.40646,C(N1[C@@H](C)CC[C@H]1C2=NC=3C=CC=4C=C5C6=CC=C(C7=CN=C([C@@H]8C[C@H](COC)CN8C(=O)[C@@H](C=9C=CC=CC9)NC(=O)OC)N7)C=C6COC5=CC4C3N2)(=O)[C@H](C(C)C)NC(=O)OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:133009,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:133009,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,velpatasvir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305405,SARS coronavirus A031,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305405,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus A031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000100,thickened alveolar septum,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,true,true,,,,,"Increased width of the tissue intervening between two adjacent pulmonary alveoli, which consists of the basement membranes of alveolar-lining epithelium (mostly type I pneumocytes) and capillary endothelium",thick pulmonary interalveolar septum,,,,,,,,,,,,,,,thickened alveolar septum,,,,,,,,,,,,,,,,,,,,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.13.990226,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007091,metaphase/anaphase transition of mitotic cell cycle,metaphase/anaphase transition by anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|mitotic metaphase/anaphase transition,"The cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.",false,,,http://purl.obolibrary.org/obo/GO_0044784|http://purl.obolibrary.org/obo/GO_0010965,,,,,,,,,,,,,,,,,,,,,"The cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,metaphase/anaphase transition by anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|mitotic metaphase/anaphase transition,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044784|http://purl.obolibrary.org/obo/GO_0010965,,,,GO:0007091,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007091,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,metaphase/anaphase transition of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_138949,Enterovirus B,Human enterovirus B|Enterovirus EV-B,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_12059,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Human enterovirus B|Enterovirus EV-B,,,,,,NCBITaxon:138949,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_12059,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Enterovirus B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000092,cell-substrate adherens junction,,,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,An adherens junction which connects a cell to the extracellular matrix.,,,,,,,,,,,,,,,,cell-substrate adherens junction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000171,respiration organ,organ of respiratory system|respiratory organ|organ of apparatus respiratorius|breathing organ|apparatus respiratorius organ|respiratory system organ|gas exchange organ,"Organ that functions in gaseous exchange between an organism and its environment. In plants, microorganisms, and many small animals, air or water makes direct contact with the organism's cells or tissue fluids, and the processes of diffusion supply the organism with dioxygen (O2) and remove carbon dioxide (CO2). In larger animals the efficiency of gaseous exchange is improved by specialized respiratory organs, such as lungs and gills, which are ventilated by breathing mechanisms.",false,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,,,,,,,,,,,,,,,,,TGMA:0001247|SPD:0000428|EMAPA:17607|http://www.snomedbrowser.com/Codes/Details/272626006,"Organ that functions in gaseous exchange between an organism and its environment. In plants, microorganisms, and many small animals, air or water makes direct contact with the organism's cells or tissue fluids, and the processes of diffusion supply the organism with dioxygen (O2) and remove carbon dioxide (CO2). In larger animals the efficiency of gaseous exchange is improved by specialized respiratory organs, such as lungs and gills, which are ventilated by breathing mechanisms.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,organ of respiratory system|respiratory organ|organ of apparatus respiratorius|breathing organ|apparatus respiratorius organ|respiratory system organ,,,,,uberon,,gas exchange organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,UBERON:0000171,,,,,,,,,,,,,,,UBERON:0000171,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#functional_classification,,,,,,,,,,respiration organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006772,STAT1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CANDF7|ISGF-3|STAT91,,,,,,,2,,,,,,,,,,Ensembl:ENSG00000115415|MIM:600555|HPRD:02777|Vega:OTTHUMG00000132699|HGNC:11362,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"signal transducer and activator of transcription 1, 91kDa",,2q32.2,,,,"GO_0000122 (EC: ISS); GO_0000790 (EC: IDA, PMID: 18035482); GO_0000978 (EC: IDA, PMID: 18035482); GO_0000979 (EC: IDA); GO_0000983 (EC: IDA); GO_0001937 (EC: IMP, PMID: 16585190); GO_0002053 (EC: ISS); GO_0003340 (EC: ISS); GO_0003690 (EC: IDA, PMID: 9630226); GO_0003700 (EC: IDA, PMID: 10820245); GO_0003700 (EC: IDA, Qualifier: NOT, PMID: 10820245); GO_0004871 (EC: IEA); GO_0005164 (EC: IPI, PMID: 10848577); GO_0005509 (EC: IEA); GO_0005515 (EC: IPI, PMID: 10848577); GO_0005634 (EC: IDA); GO_0005654 (EC: TAS); GO_0005730 (EC: IDA); GO_0005730 (EC: IDA, Qualifier: NOT); GO_0005737 (EC: IDA); GO_0005829 (EC: TAS); GO_0006357 (EC: IDA, Qualifier: NOT, PMID: 10820245); GO_0006366 (EC: IDA); GO_0006915 (EC: ISS); GO_0007259 (EC: IDA); GO_0007584 (EC: IEA); GO_0008015 (EC: ISS); GO_0009612 (EC: IEA); GO_0016032 (EC: IEA); GO_0016525 (EC: IMP, PMID: 16585190); GO_0019221 (EC: TAS); GO_0019899 (EC: IPI); GO_0030424 (EC: ISS); GO_0030425 (EC: ISS); GO_0031663 (EC: IEA); GO_0031730 (EC: IEA); GO_0032869 (EC: IEA); GO_0033209 (EC: IDA, PMID: 10848577); GO_0034097 (EC: ISS); GO_0034240 (EC: IEA); GO_0035458 (EC: IMP, PMID: 18035482); GO_0042493 (EC: IEA); GO_0042542 (EC: IEA); GO_0042802 (EC: IPI, PMID: 8605877); GO_0042803 (EC: IDA, PMID: 9630226); GO_0042981 (EC: TAS, PMID: 12108949); GO_0043124 (EC: IMP, PMID: 10848577); GO_0043330 (EC: IEA); GO_0043434 (EC: ISS); GO_0043542 (EC: IMP, Qualifier: NOT, PMID: 16585190); GO_0045893 (EC: IDA, PMID: 10973496); GO_0045944 (EC: IDA, PMID: 10820245); GO_0045944 (EC: IMP, PMID: 18035482); GO_0048661 (EC: ISS); GO_0051591 (EC: ISS); GO_0051607 (EC: IEA); GO_0060333 (EC: IDA); GO_0060333 (EC: ISS); GO_0060333 (EC: TAS); GO_0060334 (EC: TAS); GO_0060337 (EC: ISS); GO_0060337 (EC: TAS); GO_0060338 (EC: TAS); GO_0060397 (EC: TAS); GO_0061326 (EC: IMP); GO_0072136 (EC: ISS); GO_0072162 (EC: ISS); GO_0072308 (EC: ISS)",PMID: 1496401; 1502203; 7510216; 7514165; 7543024; 7657660; 7690989; 7885841; 8125298; 8232552; 8549654; 8605877; 8608597; 8621447; 8631962; 8889548; 8943351; 8986769; 9037008; 9069288; 9121453; 9135145; 9205132; 9284918; 9344858; 9355737; 9373245; 9452495; 9484840; 9584171; 9630226; 9724754; 9804857; 9843502; 9880553; 9925928; 9989503; 10067896; 10358045; 10358079; 10446176; 10464260; 10490649; 10490982; 10506573; 10602027; 10652206; 10692450; 10702714; 10764778; 10792030; 10805787; 10820245; 10848577; 10848598; 10851046; 10851062; 10918587; 10954736; 10961983; 10964507; 10973496; 10982844; 11152457; 11226159; 11238845; 11248027; 11257227; 11278462; 11278865; 11294897; 11301323; 11418623; 11438544; 11442634; 11452125; 11520787; 11594781; 11675348; 11722592; 11752148; 11777927; 11804954; 11815625; 11835405; 11839738; 11843291; 11886859; 11909852; 11909970; 11923478; 11927559; 11932384; 11972023; 11981818; 12039028; 12048190; 12070153; 12108949; 12130529; 12138178; 12161037; 12165521; 12167251; 12171910; 12191570; 12223098; 12232043; 12232802; 12270932; 12356736; 12388709; 12403783; 12426389; 12447867; 12459177; 12477932; 12539042; 12551969; 12590259; 12610144; 12629155; 12634403; 12637327; 12722480; 12734330; 12748293; 12759242; 12777975; 12788789; 12804771; 12807916; 12817007; 12832402; 12846741; 12855573; 12855578; 12856330; 12867595; 12917439; 12923054; 12948935; 12960323; 12963127; 12967644; 14499622; 14500749; 14517261; 14557668; 14599788; 14600148; 14623896; 14654078; 14654702; 14656722; 14657353; 14674010; 14688135; 14690454; 14702039; 14704793; 14746803; 14751560; 14755057; 14963018; 14976049; 14978237; 15010467; 15055356; 15123634; 15140960; 15146197; 15165826; 15210729; 15213094; 15217838; 15221897; 15280488; 15284024; 15284440; 15322115; 15467722; 15489334; 15494521; 15527154; 15604419; 15638726; 15650219; 15695802; 15778351; 15780933; 15784679; 15795279; 15824515; 15825084; 15894584; 15919942; 15979846; 15996661; 15998520; 16009940; 16077199; 16148108; 16148142; 16189514; 16195225; 16195385; 16223733; 16236267; 16254375; 16257975; 16260419; 16273093; 16298512; 16306601; 16318585; 16335966; 16344560; 16388135; 16467883; 16481475; 16501077; 16511123; 16512786; 16531398; 16571725; 16572323; 16574066; 16585190; 16628196; 16703666; 16773129; 16799645; 16878149; 16897667; 16904741; 16918696; 16934001; 16935931; 16940534; 16951379; 16978698; 17030574; 17075845; 17145596; 17182865; 17196131; 17227821; 17237409; 17266440; 17287281; 17346710; 17351669; 17353931; 17371985; 17386941; 17427945; 17442890; 17475642; 17486072; 17490620; 17523873; 17538964; 17561467; 17596301; 17617740; 17620599; 17640695; 17680769; 17686504; 17703412; 17726060; 17804871; 17878351; 17897103; 17909067; 17918184; 17923090; 17928350; 17933493; 17938255; 17983380; 17986321; 18003888; 18029348; 18035482; 18037959; 18062835; 18218993; 18225539; 18280748; 18305014; 18305569; 18338947; 18348986; 18370868; 18381204; 18401423; 18424756; 18463151; 18483262; 18500930; 18566411; 18579584; 18586252; 18591661; 18633131; 18660489; 18676680; 18723680; 18771758; 18775329; 18787082; 18787531; 18789440; 18803832; 18818378; 18832710; 18950845; 18989459; 19007958; 19012493; 19017763; 19041714; 19046253; 19074829; 19088846; 19100922; 19124747; 19131965; 19170196; 19171783; 19211553; 19223260; 19231233; 19258923; 19279332; 19333953; 19342095; 19351818; 19380416; 19393742; 19404407; 19423540; 19424608; 19434718; 19436109; 19437244; 19439556; 19453261; 19464956; 19471022; 19478064; 19479051; 19502801; 19508864; 19515782; 19553685; 19561067; 19574556; 19582813; 19594299; 19596857; 19604093; 19622834; 19625176; 19646959; 19647793; 19652026; 19656875; 19667270; 19691533; 19692168; 19781967; 19801665; 19802007; 19834108; 19853614; 19857525; 19891767; 19913121; 19915063; 19915608; 19935876; 20011528; 20045654; 20065083; 20093796; 20098684; 20103601; 20180146; 20195357; 20211142; 20225206; 20331378; 20345984; 20347693; 20353823; 20379614; 20380698; 20403236; 20406964; 20428775; 20438785; 20457620; 20503287; 20519510; 20523058; 20562129; 20568281; 20576130; 20588308; 20624457; 20628086; 20628624; 20662656; 20798561; 20802378; 20810735; 20814891; 20829351; 20832538; 20833730; 20841510; 20936779; 20937132; 20937272; 20949125; 20974984; 20980339; 21056555; 21057861; 21079652; 21084836; 21091911; 21099673; 21115047; 21139048; 21207025; 21288140; 21303487; 21307288; 21311224; 21321110; 21346151; 21354905; 21362620; 21368418; 21372127; 21385873; 21466707; 21477834; 21533215; 21571862; 21572044; 21576370; 21593149; 21674123; 21689637; 21690236; 21697347; 21714643; 21727188; 21734056; 21752694; 21772053; 21795355; 21796151; 21886773; 21890473; 21903422; 21906983; 21937453; 21988832; 22002246; 22022391; 22025054; 22038351; 22065572; 22115721; 22174846; 22178447; 22193460; 22194871; 22195034; 22217266; 22242177; 22253910; 22262126; 22320867; 22326919; 22381273; 22383882; 22401175; 22407921; 22425562; 22437822; 22474288; 22479354; 22488367; 22505724; 22514085; 22526675; 22535619; 22539792; 22558273; 22573496; 22647704; 22674974; 22693070; 22730530; 22748021; 22748593; 22757586; 22797925; 22805310; 22808166; 22811740; 22828446; 22833565; 22838736; 22844427; 22863883; 22920460; 22939629; 22942432; 22973045; 23000965; 23043228; 23068100; 23072252; 23076242; 23086340; 23108375; 23128233; 23153456; 23154639; 23180800; 23240025; 23271704; 23274199; 23306614; 23349666; 23363816; 23378427; 23383273; 23401241; 23403048; 23452095; 23471820; 23486482; 23487038; 23534974; 23541320; 23554911; 23582260; 23585528; 23588992; 23609054; 23621408; 23703473; 23704922; 23708675; 23740952; 23741352; 23756862; 23856440; 23910645; 23920124; 23940278; 23941832; 23956138; 23958647; 23984931; 24449862,,,,,,,,,,,,,,,,,,OGG:3000006772,,,,,,,,,,,,,,,,,,,"signal transducer and activator of transcription 1, 91kDa",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,STAT1,,,20140408,6772,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,doi:10.20944/preprints202003.0206.v1,,,,STAT1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0005766,primary lysosome,,A lysosome before it has fused with a vesicle or vacuole.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1140587416,A lysosome before it has fused with a vesicle or vacuole.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005766,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005766,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,primary lysosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_229206,SARS coronavirus CUHK-Su10,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:229206,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CUHK-Su10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000775,neutrophil,polymorphonuclear leucocyte|poly|polynuclear neutrophilic leukocyte|PMN|polymorphonuclear leukocyte|polynuclear neutrophilic leucocyte|polymorphonuclear neutrophil|neutrophil leukocyte|neutrophilic leucocyte|neutrophilic leukocyte|neutrophil leucocyte|neutrocyte,"Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.",false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,,,,,,,,,,CALOHA:TS-0688|BTO:0000130|FMA:62860,"Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,polymorphonuclear leucocyte|poly|polynuclear neutrophilic leukocyte|PMN|polymorphonuclear leukocyte|polynuclear neutrophilic leucocyte|polymorphonuclear neutrophil,,,neutrophil leukocyte|neutrophilic leucocyte|neutrophilic leukocyte|neutrophil leucocyte|neutrocyte,,,,,cell,,,,,,,,CL:0000775,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,neutrophil,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007052,mitotic spindle organization,mitotic spindle organisation|spindle organization and biogenesis during mitosis|mitotic spindle organization and biogenesis in cell nucleus|mitotic spindle organization in nucleus|mitotic spindle organization and biogenesis in nucleus|mitotic spindle organisation in nucleus|spindle organization and biogenesis in nucleus during mitosis|mitotic spindle organization and biogenesis|mitotic spindle stabilization,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a mitotic cell cycle.|In fission yeast most mitotic spindle organization occurs in the nucleus.",false,,,http://purl.obolibrary.org/obo/GO_1902850|http://purl.obolibrary.org/obo/GO_0007051,,,,,,,,,,,,,,,,,,,,,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a mitotic cell cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000071|GO:0043148|GO:0030472,,,,mitotic spindle organisation|spindle organization and biogenesis during mitosis,,,mitotic spindle organization and biogenesis in cell nucleus|mitotic spindle organization in nucleus|mitotic spindle organization and biogenesis in nucleus|mitotic spindle organisation in nucleus|spindle organization and biogenesis in nucleus during mitosis,,biological_process,,mitotic spindle organization and biogenesis|mitotic spindle stabilization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,In fission yeast most mitotic spindle organization occurs in the nucleus.,,http://purl.obolibrary.org/obo/GO_1902850|http://purl.obolibrary.org/obo/GO_0007051,,,,GO:0007052,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007052,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic spindle organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://github.com/geneontology/go-ontology/issues/15341,,,
http://purl.obolibrary.org/obo/GO_0050727,regulation of inflammatory response,,"Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0050727,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050727,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002440,production of molecular mediator of immune response,production of cellular mediator of immune response,"The synthesis or release of any molecular mediator of the immune response, resulting in an increase in its intracellular or extracellular levels.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The synthesis or release of any molecular mediator of the immune response, resulting in an increase in its intracellular or extracellular levels.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,production of cellular mediator of immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0002440,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002440,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,production of molecular mediator of immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000910,cytokinesis,cell cycle cytokinesis|cytokinesis involved in cell cycle,"The division of the cytoplasm and the plasma membrane of a cell and its partitioning into two daughter cells.|Note that this term should not be used for direct annotation. When annotating eukaryotic species, mitotic or meiotic cytokinesis should always be specified for manual annotation and for prokaryotic species use 'FtsZ-dependent cytokinesis ; GO:0043093' or Cdv-dependent cytokinesis ; GO:0061639.  Also, note that cytokinesis does not necessarily result in physical separation and detachment of the two daughter cells from each other.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Cytokinesis,The division of the cytoplasm and the plasma membrane of a cell and its partitioning into two daughter cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007104|GO:0033205|GO:0016288,,,,cell cycle cytokinesis|cytokinesis involved in cell cycle,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term should not be used for direct annotation. When annotating eukaryotic species, mitotic or meiotic cytokinesis should always be specified for manual annotation and for prokaryotic species use 'FtsZ-dependent cytokinesis ; GO:0043093' or Cdv-dependent cytokinesis ; GO:0061639.  Also, note that cytokinesis does not necessarily result in physical separation and detachment of the two daughter cells from each other.",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0000910,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000910,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus|http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_manually_annotate,,,,,,,,,,cytokinesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044832,positive regulation by virus of host cytokine production,,"The process in which a virus increases the frequency, rate or extent of cytokine production in its host organism.",false,,,http://purl.obolibrary.org/obo/GO_0044831,,,,,,,,,,,,,,,,janelomax,2014-02-06T13:04:23Z,,,,"The process in which a virus increases the frequency, rate or extent of cytokine production in its host organism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044831,,,,GO:0044832,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165108/,,,,GO:0044832,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation by virus of host cytokine production,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000058,A2a haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A2a haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,A2a haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006897,endocytosis,endocytic import into cell|vesicle endocytosis|plasma membrane invagination|nonselective vesicle endocytosis,A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Endocytosis,A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016193|GO:0016196|GO:0098701,,,,endocytic import into cell|vesicle endocytosis,,,plasma membrane invagination,,biological_process,,nonselective vesicle endocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006897,,,,,,true,true,,,,,,,,GO:0006897,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,endocytosis,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0070820,tertiary granule,gelatinase granule,A secretory granule that contains cathepsin and gelatinase and is readily exocytosed upon cell activation; found primarily in mature neutrophil cells.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,midori,2009-07-20T03:57:00Z,,,,A secretory granule that contains cathepsin and gelatinase and is readily exocytosed upon cell activation; found primarily in mature neutrophil cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,gelatinase granule,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0070820,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0070820,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,tertiary granule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C142924,Angiotensin II Acetate,ANGIOTENSIN II ACETATE|Angiotensin II Acetate,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C142924,,,FDA,,,,,,,,,,,,,,,,,,,,,,,,31L3HS630A,,,,,,,,,,,,,,ANGIOTENSIN II ACETATE|Angiotensin II Acetate,,,,,,,,,,,,,NCIT:C142924,Angiotensin II acetate is a drug in clinical development for the treatment of catecholamine and/or vasopressin resistant hypotension due to distributive shock.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Angiotensin II Acetate,,,,,,,CL541352,,,,,,,,,,,,Angiotensin II Acetate,,,http://www.io.nihr.ac.uk/report/angiotensin-ii-acetate-giapreza-for-vasopressor-resistant-hypotension-due-to-distributive-shock/,Pharmacologic Substance|Classification,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050658,RNA transport,,"The directed movement of RNA, ribonucleic acids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The directed movement of RNA, ribonucleic acids, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0050658,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,GO:0050658,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,RNA transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046730,induction of host immune response by virus,activation of host immune response by virus|passive viral induction of cell-mediated immune response in host|passive viral induction of host immune response|passive induction of humoral immune response in host by virus|passive activation of host immune response by virus|passive viral activation of humoral immune response in host|passive induction of host humoral immune response by virus|passive viral induction of humoral immune response in host|passive induction of host innate immune response by virus|passive induction of host immune response by virus|passive induction of host cell-mediated immune response by virus|passive induction of cell-mediated immune response in host by virus|passive viral activation of innate immune response in host|passive induction of innate immune response in host by virus|passive viral induction of innate immune response in host|passive viral activation of cell-mediated immune response in host|active induction of host immune response by virus|active viral induction of host immune response,The induction by a virus of an immune response in the host organism.,false,,,http://purl.obolibrary.org/obo/GO_0075528,,,,,,,,,,,,,,,,,,,,,The induction by a virus of an immune response in the host organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046735|GO:0046732|GO:0046734|GO:0046731|GO:0046733,,,,activation of host immune response by virus,,,passive viral induction of cell-mediated immune response in host|passive viral induction of host immune response|passive induction of humoral immune response in host by virus|passive activation of host immune response by virus|passive viral activation of humoral immune response in host|passive induction of host humoral immune response by virus|passive viral induction of humoral immune response in host|passive induction of host innate immune response by virus|passive induction of host immune response by virus|passive induction of host cell-mediated immune response by virus|passive induction of cell-mediated immune response in host by virus|passive viral activation of innate immune response in host|passive induction of innate immune response in host by virus|passive viral induction of innate immune response in host|passive viral activation of cell-mediated immune response in host,,biological_process,,active induction of host immune response by virus|active viral induction of host immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0075528,,,,GO:0046730,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32105090,,,,GO:0046730,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,induction of host immune response by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000024938,interferon alpha,fam:IFNA,Category=family.,false,,,http://purl.obolibrary.org/obo/NCIT_C20493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,fam:IFNA,,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=family.,,http://purl.obolibrary.org/obo/NCIT_C20493,,,,PR:000024938,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,A class of interferon (leukocyte interferon) produced predominantly by B lymphocytes. Located in a cluster on 9p22 there are at least 13 functional genes and 1 pseudogene.,,,PR:000024938,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,interferon alpha,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C35681,Negative Test Result,negative test result|Negative Test Result,"A test result that indicates that a specific disease, condition, or attribute being assessed is not present.",false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,"A test result that does not show the specific disease, condition, or biomarker for which the test is being done.",,,,,,,,,C35681,,,,,,,,,,"A test result that indicates that a specific disease, condition, or attribute being assessed is not present.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,negative test result|Negative Test Result,,,,,,,,,,,,,NCIT:C35681,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175425/,,negative result|tested negative,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Negative Test Result,Negative_Test_Result,,,,,,,,,,,,,,,,,,Negative Test Result,,,,Finding,,,,,,,,C1334932,
http://purl.obolibrary.org/obo/CHEBI_50990,thiazolidinediones,,"A thiadiazolidine in which the 1,3-thiazolidine ring is substituted by two oxo groups.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,"A thiadiazolidine in which the 1,3-thiazolidine ring is substituted by two oxo groups.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50990,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215613,,,,CHEBI:50990,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,thiazolidinediones,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042582,azurophil granule,primary granule,Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.,false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0005766,,,,,,,,,,,,,,,,,,,,,Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,primary granule,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0005766,,,,GO:0042582,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042582,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,azurophil granule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0050828,artery disease,,A vascular disease that is located_in an artery.,false,,,http://purl.obolibrary.org/obo/DOID_178,,,,,,,,,,,,,,,,lschriml,2014-02-12T03:08:35Z,,,,A vascular disease that is located_in an artery.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_178,,,,DOID:0050828,,,,,,,,,,,,,,,DOID:0050828,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,artery disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000004,independent continuant,,b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002]),false,,,http://purl.obolibrary.org/obo/BFO_0000002,,,,,IndependentContinuant,ic,,,,,,,,,,,,,,,b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002]),,,,,,,,,,,,,the bottom right portion of a human torso|an orchestra.|the interior of your mouth|an atom|a chair|a molecule|a spatial region|a heart|an organism|a leg,,,,,,,,,(forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001] |(iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002] |(forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002] ,"For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002])|For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001])",,,,,,,,,,,,,,,,,,,,,BFO:0000004,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000002,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,independent continuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000015,process,,"p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])",false,,,http://purl.obolibrary.org/obo/BFO_0000003,,,,,Process,process,,,,,,,,,,,,,,,"p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])",,,,,,,,"BFO 2 Reference: The realm of occurrents is less pervasively marked by the presence of natural units than is the case in the realm of independent continuants. Thus there is here no counterpart of ‘object’. In BFO 1.0 ‘process’ served as such a counterpart. In BFO 2.0 ‘process’ is, rather, the occurrent counterpart of ‘material entity’. Those natural – as contrasted with engineered, which here means: deliberately executed – units which do exist in the realm of occurrents are typically either parasitic on the existence of natural units on the continuant side, or they are fiat in nature. Thus we can count lives; we can count football games; we can count chemical reactions performed in experiments or in chemical manufacturing. We cannot count the processes taking place, for instance, in an episode of insect mating behavior.Even where natural units are identifiable, for example cycles in a cyclical process such as the beating of a heart or an organism’s sleep/wake cycle, the processes in question form a sequence with no discontinuities (temporal gaps) of the sort that we find for instance where billiard balls or zebrafish or planets are separated by clear spatial gaps. Lives of organisms are process units, but they too unfold in a continuous series from other, prior processes such as fertilization, and they unfold in turn in continuous series of post-life processes such as post-mortem decay. Clear examples of boundaries of processes are almost always of the fiat sort (midnight, a time of death as declared in an operating theater or on a death certificate, the initiation of a state of war)",,,,,"a process of cell-division,  a beating of the heart|a process of sleeping|the course of a disease|the life of an organism|your process of aging.|a process of meiosis|the flight of a bird",,,,,,,,,(iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000015,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000003,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ogms.owl|http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C412,Dactinomycin,"Dactinomycine|Actinomycin A IV|Lyovac Cosmegen|Dactinomycin|Meractinomycin|2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3|Actinomycin IV|Actinomycin-[thr-val-pro-sar-meval]|ACTINOMYCIN D|DACTINOMYCIN|Actinomycin C1|DACT|Actinomycin I1|dactinomycin|Cosmegen|Actinomycin X 1|Actinomycin D|Lyovac cosmegen","A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus.  Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04)",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,Wilms' tumor; rhabdomyosarcoma; Ewing's sarcoma; testicular cancer; gestational trophoblastic neoplasia; choriocarcinoma; melanoma; neuroblastoma; retinoblastoma; uterine sarcomas; Kaposi's sarcoma; sarcoma botryoides; soft tissue sarcoma.,An anticancer drug that is a type of antitumor antibiotic.,,,,,50-76-0,CHEBI:27666,C62H86N12O16,,C412,,,CTRP|FDA,,,,,,,"A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus.  Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04)",,,,,,Dactinomycin,,,,,,,,,,,1CC1JFE158,,,,,,,,,,,,,,"Dactinomycine|Actinomycin A IV|Lyovac Cosmegen|Dactinomycin|Meractinomycin|2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3|Actinomycin IV|Actinomycin-[thr-val-pro-sar-meval]|ACTINOMYCIN D|DACTINOMYCIN|Actinomycin C1|DACT|Actinomycin I1|dactinomycin|Cosmegen|Actinomycin X 1|Actinomycin D|Lyovac cosmegen",,,,,,,,,,,,,NCIT:C412,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Dactinomycin,Dactinomycin,,,,,,,,,3053,,,,,,39675,39675,,Dactinomycin,,,,"Amino Acid, Peptide, or Protein|Antibiotic",,,,,,,,C0010934,
http://purl.obolibrary.org/obo/BFO_0000026,one-dimensional spatial region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000006,,,,,OneDimensionalSpatialRegion,1d-s-region,,,,,,,,,,,,,,,,,,,,,,,,,,A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001]),,an edge of a cube-shaped portion of space.,,,,,,,,,(forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000026,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000006,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,one-dimensional spatial region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000061,anatomical structure,connected biological structure|biological structure,Material anatomical entity that is a single connected structure with inherent 3D shape generated by coordinated expression of the organism's own genome.,false,,,http://purl.obolibrary.org/obo/UBERON_0000465,,,,,,,,,,,,,,,,,,,,VHOG:0001759|MA:0003000|MESH:D000825|EHDAA2:0003003|BILA:0000003|FMA:67135|FMA:305751|FBbt:00007001|TGMA:0001823|HAO:0000003|AEO:0000003|TAO:0000037|XAO:0003000|EMAPA:0|GAID:781|ZFA:0000037|CARO:0000003|AAO:0010825|http://www.snomedbrowser.com/Codes/Details/362889002|http://dbpedia.org/ontology/AnatomicalStructure,Material anatomical entity that is a single connected structure with inherent 3D shape generated by coordinated expression of the organism's own genome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,connected biological structure|biological structure,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000465,,,,UBERON:0000061,,,,,,,,,,,,,,,UBERON:0000061,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,anatomical structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000129,high-flow nasal cannula oxygenation,,,false,,,http://purl.obolibrary.org/obo/NCIT_C94624,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C94624,,,,,,,,oxygen therapy,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32268019|https://www.ncbi.nlm.nih.gov/pubmed/32295710,"High-flow nasal cannula (HFNC) oxygen therapy comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. It delivers adequately heated and humidified medical gas at up to 60 L/min of flow and is considered to have a number of physiological effects: reduction of anatomical dead space, PEEP effect, constant fraction of inspired oxygen, and good humidification.",,,,,,,,,,,,,,,,high-flow nasal cannula oxygenation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MP_0010209,abnormal circulating chemokine level,,deviation from the normal levels of any of the class of pro-inflammatory cytokines that attract and activate leukocytes in the circulation|The site en.wikipedia.org/wiki/Chemokine has a good list of chemokines.,false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,csmith,2010-07-05T10:00:46Z,,,,deviation from the normal levels of any of the class of pro-inflammatory cytokines that attract and activate leukocytes in the circulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,The site en.wikipedia.org/wiki/Chemokine has a good list of chemokines.,,http://purl.obolibrary.org/obo/HP_0010978,,,,MP:0010209,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32113704,,significantly high blood levels of chemokines,,MP:0010209,,http://purl.obolibrary.org/obo/mp.owl,,,,,,,,,,,abnormal circulating chemokine level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_247956,cinchocaine,2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide|CINCHOCAINE|2-butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|alpha-butyloxycinchonic acid-gamma-diethylethylenediamine|2-butoxyquinoline-4-carboxylic acid diethylaminoethylamide|N-(2-(diethylamino)ethyl)-2-butoxycinchoninamide|2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|cinchocainum|cinchocaine|Dibucaine|2-butoxy-N-(beta-diethylaminoethyl)cinchoninamide|dibucaine base|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|2-N-butoxy-N-(2-diethylaminoethyl)cinchoninamide|cincocainio|2-butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|dibucaine|DIBUCAINE|alpha-butyloxycinchoninic acid diethylethylenediamide,"A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:US1825623|PMID:23953476|KEGG:C07879|CAS:85-79-0|Beilstein:275489|HMDB:HMDB0014668|LINCS:LSM-6018|KEGG:D00733|Wikipedia:Dibucaine|DrugBank:DB00527|Reaxys:275489|PMID:2873227|Drug_Central:859,"A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:4500,,,,2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide|CINCHOCAINE,,,,,chebi_ontology,,2-butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|alpha-butyloxycinchonic acid-gamma-diethylethylenediamine|2-butoxyquinoline-4-carboxylic acid diethylaminoethylamide|N-(2-(diethylamino)ethyl)-2-butoxycinchoninamide|2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|cinchocainum|cinchocaine|Dibucaine|2-butoxy-N-(beta-diethylaminoethyl)cinchoninamide|dibucaine base|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|2-N-butoxy-N-(2-diethylaminoethyl)cinchoninamide|cincocainio|2-butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|dibucaine|DIBUCAINE|alpha-butyloxycinchoninic acid diethylethylenediamide,,,,,,,,,0,C20H29N3O2,"InChI=1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)",PUFQVTATUTYEAL-UHFFFAOYSA-N,343.46320,343.22598,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:247956,,,,,true,true,,,,,,,,,CHEBI:247956,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,cinchocaine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032799,low-density lipoprotein receptor particle metabolic process,low-density lipoprotein receptor metabolism|low-density lipoprotein receptor metabolic process|LDL receptor metabolic process,The chemical reactions and pathways involving low-density lipoprotein receptors.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The chemical reactions and pathways involving low-density lipoprotein receptors.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,low-density lipoprotein receptor metabolism|low-density lipoprotein receptor metabolic process|LDL receptor metabolic process,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0032799,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032799,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,low-density lipoprotein receptor particle metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9364,Suramin sodium,Suramin sodium|Bayer 205,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D00808|CAS:129-46-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Suramin sodium,,,,,chebi_ontology,,Bayer 205,,,,,,,,,0,C51H34N6O23S6.6Na|C51H34N6Na6O23S6,"InChI=1S/C51H40N6O23S6.6Na/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80;;;;;;/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80);;;;;;/q;6*+1/p-6",VAPNKLKDKUDFHK-UHFFFAOYSA-H,1429.179,1427.93857,C12=C(C(=CC=C1NC(C3=CC(NC(C4=CC(NC(NC=5C=C(C(NC6=CC(C(NC=7C8=C(C(S([O-])(=O)=O)=CC7)C=C(S([O-])(=O)=O)C=C8S(=O)(=O)[O-])=O)=CC=C6C)=O)C=CC5)=O)=CC=C4)=O)=C(C)C=C3)=O)S([O-])(=O)=O)C=C(S(=O)(=O)[O-])C=C2S([O-])(=O)=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9364,,,,,,true,,,,,,,,,CHEBI:9364,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Suramin sodium,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2348,arteriosclerotic cardiovascular disease,Cardiovascular arteriosclerosis,,false,,,http://purl.obolibrary.org/obo/DOID_2349,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0004153|SNOMEDCT_US_2019_09_01:38716007|MESH:D050197|UMLS_CUI:C3665365|ICD10CM:I70|NCI:C34403|NCI:C35768|ICD9CM:440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cardiovascular arteriosclerosis,,,,,disease_ontology,,,,,,,,,Cardiovascular disease resulting from arteriosclerosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_2349,,,,DOID:2348,,,,,,,,,,,,,,,DOID:2348,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,arteriosclerotic cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_12058,Picornaviridae,Picornavirus|Picormavirus,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_464095,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_family,Picornavirus|Picormavirus,,,,,,NCBITaxon:12058,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_464095,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Picornaviridae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051081,nuclear envelope disassembly,nuclear envelope breakdown|nuclear envelope catabolism|nuclear envelope degradation,The controlled breakdown of the nuclear envelope in the context of a normal process.,false,,,http://purl.obolibrary.org/obo/GO_0030397,,,,,,,,,,,,,,,,,,,,,The controlled breakdown of the nuclear envelope in the context of a normal process.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nuclear envelope breakdown|nuclear envelope catabolism|nuclear envelope degradation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030397,,,,GO:0051081,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051081,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nuclear envelope disassembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0090596,sensory organ morphogenesis,,"Morphogenesis of a sensory organ. A sensory organ is defined as a tissue or set of tissues that work together to receive and transmit signals from external or internal stimuli. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,tanyaberardini,2014-08-22T13:23:20Z,,,,"Morphogenesis of a sensory organ. A sensory organ is defined as a tissue or set of tissues that work together to receive and transmit signals from external or internal stimuli. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0090596,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0090596,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,sensory organ morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000094,material processing,,A planned process which results in physical changes in a specified input material,false,,,http://purl.obolibrary.org/obo/OBI_0000011,,,material transformation,,,,,,,,,,,,,,,,,,A planned process which results in physical changes in a specified input material,,OBI branch derived,,,,,,,material processing,,,,"A cell lysis, production of a cloning vector, creating a buffer.",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,OBI:0000094,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,material processing,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Frank Gibson|PERSON: Bjoern Peters|PERSON: Philippe Rocca Serra|PERSON: Melanie Courtot|PERSON: Jennifer Fostel,,,,
http://purl.obolibrary.org/obo/GO_2001251,negative regulation of chromosome organization,negative regulation of chromosome organisation|negative regulation of nuclear genome maintenance|negative regulation of chromosome organization and biogenesis|negative regulation of maintenance of genome integrity,"Any process that stops, prevents or reduces the frequency, rate or extent of chromosome organization.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,yaf,2011-12-02T02:01:20Z,,,,"Any process that stops, prevents or reduces the frequency, rate or extent of chromosome organization.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,negative regulation of chromosome organisation,,,,,biological_process,,negative regulation of nuclear genome maintenance|negative regulation of chromosome organization and biogenesis|negative regulation of maintenance of genome integrity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:2001251,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:2001251,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of chromosome organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0099738,cell cortex region,perimembrane region,The complete extent of cell cortex that underlies some some region of the plasma membrane.,false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0005938,,,,,,,,,,,,,,,,,,,,,The complete extent of cell cortex that underlies some some region of the plasma membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,perimembrane region,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0005938,,,,GO:0099738,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0099738,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cell cortex region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0020064,Abnormal eosinophil count,,Any deviation from the normal number of eosinophils per volume in the blood circulation.,false,,,http://purl.obolibrary.org/obo/HP_0001879|http://purl.obolibrary.org/obo/HP_0032309,,,,,,,,,,,,,,,,robinp,,,,,Any deviation from the normal number of eosinophils per volume in the blood circulation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0020064,,,,,,,,,,,,,,,,,,2018-10-17T13:48:52Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001879|http://purl.obolibrary.org/obo/HP_0032309,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal eosinophil count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_266147,SARS coronavirus Sin0409,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:266147,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin0409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/APOLLO_SV_00000043,reproduction number,,"The average value of transmissions of the infectious agent from one infected organism to another, resulting in an infection. ",false,,,http://purl.obolibrary.org/obo/OBI_0000679,,,,,,,,,,,,,,,,,,,,,"The average value of transmissions of the infectious agent from one infected organism to another, resulting in an infection. ",,,,,,,,,,,The number of susceptible organisms that each infected organism infects.  ‘Infects’ carries the same meaning as ‘exposes’ in epidemic simulations such as SEIR simulation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,APOLLO_SV:00000043,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000679,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,reproduction number,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mathias Brochhausen,,,,ReproductionNumber
http://purl.obolibrary.org/obo/GO_0051310,metaphase plate congression,chromosome congression,"The alignment of chromosomes at the metaphase plate (spindle equator), a plane halfway between the poles of the spindle.",false,,,http://purl.obolibrary.org/obo/GO_0051303,,,,,,,,,,,,,,,,,,,,,"The alignment of chromosomes at the metaphase plate (spindle equator), a plane halfway between the poles of the spindle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chromosome congression,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051303,,,,GO:0051310,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051310,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,metaphase plate congression,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0001312,imaging technique,,"A technique used to create a representation or reproduction of an object's outward form; especially a visual representation (i.e., the formation of an image).",false,,,http://purl.obolibrary.org/obo/ERO_0000007,,,,,,,,,,,,,,,,,,,,,"A technique used to create a representation or reproduction of an object's outward form; especially a visual representation (i.e., the formation of an image).",,http://en.wikipedia.org/wiki/Imaging,,,,,,,,,,,MRI.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,ERO:0001312,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000007,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,imaging technique,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Nicole Vasilevsky,,,,
http://purl.obolibrary.org/obo/DOID_0060014,CD45 deficiency,,"A severe combined immunodeficiency that is an autosomal recessive disease with T and B lymphocyte dysfunction, due to a large deletion at one allelle and a point mutation at the other. The point mutation resulted in the alteration of intervening sequence 13 donor splice site. The population of T lymphocytes is diminished and unresponsive to mitogen stimulation. The level of B lymphocyte numbers, serum immunoglobulin decreased with age.",false,,,http://purl.obolibrary.org/obo/DOID_627,,,,,,,,,,,,,,,,,,,,,"A severe combined immunodeficiency that is an autosomal recessive disease with T and B lymphocyte dysfunction, due to a large deletion at one allelle and a point mutation at the other. The point mutation resulted in the alteration of intervening sequence 13 donor splice site. The population of T lymphocytes is diminished and unresponsive to mitogen stimulation. The level of B lymphocyte numbers, serum immunoglobulin decreased with age.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_627,,,,DOID:0060014,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,DOID:0060014,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,CD45 deficiency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_240553,SARS coronavirus TWY,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:240553,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_63607,linezolid,"Linezolid|N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide|N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|linezolid","An organofluorine compound that consists of 1,3-oxazolidin-2-one bearing an N-3-fluoro-4-(morpholin-4-yl)phenyl group as well as an acetamidomethyl group at position 5. A synthetic antibacterial agent that inhibits bacterial protein synthesis by binding to a site on 23S ribosomal RNA of the 50S subunit and prevents further formation of a functional 70S initiation complex.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:165800-03-3|PMID:22037854|Patent:WO957271|PDBeChem:ZLD|Patent:US5688792|Wikipedia:Linezolid|PMID:22064542|DrugBank:DB00601|PMID:22214776|PMID:21815204|PMID:22134348|PMID:22230331|KEGG:C08146|PMID:21899392|KEGG:D00947|PMID:21740298|PMID:22247123|LINCS:LSM-5750|Drug_Central:1584|PMID:22110086|Reaxys:7496939|PMID:22139199|PMID:22064533,"An organofluorine compound that consists of 1,3-oxazolidin-2-one bearing an N-3-fluoro-4-(morpholin-4-yl)phenyl group as well as an acetamidomethyl group at position 5. A synthetic antibacterial agent that inhibits bacterial protein synthesis by binding to a site on 23S ribosomal RNA of the 50S subunit and prevents further formation of a functional 70S initiation complex.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:6477,,,,"Linezolid|N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide",,,,,chebi_ontology,,N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|linezolid,,,,,,,,,0,C16H20FN3O4,"InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1",TYZROVQLWOKYKF-ZDUSSCGKSA-N,337.34610,337.14378,CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:63607,,,,,,true,,,,,,,,,CHEBI:63607,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,linezolid,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C16389,Cathepsin,Cathepsins|Cathepsin,"Lysosomal proteinases or endopeptidases that function optimally at an acidic pH to catalyze the hydrolysis of peptidic bonds. Elevated cathepsin enzyme activity in either serum or extracellular matrix is often indicative of pathological conditions such as Alzheimer's disease, several types of cancer, arthritis, and osteoporosis.",false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,C16389,,,CTRP,,,,,,,"Lysosomal proteinases or endopeptidases that function optimally at an acidic pH to catalyze the hydrolysis of peptidic bonds. Elevated cathepsin enzyme activity in either serum or extracellular matrix is often indicative of pathological conditions such as Alzheimer's disease, several types of cancer, arthritis, and osteoporosis.",,,,,,Cathepsin,,,,,,,,,,,,,,,,,,,,,,,,,Cathepsins|Cathepsin,,,,,,,,,,,,,NCIT:C16389,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142800|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799,,,,,,,,,,Cathepsin,Cathepsin,,,,,,,,,,,,,,,,,,Cathepsin,,,,"Enzyme|Amino Acid, Peptide, or Protein",,,,,,,,C0007428,
http://purl.obolibrary.org/obo/DOID_2320,obstructive lung disease,respiratory airway obstruction,,false,,,http://purl.obolibrary.org/obo/DOID_850,,,,,,,,,,,,,,,,,,,,MESH:D008173|UMLS_CUI:C0600260,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,respiratory airway obstruction,,,,,disease_ontology,,,,,,,,,"Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_850,,,,DOID:2320,,,,,,,,,,,,,,,DOID:2320,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,obstructive lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000211,prothrombin time,,"Measurement of the clotting ability of fibrinogen, prothrombin, proaccelerin, proconvertin and Stuart factor, usually given in seconds to formation of clot after the addition of a tissue factor or thromboplastin.",false,,,http://purl.obolibrary.org/obo/CMO_0000023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000211,,,,,,,,,,mshimoyama,2010-06-10T11:21:04Z,"Measurement of the clotting ability of fibrinogen, prothrombin, proaccelerin, proconvertin and Stuart factor, usually given in seconds to formation of clot after the addition of a tissue factor or thromboplastin.",,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000023,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,prothrombin time,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C16087,Animal Testing,Animal Testing,The use of animals for testing the safety and efficacy of drugs or treatments.,false,,,http://purl.obolibrary.org/obo/NCIT_C15760,,,,,,,,,,,C16087,,,,,,,,,,The use of animals for testing the safety and efficacy of drugs or treatments.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Animal Testing,,,,,,,,,,,,,NCIT:C16087,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C15760,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Animal Testing,Animal_Testing,,,,,,,,,,,,,,,,,,Animal Testing,,,https://www.cdc.gov/coronavirus/2019-ncov/php/animal-testing.html,Research Activity,,,,,,,,C1510899,
http://purl.obolibrary.org/obo/UBERON_0000064,organ part,cardinal organ part|regional part of organ,A multicellular structure that is a part of an organ.,false,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,,,,,,,,,,,,,,,,"currently defined in a very broad sense, may be replaced by more specific classes in the future",BIRNLEX:16|FMA:82472|AAO:0011124|EFO:0000635|http://www.snomedbrowser.com/Codes/Details/113343008|http://www.snomedbrowser.com/Codes/Details/91717005,A multicellular structure that is a part of an organ.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cardinal organ part,,,,,uberon,,regional part of organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,UBERON:0000064,,,,,,,,,,,,,,,UBERON:0000064,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,organ part,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075502,endosome membrane permeabilization involved in viral entry into host cell,viral entry into host cell via caveolae-mediated endocytosis followed by endosome membrane|viral entry into host cell via clathrin-mediated endocytosis followed by endosome membrane permeabilization,"Induction of endosome membrane permeabilization triggered by an interaction between the host membrane and a membrane-penetration protein associated with the capsid. Occurs after internalization of the virus through the endosomal pathway, and results in delivery of the virus contents into the host cell cytoplasm.",false,,,http://purl.obolibrary.org/obo/GO_0039665,,,,,,,,,,,,,,,,jane,2010-06-02T02:40:25Z,,,,"Induction of endosome membrane permeabilization triggered by an interaction between the host membrane and a membrane-penetration protein associated with the capsid. Occurs after internalization of the virus through the endosomal pathway, and results in delivery of the virus contents into the host cell cytoplasm.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0075518,,,,,,,,,biological_process,,viral entry into host cell via caveolae-mediated endocytosis followed by endosome membrane|viral entry into host cell via clathrin-mediated endocytosis followed by endosome membrane permeabilization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039665,,,,GO:0075502,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/18227861,,,,GO:0075502,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endosome membrane permeabilization involved in viral entry into host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002733,Abnormality of the lymph nodes,Abnormality of the lymph nodes|Abnormal lymph node histology,A lymph node abnormality.,false,,,http://purl.obolibrary.org/obo/HP_0100763,,,,,,,,,,,,,,,,,,,,UMLS:C0149727,A lymph node abnormality.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0008149,,,,Abnormality of the lymph nodes|Abnormal lymph node histology,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0100763,,,,HP:0002733,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,HP:0002733,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the lymph nodes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006081,cellular aldehyde metabolic process,aldehyde metabolism|alkanal metabolic process|alkanal metabolism,"The chemical reactions and pathways involving aldehydes, any organic compound with the formula R-CH=O, as carried out by individual cells.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving aldehydes, any organic compound with the formula R-CH=O, as carried out by individual cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,aldehyde metabolism|alkanal metabolic process|alkanal metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006081,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006081,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,cellular aldehyde metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_239242,SARS coronavirus CUHK-AG02,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:239242,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CUHK-AG02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000144,ORF8b,,,false,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Open Reading Frame 8b in SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,modidied definition,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,true,,,,,https://pubmed.ncbi.nlm.nih.gov/32167180/,,,,,,,,,,,,,,,,,ORF8b,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051302,regulation of cell division,,"Any process that modulates the frequency, rate or extent of the physical partitioning and separation of a cell into daughter cells.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the physical partitioning and separation of a cell into daughter cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0051302,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051302,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of cell division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006898,receptor-mediated endocytosis,receptor mediated endocytosis,"An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.",false,,,http://purl.obolibrary.org/obo/GO_0006897,,,,,,,,,,,,,,,,,,,,Wikipedia:Receptor-mediated_endocytosis,"An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,receptor mediated endocytosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006897,,,,GO:0006898,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006898,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,receptor-mediated endocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_31547,eplerenone,"7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone|Eplerenone|Epoxymexrenone|Inspra|eplerenone",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:1032|KEGG:D01115|KEGG:C12512|CAS:107724-20-9|DrugBank:DB00700|Wikipedia:Eplerenone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone|Eplerenone",,,,,chebi_ontology,,Epoxymexrenone|Inspra|eplerenone,,,,,,,,,0,C24H30O6,"InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1",JUKPWJGBANNWMW-VWBFHTRKSA-N,414.49140,414.20424,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31547,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:31547,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,eplerenone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_31536,emtricitabine,"4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one|Emtricitabine|EMTRICITABINE|4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one|(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine|4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one|(2R-cis)-4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone|(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one|(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine|5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine|(-)-FTC|(-)-2'-deoxy-5-fluoro-3'-thiacytidine","An organofluorine compound  that is 5-fluorocytosine substituted at the 1 position by a 2-(hydroxymethyl)-1,3-oxathiolan-5-yl group (2R,5S configuration). It is used in combination therapy for the treatment of HIV-1 infection.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22915463|PMID:23361642|PMID:15875341|Drug_Central:1003|CAS:143491-57-0|PMID:19493710|PMID:16401810|KEGG:C12599|PMID:16034488|PMID:14609348|PMID:22935078|PMID:11491420|PMID:17526857|Wikipedia:Emtricitabine|KEGG:D01199|PMID:16323102|PMID:14693538|PMID:25017682|PMID:23337366|Beilstein:5908714|PMID:15249567|DrugBank:DB00879|Patent:WO9214743|PMID:15977972|PMID:15588339|PMID:22917277|Patent:US5538975|PMID:15206508|PDBeChem:ETV,"An organofluorine compound  that is 5-fluorocytosine substituted at the 1 position by a 2-(hydroxymethyl)-1,3-oxathiolan-5-yl group (2R,5S configuration). It is used in combination therapy for the treatment of HIV-1 infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:174911,,,,"4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one|Emtricitabine|EMTRICITABINE",,,,,chebi_ontology,,"4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one|(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine|4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one|(2R-cis)-4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone|(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one|(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine|5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine|(-)-FTC|(-)-2'-deoxy-5-fluoro-3'-thiacytidine",,,,,,,,,0,C8H10FN3O3S,"InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1",XQSPYNMVSIKCOC-NTSWFWBYSA-N,247.24700,247.04269,Nc1nc(=O)n(cc1F)[C@@H]1CS[C@H](CO)O1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31536,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/3230464,,,,CHEBI:31536,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,emtricitabine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0500165,Abnormal blood oxygen level,Abnormal blood O2 level|Abnormal blood oxygen levels|Abnromal O2 blood concentration,An abnormality of the partial pressure of oxygen in the arterial blood.,false,,,http://purl.obolibrary.org/obo/HP_0012415,,,,,,,,,,,,,,,,http://orcid.org/0000-0001-7941-2961,,,,,An abnormality of the partial pressure of oxygen in the arterial blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal blood O2 level|Abnormal blood oxygen levels|Abnromal O2 blood concentration,,,,,,,,,,,,,HP:0500165,,,,,,,,,,,,,,,,,,2018-10-17T15:14:35Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012415,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal blood oxygen level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267393,SARS coronavirus SinP4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267393,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SinP4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000071,receptor-binding domain (SARS-CoV-2),,,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32231345,"The receptor binding domain (RBD) located on the head of S1 and bind with the cellular receptor angiotensin-converting enzyme 2 (ACE2), initiating the membrane fusion of the virus and host cell.",,,,,,,,,,,,,,,,receptor-binding domain (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019062,virion attachment to host cell,viral absorption|virion attachment to host cell surface receptor|viral attachment to host cell,The process by which a virion protein binds to molecules on the host cellular surface or host cell surface projection.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,VZ:956,The process by which a virion protein binds to molecules on the host cellular surface or host cell surface projection.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral absorption,,,virion attachment to host cell surface receptor,,biological_process,,viral attachment to host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019062,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,GO:0019062,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,virion attachment to host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_260069,SARS coronavirus HC/SZ/61/03,SARS coronavirus SZ61,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus SZ61,,,,,,NCBITaxon:260069,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HC/SZ/61/03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039642,virion nucleoid,,The region of a virion in which the nucleic acid is confined.,false,,,http://purl.obolibrary.org/obo/GO_0044423,,,,,,,,,,,,,,,,rfoulger,2012-09-07T14:14:52Z,,,,The region of a virion in which the nucleic acid is confined.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044423,,,,GO:0039642,,,,,,true,,,,true,,,,,GO:0039642,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,virion nucleoid,,,,,,,,,,,,,,,,,,,,,,http://ircmj.com/articles/102812.html,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000410,COVID virology,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The 'COVID virology' concept enables a compilation of diverse concepts that are related to COVID-19 related virology  via the Axiome 'isVirologyFor some COIVID-19'.  Thus enables the adaptation of the ontology for text mining purposes for Covid-19 related information retrieval and information extraction.,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID virology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032279,asymmetric synapse,Gray's type I synapse,"A type of synapse occurring between an axon and a dendritic spine or dendritic shaft. Asymmetric synapses, the most abundant synapse type in the central nervous system, involve axons that contain predominantly spherical vesicles and contain a thickened postsynaptic density.  Most or all synapses of this type are excitatory.",false,,,http://purl.obolibrary.org/obo/GO_0098984,,,,,,,,,,,,,,,,,,,,,"A type of synapse occurring between an axon and a dendritic spine or dendritic shaft. Asymmetric synapses, the most abundant synapse type in the central nervous system, involve axons that contain predominantly spherical vesicles and contain a thickened postsynaptic density.  Most or all synapses of this type are excitatory.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Gray's type I synapse,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0098984,,,,GO:0032279,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032279,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,asymmetric synapse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0070613,regulation of protein processing,regulation of protein maturation by peptide bond cleavage,"Any process that modulates the frequency, rate or extent of protein processing, any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein.",false,,,http://purl.obolibrary.org/obo/GO_1903317,,,,,,,,,,,,,,,,midori,2009-04-29T02:49:14Z,,,,"Any process that modulates the frequency, rate or extent of protein processing, any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0010953,,,,regulation of protein maturation by peptide bond cleavage,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1903317,,,,GO:0070613,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0070613,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of protein processing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000038,one-dimensional temporal region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000008,,,,,OneDimensionalTemporalRegion,1d-t-region,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: A temporal interval is a special kind of one-dimensional temporal region, namely one that is self-connected (is without gaps or breaks).",,,A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001]),,the temporal region during which a process occurs.,,,,,,,,,(forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000038,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000008,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ido.owl,,,,,,,,,,,one-dimensional temporal region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_2955,azithromycin,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside|azithromycinum|Azenil|Zmax|Azigram|azitromicina|(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one|Azitromin|Zithromax|Azimakrol|Hemomycin|azithromycine|Azifast",A macrolide antibiotic useful for the treatment of bacterial infections.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Beilstein:5387583|Drug_Central:276|Reaxys:5387583|CAS:83905-01-5|KEGG:D07486|DrugBank:DB00207|KEGG:C06838|PMID:15143799|Patent:US4517359|PMID:18253999|Reaxys:8820027|LINCS:LSM-5821|HMDB:HMDB0014352|Wikipedia:Azithromycin|Patent:BE892357|PDBeChem:ZIT,A macrolide antibiotic useful for the treatment of bacterial infections.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:46596,,,,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside",,,,,chebi_ontology,,"azithromycinum|Azenil|Zmax|Azigram|azitromicina|(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one|Azitromin|Zithromax|Azimakrol|Hemomycin|azithromycine|Azifast",,,,,,,,,0,C38H72N2O12,"InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",MQTOSJVFKKJCRP-BICOPXKESA-N,748.98450,748.50853,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:2955,,,,,,,,,,,,,,,CHEBI:2955,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,azithromycin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000919,CD247,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TCRZ|CD3-ZETA|CD3Q|CD3H|CD3Z|T3Z,,,,,,,1,,,,,,,,,,Ensembl:ENSG00000198821|HGNC:1677|Vega:OTTHUMG00000034593|HPRD:01729|MIM:186780,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,CD247 molecule,,1q24.2,,,,"GO_0004888 (EC: IEA); GO_0005515 (EC: IPI, PMID: 10704231); GO_0005737 (EC: IDA, PMID: 11390434); GO_0005886 (EC: IDA, PMID: 11390434); GO_0005886 (EC: TAS); GO_0016021 (EC: IEA); GO_0016032 (EC: TAS); GO_0031295 (EC: TAS); GO_0038096 (EC: TAS); GO_0042101 (EC: IDA, PMID: 8176201); GO_0042105 (EC: IEA); GO_0042802 (EC: IPI, PMID: 17055436); GO_0042803 (EC: NAS, PMID: 12110186); GO_0045087 (EC: TAS); GO_0050690 (EC: TAS); GO_0050776 (EC: TAS); GO_0050852 (EC: TAS)",PMID: 1385158; 1385321; 1390434; 1454062; 1530920; 1532817; 1717577; 2111780; 2138083; 2138330; 2145165; 2845582; 2974162; 3478717; 3785426; 7514106; 7517794; 7526385; 7528772; 7589084; 7629168; 7680960; 7737297; 7842742; 8125298; 8176201; 8366117; 8409430; 8417118; 8621646; 8626561; 8656061; 8675217; 8760790; 8809126; 8906806; 8977276; 9036949; 9045614; 9047237; 9172452; 9368621; 9448136; 9484780; 9485181; 9510190; 9575182; 9625766; 9677202; 9687533; 9743208; 9880255; 10224289; 10424441; 10449770; 10704231; 10722370; 10799879; 11048639; 11349123; 11353765; 11390434; 11463741; 11525746; 11572860; 11714771; 11827988; 11851345; 11891219; 11916964; 11920499; 11950832; 12100036; 12110186; 12165490; 12176041; 12202152; 12356870; 12420108; 12421992; 12477932; 12522270; 12587826; 12731048; 12734410; 12755691; 12847689; 12902492; 12928398; 14523017; 14526327; 14550268; 14672952; 14715568; 14757743; 14967045; 15084271; 15144186; 15186530; 15274412; 15323357; 15489334; 15489916; 15592455; 15641485; 15659558; 15743765; 15749888; 15879101; 15922712; 16049493; 16094384; 16337488; 16393980; 16454711; 16461343; 16616055; 16672702; 16710414; 17001685; 17054067; 17055436; 17134238; 17134755; 17176095; 17255353; 17464179; 17652306; 17951997; 17997796; 18051367; 18174230; 18178846; 18207249; 18215426; 18438604; 18463433; 18505733; 18714041; 18721908; 18787188; 19064610; 19082633; 19090773; 19201859; 19229850; 19259799; 19422667; 19536175; 19664385; 19710135; 19898481; 20032419; 20118245; 20179761; 20190752; 20237496; 20383147; 20453842; 20637659; 20723304; 21383967; 21474487; 21669053; 21669059; 21750679; 21779181; 21988832; 22004975; 22221142; 22292024; 22294642; 22345473; 22401598; 22505724; 22536368; 22551306; 22798681; 22844345; 22911005; 23057733; 23228155; 23525753; 23861880; 23916875,,,,,,,,,,,,,,,,,,OGG:3000000919,,,,,,,,,,,,,,,,,,,CD247 molecule,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD247,,,20140408,919,RP11-104L21.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CD247,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_1902099,regulation of metaphase/anaphase transition of cell cycle,,"Any process that modulates the frequency, rate or extent of metaphase/anaphase transition of cell cycle.",false,,,http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_1901987,,,,,,,,,,,,,,,,jl,2013-05-02T12:45:15Z,,,,"Any process that modulates the frequency, rate or extent of metaphase/anaphase transition of cell cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_1901987,,,,GO:1902099,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902099,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of metaphase/anaphase transition of cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000929,CD14,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,5,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,CD14 molecule,,5q31.1,,,,"GO_0001530 (EC: IDA, PMID: 12594207); GO_0001847 (EC: TAS, PMID: 2402637); GO_0002224 (EC: TAS); GO_0002755 (EC: TAS); GO_0002756 (EC: TAS); GO_0005515 (EC: IPI); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0005886 (EC: TAS); GO_0006909 (EC: TAS, PMID: 9548256); GO_0006915 (EC: TAS, PMID: 9548256); GO_0006954 (EC: IEA); GO_0007166 (EC: TAS, PMID: 8798531); GO_0007249 (EC: TAS); GO_0009408 (EC: IEA); GO_0009986 (EC: IEA); GO_0010008 (EC: TAS); GO_0016019 (EC: TAS, PMID: 8798531); GO_0031225 (EC: IEA); GO_0032026 (EC: IEA); GO_0032760 (EC: IDA, PMID: 12594207); GO_0034134 (EC: TAS); GO_0034138 (EC: TAS); GO_0034142 (EC: TAS); GO_0034612 (EC: IEA); GO_0035666 (EC: TAS); GO_0038123 (EC: TAS); GO_0038124 (EC: TAS); GO_0045087 (EC: TAS); GO_0045121 (EC: IEA); GO_0045471 (EC: IEA); GO_0045807 (EC: IEA); GO_0050715 (EC: IEA); GO_0070062 (EC: IDA, PMID: 19056867); GO_0070891 (EC: IDA, PMID: 12594207); GO_0071222 (EC: IDA, PMID: 12594207); GO_0071223 (EC: IDA, PMID: 12594207)",PMID: 2402637; 2448876; 2453848; 2462937; 2472171; 2779588; 3385210; 7583357; 8798531; 9142045; 9548256; 9562334; 9655682; 9665271; 10395652; 10575214; 11062291; 11076863; 11083760; 11145656; 11199329; 11257272; 11282774; 11343243; 11489942; 11732288; 11745332; 11779220; 11810121; 11825494; 11841490; 11843056; 11854210; 11876746; 11932927; 11935032; 11985523; 12006789; 12011764; 12067299; 12075251; 12082592; 12101079; 12103253; 12106839; 12117913; 12126249; 12140663; 12171914; 12174084; 12185442; 12196527; 12207338; 12324469; 12404174; 12410798; 12414752; 12417309; 12438323; 12450609; 12477932; 12492251; 12566518; 12580907; 12594207; 12624278; 12663765; 12679473; 12700637; 12731067; 12754215; 12756848; 12757265; 12825176; 12832426; 12853157; 12885845; 12897754; 12911501; 12938192; 12940436; 12942028; 12960274; 14500479; 14508193; 14510720; 14517492; 14517520; 14587643; 14617510; 14624155; 14648231; 14672339; 14673018; 14706103; 14720421; 14739370; 14996480; 15034063; 15039096; 15069085; 15080833; 15081257; 15116260; 15120158; 15132789; 15143473; 15164100; 15166925; 15175649; 15190267; 15207785; 15257175; 15269840; 15273551; 15292769; 15342556; 15356557; 15358661; 15369724; 15373760; 15378299; 15489334; 15489336; 15491315; 15516360; 15520404; 15558232; 15591473; 15599151; 15602630; 15619435; 15640605; 15647432; 15655821; 15670766; 15686783; 15714129; 15741437; 15753758; 15764151; 15777548; 15778383; 15842262; 15854776; 15867866; 15879416; 15932345; 15940135; 15946916; 15966209; 15975149; 16038043; 16046876; 16051275; 16061600; 16085746; 16101942; 16109674; 16137548; 16142747; 16148556; 16159630; 16165702; 16174094; 16174099; 16194368; 16239565; 16246938; 16266379; 16273620; 16273622; 16275943; 16283111; 16290232; 16292464; 16331574; 16335952; 16337421; 16344560; 16368002; 16381901; 16385250; 16386288; 16387800; 16409569; 16427140; 16433727; 16437636; 16443672; 16444757; 16446545; 16467036; 16473828; 16492974; 16509825; 16512634; 16520888; 16538169; 16552356; 16611358; 16614348; 16625214; 16698680; 16706818; 16749413; 16751411; 16785528; 16815140; 16836908; 16848791; 16860318; 16873708; 16879054; 16890863; 16893989; 16916546; 16933467; 16950285; 16950521; 17003960; 17007028; 17030237; 17046070; 17052752; 17056323; 17062130; 17067484; 17075287; 17086894; 17087609; 17098305; 17126402; 17187267; 17196641; 17201240; 17205552; 17207357; 17217435; 17259806; 17264400; 17274987; 17304102; 17309585; 17436151; 17438094; 17448042; 17456337; 17471431; 17511783; 17515856; 17565650; 17600225; 17607003; 17617027; 17653770; 17703412; 17802898; 17846597; 17869646; 17877764; 17877801; 17900622; 17913858; 17916440; 17919709; 17925604; 17934216; 17943182; 17949800; 17982638; 18008256; 18040078; 18056918; 18057002; 18067042; 18157711; 18158110; 18174680; 18180316; 18180796; 18182917; 18288274; 18312481; 18315435; 18320914; 18354240; 18385826; 18414664; 18415752; 18417506; 18425216; 18426570; 18458151; 18495781; 18496988; 18497880; 18519568; 18565258; 18571004; 18580445; 18580477; 18596635; 18606699; 18634146; 18664531; 18666712; 18676680; 18691306; 18714537; 18728522; 18767926; 18774388; 18794053; 18810425; 18818748; 18931892; 18938271; 18951711; 18974840; 18974842; 18987746; 18991094; 19006850; 19010986; 19019335; 19027777; 19028820; 19037967; 19046305; 19056867; 19060757; 19096003; 19131662; 19148143; 19170196; 19189651; 19200604; 19210273; 19222419; 19225544; 19242719; 19247692; 19254290; 19258923; 19263529; 19264973; 19275920; 19318422; 19337058; 19346955; 19360901; 19361972; 19365146; 19390489; 19420105; 19423540; 19433913; 19447482; 19466271; 19468702; 19479237; 19500269; 19508433; 19522765; 19527514; 19536153; 19550115; 19559392; 19572148; 19578796; 19584052; 19595045; 19605672; 19625176; 19674346; 19692168; 19701968; 19729601; 19733948; 19741468; 19758335; 19761511; 19795323; 19799036; 19809507; 19824106; 19829130; 19830784; 19845895; 19847953; 19860589; 19892918; 19913121; 19928913; 19948975; 19997857; 20039305; 20085599; 20092898; 20109306; 20109750; 20113368; 20163933; 20179016; 20207250; 20219985; 20227257; 20302606; 20346360; 20363151; 20364047; 20377740; 20381257; 20384875; 20394509; 20395963; 20398919; 20406964; 20430603; 20430725; 20438785; 20452482; 20463618; 20472010; 20472613; 20485444; 20503287; 20532808; 20536280; 20536507; 20555320; 20579716; 20587312; 20603037; 20608916; 20618347; 20628086; 20636398; 20660791; 20673868; 20677014; 20703737; 20717070; 20723409; 20730440; 20826579; 20832340; 20865702; 20964518; 21039068; 21041645; 21048031; 21052690; 21062235; 21063024; 21079949; 21084593; 21118416; 21172039; 21178007; 21191073; 21209279; 21253969; 21257965; 21277522; 21278688; 21293259; 21303362; 21333644; 21361908; 21389010; 21476947; 21489615; 21498585; 21596674; 21633598; 21700881; 21705839; 21722015; 21740312; 21745379; 21799175; 21808991; 21842127; 21885391; 21905503; 21921097; 21948372; 21988832; 22014346; 22015088; 22056216; 22219617; 22232682; 22260507; 22265692; 22363790; 22376040; 22384567; 22445606; 22482418; 22564189; 22648004; 22697010; 22703766; 22737215; 22808111; 22812245; 22937756; 22961048; 22999728; 23000519; 23009036; 23036097; 23036271; 23046822; 23049772; 23079836; 23101184; 23107636; 23121673; 23146639; 23162014; 23162132; 23194293; 23201091; 23206327; 23264655; 23277403; 23338226; 23371544; 23430250; 23510625; 23537804; 23565226; 23582034; 23589304; 23679818; 23741383; 23762319; 23786414; 23824692; 23880187; 23936239; 24044964; 24077340; 24116867; 24172224,,,,,,,,,,,,,,,,,,OGG:3000000929,,,,,,,,,,,,,,,,,,,CD14 molecule,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD14,,,20140408,929,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,CD14,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000005340,PLG,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,6,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,plasminogen,,6q26,,,,"GO_0002576 (EC: TAS); GO_0004252 (EC: IDA, PMID: 14699093); GO_0005515 (EC: IPI, PMID: 10077593); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 6216475); GO_0005886 (EC: TAS); GO_0007596 (EC: IMP, PMID: 1986355); GO_0007596 (EC: TAS); GO_0008285 (EC: TAS, PMID: 8910613); GO_0009986 (EC: IDA, PMID: 14699093); GO_0010812 (EC: IDA, PMID: 14699093); GO_0019904 (EC: IPI, PMID: 9786936); GO_0022617 (EC: IDA, PMID: 14699093); GO_0022617 (EC: TAS); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0031093 (EC: TAS); GO_0031232 (EC: IDA, PMID: 14699093); GO_0034185 (EC: IPI, PMID: 16480936); GO_0042246 (EC: IEA); GO_0042730 (EC: TAS); GO_0044267 (EC: TAS); GO_0045445 (EC: IEA); GO_0046716 (EC: IEA); GO_0048771 (EC: IEA); GO_0051603 (EC: IEA); GO_0051918 (EC: IDA, PMID: 14726399); GO_0051919 (EC: IDA, PMID: 6438154); GO_0060707 (EC: IEA); GO_0060716 (EC: IEA); GO_0070062 (EC: IDA, PMID: 19199708); GO_0071674 (EC: IEA); GO_0072562 (EC: IDA); GO_2000048 (EC: TAS, PMID: 17203182)",PMID: 122932; 126863; 134998; 142009; 146197; 158022; 479158; 659588; 1427790; 1657148; 1657149; 1909331; 1939207; 1986355; 2065054; 2157850; 2318848; 2437112; 2522013; 2745554; 2829380; 2962191; 2962641; 3030813; 3334852; 3356193; 3920216; 4226004; 4240117; 4694729; 5475635; 6094526; 6148961; 6216475; 6238949; 6438154; 6582496; 6838832; 6919539; 6980881; 7525077; 7538844; 7548163; 7586586; 7814888; 7982919; 8054447; 8162705; 8181475; 8181476; 8360181; 8392398; 8460120; 8478593; 8555184; 8611560; 8612605; 8652577; 8843739; 8910613; 9020112; 9054441; 9102221; 9102401; 9201958; 9234243; 9242524; 9305949; 9337997; 9360944; 9375744; 9428707; 9490681; 9521645; 9548733; 9596664; 9688635; 9737862; 9783753; 9786936; 9834305; 9858247; 10069369; 10077593; 10215610; 10218588; 10233898; 10512713; 10604721; 10625689; 10656799; 10700393; 10889192; 10928473; 10956663; 10964919; 10974350; 10978167; 11027681; 11100730; 11113116; 11169399; 11257124; 11263499; 11342539; 11350170; 11371191; 11438139; 11729324; 11888684; 11928826; 11939791; 12016220; 12036889; 12054798; 12080056; 12093796; 12189145; 12192005; 12228252; 12406896; 12456874; 12477932; 12604689; 12646571; 12692411; 12697748; 12700073; 12736244; 12871329; 12876630; 14574404; 14678821; 14699093; 14719094; 14726399; 14739127; 14739293; 14764098; 14769799; 15090462; 15099286; 15207811; 15211511; 15215240; 15220341; 15299951; 15321992; 15333838; 15489334; 15501816; 15529749; 15609351; 15613921; 15642732; 15677446; 15746964; 15911629; 16043488; 16087677; 16097950; 16229836; 16319056; 16478887; 16480936; 16601838; 16790522; 16828203; 17115186; 17200769; 17203182; 17206383; 17272502; 17379720; 17545513; 17606760; 17616171; 17653767; 17656680; 17890952; 17927806; 17976375; 17978577; 18039838; 18070889; 18160581; 18163891; 18223261; 18279394; 18289715; 18310038; 18329389; 18331597; 18366077; 18392331; 18566672; 18568768; 18624398; 18658146; 18667578; 18685433; 18714035; 18981180; 18983515; 19074676; 19158842; 19199708; 19308255; 19363026; 19465692; 19574304; 19712047; 19800007; 19801674; 19821587; 19850343; 19913121; 20056908; 20095998; 20112045; 20140262; 20143645; 20152941; 20346360; 20346413; 20553606; 20565259; 20617841; 20628086; 20655859; 20702651; 20709033; 20726765; 21072208; 21174000; 21236472; 21300353; 21316746; 21464960; 21467042; 21510941; 21543325; 21680799; 21755014; 21787393; 21802507; 21832858; 21900290; 21988832; 21998162; 22027013; 22079981; 22124123; 22147698; 22187433; 22197896; 22287006; 22507544; 22518846; 22619171; 22641690; 22677171; 22685231; 22732096; 22773346; 22832192; 22987920; 22996753; 23071278; 23071827; 23103380; 23118497; 23140098; 23150713; 23341464; 23449787; 23481605; 23576799; 23583624; 23645683; 23699598; 23702659; 23721211; 23853591; 24029428; 24457600; 24605649,,,,,,,,,,,,,,,,,,OGG:3000005340,,,,,,,,,,,,,,,,,,,plasminogen,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PLG,,,20140408,5340,RP1-81D8.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,PLG,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OBI_0000047,processed material,,Is a material entity that is created or changed during material processing.,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,Is a material entity that is created or changed during material processing.,,,,,,,,,processed material,,,,"Examples include gel matrices, filter paper, parafilm and buffer solutions, mass spectrometer, tissue samples",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,OBI:0000047,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,processed material,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Alan Ruttenberg,,,,
http://purl.obolibrary.org/obo/NCIT_C19830,Co-Immunoprecipitation,Co-Immunoprecipitation,"Co-immunoprecipitation (Co-IP) is a popular technique for protein interaction discovery. In a co-IP the target antigen precipitated by the antibody ""co-precipitates"" a binding partner/protein complex from a lysate. It is assumed that these proteins are related to the function of the target antigen at the cellular level.",false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,C19830,,,,,,,,,,"Co-immunoprecipitation (Co-IP) is a popular technique for protein interaction discovery. In a co-IP the target antigen precipitated by the antibody ""co-precipitates"" a binding partner/protein complex from a lysate. It is assumed that these proteins are related to the function of the target antigen at the cellular level.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Co-Immunoprecipitation,,,,,,,,,,,,,NCIT:C19830,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Co-Immunoprecipitation,Co-Immunoprecipitation,,,,,,,,,,,,,,,,,,Co-Immunoprecipitation,,,https://www.biorxiv.org/content/10.1101/2020.03.14.988345v1,Laboratory Procedure,,,,,,,,C1449705,
http://purl.obolibrary.org/obo/NCBITaxon_249075,SARS coronavirus HZS2-E,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249075,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HZS2-E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009913,epidermal cell differentiation,hypodermal cell differentiation,"The process in which a relatively unspecialized cell acquires specialized features of an epidermal cell, any of the cells making up the epidermis.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The process in which a relatively unspecialized cell acquires specialized features of an epidermal cell, any of the cells making up the epidermis.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043355,,,,,,,,,biological_process,,hypodermal cell differentiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0009913,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009913,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,epidermal cell differentiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267387,SARS coronavirus Sin848,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267387,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin848,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0070542,response to fatty acid,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0070542,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0070542,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to fatty acid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019051,induction by virus of host apoptotic process,induction of apoptosis in host by virus|activation of apoptosis in host by virus|activation by virus of host apoptotic programmed cell death|activation by virus of host apoptosis|induction by virus of host apoptotic programmed cell death|induction by virus of host apoptosis,"The set of viral processes that induce an apoptotic process in infected host cells, facilitating release and spread of progeny virions.",false,,,http://purl.obolibrary.org/obo/GO_0039526,,,,,,,,,,,,,,,,,,,,,"The set of viral processes that induce an apoptotic process in infected host cells, facilitating release and spread of progeny virions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,induction of apoptosis in host by virus|activation of apoptosis in host by virus|activation by virus of host apoptotic programmed cell death|activation by virus of host apoptosis|induction by virus of host apoptotic programmed cell death,,,induction by virus of host apoptosis,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039526,,,,GO:0019051,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32226295,,,,GO:0019051,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,induction by virus of host apoptotic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0002107,liver,jecur|iecur,"An exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes[GO].",false,,,http://purl.obolibrary.org/obo/UBERON_0006925|http://purl.obolibrary.org/obo/UBERON_0002365|http://purl.obolibrary.org/obo/UBERON_0004119|http://purl.obolibrary.org/obo/UBERON_0005172,,,,relationship type change: differentiates_from endoderm (AAO:0000139) CHANGED TO: develops_from endoderm (UBERON:0000925)[AAO],,,,,,,,,,,,,,,,MAT:0000097|MIAA:0000097|BTO:0000759|EMAPA:16846|FMA:7197|OpenCyc:Mx4rvVimppwpEbGdrcN5Y29ycA|NCIT:C12392|MESH:D008099|VHOG:0000257|AAO:0010111|EV:0100089|EHDAA2:0000997|EFO:0000887|XAO:0000133|galen:Liver|GAID:288|ZFA:0000123|MA:0000358|EHDAA:2197|UMLS:C0023884|TAO:0000123|CALOHA:TS-0564|http://www.snomedbrowser.com/Codes/Details/181268008|http://linkedlifedata.com/resource/umls/id/C0023884|http://en.wikipedia.org/wiki/Liver,"An exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes[GO].",,,,http://purl.obolibrary.org/obo/Leber_Schaf.jpg,,,,,,,,,,Organ which secretes bile and participates in formation of certain blood proteins.[AAO],"Only ZFA considers this part_of immune system - we weaken this to an overlaps relation, as in general it's only a subset of cells that have clear immune function.",,,,,"secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes[GO].",,,,,,,,,,,,,,,,uberon,,jecur|iecur,hepatic,,,,"All vertebrates possess a liver (reference 1); Later in craniate evolution, an anterior gill arch was transformed into jaws, and many new types of feeding subsequently evolved.(...) A liver evolved that, among its many functions, stores considerable energy as glycogen or lipid (reference 2).[well established][VHOG]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0006925|http://purl.obolibrary.org/obo/UBERON_0002365|http://purl.obolibrary.org/obo/UBERON_0004119|http://purl.obolibrary.org/obo/UBERON_0005172,,,,UBERON:0002107,,,,,,true,,,,,,,,,UBERON:0002107,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#major_organ|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,liver,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,"The liver is found in all vertebrates, and is typically the largest visceral organ. Its form varies considerably in different species, and is largely determined by the shape and arrangement of the surrounding organs. Nonetheless, in most species it is divided into right and left lobes; exceptions to this general rule include snakes, where the shape of the body necessitates a simple cigar-like form. The internal structure of the liver is broadly similar in all vertebrates.|An organ sometimes referred to as a liver is found associated with the digestive tract of the primitive chordate Amphioxus. However, this is an enzyme secreting gland, not a metabolic organ, and it is unclear how truly homologous it is to the vertebrate liver. The zebrafish liver differs from the mammalian liver in that the hepatocytes are not clearly organized in cords or lobules and the typical portal triads are not apparent. In addition, the zebrafish liver does not have Kuppfer cells. Furthermore, a clear distinction can be made between the male and female liver in the adult zebrafish. The female hepatocytes are very basophilic (Figure 15c) as a result of the production of vitellogenin (Van der Ven et al. 2003).",,,,,
http://purl.obolibrary.org/obo/SYMP_0000614,cough,,Cough is a respiratory system and chest symptom characterized by an explosive expulsion of air from the lungs acting as a protective mechanism to clear the air passages or as a symptom of pulmonary disturbance.,false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,,,,,,,,,,ICD9CM_2005:786.2|UMLS_CUI:C0010200|SyOID:8253|UMLS_ICD9CM_2005_AUI:A0043303,Cough is a respiratory system and chest symptom characterized by an explosive expulsion of air from the lungs acting as a protective mechanism to clear the air passages or as a symptom of pulmonary disturbance.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,SYMP:0000614,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,SYMP:0000614,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,cough,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_14566,disease of cellular proliferation,cell process disease|neoplasm,A disease that is characterized by abnormally rapid cell division.,false,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,,,,,,,,,,,,,,,,,,A disease that is characterized by abnormally rapid cell division.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:0000818,,,,cell process disease|neoplasm,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,DOID:14566,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,DOID:14566,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim,,,,,,,,,,disease of cellular proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_9352,type 2 diabetes mellitus,type II diabetes mellitus|type 2 diabetes|non-insulin-dependent diabetes mellitus|NIDDM,"A diabetes mellitus that involves high blood glucose resulting from cells fail to use insulin properly.|Xref MGI.
OMIM mapping confirmed by DO. [SN].",false,,,http://purl.obolibrary.org/obo/DOID_9351,,,,,,,,,,,,,,,,,,,,OMIM:608036|ICD10CM:E11|OMIM:603694|MESH:D003924|SNOMEDCT_US_2019_09_01:44054006|UMLS_CUI:C0011860|NCI:C26747|OMIM:601283|KEGG:04930|OMIM:601407|OMIM:125853|EFO:0001360,A diabetes mellitus that involves high blood glucose resulting from cells fail to use insulin properly.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,type II diabetes mellitus|type 2 diabetes|non-insulin-dependent diabetes mellitus|NIDDM,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Xref MGI.
OMIM mapping confirmed by DO. [SN].",,http://purl.obolibrary.org/obo/DOID_9351,,,,DOID:9352,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32224164,,,,DOID:9352,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,type 2 diabetes mellitus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000178,weight loss,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000473,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000473,,,,SYMP:0000178,,,,,,true,true,,,,,A reduction in total body weight.,,,SYMP:0000178,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,weight loss,,,,,,,,,,,,,,,,,,,,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.13.990226,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032308,Increased circulating procalcitonin level,,"An elevated concentration of procalcitonin in the blood circulation.|Procalcitonin is a 116 amino acid peptide that has an approximate MW of 14.5 kDa and belongs to the calcitonin (CT) superfamily of peptides. It can be divided into 3 sections including the amino terminus of the PCT region, immature calcitonin, and calcitonin carboxyl-terminus peptide-1 (CCP-1). Procalcitonin is encoded by CALC-1 gene located on chromosome 11. Cleavage in 1 site of the primary transcript of CALC-1 gene produces pre-PCT, which further undergoes proteolytic cleavage of its signal sequence to produce PCT. The synthesized PCT then undergoes post-translational processing to produce small peptides and mature CT. PCT is a biomarker that exhibits greater specificity than other proinflammatory markers (eg, cytokines) in identifying patients with sepsis and can be used in the diagnosis of bacterial infections. The short half-life (25-30 hours in plasma) of PCT, coupled with its virtual absence in health and specificity for bacterial infections, gives it a clear advantage over the other markers of bacterial infection.",false,,,http://purl.obolibrary.org/obo/HP_0100530,,,,,,,,,,,,,,,,peter,,,,,An elevated concentration of procalcitonin in the blood circulation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0032308,,,,,,,,,,,,,,,,,,2019-02-14T10:46:33Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Procalcitonin is a 116 amino acid peptide that has an approximate MW of 14.5 kDa and belongs to the calcitonin (CT) superfamily of peptides. It can be divided into 3 sections including the amino terminus of the PCT region, immature calcitonin, and calcitonin carboxyl-terminus peptide-1 (CCP-1). Procalcitonin is encoded by CALC-1 gene located on chromosome 11. Cleavage in 1 site of the primary transcript of CALC-1 gene produces pre-PCT, which further undergoes proteolytic cleavage of its signal sequence to produce PCT. The synthesized PCT then undergoes post-translational processing to produce small peptides and mature CT. PCT is a biomarker that exhibits greater specificity than other proinflammatory markers (eg, cytokines) in identifying patients with sepsis and can be used in the diagnosis of bacterial infections. The short half-life (25-30 hours in plasma) of PCT, coupled with its virtual absence in health and specificity for bacterial infections, gives it a clear advantage over the other markers of bacterial infection.",,http://purl.obolibrary.org/obo/HP_0100530,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076|https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Increased circulating procalcitonin level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_42223,emodin,"Emodin|1,3,8-trihydroxy-6-methylanthra-9,10-quinone|Schuttgelb|1,3,8-trihydroxy-6-methyl-9,10-anthraquinone|3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE|1,3,8-trihydroxy-6-methyl-9,10-anthracenedione","A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KNApSAcK:C00000555|PMID:19089830|PMID:16388516|PMID:22020806|PMID:12563347|LINCS:LSM-18994|PMID:22137788|PMID:17019678|PMID:22452333|PMID:17022020|PMID:19921750|PMID:18387517|Reaxys:1888141|PMID:22144110|PMID:22426603|Wikipedia:Emodin|PMID:19409890|Beilstein:1888141|PMID:19505457|KEGG:C10343|PMID:16077936|LIPID_MAPS_instance:LMPK13040008|PMID:12657721|PMID:16959273|PDBeChem:EMO|PMID:22271272|PMID:20139316|PMID:18473931|PMID:17340270|DrugBank:DB07715|CAS:518-82-1|PMID:21834668|PMID:18193729|PMID:19799875|PMID:22378302|PMID:22484343,"A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:4782|CHEBI:42221,,,,"Emodin|1,3,8-trihydroxy-6-methylanthra-9,10-quinone",,,,,chebi_ontology,,"Schuttgelb|1,3,8-trihydroxy-6-methyl-9,10-anthraquinone|3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE|1,3,8-trihydroxy-6-methyl-9,10-anthracenedione",,,,,,,,,0,C15H10O5,"InChI=1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3",RHMXXJGYXNZAPX-UHFFFAOYSA-N,270.23690,270.05282,Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:42223,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:42223,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,emodin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1904951,positive regulation of establishment of protein localization,upregulation of establishment of protein localisation|up regulation of protein positioning|up-regulation of protein positioning|positive regulation of protein positioning|positive regulation of protein recruitment|positive regulation of establishment of protein localisation|up-regulation of protein recruitment|up regulation of establishment of protein localisation|upregulation of protein positioning|upregulation of protein recruitment|up-regulation of establishment of protein localization|up regulation of protein recruitment|upregulation of establishment of protein localization|up regulation of establishment of protein localization|up-regulation of establishment of protein localisation|activation of protein positioning|activation of establishment of protein localization|activation of protein recruitment|activation of establishment of protein localisation,"Any process that activates or increases the frequency, rate or extent of establishment of protein localization.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,mec,2016-02-05T09:59:32Z,,,,"Any process that activates or increases the frequency, rate or extent of establishment of protein localization.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of establishment of protein localisation|up regulation of protein positioning|up-regulation of protein positioning|positive regulation of protein positioning|positive regulation of protein recruitment|positive regulation of establishment of protein localisation|up-regulation of protein recruitment|up regulation of establishment of protein localisation|upregulation of protein positioning|upregulation of protein recruitment|up-regulation of establishment of protein localization|up regulation of protein recruitment|upregulation of establishment of protein localization|up regulation of establishment of protein localization|up-regulation of establishment of protein localisation,,,activation of protein positioning|activation of establishment of protein localization|activation of protein recruitment|activation of establishment of protein localisation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1904951,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1904951,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of establishment of protein localization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016266,O-glycan processing,,The stepwise addition of carbohydrate or carbohydrate derivative residues to the initially added O-linked residue (usually GalNAc) to form a core O-glycan structure.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The stepwise addition of carbohydrate or carbohydrate derivative residues to the initially added O-linked residue (usually GalNAc) to form a core O-glycan structure.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0016266,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016266,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,O-glycan processing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003500,IGHG1,,,false,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,14,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,immunoglobulin heavy constant gamma 1 (G1m marker),,14q32.33,,,,"GO_0003823 (EC: TAS, PMID: 6287432); GO_0005515 (EC: IPI, PMID: 11567028); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0006956 (EC: TAS); GO_0006958 (EC: TAS); GO_0038096 (EC: TAS); GO_0045087 (EC: TAS); GO_0072562 (EC: IDA)",PMID: 826475; 955567; 992566; 1002129; 1522589; 4138920; 4923144; 5489771; 5530842; 6287432; 6811139; 6884994; 7236608; 9661813; 10681448; 10917521; 11183784; 11257305; 11297532; 11525169; 11567028; 12039524; 12477932; 12527303; 14702039; 15037082; 15174051; 15517630; 16944158; 17044868; 17177686; 17400754; 17933503; 17960657; 18821675; 19317746; 19319024; 19380743; 19542624; 19608861; 19725029; 19738201; 21565611; 21654544; 21800051; 23117283; 23225573; 23956138; 24244333; 24457600,,,,,,,,,,,,,,,,,,OGG:3000003500,,,,,,,,,,,,,,,,,,,immunoglobulin heavy constant gamma 1 (G1m marker),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IGHG1,,,20140408,3500,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,IGHG1,,"Bin Zhao, Yue Liu, Oliver He",,other,,
http://purl.obolibrary.org/obo/GO_0034682,integrin alphav-beta1 complex,alphav-beta1 integrin complex|ITGAV-ITGB1 complex,An integrin complex that comprises one alphav subunit and one beta1 subunit.,false,,,http://purl.obolibrary.org/obo/GO_0008305,,,,,,,,,,,,,,,,,,,,,An integrin complex that comprises one alphav subunit and one beta1 subunit.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,alphav-beta1 integrin complex,,,ITGAV-ITGB1 complex,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0008305,,,,GO:0034682,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0034682,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,integrin alphav-beta1 complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001919,Acute kidney injury,Acute kidney failure|Acute renal failure,"Sudden loss of renal function, as manifested by decreased urine production, and a rise in serum creatinine or blood urea nitrogen concentration (azotemia).|Acute renal failure is usually classified into prerenal (response to severe volume depletion), intrinsic (response to acute cytotoxic, ischemic, or inflammatory insults) and postrenal (response to obstruction of the passage of urine) etiologies.",false,,,http://purl.obolibrary.org/obo/HP_0000083,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:14350001000004108|UMLS:C0022660|MSH:D058186|UMLS:C2609414|SNOMEDCT_US:14669001,"Sudden loss of renal function, as manifested by decreased urine production, and a rise in serum creatinine or blood urea nitrogen concentration (azotemia).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Acute kidney failure|Acute renal failure,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Acute renal failure is usually classified into prerenal (response to severe volume depletion), intrinsic (response to acute cytotoxic, ischemic, or inflammatory insults) and postrenal (response to obstruction of the passage of urine) etiologies.",,http://purl.obolibrary.org/obo/HP_0000083,,,,HP:0001919,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/|https://www.ncbi.nlm.nih.gov/pubmed/32171076,,,,HP:0001919,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Acute kidney injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0038094,Fc-gamma receptor signaling pathway,Fc-gamma receptor signalling pathway,"A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin G (IgG) to an Fc-gamma receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.",false,,,http://purl.obolibrary.org/obo/GO_0038093,,,,,,,,,,,,,,,,rfoulger,2012-02-16T05:22:46Z,,,,"A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin G (IgG) to an Fc-gamma receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fc-gamma receptor signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0038093,,,,GO:0038094,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0038094,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,Fc-gamma receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_48390,cinacalcet,N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine|(R)-alpha-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara|cinacalcet|N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine,A secondary amino compound that is (1R)-1-(naphthalen-1-yl)ethanamine in which one of the hydrogens attached to the nitrogen is substituted by a 3-[3-(trifluoromethyl)phenyl]propyl group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:17652181|Patent:US2007060645|Drug_Central:647|Patent:US6211244|Reaxys:10191346|DrugBank:DB01012|Wikipedia:Cinacalcet|KEGG:D03504|Patent:US6011068|PMID:16680561|LINCS:LSM-5815|CAS:226256-56-0,A secondary amino compound that is (1R)-1-(naphthalen-1-yl)ethanamine in which one of the hydrogens attached to the nitrogen is substituted by a 3-[3-(trifluoromethyl)phenyl]propyl group.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine,,,,,chebi_ontology,,(R)-alpha-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara|cinacalcet|N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine,,,,,,,,,0,C22H22F3N,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1",VDHAWDNDOKGFTD-MRXNPFEDSA-N,357.41203,357.17043,C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:48390,,,,,true,true,,,,,,,,,CHEBI:48390,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,cinacalcet,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000088,ferroquine,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Ferroquine is a derivative of chloroquine used as a treatment for malaria. It is the first organometallic drug- a ferrocenyl group covalently flanked by a 4-aminoquinoline and a basic alkylamine.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,true,,,,,https://pubmed.ncbi.nlm.nih.gov/19020475/,,,,,,,,,,,,,,,,,ferroquine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0275/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C35682,Positive Laboratory Test Result,Positive Laboratory Test Result|positive test result,"A laboratory test result that indicates that a specific disease, condition, or attribute being assessed is present.",false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,A test result that reveals the presence of a specific disease or condition for which the test is being done.,,,,,,,,,C35682,,,,,,,,,,"A laboratory test result that indicates that a specific disease, condition, or attribute being assessed is present.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Positive Laboratory Test Result|positive test result,,,,,,,,,,,,,NCIT:C35682,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175425/,,positive result|positive test result|tested positive,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Positive Laboratory Test Result,Positive_Test_Result,,,,,,,,,,,,,,,,,,Positive Laboratory Test Result,,,,Laboratory or Test Result,,,,,,,,C1335447,
http://purl.obolibrary.org/obo/GO_0098636,protein complex involved in cell adhesion,cell adhesion complex,Any protein complex that is capable of carrying out some part of the process of cell adhesion to the cell matrix or to another cell.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,Any protein complex that is capable of carrying out some part of the process of cell adhesion to the cell matrix or to another cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:1990307,,,,,,,,,cellular_component,,cell adhesion complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0098636,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098636,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein complex involved in cell adhesion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032436,Abnormal C-reactive protein level,,"Any deviation from the normal concentration of C-reactive protein in the blood circulation.|C-reactive protein (CRP) is produced by the liver, and increases in concentration in response to inflammation.",false,,,http://purl.obolibrary.org/obo/HP_0010876,,,,,,,,,,,,,,,,peter,,,,,Any deviation from the normal concentration of C-reactive protein in the blood circulation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0032436,,,,,,,,,,,,,,,,,,2019-03-02T15:10:11Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"C-reactive protein (CRP) is produced by the liver, and increases in concentration in response to inflammation.",,http://purl.obolibrary.org/obo/HP_0010876,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal C-reactive protein level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005925,focal adhesion,connecting hemi-adherens junction|HAJ|hemi-adherens junction|focal contact|adhesion plaque,A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).,false,,,http://purl.obolibrary.org/obo/GO_0030055,,,,,,,,,,,,,,,,,,,,Wikipedia:Focal_adhesion,A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008357|GO:0005926,,,,connecting hemi-adherens junction|HAJ|hemi-adherens junction|focal contact,,,,,cellular_component,,adhesion plaque,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030055,,,,GO:0005925,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005925,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,focal adhesion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000027,object aggregate,,,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,ObjectAggregate,object-aggregate,,,,,,,,,,,,,,,,,"ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158.",,,,,,"BFO 2 Reference: object aggregates may gain and lose parts while remaining numerically identical (one and the same individual) over time. This holds both for aggregates whose membership is determined naturally (the aggregate of cells in your body) and aggregates determined by fiat (a baseball team, a congressional committee).|An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects ",,,b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004]),,"a symphony orchestra|defined through physical containment: the aggregate of molecules of carbon dioxide in a sealed container|the nitrogen atoms in the atmosphere|the aggregate of bearings in a constant velocity axle joint|defined through physical attachment: the aggregate of atoms in a lump of granite|defined by fiat: the aggregate of members of an organization|a collection of cells in a blood biobank.|the restaurants in Palo Alto|an organization is an aggregate whose member parts have roles of specific types (for example in a jazz band, a chess club, a football team)|a swarm of bees is an aggregate of members who are linked together through natural bonds|defined via attributive delimitations such as: the patients in this hospital|the aggregate of blood cells in your body|your collection of Meissen ceramic plates.",,,,,,,,,(forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000027,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,object aggregate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051170,import into nucleus,nuclear import|substance nuclear import|single organism nuclear import|single-organism nuclear import,The directed movement of substances into the nucleus.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,jl,2013-12-19T15:26:34Z,,,,The directed movement of substances into the nucleus.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:1902593,,,,nuclear import|substance nuclear import|single organism nuclear import,,,,,biological_process,,single-organism nuclear import,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0051170,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129059/,,,,GO:0051170,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,import into nucleus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000016,disposition,,,false,,,http://purl.obolibrary.org/obo/BFO_0000017,,,,,Disposition,disposition,,,,,,,,,,,,,,,,,,,,,,,BFO 2 Reference: Dispositions exist along a strength continuum. Weaker forms of disposition are realized in only a fraction of triggering cases. These forms occur in a significant number of cases of a similar type.,,,"b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002])",,an atom of element X has the disposition to decay to an atom of element Y|the cell wall is disposed to filter chemicals in endocytosis and exocytosis|children are innately disposed to categorize objects in certain ways.|certain people have a predisposition to colon cancer,,,,,,,,,(forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002] |(forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002] ,"If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002])",,,,,,,,,,,,,,,,,,,,,BFO:0000016,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000017,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mf.owl|http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,disposition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_5844,myocardial infarction,Myocardial infarct|heart attack,A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.|Xref MGI.,false,,,http://purl.obolibrary.org/obo/DOID_3393,,,,,,,,,,,,,,,,,,,,EFO:0000612|NCI:C27996|OMIM:608557|UMLS_CUI:C0027051|MESH:D009203|SNOMEDCT_US_2019_09_01:22298006|ICD10CM:I21,A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Myocardial infarct|heart attack,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Xref MGI.,,http://purl.obolibrary.org/obo/DOID_3393,,,,DOID:5844,,,,,,true,,,,,,,heart attack,,DOID:5844,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,myocardial infarction,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035066,positive regulation of histone acetylation,upregulation of histone acetylation|up regulation of histone acetylation|up-regulation of histone acetylation|stimulation of histone acetylation|activation of histone acetylation,"Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein.",false,,,http://purl.obolibrary.org/obo/GO_2000758,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of histone acetylation|up regulation of histone acetylation|up-regulation of histone acetylation,,,stimulation of histone acetylation|activation of histone acetylation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_2000758,,,,GO:0035066,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035066,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of histone acetylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003543,IGLL1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IGL5|IGL1|IGVPB|IGLJ14.1|IGO|IGLL|AGM2|VPREB2|CD179b|14.1,,,,,,,22,,,,,,,,,,HGNC:5870|Vega:OTTHUMG00000150673|Ensembl:ENSG00000128322|HPRD:00905|MIM:146770,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,immunoglobulin lambda-like polypeptide 1,,22q11.23,,,,"GO_0005576 (EC: IEA); GO_0006955 (EC: NAS, PMID: 2501791); GO_0016020 (EC: NAS, PMID: 2501791)",PMID: 1703205; 1760403; 1903358; 2117639; 2128466; 2501791; 2511029; 3003227; 3139558; 7961773; 8406611; 9029104; 9074928; 9419212; 10421777; 10799888; 10887125; 11564802; 11976493; 12477932; 15489334; 16289162; 16751776; 18391951; 21448238; 23124203,,,,,,,,,,,,,,,,,,OGG:3000003543,,,,,,,,,,,,,,,,,,,immunoglobulin lambda-like polypeptide 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IGLL1,,,20140408,3543,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,IGLL1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_1283333,Bat coronavirus Cp/Yunnan2011,Bat Cp-coronavirus/Yunnan2011,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat Cp-coronavirus/Yunnan2011,,,,,,NCBITaxon:1283333,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat coronavirus Cp/Yunnan2011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000212,meiotic spindle organization,meiotic spindle organisation|spindle organization during meiosis|meiotic spindle organization and biogenesis|meiotic spindle stabilization,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a meiotic cell cycle.",false,,,http://purl.obolibrary.org/obo/GO_1903046|http://purl.obolibrary.org/obo/GO_0007051,,,,,,,,,,,,,,,,,,,,,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the microtubule spindle during a meiotic cell cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043147,,,,meiotic spindle organisation|spindle organization during meiosis,,,,,biological_process,,meiotic spindle organization and biogenesis|meiotic spindle stabilization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1903046|http://purl.obolibrary.org/obo/GO_0007051,,,,GO:0000212,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000212,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,meiotic spindle organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0001062,anatomical entity,,Biological entity that is either an individual member of a biological species or constitutes the structural organization of an individual member of a biological species.,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,AEO:0000000|NCIT:C12219|TAO:0100000|MA:0000001|XAO:0000000|EHDAA2:0002229|FBbt_root:00000000|FBbt:10000000|CARO:0000000|TGMA:0001822|HAO:0000000|BIRNLEX:6|ZFA:0100000|WBbt:0000100|FMA:62955|BILA:0000000|AAO:0010841|UMLS:C1515976|http://linkedlifedata.com/resource/umls/id/C1515976,Biological entity that is either an individual member of a biological species or constitutes the structural organization of an individual member of a biological species.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,UBERON:0001062,,,,,,,,,,,,,,,UBERON:0001062,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,anatomical entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009141,nucleoside triphosphate metabolic process,nucleoside triphosphate metabolism,"The chemical reactions and pathways involving a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nucleoside triphosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0009141,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009141,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nucleoside triphosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006376,mRNA splice site selection,spliceosomal commitment complex formation|spliceosomal E complex formation|spliceosomal E complex biosynthesis|spliceosomal commitment complex biosynthesis,Selection of a splice site by components of the assembling spliceosome.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,Selection of a splice site by components of the assembling spliceosome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,spliceosomal commitment complex formation|spliceosomal E complex formation|spliceosomal E complex biosynthesis|spliceosomal commitment complex biosynthesis,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006376,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006376,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mRNA splice site selection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007143,female meiotic nuclear division,female meiotic division|female meiosis,"A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the female germline.|Note that female germ lines can be found in female or hermaphroditic organisms, so this term can be used to annotate gene products from hermaphrodites such as those of C. elegans. See also the biological process term 'meiotic nuclear division; GO:0140013'.",false,,,http://purl.obolibrary.org/obo/GO_0140013,,,,,,,,,,,,,,,,,,,,,A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the female germline.,,,,,,,,,,,,,,,,,,,,,,,,,,,,female meiotic division|female meiosis,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_4751,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that female germ lines can be found in female or hermaphroditic organisms, so this term can be used to annotate gene products from hermaphrodites such as those of C. elegans. See also the biological process term 'meiotic nuclear division; GO:0140013'.",,http://purl.obolibrary.org/obo/GO_0140013,,,,GO:0007143,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007143,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,female meiotic nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042116,macrophage activation,macrophage polarization,"A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,macrophage polarization,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042116,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042116,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,macrophage activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_256753,SARS coronavirus GZ02,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:256753,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0025142,Constitutional symptom,,"A symptom or manifestation indicating a systemic or general effect of a disease and that may affect the general well-being or status of an individual.|Note that we use the preferred term label constitutional symptom because this reflects common usage, but we do not restrict the term or its descendents to the narrow meaning of symptom, i.e., a complaint related by a patient to a physician. There is no generally accepted classification of what defines a constitutional symptom, but examples  include weight loss, fatigue, general weakness, night sweats, shaking, chills, fever, and vomiting.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,HPO:probinson,,,,,A symptom or manifestation indicating a systemic or general effect of a disease and that may affect the general well-being or status of an individual.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0025142,,,,,,,,,,,,,,,,,,2016-11-29T11:02:54Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that we use the preferred term label constitutional symptom because this reflects common usage, but we do not restrict the term or its descendents to the narrow meaning of symptom, i.e., a complaint related by a patient to a physician. There is no generally accepted classification of what defines a constitutional symptom, but examples  include weight loss, fatigue, general weakness, night sweats, shaking, chills, fever, and vomiting.",,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Constitutional symptom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001556,oocyte maturation,,"A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Oocyte_maturation,"A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0001556,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001556,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,oocyte maturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000892,sensation perception,,Sensation perception is a nervous system symptom where the information perceived by sensory receptors are interpreted.,false,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,,,,,,,,,,,,,lschriml,2010-10-15T11:54:30Z,,,,Sensation perception is a nervous system symptom where the information perceived by sensory receptors are interpreted.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,SYMP:0000892,,,,,,,,,,,,,,,SYMP:0000892,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,sensation perception,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00831727,baricitinib,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2047232,,,,DRON:00831727,"An orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory, immunomodulating and antineoplastic activities. Upon administration, baricitinib binds to JAK1/2, which inhibits JAK1/2 activation and leads to the inhibition of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This decreases the production of inflammatory cytokines and may prevent an inflammatory response.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,baricitinib,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1903317,regulation of protein maturation,,"Any process that modulates the frequency, rate or extent of protein maturation.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,vw,2014-08-18T12:59:07Z,,,,"Any process that modulates the frequency, rate or extent of protein maturation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1903317,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903317,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of protein maturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901990,regulation of mitotic cell cycle phase transition,mitotic cell cycle control,"Any process that modulates the frequency, rate or extent of mitotic cell cycle phase transition.",false,,,http://purl.obolibrary.org/obo/GO_1901987,,,,,,,,,,,,,,,,jl,2013-03-19T16:14:38Z,,,,"Any process that modulates the frequency, rate or extent of mitotic cell cycle phase transition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mitotic cell cycle control,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901987,,,,GO:1901990,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901990,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,regulation of mitotic cell cycle phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000011331,PHB2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,BCAP37|PNAS-141|REA|BAP|Bap37|p22,,,,,,,12,,,,,,,,,,HGNC:30306|Ensembl:ENSG00000215021|Vega:OTTHUMG00000168519|HPRD:17843|MIM:610704,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,prohibitin 2,,12p13,,,,"GO_0005515 (EC: IPI, PMID: 10359819); GO_0005634 (EC: ISS); GO_0005739 (EC: IDA); GO_0005743 (EC: ISS); GO_0006351 (EC: IEA); GO_0016363 (EC: IDA); GO_0030331 (EC: NAS, PMID: 10359819); GO_0033147 (EC: IEA); GO_0033600 (EC: IEA); GO_0043234 (EC: IDA); GO_0045892 (EC: IDA, PMID: 10359819); GO_0060744 (EC: IEA); GO_0060749 (EC: IEA); GO_0060762 (EC: IEA)",PMID: 8723724; 9074930; 9259555; 10359819; 10931946; 10938099; 11302691; 12477932; 12943695; 15140878; 15173318; 15231747; 15489334; 15592455; 16541075; 17008324; 17203973; 17353931; 17453341; 17500595; 17558393; 17656096; 17785450; 17932104; 18029348; 18086671; 18255255; 18457437; 18629613; 19117054; 19167051; 19454010; 19496786; 19640993; 19738201; 19805454; 19906925; 20186120; 20360068; 20562859; 20856874; 20877624; 21081666; 21139048; 21319273; 21853274; 21890473; 21906983; 21963094; 21987572; 21988832; 22190034; 22212092; 22304920; 22384121; 22536838; 22623428; 22751105; 22904065; 22939629; 22990118; 23000965; 23182705; 23246001; 23275444; 23392257; 23455922; 23548868; 23798571; 23863811; 24003225; 24457600,,,,,,,,,,,,,,,,,,OGG:3000011331,,,,,,,,,,,,,,,,,,,prohibitin 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/19640993,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PHB2,,,20140408,11331,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,PHB2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0006949,syncytium formation,,"The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane. Syncytia are normally derived from single cells that fuse or fail to complete cell division.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane. Syncytia are normally derived from single cells that fuse or fail to complete cell division.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006949,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118126/,,,,GO:0006949,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,syncytium formation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305403,SARS coronavirus A021,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305403,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus A021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000467,anatomical system,system|connected anatomical system|body system|organ system|anatomical systems,"Multicellular, connected anatomical structure that has multiple organs as parts and whose parts work together to achieve some shared function.",false,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,,,,,,,,,,,,,,,,,TAO:0001439|TGMA:0001831|VHOG:0001725|WBbt:0005746|WBbt:0005763|BILA:0000011|EMAPA:16103|UMLS:C0460002|CARO:0000011|OpenCyc:Mx4rCWM0QCtDEdyAAADggVbxzQ|AAO:0000007|NCIT:C12919|BIRNLEX:14|AEO:0000011|XAO:0003002|MA:0000003|ZFA:0001439|galen:AnatomicalSystem|EV:0100000|FMA:7149|CALOHA:TS-2088|EHDAA:392|FBbt:00004856|EHDAA2:0003011|BSA:0000049|HAO:0000011|http://en.wikipedia.org/wiki/Organ_system|http://www.snomedbrowser.com/Codes/Details/278195005|http://linkedlifedata.com/resource/umls/id/C0460002,"Multicellular, connected anatomical structure that has multiple organs as parts and whose parts work together to achieve some shared function.",,,,,,,,,,,,,,,,,,,,,,,,,,,,system,,,connected anatomical system|body system|organ system,,,,,uberon,,anatomical systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,UBERON:0000467,,,,,,,,,,,,,,,UBERON:0000467,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,anatomical system,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/EHDAA2_0001330,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000027,interstitial fibrosis,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,Modified definition,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,A build-up of scar tissue that affects interstitium (the network of tissue that supports the air sacs in lungs).,"fibrosis, interstitial",Pulmonary fibrosis,,,,,,,,,,,,,,interstitial fibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011227,Elevated C-reactive protein level,Elevated CRP,"An abnormal elevation of the C-reactive protein level in serum.|C-reactive protein (CRP) is produced by the liver, and increases in concentration in response to inflammation.",false,,,http://purl.obolibrary.org/obo/HP_0032436,,,,,,,,,,,,,,,,peter,2011-12-13T11:04:10Z,,,UMLS:C4023452|UMLS:C0742906,An abnormal elevation of the C-reactive protein level in serum.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,Elevated CRP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"C-reactive protein (CRP) is produced by the liver, and increases in concentration in response to inflammation.",,http://purl.obolibrary.org/obo/HP_0032436,,,,HP:0011227,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,elevated CRP concentration|elevation of C-reactive protein levels,,HP:0011227,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Elevated C-reactive protein level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039663,membrane fusion involved in viral entry into host cell,fusion of virus membrane with host membrane during viral entry|viral entry into host cell via membrane fusion|fusion of virus membrane with host membrane,Merging of the virion membrane and a host membrane (host plasma membrane or host organelle membrane) that is involved in the uptake of a virus into a host cell.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,rfoulger,2013-08-29T10:15:11Z,,,,Merging of the virion membrane and a host membrane (host plasma membrane or host organelle membrane) that is involved in the uptake of a virus into a host cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,fusion of virus membrane with host membrane during viral entry|viral entry into host cell via membrane fusion|fusion of virus membrane with host membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0039663,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32142651,,,,GO:0039663,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,membrane fusion involved in viral entry into host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_241629,SARS coronavirus TWC3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:241629,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000004061,LY6E,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SCA2|RIG-E|RIGE|TSA-1|SCA-2,,,,,,,8,,,,,,,,,,Ensembl:ENSG00000160932|Vega:OTTHUMG00000164754|HPRD:03227|MIM:601384|HGNC:6727,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"lymphocyte antigen 6 complex, locus E",,8q24.3,,,,"GO_0001701 (EC: IEA); GO_0005887 (EC: TAS, PMID: 8650192); GO_0007166 (EC: TAS, PMID: 8650192); GO_0030325 (EC: IEA); GO_0031225 (EC: IEA); GO_0035265 (EC: IEA); GO_0042415 (EC: IEA); GO_0048242 (EC: IEA); GO_0055010 (EC: IEA)",PMID: 8125298; 8650192; 8757598; 9366413; 9551972; 9575182; 11576217; 11784869; 12477932; 12516096; 15489334; 16712791; 18755862; 18990604; 19672991; 20237496; 21963094,,,,,,,,,,,,,,,,,,OGG:3000004061,,,,,,,,,,,,,,,,,,,"lymphocyte antigen 6 complex, locus E",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,LY6E,,,20140408,4061,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.05.979260,,,,LY6E,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0009126,purine nucleoside monophosphate metabolic process,purine nucleoside monophosphate metabolism,"The chemical reactions and pathways involving purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009123,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine nucleoside monophosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009123,,,,GO:0009126,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009126,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine nucleoside monophosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305415,SARS coronavirus C019,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305415,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1902750,negative regulation of cell cycle G2/M phase transition,downregulation of cell cycle G2/M phase transition|down regulation of cell cycle G2/M phase transition|down-regulation of cell cycle G2/M phase transition|inhibition of cell cycle G2/M phase transition,Any signalling pathway that decreases or inhibits the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_1902749|http://purl.obolibrary.org/obo/GO_1901988,,,,,,,,,,,,,,,,jl,2014-03-05T15:38:21Z,,,,Any signalling pathway that decreases or inhibits the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,downregulation of cell cycle G2/M phase transition|down regulation of cell cycle G2/M phase transition|down-regulation of cell cycle G2/M phase transition,,,inhibition of cell cycle G2/M phase transition,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1902749|http://purl.obolibrary.org/obo/GO_1901988,,,,GO:1902750,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902750,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of cell cycle G2/M phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006349,CCL3L1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SCYA3L|SCYA3L1|LD78|LD78BETA|464.2|G0S19-2|D17S1718|MIP1AP,,,,,,,17,,,,,,,,,,MIM:601395|HGNC:10628|HPRD:03234|Ensembl:ENSG00000205021|Vega:OTTHUMG00000132996,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 3-like 1,,17q21.1,,,,,PMID: 1296815; 1694014; 1972563; 2271120; 7566098; 8661057; 10364178; 10471782; 10961862; 11390394; 11449371; 11734558; 12355456; 12477932; 15028295; 15340161; 15489334; 15637236; 15728180; 15962231; 17062725; 17330138; 17604289; 17874089; 17952079; 17971457; 18360285; 18498240; 18776933; 18781860; 18989363; 19055602; 19100722; 19279442; 19741716; 19812560; 19812561; 19812562; 19812563; 19886839; 19898927; 20044164; 20095832; 20442634; 20442635; 20628649; 20659124; 21084992; 21209899; 21592988; 21816135; 21919959; 22450355; 22476153; 22484760; 22484763; 22785612; 22837109; 24405814,,,,,,,,,,,,,,,,,,OGG:3000006349,,,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 3-like 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCL3L1,,,20140408,6349,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CCL3L1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_258972,SARS coronavirus TW9,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258972,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_4194,glucose metabolism disease,disorder of glucose metabolism,,false,,,http://purl.obolibrary.org/obo/DOID_0050013,,,,,,,,,,,,,,,,,,,,NCI:C53655|UMLS_CUI:C1257958|SNOMEDCT_US_2019_09_01:126877002|MESH:D044882,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disorder of glucose metabolism,,,,,disease_ontology,,,,,,,,,A metabolic disorder characterized by abnormal blood glucose levels.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0050013,,,,DOID:4194,,,,,,,,,,,,,,,DOID:4194,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,glucose metabolism disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009162,deoxyribonucleoside monophosphate metabolic process,deoxyribonucleoside monophosphate metabolism,"The chemical reactions and pathways involving a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009123,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,deoxyribonucleoside monophosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009123,,,,GO:0009162,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009162,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,deoxyribonucleoside monophosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901988,negative regulation of cell cycle phase transition,downregulation of cell cycle phase transition|down regulation of cell cycle transition|down-regulation of cell cycle phase transition|inhibition of cell cycle transition|down regulation of cell cycle phase transition|negative regulation of cell cycle transition|down-regulation of cell cycle transition|downregulation of cell cycle transition|inhibition of cell cycle phase transition,"Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle phase transition.",false,,,http://purl.obolibrary.org/obo/GO_1901987|http://purl.obolibrary.org/obo/GO_0010948,,,,,,,,,,,,,,,,jl,2013-03-19T16:11:32Z,,,,"Any process that stops, prevents or reduces the frequency, rate or extent of cell cycle phase transition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,downregulation of cell cycle phase transition|down regulation of cell cycle transition|down-regulation of cell cycle phase transition|inhibition of cell cycle transition|down regulation of cell cycle phase transition|negative regulation of cell cycle transition|down-regulation of cell cycle transition|downregulation of cell cycle transition,,,inhibition of cell cycle phase transition,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901987|http://purl.obolibrary.org/obo/GO_0010948,,,,GO:1901988,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901988,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of cell cycle phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034620,cellular response to unfolded protein,heat shock protein activity,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.|Note that this term should not be confused with 'unfolded protein response ; GO:0030968', which refers to the signaling pathways that respond to the presence of unfolded proteins in the ER.",false,,,http://purl.obolibrary.org/obo/GO_0035967|http://purl.obolibrary.org/obo/GO_0006986,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,heat shock protein activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term should not be confused with 'unfolded protein response ; GO:0030968', which refers to the signaling pathways that respond to the presence of unfolded proteins in the ER.",,http://purl.obolibrary.org/obo/GO_0035967|http://purl.obolibrary.org/obo/GO_0006986,,,,GO:0034620,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034620,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cellular response to unfolded protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_293320,SARS coronavirus PC4-205,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:293320,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-205,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267386,SARS coronavirus Sin3765V,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267386,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin3765V,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0007506,Heart Injuries,,,false,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0007506,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/|https://www.ncbi.nlm.nih.gov/pubmed/32215613,General or unspecified injuries to the heart.,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Heart Injuries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_10763,hypertension,vascular hypertensive disorder|HTN|High blood pressure|hyperpiesia|hypertensive disease,An artery disease characterized by chronic elevated blood pressure in the arteries.,false,,,http://purl.obolibrary.org/obo/DOID_0050828,,,,,,,,,,,,,,,,,,,,MESH:D006973|UMLS_CUI:C0020538|SNOMEDCT_US_2019_09_01:38341003|NCI:C3117|EFO:0000537|ICD9CM:401-405.99|ICD10CM:I10,An artery disease characterized by chronic elevated blood pressure in the arteries.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,vascular hypertensive disorder|HTN|High blood pressure|hyperpiesia,,,,,disease_ontology,,hypertensive disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0050828,,,,DOID:10763,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217650/,,,,DOID:10763,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,hypertension,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30116-8/fulltext,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001618,virus receptor activity,viral receptor activity,Combining with a virus component and mediating entry of the virus into the cell.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,Combining with a virus component and mediating entry of the virus into the cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral receptor activity,,,,,molecular_function,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0001618,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32201080,,,,GO:0001618,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,virus receptor activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000120425,AMICA1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CREA7-1|CREA7-4|AMICA|JAML|Gm638,,,,,,,11,,,,,,,,,,HGNC:19084|Ensembl:ENSG00000160593|Vega:OTTHUMG00000166965|MIM:609770|HPRD:16482,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"adhesion molecule, interacts with CXADR antigen 1",,11q23.3,,,,"GO_0005178 (EC: IPI, PMID: 12869515); GO_0005886 (EC: IDA, PMID: 12869515); GO_0005886 (EC: TAS); GO_0005923 (EC: IDA, PMID: 15800062); GO_0007157 (EC: IDA, PMID: 12869515); GO_0007157 (EC: IMP, PMID: 18948633); GO_0007596 (EC: TAS); GO_0016021 (EC: IEA); GO_0030593 (EC: IMP, PMID: 15800062); GO_0035696 (EC: IMP, PMID: 18948633); GO_0042803 (EC: IDA, PMID: 12869515); GO_0046629 (EC: ISS); GO_0050776 (EC: TAS); GO_0050839 (EC: IPI, PMID: 12869515); GO_0050900 (EC: TAS); GO_0060054 (EC: ISS); GO_0072672 (EC: IMP, PMID: 15800062)",PMID: 10737800; 12477932; 12869515; 12975309; 14702039; 15340161; 15800062; 16344560; 18948633; 19064666; 20379614; 21982860,,,,,,,,,,,,,,,,,,OGG:3000120425,,,,,,,,,,,,,,,,,,,"adhesion molecule, interacts with CXADR antigen 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,AMICA1,,,20140408,120425,UNQ722/PRO1387,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,AMICA1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_314145,Laurasiatheria,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_40674,,,,,,,,,,,,,,,,,,,,PMID:11214318|PMID:11214319|PMID:12878460|GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_superorder,,,,,,,NCBITaxon:314145,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_40674,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Laurasiatheria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_722424,SARS coronavirus Rs_672/2006,Bat SARS coronavirus Rs_672/2006|Bat SARS CoV Rs672/2006,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:663564,,,,,,,,,ncbi_taxonomy,,Bat SARS coronavirus Rs_672/2006|Bat SARS CoV Rs672/2006,,,,,,NCBITaxon:722424,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Rs_672/2006,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032802,low-density lipoprotein particle receptor catabolic process,LDL receptor catabolic process|LDL receptor degradation|low-density lipoprotein receptor degradation|LDL receptor breakdown|low-density lipoprotein receptor catabolism|low-density lipoprotein receptor catabolic process|low-density lipoprotein receptor breakdown|LDL receptor catabolism,"The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.",false,,,http://purl.obolibrary.org/obo/GO_0032799,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,LDL receptor catabolic process|LDL receptor degradation|low-density lipoprotein receptor degradation|LDL receptor breakdown|low-density lipoprotein receptor catabolism|low-density lipoprotein receptor catabolic process|low-density lipoprotein receptor breakdown,,,,,biological_process,,LDL receptor catabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0032799,,,,GO:0032802,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032802,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,low-density lipoprotein particle receptor catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042093,T-helper cell differentiation,helper T cell differentiation|T-helper cell development,The process in which a relatively unspecialized thymocyte acquires specialized features of a T-helper cell.,false,,,http://purl.obolibrary.org/obo/GO_0002294,,,,,,,,,,,,,,,,,,,,,The process in which a relatively unspecialized thymocyte acquires specialized features of a T-helper cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,helper T cell differentiation,,,,,biological_process,,T-helper cell development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002294,,,,GO:0042093,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042093,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,T-helper cell differentiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000112,therapeutic procedure,,A treatment whose completion is hypothesized by a health care provider to eliminate a disorder or to alleviate the signs and symptoms of a disorder or pathological process.,false,,,http://purl.obolibrary.org/obo/OGMS_0000090,,,,,,,,,,,,,,,,,,,Creation data: 2018-11-27,,A treatment whose completion is hypothesized by a health care provider to eliminate a disorder or to alleviate the signs and symptoms of a disorder or pathological process.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000112,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000090,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,therapeutic procedure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006373,CXCL11,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,I-TAC|b-R1|IP-9|IP9|SCYB9B|H174|SCYB11,,,,,,,4,,,,,,,,,,HGNC:10638|MIM:604852|Ensembl:ENSG00000169248|HPRD:05329|Vega:OTTHUMG00000130101,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 11,,4q21.2,,,,"GO_0005515 (EC: IPI, PMID: 18275857); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006935 (EC: IDA, PMID: 12782716); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 10233762); GO_0007267 (EC: TAS, PMID: 10233762); GO_0008009 (EC: IDA, PMID: 12782716); GO_0008201 (EC: IMP, PMID: 18645041); GO_0010818 (EC: IMP, PMID: 18645041); GO_0030816 (EC: IDA, PMID: 12782716); GO_0042127 (EC: IMP, PMID: 12782716); GO_0043950 (EC: IDA, PMID: 12782716); GO_0048248 (EC: IDA, PMID: 12782716); GO_0051281 (EC: IDA, PMID: 12782716); GO_0070098 (EC: IMP, PMID: 18645041)",PMID: 8798467; 9370294; 9625760; 9730616; 10065899; 10233762; 10386863; 10395932; 11110785; 11390394; 11559369; 12055261; 12126650; 12162873; 12169689; 12477932; 12695288; 12782716; 12787142; 12847282; 12884299; 15122750; 15150261; 15273303; 15308116; 15342556; 15489334; 15653416; 15814716; 15885315; 16081539; 16200621; 16210647; 16358960; 16368892; 17142784; 17255201; 17363734; 18209084; 18240029; 18258269; 18275857; 18316607; 18411283; 18515987; 18577758; 18645041; 18669615; 19175890; 19274094; 19800124; 19875106; 19939453; 20036838; 20056178; 20529825; 20810571; 20848514; 21438871; 21442287; 21470996; 21645215; 21724697; 21962843; 22008312; 22160826; 22168752; 22367045; 22691213; 23012327; 23158864; 23225384; 23527708; 23559389; 23600831; 24063316,,,,,,,,,,,,,,,,,,OGG:3000006373,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 11,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCL11,,,20140408,6373,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,CXCL11,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0075524,ribosomal skipping,,"A translation process in which a specific viral peptide prevents the ribosome from covalently linking a new inserted amino acid, and lets it continue translation, thereby cleaving the nascent protein while allowing translation to continue.|This term is intended to annotate gene products involved in the process of ribosomal skipping, not viral proteins produced by this translation process.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,janelomax,2011-08-03T03:19:37Z,,,VZ:914,"A translation process in which a specific viral peptide prevents the ribosome from covalently linking a new inserted amino acid, and lets it continue translation, thereby cleaving the nascent protein while allowing translation to continue.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"This term is intended to annotate gene products involved in the process of ribosomal skipping, not viral proteins produced by this translation process.",,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0075524,,,,,,true,,,,true,,,,,GO:0075524,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribosomal skipping,,,,,,,,,,,,,,,,,,,,,,https://openi.nlm.nih.gov/detailedresult?img=PMC2885027_1036fig1&req=4,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_227998,SARS coronavirus Hong Kong/03/2003,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:227998,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Hong Kong/03/2003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258508,SARS coronavirus ShanghaiQXC2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258508,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ShanghaiQXC2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005819,spindle,,The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Spindle_apparatus,The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005819,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005819,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spindle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039520,induction by virus of host autophagy,positive regulation by virus of host autophagy|activation of host autophagy by virus,"Any process in which a virus activates or increases the frequency, rate or extent of autophagy in the host.",false,,,http://purl.obolibrary.org/obo/GO_0039519,,,,,,,,,,,,,,,,rfoulger,2011-06-22T04:24:47Z,,,VZ:846,"Any process in which a virus activates or increases the frequency, rate or extent of autophagy in the host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,positive regulation by virus of host autophagy,,,activation of host autophagy by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039519,,,,GO:0039520,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098027/,,,,GO:0039520,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,induction by virus of host autophagy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045787,positive regulation of cell cycle,upregulation of progression through cell cycle|positive regulation of cell cycle progression|positive regulation of progression through cell cycle|up regulation of progression through cell cycle|up-regulation of progression through cell cycle|activation of progression through cell cycle|stimulation of progression through cell cycle,Any process that activates or increases the rate or extent of progression through the cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,Any process that activates or increases the rate or extent of progression through the cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of progression through cell cycle|positive regulation of cell cycle progression|positive regulation of progression through cell cycle|up regulation of progression through cell cycle|up-regulation of progression through cell cycle,,,activation of progression through cell cycle|stimulation of progression through cell cycle,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0045787,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045787,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000818,Abnormality of the endocrine system,Endocrine system disease,"An abnormality of the endocrine system.|The endocrine system is composed of glands that secrete hormones directly into the bloodstream and includes the following glands: thyroid, parathyroids, adrenals, pancreas, gonads (testicles and ovaries), and pituitary. Many other organs, such as the kidney, liver, and heart, have secondary endocrine functions.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,UMLS:C4025823|UMLS:C0014130|MSH:D004700|SNOMEDCT_US:362969004,An abnormality of the endocrine system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,Endocrine system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The endocrine system is composed of glands that secrete hormones directly into the bloodstream and includes the following glands: thyroid, parathyroids, adrenals, pancreas, gonads (testicles and ovaries), and pituitary. Many other organs, such as the kidney, liver, and heart, have secondary endocrine functions.",,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0000818,,,,,,,,,,,,,,,HP:0000818,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the endocrine system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0000833,molecular assay,,"An assay that generates data about the presence, abundance, structure, function, or activity of biological molecules, or a process that occurs at a molecular level of granularity.",false,,,http://purl.obolibrary.org/obo/OBI_0000070,,,,,,,,,,,,,,,,,,,,,"An assay that generates data about the presence, abundance, structure, function, or activity of biological molecules, or a process that occurs at a molecular level of granularity.",,PERSON: Matthew Brush,,,,,,,,,,,PCR.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,ERO:0000833,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000070,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,molecular assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Nicole Vasilevsky,,,,
http://purl.obolibrary.org/obo/GO_0005102,signaling receptor binding,receptor binding|receptor ligand|receptor-associated protein activity,"Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.|Where appropriate, also consider annotating to 'receptor agonist activity ; GO:0048018'.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Ligand_(biochemistry),"Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.",,,,,,,,,,,,,,,,,,,,,,,,,,,,receptor binding,,,,,,receptor ligand,,molecular_function,,receptor-associated protein activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Where appropriate, also consider annotating to 'receptor agonist activity ; GO:0048018'.",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0005102,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118126/,,,,GO:0005102,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_agr|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_mouse|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_flybase_ribbon,,,,,,,,,,signaling receptor binding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051233,spindle midzone,central spindle|spindle equator,The area in the center of the spindle where the spindle microtubules from opposite poles overlap.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The area in the center of the spindle where the spindle microtubules from opposite poles overlap.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,central spindle|spindle equator,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0051233,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051233,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spindle midzone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006914,autophagy,,The cellular catabolic process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Autophagy_(cellular),The cellular catabolic process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016238,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006914,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006914,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,autophagy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901991,negative regulation of mitotic cell cycle phase transition,down regulation of mitotic cell cycle phase transition|down-regulation of mitotic cell cycle phase transition|downregulation of mitotic cell cycle phase transition|inhibition of mitotic cell cycle phase transition,"Any process that stops, prevents or reduces the frequency, rate or extent of mitotic cell cycle phase transition.",false,,,http://purl.obolibrary.org/obo/GO_1901990|http://purl.obolibrary.org/obo/GO_1901988|http://purl.obolibrary.org/obo/GO_0045930,,,,,,,,,,,,,,,,jl,2013-03-19T16:14:46Z,,,,"Any process that stops, prevents or reduces the frequency, rate or extent of mitotic cell cycle phase transition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,down regulation of mitotic cell cycle phase transition|down-regulation of mitotic cell cycle phase transition|downregulation of mitotic cell cycle phase transition,,,inhibition of mitotic cell cycle phase transition,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901990|http://purl.obolibrary.org/obo/GO_1901988|http://purl.obolibrary.org/obo/GO_0045930,,,,GO:1901991,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901991,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of mitotic cell cycle phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044784,metaphase/anaphase transition of cell cycle,,The cell cycle process in which a cell progresses from metaphase to anaphase as part of the cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,janelomax,2013-05-02T13:09:34Z,,,,The cell cycle process in which a cell progresses from metaphase to anaphase as part of the cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0044784,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044784,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,metaphase/anaphase transition of cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072163,mesonephric epithelium development,,"The process whose specific outcome is the progression of an epithelium in the mesonephros over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.",false,,,http://purl.obolibrary.org/obo/GO_0072073,,,,,,,,,,,,,,,,midori,2010-02-26T01:40:43Z,,,,"The process whose specific outcome is the progression of an epithelium in the mesonephros over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072073,,,,GO:0072163,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072163,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mesonephric epithelium development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C17253,Viral Genome,Viral Genome,"The total complement of hereditary material in a virus, which can be composed of either DNA or RNA.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,C17253,,,,,,,,,,"The total complement of hereditary material in a virus, which can be composed of either DNA or RNA.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Viral Genome,,,,,,,,,,,,,NCIT:C17253,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,true,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Viral Genome,Viral_Genome,,,,,,,,,,,,,,,,,,Viral Genome,,,https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/#genome-expression-studies,Gene or Genome,,,,,,,,C0042720,
http://purl.obolibrary.org/obo/OGG_3000090865,IL33,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,NF-HEV|IL1F11|C9orf26|DVS27|NFEHEV,,,,,,,9,,,,,,,,,,Ensembl:ENSG00000137033|Vega:OTTHUMG00000019516|HPRD:12275|MIM:608678|HGNC:16028,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 33,,9p24.1,,,,"GO_0002686 (EC: IEA); GO_0002826 (EC: IEA); GO_0002830 (EC: IEA); GO_0005125 (EC: IDA, PMID: 19841166); GO_0005515 (EC: IPI, PMID: 16286016); GO_0005615 (EC: IEA); GO_0005634 (EC: IEA); GO_0005694 (EC: IEA); GO_0006351 (EC: IEA); GO_0030133 (EC: IEA); GO_0032689 (EC: IEA); GO_0032736 (EC: IEA); GO_0032753 (EC: IEA); GO_0032754 (EC: IEA); GO_0032755 (EC: IEA); GO_0043032 (EC: IDA, PMID: 19841166); GO_0045944 (EC: ISS, PMID: 19841166); GO_0050729 (EC: ISS, PMID: 19841166); GO_0051024 (EC: IEA); GO_0051025 (EC: IEA); GO_0090197 (EC: IDA, PMID: 19841166)",PMID: 10566975; 12477932; 12819012; 15164053; 15489334; 16169070; 16286016; 17185418; 17623648; 17675461; 17700564; 17853410; 18250453; 18539196; 18688256; 18762778; 18787100; 18802081; 18827826; 18836528; 18941187; 18955562; 19037964; 19198610; 19204726; 19248109; 19266498; 19372185; 19393621; 19439663; 19465481; 19508382; 19559631; 19596270; 19756962; 19801525; 19841166; 19860791; 19888696; 19906013; 19913053; 19918048; 20029461; 20035719; 20072851; 20153038; 20305685; 20338108; 20379614; 20385815; 20405148; 20406635; 20532808; 20534741; 20682660; 20689058; 20708824; 20731692; 20816195; 20860503; 20926795; 20931364; 20958987; 20963466; 21037074; 21190867; 21246230; 21357533; 21431944; 21441054; 21454686; 21519352; 21674220; 21674479; 21682736; 21684348; 21734074; 21737781; 21765905; 21802127; 21804549; 21898270; 21935266; 21949719; 22079334; 22100205; 22189043; 22215666; 22233535; 22239947; 22246057; 22270365; 22304300; 22307629; 22315510; 22329990; 22349136; 22540331; 22587998; 22590860; 22627366; 22634619; 22673732; 22682001; 22699663; 22708120; 22785132; 22809957; 22819319; 22828942; 22836779; 22841163; 22858587; 22921786; 23000728; 23028054; 23039129; 23093619; 23159404; 23162017; 23178147; 23205532; 23206447; 23219168; 23261461; 23300625; 23319592; 23357301; 23362867; 23363980; 23433789; 23464866; 23472165; 23484079; 23485578; 23488689; 23521712; 23525523; 23585867; 23634226; 23641786; 23656573; 23725175; 23759184; 23764374; 23775566; 23805875; 23817569; 23855553; 23935505; 23936781; 23980170; 23999434; 24075188; 24106520; 24107076; 24116703; 24257755; 24323357; 24459820,,,,,,,,,,,,,,,,,,OGG:3000090865,,,,,,,,,,,,,,,,,,,interleukin 33,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL33,,,20140408,90865,RP11-575C20.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL33,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCIT_C126929,Some Shortness of Breath,Some Shortness of Breath|Some shortness of breath,A response indicating that an individual experiences or experienced some shortness of breath.,false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,C126929,,,,,,,,,,A response indicating that an individual experiences or experienced some shortness of breath.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Some Shortness of Breath|Some shortness of breath,,,,,,,,,,,,,NCIT:C126929,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141630/,,shortness of breath,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C126891,,,,,,,,,,Some Shortness of Breath,,,,,,,CL508083,,,,,,,,,,,,Some Shortness of Breath,,,,Intellectual Product,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0001154,Personal Protective Equipment,,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0001154,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,,Specialized clothing or equipment worn for protection against health hazards. Personal Protective Equipment may include MASKS; RESPIRATORY PROTECTIVE DEVICES; HEAD PROTECTIVE DEVICES; EYE PROTECTIVE DEVICES; EAR PROTECTIVE DEVICES; PROTECTIVE CLOTHING; and protective footwear.,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Personal Protective Equipment,,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001657,ureteric bud development,,"The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.",false,,,http://purl.obolibrary.org/obo/GO_0072164,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072164,,,,GO:0001657,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001657,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ureteric bud development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0090068,positive regulation of cell cycle process,,"Any process that increases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events.",false,,,http://purl.obolibrary.org/obo/GO_0045787,,,,,,,,,,,,,,,,tanyaberardini,2009-09-09T11:39:52Z,,,,"Any process that increases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0045787,,,,GO:0090068,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0090068,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cell cycle process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000039,post natal transmission,,,false,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,Modified definition,,,transmission of infection(biological process),,true,,,,,,Postnata transmission reflects infections in infants or children who were uninfected through pregnancy and deliveryand who subsequently become HIV-infected while breast feeding.,,,,,,,,,,,,,,,,post natal transmission,,,,,,,,,,,,,,,,,,,,,,https://www.frontiersin.org/articles/10.3389/fped.2020.00104/full|https://sti.bmj.com/content/88/Suppl_2/i44,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000115,viral transmission by vector,,,false,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral transmission by vector is a transmission of viruses to humans by a vectors such as bats.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32234468,,,,,,,,,,,,,,,,,viral transmission by vector,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042254,ribosome biogenesis,ribosome biogenesis and assembly,"A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of ribosome subunits; includes transport to the sites of protein synthesis.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of ribosome subunits; includes transport to the sites of protein synthesis.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007046,,,,ribosome biogenesis and assembly,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042254,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042254,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,ribosome biogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901989,positive regulation of cell cycle phase transition,up regulation of cell cycle phase transition|positive regulation of cell cycle transition|activation of cell cycle transition|upregulation of cell cycle transition|up-regulation of cell cycle phase transition|up regulation of cell cycle transition|up-regulation of cell cycle transition|upregulation of cell cycle phase transition|activation of cell cycle phase transition,"Any process that activates or increases the frequency, rate or extent of cell cycle phase transition.",false,,,http://purl.obolibrary.org/obo/GO_0090068|http://purl.obolibrary.org/obo/GO_1901987,,,,,,,,,,,,,,,,jl,2013-03-19T16:11:37Z,,,,"Any process that activates or increases the frequency, rate or extent of cell cycle phase transition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,up regulation of cell cycle phase transition|positive regulation of cell cycle transition|activation of cell cycle transition|upregulation of cell cycle transition|up-regulation of cell cycle phase transition|up regulation of cell cycle transition|up-regulation of cell cycle transition|upregulation of cell cycle phase transition,,,activation of cell cycle phase transition,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0090068|http://purl.obolibrary.org/obo/GO_1901987,,,,GO:1901989,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901989,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cell cycle phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050871,positive regulation of B cell activation,up-regulation of B cell activation|up regulation of B cell activation|positive regulation of B-cell activation|upregulation of B cell activation|positive regulation of B lymphocyte activation|positive regulation of B-lymphocyte activation|stimulation of B cell activation|activation of B cell activation,"Any process that activates or increases the frequency, rate or extent of B cell activation.",false,,,http://purl.obolibrary.org/obo/GO_0050864|http://purl.obolibrary.org/obo/GO_0051251,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of B cell activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,up-regulation of B cell activation|up regulation of B cell activation|positive regulation of B-cell activation|upregulation of B cell activation|positive regulation of B lymphocyte activation|positive regulation of B-lymphocyte activation,,,stimulation of B cell activation|activation of B cell activation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050864|http://purl.obolibrary.org/obo/GO_0051251,,,,GO:0050871,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050871,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of B cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_241628,SARS coronavirus TWC2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:241628,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWC2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_3118,hepatobiliary disease,liver and biliary tract disease,A gastrointestinal system disease that is located_in the liver and/or biliary tract.,false,,,http://purl.obolibrary.org/obo/DOID_77,,,,,,,,,,,,,,,,,,,,MESH:D004066|NCI:C3959|UMLS_CUI:C0267792,A gastrointestinal system disease that is located_in the liver and/or biliary tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,liver and biliary tract disease,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_77,,,,DOID:3118,,,,,,,,,,,,,,,DOID:3118,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,hepatobiliary disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_312027,SARS coronavirus WH20,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:312027,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus WH20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039646,modulation by virus of host G0/G1 transition checkpoint,G0/G1 host cell cycle checkpoint dysregulation by virus,"Any viral process that modulates the frequency, rate or extent of the host cell G0/G1 transition checkpoint.",false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2012-10-09T15:11:22Z,,,VZ:881,"Any viral process that modulates the frequency, rate or extent of the host cell G0/G1 transition checkpoint.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,G0/G1 host cell cycle checkpoint dysregulation by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039646,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/16303160,,,,GO:0039646,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host G0/G1 transition checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003553,IL1B,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL1-BETA|IL1F2|IL-1,,,,,,,2,,,,,,,,,,HGNC:5992|HPRD:00985|Vega:OTTHUMG00000131344|MIM:147720|Ensembl:ENSG00000125538,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interleukin 1, beta",,2q14,,,,"GO_0000165 (EC: IMP); GO_0000187 (EC: IDA, PMID: 10748004); GO_0001660 (EC: IEA); GO_0001934 (EC: IDA, PMID: 10748004); GO_0001934 (EC: NAS, PMID: 16477012); GO_0002711 (EC: IC, PMID: 1919436); GO_0005125 (EC: IDA, PMID: 1919436); GO_0005125 (EC: IMP, PMID: 2989698); GO_0005149 (EC: NAS, PMID: 1919436); GO_0005576 (EC: IDA); GO_0005576 (EC: NAS, PMID: 1919436); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 12483741); GO_0005615 (EC: IMP, PMID: 3493774); GO_0005829 (EC: TAS); GO_0006915 (EC: TAS, PMID: 9218611); GO_0006954 (EC: IDA, PMID: 10748004); GO_0006954 (EC: NAS, PMID: 1919436); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 10786823); GO_0007267 (EC: TAS, PMID: 2989698); GO_0007566 (EC: TAS, PMID: 16720713); GO_0008285 (EC: IDA, PMID: 3493774); GO_0009743 (EC: IEA); GO_0010575 (EC: IDA, PMID: 12958148); GO_0010575 (EC: ISS); GO_0010829 (EC: ISS, PMID: 16865359); GO_0014805 (EC: NAS, PMID: 16477012); GO_0019221 (EC: IDA, PMID: 10748004); GO_0019904 (EC: IPI, PMID: 16575408); GO_0030141 (EC: IEA); GO_0030213 (EC: IDA, PMID: 15100360); GO_0030593 (EC: IEA); GO_0030730 (EC: IDA, PMID: 19032770); GO_0030949 (EC: IC, PMID: 12958148); GO_0031622 (EC: ISS); GO_0031663 (EC: IDA); GO_0032308 (EC: ISS); GO_0032611 (EC: IEA); GO_0032725 (EC: IDA); GO_0032729 (EC: IDA); GO_0032755 (EC: TAS, PMID: 16865359); GO_0032757 (EC: IDA, PMID: 19524870); GO_0033129 (EC: NAS); GO_0033198 (EC: IEA); GO_0034116 (EC: IDA, PMID: 15100360); GO_0034116 (EC: NAS, PMID: 19281832); GO_0035066 (EC: NAS); GO_0035234 (EC: IEA); GO_0035505 (EC: IDA, PMID: 18390750); GO_0035690 (EC: IDA, PMID: 19158679); GO_0042102 (EC: IDA, PMID: 1919436); GO_0042346 (EC: IDA, PMID: 18390750); GO_0043122 (EC: IDA, PMID: 10748004); GO_0043123 (EC: IEA); GO_0043407 (EC: ISS, PMID: 16865359); GO_0043491 (EC: IMP); GO_0045080 (EC: IEA); GO_0045086 (EC: IMP, PMID: 2989698); GO_0045410 (EC: IEA); GO_0045429 (EC: IDA, PMID: 8383325); GO_0045766 (EC: ISS); GO_0045833 (EC: ISS, PMID: 16865359); GO_0045840 (EC: IMP, PMID: 2989698); GO_0045893 (EC: IDA, PMID: 15100360); GO_0045944 (EC: IEA); GO_0046330 (EC: IEA); GO_0046627 (EC: ISS, PMID: 16865359); GO_0046827 (EC: NAS, PMID: 19281832); GO_0050796 (EC: IDA, PMID: 8383325); GO_0050995 (EC: IDA, PMID: 19032770); GO_0050996 (EC: ISS, PMID: 16865359); GO_0051044 (EC: IDA, PMID: 18373975); GO_0051091 (EC: IDA, PMID: 10748004); GO_0051092 (EC: IDA, PMID: 10383454); GO_0051781 (EC: IEA); GO_0060355 (EC: NAS, PMID: 19281832); GO_0060559 (EC: IDA, PMID: 16720713); GO_0070164 (EC: ISS, PMID: 16865359); GO_0070487 (EC: IDA, PMID: 15100360); GO_0071260 (EC: IEP, PMID: 19593445); GO_0071310 (EC: IDA, PMID: 19158679); GO_0071407 (EC: IDA); GO_0071639 (EC: IDA, PMID: 19524870); GO_0097192 (EC: IEA); GO_2001240 (EC: IDA, PMID: 10748004)",PMID: 1548758; 1753956; 1835838; 1837236; 1905933; 1907279; 1918997; 1919001; 1919436; 1993354; 2001363; 2137098; 2372550; 2466831; 2536171; 2585509; 2602367; 2635664; 2898301; 2946959; 2954882; 2989698; 3259176; 3264123; 3281727; 3490654; 3493774; 6083565; 6209582; 7494249; 7511078; 7526541; 7561697; 7642516; 7706435; 7797510; 7815507; 7818827; 7878046; 7981229; 8188271; 8383325; 8432529; 8537091; 8663297; 8764000; 8852605; 8869030; 8892361; 8939574; 9062193; 9108403; 9169134; 9185130; 9218611; 9225992; 9230816; 9288832; 9378998; 9658081; 9714181; 9820540; 10339575; 10358063; 10383454; 10438928; 10512743; 10625660; 10744718; 10746728; 10748004; 10756100; 10779559; 10786823; 10854325; 10860666; 10964543; 11023482; 11051551; 11057907; 11076651; 11079552; 11083263; 11093146; 11127488; 11138328; 11145836; 11171832; 11211945; 11226333; 11233912; 11238007; 11241561; 11260714; 11264025; 11278614; 11350500; 11350506; 11380940; 11422336; 11423389; 11427627; 11448121; 11466363; 11476790; 11481169; 11498264; 11500085; 11506478; 11527622; 11531943; 11574262; 11578018; 11579484; 11600466; 11606496; 11640949; 11641511; 11665666; 11669478; 11686217; 11686480; 11703512; 11704656; 11737511; 11751881; 11751921; 11756575; 11762793; 11770040; 11774564; 11777965; 11784248; 11790645; 11801594; 11806247; 11838837; 11840488; 11847219; 11849463; 11851889; 11853544; 11857060; 11858158; 11858187; 11868623; 11876744; 11895290; 11896542; 11898000; 11920321; 11921766; 11930657; 11950481; 11955925; 11958432; 11981835; 11991722; 12009575; 12021045; 12028539; 12031914; 12034804; 12038885; 12039524; 12042033; 12044341; 12050157; 12050395; 12052540; 12052541; 12067976; 12070246; 12077278; 12082592; 12089333; 12093792; 12095061; 12100571; 12101072; 12102486; 12105837; 12114904; 12115161; 12115182; 12117921; 12117953; 12117969; 12121221; 12121679; 12133437; 12133438; 12133467; 12140751; 12149413; 12161036; 12161099; 12163271; 12164325; 12165808; 12184914; 12191486; 12193665; 12195069; 12210881; 12212456; 12215823; 12220547; 12231216; 12235117; 12239970; 12297725; 12356774; 12362317; 12370389; 12377625; 12385002; 12390476; 12391274; 12418458; 12431777; 12433284; 12441323; 12445219; 12445604; 12454835; 12468823; 12472674; 12475255; 12477932; 12482999; 12483741; 12493411; 12500190; 12519748; 12525884; 12529421; 12530978; 12533683; 12551827; 12558933; 12562360; 12568735; 12572877; 12574335; 12578333; 12593203; 12593899; 12595908; 12598547; 12606524; 12606591; 12615834; 12622850; 12626603; 12631070; 12637574; 12637896; 12651071; 12651617; 12667023; 12667656; 12668157; 12673844; 12694213; 12699881; 12700687; 12702109; 12705485; 12714264; 12718576; 12718598; 12718604; 12722027; 12725322; 12726991; 12727794; 12729191; 12730545; 12730860; 12743452; 12744771; 12746420; 12746914; 12749050; 12751042; 12752101; 12756345; 12761889; 12775358; 12788304; 12790892; 12795791; 12801479; 12801886; 12802423; 12807444; 12824054; 12828754; 12837173; 12842905; 12854083; 12860389; 12869004; 12874528; 12881225; 12890860; 12891537; 12899665; 12901853; 12913327; 12928052; 12930389; 12945076; 12958148; 12958619; 12965265; 12970400; 12974682; 13129651; 13679820; 14510824; 14512722; 14514232; 14515062; 14521725; 14522096; 14523823; 14527933; 14533660; 14563376; 14566095; 14566840; 14582815; 14584052; 14584862; 14585879; 14617515; 14632761; 14633943; 14634838; 14638340; 14644395; 14656692; 14657427; 14661113; 14662866; 14664464; 14669220; 14672899; 14673470; 14675093; 14675394; 14681913; 14691340; 14723749; 14735144; 14746807; 14750640; 14758530; 14760799; 14764742; 14961572; 14966463; 14966591; 14974822; 14982742; 14984963; 14985387; 14986816; 14990538; 14997019; 15003925; 15009068; 15014040; 15017629; 15019285; 15020601; 15036245; 15036607; 15039285; 15063762; 15068111; 15070815; 15073122; 15077300; 15082121; 15088297; 15100360; 15115662; 15127646; 15141093; 15146435; 15146559; 15159477; 15162833; 15170937; 15172100; 15175940; 15184943; 15187102; 15188375; 15188516; 15190266; 15191916; 15192144; 15194470; 15201366; 15208668; 15212826; 15220553; 15222686; 15223609; 15233701; 15235132; 15236174; 15236409; 15240151; 15247172; 15248873; 15257081; 15257727; 15265021; 15266130; 15270852; 15273551; 15279067; 15286433; 15288392; 15288631; 15289894; 15292002; 15297440; 15300588; 15300650; 15306845; 15308667; 15308963; 15318095; 15325407; 15329330; 15336915; 15338333; 15339690; 15341921; 15341923; 15347683; 15351436; 15361128; 15363219; 15372364; 15373762; 15377701; 15379752; 15380900; 15381182; 15382119; 15388258; 15458430; 15464974; 15470475; 15472991; 15476179; 15481145; 15485792; 15488638; 15489334; 15496610; 15509550; 15518810; 15520404; 15529348; 15539626; 15539764; 15540224; 15550384; 15551344; 15560757; 15561713; 15561982; 15562658; 15562761; 15566952; 15579481; 15581980; 15583831; 15592292; 15597152; 15602586; 15610073; 15633328; 15638726; 15641051; 15644653; 15658613; 15663946; 15665553; 15672946; 15679582; 15688413; 15694997; 15704154; 15710472; 15723199; 15723707; 15726267; 15727567; 15732864; 15733644; 15748898; 15755725; 15766560; 15777329; 15787640; 15797878; 15800325; 15803022; 15809210; 15810887; 15816458; 15817483; 15830637; 15833737; 15834859; 15836820; 15851404; 15866604; 15878285; 15880353; 15884119; 15885804; 15891809; 15895884; 15900570; 15900573; 15910501; 15914210; 15916853; 15917409; 15925866; 15927855; 15931231; 15950779; 15951664; 15954918; 15956727; 15966908; 15967798; 15974847; 15979578; 15986200; 16002736; 16019233; 16021081; 16025481; 16026589; 16030091; 16036505; 16038043; 16043936; 16046471; 16053468; 16078996; 16087165; 16088107; 16095699; 16095910; 16096333; 16098232; 16100774; 16106254; 16114018; 16115908; 16120761; 16126303; 16128937; 16131798; 16133074; 16133447; 16137184; 16143884; 16146780; 16155691; 16159520; 16160188; 16164697; 16172101; 16174285; 16181755; 16202743; 16206345; 16207716; 16211343; 16216268; 16217062; 16226351; 16249450; 16251478; 16253969; 16257277; 16260731; 16263000; 16268484; 16284099; 16284368; 16297587; 16304445; 16310170; 16319982; 16323614; 16324093; 16338121; 16358261; 16359550; 16361815; 16362385; 16362796; 16369899; 16375755; 16380201; 16380445; 16388753; 16389181; 16403098; 16405550; 16411061; 16424284; 16425360; 16425433; 16436009; 16439360; 16454826; 16455661; 16456796; 16464738; 16464741; 16469330; 16469798; 16477012; 16487028; 16505590; 16508980; 16510430; 16520888; 16521194; 16533337; 16538639; 16539678; 16540751; 16541711; 16546408; 16549749; 16550552; 16573560; 16574427; 16575408; 16579840; 16596202; 16601113; 16617094; 16618781; 16627678; 16634865; 16635219; 16635751; 16636119; 16637265; 16638698; 16675485; 16675961; 16684958; 16698387; 16699452; 16702372; 16708852; 16713284; 16720713; 16764597; 16766392; 16769128; 16775170; 16777324; 16780720; 16785446; 16792821; 16795034; 16798739; 16814297; 16815316; 16817913; 16820326; 16820919; 16824064; 16840032; 16842617; 16856121; 16858645; 16860880; 16864901; 16864906; 16865359; 16870193; 16883066; 16883068; 16886894; 16900886; 16905295; 16907768; 16911569; 16918024; 16930778; 16931944; 16938461; 16942951; 16945028; 16955392; 16961803; 16965825; 16973269; 16984283; 16985030; 16998242; 17002905; 17003486; 17003844; 17006606; 17006981; 17015745; 17015748; 17023519; 17026971; 17034724; 17035400; 17036048; 17052682; 17054771; 17054948; 17068065; 17069782; 17075828; 17077296; 17082635; 17083033; 17096351; 17103073; 17107380; 17114844; 17115419; 17126080; 17126449; 17132473; 17138334; 17140155; 17141301; 17142509; 17169726; 17177339; 17182583; 17189320; 17196954; 17201881; 17207379; 17213232; 17222831; 17235630; 17241868; 17257312; 17258699; 17265786; 17283089; 17284226; 17287896; 17295876; 17295877; 17297261; 17304101; 17307204; 17307379; 17309751; 17314118; 17324969; 17334075; 17335370; 17335371; 17335817; 17338374; 17341683; 17348213; 17348886; 17353049; 17353161; 17355643; 17356794; 17359523; 17360530; 17361014; 17365860; 17369174; 17380888; 17385677; 17388919; 17413037; 17420005; 17426109; 17431094; 17435158; 17444587; 17444864; 17446060; 17448042; 17453104; 17453826; 17454884; 17458053; 17458495; 17460270; 17463301; 17466952; 17471097; 17477779; 17477815; 17483707; 17492470; 17500214; 17510951; 17511783; 17518659; 17532232; 17535900; 17541951; 17548806; 17562931; 17563722; 17573384; 17575917; 17584583; 17586708; 17586709; 17587593; 17592300; 17593860; 17596594; 17596959; 17597660; 17600714; 17601350; 17607547; 17608808; 17610660; 17611197; 17611547; 17611673; 17618436; 17622713; 17627086; 17627763; 17634253; 17638785; 17640324; 17640966; 17645476; 17645589; 17656565; 17676277; 17678915; 17678975; 17681786; 17681918; 17685194; 17686006; 17703412; 17711477; 17716546; 17724799; 17763205; 17763411; 17827818; 17845308; 17846855; 17850436; 17854273; 17854800; 17867984; 17877801; 17889143; 17890880; 17895302; 17900510; 17901998; 17903994; 17907045; 17907163; 17908769; 17920311; 17926179; 17954336; 17960403; 17963170; 17964974; 17978470; 17981284; 17982107; 17986158; 17988588; 17988804; 18024394; 18038187; 18040764; 18042638; 18047563; 18048494; 18052703; 18052726; 18060744; 18062835; 18063307; 18063379; 18063673; 18065201; 18069935; 18078615; 18078818; 18080321; 18086767; 18088554; 18090474; 18092345; 18154955; 18156442; 18157816; 18163503; 18164040; 18164995; 18165865; 18173740; 18174250; 18186699; 18199150; 18216863; 18224250; 18225559; 18235016; 18239554; 18240282; 18262272; 18271063; 18273643; 18274637; 18278133; 18281687; 18281914; 18286207; 18288454; 18289837; 18291094; 18297103; 18299273; 18310311; 18311798; 18314303; 18315433; 18321309; 18322311; 18327798; 18332090; 18332211; 18333945; 18335579; 18336824; 18344712; 18346907; 18354254; 18361937; 18364273; 18366487; 18369665; 18373975; 18380966; 18384390; 18385937; 18389618; 18390750; 18392912; 18392953; 18396210; 18396211; 18416755; 18416756; 18418395; 18433382; 18441098; 18446054; 18453587; 18454664; 18465425; 18468936; 18469698; 18471873; 18472001; 18484169; 18484691; 18495419; 18496214; 18498041; 18502475; 18502965; 18510611; 18515365; 18523012; 18541658; 18545091; 18565646; 18566416; 18568448; 18568476; 18573495; 18576312; 18579366; 18579691; 18583979; 18587204; 18597398; 18603357; 18607773; 18609140; 18617366; 18628242; 18631256; 18632424; 18632425; 18633131; 18647218; 18656550; 18660489; 18664147; 18664535; 18665932; 18666137; 18668392; 18673406; 18675847; 18676680; 18676870; 18684932; 18685129; 18688641; 18694861; 18702109; 18708672; 18710415; 18714022; 18714935; 18715339; 18715757; 18715885; 18716798; 18717723; 18723088; 18725521; 18728048; 18728809; 18757527; 18761558; 18763028; 18772363; 18773331; 18779738; 18781863; 18787502; 18789941; 18794066; 18799084; 18805021; 18807132; 18815552; 18818748; 18819899; 18821666; 18826654; 18830724; 18832862; 18838388; 18849440; 18926055; 18930197; 18936436; 18940468; 18941541; 18942754; 18949424; 18949619; 18950863; 18951205; 18952062; 18953879; 18962899; 18974840; 18974842; 18977241; 18980523; 18985541; 18987561; 18997828; 19004046; 19009622; 19012493; 19013323; 19013689; 19013788; 19016479; 19019335; 19026124; 19028820; 19030199; 19031173; 19031816; 19032770; 19035492; 19042953; 19043479; 19046297; 19052845; 19053923; 19060367; 19060757; 19066720; 19074885; 19075290; 19076825; 19086955; 19089489; 19091595; 19092239; 19096964; 19097143; 19102413; 19104081; 19107653; 19112497; 19116903; 19125864; 19127818; 19131662; 19131814; 19132772; 19135625; 19141058; 19141488; 19141860; 19142372; 19148546; 19151976; 19156204; 19158679; 19164476; 19166933; 19166966; 19168721; 19170196; 19180500; 19180518; 19180798; 19184295; 19188531; 19188907; 19191798; 19194673; 19218098; 19218687; 19220961; 19222370; 19228941; 19232515; 19236331; 19238444; 19240794; 19244371; 19247692; 19248089; 19248102; 19249142; 19251436; 19258923; 19263529; 19265174; 19267370; 19267917; 19272346; 19272615; 19272692; 19274529; 19278365; 19279357; 19280228; 19281832; 19289123; 19290009; 19292049; 19295440; 19307598; 19309436; 19317746; 19322201; 19325908; 19328242; 19332120; 19333723; 19334424; 19336370; 19336475; 19336858; 19338208; 19347053; 19349390; 19367581; 19375306; 19381066; 19392835; 19398847; 19399323; 19405833; 19408823; 19418669; 19419456; 19420105; 19426391; 19427781; 19428986; 19431193; 19444759; 19448967; 19453261; 19455469; 19461122; 19470040; 19473116; 19473152; 19474090; 19479237; 19488045; 19489682; 19492240; 19494323; 19495883; 19497711; 19497848; 19503839; 19505916; 19506726; 19508602; 19513556; 19524870; 19527514; 19527699; 19544559; 19546559; 19548631; 19550417; 19551451; 19556613; 19559392; 19561107; 19563289; 19573080; 19574724; 19578796; 19592498; 19593445; 19594368; 19603010; 19604093; 19607807; 19614627; 19618316; 19625176; 19629761; 19638314; 19643686; 19644155; 19657406; 19664671; 19666082; 19671674; 19671938; 19680808; 19683555; 19684156; 19692168; 19692203; 19697035; 19698128; 19701245; 19701653; 19702713; 19706826; 19708438; 19710156; 19711225; 19714579; 19714631; 19720214; 19729601; 19733643; 19733878; 19734419; 19734969; 19735272; 19737897; 19742166; 19757173; 19760027; 19764937; 19773279; 19773451; 19775068; 19786079; 19789190; 19792847; 19793334; 19801958; 19804405; 19811432; 19811434; 19815156; 19817957; 19818512; 19820020; 19825518; 19833722; 19840475; 19844779; 19846277; 19852794; 19854014; 19854106; 19857272; 19857655; 19857676; 19860911; 19861615; 19876593; 19880327; 19889076; 19892918; 19900820; 19904240; 19904560; 19909950; 19913121; 19918044; 19930406; 19933216; 19934104; 19940477; 19948975; 19953002; 19956635; 19966052; 19996595; 20005085; 20008285; 20011938; 20012528; 20012999; 20016407; 20018936; 20027291; 20027321; 20027454; 20035239; 20036421; 20038579; 20038581; 20041150; 20042686; 20044070; 20051644; 20056178; 20056442; 20059417; 20059418; 20059579; 20060205; 20067853; 20069553; 20070312; 20070836; 20070880; 20080142; 20081319; 20087638; 20103767; 20106900; 20113359; 20113413; 20116278; 20116409; 20124101; 20131253; 20138641; 20140262; 20141484; 20141541; 20156727; 20157068; 20160043; 20175886; 20178882; 20188863; 20192980; 20193596; 20194723; 20196868; 20200422; 20206549; 20207250; 20213229; 20217044; 20227257; 20229266; 20237151; 20237496; 20301318; 20306665; 20332462; 20334849; 20334922; 20335539; 20336759; 20347268; 20349753; 20353565; 20363151; 20364673; 20369436; 20372910; 20376628; 20378615; 20378664; 20380698; 20385987; 20388088; 20399210; 20399384; 20399512; 20400062; 20405297; 20413850; 20417488; 20418110; 20427258; 20431935; 20437198; 20445104; 20447254; 20452482; 20453000; 20463618; 20467172; 20468064; 20470442; 20472558; 20472930; 20473875; 20478455; 20482626; 20483667; 20484443; 20484876; 20485444; 20486195; 20490394; 20490891; 20495003; 20495422; 20503287; 20509889; 20517696; 20518842; 20522558; 20528961; 20529668; 20534741; 20535924; 20536507; 20536609; 20551628; 20561568; 20564140; 20565774; 20565898; 20568250; 20574123; 20574532; 20581747; 20585978; 20587610; 20588114; 20594066; 20595916; 20596075; 20602615; 20603037; 20603050; 20603871; 20620944; 20625956; 20626741; 20628086; 20628624; 20631624; 20639647; 20644561; 20650788; 20659236; 20671275; 20673868; 20685652; 20690185; 20696775; 20697295; 20698171; 20702406; 20702408; 20711808; 20724540; 20729213; 20731121; 20799933; 20802483; 20811626; 20812962; 20841404; 20848209; 20848459; 20848793; 20865400; 20880267; 20887233; 20889944; 20890567; 20929277; 20934174; 20934730; 20935210; 20936699; 20940514; 20942272; 20942594; 20959405; 20961668; 20962853; 20963558; 20965572; 20975573; 20979650; 20979861; 21035110; 21037509; 21037510; 21041296; 21048223; 21048327; 21054222; 21054877; 21057224; 21061265; 21078560; 21086908; 21088871; 21107607; 21133705; 21138659; 21166654; 21173731; 21178846; 21181166; 21181220; 21199393; 21211511; 21217200; 21228685; 21235388; 21239716; 21243433; 21246243; 21251078; 21265111; 21266527; 21276216; 21288573; 21307135; 21311438; 21323660; 21366387; 21368235; 21380730; 21385549; 21385879; 21394384; 21400614; 21403867; 21411094; 21418526; 21419289; 21421008; 21424904; 21427492; 21430222; 21431944; 21433061; 21445336; 21449691; 21465264; 21484857; 21486440; 21496483; 21509504; 21523343; 21535449; 21571945; 21572958; 21585612; 21604462; 21611201; 21614008; 21621860; 21623995; 21628463; 21637346; 21653279; 21659536; 21659743; 21664353; 21671260; 21682548; 21687998; 21688665; 21697093; 21700772; 21708940; 21712624; 21717421; 21726461; 21728024; 21731057; 21732076; 21762124; 21762900; 21768915; 21771656; 21776298; 21784976; 21804018; 21811191; 21819478; 21832049; 21837414; 21840356; 21843369; 21854541; 21862584; 21866808; 21871094; 21878338; 21878622; 21898353; 21914069; 21923858; 21935932; 21940680; 21948112; 21949132; 21962386; 21968104; 21978003; 21988351; 21992747; 21994456; 22003203; 22010855; 22019906; 22021895; 22023756; 22027397; 22059992; 22064385; 22065068; 22068351; 22071871; 22072054; 22073249; 22073367; 22092925; 22095718; 22101739; 22103356; 22108531; 22124068; 22125454; 22126705; 22128229; 22154780; 22155307; 22160471; 22172512; 22173128; 22178859; 22183425; 22195044; 22227487; 22251538; 22266275; 22267217; 22275254; 22280559; 22285242; 22286731; 22311026; 22312160; 22340390; 22341060; 22344672; 22348697; 22349547; 22371121; 22382666; 22384041; 22384091; 22386525; 22389405; 22395218; 22414649; 22417897; 22425603; 22425785; 22449968; 22455686; 22455954; 22466287; 22467534; 22481167; 22487523; 22493010; 22498095; 22503230; 22513786; 22537218; 22540426; 22545750; 22547706; 22568934; 22569251; 22580886; 22596214; 22621205; 22621214; 22629474; 22629855; 22649552; 22673037; 22708826; 22710193; 22714811; 22727020; 22738689; 22739237; 22750393; 22759516; 22763042; 22763186; 22764136; 22768033; 22791816; 22795101; 22795647; 22796164; 22796220; 22796605; 22804923; 22805115; 22808497; 22811570; 22815289; 22818022; 22818222; 22822059; 22829602; 22829643; 22869038; 22878044; 22884582; 22884587; 22894561; 22898394; 22902304; 22904187; 22909148; 22911481; 22923190; 22937208; 22946471; 22947907; 22951596; 22955577; 22960943; 22995155; 22997256; 23006543; 23009887; 23013363; 23018032; 23020284; 23029154; 23052182; 23062767; 23065753; 23079713; 23105097; 23110185; 23169178; 23181791; 23184659; 23192617; 23195019; 23195574; 23199001; 23208827; 23209292; 23209411; 23209664; 23209696; 23210983; 23215648; 23215728; 23216199; 23217179; 23220433; 23226210; 23226468; 23229544; 23233369; 23237500; 23239492; 23241110; 23264411; 23269671; 23276701; 23313749; 23315075; 23317890; 23322904; 23323013; 23328087; 23328930; 23331079; 23349093; 23375040; 23383347; 23386602; 23391392; 23406266; 23417678; 23421536; 23425136; 23437386; 23452206; 23457635; 23459183; 23460134; 23460908; 23472661; 23484124; 23500159; 23508571; 23509682; 23531221; 23536554; 23546865; 23554905; 23555186; 23564444; 23571448; 23592003; 23592910; 23592922; 23610862; 23630220; 23633957; 23643268; 23650922; 23651237; 23654353; 23656735; 23657597; 23659674; 23660804; 23666803; 23680697; 23689297; 23702978; 23704929; 23717664; 23723976; 23726808; 23728092; 23737648; 23740952; 23747396; 23762029; 23773024; 23784458; 23793845; 23821953; 23822621; 23839215; 23840644; 23841472; 23884315; 23884363; 23892591; 23911403; 23927441; 23935506; 23936458; 23963575; 24022484; 24025329; 24035972; 24046015; 24078775; 24081990; 24146121; 24186874; 24265545; 24275344; 24313836; 24314919; 24338609; 24552038; 24611340,,,,,,,,,,,,,,,,,,OGG:3000003553,,,,,,,,,,,,,,,,,,,"interleukin 1, beta",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL1B,,,20140408,3553,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL1B,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CL_0000492,CD4-positive helper T cell,CD4-positive helper T-lymphocyte|CD4-positive helper T-cell|CD4-positive T-helper cell|CD4-positive helper T lymphocyte,"A CD4-positive, alpha-beta T cell that cooperates with other lymphocytes via direct contact or cytokine release to initiate a variety of immune functions.",false,,,http://purl.obolibrary.org/obo/CL_0000624,,,,,,,,,,,,,,,,,,,,FMA:70572|CALOHA:TS-1146,"A CD4-positive, alpha-beta T cell that cooperates with other lymphocytes via direct contact or cytokine release to initiate a variety of immune functions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CD4-positive helper T-lymphocyte|CD4-positive helper T-cell|CD4-positive T-helper cell|CD4-positive helper T lymphocyte,,,,,cell,,,,,,,,CL:0000492,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000624,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,CD4-positive helper T cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072524,pyridine-containing compound metabolic process,pyridine-containing compound metabolism|pyridine and derivative metabolic process,"The chemical reactions and pathways involving a pyridine-containing compound, i.e. any compound that contains pyridine or a formal derivative thereof.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,midori,2011-01-04T03:21:47Z,,,,"The chemical reactions and pathways involving a pyridine-containing compound, i.e. any compound that contains pyridine or a formal derivative thereof.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pyridine-containing compound metabolism|pyridine and derivative metabolic process,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0072524,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072524,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pyridine-containing compound metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032199,Abnormal prothrombin time,Abnormal PT,"Any deviation from the normal amount of time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.",false,,,http://purl.obolibrary.org/obo/HP_0012200,,,,,,,,,,,,,,,,peter,,,,,"Any deviation from the normal amount of time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal PT,,,,,,,,,,,,,HP:0032199,,,,,,,,,,,,,,,,,,2019-01-19T15:34:30Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012200,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal prothrombin time,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0019177,fatigue,,"Fatigue is a neurological and physiological symptom characterized by a weariness or exhaustion from labor, exertion, or stress.",false,,,http://purl.obolibrary.org/obo/SYMP_0000410,,,,,,,,,,,,,,,,,,,,,"Fatigue is a neurological and physiological symptom characterized by a weariness or exhaustion from labor, exertion, or stress.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000410,,,,SYMP:0019177,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,,,SYMP:0019177,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,fatigue,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305417,SARS coronavirus C028,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305417,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C028,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098994,disruption of host cell envelope during viral entry,,The disruption of host cell envelope by viral proteins during virus entry,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,VZ:3938,The disruption of host cell envelope by viral proteins during virus entry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0098994,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0098994,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,disruption of host cell envelope during viral entry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264990,SARS coronavirus sf098,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264990,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus sf098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2559587,Riboviria,RNA viruses|RNA viruses and viroids,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10239,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,RNA viruses|RNA viruses and viroids,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:2559587,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10239,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Riboviria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046783,modification by virus of host polysomes,viral perturbation of polysomes,Any viral process that interferes with and inhibits the assembly and function of polysomes.|See also the cellular component term 'polysome ; GO:0005844'.,false,,,http://purl.obolibrary.org/obo/GO_0039656|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,Any viral process that interferes with and inhibits the assembly and function of polysomes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral perturbation of polysomes,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,See also the cellular component term 'polysome ; GO:0005844'.,,http://purl.obolibrary.org/obo/GO_0039656|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0046783,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226,,,,GO:0046783,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modification by virus of host polysomes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000412,in silico model,,,false,,,http://purl.obolibrary.org/obo/NCIT_C16866,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Computer-based representation of physical systems and phenomena such as chemical processes.,,,,,,,,,,,,,,,,,,,,,,,in silico,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C16866,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,in silico model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_114,heart disease,,A cardiovascular system disease that involves the heart.,false,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,,,,,,,,ICD9CM:429.9|MESH:D006331|UMLS_CUI:C0018799|SNOMEDCT_US_2019_09_01:56265001|ICD10CM:I51.9|NCI:C3079,A cardiovascular system disease that involves the heart.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287,,,,DOID:114,,,,,,,,,,,,,,,DOID:114,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,heart disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_0000000002,gene,,A gene is a material entity that represents the entire DNA sequence required for synthesis of a functional protein or RNA molecule. ,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,A gene is a material entity that represents the entire DNA sequence required for synthesis of a functional protein or RNA molecule. ,,WEB: http://www.ncbi.nlm.nih.gov/books/NBK21640/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGG:0000000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,gene,,,,,,,,,,,,,,,,,,,,,,,,,,,,Oliver He,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267388,SARS coronavirus Sin849,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267388,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin849,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000073,lack of personnel,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,risk,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32242830%20%20%20%20%20%20%20%20%20,"Insufficient personnel mean there are not enough personnel in an organization and this may lead to the
fall of the organizational performance.",,,,,,,,,,,,,,,,lack of personnel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_149836,tigecycline,"(4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide|(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide","Tetracycline in which the hydroxy group at position 5 and the methyl group at position 6 are replaced by hydrogen, and with a dimethylamino substituent and an (N-tert-butylglycyl)amino substituent at positions 7 and 9, respectively. A glycylcycline antibiotic, it has activity against a broad range of Gram-positive and Gram-negative bacteria, including tetracycline-resistant organisms. It is used for the intravenous treatment of complicated skin and skin structure infections caused by susceptible organisms.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:2661|KEGG:C12012|PMID:17353249|PMID:17220399|Reaxys:8379453|PMID:17307973|PMID:17194827|CAS:220620-09-7|DrugBank:DB00560|PMID:17353238|PMID:17210772|KEGG:D01079,"Tetracycline in which the hydroxy group at position 5 and the methyl group at position 6 are replaced by hydrogen, and with a dimethylamino substituent and an (N-tert-butylglycyl)amino substituent at positions 7 and 9, respectively. A glycylcycline antibiotic, it has activity against a broad range of Gram-positive and Gram-negative bacteria, including tetracycline-resistant organisms. It is used for the intravenous treatment of complicated skin and skin structure infections caused by susceptible organisms.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:29696|CHEBI:473970,,,,"(4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide",,,,,chebi_ontology,,"(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide",,,,,,,,,0,C29H39N5O8,"InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1",FPZLLRFZJZRHSY-HJYUBDRYSA-N,585.64870,585.27986,[H][C@@]12Cc3c(cc(NC(=O)CNC(C)(C)C)c(O)c3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:149836,,,,,,true,,,,,,,,,CHEBI:149836,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tigecycline,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0010974,Abnormal myeloid leukocyte morphology,Abnormality of myeloid leukocytes,"An abnormality of myeloid leukocytes.|A myeloid leukocyte refers to a cell of the monocyte, granulocyte, or mast cell lineage.",false,,,http://purl.obolibrary.org/obo/HP_0001881,,,,,,,,,,,,,,,,peter,2011-02-06T09:24:46Z,,,UMLS:C4023618,An abnormality of myeloid leukocytes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of myeloid leukocytes,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"A myeloid leukocyte refers to a cell of the monocyte, granulocyte, or mast cell lineage.",,http://purl.obolibrary.org/obo/HP_0001881,,,,HP:0010974,,,,,,,,,,,,,,,HP:0010974,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal myeloid leukocyte morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000789,alpha-beta T cell,alpha-beta T lymphocyte|alpha-beta T-cell|alpha-beta T-lymphocyte,A T cell that expresses an alpha-beta T cell receptor complex.,false,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,,,,,,,,,,,A T cell that expresses an alpha-beta T cell receptor complex.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,alpha-beta T lymphocyte|alpha-beta T-cell|alpha-beta T-lymphocyte,,,,,cell,,,,,,,,CL:0000789,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,alpha-beta T cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042742,defense response to bacterium,defense response to bacteria|defence response to bacterium|defence response to bacteria|antibacterial peptide activity,Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042830,,,,defense response to bacteria|defence response to bacterium|defence response to bacteria,,,,,biological_process,,antibacterial peptide activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0042742,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042742,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,defense response to bacterium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/APOLLO_SV_00000550,contact tracing,,An infectious disease control strategy that identifies and treats contacted organisms in a host population.,false,,,http://purl.obolibrary.org/obo/APOLLO_SV_00000086,,,,,,,,,,,,,,,,,,,,,An infectious disease control strategy that identifies and treats contacted organisms in a host population.,,,,,,,,,,,An infectious disease control strategy that identifies and treats contacted organisms in a host population.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,APOLLO_SV:00000550,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/APOLLO_SV_00000086,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,contact tracing,,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,William R. Hogan|Matthew Diller,,,,
http://purl.obolibrary.org/obo/OGG_3000006696,SPP1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,OPN|BNSP|ETA-1|BSPI,,,,,,,4,,,,,,,,,,Ensembl:ENSG00000118785|HGNC:11255|MIM:166490|Vega:OTTHUMG00000130599|HPRD:01325,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,secreted phosphoprotein 1,,4q22.1,,,,"GO_0001649 (EC: IEA); GO_0005125 (EC: IEA); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 15516325); GO_0006954 (EC: IEA); GO_0007155 (EC: IEA); GO_0007566 (EC: TAS, PMID: 16720713); GO_0010811 (EC: IEA); GO_0022617 (EC: TAS); GO_0030198 (EC: TAS); GO_0030593 (EC: IEA); GO_0031214 (EC: IEA); GO_0031988 (EC: IEA); GO_0033280 (EC: IDA, PMID: 16720713); GO_0042995 (EC: IEA); GO_0045177 (EC: IEA); GO_0045780 (EC: IEA); GO_0046697 (EC: TAS, PMID: 16720713); GO_0048471 (EC: IEA); GO_0048545 (EC: IEA); GO_0048685 (EC: IEA); GO_0050840 (EC: IEA)",PMID: 1575754; 1729712; 1974876; 2404984; 2726470; 2736258; 2808373; 7522656; 7532190; 7592829; 7665163; 7837791; 7945249; 8195113; 8325891; 8535605; 8619474; 8663267; 8835534; 8910476; 9110174; 9547293; 9614184; 10593924; 10657301; 10673366; 10698186; 10748043; 10751402; 10766759; 10835423; 11076863; 11162551; 11375993; 11696986; 11721059; 11787071; 11801541; 11807984; 11825898; 11854181; 11861425; 11926891; 11928818; 11933203; 11940202; 11968014; 11979972; 12142743; 12377945; 12456016; 12477932; 12506143; 12527107; 12569382; 12606946; 12620651; 12640447; 12650610; 12650611; 12706004; 12761568; 12771144; 12842452; 12847283; 12879219; 12927044; 12928913; 12939547; 12949055; 12952171; 14517343; 14524533; 14534308; 14563350; 14592838; 14704150; 14706653; 14716823; 14988426; 14990565; 14996707; 15003892; 15004750; 15014008; 15019804; 15101999; 15167446; 15389974; 15479859; 15489334; 15489336; 15494684; 15501463; 15516325; 15579312; 15692970; 15696579; 15712659; 15731245; 15742429; 15742430; 15744522; 15761492; 15776015; 15845635; 15855273; 15857938; 15863395; 15868370; 15869464; 15885319; 15949549; 15954903; 15956076; 15970685; 15993098; 15998376; 15998773; 16000556; 16005200; 16009426; 16047475; 16100012; 16136472; 16145474; 16166420; 16169070; 16189514; 16199891; 16204248; 16208410; 16299231; 16303743; 16331611; 16344560; 16373617; 16381901; 16424021; 16428483; 16433860; 16489073; 16512757; 16533775; 16571650; 16614705; 16632752; 16633066; 16712791; 16713569; 16720713; 16741188; 16765311; 16786357; 16797773; 16807238; 16807684; 16817793; 16830223; 16880782; 16962083; 17005603; 17022822; 17044113; 17110905; 17130676; 17170369; 17188882; 17189522; 17227585; 17244457; 17245215; 17253181; 17289872; 17316167; 17332338; 17343740; 17360982; 17369493; 17384004; 17418101; 17439891; 17441427; 17444956; 17452979; 17464350; 17482182; 17482311; 17493236; 17496055; 17519954; 17545592; 17548669; 17565744; 17595250; 17620367; 17689681; 17696803; 17706953; 17721886; 17848618; 17852826; 17884775; 17896150; 17898038; 17938278; 17960616; 17987038; 18004082; 18037740; 18048491; 18053633; 18072945; 18079410; 18085382; 18155656; 18158320; 18160829; 18162078; 18167187; 18174176; 18178454; 18181047; 18197854; 18210151; 18210878; 18317949; 18335026; 18353318; 18388057; 18393978; 18396783; 18406574; 18410276; 18413297; 18442196; 18443355; 18459127; 18470911; 18474739; 18480255; 18493866; 18508510; 18524812; 18537194; 18549690; 18549897; 18550471; 18563556; 18593988; 18616394; 18627421; 18629582; 18651220; 18660489; 18670302; 18676742; 18682895; 18694621; 18694758; 18701136; 18722093; 18787423; 18807011; 18949741; 18952835; 18972404; 18996613; 18997126; 19010227; 19010864; 19014781; 19016748; 19017937; 19023151; 19028408; 19048398; 19076536; 19138884; 19184356; 19208558; 19212618; 19217889; 19246678; 19260859; 19281985; 19285028; 19285424; 19285954; 19287188; 19301019; 19337795; 19339987; 19340392; 19346516; 19359522; 19365701; 19366056; 19369471; 19376608; 19399415; 19400906; 19453261; 19475568; 19476604; 19528482; 19538464; 19549529; 19556240; 19562270; 19565503; 19573311; 19581305; 19593583; 19597469; 19601999; 19602039; 19603104; 19609729; 19609945; 19634115; 19638732; 19694703; 19706414; 19720619; 19740309; 19763701; 19767100; 19780053; 19781269; 19783881; 19784742; 19790060; 19798549; 19804447; 19805619; 19806573; 19813107; 19834535; 19850036; 19854170; 19885563; 19887478; 19901966; 19913121; 19948844; 19952401; 20004120; 20007708; 20008129; 20019131; 20019453; 20022267; 20037822; 20038306; 20056178; 20071328; 20074733; 20075512; 20085934; 20086024; 20101228; 20109337; 20131968; 20138033; 20144595; 20150368; 20155457; 20207476; 20219412; 20224789; 20349162; 20377868; 20378012; 20384635; 20416077; 20428925; 20453000; 20459645; 20486203; 20495387; 20501415; 20505679; 20511184; 20533542; 20545695; 20549562; 20553297; 20562127; 20576283; 20592361; 20597997; 20598232; 20625700; 20628086; 20628624; 20634891; 20638909; 20659235; 20689445; 20796249; 20819778; 20823889; 20849637; 20851233; 20863582; 20868520; 20874252; 20890897; 20921238; 20935448; 20961744; 20967421; 20967551; 20978319; 21028999; 21034455; 21044748; 21067798; 21071960; 21104439; 21152079; 21165579; 21167394; 21167650; 21174062; 21178099; 21188534; 21190594; 21207061; 21217752; 21247495; 21252118; 21263033; 21272459; 21273567; 21273622; 21290088; 21315424; 21321126; 21343932; 21365018; 21366712; 21374592; 21375772; 21397972; 21440761; 21443102; 21467192; 21469198; 21486700; 21487066; 21487672; 21501293; 21508397; 21512310; 21513757; 21520066; 21521652; 21539822; 21547579; 21556958; 21585607; 21609000; 21616556; 21630219; 21632990; 21645921; 21669963; 21673011; 21703197; 21706367; 21743018; 21763380; 21768699; 21772333; 21785824; 21796134; 21810982; 21822558; 21838826; 21842122; 21853313; 21867616; 21900386; 21909361; 21935388; 21953299; 21962803; 21963599; 21968021; 21983451; 21986140; 21988832; 21992455; 22031818; 22037483; 22037626; 22038347; 22039306; 22080623; 22093695; 22096023; 22115341; 22131818; 22158061; 22175901; 22179617; 22186244; 22207105; 22218639; 22219064; 22242114; 22261033; 22329905; 22402440; 22410369; 22421411; 22431140; 22456539; 22458913; 22461132; 22490528; 22492090; 22495819; 22499302; 22510874; 22516995; 22525502; 22530059; 22558919; 22580396; 22584029; 22591637; 22611763; 22629140; 22658130; 22675553; 22684781; 22699784; 22710694; 22711477; 22730056; 22744661; 22779921; 22784028; 22807608; 22818182; 22835614; 22844418; 22847114; 22855173; 22882568; 22895562; 22918393; 22927944; 22935225; 22960022; 22964303; 22978720; 23008732; 23033660; 23055574; 23064961; 23071279; 23072570; 23074199; 23079960; 23089492; 23097037; 23098767; 23112867; 23119061; 23122494; 23132541; 23165334; 23166604; 23203407; 23204518; 23232694; 23235966; 23244138; 23251004; 23263636; 23269624; 23274598; 23284864; 23352191; 23354516; 23361573; 23373240; 23382482; 23388534; 23407481; 23416968; 23426449; 23427088; 23437160; 23441154; 23515922; 23545719; 23589674; 23619316; 23619422; 23636305; 23652051; 23675517; 23680656; 23692545; 23717583; 23726130; 23729174; 23764959; 23774402; 23775819; 23784265; 23867349; 23880208; 23883434; 23910387; 23952692; 24084099; 24126938; 24140708; 24157812; 24188933; 24240095,,,,,,,,,,,,,,,,,,OGG:3000006696,,,,,,,,,,,,,,,,,,,secreted phosphoprotein 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,SPP1,,,20140408,6696,PSEC0156,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,SPP1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0072164,mesonephric tubule development,,"The progression of a mesonephric tubule over time, from its initial formation to the mature structure. A mesonephric tubule is an epithelial tube that is part of the mesonephros.",false,,,http://purl.obolibrary.org/obo/GO_0072163,,,,,,,,,,,,,,,,midori,2010-02-26T01:45:58Z,,,,"The progression of a mesonephric tubule over time, from its initial formation to the mature structure. A mesonephric tubule is an epithelial tube that is part of the mesonephros.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072163,,,,GO:0072164,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072164,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mesonephric tubule development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000292,heart failure,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,SYMP:0000292,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.",,,SYMP:0000292,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,heart failure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1904738,vascular associated smooth muscle cell migration,vascular smooth muscle cell migration,The orderly movement of a vascular associated smooth muscle cell from one site to another.,false,,,http://purl.obolibrary.org/obo/GO_0016477,,,,,,,,,,,,,,,,rph,2015-10-15T09:56:00Z,,,,The orderly movement of a vascular associated smooth muscle cell from one site to another.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,vascular smooth muscle cell migration,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016477,,,,GO:1904738,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,GO:1904738,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,vascular associated smooth muscle cell migration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C66097,Merimepodib,"Merimepodib|MERIMEPODIB|VX-497|MMPD|Carbamic acid, ((3-((((3-methoxy-4-(5-oxazolyl)phenyl)amino)carbonyl)amino)phenyl)methyl)-, (3S)-tetrahydro-3-furanyl ester|VI-21,497","An inosine monophosphate dehydrogenase (IMPDH) inhibitor with activity against hepatitis C virus (HCV). IMPDH catalyzes the rate-limiting step in the de novo synthesis of guanine nucleotides, and treatment with merimepodib reduces the intracellular guanine nucleotide levels that are required for RNA and DNA synthesis, resulting in antiproliferative and antiviral effect.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,198821-22-6,,C23H24N4O6,,C66097,,,FDA,,,,,,,"An inosine monophosphate dehydrogenase (IMPDH) inhibitor with activity against hepatitis C virus (HCV). IMPDH catalyzes the rate-limiting step in the de novo synthesis of guanine nucleotides, and treatment with merimepodib reduces the intracellular guanine nucleotide levels that are required for RNA and DNA synthesis, resulting in antiproliferative and antiviral effect.",,,,,,,,,,,,,,,,,2ZL2BA06FU,,,,,,,,,,,,,,"Merimepodib|MERIMEPODIB|VX-497|MMPD|Carbamic acid, ((3-((((3-methoxy-4-(5-oxazolyl)phenyl)amino)carbonyl)amino)phenyl)methyl)-, (3S)-tetrahydro-3-furanyl ester|VI-21,497",,,,,,,,,,,,,NCIT:C66097,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Merimepodib,Merimepodib,,,,,,,,,69811|70969,,,,,,,,,Merimepodib,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,Pharmacologic Substance,,,,,,,,C1259636,
http://purl.obolibrary.org/obo/GO_0017001,antibiotic catabolic process,antibiotic breakdown|antibiotic degradation|antibiotic catabolism,"The chemical reactions and pathways resulting in the breakdown of antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms.",false,,,http://purl.obolibrary.org/obo/GO_0016999,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,antibiotic breakdown|antibiotic degradation|antibiotic catabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016999,,,,GO:0017001,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0017001,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antibiotic catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C19291,Epidemiological Factors,Epidemiological Factors,The identifiable and quantifiable things which contribute to the establishment and transmission of disease.,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,C19291,,,,,,,,,,The identifiable and quantifiable things which contribute to the establishment and transmission of disease.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Epidemiological Factors,,,,,,,,,,,,,NCIT:C19291,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,true,,,,,,,epidemiology,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Epidemiological Factors,Epidemiological_Factors,,,,,,,,,,,,,,,,,,Epidemiological Factors,,,https://www.nejm.org/doi/full/10.1056/NEJMp2002125,Functional Concept,,,,,,,,C1516907,
http://purl.obolibrary.org/obo/CHEBI_71204,bepotastine,betotastine|4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid|bepotastina|(+)-4-(((S)-p-Chloro-alpha-2-pyridylbenzyl)oxy)-1-piperidinebutyric acid|bepotastinum|bepotastine,"An ether that is (S)-(4-chlorophenyl)(pyridin-2-yl)methanol in which the hydroxyl hydrogen is substituted by a 1-(3-carboxypropyl)piperidin-4-yl group. A topical, selective and non-sedating histamine (H1) receptor antagonist used (as its benzenesulfonate salt) for treatment of itching associated with allergic conjunctivitis.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23152650|Wikipedia:Bepotastine|PMID:20687621|KEGG:D09705|Patent:US2010168433|PMID:21105284|PMID:22286689|Patent:WO2008153289|DrugBank:DB04890|Drug_Central:341|Patent:EP1336602|CAS:125602-71-3|Reaxys:7910270|Patent:WO2008123701,"An ether that is (S)-(4-chlorophenyl)(pyridin-2-yl)methanol in which the hydroxyl hydrogen is substituted by a 1-(3-carboxypropyl)piperidin-4-yl group. A topical, selective and non-sedating histamine (H1) receptor antagonist used (as its benzenesulfonate salt) for treatment of itching associated with allergic conjunctivitis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,betotastine|4-((4-Chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic acid|bepotastina|(+)-4-(((S)-p-Chloro-alpha-2-pyridylbenzyl)oxy)-1-piperidinebutyric acid|bepotastinum|bepotastine,,,,,,,,,0,C21H25ClN2O3,"InChI=1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26)/t21-/m0/s1",YWGDOWXRIALTES-NRFANRHFSA-N,388.88800,388.15537,OC(=O)CCCN1CCC(CC1)O[C@@H](c1ccc(Cl)cc1)c1ccccn1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:71204,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:71204,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,bepotastine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050262,severe acute respiratory syndrome coronavirus 2 protein,2019-nCoV protein|SARS2 protein|SARS-CoV-2 protein,A protein that is encoded in the genome of severe acute respiratory syndrome coronavirus 2.,false,,,http://purl.obolibrary.org/obo/PR_000036197,,,,,,,,,,,,,,,,,,,,,A protein that is encoded in the genome of severe acute respiratory syndrome coronavirus 2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019-nCoV protein|SARS2 protein|SARS-CoV-2 protein,,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000036197,,,,PR:000050262,,,,,,,,,,,,,,,PR:000050262,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,severe acute respiratory syndrome coronavirus 2 protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_1936,atherosclerosis,,,false,,,http://purl.obolibrary.org/obo/DOID_2348,,,,,,,,,,,,,,,,,,,,EFO:0003914|UMLS_CUI:C0004153|SNOMEDCT_US_2019_09_01:38716007|MESH:D050197|ICD10CM:I70|NCI:C35768|ICD9CM:440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_2348,,,,DOID:1936,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,DOID:1936,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,atherosclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_37924,atazanavir,"dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate|atazanavir|ATZ|atazanavirum",A heavily substituted carbohydrazide that is an antiretroviral drug of the protease inhibitor (PI) class used to treat infection of human immunodeficiency virus (HIV).,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:18389089|DrugBank:DB01072|CAS:198904-31-3|PMID:17376023|PMID:15156449|PMID:15353575|KEGG:D07471|PMID:25017682|PMID:24108452|PMID:17619250|PMID:15737947|Reaxys:8101951|Wikipedia:Atazanavir|PMID:15645003|PMID:24314017,A heavily substituted carbohydrazide that is an antiretroviral drug of the protease inhibitor (PI) class used to treat infection of human immunodeficiency virus (HIV).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate",,,,,chebi_ontology,,atazanavir|ATZ|atazanavirum,,,,,,,,,0,C38H52N6O7,"InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1",AXRYRYVKAWYZBR-GASGPIRDSA-N,704.85550,704.38975,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(cc1)-c1ccccn1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:37924,,,,,true,true,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:37924,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,atazanavir,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258507,SARS coronavirus ShanghaiQXC1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258507,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ShanghaiQXC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000144,process profile,,b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002]),false,,,http://purl.obolibrary.org/obo/BFO_0000015,,,,,ProcessProfile,process-profile,,,,,,,,,,,,,,,b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002]),,,,,,,,,,,"b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005])",,"The simplest type of process profiles are what we shall call ‘quality process profiles’, which are the process profiles which serve as the foci of the sort of selective abstraction that is involved when measurements are made of changes in single qualities, as illustrated, for example, by process profiles of mass, temperature, aortic pressure, and so on.|On a somewhat higher level of complexity are what we shall call rate process profiles, which are the targets of selective abstraction focused not on determinate quality magnitudes plotted over time, but rather on certain ratios between these magnitudes and elapsed times. A speed process profile, for example, is represented by a graph plotting against time the ratio of distance covered per unit of time. Since rates may change, and since such changes, too, may have rates of change, we have to deal here with a hierarchy of process profile universals at successive levels|One important sub-family of rate process profiles is illustrated by the beat or frequency profiles of cyclical processes, illustrated by the 60 beats per minute beating process of John’s heart, or the 120 beats per minute drumming process involved in one of John’s performances in a rock band, and so on. Each such process includes what we shall call a beat process profile instance as part, a subtype of rate process profile in which the salient ratio is not distance covered but rather number of beat cycles per unit of time. Each beat process profile instance instantiates the determinable universal beat process profile. But it also instantiates multiple more specialized universals at lower levels of generality, selected from   rate process profilebeat process profileregular beat process profile3 bpm beat process profile4 bpm beat process profileirregular beat process profileincreasing beat process profileand so on.In the case of a regular beat process profile, a rate can be assigned in the simplest possible fashion by dividing the number of cycles by the length of the temporal region occupied by the beating process profile as a whole. Irregular process profiles of this sort, for example as identified in the clinic, or in the readings on an aircraft instrument panel, are often of diagnostic significance.",,,,,,,,,(forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005] |(iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000144,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000015,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,process profile,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6432,levamisole,"(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole|Lepuron|levamisolum|(S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole|(S)-(-)-levamisole|Levomysol|levamisole|Levovermax|Wormicid|(S)-(-)-tetramisole|(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole|Ketrax|(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole|levamisol|Totalon|(-)-tetramisole","A 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole that has S configuration. It is used (generally as the monohydrochloride salt) to treat parasitic worm infections in pigs, sheep and cattle and was formerly used in humans as an adjuvant to chemotherapy for the treatment of various cancers. It is also widely used as an adulterant to coccaine.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:24440755|PMID:24365689|PMID:23041983|PMID:12749943|Patent:US3274209|PMID:22337783|PMID:827785|VSDB:1798|HMDB:HMDB0014986|Patent:US3565907|LINCS:LSM-6655|PMID:366137|PMID:10701095|PMID:2050823|PMID:15109274|PMID:23921349|PMID:23152411|PMID:366135|PMID:7051554|Wikipedia:Levamisole|PMID:23649929|PMID:189006|Patent:US3579530|DrugBank:DB00848|PMID:23543977|PMID:6995094|Drug_Central:1561|PMID:6995092|KEGG:D08114|PMID:1618599|PMID:22607692|KEGG:C07070|PMID:669135|PMID:23577329|PMID:12232676|PMID:17608969|PMID:365327|Reaxys:4233256|CAS:14769-73-4,"A 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole that has S configuration. It is used (generally as the monohydrochloride salt) to treat parasitic worm infections in pigs, sheep and cattle and was formerly used in humans as an adjuvant to chemotherapy for the treatment of various cancers. It is also widely used as an adulterant to coccaine.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole",,,,,chebi_ontology,,"Lepuron|levamisolum|(S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole|(S)-(-)-levamisole|Levomysol|levamisole|Levovermax|Wormicid|(S)-(-)-tetramisole|(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole|Ketrax|(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole|levamisol|Totalon|(-)-tetramisole",,,,,,,,,0,C11H12N2S,"InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1",HLFSDGLLUJUHTE-SNVBAGLBSA-N,204.29100,204.07212,C1CN2C[C@@H](N=C2S1)c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6432,,,,,true,true,,,,,,,,,CHEBI:6432,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,levamisole,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/MP_0001847,brain inflammation,encephalitis,"local accumulation of fluid, plasma proteins, and leukocytes in the brain",false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,,,,,,"local accumulation of fluid, plasma proteins, and leukocytes in the brain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,encephalitis,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,MP:0001847,,,,,,true,,,,,,,,,MP:0001847,,http://purl.obolibrary.org/obo/mp.owl,,,,,,,,,,,brain inflammation,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1503300,BtRf-BetaCoV/SX2013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1503300,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,BtRf-BetaCoV/SX2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264388,SARS coronavirus TW-PH2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264388,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-PH2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045841,negative regulation of mitotic metaphase/anaphase transition,down-regulation of mitotic metaphase/anaphase transition|downregulation of mitotic metaphase/anaphase transition|down regulation of mitotic metaphase/anaphase transition|inhibition of mitotic metaphase/anaphase transition,"Any process that stops, prevents, or reduces the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.",false,,,http://purl.obolibrary.org/obo/GO_1901991|http://purl.obolibrary.org/obo/GO_2000816|http://purl.obolibrary.org/obo/GO_1902100|http://purl.obolibrary.org/obo/GO_0030071,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,down-regulation of mitotic metaphase/anaphase transition|downregulation of mitotic metaphase/anaphase transition|down regulation of mitotic metaphase/anaphase transition,,,inhibition of mitotic metaphase/anaphase transition,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901991|http://purl.obolibrary.org/obo/GO_2000816|http://purl.obolibrary.org/obo/GO_1902100|http://purl.obolibrary.org/obo/GO_0030071,,,,GO:0045841,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045841,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of mitotic metaphase/anaphase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000021,apex,,,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,quality,,true,,,,,,"Refers to the highest number of cases in a state or country, after which the rate of infection begins to slow.",,,,,,,,,,,,,,,,apex,,,,,,,,,,,,,,,,,,,,,,https://www.summitmedicalgroup.com/news/living-well/must-know-covid-19-vocabulary/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075523,viral translational frameshifting,ribosomal frameshifting involved in viral translation,"A process which occurs during viral translation, which involves a translational recoding mechanism called programmed ribosomal frameshifting. This causes the ribosome to alter its reading of the mRNA to an a different open reading frame to produce alternate viral proteins.|This term is intended to annotate gene products involved in the process of viral translational frameshifting, not viral proteins produced by this translation process.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,janelomax,2011-08-03T02:48:46Z,,,VZ:860,"A process which occurs during viral translation, which involves a translational recoding mechanism called programmed ribosomal frameshifting. This causes the ribosome to alter its reading of the mRNA to an a different open reading frame to produce alternate viral proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribosomal frameshifting involved in viral translation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"This term is intended to annotate gene products involved in the process of viral translational frameshifting, not viral proteins produced by this translation process.",,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0075523,,,,,,true,,,,true,,,,,GO:0075523,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral translational frameshifting,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.13.991083v1.full,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264377,SARS coronavirus TW-KC3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264377,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-KC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001401,CRP,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PTX1,,,,,,,1,,,,,,,,,,HPRD:00422|MIM:123260|HGNC:2367|Ensembl:ENSG00000132693|Vega:OTTHUMG00000035344,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"C-reactive protein, pentraxin-related",,1q23.2,,,,"GO_0001666 (EC: IEA); GO_0005515 (EC: IPI, PMID: 17785206); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005615 (EC: IEA); GO_0006953 (EC: TAS, PMID: 2477488); GO_0006954 (EC: TAS, PMID: 10408362); GO_0006958 (EC: IEA); GO_0007568 (EC: IEA); GO_0008228 (EC: TAS, PMID: 2477488); GO_0010288 (EC: IEA); GO_0010745 (EC: IDA, PMID: 18322245); GO_0010888 (EC: IDA, PMID: 18322245); GO_0015485 (EC: IEA); GO_0030169 (EC: IDA, PMID: 18322245); GO_0030175 (EC: IEA); GO_0030426 (EC: IEA); GO_0033265 (EC: TAS, PMID: 2477488); GO_0042060 (EC: IEA); GO_0042803 (EC: IEA); GO_0045471 (EC: IEA); GO_0046872 (EC: IEA); GO_0050830 (EC: TAS, PMID: 2477488); GO_0051258 (EC: IEA); GO_0071277 (EC: IEA); GO_1900006 (EC: IEA)",PMID: 265538; 403526; 762075; 1477104; 1989977; 2477447; 2477488; 2997165; 3759147; 3840479; 6427230; 6685157; 6693419; 6857266; 7881902; 8144569; 8482924; 8599761; 8613143; 10368284; 10408362; 10490997; 10675363; 11027634; 11739301; 11801683; 11857055; 11947917; 11964845; 11991668; 12033985; 12037301; 12055255; 12102655; 12104096; 12151853; 12186793; 12198121; 12213988; 12218140; 12234944; 12244213; 12351483; 12390313; 12393563; 12426217; 12426218; 12460042; 12471137; 12477932; 12529491; 12552583; 12563060; 12594844; 12616974; 12618085; 12637157; 12654086; 12663465; 12701054; 12716818; 12783932; 12819031; 12821545; 12835213; 12835218; 12842840; 12850811; 12869354; 12892901; 12934049; 12975260; 14500938; 14506615; 14508181; 14592848; 14634117; 14718574; 14744975; 14967730; 14967837; 14983228; 15044210; 15047644; 15078802; 15136507; 15271790; 15277326; 15286457; 15304023; 15306744; 15308783; 15337754; 15358216; 15380464; 15448085; 15456743; 15469865; 15472120; 15489334; 15517131; 15565375; 15579759; 15585208; 15585211; 15585215; 15585218; 15591095; 15653107; 15692104; 15735209; 15746456; 15766555; 15772777; 15777561; 15778807; 15795363; 15797975; 15798948; 15798966; 15808312; 15853546; 15859024; 15860734; 15866055; 15867284; 15878871; 15887860; 15894122; 15894827; 15897982; 15919817; 15920036; 15920065; 15920074; 15950309; 15955385; 15955391; 15993896; 15996056; 15997206; 16005364; 16005367; 16026589; 16051899; 16061741; 16087790; 16087807; 16109328; 16123325; 16131811; 16148535; 16151032; 16153429; 16170833; 16189249; 16213874; 16221209; 16257408; 16266402; 16306468; 16344720; 16352308; 16380821; 16405882; 16409458; 16417933; 16500582; 16501036; 16511556; 16534007; 16549465; 16550411; 16565153; 16580524; 16582918; 16603696; 16618976; 16643876; 16681424; 16682383; 16685271; 16698114; 16710414; 16719793; 16723442; 16731635; 16733231; 16751408; 16764962; 16765355; 16778366; 16803998; 16809555; 16809564; 16832147; 16832152; 16840032; 16847147; 16854501; 16858645; 16864904; 16879213; 16881737; 16908949; 16916777; 16963054; 16984505; 17003778; 17011566; 17044846; 17079491; 17082472; 17101857; 17110595; 17113035; 17113059; 17114654; 17126343; 17138933; 17141244; 17143564; 17148079; 17149558; 17157301; 17164456; 17185152; 17202380; 17211240; 17219082; 17220790; 17234298; 17261875; 17264952; 17279354; 17289011; 17292342; 17293598; 17325687; 17327459; 17335789; 17335903; 17343862; 17347578; 17350021; 17351284; 17355554; 17355643; 17369452; 17372148; 17380191; 17382928; 17383146; 17395501; 17400881; 17433639; 17449131; 17449922; 17452737; 17456635; 17459567; 17460724; 17477779; 17477815; 17498578; 17499233; 17511977; 17513778; 17519779; 17530289; 17531242; 17561469; 17573060; 17575367; 17581635; 17584642; 17588586; 17596285; 17597836; 17598370; 17600233; 17613401; 17615382; 17623721; 17623828; 17635239; 17641153; 17650829; 17652082; 17652155; 17653654; 17673235; 17676666; 17693973; 17697822; 17700210; 17702862; 17702963; 17706955; 17714716; 17714718; 17722225; 17763921; 17765290; 17785206; 17785926; 17806085; 17827818; 17845537; 17851127; 17851695; 17852082; 17852826; 17873311; 17878721; 17878753; 17880812; 17885262; 17888441; 17891599; 17900590; 17903293; 17909163; 17917609; 17920229; 17925606; 17934713; 17942113; 17943468; 17952446; 17956875; 17957146; 17981284; 17991470; 18000615; 18005189; 18023360; 18036188; 18054331; 18055473; 18055714; 18056120; 18060926; 18063701; 18071779; 18075240; 18078625; 18083122; 18096828; 18165866; 18167554; 18171282; 18172744; 18178503; 18182444; 18200582; 18206145; 18214695; 18216376; 18217154; 18218989; 18219371; 18219765; 18226363; 18226879; 18235049; 18241613; 18245530; 18250134; 18262272; 18263601; 18266777; 18279706; 18280482; 18285551; 18285696; 18288276; 18289549; 18296838; 18297417; 18305316; 18312679; 18316365; 18322245; 18327405; 18328265; 18332893; 18333373; 18344622; 18347271; 18347963; 18356846; 18359028; 18362454; 18365276; 18369665; 18372435; 18373721; 18378435; 18379563; 18383516; 18385179; 18385676; 18385743; 18385816; 18386294; 18388036; 18388037; 18389332; 18393253; 18394761; 18401567; 18403728; 18404970; 18412163; 18413218; 18414778; 18415802; 18418236; 18421029; 18422436; 18425592; 18428198; 18433460; 18436879; 18436884; 18439548; 18439552; 18443549; 18450770; 18458051; 18464913; 18476570; 18486609; 18489822; 18491455; 18493116; 18499652; 18500540; 18505467; 18508060; 18513241; 18513823; 18523031; 18541797; 18551710; 18556380; 18562472; 18566104; 18573122; 18573197; 18573495; 18577830; 18591402; 18605934; 18607165; 18609082; 18609102; 18616717; 18621860; 18622582; 18624398; 18632424; 18636307; 18650775; 18654020; 18654021; 18667998; 18675273; 18676680; 18685607; 18688084; 18695743; 18700811; 18702945; 18704199; 18704713; 18708524; 18710885; 18714381; 18714384; 18753723; 18753952; 18755462; 18757054; 18759279; 18764931; 18784972; 18785307; 18786923; 18790479; 18791482; 18793001; 18801352; 18805107; 18805592; 18810599; 18810717; 18818748; 18823889; 18829218; 18835219; 18836266; 18840622; 18841009; 18842294; 18842390; 18845301; 18852001; 18853099; 18853133; 18924263; 18937150; 18948966; 18952164; 18953261; 18957790; 18971492; 18974842; 18983663; 18996288; 18997194; 19004040; 19008293; 19010993; 19011614; 19019335; 19023151; 19025443; 19026696; 19029268; 19034331; 19040303; 19055599; 19060910; 19067532; 19072030; 19073362; 19074515; 19074985; 19075099; 19076828; 19077177; 19077918; 19078972; 19081678; 19084272; 19095725; 19096002; 19100387; 19101671; 19111610; 19117239; 19118119; 19122170; 19125286; 19128923; 19130414; 19136614; 19136826; 19138871; 19139603; 19139754; 19147740; 19155486; 19160050; 19168253; 19170196; 19170684; 19172699; 19178964; 19179966; 19188531; 19191811; 19193941; 19201044; 19201207; 19202332; 19203753; 19225207; 19228486; 19238141; 19240794; 19244088; 19248087; 19251259; 19252093; 19255512; 19262552; 19267250; 19267370; 19268605; 19268941; 19270348; 19272152; 19276622; 19281089; 19282426; 19282606; 19282863; 19297430; 19297456; 19322079; 19323703; 19328934; 19337791; 19343415; 19351632; 19358836; 19359657; 19360108; 19362308; 19369869; 19375128; 19377212; 19377253; 19387251; 19390179; 19394732; 19403254; 19410251; 19415164; 19415283; 19423540; 19426506; 19428053; 19433520; 19436122; 19436291; 19436676; 19436686; 19437230; 19439300; 19439303; 19461040; 19469014; 19473152; 19480860; 19482283; 19492468; 19494488; 19495883; 19499327; 19501581; 19501644; 19520972; 19521085; 19522741; 19523464; 19525580; 19527514; 19533498; 19534672; 19538326; 19545442; 19560102; 19565490; 19567438; 19568166; 19571581; 19576194; 19577754; 19578796; 19584180; 19594772; 19595394; 19602903; 19609738; 19614793; 19615354; 19617288; 19619902; 19620133; 19624831; 19625176; 19626399; 19631649; 19642908; 19643839; 19643942; 19644070; 19645035; 19667982; 19670170; 19680263; 19692124; 19692168; 19695857; 19706826; 19715516; 19719987; 19719993; 19728551; 19729797; 19736474; 19736479; 19751919; 19755616; 19760027; 19762396; 19762397; 19766699; 19783155; 19796676; 19800416; 19801321; 19806245; 19808368; 19816865; 19816870; 19818961; 19821022; 19833744; 19834334; 19850242; 19850925; 19851048; 19853918; 19855269; 19857655; 19857676; 19864399; 19874580; 19879773; 19900432; 19903811; 19906786; 19913121; 19914996; 19923014; 19929715; 19931932; 19942863; 19944144; 19946607; 19947988; 19948975; 19954777; 19956729; 19962488; 19965533; 20004425; 20005739; 20006362; 20017311; 20024640; 20031768; 20034371; 20036017; 20042240; 20047081; 20056225; 20056955; 20060752; 20068351; 20074254; 20075180; 20075509; 20075574; 20078870; 20078877; 20083961; 20131075; 20136960; 20138378; 20142117; 20145391; 20145925; 20170291; 20173307; 20179497; 20184510; 20184533; 20184536; 20186934; 20190687; 20200626; 20200627; 20211068; 20214668; 20215002; 20219150; 20220110; 20227257; 20227921; 20233980; 20237496; 20306065; 20333461; 20339115; 20339904; 20346360; 20346514; 20348053; 20359087; 20371432; 20386340; 20403997; 20406964; 20423474; 20423919; 20437055; 20438785; 20443669; 20453000; 20453690; 20465852; 20466978; 20485444; 20489166; 20494358; 20494378; 20502295; 20511616; 20522534; 20531240; 20537668; 20538124; 20538278; 20538960; 20539018; 20546810; 20552244; 20556836; 20573938; 20581772; 20587599; 20592333; 20596037; 20596713; 20599197; 20605213; 20610232; 20614004; 20618287; 20623261; 20626020; 20626239; 20626701; 20628086; 20638228; 20640440; 20651278; 20669343; 20670634; 20676960; 20679960; 20680929; 20683147; 20686879; 20690093; 20691829; 20703235; 20704541; 20706769; 20709501; 20722986; 20727736; 20730440; 20733302; 20734449; 20797493; 20805569; 20813565; 20819268; 20836727; 20843812; 20846522; 20846939; 20850446; 20852043; 20855282; 20855565; 20856253; 20874781; 20877716; 20881941; 20883364; 20929576; 20929699; 20930309; 20939118; 20949557; 20952358; 20967757; 20972697; 20974458; 20978825; 20979755; 21029360; 21029457; 21033124; 21034294; 21037097; 21037509; 21043803; 21044752; 21044781; 21054666; 21054877; 21059738; 21062467; 21067752; 21071964; 21080913; 21081932; 21086905; 21089116; 21094359; 21105323; 21108561; 21135979; 21136015; 21143859; 21143879; 21146168; 21149504; 21161711; 21162890; 21167068; 21172733; 21173097; 21173540; 21182750; 21190868; 21194909; 21195701; 21196492; 21203342; 21204606; 21215477; 21218608; 21226995; 21258804; 21270838; 21284020; 21287288; 21293934; 21294915; 21296145; 21296900; 21300955; 21305296; 21309051; 21309632; 21315565; 21323571; 21324310; 21325005; 21325757; 21357282; 21357824; 21360619; 21383176; 21402418; 21404895; 21406102; 21413847; 21414621; 21415385; 21444086; 21447704; 21455669; 21458205; 21465964; 21468168; 21476028; 21493089; 21508123; 21516340; 21519150; 21526633; 21536287; 21546857; 21553357; 21565862; 21570260; 21575917; 21592994; 21602602; 21617097; 21624120; 21625240; 21630214; 21640994; 21645137; 21647738; 21655904; 21658317; 21679689; 21685272; 21696613; 21697747; 21700090; 21714897; 21716910; 21719129; 21720757; 21729568; 21729973; 21730823; 21737650; 21740772; 21741099; 21757662; 21773944; 21794939; 21801245; 21804277; 21814873; 21816845; 21819975; 21821037; 21831326; 21832113; 21839826; 21843630; 21845926; 21856781; 21859817; 21868617; 21872279; 21883780; 21890096; 21901123; 21915265; 21923250; 21928234; 21931794; 21933586; 21934067; 21937998; 21951717; 21958326; 21970447; 21988832; 21993388; 22004660; 22014839; 22018511; 22019947; 22019953; 22025173; 22025360; 22038335; 22048011; 22055258; 22056216; 22079264; 22082888; 22095223; 22103876; 22104116; 22119118; 22134501; 22153152; 22158621; 22166506; 22178353; 22190020; 22192441; 22196954; 22203929; 22205174; 22208681; 22222005; 22241816; 22257305; 22260948; 22267327; 22267750; 22267767; 22277294; 22284830; 22291609; 22296194; 22297435; 22306563; 22311704; 22316266; 22316276; 22328138; 22329434; 22330622; 22357713; 22365588; 22392590; 22418747; 22418989; 22428468; 22430136; 22435454; 22437883; 22444955; 22446726; 22449109; 22457095; 22459389; 22464286; 22467322; 22474034; 22490475; 22492993; 22497530; 22529527; 22533665; 22545649; 22547903; 22552174; 22554299; 22556030; 22558327; 22562290; 22569431; 22569435; 22570140; 22576068; 22580582; 22588996; 22607374; 22614460; 22617158; 22641545; 22642594; 22645408; 22672862; 22676422; 22681496; 22683644; 22685243; 22685586; 22732721; 22748017; 22750226; 22763479; 22780440; 22783580; 22783989; 22796263; 22801596; 22813435; 22813921; 22816656; 22821639; 22828776; 22832641; 22836155; 22843654; 22847196; 22857740; 22867744; 22869540; 22875408; 22875596; 22884413; 22901456; 22906275; 22906998; 22911253; 22912790; 22914173; 22918393; 22939635; 22949303; 22957001; 22976070; 22982460; 22989605; 23013513; 23026925; 23046580; 23049543; 23066418; 23078984; 23087143; 23087294; 23104422; 23111890; 23116190; 23116196; 23124693; 23125484; 23126320; 23132698; 23139417; 23151748; 23158132; 23159256; 23166385; 23170819; 23182717; 23197238; 23197841; 23206444; 23212397; 23212764; 23220502; 23221172; 23224322; 23225486; 23228375; 23241067; 23254637; 23254959; 23257175; 23257395; 23263911; 23266263; 23270673; 23272049; 23274882; 23277135; 23285029; 23288467; 23306163; 23343124; 23361365; 23367494; 23375121; 23375154; 23379491; 23383155; 23393371; 23399387; 23401350; 23409097; 23425215; 23434327; 23440541; 23450030; 23463453; 23468212; 23484158; 23492986; 23516493; 23518675; 23527487; 23535585; 23547018; 23575330; 23576062; 23578742; 23579782; 23591413; 23592000; 23604041; 23618082; 23627410; 23635436; 23674518; 23692330; 23697277; 23702388; 23724031; 23724977; 23742758; 23766379; 23773138; 23784529; 23803251; 23808014; 23813138; 23813850; 23828261; 23835994; 23844046; 23852903; 23888317; 23910616; 23911413; 23935961; 23941472; 23968978; 24055729; 24072695; 24084772; 24097561; 24163955; 24206243; 24222149; 24222151; 24262327; 24347428; 24379064; 24403485; 24434384; 24440351,,,,,,,,,,,,,,,,,,OGG:3000001401,,,,,,,,,,,,,,,,,,,"C-reactive protein, pentraxin-related",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CRP,,,20140408,1401,RP11-419N10.4,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,CRP,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0046813,receptor-mediated virion attachment to host cell,"virion attachment, binding of host cell surface receptor",The process by which a virion attaches to a host cell by binding to a receptor on the host cell surface.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,The process by which a virion attaches to a host cell by binding to a receptor on the host cell surface.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"virion attachment, binding of host cell surface receptor",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0046813,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0046813,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,receptor-mediated virion attachment to host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0101003,ficolin-1-rich granule membrane,,The lipid bilayer surrounding a ficolin-1-rich granule.,false,,,http://purl.obolibrary.org/obo/GO_0030667,,,,,,,,,,,,,,,,melanie,,,,,The lipid bilayer surrounding a ficolin-1-rich granule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030667,,,,GO:0101003,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0101003,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ficolin-1-rich granule membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0005181,thoracic segment organ,upper body organ,An organ that part of the thoracic segment region. This region can be further subdividied chest and thoracic cavity regions.,false,,,http://purl.obolibrary.org/obo/UBERON_0005177,,,,,,,,,,,,,,,,,,,,EMAPA:37271|MA:0000563,An organ that part of the thoracic segment region. This region can be further subdividied chest and thoracic cavity regions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,upper body organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0005177,,,,UBERON:0005181,,,,,,,,,,,,,,,UBERON:0005181,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,thoracic segment organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048770,pigment granule,,"A small, subcellular membrane-bounded vesicle containing pigment and/or pigment precursor molecules. Pigment granule biogenesis is poorly understood, as pigment granules are derived from multiple sources including the endoplasmic reticulum, coated vesicles, lysosomes, and endosomes.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"A small, subcellular membrane-bounded vesicle containing pigment and/or pigment precursor molecules. Pigment granule biogenesis is poorly understood, as pigment granules are derived from multiple sources including the endoplasmic reticulum, coated vesicles, lysosomes, and endosomes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0048770,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048770,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pigment granule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305414,SARS coronavirus C018,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305414,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001928,Abnormality of coagulation,Coagulation abnormality|Haemorrhagic disorders|Abnormal blood coagulation studies|Coagulation abnormalities|Blood coagulation disorder,"An abnormality of the process of blood coagulation. That is, altered ability or inability of the blood to clot.",false,,,http://purl.obolibrary.org/obo/HP_0001871,,,,,,,,,,,,,,,,,,,,UMLS:C0019087|MSH:D001778|UMLS:C1846821|SNOMEDCT_US:64779008|MSH:D006474|UMLS:C0005779|SNOMEDCT_US:362970003,"An abnormality of the process of blood coagulation. That is, altered ability or inability of the blood to clot.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Coagulation abnormality|Haemorrhagic disorders|Abnormal blood coagulation studies|Coagulation abnormalities,,,,,human_phenotype,,Blood coagulation disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001871,,,,HP:0001928,,,,,,,,,,,,,,,HP:0001928,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of coagulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C13410,Transmembrane Domain,TM Domain|Transmembrane Domain|Transmembrane Region,"The portion of an integral membrane protein crossing through the plasma lemma (cell membrane) or that of an internal vesicle. This region is highly hydrophobic, approximately 20 amino acids long, and bordered by charged amino acids.",false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,C13410,,,,,,,,,,"The portion of an integral membrane protein crossing through the plasma lemma (cell membrane) or that of an internal vesicle. This region is highly hydrophobic, approximately 20 amino acids long, and bordered by charged amino acids.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TM Domain|Transmembrane Domain|Transmembrane Region,,,,,,,,,,,,,NCIT:C13410,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32231345,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Transmembrane Domain,Transmembrane_Domain,,,,,,,,,,,,,,,,,,Transmembrane Domain,,,,Amino Acid Sequence,,,,,,,,C1519623,
http://purl.obolibrary.org/obo/DRON_00014332,bevacizumab,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,253337,,,,DRON:00014332,"A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,bevacizumab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C16866,Model,Model|Model System|model|Modeling System|Models,"A representation of something, often idealized or modified to make it conceptually easier to understand.",false,,,http://purl.obolibrary.org/obo/IAO_0000030,,"A formal structure for representing and analyzing a process such as a clinical trial or the information pertaining to a restricted context (e.g., clinical trial data). [CDISC]",,,,,,,,,C16866,,,CDISC-GLOSS,,,,,,,"A representation of something, often idealized or modified to make it conceptually easier to understand.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Model|Model System|model|Modeling System|Models,,,,,,,,,,,,,NCIT:C16866,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000030,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410,,,,,,,,,,Model,Model_System,,,,,,,,,,,,,,,,,,Model,,,,Intellectual Product,,,,,,,,C3161035,
http://purl.obolibrary.org/obo/NCBITaxon_249083,SARS coronavirus LC1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249083,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus LC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002534,cytokine production involved in inflammatory response,cytokine production involved in acute inflammatory response,"The synthesis or release of a cytokine following a inflammatory stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.",false,,,http://purl.obolibrary.org/obo/GO_0002532,,,,,,,,,,,,,,,,,,,,,"The synthesis or release of a cytokine following a inflammatory stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.",,,,,,,,,,,,,,,,,,,,,,,,,,,,cytokine production involved in acute inflammatory response,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002532,,,,GO:0002534,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171193,,,,GO:0002534,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytokine production involved in inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000009540,TP53I3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PIG3,,,,,,,2,,,,,,,,,,MIM:605171|HGNC:19373|HPRD:05527|Ensembl:ENSG00000115129|Vega:OTTHUMG00000090817,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,tumor protein p53 inducible protein 3,,2p23.3,,,,"GO_0003960 (EC: IDA, PMID: 19349281); GO_0005575 (EC: ND); GO_0006739 (EC: IDA, PMID: 19349281); GO_0008270 (EC: IEA); GO_0042803 (EC: IPI, PMID: 19349281); GO_0048038 (EC: IDA, PMID: 19349281); GO_0070402 (EC: IDA, PMID: 19349281)",PMID: 8125298; 9305847; 10840161; 11919562; 12477932; 15067011; 15146197; 15192123; 15489334; 15491642; 15815621; 16009130; 16169070; 16344560; 18676680; 18801469; 19064572; 19170196; 19336552; 19343046; 19349281; 19573080; 19625176; 19692168; 19773279; 20023697; 20453000; 20603616; 21139048; 22461624; 22939629; 23241165,,,,,,,,,,,,,,,,,,OGG:3000009540,,,,,,,,,,,,,,,,,,,tumor protein p53 inducible protein 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TP53I3,,,20140408,9540,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TP53I3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_281976,SARS coronavirus GZ0401,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:281976,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ0401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249072,SARS coronavirus HZS2-Fb,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249072,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HZS2-Fb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002673,regulation of acute inflammatory response,,"Any process that modulates the frequency, rate, or extent of an acute inflammatory response.",false,,,http://purl.obolibrary.org/obo/GO_0050727,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate, or extent of an acute inflammatory response.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050727,,,,GO:0002673,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002673,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of acute inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048732,gland development,,"The process whose specific outcome is the progression of a gland over time, from its formation to the mature structure. A gland is an organ specialised for secretion.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of a gland over time, from its formation to the mature structure. A gland is an organ specialised for secretion.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0048732,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048732,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,gland development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039503,suppression by virus of host innate immune response,inhibition of host innate immune response by virus|suppression by virus of host innate immunity|negative regulation by virus of host innate immune response|negative regulation by virus of host innate immunity,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of the innate immune response of the host organism, the host's first line of defense.",false,,,http://purl.obolibrary.org/obo/GO_0030683|http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2011-05-11T04:31:17Z,,,,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of the innate immune response of the host organism, the host's first line of defense.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,inhibition of host innate immune response by virus|suppression by virus of host innate immunity|negative regulation by virus of host innate immune response|negative regulation by virus of host innate immunity,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030683|http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039503,,,,,,,,true,,true,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,GO:0039503,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host innate immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6754,Meperidine,Meperidine|meperidine|Pethidine|meperidine hydrochloride|pethidine hydrochloride|isonipecaine|meperidine HCl|pethidin|meperidol|pethidine HCl|pethanol,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D08343|HMDB:HMDB0014597|KEGG:C07128|Drug_Central:1690|CAS:57-42-1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Meperidine|meperidine,,,,,chebi_ontology,,Pethidine|meperidine hydrochloride|pethidine hydrochloride|isonipecaine|meperidine HCl|pethidin|meperidol|pethidine HCl|pethanol,,,,,,,,,0,C15H21NO2,"InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3",XADCESSVHJOZHK-UHFFFAOYSA-N,247.333,247.15723,CCOC(=O)C1(CCN(C)CC1)c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6754,,,,,true,true,,,,,,,,,CHEBI:6754,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Meperidine,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000023,carriomycin,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Carriomycin, a new polyether antibiotic, was isolated from culture broth of Streptomyces hygroscopicus strain T-42082. It is active against Gram-positive bacteria, several fungi, yeasts and mycoplasma. It is also coccidiostatic.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,,,,,,,,,,,,carriomycin,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249085,SARS coronavirus LC3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249085,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus LC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072080,nephron tubule development,,"The progression of a nephron tubule over time, from its initial formation to the mature structure. A nephron tubule is an epithelial tube that is part of the nephron, the functional part of the kidney.",false,,,http://purl.obolibrary.org/obo/GO_0072073|http://purl.obolibrary.org/obo/GO_0061326,,,,,,,,,,,,,,,,midori,2010-02-01T02:32:12Z,,,,"The progression of a nephron tubule over time, from its initial formation to the mature structure. A nephron tubule is an epithelial tube that is part of the nephron, the functional part of the kidney.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072073|http://purl.obolibrary.org/obo/GO_0061326,,,,GO:0072080,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072080,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nephron tubule development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000287,arrhythmia,heart rhythm symptom|abnormal heart beat|abnormal heart rhythm|dysrhythmia|fluctuation of heart rate,Arrhythmia is a cardiovascular system symptom consisting of an alteration in rhythm of the heartbeat either in time or force.,false,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,,,,,,,,,,,,,,,,,,Arrhythmia is a cardiovascular system symptom consisting of an alteration in rhythm of the heartbeat either in time or force.,,,,,,,,,,,,,,,,,,,,,,,,,,,SYMP:0000288|SYMP:0000668|SYMP:0000667,,,,heart rhythm symptom|abnormal heart beat|abnormal heart rhythm|dysrhythmia,,,,,symptoms,,fluctuation of heart rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,SYMP:0000287,,,,,,,,,,,,,,,SYMP:0000287,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,arrhythmia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0031457,Pulmonary opacity,,"Any lesion observed on an imaging study of the lung that is associated with increased density (usually showing as increased whiteness in the image).|Increased pulmonary opacity is caused by a decrease in the ratio of gas to soft tissue (blood, lung parenchyma and stroma) in the lung.",false,,,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,peter,,,,,Any lesion observed on an imaging study of the lung that is associated with increased density (usually showing as increased whiteness in the image).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0031457,,,,,,,,,,,,,,,,,,2017-09-17T15:59:06Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Increased pulmonary opacity is caused by a decrease in the ratio of gas to soft tissue (blood, lung parenchyma and stroma) in the lung.",,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Pulmonary opacity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249074,SARS coronavirus HZS2-D,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249074,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HZS2-D,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MP_0001848,choroid inflammation,choroiditis,"local accumulation of fluid, plasma proteins, and leukocytes in the thin, highly vascularized membrane covering most of the posterior of the eye between the retina and the sclera",false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,,,,,,"local accumulation of fluid, plasma proteins, and leukocytes in the thin, highly vascularized membrane covering most of the posterior of the eye between the retina and the sclera",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,choroiditis,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,MP:0001848,,,,,,true,,,,,,,inflammation of the eye membrane,,MP:0001848,,http://purl.obolibrary.org/obo/mp.owl,,,,,,,,,,,choroid inflammation,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toeshttps://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_8428,procainamide,4-amino-N-[2-(diethylamino)ethyl]benzamide|Procainamide|procainamida|procainamidum|procainamide|p-Amino-N-(2-diethylaminoethyl)benzamide|p-Aminobenzoic diethylaminoethylamide|Biocoryl,A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group.  It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,DrugBank:DB01035|Beilstein:2214285|Drug_Central:2270|KEGG:C07401|KEGG:D08421|Wikipedia:Procainamide|CAS:51-06-9|PMID:29494946|PMID:16230360|PMID:2494958|Reaxys:2214285|PMID:29276243|LINCS:LSM-3681,A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group.  It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4-amino-N-[2-(diethylamino)ethyl]benzamide|Procainamide,,,,,chebi_ontology,,procainamida|procainamidum|procainamide|p-Amino-N-(2-diethylaminoethyl)benzamide|p-Aminobenzoic diethylaminoethylamide|Biocoryl,,,,,,,,,0,C13H21N3O,"InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)",REQCZEXYDRLIBE-UHFFFAOYSA-N,235.32546,235.16846,CCN(CC)CCNC(=O)c1ccc(N)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:8428,,,,,true,true,,,,,,,,,CHEBI:8428,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,procainamide,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002633,GBP1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,1,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"guanylate binding protein 1, interferon-inducible",,1p22.2,,,,GO_0000139 (EC: IEA); GO_0003924 (EC: IEA); GO_0005525 (EC: IEA); GO_0005576 (EC: IEA); GO_0005829 (EC: TAS); GO_0019221 (EC: TAS); GO_0042802 (EC: IPI); GO_0051607 (EC: IEA); GO_0060333 (EC: TAS),PMID: 1715024; 7518790; 8830800; 10383748; 10676968; 11397834; 11598000; 12414522; 12477932; 12488461; 12543931; 12766061; 12881412; 14741045; 15489334; 15504415; 15937107; 16005050; 16009940; 16511497; 16712791; 16873363; 16894355; 16936281; 18260761; 18697200; 18697840; 19079332; 19150356; 19223260; 19463820; 19604093; 20237496; 20450919; 20454519; 20483731; 20716116; 20923658; 21151871; 21714544; 22059445; 22162832; 22266860; 22607347; 22692453; 22859948; 22863883; 22939629; 23042300; 23086406; 23727578; 24190970,,,,,,,,,,,,,,,,,,OGG:3000002633,,,,,,,,,,,,,,,,,,,"guanylate binding protein 1, interferon-inducible",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GBP1,,,20140408,2633,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,GBP1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCIT_C128376,Mode of Transmission,Mode of Transmission,The process by which an infection is transmitted to a person.,false,,,http://purl.obolibrary.org/obo/TRANS_0000000,,The process by which an infection is transmitted to a person.,,,,,,,,,C128376,,,NICHD,,,,,,,The process by which an infection is transmitted to a person.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mode of Transmission,,,,http://purl.obolibrary.org/obo/NCIT_C20189,,,,,,,,,NCIT:C128376,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/TRANS_0000000,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32297723,,infection spread,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128453,,,,,,,,,,Mode of Transmission,,,,,,,,Mode of Transmission,,,,,,,,,,,Mode of Transmission,,,,Phenomenon or Process,,,,,,,,C1443844,
http://purl.obolibrary.org/obo/OGG_3000006449,SGTA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,hSGT|alphaSGT|SGT,,,,,,,19,,,,,,,,,,HGNC:10819|MIM:603419|Ensembl:ENSG00000104969|HPRD:04568|Vega:OTTHUMG00000180474,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha",,19p13,,,,GO_0005515 (EC: IPI); GO_0005737 (EC: IDA); GO_0008150 (EC: ND); GO_0016032 (EC: IEA),PMID: 2158125; 7966229; 9557704; 9573291; 9740675; 9766974; 10567422; 11076863; 11230166; 11256614; 11878889; 12477932; 12482202; 12735788; 12815268; 14623262; 14667819; 14729056; 15057824; 15302935; 15489334; 15489336; 15710426; 15972823; 16169070; 16189514; 16196087; 16381901; 16580629; 16777091; 16964243; 17081983; 17558393; 17942943; 18332089; 18607086; 18759457; 19615732; 20012522; 20200332; 20516149; 20639865; 21139048; 21890473; 21900206; 21906983; 21963094; 21987572; 21988832; 22053931; 22505724; 22693264; 22733359; 22779921; 22863883; 22939629; 23000965; 23129660; 23142665; 23246001; 23433514; 23533635; 23740762; 23857189; 24195513; 24250222,,,,,,,,,,,,,,,,,,OGG:3000006449,,,,,,,,,,,,,,,,,,,"small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/16580632,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,SGTA,,,20140408,6449,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,SGTA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/DOID_936,brain disease,encephalopathy,A central nervous system disease that is located_in the brain.,false,,,http://purl.obolibrary.org/obo/DOID_331,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0085584|ICD9CM:348.9|ICD10CM:G93.9|SNOMEDCT_US_2019_09_01:81308009|NCI:C26920|ICD9CM:348.30|UMLS_CUI:C0006111|ICD10CM:G93.40|MESH:D001927|NCI:C96413,A central nervous system disease that is located_in the brain.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:8510,,,,encephalopathy,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_331,,,,DOID:936,,,,,,,,,,,,,,,DOID:936,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,brain disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901293,nucleoside phosphate biosynthetic process,nucleoside phosphate synthesis|nucleoside phosphate formation|nucleoside phosphate anabolism|nucleoside phosphate biosynthesis,The chemical reactions and pathways resulting in the formation of a nucleoside phosphate.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,bf,2012-08-20T12:33:45Z,,,,The chemical reactions and pathways resulting in the formation of a nucleoside phosphate.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nucleoside phosphate synthesis|nucleoside phosphate formation|nucleoside phosphate anabolism|nucleoside phosphate biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:1901293,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901293,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nucleoside phosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050270,host translation inhibitor nsp1 (SARS-CoV-2),"UniProtKB:P0DTC1, 1-180|non-structural protein 1 (SARS2)|PRO_0000449635|UniProtKB:P0DTD1, 1-180|nsp1 (SARS2)|leader protein (SARS2)|PRO_0000449619|rep/Clv:nsp1 (SARS2)",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 180-181.|Category=organism-modification. Note: 180 aa protein. Proteinase inferred from PMID:15564471.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725297,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 180-181.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"UniProtKB:P0DTC1, 1-180|non-structural protein 1 (SARS2)|PRO_0000449635|UniProtKB:P0DTD1, 1-180|nsp1 (SARS2)|leader protein (SARS2)|PRO_0000449619|rep/Clv:nsp1 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 180 aa protein. Proteinase inferred from PMID:15564471.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050270,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32218151,,,,PR:000050270,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,host translation inhibitor nsp1 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_162387,Metapneumovirus,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_11244,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,,,,,,,NCBITaxon:162387,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_11244,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Metapneumovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000074,A2a2a haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A2a2a haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,A2a2a haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0100287,data processing operation,,Placeholder for EDAM operation class.,false,,,http://purl.obolibrary.org/obo/IAO_0000007,,,operation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000123,,,,,,,,,,,,,,,,,,,,ERO:0100287,A series of operations on data by a computer in order to retrieve or transform or classify information.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Placeholder for EDAM operation class.,,http://purl.obolibrary.org/obo/IAO_0000007,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,data processing operation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072562,blood microparticle,cell membrane microparticle,"A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,midori,2011-01-28T11:50:56Z,,,,"A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cell membrane microparticle,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0072562,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072562,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,blood microparticle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000517,hemoptysis,haemoptysis|expectoration of blood|expectoration of blood-stained sputum|coughing up of blood,Hemoptysis is a respiratory system and chest symptom characterized by an expectoration of blood from some part of the respiratory tract.,false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,,,,,,,,,,ICD9CM_2005:786.3|UMLS_ICD9CM_2005_AUI:A0067232|UMLS_CUI:C0019079|SyOID:15073,Hemoptysis is a respiratory system and chest symptom characterized by an expectoration of blood from some part of the respiratory tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,haemoptysis|expectoration of blood|expectoration of blood-stained sputum|coughing up of blood,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,SYMP:0000517,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/?term=32113704,,haemoptysis,,SYMP:0000517,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,hemoptysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000130,common computed tomography pattern,,,false,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,information content entity,,true,,,,,,"A CT ""pattern"" refers to a nonspecific finding or collection of findings suggesting one or more
specific disease processes.",common CT pattern|common CT finding,,,,,,,,,,,,,,,common computed tomography pattern,,,,,,,,,,,,,,,,,,,,,,https://pubs.rsna.org/doi/10.1148/radiol.2020200463,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_439488,ssRNA viruses,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:439488,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,ssRNA viruses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002094,Dyspnea,Difficult to breathe|Trouble breathing|Breathing difficulty|Abnormal breathing,Difficult or labored breathing.,false,,,http://purl.obolibrary.org/obo/HP_0002795,,,,,,,,,,,,,,,,,,,,MSH:D004417|SNOMEDCT_US:230145002|SNOMEDCT_US:267036007|UMLS:C0013404,Difficult or labored breathing.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Difficult to breathe|Trouble breathing|Breathing difficulty|Abnormal breathing,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002795,,,,HP:0002094,,,,,,,,,,,,,,,HP:0002094,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Dyspnea,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9448,terbinafine,"terbinafine|(2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine|terbinafina|(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|terbinafine|terbinafinum|(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine",A tertiary amine that is N-methyl-1-naphthalenemethylamine in which the amino hydrogen is replaced by a 3-(tertbutylethynyl)allyl group. An antifungal agent administered orally (generally as the hydrochloride salt) for the treatment of skin and nail infections.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:24563892|PMID:24352873|PMID:24581620|PMID:24490976|Drug_Central:2597|DrugBank:DB00857|PMID:24588014|PMID:24447130|PMID:23895037|PMID:24389279|KEGG:D02375|PMID:24452843|PMID:24533442|Reaxys:4256376|HMDB:HMDB0014995|CAS:91161-71-6|PMID:24126579|KEGG:C08079|PMID:24497012|PMID:24576265|PMID:23750489|PMID:23841559|PMID:23802806|PMID:24477462|Wikipedia:Terbinafine|PMID:24410098|MetaCyc:CPD-10571,A tertiary amine that is N-methyl-1-naphthalenemethylamine in which the amino hydrogen is replaced by a 3-(tertbutylethynyl)allyl group. An antifungal agent administered orally (generally as the hydrochloride salt) for the treatment of skin and nail infections.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"terbinafine|(2E)-N,6,6-trimethyl-N-(1-naphthylmethyl)hept-2-en-4-yn-1-amine",,,,,chebi_ontology,,"terbinafina|(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|terbinafine|terbinafinum|(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine",,,,,,,,,0,C21H25N,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",DOMXUEMWDBAQBQ-WEVVVXLNSA-N,291.42990,291.19870,CN(CC=C\C#CC(C)(C)C)Cc1cccc2ccccc12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9448,,,,,true,true,,,,,,,,,CHEBI:9448,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,terbinafine,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045839,negative regulation of mitotic nuclear division,negative regulation of mitosis|down-regulation of mitosis|downregulation of mitosis|down regulation of mitosis|inhibition of mitosis,"Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.",false,,,http://purl.obolibrary.org/obo/GO_0007088|http://purl.obolibrary.org/obo/GO_0051784|http://purl.obolibrary.org/obo/GO_0010948|http://purl.obolibrary.org/obo/GO_0045930,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,negative regulation of mitosis|down-regulation of mitosis|downregulation of mitosis|down regulation of mitosis,,,inhibition of mitosis,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007088|http://purl.obolibrary.org/obo/GO_0051784|http://purl.obolibrary.org/obo/GO_0010948|http://purl.obolibrary.org/obo/GO_0045930,,,,GO:0045839,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045839,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of mitotic nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006143,RPL19,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,L19,,,,,,,17,,,,,,,,,,Vega:OTTHUMG00000178979|MIM:180466|Ensembl:ENSG00000108298|HPRD:01594|HGNC:10312,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,ribosomal protein L19,,17q12,,,,"GO_0000184 (EC: TAS); GO_0003723 (EC: TAS, PMID: 1577483); GO_0003735 (EC: NAS, PMID: 12962325); GO_0003735 (EC: TAS, PMID: 1577483); GO_0005730 (EC: IDA); GO_0005737 (EC: IDA); GO_0005829 (EC: TAS); GO_0006412 (EC: NAS, PMID: 12962325); GO_0006412 (EC: TAS, PMID: 1577483); GO_0006413 (EC: TAS); GO_0006414 (EC: TAS); GO_0006415 (EC: TAS); GO_0006614 (EC: TAS); GO_0010467 (EC: TAS); GO_0016032 (EC: TAS); GO_0016070 (EC: TAS); GO_0016071 (EC: TAS); GO_0019058 (EC: TAS); GO_0019083 (EC: TAS); GO_0022625 (EC: IDA, PMID: 12962325); GO_0022625 (EC: TAS, PMID: 1577483); GO_0044267 (EC: TAS); GO_0044822 (EC: IDA)",PMID: 1577483; 1598220; 3542997; 7789970; 8095182; 8125298; 8722009; 11401437; 11875025; 12149109; 12477932; 12962325; 14567916; 15161933; 15189156; 15489334; 16196087; 16609016; 17207965; 17244347; 17620599; 18676770; 18781797; 19799608; 19850743; 20020773; 21044950; 21139048; 21145461; 21182205; 21319273; 21396810; 21799931; 21890473; 21906983; 21907836; 21963094; 21987572; 21988832; 22053931; 22505724; 22586326; 22863883; 22939629; 23000965; 23084401; 23246001; 23398456; 23455922; 23463506; 24140708; 24250222; 24457600,,,,,,,,,,,,,,,,,,OGG:3000006143,,,,,,,,,,,,,,,,,,,ribosomal protein L19,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,RPL19,,,20140408,6143,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,RPL19,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000007173,TPO,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TPX|MSA|TDH2A,,,,,,,2,,,,,,,,,,Ensembl:ENSG00000115705|Vega:OTTHUMG00000090271|HGNC:12015|HPRD:06000|MIM:606765,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,thyroid peroxidase,,2p25,,,,"GO_0004447 (EC: IEA); GO_0004601 (EC: TAS, PMID: 3475693); GO_0005509 (EC: IEA); GO_0005615 (EC: IDA); GO_0005739 (EC: IEA); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 2548579); GO_0006590 (EC: IEA); GO_0006590 (EC: TAS); GO_0009986 (EC: IEA); GO_0020037 (EC: IEA); GO_0034641 (EC: TAS); GO_0035162 (EC: IDA); GO_0042446 (EC: IEA); GO_0042744 (EC: IEA); GO_0044281 (EC: TAS)",PMID: 67547; 1401057; 1722671; 2308857; 2383265; 2548579; 3153466; 3453124; 3475693; 3654979; 7550241; 7759120; 8027236; 8196171; 8964831; 9024270; 9814507; 9924196; 10084596; 10468986; 10487692; 10748076; 11061528; 11238503; 11327880; 11415848; 11874711; 11916616; 12135610; 12213873; 12454013; 12459031; 12477932; 12490071; 12501244; 12593722; 12709678; 12820316; 12843174; 12864797; 12938097; 12960013; 14751036; 15062578; 15150267; 15196594; 15203218; 15317218; 15497454; 15561711; 15562032; 15590661; 15613581; 15745925; 15761037; 16284446; 16344560; 16478776; 16614712; 16682284; 16684826; 16756464; 16868133; 16959834; 17042691; 17334650; 17381485; 17468186; 17547680; 17696828; 17845204; 17854396; 17902201; 18029348; 18029453; 18041648; 18203013; 18271683; 18314161; 18509003; 18631006; 18657294; 18710471; 19189706; 19194833; 19225535; 19243353; 19420105; 19605678; 19669106; 19730683; 19799084; 19948975; 19952225; 19960894; 20036902; 20101889; 20153806; 20182447; 20237496; 20379614; 20529857; 20573721; 20800603; 20826581; 20963560; 21490078; 21527831; 21707688; 21981063; 22093430; 22149743; 22259066; 22326521; 22387573; 22435912; 22947910; 23236987; 23329183; 23512414; 23672306; 23754668,,,,,,,,,,,,,,,,,,OGG:3000007173,,,,,,,,,,,,,,,,,,,thyroid peroxidase,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TPO,,,20140408,7173,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,TPO,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_353145,SARS coronavirus ZJ02,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:353145,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ZJ02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000055922,NKRF,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,NRF|ITBA4,,,,,,,X,,,,,,,,,,Vega:OTTHUMG00000022277|HPRD:02341|HGNC:19374|MIM:300440|Ensembl:ENSG00000186416,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,NFKB repressing factor,,Xq24,,,,"GO_0003677 (EC: IEA); GO_0005515 (EC: IPI); GO_0005634 (EC: IDA, PMID: 10562553); GO_0005730 (EC: IEA); GO_0006351 (EC: IEA); GO_0044822 (EC: IDA); GO_0045892 (EC: IDA, PMID: 10562553)",PMID: 9224902; 9442378; 10562553; 12381793; 12429849; 12477932; 14744032; 15226370; 15489334; 16107696; 16147992; 17186550; 17592041; 18025206; 18029348; 18560378; 19471022; 19542452; 19596686; 20020773; 21139048; 21145461; 21300069; 21693764; 21900206; 21903422; 21942715; 21963094; 22441735; 22446626; 22586326; 22944692; 22990118; 24457600,,,,,,,,,,,,,,,,,,OGG:3000055922,,,,,,,,,,,,,,,,,,,NFKB repressing factor,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,NKRF,,,20140408,55922,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,NKRF,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_264376,SARS coronavirus TW-KC1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264376,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-KC1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050274,3C-like proteinase (SARS-CoV-2),"rep/Clv:nsp5 (SARS2)|picornavirus 3C-like protease (SARS2)|nsp5 (SARS2)|3CL-PRO (SARS2)|3CLp (SARS2)|PRO_0000449639|UniProtKB:P0DTC1, 3264-3569|3CLpro (SARS2)|UniProtKB:P0DTD1, 3264-3569|PRO_0000449623",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the autocatalytic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3263-3264 and 3569-3570.|Category=organism-modification. Note: 306 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725301,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the autocatalytic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3263-3264 and 3569-3570.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"rep/Clv:nsp5 (SARS2)|picornavirus 3C-like protease (SARS2)|nsp5 (SARS2)|3CL-PRO (SARS2)|3CLp (SARS2)|PRO_0000449639|UniProtKB:P0DTC1, 3264-3569|3CLpro (SARS2)|UniProtKB:P0DTD1, 3264-3569|PRO_0000449623",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 306 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050274,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194944,,,,PR:000050274,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,3C-like proteinase (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005793,endoplasmic reticulum-Golgi intermediate compartment,endoplasmic reticulum-Golgi transport container|EGTC|VTC|vesicular-tubular cluster|pre-Golgi intermediate compartment|ER-Golgi intermediate compartment|ERGIC|ER-Golgi transport container,"A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi  and Golgi-to-ER transport.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Vesicular-tubular_cluster,"A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi  and Golgi-to-ER transport.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,endoplasmic reticulum-Golgi transport container|EGTC|VTC|vesicular-tubular cluster|pre-Golgi intermediate compartment|ER-Golgi intermediate compartment|ERGIC|ER-Golgi transport container,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005793,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005793,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endoplasmic reticulum-Golgi intermediate compartment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000431,sputum,,"A respiratory system symptom consisting of the matter discharged from the air passages in diseases of the lungs, bronchi, or upper respiratory tract that contains mucus and often pus, blood, fibrin, or bacterial products.",false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,,,,,,,,,,,"A respiratory system symptom consisting of the matter discharged from the air passages in diseases of the lungs, bronchi, or upper respiratory tract that contains mucus and often pus, blood, fibrin, or bacterial products.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,SYMP:0000431,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32164424,,,sputum production,SYMP:0000431,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,sputum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0033045,regulation of sister chromatid segregation,,"Any process that modulates the frequency, rate or extent of sister chromatid segregation.",false,,,http://purl.obolibrary.org/obo/GO_0051983,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of sister chromatid segregation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051983,,,,GO:0033045,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033045,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of sister chromatid segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000004,nose,peripheral olfactory organ|nose|nasal sac|nasus|olfactory apparatus|proboInOwlscis,"The olfactory organ of vertebrates, consisting of nares, olfactory epithelia and the structures and skeletal framework of the nasal cavity.",false,,,http://purl.obolibrary.org/obo/UBERON_0002268|http://purl.obolibrary.org/obo/UBERON_0010314|http://purl.obolibrary.org/obo/UBERON_0004121|http://purl.obolibrary.org/obo/UBERON_0000475,,,,,,,,,,,,,,,,,,,,MIAA:0000139|NCIT:C12756|TAO:0000047|EHDAA2:0001274|EHDAA:1502|UMLS:C0028429|ZFA:0000047|GAID:77|CALOHA:TS-2037|galen:Nose|EMAPA:16542|EV:0100370|MA:0000281|MESH:D009666|BTO:0000840|EV:0100037|MAT:0000139|OpenCyc:Mx4rvViCbJwpEbGdrcN5Y29ycA|FMA:46472|http://en.wikipedia.org/wiki/Nose|http://www.snomedbrowser.com/Codes/Details/181195007|http://linkedlifedata.com/resource/umls/id/C0028429,"The olfactory organ of vertebrates, consisting of nares, olfactory epithelia and the structures and skeletal framework of the nasal cavity.",,,,http://upload.wikimedia.org/wikipedia/commons/d/d0/Canine-nose.jpg,,,,,,,,,,"Organ that is the specialized structure of the face that contains olfactory neurons. The peripheral olfactory organ is paired[ZFA:0000047].|a protuberance in vertebrates that houses the nostrils, or nares, which admit and expel air for respiration in conjunction with the mouth. Behind the nose are the olfactory mucosa and the sinuses. Behind the nasal cavity, air next passes through the pharynx, shared with the digestive system, and then into the rest of the respiratory system. In humans, the nose is located centrally on the face; on most other mammals, it is on the upper tip of the snout[WP]. GO: The nose is the specialized structure of the face that serves as the organ of the sense of smell and as part of the respiratory system. Includes the nasi externus (external nose) and cavitas nasi (nasal cavity)[Wikipedia:Nose].|the organ that is specialized for smell and is part of the respiratory system",,,,,,,,,,,,,,,,,peripheral olfactory organ|nose|nasal sac,,,,,uberon,,nasus|olfactory apparatus|proboInOwlscis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0002268|http://purl.obolibrary.org/obo/UBERON_0010314|http://purl.obolibrary.org/obo/UBERON_0004121|http://purl.obolibrary.org/obo/UBERON_0000475,,,,UBERON:0000004,,,,,,true,,,,,,,,,UBERON:0000004,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#major_organ|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,nose,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,the structure of the nose varies across vertebrates. In tetrapods the nose is part of the respiratory system.[PMID:25312359],,,,,
http://purl.obolibrary.org/obo/BFO_0000030,object,,,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,Object,object,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: Each object is such that there are entities of which we can assert unproblematically that they lie in its interior, and other entities of which we can assert unproblematically that they lie in its exterior. This may not be so for entities lying at or near the boundary between the interior and exterior. This means that two objects – for example the two cells depicted in Figure 3 – may be such that there are material entities crossing their boundaries which belong determinately to neither cell. Something similar obtains in certain cases of conjoined twins (see below).|BFO 2 Reference: ‘objects’ are sometimes referred to as ‘grains’ [74|BFO 2 Reference: an object is a maximal causally unified material entity|BFO 2 Reference: To say that b is causally unified means: b is a material entity which is such that its material parts are tied together in such a way that, in environments typical for entities of the type in question,if c, a continuant part of b that is in the interior of b at t, is larger than a certain threshold size (which will be determined differently from case to case, depending on factors such as porosity of external cover) and is moved in space to be at t at a location on the exterior of the spatial region that had been occupied by b at t, then either b’s other parts will be moved in coordinated fashion or b will be damaged (be affected, for example, by breakage or tearing) in the interval between t and t.causal changes in one part of b can have consequences for other parts of b without the mediation of any entity that lies on the exterior of b. Material entities with no proper material parts would satisfy these conditions trivially. Candidate examples of types of causal unity for material entities of more complex sorts are as follows (this is not intended to be an exhaustive list):CU1: Causal unity via physical coveringHere the parts in the interior of the unified entity are combined together causally through a common membrane or other physical covering. The latter points outwards toward and may serve a protective function in relation to what lies on the exterior of the entity [13, 47|BFO 2 Reference: BFO rests on the presupposition that at multiple micro-, meso- and macroscopic scales reality exhibits certain stable, spatially separated or separable material units, combined or combinable into aggregates of various sorts (for example organisms into what are called ‘populations’). Such units play a central role in almost all domains of natural science from particle physics to cosmology. Many scientific laws govern the units in question, employing general terms (such as ‘molecule’ or ‘planet’) referring to the types and subtypes of units, and also to the types and subtypes of the processes through which such units develop and interact. The division of reality into such natural units is at the heart of biological science, as also is the fact that these units may form higher-level units (as cells form multicellular organisms) and that they may also form aggregates of units, for example as cells form portions of tissue and organs form families, herds, breeds, species, and so on. At the same time, the division of certain portions of reality into engineered units (manufactured artifacts) is the basis of modern industrial technology, which rests on the distributed mass production of engineered parts through division of labor and on their assembly into larger, compound units such as cars and laptops. The division of portions of reality into units is one starting point for the phenomenon of counting.",,,b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001]),,organism|grain of sand|cell|cells and organisms|solid portions of matter|planet|atom|molecule|star|engineered artifacts|organelle,,,,,,,,,,,,,,,,,,,,,,,bfo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000040,,,,BFO:0000030,,,,,,,,,,,,,,,BFO:0000030,,http://purl.obolibrary.org/obo/pr.owl|http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,object|object,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000281,mitotic cytokinesis,cytokinesis after mitosis,"A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.",false,,,http://purl.obolibrary.org/obo/GO_0061640,,,,,,,,,,,,,,,,,,,,,"A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cytokinesis after mitosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0061640,,,,GO:0000281,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000281,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,mitotic cytokinesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_48416,olmesartan,"4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid|olmesartan|4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,DrugBank:DB00275|LINCS:LSM-5893|Beilstein:7502669|Wikipedia:Olmesartan|CAS:144689-24-7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid|olmesartan",,,,,chebi_ontology,,"4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid",,,,,,,,,0,C24H26N6O3,"InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)",VTRAEEWXHOVJFV-UHFFFAOYSA-N,446.50188,446.20664,CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)C(C)(C)O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:48416,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,CHEBI:48416,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,olmesartan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012415,Abnormal blood gas level,Abnormal blood gas level,An abnormality of the partial pressure of oxygen or carbon dioxide in the arterial blood.,false,,,http://purl.obolibrary.org/obo/HP_0002795,,,,,,,,,,,,,,,,peter,2013-11-10T04:59:20Z,,,SNOMEDCT_US:312391003|UMLS:C0476337,An abnormality of the partial pressure of oxygen or carbon dioxide in the arterial blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal blood gas level,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002795,,,,HP:0012415,,,,,,,,,,,,,,,HP:0012415,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal blood gas level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_230522,SARS coronavirus Taiwan JC-2003,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:230522,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Taiwan JC-2003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6775,mesalamine,5-amino-2-hydroxybenzoic acid|5-ASA|Salofalk|Iialda|3-carboxy-4-hydroxyaniline|mesalazina|Asacol|Pentasa|m-Aminosalicylic acid|Asacolitin|mesalazinum|Fisalamine|Lixacol|Canasa|Claversal|mesalazine|5-Aminosalicylic acid|p-Aminosalicylsaeure|Mesasal|Rowasa|Mesalazine,A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LINCS:LSM-5427|PMID:23146664|KEGG:D00377|Drug_Central:1710|MetaCyc:CPD-12711|Wikipedia:Mesalamine|PMID:10648473|PMID:23137838|Reaxys:2090421|PMID:28166217|PMID:23302220|DrugBank:DB00244|Beilstein:2090421|HMDB:HMDB0014389|CAS:89-57-6|PMID:22648999|PMID:22304735,A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5-amino-2-hydroxybenzoic acid,,,,,chebi_ontology,,5-ASA|Salofalk|Iialda|3-carboxy-4-hydroxyaniline|mesalazina|Asacol|Pentasa|m-Aminosalicylic acid|Asacolitin|mesalazinum|Fisalamine|Lixacol|Canasa|Claversal|mesalazine|5-Aminosalicylic acid|p-Aminosalicylsaeure|Mesasal|Rowasa|Mesalazine,,,,,,,,,0,C7H7NO3,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",KBOPZPXVLCULAV-UHFFFAOYSA-N,153.13540,153.04259,Nc1ccc(O)c(c1)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6775,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171057,,,,CHEBI:6775,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,mesalamine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0050621,respiratory system benign neoplasm,,An organ system benign neoplasm that is located in the respiratory system which extends from the nasal sinuses to the diaphragm.,false,,,http://purl.obolibrary.org/obo/DOID_0060085|http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,,,,,,,,,,,An organ system benign neoplasm that is located in the respiratory system which extends from the nasal sinuses to the diaphragm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0060085|http://purl.obolibrary.org/obo/DOID_1579,,,,DOID:0050621,,,,,,,,,,,,,,,DOID:0050621,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,respiratory system benign neoplasm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_273522,SARS coronavirus LLJ-2004,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:273522,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus LLJ-2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032101,Unusual infection,,"A type of infection that is regarded as a sign of a pathological susceptibility to infection. There are five general subtypes. (i) Opportunistic infection, meaning infection by a pathogen that is not normally able to cause infection in a healthy host (e.g., pneumonia by Pneumocystis jirovecii or CMV); (ii) Unusual location (focus) of an infection (e.g., an aspergillus brain abscess); (iii) a protracted course or lack of adequate response to treatment (e.g., chronic rhinosinusitis); (iv) Unusual severity or intensity of an infection; and (v) unusual recurrence of infections.",false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,peter,,,,,"A type of infection that is regarded as a sign of a pathological susceptibility to infection. There are five general subtypes. (i) Opportunistic infection, meaning infection by a pathogen that is not normally able to cause infection in a healthy host (e.g., pneumonia by Pneumocystis jirovecii or CMV); (ii) Unusual location (focus) of an infection (e.g., an aspergillus brain abscess); (iii) a protracted course or lack of adequate response to treatment (e.g., chronic rhinosinusitis); (iv) Unusual severity or intensity of an infection; and (v) unusual recurrence of infections.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0032101,,,,,,,,,,,,,,,,,,2018-11-04T22:23:03Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Unusual infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002534,FYN,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,p59-FYN|SLK|SYN,,,,,,,6,,,,,,,,,,MIM:137025|Vega:OTTHUMG00000016305|HPRD:00655|Ensembl:ENSG00000010810|HGNC:4037,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"FYN oncogene related to SRC, FGR, YES",,6q21,,,,"GO_0001764 (EC: IEA); GO_0001948 (EC: IPI, PMID: 16831868); GO_0004713 (EC: EXP); GO_0004713 (EC: TAS); GO_0004715 (EC: NAS, PMID: 7822789); GO_0005515 (EC: IPI, PMID: 10209036); GO_0005524 (EC: IEA); GO_0005634 (EC: IEA); GO_0005739 (EC: IEA); GO_0005768 (EC: IDA, PMID: 15611048); GO_0005829 (EC: TAS); GO_0005886 (EC: IDA, PMID: 12150984); GO_0006468 (EC: NAS, PMID: 7822789); GO_0006816 (EC: NAS, PMID: 7822789); GO_0007173 (EC: TAS); GO_0007411 (EC: TAS); GO_0007596 (EC: TAS); GO_0007612 (EC: TAS, PMID: 1361685); GO_0007631 (EC: TAS, PMID: 8264796); GO_0008360 (EC: IEA); GO_0008543 (EC: TAS); GO_0010629 (EC: IEA); GO_0010976 (EC: IEA); GO_0014069 (EC: IEA); GO_0015631 (EC: IEA); GO_0016032 (EC: TAS); GO_0030168 (EC: TAS); GO_0030900 (EC: IEA); GO_0031295 (EC: TAS); GO_0035556 (EC: TAS, PMID: 1361685); GO_0038095 (EC: TAS); GO_0038096 (EC: TAS); GO_0042177 (EC: IEA); GO_0042493 (EC: IEA); GO_0042608 (EC: IEA); GO_0042609 (EC: IEA); GO_0042610 (EC: IEA); GO_0043548 (EC: IEA); GO_0044325 (EC: IEA); GO_0045087 (EC: TAS); GO_0045121 (EC: IDA, Qualifier: colocalizes_with, PMID: 12150984); GO_0045471 (EC: IEA); GO_0046777 (EC: IEA); GO_0046872 (EC: IEA); GO_0046875 (EC: IPI, PMID: 10498895); GO_0048011 (EC: TAS); GO_0048015 (EC: TAS); GO_0048813 (EC: IEA); GO_0050690 (EC: TAS); GO_0050798 (EC: IEA); GO_0050852 (EC: IDA, PMID: 7722293); GO_0050900 (EC: TAS); GO_0050966 (EC: IEA); GO_0051428 (EC: IEA); GO_0070851 (EC: IPI, PMID: 16479011); GO_0071375 (EC: IEA); GO_1900182 (EC: IEA); GO_2001240 (EC: IEA)",PMID: 82; 119942; 1334406; 1351058; 1361685; 1384720; 1385527; 1387715; 1446976; 1454062; 1530920; 1544885; 1696179; 1699196; 1715582; 1717997; 1985196; 3099169; 3330788; 3526330; 7504057; 7515933; 7516469; 7517401; 7521304; 7525550; 7537495; 7545683; 7565724; 7588629; 7589084; 7589101; 7589480; 7595520; 7642581; 7664083; 7681396; 7682059; 7687536; 7722293; 7760813; 7782294; 7822789; 7859737; 7929439; 8058772; 8104794; 8262983; 8264796; 8294442; 8394019; 8395016; 8483935; 8493579; 8566014; 8621384; 8621719; 8626376; 8626543; 8631859; 8655574; 8662998; 8671590; 8681387; 8756631; 8760790; 8798684; 8805332; 8805554; 8810341; 8883579; 8900205; 8910336; 8961927; 8980254; 8995358; 8995379; 9028946; 9032261; 9038134; 9043947; 9045636; 9047237; 9060467; 9079653; 9091579; 9104812; 9118959; 9121430; 9169421; 9185665; 9188452; 9195899; 9195918; 9196040; 9207119; 9230816; 9252391; 9269777; 9295288; 9311917; 9344703; 9344857; 9351806; 9351809; 9360983; 9366405; 9368621; 9417082; 9425276; 9446569; 9507006; 9531288; 9535845; 9535867; 9553134; 9573028; 9576921; 9603925; 9632142; 9648856; 9670010; 9674711; 9677430; 9687533; 9710204; 9712716; 9741627; 9748251; 9750131; 9756930; 9763511; 9778343; 9799234; 9804857; 9819391; 9822663; 9837776; 9837978; 9846481; 9856337; 9890970; 9892651; 9973379; 10022833; 10089404; 10092522; 10196263; 10209036; 10212213; 10224664; 10229084; 10339567; 10383400; 10435619; 10447714; 10458595; 10482988; 10498895; 10532312; 10544125; 10551884; 10564280; 10570256; 10571044; 10571082; 10586033; 10591186; 10629042; 10636929; 10642173; 10708762; 10733577; 10739664; 10744724; 10764799; 10790433; 10799548; 10804218; 10816433; 10829062; 10858437; 10867021; 10871840; 10872802; 10896916; 10921922; 10945997; 11005864; 11024032; 11075717; 11078745; 11087735; 11121167; 11149959; 11157475; 11158295; 11162638; 11204284; 11239464; 11262396; 11278378; 11278857; 11298344; 11353545; 11356869; 11423543; 11466305; 11483358; 11483655; 11526103; 11536198; 11546790; 11594778; 11598189; 11604131; 11677266; 11684709; 11711534; 11724572; 11739737; 11741599; 11741929; 11744621; 11777936; 11806999; 11820784; 11826099; 11839780; 11943772; 11943848; 11960376; 11983687; 11994282; 12084815; 12089510; 12096713; 12138090; 12150984; 12171928; 12181444; 12218089; 12231245; 12237775; 12244095; 12244174; 12368035; 12370810; 12372285; 12374739; 12408980; 12419528; 12426371; 12431372; 12450793; 12458214; 12471123; 12477932; 12496362; 12509223; 12524444; 12526739; 12529448; 12538589; 12545174; 12558988; 12589038; 12640114; 12660731; 12668668; 12670706; 12695509; 12697812; 12730241; 12753742; 12788081; 12835311; 12846735; 12857875; 12893833; 12917446; 12932824; 12941616; 14506255; 14517306; 14530346; 14574404; 14647465; 14662334; 14675807; 14684825; 14702039; 14757743; 14761954; 14761972; 14965316; 14980517; 14993658; 14999081; 15033366; 15078178; 15082191; 15098360; 15144186; 15169881; 15175272; 15190072; 15206927; 15208330; 15345594; 15345598; 15489334; 15494732; 15514010; 15536091; 15537652; 15556646; 15557120; 15588985; 15611048; 15638726; 15707590; 15708437; 15713745; 15872086; 15925565; 16014719; 16115884; 16145685; 16237174; 16316995; 16344560; 16374509; 16387660; 16400523; 16454711; 16479011; 16503409; 16537602; 16597701; 16713569; 16777849; 16782058; 16818765; 16831868; 16860569; 16882656; 16888650; 16891393; 16899217; 16938345; 16964398; 17129785; 17130124; 17164290; 17189269; 17192257; 17334644; 17417065; 17474147; 17599905; 17701175; 17703099; 17785434; 17943724; 18056706; 18067320; 18089558; 18174230; 18180382; 18267011; 18337055; 18564062; 18628988; 18710921; 18714047; 18842137; 18849153; 18922801; 18978678; 18991950; 19131339; 19258392; 19258394; 19290918; 19330793; 19468241; 19501919; 19542604; 19567819; 19690143; 19711372; 19728795; 19733625; 19805512; 19807924; 19816407; 19913121; 19917775; 19953087; 19955046; 19958149; 19968749; 20012528; 20056178; 20056645; 20151426; 20182632; 20360068; 20506281; 20534535; 20584982; 20628086; 20658524; 20682987; 20855525; 21098700; 21139048; 21298565; 21364031; 21371426; 21480388; 21513984; 21592972; 21642356; 21692989; 21738584; 21749309; 21757751; 21799250; 21881001; 21890473; 21900206; 21952639; 21963094; 21988832; 22161863; 22189847; 22354875; 22403409; 22422068; 22442244; 22447928; 22474169; 22653218; 22689581; 22709448; 22745667; 22833681; 22843238; 22868769; 22939624; 22987042; 23000965; 23077515; 23128233; 23175838; 23188823; 23250004; 23300847; 23438599; 23455924; 23497302; 23606749; 23918783; 24413734,,,,,,,,,,,,,,,,,,OGG:3000002534,,,,,,,,,,,,,,,,,,,"FYN oncogene related to SRC, FGR, YES",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FYN,,,20140408,2534,RP1-66H14.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,FYN,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000004,enzyme level signalling struggling liver,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,Modified definition,,,,,true,,,,,,Increased levels of the liver enzymes that affect liver functioning.,,,,,,,,,,,,,,,,enzyme level signalling struggling liver,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001881,Abnormal leukocyte morphology,Abnormal leukocyte function|Abnormality of leukocytes,"An abnormality of leukocytes.|Leukocytes are nucleated cells of the myeloid or lymphoid lineages, found in blood or other tissue.",false,,,http://purl.obolibrary.org/obo/HP_0010987|http://purl.obolibrary.org/obo/HP_0001871,,,,,,,,,,,,,,,,,,,,UMLS:C0152009|SNOMEDCT_US:24827003|SNOMEDCT_US:134199001,An abnormality of leukocytes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal leukocyte function|Abnormality of leukocytes,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Leukocytes are nucleated cells of the myeloid or lymphoid lineages, found in blood or other tissue.",,http://purl.obolibrary.org/obo/HP_0010987|http://purl.obolibrary.org/obo/HP_0001871,,,,HP:0001881,,,,,,,,,,,,,,,HP:0001881,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal leukocyte morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000834,CASP1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,P45|ICE|IL1BC,,,,,,,11,,,,,,,,,,Vega:OTTHUMG00000048072|MIM:147678|HPRD:00977|Ensembl:ENSG00000137752|HGNC:1499,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"caspase 1, apoptosis-related cysteine peptidase",,11q23,,,,"GO_0001666 (EC: IEA); GO_0004197 (EC: IBA); GO_0004197 (EC: TAS); GO_0005515 (EC: IPI, PMID: 11374873); GO_0005576 (EC: IEA); GO_0005737 (EC: IBA); GO_0005829 (EC: TAS); GO_0006508 (EC: IDA, PMID: 12888622); GO_0006915 (EC: TAS, PMID: 7876192); GO_0006919 (EC: TAS, PMID: 10799503); GO_0007165 (EC: TAS, PMID: 1373520); GO_0008656 (EC: TAS, PMID: 10799503); GO_0032496 (EC: IEA); GO_0032611 (EC: IEA); GO_0033198 (EC: IEA); GO_0035872 (EC: TAS); GO_0043123 (EC: IEP, PMID: 12761501); GO_0045087 (EC: TAS); GO_0050717 (EC: IEA); GO_0050718 (EC: IEA); GO_0050727 (EC: IBA); GO_0051882 (EC: IEA); GO_0060081 (EC: IEA); GO_0070269 (EC: IEA); GO_0071260 (EC: IEP, PMID: 19593445); GO_0071310 (EC: IDA, PMID: 19158679); GO_0072557 (EC: IBA); GO_0072557 (EC: ISS); GO_0072558 (EC: IDA, PMID: 12191486); GO_0072559 (EC: IDA, PMID: 15030775); GO_0097169 (EC: IDA, PMID: 19158676); GO_0097194 (EC: IBA)",PMID: 1321594; 1373520; 1574116; 1919001; 7642516; 7721861; 7797510; 7876192; 8034320; 8035875; 8044845; 8125298; 8861900; 8962078; 8978814; 8999548; 9002959; 9070648; 9115219; 9190289; 9219695; 9250871; 9334240; 9334338; 9435230; 9535906; 9548463; 9593687; 9632733; 9705209; 9705938; 9727491; 9792675; 9804161; 9830039; 9875225; 9894612; 9987822; 9990034; 10069390; 10329646; 10353249; 10438581; 10477277; 10510468; 10660263; 10708425; 10799503; 11085743; 11226410; 11374873; 11390368; 11432859; 11437653; 11438643; 11472070; 11536016; 11684016; 11821383; 11953316; 11967258; 11997061; 12019269; 12096920; 12170183; 12191486; 12215842; 12387869; 12459189; 12459463; 12477932; 12628757; 12692130; 12761501; 12888622; 14584052; 14669344; 15030775; 15039421; 15107016; 15296730; 15326478; 15383541; 15471361; 15489334; 15498465; 15561713; 15749123; 15809717; 16037825; 16087165; 16123779; 16260731; 16286016; 16405550; 16428475; 16575408; 16621994; 16778130; 16780720; 16785446; 16817903; 16903774; 16920334; 17036048; 17173859; 17196042; 17207965; 17303764; 17360653; 17418785; 17477815; 17597823; 17623017; 17703412; 17959595; 18029348; 18209072; 18263705; 18263805; 18304957; 18329368; 18523309; 18550243; 18577712; 18590738; 18799371; 18828051; 18981155; 19013323; 19074885; 19117953; 19141860; 19158676; 19158679; 19258923; 19269008; 19275586; 19382257; 19414860; 19439663; 19573080; 19593445; 19648107; 19737897; 19773279; 19779610; 19825518; 19833722; 19913121; 20038581; 20048342; 20060974; 20170165; 20184726; 20197547; 20402676; 20485444; 20503287; 20628086; 20808838; 20852925; 20855536; 20959405; 21037509; 21048031; 21052690; 21311905; 21320026; 21463955; 21757759; 21792841; 21832064; 21862576; 21862623; 22046355; 22046441; 22195745; 22227487; 22491736; 22537218; 22833538; 22837397; 23021143; 23209292; 23226468; 23236067; 23278288; 23386603; 23508996; 23590971; 23637985; 23703390; 23793845; 23839215; 23884363; 24022484; 24356306,,,,,,,,,,,,,,,,,,OGG:3000000834,,,,,,,,,,,,,,,,,,,"caspase 1, apoptosis-related cysteine peptidase",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171193,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CASP1,,,20140408,834,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CASP1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0039701,microtubule-dependent intracellular transport of viral material towards cell periphery,,The directed movement of the viral genome or a viral particle towards the cell periphery using host microtubules. Mostly used by viruses that replicate their genome near or in the nucleus to allows newly assembled viral progeny to reach the plasma membrane.,false,,,http://purl.obolibrary.org/obo/GO_0075519,,,,,,,,,,,,,,,,rfoulger,2013-11-06T16:09:57Z,,,VZ:1816,The directed movement of the viral genome or a viral particle towards the cell periphery using host microtubules. Mostly used by viruses that replicate their genome near or in the nucleus to allows newly assembled viral progeny to reach the plasma membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0075519,,,,GO:0039701,,,,,,true,,,,true,,,,,GO:0039701,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,microtubule-dependent intracellular transport of viral material towards cell periphery,,,,,,,,,,,,,,,,,,,,,,https://puresoluble.com/covid-19-services/,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0002038,T follicular helper cell,Tfh|T(FH)|follicular helper T-cell|follicular T-cell|follicular T-helper cell|follicular T cell|follicular helper T cell|follicular B helper T cell,"A CD4-positive, CXCR5-positive, CCR7-negative alpha-beta T cell located in follicles of secondary lymph nodes that expresses is BCL6-high, ICOS-high and PD1-high, and stimulates follicular B cells to undergo class-switching and antibody production.",false,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,,,,,,tmeehan,2009-10-29T04:01:27Z,,,,"A CD4-positive, CXCR5-positive, CCR7-negative alpha-beta T cell located in follicles of secondary lymph nodes that expresses is BCL6-high, ICOS-high and PD1-high, and stimulates follicular B cells to undergo class-switching and antibody production.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Tfh|T(FH),,,,,cell,,follicular helper T-cell|follicular T-cell|follicular T-helper cell|follicular T cell|follicular helper T cell|follicular B helper T cell,,,,,,CL:0002038,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,true,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,T follicular helper cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGI_0000088,mutation,,"In genetics, a mutation is a change of the nucleotide sequence of the genome of an organism, virus, or extrachromosomal genetic element. ",false,,,http://purl.obolibrary.org/obo/OGI_0000012,,,,,,,,,,,,,,,,,,,,,"In genetics, a mutation is a change of the nucleotide sequence of the genome of an organism, virus, or extrachromosomal genetic element. ",,http://en.wikipedia.org/wiki/Mutation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGI:0000088,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGI_0000012,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,http://purl.obolibrary.org/obo/ogi.owl,,,,,,,,,,,mutation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000024,sign,,"A quality of a patient, a material entity that is part of a patient, or a processual entity that a patient participates in, any one of which is observed in a physical examination and is deemed by the clinician to be of clinical significance.",false,,,http://purl.obolibrary.org/obo/BFO_0000001,,,,,,,,,,,,,,,,,,,creation date: 2010-11-18T11:14:36Z,,"A quality of a patient, a material entity that is part of a patient, or a processual entity that a patient participates in, any one of which is observed in a physical examination and is deemed by the clinician to be of clinical significance.",,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,note: defined class,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000024,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000001,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,sign,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/SYMP_0000387,head symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000597,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms that manifest in any of the part of head,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000597,,,,SYMP:0000387,,modified definition,,,,,,,,,,,,,SYMP:0000387,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,head symptom,,,,,,,,,,,,,,,,,,,,,,https://www.macmillan.org.uk/cancer-information-and-support/head-and-neck-cancer/signs-and-symptoms-of-head-and-neck-cancer,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0070160,tight junction,occluding cell junction|occluding junction,A cell-cell junction that seals cells together in an epithelium in a way that prevents even small molecules from leaking from one side of the sheet to the other.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Tight_junction,A cell-cell junction that seals cells together in an epithelium in a way that prevents even small molecules from leaking from one side of the sheet to the other.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,occluding cell junction|occluding junction,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0070160,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0070160,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,tight junction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000117,asymptomatic,,a disease stage characterized by the lack of symptoms associated with a given disease,false,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,,,,,,,,,,creation date: 2018-11-27,,a disease stage characterized by the lack of symptoms associated with a given disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000117,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,asymptomatic,,,,,,,,,,,,,,,,,,,,,,https://www.summitmedicalgroup.com/news/living-well/must-know-covid-19-vocabulary/,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001158,CKM,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,M-CK|CKMM,,,,,,,19,,,,,,,,,,MIM:123310|Vega:OTTHUMG00000181782|HGNC:1994|HPRD:00426|Ensembl:ENSG00000104879,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"creatine kinase, muscle",,19q13.32,,,,GO_0004111 (EC: IEA); GO_0005524 (EC: IEA); GO_0005829 (EC: TAS); GO_0006600 (EC: TAS); GO_0034641 (EC: TAS); GO_0044281 (EC: TAS); GO_0046314 (EC: IEA),PMID: 1690725; 2309701; 2331374; 2903158; 2914937; 3031982; 3778496; 7057800; 7805577; 7808454; 8524781; 9748661; 10089465; 10893433; 11922612; 12039490; 12432079; 12477932; 12601813; 12972258; 15057824; 15161933; 15489334; 15504039; 15967462; 16037885; 16079652; 16087811; 16092153; 16120572; 16289162; 16344560; 16373479; 16810680; 16981706; 17000714; 17303563; 17478608; 17885020; 18055044; 18222470; 18801770; 18810980; 18833644; 19039220; 19125286; 19337554; 19422651; 19523464; 19670037; 19913121; 20157874; 20525694; 20536908; 20558199; 20588136; 20588308; 20591515; 20628086; 20634891; 20669347; 20952631; 21139048; 21426302; 21448949; 21456469; 21516340; 21565611; 21706313; 21768101; 21873942; 21931810; 22592287; 23122801; 23274523; 23436474,,,,,,,,,,,,,,,,,,OGG:3000001158,,,,,,,,,,,,,,,,,,,"creatine kinase, muscle",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CKM,,,20140408,1158,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CKM,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000003661,IRF3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,19,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interferon regulatory factor 3,,19q13.3-q13.4,,,,"GO_0000122 (EC: IEA); GO_0002224 (EC: TAS); GO_0002756 (EC: TAS); GO_0003677 (EC: NAS, PMID: 12062447); GO_0003700 (EC: IEA); GO_0003712 (EC: TAS, PMID: 8524823); GO_0005515 (EC: IPI, PMID: 15841462); GO_0005634 (EC: IDA, PMID: 17079289); GO_0005654 (EC: TAS); GO_0005737 (EC: IDA); GO_0005829 (EC: TAS); GO_0006366 (EC: TAS, PMID: 8524823); GO_0006915 (EC: TAS); GO_0006974 (EC: TAS, PMID: 16979567); GO_0016032 (EC: IEA); GO_0019221 (EC: TAS); GO_0031663 (EC: IEA); GO_0032480 (EC: TAS); GO_0032481 (EC: TAS); GO_0032727 (EC: ISS); GO_0032728 (EC: ISS); GO_0032728 (EC: TAS, PMID: 16979567); GO_0034138 (EC: TAS); GO_0034142 (EC: TAS); GO_0035666 (EC: TAS); GO_0039530 (EC: TAS, PMID: 16979567); GO_0042802 (EC: IPI, PMID: 15841462); GO_0042803 (EC: IPI, PMID: 12062447); GO_0043123 (EC: IEA); GO_0043330 (EC: IEA); GO_0044212 (EC: IEA); GO_0045087 (EC: TAS); GO_0045351 (EC: IEA); GO_0045358 (EC: IEA); GO_0050689 (EC: IEA); GO_0050715 (EC: IEA); GO_0051607 (EC: ISS); GO_0060333 (EC: TAS); GO_0060337 (EC: TAS); GO_0060340 (EC: IEA); GO_0071359 (EC: IEA); GO_0071888 (EC: TAS, PMID: 16846591)",PMID: 8524823; 9463386; 9488451; 9566918; 9649509; 9660935; 9803267; 9865487; 10082512; 10492399; 10521456; 10805757; 10920266; 11035028; 11124948; 11162841; 11303025; 11314014; 11724783; 11846977; 11884139; 11907205; 11940575; 11972054; 12062447; 12138184; 12354379; 12473110; 12477932; 12524442; 12582166; 12604599; 12692549; 12702806; 12829834; 12829839; 12883638; 14517278; 14555995; 14555996; 14557267; 14668346; 14702039; 14703513; 14729983; 14739303; 14747533; 14747536; 14982987; 15107417; 15220448; 15251447; 15276183; 15303122; 15315758; 15342556; 15452220; 15489334; 15502848; 15510218; 15582653; 15695821; 15761153; 15764595; 15767394; 15841462; 15919920; 15955070; 16143103; 16153868; 16154084; 16182584; 16189514; 16199137; 16301520; 16344560; 16362036; 16394098; 16501100; 16513254; 16537515; 16585524; 16699525; 16846591; 16940530; 16979567; 16984921; 16988763; 17015689; 17079289; 17079482; 17121613; 17126870; 17138826; 17142768; 17182689; 17215277; 17251580; 17296604; 17328045; 17393359; 17449641; 17526488; 17540767; 17560375; 17599067; 17608743; 17626075; 17641046; 17652396; 17703412; 17761676; 17823124; 18029348; 18082865; 18203148; 18216110; 18252870; 18272195; 18272581; 18362887; 18440553; 18450748; 18539711; 18579584; 18635538; 18636086; 18641315; 18676680; 18711448; 18713996; 18781139; 18818105; 18927075; 19012493; 19017982; 19028691; 19038458; 19124752; 19152337; 19153595; 19170196; 19201840; 19211751; 19213861; 19239434; 19258923; 19265157; 19349300; 19380831; 19426920; 19434718; 19445677; 19454348; 19515829; 19553679; 19625176; 19646728; 19656901; 19692168; 19701189; 19706707; 19710021; 19826915; 19854139; 19858727; 19890046; 19893624; 19913121; 19955181; 19956647; 20048147; 20048166; 20154210; 20211142; 20308324; 20331378; 20351107; 20360684; 20380698; 20380700; 20381110; 20418377; 20454685; 20483755; 20485298; 20501320; 20503287; 20511230; 20581830; 20604809; 20628086; 20628368; 20631144; 20711230; 20826620; 20886096; 20933442; 20980500; 21079688; 21084468; 21084487; 21120614; 21182093; 21200386; 21225257; 21228327; 21245146; 21248248; 21281747; 21347389; 21411754; 21419663; 21468605; 21497908; 21632562; 21698224; 21768204; 21782231; 21816816; 21835786; 21859832; 21886773; 21890473; 21903422; 21906983; 21931555; 21935451; 21940674; 21988832; 22027828; 22028379; 22072751; 22079989; 22114345; 22127978; 22158869; 22170100; 22208359; 22294846; 22307793; 22388039; 22394560; 22394562; 22479513; 22588174; 22593165; 22647704; 22705311; 22709905; 22745372; 22843696; 22906770; 22908223; 23027953; 23028469; 23077293; 23122814; 23154183; 23281696; 23303668; 23478265; 23512614; 23532851; 23552418; 23596302; 23649622; 23650567; 23824799; 23846693; 23951545; 23994473; 24049179; 24250222; 24275658,,,,,,,,,,,,,,,,,,OGG:3000003661,,,,,,,,,,,,,,,,,,,interferon regulatory factor 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142938,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IRF3,,,20140408,3661,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IRF3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_3380,captopril,1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline|Garranil|Captopryl|Tensoprel|Captoril|Lopirin|(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|CP|D-3-mercapto-2-methylpropanoyl-L-proline|Capoten|Apopril|L-Captopril|Hypertil|captoprilum|Acepress|D-2-methyl-3-mercaptopropanoyl-L-proline|TensoboInOwln|Cesplon|Captolane|captopril|Tenosbon|Dilabar,A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23435971|Patent:US4046889|CAS:62571-86-2|PMID:23161035|PMID:2420897|KEGG:D00251|PMID:23137627|Beilstein:477887|LINCS:LSM-5648|PMID:23422724|PMID:23429803|PMID:23410042|PMID:23299024|DrugBank:DB01197|PMID:23397376|Wikipedia:Captopril|Drug_Central:484|PMID:23328620|Patent:US4105776|PMID:23278692,A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline,,,,,chebi_ontology,,Garranil|Captopryl|Tensoprel|Captoril|Lopirin|(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|CP|D-3-mercapto-2-methylpropanoyl-L-proline|Capoten|Apopril|L-Captopril|Hypertil|captoprilum|Acepress|D-2-methyl-3-mercaptopropanoyl-L-proline|TensoboInOwln|Cesplon|Captolane|captopril|Tenosbon|Dilabar,,,,,,,,,0,C9H15NO3S,"InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1",FAKRSMQSSFJEIM-RQJHMYQMSA-N,217.28500,217.07726,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:3380,,,,,,true,,,,,,,,,CHEBI:3380,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,captopril,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001437,CSF2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,GMCSF,,,,,,,5,,,,,,,,,,Vega:OTTHUMG00000059637|MIM:138960|HPRD:00734|Ensembl:ENSG00000164400|HGNC:2434,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,colony stimulating factor 2 (granulocyte-macrophage),,5q31.1,,,,"GO_0001892 (EC: IEA); GO_0005125 (EC: IEA); GO_0005129 (EC: IEA); GO_0005515 (EC: IPI, PMID: 18692472); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006955 (EC: IEA); GO_0008083 (EC: IEA); GO_0008284 (EC: IEA); GO_0010628 (EC: IDA, PMID: 10666185); GO_0010744 (EC: IDA, PMID: 19032770); GO_0032747 (EC: IDA); GO_0042045 (EC: IEA); GO_0042116 (EC: IEA); GO_0042523 (EC: IDA, PMID: 9722506); GO_0043011 (EC: IEA); GO_0045740 (EC: IDA, PMID: 9722506); GO_0045918 (EC: IDA, PMID: 10666185); GO_0071222 (EC: IEA); GO_0071803 (EC: IDA, PMID: 15220135); GO_0097028 (EC: IDA); GO_2001240 (EC: IDA, PMID: 10666185)",PMID: 1569568; 1675789; 1702217; 1737041; 1837174; 1918997; 2645577; 2999978; 3083507; 3486413; 3876930; 3898082; 3923623; 3925454; 7642615; 7695626; 7727786; 7818827; 7957082; 8018916; 8278375; 8516290; 8910448; 9162089; 9211889; 9722506; 10477722; 10572088; 10666185; 10734053; 11289721; 11522597; 11763346; 11847009; 11855781; 11880043; 11883735; 11956032; 11963838; 12022701; 12031914; 12050184; 12144536; 12162871; 12171249; 12356579; 12356582; 12397015; 12421569; 12444058; 12477932; 12488507; 12496443; 12538575; 12548211; 12562384; 12565831; 12568301; 12615367; 12629028; 12637324; 12646185; 12663443; 12695562; 12743567; 12744771; 12759409; 12855588; 12926133; 12928384; 12935848; 12954601; 13679820; 14503968; 14512323; 14530365; 14564341; 14567558; 14628073; 14630612; 14662891; 14726527; 14730225; 15009203; 15078892; 15123671; 15129224; 15136573; 15201279; 15218949; 15220135; 15245433; 15269821; 15308671; 15340054; 15358207; 15372022; 15388258; 15388264; 15475489; 15479432; 15481145; 15489334; 15528381; 15541716; 15576295; 15621725; 15927668; 16027123; 16167889; 16211258; 16305336; 16380083; 16487109; 16491014; 16716376; 16783532; 16896315; 16912178; 16949316; 17142110; 17205286; 17273755; 17311927; 17342342; 17355643; 17362254; 17512774; 17533050; 17619839; 17681858; 17703412; 17713553; 17894541; 17914409; 17934321; 17938902; 18027871; 18089573; 18219369; 18254319; 18353856; 18434187; 18439101; 18441098; 18523302; 18676680; 18692472; 18701168; 18755511; 18804273; 18830265; 18926300; 18928604; 18945465; 18971287; 18974369; 18974840; 19028820; 19032770; 19050289; 19131452; 19131662; 19141860; 19158269; 19164476; 19170196; 19222422; 19225544; 19230854; 19247692; 19258923; 19263529; 19282464; 19324950; 19379606; 19453261; 19479237; 19494510; 19559392; 19560459; 19578876; 19625176; 19692168; 19699526; 19730683; 19773451; 19807655; 19913121; 20015396; 20056792; 20078425; 20233331; 20382843; 20452482; 20483917; 20485444; 20503287; 20527084; 20536507; 20603037; 20628086; 20673868; 20802406; 20811626; 20829438; 20956574; 20959405; 21052690; 21071541; 21123547; 21262803; 21324206; 21486701; 21506110; 21705618; 21724805; 21873076; 21931646; 22031867; 22200506; 22430742; 22446963; 22655069; 22698406; 22698407; 22837488; 22911897; 23069312; 23128233; 23520016; 23548906; 23585475; 23600834; 23696637; 24211252; 24275678,,,,,,,,,,,,,,,,,,OGG:3000001437,,,,,,,,,,,,,,,,,,,colony stimulating factor 2 (granulocyte-macrophage),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113714,,GMCSF,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CSF2,,,20140408,1437,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CSF2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_1699360,Bat SARS-like coronavirus YNLF_31C,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1699360,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS-like coronavirus YNLF_31C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003003,GZMK,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TRYP2,,,,,,,5,,,,,,,,,,MIM:600784|HGNC:4711|HPRD:02872,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,granzyme K (granzyme 3; tryptase II),,5q11.2,,,,"GO_0004252 (EC: IEA); GO_0005576 (EC: IEA); GO_0008236 (EC: TAS, PMID: 8656064)",PMID: 1460416; 3262682; 7758581; 8039831; 8656064; 8929545; 12384499; 12387726; 12477932; 15489334; 17008916; 17308307; 17438453; 19059912; 19201868; 20377743; 20876349; 21666061; 21988832,,,,,,,,,,,,,,,,,,OGG:3000003003,,,,,,,,,,,,,,,,,,,granzyme K (granzyme 3; tryptase II),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GZMK,,,20140408,3003,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,GZMK,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0007088,regulation of mitotic nuclear division,regulation of mitosis,"Any process that modulates the frequency, rate or extent of mitosis.",false,,,http://purl.obolibrary.org/obo/GO_0051783,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of mitosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of mitosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051783,,,,GO:0007088,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007088,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of mitotic nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031254,cell trailing edge,trailing edge|back of cell,The area of a motile cell opposite to the direction of movement.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The area of a motile cell opposite to the direction of movement.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,trailing edge|back of cell,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0031254,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031254,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,cell trailing edge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031424,keratinization,,"The process in which the cytoplasm of the outermost cells of the vertebrate epidermis is replaced by keratin. Keratinization occurs in the stratum corneum, feathers, hair, claws, nails, hooves, and horns.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process in which the cytoplasm of the outermost cells of the vertebrate epidermis is replaced by keratin. Keratinization occurs in the stratum corneum, feathers, hair, claws, nails, hooves, and horns.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0031424,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031424,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,keratinization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000061,inflammation,,"Inflammation is a general symptom where there is a local response to cellular injury that is marked by capillary dilatation, leukocytic infiltration, redness, heat, pain, swelling, and often loss of function and that serves as a mechanism initiating the elimination of noxious agents and of damaged tissue.",false,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,,,,,,,,,,,,,,,,,,"Inflammation is a general symptom where there is a local response to cellular injury that is marked by capillary dilatation, leukocytic infiltration, redness, heat, pain, swelling, and often loss of function and that serves as a mechanism initiating the elimination of noxious agents and of damaged tissue.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,SYMP:0000061,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,SYMP:0000061,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,inflammation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002088,Abnormal lung morphology,Abnormality of the lungs|Abnormally shaped lung|Unusal lung shape|Abnormality of lung morphology|Lung disease,Any structural anomaly of the lung.,false,,,http://purl.obolibrary.org/obo/HP_0012252,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:19829001|UMLS:C0024115|UMLS:C4021760|MSH:D008171,Any structural anomaly of the lung.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of the lungs|Abnormally shaped lung|Unusal lung shape|Abnormality of lung morphology,,,,,human_phenotype,,Lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012252,,,,HP:0002088,,,,,,,,,,,,,,,HP:0002088,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal lung morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030449,regulation of complement activation,regulation of complement cascade,"Any process that modulates the frequency, rate or extent of complement activation.",false,,,http://purl.obolibrary.org/obo/GO_0002697|http://purl.obolibrary.org/obo/GO_0002920,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of complement activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of complement cascade,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002697|http://purl.obolibrary.org/obo/GO_0002920,,,,GO:0030449,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030449,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of complement activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000006,touching eyes,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,Modified definition,,,behaviour process,,true,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25637115,A face-touching behavior involving eye touches.,,,,,,,,,,,,,,,,touching eyes,,,,,,,,,,,,,,,,,,,,,,https://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00018971,adalimumab,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,327361,,,,DRON:00018971,"A recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,adalimumab,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000775,"chromosome, centromeric region","chromosome, centric region|centromere complex|centromere|chromosome, pericentric region","The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.|Note that this term can be used in place of the obsolete cellular component term 'centromere ; GO:0005698'.",false,,,http://purl.obolibrary.org/obo/GO_0098687,,,,,,,,,,,,,,,,,,,,SO:0000577,"The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0097521,,,,"chromosome, centric region|centromere complex",,,,,cellular_component,,"centromere|chromosome, pericentric region",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term can be used in place of the obsolete cellular component term 'centromere ; GO:0005698'.,,http://purl.obolibrary.org/obo/GO_0098687,,,,GO:0000775,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000775,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"chromosome, centromeric region",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000040,material entity,,,false,,,http://purl.obolibrary.org/obo/BFO_0000004,,,,,MaterialEntity,material,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here.|BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60|BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity.",,,A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002]),,a tornado|an energy wave|a puff of smoke|a hurricane|the undetached arm of a human being|a flame|a photon|an aggregate of human beings.|a sea wave|an epidemic|a human being|a forest fire,,,,,,,,,(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002] |(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002] |(forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002] ,Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])|every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002]),,,,,,,,,,,,,bfo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000004,,,,BFO:0000040,,,,,,,,,,,,,,,BFO:0000040,,http://purl.obolibrary.org/obo/pr.owl|http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ogms.owl|http://purl.obolibrary.org/obo/dron.owl|http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,material entity|material entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039678,viral genome ejection through host cell envelope,viral genome injection through bacterial membranes|phage genome ejection,"Ejection by a non-enveloped prokaryotic virus of its genome into the host cytoplasm. Caudovirales carry an ejection apparatus that can be long and contractile, long and noncontractile, or short, and is able to penetrate the host cell envelope to deliver the viral genome into the host cell cytoplasm.|When a pore-forming protein is involved, see also 'pore-mediated entry of viral genome into host cell ; GO:0044694'.",false,,,http://purl.obolibrary.org/obo/GO_0046718,,,,,,,,,,,,,,,,rfoulger,2013-09-26T11:56:48Z,,,,"Ejection by a non-enveloped prokaryotic virus of its genome into the host cytoplasm. Caudovirales carry an ejection apparatus that can be long and contractile, long and noncontractile, or short, and is able to penetrate the host cell envelope to deliver the viral genome into the host cell cytoplasm.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral genome injection through bacterial membranes|phage genome ejection,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"When a pore-forming protein is involved, see also 'pore-mediated entry of viral genome into host cell ; GO:0044694'.",,http://purl.obolibrary.org/obo/GO_0046718,,,,GO:0039678,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0039678,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral genome ejection through host cell envelope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1903362,regulation of cellular protein catabolic process,regulation of cellular protein breakdown|regulation of cellular protein catabolism|regulation of cellular protein degradation|regulation of degradation of cyclin|regulation of cyclin degradation|regulation of cyclin catabolic process|regulation of cyclin catabolism|regulation of cyclin breakdown,"Any process that modulates the frequency, rate or extent of cellular protein catabolic process.",false,,,http://purl.obolibrary.org/obo/GO_0042176,,,,,,,,,,,,,,,,kmv,2014-08-21T15:05:45Z,,,,"Any process that modulates the frequency, rate or extent of cellular protein catabolic process.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:2000598,,,,regulation of cellular protein breakdown|regulation of cellular protein catabolism|regulation of cellular protein degradation,,,regulation of degradation of cyclin|regulation of cyclin degradation|regulation of cyclin catabolic process|regulation of cyclin catabolism|regulation of cyclin breakdown,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0042176,,,,GO:1903362,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903362,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of cellular protein catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072376,protein activation cascade,protein activitory cascade|protein activation pathway,"A response to a stimulus that consists of a sequential series of modifications to a set of proteins where the product of one reaction acts catalytically in the following reaction. The magnitude of the response is typically amplified at each successive step in the cascade. Modifications typically include proteolysis or covalent modification, and may also include binding events.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,midori,2010-11-22T02:54:18Z,,,,"A response to a stimulus that consists of a sequential series of modifications to a set of proteins where the product of one reaction acts catalytically in the following reaction. The magnitude of the response is typically amplified at each successive step in the cascade. Modifications typically include proteolysis or covalent modification, and may also include binding events.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein activitory cascade|protein activation pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0072376,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072376,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein activation cascade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_1287,cardiovascular system disease,disease of subdivision of hemolymphoid system,"A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.",false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0007222|SNOMEDCT_US_2019_09_01:49601007|ICD9CM:429.2|MESH:D002318|NCI:C2931,"A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:73,,,,disease of subdivision of hemolymphoid system,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:1287,,,,,,,,,,,,,,,DOID:1287,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,cardiovascular system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039525,modulation by virus of host chromatin organization,modulation of host chromatin by virus|modulation by virus of host chromatin organisation|modulation of host chromatin structure by virus|regulation by virus of host chromatin organization,Any process in which a virus effects a change in the organization of chromatin in the host.,false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2011-06-22T05:11:13Z,,,,Any process in which a virus effects a change in the organization of chromatin in the host.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,modulation of host chromatin by virus|modulation by virus of host chromatin organisation|modulation of host chromatin structure by virus,,,,,biological_process,,regulation by virus of host chromatin organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039525,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226,,,,GO:0039525,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host chromatin organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000366,Abnormality of the nose,Nasal abnormality|Nasal anomaly|Anomaly of the nose|Abnormality of the nose|Malformation of the nose|Nasal malformation|Nasal deformity|Deformity of the nose,An abnormality of the nose.,false,,,http://purl.obolibrary.org/obo/HP_0000271,,,,,,,,,,,,,,,,,,,,UMLS:C2235909|UMLS:C0265736|SNOMEDCT_US:128274005|SNOMEDCT_US:72089000|UMLS:C0240547,An abnormality of the nose.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Nasal abnormality|Nasal anomaly|Anomaly of the nose|Abnormality of the nose,,,Malformation of the nose|Nasal malformation|Nasal deformity|Deformity of the nose,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000271,,,,HP:0000366,,,,,,,,,,,,,,,HP:0000366,,http://purl.obolibrary.org/obo/hp.owl,http://purl.oboInOwllibrary.org/oboInOwl/hp#hposlim_core,,,,,,,,,,Abnormality of the nose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_11162,respiratory failure,respiratory insufficiency/failure|acute-on-chronic respiratory failure|chronic respiratory failure|acute respiratory Failure|acute and chronic respiratory failure,A lung disease characterized by inadequate gas exchange by the respiratory system.,false,,,http://purl.obolibrary.org/obo/DOID_850,,,,,,,,,,,,,,,,,,,,NCI:C27043|ICD10CM:J96.0|ICD9CM:518.81|UMLS_CUI:C0264490|SNOMEDCT_US_2019_09_01:65710008,A lung disease characterized by inadequate gas exchange by the respiratory system.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:11392|DOID:11391|DOID:11393,,,,respiratory insufficiency/failure|acute-on-chronic respiratory failure|chronic respiratory failure|acute respiratory Failure|acute and chronic respiratory failure,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_850,,,,DOID:11162,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32104915,,,,DOID:11162,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,respiratory failure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_33208,Metazoa,metazoans|multicellular animals|Animalia|animals,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_33154,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,metazoans|multicellular animals,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_kingdom,Animalia|animals,,,,,,NCBITaxon:33208,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_33154,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Metazoa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000055,vessel,,"A tubular structure that contains, conveys body fluid, such as blood or lymph.",false,,,http://purl.obolibrary.org/obo/UBERON_0004111,,,,,,,,,,,,,,,,,,,,,"A tubular structure that contains, conveys body fluid, such as blood or lymph.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0004111,,,,UBERON:0000055,,,,,,,,,,,,,,,UBERON:0000055,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,vessel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,,"An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus.",false,,,http://purl.obolibrary.org/obo/GO_0002250,,,,,,,,,,,,,,,,,,,,,"An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002250,,,,GO:0002460,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002460,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2759,Eukaryota,eukaryotes|eucaryotes|Eucarya|eukaryotes|Eucaryotae|Eukaryotae|Eukarya,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_131567,,,,,,,,,,,,,,,,,,,,PMID:30257078|GC_ID:1|PMID:23020233,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,eukaryotes|eucaryotes,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_superkingdom,Eucarya|eukaryotes|Eucaryotae|Eukaryotae|Eukarya,,,,,,NCBITaxon:2759,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_131567,,,,,,,,,,,,,,,,"One of the three domains of life (the others being bacteria and archea), also called Eukarya. These are organisms whose cells are enclosed in membranes and possess a nucleus. They comprise almost all multicellular and many unicellular organisms, and are traditionally divided into groups (sometimes called kingdoms) including Animals; plants; fungi; and various algae and other taxa that were previously part of the old kingdom Protista.",,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0002530,gland,glandular organ|glandula|Druese,an organ that functions as a secretory or excretory organ,false,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,,,,,,,,,,,,,,,,,FMA:7146|BTO:0000522|EHDAA:2161|FBbt:00100317|NCIT:C13319|HAO:0000375|UMLS:C1285092|MAT:0000021|MIAA:0000021|AEO:0000096|OpenCyc:Mx4rwP3vyJwpEbGdrcN5Y29ycA|FMA:86294|EHDAA:6522|EHDAA:4475|galen:Gland|EMAPA:18425|WikipediaCategory:Glands|EFO:0000797|MA:0003038|EHDAA2:0003096|AAO:0000212|http://www.snomedbrowser.com/Codes/Details/134358001|http://en.wikipedia.org/wiki/Gland|http://linkedlifedata.com/resource/umls/id/C1285092,an organ that functions as a secretory or excretory organ,,,,http://upload.wikimedia.org/wikipedia/commons/a/a1/Gray1026.png,,,,,,,,,,,,,,,,,,,,,,,UBERON:MIAA_0000021,,,,glandular organ,,,,,uberon,,glandula|Druese,glandular,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,UBERON:0002530,,,,,,,,,,,,,,,UBERON:0002530,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,gland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_63611,moxifloxacin,"1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|Moxifloxacin|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid|moxifloxacin","A quinolone that consists of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents.",false,,,http://purl.obolibrary.org/obo/CHEBI_87211,,,,,,,,,,,,,,,,,,,,KEGG:C07663|CAS:151096-09-2|Patent:EP550903|KEGG:D08237|VSDB:2983|Wikipedia:Moxifloxacin|Reaxys:8365827|DrugBank:DB00218|Drug_Central:1854|LINCS:LSM-5746,"A quinolone that consists of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:7007,,,,"1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|Moxifloxacin",,,,,chebi_ontology,,"1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid|moxifloxacin",,,,,,,,,0,C21H24FN3O4,"InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1",FABPRXSRWADJSP-MEDUHNTESA-N,401.43140,401.17508,[H][C@@]12CCCN[C@]1([H])CN(C2)c1c(F)cc2c(c1OC)n(cc(C(O)=O)c2=O)C1CC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_87211,,,,CHEBI:63611,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,CHEBI:63611,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,moxifloxacin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C16357,Western Blotting,"Western Blot|Western Blotting|WESTERN BLOT|Blotting, Western",A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes.,false,,,http://purl.obolibrary.org/obo/ERO_0000833,,A method for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes.,,,,,,,,,C16357,,,CDISC|CTRP,,,,,,,A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes.,,,,,,Western Blotting,,,,,,,,,,,,,,,,,,,,,,,,,"Western Blot|Western Blotting|WESTERN BLOT|Blotting, Western",,,,,,,,,,,,,NCIT:C16357,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C85492|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830,,,,,,,,,,Western Blotting,Blotting_Western,,,,,,,,,,,,,,,,,,Western Blotting,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.07.982264,Laboratory Procedure,,,,,,,,C0949466,
http://purl.obolibrary.org/obo/NCBITaxon_264378,SARS coronavirus TW-GD1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264378,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-GD1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000111,CD16 positive CD56 positive lymphocyte,,,false,,,http://purl.obolibrary.org/obo/NCIT_C12535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C12535,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32193831/,Lymphocyte subsets expressing phenotypic markers CD16 and CD56.,,,,,,,,,,,,,,,,CD16 positive CD56 positive lymphocyte,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000257101,ZNF683,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,1,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,zinc finger protein 683,,1p36.11,,,,GO_0001779 (EC: IEA); GO_0003677 (EC: IEA); GO_0005634 (EC: IEA); GO_0006351 (EC: IEA); GO_0006355 (EC: IEA); GO_0046872 (EC: IEA),PMID: 12477932; 15489334; 16710414,,,,,,,,,,,,,,,,,,OGG:3000257101,,,,,,,,,,,,,,,,,,,zinc finger protein 683,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ZNF683,,,20140408,257101,RP11-569G9.6,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,ZNF683,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_267385,SARS coronavirus Sin3408,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267385,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin3408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019363,pyridine nucleotide biosynthetic process,pyridine nucleotide anabolism|pyridine nucleotide formation|pyridine nucleotide biosynthesis|pyridine nucleotide synthesis,"The chemical reactions and pathways resulting in the formation of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.",false,,,http://purl.obolibrary.org/obo/GO_0072525|http://purl.obolibrary.org/obo/GO_0051188|http://purl.obolibrary.org/obo/GO_0009165|http://purl.obolibrary.org/obo/GO_0019362,,,,,,,,,,,,,,,,,,,,MetaCyc:PYRIDNUCSYN-PWY,"The chemical reactions and pathways resulting in the formation of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pyridine nucleotide anabolism|pyridine nucleotide formation|pyridine nucleotide biosynthesis|pyridine nucleotide synthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072525|http://purl.obolibrary.org/obo/GO_0051188|http://purl.obolibrary.org/obo/GO_0009165|http://purl.obolibrary.org/obo/GO_0019362,,,,GO:0019363,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019363,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pyridine nucleotide biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_252654,SARS coronavirus BJ302,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:252654,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ302,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C157816,Chronic Respiratory Disease,Chronic Respiratory Disease,,false,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,C157816,,,CPTAC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Chronic Respiratory Disease,,,,,,,,,,,,,NCIT:C157816,"The term chronic respiratory diseases (CRDs) describes a range of diseases of the airways and the other structures of the lungs. They include asthma and respiratory allergies, chronic obstructive pulmonary disease (COPD), occupational lung diseases, sleep apnea syndrome and pulmonary hypertension.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C158520|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C158035|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952,,,,,,,,,,Chronic Respiratory Disease,,,,,,,,,,,,,,,,,,,Chronic Respiratory Disease,,,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30167-3/fulltext,Disease or Syndrome,,,,,,,,C0264220,
http://purl.obolibrary.org/obo/OGG_3000003554,IL1R1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,D2S1473|P80|IL-1R-alpha|CD121A|IL1RA|IL1R,,,,,,,2,,,,,,,,,,HPRD:00994|MIM:147810|Ensembl:ENSG00000115594|Vega:OTTHUMG00000130783|HGNC:5993,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interleukin 1 receptor, type I",,2q12,,,,"GO_0002020 (EC: IEA); GO_0004871 (EC: TAS, PMID: 2530587); GO_0004888 (EC: TAS, PMID: 2530587); GO_0004908 (EC: IDA, PMID: 10383454); GO_0004909 (EC: IEA); GO_0005161 (EC: IPI, PMID: 16477012); GO_0005515 (EC: IPI, PMID: 12925853); GO_0005576 (EC: IEA); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 2530587); GO_0006955 (EC: TAS, PMID: 9120302); GO_0007166 (EC: TAS, PMID: 1833184); GO_0009986 (EC: IEA); GO_0016020 (EC: IDA, PMID: 16477012); GO_0050727 (EC: IEA); GO_0070498 (EC: IDA, PMID: 10383454); GO_0070555 (EC: IDA, PMID: 10383454)",PMID: 1672292; 1833184; 2521881; 2530587; 2532321; 2946959; 7818827; 7878046; 8327496; 8599092; 9062193; 9062194; 9120302; 9360994; 9371760; 9374458; 9575168; 10191101; 10373529; 10383454; 10737800; 10854325; 10903327; 11040178; 11083263; 11127457; 11197691; 11220627; 11233912; 11278614; 11380474; 11380940; 11390630; 11427627; 11506478; 11508575; 11527622; 11578018; 11641511; 11665666; 11742191; 11752505; 11762793; 11790645; 11820460; 11838837; 11846196; 11849463; 11851889; 11956022; 12028539; 12038885; 12077269; 12082592; 12095061; 12133437; 12136897; 12138282; 12145738; 12164325; 12212456; 12240899; 12242293; 12363051; 12412204; 12424621; 12425801; 12472674; 12477576; 12477932; 12496252; 12558814; 12595908; 12609980; 12659850; 12721283; 12729621; 12752101; 12804791; 12890860; 12925853; 14557872; 14563376; 14644395; 14680589; 14734209; 14735144; 14758530; 14872281; 15170937; 15188516; 15190266; 15300624; 15361128; 15375600; 15388348; 15472211; 15481335; 15489334; 15653174; 15723707; 15789892; 15797878; 15866876; 15919456; 16024789; 16100774; 16258158; 16286467; 16301860; 16305343; 16323614; 16344560; 16354686; 16477012; 16564702; 16573560; 16911713; 16937503; 16938461; 17083033; 17113392; 17257312; 17324958; 17413037; 17477815; 17480058; 17517439; 17584583; 17607501; 17622942; 17627763; 17688691; 17703412; 17889143; 18052726; 18321953; 18322311; 18484169; 18576303; 18624935; 18632425; 18763028; 18773331; 18810365; 18818748; 18996842; 19019335; 19064572; 19076825; 19117745; 19141860; 19142372; 19180518; 19211154; 19232518; 19258923; 19290009; 19332120; 19339270; 19408823; 19428986; 19431193; 19453261; 19470040; 19488045; 19527514; 19573080; 19594368; 19683555; 19684156; 19702713; 19716405; 19729601; 19738620; 19773279; 19773451; 19801678; 19819943; 19822442; 19844779; 19860911; 19913121; 19940113; 19948975; 19950169; 19965648; 20054003; 20064081; 20066156; 20120526; 20140262; 20213229; 20237496; 20349753; 20353565; 20400062; 20452482; 20503287; 20523065; 20568250; 20602615; 20603050; 20628086; 20628624; 20673868; 20709104; 20799037; 20800603; 20806065; 20811626; 20816195; 20818961; 20819778; 20956022; 20959405; 21083841; 21086908; 21281963; 21435443; 21787753; 21858107; 21998454; 22031183; 22173128; 22262840; 22267087; 22285486; 22385245; 22417897; 22426547; 22435759; 22509941; 22515947; 22561531; 22574108; 22594576; 22904187; 23022958; 23128233; 23375040; 23407395; 23634226; 23969696; 23999434,,,,,,,,,,,,,,,,,,OGG:3000003554,,,,,,,,,,,,,,,,,,,"interleukin 1 receptor, type I",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL1R1,,,20140408,3554,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL1R1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0002157,Azotemia,Azotaemia,"An increased concentration of nitrogen compounds in the blood.|Abnormal levels of nitrogen-containing compounds, such as urea and creatinine.",false,,,http://purl.obolibrary.org/obo/HP_0004364,,,,,,,,,,,,,,,,,,,,MSH:D053099|UMLS:C0242528|SNOMEDCT_US:445009001,An increased concentration of nitrogen compounds in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Azotaemia,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Abnormal levels of nitrogen-containing compounds, such as urea and creatinine.",,http://purl.obolibrary.org/obo/HP_0004364,,,,HP:0002157,,,,,,,,,,,,,,,HP:0002157,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Azotemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249073,SARS coronavirus JMD,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249073,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus JMD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTD8,protein 7b (SARS-CoV-2),PRO_0000449799|ORF7b (SARS2)|non-structural protein 7b (SARS2)|ns7b (SARS2)|accessory protein 7b (SARS2)|GU280_gp08|ORF7b,A protein that is a translation product of the ORF7b gene in SARS-CoV-2.|Category=organism-gene. Note: 43 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725318|UniProtKB:P0DTD8,A protein that is a translation product of the ORF7b gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PRO_0000449799|ORF7b (SARS2)|non-structural protein 7b (SARS2)|ns7b (SARS2)|accessory protein 7b (SARS2),,,,,protein,,GU280_gp08|ORF7b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 43 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTD8,,,,,,true,,,,,,,,,PR:P0DTD8,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,protein 7b (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/APOLLO_SV_00000002,basic reproduction number,,The average number of transmissions of an infectious agent from an infectious organism to a susceptible organism within a completely susceptible population.|MB: Here we run into the well know DL problem that we cannot specify that the infectious agent that is transmitted is of the same type that the infectious agent the population is susceptible to.,false,,,http://purl.obolibrary.org/obo/APOLLO_SV_00000043,,,,,,,,,,,,,,,,,,,,,The average number of transmissions of an infectious agent from an infectious organism to a susceptible organism within a completely susceptible population.,,,,,,,,,,,The number of organisms that each infected organism infects in a completely susceptible population during its infectious period.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,APOLLO_SV:00000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,MB: Here we run into the well know DL problem that we cannot specify that the infectious agent that is transmitted is of the same type that the infectious agent the population is susceptible to.,,http://purl.obolibrary.org/obo/APOLLO_SV_00000043,,,,,,,,,,true,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/?term=32113704%5Buid%5D,,R0|basic reproduction rate|R-Naught|multiplicity of infection|reproduction number,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,basic reproduction number,,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,William R. Hogan,,,,basicReproductionNumbers
http://purl.obolibrary.org/obo/NCBITaxon_305404,SARS coronavirus A030,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305404,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus A030,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_296837,SARS coronavirus PC4-115,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:296837,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-115,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000017,realizable entity,,,false,,,http://purl.obolibrary.org/obo/BFO_0000020,,,,,RealizableEntity,realizable,,,,,,,,,,,,,,,,,,,,,,,,,,To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002]),,the role of being a doctor|the function of your reproductive organs|the role of this boundary to delineate where Utah and Colorado meet|the disposition of this piece of metal to conduct electricity.|the disposition of your blood to coagulate,,,,,,,,,(forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002] |(forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002] ,All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002]),,,,,,,,,,,,,,,,,,,,,BFO:0000017,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000020,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,realizable entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000028,three-dimensional spatial region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000006,,,,,ThreeDimensionalSpatialRegion,3d-s-region,,,,,,,,,,,,,,,,,,,,,,,,,,A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001]),,"a cube-shaped region of space|a sphere-shaped region of space,",,,,,,,,,(forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000028,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000006,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,three-dimensional spatial region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000086,vascular congestion,,,false,,,http://purl.obolibrary.org/obo/HP_0001871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001871,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,Obstruction of the normal flux of blood within the blood vessel network of the lung resulting in engorgement of pulmonary vessels; frequently precedes pulmonary edema,,pulmonary vascular congestion,,,,,,,,,,,,,,vascular congestion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_23359,colchicine,"N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide","An  alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:24074178|Beilstein:2228812|DrugBank:DB01394|Reaxys:2228812|HMDB:HMDB0015466|LINCS:LSM-6449|CAS:54192-66-4|PMID:9819133|PMID:7200520|PMID:10680067,"An  alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide",,,,,chebi_ontology,,,,,,,,,,,0,C22H25NO6,"InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)",IAKHMKGGTNLKSZ-UHFFFAOYSA-N,399.43704,399.16819,COc1cc2CCC(NC(C)=O)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:23359,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:23359,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,colchicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009896,positive regulation of catabolic process,positive regulation of breakdown|up regulation of catabolic process|upregulation of catabolic process|positive regulation of catabolism|positive regulation of degradation|up-regulation of catabolic process|stimulation of catabolic process|activation of catabolic process,"Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,positive regulation of breakdown|up regulation of catabolic process|upregulation of catabolic process|positive regulation of catabolism|positive regulation of degradation|up-regulation of catabolic process,,,stimulation of catabolic process|activation of catabolic process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0009896,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009896,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10239,Viruses,viruses|Vira|Viridae,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_1,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_superkingdom,viruses|Vira|Viridae,,,,,,NCBITaxon:10239,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_1,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Viruses,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019884,antigen processing and presentation of exogenous antigen,"antigen presentation, exogenous antigen",The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of exogenous origin on its cell surface in association with an MHC protein complex.,false,,,http://purl.obolibrary.org/obo/GO_0019882,,,,,,,,,,,,,,,,,,,,,The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of exogenous origin on its cell surface in association with an MHC protein complex.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"antigen presentation, exogenous antigen",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019882,,,,GO:0019884,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019884,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antigen processing and presentation of exogenous antigen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011893,Abnormal leukocyte count,Abnormal white blood cell count,Number of leukocytes per volume of blood beyond normal limits.,false,,,http://purl.obolibrary.org/obo/HP_0001881,,,,,,,,,,,,,,,,peter,2012-06-02T05:32:39Z,,,SNOMEDCT_US:165509000|UMLS:C0580531,Number of leukocytes per volume of blood beyond normal limits.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal white blood cell count,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001881,,,,HP:0011893,,,,,,,,,,,,,,,HP:0011893,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal leukocyte count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C66930,Angiotensin II Receptor Antagonist,ARB|Angiotensin Receptor Blockers|Angiotensin II Receptor Blocker|Angiotensin II Receptor Antagonists|Angiotensin II Receptor Antagonist,"A class of agents that act by selectively inhibiting angiotensin II receptor activation in the renin-angiotensin-aldosterone system. Angiotensin II receptor antagonists bind to and block the activation of angiotensin II type 1 (AT1) receptors, thereby reducing production and secretion of aldosterone, amongst other actions. The combined effects result in reduction of blood pressure. Although this class of agents is also used in diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure, it is primarily used for the treatment of hypertension in cases where the patient is intolerant of ACE inhibitor therapy.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,"A pharmaceutical agent that selectively inhibits angiotensin II receptor activation in the renin-angiotensin-aldosterone system reducing production and secretion of aldosterone, amongst other actions. The combined effects result in reduction of blood pressure. It is primarily used for the reduction of proteinuria and the treatment of hypertension in cases where the patient is intolerant of ACE inhibitor therapy.",,,,,,,,,C66930,,,NICHD,,,,,,,"A class of agents that act by selectively inhibiting angiotensin II receptor activation in the renin-angiotensin-aldosterone system. Angiotensin II receptor antagonists bind to and block the activation of angiotensin II type 1 (AT1) receptors, thereby reducing production and secretion of aldosterone, amongst other actions. The combined effects result in reduction of blood pressure. Although this class of agents is also used in diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure, it is primarily used for the treatment of hypertension in cases where the patient is intolerant of ACE inhibitor therapy.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ARB|Angiotensin Receptor Blockers|Angiotensin II Receptor Blocker|Angiotensin II Receptor Antagonists|Angiotensin II Receptor Antagonist,,,,http://purl.obolibrary.org/obo/NCIT_C1909,,,,,,,,,NCIT:C66930,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118468,,,,,,,,,,Angiotensin II Receptor Antagonist,Angiotensin_II_Receptor_Antagonist,,,,,,,Angiotensin II Receptor Antagonist,,,,,,,,,,,Angiotensin II Receptor Antagonist,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,Chemical Viewed Functionally,,,,,,,,C0521942,
http://purl.obolibrary.org/obo/CMO_0000294,pulse,,The count of the rhythmic contractions and expansions of an artery due to the surge of blood from the beat of the heart.,false,,,http://purl.obolibrary.org/obo/CMO_0000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000294,,,,,,,,,,mshimoyama,2010-08-04T10:37:40Z,The count of the rhythmic contractions and expansions of an artery due to the surge of blood from the beat of the heart.,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000001,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,pulse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000006,spatial region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000141,,,,,SpatialRegion,s-region,,,,,,,,,,,,,,,,,,,,,,,"Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional.|BFO 2 Reference: Spatial regions do not participate in processes.",,,A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001]),,,,,,,,,,,(forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001] |(forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001] ,All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001]),,,,,,,,,,,,,,,,,,,,,BFO:0000006,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000141,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,spatial region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_230471,SARS coronavirus ZJ01,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:230471,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ZJ01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000898,cardiac fibrillation,,"An arrhythmia characterized by rapid, irregular, and unsynchronized contraction of muscle fibers within the heart.",false,,,http://purl.obolibrary.org/obo/SYMP_0000287,,,,,,,,,,,,,,,,,,,,,"An arrhythmia characterized by rapid, irregular, and unsynchronized contraction of muscle fibers within the heart.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000287,,,,SYMP:0000898,,,,,,,,,,,,,,,SYMP:0000898,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,cardiac fibrillation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249067,SARS coronavirus HGZ8L1-B,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249067,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HGZ8L1-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0000605,prevention and control intervention,,"An intervention involving increasing human or animal resistance against disease (e.g., immunization),  control of transmission agents,  prevention and control of environmental hazards, or prevention and control of social factors leading to disease. It includes preventive measures in individual cases.|MeSH qualifier ID : Q000517",false,,,http://purl.obolibrary.org/obo/ERO_0000347,,,,,,,,,,,,,,,,,,,,,"An intervention involving increasing human or animal resistance against disease (e.g., immunization),  control of transmission agents,  prevention and control of environmental hazards, or prevention and control of social factors leading to disease. It includes preventive measures in individual cases.",,http://www.nlm.nih.gov/cgi/mesh/2010/MB_cgi?mode=&index=218879&field=qual&HM=&II=&PA=&form=&input=,,,,,,,prevention and control intervention,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000123,,,,,,,,,,,,,,,,,,,,ERO:0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,MeSH qualifier ID : Q000517,,http://purl.obolibrary.org/obo/ERO_0000347,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,prevention and control intervention,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Matthew Brush,,,,
http://purl.obolibrary.org/obo/GO_0075527,viral RNA editing,RNA editing involved in viral mRNA transcription,"The process by which bases in viral mRNA are chemically altered during viral transcription. This is usually the incorporation of 1 - 6 additional nucleotides, which shifts the reading frame, allowing the generation of different protein products or through a specific nucleotide change that eliminates the termination codon.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,janelomax,2011-08-04T02:07:03Z,,,VZ:857,"The process by which bases in viral mRNA are chemically altered during viral transcription. This is usually the incorporation of 1 - 6 additional nucleotides, which shifts the reading frame, allowing the generation of different protein products or through a specific nucleotide change that eliminates the termination codon.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,RNA editing involved in viral mRNA transcription,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0075527,,,,,,true,,,,true,,,,,GO:0075527,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral RNA editing,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.02.973255v1.full,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_235413,SARS coronavirus Sin2677,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:235413,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin2677,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006956,complement activation,complement response|complement cascade|complement activity,"Any process involved in the activation of any of the steps of the complement cascade, which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes; the initial steps of complement activation involve one of three pathways, the classical pathway, the alternative pathway, and the lectin pathway, all of which lead to the terminal complement pathway.",false,,,http://purl.obolibrary.org/obo/GO_0006959,,,,,,,,,,,,,,,,,,,,,"Any process involved in the activation of any of the steps of the complement cascade, which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes; the initial steps of complement activation involve one of three pathways, the classical pathway, the alternative pathway, and the lectin pathway, all of which lead to the terminal complement pathway.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,complement response|complement cascade,,,,,biological_process,,complement activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006959,,,,GO:0006956,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006956,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,complement activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0015949,nucleobase-containing small molecule interconversion,,"The chemical reactions and pathways by which a nucleobase, nucleoside or nucleotide small molecule is synthesized from another nucleobase, nucleoside or nucleotide small molecule.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,MetaCyc:P1-PWY,"The chemical reactions and pathways by which a nucleobase, nucleoside or nucleotide small molecule is synthesized from another nucleobase, nucleoside or nucleotide small molecule.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0015949,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0015949,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,nucleobase-containing small molecule interconversion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000128,heptad repeat 1 (SARS-CoV-2),,,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,modified definition,,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32231345,"Heptad repeat 1 (HR1) is a fragment of spike protien of SARS COV-2, forms a  six-helical bundle interacting with HR2 , plays a key role during the viral membrane fusion process.",,,,,,,,,,,,,,,,heptad repeat 1 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0050161,lower respiratory tract disease,,A respiratory system disease which involves the lower respiratory tract.,false,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,,,,,,,,,,ICD9CM:478.19|UMLS_CUI:C0029581,A respiratory system disease which involves the lower respiratory tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1579,,,,DOID:0050161,,,,,,,,,,,,,,,DOID:0050161,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,lower respiratory tract disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0001004,respiratory system,apparatus respiratorius|respiratory system|Atmungssystem|systema respiratorium|apparatus respiratorius,Functional system which consists of structures involved in respiration.,false,,,http://purl.obolibrary.org/obo/UBERON_0000467,,,,,,,,,,,,,,,,,,,,CALOHA:TS-1319|EHDAA2:0001604|EMAPA:16727|TAO:0000272|MESH:D012137|BTO:0000203|MA:0000327|UMLS:C0035237|FMA:7158|EHDAA:2203|OpenCyc:Mx4rvVjzFJwpEbGdrcN5Y29ycA|EV:0100036|XAO:0000117|EFO:0000804|ZFA:0000272|NCIT:C12779|MIAA:0000030|AAO:0000541|MAT:0000030|GAID:78|VHOG:0000202|http://en.wikipedia.org/wiki/Respiratory_system|http://www.snomedbrowser.com/Codes/Details/278197002|http://linkedlifedata.com/resource/umls/id/C0035237,Functional system which consists of structures involved in respiration.,,,,http://upload.wikimedia.org/wikipedia/commons/5/5e/Respiratory_system_complete_en.svg,,,,,,,,,,The anatomical system in which the exchange of oxygen and carbon dioxide between the organism and its environment.[AAO],,,,,,,,,,,,,,,,,apparatus respiratorius|respiratory system,,,,,uberon,,Atmungssystem|systema respiratorium|apparatus respiratorius,,,,,There is no doubt that the primitive pattern of vertebrate air-breathing is the buccal pulse pump found in actinopterygian fishes.[well established][VHOG],,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000467,,,,UBERON:0001004,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/?term=32113704,,,,UBERON:0001004,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#functional_classification|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,respiratory system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050267,spike protein S1 (SARS-CoV-2),"S1 (SARS2)|UniProtKB:P0DTC2, 13-685|PRO_0000449647","A spike glycoprotein, signal peptide removed form (SARS-CoV-2) that has been processed by proteolytic cleavage to yield the N-terminal portion. UniProtKB:P0DTC2, 13-685.|Category=organism-modification.",false,,,http://purl.obolibrary.org/obo/PR_000050266,,,,,,,,,,,,,,,,,,,,,"A spike glycoprotein, signal peptide removed form (SARS-CoV-2) that has been processed by proteolytic cleavage to yield the N-terminal portion. UniProtKB:P0DTC2, 13-685.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"S1 (SARS2)|UniProtKB:P0DTC2, 13-685|PRO_0000449647",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification.,,http://purl.obolibrary.org/obo/PR_000050266,,,,PR:000050267,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151553/,,,,PR:000050267,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,spike protein S1 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050284,RNA-directed RNA polymerase (SARS-CoV-2),"RdRp (SARS2)|UniProtKB:P0DTD1, 4393-5324|nsp12 (SARS2)|ORF1ab/Clv:nsp12 (SARS2)|Pol (SARS2)|PRO_0000449629",An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4392-4393 and 5324-5325.|Category=organism-modification. Note: 932 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050283,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725307,An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4392-4393 and 5324-5325.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"RdRp (SARS2)|UniProtKB:P0DTD1, 4393-5324|nsp12 (SARS2)|ORF1ab/Clv:nsp12 (SARS2)|Pol (SARS2)|PRO_0000449629",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 932 aa protein.,,http://purl.obolibrary.org/obo/PR_000050283,,,,PR:000050284,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32277040,,,,PR:000050284,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,RNA-directed RNA polymerase (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_7,disease of anatomical entity,,A disease that manifests in a defined anatomical structure.,false,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,,,,,,,,,,,,,,,,,,A disease that manifests in a defined anatomical structure.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:71|DOID:8|DOID:2|DOID:72|DOID:1|DOID:5,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,DOID:7,,,,,,,,,,,,,,,DOID:7,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,disease of anatomical entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0022625,cytosolic large ribosomal subunit,50S ribosomal subunit|prokaryotic large ribosomal subunit|eukaryotic ribosomal LSU|60S ribosomal subunit,The large subunit of a ribosome located in the cytosol.,false,,,http://purl.obolibrary.org/obo/GO_0015934,,,,,,,,,,,,,,,,,,,,,The large subunit of a ribosome located in the cytosol.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009282|GO:0005842|GO:0030498|GO:0030872,,,,,,,50S ribosomal subunit|prokaryotic large ribosomal subunit|eukaryotic ribosomal LSU|60S ribosomal subunit,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0015934,,,,GO:0022625,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0022625,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytosolic large ribosomal subunit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051307,meiotic chromosome separation,meiotic chromosome resolution|chromosome separation during meiosis,The process in which chromosomes are physically detached from each other during meiosis.,false,,,http://purl.obolibrary.org/obo/GO_0051304|http://purl.obolibrary.org/obo/GO_1903046,,,,,,,,,,,,,,,,,,,,,The process in which chromosomes are physically detached from each other during meiosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,meiotic chromosome resolution|chromosome separation during meiosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051304|http://purl.obolibrary.org/obo/GO_1903046,,,,GO:0051307,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051307,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,meiotic chromosome separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MONDO_0019540,diffuse alveolar hemorrhage (disease),diffuse alveolar hemorrhage,,false,,,http://purl.obolibrary.org/obo/MONDO_0015118,,,,,,,,,,,,,,,,,,,,HP:0025420|ICD10:J98.4|UMLS:CN206369|Orphanet:90060,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,diffuse alveolar hemorrhage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/MONDO_0015118,,,http://www.orpha.net/ORDO/Orphanet_90060|http://linkedlifedata.com/resource/umls/id/CN206369,MONDO:0019540,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,"Diffuse alveolar hemorrhage (DAH) is a life-threatening and medical emergency that can be caused by numerous disorders and presents with hemoptysis, anemia, and diffuse alveolar infiltrates.",,,MONDO:0019540,,http://purl.obolibrary.org/obo/mondo.owl,http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_clinical_situation,,,,,,,,,,diffuse alveolar hemorrhage (disease),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901658,glycosyl compound catabolic process,glycosyl compound catabolism|glycosyl compound degradation|glycosyl compound breakdown,The chemical reactions and pathways resulting in the breakdown of glycosyl compound.,false,,,http://purl.obolibrary.org/obo/GO_1901136,,,,,,,,,,,,,,,,pr,2012-11-20T14:24:11Z,,,,The chemical reactions and pathways resulting in the breakdown of glycosyl compound.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,glycosyl compound catabolism|glycosyl compound degradation|glycosyl compound breakdown,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901136,,,,GO:1901658,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901658,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,glycosyl compound catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000000001,protein,,"An amino acid chain that is produced de novo by ribosome-mediated translation of a genetically-encoded mRNA, and any derivatives thereof.|The definition above excludes protein complexes, which some also consider a protein. Those who wish to refer to a class representing both senses of the word are directed to CHEBI:36080. Proteins (in the sense defined here) that descended from a common ancestor can be classified into families and superfamilies composed of products of evolutionarily-related genes. The domain architecture of a protein is described by the order of its constituent domains. Proteins with the same domains in the same order are defined as homeomorphic [PRO:WCB].",false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,"An amino acid chain that is produced de novo by ribosome-mediated translation of a genetically-encoded mRNA, and any derivatives thereof.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The definition above excludes protein complexes, which some also consider a protein. Those who wish to refer to a class representing both senses of the word are directed to CHEBI:36080. Proteins (in the sense defined here) that descended from a common ancestor can be classified into families and superfamilies composed of products of evolutionarily-related genes. The domain architecture of a protein is described by the order of its constituent domains. Proteins with the same domains in the same order are defined as homeomorphic [PRO:WCB].",,http://purl.obolibrary.org/obo/BFO_0000040,,,,PR:000000001,,,,,,,,,,,,,,,PR:000000001,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_25212,metabolite,metabolite|primary metabolites|metabolites|secondary metabolites,Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:26619|CHEBI:35220,,,,metabolite,,,,,chebi_ontology,,primary metabolites|metabolites|secondary metabolites,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,CHEBI:25212,,,,,,,,,,,,,,,CHEBI:25212,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,metabolite,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264385,SARS coronavirus TW-YM3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264385,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-YM3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006047,UDP-N-acetylglucosamine metabolic process,UDP-N-acetylglucosamine metabolism,"The chemical reactions and pathways involving UDP-N-acetylglucosamine, a substance composed of N-acetylglucosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving UDP-N-acetylglucosamine, a substance composed of N-acetylglucosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,UDP-N-acetylglucosamine metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006047,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006047,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,UDP-N-acetylglucosamine metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000034,end-organ dysfunction,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,,,,,disease,,true,,,,,,"End organ damage is defined as presence of any one or more of the following features: hypercalcemia, renal failure, anemia, and lytic bone lesions (which can be diagnosed on bone radiographs).",End Organ Damage,,,,,,,,,,,,,,,end-organ dysfunction,,,,,,,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT04316884,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_651668,Human herpesvirus 8 strain rKSHV.219,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_37296,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:651668,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_37296,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human herpesvirus 8 strain rKSHV.219,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000727,C5,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,C5a|CPAMD4|C5b,,,,,,,9,,,,,,,,,,HPRD:00405|MIM:120900|Ensembl:ENSG00000106804|HGNC:1331|Vega:OTTHUMG00000020579,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,complement component 5,,9q33-q34,,,,"GO_0000187 (EC: TAS, PMID: 7649993); GO_0001701 (EC: IEA); GO_0002523 (EC: IEA); GO_0004866 (EC: IEA); GO_0005102 (EC: TAS, PMID: 10820279); GO_0005515 (EC: IPI); GO_0005576 (EC: TAS); GO_0005579 (EC: IEA); GO_0005615 (EC: IEA); GO_0006874 (EC: IEA); GO_0006935 (EC: TAS, PMID: 10820279); GO_0006950 (EC: TAS, PMID: 9590258); GO_0006954 (EC: TAS, PMID: 8759757); GO_0006956 (EC: TAS); GO_0006957 (EC: IEA); GO_0006958 (EC: IEA); GO_0007166 (EC: TAS, PMID: 10820279); GO_0007186 (EC: TAS, PMID: 8898085); GO_0008009 (EC: TAS, PMID: 10820279); GO_0010575 (EC: IDA, PMID: 14566334); GO_0010700 (EC: IEA); GO_0010760 (EC: IDA, PMID: 14566334); GO_0019835 (EC: IEA); GO_0030449 (EC: TAS); GO_0031714 (EC: IEA); GO_0033602 (EC: IEA); GO_0042593 (EC: IEA); GO_0045087 (EC: TAS); GO_0045766 (EC: IEA); GO_0050921 (EC: IEA); GO_0060326 (EC: TAS, PMID: 10820279); GO_0070062 (EC: IDA, PMID: 19056867); GO_0090197 (EC: IDA, PMID: 14566334)",PMID: 106884; 690134; 1387399; 1847994; 1984448; 1996961; 2579066; 2730871; 2784981; 2808363; 3052276; 3365401; 3408713; 3624872; 7649993; 7661861; 7730648; 7835913; 7911492; 8175701; 8630395; 8702752; 8759757; 8889548; 8898085; 9007977; 9188742; 9218605; 9553099; 9590258; 10352266; 10820279; 11367533; 11752456; 11939578; 12477932; 12488432; 12878586; 12881318; 12937147; 14556080; 14566334; 14662858; 15278436; 15383587; 15488949; 15550394; 15585680; 15598652; 15768031; 15778377; 15879120; 15995705; 16335952; 16452172; 16670089; 16823297; 16879222; 17023413; 17322907; 17428459; 17482181; 17498719; 17505301; 17533009; 17634448; 17644516; 17703412; 17804836; 17880261; 18039528; 18240029; 18300128; 18411281; 18576341; 18644651; 18714034; 18759306; 18953960; 18974840; 19028820; 19056867; 19110536; 19116907; 19131662; 19162005; 19180477; 19225544; 19230171; 19247692; 19258923; 19263529; 19265162; 19324972; 19336421; 19344414; 19375167; 19401279; 19414197; 19416238; 19423540; 19479237; 19503088; 19559392; 19565500; 19674979; 19729601; 19741008; 19843088; 19864026; 19902201; 19909405; 19913121; 19918040; 19948975; 20022638; 20030635; 20049410; 20109314; 20124699; 20133685; 20143644; 20205706; 20219786; 20233754; 20237496; 20353580; 20406964; 20424189; 20438785; 20444755; 20453842; 20479942; 20498205; 20503287; 20536507; 20545943; 20591742; 20603037; 20628086; 20797713; 20813982; 20822712; 20880552; 20962850; 21393613; 21890473; 21926466; 22244896; 22258234; 22284611; 22308306; 22452399; 22496247; 22500023; 22528500; 22802338; 22812419; 22820624; 23028051; 23071133; 23321589; 23371790; 23401592; 23602531; 23662819; 23792503; 23833239; 24521109,,,,,,,,,,,,,,,,,,OGG:3000000727,,,,,,,,,,,,,,,,,,,complement component 5,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,C5,,,20140408,727,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,C5,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0014068,positive regulation of phosphatidylinositol 3-kinase signaling,positive regulation of phosphoinositide 3-kinase cascade|upregulation of phosphatidylinositol 3-kinase cascade|positive regulation of PI 3-kinase cascade|up regulation of phosphatidylinositol 3-kinase cascade|positive regulation of PI3K cascade|up-regulation of phosphatidylinositol 3-kinase cascade|activation of phosphoinositide 3-kinase cascade|stimulation of phosphatidylinositol 3-kinase cascade|positive regulation of phosphatidylinositol 3-kinase cascade,"Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,positive regulation of phosphoinositide 3-kinase cascade|upregulation of phosphatidylinositol 3-kinase cascade|positive regulation of PI 3-kinase cascade|up regulation of phosphatidylinositol 3-kinase cascade|positive regulation of PI3K cascade|up-regulation of phosphatidylinositol 3-kinase cascade,,,activation of phosphoinositide 3-kinase cascade|stimulation of phosphatidylinositol 3-kinase cascade,,biological_process,,positive regulation of phosphatidylinositol 3-kinase cascade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0014068,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0014068,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of phosphatidylinositol 3-kinase signaling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003682,ITGAE,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CD103|HUMINAE,,,,,,,17,,,,,,,,,,Vega:OTTHUMG00000177634|MIM:604682|HGNC:6147|HPRD:05249|Ensembl:ENSG00000083457,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)",,17p13,,,,GO_0005886 (EC: TAS); GO_0007155 (EC: IEA); GO_0007229 (EC: IEA); GO_0008305 (EC: IEA); GO_0009897 (EC: IEA); GO_0030198 (EC: TAS); GO_0046872 (EC: IEA),PMID: 1542691; 3498635; 7614974; 8119947; 8526015; 8580465; 9676575; 9765275; 10673275; 10790430; 10837471; 10978890; 11311556; 12370249; 12414996; 12434297; 12477932; 14532999; 15196058; 15489334; 16169070; 16177076; 16216886; 16920912; 17325197; 17975119; 18182176; 18492951; 18839057; 19023099; 19074885; 19150377; 19604725; 20237496; 20379614; 20417566; 20588308; 20875079; 21739671; 21917686; 21948982; 22505724; 22922816; 24250222,,,,,,,,,,,,,,,,,,OGG:3000003682,,,,,,,,,,,,,,,,,,,"integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ITGAE,,,20140408,3682,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,ITGAE,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0001823,mesonephros development,Wolffian body development,"The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.",false,,,http://purl.obolibrary.org/obo/GO_0001822,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Wolffian body development,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0001822,,,,GO:0001823,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001823,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mesonephros development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000227,cell measurement,,Any quantification of a morphological or physiological parameter of one or more cells.  A cell is a membrane-enclosed protoplasmic mass constituting the smallest structural unit of an organism that is capable of independent functioning.,false,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000227,,,,,,,,,,mshimoyama,2010-06-17T10:30:36Z,Any quantification of a morphological or physiological parameter of one or more cells.  A cell is a membrane-enclosed protoplasmic mass constituting the smallest structural unit of an organism that is capable of independent functioning.,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,cell measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009405,pathogenesis,virulence,"The set of specific processes that generate the ability of an organism to induce an abnormal, generally detrimental state in another organism.|Note that this term should not be used to annotate gene products that are involved in the host response to pathogenesis. It should only be used to annotate those gene products involved in the generation of pathogenesis by the pathogen itself.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The set of specific processes that generate the ability of an organism to induce an abnormal, generally detrimental state in another organism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,virulence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term should not be used to annotate gene products that are involved in the host response to pathogenesis. It should only be used to annotate those gene products involved in the generation of pathogenesis by the pathogen itself.,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0009405,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0009405,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus,,,,,,,,,,pathogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009145,purine nucleoside triphosphate biosynthetic process,purine nucleoside triphosphate formation|purine nucleoside triphosphate anabolism|purine nucleoside triphosphate synthesis|purine nucleoside triphosphate biosynthesis,"The chemical reactions and pathways resulting in the formation of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009144|http://purl.obolibrary.org/obo/GO_0009142,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine nucleoside triphosphate formation|purine nucleoside triphosphate anabolism|purine nucleoside triphosphate synthesis|purine nucleoside triphosphate biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009144|http://purl.obolibrary.org/obo/GO_0009142,,,,GO:0009145,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009145,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine nucleoside triphosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0028856,Vascular Remodeling,,,false,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0028856,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,"The active alterations of vascular wall structures, often leading to elevated VASCULAR RESISTANCE. It is associated with AGING; ATHEROSCLEROSIS; DIABETES MELLITUS; HYPERTENSION; PREGNANCY; PULMONARY HYPERTENSION; and STROKE, but is also a normal part of EMBRYOGENESIS.",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Vascular Remodeling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000057,A2a2 haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A2a2 haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,A2a2 haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_135632,camostat,camostat mesylate|camostat mesilate,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:59721-28-7|Drug_Central:471,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,camostat mesylate|camostat mesilate,,,,,,,,,0,C20H22N4O5,"InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)",XASIMHXSUQUHLV-UHFFFAOYSA-N,398.413,398.15902,C(OC1=CC=C(C=C1)CC(OCC(N(C)C)=O)=O)(=O)C2=CC=C(C=C2)NC(=N)N,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:135632,,,,,,true,,,,,,,,,CHEBI:135632,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,camostat,,,,,,,,,,,,,,,,,,,,,,https://www.drugtargetreview.com/news/58915/nafamostat-inhibits-sars-cov-2-infection-preventing-covid-19-transmission/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_231521,SARS coronavirus HKU-66078,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231521,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HKU-66078,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_742005,Bat SARS coronavirus HKU3-8,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:742005,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C11364,Cytarabine/Homoharringtonine/Interferon Alfa,Cytarabine/Homoharringtonine/Interferon Alfa|ARA-C/HH/IFN-A,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C11364,Obsolete_Concept,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cytarabine/Homoharringtonine/Interferon Alfa|ARA-C/HH/IFN-A,,,,,,,,,,,,,NCIT:C11364,"Triple combination regimen with IFN-alpha, Cytarabine and Homoharringtonine",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,,,,,,https://pubmed.ncbi.nlm.nih.gov/12942553/,,,homoharringtonine,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Cytarabine/Homoharringtonine/Interferon Alfa,Cytarabine_Homoharringtonine_Interferon-Alfa,,,,,,,,,,,,,,,,,,Cytarabine/Homoharringtonine/Interferon Alfa,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127386/,Therapeutic or Preventive Procedure,,,,,,,,C0678006,
http://purl.obolibrary.org/obo/CHEBI_27618,chalcone,"1,3-diphenylprop-2-en-1-one|Chalcone|alpha-benzylideneacetophenone|styryl phenyl ketone|1,3-Diphenyl-2-propen-1-one|Benzylideneacetophenone|beta-benzoylstyrene|Chalkon|beta-phenylacrylophenone",A member of the class of chalcones that is acetophenone in which one of the methyl hydrogens has been replaced by a benzylidene group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:94-41-7|Beilstein:509985|Wikipedia:Chalcone|KEGG:C01484|Gmelin:29124|PMID:24510324|Reaxys:509985,A member of the class of chalcones that is acetophenone in which one of the methyl hydrogens has been replaced by a benzylidene group.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:3571|CHEBI:23085,,,,"1,3-diphenylprop-2-en-1-one|Chalcone",,,,,chebi_ontology,,"alpha-benzylideneacetophenone|styryl phenyl ketone|1,3-Diphenyl-2-propen-1-one|Benzylideneacetophenone|beta-benzoylstyrene|Chalkon|beta-phenylacrylophenone",,,,,,,,,0,C15H12O,InChI=1S/C15H12O/c16-15(14-9-5-2-6-10-14)12-11-13-7-3-1-4-8-13/h1-12H,DQFBYFPFKXHELB-UHFFFAOYSA-N,208.25518,208.08882,[H]C(=C([H])c1ccccc1)C(=O)c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:27618,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:27618,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,chalcone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0060428,lung epithelium development,pulmonary epithelium development,The biological process whose specific outcome is the progression of the lung epithelium from an initial condition to its mature state. This process begins with the formation of lung epithelium and ends with the mature structure. The lung epithelium is the specialized epithelium that lines the inside of the lung.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,The biological process whose specific outcome is the progression of the lung epithelium from an initial condition to its mature state. This process begins with the formation of lung epithelium and ends with the mature structure. The lung epithelium is the specialized epithelium that lines the inside of the lung.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pulmonary epithelium development,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0060428,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/|https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,GO:0060428,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lung epithelium development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_40674,Mammalia,mammals|mammals,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_7742,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mammals,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_class,mammals,,,,,,NCBITaxon:40674,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_7742,,,,,,,,,,,,,,,,"Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.",,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Mammalia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019028,viral capsid,,"The protein coat that surrounds the infective nucleic acid in some virus particles. It comprises numerous regularly arranged subunits, or capsomeres.",false,,,http://purl.obolibrary.org/obo/GO_0044423,,,,,,,,,,,,,,,,,,,,Wikipedia:Capsid,"The protein coat that surrounds the infective nucleic acid in some virus particles. It comprises numerous regularly arranged subunits, or capsomeres.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046728,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044423,,,,GO:0019028,,,,,,,,true,,true,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,GO:0019028,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,viral capsid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_10533,viral pneumonia,,"A pneumonia described as an inflammatory illness of the lung commonly caused by viruses such as influenza virus, parainfluenza, adenovirus, rhinovirus, herpes simplex virus, respiratory syncytial virus, hantavirus, and cytomegalovirus.",false,,,http://purl.obolibrary.org/obo/DOID_552,,,,,,,,,,,,,,,,,,,,ICD10CM:J12.9|ICD9CM:480|MESH:D011024|UMLS_CUI:C0032310|SNOMEDCT_US_2019_09_01:75570004,"A pneumonia described as an inflammatory illness of the lung commonly caused by viruses such as influenza virus, parainfluenza, adenovirus, rhinovirus, herpes simplex virus, respiratory syncytial virus, hantavirus, and cytomegalovirus.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:13167,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_552,,,,DOID:10533,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,DOID:10533,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,viral pneumonia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_68595,telaprevir,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide|VX 950|Incivek|VX-950|(1S,3aR,6aS)-(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide","An oligopeptide consisting of N-(pyrazin-2-ylcarbonyl)cyclohexylalanyl, 3-methylvalyl, octahydrocyclopenta[c]pyrrole-1-carboxy, and 3-amino-N-cyclopropyl-2-oxohexanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22471376|PMID:22222799|PMID:22212567|PMID:20945948|Reaxys:10511882|PMID:22954756|PMID:23016967|PMID:22169996|Patent:US2005197301|PMID:22423262|PMID:22345334|Drug_Central:4173|PMID:22889114|CAS:402957-28-2|Wikipedia:Telaprevir|PMID:21940388|PMID:22383557|HMDB:HMDB0015616|PMID:22902721|PMID:22239508|PMID:22515133|Patent:US2006281688|PMID:22404758|PMID:22806681|PMID:25017682|PMID:22537438|Patent:WO2006127289|PMID:22642697|Patent:WO2005025517|PMID:22439668|PMID:22506260|PMID:21884670|PMID:22039291|Patent:US2006276407|PMID:22095516|Patent:WO2011103932|Patent:US2006252698|KEGG:D09012|PMID:22180548|PMID:22511937|Patent:US2007087973|Patent:US2006276405,"An oligopeptide consisting of N-(pyrazin-2-ylcarbonyl)cyclohexylalanyl, 3-methylvalyl, octahydrocyclopenta[c]pyrrole-1-carboxy, and 3-amino-N-cyclopropyl-2-oxohexanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide",,,,,chebi_ontology,,"VX 950|Incivek|VX-950|(1S,3aR,6aS)-(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide",,,,,,,,,0,C36H53N7O6,"InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1",BBAWEDCPNXPBQM-GDEBMMAJSA-N,679.84930,679.40573,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:68595,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:68595,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,telaprevir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1990752,microtubule end,,"Any end of a microtubule. Microtubule ends differ in that the so-called microtubule plus-end is the one that preferentially grows by polymerization, with respect to the minus-end.|This term should be used when it is not possible to distinguish between the two microtubule ends, e.g. during image annotation. Whenever possible, please annotate to one of the more specific children GO:0035371 'microtubule plus-end' or GO:0036449 'microtubule minus-end'.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,pr,2015-05-25T12:50:31Z,,,,"Any end of a microtubule. Microtubule ends differ in that the so-called microtubule plus-end is the one that preferentially grows by polymerization, with respect to the minus-end.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"This term should be used when it is not possible to distinguish between the two microtubule ends, e.g. during image annotation. Whenever possible, please annotate to one of the more specific children GO:0035371 'microtubule plus-end' or GO:0036449 'microtubule minus-end'.",,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:1990752,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1990752,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,microtubule end,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0010987,Abnormal cellular immune system morphology,,An abnormality of the morphology or counts of the cells that make up the immune system.,false,,,http://purl.obolibrary.org/obo/HP_0032251,,,,,,,,,,,,,,,,peter,2011-02-08T12:49:47Z,,,UMLS:C4023612,An abnormality of the morphology or counts of the cells that make up the immune system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0032251,,,,HP:0010987,,,,,,,,,,,,,,,HP:0010987,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal cellular immune system morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1415834,Bat SARS-like coronavirus Rs3367,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1415834,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS-like coronavirus Rs3367,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019013,viral nucleocapsid,core|nucleocapsid,The complete protein-nucleic acid complex that is the packaged form of the genome in a virus particle.,false,,,http://purl.obolibrary.org/obo/GO_0044423,,,,,,,,,,,,,,,,,,,,,The complete protein-nucleic acid complex that is the packaged form of the genome in a virus particle.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019014,core,,,nucleocapsid,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044423,,,,GO:0019013,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32218151,,,,GO:0019013,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,viral nucleocapsid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_260743,SARS coronavirus NS-1,SARS coronavirus strain NS-1,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus strain NS-1,,,,,,NCBITaxon:260743,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus NS-1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0036498,IRE1-mediated unfolded protein response,IRE1 signal transduction pathway|endoplasmic reticulum unfolded protein response; IRE1 signaling|IRE1 branch of UPR|UPR signaling by IRE1 stress sensor|IRE1p unfolded protein response|IRE1alpha unfolded protein response|IRE1 signaling in response to endoplasmic reticulum stress|inositol-requiring enzyme 1-mediated unfolded protein response|inositol-requiring transmembrane kinase/endonuclease signal transduction|ERN1-mediated unfolded protein response,"A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB.|Consider also annotating to 'eiF2alpha phosphorylation in response to endoplasmic reticulum stress ; GO:0036492' or its descendants.",false,,,http://purl.obolibrary.org/obo/GO_0030968,,,,,,,,,,,,,,,,rebeccafoulger,2015-02-05T13:12:12Z,,,,"A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB.",,,,,,,,,,,,,,,,,,,,,,,,,,,,IRE1 signal transduction pathway,,,endoplasmic reticulum unfolded protein response; IRE1 signaling|IRE1 branch of UPR|UPR signaling by IRE1 stress sensor,,,IRE1p unfolded protein response|IRE1alpha unfolded protein response,,biological_process,,IRE1 signaling in response to endoplasmic reticulum stress|inositol-requiring enzyme 1-mediated unfolded protein response|inositol-requiring transmembrane kinase/endonuclease signal transduction|ERN1-mediated unfolded protein response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Consider also annotating to 'eiF2alpha phosphorylation in response to endoplasmic reticulum stress ; GO:0036492' or its descendants.,,http://purl.obolibrary.org/obo/GO_0030968,,,,GO:0036498,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0036498,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,IRE1-mediated unfolded protein response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10515,Human adenovirus 2,Adenovirus 2|Adenovirus type 2|Human adenovirus type 2|adenovirus-2|Human mastadenovirus 2|Mastadenovirus h2|Human adenovirus C2|Mastadenovirus 2,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_129951,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Adenovirus 2|Adenovirus type 2|Human adenovirus type 2|adenovirus-2|Human mastadenovirus 2|Mastadenovirus h2|Human adenovirus C2|Mastadenovirus 2,,,,,,NCBITaxon:10515,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_129951,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human adenovirus 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003281,Increased serum ferritin,Increased serum ferritin level|Hyperferritinaemia|Hyperferritinemia|Increased plasma ferritin|Elevated serum ferritin|Increased ferritin|High ferritin level,"Abnormal raised concentration of ferritin, a ubiquitous intracellular protein that stores iron, in the blood.|Ferritin levels measured in serum usually have a direct correlation with the total amount of iron stored in the body, but ferritin levels may also be increased with anemia of chronic disease or in the course of an acute phase reaction.",false,,,http://purl.obolibrary.org/obo/HP_0040133,,,,,,,,,,,,,,,,,,,,UMLS:C0743912|UMLS:C0241013|UMLS:C3854388,"Abnormal raised concentration of ferritin, a ubiquitous intracellular protein that stores iron, in the blood.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Increased serum ferritin level|Hyperferritinaemia|Hyperferritinemia|Increased plasma ferritin|Elevated serum ferritin|Increased ferritin|High ferritin level,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Ferritin levels measured in serum usually have a direct correlation with the total amount of iron stored in the body, but ferritin levels may also be increased with anemia of chronic disease or in the course of an acute phase reaction.",,http://purl.obolibrary.org/obo/HP_0040133,,,,HP:0003281,,,,,,,,,,,,,,,HP:0003281,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Increased serum ferritin,,,,,,,,,,,,,,,,,,,,,,https://www.researchsquare.com/article/rs-18079/v1,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000070,"4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione'",,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione' is also known as TDZD-8 , it is a thiadiazolidinone (TDZD) analogue that acts as a highly selective, non-ATP competitive inhibitor of GSK-3ß",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,,,,,,,,,,,,,,"4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione'",,,,,,,,,,,,,,,,,,,,,,https://www.trc-canada.com/product-detail/?B285725,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0060072,benign neoplasm,,A disease of cellular proliferation that results in abnormal growths in the body which lack the ability to metastasize.,false,,,http://purl.obolibrary.org/obo/DOID_14566,,,,,,,,,,,,,,,,lschriml,2011-05-11T12:18:41Z,,,,A disease of cellular proliferation that results in abnormal growths in the body which lack the ability to metastasize.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_14566,,,,DOID:0060072,,,,,,,,,,,,,,,DOID:0060072,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,benign neoplasm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay","mRNA breakdown, nonsense-mediated decay|nuclear mRNA catabolic process, nonsense-mediated decay|mRNA degradation, nonsense-mediated decay|mRNA catabolic process, nonsense-mediated|nonsense-mediated mRNA decay|mRNA catabolism, nonsense-mediated","The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.",false,,,http://purl.obolibrary.org/obo/GO_0000956,,,,,,,,,,,,,,,,,,,,Wikipedia:Nonsense-mediated_mRNA_decay|Wikipedia:Nonsense-mediated_decay,"The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"mRNA breakdown, nonsense-mediated decay|nuclear mRNA catabolic process, nonsense-mediated decay|mRNA degradation, nonsense-mediated decay|mRNA catabolic process, nonsense-mediated|nonsense-mediated mRNA decay|mRNA catabolism, nonsense-mediated",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000956,,,,GO:0000184,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000184,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006760,folic acid-containing compound metabolic process,folic acid-containing compound metabolism|vitamin M and derivative metabolic process|folic acid and derivative metabolism|vitamin B9 and derivative metabolism|vitamin M and derivative metabolism|folate and derivative metabolic process|folate-containing compound metabolism|folate-containing compound metabolic process|vitamin B9 and derivative metabolic process|folic acid and derivative metabolic process|folate and derivative metabolism,"The chemical reactions and pathways involving a folic acid-containing compound, i.e. any of a group of heterocyclic compounds based on the pteroic acid skeleton conjugated with one or more L-glutamic acid or L-glutamate units.",false,,,http://purl.obolibrary.org/obo/GO_0006732|http://purl.obolibrary.org/obo/GO_0042558,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a folic acid-containing compound, i.e. any of a group of heterocyclic compounds based on the pteroic acid skeleton conjugated with one or more L-glutamic acid or L-glutamate units.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,folic acid-containing compound metabolism|vitamin M and derivative metabolic process|folic acid and derivative metabolism|vitamin B9 and derivative metabolism|vitamin M and derivative metabolism|folate and derivative metabolic process|folate-containing compound metabolism|folate-containing compound metabolic process|vitamin B9 and derivative metabolic process|folic acid and derivative metabolic process|folate and derivative metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006732|http://purl.obolibrary.org/obo/GO_0042558,,,,GO:0006760,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006760,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,folic acid-containing compound metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249082,SARS coronavirus ZS-A,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249082,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ZS-A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050000,chromosome localization,chromosome localisation|establishment and maintenance of chromosome localization|establishment and maintenance of chromosome position,"Any process in which a chromosome is transported to, or maintained in, a specific location.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"Any process in which a chromosome is transported to, or maintained in, a specific location.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chromosome localisation|establishment and maintenance of chromosome localization|establishment and maintenance of chromosome position,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0050000,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050000,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,chromosome localization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035904,aorta development,,"The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,rfoulger,2011-06-24T11:00:07Z,,,,"The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0035904,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035904,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,aorta development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002715,Abnormality of the immune system,Immunological abnormality|Abnormality of the immune system,"An abnormality of the immune system.|The immune system is composed of organs and interdependent cell types that collectively protect the body from infections and from the growth of tumor cells. The organs of the immune system comprise the bone marrow, the spleen, the thymus,the lymph nodes, and the cell types comprise B cells, T cells, natural killer cells, granulocytes,dendritic cells, and macrophages.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,UMLS:C4021753,An abnormality of the immune system.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0010986|HP:0003257|HP:0003346,,,,Immunological abnormality|Abnormality of the immune system,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The immune system is composed of organs and interdependent cell types that collectively protect the body from infections and from the growth of tumor cells. The organs of the immune system comprise the bone marrow, the spleen, the thymus,the lymph nodes, and the cell types comprise B cells, T cells, natural killer cells, granulocytes,dendritic cells, and macrophages.",,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0002715,,,,,,,,,,,,,,,HP:0002715,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the immune system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_5835,hypericin,"Hypericin|1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione|hypericum red|Hyperizin|1:6:8:10:11:13-hexahydroxy-3:4-dimethyl-meso-naphthodianthrene-7:14-dione|hipericina|hypericine",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Beilstein:1917913|CAS:548-04-9|Gmelin:926160|KEGG:C07606|LINCS:LSM-2650|LIPID_MAPS_instance:LMPK13040001|KNApSAcK:C00002829|Patent:US2707704,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Hypericin|1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione",,,,,chebi_ontology,,hypericum red|Hyperizin|1:6:8:10:11:13-hexahydroxy-3:4-dimethyl-meso-naphthodianthrene-7:14-dione|hipericina|hypericine,,,,,,,,,0,C30H16O8,"InChI=1S/C30H16O8/c1-7-3-9(31)19-23-15(7)16-8(2)4-10(32)20-24(16)28-26-18(12(34)6-14(36)22(26)30(20)38)17-11(33)5-13(35)21(29(19)37)25(17)27(23)28/h3-6,31-36H,1-2H3",BTXNYTINYBABQR-UHFFFAOYSA-N,504.44324,504.08452,Cc1cc(O)c2c3c1c1c(C)cc(O)c4c1c1c5c(c(O)cc(O)c5c4=O)c4c(O)cc(O)c(c4c31)c2=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:5835,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:5835,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,hypericin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0002268,olfactory organ,olfactory sense organ|olfactory sensory organ|olfactory organ|primary olfactory organ|main olfactory organ|organ olfactus|organum olfactorium|olfactory neuroepithelium,An organ that houses olfactory neurons and is responsible for the sense of smell. Examples include the vertebrate nose and the Drosophila dorsal organ.,false,,,http://purl.obolibrary.org/obo/UBERON_0000020,,,,,,,,,,,,,,,,,,,,VHOG:0000287|BTO:0001772|FMA:77659|AAO:0010180|XAO:0000273|FBbt:00005158,An organ that houses olfactory neurons and is responsible for the sense of smell. Examples include the vertebrate nose and the Drosophila dorsal organ.,,,,,,,,"An olfactory organ overlaps with the olfactory system, because some parts of the nose (e.g. nasal skeleton) are parts of the skeletal system, which is spatially disjoint",,,,,,,"fma general anatomical term. xao has no subtypes (but Johnstons organ develops from this). An olfactory organ overlaps with the olfactory system, because some parts of the nose (e.g. nasal skeleton) are parts of the skeletal system, which is spatially disjoint",,,,,,,,,,,,,,,,olfactory sense organ|olfactory sensory organ|olfactory organ,,,primary olfactory organ|main olfactory organ,,uberon,,organ olfactus|organum olfactorium|olfactory neuroepithelium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000020,,,,UBERON:0002268,,,,,,,,,,,,,,,UBERON:0002268,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#functional_classification,,,,,,,,,,olfactory organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_41977,daunorubicin,"(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Daunorubicin|daunorubicinum|(+)-daunomycin|DAUNOMYCIN|Daunomycin|acetyladriamycin|leukaemomycin C|(8S-cis)-8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|daunorubicin",A natural product found in Actinomadura roseola.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:786|Reaxys:1445583|PMID:24396448|PMID:10820108|PMID:23414337|LINCS:LSM-2962|LIPID_MAPS_instance:LMPK13050002|CAS:20830-81-3|Beilstein:1445583|PMID:23900905|KEGG:D07776|KEGG:C01907|Wikipedia:Daunorubicin|PDBeChem:DM1|DrugBank:DB00694,A natural product found in Actinomadura roseola.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:41970|CHEBI:65723|CHEBI:4330|CHEBI:23560,,,,"(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Daunorubicin",,,,,chebi_ontology,,"daunorubicinum|(+)-daunomycin|DAUNOMYCIN|Daunomycin|acetyladriamycin|leukaemomycin C|(8S-cis)-8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|daunorubicin",,,,,,,,,0,C27H29NO10,"InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1",STQGQHZAVUOBTE-VGBVRHCVSA-N,527.51990,527.17915,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:41977,,,,,,true,,,,,,,,,CHEBI:41977,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,daunorubicin,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039524,suppression by virus of host mRNA processing,negative regulation by virus of host mRNA processing|inhibition of host mRNA processing by virus|inhibition of host pre-mRNA processing by virus|inhibition by virus of host mRNA processing,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of mRNA processing in the host cell. mRNA processing is the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.",false,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2011-06-22T04:51:55Z,,,VZ:903,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of mRNA processing in the host cell. mRNA processing is the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,negative regulation by virus of host mRNA processing,,,inhibition of host mRNA processing by virus|inhibition of host pre-mRNA processing by virus|inhibition by virus of host mRNA processing,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039524,,,,,,true,,,,true,,,,,GO:0039524,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host mRNA processing,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000036,sneezing by symptomatic patient,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,behaviour process,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32105090,Sneezing by symptomatic patients.,,,,,,,,,,,,,,,,sneezing by symptomatic patient,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IAO_0000104,plan specification,,"a directive information entity that when concretized it is realized in a process in which the bearer tries to achieve the objectives, in part by taking the actions specified. Plan specifications includes parts such as objective specification, action specifications and conditional specifications.|A directive information entity with action specifications and objective specifications as parts that, when concretized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified.|2/3/2009 Comment from OBI review.

Action specification not well enough specified.
Conditional specification not well enough specified.
Question whether all plan specifications have objective specifications.

Request that IAO either clarify these or change definitions not to use them|2/3/2009 Comment from OBI review.
 
 Action specification not well enough specified.
 Conditional specification not well enough specified.
 Question whether all plan specifications have objective specifications.
 
 Request that IAO either clarify these or change definitions not to use them",false,,,http://purl.obolibrary.org/obo/IAO_0000033,,,,,,,,,,,,,,,,,,,,,"a directive information entity that when concretized it is realized in a process in which the bearer tries to achieve the objectives, in part by taking the actions specified. Plan specifications includes parts such as objective specification, action specifications and conditional specifications.|A directive information entity with action specifications and objective specifications as parts that, when concretized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified.",,OBI Plan and Planned Process branch|OBI_0000344,,,,,,"Alternative previous definition: a plan is a set of instructions that specify how an objective should be achieved|2014-03-31: A plan specification can have other parts, such as conditional specifications.|2009-03-16: provenance: a term a plan was proposed for OBI (OBI_0000344) , edited by the PlanAndPlannedProcess branch. Original definition was "" a plan is a specification of a process that is realized by an actor to achieve the objective specified as part of the plan"". It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.",plan specification,,,,PMID: 18323827.Nat Med. 2008 Mar;14(3):226.New plan proposed to help resolve conflicting medical advice.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122|http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,IAO:0000104,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"2/3/2009 Comment from OBI review.

Action specification not well enough specified.
Conditional specification not well enough specified.
Question whether all plan specifications have objective specifications.

Request that IAO either clarify these or change definitions not to use them|2/3/2009 Comment from OBI review.
 
 Action specification not well enough specified.
 Conditional specification not well enough specified.
 Question whether all plan specifications have objective specifications.
 
 Request that IAO either clarify these or change definitions not to use them",,http://purl.obolibrary.org/obo/IAO_0000033,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,plan specification,,,,,,,,,,,,,,,,,,,,,,,,,,,,Alan Ruttenberg,,,,
http://purl.obolibrary.org/obo/GO_0002495,antigen processing and presentation of peptide antigen via MHC class II,peptide antigen processing and presentation via MHC class II,"The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.",false,,,http://purl.obolibrary.org/obo/GO_0002504,,,,,,,,,,,,,,,,,,,,,"The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,peptide antigen processing and presentation via MHC class II,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002504,,,,GO:0002495,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002495,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antigen processing and presentation of peptide antigen via MHC class II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0040089,Abnormal natural killer cell count,Abnormal number of natural killer cells|Abnormality of natural killer cell count|Abnormal natural killer cell count|Abnormal NK cell count,"Any deviation from the normal overall count of natural killer (NK) cells in the circulation or a deviation from the normal distribution of NK cell subtypes.|In human peripheral blood, five NK cell subpopulations can be defined on the basis of the relative expression of the markers CD16 and CD56: (1) CD56bright CD16- (50-70% of CD56bright), (2) CD56bright CD16dim (30-50% of CD56bright), (3) CD56dim CD16-, (4) CD56dim CD16bright, and (5) CD56- CD16bright. In healthy individuals, populations (3) and (5) are numerically in the minority.",false,,,http://purl.obolibrary.org/obo/HP_0012176,,,,,,,,,,,,,,,,HPO:skoehler,,,,UMLS:C4021036,Any deviation from the normal overall count of natural killer (NK) cells in the circulation or a deviation from the normal distribution of NK cell subtypes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal number of natural killer cells|Abnormality of natural killer cell count|Abnormal natural killer cell count|Abnormal NK cell count,,,,,,,,,,,,,HP:0040089,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"In human peripheral blood, five NK cell subpopulations can be defined on the basis of the relative expression of the markers CD16 and CD56: (1) CD56bright CD16- (50-70% of CD56bright), (2) CD56bright CD16dim (30-50% of CD56bright), (3) CD56dim CD16-, (4) CD56dim CD16bright, and (5) CD56- CD16bright. In healthy individuals, populations (3) and (5) are numerically in the minority.",,http://purl.obolibrary.org/obo/HP_0012176,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal natural killer cell count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0097525,spliceosomal snRNP complex,,A ribonucleoprotein complex involved in formation of the spliceosome and composed of one or more snRNA and multiple protein components.,false,,,http://purl.obolibrary.org/obo/GO_0030532,,,,,,,,,,,,,,,,paola,2013-10-18T15:57:45Z,,,,A ribonucleoprotein complex involved in formation of the spliceosome and composed of one or more snRNA and multiple protein components.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030532,,,,GO:0097525,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0097525,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spliceosomal snRNP complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044831,modulation by virus of host cytokine production,,"Any process in which a virus modulates the frequency, rate or extent of cytokine production in its host organism.",false,,,http://purl.obolibrary.org/obo/GO_0075528,,,,,,,,,,,,,,,,janelomax,2014-02-06T12:49:02Z,,,,"Any process in which a virus modulates the frequency, rate or extent of cytokine production in its host organism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0075528,,,,GO:0044831,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165108/,,,,GO:0044831,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host cytokine production,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0014069,postsynaptic density,neuronal postsynaptic density|post synaptic density|post-synaptic density|postsynaptic density of dendrite,"An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.",false,,,http://purl.obolibrary.org/obo/GO_0099572,,,,,,,,,,,,,,,,paola,2013-07-02T09:44:28Z,,,NIF_Subcellular:sao1196688972|Wikipedia:Postsynaptic_density,"An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0097481|GO:0097483,,,,neuronal postsynaptic density|post synaptic density|post-synaptic density,,,postsynaptic density of dendrite,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0099572,,,,GO:0014069,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0014069,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_synapse,,,,,,,,,,postsynaptic density,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_552,pneumonia,acute pneumonia,"A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation). It results from a variety of causes including infection with bacteria, viruses, fungi or parasites, and chemical or physical injury to the lungs. It is accompanied by fever, chills, cough, and difficulty in breathing.",false,,,http://purl.obolibrary.org/obo/DOID_850,,,,,,,,,,,,,,,,,,,,NCI:C3333|SNOMEDCT_US_2019_09_01:233604007|MESH:D011014|UMLS_CUI:C0032285,"A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation). It results from a variety of causes including infection with bacteria, viruses, fungi or parasites, and chemical or physical injury to the lungs. It is accompanied by fever, chills, cough, and difficulty in breathing.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:11742|DOID:5871|DOID:10509,,,,acute pneumonia,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_850,,,,DOID:552,,,,,,,,,,,,,,,DOID:552,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,pneumonia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000462,symptom,,"A symptom is a perceived change in function, sensation, loss, disturbance or appearance reported by a patient indicative of a disease.",false,,,http://purl.obolibrary.org/obo/BFO_0000017,,,,,,,,,,,,,,,,,,,,SyOID:14974,"A symptom is a perceived change in function, sensation, loss, disturbance or appearance reported by a patient indicative of a disease.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000017,,,,SYMP:0000462,,,,,,,,,,,,,,,SYMP:0000462,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,symptom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IAO_0000027,data item,,"a data item is an information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements.",false,,,http://purl.obolibrary.org/obo/IAO_0000030,,,data,,,,,,,,,,,,,,,,,,"a data item is an information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements.",,,,,,,,"2009-03-16: removed datum as alternative term as datum specifically refers to singular form, and is thus not an exact synonym.|2014-03-31: See discussion at http://odontomachus.wordpress.com/2014/03/30/aboutness-objects-propositions/|2/2/2009 Alan and Bjoern discussing FACS run output data. This is a data item because it is about the cell population. Each element records an event and is typically further composed a set of measurment data items that record the fluorescent intensity stimulated by one of the lasers.|2009-03-16: removed datum as alternative term as datum specifically refers to singular form, and is thus not an exact synonym.|2009-03-16: data item deliberatly ambiguous: we merged data set and datum to be one entity, not knowing how to define singular versus plural. So data item is more general than datum.|JAR: datum     -- well, this will be very tricky to define, but maybe some 
information-like stuff that might be put into a computer and that is 
meant, by someone, to denote and/or to be interpreted by some 
process... I would include lists, tables, sentences... I think I might 
defer to Barry, or to Brian Cantwell Smith

JAR: A data item is an approximately justified approximately true approximate belief|2009-03-16: data item deliberatly ambiguous: we merged data set and datum to be one entity, not knowing how to define singular versus plural. So data item is more general than datum.",data item|data item,,,,"Data items include counts of things, analyte concentrations, and statistical summaries.",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000125,,,,,,,,,,,,,,,,,,,,IAO:0000027,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000030,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl|http://purl.obolibrary.org/obo/apollo_sv.owl|http://purl.obolibrary.org/obo/iao.owl,,,,,,,,,,,data item,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Jonathan Rees|PERSON: Chris Stoeckert|PERSON: Alan Ruttenberg|PERSON: Jonathan Rees|PERSON: Chris Stoeckert|PERSON: Alan Ruttenberg,,,,
http://purl.obolibrary.org/obo/NCIT_C35549,Hypoxic Ischemic Encephalopathy,Hypoxic Ischemic Encephalopathy|HIE|Anoxic encephalopathy,"Ischemic brain damage in which the entire brain is deprived of oxygen. It may be fatal or lead to long term disabilities including developmental delays, intellectual disability, and seizures.",false,,,http://purl.obolibrary.org/obo/DOID_936,,Injury to the central nervous system that occurs when there is insufficient delivery of oxygen to all or part of the brain.,,,,,,,,,C35549,,,NICHD,,,,,,,"Ischemic brain damage in which the entire brain is deprived of oxygen. It may be fatal or lead to long term disabilities including developmental delays, intellectual disability, and seizures.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Hypoxic Ischemic Encephalopathy|HIE|Anoxic encephalopathy,,,,http://purl.obolibrary.org/obo/NCIT_C26920,,,,,,,,,NCIT:C35549,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_936,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,hypoxic encephalopathy,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118466|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99147,,,,,,,,,,Hypoxic Ischemic Encephalopathy,Hypoxic_Encephalopathy,,,,,,,Hypoxic Ischemic Encephalopathy,,,,,,,,,,,Hypoxic Ischemic Encephalopathy,,,,Disease or Syndrome,,,,,,,,C0752304,
http://purl.obolibrary.org/obo/PR_000050275,non-structural protein 6 (SARS-CoV-2),"PRO_0000449640|rep/Clv:nsp6 (SARS2)|PRO_0000449624|UniProtKB:P0DTD1, 3570-3859|UniProtKB:P0DTC1, 3570-3859|nsp6 (SARS2)",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3569-3570 and 3859-3860.|Category=organism-modification. Note: 290 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725302,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3569-3570 and 3859-3860.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"PRO_0000449640|rep/Clv:nsp6 (SARS2)|PRO_0000449624|UniProtKB:P0DTD1, 3570-3859|UniProtKB:P0DTC1, 3570-3859|nsp6 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 290 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050275,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32292901,,,,PR:000050275,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 6 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_3640,chlorothiazide,"Chlorothiazide|6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|clorotiazida|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|chlorothiazidum|chlorothiazide","4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:29438107|KEGG:C07461|Wikipedia:Chlorothiazide|DrugBank:DB00880|PMID:3712385|PMID:28166217|CAS:58-94-6|PMID:2160536|Drug_Central:609|KEGG:D00519|Patent:US2809194|PMID:10891117|Beilstein:1084805|LINCS:LSM-5942,"4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:162615,,,,"Chlorothiazide|6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",,,,,chebi_ontology,,"6-chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|clorotiazida|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|chlorothiazidum|chlorothiazide",,,,,,,,,0,C7H6ClN3O4S2,"InChI=1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13)",JBMKAUGHUNFTOL-UHFFFAOYSA-N,295.72300,294.94883,NS(=O)(=O)c1cc2c(NC=NS2(=O)=O)cc1Cl,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:3640,,,,,true,true,,,,,,,,,CHEBI:3640,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,chlorothiazide,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003001,GZMA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CTLA3|HFSP,,,,,,,5,,,,,,,,,,Vega:OTTHUMG00000097011|MIM:140050|HGNC:4708|HPRD:00771|Ensembl:ENSG00000145649,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)",,5q11-q12,,,,"GO_0001772 (EC: TAS, PMID: 12524539); GO_0004252 (EC: IDA, PMID: 11331782); GO_0005515 (EC: IPI, PMID: 12524539); GO_0005576 (EC: IEA); GO_0005634 (EC: TAS, PMID: 11909973); GO_0006915 (EC: TAS, PMID: 12524539); GO_0006955 (EC: TAS, PMID: 12524539); GO_0019835 (EC: IEA); GO_0032078 (EC: IDA, PMID: 12524539); GO_0042803 (EC: IDA, PMID: 12819770); GO_0043065 (EC: IDA, PMID: 12524539); GO_0043392 (EC: IDA, PMID: 12524539); GO_0051354 (EC: IDA, PMID: 12524539); GO_0051603 (EC: IDA, PMID: 12524539)",PMID: 1860869; 3047119; 3237717; 3257574; 3262682; 3263427; 3533635; 7751653; 7912927; 8288245; 9256474; 9531325; 11060286; 11331782; 11555662; 11909973; 12477932; 12524539; 12555094; 12721789; 12819769; 12819770; 15238416; 15342556; 15489334; 15911377; 15998831; 16440001; 17008916; 17116752; 17138956; 17308307; 17703412; 18317234; 18485875; 18776661; 18951048; 19014932; 19059912; 19258923; 19343046; 19506301; 19875524; 20503287; 20536382; 21068403; 21349256; 21709155; 22476618,,,,,,,,,,,,,,,,,,OGG:3000003001,,,,,,,,,,,,,,,,,,,"granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GZMA,,,20140408,3001,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,GZMA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0009201,ribonucleoside triphosphate biosynthetic process,ribonucleoside triphosphate formation|ribonucleoside triphosphate synthesis|ribonucleoside triphosphate anabolism|ribonucleoside triphosphate biosynthesis,"The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009199|http://purl.obolibrary.org/obo/GO_0009142,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribonucleoside triphosphate formation|ribonucleoside triphosphate synthesis|ribonucleoside triphosphate anabolism|ribonucleoside triphosphate biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009199|http://purl.obolibrary.org/obo/GO_0009142,,,,GO:0009201,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009201,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribonucleoside triphosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_5362,focal epithelial hyperplasia,Heck's disease|Heck disease|Multifocal epithelial hyperplasia,"A viral infectious disease that results_in infection located_in mouth, has_material_basis_in human papillomavirus (types 13 or 32), has_symptom papules or nodules in the oral cavity.|OMIM mapping confirmed by DO. [SN].",false,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,,,,,,,,,NCI:C97083|OMIM:229045|UMLS_CUI:C0206067|SNOMEDCT_US_2019_09_01:36949004|MESH:D017573,"A viral infectious disease that results_in infection located_in mouth, has_material_basis_in human papillomavirus (types 13 or 32), has_symptom papules or nodules in the oral cavity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Heck's disease|Heck disease|Multifocal epithelial hyperplasia,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,OMIM mapping confirmed by DO. [SN].,,http://purl.obolibrary.org/obo/DOID_934,,,,DOID:5362,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,DOID:5362,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,focal epithelial hyperplasia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010008,endosome membrane,endosomal membrane,The lipid bilayer surrounding an endosome.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao978443756,The lipid bilayer surrounding an endosome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,endosomal membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0010008,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010008,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endosome membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_18208,benzylpenicillin,"Benzylpenicillin|2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic acid|PCG|PG|(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|benzylpenicillinum|benzyl benicillin|benzylpenicillinic acid|bensylpenicillin|benzylpenicilline|6-(2-phenylacetamido)penicillanic acid|PENICILLIN G|free penicillin II|bencilpenicilina|Penicillin G|benzylpenicillin",A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:16033609|PMID:29355985|DrugBank:DB01053|PMID:6161899|PMID:1709917|Gmelin:781913|PMID:29017833|PMID:11906332|HMDB:HMDB0015186|PMID:27731424|PMID:10930630|Patent:US3024169|KEGG:C05551|PMID:12850488|PMID:24631718|PMID:2083978|PMID:25998949|Drug_Central:2082|PMID:7602118|PMID:1384868|KEGG:D02336|PMID:24485692|PMID:7716788|CAS:61-33-6|Wikipedia:Benzylpenicillin|Beilstein:44740|Reaxys:44740|LINCS:LSM-3229|PDBeChem:PNN|PMID:12569987|PMID:11431418,A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:45073|CHEBI:25866|CHEBI:7962|CHEBI:14743,,,,"Benzylpenicillin|2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic acid",,,,,chebi_ontology,,"PCG|PG|(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|benzylpenicillinum|benzyl benicillin|benzylpenicillinic acid|bensylpenicillin|benzylpenicilline|6-(2-phenylacetamido)penicillanic acid|PENICILLIN G|free penicillin II|bencilpenicilina|Penicillin G|benzylpenicillin",,,,,,,,,0,C16H18N2O4S,"InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",JGSARLDLIJGVTE-MBNYWOFBSA-N,334.392,334.09873,N12C([C@H]([C@]1(SC([C@@H]2C(O)=O)(C)C)[H])NC(CC3=CC=CC=C3)=O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:18208,,,,,,true,,,,,,,,,CHEBI:18208,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,benzylpenicillin,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0100806,Sepsis,Infection in blood stream,Systemic inflammatory response to infection.,false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,doelkens,2011-06-09T01:05:51Z,,,MSH:D018805|UMLS:C0036690,Systemic inflammatory response to infection.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Infection in blood stream,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,HP:0100806,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,,,,HP:0100806,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Sepsis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005685,U1 snRNP,snRNP U1,A ribonucleoprotein complex that contains small nuclear RNA U1.,false,,,http://purl.obolibrary.org/obo/GO_0097525,,,,,,,,,,,,,,,,,,,,,A ribonucleoprotein complex that contains small nuclear RNA U1.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,snRNP U1,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0097525,,,,GO:0005685,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005685,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,U1 snRNP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264387,SARS coronavirus TW-PH1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264387,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-PH1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264989,SARS coronavirus cw049,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264989,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus cw049,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6078,ivermectin,Sklice|ivermectin|Vetrimec|ivermectino|ivermectinum|Ivermax|Zimecterin|Stromectol|Ivomec|Mectizan|Privermectin|Noromectin|ivermectine,"A mixture consisting of >= 90% 22,23-dihydroavermectin B1a (R = Me) and <= 10% 22,23-dihydroavermectin B1b (R = H). A semi-synthetic derivative of abamectin, it is used as a broad-spectrum antiparasite medication, particularly against worms (except tapeworms), although it is also effective against most mites and some lice.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D00804|PMID:22039784|Wikipedia:Ivermectin|PMID:21831526|CAS:70288-86-7|HMDB:HMDB0014740|PMID:18718154|PMID:22047763|DrugBank:DB00602|Patent:US4199569|PMID:21824728|PMID:22039801|PMID:15078277,"A mixture consisting of >= 90% 22,23-dihydroavermectin B1a (R = Me) and <= 10% 22,23-dihydroavermectin B1b (R = H). A semi-synthetic derivative of abamectin, it is used as a broad-spectrum antiparasite medication, particularly against worms (except tapeworms), although it is also effective against most mites and some lice.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,Sklice|ivermectin|Vetrimec|ivermectino|ivermectinum|Ivermax|Zimecterin|Stromectol|Ivomec|Mectizan|Privermectin|Noromectin|ivermectine,,,,,,,,,0,C47H71O14R,,,860.060,859.48438,[H][C@@]12CC=C(C)\[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)\C=C\C=C3/CO[C@]4([H])[C@H](O)C(C)=C[C@@]([H])(C(=O)O[C@@H](C1)C[C@]1(CC[C@H](C)[C@]([H])(O1)[C@@H](C)C[*])O2)[C@]34O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6078,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129059/,,,,CHEBI:6078,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ivermectin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1903046,meiotic cell cycle process,,A process that is part of the meiotic cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,jl,2014-05-22T14:22:28Z,,,,A process that is part of the meiotic cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:1903046,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903046,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe|http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_annotate,,,,,,,,,,meiotic cell cycle process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003578,IL9,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL-9|HP40|P40,,,,,,,5,,,,,,,,,,Ensembl:ENSG00000145839|HPRD:00910|HGNC:6029|MIM:146931|Vega:OTTHUMG00000129147,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 9,,5q31.1,,,,"GO_0005125 (EC: IEA); GO_0005140 (EC: IEA); GO_0005615 (EC: IEA); GO_0006954 (EC: TAS, PMID: 9371819); GO_0006955 (EC: IEA); GO_0008083 (EC: IEA); GO_0008284 (EC: TAS, PMID: 1680606); GO_0030307 (EC: IEA); GO_0045407 (EC: ISS)",PMID: 1680606; 1901233; 1903074; 1908723; 1971295; 2129501; 2508790; 7544789; 7666875; 8379467; 8516290; 8756628; 9371819; 10464327; 11115404; 11588013; 11842292; 11937570; 12082592; 12477932; 12482498; 12588703; 12594054; 12646606; 12789235; 14722888; 15007348; 15123239; 15128795; 15289339; 15372022; 15489334; 15621723; 15699153; 15713213; 15735688; 16322282; 16611254; 16763206; 17083349; 17517104; 17541281; 17703412; 18032114; 18298822; 18339896; 18349591; 18633131; 18974840; 19005922; 19028820; 19131662; 19258923; 19263529; 19387455; 19536153; 19559392; 19573080; 19729601; 19773279; 19845895; 19913121; 20020328; 20159257; 20237496; 20306823; 20332709; 20452482; 20498357; 20503287; 20568250; 20595916; 20628086; 20673868; 20674401; 20861646; 21360526; 21371865; 21418620; 21498517; 21765905; 21807780; 21898141; 22612419; 22772464; 22841205; 22841206; 22971662; 23034251; 23376058; 23700286; 24032555; 24216482; 24468256,,,,,,,,,,,,,,,,,,OGG:3000003578,,,,,,,,,,,,,,,,,,,interleukin 9,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL9,,,20140408,3578,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL9,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_231520,SARS coronavirus HKU-65806,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231520,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HKU-65806,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_240549,SARS coronavirus TWH,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:240549,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006986,response to unfolded protein,heat shock protein activity,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.|Note that this term should not be confused with 'unfolded protein response ; GO:0030968', which refers to one specific response to the presence of unfolded proteins in the ER.",false,,,http://purl.obolibrary.org/obo/GO_0035966,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,heat shock protein activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term should not be confused with 'unfolded protein response ; GO:0030968', which refers to one specific response to the presence of unfolded proteins in the ER.",,http://purl.obolibrary.org/obo/GO_0035966,,,,GO:0006986,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006986,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to unfolded protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019867,outer membrane,,The external membrane of Gram-negative bacteria or certain organelles such as mitochondria and chloroplasts; freely permeable to most ions and metabolites.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The external membrane of Gram-negative bacteria or certain organelles such as mitochondria and chloroplasts; freely permeable to most ions and metabolites.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0019867,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019867,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics,,,,,,,,,,outer membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001462,VCAN,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,WGN|ERVR|WGN1|PG-M|CSPG2|GHAP,,,,,,,5,,,,,,,,,,HGNC:2464|Vega:OTTHUMG00000131321|MIM:118661|Ensembl:ENSG00000038427|HPRD:00340,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,versican,,5q14.3,,,,"GO_0005509 (EC: IEA); GO_0005515 (EC: IPI); GO_0005539 (EC: TAS, PMID: 7528742); GO_0005540 (EC: IEA); GO_0005576 (EC: TAS); GO_0005578 (EC: IEA); GO_0005615 (EC: IDA); GO_0005796 (EC: TAS); GO_0005975 (EC: TAS); GO_0007155 (EC: IEA); GO_0007275 (EC: TAS, PMID: 2583089); GO_0007507 (EC: IEA); GO_0008037 (EC: TAS, PMID: 2583089); GO_0008347 (EC: IDA, PMID: 18431253); GO_0030198 (EC: TAS); GO_0030203 (EC: TAS); GO_0030204 (EC: TAS); GO_0030206 (EC: TAS); GO_0030207 (EC: TAS); GO_0030208 (EC: TAS); GO_0030246 (EC: IEA); GO_0031012 (EC: IDA, Qualifier: colocalizes_with); GO_0031012 (EC: ISS, Qualifier: colocalizes_with); GO_0043202 (EC: TAS); GO_0043231 (EC: IDA); GO_0044281 (EC: TAS)",PMID: 1429726; 1478664; 2466833; 2469524; 2583089; 2820964; 7528742; 7566098; 7748141; 7806529; 7876137; 7921538; 8601689; 8627343; 8824283; 9294172; 9848887; 10198161; 10397680; 10400671; 10571340; 10950950; 11038354; 11083865; 11278559; 11566024; 11726670; 11805102; 11839575; 11932252; 12221092; 12438652; 12477932; 12553048; 12888576; 12907688; 12972299; 14558097; 14724283; 15073129; 15142969; 15146197; 15336555; 15342556; 15522894; 15590670; 15599946; 15712181; 15748997; 15871917; 16043844; 16110303; 16311904; 16344560; 16431924; 16493581; 16636652; 16648628; 16839865; 16877430; 16917090; 17065588; 17097211; 17213182; 17363913; 17453002; 17728259; 18431253; 18484070; 18621549; 18704747; 18819099; 19073385; 19160015; 19269971; 19506372; 19655167; 19662655; 19669783; 19700613; 19717812; 19901218; 20053631; 20201926; 20204274; 20301747; 20379614; 20452482; 20489207; 20516156; 20619446; 20673868; 20729814; 21063030; 21078678; 21136024; 21185131; 21185747; 21244575; 21505857; 21546273; 21596823; 21738396; 21791066; 21828051; 21906983; 22096483; 22155153; 22318369; 22360420; 22393310; 22406535; 22493503; 22739342; 22951719; 23002209; 23024773; 23099107; 23180826; 23201264; 23424670; 23568740; 23571384; 23963449; 24174867,,,,,,,,,,,,,,,,,,OGG:3000001462,,,,,,,,,,,,,,,,,,,versican,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,VCAN,,,20140408,1462,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,VCAN,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_243925,SARS coronavirus HPZ-2003,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:243925,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HPZ-2003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_76010,dolutegravir,"(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide|S/GSK1349572","A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid with the amino group of 2,4-difluorobenzylamine. Used (as its sodium salt) for treatment of HIV-1.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23669385|PMID:23942060|PMID:23885999|Wikipedia:Dolutegravir|PMID:24052331|PMID:23845180|PMID:23798668|Reaxys:12732602|Drug_Central:4805|PMID:23306000|PMID:24074642|CAS:1051375-16-6|PMID:23132334|PMID:23830355|PMID:22018760|PMID:23807273|PMID:23075918|PMID:22878423|PMID:23455469|PMID:24096683|PMID:23413040|PMID:23225901|PMID:23824675|PMID:23817375|PMID:23432922|PMID:23295935|PMID:22905856|Patent:EP2602260|KEGG:D10066|PDBeChem:DLU|PMID:22205735|Patent:WO2006116764|PMID:23777012,"A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid with the amino group of 2,4-difluorobenzylamine. Used (as its sodium salt) for treatment of HIV-1.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide",,,,,chebi_ontology,,S/GSK1349572,,,,,,,,,0,C20H19F2N3O5,"InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1",RHWKPHLQXYSBKR-BMIGLBTASA-N,419.37880,419.12928,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:76010,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:76010,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,dolutegravir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0031983,Abnormal pulmonary thoracic imaging finding,Abnormal chest radiograph finding (lung),"This term groups terms representing abnormal findings derived from chest X-ray investigation of the lung. In general, lung abnormalities can manifest as opacities (areas of increased density) or as regions with decreased density.",false,,,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,peter,,,,,"This term groups terms representing abnormal findings derived from chest X-ray investigation of the lung. In general, lung abnormalities can manifest as opacities (areas of increased density) or as regions with decreased density.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal chest radiograph finding (lung),,,,,,,,,,,,,HP:0031983,,,,,,,,,,,,,,,,,,2018-07-08T13:38:01Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal pulmonary thoracic imaging finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IDO_0000520,communicability period,,A continuous temporal interval during which an infectious agent host bears a contagiousness disposition.,false,,,http://purl.obolibrary.org/obo/BFO_0000038,,,,,,,,,,,,,,,,,,,,,A continuous temporal interval during which an infectious agent host bears a contagiousness disposition.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IDO:0000520,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000038,,,,,,,,,,,,,,true,,,incubation period,,,,http://purl.obolibrary.org/obo/ido.owl,,,,,,,,,,,communicability period,,,,,,,,,,,,,,,,,,,,,,https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/assumptions.html,,,,,,Albert Goldfain|Alexander Diehl|Lindsay Cowell,,,,
http://purl.obolibrary.org/obo/IDO_0000531,host,,An organism bearing a host role.,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,An organism bearing a host role.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IDO:0000531,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ido.owl,,,,,,,,,,,host,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain|Alexander Diehl|Lindsay Cowell,,,,
http://purl.obolibrary.org/obo/UBERON_0018229,renin-angiotensin system,renin-angiotensin system|renin angiotensin system|renin angiotensin aldosterone system|renin-angiotensin-aldosterone system,"A system consisting of renin, angiotensin-converting enzyme, and angiotensin II. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming angiotensin I. The converting enzyme contained in the lung acts on angiotensin I in the plasma converting it to angiotensin II, the most powerful directly pressor substance known. It causes contraction of the arteriolar smooth muscle and has other indirect actions mediated through the adrenal cortex.",false,,,http://purl.obolibrary.org/obo/UBERON_0011216,,,,,,,,,,,,,,,,,,,may be replaced by a GO process in future,MESH:G06.535.805|FMA:74787,"A system consisting of renin, angiotensin-converting enzyme, and angiotensin II. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming angiotensin I. The converting enzyme contained in the lung acts on angiotensin I in the plasma converting it to angiotensin II, the most powerful directly pressor substance known. It causes contraction of the arteriolar smooth muscle and has other indirect actions mediated through the adrenal cortex.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,renin-angiotensin system|renin angiotensin system|renin angiotensin aldosterone system|renin-angiotensin-aldosterone system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0011216,,,,UBERON:0018229,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32186952/,,,,UBERON:0018229,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim,,,,,,,,,,renin-angiotensin system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0038093,Fc receptor signaling pathway,Fc receptor signalling pathway,"A series of molecular signals initiated by the binding of the Fc portion of an immunoglobulin to an Fc receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,rfoulger,2012-02-16T05:11:30Z,,,,"A series of molecular signals initiated by the binding of the Fc portion of an immunoglobulin to an Fc receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fc receptor signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_4751,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0038093,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0038093,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,Fc receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043300,regulation of leukocyte degranulation,regulation of immune cell degranulation|regulation of leucocyte degranulation|regulation of immune cell granule exocytosis|regulation of leukocyte granule exocytosis,"Any process that modulates the frequency, rate, or extent of leukocyte degranulation.",false,,,http://purl.obolibrary.org/obo/GO_0002697,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate, or extent of leukocyte degranulation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of immune cell degranulation|regulation of leucocyte degranulation|regulation of immune cell granule exocytosis|regulation of leukocyte granule exocytosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002697,,,,GO:0043300,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043300,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of leukocyte degranulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249084,SARS coronavirus LC2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249084,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus LC2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_114785,erlotinib,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|erlotinib|[6,7-bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|erlotinibum|[6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine",A quinazoline compound having a (3-ethynylphenyl)amino group at the 4-position and two 2-methoxyethoxy groups at the 6- and 7-positions.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:15711537|PMID:17983745|PMID:16480284|PMID:30039303|PMID:14684309|PMID:16014883|PMID:16014882|CAS:183321-74-6|Reaxys:8798958|HMDB:HMDB0014671|PDBeChem:AQ4|PMID:29687154|KEGG:D07907|PMID:30071517|PMID:30158288|Patent:US2010094004|PMID:29448920|PMID:17889528|DrugBank:DB00530|PMID:12270171|PMID:29579331|LINCS:LSM-1097|Drug_Central:1045|PMID:30150014|Wikipedia:Erlotinib,A quinazoline compound having a (3-ethynylphenyl)amino group at the 4-position and two 2-methoxyethoxy groups at the 6- and 7-positions.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:40877,,,,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",,,,,chebi_ontology,,"erlotinib|[6,7-bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|erlotinibum|[6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine",,,,,,,,,0,C22H23N3O4,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",AAKJLRGGTJKAMG-UHFFFAOYSA-N,393.43570,393.16886,COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:114785,,,,,true,true,,,,,,,,,CHEBI:114785,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,erlotinib,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_262338,SARS coronavirus GD03T0013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:262338,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GD03T0013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000145,ORF8a,,,false,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Open Reading Frame 8a in SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,modified definition,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,true,,,,,https://pubmed.ncbi.nlm.nih.gov/32167180/,,,,,,,,,,,,,,,,,ORF8a,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v1,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000528,cardiovascular system symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0159049|UMLS_ICD9CM_2005_AUI:A0284192|SyOID:2147|ICD9CM_2005:785,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms of cardiovascular system developed based on type of heart disease.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000528,,modified definition,,,,,,,,,,,,,SYMP:0000528,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,cardiovascular system symptom,,,,,,,,,,,,,,,,,,,,,,https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000054209,TREM2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TREM-2|Trem2a|Trem2b|Trem2c,,,,,,,6,,,,,,,,,,Vega:OTTHUMG00000014671|MIM:605086|HPRD:05473|HGNC:17761|Ensembl:ENSG00000095970,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,triggering receptor expressed on myeloid cells 2,,6p21.1,,,,"GO_0001530 (EC: IEA); GO_0004872 (EC: TAS, PMID: 10799849); GO_0005576 (EC: IEA); GO_0005886 (EC: TAS); GO_0006959 (EC: TAS, PMID: 10799849); GO_0007411 (EC: TAS); GO_0016021 (EC: IEA); GO_0045087 (EC: TAS)",PMID: 10799849; 12080485; 12477932; 12645956; 12754369; 12913093; 12925681; 15489334; 15966270; 16505336; 16715077; 17530208; 18546367; 18551625; 19019460; 19079182; 19230638; 19457124; 19913121; 20301376; 20421649; 20628086; 20640189; 21834902; 22939635; 23150908; 23150934; 23380991; 23391427; 23407992; 23533697; 23582655; 23721075; 23759145; 23800361; 23855982; 23855984; 23870839; 24078628; 24131187,,,,,,,,,,,,,,,,,,OGG:3000054209,,,,,,,,,,,,,,,,,,,triggering receptor expressed on myeloid cells 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TREM2,,,20140408,54209,RP1-238O23.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,TREM2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0005741,mitochondrial outer membrane,outer mitochondrial membrane,"The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.",false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0031968,,,,,,,,,,,,,,,,,,,,Wikipedia:Outer_mitochondrial_membrane|NIF_Subcellular:sao1289741256,"The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,outer mitochondrial membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0031968,,,,GO:0005741,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005741,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitochondrial outer membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_2666,amitriptyline,"3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine|Amitriptyline|10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene|3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene|10,11-dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-Delta(5),gamma-propylamine|3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d][1,4]cycloheptadiene|5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene|Amitriptylin","An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,DrugBank:DB00321|LINCS:LSM-3190|Patent:WO2011089289|HMDB:HMDB0014466|Wikipedia:Amitriptyline|PMID:24447704|Patent:CN101780063|PMID:18359012|KEGG:D07448|KEGG:C06824|VSDB:2962|Beilstein:2217885|Reaxys:2217885|CAS:50-48-6|Drug_Central:180|PMID:15554244,"An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine|Amitriptyline",,,,,chebi_ontology,,"10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene|3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene|10,11-dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-Delta(5),gamma-propylamine|3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d][1,4]cycloheptadiene|5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene|Amitriptylin",,,,,,,,,0,C20H23N,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",KRMDCWKBEZIMAB-UHFFFAOYSA-N,277.40336,277.18305,CN(C)CCC=C1c2ccccc2CCc2ccccc12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:2666,,,,,true,true,,,,,,,,,CHEBI:2666,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,amitriptyline,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030136,clathrin-coated vesicle,,A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes.,false,,,http://purl.obolibrary.org/obo/GO_0030135,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao148845161,A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030135,,,,GO:0030136,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030136,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,clathrin-coated vesicle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000040,A2a1 haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A2a1 haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,A2a1 haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_50868,penicillamine,"2-amino-3-methyl-3-sulfanylbutanoic acid|3-sulfanylvaline|D,L-penicillamine|(+-)-penicillamine|3,3-dimethylcysteine|beta-mercaptovaline|DL-3-mercaptovaline|DL-beta-mercaptovaline|2-amino-3-mercapto-3-methylbutyric acid",An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Beilstein:1722376|CAS:52-66-4|DrugBank:DB00859,An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2-amino-3-methyl-3-sulfanylbutanoic acid|3-sulfanylvaline,,,,,chebi_ontology,,"D,L-penicillamine|(+-)-penicillamine|3,3-dimethylcysteine|beta-mercaptovaline|DL-3-mercaptovaline|DL-beta-mercaptovaline|2-amino-3-mercapto-3-methylbutyric acid",,,,,,,,,0,C5H11NO2S,"InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)",VVNCNSJFMMFHPL-UHFFFAOYSA-N,149.21238,149.05105,CC(C)(S)C(N)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50868,,,,,true,true,,,,,,,,,CHEBI:50868,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,penicillamine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_75045,dabrafenib,"N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide|dabrafenib","An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:19689971|PMID:23537694|PMID:23515890|PMID:23844038|PMID:23656699|CAS:1195765-45-7|PMID:23290787|PMID:23463215|Patent:WO2011047238|PMID:23470635|PMID:23833299|PMID:23403819|PMID:23249624|PMID:23621583|Wikipedia:Dabrafenib|PMID:23795808|PMID:23846776|PMID:23881668|PMID:23714462|PMID:23276366|PMID:23807941|PMID:23552670|PMID:23237741|PMID:23608920|Drug_Central:4801|LINCS:LSM-6303|PMID:23709751|PMID:23317446|PMID:23617957|PMID:23870055|PMID:22981500|KEGG:D10064,"An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide",,,,,chebi_ontology,,dabrafenib,,,,,,,,,0,C23H20F3N5O2S2,"InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)",BFSMGDJOXZAERB-UHFFFAOYSA-N,519.56200,519.10105,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(s1)-c1ccnc(N)n1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:75045,,,,,,true,,,,,,,,,CHEBI:75045,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,dabrafenib,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050678,regulation of epithelial cell proliferation,,"Any process that modulates the frequency, rate or extent of epithelial cell proliferation.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of epithelial cell proliferation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0050678,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050678,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of epithelial cell proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001392,Abnormality of the liver,Abnormality of the liver|Liver abnormality|Abnormal liver|Liver disease,An abnormality of the liver.,false,,,http://purl.obolibrary.org/obo/HP_0002012,,,,,,,,,,,,,,,,,,,,UMLS:C0023895|MSH:D008107|UMLS:C4021780|SNOMEDCT_US:235856003,An abnormality of the liver.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of the liver|Liver abnormality|Abnormal liver,,,,,human_phenotype,,Liver disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002012,,,,HP:0001392,,,,,,,,,,,,,,,HP:0001392,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the liver,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003503,IGHG4,,,false,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,14,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,immunoglobulin heavy constant gamma 4 (G4m marker),,14q32.33,,,,GO_0003823 (EC: IEA); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0006956 (EC: TAS); GO_0006958 (EC: TAS); GO_0038096 (EC: TAS); GO_0045087 (EC: TAS); GO_0072562 (EC: IDA),PMID: 4192699; 6299662; 6327276; 6407005; 6421489; 6804948; 11257305; 12477932,,,,,,,,,,,,,,,,,,OGG:3000003503,,,,,,,,,,,,,,,,,,,immunoglobulin heavy constant gamma 4 (G4m marker),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IGHG4,,,20140408,3503,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,IGHG4,,"Bin Zhao, Yue Liu, Oliver He",,other,,
http://purl.obolibrary.org/obo/NCBITaxon_8570,Serpentes,snakes|snakes|Ophidia,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_8457,,,,,,,,,,,,,,,,,,,,PMID:19281946|GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,snakes,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_infraorder,snakes|Ophidia,,,,,,NCBITaxon:8570,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_8457,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Serpentes,,,,,,,,,,,,,,,,,,,,,,https://www.sciencedaily.com/releases/2020/03/200326144342.htm,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000109,quick test,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,diagnosis,,true,,,,,,A rapid diagnostic test (RDT) is a medical diagnostic test that is quick and easy to perform.,Rapid test|RDT|Rapid diagnostic test,,,,,,,,,,,,,,,quick test,,,,,,,,,,,,,,,,,,,,,,https://www.bosch.com/stories/vivalytic-rapid-test-for-covid-19/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C85447,Recombinant Human Angiotensin Converting Enzyme 2 APN01,rhACE2 APN01|APN01|Recombinant Human Angiotensin Converting Enzyme 2 APN01,"A recombinant, soluble glycosylated form of human angiotensin converting enzyme 2 (rhACE2) with antihypertensive and potential antineoplastic activities. Recombinant human angiotensin converting enzyme 2 APN01 may normalize ACE2 levels, cleaving angiotensin II to create angiotensin-(1-7) and restoring the function of the renin-angiotensin system (RAS). ACE2, a homolog of ACE1, appears to function as a negative regulator of the RAS system by converting angiotensin II to angiotensin-(1-7), a peptide with actions that counteract the cardiovascular actions of angiotensin II. In addition, angiotensin-(1-7) may inhibit cyclooxygenase 2 (COX-2) and the production of proinflammatory prostaglandins and may activate the angiotensin-(1-7) G protein-coupled receptor Mas, resulting in diminished tumor cell proliferation. ACE2 levels may be reduced in malignancy and diabetes and in liver, cardiovascular and lung diseases.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C85447,,,,,,,,,,"A recombinant, soluble glycosylated form of human angiotensin converting enzyme 2 (rhACE2) with antihypertensive and potential antineoplastic activities. Recombinant human angiotensin converting enzyme 2 APN01 may normalize ACE2 levels, cleaving angiotensin II to create angiotensin-(1-7) and restoring the function of the renin-angiotensin system (RAS). ACE2, a homolog of ACE1, appears to function as a negative regulator of the RAS system by converting angiotensin II to angiotensin-(1-7), a peptide with actions that counteract the cardiovascular actions of angiotensin II. In addition, angiotensin-(1-7) may inhibit cyclooxygenase 2 (COX-2) and the production of proinflammatory prostaglandins and may activate the angiotensin-(1-7) G protein-coupled receptor Mas, resulting in diminished tumor cell proliferation. ACE2 levels may be reduced in malignancy and diabetes and in liver, cardiovascular and lung diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,rhACE2 APN01|APN01|Recombinant Human Angiotensin Converting Enzyme 2 APN01,,,,,,,,,,,,,NCIT:C85447,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32125455,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784,,,,,,,,,,Recombinant Human Angiotensin Converting Enzyme 2 APN01,,,,,,,CL412316,,,,,,,,,642531,642531,,Recombinant Human Angiotensin Converting Enzyme 2 APN01,,,,Pharmacologic Substance,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000008,fibrin fragment D,,,false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,D-dimers are protein products of cross-linked fibrin degradation that are present in the blood of most healthy individuals in only negligible amounts (of the order 100-200 ng/mL).,D-dimer,,,,,,,,,,,,,,,fibrin fragment D,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000302,response to reactive oxygen species,response to AOS|response to active oxygen species|response to ROI|response to reactive oxidative species|response to reactive oxygen intermediate|response to ROS,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,response to AOS|response to active oxygen species|response to ROI|response to reactive oxidative species|response to reactive oxygen intermediate|response to ROS,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0000302,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000302,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to reactive oxygen species,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006351,CCL4,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,G-26|MIP-1-beta|LAG1|AT744.1|MIP1B|SCYA2|SCYA4|MIP1B1|HC21|LAG-1|ACT2,,,,,,,17,,,,,,,,,,MIM:182284|HPRD:01657|HGNC:10630,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 4,,17q12,,,,"GO_0005125 (EC: TAS, PMID: 2462251); GO_0005515 (EC: IPI); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006928 (EC: TAS, PMID: 9759849); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0007155 (EC: TAS, PMID: 10929056); GO_0007163 (EC: TAS, PMID: 9759849); GO_0007165 (EC: TAS, PMID: 10929056); GO_0007267 (EC: TAS, PMID: 2521882); GO_0008009 (EC: IEA); GO_0009615 (EC: TAS, PMID: 9743377); GO_0009636 (EC: IDA, PMID: 10841574); GO_0031726 (EC: IPI, PMID: 7545673); GO_0031730 (EC: IPI, PMID: 10679098); GO_0042802 (EC: IPI); GO_0043922 (EC: IDA, PMID: 10841574); GO_0050850 (EC: IMP, PMID: 10679098); GO_0051928 (EC: IDA, PMID: 8699119); GO_0060326 (EC: TAS, PMID: 10929056); GO_2000503 (EC: IDA, PMID: 7545673)",PMID: 1894635; 1972563; 2247088; 2462251; 2521353; 2521882; 2568930; 2809212; 7545673; 7566098; 7594543; 7622448; 8077676; 8134838; 8525373; 8661057; 8663314; 8699119; 8898753; 8906795; 8906796; 9256481; 9359702; 9405404; 9420238; 9520456; 9521068; 9558100; 9576751; 9658081; 9743377; 9759849; 9973507; 10049593; 10089882; 10395844; 10470075; 10540332; 10608777; 10644351; 10679098; 10751368; 10820198; 10841574; 10900358; 10929056; 10938094; 10985253; 11023526; 11129109; 11278300; 11313374; 11470920; 11485305; 11602715; 11685466; 11751963; 12036855; 12070155; 12089333; 12200385; 12218153; 12370346; 12377943; 12393595; 12393716; 12401480; 12411442; 12427015; 12445801; 12477932; 12574335; 12603824; 12651610; 12679478; 14582706; 14673550; 14718574; 14746807; 14761932; 15067078; 15142381; 15481145; 15489334; 15529362; 15585099; 15588341; 15638726; 15645140; 15780175; 15817944; 15831560; 15843566; 15897346; 16160188; 16354571; 16379602; 16393999; 16625196; 16697675; 16773571; 16841089; 16963564; 17005260; 17330138; 17431094; 17644519; 17703412; 17765942; 18076643; 18203956; 18346864; 18368065; 18623207; 18802359; 19047106; 19057841; 19074730; 19103522; 19234184; 19258923; 19328808; 19358850; 19565503; 19620252; 19841187; 19846870; 19917679; 20056178; 20200978; 20380698; 20403075; 20482449; 20503287; 20504918; 20575639; 20598119; 20702408; 20817073; 20855878; 20952681; 20959807; 21030011; 21082024; 21264298; 21464938; 21890375; 21914058; 21978000; 22085486; 22156348; 22407921; 23152559; 23509148; 23760235; 23996681; 24116893; 24370436,,,,,,,,,,,,,,,,,,OGG:3000006351,,,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 4,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCL4,,,20140408,6351,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CCL4,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0039593,suppression by virus of host exit from mitosis,inhibition of host mitotic exit by virus,Any viral process which decreases the rate or extent of a host cell leaving M phase of the cell cycle. M phase is the part of the mitotic cell cycle during which mitosis and cytokinesis take place.,false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2012-06-25T02:21:20Z,,,VZ:877,Any viral process which decreases the rate or extent of a host cell leaving M phase of the cell cycle. M phase is the part of the mitotic cell cycle during which mitosis and cytokinesis take place.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,inhibition of host mitotic exit by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039593,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/17413032,,,,GO:0039593,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host exit from mitosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000145,relational quality,,"b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001])",false,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,RelationalQuality,r-quality,,,,,,,,,,,,,,,"b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001])",,,,,,,,,,,,,"a marriage bond, an instance of requited love, an obligation between one person and another.|John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married.",,,,,,,,,(iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000145,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,relational quality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264386,SARS coronavirus TW-YM4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264386,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-YM4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051222,positive regulation of protein transport,up regulation of protein transport|up-regulation of protein transport|upregulation of protein transport|activation of protein transport|stimulation of protein transport,"Any process that activates or increases the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.",false,,,http://purl.obolibrary.org/obo/GO_1904951,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,up regulation of protein transport|up-regulation of protein transport|upregulation of protein transport,,,activation of protein transport|stimulation of protein transport,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1904951,,,,GO:0051222,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051222,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of protein transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0010070,Mortality,,,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0010070,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,true,,,,,,All deaths reported in a given population.,Case fatality rate|death rate,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Mortality,,,,,,,,,,,,,,,,,,,,,,https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-glossary-of-terms/,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000113,transmission from asymptomatic people,,,false,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,transmission of infection(biological process),,true,,,,,,"Asymptomatic transmission refers to transmission of the virus from a person, who does not develop symptoms.",Asymptomatic transmission,,,,,,,,,,,,,,,transmission from asymptomatic people,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264375,SARS coronavirus TW-JC2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264375,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-JC2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/APOLLO_SV_00000331,infection in population,,an infection in an ecosystem occurring in one population of organisms,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,an infection in an ecosystem occurring in one population of organisms,,,,,,,,,infection in a population,,an infection in an ecosystem occurring in one population of organisms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,APOLLO_SV:00000331,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,true,,,,,,,Community Spread,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,infection in population,,,,,,,,,,,,,,,,,,,,,,https://www.summitmedicalgroup.com/news/living-well/must-know-covid-19-vocabulary/,,,,,,William R. Hogan,,,,Infection
http://purl.obolibrary.org/obo/MONDO_0005794,Herpesviridae infectious disease,"herpesvirus infection|Herpesviridae infections|Herpesviridae disease or disorder|Herpesviridae caused disease or disorder|infection, Herpesviridae|Herpesviridae infection|Herpesvirus infection|infections, Herpesviridae|Herpesvirus infections|herpes infection|infection, Herpesvirus|infections, Herpesvirus",Virus diseases caused by the herpesviridae.,false,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,,,,,,,,,MESH:D006566|EFO:0007309|SCTID:23513009,Virus diseases caused by the herpesviridae.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,herpesvirus infection|Herpesviridae infections|Herpesviridae disease or disorder|Herpesviridae caused disease or disorder,,,,,,,"infection, Herpesviridae|Herpesviridae infection|Herpesvirus infection|infections, Herpesviridae|Herpesvirus infections|herpes infection|infection, Herpesvirus|infections, Herpesvirus",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934,,http://purl.obolibrary.org/obo/DOID_2939,http://identifiers.org/mesh/D006566|http://identifiers.org/snomedct/23513009,MONDO:0005794,,,,,,,,,,,,,,,MONDO:0005794,,http://purl.obolibrary.org/obo/mondo.owl,,,,,,,,,,,Herpesviridae infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003624,INHBA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,EDF|FRP,,,,,,,7,,,,,,,,,,HGNC:6066|HPRD:00929|MIM:147290,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"inhibin, beta A",,7p15-p13,,,,"GO_0000082 (EC: IDA, PMID: 9884026); GO_0001541 (EC: IGI, PMID: 10932194); GO_0001541 (EC: NAS, PMID: 9166111); GO_0001942 (EC: IGI, PMID: 10932194); GO_0002244 (EC: IDA, PMID: 15451575); GO_0005125 (EC: IDA, PMID: 9884026); GO_0005179 (EC: TAS, PMID: 12456957); GO_0005515 (EC: IPI, PMID: 12697670); GO_0005576 (EC: IDA, PMID: 12213882); GO_0005576 (EC: TAS); GO_0006357 (EC: IDA, PMID: 11948405); GO_0006952 (EC: TAS, PMID: 12456957); GO_0007050 (EC: IDA, PMID: 9884026); GO_0007166 (EC: TAS, PMID: 12456957); GO_0007267 (EC: TAS, PMID: 12456957); GO_0007399 (EC: NAS, PMID: 10320815); GO_0008083 (EC: TAS, PMID: 12324653); GO_0008285 (EC: IDA, PMID: 11948405); GO_0008584 (EC: IGI, PMID: 10932194); GO_0010862 (EC: IDA, PMID: 19736306); GO_0017046 (EC: IPI, PMID: 16198295); GO_0030154 (EC: TAS, PMID: 12456957); GO_0030218 (EC: NAS, PMID: 1310063); GO_0030308 (EC: IDA); GO_0032924 (EC: IDA, PMID: 9884026); GO_0040007 (EC: IEA); GO_0042326 (EC: TAS, PMID: 12456957); GO_0042476 (EC: IGI, PMID: 10932194); GO_0042493 (EC: IDA); GO_0042541 (EC: IDA, PMID: 1310063); GO_0042701 (EC: IGI, PMID: 10932194); GO_0042802 (EC: IPI, PMID: 2575216); GO_0043509 (EC: IDA, PMID: 7890768); GO_0043512 (EC: IDA, PMID: 7890768); GO_0045077 (EC: TAS, PMID: 12456957); GO_0045578 (EC: TAS, PMID: 12456957); GO_0045648 (EC: IDA, PMID: 9032295); GO_0045650 (EC: TAS, PMID: 12456957); GO_0045786 (EC: IDA, PMID: 9884026); GO_0045893 (EC: IDA); GO_0045944 (EC: IDA, PMID: 12702211); GO_0046880 (EC: IGI, PMID: 10932194); GO_0046881 (EC: TAS, PMID: 12456957); GO_0046882 (EC: NAS, PMID: 3267209); GO_0046982 (EC: IEA); GO_0048333 (EC: IEA); GO_0060021 (EC: IGI, PMID: 10932194); GO_0060279 (EC: ISS); GO_0061029 (EC: ISS); GO_0070699 (EC: IPI, PMID: 7890768); GO_0071372 (EC: IEA); GO_0071397 (EC: IEA); GO_0097191 (EC: IDA, PMID: 9884026); GO_2001241 (EC: IDA, PMID: 8267637)",PMID: 1310063; 1646080; 1777673; 2575216; 2767687; 3267209; 3345731; 3754442; 3758355; 7887917; 7890768; 8015550; 8125298; 8242742; 8267637; 8397373; 8955111; 9032295; 9166111; 9202237; 9872992; 9884026; 10320815; 10746731; 10859029; 10865214; 10932194; 11134153; 11266516; 11344232; 11459787; 11948405; 11969340; 12088879; 12149426; 12161551; 12213882; 12324653; 12399529; 12414903; 12456957; 12477932; 12524226; 12587530; 12651901; 12660162; 12665510; 12690205; 12697670; 12702211; 12721183; 12853948; 12877256; 14613548; 14671202; 14671321; 14738881; 14993131; 15031321; 15070957; 15094188; 15123352; 15123686; 15188178; 15205401; 15292256; 15374731; 15451571; 15451575; 15489334; 15580313; 15737465; 15950648; 16081641; 16198295; 16344560; 16423381; 16643884; 16751776; 16820918; 16988001; 17204604; 17384470; 17436000; 17462637; 17478557; 17681301; 17909904; 17929017; 17954979; 17968943; 18001154; 18077449; 18089557; 18156495; 18166170; 18299275; 18319260; 18353928; 18359784; 18381582; 18413775; 18423626; 18450971; 18460206; 18535106; 18600473; 18608101; 18695873; 18719101; 18768470; 18854336; 19027859; 19028479; 19064572; 19086053; 19091310; 19095948; 19128983; 19141859; 19158274; 19196915; 19200970; 19240652; 19257827; 19308293; 19324968; 19383344; 19386982; 19539911; 19574343; 19615428; 19641514; 19661148; 19733294; 19736306; 19885849; 20028875; 20036850; 20043075; 20194748; 20200332; 20203128; 20226172; 20309641; 20379614; 20610541; 20628624; 20634197; 20634891; 20660033; 20704626; 20720391; 20734064; 20926007; 21102462; 21132402; 21222045; 21464440; 21475087; 21529351; 21576276; 21640344; 21767104; 21846490; 21952245; 21992678; 22161160; 22219177; 22234949; 22296042; 22416010; 22425195; 22439617; 22548442; 22549017; 22579070; 22685232; 22845186; 23024260; 23205865; 23470693; 23589129; 23793025; 23831638; 24227781; 24395917,,,,,,,,,,,,,,,,,,OGG:3000003624,,,,,,,,,,,,,,,,,,,"inhibin, beta A",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,INHBA,,,20140408,3624,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,|https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,INHBA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_511429,SARS coronavirus BJ182-12,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:511429,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ182-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009199,ribonucleoside triphosphate metabolic process,ribonucleoside triphosphate metabolism,"The chemical reactions and pathways involving a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009141,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribonucleoside triphosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009141,,,,GO:0009199,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009199,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribonucleoside triphosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C102401,High Risk,High Risk|HIGH RISK,The potential future harm that may arise from some present action or attribute or condition is almost certain.,false,,,http://purl.obolibrary.org/obo/NCIT_C17103,,The potential future harm that may arise from some present action or attribute or condition is almost certain.,,,,,,,,,C102401,,,CDISC,,,,,,,The potential future harm that may arise from some present action or attribute or condition is almost certain.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,High Risk|HIGH RISK,,,,,,,,,,,,,NCIT:C102401,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,,,true,,,,,,,risky group|higher risk,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C101848|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830,,,,,,,,,,High Risk,,High Risk,,,,,,,,,,,,,,,,,High Risk,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,Conceptual Entity,,,,,,,,C0332167,
http://purl.obolibrary.org/obo/NCBITaxon_231522,SARS coronavirus GZ50,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231522,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ50,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000124,degeneration of the alveolar epithelia,,,false,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,Modified definition,,,,,true,true,,,,,Reversible damage to an epithelial surface characterized by detachment of viable cells from the epithelial surface and nuclear condensation (pyknosis) and cellular shrinkage of scattered cells within the epithelium.,,,,,,,,,,,,,,,,degeneration of the alveolar epithelia,,,,,,,,,,,,,,,,,,,,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.13.990226,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011897,Neutrophilia,Increased blood neutrophil counts,Increased number of neutrophils circulating in blood.,false,,,http://purl.obolibrary.org/obo/HP_0011991,,,,,,,,,,,,,,,,peter,2012-06-03T03:16:43Z,,,UMLS:C4023140,Increased number of neutrophils circulating in blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Increased blood neutrophil counts,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011991,,,,HP:0011897,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524|https://www.ncbi.nlm.nih.gov/pubmed/32213337,,,,HP:0011897,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Neutrophilia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000042,transmission to healthcare workers,,,false,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,Modified definition,,,transmission of infection,,true,,,true,,,Transmission of infection to healthcare workers|Transmission of infection to healthcare workers i,,,,,,,,,,,,,,,,transmission to healthcare workers,,,,,,,,,,,,,,,,,,,,,,https://www.medscape.com/viewarticle/530539|https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30644-9/fulltext,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0033554,cellular response to stress,,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).|Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0033554,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32169481,,,,GO:0033554,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_manually_annotate,,,,,,,,,,cellular response to stress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050271,non-structural protein 2 (SARS-CoV-2),"PRO_0000449636|p65 homolog (SARS2)|rep/Clv:nsp2 (SARS2)|nsp2 (SARS2)|UniProtKB:P0DTC1, 181-818|PRO_0000449620|UniProtKB:P0DTD1, 181-818",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 180-181 and 818-819.|Category=organism-modification. Note: 638 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725298,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 180-181 and 818-819.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"PRO_0000449636|p65 homolog (SARS2)|rep/Clv:nsp2 (SARS2)|nsp2 (SARS2)|UniProtKB:P0DTC1, 181-818|PRO_0000449620|UniProtKB:P0DTD1, 181-818",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 638 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050271,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32083328,,,,PR:000050271,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 2 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_16240,hydrogen peroxide,dihydrogen peroxide|dihydrogen(peroxide)|dioxidane|HYDROGEN PEROXIDE|Hydrogen peroxide|bis(hydridooxygen)(O--O)|hydrogen peroxide|perhydrol|H2O2|Oxydol|HOOH|[OH(OH)]|dihydrogen dioxide,An inorganic peroxide consisting of two hydroxy groups joined by a covalent oxygen-oxygen single bond.,false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,PMID:26365231|PMID:14679422|PDBeChem:PEO|HMDB:HMDB0003125|PMID:11105916|PMID:18179203|PMID:11318558|PMID:26352695|PMID:16337875|PMID:9100841|PMID:11893576|PMID:19509065|PMID:9168257|PMID:12934880|KEGG:D00008|PMID:18182702|PMID:10849784|PPDB:387|PMID:19229032|PMID:9051670|Wikipedia:Hydrogen_peroxide|MolBase:932|Drug_Central:3281|PMID:15028418|PMID:16463018|PMID:12867293|PMID:17020896|CAS:7722-84-1|KEGG:C00027|Gmelin:509|PMID:8048546|PMID:18443210|PMID:10557015|PMID:7581816|PMID:18306736|PMID:15133946|PMID:17948137|PMID:7548021|PMID:19297450|PMID:11033421|PMID:17610934|PMID:19107210|PMID:15298493|PMID:18592736|PMID:11864786|PMID:8375042|PMID:8451754|PMID:16864869|Reaxys:3587191|Beilstein:3587191|PMID:11387393|PMID:17179007|PMID:11809417|MetaCyc:HYDROGEN-PEROXIDE|PMID:9558114|PMID:9202721|PMID:10455187,An inorganic peroxide consisting of two hydroxy groups joined by a covalent oxygen-oxygen single bond.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:13354|CHEBI:24637|CHEBI:44812|CHEBI:13355|CHEBI:5586,,,,dihydrogen peroxide|dihydrogen(peroxide)|dioxidane|HYDROGEN PEROXIDE|Hydrogen peroxide|bis(hydridooxygen)(O--O)|hydrogen peroxide,,,,,chebi_ontology,,perhydrol|H2O2|Oxydol|HOOH|[OH(OH)]|dihydrogen dioxide,,,,,,,,,0,H2O2,InChI=1S/H2O2/c1-2/h1-2H,MHAJPDPJQMAIIY-UHFFFAOYSA-N,34.01468,34.00548,[H]OO[H],,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,CHEBI:16240,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,,,CHEBI:16240,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,hydrogen peroxide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011112,Abnormality of serum cytokine level,,"Abnormality of the cytokine levels in the blood, i.e., an abnormality of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells.",false,,,http://purl.obolibrary.org/obo/HP_0011111,,,,,,,,,,,,,,,,peter,2011-06-12T09:03:40Z,,,MP:0010210|UMLS:C4023535,"Abnormality of the cytokine levels in the blood, i.e., an abnormality of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011111,,,,HP:0011112,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/?term=32113704|https://www.ncbi.nlm.nih.gov/pubmed/32305588,,,extreme rise in inflammatory cytokines|significantly high blood levels of cytokines|increased levels of plasma pro-inflammatory cytokines,HP:0011112,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of serum cytokine level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C143657,"Lung Infection, CTCAE","Lung Infection, CTCAE|Lung infection","A disorder characterized by an infectious process involving the lungs, including pneumonia.",false,,,http://purl.obolibrary.org/obo/DOID_1579,,"A disorder characterized by an infectious process involving the lungs, including pneumonia.",,,,,,,,,C143657,,,CTCAE,,,,,,,"A disorder characterized by an infectious process involving the lungs, including pneumonia.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C143171,"Lung Infection, CTCAE|Lung infection",,,,,,,,,,,,,NCIT:C143657,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,"Lung Infection, CTCAE",,Lung Infection|Lung infection,,,,,CL541914,,,,,,,,,,,,"Lung Infection, CTCAE",,,https://www.webmd.com/lung/covid-and-pneumonia#1,Finding,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019082,viral protein processing,,Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a viral protein.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a viral protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019082,,,,,,true,,,,true,,,,,GO:0019082,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral protein processing,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.02.19.956581v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_135466,nafamostat,nafamostat mesylate|nafamostat mesilate|ronastat|nafamostat dihydrochloride|nafamostat HCl|nafamstat|FUT-175|nafamostat hydrochloride,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:81525-10-2|Drug_Central:1867,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,nafamostat mesylate|nafamostat mesilate|ronastat|nafamostat dihydrochloride|nafamostat HCl|nafamstat|FUT-175|nafamostat hydrochloride,,,,,,,,,0,C19H17N5O2,"InChI=1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24)",MQQNFDZXWVTQEH-UHFFFAOYSA-N,347.371,347.13822,C(=N)(N)C1=CC=2C(C=C1)=CC(=CC2)OC(=O)C3=CC=C(C=C3)NC(=N)N,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:135466,,,,,,true,,,,,,,,,CHEBI:135466,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,nafamostat,,,,,,,,,,,,,,,,,,,,,,https://www.eurekalert.org/pub_releases/2020-03/tiom-nie032420.php,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002919,CXCL1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MGSA|NAP-3|SCYB1|GROa|MGSA-a|GRO1|FSP,,,,,,,4,,,,,,,,,,Vega:OTTHUMG00000160866|MIM:155730|Ensembl:ENSG00000163739|HPRD:01119|HGNC:4602,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",,4q21,,,,"GO_0005102 (EC: TAS, PMID: 10820279); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006935 (EC: TAS, PMID: 10820279); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 10820279); GO_0007186 (EC: TAS, PMID: 10820279); GO_0007399 (EC: TAS, PMID: 9058825); GO_0008009 (EC: IEA); GO_0008047 (EC: TAS, PMID: 9079638); GO_0008083 (EC: IEA); GO_0008283 (EC: TAS, PMID: 8380167); GO_0008285 (EC: TAS, PMID: 9551928); GO_0030036 (EC: TAS, PMID: 9725262); GO_0035556 (EC: TAS, PMID: 9551928); GO_0043085 (EC: TAS, PMID: 9079638); GO_0060326 (EC: TAS, PMID: 10820279)",PMID: 1379593; 1906501; 2129556; 2182761; 2217207; 2655583; 2670560; 2890161; 2909392; 2970963; 3264403; 7561066; 7592830; 7806518; 8089846; 8380167; 8397104; 8550564; 8597869; 8702798; 8940121; 8942852; 9058825; 9079638; 9152234; 9551928; 9725262; 10095777; 10343098; 10437780; 10820279; 10881932; 11023497; 11349045; 11390582; 11470861; 11524231; 11816717; 12012624; 12089333; 12388718; 12477932; 12591113; 12734381; 12744776; 13679391; 14530367; 15133028; 15218300; 15340161; 15489334; 15492419; 15843053; 15896780; 15994316; 16086366; 16098041; 16567391; 16617094; 16712791; 16934308; 16941962; 17022986; 17060621; 17062666; 17096385; 17456471; 17466952; 17581194; 17703315; 17703412; 17999991; 18056965; 18065201; 18211687; 18240029; 18276907; 18283335; 18451219; 18577758; 19103522; 19176759; 19258312; 19258923; 19430878; 19435811; 19549892; 19780053; 19838218; 19906815; 20042592; 20195728; 20237496; 20495539; 20503287; 20621720; 20628624; 20685145; 20702723; 20731665; 21042742; 21075844; 21220697; 21257927; 21343381; 21396766; 21531038; 21820916; 21928244; 21994122; 22030312; 22069268; 22125641; 22129625; 22173151; 22183310; 22251138; 22615136; 22732298; 22770218; 22902060; 22975476; 23027620; 23043537; 23128233; 23198952; 23207068; 23225384; 23269549; 23334998; 23389772; 23444042; 23479735; 23505918; 23519936; 23554905; 23732813; 23815949; 23967336; 24273934; 24600982,,,,,,,,,,,,,,,,,,OGG:3000002919,,,,,,,,,,,,,,,,,,,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCL1,,,20140408,2919,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CXCL1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_2000009606,gene of Homo sapiens,,A gene of an organism of Homo sapiens,false,,,http://purl.obolibrary.org/obo/OGG_2000002759,,,,,,,,,,,,,,,,,,,,,A gene of an organism of Homo sapiens,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGG:2000009606,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2000002759,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,gene of Homo sapiens,,,,,,,,,,,,,,,9606,,,,,,,,,,,,,"Yue Liu, Bin Zhao, Oliver He",,,,
http://purl.obolibrary.org/obo/OAE_0000002,medical intervention,,"medical intervention is a planned process that has the goal of diagnosing, preventing or relieving illness or injury. ",false,,,http://purl.obolibrary.org/obo/ERO_0000347,,,,,,,,,,,,,,,,,,,,,"medical intervention is a planned process that has the goal of diagnosing, preventing or relieving illness or injury. ",,WEB: http://wiki.answers.com/Q/What_is_medical_intervention,,,,,,"The act of intervening, interfering or interceding with the intent of modifying the outcome. In medicine, an intervention is usually undertaken to help treat or cure a condition. For example, ""Acupuncture as a therapeutic intervention is widely practiced in the United States,"" 
Reference:
http://www.medterms.com/script/main/art.asp?articlekey=34214 . Some interventions can be used for diagnosis. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OAE:0000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000347,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/oae.owl,,,,,,,,,,,medical intervention,,,,,,,,,,,,,,,,,,,,,,,,,,,,YH,,,,
http://purl.obolibrary.org/obo/PR_000050276,non-structural protein 7 (SARS-CoV-2),"nsp7 (SARS2)|UniProtKB:P0DTD1, 3860-3942|UniProtKB:P0DTC1, 3860-3942|rep/Clv:nsp7 (SARS2)|PRO_0000449625|PRO_0000449641",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3859-3860 and 3942-3943.|Category=organism-modification. Note: 83 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725303,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3859-3860 and 3942-3943.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"nsp7 (SARS2)|UniProtKB:P0DTD1, 3860-3942|UniProtKB:P0DTC1, 3860-3942|rep/Clv:nsp7 (SARS2)|PRO_0000449625|PRO_0000449641",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 83 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050276,,,,,,true,,,,,,,,,PR:000050276,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 7 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0140013,meiotic nuclear division,,One of the two nuclear divisions that occur as part of the meiotic cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_1903046|http://purl.obolibrary.org/obo/GO_0000280,,,,,,,,,,,,,,,,pg,2017-03-23T09:40:00Z,,,,One of the two nuclear divisions that occur as part of the meiotic cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1903046|http://purl.obolibrary.org/obo/GO_0000280,,,,GO:0140013,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0140013,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,meiotic nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005876,spindle microtubule,,Any microtubule that is part of a mitotic or meiotic spindle; anchored at one spindle pole.,false,,,http://purl.obolibrary.org/obo/GO_0005874,,,,,,,,,,,,,,,,,,,,,Any microtubule that is part of a mitotic or meiotic spindle; anchored at one spindle pole.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005874,,,,GO:0005876,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005876,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spindle microtubule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009124,nucleoside monophosphate biosynthetic process,nucleoside monophosphate formation|nucleoside monophosphate biosynthesis|nucleoside monophosphate anabolism|nucleoside monophosphate synthesis,"The chemical reactions and pathways resulting in the formation of a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_1901293|http://purl.obolibrary.org/obo/GO_0009123,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nucleoside monophosphate formation|nucleoside monophosphate biosynthesis|nucleoside monophosphate anabolism|nucleoside monophosphate synthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901293|http://purl.obolibrary.org/obo/GO_0009123,,,,GO:0009124,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009124,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nucleoside monophosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000480,nervous system symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,UMLS_ICD9CM_2005_AUI:A0284131|ICD9CM_2005:781|SyOID:90|UMLS_CUI:C0159033,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms that are caused by nervous system problem,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000480,,modified definition,,,,,,,,,,,,,SYMP:0000480,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,nervous system symptom,,,,,,,,,,,,,,,,,,,,,,https://www.uofmhealth.org/health-library/nersp,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_3683,lung benign neoplasm,tumor of the lung,,false,,,http://purl.obolibrary.org/obo/DOID_850|http://purl.obolibrary.org/obo/DOID_0050621,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0024121|MESH:D008175|NCI:C3200|SNOMEDCT_US_2019_09_01:126713003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tumor of the lung,,,,,disease_ontology,,,,,,,,,"A non-metastasizing neoplasm that arises from the lung parenchyma or the bronchi. Representative examples include lung adenoma, lung hamartoma, and endobronchial lipoma",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_850|http://purl.obolibrary.org/obo/DOID_0050621,,,,DOID:3683,,,,,,,,,,,,,,,DOID:3683,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,lung benign neoplasm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2988,antiphospholipid syndrome,Antiphospholipid syndrome|antiphospholipid antibody syndrome,An autoimmune hypersensitivity disease that is characterized by recurrent venous or arterial thrombosis and/or fetal losses associated with characteristic elevated levels of antibodies directed against membrane anionic phospholipids (anticardiolipin).|OMIM mapping confirmed by DO. [SN].,false,,,http://purl.obolibrary.org/obo/DOID_0060051,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:26843008|OMIM:107320|UMLS_CUI:C0085278|GARD:5824|ICD10CM:D68.61|NCI:C61283|MESH:D016736,An autoimmune hypersensitivity disease that is characterized by recurrent venous or arterial thrombosis and/or fetal losses associated with characteristic elevated levels of antibodies directed against membrane anionic phospholipids (anticardiolipin).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Antiphospholipid syndrome|antiphospholipid antibody syndrome,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,OMIM mapping confirmed by DO. [SN].,,http://purl.obolibrary.org/obo/DOID_0060051,,,,DOID:2988,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,DOID:2988,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,antiphospholipid syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005840,ribosome,membrane bound ribosome|free ribosome|ribosomal RNA,"An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1429207766|Wikipedia:Ribosome,"An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0033279,,,,,,,membrane bound ribosome|free ribosome,,cellular_component,,ribosomal RNA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005840,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005840,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus,,,,,,,,,,ribosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C125062,Tomivosertib,"TOMIVOSERTIB|EFT-508|eFT508|Tomivosertib|Spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-Amino-4-pyrimidinyl)amino)-8'-methyl-","An orally bioavailable inhibitor of mitogen-activated protein kinase (MAPK)-interacting serine/threonine-protein kinase 1 (MNK1) and 2 (MNK2), with potential antineoplastic activity. Upon oral administration, tomivosertib binds to and inhibits the activity of MNK1 and 2. This prevents MNK1/2-mediated signaling, and inhibits the phosphorylation of certain regulatory proteins, including eukaryotic translation initiation factor 4E (eIF4E), that regulate the translation of messenger RNAs (mRNAs) involved in tumor cell proliferation, angiogenesis, survival and immune signaling. This inhibits tumor cell proliferation in MNK1/2-overexpressing tumor cells. MNK1/2 are overexpressed in a variety of tumor cell types and promote phosphorylation of eIF4E; eIF4E is overexpressed in many tumor cell types and contributes to tumor development, maintenance and resistance.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,1849590-01-7,,,,C125062,,,CTRP|FDA,,,,,,,"An orally bioavailable inhibitor of mitogen-activated protein kinase (MAPK)-interacting serine/threonine-protein kinase 1 (MNK1) and 2 (MNK2), with potential antineoplastic activity. Upon oral administration, tomivosertib binds to and inhibits the activity of MNK1 and 2. This prevents MNK1/2-mediated signaling, and inhibits the phosphorylation of certain regulatory proteins, including eukaryotic translation initiation factor 4E (eIF4E), that regulate the translation of messenger RNAs (mRNAs) involved in tumor cell proliferation, angiogenesis, survival and immune signaling. This inhibits tumor cell proliferation in MNK1/2-overexpressing tumor cells. MNK1/2 are overexpressed in a variety of tumor cell types and promote phosphorylation of eIF4E; eIF4E is overexpressed in many tumor cell types and contributes to tumor development, maintenance and resistance.",,,,,,Tomivosertib,,,,,,,,,,,U2H19X4WBV,,,,,,,,,,,,,,"TOMIVOSERTIB|EFT-508|eFT508|Tomivosertib|Spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-Amino-4-pyrimidinyl)amino)-8'-methyl-",,,,,,,,,,,,,NCIT:C125062,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Tomivosertib,,,,,,,CL503903,,,,,,,,,777456,777456,,Tomivosertib,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,Pharmacologic Substance,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_229992,SARS coronavirus Frankfurt 1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:229992,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/19698190,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Frankfurt 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_50730,montelukast,Montelukast|MONTELUKAST|{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid|montelukast|(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Beilstein:7896575|KEGG:C07482|KEGG:D08229|Patent:EP1886997|DrugBank:DB00471|CAS:158966-92-8|Wikipedia:Montelukast|Drug_Central:1836|PDBeChem:MTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:49756|CHEBI:6992,,,,Montelukast|MONTELUKAST|{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid,,,,,chebi_ontology,,montelukast|(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid,,,,,,,,,0,C35H36ClNO3S,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",UCHDWCPVSPXUMX-TZIWLTJVSA-N,586.18398,585.21044,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC1)CC(O)=O)c1cccc(C=C\c2ccc3ccc(Cl)cc3n2)c1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50730,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:50730,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,montelukast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0010935,Abnormality of the upper urinary tract,Abnormality of the upper urinary tract,An abnormality of the upper urinary tract.|The upper urinary tract is a subdivision of urinary system which consists of the kidney and the ureters.,false,,,http://purl.obolibrary.org/obo/HP_0000079,,,,,,,,,,,,,,,,peter,2011-01-16T11:37:29Z,,,UMLS:C4023641,An abnormality of the upper urinary tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of the upper urinary tract,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,The upper urinary tract is a subdivision of urinary system which consists of the kidney and the ureters.,,http://purl.obolibrary.org/obo/HP_0000079,,,,HP:0010935,,,,,,,,,,,,,,,HP:0010935,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the upper urinary tract,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000068,zotatifin,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"A selective inhibitor of the eukaryotic translation initiation factor 4A (eIF4A), with potential antineoplastic activity.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,,,,,,,,,,,,zotatifin,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030057,desmosome,macula adherens|spot desmosome,A cell-cell junction in which: on the cytoplasmic surface of each interacting plasma membrane is a dense plaque composed of a mixture of intracellular anchor proteins; a bundle of keratin intermediate filaments is attached to the surface of each plaque; transmembrane adhesion proteins of the cadherin family bind to the plaques and interact through their extracellular domains to hold the adjacent membranes together by a Ca2+-dependent mechanism.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Desmosome,A cell-cell junction in which: on the cytoplasmic surface of each interacting plasma membrane is a dense plaque composed of a mixture of intracellular anchor proteins; a bundle of keratin intermediate filaments is attached to the surface of each plaque; transmembrane adhesion proteins of the cadherin family bind to the plaques and interact through their extracellular domains to hold the adjacent membranes together by a Ca2+-dependent mechanism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,macula adherens|spot desmosome,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030057,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030057,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,desmosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000059,severe symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Worsened symptoms showing the severity of disease,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,modified definition,,symptom,,true,,,,,,,,,,,,,,,,,,,,,,severe symptom,,,,,,,,,,,,,,,,,,,,,,https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963|https://www.health.harvard.edu/diseases-and-conditions/covid-19-basics|https://www.webmd.com/lung/covid-19-symptoms#2-3,,,,,,,,,,
http://purl.obolibrary.org/obo/OGI_0000012,genetic variation,,"Genetic variationis a variation in alleles of genes, occurs both within and among populations. ",false,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,,,,,,,,,,,,,,"Genetic variationis a variation in alleles of genes, occurs both within and among populations. ",,http://en.wikipedia.org/wiki/Genetic_variation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGI:0000012,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogi.owl,,,,,,,,,,,genetic variation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001939,Abnormality of metabolism/homeostasis,Laboratory abnormality|Metabolism abnormality,,false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,UMLS:C4021768,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0002146|HP:0004367|HP:0004355,,,,Laboratory abnormality|Metabolism abnormality,,,,,human_phenotype,,,,,,,,,Disorders of metabolism and homeostasis,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0001939,,,,,,,,,,,,,,,HP:0001939,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of metabolism/homeostasis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_1247,blood coagulation disease,postpartum coagulation defect with delivery|postpartum coagulation defect,,false,,,http://purl.obolibrary.org/obo/DOID_74,,,,,,,,,,,,,,,,,,,,ICD9CM:286|SNOMEDCT_US_2019_09_01:64779008|NCI:C2902|MESH:D001778|ICD10CM:D68.9|UMLS_CUI:C0005779,,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:9474|DOID:13997,,,,postpartum coagulation defect with delivery|postpartum coagulation defect,,,,,disease_ontology,,,,,,,,,A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_74,,,,DOID:1247,,,,,,,,,,,,,,,DOID:1247,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,blood coagulation disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_5613,haloperidol,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one|haloperidol|4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|4-(4-(para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|1-(3-p-fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine|haloperidolum|4'-fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol|gamma-(4-(p-chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone,A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:BE577977|KEGG:C01814|DrugBank:DB00502|PMID:6725621|Beilstein:331267|Drug_Central:1353|KEGG:D00136|Patent:US3438991|CAS:52-86-8|Patent:GB895309|Wikipedia:Haloperidol|PMID:25007358|Reaxys:331267|PMID:7602118|LINCS:LSM-3512|PMID:10628896|PMID:11304647,A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,,,,,chebi_ontology,,haloperidol|4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|4-(4-(para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|1-(3-p-fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine|haloperidolum|4'-fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol|gamma-(4-(p-chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone,,,,,,,,,0,C21H23ClFNO2,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",LNEPOXFFQSENCJ-UHFFFAOYSA-N,375.86400,375.14013,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:5613,,,,,,true,,,,,,,,,CHEBI:5613,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,haloperidol,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0060056,hypersensitivity reaction disease,,An immune system disease that has_material_basis_in abnormal immune responses.,false,,,http://purl.obolibrary.org/obo/DOID_2914,,,,,,,,,,,,,,,,,,,,,An immune system disease that has_material_basis_in abnormal immune responses.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_2914,,,,DOID:0060056,,,,,,,,,,,,,,,DOID:0060056,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,hypersensitivity reaction disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_5001,fenofibrate,Fenofibrate|propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate|Tricor (TN)|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Procetofen|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Finofibrate|Lipantil (TN),A chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:18212815|Patent:US4058552|DrugBank:DB01039|Drug_Central:1152|PMID:17449930|KEGG:D00565|Patent:DE2250327|Reaxys:2062462|LINCS:LSM-3107|CAS:49562-28-9|KEGG:C07586|Wikipedia:Fenofibrate|HMDB:HMDB0015173,A chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fenofibrate|propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate,,,,,chebi_ontology,,Tricor (TN)|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Procetofen|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Finofibrate|Lipantil (TN),,,,,,,,,0,C20H21ClO4,"InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3",YMTINGFKWWXKFG-UHFFFAOYSA-N,360.83100,360.11284,CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:5001,,,,,true,true,,,,,,,,,CHEBI:5001,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,fenofibrate,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098670,entry receptor-mediated virion attachment to host cell,viral attachment to host entry receptor,The process by which a virion attaches to a host cell by binding to a receptor on the host cell surface that mediates/triggers viral entry by endocytosis/pinocytosis or by inducing fusion/penetration.,false,,,http://purl.obolibrary.org/obo/GO_0046813,,,,,,,,,,,,,,,,dos,2017-01-16T13:18:27Z,,,VZ:3942,The process by which a virion attaches to a host cell by binding to a receptor on the host cell surface that mediates/triggers viral entry by endocytosis/pinocytosis or by inducing fusion/penetration.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral attachment to host entry receptor,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046813,,,,GO:0098670,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0098670,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,entry receptor-mediated virion attachment to host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011021,Abnormality of circulating enzyme level,,,false,,,http://purl.obolibrary.org/obo/HP_0010876,,,,,,,,,,,,,,,,peter,2011-02-28T08:46:34Z,,,UMLS:C4023591,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,Aberrant concentration in the blood of any of the proteins that act as catalysts for biological reactions,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010876,,,,HP:0011021,,,,,,,,,,,,,,,HP:0011021,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of circulating enzyme level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039690,positive stranded viral RNA replication,ss(+) viral RNA replication,"A viral genome replication process where the template genome is positive stranded, single stranded RNA ((+)ssRNA). Replication of the positive strand leads to dsRNA formation, which in turn is transcribed into positive single stranded RNA.",false,,,http://purl.obolibrary.org/obo/GO_0039694,,,,,,,,,,,,,,,,rfoulger,2013-10-17T15:45:40Z,,,VZ:1116,"A viral genome replication process where the template genome is positive stranded, single stranded RNA ((+)ssRNA). Replication of the positive strand leads to dsRNA formation, which in turn is transcribed into positive single stranded RNA.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,ss(+) viral RNA replication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039694,,,,GO:0039690,,,,,,,,true,,true,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,GO:0039690,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive stranded viral RNA replication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000114,thrombocytopenia,,doid/symp duplicate,false,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,doid/symp duplicate,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,SYMP:0000114,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,"Thrombocytopenia or low platelet count is a lower than normal number of platelets (less than 150,000 platelets per microliter) in the blood.",,,SYMP:0000114,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,thrombocytopenia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_349343,Bat SARS coronavirus Rp2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:349343,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus Rp2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007093,mitotic cell cycle checkpoint,mitotic checkpoint,A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.,false,,,http://purl.obolibrary.org/obo/GO_0000075|http://purl.obolibrary.org/obo/GO_0045930,,,,,,,,,,,,,,,,,,,,,A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0031575|GO:0071780,,,,,,,,,biological_process,,mitotic checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000075|http://purl.obolibrary.org/obo/GO_0045930,,,,GO:0007093,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007093,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic cell cycle checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0002368,endocrine gland,ductless gland|glandula endocrina|glandulae endocrinae|ductless gland,"Endocrine glands are glands of the endocrine system that secrete their products directly into the circulatory system rather than through a duct.[WP, modified].",false,,,http://purl.obolibrary.org/obo/UBERON_0002530,,,,,,,,,,,,,,,,,,,,GAID:335|UMLS:C0014133|OpenCyc:Mx4rvbkiRZwpEbGdrcN5Y29ycA|FMA:9602|MA:0002563|BTO:0001488|EMAPA:35999|AEO:0000098|NCIT:C12704|MESH:D004702|EHDAA2:0003098|CALOHA:TS-1300|http://linkedlifedata.com/resource/umls/id/C0014133|http://en.wikipedia.org/wiki/Endocrine_gland|http://www.snomedbrowser.com/Codes/Details/40818001,"Endocrine glands are glands of the endocrine system that secrete their products directly into the circulatory system rather than through a duct.[WP, modified].",,,,http://upload.wikimedia.org/wikipedia/commons/d/da/Illu_endocrine_system.png,,,,,,,,,,,,,,,,,,,,,,,,,,,ductless gland|glandula endocrina,,,,,uberon,,glandulae endocrinae|ductless gland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0002530,,,,UBERON:0002368,,,,,,,,,,,,,,,UBERON:0002368,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim,,,,,,,,,,endocrine gland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267398,SARS coronavirus Sin850,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267398,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009152,purine ribonucleotide biosynthetic process,purine ribonucleotide biosynthesis|purine ribonucleotide synthesis|purine ribonucleotide anabolism|purine ribonucleotide formation,"The chemical reactions and pathways resulting in the formation of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009165|http://purl.obolibrary.org/obo/GO_0009260|http://purl.obolibrary.org/obo/GO_0072522,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine ribonucleotide biosynthesis|purine ribonucleotide synthesis|purine ribonucleotide anabolism|purine ribonucleotide formation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009165|http://purl.obolibrary.org/obo/GO_0009260|http://purl.obolibrary.org/obo/GO_0072522,,,,GO:0009152,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009152,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine ribonucleotide biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061615,glycolytic process through fructose-6-phosphate,glycolysis through fructose-6-phosphate,"The chemical reactions and pathways resulting in the breakdown of a monosaccharide into pyruvate, occurring through a fructose-6-phosphate intermediate, with the concomitant production of ATP and NADH.",false,,,http://purl.obolibrary.org/obo/GO_0046034|http://purl.obolibrary.org/obo/GO_0006090|http://purl.obolibrary.org/obo/GO_0016052,,,,,,,,,,,,,,,,dph,2014-04-08T10:08:49Z,,,MetaCyc:PWY-5484,"The chemical reactions and pathways resulting in the breakdown of a monosaccharide into pyruvate, occurring through a fructose-6-phosphate intermediate, with the concomitant production of ATP and NADH.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,glycolysis through fructose-6-phosphate,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046034|http://purl.obolibrary.org/obo/GO_0006090|http://purl.obolibrary.org/obo/GO_0016052,,,,GO:0061615,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061615,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,glycolytic process through fructose-6-phosphate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0120114,Sm-like protein family complex,,"A protein complex containing members of the Like-Sm family of proteins, which includes both the Sm proteins and the Lsm proteins, and which generally form hexameric or heptameric ring structures which bind to RNA. While some of these ring complexes may form independently of RNA, many only form in association with their target RNA. In addition to Lsm-family proteins, many of these complexes contain additional protein members. Members of this family of complexes include the snRNPs which comprise the majority of the spliceosome. Others are involved in the 5' to 3' degradation pathways of mRNAs in the cytoplasm and of unspliced transcripts in the nucleus, as well as other diverse roles.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,kchris,2017-11-06T18:46:43Z,,,,"A protein complex containing members of the Like-Sm family of proteins, which includes both the Sm proteins and the Lsm proteins, and which generally form hexameric or heptameric ring structures which bind to RNA. While some of these ring complexes may form independently of RNA, many only form in association with their target RNA. In addition to Lsm-family proteins, many of these complexes contain additional protein members. Members of this family of complexes include the snRNPs which comprise the majority of the spliceosome. Others are involved in the 5' to 3' degradation pathways of mRNAs in the cytoplasm and of unspliced transcripts in the nucleus, as well as other diverse roles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0120114,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0120114,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,Sm-like protein family complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_28774,"3,3',5'-triiodothyronine","3,3',5'-Triiodothyronine|3,3',5'-triiodothyronine|Triiodothyronine, reverse|O-(4-hydroxy-3,5-diiodophenyl)-3-iodotyrosine|4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenylalanine|Reverse triiodothyronine",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:5817-39-0|Beilstein:2823534|KEGG:C07639,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:19863|CHEBI:1365,,,,"3,3',5'-Triiodothyronine|3,3',5'-triiodothyronine",,,,,chebi_ontology,,"Triiodothyronine, reverse|O-(4-hydroxy-3,5-diiodophenyl)-3-iodotyrosine|4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenylalanine|Reverse triiodothyronine",,,,,,,,,0,C15H12I3NO4,"InChI=1S/C15H12I3NO4/c16-9-3-7(4-12(19)15(21)22)1-2-13(9)23-8-5-10(17)14(20)11(18)6-8/h1-3,5-6,12,20H,4,19H2,(H,21,22)",HZCBWYNLGPIQRK-UHFFFAOYSA-N,650.97353,650.79004,NC(Cc1ccc(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:28774,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,CHEBI:28774,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,"3,3',5'-triiodothyronine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_227861,SARS coronavirus Taiwan,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:227861,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Taiwan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IDO_0000519,incubation period,,A continuous temporal interval beginning with the extablishment of an infectious agent colony and ending with the onset of symptoms (or infectious disease course?).,false,,,http://purl.obolibrary.org/obo/BFO_0000038,,,,,,,,,,,,,,,,,,,,,A continuous temporal interval beginning with the extablishment of an infectious agent colony and ending with the onset of symptoms (or infectious disease course?).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IDO:0000519,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000038,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/32150748,,time period,,,,http://purl.obolibrary.org/obo/ido.owl,,,,,,,,,,,incubation period,,,,,,,,,,,,,,,,,,,,,,https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/assumptions.html#a2,,,,,,Albert Goldfain|Alexander Diehl|Lindsay Cowell,,,,
http://purl.obolibrary.org/obo/GO_0140014,mitotic nuclear division,,"A mitotic cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell.",false,,,http://purl.obolibrary.org/obo/GO_0000280,,,,,,,,,,,,,,,,pg,2017-03-23T14:44:23Z,,,,"A mitotic cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000280,,,,GO:0140014,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0140014,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,mitotic nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258968,SARS coronavirus TW5,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258968,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000146,two-dimensional continuant fiat boundary,,,false,,,http://purl.obolibrary.org/obo/BFO_0000140,,,,,TwoDimensionalContinuantFiatBoundary,2d-cf-boundary,,,,,,,,,,,,,,,,,,,,,,,,,,a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001]),,,,,,,,,,,(iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000146,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000140,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,two-dimensional continuant fiat boundary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901987,regulation of cell cycle phase transition,cell cycle control|regulation of cell cycle transition,"Any process that modulates the frequency, rate or extent of cell cycle phase transition.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,jl,2013-03-19T16:11:27Z,,,,"Any process that modulates the frequency, rate or extent of cell cycle phase transition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cell cycle control|regulation of cell cycle transition,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1901987,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901987,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of cell cycle phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050283,ORF1ab proteolytic cleavage product (SARS-CoV-2),ORF1ab/ClvPrd (SARS2),A replicase polyprotein 1ab (SARS-CoV-2) that has been processed by proteolytic cleavage.|Category=organism-modification.,false,,,http://purl.obolibrary.org/obo/PR_P0DTD1-1|http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,,A replicase polyprotein 1ab (SARS-CoV-2) that has been processed by proteolytic cleavage.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ORF1ab/ClvPrd (SARS2),,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification.,,http://purl.obolibrary.org/obo/PR_P0DTD1-1|http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050283,,,,,,,,,,,,,,,PR:000050283,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,ORF1ab proteolytic cleavage product (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050266,"spike glycoprotein, signal peptide removed form (SARS-CoV-2)","UniProtKB:P0DTC2, 13-1273|PRO_0000449646|S/SigPep- (SARS2)","A spike glycoprotein (SARS-CoV-2) that has had the signal peptide removed. UniProtKB:P0DTC2, 13-1273.|Category=organism-modification.",false,,,http://purl.obolibrary.org/obo/PR_P0DTC2,,,,,,,,,,,,,,,,,,,,,"A spike glycoprotein (SARS-CoV-2) that has had the signal peptide removed. UniProtKB:P0DTC2, 13-1273.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"UniProtKB:P0DTC2, 13-1273|PRO_0000449646|S/SigPep- (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification.,,http://purl.obolibrary.org/obo/PR_P0DTC2,,,,PR:000050266,,,,,,,,,,,,,,,PR:000050266,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,"spike glycoprotein, signal peptide removed form (SARS-CoV-2)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_742004,Bat SARS coronavirus HKU3-7,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:742004,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001871,Abnormality of blood and blood-forming tissues,Abnormality of the hematopoietic system|Abnormality of blood and blood-forming tissues|Hematological abnormality|Abnormality of the haematopoietic system|Hematologic disease,"An abnormality of the hematopoietic system.|The hematopoietic system comprises the organs that are involved in the production of blood, primarily the bone marrow, spleen, tonsils, and lymph nodes.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,UMLS:C4020864|MSH:D006402|SNOMEDCT_US:34093004|SNOMEDCT_US:191124002|UMLS:C0018939|UMLS:C0850715,An abnormality of the hematopoietic system.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0003135,,,,Abnormality of the hematopoietic system|Abnormality of blood and blood-forming tissues|Hematological abnormality,,,,,human_phenotype,,Abnormality of the haematopoietic system|Hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The hematopoietic system comprises the organs that are involved in the production of blood, primarily the bone marrow, spleen, tonsils, and lymph nodes.",,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0001871,,,,,,,,,,,,,,,HP:0001871,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of blood and blood-forming tissues,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0000722,patient screening,,"A clinical assay that is performed as a preliminary procedure, such as a test or examination, to detect the most characteristic sign or signs of a disorder or a condition that may require further investigation.",false,,,http://purl.obolibrary.org/obo/ERO_0001288,,,,,,,,,,,,,,,,,,,,,"A clinical assay that is performed as a preliminary procedure, such as a test or examination, to detect the most characteristic sign or signs of a disorder or a condition that may require further investigation.",,http://medical-dictionary.thefreedictionary.com/screening,,,,,,,,,,,"Patients are screened during the recruitment process of a clinical trial, to ensure they meet the criteria.",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,ERO:0000722,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0001288,,,,,,,,,,true,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175425/,,population screening,Screening,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,patient screening,,,,,,,,,,,,,,,,,,,,,,https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-glossary-of-terms/,,,,,,PERSON: Nicole Vasilevsky,,,,
http://purl.obolibrary.org/obo/GO_0019072,viral genome packaging,,The encapsulation of the viral genome within the capsid.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,The encapsulation of the viral genome within the capsid.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019072,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32282268,,,,GO:0019072,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral genome packaging,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C50640,Low Blood Oxygen Saturation,"Low Oxygen Saturation|Oxygen Saturation, Low|Low Blood Oxygen Saturation|Desaturation|Saturation, Low Oxygen|Oxygen Saturation Decreased",A low level of the degree to which oxygen is bound to hemoglobin given as a percentage calculated by dividing the maximum oxygen capacity into the actual oxygen content and multiplying by 100. Oxygen saturation usually is measured using pulse oximetry.,false,,,http://purl.obolibrary.org/obo/SYMP_0019139,,A decrease in the concentration of oxyhemoglobin as contrasted to the concentration deoxyhemoglobin in the blood.|The calculated measurements indicating the degree to which oxygen is bound to hemoglobin is low.,,,,,,,,,C50640,,,MedDRA|NICHD|FDA,,,,,,,A low level of the degree to which oxygen is bound to hemoglobin given as a percentage calculated by dividing the maximum oxygen capacity into the actual oxygen content and multiplying by 100. Oxygen saturation usually is measured using pulse oximetry.,,,,,,,,,,,,,,,,Patient Code (Appendix B),,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C54450,,"Low Oxygen Saturation|Oxygen Saturation, Low|Low Blood Oxygen Saturation|Desaturation|Saturation, Low Oxygen|Oxygen Saturation Decreased",,,,http://purl.obolibrary.org/obo/NCIT_C100104,,,,,,,,,NCIT:C50640,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,,,,,,,,,true,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216961|https://www.ncbi.nlm.nih.gov/books/NBK554776/,,decreased oxygen saturation,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C54450|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118464|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C62596,,,,,,,,,,Low Blood Oxygen Saturation,Low_Blood_Oxygen_Saturation,Oxygen saturation low,,,,,,Low Blood Oxygen Saturation,,,,,,,,,,,Low Blood Oxygen Saturation,,,,Finding,,,,,,,,C0746961,
http://purl.obolibrary.org/obo/GO_0060993,kidney morphogenesis,,Morphogenesis of a kidney. A kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,dph,2010-01-19T08:16:55Z,,,,Morphogenesis of a kidney. A kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0060993,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0060993,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,kidney morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042471,ear morphogenesis,hearing organ morphogenesis,"The process in which the anatomical structures of the ear are generated and organized. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.",false,,,http://purl.obolibrary.org/obo/GO_0090596,,,,,,,,,,,,,,,,,,,,,"The process in which the anatomical structures of the ear are generated and organized. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hearing organ morphogenesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0090596,,,,GO:0042471,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042471,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ear morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000038,travel restriction,,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,Intervention,,true,,,,,,"A law preventing people from travelling somewhere, especially preventing a particular person or group from entering a particular country:",Travel ban,,,,,,,,,,,,,,,travel restriction,,,,,,,,,,,,,,,,,,,,,,https://wwwnc.cdc.gov/travel/notices/warning/coronavirus-global,,,,,,,,,,
http://purl.obolibrary.org/obo/MONDO_0024352,viral respiratory tract infection,viral respiratory tract infection,"A respiratory tract infection caused by a virus. Viruses represent the most common causes of upper and lower respiratory tract infections and include rhinoviruses, influenza viruses, parainfluenza viruses, and respiratory syncytial virus.",false,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,,,,,,,,,NCIT:C27219|SCTID:312133006|ICD9:519.8,"A respiratory tract infection caused by a virus. Viruses represent the most common causes of upper and lower respiratory tract infections and include rhinoviruses, influenza viruses, parainfluenza viruses, and respiratory syncytial virus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral respiratory tract infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934,,http://linkedlifedata.com/resource/umls/id/C0877203,http://purl.obolibrary.org/obo/NCIT_C27219|http://identifiers.org/snomedct/312133006,MONDO:0024352,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32293833,,respiratory viral infections,,MONDO:0024352,,http://purl.obolibrary.org/obo/mondo.owl,,,,,,,,,,,viral respiratory tract infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002283,neutrophil activation involved in immune response,neutrophil activation during immune response,"The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.",false,,,http://purl.obolibrary.org/obo/GO_0042119,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,neutrophil activation during immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0042119,,,,GO:0002283,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002283,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neutrophil activation involved in immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045730,respiratory burst,oxidative burst|metabolic burst,"A phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Respiratory_burst,"A phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,oxidative burst|metabolic burst,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0045730,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045730,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,respiratory burst,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051188,cofactor biosynthetic process,cofactor synthesis|cofactor biosynthesis|cofactor anabolism|cofactor formation,"The chemical reactions and pathways resulting in the formation of a cofactor, a substance that is required for the activity of an enzyme or other protein.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a cofactor, a substance that is required for the activity of an enzyme or other protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cofactor synthesis|cofactor biosynthesis|cofactor anabolism|cofactor formation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0051188,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051188,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cofactor biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_235412,SARS coronavirus Sin2679,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:235412,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin2679,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0036338,viral membrane,,"The lipid bilayer of a virion, a complete fully infectious extracellular virus particle.",false,,,http://purl.obolibrary.org/obo/GO_0044423,,,,,,,,,,,,,,,,rfoulger,2012-09-07T13:28:21Z,,,,"The lipid bilayer of a virion, a complete fully infectious extracellular virus particle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044423,,,,GO:0036338,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,GO:0036338,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249066,SARS coronavirus HGZ8L1-A,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249066,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HGZ8L1-A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003326,Myalgia,Muscle ache|Muscle pain|Myalgias,Pain in muscle.,false,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,,,,,,,,,,,,,,,,,MSH:D063806|UMLS:C0231528|SNOMEDCT_US:68962001,Pain in muscle.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0003718,,,,Muscle ache|Muscle pain,,,,,human_phenotype,,Myalgias,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,HP:0003326,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/|https://www.ncbi.nlm.nih.gov/pubmed/31986264,,,,HP:0003326,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Myalgia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032180,Abnormal circulating metabolite concentration,,An abnormal level of an analyte measured in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0001939,,,,,,,,,,,,,,,,peter,,,,,An abnormal level of an analyte measured in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0032180,,,,,,,,,,,,,,,,,,2019-01-12T13:45:59Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001939,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal circulating metabolite concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C1287,Recombinant Granulocyte Colony-Stimulating Factor,Recombinant Granulocyte Colony-Stimulating Factor|rhG-CSF|Recombinant Colony-Stimulating Factor 3,"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine granulocyte colony-stimulating factor (G-CSF).  Secreted by monocytes, macrophages and neutrophils and other cells after activation, G-CSF stimulates the proliferation and differentiation of hematopoietic progenitor cells committed to the neutrophil/ granulocyte lineage. (NCI04)",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,Neutropenia,,,,,,143011-72-7,,,,C1287,,,,,,,,,,"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine granulocyte colony-stimulating factor (G-CSF).  Secreted by monocytes, macrophages and neutrophils and other cells after activation, G-CSF stimulates the proliferation and differentiation of hematopoietic progenitor cells committed to the neutrophil/ granulocyte lineage. (NCI04)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Recombinant Granulocyte Colony-Stimulating Factor|rhG-CSF|Recombinant Colony-Stimulating Factor 3,,,,,,,,,,,,,NCIT:C1287,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Recombinant Granulocyte Colony-Stimulating Factor,Recombinant_Granulocyte_Colony_Stimulating_Factor,,,,,,,,,614371|614629,,,,,,618712,618712,,Recombinant Granulocyte Colony-Stimulating Factor,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,"Immunologic Factor|Amino Acid, Peptide, or Protein",,,,,,,,C0376562,
http://purl.obolibrary.org/obo/GO_0009100,glycoprotein metabolic process,glycoprotein metabolism,"The chemical reactions and pathways involving glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,glycoprotein metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0009100,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009100,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila,,,,,,,,,,glycoprotein metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_76804,Nidovirales,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_order,,,,,,,NCBITaxon:76804,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Nidovirales,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000034,function,,,false,,,http://purl.obolibrary.org/obo/BFO_0000016,,,,,Function,function,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: In the past, we have distinguished two varieties of function, artifactual function and biological function. These are not asserted subtypes of BFO:function however, since the same function – for example: to pump, to transport – can exist both in artifacts and in biological entities. The asserted subtypes of function that would be needed in order to yield a separate monoheirarchy are not artifactual function, biological function, etc., but rather transporting function, pumping function, etc.",,,"A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001])",,the function of amylase in saliva to break down starch into sugar|the function of a heart pacemaker to regulate the beating of a heart through electricity|the function of a hammer to drive in nails,,,,,,,,,(forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000034,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000016,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,function,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044262,cellular carbohydrate metabolic process,cellular carbohydrate metabolism|main pathways of carbohydrate metabolism|main pathways of carbohydrate metabolic process,"The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0006092,,,,cellular carbohydrate metabolism,,,main pathways of carbohydrate metabolism|main pathways of carbohydrate metabolic process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0044262,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044262,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cellular carbohydrate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0006925,digestive system gland,digestive gland,Any gland that is part of the digestive system.,false,,,http://purl.obolibrary.org/obo/UBERON_0002368|http://purl.obolibrary.org/obo/UBERON_0013765,,,,,,,,,,,,,,,,,,,,BTO:0000345|AAO:0000130,Any gland that is part of the digestive system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,digestive gland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0002368|http://purl.obolibrary.org/obo/UBERON_0013765,,,,UBERON:0006925,,,,,,,,,,,,,,,UBERON:0006925,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim,,,,,,,,,,digestive system gland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007113,TMPRSS2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PRSS10|PP9284,,,,,,,21,,,,,,,,,,Vega:OTTHUMG00000086762|Ensembl:ENSG00000184012|HGNC:11876|HPRD:03637|MIM:602060,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"transmembrane protease, serine 2",,21q22.3,,,,"GO_0004252 (EC: IEA); GO_0005044 (EC: IEA); GO_0005887 (EC: TAS, PMID: 9325052); GO_0008236 (EC: TAS, PMID: 9325052); GO_0070062 (EC: IDA, PMID: 19056867)",PMID: 8125298; 9325052; 10485450; 10830953; 11169526; 11245484; 11322890; 11414763; 12477932; 15065083; 15342556; 15489334; 15537383; 16575875; 16585160; 16820092; 16973594; 17032499; 17207965; 17367471; 17390040; 17584912; 17632455; 17654723; 17804708; 18029348; 18065961; 18172298; 18385909; 18474293; 18483239; 18519767; 18519769; 18562527; 18583469; 18676740; 18694509; 18922926; 19029822; 19056867; 19147579; 19158246; 19190343; 19242826; 19396154; 19465903; 19494719; 19584163; 19597533; 19649210; 19664128; 19762545; 19933109; 20068566; 20118910; 20382709; 20442300; 20631123; 20798944; 20800881; 20878952; 21036922; 21040948; 21068237; 21123387; 21169414; 21325420; 21377967; 21499238; 21584900; 21600800; 21676887; 21677539; 21680704; 21731703; 21743434; 21743959; 21802835; 21937078; 22076164; 22222211; 22313860; 22558251; 22674214; 22736790; 22860005; 22930729; 22993300; 23192872; 23352841; 23447416; 23472063; 23535644; 23536651; 23701505; 23850495; 24027332; 24195515; 24227843; 24292212; 24297949,,,,,,,,,,,,,,,,,,OGG:3000007113,,,,,,,,,,,,,,,,,,,"transmembrane protease, serine 2",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32276929,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TMPRSS2,,,20140408,7113,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TMPRSS2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0007094,mitotic spindle assembly checkpoint,mitotic cell cycle spindle assembly checkpoint|Dma1-dependent checkpoint|Mad2-dependent checkpoint|SAC-independent checkpoint,A cell cycle checkpoint that delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and chromosomes are attached to the spindle.,false,,,http://purl.obolibrary.org/obo/GO_0045841|http://purl.obolibrary.org/obo/GO_0071173|http://purl.obolibrary.org/obo/GO_0071174,,,,,,,,,,,,,,,,,,,,,A cell cycle checkpoint that delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and chromosomes are attached to the spindle.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0044810,,,,mitotic cell cycle spindle assembly checkpoint,,,Dma1-dependent checkpoint|Mad2-dependent checkpoint|SAC-independent checkpoint,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0045841|http://purl.obolibrary.org/obo/GO_0071173|http://purl.obolibrary.org/obo/GO_0071174,,,,GO:0007094,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007094,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic spindle assembly checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0007100,primary circulatory organ,heart|dorsal tube|adult heart,"A hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood or analogs[GO,modified].|Gene notes: Bmp, Nkx, Gata",false,,,http://purl.obolibrary.org/obo/UBERON_0015228,,,,,,,,,,,,,,,,,,,,TADS:0000147|FBbt:00003154|SPD:0000130|http://www.sciencemag.org/content/313/5795/1922/F1.large.jpg,"A hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood or analogs[GO,modified].",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,heart|dorsal tube,,uberon,,adult heart,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Gene notes: Bmp, Nkx, Gata",,http://purl.obolibrary.org/obo/UBERON_0015228,,,,UBERON:0007100,,,,,,,,,,,,,,,UBERON:0007100,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,primary circulatory organ,,,,,,,,,,,,,,,,,,,,,,,,,,,"note we reserve the subclass 'heart' from the vertebrate multi-chambered heart. 'The first heart-like organ is believed to have appeared 500my ago in an ancestral bilaterian'. Amniotes: four-chambered heart. Amphibians: two atria, one ventricle, pulmonary; fish: single atrium and ventricle; amphioxus: tubular, non-striated, closed, unidirectional; ascidians: tubular, striated, open, bidirectional; arthropods: tubular, open; C elegans: contractile pharynx; Cnideria: striated muscle cells associated with gastrodermis",,,,,
http://purl.obolibrary.org/obo/CHEBI_145994,remdesivir,"2-ethylbutyl N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alaninate|(2S)-2-{(2R,3S,4R,5R)-[5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]phenoxy-(S)-phosphorylamino}propionic acid 2-ethyl-butyl ester|2-ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate|remdesivirum|remdesivir|GS 5734|GS-5734|GS5734","A carboxylic ester resulting from the formal condensation of the carboxy group of N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alanine with the hydroxy group of 2-ethylbutan-1-ol. A broad-spectrum antiviral prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus, MERS-CoV and SARS-CoV. It is currently in Phase III clinical trials for the treatment of Covid-19 in adults.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:31924756|PMID:32147516|PMID:26934220|PMID:32152082|PMID:32094225|PMID:30275474|PMCID:PMC5630887|CAS:1809249-37-3|Wikipedia:Remdesivir|PMID:32145386|PMID:31142680|DrugBank:DB14761|PMID:30987343|PMID:29511076|PMID:28262699|KEGG:D11472|PMID:32054787|PMID:31233808|PMID:32020029|PMID:28124907|PMID:28659436,"A carboxylic ester resulting from the formal condensation of the carboxy group of N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alanine with the hydroxy group of 2-ethylbutan-1-ol. A broad-spectrum antiviral prodrug with potent in vitro antiviral activity against a diverse panel of RNA viruses such as Ebola virus, MERS-CoV and SARS-CoV. It is currently in Phase III clinical trials for the treatment of Covid-19 in adults.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2-ethylbutyl N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alaninate",,,,,chebi_ontology,,"(2S)-2-{(2R,3S,4R,5R)-[5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]phenoxy-(S)-phosphorylamino}propionic acid 2-ethyl-butyl ester|2-ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate|remdesivirum|remdesivir|GS 5734|GS-5734|GS5734",,,,,,,,,0,C27H35N6O8P,"InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1",RWWYLEGWBNMMLJ-YSOARWBDSA-N,602.585,602.22540,[C@]1(O[C@@H]([C@H]([C@H]1O)O)CO[P@@](N[C@H](C(OCC(CC)CC)=O)C)(OC=2C=CC=CC2)=O)(C#N)C=3N4N=CN=C(C4=CC3)N,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:145994,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32309622,,,,CHEBI:145994,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,remdesivir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001889,liver development,,"The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.",false,,,http://purl.obolibrary.org/obo/GO_0048732,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0048732,,,,GO:0001889,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001889,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,liver development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0006532,Recurrent pneumonia,"Pulmonary infections|Pulmonary infection|Recurrent pulmonary infections|Recurrent pneumonia|Multiple pulmonary infections|Pneumonia, recurrent episodes|pulmonary infections, recurrent|Pneumonia, recurrent","An increased susceptibility to pneumonia as manifested by a history of recurrent episodes of pneumonia.|Recurrent pneumonia is defined as two or more episodes in a single year, or at least three episodes ever, with radiographic clearing of densities between occurrences.",false,,,http://purl.obolibrary.org/obo/HP_0002783,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:699014000|UMLS:C0876973|UMLS:C1859117|UMLS:C0694550|SNOMEDCT_US:128601007|UMLS:C0748140,An increased susceptibility to pneumonia as manifested by a history of recurrent episodes of pneumonia.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0002096|HP:0002095,,,,"Pulmonary infections|Pulmonary infection|Recurrent pulmonary infections|Recurrent pneumonia|Multiple pulmonary infections|Pneumonia, recurrent episodes|pulmonary infections, recurrent|Pneumonia, recurrent",,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Recurrent pneumonia is defined as two or more episodes in a single year, or at least three episodes ever, with radiographic clearing of densities between occurrences.",,http://purl.obolibrary.org/obo/HP_0002783,,,,HP:0006532,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32220422,,,,HP:0006532,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Recurrent pneumonia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003458,IFNG,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IFG|IFI,,,,,,,12,,,,,,,,,,HGNC:5438|Vega:OTTHUMG00000169113|HPRD:00957|Ensembl:ENSG00000111537|MIM:147570,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interferon, gamma",,12q14,,,,"GO_0000060 (EC: IDA, PMID: 15604419); GO_0000122 (EC: ISS); GO_0001781 (EC: IEA); GO_0002026 (EC: IEA); GO_0002053 (EC: ISS); GO_0002250 (EC: IBA); GO_0002302 (EC: IEA); GO_0003340 (EC: ISS); GO_0005125 (EC: IBA); GO_0005133 (EC: IEA); GO_0005576 (EC: IDA); GO_0005576 (EC: TAS); GO_0005615 (EC: IBA); GO_0006915 (EC: IGI, PMID: 7828849); GO_0006928 (EC: TAS, PMID: 10477596); GO_0006959 (EC: IBA); GO_0007050 (EC: IDA, PMID: 16942485); GO_0007166 (EC: TAS, PMID: 10477596); GO_0009615 (EC: IDA, PMID: 16280321); GO_0009897 (EC: IEA); GO_0019221 (EC: TAS); GO_0019882 (EC: IEA); GO_0030593 (EC: IEA); GO_0030968 (EC: IEA); GO_0031642 (EC: IEA); GO_0032224 (EC: IEA); GO_0032700 (EC: IDA, PMID: 18501882); GO_0032735 (EC: IDA, PMID: 7605994); GO_0032747 (EC: IDA); GO_0032760 (EC: IEA); GO_0033141 (EC: IDA, PMID: 16280321); GO_0033141 (EC: NAS); GO_0034393 (EC: IDA, PMID: 16942485); GO_0042102 (EC: IEA); GO_0042493 (EC: IEA); GO_0042511 (EC: IDA, PMID: 15604419); GO_0042742 (EC: IEA); GO_0042832 (EC: IEA); GO_0044130 (EC: IEA); GO_0045080 (EC: IEA); GO_0045084 (EC: IEA); GO_0045348 (EC: IEA); GO_0045410 (EC: IEA); GO_0045429 (EC: IDA, PMID: 8383325); GO_0045666 (EC: IEA); GO_0045672 (EC: IDA, PMID: 16220542); GO_0045785 (EC: IEA); GO_0045944 (EC: IEA); GO_0048304 (EC: IEA); GO_0048662 (EC: IDA, PMID: 16942485); GO_0050718 (EC: IEA); GO_0050796 (EC: IDA, PMID: 8383325); GO_0051044 (EC: IDA, PMID: 18373975); GO_0051607 (EC: IEA); GO_0051712 (EC: IDA, PMID: 7544003); GO_0060333 (EC: TAS); GO_0060334 (EC: TAS); GO_0060550 (EC: IDA, PMID: 9282826); GO_0060552 (EC: IDA, PMID: 9282826); GO_0060557 (EC: IDA, PMID: 9282826); GO_0060559 (EC: IDA, PMID: 9282826); GO_0071222 (EC: IEA); GO_0071351 (EC: IEA); GO_0072308 (EC: ISS); GO_0097191 (EC: IDA, PMID: 16942485); GO_2000309 (EC: IDA, PMID: 16220542)",PMID: 1400376; 1525157; 1662603; 1708818; 1902591; 1905933; 1905983; 2452186; 2504704; 2514776; 2860101; 3109913; 3139842; 6173769; 6176945; 6180322; 6305337; 6329718; 6427223; 7511078; 7523014; 7526537; 7544003; 7583919; 7587386; 7590734; 7605994; 7617032; 7673114; 7815507; 7818827; 7828849; 7904170; 7941321; 8065455; 8102828; 8188658; 8247028; 8345204; 8383325; 8537091; 8557999; 8598486; 8619916; 8631301; 8648753; 8661419; 8679287; 8706326; 8760410; 8764000; 8765022; 8769094; 8809126; 8974399; 9108403; 9225992; 9282826; 9534962; 9651359; 9658081; 9712080; 9743208; 9916748; 10358150; 10388525; 10438928; 10446807; 10477596; 10775602; 10860730; 10933622; 10986460; 11240951; 11250200; 11266927; 11266928; 11292301; 11298489; 11298547; 11315919; 11316066; 11354638; 11391238; 11404167; 11528517; 11544427; 11544434; 11700035; 11751951; 11755617; 11772518; 11774563; 11781187; 11781192; 11786536; 11796707; 11821159; 11830476; 11831440; 11841489; 11854199; 11854210; 11857052; 11857344; 11861290; 11865054; 11876761; 11900986; 11906646; 11920321; 11936954; 11943142; 11947926; 11953317; 11964313; 11966872; 11970958; 11980899; 11981433; 11984595; 11986281; 11986939; 11991675; 12006410; 12011077; 12020266; 12042661; 12047360; 12050152; 12060750; 12070781; 12084660; 12089333; 12089714; 12097398; 12102661; 12105273; 12162871; 12162874; 12165521; 12170266; 12191570; 12192641; 12203138; 12209087; 12219025; 12223098; 12223516; 12232842; 12239181; 12296868; 12358843; 12366695; 12368207; 12370350; 12370385; 12377943; 12389079; 12393446; 12394188; 12401479; 12420205; 12438348; 12438388; 12441140; 12444137; 12451269; 12471139; 12473063; 12477932; 12479817; 12486605; 12507818; 12526950; 12531694; 12531774; 12533683; 12542496; 12548511; 12552499; 12555203; 12558814; 12579348; 12581491; 12588705; 12590978; 12594832; 12595908; 12609526; 12615834; 12633940; 12645529; 12653164; 12700631; 12727482; 12727483; 12738388; 12750172; 12751024; 12754213; 12761564; 12788307; 12788577; 12794718; 12804771; 12813035; 12818128; 12819637; 12850811; 12851716; 12854077; 12890425; 12909463; 12914676; 12917425; 12928400; 12938195; 12944981; 12960156; 12965263; 12968017; 12975380; 14499500; 14511565; 14514772; 14522096; 14558082; 14566095; 14601649; 14602571; 14607827; 14607900; 14607968; 14625191; 14631168; 14661818; 14675394; 14675398; 14681912; 14688135; 14690454; 14692664; 14694183; 14698136; 14704034; 14734640; 14734771; 14753294; 14872501; 14959851; 14962095; 14969768; 14976609; 14978096; 14988089; 14992891; 14993214; 15004750; 15007355; 15018649; 15019280; 15041164; 15051500; 15066699; 15068623; 15078471; 15115662; 15120189; 15135368; 15162834; 15166131; 15170937; 15182335; 15189946; 15194285; 15200452; 15207246; 15214940; 15215891; 15235581; 15247172; 15251440; 15265425; 15271977; 15297269; 15316224; 15320903; 15322002; 15322007; 15324937; 15327519; 15345584; 15347683; 15361128; 15361241; 15367434; 15372109; 15374002; 15381817; 15390286; 15448160; 15458467; 15462469; 15481145; 15489334; 15498860; 15499631; 15501397; 15511228; 15522880; 15550390; 15556691; 15570643; 15580300; 15585559; 15599305; 15603866; 15604419; 15611657; 15621151; 15624893; 15628695; 15634895; 15638726; 15643599; 15644127; 15652446; 15661939; 15674394; 15675129; 15679925; 15681246; 15681825; 15695523; 15708894; 15709194; 15710386; 15718915; 15725351; 15731046; 15733644; 15737643; 15749687; 15763337; 15773449; 15778222; 15780879; 15784411; 15800938; 15811521; 15815688; 15816837; 15818327; 15841043; 15842590; 15853924; 15858598; 15870936; 15880044; 15890243; 15900487; 15901906; 15905622; 15919929; 15925543; 15931634; 15932621; 15932627; 15935691; 15936090; 15941525; 15944226; 15944319; 15950283; 15969687; 15979955; 15985639; 15992611; 16002423; 16014948; 16024776; 16024856; 16034083; 16051062; 16051377; 16051797; 16085646; 16098562; 16108727; 16115485; 16127458; 16129616; 16148108; 16148152; 16160188; 16166103; 16182624; 16183136; 16200827; 16201318; 16204617; 16210653; 16216674; 16220542; 16232344; 16243534; 16257975; 16263796; 16266858; 16280321; 16302211; 16310045; 16318585; 16323127; 16364177; 16367922; 16375755; 16378074; 16386594; 16391178; 16403098; 16409297; 16410273; 16421220; 16425360; 16427044; 16427155; 16430971; 16433832; 16434471; 16474934; 16476013; 16478776; 16484229; 16487026; 16487180; 16493441; 16504056; 16538877; 16540751; 16567828; 16574426; 16616105; 16621981; 16647017; 16672072; 16678358; 16681592; 16689860; 16690980; 16704689; 16718821; 16720107; 16723718; 16724074; 16730575; 16737571; 16754651; 16762155; 16785527; 16820703; 16824159; 16861661; 16861684; 16863661; 16873363; 16889932; 16897354; 16903774; 16914208; 16916659; 16919160; 16930778; 16938461; 16938650; 16942485; 16944293; 16950634; 16961714; 16962335; 16966412; 16970687; 16984280; 17002607; 17006334; 17013806; 17013989; 17015683; 17021766; 17023015; 17026468; 17028199; 17033822; 17035315; 17049266; 17082625; 17097497; 17110450; 17117487; 17121582; 17136124; 17138053; 17138064; 17142750; 17142760; 17145371; 17148586; 17152005; 17154717; 17159260; 17180012; 17182600; 17198275; 17207568; 17209781; 17211638; 17215337; 17215375; 17215524; 17217140; 17227821; 17237409; 17238853; 17257312; 17261759; 17262717; 17266440; 17276141; 17300840; 17301401; 17304101; 17347451; 17348243; 17355643; 17363708; 17363736; 17373677; 17376993; 17388919; 17392024; 17392368; 17405833; 17441979; 17444864; 17454884; 17456233; 17470541; 17477815; 17495004; 17498265; 17509455; 17521325; 17521731; 17532201; 17544674; 17546485; 17552041; 17553352; 17566759; 17572155; 17582674; 17600593; 17612762; 17613714; 17627763; 17640674; 17641021; 17641061; 17654453; 17655693; 17656678; 17674321; 17682837; 17697145; 17697357; 17700165; 17703412; 17709420; 17713715; 17714919; 17719815; 17728221; 17765942; 17786190; 17827383; 17845304; 17846855; 17852079; 17875674; 17878156; 17885647; 17889143; 17900510; 17911610; 17916356; 17922402; 17936906; 17937104; 17940602; 17947510; 17953379; 17960405; 17974504; 17976320; 17981204; 17986123; 17986321; 17988266; 17988330; 17989610; 17994425; 17996064; 18039196; 18041006; 18051824; 18056971; 18062835; 18062910; 18070901; 18077789; 18091521; 18158121; 18174230; 18174256; 18174382; 18192275; 18199488; 18199828; 18199975; 18205804; 18209080; 18209488; 18230112; 18249037; 18263601; 18266836; 18275276; 18275349; 18276105; 18279717; 18286551; 18287876; 18287963; 18300036; 18300344; 18307517; 18312596; 18322182; 18332247; 18337305; 18339625; 18339897; 18361934; 18361939; 18365030; 18366487; 18368485; 18373975; 18375019; 18385742; 18385764; 18388182; 18388249; 18390192; 18394346; 18410260; 18414664; 18414898; 18417583; 18426658; 18476609; 18485114; 18497880; 18501882; 18502564; 18506884; 18512784; 18514317; 18519231; 18521569; 18522869; 18525269; 18533937; 18539368; 18547161; 18548239; 18550653; 18556463; 18560378; 18560870; 18568448; 18569454; 18571695; 18572307; 18576303; 18579762; 18580959; 18582197; 18589089; 18593330; 18593367; 18600325; 18614592; 18620489; 18627514; 18632425; 18633131; 18633332; 18639520; 18641361; 18655181; 18660489; 18663124; 18670216; 18672993; 18676680; 18678243; 18678988; 18680515; 18684979; 18693134; 18708162; 18708672; 18712791; 18773331; 18776133; 18787531; 18789440; 18792803; 18793716; 18793860; 18802076; 18802113; 18805021; 18806746; 18818748; 18820938; 18832710; 18842170; 18843763; 18923705; 18932275; 18937577; 18941172; 18945465; 18945831; 18953482; 18972297; 18976633; 18989229; 19005292; 19010294; 19012493; 19019335; 19031096; 19058987; 19065267; 19066394; 19071156; 19074829; 19074885; 19089914; 19089920; 19091593; 19095736; 19096039; 19101991; 19109132; 19116009; 19117745; 19121222; 19122650; 19122664; 19124156; 19126646; 19129484; 19135418; 19141860; 19149916; 19152246; 19155099; 19160541; 19168733; 19170196; 19172849; 19177264; 19189859; 19190772; 19192232; 19199539; 19200845; 19207121; 19210359; 19225954; 19227440; 19231233; 19232001; 19236347; 19247692; 19250279; 19254267; 19255340; 19258311; 19258593; 19258635; 19258923; 19264674; 19264973; 19269302; 19269948; 19274101; 19279332; 19279357; 19289181; 19297619; 19306922; 19317046; 19332120; 19336263; 19336370; 19336475; 19339796; 19340290; 19358670; 19370405; 19372249; 19372459; 19375805; 19386363; 19386798; 19401385; 19403671; 19408823; 19419945; 19426601; 19427704; 19428330; 19437232; 19450146; 19450149; 19457071; 19458616; 19461480; 19470040; 19472212; 19479051; 19480854; 19481774; 19488421; 19489682; 19495883; 19505916; 19508433; 19527514; 19536281; 19543959; 19547871; 19552791; 19559726; 19586939; 19592490; 19594368; 19596857; 19597472; 19608431; 19622834; 19625176; 19626047; 19634484; 19639725; 19642044; 19652739; 19657406; 19665935; 19681846; 19682920; 19683555; 19692168; 19696431; 19706920; 19707556; 19710464; 19723394; 19727876; 19729799; 19733878; 19735490; 19747638; 19756986; 19757192; 19757302; 19759281; 19765856; 19766898; 19768696; 19773451; 19773677; 19789190; 19796538; 19813110; 19818655; 19822083; 19822293; 19840475; 19858302; 19860911; 19861015; 19861016; 19879772; 19890236; 19893204; 19913121; 19913506; 19917178; 19918044; 19919944; 19929378; 19934306; 19934811; 19938203; 19938975; 19940027; 19941336; 19948975; 19958312; 19959217; 19960790; 20001857; 20004112; 20004979; 20008289; 20027291; 20028654; 20030937; 20038203; 20055726; 20056084; 20059579; 20061995; 20067407; 20082482; 20097948; 20100010; 20105444; 20110463; 20123968; 20130213; 20131287; 20145925; 20154512; 20167631; 20177758; 20178622; 20186935; 20194818; 20196868; 20207982; 20213229; 20217044; 20228669; 20228799; 20230666; 20231691; 20231901; 20237496; 20303284; 20305143; 20331378; 20331838; 20345984; 20348497; 20349753; 20353805; 20359550; 20367137; 20368273; 20368278; 20370995; 20375623; 20379614; 20381453; 20388088; 20394835; 20404426; 20415786; 20418110; 20419805; 20443055; 20453000; 20477883; 20482522; 20484443; 20484656; 20484876; 20485444; 20503287; 20504369; 20510064; 20511558; 20525893; 20530519; 20531015; 20533927; 20535218; 20544370; 20565368; 20574006; 20580745; 20581146; 20586818; 20587546; 20587610; 20588103; 20588308; 20596075; 20603050; 20625487; 20628086; 20636896; 20640364; 20644110; 20653995; 20655098; 20665551; 20666952; 20685939; 20696832; 20711808; 20714752; 20720198; 20720222; 20720564; 20722470; 20726231; 20732366; 20799037; 20808133; 20809185; 20811626; 20814675; 20817868; 20821074; 20825427; 20828526; 20839488; 20848535; 20849534; 20875052; 20883321; 20888416; 20889558; 20889566; 20932510; 20934357; 20939703; 20949125; 20953611; 20958339; 20959405; 20960273; 20974954; 20974955; 20979795; 20980339; 21037509; 21061434; 21067601; 21078084; 21082024; 21084489; 21085635; 21086908; 21090238; 21094940; 21099673; 21112094; 21115099; 21117871; 21127885; 21127993; 21132384; 21149447; 21161299; 21167738; 21168725; 21179438; 21183733; 21189447; 21196650; 21199896; 21204904; 21211989; 21215074; 21215285; 21224476; 21226554; 21229844; 21239188; 21248298; 21271775; 21281983; 21282066; 21288140; 21297633; 21323572; 21323660; 21332391; 21334249; 21368230; 21381020; 21385594; 21403886; 21418620; 21423578; 21427975; 21430066; 21433155; 21440743; 21441456; 21458658; 21470497; 21477169; 21487893; 21491089; 21493784; 21505270; 21510811; 21515918; 21531896; 21533215; 21540006; 21562161; 21562768; 21572044; 21586573; 21591983; 21613464; 21622562; 21641233; 21649525; 21658970; 21659535; 21669226; 21688665; 21703188; 21711552; 21712100; 21719187; 21721104; 21724697; 21725055; 21728784; 21729551; 21752694; 21755390; 21772053; 21774972; 21778700; 21798578; 21798758; 21802664; 21805152; 21819478; 21829141; 21847627; 21857377; 21858117; 21864611; 21872231; 21873264; 21917128; 21926633; 21930700; 21931651; 21937453; 21940994; 21949691; 21962843; 21966356; 21966367; 22037448; 22041017; 22045868; 22057682; 22058328; 22069319; 22075702; 22079980; 22095765; 22117500; 22137120; 22140472; 22143036; 22163006; 22172723; 22189538; 22194871; 22221541; 22226324; 22228808; 22263663; 22268679; 22283891; 22323453; 22325340; 22327783; 22350281; 22358381; 22378844; 22385244; 22392581; 22395607; 22410067; 22410761; 22416258; 22422499; 22426116; 22444955; 22447512; 22465880; 22466287; 22474288; 22484483; 22487478; 22496218; 22526675; 22554587; 22564607; 22587568; 22610275; 22622197; 22623148; 22624006; 22647601; 22672824; 22673732; 22677194; 22683002; 22684265; 22685317; 22691562; 22698804; 22699677; 22704696; 22706089; 22711893; 22718836; 22727646; 22731611; 22738830; 22740319; 22748084; 22749533; 22753928; 22757586; 22759859; 22766105; 22767256; 22778764; 22784413; 22805115; 22809599; 22814515; 22815836; 22824211; 22826629; 22847200; 22851706; 22880090; 22882906; 22885102; 22896630; 22898392; 22924705; 22932225; 22952667; 22983442; 22983646; 22986484; 22992806; 23028695; 23040881; 23045477; 23061992; 23071273; 23077565; 23101722; 23107828; 23125442; 23128233; 23133532; 23133672; 23139419; 23152883; 23159874; 23179933; 23185315; 23213275; 23223131; 23224615; 23240025; 23243276; 23252864; 23253667; 23255246; 23259293; 23265966; 23271704; 23280240; 23289765; 23295883; 23321919; 23343479; 23349093; 23359533; 23362867; 23378427; 23388331; 23401468; 23404187; 23412855; 23416458; 23449998; 23460743; 23461851; 23462597; 23487038; 23507374; 23582260; 23592910; 23632060; 23638863; 23639073; 23685791; 23692034; 23711712; 23720660; 23737189; 23740952; 23785756; 23786562; 23793505; 23803376; 23806637; 23811275; 23857000; 23874969; 23880295; 23891168; 23901078; 23998448; 24012417; 24055710; 24088808; 24140406; 24313836; 24459820,,,,,,,,,,,,,,,,,,OGG:3000003458,,,,,,,,,,,,,,,,,,,"interferon, gamma",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IFNG,,,20140408,3458,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IFNG,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_285949,SARS coronavirus civet020,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:285949,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus civet020,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075512,clathrin-dependent endocytosis of virus by host cell,clathrin-mediated endocytosis of virus by host cell|viral penetration via clathrin-mediated endocytosis|viral entry into host cell via clathrin-mediated endocytosis followed by endosome lysis|viral entry into host cell via clathrin-mediated endocytosis,"Any clathrin-mediated endocytosis that is involved in the uptake of a virus into a host cell. Begins by invagination of a specific region of the host cell plasma membrane around the bound virus to form a clathrin-coated pit, which then pinches off to form a clathrin-coated endocytic vesicle containing the virus.",false,,,http://purl.obolibrary.org/obo/GO_0075509|http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,janelomax,2011-07-27T02:08:54Z,,,VZ:957,"Any clathrin-mediated endocytosis that is involved in the uptake of a virus into a host cell. Begins by invagination of a specific region of the host cell plasma membrane around the bound virus to form a clathrin-coated pit, which then pinches off to form a clathrin-coated endocytic vesicle containing the virus.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0075516,,,,clathrin-mediated endocytosis of virus by host cell|viral penetration via clathrin-mediated endocytosis,,,viral entry into host cell via clathrin-mediated endocytosis followed by endosome lysis,,biological_process,,viral entry into host cell via clathrin-mediated endocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0075509|http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0075512,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226,,,,GO:0075512,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,clathrin-dependent endocytosis of virus by host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005769,early endosome,,A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:nlx_subcell_20090701,A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005769,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005769,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,early endosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000072,BEL based model,,,false,,,http://identifiers.org/mamo/MAMO_0000023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://identifiers.org/mamo/MAMO_0000023,,,,,,,,Model,,true,,,,,,Biological expression language (BEL) has been developed to allow the representation of the huge variety of causal relationships expressed in the literature.,BEL-based approach,,,,,,,,,,,,,,,BEL based model,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.04.14.040667v1,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011042,Abnormal blood potassium concentration,Abnormality of potassium homeostasis|Abnormal blood K concentration,An abnormal concentration of potassium.,false,,,http://purl.obolibrary.org/obo/HP_0010930,,,,,,,,,,,,,,,,peter,2011-03-09T11:00:32Z,,,UMLS:C4023575,An abnormal concentration of potassium.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of potassium homeostasis|Abnormal blood K concentration,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010930,,,,HP:0011042,,,,,,,,,,,,,,,HP:0011042,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal blood potassium concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005770,late endosome,PVC|prevacuolar compartment,"A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:nlx_subcell_20090702,"A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.",,,,,,,,,,,,,,,,,,,,,,,,,,,,PVC,,,prevacuolar compartment,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005770,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005770,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,late endosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_2000002759,gene of Eukaryota,,A gene of an organism of Eukaryota,false,,,http://purl.obolibrary.org/obo/OGG_0000000002,,,,,,,,,,,,,,,,,,,,,A gene of an organism of Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGG:2000002759,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_0000000002,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,gene of Eukaryota,,,,,,,,,,,,,,,2759,,,,,,,,,,,,,"Yue Liu, Bin Zhao, Oliver He",,,,
http://purl.obolibrary.org/obo/GO_0042273,ribosomal large subunit biogenesis,ribosomal large subunit biogenesis and assembly,"A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a large ribosomal subunit; includes transport to the sites of protein synthesis.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a large ribosomal subunit; includes transport to the sites of protein synthesis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribosomal large subunit biogenesis and assembly,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042273,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042273,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,ribosomal large subunit biogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_82941,fosamprenavir,"(3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-phenyl-3-(phosphonooxy)butan-2-yl]carbamate|FOS-APV|fosamprenavir","A sulfonamide with a structure based on that of sulfanilamide substituted on the sulfonamide nitrogen by a (2R,3S)-4-phenyl-2-(phosphonooxy)-3-({[(3S)-tetrahydrofuran-3-yloxy]carbonyl}amino)butyl group. It is a pro-drug of the HIV protease inhibitor and antiretroviral drug amprenavir.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:24929949|Wikipedia:Fosamprenavir|Drug_Central:1240|PMID:23314414|PMID:25155604|PMID:16890834|HMDB:HMDB0015416|PMID:24741696|PMID:25017682|CAS:226700-79-4|KEGG:D02497|PMID:23811744|DrugBank:DB01319|PMID:22100576|Reaxys:9824450,"A sulfonamide with a structure based on that of sulfanilamide substituted on the sulfonamide nitrogen by a (2R,3S)-4-phenyl-2-(phosphonooxy)-3-({[(3S)-tetrahydrofuran-3-yloxy]carbonyl}amino)butyl group. It is a pro-drug of the HIV protease inhibitor and antiretroviral drug amprenavir.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-phenyl-3-(phosphonooxy)butan-2-yl]carbamate",,,,,chebi_ontology,,FOS-APV|fosamprenavir,,,,,,,,,0,C25H36N3O9PS,"InChI=1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1",MLBVMOWEQCZNCC-OEMFJLHTSA-N,585.60700,585.19099,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:82941,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:82941,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,fosamprenavir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_293936,SARS coronavirus PC4-227,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:293936,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-227,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0099024,plasma membrane invagination,,An infolding of the plasma membrane.,false,,,http://purl.obolibrary.org/obo/GO_0010324,,,,,,,,,,,,,,,,,,,,,An infolding of the plasma membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0010324,,,,GO:0099024,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0099024,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,plasma membrane invagination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012647,Abnormal inflammatory response,Abnormal inflammatory response,"Any anomaly of the inflammatory response, a response to injury or infection characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.",false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,peter,2014-02-01T01:25:42Z,,,UMLS:C4022805,"Any anomaly of the inflammatory response, a response to injury or infection characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal inflammatory response,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,HP:0012647,,,,,,,,,,,,,,,HP:0012647,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000332,BIRC5,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,EPR-1|API4,,,,,,,17,,,,,,,,,,MIM:603352|HGNC:593|Vega:OTTHUMG00000177505|Ensembl:ENSG00000089685|HPRD:04520,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,baculoviral IAP repeat containing 5,,17q25,,,,"GO_0000086 (EC: IDA, PMID: 9859993); GO_0000228 (EC: IDA, PMID: 16322459); GO_0000278 (EC: TAS); GO_0000775 (EC: IDA, PMID: 11084331); GO_0000777 (EC: IDA, PMID: 15665297); GO_0000910 (EC: IMP, PMID: 12805209); GO_0004869 (EC: IEA); GO_0005515 (EC: IPI, PMID: 11069302); GO_0005634 (EC: IDA, PMID: 15665297); GO_0005737 (EC: IDA); GO_0005814 (EC: IDA, PMID: 9859993); GO_0005819 (EC: IEA); GO_0005829 (EC: IDA, PMID: 12773388); GO_0005829 (EC: TAS); GO_0005874 (EC: IEA); GO_0005876 (EC: IDA, PMID: 11069302); GO_0005881 (EC: IDA, PMID: 9859993); GO_0006351 (EC: IEA); GO_0006468 (EC: IDA); GO_0006915 (EC: IEA); GO_0007059 (EC: IEA); GO_0007067 (EC: IEA); GO_0007067 (EC: TAS, PMID: 16291752); GO_0008017 (EC: IDA, PMID: 9859993); GO_0008017 (EC: TAS); GO_0008270 (EC: IDA, PMID: 10876248); GO_0008270 (EC: NAS, PMID: 10949039); GO_0008284 (EC: TAS, PMID: 16344111); GO_0008536 (EC: IPI, PMID: 18591255); GO_0015631 (EC: IDA, PMID: 9859993); GO_0019899 (EC: IPI, PMID: 16322459); GO_0030496 (EC: IDA, PMID: 11069302); GO_0031021 (EC: IDA, PMID: 9859993); GO_0031503 (EC: IMP, PMID: 16239925); GO_0031536 (EC: IMP, PMID: 12805209); GO_0031577 (EC: IMP, PMID: 12805209); GO_0032133 (EC: IPI, PMID: 15260989); GO_0042802 (EC: IPI, PMID: 16291752); GO_0042803 (EC: IDA, PMID: 10876248); GO_0042803 (EC: IPI, PMID: 16291752); GO_0043027 (EC: IMP, PMID: 9859993); GO_0043066 (EC: IDA, PMID: 10626797); GO_0043066 (EC: IMP); GO_0043154 (EC: IDA, PMID: 12773388); GO_0043154 (EC: IMP, PMID: 9859993); GO_0045892 (EC: IMP); GO_0045931 (EC: IMP, PMID: 16291752); GO_0046872 (EC: IEA); GO_0046982 (EC: IDA, PMID: 16291752); GO_0048037 (EC: IDA, PMID: 12773388); GO_0050897 (EC: NAS, PMID: 10949039); GO_0051087 (EC: IPI, PMID: 18086682); GO_0051301 (EC: IMP, PMID: 12805209); GO_0051303 (EC: IMP, PMID: 12805209)",PMID: 7947793; 8106347; 8125298; 9256286; 9556606; 9850056; 9859993; 10626797; 10713676; 10876248; 10891443; 10949039; 11024045; 11069302; 11076863; 11084331; 11134084; 11170436; 11256614; 11516652; 11712083; 11728454; 11773702; 11821157; 11844831; 11861764; 11875736; 11877677; 11888845; 11925104; 11976319; 12073047; 12085263; 12115583; 12119561; 12133447; 12143224; 12168867; 12174930; 12235242; 12363043; 12374680; 12388702; 12393476; 12419797; 12477932; 12495661; 12510154; 12517802; 12556969; 12569609; 12609713; 12643601; 12654446; 12660240; 12678716; 12709681; 12773388; 12794243; 12805209; 12833149; 12854136; 12883703; 12885482; 12925766; 12926071; 12963850; 14523021; 14527689; 14581472; 14583779; 14597555; 14597622; 14610074; 14614132; 14676801; 14699067; 14734714; 14741722; 14988404; 15004200; 15077160; 15126108; 15138717; 15139971; 15148334; 15149158; 15195112; 15218035; 15249581; 15260989; 15271987; 15280424; 15294091; 15309737; 15326475; 15334064; 15334693; 15383173; 15456784; 15457550; 15477601; 15489334; 15489336; 15489959; 15512811; 15531913; 15541727; 15541814; 15547736; 15569667; 15611790; 15623349; 15628841; 15637054; 15638381; 15655550; 15665297; 15670305; 15685548; 15688031; 15709157; 15729715; 15735703; 15743529; 15802787; 15809755; 15817155; 15829320; 15829330; 15831281; 15870931; 15882878; 15894266; 15896468; 15916722; 15923164; 15924721; 15928668; 15936846; 15938719; 15943789; 15986442; 15991282; 15993841; 16026775; 16048634; 16055565; 16108013; 16123317; 16142334; 16142363; 16171786; 16173017; 16202147; 16211215; 16211302; 16239925; 16254145; 16291752; 16322459; 16329164; 16344111; 16364925; 16372125; 16375115; 16375117; 16381901; 16404364; 16407408; 16427043; 16436504; 16462771; 16470228; 16512495; 16516635; 16525632; 16525657; 16529600; 16534839; 16552335; 16565220; 16571674; 16595680; 16608879; 16644787; 16671090; 16712791; 16714396; 16732934; 16761316; 16762323; 16764853; 16773218; 16807248; 16825985; 16826583; 16847054; 16850112; 16863850; 16873289; 16950794; 17008426; 17012855; 17015676; 17018890; 17038538; 17045968; 17077982; 17084966; 17087938; 17095626; 17098350; 17099693; 17108713; 17124585; 17127378; 17128412; 17143520; 17167759; 17170079; 17203351; 17204284; 17219991; 17225522; 17239009; 17255535; 17274640; 17283539; 17285125; 17289902; 17304504; 17328950; 17337592; 17341657; 17353931; 17357516; 17361097; 17376603; 17393113; 17441339; 17451195; 17457057; 17464868; 17505517; 17509581; 17533050; 17534699; 17536304; 17543072; 17548900; 17559540; 17569112; 17582222; 17584963; 17609820; 17613533; 17616652; 17624454; 17633470; 17634026; 17635796; 17638911; 17641414; 17656368; 17666323; 17672950; 17680529; 17681274; 17687492; 17693049; 17704744; 17706282; 17714426; 17718383; 17785436; 17805549; 17828494; 17828496; 17828507; 17869043; 17877643; 17879398; 17881355; 17905101; 17927889; 17943598; 17956729; 17959540; 17961802; 17962949; 17965335; 17967504; 17982126; 17993464; 18027854; 18029348; 18032822; 18035418; 18048012; 18055328; 18057009; 18058462; 18069771; 18079751; 18086682; 18089792; 18154598; 18171482; 18171606; 18181175; 18192073; 18206228; 18226337; 18227733; 18242580; 18243099; 18250050; 18251132; 18251156; 18251581; 18266976; 18278445; 18298903; 18301249; 18316606; 18327814; 18329369; 18332262; 18334114; 18336724; 18336887; 18364081; 18391576; 18393241; 18401527; 18414895; 18425079; 18425331; 18426652; 18431086; 18438971; 18451140; 18451232; 18476631; 18477699; 18498065; 18510850; 18519556; 18539906; 18553460; 18563330; 18566409; 18574502; 18591255; 18593915; 18593928; 18595518; 18599610; 18611860; 18630507; 18632631; 18642030; 18652770; 18670822; 18676762; 18687517; 18701842; 18704463; 18708766; 18712773; 18716870; 18758234; 18815458; 18815881; 18818705; 18824294; 18825388; 18829549; 18839071; 18842333; 18856066; 18927499; 18928590; 18928599; 18946675; 18949405; 18950577; 18981709; 18998509; 19018856; 19018973; 19025652; 19032823; 19033926; 19034775; 19038421; 19074885; 19102934; 19112393; 19120021; 19130609; 19131553; 19134343; 19141860; 19144991; 19171073; 19173802; 19176119; 19207554; 19211844; 19218139; 19219613; 19242064; 19244345; 19244543; 19247455; 19252483; 19258429; 19272804; 19272817; 19280061; 19285711; 19287462; 19287963; 19293795; 19298527; 19320741; 19322201; 19336448; 19347901; 19352701; 19357306; 19361279; 19363521; 19366855; 19379562; 19397802; 19405109; 19421758; 19423183; 19428321; 19439469; 19440933; 19451595; 19469654; 19472128; 19483728; 19497660; 19500507; 19506533; 19585499; 19605357; 19615253; 19621386; 19624872; 19628339; 19632843; 19636556; 19639203; 19664395; 19676105; 19679061; 19705503; 19716375; 19724852; 19728912; 19728914; 19729377; 19732355; 19756737; 19763917; 19767411; 19778801; 19781773; 19787275; 19806913; 19832036; 19840459; 19885569; 19887369; 19895735; 19895744; 19903782; 19913527; 19921309; 19933689; 19939880; 19949374; 19951584; 19951914; 19956893; 19995937; 20010504; 20011512; 20019839; 20027603; 20028510; 20033843; 20041268; 20050981; 20056675; 20057973; 20072652; 20094073; 20100132; 20101202; 20104682; 20126979; 20128283; 20178473; 20181247; 20193113; 20193400; 20195727; 20235790; 20236666; 20306657; 20346215; 20357690; 20360068; 20361940; 20367605; 20368071; 20372866; 20394854; 20398291; 20401641; 20403046; 20406824; 20427271; 20430742; 20430883; 20444731; 20453000; 20470195; 20501415; 20503268; 20506498; 20515940; 20524087; 20551096; 20596624; 20597995; 20627126; 20627293; 20638385; 20668868; 20673487; 20682707; 20698994; 20716114; 20717727; 20724919; 20728447; 20735270; 20735841; 20798131; 20800603; 20807887; 20819778; 20822926; 20826780; 20826784; 20842728; 20851637; 20856855; 20862566; 20868995; 20881643; 20882051; 20929126; 20929775; 20939430; 20957442; 20959405; 20978324; 20978950; 20979750; 21034499; 21041181; 21048031; 21055155; 21057000; 21062054; 21074309; 21082354; 21083600; 21092276; 21093004; 21106262; 21108736; 21130077; 21139048; 21148584; 21154810; 21156966; 21158719; 21159887; 21161671; 21187067; 21198263; 21211287; 21215029; 21219826; 21220185; 21223797; 21252625; 21279308; 21292023; 21296634; 21304814; 21309483; 21312234; 21330050; 21342791; 21351527; 21355309; 21358596; 21362215; 21364656; 21364662; 21367753; 21385904; 21402055; 21415216; 21424389; 21431279; 21443519; 21470426; 21472129; 21516372; 21518489; 21526486; 21536684; 21538024; 21552210; 21554500; 21565982; 21569999; 21572400; 21585553; 21611748; 21612579; 21613637; 21633298; 21634118; 21674243; 21695980; 21705450; 21718681; 21729321; 21729543; 21729576; 21737502; 21757750; 21765467; 21788344; 21794903; 21826474; 21852011; 21855041; 21856925; 21861135; 21867615; 21874565; 21878572; 21880190; 21897272; 21900948; 21906983; 21910343; 21933669; 21963094; 21979596; 21988832; 22020290; 22032967; 22033156; 22035627; 22045227; 22052111; 22055399; 22056470; 22065492; 22075159; 22076382; 22089920; 22103896; 22110249; 22126543; 22126788; 22152688; 22154363; 22159225; 22161156; 22161157; 22174091; 22182412; 22193624; 22199273; 22214342; 22237452; 22244766; 22266808; 22274581; 22288915; 22293278; 22295057; 22306317; 22311150; 22318371; 22325225; 22333553; 22334690; 22336533; 22340101; 22357620; 22389513; 22391172; 22407831; 22410464; 22416874; 22426960; 22446832; 22459568; 22491741; 22502701; 22503977; 22507272; 22513782; 22517713; 22528514; 22528517; 22530010; 22550469; 22563025; 22568207; 22569715; 22581315; 22607367; 22645176; 22646166; 22680927; 22696161; 22711176; 22713668; 22723337; 22740207; 22749932; 22819074; 22848370; 22858571; 22886454; 22925504; 22930255; 22935455; 22957790; 22958786; 22961763; 22981350; 23028610; 23030305; 23041974; 23042483; 23053158; 23065255; 23084269; 23087365; 23091600; 23097134; 23106581; 23124118; 23126236; 23131769; 23143666; 23146905; 23152437; 23161837; 23167185; 23167260; 23168152; 23176035; 23185410; 23219440; 23232114; 23244104; 23254909; 23258739; 23280017; 23281010; 23296940; 23310986; 23317219; 23323858; 23324341; 23333752; 23338618; 23340171; 23358177; 23358691; 23368531; 23380758; 23405077; 23405201; 23414714; 23449974; 23467576; 23477121; 23494669; 23504337; 23564498; 23572266; 23581553; 23611357; 23613251; 23618862; 23640047; 23643942; 23645041; 23677479; 23679249; 23690235; 23720494; 23728352; 23732815; 23747271; 23828577; 23847060; 23856250; 23898122; 23924925; 23938875; 23942779; 23948878; 23979427; 24024966; 24077840; 24128853; 24165223; 24239173,,,,,,,,,,,,,,,,,,OGG:3000000332,,,,,,,,,,,,,,,,,,,baculoviral IAP repeat containing 5,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,BIRC5,,,20140408,332,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,BIRC5,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0030972,Abnormal systemic blood pressure,Abnormal systemic BP,A chronic deviation from normal pressure in the systemic arterial system.,false,,,http://purl.obolibrary.org/obo/HP_0011025,,,,,,,,,,,,,,,,robinp,,,,,A chronic deviation from normal pressure in the systemic arterial system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal systemic BP,,,,,,,,,,,,,HP:0030972,,,,,,,,,,,,,,,,,,2017-04-18T13:55:40Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011025,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal systemic blood pressure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045335,phagocytic vesicle,phagosome,A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis.,false,,,http://purl.obolibrary.org/obo/GO_0030139,,,,,,,,,,,,,,,,,,,,Wikipedia:Phagosome,A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,phagosome,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030139,,,,GO:0045335,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045335,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,phagocytic vesicle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267397,SARS coronavirus Sin847,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267397,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin847,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006288,SAA1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SAA2|TP53I4|SAA|PIG4,,,,,,,11,,,,,,,,,,HGNC:10513|HPRD:00097|Ensembl:ENSG00000173432|MIM:104750|Vega:OTTHUMG00000166147,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,serum amyloid A1,,11p15.1,,,,"GO_0001664 (EC: IDA, PMID: 9892621); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0006953 (EC: NAS, PMID: 9815279); GO_0007204 (EC: IDA, PMID: 9892621); GO_0007204 (EC: NAS, PMID: 7561109); GO_0030168 (EC: NAS, PMID: 1697614); GO_0030593 (EC: NAS, PMID: 12557751); GO_0034364 (EC: IEA); GO_0045087 (EC: TAS); GO_0045785 (EC: IDA, PMID: 11830469); GO_0045785 (EC: NAS, PMID: 7561109); GO_0048246 (EC: IDA, PMID: 7561109); GO_0048247 (EC: IDA, PMID: 7636186); GO_0050708 (EC: NAS, PMID: 9605178); GO_0050715 (EC: IDA, PMID: 12857601); GO_0050716 (EC: NAS, PMID: 12857601); GO_0050728 (EC: NAS, PMID: 9823935); GO_0070062 (EC: IDA, PMID: 19199708); GO_0071682 (EC: TAS)",PMID: 1259755; 1546977; 1656519; 1697614; 1971508; 2017667; 2595451; 2834384; 2890635; 3183061; 3442653; 3800865; 3839415; 4816450; 5055786; 5056669; 6155694; 7115671; 7516407; 7561109; 7636186; 7655463; 7851899; 8188252; 8512321; 8783012; 8995276; 9252455; 9305847; 9605178; 9815279; 9823935; 9892621; 10531386; 10753626; 11592044; 11830469; 11946204; 12011456; 12031974; 12056504; 12077270; 12410800; 12456883; 12477932; 12557751; 12606051; 12687559; 12762135; 12762136; 12857601; 12973732; 14696796; 14718574; 14738910; 14871291; 15018633; 15161744; 15170927; 15188355; 15225640; 15489334; 15561721; 15729583; 15910745; 15972323; 16011988; 16118480; 16120612; 16152805; 16155472; 16219644; 16236134; 16651021; 16737350; 16864904; 17015746; 17039260; 17039310; 17237436; 17329325; 17461519; 17552057; 17676666; 17806085; 17849429; 17968686; 18299466; 18322992; 18385816; 18566366; 18571179; 18695905; 18726069; 18768891; 19007930; 19167353; 19171342; 19199708; 19453393; 19549924; 19726303; 19729864; 19755416; 19758820; 19833744; 19850938; 19913121; 19922330; 19925664; 20022911; 20061576; 20177146; 20184536; 20237496; 20435930; 20463814; 20502455; 20628086; 20677144; 20713982; 20853849; 20869715; 20877498; 20964562; 20979827; 21067563; 21103356; 21103663; 21124955; 21141971; 21309051; 21325601; 21449704; 21465531; 21569756; 21624307; 21876610; 21953030; 22011672; 22076945; 22300576; 22341353; 22367597; 22371903; 22447522; 22552174; 22766792; 22768267; 22771314; 22827403; 22901189; 23165195; 23171281; 23223242; 23230824; 23238662; 23255027; 23300020; 23357645; 23391827; 23437051; 23454129; 23522429; 23566403; 23623642; 23776697; 23836469; 23898911,,,,,,,,,,,,,,,,,,OGG:3000006288,,,,,,,,,,,,,,,,,,,serum amyloid A1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,SAA1,,,20140408,6288,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,SAA1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_24431,chemical entity,chemical entity,"A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances.",false,,,http://purl.obolibrary.org/obo/BFO_0000030,,,,,,,,,,,,,,,,,,,,,"A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chemical entity,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000030,,,,CHEBI:24431,,,,,,,,,,,,,,,CHEBI:24431,,http://purl.obolibrary.org/obo/pr.owl|http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,chemical entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000841,Hyperactive renin-angiotensin system,Increased plasma renin activity,"An abnormally increased activity of the renin-angiotensin system, causing hypertension by a combination of volume excess and vasoconstrictor mechanisms.|If the kidneys sense reduced renal blood flow, as can happen with reduced blood pressure, they secrete renin into the blood, where it reacts with angiotensinogen to produce angiotensin I, which is converted to angiotensin II by angiotensin converting enzyme (ACE). Both angiotensin I and II are vasoconstrictors. Angiotensin II additionally leads to the production of aldosterone by the adrenal cortex, which in turn leads to an increase in blood volume.",false,,,http://purl.obolibrary.org/obo/HP_0000847,,,,,,,,,,,,,,,,,,,,UMLS:C1846345|UMLS:C3150267,"An abnormally increased activity of the renin-angiotensin system, causing hypertension by a combination of volume excess and vasoconstrictor mechanisms.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,Increased plasma renin activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"If the kidneys sense reduced renal blood flow, as can happen with reduced blood pressure, they secrete renin into the blood, where it reacts with angiotensinogen to produce angiotensin I, which is converted to angiotensin II by angiotensin converting enzyme (ACE). Both angiotensin I and II are vasoconstrictors. Angiotensin II additionally leads to the production of aldosterone by the adrenal cortex, which in turn leads to an increase in blood volume.",,http://purl.obolibrary.org/obo/HP_0000847,,,,HP:0000841,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,HP:0000841,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Hyperactive renin-angiotensin system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045931,positive regulation of mitotic cell cycle,positive regulation of mitotic cell cycle progression|up-regulation of progression through mitotic cell cycle|up regulation of progression through mitotic cell cycle|upregulation of progression through mitotic cell cycle|positive regulation of progression through mitotic cell cycle|stimulation of progression through mitotic cell cycle|activation of progression through mitotic cell cycle,Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_0045787,,,,,,,,,,,,,,,,,,,,,Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,positive regulation of mitotic cell cycle progression|up-regulation of progression through mitotic cell cycle|up regulation of progression through mitotic cell cycle|upregulation of progression through mitotic cell cycle|positive regulation of progression through mitotic cell cycle,,,stimulation of progression through mitotic cell cycle|activation of progression through mitotic cell cycle,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0045787,,,,GO:0045931,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045931,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0036508,"protein alpha-1,2-demannosylation",mannose trimming|glycoprotein mannose trimming,"The removal of one or more alpha 1,2-linked mannose residues from a mannosylated protein.|Consider also annotating to 'mannosyl-oligosaccharide 1,2-alpha-mannosidase activity ; GO:0004571'.",false,,,http://purl.obolibrary.org/obo/GO_0036507,,,,,,,,,,,,,,,,rebeccafoulger,2015-06-11T13:58:50Z,,,,"The removal of one or more alpha 1,2-linked mannose residues from a mannosylated protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,mannose trimming,,,,,,,,biological_process,,glycoprotein mannose trimming,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Consider also annotating to 'mannosyl-oligosaccharide 1,2-alpha-mannosidase activity ; GO:0004571'.",,http://purl.obolibrary.org/obo/GO_0036507,,,,GO:0036508,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0036508,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"protein alpha-1,2-demannosylation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000002,virus excretion,,,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Release of virus from host cell through events like cell death (lysis), budding, and exocytosis",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,Modified definition,,viral process,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173567/,,,,,,,,,,,,,,,,,virus excretion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012115,Hepatitis,Liver inflammation,Inflammation of the liver.,false,,,http://purl.obolibrary.org/obo/HP_0410042|http://purl.obolibrary.org/obo/HP_0012649,,,,,,,,,,,,,,,,hecht,2012-09-16T05:03:29Z,,,UMLS:C0019158|MSH:D006505|SNOMEDCT_US:128241005,Inflammation of the liver.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Liver inflammation,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0410042|http://purl.obolibrary.org/obo/HP_0012649,,,,HP:0012115,,,,,,,,,,,,,,,HP:0012115,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Hepatitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000147,ORF9c,,,false,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Open Reading Frame 9c in SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,modified definition,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,true,,,,,https://pubmed.ncbi.nlm.nih.gov/32167180/,,,,,,,,,,,,,,,,,ORF9c,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019065,receptor-mediated endocytosis of virus by host cell,receptor mediated endocytosis of virus by host|virus receptor-mediated endocytosis by host|viral receptor mediated endocytosis|receptor mediated endocytosis by host of virus particle|receptor-mediated endocytosis of virus by host|receptor mediated endocytosis of virus particle by host|viral entry into host cell via receptor-mediated endocytosis,Any receptor-mediated endocytosis that is involved in the uptake of a virus into a host cell; successive instances of virus endocytosis result in the accumulation of virus particles within the cell.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,Any receptor-mediated endocytosis that is involved in the uptake of a virus into a host cell; successive instances of virus endocytosis result in the accumulation of virus particles within the cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,receptor mediated endocytosis of virus by host|virus receptor-mediated endocytosis by host|viral receptor mediated endocytosis|receptor mediated endocytosis by host of virus particle|receptor-mediated endocytosis of virus by host|receptor mediated endocytosis of virus particle by host,,,,,biological_process,,viral entry into host cell via receptor-mediated endocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019065,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/18227861,,,,GO:0019065,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,receptor-mediated endocytosis of virus by host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001493,CTLA4,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CELIAC3|CTLA-4|GRD4|CD152|CD|GSE|IDDM12,,,,,,,2,,,,,,,,,,HPRD:00474|MIM:123890|HGNC:2505|Ensembl:ENSG00000163599|Vega:OTTHUMG00000132877,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,cytotoxic T-lymphocyte-associated protein 4,,2q33,,,,"GO_0005515 (EC: IPI, PMID: 11279501); GO_0005794 (EC: IDA, PMID: 15814706); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 3220103); GO_0006955 (EC: IEA); GO_0006974 (EC: IMP, PMID: 17875758); GO_0009897 (EC: IDA, PMID: 18641304); GO_0030889 (EC: IMP, PMID: 17875758); GO_0031295 (EC: TAS); GO_0042130 (EC: IEA); GO_0043065 (EC: IMP, PMID: 17875758); GO_0045334 (EC: IDA, PMID: 15814706); GO_0045590 (EC: IDA, PMID: 18641304); GO_0048471 (EC: IDA, PMID: 15814706); GO_0050777 (EC: IEA); GO_0050853 (EC: IMP, PMID: 17875758)",PMID: 1713603; 1714933; 3220103; 7513726; 7545666; 7559643; 7694153; 7807015; 8638161; 8817351; 9200449; 9228944; 9256472; 9259273; 9712716; 9724847; 9812899; 9813138; 9973379; 10189842; 10369864; 10372542; 10475192; 10493833; 10556814; 10618429; 10799854; 10831323; 10842319; 10903931; 10924276; 11021528; 11081251; 11086105; 11092697; 11098935; 11128657; 11158025; 11162656; 11167807; 11239948; 11279501; 11279502; 11286636; 11288988; 11327371; 11426024; 11477480; 11522687; 11555351; 11580858; 11583591; 11583755; 11606170; 11678447; 11678454; 11681491; 11685455; 11726229; 11735222; 11751964; 11752507; 11771526; 11776689; 11788096; 11826026; 11826754; 11842815; 11857062; 11886967; 11900275; 11916172; 11936461; 11978629; 11994459; 12003670; 12007590; 12021137; 12021313; 12022356; 12030917; 12032199; 12047357; 12047362; 12050220; 12058260; 12060749; 12071705; 12097196; 12114354; 12121283; 12135671; 12173468; 12185534; 12195015; 12202150; 12225635; 12225905; 12244107; 12297345; 12355442; 12384790; 12393538; 12444128; 12455815; 12458054; 12458055; 12465728; 12477932; 12507781; 12508774; 12515273; 12534352; 12540792; 12555221; 12559633; 12574361; 12582153; 12606712; 12610047; 12618861; 12696006; 12717632; 12724780; 12732844; 12780750; 12791095; 12794109; 12826605; 12838528; 12858454; 12864988; 12873588; 12894875; 12911663; 12914522; 12942714; 14505215; 14522090; 14566095; 14567561; 14616291; 14620161; 14629291; 14675397; 14678452; 14705224; 14709415; 14715845; 14720259; 14730632; 14751028; 14975605; 14986169; 15018649; 15019278; 15019292; 15022315; 15055474; 15059373; 15061706; 15114591; 15128776; 15132716; 15138458; 15140570; 15180809; 15182328; 15199380; 15208156; 15218356; 15237707; 15240634; 15248219; 15301861; 15305888; 15334480; 15356063; 15378793; 15452244; 15476165; 15485777; 15486062; 15489334; 15494488; 15507878; 15517637; 15540511; 15546339; 15549146; 15579786; 15610363; 15610849; 15617700; 15621571; 15629882; 15640608; 15649153; 15652423; 15657618; 15688186; 15708585; 15708894; 15711022; 15784471; 15785242; 15790344; 15812539; 15814706; 15815621; 15818712; 15841095; 15860238; 15881277; 15888281; 15888380; 15904974; 15928253; 15940668; 15943829; 15953005; 15961581; 15973119; 15994283; 16002699; 16005527; 16015687; 16025255; 16025348; 16034471; 16040335; 16045690; 16046318; 16081581; 16101935; 16112024; 16133179; 16136471; 16137550; 16178018; 16189655; 16198253; 16206510; 16227604; 16229750; 16237465; 16248997; 16259622; 16276008; 16279844; 16299026; 16313305; 16325273; 16352685; 16362660; 16373368; 16378074; 16380915; 16390390; 16393254; 16405845; 16417239; 16445777; 16476059; 16489681; 16504663; 16509873; 16512757; 16527605; 16564528; 16567828; 16571085; 16604497; 16611252; 16614815; 16620985; 16629714; 16638702; 16640877; 16641053; 16670525; 16671945; 16708397; 16712655; 16750991; 16756466; 16767670; 16769128; 16775619; 16788246; 16792673; 16797372; 16818761; 16831326; 16849765; 16868438; 16869018; 16872485; 16891094; 16893393; 16916658; 16926542; 16931720; 16972006; 16980072; 17000707; 17004266; 17005693; 17015751; 17020648; 17023015; 17048303; 17079164; 17082597; 17130532; 17130562; 17138053; 17150279; 17154080; 17192819; 17197413; 17209142; 17225925; 17257313; 17269936; 17280620; 17284227; 17287608; 17334650; 17341301; 17341658; 17384200; 17426089; 17427759; 17439880; 17456215; 17459075; 17465502; 17469155; 17482523; 17504905; 17521325; 17524498; 17526951; 17558709; 17652883; 17659059; 17666451; 17678726; 17703412; 17712006; 17712998; 17767555; 17785798; 17785820; 17825114; 17846597; 17875758; 17919231; 17920697; 17937736; 17938902; 17941906; 17942509; 17949264; 17960657; 17970696; 17970785; 18000051; 18021981; 18031393; 18041714; 18047932; 18049163; 18056379; 18056853; 18059468; 18076363; 18078835; 18081831; 18088253; 18093182; 18095376; 18162511; 18174230; 18200060; 18223493; 18246813; 18256061; 18282809; 18292106; 18292987; 18296657; 18328194; 18337305; 18341485; 18361934; 18371160; 18378005; 18396212; 18443194; 18448390; 18449568; 18462498; 18466513; 18466531; 18493148; 18498289; 18523152; 18528295; 18545145; 18556337; 18563180; 18576317; 18580850; 18595775; 18633131; 18636124; 18641304; 18665147; 18676680; 18680513; 18687223; 18691306; 18691768; 18705023; 18752454; 18757416; 18778710; 18780601; 18782261; 18783892; 18817831; 18818748; 18848621; 18925838; 18929517; 18930330; 18940880; 18974840; 18978792; 19012493; 19014504; 19019335; 19020530; 19026137; 19028820; 19036923; 19037649; 19073967; 19089435; 19092854; 19103559; 19129082; 19131662; 19136037; 19141582; 19143820; 19147248; 19170196; 19173720; 19173804; 19175525; 19180256; 19188433; 19202444; 19222422; 19225544; 19230824; 19247692; 19254250; 19258923; 19263529; 19263877; 19264973; 19269255; 19275586; 19284444; 19284445; 19322201; 19332044; 19332045; 19333938; 19345707; 19376178; 19380781; 19386687; 19403062; 19404967; 19430480; 19438904; 19473815; 19479237; 19490216; 19503088; 19505258; 19524188; 19527514; 19530270; 19543113; 19547759; 19559392; 19559744; 19563524; 19570209; 19570770; 19578600; 19592124; 19595177; 19602000; 19609446; 19621172; 19622768; 19625176; 19625381; 19638588; 19658300; 19669200; 19672595; 19688278; 19692168; 19731979; 19734241; 19735272; 19735686; 19737153; 19737369; 19740340; 19758313; 19766059; 19776380; 19778566; 19780033; 19787358; 19811307; 19815302; 19815671; 19817985; 19824886; 19857736; 19884265; 19894308; 19895365; 19895409; 19896092; 19913121; 19913589; 19922464; 19949652; 19950182; 19951233; 19951419; 19956097; 19959217; 20012554; 20015215; 20016193; 20016783; 20017310; 20020126; 20030788; 20037585; 20066438; 20072139; 20082854; 20087947; 20113255; 20123855; 20134044; 20138855; 20141578; 20145677; 20190752; 20214754; 20219786; 20224272; 20233754; 20237496; 20300120; 20306312; 20331378; 20331384; 20345871; 20352109; 20358027; 20371478; 20378605; 20378664; 20388336; 20394753; 20395963; 20408864; 20416077; 20418973; 20433886; 20435510; 20439292; 20444755; 20445568; 20453000; 20453842; 20470888; 20477885; 20482250; 20491567; 20498205; 20503287; 20536507; 20537165; 20538028; 20557968; 20565774; 20578265; 20578982; 20586801; 20587610; 20588168; 20596022; 20603037; 20608155; 20610662; 20615526; 20628086; 20633650; 20650297; 20704820; 20716038; 20716621; 20732370; 20805278; 20813679; 20825955; 20848568; 20868585; 20869265; 20881011; 20920330; 20940051; 20962850; 21034161; 21040781; 21044351; 21049406; 21054240; 21081144; 21082224; 21084022; 21085187; 21091900; 21131701; 21154316; 21160481; 21161390; 21165767; 21168689; 21170090; 21251066; 21291098; 21316924; 21346773; 21356099; 21387262; 21414236; 21422625; 21453059; 21474713; 21503616; 21513760; 21519805; 21537684; 21553055; 21594562; 21599853; 21612409; 21615267; 21620894; 21644231; 21661409; 21669243; 21677403; 21722820; 21723783; 21744007; 21784728; 21797987; 21807564; 21829393; 21832820; 21841780; 21847627; 21866398; 21909273; 21915163; 21934066; 21982860; 22011251; 22027421; 22028176; 22053592; 22094905; 22118691; 22136395; 22153879; 22155204; 22178694; 22179750; 22218756; 22245568; 22249287; 22262842; 22271879; 22288822; 22307437; 22318401; 22340049; 22342451; 22354566; 22359319; 22376040; 22414241; 22418270; 22493691; 22497911; 22547705; 22574131; 22579879; 22699762; 22700162; 22707194; 22711308; 22718509; 22722994; 22723841; 22727980; 22733023; 22753931; 22783574; 22811616; 22836632; 22844542; 22902304; 22905924; 22917707; 22922453; 22923220; 22932817; 22951729; 22964358; 22968483; 22989439; 23009570; 23010350; 23010434; 23018253; 23039885; 23049754; 23138463; 23232526; 23246583; 23252863; 23254121; 23261408; 23261825; 23264071; 23264102; 23289635; 23300559; 23323522; 23354631; 23359812; 23367498; 23372431; 23400950; 23411043; 23413900; 23413908; 23432218; 23432692; 23448385; 23551963; 23567921; 23597029; 23613833; 23628397; 23634660; 23641913; 23661460; 23661465; 23666060; 23669295; 23725008; 23739065; 23756164; 23770251; 23782302; 23802171; 23830732; 23851140; 23851684; 23900675; 23922195; 23936412; 23936819; 24028204; 24103478; 24517008; 24611333,,,,,,,,,,,,,,,,,,OGG:3000001493,,,,,,,,,,,,,,,,,,,cytotoxic T-lymphocyte-associated protein 4,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CTLA4,,,20140408,1493,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CTLA4,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000002099,ESR1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,ESTRR|Era|NR3A1|ER|ESR|ESRA,,,,,,,6,,,,,,,,,,Vega:OTTHUMG00000016103|HPRD:00589|MIM:133430|HGNC:3467|Ensembl:ENSG00000091831,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,estrogen receptor 1,,6q25.1,,,,"GO_0001046 (EC: IDA, PMID: 15345745); GO_0001547 (EC: IEA); GO_0002064 (EC: IEA); GO_0003682 (EC: IEA); GO_0003700 (EC: NAS, PMID: 12552091); GO_0003707 (EC: TAS, PMID: 10749889); GO_0005496 (EC: ISS); GO_0005515 (EC: IPI, PMID: 10359819); GO_0005634 (EC: IDA, PMID: 15569929); GO_0005654 (EC: TAS); GO_0005794 (EC: IEA); GO_0005886 (EC: IDA, PMID: 15569929); GO_0006338 (EC: NAS, PMID: 12351687); GO_0006351 (EC: TAS, PMID: 2040605); GO_0006355 (EC: NAS, PMID: 3753802); GO_0006367 (EC: TAS); GO_0007165 (EC: TAS, PMID: 10749889); GO_0007200 (EC: ISS); GO_0007204 (EC: ISS); GO_0008013 (EC: IPI, PMID: 15304487); GO_0008134 (EC: IEA); GO_0008209 (EC: IEA); GO_0008270 (EC: IEA); GO_0008584 (EC: IEA); GO_0010467 (EC: TAS); GO_0010629 (EC: IDA); GO_0010863 (EC: ISS); GO_0016020 (EC: NAS, PMID: 11960618); GO_0016021 (EC: IEA); GO_0019899 (EC: IPI, PMID: 12039952); GO_0030235 (EC: NAS, PMID: 12389206); GO_0030284 (EC: NAS, PMID: 3753802); GO_0030518 (EC: ISS); GO_0030520 (EC: NAS, PMID: 3753802); GO_0032355 (EC: IDA, PMID: 15304487); GO_0034056 (EC: IDA, PMID: 15345745); GO_0038052 (EC: IGI, PMID: 18722177); GO_0042802 (EC: IPI, PMID: 11265755); GO_0042981 (EC: IEA); GO_0043124 (EC: IDA, PMID: 16043358); GO_0043433 (EC: IDA, PMID: 10816575); GO_0043627 (EC: IDA, PMID: 11581164); GO_0045429 (EC: IDA); GO_0045944 (EC: IDA, PMID: 15345745); GO_0048146 (EC: IEA); GO_0048386 (EC: IDA, PMID: 15831516); GO_0051000 (EC: IDA); GO_0051091 (EC: IDA, PMID: 10681512); GO_0060065 (EC: IEA); GO_0060068 (EC: IEA); GO_0060523 (EC: IEA); GO_0060527 (EC: IEA); GO_0060687 (EC: IEA); GO_0060745 (EC: IEA); GO_0060749 (EC: IEA); GO_0060750 (EC: IEA); GO_0071392 (EC: ISS)",PMID: 1476547; 1567414; 1577818; 1603086; 1779972; 2015052; 2040605; 2247153; 2792078; 3145193; 3753802; 3754034; 7476978; 7539106; 7641693; 7651415; 7838153; 7916651; 7923369; 8090165; 8221895; 8240974; 8308015; 8406468; 8524784; 8541239; 8598193; 8600444; 8600466; 8616895; 8647321; 8887632; 8961262; 9039267; 9058380; 9099865; 9115274; 9121466; 9171229; 9171231; 9192892; 9192902; 9195227; 9222609; 9259327; 9328340; 9338790; 9346901; 9393949; 9395481; 9427757; 9430642; 9448000; 9473491; 9489701; 9528769; 9600906; 9619507; 9627117; 9628876; 9628887; 9632676; 9653119; 9702189; 9710597; 9717844; 9765300; 9773978; 9773983; 9774463; 9774640; 9817600; 9841876; 9849967; 9875847; 9891036; 9892017; 10022127; 10085091; 10207098; 10334989; 10359819; 10428798; 10446910; 10454579; 10480874; 10490106; 10567404; 10598586; 10598587; 10619354; 10620335; 10648597; 10681512; 10706293; 10706618; 10706629; 10707955; 10713182; 10731636; 10737800; 10748020; 10749889; 10760302; 10766163; 10770935; 10816575; 10829018; 10866662; 10872826; 10903152; 10908561; 10938099; 10949034; 10970861; 11003650; 11004670; 11013076; 11014206; 11018265; 11029009; 11032808; 11043578; 11050077; 11050174; 11053406; 11073968; 11092403; 11092404; 11113179; 11113208; 11117529; 11121195; 11127213; 11139535; 11139588; 11140838; 11146623; 11149476; 11165056; 11178989; 11231990; 11239543; 11244506; 11250900; 11265755; 11266503; 11279242; 11316004; 11353774; 11355046; 11358671; 11358960; 11369763; 11376110; 11383910; 11389589; 11397855; 11429412; 11432835; 11435445; 11436125; 11437591; 11458981; 11458983; 11477071; 11481323; 11493692; 11507039; 11525424; 11555647; 11563984; 11564035; 11564893; 11574675; 11581164; 11591700; 11595700; 11595744; 11682624; 11682626; 11689445; 11689696; 11696545; 11704680; 11710886; 11716992; 11720251; 11731608; 11765043; 11773069; 11773441; 11773443; 11773444; 11774719; 11779858; 11782371; 11792840; 11795466; 11798902; 11803451; 11818499; 11818702; 11823467; 11826769; 11836633; 11838047; 11839580; 11844790; 11846326; 11854298; 11857578; 11861507; 11867202; 11867270; 11867769; 11875103; 11886765; 11887032; 11887937; 11894143; 11903314; 11911945; 11914066; 11918216; 11919305; 11922631; 11923430; 11923465; 11925413; 11931763; 11937504; 11938861; 11953755; 11955468; 11959092; 11959119; 11960618; 11971969; 11971975; 11981030; 11984699; 11986316; 11992565; 11997270; 12006396; 12011094; 12014437; 12021179; 12021200; 12031042; 12034840; 12039952; 12040178; 12059984; 12088102; 12088871; 12088878; 12093745; 12093804; 12096841; 12098649; 12100115; 12110951; 12111450; 12112006; 12112198; 12113882; 12115520; 12118371; 12119130; 12119550; 12138116; 12138194; 12145209; 12145334; 12145336; 12147702; 12154211; 12160997; 12167865; 12169981; 12174171; 12174912; 12183765; 12185415; 12193552; 12195069; 12198596; 12200415; 12206920; 12207170; 12207901; 12231116; 12242035; 12270131; 12351687; 12351689; 12374744; 12381474; 12389206; 12398989; 12400015; 12403846; 12412813; 12429765; 12438984; 12446585; 12453411; 12457453; 12466266; 12466272; 12475718; 12475719; 12477541; 12477932; 12479814; 12482846; 12482985; 12496244; 12509901; 12511607; 12515753; 12524070; 12527756; 12535528; 12547192; 12547836; 12552091; 12552233; 12553013; 12554660; 12554766; 12554772; 12556917; 12566449; 12566932; 12568733; 12574216; 12574227; 12576474; 12576490; 12588759; 12594000; 12594813; 12597128; 12605096; 12612060; 12612073; 12612084; 12627470; 12630920; 12639951; 12642782; 12646062; 12650698; 12660241; 12667452; 12682286; 12691862; 12710997; 12711000; 12712467; 12714702; 12718576; 12727987; 12727990; 12733715; 12736255; 12738788; 12740031; 12750288; 12757654; 12770739; 12774124; 12775708; 12781038; 12810552; 12815477; 12817755; 12821935; 12824724; 12837697; 12839940; 12842887; 12847685; 12852830; 12853125; 12855746; 12856811; 12861133; 12873981; 12873984; 12874288; 12878603; 12879219; 12889606; 12891629; 12894229; 12895004; 12895309; 12897156; 12899921; 12914574; 12915669; 12917323; 12917342; 12917706; 12927786; 12943695; 12943696; 12954762; 12961063; 12962497; 12962933; 12969589; 12970748; 13678390; 14499686; 14503979; 14504194; 14505233; 14506618; 14506733; 14508827; 14519529; 14520218; 14521715; 14522892; 14528100; 14528452; 14559803; 14562991; 14563649; 14568562; 14574404; 14600184; 14617632; 14630091; 14634838; 14670179; 14674143; 14675539; 14680815; 14688157; 14691461; 14701856; 14702340; 14710360; 14715865; 14715875; 14722073; 14725686; 14736707; 14739282; 14742696; 14761887; 14761960; 14762440; 14764652; 14764789; 14764897; 14766010; 14767512; 14960313; 14963108; 14966289; 14972425; 14973389; 14973390; 14981916; 14985328; 14999525; 15001646; 15019994; 15020686; 15026080; 15033483; 15033914; 15034868; 15039427; 15041725; 15047147; 15056731; 15059947; 15060164; 15060629; 15066214; 15066997; 15070949; 15070958; 15070964; 15078875; 15082146; 15084241; 15084343; 15084345; 15103224; 15108352; 15111769; 15120696; 15133719; 15140878; 15145444; 15145521; 15161711; 15167446; 15167447; 15169784; 15171723; 15171727; 15173068; 15193490; 15205361; 15205473; 15208259; 15211069; 15213208; 15217512; 15217907; 15229223; 15231873; 15254226; 15254780; 15254972; 15258723; 15261302; 15263903; 15272917; 15282304; 15282324; 15289619; 15304355; 15304487; 15308690; 15314175; 15318176; 15324358; 15330195; 15342491; 15345050; 15345745; 15351732; 15351741; 15354856; 15358197; 15361380; 15368362; 15368436; 15375600; 15380041; 15381239; 15383283; 15389627; 15467744; 15471764; 15474036; 15474102; 15474761; 15476574; 15496419; 15496458; 15514030; 15517129; 15521089; 15523071; 15525592; 15525597; 15528307; 15532726; 15536156; 15538384; 15539439; 15541640; 15545229; 15552843; 15556606; 15557281; 15569417; 15569929; 15576061; 15579769; 15579774; 15581976; 15591788; 15592589; 15595626; 15602573; 15604093; 15604249; 15607532; 15607534; 15609040; 15609101; 15613410; 15615701; 15616899; 15625066; 15637147; 15641807; 15642162; 15642950; 15645536; 15647972; 15651230; 15654505; 15654614; 15657064; 15657427; 15661863; 15666801; 15668497; 15674350; 15692074; 15693887; 15694343; 15694360; 15698546; 15705965; 15709176; 15713534; 15723135; 15734595; 15743834; 15744038; 15746193; 15749482; 15755860; 15763593; 15772083; 15781005; 15784253; 15784714; 15798095; 15800680; 15802375; 15802376; 15807179; 15808510; 15817658; 15824731; 15827868; 15831449; 15831512; 15831516; 15837795; 15842934; 15851513; 15856463; 15862818; 15862951; 15862952; 15870696; 15870697; 15878968; 15886208; 15886699; 15891768; 15899520; 15899841; 15899960; 15919818; 15923424; 15934440; 15940264; 15940291; 15941852; 15947004; 15960894; 15961417; 15961505; 15964790; 15964799; 15965230; 15966503; 15987735; 15988012; 15999471; 16005459; 16009131; 16014638; 16037132; 16042580; 16043358; 16046054; 16051668; 16055089; 16061635; 16061840; 16076840; 16086289; 16087727; 16087863; 16091743; 16098017; 16098857; 16099331; 16113100; 16117875; 16118406; 16119004; 16123086; 16133690; 16138832; 16139450; 16144952; 16150902; 16151677; 16153823; 16154319; 16159931; 16160748; 16168103; 16168121; 16169423; 16176503; 16179380; 16179580; 16199553; 16200719; 16202920; 16203927; 16210018; 16210384; 16213843; 16215870; 16216907; 16216908; 16219765; 16226051; 16238543; 16242874; 16243557; 16244490; 16252695; 16260521; 16269961; 16271083; 16273733; 16278681; 16280033; 16280269; 16284392; 16286534; 16288053; 16292600; 16293641; 16314411; 16317584; 16322326; 16322330; 16326832; 16331275; 16332659; 16344560; 16361951; 16362385; 16365013; 16388018; 16396937; 16406987; 16417078; 16417649; 16427018; 16430179; 16439465; 16452229; 16453284; 16455494; 16469706; 16469747; 16477374; 16477637; 16478760; 16483936; 16484614; 16489075; 16492615; 16492926; 16497729; 16497877; 16500359; 16502042; 16504171; 16522460; 16522905; 16524385; 16524927; 16537702; 16538187; 16538531; 16541319; 16549430; 16551651; 16553027; 16554032; 16555127; 16574784; 16595228; 16601072; 16603732; 16604479; 16606610; 16608856; 16612068; 16612467; 16622736; 16628468; 16633737; 16636675; 16638864; 16645038; 16645043; 16647340; 16648639; 16648749; 16651265; 16651450; 16675542; 16675850; 16679312; 16684779; 16690750; 16691199; 16699281; 16709599; 16713399; 16720731; 16723714; 16735942; 16753154; 16754886; 16756716; 16757575; 16758971; 16762184; 16762402; 16762623; 16766435; 16769725; 16782818; 16788818; 16791482; 16791593; 16793950; 16794079; 16796589; 16799708; 16807247; 16808847; 16809346; 16809442; 16816928; 16846491; 16855153; 16859128; 16860316; 16860797; 16873370; 16873715; 16880783; 16886637; 16901007; 16912174; 16914837; 16923966; 16935316; 16939403; 16949384; 16949387; 16949390; 16949392; 16954434; 16957778; 16968748; 16972020; 16977255; 16988190; 17006756; 17006958; 17008324; 17008385; 17010478; 17011556; 17016614; 17021946; 17023856; 17043237; 17046193; 17089081; 17095210; 17097034; 17099213; 17105837; 17109894; 17116097; 17118173; 17121748; 17127213; 17130235; 17135255; 17143016; 17158759; 17160687; 17176215; 17184825; 17185393; 17186378; 17187234; 17192785; 17203178; 17220347; 17224934; 17241382; 17252199; 17264952; 17268813; 17274640; 17275994; 17283037; 17284441; 17287066; 17289570; 17299137; 17309937; 17311814; 17312152; 17312270; 17316413; 17317669; 17324916; 17325140; 17327435; 17332369; 17333335; 17347654; 17349986; 17350616; 17350773; 17350824; 17356055; 17363140; 17365134; 17372038; 17378156; 17388661; 17389465; 17391528; 17391927; 17392432; 17392787; 17400812; 17405842; 17405848; 17408018; 17409042; 17410321; 17413977; 17415682; 17417639; 17418098; 17419075; 17443129; 17446729; 17452356; 17452407; 17453340; 17453687; 17454161; 17455211; 17463000; 17473282; 17478088; 17493601; 17502350; 17505062; 17505773; 17507624; 17507630; 17510501; 17511620; 17512111; 17513703; 17520659; 17531923; 17540666; 17545528; 17545634; 17548071; 17553133; 17556378; 17558892; 17562079; 17564514; 17589376; 17590503; 17591692; 17591841; 17594514; 17598904; 17599055; 17599361; 17599809; 17609204; 17609434; 17609999; 17614350; 17615152; 17616709; 17617929; 17627277; 17630774; 17631492; 17631495; 17633471; 17634528; 17641689; 17646097; 17646279; 17646391; 17652530; 17656465; 17656679; 17666584; 17666587; 17686882; 17697320; 17699868; 17704057; 17706202; 17706611; 17713466; 17717078; 17728669; 17761946; 17825481; 17852416; 17854418; 17884941; 17885486; 17889406; 17891599; 17895504; 17896124; 17903300; 17904846; 17908967; 17909265; 17911387; 17914104; 17916182; 17921385; 17924141; 17932104; 17932106; 17932744; 17939379; 17948189; 17951080; 17951536; 17953702; 17960587; 17962916; 17971628; 17975005; 17991426; 17992477; 17998543; 18006911; 18025262; 18029348; 18037365; 18037997; 18042273; 18048499; 18053221; 18062975; 18070128; 18070427; 18089703; 18089809; 18089911; 18096994; 18097104; 18157729; 18162533; 18164902; 18165170; 18165171; 18165403; 18166184; 18174157; 18178192; 18184269; 18189290; 18195227; 18197009; 18200028; 18202578; 18204896; 18210333; 18216219; 18229450; 18239068; 18243128; 18247370; 18252198; 18261753; 18264135; 18271972; 18285546; 18288931; 18294052; 18297304; 18301357; 18305958; 18307035; 18309176; 18310301; 18313384; 18316615; 18316616; 18339713; 18342444; 18350145; 18350156; 18359774; 18360040; 18363044; 18365014; 18367190; 18372406; 18375409; 18379196; 18385916; 18388150; 18390216; 18391223; 18394649; 18403716; 18406438; 18407895; 18408366; 18414007; 18421025; 18424448; 18424506; 18433299; 18441008; 18445128; 18445666; 18445777; 18449864; 18450649; 18450951; 18451095; 18451179; 18451880; 18452179; 18459544; 18471979; 18481172; 18483178; 18483257; 18483281; 18483465; 18483761; 18484708; 18485221; 18492705; 18498351; 18499756; 18505767; 18508261; 18508999; 18510611; 18511131; 18518979; 18519947; 18533032; 18534028; 18543253; 18546531; 18548852; 18550720; 18550772; 18558727; 18559568; 18560894; 18563714; 18565642; 18568888; 18569528; 18569637; 18577416; 18579858; 18582450; 18588516; 18593825; 18593897; 18593923; 18593928; 18597742; 18599548; 18600402; 18615623; 18617186; 18627768; 18629629; 18631401; 18632615; 18636124; 18644836; 18644889; 18645020; 18646531; 18652667; 18660489; 18676680; 18678289; 18680103; 18681789; 18687423; 18688042; 18690166; 18706253; 18708366; 18708376; 18715613; 18719354; 18720455; 18720524; 18722177; 18722876; 18727987; 18728018; 18752050; 18753331; 18755890; 18758908; 18762230; 18765668; 18767927; 18790736; 18794456; 18798271; 18814026; 18816632; 18818283; 18820009; 18825311; 18825402; 18835831; 18837888; 18837889; 18838536; 18839613; 18843190; 18844082; 18846948; 18850387; 18852215; 18853184; 18854778; 18925325; 18941890; 18941930; 18942332; 18949048; 18949413; 18950845; 18951949; 18952763; 18955141; 18958632; 18980759; 18980828; 18984578; 18990228; 18990386; 18991569; 18992263; 18997820; 19001520; 19008156; 19011961; 19011999; 19012097; 19018086; 19021634; 19027010; 19028706; 19030709; 19031816; 19031960; 19032032; 19032364; 19032828; 19034514; 19039327; 19060449; 19061285; 19064572; 19074826; 19079262; 19080622; 19082882; 19084502; 19086053; 19087310; 19093296; 19094228; 19095746; 19106221; 19107851; 19112174; 19117054; 19117995; 19122208; 19124506; 19126777; 19142184; 19147702; 19152063; 19157583; 19158089; 19159686; 19162354; 19170196; 19172223; 19175383; 19185056; 19188451; 19191023; 19194457; 19198856; 19199249; 19200973; 19205871; 19205874; 19208263; 19208313; 19217090; 19219042; 19219433; 19233358; 19247692; 19255718; 19261198; 19276281; 19284296; 19287951; 19287996; 19298602; 19299445; 19302287; 19309393; 19318036; 19319135; 19320640; 19321454; 19321582; 19328202; 19331827; 19336370; 19347708; 19351845; 19364822; 19367380; 19369417; 19370415; 19375130; 19377875; 19382890; 19383337; 19383343; 19383788; 19383985; 19386104; 19386276; 19398483; 19399944; 19401155; 19403568; 19406238; 19411060; 19414598; 19415745; 19419938; 19420105; 19421079; 19422801; 19423554; 19424606; 19429434; 19429457; 19433264; 19433448; 19435816; 19436038; 19438492; 19439407; 19446283; 19451226; 19453261; 19458056; 19460354; 19473078; 19476621; 19478391; 19487288; 19489872; 19491275; 19491387; 19503094; 19505920; 19506792; 19506903; 19509105; 19509295; 19519176; 19524139; 19526339; 19551860; 19555348; 19556341; 19556604; 19556726; 19560472; 19563758; 19569049; 19574173; 19574343; 19574409; 19574448; 19574486; 19578796; 19578917; 19581569; 19584059; 19586561; 19591174; 19593135; 19595769; 19598235; 19604497; 19605405; 19608186; 19620290; 19625176; 19630952; 19636371; 19652226; 19654868; 19657752; 19666427; 19667268; 19673915; 19675450; 19676041; 19692168; 19693267; 19695239; 19697122; 19706389; 19706809; 19711044; 19712589; 19715484; 19718048; 19720835; 19720911; 19723634; 19724876; 19728929; 19729795; 19730444; 19735754; 19738412; 19739075; 19739677; 19746436; 19749156; 19755138; 19758455; 19760036; 19761138; 19762712; 19763509; 19772891; 19775474; 19776291; 19789190; 19793653; 19797124; 19801982; 19805454; 19809499; 19814616; 19820388; 19822194; 19826002; 19828692; 19835506; 19838210; 19842032; 19858209; 19860128; 19861327; 19866355; 19876927; 19882362; 19884274; 19886840; 19887485; 19887647; 19890323; 19893013; 19897598; 19903038; 19904497; 19905901; 19913121; 19917725; 19926619; 19926790; 19927160; 19933466; 19933843; 19934104; 19934375; 19936541; 19938352; 19938958; 19940156; 19940364; 19941161; 19944560; 19946334; 19948975; 19950602; 19952285; 19952760; 19953095; 19955102; 19956635; 19956831; 19959825; 19960008; 19995069; 20001343; 20015871; 20025868; 20032008; 20035625; 20043081; 20046055; 20052536; 20056644; 20059631; 20060387; 20060929; 20061782; 20063045; 20065040; 20070947; 20079471; 20079837; 20080630; 20080637; 20080857; 20080953; 20086172; 20087349; 20095908; 20097268; 20101232; 20103625; 20104649; 20109227; 20109228; 20110403; 20111054; 20116372; 20128071; 20128772; 20130088; 20148360; 20153324; 20153472; 20172536; 20172949; 20173016; 20178635; 20179226; 20179234; 20180843; 20181721; 20184719; 20197310; 20197399; 20197727; 20198335; 20200160; 20200813; 20200978; 20207742; 20210479; 20213082; 20215396; 20215421; 20215536; 20219974; 20228224; 20237151; 20299092; 20300195; 20301197; 20301425; 20302909; 20304699; 20305046; 20305143; 20305341; 20305683; 20308044; 20308691; 20332105; 20335148; 20337221; 20338046; 20339947; 20346360; 20347265; 20348243; 20351714; 20353269; 20353944; 20357503; 20360387; 20372779; 20372799; 20375995; 20378615; 20379614; 20381444; 20382698; 20383761; 20388208; 20388878; 20392877; 20398657; 20403436; 20411337; 20413580; 20417295; 20417581; 20421786; 20429621; 20436503; 20439495; 20448663; 20452482; 20453000; 20453838; 20458558; 20460377; 20460512; 20468064; 20480654; 20487521; 20492382; 20505342; 20508921; 20514458; 20519370; 20524935; 20525555; 20532479; 20534720; 20534768; 20538124; 20542061; 20547749; 20550710; 20554715; 20556506; 20557310; 20559649; 20570923; 20578216; 20581058; 20581768; 20586553; 20592363; 20593765; 20595634; 20596625; 20599431; 20599614; 20602165; 20608937; 20609538; 20615892; 20628086; 20628746; 20631257; 20634197; 20634891; 20656393; 20661439; 20664970; 20673868; 20674091; 20691160; 20697762; 20699091; 20702456; 20711807; 20716560; 20727239; 20729390; 20732949; 20734064; 20797424; 20797716; 20800603; 20817241; 20819530; 20819792; 20827267; 20844986; 20846920; 20850223; 20852966; 20855884; 20872186; 20873988; 20880607; 20880986; 20881960; 20884142; 20887985; 20889718; 20890067; 20920367; 20927313; 20935677; 20945400; 20953833; 20956553; 20958960; 20959426; 20960162; 20961463; 20961965; 20962507; 20966540; 20978187; 20979911; 21029696; 21040551; 21041310; 21050467; 21059289; 21078168; 21078666; 21079811; 21084382; 21099731; 21102415; 21102521; 21104395; 21106950; 21119048; 21127007; 21139866; 21146582; 21149515; 21152022; 21152100; 21163127; 21173433; 21173974; 21174060; 21182203; 21182205; 21184272; 21196169; 21200092; 21203528; 21207255; 21207861; 21209395; 21209903; 21211272; 21211522; 21212417; 21216218; 21216543; 21217774; 21220187; 21248301; 21262040; 21263130; 21266162; 21269226; 21269613; 21271213; 21273576; 21282336; 21285458; 21292820; 21295396; 21300759; 21304949; 21308739; 21309471; 21323952; 21330404; 21344398; 21348637; 21351528; 21356307; 21367855; 21378170; 21397694; 21410323; 21422801; 21423915; 21427057; 21437249; 21444077; 21445275; 21445546; 21447808; 21458421; 21463834; 21468554; 21480391; 21486948; 21487104; 21491087; 21502505; 21503962; 21505052; 21506659; 21509526; 21520258; 21523370; 21527249; 21536917; 21540461; 21552322; 21570196; 21572391; 21572428; 21597315; 21607583; 21607585; 21610700; 21623207; 21625942; 21632819; 21640622; 21642474; 21644229; 21655654; 21658000; 21658281; 21673408; 21680658; 21684697; 21691043; 21695903; 21699784; 21700719; 21703046; 21706051; 21707866; 21713035; 21720911; 21734414; 21736840; 21741601; 21747171; 21749714; 21757754; 21760950; 21761334; 21761362; 21761367; 21762042; 21762477; 21781458; 21784129; 21823190; 21826373; 21835891; 21837403; 21837769; 21840040; 21840388; 21840910; 21841772; 21842124; 21858728; 21866462; 21868451; 21878914; 21880074; 21888973; 21901395; 21907792; 21907803; 21920899; 21922275; 21924251; 21934279; 21937726; 21943781; 21946067; 21947828; 21951066; 21966761; 21972702; 21980607; 21983130; 21984528; 21984853; 21984905; 21986093; 22001950; 22004841; 22009847; 22012767; 22014058; 22022496; 22031296; 22038234; 22049316; 22052998; 22056872; 22064478; 22068927; 22071320; 22074947; 22081016; 22083956; 22086303; 22092403; 22102068; 22107784; 22119825; 22125492; 22132110; 22138413; 22139072; 22141363; 22142990; 22170254; 22174013; 22193044; 22198466; 22199302; 22199306; 22201220; 22203942; 22207717; 22213398; 22216287; 22222969; 22226967; 22227247; 22228098; 22228197; 22230296; 22240483; 22245602; 22247547; 22249258; 22266331; 22266855; 22266866; 22266976; 22271290; 22271294; 22273809; 22275375; 22277987; 22283119; 22284250; 22286763; 22291085; 22291950; 22295098; 22295107; 22296324; 22310000; 22311020; 22311091; 22324545; 22326682; 22328322; 22328528; 22336175; 22342729; 22344619; 22347418; 22359603; 22362381; 22374427; 22375075; 22382029; 22383897; 22389694; 22394363; 22396492; 22399296; 22402113; 22404101; 22414972; 22415229; 22426783; 22446103; 22446104; 22457607; 22460789; 22463081; 22508765; 22509838; 22521644; 22524805; 22531679; 22543272; 22547449; 22549810; 22550166; 22562654; 22564243; 22569715; 22580007; 22580535; 22590818; 22606272; 22613997; 22615145; 22622808; 22626971; 22632162; 22668753; 22669764; 22727021; 22733972; 22747683; 22749220; 22759734; 22760258; 22784503; 22784973; 22787161; 22791811; 22792352; 22799738; 22800951; 22806965; 22807578; 22808109; 22810499; 22819972; 22820289; 22850893; 22853951; 22865929; 22882944; 22884659; 22890138; 22902633; 22907427; 22908231; 22921477; 22927007; 22936801; 22939624; 22962310; 22970307; 22971276; 22972951; 22976807; 22978347; 22982060; 23018357; 23023562; 23024189; 23030067; 23032375; 23041672; 23042285; 23042805; 23051957; 23056216; 23056236; 23060440; 23071688; 23074152; 23074960; 23078272; 23088992; 23098495; 23098526; 23098699; 23116284; 23128795; 23131391; 23133636; 23137636; 23145106; 23150099; 23159625; 23177411; 23178685; 23199240; 23206990; 23242655; 23242705; 23244119; 23245353; 23248117; 23250869; 23251661; 23257935; 23267128; 23268322; 23271418; 23272245; 23285017; 23305873; 23307470; 23319822; 23322423; 23324193; 23328702; 23338998; 23342072; 23342282; 23350368; 23362266; 23390529; 23397283; 23402757; 23403054; 23437003; 23437920; 23450473; 23463097; 23467929; 23468243; 23471591; 23474223; 23493373; 23497414; 23499324; 23506158; 23515291; 23522078; 23524984; 23525242; 23526455; 23535729; 23535733; 23546553; 23546601; 23546602; 23559367; 23563607; 23570281; 23576398; 23580323; 23580588; 23583297; 23584859; 23585209; 23591816; 23593326; 23609470; 23614677; 23620292; 23625281; 23636943; 23644255; 23666105; 23668054; 23676274; 23678541; 23687977; 23695389; 23704881; 23707549; 23733894; 23737135; 23741969; 23747343; 23749503; 23762395; 23763623; 23774759; 23809427; 23810005; 23810008; 23812730; 23814048; 23821363; 23825704; 23859042; 23860318; 23861392; 23867501; 23868472; 23873111; 23874775; 23912458; 23913373; 23915851; 23917948; 23923078; 23950888; 24015267; 24015958; 24023309; 24062311; 24086615; 24096540; 24099775; 24101509; 24121066; 24125069; 24133901; 24140101; 24162602; 24185510; 24185512; 24217577; 24217905; 24269135; 24304549; 24389498; 24449583; 24449868,,,,,,,,,,,,,,,,,,OGG:3000002099,,,,,,,,,,,,,,,,,,,estrogen receptor 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ESR1,,,20140408,2099,RP1-130E4.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,ESR1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/APOLLO_SV_00000086,infectious disease control strategy,,A plan specification whose objective specification is an infectious disease control objective specification.|The essential goal of an infectious disease control strategy is to protect the susceptible organisms in a population.,false,,,http://purl.obolibrary.org/obo/IAO_0000104,,,,,,,,,,,,,,,,,,,,,A plan specification whose objective specification is an infectious disease control objective specification.,,,,,,,,,,,A plan with the goal of preventing or mitigating the effects of infections in a population due to one or more pathogens.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,APOLLO_SV:00000086,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,The essential goal of an infectious disease control strategy is to protect the susceptible organisms in a population.,,http://purl.obolibrary.org/obo/IAO_0000104,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,infectious disease control strategy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,InfectiousDiseaseControlMeasure
http://purl.obolibrary.org/obo/NCBITaxon_511431,SARS coronavirus BJ182-8,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:511431,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ182-8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_235414,SARS coronavirus Sin2500,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:235414,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin2500,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249068,SARS coronavirus HSZ2-A,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249068,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HSZ2-A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0090150,establishment of protein localization to membrane,establishment of protein localization in membrane|establishment of protein localisation in membrane,The directed movement of a protein to a specific location in a membrane.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,tanyaberardini,2009-12-08T03:18:51Z,,,,The directed movement of a protein to a specific location in a membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,establishment of protein localization in membrane|establishment of protein localisation in membrane,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0090150,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0090150,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,establishment of protein localization to membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00018939,eculizumab,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,591781,,,,DRON:00018939,"A humanized monoclonal antibody directed against terminal complement protein C5. Eculizumab binds to terminal complement protein C5, thereby blocking C5 cleavage into pro-inflammatory components and blocking the complement-mediated destruction of paroxysmal nocturnal hemoglobinuria (PNH) red blood cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,eculizumab,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_474180,caspofungin,"(10R,12S)-N-{(2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-[(2-aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide|Caspofungin|caspofungin|1-[(4R,5S)-5-[(2-aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0|(4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide","A semisynthetic cyclic hexapeptide echinocandin antibiotic which exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,DrugBank:DB00520|Patent:WO9421677|Patent:US5378804|KEGG:D07626|Beilstein:8471798|PMID:24270605|Drug_Central:2977|CAS:162808-62-0,"A semisynthetic cyclic hexapeptide echinocandin antibiotic which exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:599509,,,,"(10R,12S)-N-{(2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-[(2-aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide|Caspofungin",,,,,chebi_ontology,,"caspofungin|1-[(4R,5S)-5-[(2-aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0|(4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide",,,,,,,,,0,C52H88N10O15,"InChI=1S/C52H88N10O15/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75)/t28-,29+,30+,33+,34-,35-,36+,37-,38+,40-,41-,42-,43-,44-,45-,46-/m0/s1",JYIKNQVWKBUSNH-WVDDFWQHSA-N,1093.315,1092.64306,[C@@]12(N(C[C@@H](C1)O)C([C@H]([C@@H](C)O)NC(=O)[C@](C[C@H]([C@@H](NCCN)NC([C@@H]3[C@H](CCN3C([C@H]([C@@H](CCN)O)NC(=O)[C@H]([C@@H]([C@H](C4=CC=C(C=C4)O)O)O)NC2=O)=O)O)=O)O)(NC(CCCCCCCC[C@H](C[C@H](CC)C)C)=O)[H])=O)[H],,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:474180,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:474180,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,caspofungin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007124,TNF,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TNFSF2|DIF|TNF-alpha|TNFA,,,,,,,6,,,,,,,,,,Vega:OTTHUMG00000031194|MIM:191160|HGNC:11892|HPRD:01855|Ensembl:ENSG00000232810,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,tumor necrosis factor,,6p21.3,,,,"GO_0000060 (EC: IDA, PMID: 16280327); GO_0000122 (EC: IDA, PMID: 15345745); GO_0000165 (EC: IMP); GO_0000185 (EC: IDA, PMID: 15310755); GO_0000187 (EC: IDA, PMID: 10748004); GO_0001666 (EC: IEA); GO_0001775 (EC: IEA); GO_0001819 (EC: IDA, PMID: 17922812); GO_0001891 (EC: ISS); GO_0001934 (EC: IDA, PMID: 10748004); GO_0002020 (EC: IPI, PMID: 12777399); GO_0002037 (EC: IEA); GO_0002439 (EC: IMP, PMID: 14512626); GO_0002740 (EC: IDA, PMID: 10443688); GO_0002876 (EC: IEA); GO_0002925 (EC: IEA); GO_0003009 (EC: IEA); GO_0005125 (EC: IDA, PMID: 10748004); GO_0005164 (EC: IDA, PMID: 14512626); GO_0005515 (EC: IPI, PMID: 11878931); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 10443688); GO_0005886 (EC: TAS); GO_0005887 (EC: IDA, PMID: 18355445); GO_0006006 (EC: IEA); GO_0006915 (EC: TAS); GO_0006919 (EC: IDA, PMID: 16723520); GO_0006927 (EC: IDA, PMID: 3883195); GO_0006954 (EC: IDA, PMID: 10748004); GO_0006959 (EC: IEA); GO_0007254 (EC: IEA); GO_0008285 (EC: IEA); GO_0008625 (EC: IDA, PMID: 10521396); GO_0008625 (EC: NAS); GO_0008630 (EC: IEA); GO_0008652 (EC: IEA); GO_0009612 (EC: IEA); GO_0009615 (EC: IDA, PMID: 10490959); GO_0009651 (EC: TAS, PMID: 18355445); GO_0009887 (EC: IEA); GO_0009897 (EC: ISS); GO_0009986 (EC: IDA, PMID: 18355445); GO_0010629 (EC: IDA, PMID: 15345745); GO_0010693 (EC: IEA); GO_0010888 (EC: NAS, PMID: 16464856); GO_0014823 (EC: IEA); GO_0019722 (EC: IEA); GO_0030198 (EC: IEA); GO_0030316 (EC: IEA); GO_0030730 (EC: IDA, PMID: 19032770); GO_0031334 (EC: IDA, PMID: 12813029); GO_0031622 (EC: ISS); GO_0031663 (EC: IDA); GO_0032715 (EC: IDA, PMID: 10443688); GO_0032722 (EC: IDA, PMID: 10490959); GO_0032729 (EC: IEA); GO_0032741 (EC: IEA); GO_0032755 (EC: IEA); GO_0032800 (EC: IDA, PMID: 10443688); GO_0033138 (EC: IDA, PMID: 17389591); GO_0033209 (EC: IMP, PMID: 10748004); GO_0034116 (EC: IDA, PMID: 10604883); GO_0042346 (EC: IDA, PMID: 17922812); GO_0042493 (EC: IEA); GO_0042802 (EC: IDA, PMID: 14512626); GO_0043065 (EC: IDA, PMID: 16723520); GO_0043068 (EC: IDA, PMID: 16611992); GO_0043122 (EC: IDA, PMID: 10748004); GO_0043123 (EC: IDA, PMID: 15310755); GO_0043242 (EC: IDA, PMID: 17389591); GO_0043243 (EC: IDA, PMID: 12813029); GO_0043280 (EC: IDA, PMID: 11577081); GO_0043406 (EC: IDA, PMID: 12813029); GO_0043491 (EC: IMP); GO_0043507 (EC: IDA, PMID: 17389591); GO_0043525 (EC: IEA); GO_0044130 (EC: IEA); GO_0044212 (EC: IDA, PMID: 17350185); GO_0045071 (EC: IDA, PMID: 10490959); GO_0045080 (EC: IDA, PMID: 10490959); GO_0045121 (EC: IDA, PMID: 17010968); GO_0045416 (EC: IDA); GO_0045429 (EC: IDA, PMID: 8383325); GO_0045599 (EC: NAS, PMID: 16464856); GO_0045668 (EC: IEA); GO_0045672 (EC: IDA, PMID: 17888176); GO_0045840 (EC: IEA); GO_0045892 (EC: IDA, PMID: 16895791); GO_0045893 (EC: IDA, PMID: 10748004); GO_0045944 (EC: IDA, PMID: 15345745); GO_0045944 (EC: IGI, PMID: 16803872); GO_0045994 (EC: IEA); GO_0046325 (EC: IEA); GO_0046330 (EC: IEA); GO_0048566 (EC: IEP); GO_0048661 (EC: IDA, PMID: 16518841); GO_0050715 (EC: IDA, PMID: 10443688); GO_0050796 (EC: IDA, PMID: 8383325); GO_0050806 (EC: IEA); GO_0050830 (EC: IEA); GO_0050901 (EC: IDA, PMID: 10820279); GO_0050995 (EC: IDA, PMID: 19032770); GO_0051023 (EC: IEA); GO_0051044 (EC: IDA, PMID: 18373975); GO_0051091 (EC: IDA, PMID: 10748004); GO_0051092 (EC: IDA, PMID: 10383454); GO_0051222 (EC: IDA, PMID: 15310755); GO_0051384 (EC: IDA, PMID: 10443688); GO_0051533 (EC: IDA, PMID: 16803872); GO_0051798 (EC: IEA); GO_0051897 (EC: IEA); GO_0055037 (EC: ISS); GO_0060557 (EC: IDA, PMID: 1690216); GO_0060559 (EC: IDA, PMID: 1690216); GO_0060664 (EC: IEA); GO_0060693 (EC: IEA); GO_0061048 (EC: IDA, PMID: 17350185); GO_0070374 (EC: NAS, PMID: 18606301); GO_0071230 (EC: IEA); GO_0071316 (EC: IDA, PMID: 18676776); GO_0071407 (EC: IDA); GO_0071677 (EC: NAS); GO_0071803 (EC: IDA, PMID: 15220135); GO_0097190 (EC: TAS); GO_0097191 (EC: IDA, PMID: 11577081); GO_0097527 (EC: IDA, PMID: 11101870); GO_1902043 (EC: IEA); GO_2000010 (EC: IDA, PMID: 19366699); GO_2000343 (EC: IDA); GO_2001240 (EC: IDA, PMID: 10666185)",PMID: 1279199; 1310388; 1331108; 1380260; 1402651; 1548758; 1550865; 1690216; 1905933; 1918997; 1918999; 1964681; 1993354; 2009860; 2158863; 2170559; 2413547; 2537468; 2551905; 2848815; 2922050; 2995927; 3001529; 3031624; 3139842; 3351931; 3417634; 3464978; 3552045; 3555974; 3856324; 3883195; 3932069; 6392892; 7494249; 7511078; 7523444; 7526541; 7536422; 7561697; 7664431; 7693046; 7695626; 7704970; 7706435; 7739525; 7758105; 7815507; 7818827; 7852363; 7859743; 7930591; 7935762; 7966397; 8182064; 8267288; 8288897; 8336080; 8336118; 8381971; 8383325; 8482849; 8499947; 8590321; 8597870; 8707350; 8724035; 8764000; 8806809; 8852605; 8869635; 8870842; 9034191; 9108403; 9110146; 9223523; 9225992; 9226228; 9230816; 9269771; 9269777; 9278385; 9334723; 9344703; 9378998; 9438495; 9442056; 9449720; 9488135; 9552007; 9568681; 9639071; 9651389; 9658081; 9670843; 9730685; 9744279; 9828130; 9920899; 10202016; 10205166; 10339575; 10369255; 10376933; 10383454; 10388525; 10415019; 10438928; 10443688; 10450718; 10490959; 10521396; 10604883; 10634209; 10666185; 10669763; 10747938; 10748004; 10775602; 10799478; 10820279; 10839541; 10843712; 10929056; 10964543; 11000208; 11023480; 11023482; 11023485; 11035665; 11037831; 11045789; 11057907; 11072751; 11083263; 11092520; 11097747; 11101870; 11106199; 11113269; 11118029; 11120931; 11121160; 11138328; 11144293; 11145126; 11153078; 11153913; 11157631; 11163081; 11163083; 11165717; 11167813; 11176446; 11179110; 11179116; 11192323; 11196671; 11196686; 11199329; 11211945; 11223972; 11230752; 11233912; 11241233; 11243953; 11244489; 11246532; 11250044; 11257271; 11258696; 11264025; 11266856; 11266927; 11266928; 11267084; 11273064; 11278695; 11285131; 11294926; 11298547; 11316066; 11316069; 11319038; 11319647; 11319665; 11324946; 11325850; 11328953; 11334675; 11349201; 11354638; 11371414; 11379335; 11389006; 11391238; 11401868; 11401880; 11404167; 11409121; 11411907; 11423177; 11427627; 11453117; 11500363; 11506397; 11506478; 11508580; 11522182; 11528523; 11533078; 11544427; 11544434; 11570978; 11571703; 11576577; 11577081; 11579140; 11585553; 11600224; 11602715; 11602932; 11607791; 11640949; 11640992; 11668577; 11689215; 11689614; 11697432; 11704803; 11715861; 11716174; 11722460; 11724772; 11725485; 11730934; 11735091; 11737072; 11737221; 11743056; 11744409; 11748357; 11751963; 11752507; 11756988; 11759867; 11774563; 11774822; 11775944; 11776328; 11781187; 11781708; 11792123; 11796554; 11798757; 11798770; 11799112; 11800584; 11801679; 11808761; 11816715; 11820636; 11824966; 11826759; 11828995; 11830340; 11830425; 11830590; 11831440; 11831864; 11832442; 11838837; 11841482; 11841484; 11841486; 11846846; 11847479; 11849390; 11849463; 11851889; 11852287; 11857057; 11858187; 11860474; 11861275; 11864973; 11868623; 11874184; 11874815; 11877397; 11878931; 11884401; 11886974; 11888514; 11891016; 11891022; 11893711; 11893712; 11896460; 11904678; 11906646; 11907116; 11909956; 11911478; 11916086; 11920321; 11922568; 11923482; 11924527; 11940577; 11954826; 11956055; 11958572; 11958574; 11960393; 11961180; 11962732; 11966578; 11968047; 11968052; 11971816; 11971973; 11975986; 11979305; 11980617; 11981433; 11983108; 11983212; 11988644; 11990931; 11991675; 12004062; 12006387; 12006640; 12009575; 12010662; 12011375; 12014672; 12019209; 12021142; 12022360; 12028020; 12030367; 12030733; 12031914; 12031976; 12032749; 12032830; 12034045; 12036088; 12039524; 12042033; 12047333; 12047360; 12048203; 12049175; 12050189; 12050565; 12054739; 12055326; 12058258; 12067299; 12067756; 12067976; 12074713; 12078789; 12082592; 12084660; 12086951; 12086962; 12089333; 12089610; 12089714; 12090473; 12091169; 12091338; 12091490; 12095061; 12097398; 12099552; 12100025; 12100575; 12101072; 12101079; 12102486; 12105273; 12107724; 12115605; 12115625; 12116197; 12117921; 12117943; 12117953; 12123862; 12124654; 12126516; 12133353; 12133434; 12135128; 12135369; 12135427; 12135759; 12142377; 12144133; 12145682; 12148593; 12149604; 12153747; 12160518; 12161098; 12161427; 12162435; 12162437; 12162871; 12163195; 12163370; 12164325; 12165487; 12165799; 12167698; 12169181; 12170268; 12171600; 12171811; 12173300; 12180762; 12183057; 12185082; 12187026; 12190096; 12192111; 12195699; 12198621; 12200397; 12202945; 12205044; 12213594; 12215823; 12220546; 12230503; 12232842; 12234707; 12235090; 12237295; 12240899; 12244188; 12270547; 12270556; 12296856; 12297049; 12297050; 12297113; 12297724; 12351419; 12368210; 12370346; 12370360; 12370403; 12370499; 12370503; 12372982; 12378118; 12383455; 12383917; 12387878; 12387879; 12390476; 12391248; 12391840; 12392301; 12392859; 12393608; 12393619; 12393699; 12393755; 12395215; 12396374; 12396377; 12396555; 12397597; 12404162; 12406900; 12411040; 12414751; 12415586; 12420104; 12423676; 12424537; 12438348; 12438370; 12438440; 12438965; 12439617; 12441140; 12441346; 12444137; 12445207; 12445803; 12447749; 12451269; 12451465; 12453902; 12457980; 12459320; 12459639; 12472577; 12472598; 12475426; 12477932; 12478078; 12482669; 12483736; 12485196; 12485861; 12488366; 12490310; 12492251; 12496175; 12496396; 12501066; 12504564; 12506026; 12507818; 12508775; 12513816; 12526952; 12528108; 12530117; 12530118; 12537602; 12538692; 12542496; 12545006; 12548461; 12548511; 12553033; 12554901; 12555203; 12558814; 12559632; 12559634; 12566517; 12568117; 12574335; 12574344; 12574959; 12579167; 12580317; 12581498; 12587980; 12590978; 12590981; 12591385; 12591926; 12594207; 12595628; 12595908; 12601524; 12603009; 12606947; 12607668; 12609060; 12609526; 12620429; 12622777; 12626032; 12626603; 12631070; 12632436; 12637641; 12640117; 12641410; 12644006; 12644590; 12645577; 12651071; 12653732; 12654235; 12654703; 12655064; 12657115; 12661999; 12663241; 12673844; 12679941; 12682890; 12687213; 12687247; 12690081; 12691703; 12691705; 12691826; 12692009; 12692291; 12694213; 12699902; 12702205; 12707271; 12707358; 12709814; 12714268; 12714269; 12714560; 12715715; 12717265; 12718576; 12720537; 12727482; 12730860; 12732844; 12743452; 12744771; 12746914; 12747595; 12749050; 12750172; 12750939; 12751024; 12753658; 12753742; 12756345; 12762136; 12768019; 12770792; 12770796; 12773519; 12777399; 12782345; 12783130; 12783210; 12787424; 12788886; 12792476; 12794406; 12794527; 12795334; 12795791; 12799216; 12802423; 12802709; 12804035; 12809834; 12810683; 12811429; 12811828; 12813029; 12815949; 12816730; 12818128; 12818408; 12823767; 12824709; 12826369; 12828656; 12828754; 12829646; 12829659; 12834858; 12837287; 12839521; 12839942; 12842760; 12847678; 12849705; 12850624; 12850808; 12850811; 12851716; 12854077; 12855762; 12858454; 12859597; 12864989; 12867430; 12869351; 12870175; 12871600; 12871882; 12876073; 12878172; 12880679; 12882963; 12887920; 12888330; 12888880; 12889993; 12891537; 12892736; 12898475; 12899665; 12906716; 12909463; 12911663; 12915440; 12915457; 12917036; 12919285; 12923493; 12925536; 12928370; 12930304; 12933883; 12934185; 12938195; 12940442; 12940515; 12941546; 12944979; 12945076; 12947552; 12952969; 12953135; 12954601; 12957651; 12959221; 12959973; 12960156; 12960255; 12960355; 12960751; 12962917; 12966432; 12967650; 12969378; 12970400; 13679820; 14500138; 14500462; 14500687; 14512626; 14514692; 14514772; 14517700; 14519430; 14519761; 14530204; 14530285; 14530313; 14530362; 14530365; 14532277; 14534724; 14550782; 14555463; 14563376; 14566095; 14567462; 14572449; 14572618; 14572794; 14581470; 14592496; 14593215; 14606512; 14607690; 14607966; 14612430; 14613268; 14615042; 14615367; 14616291; 14617036; 14617046; 14623370; 14623371; 14625134; 14625191; 14630568; 14633738; 14635012; 14636244; 14637275; 14642160; 14643088; 14644777; 14646574; 14651518; 14651527; 14652008; 14655898; 14656967; 14657427; 14657629; 14659806; 14662866; 14662883; 14671137; 14674935; 14681231; 14681301; 14681891; 14685701; 14688105; 14693849; 14696796; 14698136; 14701704; 14703611; 14708348; 14714556; 14715628; 14716517; 14718619; 14718719; 14720421; 14722888; 14723749; 14727453; 14731353; 14732222; 14732344; 14734776; 14734780; 14741380; 14743216; 14744383; 14744790; 14756669; 14758530; 14760938; 14761884; 14766265; 14767724; 14872499; 14960532; 14962095; 14962963; 14963043; 14963369; 14966591; 14967554; 14969768; 14978035; 14978132; 14979058; 14982742; 14986816; 14987295; 14988320; 14990112; 14992821; 14994383; 15003925; 15007139; 15009068; 15009105; 15009176; 15009808; 15013759; 15014429; 15014438; 15016407; 15017311; 15018649; 15019283; 15027477; 15030461; 15036247; 15036607; 15041705; 15043686; 15044327; 15055475; 15055529; 15056081; 15057268; 15057902; 15059302; 15061799; 15063602; 15066699; 15068388; 15070815; 15071492; 15077289; 15084940; 15086488; 15100460; 15104370; 15104672; 15104679; 15111313; 15112338; 15120188; 15120189; 15124210; 15124762; 15127646; 15127972; 15128741; 15128916; 15131465; 15135368; 15137526; 15140018; 15142214; 15142381; 15142990; 15145213; 15145954; 15146559; 15149631; 15152368; 15157159; 15158680; 15161508; 15161830; 15162831; 15163120; 15167972; 15174288; 15175153; 15182332; 15184943; 15188512; 15189946; 15191888; 15194284; 15194285; 15200452; 15201584; 15202783; 15203561; 15207246; 15212671; 15214940; 15217507; 15219382; 15219383; 15220135; 15220553; 15221977; 15223011; 15223607; 15223609; 15223612; 15223716; 15223990; 15230290; 15232637; 15235132; 15236174; 15236755; 15238257; 15239085; 15246652; 15247172; 15248209; 15251463; 15254878; 15256287; 15256977; 15257049; 15257453; 15263792; 15265021; 15269840; 15271127; 15271933; 15272094; 15273551; 15273737; 15276234; 15277733; 15279067; 15280021; 15280623; 15284722; 15286263; 15288392; 15288471; 15288631; 15289017; 15292002; 15301589; 15301860; 15304089; 15306845; 15307952; 15308304; 15308875; 15310755; 15313687; 15315967; 15316669; 15319168; 15319381; 15325795; 15326480; 15327404; 15331607; 15331795; 15332393; 15334474; 15337758; 15339882; 15340354; 15341923; 15342556; 15345185; 15345745; 15347683; 15351436; 15354858; 15355698; 15358608; 15361124; 15361128; 15366429; 15367225; 15370717; 15371770; 15374002; 15380900; 15381184; 15387905; 15388258; 15388264; 15449074; 15452110; 15457442; 15458430; 15458467; 15468911; 15469436; 15469865; 15474092; 15479128; 15481145; 15482484; 15485576; 15485837; 15486341; 15489334; 15489542; 15492857; 15495570; 15495787; 15504546; 15504978; 15507966; 15507967; 15513316; 15515013; 15516323; 15517637; 15520404; 15523649; 15523691; 15524285; 15526004; 15526005; 15531184; 15533517; 15537425; 15540224; 15542843; 15543003; 15545623; 15545823; 15546338; 15548263; 15550384; 15555301; 15555625; 15556647; 15560757; 15564333; 15565405; 15565953; 15570075; 15572357; 15576488; 15579481; 15583831; 15585313; 15587751; 15592292; 15592496; 15597152; 15599305; 15600254; 15603866; 15604419; 15611081; 15614591; 15619425; 15620462; 15621151; 15622443; 15623376; 15626980; 15627647; 15629131; 15632117; 15638425; 15640107; 15640148; 15641051; 15641080; 15644653; 15647276; 15649304; 15650331; 15650893; 15652446; 15654990; 15660126; 15661163; 15663746; 15663966; 15667484; 15667501; 15667866; 15667911; 15668241; 15670287; 15670770; 15677734; 15679580; 15681825; 15685549; 15686588; 15690532; 15691236; 15693080; 15694363; 15694386; 15695296; 15699425; 15701637; 15704154; 15708894; 15710474; 15710602; 15712606; 15713215; 15714129; 15717274; 15717635; 15718915; 15722350; 15722553; 15723199; 15723707; 15725578; 15726267; 15727562; 15728381; 15730950; 15731048; 15733644; 15733973; 15748898; 15750822; 15754412; 15755722; 15763337; 15766528; 15766560; 15773449; 15777836; 15780075; 15780175; 15780879; 15784408; 15784410; 15784411; 15787640; 15788755; 15790514; 15790681; 15790988; 15797745; 15797957; 15798948; 15799583; 15800006; 15800781; 15803022; 15809210; 15809899; 15810887; 15811521; 15813606; 15814282; 15816837; 15817702; 15817713; 15817944; 15818327; 15820084; 15825968; 15828019; 15832029; 15837333; 15841043; 15842262; 15842590; 15842659; 15842729; 15845475; 15845648; 15847100; 15848524; 15851552; 15854776; 15854959; 15860935; 15866693; 15870936; 15875188; 15878915; 15879291; 15885323; 15890243; 15894515; 15895461; 15896304; 15901240; 15901845; 15901906; 15902922; 15903021; 15904673; 15910294; 15917409; 15919211; 15919456; 15923644; 15925543; 15927351; 15927374; 15927855; 15929757; 15931230; 15932622; 15935956; 15937090; 15940715; 15941417; 15941525; 15951664; 15955385; 15956282; 15956727; 15958080; 15963988; 15964333; 15967797; 15968724; 15969671; 15971421; 15972386; 15976383; 15978325; 15978856; 15979578; 15979955; 15984988; 15985479; 15986200; 15987860; 15988006; 15990085; 15992611; 15993097; 15994321; 15999154; 16004996; 16006475; 16009345; 16011481; 16021081; 16024973; 16027740; 16029496; 16030091; 16039994; 16040075; 16046099; 16046471; 16051275; 16051302; 16075747; 16081933; 16082153; 16083851; 16086278; 16087126; 16091223; 16095006; 16095118; 16096333; 16098388; 16099338; 16100725; 16100774; 16105652; 16105945; 16107336; 16107511; 16107886; 16109906; 16110031; 16115611; 16116311; 16120761; 16123045; 16124898; 16127755; 16132956; 16133992; 16134057; 16135717; 16135957; 16135983; 16137184; 16138112; 16140265; 16141456; 16143422; 16148157; 16148556; 16159730; 16160188; 16164695; 16164697; 16166621; 16170833; 16172101; 16173529; 16174285; 16176285; 16181755; 16182624; 16183136; 16191343; 16193177; 16199883; 16202081; 16202743; 16202847; 16203766; 16204594; 16204600; 16207331; 16210389; 16211257; 16215460; 16224057; 16224188; 16227624; 16232344; 16235536; 16239914; 16243340; 16246225; 16246259; 16249504; 16251478; 16252073; 16253303; 16254197; 16259478; 16260352; 16260427; 16260783; 16263419; 16269080; 16269960; 16272296; 16276011; 16277898; 16279907; 16280327; 16282562; 16284098; 16284099; 16286275; 16293872; 16298864; 16299685; 16301860; 16313253; 16313297; 16313841; 16314440; 16317381; 16318585; 16319143; 16319659; 16322490; 16322943; 16323137; 16323614; 16324093; 16325265; 16331275; 16339571; 16339574; 16340448; 16343069; 16343435; 16359550; 16368349; 16369102; 16374139; 16375755; 16378074; 16386594; 16386648; 16388753; 16389181; 16391465; 16393214; 16393721; 16393767; 16397758; 16400484; 16400883; 16403098; 16407614; 16410066; 16410254; 16411061; 16413198; 16418737; 16421346; 16423623; 16424170; 16424284; 16425360; 16426238; 16427155; 16427740; 16427798; 16428794; 16429233; 16430709; 16431125; 16433832; 16438713; 16444434; 16445909; 16446172; 16454711; 16456144; 16458016; 16463424; 16464740; 16464741; 16464856; 16467041; 16473522; 16474009; 16475830; 16476505; 16503400; 16505113; 16507146; 16507998; 16516271; 16517578; 16518755; 16518841; 16519772; 16520888; 16522396; 16533817; 16534418; 16538176; 16538639; 16538877; 16539678; 16539828; 16540751; 16543241; 16545485; 16545788; 16547255; 16549165; 16552356; 16554734; 16564576; 16564703; 16567828; 16567888; 16569263; 16571778; 16572445; 16573780; 16574427; 16579840; 16580225; 16581306; 16581430; 16585076; 16585124; 16596274; 16596276; 16601113; 16603398; 16611251; 16611992; 16614115; 16617094; 16621960; 16622749; 16622779; 16628468; 16633737; 16635219; 16638698; 16641217; 16643431; 16647242; 16672072; 16681592; 16688007; 16691430; 16697675; 16698276; 16699450; 16699452; 16701011; 16702372; 16702858; 16707559; 16707968; 16711541; 16716376; 16718633; 16720051; 16720107; 16720636; 16722148; 16723255; 16723520; 16728705; 16730227; 16730575; 16741147; 16751383; 16757480; 16762155; 16775170; 16778150; 16785565; 16786763; 16786764; 16788244; 16788246; 16793930; 16796744; 16798739; 16803872; 16803995; 16803996; 16804395; 16814297; 16815316; 16820326; 16820919; 16820934; 16824064; 16824070; 16824159; 16827183; 16827185; 16829620; 16835229; 16835238; 16846840; 16857678; 16859504; 16859780; 16861224; 16863613; 16864906; 16865291; 16867312; 16872485; 16875346; 16879054; 16879221; 16882065; 16882174; 16885196; 16890076; 16891799; 16895750; 16895791; 16896069; 16897113; 16907849; 16908592; 16908746; 16909270; 16911569; 16916598; 16919469; 16919536; 16926287; 16930761; 16930778; 16931032; 16931134; 16932925; 16935932; 16936264; 16937502; 16938178; 16938460; 16938461; 16950634; 16951360; 16951943; 16952484; 16952987; 16953332; 16960936; 16961803; 16962335; 16970270; 16971410; 16979413; 16980557; 16982833; 16984280; 16984283; 16984517; 16987073; 16987811; 16988194; 16998242; 17001213; 17003486; 17003844; 17005410; 17006329; 17007883; 17010968; 17014432; 17014622; 17016618; 17018637; 17020650; 17020651; 17030448; 17034639; 17036337; 17047287; 17049565; 17052277; 17052682; 17052690; 17053845; 17054908; 17055360; 17057944; 17062130; 17063315; 17064665; 17068065; 17069807; 17070109; 17071494; 17074545; 17074928; 17077296; 17079017; 17079667; 17082635; 17084384; 17086054; 17087110; 17087739; 17090647; 17097497; 17101473; 17101499; 17103073; 17105909; 17108674; 17109502; 17113059; 17113632; 17114809; 17115419; 17117950; 17119950; 17123322; 17123692; 17129465; 17130566; 17130569; 17132473; 17133355; 17138053; 17139467; 17141242; 17141246; 17141882; 17142509; 17143972; 17145371; 17145373; 17160953; 17164537; 17166738; 17167711; 17171665; 17173255; 17174749; 17185628; 17192490; 17192785; 17192953; 17194482; 17196641; 17198275; 17201881; 17205128; 17207378; 17207568; 17207711; 17208210; 17208287; 17208993; 17209781; 17213232; 17213876; 17216494; 17220333; 17221211; 17222850; 17223386; 17227768; 17234183; 17234379; 17238853; 17244513; 17255827; 17257312; 17261759; 17268200; 17272816; 17277048; 17277102; 17285966; 17287608; 17295710; 17298451; 17298885; 17303222; 17303559; 17304101; 17304103; 17305696; 17307728; 17311253; 17312171; 17314689; 17315188; 17324969; 17328044; 17330135; 17332138; 17335072; 17335371; 17336597; 17343250; 17346438; 17347550; 17348243; 17349210; 17349875; 17350022; 17350185; 17351514; 17353161; 17355643; 17356374; 17356550; 17359518; 17360657; 17360787; 17362351; 17367855; 17369174; 17373637; 17373677; 17376903; 17376917; 17380115; 17380888; 17382880; 17388919; 17389591; 17395331; 17397790; 17397798; 17397847; 17400536; 17401435; 17405915; 17408448; 17408492; 17412556; 17415203; 17416344; 17426528; 17428349; 17428620; 17428673; 17431682; 17434489; 17439892; 17442953; 17444864; 17445540; 17446901; 17448042; 17449468; 17450233; 17451964; 17452160; 17452460; 17452560; 17452777; 17454170; 17454884; 17458901; 17460948; 17471239; 17471286; 17472990; 17475642; 17475896; 17476188; 17477779; 17477815; 17479109; 17482757; 17483581; 17483704; 17493155; 17493863; 17495957; 17496310; 17497030; 17497035; 17498265; 17498268; 17499233; 17503085; 17505301; 17507924; 17509030; 17509552; 17510437; 17511783; 17513605; 17515611; 17516296; 17521325; 17522703; 17530646; 17530706; 17531241; 17532082; 17532302; 17536219; 17541791; 17541951; 17543146; 17544514; 17544674; 17550423; 17553030; 17554369; 17559370; 17559942; 17560079; 17560652; 17562093; 17562931; 17564320; 17565648; 17565649; 17568575; 17572155; 17573384; 17576577; 17579071; 17581202; 17581788; 17583675; 17584976; 17586554; 17587429; 17589947; 17592115; 17592300; 17592954; 17593951; 17595314; 17597660; 17599062; 17599736; 17600229; 17606294; 17607501; 17607547; 17612762; 17618436; 17624216; 17626836; 17627763; 17631138; 17631734; 17631742; 17635596; 17635597; 17635859; 17638785; 17640324; 17641010; 17645589; 17646145; 17653830; 17654453; 17656331; 17657677; 17660390; 17665457; 17666321; 17667716; 17668322; 17671691; 17672967; 17673491; 17674321; 17678725; 17681786; 17684700; 17686006; 17686102; 17686222; 17686276; 17689273; 17689932; 17690329; 17697145; 17698217; 17700165; 17700364; 17701456; 17701768; 17702576; 17703412; 17704111; 17705580; 17706953; 17707405; 17708628; 17710405; 17710577; 17711410; 17712006; 17712635; 17714554; 17714763; 17716775; 17717744; 17724799; 17727652; 17728075; 17728221; 17761309; 17763205; 17763324; 17763852; 17763921; 17767555; 17768594; 17785317; 17785864; 17823082; 17823083; 17823284; 17823444; 17845635; 17846855; 17850436; 17851856; 17854800; 17873294; 17877801; 17879952; 17881124; 17881900; 17881920; 17888176; 17889143; 17890880; 17892998; 17895302; 17895594; 17896809; 17900510; 17903994; 17906092; 17907045; 17908769; 17910605; 17911088; 17913045; 17913961; 17920036; 17921876; 17922812; 17927494; 17927932; 17928988; 17935818; 17936906; 17937745; 17938134; 17942758; 17947510; 17952840; 17953695; 17960400; 17971052; 17974504; 17976926; 17978470; 17981284; 17981921; 17986934; 17988266; 17988528; 17988552; 17988588; 17988804; 17989340; 17989610; 17990358; 17996648; 17996942; 17997607; 17999785; 18000721; 18001298; 18003704; 18004767; 18006630; 18021367; 18021981; 18023359; 18029463; 18030367; 18032780; 18036648; 18040839; 18041006; 18048771; 18049448; 18051225; 18055234; 18055729; 18055871; 18056971; 18060802; 18061975; 18062795; 18063307; 18063379; 18068948; 18069935; 18070287; 18071035; 18071881; 18076359; 18078481; 18078928; 18079408; 18080320; 18081437; 18083042; 18083240; 18083784; 18086782; 18088017; 18088351; 18088549; 18088554; 18089811; 18090276; 18091521; 18092345; 18093792; 18094051; 18094730; 18095602; 18097033; 18155667; 18156701; 18157711; 18158110; 18158121; 18164590; 18165865; 18174230; 18174250; 18176176; 18176993; 18177545; 18180317; 18182917; 18187448; 18194515; 18196539; 18199670; 18199828; 18202225; 18205195; 18206417; 18209523; 18215180; 18219322; 18222174; 18223493; 18224289; 18231755; 18231758; 18234086; 18234565; 18240225; 18240960; 18249219; 18251167; 18252868; 18256059; 18260730; 18263601; 18266953; 18271063; 18272527; 18273051; 18273643; 18274637; 18274638; 18275007; 18275506; 18278185; 18279834; 18281372; 18283248; 18284424; 18286287; 18289203; 18292233; 18292388; 18292749; 18294286; 18295546; 18297686; 18299433; 18300111; 18301299; 18303186; 18303205; 18307033; 18307517; 18307978; 18308368; 18308930; 18309109; 18309487; 18311806; 18312445; 18312678; 18314537; 18316608; 18319718; 18320014; 18322311; 18328265; 18328809; 18330749; 18331441; 18334870; 18335579; 18336259; 18336639; 18336852; 18337305; 18337563; 18341619; 18344712; 18344999; 18345002; 18346639; 18346907; 18348163; 18350251; 18353715; 18354232; 18354254; 18355201; 18355445; 18356846; 18361934; 18362084; 18363738; 18363879; 18364273; 18366487; 18373975; 18375254; 18381783; 18381799; 18383524; 18384390; 18384449; 18385169; 18385757; 18388249; 18391721; 18391842; 18392953; 18394614; 18396154; 18396294; 18398712; 18404970; 18405969; 18405996; 18408074; 18409070; 18413212; 18416134; 18416756; 18418000; 18422436; 18426866; 18427872; 18428025; 18433468; 18434886; 18437285; 18438653; 18438841; 18439101; 18440775; 18441098; 18442814; 18444945; 18446055; 18447907; 18450464; 18451575; 18452158; 18454664; 18463678; 18472000; 18483465; 18484240; 18485518; 18485876; 18489434; 18493210; 18495419; 18496214; 18496506; 18499473; 18502564; 18502965; 18510721; 18511747; 18512781; 18513389; 18515978; 18521569; 18524817; 18534053; 18534084; 18535206; 18538149; 18543247; 18544535; 18545091; 18546202; 18547669; 18547996; 18549718; 18550063; 18550705; 18550789; 18551071; 18551993; 18552856; 18558283; 18560870; 18563738; 18565022; 18566306; 18566436; 18566561; 18566867; 18571009; 18573564; 18574677; 18575614; 18577652; 18579335; 18580445; 18580852; 18581940; 18583979; 18584048; 18587204; 18589089; 18591313; 18596918; 18597405; 18600213; 18600307; 18603357; 18606301; 18606850; 18608123; 18610831; 18610832; 18613029; 18615253; 18618239; 18619701; 18620570; 18621737; 18624881; 18624934; 18627514; 18628756; 18631256; 18632424; 18632425; 18633131; 18633332; 18633768; 18634156; 18634161; 18635549; 18635873; 18639610; 18640487; 18640689; 18643840; 18645056; 18645461; 18646527; 18649336; 18656701; 18658144; 18660489; 18665050; 18665387; 18665932; 18666029; 18667537; 18668392; 18668547; 18670216; 18673406; 18673463; 18675783; 18675993; 18676404; 18676680; 18676776; 18676870; 18678243; 18678874; 18679053; 18680515; 18685607; 18689851; 18692180; 18698679; 18700166; 18702109; 18703994; 18705845; 18708672; 18709160; 18710329; 18710415; 18710885; 18711258; 18715339; 18715507; 18716131; 18716928; 18717726; 18719920; 18720901; 18726101; 18728048; 18752500; 18753141; 18754435; 18755269; 18755511; 18755820; 18758806; 18763028; 18764880; 18766139; 18768512; 18773331; 18773665; 18778820; 18792803; 18794066; 18796448; 18797411; 18797991; 18804983; 18805021; 18807256; 18809684; 18811622; 18814905; 18815054; 18815552; 18815866; 18818748; 18820938; 18821672; 18825399; 18826950; 18827481; 18832862; 18834321; 18834925; 18838202; 18839132; 18846826; 18852869; 18854757; 18926711; 18930140; 18930330; 18931463; 18931892; 18936436; 18937577; 18942752; 18942754; 18945465; 18947693; 18949133; 18949366; 18949385; 18949619; 18951205; 18952604; 18953879; 18962899; 18971284; 18974840; 18974842; 18981134; 18989801; 18990758; 18990769; 18992196; 18992723; 18996102; 18996288; 18996291; 18997459; 18997986; 19002558; 19004142; 19005292; 19008611; 19009622; 19012493; 19013788; 19017992; 19019335; 19021060; 19022640; 19023492; 19026125; 19026135; 19028820; 19031138; 19031816; 19032770; 19032806; 19035456; 19035492; 19036374; 19038328; 19050632; 19052146; 19055487; 19056482; 19057521; 19058789; 19058987; 19060367; 19060757; 19064125; 19064572; 19065318; 19066187; 19072030; 19073786; 19076989; 19082505; 19082897; 19084540; 19086955; 19088256; 19089489; 19091593; 19091752; 19094228; 19099590; 19103526; 19104039; 19107725; 19107922; 19109170; 19109523; 19110660; 19115949; 19117726; 19117745; 19120272; 19121222; 19122175; 19126414; 19126646; 19127455; 19129484; 19131662; 19131814; 19133041; 19135670; 19142017; 19143814; 19144181; 19144193; 19147919; 19148387; 19151112; 19152111; 19152246; 19155075; 19156215; 19164257; 19164476; 19167443; 19167444; 19167759; 19168721; 19168815; 19169931; 19170196; 19175398; 19180470; 19180512; 19180798; 19183163; 19193342; 19196314; 19196817; 19200845; 19201028; 19201038; 19201817; 19203796; 19208590; 19212208; 19213875; 19214380; 19218098; 19218353; 19218687; 19219422; 19223152; 19223501; 19225544; 19225954; 19229070; 19230022; 19230467; 19231997; 19233472; 19234184; 19236316; 19238444; 19238748; 19242068; 19242354; 19244371; 19246452; 19247692; 19247707; 19248089; 19249901; 19250144; 19250279; 19250650; 19253056; 19257928; 19257990; 19258635; 19258923; 19260858; 19261809; 19263529; 19264393; 19267370; 19272692; 19276869; 19278365; 19279689; 19281305; 19282863; 19286392; 19289181; 19289468; 19292050; 19295440; 19298660; 19299722; 19301111; 19309429; 19318316; 19322919; 19328242; 19328558; 19332120; 19333723; 19336370; 19336475; 19338208; 19338485; 19338536; 19339243; 19339270; 19339767; 19340565; 19344623; 19347053; 19347588; 19351958; 19353239; 19358670; 19358850; 19360326; 19365401; 19366699; 19367093; 19367363; 19369902; 19374512; 19374589; 19375766; 19375805; 19376428; 19385047; 19386363; 19386798; 19390969; 19392621; 19392789; 19392797; 19393188; 19394608; 19405090; 19407154; 19407822; 19408823; 19409515; 19411070; 19411391; 19413740; 19419979; 19420105; 19421420; 19423537; 19424555; 19427781; 19436686; 19436689; 19439012; 19445962; 19448410; 19450147; 19453261; 19453840; 19455469; 19459480; 19461480; 19467887; 19468203; 19469656; 19470040; 19470238; 19470239; 19472212; 19474090; 19474452; 19477545; 19478694; 19479051; 19479237; 19480843; 19481774; 19483297; 19488421; 19491251; 19491387; 19493496; 19495883; 19497039; 19498318; 19500335; 19500510; 19501525; 19505222; 19505916; 19505919; 19508433; 19508602; 19522649; 19524512; 19527514; 19527699; 19528505; 19530270; 19531281; 19531474; 19533439; 19538860; 19542367; 19542865; 19543846; 19544559; 19545551; 19546559; 19546880; 19548417; 19550417; 19551157; 19553068; 19555357; 19556613; 19556827; 19559392; 19563465; 19564826; 19573080; 19574026; 19576194; 19578796; 19581111; 19584886; 19585232; 19586939; 19592490; 19594368; 19602845; 19606693; 19608431; 19614955; 19615068; 19618378; 19619514; 19619938; 19621989; 19625176; 19626584; 19635931; 19637776; 19638314; 19643162; 19644155; 19645041; 19649705; 19650780; 19651533; 19654554; 19657354; 19657406; 19658300; 19659788; 19659809; 19661089; 19664671; 19665818; 19672706; 19673019; 19679065; 19683483; 19683526; 19683555; 19692168; 19692203; 19695094; 19697035; 19698992; 19700502; 19706048; 19706600; 19707465; 19708125; 19710156; 19710421; 19714324; 19714631; 19716548; 19717436; 19717938; 19720680; 19723083; 19723394; 19723627; 19728295; 19729601; 19729797; 19729799; 19732761; 19732770; 19732956; 19733878; 19735075; 19735272; 19738171; 19738620; 19741298; 19742166; 19744138; 19752769; 19755636; 19758199; 19758203; 19760027; 19760502; 19762398; 19764567; 19769302; 19769745; 19771178; 19772798; 19773279; 19773451; 19774383; 19775068; 19776336; 19776629; 19778488; 19779724; 19784808; 19787624; 19789190; 19789454; 19789511; 19790045; 19790073; 19796538; 19799649; 19800032; 19800767; 19801788; 19803352; 19803813; 19804405; 19806584; 19811435; 19811436; 19811499; 19813110; 19815509; 19817985; 19818126; 19818512; 19819209; 19822082; 19823053; 19825522; 19830555; 19830738; 19833626; 19836613; 19837795; 19840475; 19844779; 19845893; 19846139; 19846171; 19846277; 19847187; 19849941; 19850087; 19850743; 19851445; 19851831; 19860001; 19860911; 19861860; 19874800; 19876004; 19879772; 19880327; 19885605; 19889458; 19890236; 19890474; 19892918; 19894308; 19897767; 19900796; 19903048; 19909503; 19910467; 19910617; 19910749; 19913121; 19922107; 19933216; 19934104; 19941336; 19945777; 19948975; 19949084; 19951374; 19954656; 19954777; 19956564; 19956635; 19957794; 19959217; 19966052; 19966089; 20001857; 20002873; 20004605; 20004646; 20005085; 20005846; 20007453; 20007938; 20009360; 20012441; 20012959; 20012999; 20014019; 20015215; 20015663; 20020446; 20022049; 20027315; 20029655; 20032122; 20035378; 20035431; 20037209; 20038579; 20039412; 20043171; 20047977; 20051654; 20053569; 20056178; 20056442; 20059579; 20061995; 20063037; 20064200; 20064526; 20067407; 20067853; 20068037; 20070603; 20070836; 20074459; 20074664; 20078877; 20080841; 20080912; 20082482; 20082645; 20083555; 20083573; 20085599; 20086025; 20087644; 20087947; 20088864; 20096599; 20097868; 20097948; 20100586; 20100935; 20103767; 20104750; 20104757; 20106534; 20107186; 20113413; 20118277; 20120526; 20121167; 20124101; 20126546; 20128678; 20131287; 20132806; 20132814; 20133817; 20140872; 20145387; 20145925; 20146672; 20147981; 20156727; 20157068; 20160043; 20162115; 20163933; 20166876; 20173430; 20177069; 20177654; 20178529; 20178622; 20178892; 20180006; 20181653; 20181891; 20184663; 20186155; 20187770; 20188863; 20189261; 20189706; 20191326; 20191386; 20193596; 20194454; 20194818; 20200422; 20202153; 20203691; 20206339; 20206550; 20207250; 20210814; 20213229; 20213805; 20214763; 20217044; 20217072; 20224758; 20224765; 20227257; 20228669; 20228833; 20229266; 20231691; 20231985; 20237236; 20237317; 20237426; 20299515; 20299531; 20300049; 20301193; 20304956; 20305143; 20306665; 20306666; 20306684; 20307265; 20307542; 20307689; 20331378; 20333386; 20334849; 20334922; 20335604; 20335630; 20337945; 20339904; 20339974; 20346360; 20348510; 20349238; 20349753; 20352242; 20353421; 20354226; 20355242; 20356387; 20357201; 20357716; 20361391; 20363151; 20363332; 20364405; 20368273; 20370995; 20371430; 20372910; 20372945; 20373002; 20380698; 20381257; 20381376; 20383177; 20384434; 20386917; 20388088; 20388617; 20388705; 20393185; 20395963; 20396411; 20396431; 20398373; 20399210; 20399512; 20399529; 20404426; 20407468; 20418110; 20419805; 20420684; 20422754; 20423777; 20424554; 20430728; 20430958; 20431935; 20437058; 20441409; 20449757; 20450741; 20452482; 20453000; 20454933; 20456305; 20459604; 20459687; 20460119; 20463618; 20465445; 20470442; 20470944; 20472930; 20473875; 20484443; 20484876; 20485444; 20486195; 20486865; 20486867; 20487628; 20490891; 20491592; 20492333; 20493182; 20493832; 20495148; 20499285; 20502044; 20503287; 20509143; 20511226; 20512382; 20514989; 20518833; 20518840; 20518842; 20521320; 20522203; 20522558; 20526020; 20533298; 20534169; 20535510; 20535794; 20535924; 20536507; 20536548; 20536609; 20537163; 20537485; 20538960; 20541027; 20548340; 20563362; 20564140; 20565774; 20566643; 20568250; 20573209; 20574005; 20576226; 20576301; 20578265; 20578820; 20580040; 20587610; 20588103; 20588308; 20596903; 20599393; 20599735; 20600447; 20603037; 20603050; 20608170; 20609223; 20617584; 20618340; 20619088; 20621566; 20625422; 20626741; 20627040; 20628086; 20628624; 20637704; 20639461; 20640364; 20640910; 20644561; 20646084; 20650298; 20650301; 20652825; 20659236; 20661026; 20662065; 20662694; 20663564; 20665551; 20668555; 20673868; 20682333; 20682687; 20683885; 20695192; 20701626; 20702406; 20703737; 20709566; 20714375; 20720222; 20722470; 20725607; 20729202; 20731043; 20731121; 20731689; 20731692; 20732366; 20733583; 20734064; 20736038; 20796230; 20798494; 20798956; 20802378; 20805562; 20805766; 20810691; 20811626; 20811902; 20814201; 20814569; 20816195; 20817073; 20817730; 20819413; 20825556; 20826751; 20830806; 20835611; 20846452; 20846669; 20848459; 20849900; 20854131; 20854863; 20857483; 20860222; 20864106; 20870895; 20872355; 20874489; 20878356; 20880267; 20880607; 20882404; 20883322; 20884746; 20886274; 20887379; 20888911; 20920206; 20929536; 20931685; 20932773; 20933106; 20935448; 20936699; 20937002; 20937806; 20942272; 20942594; 20944558; 20946339; 20946625; 20947251; 20951096; 20952689; 20953524; 20953611; 20956574; 20957367; 20960273; 20961668; 20963496; 20964626; 20965572; 20966071; 20967696; 20971923; 20973681; 20978325; 20979861; 20980264; 21029472; 21033124; 21033253; 21037509; 21040915; 21042029; 21044752; 21046226; 21048327; 21052690; 21054877; 21057163; 21057561; 21059493; 21060270; 21061265; 21067752; 21068403; 21075101; 21078874; 21080879; 21082024; 21082225; 21086908; 21090238; 21091999; 21093436; 21094815; 21097392; 21102463; 21103669; 21103885; 21107607; 21107701; 21112094; 21120488; 21120500; 21127983; 21129244; 21130787; 21135495; 21136171; 21147638; 21147642; 21148792; 21149504; 21153318; 21153326; 21153349; 21153361; 21153921; 21160173; 21165572; 21167738; 21169032; 21173731; 21177755; 21178846; 21181166; 21185609; 21186276; 21187523; 21192298; 21205918; 21211511; 21211655; 21212278; 21212403; 21212994; 21215285; 21218642; 21219546; 21226932; 21228323; 21228685; 21228795; 21229844; 21237555; 21237580; 21245386; 21246243; 21246958; 21249467; 21253506; 21254282; 21256190; 21266470; 21271217; 21271873; 21274647; 21275162; 21282514; 21286722; 21292512; 21296384; 21296591; 21297077; 21298033; 21307151; 21313996; 21316358; 21316985; 21317641; 21319595; 21319995; 21323572; 21331077; 21336601; 21341430; 21344384; 21346237; 21346775; 21350240; 21350819; 21355310; 21357402; 21362045; 21367920; 21370248; 21373785; 21377791; 21380730; 21382272; 21384095; 21385538; 21385558; 21386799; 21393356; 21396892; 21400214; 21400614; 21401328; 21403867; 21403886; 21408088; 21408173; 21411417; 21412035; 21420089; 21423726; 21431944; 21441465; 21442077; 21443923; 21450487; 21454254; 21455632; 21457223; 21458669; 21465273; 21469124; 21473134; 21474332; 21474440; 21476000; 21477635; 21478032; 21482826; 21486440; 21494616; 21498926; 21499693; 21508505; 21509504; 21521472; 21525886; 21527635; 21527853; 21527907; 21535954; 21542902; 21544635; 21551367; 21553055; 21553284; 21559086; 21559479; 21559831; 21562054; 21569377; 21572952; 21573018; 21573932; 21575121; 21586325; 21591983; 21593777; 21596021; 21600698; 21604171; 21606490; 21609779; 21611196; 21616679; 21620750; 21621418; 21621860; 21623992; 21624061; 21626471; 21631181; 21631297; 21633892; 21637953; 21639826; 21640790; 21641234; 21658307; 21658310; 21658326; 21659535; 21668366; 21670314; 21670923; 21670964; 21675251; 21679760; 21682548; 21688665; 21693096; 21697747; 21701244; 21702700; 21703188; 21712100; 21714933; 21716128; 21722904; 21729551; 21729562; 21733366; 21735105; 21741441; 21749603; 21752952; 21756957; 21762706; 21776298; 21777517; 21777909; 21782178; 21784129; 21784970; 21788151; 21789799; 21798984; 21802960; 21806780; 21809123; 21810022; 21811986; 21812905; 21813066; 21818296; 21820422; 21826654; 21828047; 21830421; 21833533; 21845541; 21845872; 21846573; 21846948; 21847627; 21849807; 21849907; 21851198; 21854221; 21858100; 21858117; 21860020; 21860543; 21865054; 21870243; 21873076; 21875833; 21878338; 21880216; 21885496; 21886773; 21898706; 21900165; 21904873; 21906436; 21907587; 21912593; 21915486; 21917899; 21920667; 21922073; 21924074; 21931646; 21933669; 21933882; 21937453; 21945535; 21948112; 21949132; 21965637; 21966220; 21966367; 21967963; 21969554; 21970639; 21978000; 21978003; 21980981; 21983349; 21985478; 21988415; 21995333; 22001640; 22004920; 22010076; 22010829; 22012292; 22015686; 22016814; 22019000; 22019249; 22021194; 22021612; 22025632; 22027829; 22035595; 22045868; 22047608; 22053594; 22053613; 22053710; 22057071; 22057691; 22059991; 22068351; 22070668; 22072539; 22081334; 22086907; 22088456; 22088844; 22093255; 22093778; 22095071; 22095602; 22096007; 22097889; 22099304; 22100609; 22104567; 22105495; 22106856; 22127698; 22142046; 22151084; 22151832; 22153345; 22156348; 22172512; 22177457; 22183425; 22187701; 22188951; 22195005; 22199285; 22200181; 22200508; 22205204; 22207023; 22207455; 22217359; 22219323; 22221522; 22223068; 22225778; 22227290; 22228181; 22230689; 22239507; 22239528; 22243719; 22246057; 22257833; 22258491; 22262846; 22264991; 22265273; 22266116; 22266275; 22268119; 22269998; 22271589; 22276993; 22280559; 22284365; 22287006; 22289556; 22294627; 22301094; 22301607; 22301786; 22311210; 22320863; 22321707; 22321809; 22326557; 22327199; 22330622; 22338227; 22340390; 22341723; 22350281; 22351606; 22363611; 22363701; 22365967; 22366404; 22366579; 22369788; 22382194; 22384111; 22385244; 22386367; 22387051; 22389764; 22393042; 22395607; 22404198; 22405769; 22407921; 22410150; 22420891; 22422499; 22426431; 22431252; 22434667; 22436801; 22454477; 22461198; 22463742; 22465880; 22466076; 22468900; 22470014; 22471589; 22473048; 22475215; 22479352; 22481167; 22484242; 22484483; 22486303; 22487393; 22487520; 22488302; 22496218; 22496489; 22504646; 22504829; 22506067; 22507624; 22509108; 22512415; 22513115; 22515582; 22525685; 22526394; 22527933; 22528837; 22532631; 22534470; 22534629; 22536381; 22538781; 22542718; 22554453; 22558919; 22562260; 22562290; 22563871; 22564606; 22565852; 22566686; 22569435; 22572643; 22577092; 22579868; 22580582; 22580620; 22581210; 22591361; 22593232; 22595285; 22609212; 22610275; 22616715; 22619347; 22621205; 22629855; 22634176; 22649007; 22655468; 22658256; 22661088; 22661255; 22664006; 22664325; 22673037; 22673732; 22675546; 22675954; 22678805; 22680042; 22682513; 22683888; 22684480; 22691114; 22695741; 22696185; 22698992; 22702470; 22703762; 22707636; 22708547; 22711844; 22714118; 22714811; 22727980; 22729740; 22733992; 22738830; 22742591; 22742857; 22749237; 22749533; 22749718; 22752116; 22759465; 22759859; 22766105; 22767148; 22772094; 22778029; 22783580; 22797138; 22798670; 22801493; 22802339; 22808100; 22808497; 22810465; 22814248; 22826629; 22835835; 22836756; 22863952; 22869322; 22872022; 22883217; 22883518; 22884017; 22884417; 22884981; 22891927; 22897390; 22897480; 22898217; 22902304; 22903530; 22905199; 22913362; 22917968; 22918199; 22921153; 22921402; 22922291; 22922824; 22923002; 22927431; 22937208; 22937788; 22940143; 22944040; 22945416; 22947142; 22947907; 22948157; 22949029; 22950839; 22960943; 22964479; 22982041; 22983646; 22984233; 22986484; 22986613; 22986753; 22990108; 22990365; 22990627; 22992806; 22995913; 22999526; 23009757; 23011034; 23013131; 23021488; 23028059; 23028877; 23029405; 23032186; 23032187; 23033000; 23034253; 23036097; 23046723; 23050663; 23057546; 23058031; 23065208; 23066418; 23067363; 23068962; 23069299; 23070544; 23071313; 23073259; 23077985; 23079033; 23081800; 23082052; 23086255; 23089051; 23092582; 23092711; 23096596; 23100065; 23100272; 23103767; 23110185; 23122308; 23137321; 23139429; 23141142; 23142559; 23159355; 23159874; 23164102; 23167810; 23168096; 23169178; 23176610; 23179933; 23183825; 23192010; 23193891; 23195574; 23204162; 23209346; 23209731; 23212700; 23217179; 23225254; 23229544; 23233369; 23246833; 23249640; 23254337; 23255681; 23258148; 23258237; 23265967; 23275336; 23276701; 23280137; 23281720; 23284977; 23288922; 23290099; 23294492; 23294973; 23294975; 23297421; 23298660; 23300810; 23305356; 23313255; 23315809; 23317256; 23317877; 23322904; 23326309; 23326472; 23327497; 23328497; 23331923; 23333028; 23333893; 23333920; 23334278; 23335080; 23338599; 23339186; 23343370; 23349048; 23349093; 23349721; 23357300; 23359411; 23359428; 23359489; 23363891; 23376082; 23377880; 23378732; 23380141; 23388693; 23393163; 23394901; 23396208; 23403273; 23406059; 23413901; 23425028; 23432860; 23437179; 23451177; 23459075; 23462597; 23465534; 23466425; 23470607; 23472126; 23484124; 23484152; 23485383; 23485538; 23487197; 23489698; 23494178; 23498057; 23500081; 23500159; 23503445; 23507260; 23527193; 23527710; 23532748; 23542051; 23546865; 23550407; 23552949; 23553861; 23555579; 23557460; 23559847; 23567762; 23576453; 23577187; 23581259; 23588423; 23590297; 23592910; 23593411; 23593415; 23594457; 23597429; 23601741; 23602201; 23607333; 23615914; 23619127; 23625043; 23630220; 23630362; 23632060; 23634661; 23638863; 23639307; 23639700; 23640160; 23643268; 23651237; 23651848; 23657597; 23657600; 23658704; 23661556; 23661584; 23663047; 23669395; 23673311; 23677169; 23680697; 23682387; 23683942; 23703343; 23704210; 23712703; 23713409; 23717605; 23720844; 23723980; 23732752; 23732909; 23740956; 23745338; 23746176; 23746843; 23748363; 23751348; 23768164; 23774701; 23777202; 23785756; 23785788; 23793505; 23795660; 23800059; 23816715; 23821300; 23828749; 23834030; 23861398; 23864804; 23870134; 23877857; 23880295; 23884763; 23900678; 23911749; 23918043; 23923372; 23925283; 23935096; 23936398; 23936458; 23940760; 23943369; 23943614; 23965971; 23989985; 24012198; 24018067; 24041577; 24049437; 24067962; 24077340; 24078775; 24140406; 24145654; 24186266; 24265545; 24294778; 24299316; 24307062; 24307172; 24313836; 24314919; 24316671; 24338609; 24340926; 24371310; 24403490; 24409675; 24459820; 24611333; 24611335,,,,,,,,,,,,,,,,,,OGG:3000007124,,,,,,,,,,,,,,,,,,,tumor necrosis factor,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32105090,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TNF,,,20140408,7124,DADB-70P7.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TNF,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OBI_0000917,nasal swab specimen,,"A specimen obtained using a cotton swab on a stick, passed up the nostril to obtain a sample of
exudate and epithelial debris for microbiological or cellular examination.",false,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,,,,,,,,,,,"A specimen obtained using a cotton swab on a stick, passed up the nostril to obtain a sample of
exudate and epithelial debris for microbiological or cellular examination.",,WEB: http://www.wpro.who.int/NR/rdonlyres/EFD2B9A7-2265-4AD0-BC98-97937B4FA83C/0/manualonanimalaidiagnosisandsurveillance.pdf,,,,,,,nasal swab specimen,,,,type of sample used in the PCIRN influenza network,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,OBI:0000917,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144858/,,nasal swab,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,nasal swab specimen,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Melanie Courtot,,,,
http://purl.obolibrary.org/obo/GO_0030593,neutrophil chemotaxis,,"The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.",false,,,http://purl.obolibrary.org/obo/GO_0050900,,,,,,,,,,,,,,,,,,,,,"The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050900,,,,GO:0030593,,,,,,true,true,,,,,,,,GO:0030593,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neutrophil chemotaxis,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_285948,SARS coronavirus civet019,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:285948,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus civet019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C16751,Interview,Interview,"A conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc.",false,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,C16751,,,CTRP,,,,,,,"A conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc.",,,,,,Interview,,,,,,,,,,,,,,,,,,,,,,,,,Interview,,,,,,,,,,,,,NCIT:C16751,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,true,,,,,,,interview/survey,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977,,,,,,,,,,Interview,Interview,,,,,,,,,,,,,,,,,,Interview,,,https://surveys-covid19.sciensano.be/index.php/546282?lang=en,Occupational Activity,,,,,,,,C0021822,
http://purl.obolibrary.org/obo/GO_0051306,mitotic sister chromatid separation,mitotic sister chromatid resolution|sister chromatid separation during mitosis|chromosome separation during mitosis|mitotic chromosome separation,The process in which sister chromatids are physically detached from each other during mitosis.,false,,,http://purl.obolibrary.org/obo/GO_0051304,,,,,,,,,,,,,,,,,,,,,The process in which sister chromatids are physically detached from each other during mitosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mitotic sister chromatid resolution|sister chromatid separation during mitosis,,,,,biological_process,,chromosome separation during mitosis|mitotic chromosome separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051304,,,,GO:0051306,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051306,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic sister chromatid separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001879,Abnormal eosinophil morphology,Abnormality of eosinophils,"An abnormal count or structure of eosinophils.|Eosinophils stain with acidophilic dyes including eosin red. They have a bilobed nucleus, are weakly phagocytic, and are involved in the immune defense against worms. Eosinophils are released into the peripheral blood in a phenotypically mature state, and are capable of undergoing activation and recruitment into tissues in response to appropriate stimuli, most notably cytokines interleukin-5 and the eotaxins. Eosinophils spend only a brief time in the peripheral blood (half-life of about 18 hours) before they migrate to the thymus or gastrointestinal tract, where they reside under homeostatic conditions. In response to inflammatory stimuli, eosinophils develop from committed bone marrow progenitors, after which they exit, migrate into the blood and subsequently accumulate in peripheral tissues where survival is prolonged.",false,,,http://purl.obolibrary.org/obo/HP_0001911,,,,,,,,,,,,,,,,,,,,UMLS:C4025738,An abnormal count or structure of eosinophils.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of eosinophils,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Eosinophils stain with acidophilic dyes including eosin red. They have a bilobed nucleus, are weakly phagocytic, and are involved in the immune defense against worms. Eosinophils are released into the peripheral blood in a phenotypically mature state, and are capable of undergoing activation and recruitment into tissues in response to appropriate stimuli, most notably cytokines interleukin-5 and the eotaxins. Eosinophils spend only a brief time in the peripheral blood (half-life of about 18 hours) before they migrate to the thymus or gastrointestinal tract, where they reside under homeostatic conditions. In response to inflammatory stimuli, eosinophils develop from committed bone marrow progenitors, after which they exit, migrate into the blood and subsequently accumulate in peripheral tissues where survival is prolonged.",,http://purl.obolibrary.org/obo/HP_0001911,,,,HP:0001879,,,,,,,,,,,,,,,HP:0001879,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal eosinophil morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000027178,IL37,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,FIL1(ZETA)|IL-37|IL-1H4|IL1H4|IL-1RP1|IL-1F7|IL1RP1|FIL1Z|IL1F7|IL-1H|FIL1,,,,,,,2,,,,,,,,,,MIM:605510|Vega:OTTHUMG00000131345|Ensembl:ENSG00000125571|HPRD:05695|HGNC:15563,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 37,,2q12-q14.1,,,,"GO_0005125 (EC: IEA); GO_0005149 (EC: NAS, PMID: 10744718); GO_0005149 (EC: TAS, PMID: 10625660); GO_0005576 (EC: NAS, PMID: 10625660); GO_0005576 (EC: TAS, PMID: 10744718); GO_0005615 (EC: IEA); GO_0005634 (EC: IEA); GO_0005829 (EC: IEA); GO_0006954 (EC: IEA); GO_0006955 (EC: NAS, PMID: 10625660)",PMID: 8188271; 9169134; 10512743; 10625660; 10744718; 10860666; 11093146; 11145836; 11278614; 11466363; 11574262; 11991722; 11991723; 12096920; 12381835; 12477932; 12496389; 15489334; 15527767; 15815621; 17207965; 18390730; 18484691; 19874811; 20141484; 20237496; 20935647; 21072596; 21394384; 21873195; 22646996; 23159404; 23171316; 23182761; 23600829; 23932459,,,,,,,,,,,,,,,,,,OGG:3000027178,,,,,,,,,,,,,,,,,,,interleukin 37,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171193,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL37,,,20140408,27178,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL37,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0042274,ribosomal small subunit biogenesis,ribosomal small subunit biogenesis and assembly,"A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a small ribosomal subunit; includes transport to the sites of protein synthesis.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a small ribosomal subunit; includes transport to the sites of protein synthesis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribosomal small subunit biogenesis and assembly,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042274,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042274,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,ribosomal small subunit biogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000126,SARS-CoV-2 model,,,false,,,http://purl.obolibrary.org/obo/NCIT_C71164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C71164,,,,,Modified definition,,,Animal testing,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32269068,Animal models manifesting  SARS-CoV infections.,,,,,,,,,,,,,,,,SARS-CoV-2 model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9513,thalidomide,"Thalidomide|rac-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione|Talimol|3-phthalimidoglutarimide|talidomida|alpha-phthalimidoglutarimide|N-Phthalyl-glutaminsaeure-imid|Softenon|N-phthaloylglutamimide|(+-)-N-(2,6-dioxo-3-piperidyl)phthalimide|N-(2,6-dioxo-3-piperidyl)phthalimide|alpha-N-phthalylglutaramide|N-phthalylglutamic acid imide|(+-)-thalidomide|Distaval|alpha-(N-phthalimido)glutarimide|Sedalis|2,6-dioxo-3-phthalimidopiperidine|thalidomidum|thalidomide|K-17|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline",A  racemate comprising equimolar amounts of R- and S-thalidomide.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:US2012142734|HMDB:HMDB0015175|Wikipedia:Thalidomide|PMID:21207098|PMID:17449064|Reaxys:30233|PMID:12724820|Patent:GB768821|PMID:14689682|KEGG:D00754|Patent:WO2013100657|PMID:8469046|PMID:11349879|LINCS:LSM-1914|PMID:18925849|KEGG:C07910|DrugBank:DB01041|CAS:50-35-1|PMID:2694291|PMID:11803357,A  racemate comprising equimolar amounts of R- and S-thalidomide.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Thalidomide|rac-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione",,,,,chebi_ontology,,"Talimol|3-phthalimidoglutarimide|talidomida|alpha-phthalimidoglutarimide|N-Phthalyl-glutaminsaeure-imid|Softenon|N-phthaloylglutamimide|(+-)-N-(2,6-dioxo-3-piperidyl)phthalimide|N-(2,6-dioxo-3-piperidyl)phthalimide|alpha-N-phthalylglutaramide|N-phthalylglutamic acid imide|(+-)-thalidomide|Distaval|alpha-(N-phthalimido)glutarimide|Sedalis|2,6-dioxo-3-phthalimidopiperidine|thalidomidum|thalidomide|K-17|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline",,,,,,,,,0,C13H10N2O4,,,258.233,258.06406,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9513,,,,,,true,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:9513,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,thalidomide,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202002.0395/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003256,Abnormality of the coagulation cascade,Coagulopathy,"An abnormality of the coagulation cascade, which is comprised of the contact activation pathway (also known as the intrinsic pathway) and the tissue factor pathway (also known as the extrinsic pathway) as well as cofactors and regulators.",false,,,http://purl.obolibrary.org/obo/HP_0001928,,,,,,,,,,,,,,,,,,,,MSH:D001778|SNOMEDCT_US:64779008|UMLS:C0005779|SNOMEDCT_US:362970003,"An abnormality of the coagulation cascade, which is comprised of the contact activation pathway (also known as the intrinsic pathway) and the tissue factor pathway (also known as the extrinsic pathway) as well as cofactors and regulators.",,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0001925,,,,Coagulopathy,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001928,,,,HP:0003256,,,,,,,,,,,,,,,HP:0003256,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the coagulation cascade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_12987,agranulocytosis,granulocytopenia|Granulocytopenic disorder|Granulopenia,,false,,,http://purl.obolibrary.org/obo/DOID_615,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0001824|MESH:D000380|ICD10CM:D70|SNOMEDCT_US_2019_09_01:17182001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,granulocytopenia|Granulocytopenic disorder|Granulopenia,,,,,disease_ontology,,,,,,,,,A marked decrease in the number of mature granulocytes (most often neutrophils) in the peripheral blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_615,,,,DOID:12987,,,,,,,,,,,,,,,DOID:12987,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,agranulocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_8198,trans-piceid,"3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl beta-D-glucopyranoside|trans-resveratrol 3-O-beta-D-glucoside|3,4',5-trihydroxystilbene-3-beta-D-glucoside|Polydatin|Piceid|trans-resveratrol 3-beta-D-glucoside|3,4,5-Trihydroxystilbene-3-beta-monoglucoside|trans-resveratrol 3-beta-glucoside",A stilbenoid that is trans-resveratrol substituted at position 3 by a beta-D-glucosyl residue.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:C10275|PMID:23788185|PMID:22956122|KNApSAcK:C00002896|PMID:23342161|PMID:23742076|PMID:24262561|PMID:24020412|PMID:23566471|PMID:23646479|Reaxys:54837|PMID:23499836|PMID:23862567|PMID:23833942|PMID:23137955|PMID:23241098|PMID:23431240|CAS:27208-80-6|PMID:24138806|PMID:23637874|PMID:23980421|LIPID_MAPS_instance:LMPK13090012|PMID:23945645|Drug_Central:4613,A stilbenoid that is trans-resveratrol substituted at position 3 by a beta-D-glucosyl residue.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl beta-D-glucopyranoside,,,,,chebi_ontology,,"trans-resveratrol 3-O-beta-D-glucoside|3,4',5-trihydroxystilbene-3-beta-D-glucoside|Polydatin|Piceid|trans-resveratrol 3-beta-D-glucoside|3,4,5-Trihydroxystilbene-3-beta-monoglucoside|trans-resveratrol 3-beta-glucoside",,,,,,,,,0,C20H22O8,"InChI=1S/C20H22O8/c21-10-16-17(24)18(25)19(26)20(28-16)27-15-8-12(7-14(23)9-15)2-1-11-3-5-13(22)6-4-11/h1-9,16-26H,10H2/b2-1+/t16-,17-,18+,19-,20-/m1/s1",HSTZMXCBWJGKHG-CUYWLFDKSA-N,390.38390,390.13147,OC[C@H]1O[C@@H](Oc2cc(O)cc(C=C\c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:8198,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:8198,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,trans-piceid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046755,viral budding,virion budding|viral capsid envelopment|virus budding,"A viral process by which enveloped viruses acquire a host-derived membrane enriched in viral proteins to form their external envelope. The process starts when nucleocapsids, assembled or in the process of being built, induce formation of a membrane curvature in the host plasma or organelle membrane and wrap up in the forming bud. The process ends when the bud is eventually pinched off by membrane scission to release the enveloped particle into the lumenal or extracellular space.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,VZ:1947,"A viral process by which enveloped viruses acquire a host-derived membrane enriched in viral proteins to form their external envelope. The process starts when nucleocapsids, assembled or in the process of being built, induce formation of a membrane curvature in the host plasma or organelle membrane and wrap up in the forming bud. The process ends when the bud is eventually pinched off by membrane scission to release the enveloped particle into the lumenal or extracellular space.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046744,,,,,,,virion budding,,biological_process,,viral capsid envelopment|virus budding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0046755,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32167747,,,,GO:0046755,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral budding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C18117,Surface Plasmon Resonance,Surface Plasmon Resonance|SURFACE PLASMON RESONANCE,"A quantum optical-electrical phenomena consisting of an alteration in light reflectance as a result of binding of molecules to a surface from which total internal reflection is occurring. Used to detect macromolecular interactions, SPR can be used as the basis for a sensor which is capable of sensitive and quantitative measurement of a broad spectrum of chemical and biological entities.",false,,,http://purl.obolibrary.org/obo/ERO_0000833,,A quantum optical-electrical phenomena consisting of an alteration in light reflectance as a result of binding of molecules to a surface from which total internal reflection is occurring.,,,,,,,,,C18117,,,CDISC,,,,,,,"A quantum optical-electrical phenomena consisting of an alteration in light reflectance as a result of binding of molecules to a surface from which total internal reflection is occurring. Used to detect macromolecular interactions, SPR can be used as the basis for a sensor which is capable of sensitive and quantitative measurement of a broad spectrum of chemical and biological entities.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Surface Plasmon Resonance|SURFACE PLASMON RESONANCE,,,,,,,,,,,,,NCIT:C18117,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C85492|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830,,,,,,,,,,Surface Plasmon Resonance,Surface_Plasmon_Resonance,,,,,,CL448910,,,,,,,,,,,,Surface Plasmon Resonance,,,https://www.biorxiv.org/content/10.1101/2020.03.14.988345v1,Molecular Biology Research Technique,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016477,cell migration,,The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Cell_migration,The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0016477,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0016477,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cell migration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_3638,chloroquine,"Chloroquine|N(4)-(7-chloroquinolin-4-yl)-N(1),N(1)-diethylpentane-1,4-diamine|Reumachlor|chloroquinum|Chlorochin|N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|chloroquine|Nivaquine B|Capquin|Bemaphate|Aralen|Artrichin|cloroquina|Sanoquin|Resoquine","An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23891850|Patent:US2233970|PMID:25285162|Reaxys:482809|Drug_Central:607|PMID:18052874|PMID:23644906|PMID:19426658|PMID:23852712|LINCS:LSM-1901|KEGG:D02366|HMDB:HMDB0014746|PMID:17594118|PMID:23635029|Patent:DE683692|PDBeChem:CLQ|Beilstein:482809|PMID:23580861|CAS:54-05-7|PMID:11198399|Wikipedia:Chloroquine|Gmelin:781126|PMID:23288916|DrugBank:DB00608|PMID:23706562|KEGG:C07625,"An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Chloroquine|N(4)-(7-chloroquinolin-4-yl)-N(1),N(1)-diethylpentane-1,4-diamine",,,,,chebi_ontology,,"Reumachlor|chloroquinum|Chlorochin|N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|chloroquine|Nivaquine B|Capquin|Bemaphate|Aralen|Artrichin|cloroquina|Sanoquin|Resoquine",,,,,,,,,0,C18H26ClN3,"InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)",WHTVZRBIWZFKQO-UHFFFAOYSA-N,319.87200,319.18153,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:3638,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32311322,,,,CHEBI:3638,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,chloroquine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000061,pathological bodily process,,A bodily process that is clinically abnormal.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T11:54:29Z,,A bodily process that is clinically abnormal.,,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl|http://purl.obolibrary.org/obo/ogms.owl|http://purl.obolibrary.org/obo/oae.owl,,,,,,,,,,,pathological bodily process,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/GO_1902563,regulation of neutrophil activation,,"Any process that modulates the frequency, rate or extent of neutrophil activation.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,ecu,2013-12-10T15:33:08Z,,,,"Any process that modulates the frequency, rate or extent of neutrophil activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1902563,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902563,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of neutrophil activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000914,CD2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LFA-2|SRBC|T11,,,,,,,1,,,,,,,,,,Vega:OTTHUMG00000022750|Ensembl:ENSG00000116824|HPRD:01750|HGNC:1639|MIM:186990,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,CD2 molecule,,1p13.1,,,,"GO_0001766 (EC: TAS, PMID: 11376005); GO_0004872 (EC: NAS, PMID: 7544493); GO_0005102 (EC: IPI, PMID: 17344209); GO_0005515 (EC: IPI, PMID: 12356317); GO_0005576 (EC: IEA); GO_0005886 (EC: TAS); GO_0005887 (EC: NAS, PMID: 7544493); GO_0006915 (EC: TAS, PMID: 10575274); GO_0007166 (EC: TAS, PMID: 10575274); GO_0007596 (EC: TAS); GO_0009897 (EC: IDA); GO_0009898 (EC: IEA); GO_0009986 (EC: IDA, PMID: 15345303); GO_0016337 (EC: NAS, PMID: 7544493); GO_0030101 (EC: NAS, PMID: 12714509); GO_0030887 (EC: NAS, PMID: 12714509); GO_0032760 (EC: IDA, PMID: 19109405); GO_0034113 (EC: IDA, PMID: 15345303); GO_0042110 (EC: TAS, PMID: 2471997); GO_0042803 (EC: IEA); GO_0045580 (EC: NAS, PMID: 11544295); GO_0046658 (EC: IEA); GO_0050900 (EC: TAS); GO_1902715 (EC: IDA, PMID: 19109405); GO_2000484 (EC: IMP, PMID: 19109405)",PMID: 1346273; 1351089; 1377404; 1385321; 1832084; 1970422; 1976695; 2111780; 2437578; 2444890; 2471997; 2883656; 2894031; 2901953; 3490670; 7517794; 7539755; 7544493; 7589092; 7686927; 7915183; 7933095; 7994575; 8125298; 8551220; 8809126; 8977276; 9270771; 9475352; 9677430; 9741631; 9743208; 9843987; 9857189; 10380930; 10404223; 10510361; 10575274; 10642604; 10722370; 11090067; 11152963; 11376005; 11544295; 11575926; 11591762; 11602341; 11932928; 12032326; 12356317; 12369898; 12426371; 12477932; 12530983; 12618476; 12690097; 12714509; 12731040; 15345303; 15489334; 15528362; 16000308; 16049493; 16710414; 16803907; 17020880; 17085486; 17168569; 17344209; 18051367; 18318997; 18431797; 19109405; 19237575; 19494291; 19502238; 19586919; 19898481; 20813844; 21048031; 21300823; 21982860; 21987572; 21988832; 22013130; 22084431; 22222639; 22634534; 23112830; 23314748; 23760244; 24072102,,,,,,,,,,,,,,,,,,OGG:3000000914,,,,,,,,,,,,,,,,,,,CD2 molecule,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD2,,,20140408,914,RP4-655N15.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CD2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/PR_000050280,non-structural protein 11 (SARS-CoV-2),"UniProtKB:P0DTC1, 4393-4405|rep/Clv:nsp11 (SARS2)|nsp11 (SARS2)|PRO_0000449645","An ORF1a proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4392-4393 and 4405-4406. UniProtKB:P0DTC1, 4393-4405.|Category=organism-modification. Note: 13 aa protein.",false,,,http://purl.obolibrary.org/obo/PR_000050282,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725312,"An ORF1a proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4392-4393 and 4405-4406. UniProtKB:P0DTC1, 4393-4405.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"UniProtKB:P0DTC1, 4393-4405|rep/Clv:nsp11 (SARS2)|nsp11 (SARS2)|PRO_0000449645",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 13 aa protein.,,http://purl.obolibrary.org/obo/PR_000050282,,,,PR:000050280,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32292901,,,,PR:000050280,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 11 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002597,Abnormality of the vasculature,Vascular abnormalities|Abnormality of the vasculature|Abnormality of blood vessels,An abnormality of the vasculature.,false,,,http://purl.obolibrary.org/obo/HP_0001626,,,,,,,,,,,,,,,,,,,,UMLS:C0241657,An abnormality of the vasculature.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Vascular abnormalities|Abnormality of the vasculature|Abnormality of blood vessels,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001626,,,,HP:0002597,,,,,,,,,,,,,,,HP:0002597,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the vasculature,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_235411,SARS coronavirus Sin2748,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:235411,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin2748,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267399,SARS coronavirus Sin3408L,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267399,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin3408L,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0031691,Severe viral infection,,"An unusually severe viral infection.|The majority of viral infections acquired by nonimmunosuppressed individuals are asymptomatic or result in mild clinical manifestations. These individuals are able to mount effective immune responses that either clear the virus from the body or, for viruses that establish latency, maintain the virus in a dormant state. For individuals who are immunocompromised, because of a genetic immunodeficiency or immunosuppressive drug therapy, viral infections may result in life-threatening disease. Such patients present with infections that are severe, persistent, recurrent, or refractory to therapy and are usually caused by viruses of low virulence prevalent in the community.",false,,,http://purl.obolibrary.org/obo/HP_0032169,,,,,,,,,,,,,,,,peter,,,,,An unusually severe viral infection.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0031691,,,,,,,,,,,,,,,,,,2017-12-17T22:28:59Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The majority of viral infections acquired by nonimmunosuppressed individuals are asymptomatic or result in mild clinical manifestations. These individuals are able to mount effective immune responses that either clear the virus from the body or, for viruses that establish latency, maintain the virus in a dormant state. For individuals who are immunocompromised, because of a genetic immunodeficiency or immunosuppressive drug therapy, viral infections may result in life-threatening disease. Such patients present with infections that are severe, persistent, recurrent, or refractory to therapy and are usually caused by viruses of low virulence prevalent in the community.",,http://purl.obolibrary.org/obo/HP_0032169,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Severe viral infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0001285,organismal assay,,"An assay that generates data about the physical characteristics,  physological functions, or behavior of organisms or viruses.",false,,,http://purl.obolibrary.org/obo/OBI_0000070,,,,,,,,,,,,,,,,,,,,,"An assay that generates data about the physical characteristics,  physological functions, or behavior of organisms or viruses.",,PERSON: Matthew Brush,,,,,,,,,,,Phenotype characterization of a transgenic mouse.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,ERO:0001285,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000070,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,organismal assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Nicole Vasilevsky,,,,
http://purl.obolibrary.org/obo/MP_0001853,heart inflammation,carditis|cardiac inflammation,"local accumulation of fluid, plasma proteins, and leukocytes in the heart",false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,,,,,,"local accumulation of fluid, plasma proteins, and leukocytes in the heart",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,carditis|cardiac inflammation,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,MP:0001853,,,,,,true,,,,,,,,,MP:0001853,,http://purl.obolibrary.org/obo/mp.owl,,,,,,,,,,,heart inflammation,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0025389,Pulmonary interstitial high-resolution computed tomography abnormality,Pulmonary interstitiatial HRCT abnormality,High-resolution computed tomography (HRCT) can distinguish findings that characterize characterise interstitial lung diseases in a way not possible with other modalities.,false,,,http://purl.obolibrary.org/obo/HP_0031983|http://purl.obolibrary.org/obo/HP_0006530,,,,,,,,,,,,,,,,HPO:probinson,,,,,High-resolution computed tomography (HRCT) can distinguish findings that characterize characterise interstitial lung diseases in a way not possible with other modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pulmonary interstitiatial HRCT abnormality,,,,,,,,,,,,,HP:0025389,,,,,,,,,,,,,,,,,,2017-04-22T12:46:42Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0031983|http://purl.obolibrary.org/obo/HP_0006530,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Pulmonary interstitial high-resolution computed tomography abnormality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001626,Abnormality of the cardiovascular system,Abnormality of the cardiovascular system|Cardiovascular abnormality|Cardiovascular disease,"Any abnormality of the cardiovascular system.|The cardiovascular system consists of the heart, vasculature, and the lymphatic system.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,UMLS:C0007222|SNOMEDCT_US:49601007|MSH:D018376|MSH:D002318|UMLS:C0243050,Any abnormality of the cardiovascular system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of the cardiovascular system|Cardiovascular abnormality,,,,,human_phenotype,,Cardiovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The cardiovascular system consists of the heart, vasculature, and the lymphatic system.",,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0001626,,,,,,,,,,,,,,,HP:0001626,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the cardiovascular system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031252,cell leading edge,front of cell|leading edge of cell,The area of a motile cell closest to the direction of movement.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The area of a motile cell closest to the direction of movement.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,front of cell|leading edge of cell,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0031252,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031252,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,cell leading edge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007098,TLR3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IIAE2|CD283,,,,,,,4,,,,,,,,,,HGNC:11849|HPRD:04324|MIM:603029,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,toll-like receptor 3,,4q35,,,,"GO_0000139 (EC: TAS); GO_0002224 (EC: TAS); GO_0002282 (EC: IEA); GO_0002756 (EC: TAS); GO_0003725 (EC: IDA, PMID: 16111635); GO_0003725 (EC: NAS, PMID: 12054664); GO_0004872 (EC: TAS, PMID: 10426995); GO_0004888 (EC: NAS, PMID: 12054664); GO_0005515 (EC: IPI, PMID: 16858407); GO_0005737 (EC: IDA, PMID: 19740627); GO_0005765 (EC: IDA, PMID: 17897319); GO_0005789 (EC: TAS); GO_0005887 (EC: TAS, PMID: 9435236); GO_0006954 (EC: IEA); GO_0006972 (EC: NAS, PMID: 12054664); GO_0007165 (EC: TAS, PMID: 10426995); GO_0007249 (EC: TAS); GO_0007250 (EC: NAS, PMID: 12054664); GO_0007252 (EC: IDA, PMID: 19740627); GO_0008584 (EC: IEA); GO_0009597 (EC: NAS, PMID: 12054664); GO_0009986 (EC: IDA, Qualifier: NOT, PMID: 19740627); GO_0010008 (EC: TAS); GO_0016020 (EC: NAS, PMID: 12054664); GO_0032722 (EC: IDA, PMID: 19740627); GO_0032728 (EC: ISS); GO_0032735 (EC: ISS); GO_0032755 (EC: IDA, PMID: 19740627); GO_0032757 (EC: IDA, PMID: 17128265); GO_0032760 (EC: ISS); GO_0034123 (EC: IDA, PMID: 17128265); GO_0034138 (EC: TAS); GO_0034142 (EC: TAS); GO_0034346 (EC: IEA); GO_0035458 (EC: IEA); GO_0035666 (EC: TAS); GO_0035690 (EC: IEA); GO_0036020 (EC: TAS); GO_0042346 (EC: IDA, PMID: 19740627); GO_0042742 (EC: TAS, PMID: 10426995); GO_0043065 (EC: IEA); GO_0043123 (EC: IEA); GO_0043330 (EC: IDA); GO_0045078 (EC: IDA, PMID: 16286015); GO_0045080 (EC: IEA); GO_0045087 (EC: TAS, PMID: 15356140); GO_0045356 (EC: IDA, PMID: 16286015); GO_0045359 (EC: IDA, PMID: 16286015); GO_0045359 (EC: IMP, PMID: 12054664); GO_0045671 (EC: NAS, PMID: 12133979); GO_0045944 (EC: ISS); GO_0046330 (EC: IEA); GO_0050729 (EC: IC, PMID: 19740627); GO_0051092 (EC: IEA); GO_0051607 (EC: TAS, PMID: 15356140); GO_0052033 (EC: IEA); GO_0071260 (EC: IEP, PMID: 19593445); GO_0071346 (EC: IEA); GO_0071360 (EC: IEA); GO_0097191 (EC: IDA); GO_0097527 (EC: IDA)",PMID: 9435236; 10066798; 10426995; 10820283; 11561001; 11607032; 11782555; 12054664; 12133979; 12477932; 12509442; 12539043; 12609980; 12646618; 12672806; 12692549; 12855817; 14519765; 14557267; 14575692; 14729660; 14982987; 14987294; 15064760; 15107846; 15119015; 15153468; 15212709; 15226270; 15315972; 15340161; 15356140; 15502848; 15579900; 15652398; 15731229; 15737993; 15767394; 15778392; 15845391; 15935884; 15961631; 15972671; 16029432; 16035096; 16043704; 16111635; 16115877; 16144834; 16146574; 16160153; 16286015; 16289658; 16293707; 16344560; 16399790; 16424203; 16473828; 16482523; 16484229; 16533755; 16585585; 16628196; 16720699; 16847112; 16858407; 16877304; 16914605; 16935934; 16950283; 17043099; 17085778; 17128265; 17142768; 17142772; 17150911; 17178723; 17209042; 17254392; 17292969; 17301562; 17314152; 17434873; 17449641; 17521732; 17525119; 17534115; 17573354; 17602875; 17626075; 17660379; 17703412; 17786279; 17805015; 17851256; 17872438; 17878161; 17897319; 17908959; 17939877; 17947455; 17962643; 17962701; 17963596; 17964520; 17982077; 18021446; 18029758; 18172197; 18204787; 18253710; 18262679; 18325643; 18367536; 18385087; 18394314; 18437017; 18442983; 18508883; 18541719; 18544529; 18562533; 18566014; 18566393; 18568036; 18684960; 18686608; 18715647; 18725521; 18753640; 18775079; 18776324; 18776592; 18779317; 18810425; 18813073; 18818748; 18832709; 18849495; 18946062; 18949355; 18978302; 18988918; 19001446; 19016379; 19019335; 19035519; 19055649; 19120481; 19134117; 19164128; 19231996; 19234180; 19247444; 19254290; 19258923; 19265130; 19299748; 19362356; 19378782; 19423540; 19437550; 19475618; 19494321; 19505919; 19522763; 19527514; 19542247; 19593445; 19597128; 19625408; 19628747; 19631980; 19646728; 19656899; 19740627; 19741468; 19748983; 19752565; 19758322; 19769802; 19779021; 19795416; 19810822; 19833099; 19855253; 19878930; 19887600; 19890046; 19902255; 19914718; 19948350; 19951172; 19966137; 19966777; 20009359; 20047764; 20100933; 20124101; 20194452; 20197609; 20200155; 20227302; 20237496; 20309865; 20331378; 20367642; 20381870; 20406303; 20406964; 20422193; 20438785; 20452482; 20472559; 20483009; 20483744; 20483774; 20503287; 20514466; 20523058; 20588308; 20595247; 20604744; 20636339; 20639488; 20651983; 20673868; 20685081; 20691286; 20819670; 20832341; 20855885; 20957750; 20977567; 20978888; 21061265; 21079408; 21093032; 21129170; 21132533; 21148036; 21173679; 21179282; 21189260; 21216866; 21220319; 21223583; 21239167; 21245912; 21255094; 21266579; 21367858; 21398612; 21454254; 21474651; 21481769; 21498625; 21515789; 21563279; 21623661; 21646299; 21691053; 21695056; 21708001; 21712495; 21722947; 21730023; 21735101; 21802664; 21829730; 21839239; 21843566; 21844166; 21847628; 21903422; 21911421; 21911422; 21911501; 21911973; 21931545; 21949112; 21952237; 21960283; 21978158; 21990957; 21998457; 22016778; 22024499; 22030901; 22038398; 22039520; 22057682; 22065573; 22070917; 22102050; 22147891; 22174453; 22200507; 22205631; 22205660; 22260507; 22310660; 22323545; 22415225; 22421267; 22421964; 22457005; 22466005; 22479513; 22504413; 22537752; 22549436; 22552940; 22568929; 22572822; 22579623; 22590509; 22591330; 22611194; 22685032; 22745793; 22759966; 22762377; 22771581; 22825813; 22849850; 22851595; 22864531; 22865861; 22912896; 22944378; 22948160; 22950839; 22960172; 22989785; 23053995; 23056170; 23056470; 23076446; 23103873; 23115281; 23151015; 23166319; 23179584; 23220997; 23240626; 23245579; 23255072; 23255358; 23269203; 23290562; 23353987; 23369718; 23396947; 23404408; 23425350; 23467704; 23489702; 23497334; 23534905; 23541683; 23548575; 23647955; 23668802; 23673618; 23716670; 23717201; 23721942; 23723066; 23844087; 23908180; 23946637; 23962979; 24070541; 24198284,,,,,,,,,,,,,,,,,,OGG:3000007098,,,,,,,,,,,,,,,,,,,toll-like receptor 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TLR3,,,20140408,7098,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,doi:10.20944/preprints202003.0206.v1,,,,TLR3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000201633,TIGIT,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,VSTM3|VSIG9|WUCAM,,,,,,,3,,,,,,,,,,HGNC:26838|HPRD:08804|Vega:OTTHUMG00000159331|MIM:612859|Ensembl:ENSG00000181847,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,T cell immunoreceptor with Ig and ITIM domains,,3q13.31,,,,"GO_0005102 (EC: IPI, PMID: 19011627); GO_0005515 (EC: IPI, PMID: 19011627); GO_0005886 (EC: IEA); GO_0009986 (EC: IDA, PMID: 19011627); GO_0016021 (EC: IEA); GO_0032695 (EC: IMP, PMID: 19011627); GO_0032733 (EC: IMP, PMID: 19011627); GO_0050868 (EC: IDA, PMID: 19011627); GO_0050868 (EC: IMP, PMID: 19011627)",PMID: 12477932; 14702039; 19011627; 19197944; 19815499; 21416464; 21982860; 22421438; 22427644; 22706088; 23154388,,,,,,,,,,,,,,,,,,OGG:3000201633,,,,,,,,,,,,,,,,,,,T cell immunoreceptor with Ig and ITIM domains,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TIGIT,,,20140408,201633,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TIGIT,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000055,"flatten the curve
",,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,, Flattening that curve means preventing a surge of new cases in a very short period.,Flattening the curve,,,,,,,,,,,,,,,"flatten the curve
",,,,,,,,,,,,,,,,,,,,,,https://www.summitmedicalgroup.com/news/living-well/must-know-covid-19-vocabulary/,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000019,nonpharmaceutical Intervention,,,false,,,http://purl.obolibrary.org/obo/ERO_0000347,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000347,,,,,,,,intervenntion,,true,,,,,,"Nonpharmaceutical Interventions (NPIs)  are actions, apart from getting vaccinated and taking medicine, that people and communities can take to help slow the spread of illnesses like pandemic influenza (flu). ",community mitigation strategies.,,,,,,,,,,,,,,,nonpharmaceutical Intervention,,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000005551,PRF1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HPLH2|P1|PFP|FLH2|PFN1,,,,,,,10,,,,,,,,,,MIM:170280|HPRD:01362|Vega:OTTHUMG00000018412|HGNC:9360|Ensembl:ENSG00000180644,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,perforin 1 (pore forming protein),,10q22,,,,"GO_0002357 (EC: ISS); GO_0002418 (EC: ISS); GO_0005509 (EC: ISS); GO_0005515 (EC: IPI, PMID: 11911826); GO_0005576 (EC: IEA); GO_0005886 (EC: IEA); GO_0006915 (EC: TAS, PMID: 10779745); GO_0006968 (EC: TAS, PMID: 10779745); GO_0016021 (EC: IDA); GO_0016023 (EC: IEA); GO_0019835 (EC: ISS); GO_0022829 (EC: IDA); GO_0031904 (EC: IEA); GO_0044194 (EC: ISS); GO_0051260 (EC: IDA); GO_0051607 (EC: ISS); GO_0055085 (EC: IDA)",PMID: 1505959; 2395434; 2420467; 2425429; 2480391; 2592021; 3261391; 3419519; 8676885; 8770355; 9557729; 9671507; 10072525; 10583959; 10779745; 11082062; 11179007; 11565555; 11586066; 11911826; 12009596; 12072512; 12131187; 12270380; 12368910; 12372421; 12477932; 12574394; 12672182; 12919092; 14512315; 14634500; 14697980; 14757862; 14996347; 15028722; 15113754; 15164054; 15336785; 15342365; 15489334; 15576364; 15641052; 15728124; 15818305; 15921391; 15998831; 16169070; 16278825; 16344560; 16374518; 16385451; 16524880; 16611250; 16611257; 16720836; 16770700; 16791263; 16860143; 16908262; 16914553; 16967044; 17055354; 17213580; 17222571; 17266056; 17311987; 17360532; 17475905; 17477373; 17627755; 17652853; 17674359; 17703412; 17724145; 17873118; 18097852; 18190960; 18198357; 18275349; 18311812; 18496551; 18523274; 18580471; 18615597; 18710388; 18927437; 19058215; 19141320; 19150377; 19258923; 19284501; 19380804; 19394279; 19553259; 19639728; 19651491; 20019066; 20035050; 20049450; 20092789; 20100010; 20221423; 20225066; 20229057; 20237496; 20301617; 20306696; 20368273; 20497195; 20497254; 20503287; 20523897; 20580434; 20618609; 20638125; 20921521; 21048031; 21157294; 21307295; 21388427; 21518502; 21535078; 21661365; 21674762; 21685908; 21867635; 21881043; 21931672; 21960590; 22001684; 22084442; 22169516; 22173634; 22268729; 22359105; 22395607; 22425625; 22437823; 22759804; 22768097; 22829880; 23073042; 23160464; 23179144; 23216954; 23377437; 23528102; 23592409; 23853583; 24157130,,,,,,,,,,,,,,,,,,OGG:3000005551,,,,,,,,,,,,,,,,,,,perforin 1 (pore forming protein),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PRF1,,,20140408,5551,RP11-710A11.3,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,PRF1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000000249,ALPL,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TNSALP|AP-TNAP|HOPS|APTNAP|TNAP,,,,,,,1,,,,,,,,,,HGNC:438|MIM:171760|Ensembl:ENSG00000162551|HPRD:01377|Vega:OTTHUMG00000002949,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"alkaline phosphatase, liver/bone/kidney",,1p36.12,,,,"GO_0001501 (EC: TAS, PMID: 9781036); GO_0001958 (EC: IEA); GO_0003006 (EC: IEA); GO_0004035 (EC: IEA); GO_0005515 (EC: IPI, PMID: 15208311); GO_0005615 (EC: IEA); GO_0005886 (EC: IEA); GO_0016021 (EC: IEA); GO_0016462 (EC: IDA, PMID: 19874193); GO_0031012 (EC: IEA); GO_0031225 (EC: IEA); GO_0032496 (EC: IEA); GO_0033280 (EC: IEP, PMID: 17023519); GO_0046677 (EC: IEA); GO_0046872 (EC: IEA); GO_0051384 (EC: IEA); GO_0070062 (EC: IDA, PMID: 19056867); GO_0071407 (EC: IEA); GO_0071529 (EC: IEA)",PMID: 1321014; 1409720; 1458595; 2220817; 2346496; 2928120; 3165380; 3174660; 3410475; 3446011; 3532105; 3954357; 6933471; 7509208; 7833929; 8406453; 8954059; 9020858; 9192863; 9747027; 9781036; 9814472; 9823315; 9844100; 10094560; 10332035; 10508980; 10679946; 10690885; 10737975; 10834525; 10865224; 11073119; 11438998; 11479741; 11528114; 11745997; 11760847; 11810413; 11834095; 11855933; 11999978; 12357339; 12372831; 12397600; 12412800; 12477932; 12638946; 12788869; 12815606; 12920074; 14517339; 14702039; 14756545; 15135428; 15146197; 15208311; 15230135; 15248185; 15476587; 15489334; 15562030; 15629439; 15660230; 15694177; 15824850; 16344560; 16583221; 16602701; 16681433; 16893177; 16932897; 17023519; 17043047; 17195227; 17229666; 17242729; 17253930; 17395561; 17516619; 17563703; 17719863; 17922851; 18029348; 18037100; 18158785; 18160010; 18328985; 18422967; 18455459; 18469019; 18496130; 18500657; 18523927; 18572267; 18579124; 18605934; 18665784; 18724009; 18769922; 18940312; 19012630; 19056867; 19084045; 19303062; 19335222; 19419944; 19423565; 19453261; 19500388; 19631305; 19641839; 19729429; 19744961; 19751416; 19751417; 19856264; 19860546; 19874193; 19884277; 19888898; 19931660; 20048161; 20139978; 20175736; 20231843; 20301329; 20345388; 20355242; 20379614; 20558539; 20634292; 20809279; 20828673; 20888271; 20924064; 20977932; 21168482; 21179104; 21191615; 21289095; 21402707; 21419245; 21558934; 21713451; 21886157; 21956185; 22001757; 22024719; 22154904; 22167380; 22211102; 22228761; 22268729; 22300680; 22395920; 22569225; 22672431; 22702738; 22703652; 22994584; 23039266; 23124780; 23149655; 23223140; 23328739; 23419404; 23427088; 23432910; 23509830; 23612078; 23648065; 23897810,,,,,,,,,,,,,,,,,,OGG:3000000249,,,,,,,,,,,,,,,,,,,"alkaline phosphatase, liver/bone/kidney",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ALPL,,,20140408,249,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,ALPL,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/DOID_614,lymphopenia,Lymphocytopenia,A leukopenia that is the condition of having an abnormally low level of lymphocytes in the blood.,false,,,http://purl.obolibrary.org/obo/DOID_615,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:48813009|ICD9CM:288.51|UMLS_CUI:C0024312|MESH:D008231|ICD10CM:D72.810,A leukopenia that is the condition of having an abnormally low level of lymphocytes in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lymphocytopenia,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_615,,,,DOID:614,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32226636|https://www.ncbi.nlm.nih.gov/pubmed/32109013|https://www.ncbi.nlm.nih.gov/pubmed/31986264,,,,DOID:614,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,lymphopenia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007080,mitotic metaphase plate congression,,"The cell cycle process in which chromosomes are aligned at the metaphase plate, a plane halfway between the poles of the mitotic spindle, during mitosis.",false,,,http://purl.obolibrary.org/obo/GO_0051310,,,,,,,,,,,,,,,,,,,,,"The cell cycle process in which chromosomes are aligned at the metaphase plate, a plane halfway between the poles of the mitotic spindle, during mitosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051310,,,,GO:0007080,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007080,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic metaphase plate congression,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_409,liver disease,hepatic disorder|disorder of liver,,false,,,http://purl.obolibrary.org/obo/DOID_3118,,,,,,,,,,,,,,,,,,,,ICD9CM:573.9|NCI:C3196|SNOMEDCT_US_2019_09_01:235856003|MESH:D008107|UMLS_CUI:C0023895|ICD10CM:K76.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:2164|DOID:46|DOID:2165,,,,hepatic disorder|disorder of liver,,,,,disease_ontology,,,,,,,,,A disease involving the liver.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_3118,,,,DOID:409,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,DOID:409,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,liver disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000948,heart,chambered heart|vertebrate heart|branchial heart|Herz@de|cardium,"A myogenic muscular circulatory organ found in the vertebrate cardiovascular system composed of chambers of cardiac muscle. It is the primary circulatory organ.|Taxon notes:"" the ascidian tube-like heart lacks chambers....The ascidian heart is formed after metamorphosis as a simple tube-like structure with a single-layered myoepithelium that is continuous with a single-layered pericar- dial wall. It lacks chambers and endocardium.... The innovation of the chambered heart was a key event in vertebrate evolution, because the chambered heart generates one-way blood flow with high pressure, a critical requirement for the efficient blood supply of large-body vertebrates... all extant vertebrates have hearts with two or more chambers (Moorman and Christoffels 2003)"" DOI:10.1101/gad.1485706",false,,,http://purl.obolibrary.org/obo/UBERON_0005181|http://purl.obolibrary.org/obo/UBERON_0007100|http://purl.obolibrary.org/obo/UBERON_0010314|http://purl.obolibrary.org/obo/UBERON_0004120,,,,relationship type change: differentiates_from lateral plate mesoderm (AAO:0010574) CHANGED TO: develops_from lateral plate mesoderm (UBERON:0003081)[AAO],,,,,,,,,,,,,,,,galen:Heart|EFO:0000815|MAT:0000036|OpenCyc:Mx4rvVjvDpwpEbGdrcN5Y29ycA|EHDAA2:0000738|XAO:0000064|BTO:0000562|MESH:D006321|ZFA:0000114|MIAA:0000036|AAO:0010210|NCIT:C12727|EMAPA:16105|FMA:7088|VHOG:0000276|CALOHA:TS-0445|EV:0100018|BILA:0000020|UMLS:C0018787|GAID:174|EHDAA:420|TAO:0000114|MA:0000072|http://linkedlifedata.com/resource/umls/id/C0018787|http://en.wikipedia.org/wiki/Heart|http://www.snomedbrowser.com/Codes/Details/302509004,A myogenic muscular circulatory organ found in the vertebrate cardiovascular system composed of chambers of cardiac muscle. It is the primary circulatory organ.,,,,,,,,,,,,,,"Part of the circulatory system responsible for pumping blood; composed of three chambers--two atria and one ventricle.[AAO]|Blood pumping organ composed of four chambers: sinus venosus, atrium, cardiac ventricle and bulbus arteriosus.[TAO]",,,,,,,,,,,,,,,,,chambered heart|vertebrate heart,,,branchial heart,,uberon,,Herz@de|cardium,cardiac,,,,"As noted, the hearts of birds and mammals have four chambers that arises from the two chambers (atrium and ventricle) of the fish heart.[well established][VHOG]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Taxon notes:"" the ascidian tube-like heart lacks chambers....The ascidian heart is formed after metamorphosis as a simple tube-like structure with a single-layered myoepithelium that is continuous with a single-layered pericar- dial wall. It lacks chambers and endocardium.... The innovation of the chambered heart was a key event in vertebrate evolution, because the chambered heart generates one-way blood flow with high pressure, a critical requirement for the efficient blood supply of large-body vertebrates... all extant vertebrates have hearts with two or more chambers (Moorman and Christoffels 2003)"" DOI:10.1101/gad.1485706",,http://purl.obolibrary.org/obo/UBERON_0005181|http://purl.obolibrary.org/obo/UBERON_0007100|http://purl.obolibrary.org/obo/UBERON_0010314|http://purl.obolibrary.org/obo/UBERON_0004120,,,,UBERON:0000948,,,,,,true,,,,,,,,,UBERON:0000948,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#major_organ|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,heart,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042119,neutrophil activation,,"The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042119,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042119,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neutrophil activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1508227,Bat SARS-like coronavirus,Bat Betacoronavirus SARS related virus|SARS-related bat coronavirus|Bat SARS-related coronavirus,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat Betacoronavirus SARS related virus|SARS-related bat coronavirus|Bat SARS-related coronavirus,,,,,,NCBITaxon:1508227,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS-like coronavirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0071173,spindle assembly checkpoint,SAC,A cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and chromosomes are attached to the spindle.|Note that this term should not be used for direct manual annotation as it should always be possible to specify the type of spindle assembly checkpoint (mitotic or meiotic).,false,,,http://purl.obolibrary.org/obo/GO_0031577,,,,,,,,,,,,,,,,midori,2009-11-23T12:36:57Z,,,,A cell cycle checkpoint that delays the metaphase/anaphase transition until the spindle is correctly assembled and chromosomes are attached to the spindle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,SAC,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term should not be used for direct manual annotation as it should always be possible to specify the type of spindle assembly checkpoint (mitotic or meiotic).,,http://purl.obolibrary.org/obo/GO_0031577,,,,GO:0071173,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0071173,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_manually_annotate,,,,,,,,,,spindle assembly checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C49678,Respiratory Rate,RESP|RESPRATE|Respiratory Rate,"The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute.",false,,,http://purl.obolibrary.org/obo/CMO_0000000,,"The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)",,,,,,,,,C49678,,,NICHD|CDISC|NCPDP,,,,,,,"The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,RESP|RESPRATE|Respiratory Rate,,,,http://purl.obolibrary.org/obo/NCIT_C45233,,,,,,,,,NCIT:C49678,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32189136/,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C91101|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66741|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C120534|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99147|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C120535|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C89506|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67153|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C89415,,,,,,,,,,Respiratory Rate,Respiratory_Rate,,,,,,,Respiratory Rate,,,,,,,,,,,Respiratory Rate,,,,Quantitative Concept,,,,,,,,C0231832,
http://purl.obolibrary.org/obo/OGG_2250009606,gene of Homo sapiens with other gene disposition,,A gene of Homo sapiens that has a other gene disposition,false,,,http://purl.obolibrary.org/obo/OGG_2000009606,,,,,,,,,,,,,,,,,,,,,A gene of Homo sapiens that has a other gene disposition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGG:2250009606,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2000009606,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,gene of Homo sapiens with other gene disposition,,,,,,,,,,,,,,,9606,,,,,,,,,,,,,"Bin Zhao, Oliver He",,,,
http://purl.obolibrary.org/obo/HP_0002018,Nausea,Nausea,A sensation of unease in the stomach together with an urge to vomit.,false,,,http://purl.obolibrary.org/obo/HP_0002017,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:422587007|MSH:D009325|UMLS:C0027497|MEDDRA:10028813,A sensation of unease in the stomach together with an urge to vomit.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Nausea,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002017,,,,HP:0002018,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678|https://www.ncbi.nlm.nih.gov/pubmed/31986264,,,,HP:0002018,,http://purl.obolibrary.org/obo/hp.owl,http://purl.oboInOwllibrary.org/oboInOwl/hp#hposlim_core,,,,,,,,,,Nausea,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001440,CSF3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CSF3OS|C17orf33|GCSF,,,,,,,17,,,,,,,,,,HGNC:2438|HPRD:00736|Vega:OTTHUMG00000133247|Ensembl:ENSG00000108342|MIM:138970,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,colony stimulating factor 3 (granulocyte),,17q11.2-q12,,,,"GO_0005125 (EC: IDA); GO_0005125 (EC: NAS, PMID: 15664994); GO_0005130 (EC: TAS, PMID: 2420009); GO_0005615 (EC: IEA); GO_0006955 (EC: IEA); GO_0007275 (EC: TAS, PMID: 2420009); GO_0008083 (EC: IEA); GO_0008284 (EC: IEA); GO_0014068 (EC: IDA); GO_0019221 (EC: NAS, PMID: 15664994); GO_0019899 (EC: IPI, PMID: 12393522); GO_0030838 (EC: IDA); GO_0030851 (EC: NAS, PMID: 15664994); GO_0032092 (EC: IDA); GO_0033138 (EC: IDA); GO_0042993 (EC: IDA); GO_0045944 (EC: IDA); GO_0050731 (EC: IDA); GO_0051897 (EC: IDA); GO_0071222 (EC: IEA); GO_0071345 (EC: IDA); GO_1901215 (EC: IEA); GO_2000251 (EC: IDA)",PMID: 1281454; 1281794; 1692828; 2420009; 2423327; 2448221; 2453015; 2456256; 3034599; 3484805; 3494801; 3499671; 3501046; 7518249; 7522243; 7524894; 7685117; 8554326; 8708536; 8794774; 10364174; 10473051; 10584986; 10617744; 11436203; 11795665; 11861308; 11877288; 11920209; 12009905; 12027409; 12034575; 12152985; 12393522; 12393561; 12397015; 12456601; 12477932; 12548211; 12562880; 12568301; 12627849; 12636092; 12676791; 12717025; 12946100; 12954601; 14587040; 14751388; 14769149; 15019810; 15028279; 15214947; 15218949; 15576295; 15616013; 15622763; 15664994; 16037394; 16051386; 16211258; 16230423; 16492764; 16498082; 16712791; 16735597; 16822885; 16912178; 16980970; 17047971; 17115186; 17176065; 17342342; 17572226; 17703412; 17852446; 17879956; 17894541; 18029348; 18095095; 18196568; 18219369; 18297540; 18353856; 18358673; 18484240; 18515229; 18537187; 18597629; 18633131; 18675273; 18676680; 18785976; 18806347; 18952897; 19141860; 19151252; 19170196; 19172109; 19258923; 19453261; 19526310; 19539215; 19625176; 19640182; 19692168; 19789190; 19913121; 20012635; 20021260; 20139978; 20172861; 20179985; 20237318; 20237496; 20361316; 20435882; 20452482; 20485444; 20503287; 20523065; 20557950; 20628086; 20673868; 20680910; 20810026; 20957751; 20959405; 21039040; 21079612; 21092001; 21224471; 21262770; 21273924; 21334074; 21335665; 21524920; 21539498; 21645282; 21738478; 21738480; 21844566; 21935680; 21981141; 21999467; 22045733; 22120987; 22171570; 22313638; 22336152; 22440005; 22443081; 22465760; 22528488; 22751169; 22788528; 22829643; 22944463; 23063381; 23087180; 23244154; 23319418; 23530240; 23548906,,,,,,,,,,,,,,,,,,OGG:3000001440,,,,,,,,,,,,,,,,,,,colony stimulating factor 3 (granulocyte),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32305588,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CSF3,,,20140408,1440,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CSF3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0090201,negative regulation of release of cytochrome c from mitochondria,,"Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.|The release of cytochrome c from mitochondria is a central event in the signaling phase of the apoptotic process, and it is often used by researchers to monitor this type of cell death. Any event that induces apoptosis will at some point induce the release of cytochrome c from mitochondria. Therefore, this term should only be used to annotate gene products that directly and negatively regulate this process.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,tanyaberardini,2009-12-18T11:35:20Z,,,,"Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The release of cytochrome c from mitochondria is a central event in the signaling phase of the apoptotic process, and it is often used by researchers to monitor this type of cell death. Any event that induces apoptosis will at some point induce the release of cytochrome c from mitochondria. Therefore, this term should only be used to annotate gene products that directly and negatively regulate this process.",,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0090201,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0090201,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of release of cytochrome c from mitochondria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006352,CCL5,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SISd|SCYA5|SIS-delta|TCP228|eoCP|D17S136E|RANTES,,,,,,,17,,,,,,,,,,HPRD:01751|HGNC:10632|Ensembl:ENSG00000161570|Vega:OTTHUMG00000132949|MIM:187011,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 5,,17q12,,,,"GO_0000165 (EC: IMP); GO_0002407 (EC: TAS, PMID: 18337562); GO_0002548 (EC: IC, PMID: 10660125); GO_0002676 (EC: TAS, PMID: 10488085); GO_0004435 (EC: IDA, PMID: 10734056); GO_0004672 (EC: IDA, PMID: 10734056); GO_0005515 (EC: IPI); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0005737 (EC: IEA); GO_0006468 (EC: IDA, PMID: 10734056); GO_0006816 (EC: IDA, PMID: 10734056); GO_0006874 (EC: IDA, PMID: 10734056); GO_0006887 (EC: IDA, PMID: 10734056); GO_0006935 (EC: NAS, PMID: 1380064); GO_0006954 (EC: IDA); GO_0007159 (EC: IDA, PMID: 8558019); GO_0007267 (EC: IDA, PMID: 8558019); GO_0008009 (EC: IDA, PMID: 1699135); GO_0008009 (EC: NAS, PMID: 7524281); GO_0009615 (EC: TAS, PMID: 10488085); GO_0009636 (EC: IDA, PMID: 10841574); GO_0010535 (EC: TAS, PMID: 11278738); GO_0010759 (EC: IDA, PMID: 16778803); GO_0010820 (EC: IDA, PMID: 16778803); GO_0014068 (EC: IDA, PMID: 7544376); GO_0014911 (EC: IDA); GO_0016004 (EC: IDA, PMID: 10734056); GO_0030298 (EC: IDA, PMID: 10488085); GO_0030335 (EC: IDA, PMID: 7545673); GO_0031328 (EC: IDA, PMID: 18337562); GO_0031584 (EC: IDA, PMID: 9469451); GO_0031663 (EC: IDA); GO_0031726 (EC: IDA, PMID: 10910894); GO_0031726 (EC: IPI, PMID: 10660125); GO_0031726 (EC: TAS, PMID: 9417081); GO_0031729 (EC: TAS, PMID: 9417081); GO_0031730 (EC: IPI, PMID: 9139699); GO_0033634 (EC: IDA, PMID: 8558019); GO_0034112 (EC: IDA, PMID: 10488085); GO_0042056 (EC: IDA, PMID: 15001559); GO_0042102 (EC: IDA, PMID: 18832695); GO_0042119 (EC: IDA, PMID: 10488085); GO_0042327 (EC: IDA, PMID: 18337562); GO_0042379 (EC: IPI, PMID: 7517217); GO_0042531 (EC: IDA, PMID: 9417081); GO_0042803 (EC: IDA, PMID: 10488085); GO_0043491 (EC: IMP); GO_0043621 (EC: IDA, PMID: 10488085); GO_0043623 (EC: IDA, PMID: 18337562); GO_0043922 (EC: IDA, PMID: 10841574); GO_0044344 (EC: IEP, PMID: 9407497); GO_0045070 (EC: TAS, PMID: 10488085); GO_0045071 (EC: IDA, PMID: 10490959); GO_0045089 (EC: TAS); GO_0045744 (EC: IDA, PMID: 10734056); GO_0045785 (EC: IDA, PMID: 10910894); GO_0045948 (EC: NAS, PMID: 18337562); GO_0046427 (EC: TAS, PMID: 11278738); GO_0046817 (EC: IDA, PMID: 8631850); GO_0048245 (EC: IDA, PMID: 16778803); GO_0048246 (EC: TAS, PMID: 18337562); GO_0048661 (EC: IDA); GO_0050679 (EC: IEA); GO_0050863 (EC: IDA, PMID: 10488085); GO_0050918 (EC: IDA, PMID: 15001559); GO_0051262 (EC: IDA, PMID: 10488085); GO_0051928 (EC: IDA, PMID: 8699119); GO_0061098 (EC: IDA, PMID: 10488085); GO_0070098 (EC: TAS, PMID: 18337562); GO_0070100 (EC: IDA, PMID: 8631850); GO_0070233 (EC: IDA, PMID: 10488085); GO_0070234 (EC: IDA, PMID: 10488085); GO_0071346 (EC: IEP, PMID: 9407497); GO_0071347 (EC: IEP, PMID: 9407497); GO_0071356 (EC: IEP, PMID: 9407497); GO_0071407 (EC: IDA); GO_0090026 (EC: IDA, PMID: 1699135); GO_2000110 (EC: IEA); GO_2000503 (EC: IDA, PMID: 7545673)",PMID: 1380064; 1691736; 1699135; 2456327; 2834384; 7517217; 7524281; 7537088; 7542919; 7544376; 7545673; 7689610; 8525373; 8558019; 8573157; 8576227; 8631850; 8642344; 8663314; 8699119; 8898753; 8976200; 9009162; 9120310; 9139699; 9256481; 9289016; 9359702; 9405404; 9407497; 9417081; 9420238; 9469451; 9516414; 9517988; 9558100; 9576751; 9826729; 9889151; 10200305; 10213461; 10221653; 10415069; 10477718; 10488085; 10490959; 10583963; 10640778; 10644351; 10660125; 10713092; 10734056; 10770925; 10774549; 10775626; 10820198; 10841574; 10872839; 10882583; 10910894; 10964543; 10985253; 11083865; 11116158; 11125885; 11197694; 11278738; 11313374; 11350939; 11390394; 11449371; 11500196; 11509627; 11544456; 11602715; 11750041; 11751963; 11816717; 11844139; 11878903; 11897701; 11907119; 11920567; 11929421; 11959378; 11976403; 12081195; 12089333; 12093895; 12114533; 12139952; 12154092; 12164740; 12165487; 12173306; 12200463; 12204866; 12218153; 12270118; 12359436; 12377943; 12445801; 12462338; 12475226; 12477932; 12509457; 12557141; 12610055; 12660426; 12663241; 12668159; 12753088; 12763925; 12789231; 12803993; 12819030; 12837926; 12842758; 12847218; 12858455; 12953261; 12960233; 14637022; 14647058; 14651522; 14687494; 14687706; 15001559; 15001640; 15021309; 15064621; 15067078; 15122808; 15140220; 15142381; 15192276; 15228586; 15239133; 15256089; 15265023; 15280531; 15302103; 15319853; 15368437; 15459010; 15468376; 15471370; 15481145; 15482330; 15488313; 15489334; 15500552; 15537425; 15588341; 15592421; 15602730; 15611878; 15630704; 15645140; 15715189; 15740484; 15742444; 15780175; 15781227; 15793370; 15794069; 15817944; 15848524; 15850807; 15851378; 15857508; 15863470; 15890969; 15899487; 15923218; 15971427; 15978191; 16024972; 16029496; 16032408; 16046258; 16078996; 16161154; 16206161; 16239564; 16246299; 16254204; 16314800; 16323127; 16340468; 16343773; 16354571; 16379602; 16393999; 16437690; 16441357; 16442182; 16468043; 16489254; 16507178; 16511411; 16517749; 16564576; 16614115; 16635746; 16697675; 16712791; 16719905; 16778803; 16791620; 16799229; 16807236; 16841089; 16855620; 16864713; 16864989; 16865553; 16897666; 16911685; 16988194; 16995340; 16997300; 17005260; 17015691; 17016617; 17018392; 17027916; 17038526; 17063508; 17074812; 17075265; 17076674; 17101151; 17112859; 17117952; 17192395; 17202846; 17207890; 17305874; 17328045; 17413295; 17416433; 17416748; 17417600; 17426779; 17431094; 17488389; 17494888; 17504241; 17519498; 17530998; 17540042; 17541284; 17560067; 17565659; 17585540; 17586317; 17596666; 17599774; 17620002; 17625600; 17653092; 17674321; 17678722; 17678915; 17700210; 17703412; 17711627; 17728497; 17765942; 17884183; 17909104; 17922439; 17984846; 17986095; 17989610; 17990036; 18060801; 18162936; 18186796; 18191726; 18195571; 18217191; 18218038; 18240029; 18306985; 18336625; 18337562; 18361934; 18385174; 18415893; 18426815; 18439751; 18447907; 18461620; 18559339; 18636124; 18663025; 18676680; 18678243; 18696265; 18706447; 18716401; 18790652; 18800033; 18824472; 18832695; 18936436; 18953865; 18956302; 18958622; 18986692; 19017985; 19064579; 19073147; 19080516; 19099590; 19099677; 19105348; 19122644; 19124744; 19140875; 19156204; 19157676; 19170196; 19172384; 19201454; 19201759; 19226274; 19240255; 19242540; 19247692; 19258635; 19258923; 19264973; 19333930; 19334035; 19335954; 19342158; 19347053; 19349390; 19360811; 19382425; 19416867; 19420105; 19423540; 19425063; 19427114; 19455469; 19458908; 19493460; 19524301; 19533303; 19578796; 19607806; 19625176; 19628738; 19646363; 19658300; 19661268; 19692168; 19699525; 19703339; 19730683; 19779041; 19830727; 19841187; 19846984; 19847187; 19874825; 19893003; 19913121; 19917679; 19953896; 19996575; 20038229; 20067109; 20121167; 20186291; 20203694; 20237496; 20299965; 20331378; 20378664; 20395963; 20403075; 20406964; 20430255; 20432237; 20438785; 20453000; 20484300; 20503287; 20518834; 20523058; 20531015; 20540976; 20626297; 20628086; 20685145; 20725607; 20729133; 20731692; 20732991; 20734064; 20799037; 20805685; 20861350; 20869067; 20884746; 20978355; 21054877; 21063127; 21189258; 21196302; 21252118; 21258798; 21335555; 21336628; 21356384; 21368236; 21376715; 21418786; 21454528; 21486440; 21510799; 21547257; 21575514; 21586622; 21610221; 21616095; 21617311; 21638128; 21658938; 21671175; 21701779; 21707929; 21734400; 21738469; 21827949; 21839152; 21890375; 21918813; 21921047; 21945445; 21963154; 21988832; 22085486; 22095608; 22162987; 22189589; 22205974; 22265023; 22271279; 22282655; 22300682; 22321225; 22355269; 22374185; 22380870; 22401175; 22412377; 22444510; 22447977; 22473756; 22490648; 22494696; 22506069; 22534629; 22541401; 22554651; 22576913; 22637726; 22664104; 22664781; 22691208; 22732186; 22738652; 22750227; 22797700; 22857950; 22987449; 23029252; 23039889; 23065234; 23071760; 23074171; 23152559; 23165450; 23179318; 23180368; 23190507; 23207898; 23210681; 23219091; 23267209; 23276697; 23312573; 23480650; 23490419; 23577146; 23660804; 23790189; 23818986; 23900864; 23935096; 23998932; 24053708; 24067464; 24078580; 24116893; 24133061; 24157824; 24273921,,,,,,,,,,,,,,,,,,OGG:3000006352,,,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 5,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCL5,,,20140408,6352,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,CCL5,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000003558,IL2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL-2|TCGF|lymphokine,,,,,,,4,,,,,,,,,,HPRD:00979|HGNC:6001|MIM:147680,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 2,,4q26-q27,,,,"GO_0001933 (EC: IEA); GO_0002903 (EC: IDA, PMID: 9184696); GO_0005125 (EC: IDA, PMID: 10072077); GO_0005134 (EC: IDA, PMID: 8262055); GO_0005134 (EC: TAS, PMID: 3925347); GO_0005576 (EC: TAS); GO_0005615 (EC: TAS, PMID: 6608729); GO_0006955 (EC: TAS, PMID: 2342538); GO_0007155 (EC: TAS, PMID: 10929056); GO_0007204 (EC: IEA); GO_0007205 (EC: IEA); GO_0007267 (EC: TAS, PMID: 8476561); GO_0008083 (EC: TAS, PMID: 8476561); GO_0008284 (EC: TAS, PMID: 8476561); GO_0019209 (EC: TAS, PMID: 8476561); GO_0030101 (EC: TAS, PMID: 8476561); GO_0030217 (EC: TAS, PMID: 8476561); GO_0030246 (EC: IEA); GO_0030307 (EC: TAS, PMID: 8476561); GO_0030890 (EC: IDA, PMID: 9184696); GO_0031851 (EC: IEA); GO_0032729 (EC: IEA); GO_0032740 (EC: IDA, PMID: 16482511); GO_0034105 (EC: IC, PMID: 16482511); GO_0042104 (EC: IDA, PMID: 10072077); GO_0042523 (EC: IDA, PMID: 19088061); GO_0043066 (EC: TAS, PMID: 8476561); GO_0043208 (EC: IEA); GO_0045591 (EC: IEA); GO_0045822 (EC: IEA); GO_0045944 (EC: IEA); GO_0046013 (EC: IEA); GO_0048304 (EC: IEA); GO_0050672 (EC: IEA); GO_0050728 (EC: IEA); GO_0050729 (EC: IC, PMID: 16482511); GO_0051024 (EC: IEA); GO_0060999 (EC: IEA); GO_0097192 (EC: IEA)",PMID: 1316918; 1346976; 1394441; 1396583; 1510960; 1527859; 1631562; 1830926; 1832084; 1888898; 1905933; 1993646; 2052609; 2109157; 2303462; 2315327; 2342538; 2552026; 2793860; 2842093; 3260003; 3262520; 3264184; 3265909; 3491296; 3500515; 3877307; 3925347; 6201860; 6306584; 6312994; 6318318; 6321163; 6324170; 6330695; 6333684; 6403867; 6608729; 7523014; 7529123; 7589092; 7591871; 7642615; 7695626; 7697734; 7722480; 7734194; 7957556; 7963560; 7983746; 7999066; 8049354; 8095514; 8102828; 8118889; 8183373; 8207793; 8262055; 8402910; 8476561; 8493579; 8598486; 8626603; 8706326; 8757311; 8765022; 8769094; 8824916; 9007200; 9045614; 9045910; 9065434; 9184696; 9187267; 9209269; 9226175; 9311917; 9334723; 9516115; 9517986; 9534962; 9712080; 9811677; 10072077; 10196292; 10201969; 10207088; 10393966; 10570282; 10618429; 10662798; 10825200; 10929056; 10985305; 11035066; 11093171; 11114167; 11254713; 11261789; 11315919; 11350667; 11354638; 11385624; 11418623; 11525806; 11544437; 11689614; 11714800; 11743717; 11826762; 11841848; 11911478; 11914641; 11940709; 11981437; 12055219; 12072494; 12089714; 12105273; 12121273; 12144536; 12162871; 12171778; 12176041; 12193716; 12200381; 12354082; 12354383; 12358847; 12392859; 12393431; 12409183; 12456594; 12464620; 12477932; 12480696; 12486027; 12504009; 12536241; 12542496; 12557940; 12582206; 12604780; 12605694; 12610796; 12633940; 12646760; 12687247; 12717025; 12727482; 12727483; 12759392; 12808095; 12816983; 12826155; 12826231; 12851716; 12864971; 12884288; 12944981; 12960316; 14499500; 14522096; 14566095; 14607923; 14607929; 14675394; 14680494; 14687725; 14688528; 14707112; 14715519; 14722108; 14975604; 15001467; 15005726; 15057902; 15100259; 15104679; 15120188; 15152368; 15170937; 15175153; 15187164; 15191519; 15238074; 15247007; 15259063; 15271977; 15339934; 15347678; 15353479; 15361128; 15458467; 15489334; 15514847; 15539078; 15562014; 15563472; 15638726; 15654770; 15676209; 15686714; 15710467; 15728489; 15733644; 15749888; 15814282; 15841182; 15841456; 15895884; 15904474; 15910743; 15951664; 15964333; 15976176; 16060678; 16091861; 16100774; 16125242; 16132828; 16148026; 16164695; 16169852; 16293250; 16293754; 16323127; 16333313; 16354571; 16361891; 16389181; 16393999; 16477002; 16478922; 16482511; 16518704; 16567828; 16573560; 16584887; 16606671; 16621991; 16678358; 16690518; 16783532; 16805135; 16824159; 16864905; 16864906; 16885196; 16889932; 16920920; 16938461; 16961803; 16966412; 16984280; 17002904; 17052299; 17077180; 17097050; 17110377; 17115417; 17142786; 17152005; 17175263; 17177332; 17203290; 17207965; 17215524; 17222831; 17237447; 17257312; 17327408; 17332243; 17336597; 17337059; 17355643; 17396252; 17439892; 17444587; 17457216; 17460561; 17537734; 17541281; 17558408; 17571248; 17604883; 17627763; 17651815; 17703412; 17714919; 17715020; 17728221; 17761346; 17889143; 17900510; 17913045; 17949552; 17956522; 17981641; 17981806; 17985312; 17994425; 18021367; 18021981; 18023521; 18073500; 18077789; 18095604; 18097023; 18165865; 18174230; 18192685; 18207244; 18209044; 18239807; 18271063; 18275276; 18299274; 18309287; 18311140; 18324310; 18331736; 18348982; 18418394; 18423386; 18430737; 18481948; 18496418; 18522869; 18539368; 18543227; 18566561; 18570590; 18574615; 18576303; 18593762; 18614637; 18624934; 18628433; 18632425; 18633131; 18650128; 18663124; 18670216; 18676680; 18676770; 18714042; 18755820; 18761558; 18768844; 18769450; 18773331; 18776133; 18780166; 18780949; 18794598; 18805825; 18818748; 18932275; 18942754; 18972297; 18991615; 19013323; 19019335; 19058298; 19058987; 19073967; 19088061; 19099187; 19105930; 19117745; 19126646; 19135418; 19141488; 19170196; 19200845; 19201773; 19234188; 19250279; 19258923; 19275586; 19279357; 19284443; 19302705; 19332120; 19339796; 19351491; 19364969; 19375249; 19404967; 19406689; 19408823; 19414780; 19427348; 19430480; 19450160; 19453859; 19470040; 19471255; 19494280; 19495883; 19497711; 19502081; 19505916; 19522766; 19523143; 19527514; 19543959; 19573080; 19594368; 19625176; 19638314; 19648290; 19675167; 19683555; 19692168; 19693089; 19693092; 19707465; 19710466; 19718824; 19733878; 19773279; 19773451; 19787624; 19832038; 19860911; 19889958; 19892918; 19913121; 19925666; 19938203; 19951419; 19965651; 20012528; 20027321; 20049409; 20060205; 20072139; 20082482; 20100932; 20112382; 20129796; 20145925; 20177758; 20179739; 20182632; 20184734; 20190192; 20190752; 20193755; 20203524; 20213229; 20219786; 20221423; 20222161; 20225066; 20227890; 20233754; 20236616; 20331378; 20378664; 20418110; 20424473; 20438365; 20444755; 20452482; 20453000; 20453842; 20465575; 20484443; 20485444; 20498205; 20503287; 20535218; 20542085; 20544350; 20553587; 20557936; 20561440; 20562654; 20568250; 20594918; 20595916; 20596022; 20599261; 20603050; 20626741; 20628086; 20671116; 20673868; 20679529; 20716621; 20802378; 20811626; 20814620; 20839488; 20870937; 20880293; 20883322; 20926141; 20942272; 20960273; 20962850; 21035858; 21037099; 21061265; 21072155; 21085635; 21086908; 21112091; 21162873; 21167738; 21176845; 21179414; 21198755; 21258967; 21269573; 21282039; 21288140; 21292764; 21297633; 21304239; 21317396; 21372257; 21375519; 21383498; 21394196; 21423578; 21425124; 21425313; 21482826; 21531896; 21532597; 21620040; 21640045; 21642596; 21648020; 21685912; 21688385; 21711552; 21819478; 21829393; 21839273; 21876034; 21889323; 21890374; 21905023; 21905024; 21925225; 21976679; 21978000; 21984699; 22036096; 22040441; 22062588; 22077623; 22111667; 22112982; 22174157; 22242968; 22246628; 22281835; 22313865; 22337875; 22434682; 22461703; 22467658; 22472080; 22474330; 22479496; 22504653; 22524835; 22554193; 22585398; 22609631; 22623329; 22634617; 22645657; 22732586; 22736314; 22791129; 22797138; 22819245; 22891215; 22905203; 22910795; 22932225; 22984628; 23009887; 23019580; 23058031; 23103669; 23104097; 23128233; 23129528; 23172754; 23185455; 23192659; 23217119; 23265966; 23272100; 23278180; 23303246; 23317891; 23319613; 23328843; 23349093; 23380740; 23414538; 23418630; 23451206; 23487197; 23541403; 23586039; 23640893; 23645042; 23665382; 23676143; 23677467; 23724099; 23806696; 23817571; 23857000; 24019486; 24098138,,,,,,,,,,,,,,,,,,OGG:3000003558,,,,,,,,,,,,,,,,,,,interleukin 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32169119,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL2,,,20140408,3558,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_38215,calcium channel blocker,calcium channel antagonists|calcium channel blockers|calcium channel antagonist,One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,calcium channel antagonists|calcium channel blockers|calcium channel antagonist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:38215,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32220710,,,,CHEBI:38215,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,calcium channel blocker,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_9443,Primates,primate|Primata|primates,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_40674,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,primate,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_order,Primata|primates,,,,,,NCBITaxon:9443,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_40674,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Primates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_689832,Sedoreovirinae,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10880,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_subfamily,,,,,,,NCBITaxon:689832,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10880,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Sedoreovirinae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031100,animal organ regeneration,,The regrowth of a lost or destroyed animal organ.,false,,,http://purl.obolibrary.org/obo/GO_0031099,,,,,,,,,,,,,,,,,,,,,The regrowth of a lost or destroyed animal organ.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0031099,,,,GO:0031100,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031100,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,animal organ regeneration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000489,cavitated compound organ,cavitated organ|cavitated compound organs,Compound organ that contains one or more macroscopic anatomical spaces.,false,,,http://purl.obolibrary.org/obo/UBERON_0003103,,,,,,,,,,,,,,,,,,,"this class was introduced for consistency with CARO, however, it has yet to be used in this or other ontologies. It may be retired in the future",VHOG:0001730|TAO:0001490|HAO:0000072|EHDAA2:0003072|AEO:0000072|FMA:55671|TGMA:0001857|CARO:0000072|ZFA:0001490|BILA:0000072|XAO:0003165|AAO:0010016,Compound organ that contains one or more macroscopic anatomical spaces.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cavitated organ,,,,,uberon,,cavitated compound organs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0003103,,,,UBERON:0000489,,,,,,,,,,,,,,,UBERON:0000489,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim,,,,,,,,,,cavitated compound organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007137,TNNI3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CMD1FF|CMH7|RCM1|CMD2A|TNNC1|cTnI,,,,,,,19,,,,,,,,,,HGNC:11947|MIM:191044|HPRD:11769|Ensembl:ENSG00000129991|Vega:OTTHUMG00000180589,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,troponin I type 3 (cardiac),,19q13.4,,,,"GO_0001570 (EC: ISS); GO_0001980 (EC: ISS); GO_0003779 (EC: IDA, PMID: 10806205); GO_0005515 (EC: IPI, PMID: 10806205); GO_0005829 (EC: TAS); GO_0005861 (EC: IDA, PMID: 10806205); GO_0006874 (EC: ISS); GO_0006940 (EC: IEA); GO_0007507 (EC: ISS); GO_0019855 (EC: IPI, PMID: 12809519); GO_0019901 (EC: IPI, PMID: 12721663); GO_0019904 (EC: IPI, PMID: 11984006); GO_0030017 (EC: TAS, PMID: 16754800); GO_0030049 (EC: TAS); GO_0030172 (EC: IPI, PMID: 11735257); GO_0031014 (EC: IPI, PMID: 15542288); GO_0032780 (EC: IDA, PMID: 11735257); GO_0032780 (EC: IMP, PMID: 10806205); GO_0046872 (EC: IEA); GO_0048306 (EC: IPI, PMID: 7957210); GO_0055010 (EC: IMP, PMID: 11815426); GO_0060047 (EC: IMP, PMID: 12531876); GO_0060048 (EC: IMP, PMID: 11735257)",PMID: 1934363; 1959915; 2226790; 2226863; 2584239; 7957210; 8125298; 8406024; 8661099; 8798526; 9219516; 9241277; 9346285; 9560191; 9605869; 10191089; 10387074; 10806205; 10850966; 11121119; 11596911; 11735257; 11801593; 11815426; 11853553; 11904166; 11984006; 12044157; 12060657; 12093807; 12122471; 12151382; 12242268; 12270775; 12383268; 12477932; 12525172; 12531876; 12626203; 12707239; 12721663; 12732641; 12803836; 12809519; 12826210; 12840750; 12939162; 12967628; 12974739; 14551240; 14575308; 14596793; 14661957; 15049709; 15070570; 15134451; 15147183; 15257080; 15350489; 15367881; 15542288; 15601779; 15604421; 15607392; 15698845; 15718266; 15867176; 15961398; 16157639; 16199542; 16236952; 16288990; 16302972; 16338248; 16338262; 16358990; 16516408; 16754800; 16765375; 16887211; 16916777; 17101185; 17140583; 17303066; 17574519; 17587709; 17594788; 17710247; 18032382; 18042489; 18042776; 18064406; 18092822; 18094010; 18175163; 18381864; 18403758; 18430738; 18445579; 18513529; 18569954; 18571749; 18682663; 18760145; 18810980; 18835219; 18976355; 18986304; 19003742; 19008306; 19016149; 19035361; 19090253; 19145004; 19149795; 19150014; 19221927; 19293840; 19299763; 19321456; 19372185; 19387251; 19426736; 19455094; 19463339; 19523464; 19568166; 19571537; 19580729; 19590045; 19651143; 19696481; 19797054; 19833747; 19853701; 19875404; 19920153; 19925440; 20008898; 20025646; 20030529; 20031618; 20035081; 20043329; 20079546; 20086309; 20140242; 20188720; 20215591; 20301486; 20301725; 20358260; 20359594; 20378771; 20474083; 20523292; 20555264; 20588136; 20624503; 20800588; 20817590; 20889975; 20923987; 20924643; 20975235; 21184543; 21214502; 21304210; 21456469; 21549291; 21574239; 21730823; 21757825; 21777381; 21993227; 22029801; 22052454; 22072229; 22119115; 22353438; 22449338; 22456184; 22465126; 22491666; 22493448; 22500757; 22675533; 22704287; 22761714; 22876777; 22982904; 23144315; 23163407; 23184341; 23220502; 23238359; 23247055; 23274622; 23326389; 23329791; 23393062; 23396754; 23397594; 23469039; 23539503; 23552626; 23604180; 23660299; 23788249; 23829708,,,,,,,,,,,,,,,,,,OGG:3000007137,,,,,,,,,,,,,,,,,,,troponin I type 3 (cardiac),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/31986264,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TNNI3,,,20140408,7137,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TNNI3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_10358,Cytomegalovirus,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10357,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,,,,,,,NCBITaxon:10358,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10357,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Cytomegalovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072686,mitotic spindle,,A spindle that forms as part of mitosis. Mitotic and meiotic spindles contain distinctive complements of proteins associated with microtubules.,false,,,http://purl.obolibrary.org/obo/GO_0005819,,,,,,,,,,,,,,,,midori,2011-07-08T05:08:16Z,,,,A spindle that forms as part of mitosis. Mitotic and meiotic spindles contain distinctive complements of proteins associated with microtubules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005819,,,,GO:0072686,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072686,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic spindle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006910,"phagocytosis, recognition",recognition of phagocytosed substance by phagocytic cell,"The initial step in phagocytosis involving adhesion to bacteria, immune complexes and other particulate matter, or an apoptotic cell and based on recognition of factors such as bacterial cell wall components, opsonins like complement and antibody or protein receptors and lipids like phosphatidyl serine, and leading to intracellular signaling in the phagocytosing cell.|Note that cell surface molecules involved in the direct binding of bacteria may be also annotated to the molecular function term 'bacterial cell surface binding ; GO:0051635'. Note that cell surface molecules involved in the direct binding to opsonins such as complement components or antibodies may be also annotated to the term 'opsonin binding ; GO:0001846'.",false,,,http://purl.obolibrary.org/obo/GO_0008037,,,,,,,,,,,,,,,,,,,,,"The initial step in phagocytosis involving adhesion to bacteria, immune complexes and other particulate matter, or an apoptotic cell and based on recognition of factors such as bacterial cell wall components, opsonins like complement and antibody or protein receptors and lipids like phosphatidyl serine, and leading to intracellular signaling in the phagocytosing cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,recognition of phagocytosed substance by phagocytic cell,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that cell surface molecules involved in the direct binding of bacteria may be also annotated to the molecular function term 'bacterial cell surface binding ; GO:0051635'. Note that cell surface molecules involved in the direct binding to opsonins such as complement components or antibodies may be also annotated to the term 'opsonin binding ; GO:0001846'.,,http://purl.obolibrary.org/obo/GO_0008037,,,,GO:0006910,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006910,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"phagocytosis, recognition",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0002531,"Arrhythmias, Cardiac",,,false,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0002531,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/3221830,"Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,"Arrhythmias, Cardiac",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_511430,SARS coronavirus BJ182-4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:511430,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ182-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2497574,Monjiviricetes,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2497570,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_class,,,,,,,NCBITaxon:2497574,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2497570,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Monjiviricetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050789,regulation of biological process,regulation of physiological process,"Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.",false,,,http://purl.obolibrary.org/obo/GO_0008150,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0050791,,,,regulation of physiological process,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0008150,,,,GO:0050789,,,,,,,,,,,,,,,GO:0050789,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus|http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_annotate,,,,,,,,,,regulation of biological process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MAXO_0010301,rectal swab,anal swab|swab collection of rectum,Collection biological material from within the rectum. A cotton swab is inserted into the opening and rotated and then withdrawn.,false,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,,,,,,http://orcid.org/0000-0001-7941-2961,,,,,Collection biological material from within the rectum. A cotton swab is inserted into the opening and rotated and then withdrawn.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,anal swab|swab collection of rectum,,,,,,,,,,,,,MAXO:0010301,,,,,,,,,,,,,,,,,,2020-03-27T20:39:14Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,,,,,,http://purl.obolibrary.org/obo/maxo.owl,,,,,,,,,,,rectal swab|rectal swab collection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042571,"immunoglobulin complex, circulating",antibody,"An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component.|Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available.",false,,,http://purl.obolibrary.org/obo/GO_0019814,,,,,,,,,,,,,,,,,,,,Wikipedia:Antibody,"An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,antibody,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available.,,http://purl.obolibrary.org/obo/GO_0019814,,,,GO:0042571,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042571,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"immunoglobulin complex, circulating",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C115164,Nosocomial Infection,Nosocomial Infection|HAI|Hospital-Onset Infection|Hospital-Acquired Infection|Healthcare-Associated Infection,An infection acquired in a hospital or other healthcare setting.,false,,,http://purl.obolibrary.org/obo/NCIT_C128376,,An infection acquired in a hospital or other healthcare setting.,,,,,,,,,C115164,,,MedDRA|NICHD,,,,,,,An infection acquired in a hospital or other healthcare setting.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Nosocomial Infection|HAI|Hospital-Onset Infection|Hospital-Acquired Infection|Healthcare-Associated Infection,,,,http://purl.obolibrary.org/obo/NCIT_C26726,,,,,,,,,NCIT:C115164,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113704|https://www.ncbi.nlm.nih.gov/pubmed/32259546,,nosocomial transmission,nosocomial viral transmission,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118464|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128453,,,,,,,,,,Nosocomial Infection,,Nosocomial infection,,,,,,Nosocomial Infection,,,,,,,,,,,Nosocomial Infection,,,,Disease or Syndrome,,,,,,,,C0205721,
http://purl.obolibrary.org/obo/GO_0009144,purine nucleoside triphosphate metabolic process,purine nucleoside triphosphate metabolism,"The chemical reactions and pathways involving purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009141,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine nucleoside triphosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009141,,,,GO:0009144,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009144,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine nucleoside triphosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/FMA_62872,Immunoglobulin G,IgG,,false,,,http://purl.obolibrary.org/obo/FMA_62871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IgG,,,,,fma,,,,,,,,,"It is a monomeric gamma globulin protein consisting of two gamma heavy chains and either two kappa light chains or two lambda light chains, connected by disulfide bonds.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/FMA_62871,,,,FMA:62872,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32284614,,,,FMA:62872,,http://purl.obolibrary.org/obo/fma.owl,,,,,,,,,,,Immunoglobulin G,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_134730,umifenovir,arbidole|arbidol,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:4868|CAS:131707-25-0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,arbidole|arbidol,,,,,,,,,0,C22H25BrN2O3S,"InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3",KCFYEAOKVJSACF-UHFFFAOYSA-N,477.416,476.07693,C(OCC)(=O)C=1C=2C(N(C)C1CSC3=CC=CC=C3)=CC(Br)=C(O)C2CN(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:134730,,,,,,true,,,,,,,,,CHEBI:134730,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,umifenovir,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response","CD4-positive, alpha-beta T-lymphocyte differentiation during immune response|CD4-positive, alpha-beta T cell development involved in immune response|CD4-positive, alpha-beta T-cell differentiation during immune response|CD4-positive, alpha-beta T lymphocyte differentiation during immune response|CD4-positive, alpha-beta T cell differentiation during immune response","The process in which an antigenically naive CD4-positive, alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell as part of an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells.|Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.",false,,,http://purl.obolibrary.org/obo/GO_0035710|http://purl.obolibrary.org/obo/GO_0042110|http://purl.obolibrary.org/obo/GO_0002293|http://purl.obolibrary.org/obo/GO_0046631,,,,,,,,,,,,,,,,,,,,,"The process in which an antigenically naive CD4-positive, alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell as part of an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,"CD4-positive, alpha-beta T-lymphocyte differentiation during immune response|CD4-positive, alpha-beta T cell development involved in immune response|CD4-positive, alpha-beta T-cell differentiation during immune response|CD4-positive, alpha-beta T lymphocyte differentiation during immune response|CD4-positive, alpha-beta T cell differentiation during immune response",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.,,http://purl.obolibrary.org/obo/GO_0035710|http://purl.obolibrary.org/obo/GO_0042110|http://purl.obolibrary.org/obo/GO_0002293|http://purl.obolibrary.org/obo/GO_0046631,,,,GO:0002294,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002294,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"CD4-positive, alpha-beta T cell differentiation involved in immune response",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002093,Respiratory insufficiency,progressive respiratory failure|Respiratory impairment|Respiratory function loss,,false,,,http://purl.obolibrary.org/obo/HP_0002795,,,,,,,,,,,,,,,,,,,,UMLS:C4020855|SNOMEDCT_US:409623005|MSH:D012131|UMLS:C0035229,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0004893|HP:0005937|HP:0006542,,,,progressive respiratory failure|Respiratory impairment,,,,,human_phenotype,,Respiratory function loss,,,,,,,"Impairment of gas exchange within the lungs secondary to a disease process, neoplasm, or trauma, possibly resulting in hypoxia, hypercarbia, or both, but not requiring intubation or mechanical ventilation. Patients are normally managed with pharmaceutical therapy, supplemental oxygen, or both.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002795,,,,HP:0002093,,,,,,,,,,,,,,,HP:0002093,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Respiratory insufficiency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000141,bilateral involvement,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,common CT pattern,,true,,,,,,"Bilateral, diffuse ground-glass opacities.",,,,,,,,,,,,,,,,bilateral involvement,,,,,,,,,,,,,,,,,,,,,,https://pubs.rsna.org/doi/10.1148/radiol.2020200463,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002287,alpha-beta T cell activation involved in immune response,alpha-beta T-cell activation during immune response|alpha-beta T-lymphocyte activation during immune response|alpha-beta T cell activation during immune response|alpha-beta T lymphocyte activation during immune response,"The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.",false,,,http://purl.obolibrary.org/obo/GO_0046631|http://purl.obolibrary.org/obo/GO_0002286,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,alpha-beta T-cell activation during immune response|alpha-beta T-lymphocyte activation during immune response|alpha-beta T cell activation during immune response|alpha-beta T lymphocyte activation during immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046631|http://purl.obolibrary.org/obo/GO_0002286,,,,GO:0002287,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002287,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,alpha-beta T cell activation involved in immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044659,viral release from host cell by cytolysis,viral release by host cell lysis|viral release by cell lysis|viral exit from host cell by cytolysis|lytic viral release|lytic viral life cycle|cytolysis by virus of host cell,The killing by a virus of a cell by means of the rupture of cell membranes and the loss of cytoplasm.,false,,,http://purl.obolibrary.org/obo/GO_0009987|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,janelomax,2012-08-01T13:16:39Z,,,VZ:1077,The killing by a virus of a cell by means of the rupture of cell membranes and the loss of cytoplasm.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019077|GO:0046756,,,,viral release by host cell lysis|viral release by cell lysis|viral exit from host cell by cytolysis|lytic viral release,,,,,biological_process,,lytic viral life cycle|cytolysis by virus of host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0044659,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32167747,,,,GO:0044659,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral release from host cell by cytolysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,https://github.com/geneontology/go-ontology/issues/18852,,,
http://purl.obolibrary.org/obo/OGG_3000003948,LDHC,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CT32|LDH3|LDHX,,,,,,,11,,,,,,,,,,MIM:150150|Vega:OTTHUMG00000167722|Ensembl:ENSG00000166796|HPRD:01027|HGNC:6544,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,lactate dehydrogenase C,,11p15.1,,,,GO_0004459 (EC: IEA); GO_0005737 (EC: IEA); GO_0006096 (EC: IEA); GO_0006754 (EC: IEA); GO_0019244 (EC: IEA); GO_0019516 (EC: IEA); GO_0030317 (EC: IEA); GO_0031514 (EC: IEA); GO_0044262 (EC: IEA),PMID: 2440048; 2596827; 2844458; 2930531; 3175768; 7382246; 8318584; 8614414; 11125887; 11377399; 11582518; 12438276; 12477932; 14985855; 15489334; 16600870; 17178662; 17207965; 17935709; 18368308; 18930904; 20499337; 21124955; 21858537; 22990118; 23077236; 23428871,,,,,,,,,,,,,,,,,,OGG:3000003948,,,,,,,,,,,,,,,,,,,lactate dehydrogenase C,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,LDHC,,,20140408,3948,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,LDHC,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_24261,glucocorticoid,glucocorticoids,"Glucocorticoids are a class of steroid hormones that regulate a variety of physiological processes, in particular control of the concentration of glucose in blood.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,"Glucocorticoids are a class of steroid hormones that regulate a variety of physiological processes, in particular control of the concentration of glucose in blood.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,glucocorticoids,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:24261,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32149773,,,,CHEBI:24261,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,glucocorticoid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000085,computational phylogenetic analysis,,,false,,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,Modified definition,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167166,Application of computational strategies for phylogenetic analysis.,,,,,,,,,,,,,,,,computational phylogenetic analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_349342,Bat SARS coronavirus Rp1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:349342,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus Rp1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_742002,Bat SARS coronavirus HKU3-5,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:742002,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_974,upper respiratory tract disease,,A respiratory system disease which involves the upper respiratory tract.,false,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,,,,,,,,,,ICD9CM:478.19|UMLS_CUI:C0029581,A respiratory system disease which involves the upper respiratory tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1579,,,,DOID:974,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32186711,,,,DOID:974,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,upper respiratory tract disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0071174,mitotic spindle checkpoint,mitotic cell cycle spindle checkpoint,"A mitotic cell cycle checkpoint that originates from the spindle and delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and oriented, the completion of anaphase until chromosomes are attached to the spindle, or mitotic exit and cytokinesis when the spindle does not form.|Note that this term should not be used for direct manual annotation as it should always be possible to specify the type of spindle checkpoint (assembly, orientation or Dma1-dependent).",false,,,http://purl.obolibrary.org/obo/GO_0007093|http://purl.obolibrary.org/obo/GO_0031577,,,,,,,,,,,,,,,,midori,2009-11-23T12:41:36Z,,,,"A mitotic cell cycle checkpoint that originates from the spindle and delays the metaphase/anaphase transition of a mitotic nuclear division until the spindle is correctly assembled and oriented, the completion of anaphase until chromosomes are attached to the spindle, or mitotic exit and cytokinesis when the spindle does not form.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mitotic cell cycle spindle checkpoint,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term should not be used for direct manual annotation as it should always be possible to specify the type of spindle checkpoint (assembly, orientation or Dma1-dependent).",,http://purl.obolibrary.org/obo/GO_0007093|http://purl.obolibrary.org/obo/GO_0031577,,,,GO:0071174,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0071174,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_manually_annotate,,,,,,,,,,mitotic spindle checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045178,basal part of cell,,"The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0045178,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045178,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,basal part of cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0005957,Breathing dysregulation,,,false,,,http://purl.obolibrary.org/obo/HP_0002795,,,,,,,,,,,,,,,,,,,,UMLS:C3808046,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002795,,,,HP:0005957,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217650/,Any disturbance to the fine-tuned breath-by-breath regulation of breathing.,,,HP:0005957,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Breathing dysregulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000005,ShuFengJieDu,,,false,,,http://purl.obolibrary.org/obo/OMIT_0009582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Shufengjiedu Capsule (SFJD) is a type of Chinese traditional medicine compound for the treatment of acute upper respiratory tract infection,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OMIT_0009582,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32186952/,,,,,,,,,,,,,,,,,ShuFengJieDu,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_31959,pantethine,"(2R,2'R)-N,N'-{disulfanediylbis[ethane-2,1-diylimino(3-oxopropane-3,1-diyl)]}bis(2,4-dihydroxy-3,3-dimethylbutanamide)|Pantetina|D-pantethine|N-[2-[2-[2-[3-[(2,4-dihydroxy-3,3-dimethyl-butanoyl)amino]propanoylamino]ethyldisulfanyl]ethylcarbamoyl]ethyl]-2,4-dihydroxy-3,3-dimethyl-butanamide|Bis(pantothenamidoethyl) disulfide|Pantomin|D-Bis(N-pantothenyl-beta-aminoethyl) disulfide|(R-(R*,R*))-N,N'-(Dithiobis(ethyleneimino(3-oxopropane-3,1-diyl)))bis(2,4-dihydroxy-3,3-dimethylbutyramide)",An organic disulfide that consists of two molecules of pantothenic acid linked by amide bonds to a cysteamine disulfide bridging group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:21925346|PMID:20351285|HMDB:HMDB0003828|CAS:16816-67-4|PMID:20416081|KEGG:D01234|PMID:21551303|KEGG:C12661|Wikipedia:Pantethine|PMID:21963510|PMID:21155629|Drug_Central:3417|Reaxys:1718252,An organic disulfide that consists of two molecules of pantothenic acid linked by amide bonds to a cysteamine disulfide bridging group.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(2R,2'R)-N,N'-{disulfanediylbis[ethane-2,1-diylimino(3-oxopropane-3,1-diyl)]}bis(2,4-dihydroxy-3,3-dimethylbutanamide)",,,,,chebi_ontology,,"Pantetina|D-pantethine|N-[2-[2-[2-[3-[(2,4-dihydroxy-3,3-dimethyl-butanoyl)amino]propanoylamino]ethyldisulfanyl]ethylcarbamoyl]ethyl]-2,4-dihydroxy-3,3-dimethyl-butanamide|Bis(pantothenamidoethyl) disulfide|Pantomin|D-Bis(N-pantothenyl-beta-aminoethyl) disulfide|(R-(R*,R*))-N,N'-(Dithiobis(ethyleneimino(3-oxopropane-3,1-diyl)))bis(2,4-dihydroxy-3,3-dimethylbutyramide)",,,,,,,,,0,C22H42N4O8S2,"InChI=1S/C22H42N4O8S2/c1-21(2,13-27)17(31)19(33)25-7-5-15(29)23-9-11-35-36-12-10-24-16(30)6-8-26-20(34)18(32)22(3,4)14-28/h17-18,27-28,31-32H,5-14H2,1-4H3,(H,23,29)(H,24,30)(H,25,33)(H,26,34)/t17-,18-/m0/s1",DJWYOLJPSHDSAL-ROUUACIJSA-N,554.72100,554.24441,CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31959,,,,,true,true,,,,,,,,,CHEBI:31959,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,pantethine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000322,pneumocyte,pneumonocyte|alveolar epithelial cell,An epithelial cell that lines the peripheral gas exchange region of the lungs of air-breathing vertebrates.,false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,,,,,,,,,,BTO:0000395|CALOHA:TS-2168|FMA:62499,An epithelial cell that lines the peripheral gas exchange region of the lungs of air-breathing vertebrates.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pneumonocyte|alveolar epithelial cell,,,,,cell,,,,,,,,CL:0000322,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,pneumocyte,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000002,A2M,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,S863-7|FWP007|A2MD|CPAMD5,,,,,,,12,,,,,,,,,,Ensembl:ENSG00000175899|HPRD:00072|Vega:OTTHUMG00000150267|MIM:103950|HGNC:7,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,alpha-2-macroglobulin,,12p13.31,,,,"GO_0001869 (EC: IDA, PMID: 12538697); GO_0002020 (EC: IPI, PMID: 18485748); GO_0002576 (EC: TAS); GO_0004867 (EC: IDA, PMID: 12538697); GO_0005515 (EC: IPI, PMID: 14687906); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0005829 (EC: TAS); GO_0007264 (EC: TAS); GO_0007596 (EC: TAS); GO_0007597 (EC: TAS); GO_0010951 (EC: IDA, PMID: 12538697); GO_0019838 (EC: IDA, PMID: 9398211); GO_0019899 (EC: IPI, PMID: 11435418); GO_0019959 (EC: IPI, PMID: 10880251); GO_0019966 (EC: IDA, PMID: 9714181); GO_0022617 (EC: TAS); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0031093 (EC: TAS); GO_0043120 (EC: IDA, PMID: 9714181); GO_0048863 (EC: IEA); GO_0051056 (EC: TAS); GO_0070062 (EC: IDA); GO_0072562 (EC: IDA)",PMID: 59727; 80233; 89758; 1281457; 1370808; 1374237; 1692292; 1697852; 1702714; 1707161; 1724156; 2408344; 2430963; 2459995; 2460294; 2466831; 2467766; 2476070; 2581245; 3289986; 6153632; 6165619; 6167263; 6172288; 6191979; 6195065; 6203908; 6698368; 7519849; 7524416; 7533162; 7533769; 7680268; 7690356; 8583572; 8662763; 9166830; 9344465; 9398211; 9428387; 9714181; 9724081; 9831625; 9865955; 10373500; 10652313; 10681572; 10714547; 10731476; 10880251; 11023837; 11036822; 11058789; 11099722; 11100124; 11121179; 11162584; 11166925; 11231028; 11281447; 11290389; 11435418; 11436125; 11455130; 11484172; 11496365; 11498265; 11811950; 11823454; 11901360; 11910179; 11916201; 11987698; 12015318; 12042276; 12059070; 12062545; 12123860; 12175343; 12194978; 12221172; 12394648; 12477932; 12538697; 12631277; 12754519; 12755614; 12755687; 12782337; 12782964; 12966032; 14506912; 14637088; 14675603; 14678766; 14687906; 14715656; 14718574; 14759632; 14760718; 15023809; 15226301; 15231748; 15468911; 15489334; 15511627; 15611997; 15793779; 15862967; 15908432; 15910735; 15931081; 15950906; 16040006; 16169070; 16232083; 16289162; 16297527; 16335952; 16384981; 16402284; 16407218; 16456795; 16641085; 16650578; 16784755; 16910174; 17071617; 17110338; 17288987; 17403113; 17453620; 17608619; 17967834; 18029348; 18075673; 18077315; 18171086; 18191876; 18382889; 18485748; 18499670; 18579803; 18624398; 18706476; 19074141; 19105203; 19472074; 19639019; 19913121; 20048078; 20085233; 20156641; 20207732; 20301340; 20381197; 20401725; 20493925; 20575108; 20587546; 20628086; 20637261; 20800603; 20861575; 21163940; 21216953; 21541797; 21642630; 21900206; 21971609; 21988832; 22268729; 22541546; 22576683; 22971340; 23064953; 23086799; 23089609; 23186781; 23353684; 23379699; 23397525; 23535567; 23602568; 23643808; 23721263; 23786280; 23846698,,,,,,,,,,,,,,,,,,OGG:3000000002,,,,,,,,,,,,,,,,,,,alpha-2-macroglobulin,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,A2M,,,20140408,2,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,A2M,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_63580,ribavirin,"1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide|RBV|1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|ribavirinum|ribavirine|ribavirin|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|ribavirina","A 1-ribosyltriazole that is the 1-ribofuranosyl derivative of 1,2,4-triazole-3-carboxamide. A synthetic guanosine analogue, it is an inhibitor of HCV polymerase and possesses a broad spectrum of activity against DNA and RNA viruses.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22156853|PMID:22212568|PMID:21827730|Drug_Central:2373|Wikipedia:Ribavirin|PMID:22212569|PMID:29438107|PMID:22212572|Beilstein:892462|LINCS:LSM-5701|PMID:22052220|PMID:22220723|KEGG:D00423|PMID:22212566|PMID:22239498|PMID:22212579|PMID:22052088|PMID:22158703|PMID:22212576|DrugBank:DB00811|Reaxys:892462|PMID:22239511|CAS:36791-04-5,"A 1-ribosyltriazole that is the 1-ribofuranosyl derivative of 1,2,4-triazole-3-carboxamide. A synthetic guanosine analogue, it is an inhibitor of HCV polymerase and possesses a broad spectrum of activity against DNA and RNA viruses.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:8840,,,,"1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide",,,,,chebi_ontology,,"RBV|1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|ribavirinum|ribavirine|ribavirin|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|ribavirina",,,,,,,,,0,C8H12N4O5,"InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1",IWUCXVSUMQZMFG-AFCXAGJDSA-N,244.20470,244.08077,NC(=O)c1ncn(n1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:63580,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32227493,,,,CHEBI:63580,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ribavirin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046754,viral exocytosis,,"The exit of enveloped or unenveloped virion particles from the host cell by exocytosis, without causing cell lysis.",false,,,http://purl.obolibrary.org/obo/GO_0046753,,,,,,,,,,,,,,,,,,,,,"The exit of enveloped or unenveloped virion particles from the host cell by exocytosis, without causing cell lysis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046753,,,,GO:0046754,,,,,,true,,,,true,,,,,GO:0046754,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral exocytosis,,,,,,,,,,,,,,,,,,,,,,https://arstechnica.com/science/2020/03/covid-19-the-biology-of-an-effective-therapy/,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000099,pain,,"A sensation perception where there is an unpleasant sensation that usually indicates the body is threatened or damaged. The sensation may be sharp or dull, short-lived or chronic, intermittent or continual, confined to one area or spread over the entire body.",false,,,http://purl.obolibrary.org/obo/SYMP_0000892,,,,,,,,,,,,,,,,,,,,,"A sensation perception where there is an unpleasant sensation that usually indicates the body is threatened or damaged. The sensation may be sharp or dull, short-lived or chronic, intermittent or continual, confined to one area or spread over the entire body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000892,,,,SYMP:0000099,,,,,,,,,,,,,,,SYMP:0000099,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,pain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000028755,TRAC,,,false,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,TRCA|TRA|IMD7|TCRA,,,,,,,14,,,,,,,,,,MIM:186880|HGNC:12029|IMGT/GENE-DB:TRAC,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,T cell receptor alpha constant,,14q11,,,,GO_0005886 (EC: TAS); GO_0016021 (EC: IEA); GO_0031295 (EC: TAS); GO_0050776 (EC: TAS); GO_0050852 (EC: TAS),PMID: 3873654; 3875483; 8188290; 11048639; 11827988; 12429093; 12796775; 15489916; 16079912; 19349973; 19470682; 20965830; 21206088,,,,,,,,,,,,,,,,,,OGG:3000028755,,,,,,,,,,,,,,,,,,,T cell receptor alpha constant,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TRAC,,,20140408,28755,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,TRAC,,"Bin Zhao, Yue Liu, Oliver He",,other,,
http://purl.obolibrary.org/obo/OGG_3000000356,FASLG,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,APTL|CD178|CD95-L|FASL|ALPS1B|APT1LG1|TNFSF6|CD95L,,,,,,,1,,,,,,,,,,Ensembl:ENSG00000117560|HPRD:00610|HGNC:11936|MIM:134638|Vega:OTTHUMG00000034841,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"Fas ligand (TNF superfamily, member 6)",,1q23,,,,"GO_0000122 (EC: IDA, PMID: 17557115); GO_0005102 (EC: TAS, PMID: 7826947); GO_0005125 (EC: IEA); GO_0005164 (EC: IEA); GO_0005515 (EC: IPI, PMID: 12198154); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 18835034); GO_0005634 (EC: IDA, PMID: 17557115); GO_0005887 (EC: TAS, PMID: 7826947); GO_0005901 (EC: IEA); GO_0006351 (EC: IEA); GO_0006915 (EC: TAS); GO_0006919 (EC: IGI, PMID: 19364818); GO_0006919 (EC: IMP, PMID: 18293083); GO_0006919 (EC: TAS); GO_0006925 (EC: IEA); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 7826947); GO_0007267 (EC: TAS, PMID: 7826947); GO_0008284 (EC: IEA); GO_0008625 (EC: IDA, PMID: 18835034); GO_0009897 (EC: IEA); GO_0016525 (EC: IDA, PMID: 18835034); GO_0030644 (EC: IEA); GO_0032496 (EC: IEA); GO_0043065 (EC: IDA, PMID: 14749367); GO_0043123 (EC: IEP, PMID: 12761501); GO_0043202 (EC: IEA); GO_0043525 (EC: IEA); GO_0045742 (EC: IEA); GO_0046666 (EC: IEA); GO_0048388 (EC: IEA); GO_0048471 (EC: IEA); GO_0060205 (EC: IEA); GO_0070062 (EC: IDA, PMID: 17076679); GO_0070231 (EC: IDA, PMID: 17076679); GO_0070266 (EC: IDA, PMID: 11101870); GO_0070848 (EC: IEA); GO_0097190 (EC: IDA, PMID: 11101870); GO_0097190 (EC: TAS); GO_0097191 (EC: IDA); GO_0097527 (EC: IDA, PMID: 11101870); GO_2000353 (EC: IDA, PMID: 18835034); GO_2001239 (EC: TAS)",PMID: 7505205; 7528780; 7530336; 7536190; 7539892; 7566174; 7589480; 7826947; 7980502; 8521815; 8681376; 8787672; 8906799; 8910274; 9002959; 9022072; 9126929; 9215629; 9226175; 9228058; 9247148; 9261095; 9405425; 9427603; 9475352; 9672636; 9721089; 9801169; 9872321; 9920849; 9971775; 10072505; 10224289; 10318773; 10630977; 10671224; 10799864; 11013215; 11036836; 11048727; 11101870; 11208609; 11276204; 11438180; 11500835; 11559749; 11606059; 11716959; 11739488; 11741599; 11751256; 11786482; 11788891; 11801650; 11809905; 11830480; 11845233; 11856352; 11882326; 11895550; 11908702; 11909874; 11925103; 11961305; 11965496; 11994433; 11994542; 12009596; 12021072; 12021310; 12023017; 12100038; 12113885; 12137598; 12161534; 12198154; 12208869; 12220636; 12372468; 12393889; 12414525; 12414956; 12421989; 12454289; 12464266; 12477932; 12482410; 12482505; 12490654; 12507389; 12513781; 12515623; 12557947; 12559631; 12583439; 12594300; 12618758; 12629150; 12637505; 12651606; 12698366; 12700199; 12707034; 12710855; 12717632; 12742662; 12742739; 12753742; 12761501; 12783210; 12787425; 12794109; 12803240; 12807917; 12849704; 12854132; 12867600; 12884192; 12887920; 12918731; 12923319; 12928375; 12930319; 14514471; 14534535; 14560009; 14602201; 14625471; 14634098; 14642527; 14644197; 14668794; 14669310; 14698859; 14705811; 14739003; 14739407; 14739535; 14749367; 14962292; 14967838; 14977837; 14988839; 14996347; 15019279; 15042330; 15073283; 15078178; 15093732; 15138553; 15173177; 15178561; 15183989; 15195700; 15218339; 15240787; 15272306; 15277733; 15287856; 15302589; 15314293; 15337758; 15339846; 15358139; 15457562; 15480896; 15489334; 15492869; 15542843; 15557763; 15579659; 15653751; 15659383; 15674374; 15686714; 15694838; 15791651; 15795317; 15803113; 15806311; 15814666; 15816832; 15833141; 15843521; 15849828; 15858021; 15870081; 15870181; 15907374; 15928037; 15936090; 15937082; 15938782; 15962391; 15968727; 15975999; 15979995; 15991293; 15996722; 16000573; 16081306; 16087126; 16124644; 16133992; 16155003; 16157125; 16157266; 16158329; 16163374; 16181301; 16186185; 16204241; 16212902; 16273638; 16282344; 16298578; 16306044; 16313826; 16318909; 16332967; 16332972; 16364925; 16441482; 16474169; 16487513; 16498403; 16512757; 16514159; 16538171; 16538172; 16595635; 16595663; 16601838; 16627752; 16691186; 16710414; 16736614; 16767155; 16770006; 16808908; 16858424; 16868256; 16902496; 16972019; 16987075; 16990614; 17000697; 17008914; 17014925; 17053166; 17056762; 17071607; 17076679; 17101499; 17118988; 17123522; 17123604; 17136494; 17164290; 17173971; 17183065; 17198275; 17290285; 17381722; 17465232; 17491259; 17545588; 17557115; 17559541; 17564320; 17598974; 17605793; 17654480; 17667919; 17688234; 17703232; 17704118; 17704746; 17727731; 17762757; 17823283; 17853317; 17912957; 17916181; 17938571; 17941899; 17943461; 17961631; 17962219; 17966039; 17969524; 17997887; 18000680; 18045865; 18050226; 18057579; 18068525; 18069935; 18076022; 18078642; 18162459; 18174230; 18217400; 18220834; 18292515; 18293083; 18302883; 18314443; 18316328; 18324486; 18359029; 18361934; 18374107; 18383830; 18392917; 18422813; 18427836; 18473402; 18483392; 18501631; 18505906; 18509086; 18541195; 18548110; 18561948; 18567840; 18577653; 18666137; 18676680; 18727868; 18757527; 18789888; 18800686; 18813857; 18818748; 18835034; 18844072; 18854777; 19009351; 19010354; 19015953; 19019335; 19041431; 19052714; 19079288; 19124506; 19141860; 19146781; 19155494; 19170196; 19176318; 19181929; 19183163; 19219602; 19240174; 19244619; 19266094; 19305072; 19332441; 19337311; 19364818; 19390575; 19403301; 19434529; 19458913; 19505222; 19527514; 19531476; 19535642; 19538867; 19542541; 19565204; 19572057; 19573080; 19614955; 19625176; 19628789; 19641134; 19692168; 19773279; 19779494; 19789190; 19807924; 19810143; 19812265; 19826071; 19854829; 19890662; 19926197; 19937732; 19941645; 19960225; 20012528; 20013612; 20074157; 20101459; 20106900; 20150914; 20165911; 20190752; 20193111; 20204402; 20219325; 20222173; 20237496; 20301287; 20353032; 20359312; 20371612; 20378615; 20379197; 20379614; 20385987; 20393600; 20394629; 20406899; 20408337; 20438363; 20501759; 20533543; 20568250; 20572163; 20602615; 20618494; 20624652; 20650551; 20673483; 20675370; 20726934; 20842669; 20959405; 21087335; 21102463; 21107701; 21122378; 21152963; 21159039; 21227011; 21270445; 21271302; 21285513; 21286777; 21354149; 21368861; 21466843; 21516345; 21528407; 21605112; 21691772; 21725926; 21729539; 21746966; 21803845; 21806408; 21807637; 21808135; 21864388; 21864851; 21879377; 21909273; 21910009; 21940365; 21955608; 22027769; 22161157; 22172872; 22182632; 22199323; 22207003; 22211869; 22330070; 22331638; 22341864; 22344564; 22449797; 22461695; 22499988; 22535954; 22558309; 22609371; 22631677; 22645131; 22702044; 22706245; 22726303; 22732091; 22763913; 22821704; 22842170; 22860894; 22927007; 22946667; 23045958; 23065018; 23076876; 23128233; 23153021; 23177026; 23184030; 23192951; 23234803; 23269121; 23280017; 23285481; 23330016; 23392773; 23405244; 23420824; 23504349; 23534738; 23582102; 23618817; 23681795; 23682624; 23697029; 23923075; 24072745; 24178789; 24184557; 24265545; 24291222,,,,,,,,,,,,,,,,,,OGG:3000000356,,,,,,,,,,,,,,,,,,,"Fas ligand (TNF superfamily, member 6)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FASLG,,,20140408,356,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,FASLG,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0005753,mitochondrial proton-transporting ATP synthase complex,mitochondrial respiratory chain complex V,A proton-transporting ATP synthase complex found in the mitochondrial membrane.,false,,,http://purl.obolibrary.org/obo/GO_0045259|http://purl.obolibrary.org/obo/GO_0098800,,,,,,,,,,,,,,,,,,,,,A proton-transporting ATP synthase complex found in the mitochondrial membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016470,,,,mitochondrial respiratory chain complex V,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0045259|http://purl.obolibrary.org/obo/GO_0098800,,,,GO:0005753,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005753,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitochondrial proton-transporting ATP synthase complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000110,"self-observation
",,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,Intervention,,true,,,,,,Self-monitoring is a personality characteristic that makes an individual pay closer attention to a social situation so that they can change their behaviors to fit that situation., Self-Monitoring,,,,,,,,,,,,,,,"self-observation
",,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000459,digestive system symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,SyOID:5330|UMLS_ICD9CM_2005_AUI:A0284224|UMLS_CUI:C0159058|ICD9CM_2005:787,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Signs and Symptoms of the Digestive system problems,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000459,,modified definition,,,,,,,,,,,,,SYMP:0000459,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,digestive system symptom,,,,,,,,,,,,,,,,,,,,,,http://conditions.health.qld.gov.au/HealthCondition/home/topic/9/189/signs-and-symptoms-of-the-digestive-system,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002795,Functional respiratory abnormality,Functional respiratory abnormality|Abnormal respiration|Respiratory problem,This category describes not-primarily structural lesions.,false,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,,,,,,,,,,Fyler:4200|UMLS:C4025677,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Functional respiratory abnormality|Abnormal respiration,,,,,human_phenotype,,Respiratory problem,,,,,,,Anomaly in the movement of gases into and out of the lung,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This category describes not-primarily structural lesions.,,http://purl.obolibrary.org/obo/HP_0002086,,,,HP:0002795,,,,,,,,,,,,,,,HP:0002795,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Functional respiratory abnormality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046740,"transport of virus in host, cell to cell","spread of virus within host, cell to cell|cell to cell spread of virus within host|viral spread within host, cell to cell|intercellular virus transport|spread of virus in host, cell to cell",The transport of a virus between adjacent cells in a multicellular organism.,false,,,http://purl.obolibrary.org/obo/GO_0046794,,,,,,,,,,,,,,,,,,,,VZ:1018,The transport of a virus between adjacent cells in a multicellular organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"spread of virus within host, cell to cell|cell to cell spread of virus within host|viral spread within host, cell to cell|intercellular virus transport",,,,,biological_process,,"spread of virus in host, cell to cell",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046794,,,,GO:0046740,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0046740,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"transport of virus in host, cell to cell",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051604,protein maturation,,Any process leading to the attainment of the full functional capacity of a protein.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,Any process leading to the attainment of the full functional capacity of a protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0051604,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051604,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,protein maturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006355,CCL8,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MCP-2|SCYA8|MCP2|SCYA10|HC14,,,,,,,17,,,,,,,,,,MIM:602283|HGNC:10635|Vega:OTTHUMG00000132883|Ensembl:ENSG00000108700|HPRD:03791,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 8,,17q11.2,,,,"GO_0004672 (EC: IDA, PMID: 10734056); GO_0005615 (EC: IEA); GO_0006468 (EC: IDA, PMID: 10734056); GO_0006816 (EC: IDA, PMID: 10734056); GO_0006874 (EC: IDA, PMID: 10734056); GO_0006887 (EC: IDA, PMID: 10734056); GO_0006935 (EC: TAS, PMID: 9468473); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 9119400); GO_0007267 (EC: IDA, PMID: 10734056); GO_0008009 (EC: IEA); GO_0008201 (EC: IEA); GO_0009615 (EC: TAS, PMID: 9468473); GO_0016004 (EC: IDA, PMID: 10734056); GO_0043085 (EC: IDA, PMID: 10734056); GO_0060326 (EC: TAS, PMID: 9468473)",PMID: 1613466; 2518726; 8189067; 8661057; 8898111; 9005985; 9070881; 9115216; 9119400; 9405404; 9468473; 9558113; 9730840; 10477718; 10734056; 10734104; 11083865; 11087354; 12149192; 12477932; 12539042; 13679391; 14647058; 15489334; 15607028; 15644410; 17487826; 17703412; 18256320; 18602166; 18636124; 18660381; 18684849; 18818748; 18835932; 19019335; 19224633; 19258923; 19415413; 19423540; 19527514; 19865101; 20056178; 20181935; 20406964; 20438785; 20503287; 21220697; 21514686; 21945122; 22412388; 22987449; 23418602,,,,,,,,,,,,,,,,,,OGG:3000006355,,,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 8,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCL8,,,20140408,6355,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CCL8,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0034404,nucleobase-containing small molecule biosynthetic process,"nucleobase, nucleoside and nucleotide synthesis|nucleobase, nucleoside and nucleotide biosynthesis|nucleobase, nucleoside and nucleotide anabolism|nucleobase, nucleoside and nucleotide formation","The chemical reactions and pathways resulting in the formation of a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"nucleobase, nucleoside and nucleotide synthesis|nucleobase, nucleoside and nucleotide biosynthesis|nucleobase, nucleoside and nucleotide anabolism|nucleobase, nucleoside and nucleotide formation",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0034404,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034404,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nucleobase-containing small molecule biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0040218,Reduced natural killer cell count,Reduced NK cell number|Reduced natural killer cell number,"Less than normal number of natural killer cells, a type of lymphocyte in the innate immune system with an ability to mediate cytotoxicity and produce cytokines after the ligation of a germline-encoded activation receptor.",false,,,http://purl.obolibrary.org/obo/HP_0040089,,,,,,,,,,,,,,,,,,,,UMLS:C1855767,"Less than normal number of natural killer cells, a type of lymphocyte in the innate immune system with an ability to mediate cytotoxicity and produce cytokines after the ligation of a germline-encoded activation receptor.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Reduced NK cell number|Reduced natural killer cell number,,,,,,,,,,,,,HP:0040218,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0040089,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Reduced natural killer cell count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000925,CD8A,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CD8|MAL|Leu2|p32,,,,,,,2,,,,,,,,,,HGNC:1706|Vega:OTTHUMG00000130265|Ensembl:ENSG00000153563|MIM:186910|HPRD:01737,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,CD8a molecule,,2p12,,,,"GO_0002456 (EC: IEA); GO_0005515 (EC: IPI, PMID: 2470098); GO_0005576 (EC: IEA); GO_0005886 (EC: TAS); GO_0005887 (EC: NAS, PMID: 2496167); GO_0006955 (EC: NAS, PMID: 11131152); GO_0007169 (EC: NAS, PMID: 9830036); GO_0009897 (EC: IDA, PMID: 17213291); GO_0015026 (EC: NAS, PMID: 11131152); GO_0019882 (EC: NAS, PMID: 2496167); GO_0019901 (EC: IEA); GO_0042101 (EC: NAS, PMID: 11131152); GO_0042110 (EC: NAS, PMID: 9830036); GO_0042288 (EC: NAS, PMID: 11131152); GO_0042803 (EC: IEA); GO_0045065 (EC: IEA); GO_0050776 (EC: TAS); GO_0050850 (EC: IEA); GO_0051607 (EC: IEA)",PMID: 1377690; 1541829; 1547508; 1676132; 1831127; 1834739; 1908512; 2470098; 2493728; 2496167; 2509342; 2536941; 2701945; 2877435; 3145195; 3871356; 3918796; 3936473; 6440142; 6605969; 8127870; 9177355; 9331948; 9366416; 9550407; 9790534; 9804427; 9830036; 10022843; 10444591; 10490978; 10562325; 10623829; 10809759; 10843658; 11102443; 11131152; 11140838; 11251883; 11435463; 11729321; 11914379; 11937547; 12124384; 12215456; 12477932; 12594841; 12899833; 14500983; 14559993; 14702039; 15078895; 15927673; 15975922; 16344560; 16354571; 16454711; 16818755; 16821115; 17213291; 17658607; 17678538; 17950725; 18089323; 18156204; 18398508; 18418773; 18483277; 18625635; 18650384; 18695005; 18833003; 18956469; 19149577; 19751272; 19752186; 19768696; 20053942; 20237496; 20644117; 20682852; 20704820; 20850477; 21142701; 21257970; 21430066; 21518761; 21543478; 21645925; 21813446; 21818290; 21936714; 21948982; 21954283; 21988832; 22001684; 22013062; 22045731; 22103833; 22143984; 22175768; 22185976; 22345473; 22551306; 22811543; 22844345; 23185362; 23225889; 23363813; 23400868; 23640800; 23878500; 24047902; 24297179,,,,,,,,,,,,,,,,,,OGG:3000000925,,,,,,,,,,,,,,,,,,,CD8a molecule,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD8A,,,20140408,925,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CD8A,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0048608,reproductive structure development,,"The reproductive developmental process whose specific outcome is the progression of structures that will be used in the process of creating new individuals from one or more parents, from their formation to the mature structures.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The reproductive developmental process whose specific outcome is the progression of structures that will be used in the process of creating new individuals from one or more parents, from their formation to the mature structures.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0048608,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048608,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,reproductive structure development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IDO_0000593,transmission period,,A continuous temporal interval during which a transmission process occurs.,false,,,http://purl.obolibrary.org/obo/BFO_0000038,,,,,,,,,,,,,,,,,,,,,A continuous temporal interval during which a transmission process occurs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IDO:0000593,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000038,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/32194239,,incubation period,,,,http://purl.obolibrary.org/obo/ido.owl,,,,,,,,,,,transmission period,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain|Alexander Diehl|Lindsay Cowell,,,,
http://purl.obolibrary.org/obo/CHEBI_145999,cinanserin,(2E)-N-(2-{[3-(dimethylamino)propyl]sulfanyl}phenyl)-3-phenylprop-2-enamide|cinanserina|cinanserinum|cinanserine|cinanserin,An aryl sulfide that is (2E)-3-phenyl-N-(2-sulfanylphenyl)prop-2-enamide in which the hydrogen of the thiol group is substituted by a 3-(dimethylamino)propyl group. It is a 5-hydroxytryptamine receptor antagonist and an inhibitor of SARS-CoV replication.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:1178659|PMID:5348442|PMID:4776363|PMID:4725521|PMID:4939050|PMID:4946100|PMID:4254977|PMID:23131569|PMID:26851778|PMID:5409554|CAS:1166-34-3|PMID:30417783|PMID:1301238|PMID:7667390|PMID:142996|PMID:23523219|Wikipedia:Cinanserin|PMID:3237811|PMID:4929084|PMID:24971515|PMID:15890949|PMID:18827378,An aryl sulfide that is (2E)-3-phenyl-N-(2-sulfanylphenyl)prop-2-enamide in which the hydrogen of the thiol group is substituted by a 3-(dimethylamino)propyl group. It is a 5-hydroxytryptamine receptor antagonist and an inhibitor of SARS-CoV replication.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,(2E)-N-(2-{[3-(dimethylamino)propyl]sulfanyl}phenyl)-3-phenylprop-2-enamide,,,,,chebi_ontology,,cinanserina|cinanserinum|cinanserine|cinanserin,,,,,,,,,0,C20H24N2OS,"InChI=1S/C20H24N2OS/c1-22(2)15-8-16-24-19-12-7-6-11-18(19)21-20(23)14-13-17-9-4-3-5-10-17/h3-7,9-14H,8,15-16H2,1-2H3,(H,21,23)/b14-13+",RSUVYMGADVXGOU-BUHFOSPRSA-N,340.490,340.16093,C=1(C=CC=CC1NC(=O)/C=C/C=2C=CC=CC2)SCCCN(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:145999,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:145999,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,cinanserin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006612,protein targeting to membrane,protein membrane targeting|protein-membrane targeting,"The process of directing proteins towards a membrane, usually using signals contained within the protein.",false,,,http://purl.obolibrary.org/obo/GO_0090150|http://purl.obolibrary.org/obo/GO_0006605,,,,,,,,,,,,,,,,,,,,,"The process of directing proteins towards a membrane, usually using signals contained within the protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein membrane targeting|protein-membrane targeting,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0090150|http://purl.obolibrary.org/obo/GO_0006605,,,,GO:0006612,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006612,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein targeting to membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019076,viral release from host cell,viral exit|release of virus from host|virus exit from host cell|viral release|viral shedding,"The dissemination of mature viral particles from the host cell, e.g. by cell lysis or the budding of virus particles from the cell membrane.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,VZ:1076,"The dissemination of mature viral particles from the host cell, e.g. by cell lysis or the budding of virus particles from the cell membrane.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral exit|release of virus from host|virus exit from host cell|viral release|viral shedding,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019076,,,,,,true,,,,true,,,,,GO:0019076,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral release from host cell,,,,,,,,,,,,,,,,,,,,,,https://www.antibodies-online.com/resources/18/5410/sars-cov-2-life-cycle-stages-and-inhibition-targets/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_285947,SARS coronavirus civet014,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:285947,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus civet014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006237,RRAS,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,19,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,related RAS viral (r-ras) oncogene homolog,,19q13.33,,,,"GO_0003924 (EC: IDA, PMID: 16773572); GO_0005515 (EC: IPI, PMID: 17474147); GO_0005525 (EC: IEA); GO_0005886 (EC: TAS); GO_0007265 (EC: TAS, PMID: 3098437); GO_0007268 (EC: TAS); GO_0007411 (EC: TAS); GO_0019003 (EC: IDA, PMID: 16773572); GO_0030336 (EC: IEA); GO_0032403 (EC: IDA); GO_0045766 (EC: IMP); GO_0070062 (EC: IDA, PMID: 19056867)",PMID: 3098437; 7761092; 7809086; 8232588; 10224125; 10412982; 10570155; 10671570; 10713701; 10777492; 10848612; 11042683; 11560935; 11857081; 12386818; 12477932; 12529399; 12548599; 12620389; 12890755; 15031288; 15242332; 15297673; 15489334; 15525681; 16537651; 16754664; 16773572; 16914723; 17107957; 17163575; 17474147; 17664272; 18624398; 19011236; 19056867; 19116136; 19805522; 19843518; 20385769; 20585650; 21139048; 21390152; 21660952; 21674799; 21906983; 21987572; 21988832; 22897853; 23000965; 23209424,,,,,,,,,,,,,,,,,,OGG:3000006237,,,,,,,,,,,,,,,,,,,related RAS viral (r-ras) oncogene homolog,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,RRAS,,,20140408,6237,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,RRAS,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0030683,mitigation of host immune response by virus,suppression by virus of host extracellular antiviral response|suppression of host intracellular antiviral response by virus|suppression of host extracellular antiviral response by virus|negative regulation by virus of intracellular antiviral response|inhibition of extracellular antiviral response|mitigation by virus of host immune response|viral inhibition of intracellular antiviral response|negative regulation by virus of extracellular antiviral response|negative regulation of host extracellular antiviral response by virus|negative regulation of host intracellular antiviral response by virus|suppression by virus of host intracellular antiviral response|suppression by virus of host immune response|evasion by virus of host immune response|evasion or tolerance by virus of host immune response,A process by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.,false,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,A process by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019052|GO:0019053,,,,suppression by virus of host extracellular antiviral response|suppression of host intracellular antiviral response by virus|suppression of host extracellular antiviral response by virus|negative regulation by virus of intracellular antiviral response|inhibition of extracellular antiviral response|mitigation by virus of host immune response|viral inhibition of intracellular antiviral response|negative regulation by virus of extracellular antiviral response|negative regulation of host extracellular antiviral response by virus|negative regulation of host intracellular antiviral response by virus|suppression by virus of host intracellular antiviral response,,,suppression by virus of host immune response|evasion by virus of host immune response,,biological_process,,evasion or tolerance by virus of host immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0030683,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145538/,,,,GO:0030683,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitigation of host immune response by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_237640,SARS coronavirus Taiwan TC2,SARS coronavirus TC2,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus TC2,,,,,,NCBITaxon:237640,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Taiwan TC2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039649,modulation by virus of host ubiquitin-protein ligase activity,modulation of host E3 ubiquitin ligases by virus,The process in which a virus effects a change in host ubiquitin-protein ligase activity. Ubiquitin-protein ligase activity catalyzes the reaction: ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine.,false,,,http://purl.obolibrary.org/obo/GO_0039648|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2012-10-09T15:26:56Z,,,,The process in which a virus effects a change in host ubiquitin-protein ligase activity. Ubiquitin-protein ligase activity catalyzes the reaction: ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,modulation of host E3 ubiquitin ligases by virus,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039648|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039649,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/27519799,,,,GO:0039649,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host ubiquitin-protein ligase activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0080600,COVID-19,2019 Novel Coronavirus (2019-nCoV)|Wuhan coronavirus infection|Wuhan seafood market pneumonia virus infection|2019-nCoV infection,"A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.",false,,,http://purl.obolibrary.org/obo/DOID_0080599,,,,,,,,,,,,,,,,,,,,,"A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2019 Novel Coronavirus (2019-nCoV)|Wuhan coronavirus infection|Wuhan seafood market pneumonia virus infection|2019-nCoV infection,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0080599,,,,DOID:0080600,,,,,,true,,,,,,,SARS-CoV-2 infection,,DOID:0080600,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,COVID-19,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046434,organophosphate catabolic process,organophosphate breakdown|organophosphate catabolism|organophosphate degradation,"The chemical reactions and pathways resulting in the breakdown of organophosphates, any phosphate-containing organic compound.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of organophosphates, any phosphate-containing organic compound.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,organophosphate breakdown|organophosphate catabolism|organophosphate degradation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0046434,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046434,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,organophosphate catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0036019,endolysosome,,"An transient hybrid organelle formed by fusion of a late endosome with a lysosome, and in which active degradation takes place.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,rfoulger,2011-10-13T02:35:13Z,,,,"An transient hybrid organelle formed by fusion of a late endosome with a lysosome, and in which active degradation takes place.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0036019,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0036019,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endolysosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046786,viral replication complex formation and maintenance,,The process of organizing and assembling viral replication proteins in preparation for viral replication.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,The process of organizing and assembling viral replication proteins in preparation for viral replication.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0046786,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32149036,,,,GO:0046786,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral replication complex formation and maintenance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000794,condensed nuclear chromosome,nuclear mitotic chromosome|meiotic chromosome,A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct nuclear chromosome.|Note that this term and its children can be used to annotate gene products that localize to a mitotic chromosome in an organism that undergoes a 'closed mitosis' in which the nuclear envelope does not break down during mitosis and for gene products that localize to a meiotic chromosome.,false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0000793,,,,,,,,,,,,,,,,,,,,,A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct nuclear chromosome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,nuclear mitotic chromosome|meiotic chromosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term and its children can be used to annotate gene products that localize to a mitotic chromosome in an organism that undergoes a 'closed mitosis' in which the nuclear envelope does not break down during mitosis and for gene products that localize to a meiotic chromosome.,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0000793,,,,GO:0000794,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000794,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,condensed nuclear chromosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098997,fusion of virus membrane with host outer membrane,viral penetration via membrane fusion|viral envelope fusion|viral envelope fusion with host outer membrane|fusion of viral membrane with host outer membrane|viral-cell fusion molecule activity,Fusion of a viral membrane with the host cell outer membrane during viral entry.,false,,,http://purl.obolibrary.org/obo/GO_0039663,,,,,,,,,,,,,,,,,,,,VZ:3941,Fusion of a viral membrane with the host cell outer membrane during viral entry.,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral penetration via membrane fusion|viral envelope fusion,,,viral envelope fusion with host outer membrane,,,,,biological_process,,fusion of viral membrane with host outer membrane|viral-cell fusion molecule activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039663,,,,GO:0098997,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32142651,,,,GO:0098997,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,fusion of virus membrane with host outer membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006605,protein targeting,protein sorting along secretory pathway|nascent polypeptide association,"The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif.|Note that protein targeting encompasses the transport of the protein to the specified location, and may also include additional steps such as protein processing.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Protein_targeting,"The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein sorting along secretory pathway,,biological_process,,nascent polypeptide association,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that protein targeting encompasses the transport of the protein to the specified location, and may also include additional steps such as protein processing.",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006605,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006605,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,protein targeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000028992,MACROD1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LRP16,,,,,,,11,,,,,,,,,,Ensembl:ENSG00000133315|Vega:OTTHUMG00000167843|MIM:610400|HGNC:29598|HPRD:17448,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,MACRO domain containing 1,,11q11,,,,"GO_0005515 (EC: IPI, PMID: 17914104); GO_0005634 (EC: IDA); GO_0005739 (EC: IEA); GO_0006974 (EC: IMP); GO_0016798 (EC: IDA); GO_0019213 (EC: IDA); GO_0042278 (EC: IDA); GO_0051725 (EC: IDA)",PMID: 12107411; 12477932; 12578638; 12790785; 15489334; 15691879; 16368544; 16831279; 17532767; 17914104; 19022849; 19403568; 19698216; 19824120; 19840441; 19958623; 20035625; 20355243; 21483817; 23824909,,,,,,,,,,,,,,,,,,OGG:3000028992,,,,,,,,,,,,,,,,,,,MACRO domain containing 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,MACROD1,,,20140408,28992,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,MACROD1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_65408,andrographolide,"(3E,4S)-4-hydroxy-3-{2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one|(1R-(1-alpha(E(S)),4abeta,5alpha,6alpha,8aalpha))-3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-2(3H)-furanone|3alpha,14,15,18-tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic acid gamma-Lactone|3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl)ethylidene)dihydro-4-hydroxyfuran-2(3H)-one","A labdane diterpenoid isolated from the leaves and roots of Andrographis paniculata that exhibits anti-HIV, anti-inflammatory and antineoplastic properties.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22858223|PMID:19110075|Patent:EP2411004|KEGG:C20214|Reaxys:5609598|Patent:CN102397273|Wikipedia:Andrographolide|CAS:5508-58-7|PMID:18464090|PMID:22512591|PMID:22026410|PMID:15894448,"A labdane diterpenoid isolated from the leaves and roots of Andrographis paniculata that exhibits anti-HIV, anti-inflammatory and antineoplastic properties.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(3E,4S)-4-hydroxy-3-{2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one",,,,,chebi_ontology,,"(1R-(1-alpha(E(S)),4abeta,5alpha,6alpha,8aalpha))-3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-2(3H)-furanone|3alpha,14,15,18-tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic acid gamma-Lactone|3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl)ethylidene)dihydro-4-hydroxyfuran-2(3H)-one",,,,,,,,,0,C20H30O5,"InChI=1S/C20H30O5/c1-12-4-7-16-19(2,9-8-17(23)20(16,3)11-21)14(12)6-5-13-15(22)10-25-18(13)24/h5,14-17,21-23H,1,4,6-11H2,2-3H3/b13-5+/t14-,15-,16+,17-,19+,20+/m1/s1",BOJKULTULYSRAS-OTESTREVSA-N,350.44920,350.20932,[H][C@]12CCC(=C)[C@@H](CC=C3/[C@H](O)COC3=O)[C@]1(C)CC[C@@H](O)[C@@]2(C)CO,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:65408,,,,,,true,,,,,,,,,CHEBI:65408,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,andrographolide,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_5295,intestinal disease,,A gastrointestinal system disease that is located_in the intestine.,false,,,http://purl.obolibrary.org/obo/DOID_77,,,,,,,,,,,,,,,,,,,,NCI:C26801|MESH:D007410|ICD9CM:569.9|SNOMEDCT_US_2019_09_01:85919009|ICD10CM:K63.9|UMLS_CUI:C0021831,A gastrointestinal system disease that is located_in the intestine.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:8591|DOID:8558|DOID:10759|DOID:11222|DOID:11789|DOID:8531,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_77,,,,DOID:5295,,,,,,,,,,,,,,,DOID:5295,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,intestinal disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000023,blood chemistry measurement,,A quantification of a parameter of the chemical composition of blood.,false,,,http://purl.obolibrary.org/obo/CMO_0000035,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000023,,,,,,,,,,,,A quantification of a parameter of the chemical composition of blood.,,,,,,,,,,,,blood molecular composition measurement,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000035,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,blood chemistry measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_11394,adult respiratory distress syndrome,ARDS|Shock lung|Non-cardiogenic pulmonary edema|adult RDS,"A respiratory failure that results from diffuse injury to the endothelium of the lung (as in sepsis, chest trauma, massive blood transfusion, aspiration of the gastric contents, or pneumonia) and is characterized by pulmonary edema with an abnormally high amount of protein in the edematous fluid and by difficult rapid breathing and hypoxemia.|PRISM.",false,,,http://purl.obolibrary.org/obo/DOID_11162,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:67782005|UMLS_CUI:C0035222|NCI:C3353|MESH:D012128|ICD10CM:J80|GARD:5698,"A respiratory failure that results from diffuse injury to the endothelium of the lung (as in sepsis, chest trauma, massive blood transfusion, aspiration of the gastric contents, or pneumonia) and is characterized by pulmonary edema with an abnormally high amount of protein in the edematous fluid and by difficult rapid breathing and hypoxemia.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ARDS|Shock lung|Non-cardiogenic pulmonary edema|adult RDS,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,PRISM.,,http://purl.obolibrary.org/obo/DOID_11162,,,,DOID:11394,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203709|https://www.ncbi.nlm.nih.gov/pubmed/?term=32113704,,acute respiratory distress syndrome,,DOID:11394,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,adult respiratory distress syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075733,intracellular transport of virus,movement of virus within host cell|intracellular transport of viral material|viral genome transport in host cell|egress of virus within host cell|viral egress|intracellular virion transport,"The directed movement of a virus, or part of a virus, within the host cell.",false,,,http://purl.obolibrary.org/obo/GO_0046794,,,,,,,,,,,,,,,,jane,2009-05-01T04:01:33Z,,,,"The directed movement of a virus, or part of a virus, within the host cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046795|GO:0046788|GO:0046796,,,,movement of virus within host cell|intracellular transport of viral material|viral genome transport in host cell|egress of virus within host cell,,,,,biological_process,,viral egress|intracellular virion transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046794,,,,GO:0075733,,,,,,true,,,,true,,,,,GO:0075733,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,intracellular transport of virus,,,,,,,,,,,,,,,,,,,,,,https://www.nature.com/articles/s41564-020-0688-y,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_63452,midostaurin,"N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide|CGP-41251|midostaurin|PKC 412|CGP 41251|4'-N-benzoylstaurosporine|PKC412|benzoylstaurosporine",An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D05029|Reaxys:7345336|CAS:120685-11-2|LINCS:LSM-2287|Wikipedia:Midostaurin|PMID:20980353,An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide",,,,,chebi_ontology,,CGP-41251|midostaurin|PKC 412|CGP 41251|4'-N-benzoylstaurosporine|PKC412|benzoylstaurosporine,,,,,,,,,0,C35H30N4O4,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",BMGQWWVMWDBQGC-IIFHNQTCSA-N,570.63710,570.22671,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:63452,,,,,,true,,,,,,,,,CHEBI:63452,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,midostaurin,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_615,leukopenia,Leucopenia,"A leukocyte disorder that is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.",false,,,http://purl.obolibrary.org/obo/DOID_9500,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0023530|SNOMEDCT_US_2019_09_01:84828003|ICD9CM:288.50|MESH:D007970|ICD10CM:D72.819,"A leukocyte disorder that is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Leucopenia,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_9500,,,,DOID:615,,,,,,true,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32112884|https://www.ncbi.nlm.nih.gov/pubmed/31986264,,,,DOID:615,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,leukopenia,,,,,,,,,,,,,,,,,,,,,,https://doi.org/10.1101/2020.02.06.20020974/,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_5855,ibuprofen,Ibuprofen|2-[4-(2-methylpropyl)phenyl]propanoic acid|Urem|Butylenin|Apsifen|2-(4-isobutylphenyl)propanoic acid|alpha-(4-isobutylphenyl)propionic acid|Ibumetin|Medipren|Motrin|alpha-(p-isobutylphenyl)propionic acid|Mynosedin|Inabrin|Roidenin|Dolo-Dolgit|Liptan|(4-isobutylphenyl)-alpha-methylacetic acid|Nurofen|Nobfen|(+-)-p-isobutylhydratropic acid|(+-)-2-(p-isobutylphenyl)propionic acid|Epobron|Femadon|Ibutid|Dolgit|Trendar|Amibufen|Nuprin|(+-)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acid|Anflagen|Adran|Bluton|Nobgen|Ebufac|Brufen|(RS)-ibuprofen|Ibuprocin|Lamidon|Anco|Ibu-Attritin|Dolgin|Inoven|Haltran|Brufort|Advil|Seclodin|Buburone|Suspren|(+-)-ibuprofen|Rufen|4-isobutylhydratropic acid|Tabalon|Pediaprofen|Dolgirid|Lebrufen,A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:GB971700|HMDB:HMDB0001925|DrugBank:DB01050|Beilstein:2049713|KEGG:C01588|CAS:15687-27-1|Drug_Central:1407|PMID:25708941|PMID:16176022|PMID:18697608|PMID:21368281|PMID:18335846|Patent:US5215755|PMID:15506544|Patent:US3385886|Reaxys:2049713|PMID:24168233|PMID:25915907|KEGG:D00126|PMID:12723739|PMID:29756342|PMID:14562167|PMID:11433218|LINCS:LSM-1354|Patent:US6727286|Wikipedia:Ibuprofen|Patent:US3228831,A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Ibuprofen|2-[4-(2-methylpropyl)phenyl]propanoic acid,,,,,chebi_ontology,,Urem|Butylenin|Apsifen|2-(4-isobutylphenyl)propanoic acid|alpha-(4-isobutylphenyl)propionic acid|Ibumetin|Medipren|Motrin|alpha-(p-isobutylphenyl)propionic acid|Mynosedin|Inabrin|Roidenin|Dolo-Dolgit|Liptan|(4-isobutylphenyl)-alpha-methylacetic acid|Nurofen|Nobfen|(+-)-p-isobutylhydratropic acid|(+-)-2-(p-isobutylphenyl)propionic acid|Epobron|Femadon|Ibutid|Dolgit|Trendar|Amibufen|Nuprin|(+-)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acid|Anflagen|Adran|Bluton|Nobgen|Ebufac|Brufen|(RS)-ibuprofen|Ibuprocin|Lamidon|Anco|Ibu-Attritin|Dolgin|Inoven|Haltran|Brufort|Advil|Seclodin|Buburone|Suspren|(+-)-ibuprofen|Rufen|4-isobutylhydratropic acid|Tabalon|Pediaprofen|Dolgirid|Lebrufen,,,,,,,,,0,C13H18O2,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",HEFNNWSXXWATRW-UHFFFAOYSA-N,206.28082,206.13068,CC(C)Cc1ccc(cc1)C(C)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:5855,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32256706,,,,CHEBI:5855,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ibuprofen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2497569,Negarnaviricota,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_phylum,,,,,,,NCBITaxon:2497569,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Negarnaviricota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PATO_0001415,morbidity,,A quality inhering in a population by virtue of the proportion of its members that are ill at a given time.,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,A quality inhering in a population by virtue of the proportion of its members that are ill at a given time.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,quality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,PATO:0001415,,,,,,true,,,,,,,,,PATO:0001415,,http://purl.obolibrary.org/obo/pato.owl,http://purl.oboInOwllibrary.org/oboInOwl/pato#attribute_slim|http://purl.oboInOwllibrary.org/oboInOwl/pato#scalar_slim,,,,,,,,,,morbidity,,,,,,,,,,,,,,,,,,,,,,https://erj.ersjournals.com/content/early/2020/03/17/13993003.00547-2020,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006372,CXCL6,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,GCP-2|GCP2|SCYB6|CKA-3,,,,,,,4,,,,,,,,,,Ensembl:ENSG00000124875|HGNC:10643|MIM:138965|Vega:OTTHUMG00000130010|HPRD:00735,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 6,,4q13.3,,,,"GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006935 (EC: TAS, PMID: 9164944); GO_0006954 (EC: TAS, PMID: 8399143); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 9164944); GO_0007267 (EC: TAS, PMID: 9164944); GO_0008009 (EC: IEA); GO_0008201 (EC: IEA); GO_0060326 (EC: TAS, PMID: 8399143)",PMID: 8399143; 8423327; 9057843; 9164944; 9465307; 9692902; 10343098; 10593335; 12477932; 12524079; 12533683; 12591113; 12628493; 12882792; 12950257; 15214047; 15342556; 15489334; 15652347; 15815621; 17022986; 17703412; 17827342; 18240029; 18443119; 18563170; 18577758; 18782286; 18842116; 19240061; 19258923; 19369450; 20503287; 20507572; 20628624; 21236563; 22886775; 23128233; 23814098,,,,,,,,,,,,,,,,,,OGG:3000006372,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 6,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCL6,,,20140408,6372,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CXCL6,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000000708,C1QBP,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,gC1qR|GC1QBP|SF2p32|gC1Q-R|HABP1|p32,,,,,,,17,,,,,,,,,,Vega:OTTHUMG00000177875|HGNC:1243|MIM:601269|HPRD:03168|Ensembl:ENSG00000108561,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"complement component 1, q subcomponent binding protein",,17p13.3,,,,"GO_0000122 (EC: IDA, PMID: 15243141); GO_0001849 (EC: IDA, PMID: 8195709); GO_0003714 (EC: IDA, PMID: 15243141); GO_0003729 (EC: ISS); GO_0005080 (EC: IEA); GO_0005515 (EC: IPI, PMID: 10831594); GO_0005540 (EC: IDA, PMID: 8567680); GO_0005615 (EC: IEA); GO_0005634 (EC: IDA, PMID: 15243141); GO_0005730 (EC: IEA); GO_0005737 (EC: ISS); GO_0005739 (EC: IDA, PMID: 19164550); GO_0005759 (EC: IEA); GO_0005829 (EC: IDA, PMID: 15243141); GO_0005886 (EC: TAS); GO_0006351 (EC: IEA); GO_0006397 (EC: IEA); GO_0006915 (EC: IEA); GO_0006955 (EC: TAS, PMID: 8195709); GO_0006958 (EC: IEA); GO_0007596 (EC: TAS); GO_0007597 (EC: TAS); GO_0008134 (EC: IDA, PMID: 15243141); GO_0008380 (EC: IEA); GO_0009986 (EC: IDA, PMID: 17881511); GO_0014065 (EC: IMP, PMID: 16177118); GO_0016020 (EC: IDA, PMID: 11290596); GO_0016032 (EC: IEA); GO_0030449 (EC: IDA, PMID: 8195709); GO_0030984 (EC: IDA, PMID: 8662673); GO_0031690 (EC: ISS); GO_0032689 (EC: IDA, PMID: 17881511); GO_0032695 (EC: IDA, PMID: 16177118); GO_0039534 (EC: IDA, PMID: 19164550); GO_0039536 (EC: IDA, PMID: 19164550); GO_0042256 (EC: IMP); GO_0043065 (EC: IMP, PMID: 15031724); GO_0045087 (EC: IEA); GO_0045785 (EC: IMP); GO_0048025 (EC: IDA, PMID: 10022843); GO_0050687 (EC: IMP, PMID: 19164550); GO_0051897 (EC: IMP, PMID: 16177118); GO_0070131 (EC: ISS); GO_0090023 (EC: IDA, PMID: 9461517); GO_0097177 (EC: ISS); GO_1900026 (EC: IMP, PMID: 11859136); GO_1901165 (EC: IMP); GO_2000510 (EC: IMP, PMID: 16140380)",PMID: 1830244; 2372546; 7778269; 8189522; 8195709; 8262387; 8567680; 8626563; 8662673; 8710908; 9284938; 9461517; 9721222; 10022843; 10097078; 10747014; 10823864; 10831594; 11278463; 11290596; 11350968; 11549288; 11773076; 11859136; 11866440; 11870091; 12220632; 12443542; 12477932; 12538033; 12574814; 12833064; 14559993; 14583623; 14667819; 15031724; 15163734; 15231747; 15243141; 15324660; 15467913; 15489334; 16039650; 16140380; 16164755; 16177118; 16196087; 16212417; 16455055; 16537587; 16641292; 16713569; 16721827; 16871385; 16893067; 17314511; 17620012; 17620599; 17676665; 17881511; 17892212; 17907801; 17979178; 18172692; 18358546; 18460468; 18538737; 18676636; 18757437; 18781797; 19004836; 19149558; 19164550; 19190731; 19423540; 19454010; 19473882; 19523114; 19565630; 19608861; 19710015; 19738201; 19828637; 19836239; 19913121; 20020773; 20100866; 20186120; 20360068; 20406964; 20438785; 20617170; 20628086; 20877624; 21081666; 21139048; 21145461; 21156793; 21205079; 21248045; 21536672; 21536856; 21559373; 21627988; 21725590; 21726808; 21890473; 21906983; 21988832; 22008525; 22101277; 22114354; 22118674; 22145905; 22268729; 22354994; 22451658; 22700724; 22771308; 22863883; 22904065; 22939629; 22952844; 22960332; 23246001; 23378602; 23402259; 23438482; 23455922; 23667531; 23692256; 23798571; 23929393; 24174616; 24244333; 24250222; 24255178; 24457600,,,,,,,,,,,,,,,,,,OGG:3000000708,,,,,,,,,,,,,,,,,,,"complement component 1, q subcomponent binding protein",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,C1QBP,,,20140408,708,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,C1QBP,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0032970,regulation of actin filament-based process,,"Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the actin cytoskeleton.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the actin cytoskeleton.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0032970,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032970,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of actin filament-based process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C142470,Data Capture,data capture|Data Capture,The process by which data is collected de novo from the source.,false,,,http://purl.obolibrary.org/obo/IAO_0000027,,See data entry.,,,,,,,,,C142470,,,CDISC-GLOSS,,,,,,,The process by which data is collected de novo from the source.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,data capture|Data Capture,,,,,,,,,,,,,NCIT:C142470,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410,,,,,,,,,,Data Capture,,,,,,,CL540449,,,,,,,,,,,,Data Capture,,,https://www.scandit.com/industries/healthcare/covid-19-app/,Activity,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901216,positive regulation of neuron death,upregulation of neuron cell death|up regulation of neuron cell death|upregulation of neuronal cell death|up-regulation of neuronal cell death|up-regulation of neuron cell death|up regulation of neuron death|positive regulation of neuron cell death|positive regulation of neuronal cell death|up-regulation of neuron death|upregulation of neuron death|up regulation of neuronal cell death|activation of neuron death|activation of neuronal cell death|activation of neuron cell death,"Any process that activates or increases the frequency, rate or extent of neuron death.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,rph,2012-08-02T09:58:15Z,,,,"Any process that activates or increases the frequency, rate or extent of neuron death.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of neuron cell death|up regulation of neuron cell death|upregulation of neuronal cell death|up-regulation of neuronal cell death|up-regulation of neuron cell death|up regulation of neuron death|positive regulation of neuron cell death|positive regulation of neuronal cell death|up-regulation of neuron death|upregulation of neuron death|up regulation of neuronal cell death,,,activation of neuron death|activation of neuronal cell death|activation of neuron cell death,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1901216,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901216,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of neuron death,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039652,activation by virus of host NF-kappaB transcription factor activity,activation of host NF-kappa-B by virus,"Any process in which a virus starts, promotes, or enhances the activity of the host transcription factor NF-kappaB.",false,,,http://purl.obolibrary.org/obo/GO_0039656|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2012-10-11T16:04:31Z,,,VZ:841,"Any process in which a virus starts, promotes, or enhances the activity of the host transcription factor NF-kappaB.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,activation of host NF-kappa-B by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039656|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039652,,,,,,true,,,,true,,,,,GO:0039652,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,activation by virus of host NF-kappaB transcription factor activity,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0099008,viral entry via permeabilization of inner membrane,viral penetration via permeabilization of host membrane,"The entry of a non-enveloped virus into the cytoplasm of a host prokaryotic cell, following fusion with the outer membrane, via permeabilization of the plasma (inner) membrane.  In the case of some double stranded RNA viruses of prokaryotes this occurs via interaction of a membrane-interacting component of the capsid, leading to depolarization an permeabilization of the plasma membrane.",false,,,http://purl.obolibrary.org/obo/GO_0140267,,,,,,,,,,,,,,,,,,,,VZ:985,"The entry of a non-enveloped virus into the cytoplasm of a host prokaryotic cell, following fusion with the outer membrane, via permeabilization of the plasma (inner) membrane.  In the case of some double stranded RNA viruses of prokaryotes this occurs via interaction of a membrane-interacting component of the capsid, leading to depolarization an permeabilization of the plasma membrane.",,,,,,,,,,,,,,,,,,,,,,,,,,,,viral penetration via permeabilization of host membrane,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0140267,,,,GO:0099008,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32236561,,,,GO:0099008,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral entry via permeabilization of inner membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9613,tolazamide,"N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide|U-17835|4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide|BRN 1323565|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Norglycin|EINECS 214-588-3|tolazamide|1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea|1-(hexahydro-1-azepinyl)-3-p-tolylsulfonylurea|U 17835|CCRIS 591|tolazamidum|N-(p-toluenesulfonyl)-N'-hexamethyleniminourea|Diabewas|tolazamida|Tolinase","An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LINCS:LSM-2699|PMID:15901207|Wikipedia:Tolazamide|Reaxys:1323565|DrugBank:DB00839|KEGG:D00379|PMID:8237731|Patent:GB887886|HMDB:HMDB0014977|Drug_Central:2694|CAS:1156-19-0,"An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide,,,,,chebi_ontology,,"U-17835|4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide|BRN 1323565|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Norglycin|EINECS 214-588-3|tolazamide|1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea|1-(hexahydro-1-azepinyl)-3-p-tolylsulfonylurea|U 17835|CCRIS 591|tolazamidum|N-(p-toluenesulfonyl)-N'-hexamethyleniminourea|Diabewas|tolazamida|Tolinase",,,,,,,,,0,C14H21N3O3S,"InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)",OUDSBRTVNLOZBN-UHFFFAOYSA-N,311.40000,311.13036,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9613,,,,,true,true,,,,,,,,,CHEBI:9613,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tolazamide,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0040081,Abnormal circulating creatine kinase concentration,Abnormal circulating CK concentration|Abnormal circulation phospho-CK concentration|Abnormal levels of creatine kinase in blood|Abnormal circulating CPK concentration,Any deviation from the normal circulating creatine kinase concentration.,false,,,http://purl.obolibrary.org/obo/HP_0011021,,,,,,,,,,,,,,,,HPO:skoehler,,,,UMLS:C4022449,Any deviation from the normal circulating creatine kinase concentration.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal circulating CK concentration|Abnormal circulation phospho-CK concentration|Abnormal levels of creatine kinase in blood|Abnormal circulating CPK concentration,,,,,,,,,,,,,HP:0040081,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011021,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,,Abnormal levels of creatine kinase in blood,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal circulating creatine kinase concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_228409,SARS coronavirus BJ03,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:228409,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/15629030,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000087,mobile application,,,false,,,http://purl.obolibrary.org/obo/OBI_0000968,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000968,,,,,,,,diagnostics,,true,,,,,,"A mobile app is a software application developed specifically for use on small, wireless computing devices, such as smartphones and tablets, rather than desktop or laptop computers.",,,,,,,,,,,,,,,,mobile application,,,,,,,,,,,,,,,,,,,,,,https://www.geospatialworld.net/blogs/popular-apps-covid-19/,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_74,hematopoietic system disease,Blood dyscrasia|Hematological disease|disease of hematopoietic system|DISEASE OF THE BLOOD AND BLOOD-FORMING ORGANS|blood disorder|disease of haematopoietic system|Blood disease|haematopoietic system disease,A disease of anatomical entity that has_material_basis_in hematopoietic cells.,false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,ICD9CM:289.9|MESH:D006402|ICD10CM:D75.9|SNOMEDCT_US_2019_09_01:191124002|UMLS_CUI:C0018939|NCI:C26323,A disease of anatomical entity that has_material_basis_in hematopoietic cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Blood dyscrasia|Hematological disease|disease of hematopoietic system|DISEASE OF THE BLOOD AND BLOOD-FORMING ORGANS|blood disorder|disease of haematopoietic system|Blood disease|haematopoietic system disease,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:74,,,,,,,,,,,,,,,DOID:74,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,hematopoietic system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061621,canonical glycolysis,,"The glycolytic process that begins with the conversion of glucose to glucose-6-phosphate by glucokinase activity. Glycolytic processes are the  chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP.",false,,,http://purl.obolibrary.org/obo/GO_0061620|http://purl.obolibrary.org/obo/GO_0061718|http://purl.obolibrary.org/obo/GO_0006735,,,,,,,,,,,,,,,,dph,2014-04-14T09:21:54Z,,,Reactome:R-HSA-70171|MetaCyc:ANAGLYCOLYSIS-PWY|MetaCyc:PWY66-400|Wikipedia:Glycolysis,"The glycolytic process that begins with the conversion of glucose to glucose-6-phosphate by glucokinase activity. Glycolytic processes are the  chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0061620|http://purl.obolibrary.org/obo/GO_0061718|http://purl.obolibrary.org/obo/GO_0006735,,,,GO:0061621,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061621,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,canonical glycolysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_4356,desferrioxamine B,N'-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide|Deferrioxamine|deferoxamine|Desferrioxamine|DFO|deferrioxamine B|deferoxamina|Deferoxamin|deferoxaminum,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:C06940|KEGG:D03670|Drug_Central:792|Beilstein:2514118|Patent:BE609053|DrugBank:DB00746|CAS:70-51-9|LINCS:LSM-6541|Wikipedia:Deferoxamine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N'-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide,,,,,chebi_ontology,,Deferrioxamine|deferoxamine|Desferrioxamine|DFO|deferrioxamine B|deferoxamina|Deferoxamin|deferoxaminum,,,,,,,,,0,C25H48N6O8,"InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)",UBQYURCVBFRUQT-UHFFFAOYSA-N,560.68400,560.35336,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:4356,,,,,true,true,,,,,,,,,CHEBI:4356,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,desferrioxamine B,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000143,ORF7,,,false,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Open Reading Frame 7 in SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C13292,,,,,,modified definition,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,true,,,,,https://pubmed.ncbi.nlm.nih.gov/32167180/,,,,,,,,,,,,,,,,,ORF7,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0100530,Abnormal calcium-phosphate regulating hormone level,Abnormal Ca2+ PO4 regulating hormone level|Abnormal Ca-PHOS regulating hormone level,Any deviation from the normal concentration in the blood circulation of a hormone that is involved in the regulation of phosphate and calcium.,false,,,http://purl.obolibrary.org/obo/HP_0003117,,,,,,,,,,,,,,,,doelkens,2010-12-20T12:00:26Z,,,UMLS:C4022031,Any deviation from the normal concentration in the blood circulation of a hormone that is involved in the regulation of phosphate and calcium.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal Ca2+ PO4 regulating hormone level|Abnormal Ca-PHOS regulating hormone level,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0003117,,,,HP:0100530,,,,,,,,,,,,,,,HP:0100530,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal calcium-phosphate regulating hormone level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10880,Reoviridae,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_family,,,,,,,NCBITaxon:10880,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2559587,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Reoviridae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_385687,SARS coronavirus WF188,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:385687,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus WF188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_135870,thymopentin,thymopoietin 32-36|thymopoietin pentapeptide,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:2645|CAS:69558-55-0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,thymopoietin 32-36|thymopoietin pentapeptide,,,,,,,,,0,C30H49N9O9,"InChI=1S/C30H49N9O9/c1-16(2)24(28(46)38-22(29(47)48)14-17-8-10-18(40)11-9-17)39-27(45)21(15-23(41)42)37-26(44)20(7-3-4-12-31)36-25(43)19(32)6-5-13-35-30(33)34/h8-11,16,19-22,24,40H,3-7,12-15,31-32H2,1-2H3,(H,36,43)(H,37,44)(H,38,46)(H,39,45)(H,41,42)(H,47,48)(H4,33,34,35)/t19-,20-,21-,22-,24-/m0/s1",PSWFFKRAVBDQEG-YGQNSOCVSA-N,679.766,679.36532,[H]N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(O)C=C1)C(O)=O)=O)=O)=O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:135870,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:135870,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,thymopentin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006375,XCL1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LPTN|LTN|ATAC|SCYC1|SCM-1a|SCM-1|SCM1|SCM1A,,,,,,,1,,,,,,,,,,MIM:600250|HGNC:10645|Vega:OTTHUMG00000034548|HPRD:02595|Ensembl:ENSG00000143184,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C motif) ligand 1,,1q23,,,,"GO_0001916 (EC: IDA, PMID: 18832695); GO_0002690 (EC: ISS); GO_0002725 (EC: IDA, PMID: 10887101); GO_0002726 (EC: ISS); GO_0002826 (EC: IC, PMID: 10887101); GO_0005576 (EC: TAS); GO_0005615 (EC: ISS); GO_0006955 (EC: IEA); GO_0007165 (EC: IC, PMID: 9632725); GO_0007267 (EC: IDA, PMID: 7602097); GO_0008009 (EC: IDA, PMID: 7602097); GO_0009615 (EC: IDA, PMID: 14734774); GO_0010820 (EC: IDA, PMID: 7602097); GO_0030593 (EC: TAS, PMID: 11889129); GO_0032689 (EC: IDA, PMID: 10887101); GO_0032703 (EC: IDA, PMID: 10887101); GO_0032733 (EC: IDA, PMID: 18832695); GO_0035782 (EC: IDA, PMID: 9029087); GO_0042379 (EC: IDA, PMID: 9632725); GO_0042379 (EC: NAS, PMID: 7602097); GO_0042803 (EC: IDA, PMID: 11889129); GO_0043433 (EC: IDA, PMID: 10887101); GO_0045892 (EC: IDA, PMID: 10887101); GO_0050727 (EC: IDA, PMID: 18832695); GO_0051209 (EC: ISS); GO_0051281 (EC: IDA, PMID: 7602097); GO_0071353 (EC: ISS); GO_0071560 (EC: ISS); GO_0071636 (EC: IDA, PMID: 18832695); GO_0071663 (EC: IDA, PMID: 18832695); GO_0090023 (EC: ISS); GO_2000412 (EC: ISS); GO_2000503 (EC: IDA, PMID: 9029087); GO_2000513 (EC: IDA, PMID: 18832695); GO_2000518 (EC: IDA, PMID: 10887101); GO_2000538 (EC: ISS); GO_2000553 (EC: ISS); GO_2000556 (EC: ISS); GO_2000558 (EC: ISS); GO_2000562 (EC: IDA, PMID: 10887101); GO_2000563 (EC: ISS); GO_2000566 (EC: IDA, PMID: 10887101)",PMID: 7602097; 7615002; 7875320; 7973732; 8849694; 8977329; 9029087; 9079718; 9199871; 9632725; 10433555; 10887101; 11083865; 11154210; 11303872; 11446740; 11601972; 11683588; 11878903; 11889129; 12053063; 12393716; 12477932; 12847680; 14568926; 14707146; 14734774; 15489334; 15857508; 16710414; 16923584; 17077010; 17903295; 18322986; 18364395; 18832695; 18838386; 19064610; 19074885; 19536175; 19797511; 20237496; 20541533; 21270681,,,,,,,,,,,,,,,,,,OGG:3000006375,,,,,,,,,,,,,,,,,,,chemokine (C motif) ligand 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,XCL1,,,20140408,6375,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,XCL1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000001508,CTSB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CPSB|APPS,,,,,,,8,,,,,,,,,,HGNC:2527|HPRD:00287|MIM:116810|Vega:OTTHUMG00000090799|Ensembl:ENSG00000164733,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,cathepsin B,,8p22,,,,"GO_0002224 (EC: TAS); GO_0004197 (EC: IDA); GO_0005515 (EC: IPI, PMID: 16364318); GO_0005518 (EC: IDA); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005615 (EC: ISS); GO_0005622 (EC: TAS, PMID: 1645961); GO_0005730 (EC: IDA); GO_0005739 (EC: IEA); GO_0005764 (EC: IDA, PMID: 1837142); GO_0006508 (EC: IDA, PMID: 7890620); GO_0008233 (EC: IDA, PMID: 7890620); GO_0008234 (EC: IDA, PMID: 8811434); GO_0022617 (EC: TAS); GO_0030198 (EC: TAS); GO_0030574 (EC: IDA); GO_0030574 (EC: TAS); GO_0030855 (EC: IEP); GO_0036021 (EC: TAS); GO_0042470 (EC: IEA); GO_0042981 (EC: TAS, PMID: 16130169); GO_0043231 (EC: IDA); GO_0043394 (EC: IPI); GO_0045087 (EC: TAS); GO_0048471 (EC: IDA, PMID: 15614436); GO_0050790 (EC: IEA); GO_0051603 (EC: IDA); GO_0070062 (EC: IDA, PMID: 19199708); GO_0097067 (EC: IEP)",PMID: 417724; 1326552; 1577456; 1597471; 1637335; 1645961; 1837142; 1868826; 1900515; 1984484; 1996959; 2061332; 2476070; 3010323; 3463996; 3542996; 3972105; 6203523; 6351842; 7509303; 7622042; 7718586; 7890620; 8014475; 8083219; 8112600; 8617355; 8635854; 8811434; 9076588; 9295331; 9299326; 9360997; 9412840; 9539769; 9582368; 9585570; 9632704; 9733783; 9770500; 9776083; 9928950; 10353845; 10395917; 10512713; 10777578; 10849756; 10876156; 11016923; 11115496; 11134363; 11139332; 11162551; 11228542; 11241311; 11435427; 11513559; 11514663; 11536009; 11746262; 11815600; 11932257; 12057992; 12072442; 12086583; 12102727; 12185082; 12186841; 12189154; 12201820; 12437117; 12437120; 12477932; 12581740; 12589965; 12643545; 12677446; 12726991; 12887051; 12893746; 12926111; 14503883; 14702039; 14729603; 14730346; 14984956; 15016552; 15100281; 15122332; 15231747; 15255544; 15262981; 15274632; 15489334; 15512772; 15614436; 15679122; 15710602; 15799821; 15807897; 15816632; 15831716; 15832773; 16034129; 16051222; 16077201; 16130169; 16169070; 16303743; 16315320; 16364318; 16381007; 16492714; 16534247; 16709808; 16733801; 16894574; 16913838; 16914553; 17064696; 17081065; 17504810; 17507477; 17519890; 17724614; 17726009; 17982689; 17990360; 17991740; 18029348; 18163891; 18296264; 18314113; 18472965; 18515357; 18543249; 18566385; 18566436; 18598236; 18616803; 18706099; 18714186; 18718938; 18760860; 18949742; 19004543; 19040356; 19199708; 19331819; 19414800; 19434518; 19454696; 19615732; 19661440; 19692168; 19700239; 19774387; 19811804; 19913121; 19915865; 19930869; 20008285; 20042316; 20180636; 20302512; 20424577; 20536394; 20563251; 20567828; 20584670; 20627011; 20628086; 20661471; 20699092; 20706999; 20833970; 20880494; 20930303; 21060833; 21092200; 21112096; 21139048; 21199580; 21250859; 21323990; 21508263; 21541353; 21562164; 21585286; 21600167; 21742978; 21832049; 21835790; 21840777; 21850018; 21880013; 21890473; 21900206; 21925292; 21945151; 21948970; 21967108; 22066471; 22118674; 22127599; 22138708; 22190034; 22209964; 22222211; 22262857; 22266111; 22268729; 22278224; 22287159; 22322590; 22384200; 22464443; 22467319; 22571763; 22693552; 22695494; 22732093; 22745374; 22782900; 22851129; 22939629; 22949512; 23024364; 23063511; 23189279; 23195957; 23219593; 23222509; 23222817; 23292187; 23349634; 23362198; 23466190; 23591598; 23602568; 23603447; 23633927; 23667900; 23677785; 23708264; 23867824,,,,,,,,,,,,,,,,,,OGG:3000001508,,,,,,,,,,,,,,,,,,,cathepsin B,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CTSB,,,20140408,1508,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CTSB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0039614,induction by virus of host protein phosphorylation,,"Any process in which a virus activates or increases the frequency, rate or extent of phosphorylation of viral or host proteins in a host.",false,,,http://purl.obolibrary.org/obo/GO_0039612,,,,,,,,,,,,,,,,rfoulger,2012-07-06T11:15:56Z,,,,"Any process in which a virus activates or increases the frequency, rate or extent of phosphorylation of viral or host proteins in a host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039612,,,,GO:0039614,,,,,,true,,,,true,,,,,GO:0039614,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,induction by virus of host protein phosphorylation,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000004914,NTRK1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,p140-TrkA|TRK1|TRK|TRKA|Trk-A|MTC,,,,,,,1,,,,,,,,,,Ensembl:ENSG00000198400|HPRD:01869|HGNC:8031|MIM:191315|Vega:OTTHUMG00000041304,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"neurotrophic tyrosine kinase, receptor, type 1",,1q21-q22,,,,"GO_0000186 (EC: TAS); GO_0004714 (EC: IDA, PMID: 15488758); GO_0005166 (EC: IEA); GO_0005515 (EC: IPI, PMID: 12237455); GO_0005524 (EC: IEA); GO_0005768 (EC: TAS); GO_0005769 (EC: ISS); GO_0005770 (EC: ISS); GO_0005886 (EC: ISS); GO_0005886 (EC: TAS); GO_0005887 (EC: IDA, PMID: 15488758); GO_0006468 (EC: IDA, PMID: 15488758); GO_0007169 (EC: TAS); GO_0007190 (EC: TAS); GO_0007202 (EC: TAS); GO_0007264 (EC: TAS); GO_0007265 (EC: TAS); GO_0007411 (EC: IEA); GO_0007568 (EC: IEA); GO_0007611 (EC: IEA); GO_0008285 (EC: IDA, PMID: 15488758); GO_0008285 (EC: IDA, Qualifier: NOT, PMID: 15488758); GO_0009314 (EC: IEA); GO_0009986 (EC: IEA); GO_0010465 (EC: IDA, PMID: 15488758); GO_0010623 (EC: ISS); GO_0010976 (EC: IDA, PMID: 15488758); GO_0010976 (EC: IDA, Qualifier: NOT, PMID: 15488758); GO_0014823 (EC: IEA); GO_0018108 (EC: IDA, PMID: 15488758); GO_0021553 (EC: IEA); GO_0030183 (EC: IEA); GO_0030424 (EC: IEA); GO_0030425 (EC: IEA); GO_0031410 (EC: IEA); GO_0031667 (EC: IEA); GO_0031901 (EC: IEA); GO_0031902 (EC: IEA); GO_0032320 (EC: IDA, PMID: 15488758); GO_0032320 (EC: IDA, Qualifier: NOT, PMID: 15488758); GO_0042490 (EC: IEA); GO_0042493 (EC: IEA); GO_0042803 (EC: IDA, PMID: 17196528); GO_0043025 (EC: IEA); GO_0043068 (EC: ISS); GO_0043121 (EC: TAS, PMID: 9290260); GO_0043234 (EC: ISS); GO_0043235 (EC: IDA); GO_0043524 (EC: ISS); GO_0045471 (EC: IEA); GO_0045766 (EC: IDA, PMID: 15488758); GO_0046579 (EC: IDA, PMID: 15488758); GO_0046579 (EC: IDA, Qualifier: NOT, PMID: 15488758); GO_0046777 (EC: IDA, PMID: 15488758); GO_0046875 (EC: IEA); GO_0048011 (EC: IDA, PMID: 15488758); GO_0048011 (EC: TAS); GO_0048015 (EC: TAS); GO_0048406 (EC: IDA, PMID: 15488758); GO_0048406 (EC: IDA, Qualifier: NOT, PMID: 15488758); GO_0048485 (EC: ISS); GO_0048678 (EC: IEA); GO_0050965 (EC: IEA); GO_0050966 (EC: IEA); GO_0051092 (EC: IDA, PMID: 15488758); GO_0051599 (EC: IEA); GO_0051602 (EC: IEA); GO_0051968 (EC: IEA); GO_0060009 (EC: IEA); GO_0060385 (EC: ISS); GO_0070374 (EC: IDA, PMID: 15488758); GO_0070374 (EC: IDA, Qualifier: NOT, PMID: 15488758); GO_0071316 (EC: IEA); GO_1990090 (EC: ISS)",PMID: 1463607; 1532241; 1656363; 1695324; 1706478; 1715690; 1849459; 1850821; 2869410; 2927393; 2966065; 7509449; 7510697; 7541035; 7542991; 7565764; 7601468; 7657647; 7806500; 7823156; 8155326; 8183561; 8226808; 8325889; 8384556; 8524391; 8577769; 8610109; 8621424; 8696348; 8889548; 8943228; 8957089; 9069267; 9099755; 9182757; 9282923; 9290260; 9341772; 9507002; 9856458; 9867838; 9927421; 10090906; 10092678; 10103137; 10233776; 10329710; 10330344; 10388563; 10391209; 10443680; 10490030; 10567924; 10629055; 10679771; 10708759; 10712923; 10747026; 10748052; 10861667; 10982191; 11071380; 11147812; 11150334; 11157096; 11159935; 11244088; 11251075; 11310631; 11466412; 11520933; 11668614; 11705863; 11729324; 11733534; 11738045; 11850535; 11859925; 12006576; 12102460; 12150951; 12208732; 12210794; 12237455; 12406349; 12446789; 12471037; 12477932; 12536040; 14642435; 14691455; 14985763; 14988025; 15024033; 15159601; 15167895; 15273715; 15362372; 15488758; 15489334; 15513915; 15523689; 15637590; 15753086; 15870692; 15950763; 15961390; 16091303; 16113645; 16138253; 16181609; 16246731; 16275928; 16284401; 16373086; 16483615; 16546643; 16586073; 16701206; 16704535; 16710414; 16786155; 16805430; 16860569; 16862449; 16919030; 16935282; 16939974; 16996570; 17143529; 17196528; 17267689; 17447019; 17531524; 17548467; 17617666; 17619016; 17635673; 17667845; 17671718; 17673289; 17850422; 17971243; 18005706; 18072090; 18077166; 18174161; 18203754; 18221326; 18270328; 18305571; 18319596; 18322713; 18419753; 18427551; 18457658; 18678285; 18719857; 18727839; 18780967; 19086053; 19115484; 19120874; 19167335; 19169037; 19177265; 19250380; 19330021; 19386345; 19399531; 19417027; 19435634; 19453261; 19564412; 19598235; 19635108; 19651702; 19730683; 19734938; 19749791; 19758420; 19816090; 19883730; 19913121; 19945432; 19953087; 19957796; 20003389; 20186105; 20209132; 20219210; 20301434; 20301726; 20424473; 20542022; 20600627; 20628086; 20663926; 20680486; 20854189; 20943663; 20977883; 21123453; 21137076; 21139137; 21150695; 21154590; 21184737; 21236475; 21295543; 21317683; 21321391; 21332718; 21397006; 21419569; 21429417; 21503896; 21570973; 21645891; 21728718; 21849536; 21990266; 22128158; 22138126; 22272270; 22343487; 22410777; 22445970; 22454143; 22539856; 22561027; 22623531; 22653642; 22782892; 22902478; 22932111; 22939624; 22954667; 22992069; 23266087; 23400852; 23471969; 23489213; 23569426; 23589303; 23746174; 23788249; 23841091; 23869086; 24162815; 24369899,,,,,,,,,,,,,,,,,,OGG:3000004914,,,,,,,,,,,,,,,,,,,"neurotrophic tyrosine kinase, receptor, type 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,NTRK1,,,20140408,4914,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,NTRK1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0005875,microtubule associated complex,,Any multimeric complex connected to a microtubule.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,Any multimeric complex connected to a microtubule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005875,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005875,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,microtubule associated complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000236,B cell,B lymphocyte|B-cell|B-lymphocyte,A lymphocyte of B lineage that is capable of B cell mediated immunity.,false,,,http://purl.obolibrary.org/obo/NCIT_C12535,,,,,,,,,,,,,,,,,,,,BTO:0000776|CALOHA:TS-0068|FMA:62869|VHOG:0001480,A lymphocyte of B lineage that is capable of B cell mediated immunity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B lymphocyte|B-cell|B-lymphocyte,,,,,cell,,,,,,,,CL:0000236,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C12535,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,B cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000473,"nutrition, metabolism, and development symptom",,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,UMLS_ICD9CM_2005_AUI:A0284163|SyOID:2644|ICD9CM_2005:783|UMLS_CUI:C0159041,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms concerning nutrition metabolism and development,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000473,,,,,,,,,,,,,,,SYMP:0000473,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,"nutrition, metabolism, and development symptom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0027237,Drug Repositioning,,,false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0027237,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32256547,The deliberate and methodical practice of finding new applications for existing drugs.,drug repurposing,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Drug Repositioning,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0002365,exocrine gland,glandula exocrina|ducted gland,"A gland that secretes products (excluding hormones and other chemical messengers) into ducts (duct glands) which lead directly into the external environment[WP]. Typical exocrine glands include sweat glands, salivary glands, mammary glands, stomach, liver, pancreas",false,,,http://purl.obolibrary.org/obo/UBERON_0002530,,,,,,,,,,,,,,,,,,,,AEO:0000097|EMAPA:35327|UMLS:C0015282|MESH:D005088|CALOHA:TS-2012|MA:0002564|NCIT:C12712|FMA:9596|EHDAA2:0003097|BTO:0000765|GAID:34|http://en.wikipedia.org/wiki/Exocrine_gland|http://www.snomedbrowser.com/Codes/Details/115976003|http://linkedlifedata.com/resource/umls/id/C0015282,"A gland that secretes products (excluding hormones and other chemical messengers) into ducts (duct glands) which lead directly into the external environment[WP]. Typical exocrine glands include sweat glands, salivary glands, mammary glands, stomach, liver, pancreas",,,,,,,,"Currently this is logically defined by the system it belongs to, but a better system may be base this on presence/absence of ducts. However, the dual nature of the liver should be taken into consideration here. Consider adding subclasses",,,,,,,,,,,,,,,,,,,,,,,glandula exocrina|ducted gland,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0002530,,,,UBERON:0002365,,,,,,,,,,,,,,,UBERON:0002365,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim,,,,,,,,,,exocrine gland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0015935,small ribosomal subunit,ribosomal small subunit,The smaller of the two subunits of a ribosome.,false,,,http://purl.obolibrary.org/obo/GO_0044391,,,,,,,,,,,,,,,,,,,,,The smaller of the two subunits of a ribosome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribosomal small subunit,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044391,,,,GO:0015935,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0015935,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,small ribosomal subunit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000010663,CXCR6,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TYMSTR|BONZO|CD186|STRL33,,,,,,,3,,,,,,,,,,HPRD:05520|Ensembl:ENSG00000172215|Vega:OTTHUMG00000133448|HGNC:16647|MIM:605163,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) receptor 6,,3p21,,,,"GO_0004930 (EC: TAS, PMID: 9166430); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 9166430); GO_0006935 (EC: IEA); GO_0006954 (EC: IEA); GO_0007186 (EC: TAS, PMID: 9166430); GO_0015026 (EC: IEA); GO_0016494 (EC: IEA); GO_0019079 (EC: TAS, PMID: 9230441)",PMID: 9166430; 9230441; 9285716; 9736741; 10590105; 10877489; 10933620; 10975845; 11017100; 11290797; 11711593; 12044980; 12070001; 12477932; 12761559; 12914753; 14634054; 15053339; 15489334; 15650194; 15736401; 15817921; 15992849; 16200580; 16470129; 16870145; 17615381; 17640964; 17725420; 18194461; 18240029; 18250446; 18293410; 18452560; 18577758; 18656707; 18760678; 19074906; 19231068; 19690611; 20056178; 20628624; 20646641; 20704485; 20854195; 20921899; 21203549; 21233446; 21303517; 21468586; 21527066; 21773780; 22079021; 22086059; 22113484; 22678828; 22842622; 23229614; 23628207,,,,,,,,,,,,,,,,,,OGG:3000010663,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) receptor 6,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCR6,,,20140408,10663,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,CXCR6,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_293935,SARS coronavirus PC4-136,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:293935,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039545,suppression by virus of host MAVS activity,inhibition of host MAVS by virus|suppression by virus of host mitochondrial antiviral-signaling protein,"Any process in which a virus stops, prevents, or reduces the activity of MAVS (mitochondrial antiviral signaling protein), a signal transducer that lies downstream of the viral RNA receptors MDA-5 and RIG-I to coordinate host innate immune responses.|This term is for annotation of viral proteins that counteract the host anti-viral innate immune response.",false,,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048,,,,,,,,,,,,,,,,rfoulger,2012-01-19T02:37:20Z,,,VZ:704,"Any process in which a virus stops, prevents, or reduces the activity of MAVS (mitochondrial antiviral signaling protein), a signal transducer that lies downstream of the viral RNA receptors MDA-5 and RIG-I to coordinate host innate immune responses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,inhibition of host MAVS by virus|suppression by virus of host mitochondrial antiviral-signaling protein,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This term is for annotation of viral proteins that counteract the host anti-viral innate immune response.,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048,,,,GO:0039545,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/25135833,,,,GO:0039545,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host MAVS activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267396,SARS coronavirus Sin846,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267396,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin846,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050285,helicase (SARS-CoV-2),"Hel (SARS2)|PRO_0000449630|UniProtKB:P0DTD1, 5325-5925|ORF1ab/Clv:nsp13 (SARS2)|nsp13 (SARS2)",An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 5324-5325 and 5925-5926.|Category=organism-modification. Note: 601 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050283,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725308,An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 5324-5325 and 5925-5926.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Hel (SARS2)|PRO_0000449630|UniProtKB:P0DTD1, 5325-5925|ORF1ab/Clv:nsp13 (SARS2)|nsp13 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 601 aa protein.,,http://purl.obolibrary.org/obo/PR_000050283,,,,PR:000050285,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,PR:000050285,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,helicase (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_284672,SARS coronavirus TJF,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:284672,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TJF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003672,ITGA1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,VLA1|CD49a,,,,,,,5,,,,,,,,,,HGNC:6134|HPRD:01892|MIM:192968,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"integrin, alpha 1",,5q11.2,,,,"GO_0000187 (EC: IEA); GO_0001669 (EC: IEA); GO_0005178 (EC: IEA); GO_0005515 (EC: IPI, PMID: 16754661); GO_0005518 (EC: TAS, PMID: 8428973); GO_0005886 (EC: TAS); GO_0006936 (EC: TAS); GO_0007155 (EC: IEA); GO_0007229 (EC: IEA); GO_0007411 (EC: TAS); GO_0007596 (EC: TAS); GO_0008285 (EC: IMP, PMID: 15592458); GO_0008305 (EC: TAS, PMID: 8428973); GO_0009897 (EC: IEA); GO_0019903 (EC: IPI, PMID: 15592458); GO_0030198 (EC: TAS); GO_0030593 (EC: IEA); GO_0032516 (EC: IDA, PMID: 15592458); GO_0042059 (EC: ISS); GO_0042311 (EC: IEA); GO_0043005 (EC: IEA); GO_0043204 (EC: IEA); GO_0043525 (EC: IEA); GO_0045121 (EC: IEA); GO_0045123 (EC: IEA); GO_0045178 (EC: IEA); GO_0046872 (EC: IEA); GO_0046982 (EC: IEA); GO_0070062 (EC: IDA, PMID: 19056867)",PMID: 1429908; 1690718; 1693624; 1807406; 1827128; 2099238; 2144294; 2169872; 2229189; 2341567; 3033641; 3546305; 7493648; 7806264; 7897185; 8387021; 8428973; 8557756; 8717325; 8814241; 8898357; 9139675; 9154536; 9688542; 9699516; 10094488; 10196235; 10455165; 10457223; 10595787; 10666376; 10684262; 10713152; 10714390; 11307375; 11336656; 11454259; 11572855; 11877061; 11937138; 12042322; 12078857; 12477932; 12482545; 12662928; 12694973; 12734939; 12883474; 14627618; 14660600; 15109703; 15132990; 15372022; 15485856; 15592458; 15679046; 16008586; 16043429; 16335952; 16412752; 16472776; 16754661; 17312461; 17603494; 17669516; 17891451; 17931993; 17982677; 18048918; 18081024; 18269595; 18377961; 18454440; 18587047; 18647959; 18813796; 19056867; 19397781; 19730683; 19780039; 19850917; 19913121; 20232313; 20436081; 20531279; 20628086; 21521694; 21647271; 21946350; 21947080; 21965670; 22001757; 22002573; 22020760; 22030389; 22298882; 22698912; 22847004; 22919661; 23070086; 23284291; 23284937; 23419831; 23448258; 24124332; 24187131; 24250222,,,,,,,,,,,,,,,,,,OGG:3000003672,,,,,,,,,,,,,,,,,,,"integrin, alpha 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ITGA1,,,20140408,3672,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,ITGA1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/SYMP_0000095,myocarditis,,doid/symp duplicate,false,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,doid/symp duplicate,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,SYMP:0000095,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215613,Myocarditis is a disease marked by the inflammation of the heart muscle known as the myocardium — the muscular layer of the heart wall.,,,SYMP:0000095,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,myocarditis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C19146,In Vitro Model,In Vitro Model,,false,,,http://purl.obolibrary.org/obo/NCIT_C17456,,,,,,,,,,,C19146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,In Vitro Model,,,,,,,,,,,,,NCIT:C19146,In vitro (Latin for within the glass) refers to the technique of performing a given procedure in a controlled environment outside of a living organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17456,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,In Vitro Model,in_vitro_Model,,,,,,,,,,,,,,,,,,In Vitro Model,,,,Research Activity,,,,,,,,C1515654,
http://purl.obolibrary.org/obo/SYMP_0000899,ventricular fibrillation,v-fib,"A cardiac fibrillation associated with quivering of the lower chambers of the heart, preventing blood from being pumped and causing cardiac arrest.",false,,,http://purl.obolibrary.org/obo/SYMP_0000898,,,,,,,,,,,,,,,,,,,,,"A cardiac fibrillation associated with quivering of the lower chambers of the heart, preventing blood from being pumped and causing cardiac arrest.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,v-fib,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000898,,,,SYMP:0000899,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/3221830,,,,SYMP:0000899,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,ventricular fibrillation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000300,COVID transmission process,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The 'COVID transmission process' concept enables a compilation of diverse concepts that are related to transmission of SARS-CoV-2  via the Axiome 'isPreventionAndControlFor some COIVID-19'.  Thus enables the adaptation of the ontology for text mining purposes for Covid-19 related information retrieval and information extraction.,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID transmission process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00016951,peginterferon alfa-2a,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,120608,,,,DRON:00016951,"A covalent conjugate of recombinant interferon alfa, subtype 2a, and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha-2a protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha-2a, thereby extending the duration of its therapeutic effects, but may also reduce interferon-mediated stimulation of an immune response.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,peginterferon alfa-2a,,,,,,,,,,,,,,,,,,,,,,https://www.medicinenet.com/interferon/article.htm,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005775,vacuolar lumen,,The volume enclosed within the vacuolar membrane.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The volume enclosed within the vacuolar membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005775,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005775,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,vacuolar lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000089,chemiluminescence-linked immunosorbent assay,,,false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221133,Chemiluminescence immunoassay (CLIA) is an assay that combine chemiluminescence technique with immunochemical reactions.,Chemiluminescence immunoassay,,,,,,,,,,,,,,,chemiluminescence-linked immunosorbent assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C29490,Tenofovir,Tenofovir|GS-1275|(R)-9-(2-Phosphonomethoxypropyl)adenine|(R)-9-(Phosphonomethoxypropyl)adenine|TENOFOVIR|PMPA|GS-1278|(((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid,A nucleoside reverse transcriptase inhibitor analog of adenosine.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,147127-20-6|206184-49-8,CHEBI:63625|CHEBI:63716,C9H14N5O4P.H2O,,C29490,,,CTRP|FDA,,,,,,,A nucleoside reverse transcriptase inhibitor analog of adenosine.,,,,,,Tenofovir,,,,,,,,,,,99YXE507IL,,,,,,,,,,,,,,Tenofovir|GS-1275|(R)-9-(2-Phosphonomethoxypropyl)adenine|(R)-9-(Phosphonomethoxypropyl)adenine|TENOFOVIR|PMPA|GS-1278|(((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid,,,,,,,,,,,,,NCIT:C29490,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222463,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Tenofovir,Tenofovir,,,,,,,,,,,,,,,540635,540635,,Tenofovir,,,,"Pharmacologic Substance|Nucleic Acid, Nucleoside, or Nucleotide",,,,,,,,C0384228,
https://bio.scai.fraunhofer.de/ontology/COVID_0000066,proelastase,,,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Proelastase is metabolite formed in the pancreas and converted to elastase by the activation of trypsin.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/|https://pubmed.ncbi.nlm.nih.gov/5435442/,,,,,,,,,,,,,,,,,proelastase,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000692,low blood pressure,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,SYMP:0000692,,,,,,true,,,,,,A blood pressure reading lower than 90 millimeters of mercury (mm Hg) for the top number (systolic) or 60 mm Hg for the bottom number (diastolic) is generally considered low blood pressure.,plummeting blood pressure,,SYMP:0000692,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,low blood pressure,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_11118,Coronaviridae,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2499399,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_family,,,,,,,NCBITaxon:11118,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2499399,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Coronaviridae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0200119,Acute hepatitis,Acute liver inflammation,"Acute hepatic injury resulting from inflammation typically accompanied by increased serum alanine transaminase activity. Etiologies include viral hepatitis, drugs, toxins, and autoimmune disorders.",false,,,http://purl.obolibrary.org/obo/HP_0012115,,,,,,,,,,,,,,,,sebastiankohler,2013-06-11T11:15:57Z,,,UMLS:C0267797|SNOMEDCT_US:37871000,"Acute hepatic injury resulting from inflammation typically accompanied by increased serum alanine transaminase activity. Etiologies include viral hepatitis, drugs, toxins, and autoimmune disorders.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Acute liver inflammation,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012115,,,,HP:0200119,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,HP:0200119,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Acute hepatitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C14139,Immunocompromised,immunocompromised host|immunosuppressed patient|Immunocompromised Host|immunocompromised patient|Immunosuppressed Host|Immunocompromised|Immunosuppressed|immunocompromised|Immunocompromised Patient|Immunosuppressed Patient|immunosuppressed host,"A loss of any arm of immune functions, resulting in potential or actual increase in infections. This state may be reached secondary to specific genetic lesions, syndromes with unidentified or polygenic causes, acquired deficits from other disease states, or as result of therapy for other diseases or conditions.",false,,,http://purl.obolibrary.org/obo/HP_0002715,,"Having a weakened immune system caused by certain diseases or treatments.|A loss of any arm of immune functions resulting in potential or actual increase in infections. This state may be reached due to specific genetic lesions, syndromes with unidentified or polygenic causes, acquired deficits from other disease states, or as result of therapy for other diseases or conditions.",,,,,,,,,C14139,,,NICHD,,,,,,,"A loss of any arm of immune functions, resulting in potential or actual increase in infections. This state may be reached secondary to specific genetic lesions, syndromes with unidentified or polygenic causes, acquired deficits from other disease states, or as result of therapy for other diseases or conditions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,immunocompromised host|immunosuppressed patient|Immunocompromised Host|immunocompromised patient|Immunosuppressed Host|Immunocompromised|Immunosuppressed|immunocompromised|Immunocompromised Patient|Immunosuppressed Patient|immunosuppressed host,,,,http://purl.obolibrary.org/obo/NCIT_C3507,,,,,,,,,NCIT:C14139,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002715,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118468|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128453,,,,,,,,,,Immunocompromised,Immunocompromised,,,,,,,Immunocompromised,,,,,,,,,,,Immunocompromised,,,https://www.summitmedicalgroup.com/news/living-well/must-know-covid-19-vocabulary/,Clinical Attribute,,,,,,,,C0085393,
https://bio.scai.fraunhofer.de/ontology/COVID_0000122,enrichment  for domain families within the interacting proteins,,,false,,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,,,,Assay,,true,,,,,,Enrichment analysis by employing structural and functional information on families of protein domains as annotation terms.,,,,,,,,,,,,,,,,enrichment  for domain families within the interacting proteins,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v1.full.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_421707,abacavir,"{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol|Abacavir|ABC|abacavir|{(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol","A 2,6-diaminopurine that is (1S)-cyclopent-2-en-1-ylmethanol in which the pro-R hydrogen at the 4-position is substituted by a 2-amino-6-(cyclopropylamino)-9H-purin-9-yl group. A nucleoside analogue reverse transcriptase inhibitor (NRTI) with antiretroviral activity against HIV, it is used (particularly as the sulfate) with other antiretrovirals in combination therapy of HIV infection.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:15887959|KEGG:C07624|Drug_Central:34|PMID:16759112|CAS:136470-78-5|PMID:16539393|PMID:17870541|Reaxys:7493116|KEGG:D07057|PMID:25017682|DrugBank:DB01048|Beilstein:7493116|PMID:12781181|Wikipedia:Abacavir|PMID:18029175|PMID:25674793|PMID:11806176|PMID:16458506|PMID:11678376|PMID:17172311|PMID:24751900|PMID:26024233|PMID:18549801,"A 2,6-diaminopurine that is (1S)-cyclopent-2-en-1-ylmethanol in which the pro-R hydrogen at the 4-position is substituted by a 2-amino-6-(cyclopropylamino)-9H-purin-9-yl group. A nucleoside analogue reverse transcriptase inhibitor (NRTI) with antiretroviral activity against HIV, it is used (particularly as the sulfate) with other antiretrovirals in combination therapy of HIV infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:520984|CHEBI:193608|CHEBI:525912|CHEBI:2360|CHEBI:441792,,,,"{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol|Abacavir",,,,,chebi_ontology,,ABC|abacavir|{(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol,,,,,,,,,0,C14H18N6O,"InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1",MCGSCOLBFJQGHM-SCZZXKLOSA-N,286.33230,286.15421,Nc1nc(NC2CC2)c2ncn([C@@H]3C[C@H](CO)C=C3)c2n1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:421707,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:421707,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,abacavir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_50846,immunomodulator,Immunological factor|Biomodulator|Immune factor|immunomodulators|Immunologic factor,Biologically active substance whose activity affects or plays a role in the functioning of the immune system.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Wikipedia:Immunotherapy,Biologically active substance whose activity affects or plays a role in the functioning of the immune system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,Immunological factor|Biomodulator|Immune factor|immunomodulators|Immunologic factor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50846,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32255510,,,,CHEBI:50846,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,immunomodulator,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009167,purine ribonucleoside monophosphate metabolic process,purine ribonucleoside monophosphate metabolism,"The chemical reactions and pathways involving purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009126|http://purl.obolibrary.org/obo/GO_0009161,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine ribonucleoside monophosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009126|http://purl.obolibrary.org/obo/GO_0009161,,,,GO:0009167,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009167,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine ribonucleoside monophosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249078,SARS coronavirus HGZ8L2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249078,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HGZ8L2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000108,alveolar exudate,,,false,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,phenotypic abnormailty,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32114094,"Pathological process the alveoli, diffusely in both lungs are filled with either water (pulmonary edema), blood or inflammatory exudate.",,,,,,,,,,,,,,,,alveolar exudate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000234,Abnormality of the head,Abnormal head|Abnormality of the head|Head abnormality,An abnormality of the head.,false,,,http://purl.obolibrary.org/obo/HP_0000152,,,,,,,,,,,,,,,,,,,,UMLS:C4021812,An abnormality of the head.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal head|Abnormality of the head|Head abnormality,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000152,,,,HP:0000234,,,,,,,,,,,,,,,HP:0000234,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the head,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019048,modulation by virus of host process,virus-host interaction|host-virus interaction|modulation by virus of host anatomy or process|viral interaction with host|virus-host process|viral-host process|modulation by virus of host anatomical structure or process|modulation by virus of host morphology or physiology|disruption by virus of host cell,The process in which a virus effects a change in the structure or processes of its host organism.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,janelomax,2012-08-01T13:41:00Z,,,VZ:886,The process in which a virus effects a change in the structure or processes of its host organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0044661|GO:0044792,virus-host interaction,,,host-virus interaction|modulation by virus of host anatomy or process|viral interaction with host|virus-host process|viral-host process,,,,,biological_process,,modulation by virus of host anatomical structure or process|modulation by virus of host morphology or physiology|disruption by virus of host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019048,,,,,,true,,,,true,,,,,GO:0019048,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host process,,,,,,,,,,,,,,,,,,,,,,https://www.researchsquare.com/article/rs-17218/v1,,,,,,,https://github.com/geneontology/go-ontology/issues/18719|https://github.com/geneontology/go-ontology/issues/18605,,,
http://purl.obolibrary.org/obo/NCBITaxon_305409,SARS coronavirus B033,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305409,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus B033,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_8457,Sauropsida,sauropsids,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_7742,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,sauropsids,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:8457,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_7742,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Sauropsida,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_1110054,autoimmune disease,,Is a disease characterized by an immune response of an organism against parts of itself,false,,,http://purl.obolibrary.org/obo/DOID_2914,,,,,,,,,,,,,,,,,,,,,Is a disease characterized by an immune response of an organism against parts of itself,,IEDB,,,,,,,autoimmune disease,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000123,,,,,,,,,,,,,,,,,,,,OBI:1110054,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_2914,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32302437,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,autoimmune disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,IEDB,,,,
http://purl.obolibrary.org/obo/OMIT_0016234,CD4-Positive T-Lymphocytes,,,false,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0016234,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,true,true,,,,,"A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,CD4-Positive T-Lymphocytes,,,,,,,,,,,,,,,,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.18.20024364v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258966,SARS coronavirus TW3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258966,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0100051,specimen,,A material entity that has the specimen role.,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,A material entity that has the specimen role.,,GROUP: OBI Biomaterial Branch,,,,,,Note: definition is in specimen creation objective which is defined as an objective to obtain and store a material entity for potential use as an input during an investigation.,specimen,,,,Biobanking of blood taken and stored in a freezer for potential future investigations stores specimen.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,OBI:0100051,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,specimen,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: James Malone|PERSON: Philippe Rocca-Serra,,,,
http://purl.obolibrary.org/obo/GO_0033002,muscle cell proliferation,myocyte proliferation,The expansion of a muscle cell population by cell division.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The expansion of a muscle cell population by cell division.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,myocyte proliferation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0033002,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033002,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,muscle cell proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050864,regulation of B cell activation,regulation of B lymphocyte activation|regulation of B-cell activation|regulation of B-lymphocyte activation,"Any process that modulates the frequency, rate or extent of B cell activation.",false,,,http://purl.obolibrary.org/obo/GO_0051249,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of B cell activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of B lymphocyte activation|regulation of B-cell activation|regulation of B-lymphocyte activation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051249,,,,GO:0050864,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050864,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of B cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000090,treatment,,"A planned process whose completion is hypothesized by a health care provider to eliminate, prevent, or alleviate the signs and symptoms of a disorder or pathological process",false,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,creation date: 2010-03-31T04:51:11Z,,"A planned process whose completion is hypothesized by a health care provider to eliminate, prevent, or alleviate the signs and symptoms of a disorder or pathological process",,http://code.google.com/p/ogms/issues/detail?id=35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000090,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,true,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,treatment of symptoms,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000014,alveolar damage,,,false,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32198713,Damage to the walls of the air sacs (alveoli) of the lung,,Emphysema,,,,,,,,,,,,,,alveolar damage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030666,endocytic vesicle membrane,,The lipid bilayer surrounding an endocytic vesicle.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The lipid bilayer surrounding an endocytic vesicle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030666,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030666,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endocytic vesicle membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000035,blood measurement,,"A measurement of the blood, it's contents, cells or other factors contained within the blood.",false,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000035,,,,,,,,,,,,"A measurement of the blood, it's contents, cells or other factors contained within the blood.",,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,blood measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007138,TNNT1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,NEM5|STNT|TNTS|ANM|TNT,,,,,,,19,,,,,,,,,,HGNC:11948|HPRD:01841|Ensembl:ENSG00000105048|Vega:OTTHUMG00000180542|MIM:191041,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"troponin T type 1 (skeletal, slow)",,19q13.4,,,,"GO_0003009 (EC: IMP, PMID: 10952871); GO_0005523 (EC: IMP, PMID: 15665378); GO_0005829 (EC: TAS); GO_0005861 (EC: IDA, PMID: 18032382); GO_0005861 (EC: IMP, PMID: 15665378); GO_0030049 (EC: TAS); GO_0031014 (EC: IEA); GO_0031444 (EC: IEA); GO_0045932 (EC: IDA, PMID: 18032382)",PMID: 1473264; 1505979; 1551677; 1706783; 2687327; 2824479; 3611073; 6822572; 8135831; 8403232; 8681137; 8987992; 9448267; 9724539; 10191089; 10451243; 10529204; 10601315; 10952871; 11904166; 12477932; 15489334; 15495263; 15665378; 15761153; 15967462; 16169070; 16189514; 18032382; 18579801; 19326042; 19541721; 19690080; 19913121; 19916752; 20038417; 20301465; 20380359; 20628086; 20889975; 21111984; 21139048; 21448949; 21683708; 21729325; 21784424; 21900206; 22239123; 22448368; 22977240; 23244308,,,,,,,,,,,,,,,,,,OGG:3000007138,,,,,,,,,,,,,,,,,,,"troponin T type 1 (skeletal, slow)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TNNT1,,,20140408,7138,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TNNT1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000002266,FGG,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,4,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,fibrinogen gamma chain,,4q28,,,,"GO_0002576 (EC: TAS); GO_0005102 (EC: IEA); GO_0005576 (EC: TAS); GO_0005577 (EC: IEA); GO_0005615 (EC: IDA, PMID: 6777381); GO_0005886 (EC: TAS); GO_0005938 (EC: IEA); GO_0007165 (EC: IEA); GO_0007596 (EC: TAS); GO_0009897 (EC: IDA, PMID: 6777381); GO_0009986 (EC: IDA, PMID: 6777381); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0030674 (EC: IEA); GO_0031091 (EC: IDA, PMID: 6777381); GO_0031093 (EC: TAS); GO_0046872 (EC: IEA); GO_0051258 (EC: IEA); GO_0051592 (EC: IDA, PMID: 6777381); GO_0070062 (EC: IDA, PMID: 19056867); GO_0072562 (EC: IDA)",PMID: 936108; 1421174; 1429662; 1455400; 1685103; 1733971; 1744509; 1892842; 2071611; 2133219; 2257302; 2328317; 2496144; 2665853; 2738036; 2742826; 2819242; 2971042; 2971046; 2976995; 2990550; 3160702; 3337908; 3563970; 3708159; 5084810; 6091742; 6092346; 6281794; 6325435; 6326808; 6383194; 6451630; 6575389; 6575689; 6592597; 6688357; 6689067; 6777381; 6860649; 6933547; 6957371; 7306501; 7356959; 7822297; 7841300; 7878009; 8080993; 8384496; 8400260; 8404605; 8470043; 8566791; 8756701; 8905624; 9016719; 9028318; 9207064; 9333233; 9628725; 9712878; 10074346; 10391209; 10467729; 10605720; 10747940; 10828988; 11001902; 11073102; 11307817; 11435303; 11562340; 11744726; 11748101; 11986213; 11986220; 12356313; 12477932; 12501189; 12617173; 12624729; 12663453; 12871494; 12900415; 14691567; 14760718; 14764520; 15217804; 15284111; 15304042; 15311153; 15489334; 15583736; 15632207; 15641787; 15671034; 15735812; 15773976; 15795540; 16005629; 16051597; 16113784; 16141000; 16144795; 16263699; 16335952; 16363805; 16420584; 16524883; 16525568; 16581250; 16614319; 16705085; 16706972; 16928957; 16940416; 17018627; 17241179; 17263791; 17264959; 17403086; 17445871; 17543500; 17565664; 17591786; 17643375; 17650452; 17688324; 17827388; 17849064; 17854317; 17883696; 17938819; 17949478; 17951283; 17956865; 18000621; 18202324; 18208536; 18239174; 18278190; 18331453; 18567199; 18676163; 18690352; 18772067; 18779330; 18832913; 18842294; 18848323; 18974842; 18983496; 18989528; 19034331; 19056867; 19059206; 19122172; 19190816; 19332210; 19404553; 19412134; 19492150; 19515723; 19650644; 19687509; 19913121; 19923982; 19948975; 20031577; 20059469; 20128871; 20167083; 20237496; 20508898; 20589319; 20628086; 20666993; 20709368; 20838743; 20981788; 21057694; 21103663; 21174007; 21502573; 21694469; 21757653; 21980494; 22078561; 22437918; 22463367; 22489912; 22760446; 22836683; 23036532; 23056168; 23061815; 23306717; 23348147; 23385359; 23422752; 23645504; 23650146; 23750785; 23852822; 23877568; 23969696; 23990470; 23995838,,,,,,,,,,,,,,,,,,OGG:3000002266,,,,,,,,,,,,,,,,,,,fibrinogen gamma chain,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FGG,,,20140408,2266,PRO2061,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,FGG,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000139,"N95 respirator
",,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,,An N95 respirator is a respiratory protective device designed to achieve a very close facial fit and very efficient filtration of airborne particles.,,,,,,,,,,,,,,,,"N95 respirator
",,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C258,Antibiotic,Antibiotic Drugs|Antibiotic Therapy|Antibiotics|antibiotic|Antimicrobial|antimicrobial|Antimicrobial Agent|Antibiotic Agents|Antibiotic,"Substances naturally produced by microorganisms or their derivatives that selectively target microorganisms not humans. Antibiotics kill or inhibit the growth of microorganisms by targeting components of the microbial cell absent from human cells, including bacterial cell walls, cell membrane, and 30S or 50S ribosomal subunits. These substances are used in the treatment of bacterial and other microbial infections.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,"Substances that kill or inhibit the growth or other functions of microorganisms. These substances are used in the treatment of bacterial and other microbial infections, though this term is most often used to describe antibacterial agents.|A substance that kills microorganisms such as bacteria or mold, or stops them from growing and causing disease.",,,,,,,,,C258,,,CPTAC|NICHD|CTRP,,,,,,,"Substances naturally produced by microorganisms or their derivatives that selectively target microorganisms not humans. Antibiotics kill or inhibit the growth of microorganisms by targeting components of the microbial cell absent from human cells, including bacterial cell walls, cell membrane, and 30S or 50S ribosomal subunits. These substances are used in the treatment of bacterial and other microbial infections.",,,,,,Antibiotic,,,,,,,,,,,,,,,,,,,,,,,,,Antibiotic Drugs|Antibiotic Therapy|Antibiotics|antibiotic|Antimicrobial|antimicrobial|Antimicrobial Agent|Antibiotic Agents|Antibiotic,,,,http://purl.obolibrary.org/obo/NCIT_C1909,,,,,,,,,NCIT:C258,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32179150,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156953|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128453|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159412,,,,,,,,,,Antibiotic,Antibiotic,,,,,,,Antibiotic,,,,,,,,,,,Antibiotic,,,,Chemical Viewed Functionally,,,,,,,,C0003232,
http://purl.obolibrary.org/obo/SYMP_0019138,immune system symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0017795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0017795,,,,SYMP:0019138,,,,,,true,,,,,,Symptoms of Immune System Problems,,immune system in overdrive,SYMP:0019138,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,immune system symptom,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042311,vasodilation,vasodilatation|positive regulation of blood vessel size,"An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Vasodilation,"An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,vasodilatation|positive regulation of blood vessel size,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0042311,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,GO:0042311,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,vasodilation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006119,oxidative phosphorylation,respiratory-chain phosphorylation,"The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis.",false,,,http://purl.obolibrary.org/obo/GO_0046034,,,,,,,,,,,,,,,,,,,,Wikipedia:Oxidative_phosphorylation,"The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,respiratory-chain phosphorylation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046034,,,,GO:0006119,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006119,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,oxidative phosphorylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009165,nucleotide biosynthetic process,nucleotide anabolism|nucleotide synthesis|nucleotide biosynthesis|nucleotide formation,"The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).",false,,,http://purl.obolibrary.org/obo/GO_1901293,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nucleotide anabolism|nucleotide synthesis|nucleotide biosynthesis|nucleotide formation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901293,,,,GO:0009165,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009165,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nucleotide biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,immune response-regulating cell surface receptor signalling pathway involved in phagocytosis|phagocytosis triggered by activation of immune response cell surface activating receptor,An immune response-regulating cell surface receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.,false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,,An immune response-regulating cell surface receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,immune response-regulating cell surface receptor signalling pathway involved in phagocytosis|phagocytosis triggered by activation of immune response cell surface activating receptor,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0002433,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002433,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034394,protein localization to cell surface,protein localization at cell surface|protein localisation at cell surface,"A process in which a protein is transported to, or maintained in, a location within the external part of the cell wall and/or plasma membrane.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A process in which a protein is transported to, or maintained in, a location within the external part of the cell wall and/or plasma membrane.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein localization at cell surface|protein localisation at cell surface,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0034394,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034394,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein localization to cell surface,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032091,negative regulation of protein binding,downregulation of protein binding|down-regulation of protein binding|down regulation of protein binding|inhibition of protein binding,"Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,downregulation of protein binding|down-regulation of protein binding|down regulation of protein binding,,,inhibition of protein binding,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0032091,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032091,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of protein binding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0021545,cranial nerve development,,"The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0021545,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0021545,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cranial nerve development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0033047,regulation of mitotic sister chromatid segregation,,"Any process that modulates the frequency, rate or extent of sister chromatid segregation during mitosis.",false,,,http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_0007088,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of sister chromatid segregation during mitosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033045|http://purl.obolibrary.org/obo/GO_0007088,,,,GO:0033047,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033047,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of mitotic sister chromatid segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0025555,"Pneumonia, Ventilator-Associated",,,false,,,http://purl.obolibrary.org/obo/OMIT_0004723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0025555,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OMIT_0004723,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,Serious INFLAMMATION of the LUNG in patients who required the use of PULMONARY VENTILATOR. It is usually caused by bacterial CROSS INFECTION in hospitals.,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,"Pneumonia, Ventilator-Associated",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006732,coenzyme metabolic process,coenzyme and prosthetic group metabolism|coenzyme and prosthetic group metabolic process|coenzyme metabolism|group transfer coenzyme metabolism|group transfer coenzyme metabolic process,"The chemical reactions and pathways involving coenzymes, any of various nonprotein organic cofactors that are required, in addition to an enzyme and a substrate, for an enzymatic reaction to proceed.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving coenzymes, any of various nonprotein organic cofactors that are required, in addition to an enzyme and a substrate, for an enzymatic reaction to proceed.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0006752,coenzyme and prosthetic group metabolism|coenzyme and prosthetic group metabolic process,,,coenzyme metabolism,,,group transfer coenzyme metabolism|group transfer coenzyme metabolic process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006732,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006732,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,coenzyme metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000940,condensed chromosome outer kinetochore,outer kinetochore of condensed chromosome|outer kinetochore plate,The region of a condensed chromosome kinetochore most external to centromeric DNA; this outer region mediates kinetochore-microtubule interactions.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The region of a condensed chromosome kinetochore most external to centromeric DNA; this outer region mediates kinetochore-microtubule interactions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,outer kinetochore of condensed chromosome,,,outer kinetochore plate,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0000940,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000940,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,condensed chromosome outer kinetochore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000076,DNA replication checkpoint,,"A cell cycle checkpoint that prevents the initiation of nuclear division until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.",false,,,http://purl.obolibrary.org/obo/GO_0031570,,,,,,,,,,,,,,,,,,,,,"A cell cycle checkpoint that prevents the initiation of nuclear division until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0031570,,,,GO:0000076,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000076,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,DNA replication checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_8028,perphenazine,2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol|Perphenazine|4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|perphenazinum|perphenazine|Chlorpiprazine|perfenazina|4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol|2-chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|gamma-(4-(beta-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|Perfenazine|Trilafon|Perphenazin|2-(4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol,A phenothiazine derivative in which the phenothiazine tricycle carries a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at N-10.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,DrugBank:DB00850|Beilstein:54730|Wikipedia:Perphenazine|Reaxys:54730|Patent:US2766235|HMDB:HMDB0014988|LINCS:LSM-2224|Drug_Central:2113|Patent:US2860138|PMID:26660173|KEGG:D00503|CAS:58-39-9|PMID:14401911|PMID:15674907|PMID:1650428|KEGG:C07427|PMID:27150024,A phenothiazine derivative in which the phenothiazine tricycle carries a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at N-10.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol|Perphenazine,,,,,chebi_ontology,,4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|perphenazinum|perphenazine|Chlorpiprazine|perfenazina|4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol|2-chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|gamma-(4-(beta-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|Perfenazine|Trilafon|Perphenazin|2-(4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol,,,,,,,,,0,C21H26ClN3OS,"InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2",RGCVKNLCSQQDEP-UHFFFAOYSA-N,403.96946,403.14851,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:8028,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:8028,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,perphenazine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C38103,Chest Radiography,chest x-ray|Chest Radiography|Chest X-ray,An x-ray examination of the chest.,false,,,http://purl.obolibrary.org/obo/ERO_0001312,,"An x-ray of the structures inside the chest. An x-ray is a type of high-energy radiation that can go through the body and onto film, making pictures of areas inside the chest, which can be used to diagnose disease.",,,,,,,,,C38103,,,,,,,,,,An x-ray examination of the chest.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chest x-ray|Chest Radiography|Chest X-ray,,,,,,,,,,,,,NCIT:C38103,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0001312,,,,,,,,,,true,,,,,,,chest scan,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Chest Radiography,Chest_Radiography,,,,,,,,,,,,,,,,,,Chest Radiography,,,https://www.ebi.ac.uk/ols/search?q=chest+X-ray&groupField=iri&start=0,Diagnostic Procedure,,,,,,,,C0039985,
http://purl.obolibrary.org/obo/GO_0046738,induction of innate immune response in host by virus,active viral induction of innate immune response in host|active induction of innate immune response in host by virus,"The intentional, virally-encoded stimulation of an innate host defense response to viral infection.",false,,,http://purl.obolibrary.org/obo/GO_0046730,,,,,,,,,,,,,,,,,,,,,"The intentional, virally-encoded stimulation of an innate host defense response to viral infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,active viral induction of innate immune response in host,,,,,biological_process,,active induction of innate immune response in host by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046730,,,,GO:0046738,,,,,,true,,,,true,,,,,GO:0046738,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,induction of innate immune response in host by virus,,,,,,,,,,,,,,,,,,,,,,https://www.nature.com/articles/s41418-020-0530-3,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2349,arteriosclerosis,Arteriosclerotic vascular disease|Arteriosclerosis,An artery disease that is characterized by a thickening and hardening of arterial walls in the arteries.,false,,,http://purl.obolibrary.org/obo/DOID_0050828,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:28960008|MESH:D001161|ICD10CM:I70|UMLS_CUI:C0003850|NCI:C34398,An artery disease that is characterized by a thickening and hardening of arterial walls in the arteries.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Arteriosclerotic vascular disease|Arteriosclerosis,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0050828,,,,DOID:2349,,,,,,,,,,,,,,,DOID:2349,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,arteriosclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000271,Abnormality of the face,Disorder of face|Abnormality of the visage|Abnormality of the physiognomy|Abnormality of the countenance|Abnormality of the face|Facial abnormality|Abnormal face|Disorder of the face|Anomaly of the face|Anomaly of face|Facial anomaly,An abnormality of the face.,false,,,http://purl.obolibrary.org/obo/HP_0000234,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:398302004|SNOMEDCT_US:398206004|SNOMEDCT_US:32003007|UMLS:C1290857|SNOMEDCT_US:118930001|UMLS:C4025871|UMLS:C0266617,An abnormality of the face.,,,,,,,,,,,,,,,,,,,,,,,,,,,,Disorder of face|Abnormality of the visage|Abnormality of the physiognomy|Abnormality of the countenance,,,Abnormality of the face|Facial abnormality|Abnormal face,,,Disorder of the face,,human_phenotype,,Anomaly of the face|Anomaly of face|Facial anomaly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000234,,,,HP:0000271,,,,,,,,,,,,,,,HP:0000271,,http://purl.obolibrary.org/obo/hp.owl,http://purl.oboInOwllibrary.org/oboInOwl/hp#hposlim_core,,,,,,,,,,Abnormality of the face,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0060205,cytoplasmic vesicle lumen,cytoplasmic membrane-bounded vesicle lumen|cytoplasmic membrane-enclosed vesicle lumen,The volume enclosed by a cytoplasmic vesicle.,false,,,http://purl.obolibrary.org/obo/GO_0031983|http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The volume enclosed by a cytoplasmic vesicle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,cytoplasmic membrane-bounded vesicle lumen|cytoplasmic membrane-enclosed vesicle lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0031983|http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0060205,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0060205,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytoplasmic vesicle lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0070972,protein localization to endoplasmic reticulum,protein localisation in endoplasmic reticulum|protein localization in ER|protein localization in endoplasmic reticulum,"A process in which a protein is transported to, or maintained in, a location within the endoplasmic reticulum.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,midori,2009-10-02T12:43:34Z,,,,"A process in which a protein is transported to, or maintained in, a location within the endoplasmic reticulum.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein localisation in endoplasmic reticulum|protein localization in ER|protein localization in endoplasmic reticulum,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0070972,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0070972,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein localization to endoplasmic reticulum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0090026,positive regulation of monocyte chemotaxis,,"Any process that increases the frequency, rate, or extent of monocyte chemotaxis.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,tanyaberardini,2009-08-03T10:18:54Z,,,,"Any process that increases the frequency, rate, or extent of monocyte chemotaxis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0090026,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0090026,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of monocyte chemotaxis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000968,device,,"A material entity that is designed to perform a function in a scientific investigation, but is not a reagent.",false,,,http://purl.obolibrary.org/obo/OBI_0000047,,,instrument,,,,,,,,,,,,,,,,,,"A material entity that is designed to perform a function in a scientific investigation, but is not a reagent.",,OBI development call 2012-12-17.,,,,,,"2012-12-17 JAO: In common lab usage, there is a distinction made between devices and reagents that is difficult to model. Therefore we have chosen to specifically exclude reagents from the definition of ""device"", and are enumerating the types of roles that a reagent can perform.

2013-6-5 MHB: The following clarifications are outcomes of the May 2013 Philly Workshop. Reagents are distinguished from devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in some chemical interaction or reaction during the realization of their experimental role. By contrast, devices do not participate in such chemical reactions/interactions.  Note that there are cases where devices use reagent components during their operation, where the reagent-device distinction is less clear.  For example:

(1) An HPLC machine is considered a device, but has a column that holds a stationary phase resin as an operational component.  This resin qualifies as a device if it participates purely in size exclusion, but bears a reagent role that is realized in the running of a column if it interacts electrostatically or chemically with the evaluant. The container the resin is in (“the column”) considered alone is a device. So the entire column as well as the entire HPLC machine are devices that have a reagent as an operating part.

(2) A pH meter is a device, but its electrode component bears a reagent role in virtue of its interacting directly with the evaluant in execution of an assay.

(3) A gel running  box  is a device that has a metallic lead as a component that participates in a chemical reaction with the running buffer when a charge is passed through it.  This metallic lead is considered to have a reagent role as a component of this device realized in the running of a gel.

In the examples above, a reagent is an operational component of a device, but the device itself does not realize a reagent role (as bearing a reagent role is not transitive across the part_of relation).  In this way, the asserted disjointness between a reagent and device holds, as both roles are never realized in the same bearer during execution of an assay.  ",device,,,,An autoclave is a device that sterlizes instruments or contaminated waste by applying high temperature and pressure.|A voltmeter is a measurement device which is intended to perform some measure function.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,OBI:0000968,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000047,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,device,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Helen Parkinson,,,,
http://purl.obolibrary.org/obo/CHEBI_134743,simeprevir,TMC435350|olysio|TMC-435|simeprevir sodium,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:923604-59-5|Drug_Central:4812,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,TMC435350|olysio|TMC-435|simeprevir sodium,,,,,,,,,0,C38H47N5O7S2,"InChI=1S/C38H47N5O7S2/c1-21(2)30-20-51-35(40-30)29-18-32(26-13-14-31(49-5)22(3)33(26)39-29)50-24-16-27-28(17-24)36(45)43(4)15-9-7-6-8-10-23-19-38(23,41-34(27)44)37(46)42-52(47,48)25-11-12-25/h8,10,13-14,18,20-21,23-25,27-28H,6-7,9,11-12,15-17,19H2,1-5H3,(H,41,44)(H,42,46)/b10-8-/t23-,24-,27-,28-,38-/m1/s1",JTZZSQYMACOLNN-VDWJNHBNSA-N,749.943,749.29169,C1=CCCCCN(C([C@]2([C@](C(N[C@]3([C@]1(C3)[H])C(NS(C4CC4)(=O)=O)=O)=O)(C[C@](C2)(OC5=CC(=NC6=C5C=CC(=C6C)OC)C7=NC(=CS7)C(C)C)[H])[H])[H])=O)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:134743,,,,,true,true,,,,,,,,,CHEBI:134743,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,simeprevir,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_81068,Shikonin,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:517-89-5|KEGG:C17412|LINCS:LSM-6309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,,,,,,,,,,0,C16H16O5,"InChI=1S/C16H16O5/c1-8(2)3-4-10(17)9-7-13(20)14-11(18)5-6-12(19)15(14)16(9)21/h3,5-7,10,17-19H,4H2,1-2H3/t10-/m1/s1",NEZONWMXZKDMKF-SNVBAGLBSA-N,288.29520,288.09977,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:81068,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:81068,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Shikonin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000780,"condensed nuclear chromosome, centromeric region","condensed nuclear chromosome, centric region|condensed nuclear chromosome, centromere|condensed nuclear chromosome, pericentric region","The region of a condensed nuclear chromosome that includes the centromere and associated proteins, including the kinetochore. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.|Note that this term can be used in place of the obsolete cellular component term 'centromere ; GO:0005698'. Use with caution because this term refers to a specific region of the chromosome and not a protein complex.",false,,,http://purl.obolibrary.org/obo/GO_0000779,,,,,,,,,,,,,,,,,,,,,"The region of a condensed nuclear chromosome that includes the centromere and associated proteins, including the kinetochore. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"condensed nuclear chromosome, centric region",,,,,cellular_component,,"condensed nuclear chromosome, centromere|condensed nuclear chromosome, pericentric region",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term can be used in place of the obsolete cellular component term 'centromere ; GO:0005698'. Use with caution because this term refers to a specific region of the chromosome and not a protein complex.,,http://purl.obolibrary.org/obo/GO_0000779,,,,GO:0000780,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000780,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"condensed nuclear chromosome, centromeric region",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0071294,cellular response to zinc ion,cellular response to zinc,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,midori,2009-12-10T04:17:10Z,,,,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular response to zinc,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0071294,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0071294,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cellular response to zinc ion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000081,clinical sign,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,Modified definition,,,Symptoms,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32133578,A clinical finding as opposed to a symptoms which is what the patient report.,,,,,,,,,,,,,,,,clinical sign|clinical signs,,,,,,,,,,,,,,,,,,,,,,https://oxfordmedicine.com/view/10.1093/med/9780199898152.001.0001/med-9780199898152-chapter-26,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007037,TFRC,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TFR1|TFR|TRFR|p90|TR|T9|CD71,,,,,,,3,,,,,,,,,,MIM:190010|Vega:OTTHUMG00000155714|HPRD:01812|HGNC:11763|Ensembl:ENSG00000072274,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,transferrin receptor,,3q29,,,,"GO_0001558 (EC: IMP, Qualifier: NOT, PMID: 7556058); GO_0003725 (EC: IDA); GO_0004998 (EC: NAS, PMID: 1871153); GO_0005515 (EC: IPI, PMID: 10638746); GO_0005576 (EC: IDA, PMID: 1871153); GO_0005615 (EC: IDA); GO_0005768 (EC: IDA, PMID: 14612438); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 6090955); GO_0005905 (EC: IDA, PMID: 12857860); GO_0006879 (EC: NAS, PMID: 1871153); GO_0006879 (EC: TAS); GO_0006898 (EC: NAS, PMID: 1871153); GO_0006898 (EC: TAS, PMID: 10192390); GO_0008233 (EC: IEA); GO_0009897 (EC: IEA); GO_0009986 (EC: IDA, PMID: 7556058); GO_0016020 (EC: NAS, PMID: 1871153); GO_0016023 (EC: IDA, PMID: 15229288); GO_0016032 (EC: IEA); GO_0030316 (EC: IEA); GO_0033572 (EC: TAS); GO_0042127 (EC: IMP, Qualifier: NOT, PMID: 7556058); GO_0042470 (EC: IEA); GO_0042802 (EC: IPI); GO_0043231 (EC: IDA); GO_0044822 (EC: IDA); GO_0045780 (EC: IEA); GO_0048471 (EC: IEA); GO_0055085 (EC: TAS); GO_0070062 (EC: IDA); GO_0072562 (EC: IDA); GO_0097286 (EC: IDA, PMID: 7556058)",PMID: 1380674; 1421756; 1421757; 1871153; 2229063; 2298808; 2327986; 2398066; 2507316; 2874839; 3007223; 3013873; 3568132; 3582362; 6090955; 6094009; 6268632; 6273413; 6309000; 7556058; 7744867; 7780197; 7789520; 7864799; 7994765; 8394993; 8408022; 8631371; 8671324; 9120267; 9136890; 9341758; 9358047; 9414644; 9428630; 9448136; 9465039; 9782058; 10192390; 10377239; 10451539; 10531064; 10638746; 11027676; 11096344; 11702220; 11783942; 11800564; 11891802; 11929045; 11944994; 11988743; 11997026; 12032198; 12071581; 12163483; 12200453; 12210842; 12222675; 12372835; 12406888; 12445428; 12473103; 12477932; 12538733; 12553165; 12667138; 12707725; 12767055; 12857860; 12904899; 14592831; 14612438; 14691533; 14705946; 14705953; 14722085; 14727087; 14752097; 14769051; 14980223; 15047825; 15229288; 15313461; 15349772; 15371488; 15489334; 15525538; 15569681; 15592455; 15623846; 15668490; 15775751; 15784911; 15880641; 15894659; 15924420; 15941956; 15951569; 15987753; 16085060; 16092918; 16271988; 16325581; 16326028; 16332734; 16335952; 16344560; 16354665; 16508012; 16564538; 16704960; 16788758; 16893896; 17059402; 17062801; 17081065; 17125792; 17173037; 17213182; 17287727; 17327328; 17407154; 17493600; 17872946; 17877204; 17927572; 17956864; 17994011; 18003730; 18155160; 18166587; 18218624; 18362144; 18411250; 18445768; 18541582; 18579154; 18586377; 18621559; 18635001; 18665828; 18676680; 18677382; 18694648; 18781797; 19021568; 19066835; 19135902; 19170196; 19223469; 19238537; 19258483; 19290554; 19308738; 19394251; 19471022; 19625176; 19692168; 19693784; 19711434; 19728552; 19738201; 19819738; 19828835; 19838776; 19859668; 19862010; 19864458; 19875448; 19913121; 19917294; 19968988; 20001236; 20041272; 20071291; 20085643; 20086096; 20133674; 20139978; 20161783; 20360068; 20369475; 20424473; 20497464; 20587610; 20604729; 20628086; 20634958; 20716799; 20821024; 20870579; 20880565; 20980512; 21036394; 21081666; 21139048; 21149283; 21165552; 21182205; 21187331; 21252943; 21297444; 21323588; 21384276; 21415701; 21523522; 21674799; 21693764; 21750710; 21788477; 21849092; 21859709; 21870996; 21875946; 21906983; 21922073; 21963094; 21987572; 22090097; 22096579; 22158540; 22167341; 22268729; 22278244; 22304920; 22308388; 22356162; 22505724; 22525445; 22623428; 22750506; 22763969; 22768652; 23016877; 23042282; 23160040; 23222517; 23357852; 23384347; 23384534; 23390091; 23464991; 23606747; 23749212; 23754414; 23798571; 24457600,,,,,,,,,,,,,,,,,,OGG:3000007037,,,,,,,,,,,,,,,,,,,transferrin receptor,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TFRC,,,20140408,7037,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,TFRC,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_10359,Human betaherpesvirus 5,HHV-5|Human cytomegalovirus|human herpesvirus type 5|Human herpesvirus 5,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10358,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HHV-5,,,Human cytomegalovirus,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,human herpesvirus type 5|Human herpesvirus 5,,,,,,NCBITaxon:10359,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10358,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human betaherpesvirus 5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002098,Respiratory distress,Difficulty breathing|Breathing difficulties|Respiratory difficulties|Short of breath|Shortness of breath,"Difficulty in breathing. The physical presentation of respiratory distress is generally referred to as labored breathing, while the sensation of respiratory distress is called shortness of breath or dyspnea.",false,,,http://purl.obolibrary.org/obo/HP_0002094,,,,,,,,,,,,,,,,,,,,MSH:D004417|SNOMEDCT_US:230145002|SNOMEDCT_US:267036007|SNOMEDCT_US:271825005|UMLS:C0013404|UMLS:C0476273,"Difficulty in breathing. The physical presentation of respiratory distress is generally referred to as labored breathing, while the sensation of respiratory distress is called shortness of breath or dyspnea.",,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0002880,,,,Difficulty breathing|Breathing difficulties|Respiratory difficulties,,,,,human_phenotype,,Short of breath|Shortness of breath,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002094,,,,HP:0002098,,,,,,true,,,,,,,shortness of breath|difficulty breathing,,HP:0002098,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Respiratory distress,,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030667,secretory granule membrane,secretory vesicle membrane,The lipid bilayer surrounding a secretory granule.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The lipid bilayer surrounding a secretory granule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,secretory vesicle membrane,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030667,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030667,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,secretory granule membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C2663,Chinese Herbs,Chinese Herbs,Herbs used in Chinese Herbal Therapy for toxicity attenuation. (NCI),false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,C2663,,,,,,,,,,Herbs used in Chinese Herbal Therapy for toxicity attenuation. (NCI),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Chinese Herbs,,,,,,,,,,,,,NCIT:C2663,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32145402,,,traditional Chinese medicine,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Chinese Herbs,Chinese_Herbs,,,,,,,,,,,,,,,38529,38529,,Chinese Herbs,,,,Substance,,,,,,,,C1134558,
http://purl.obolibrary.org/obo/NCIT_C12486,Plasma Cell,Plasma Cell|plasmacyte|Plasmacytes|Plasmocyte|plasmacytic|Plasma Cells|plasma cell,A fully mature B-Cell that produces a specific antibody.,false,,,http://purl.obolibrary.org/obo/CL_0000000,,A type of immune cell that makes large amounts of a specific antibody. Plasmacytes develop from B cells that have been activated.  A plasmacyte is a type of white blood cell.,,,,,,,,,C12486,,,CTRP,,,,,,,A fully mature B-Cell that produces a specific antibody.,,,,,,Plasma Cell,,,,,,,,,,,,,,,,,,,,,,,,,Plasma Cell|plasmacyte|Plasmacytes|Plasmocyte|plasmacytic|Plasma Cells|plasma cell,,,,,,,,,,,,,NCIT:C12486,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142773,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799,,,,,,,,,,Plasma Cell,Plasma_Cell,,,,,,,,,,,,,,,,,,Plasma Cell,,,,Cell,,,,,,,,C0032112,
http://purl.obolibrary.org/obo/OGG_3000051348,KLRF1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CLEC5C|NKp80,,,,,,,12,,,,,,,,,,Vega:OTTHUMG00000168391|HPRD:05432|Ensembl:ENSG00000150045|MIM:605029|HGNC:13342,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"killer cell lectin-like receptor subfamily F, member 1",,12p13.31,,,,"GO_0004888 (EC: TAS, PMID: 10671213); GO_0005887 (EC: TAS, PMID: 10671213); GO_0007166 (EC: TAS, PMID: 10671213); GO_0016020 (EC: TAS, PMID: 10671213); GO_0030246 (EC: IEA); GO_0032393 (EC: TAS, PMID: 10671213)",PMID: 10671213; 11265639; 11513955; 12477932; 15489334; 18922855; 20237496; 21149606; 23609447; 23929856,,,,,,,,,,,,,,,,,,OGG:3000051348,,,,,,,,,,,,,,,,,,,"killer cell lectin-like receptor subfamily F, member 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,KLRF1,,,20140408,51348,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,KLRF1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/BFO_0000002,continuant,,,false,,,http://purl.obolibrary.org/obo/BFO_0000001,,,,,Continuant,continuant,,,,,,,,,,,,,,,,,,,,,,,"Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants|BFO 2 Reference: Continuant entities are entities which can be sliced to yield parts only along the spatial dimension, yielding for example the parts of your table which we call its legs, its top, its nails. ‘My desk stretches from the window to the door. It has spatial parts, and can be sliced (in space) in two. With respect to time, however, a thing is a continuant.’ [60, p. 240",,,"A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])",,,,,,,,,,,(forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002] |(forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002] |(forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002] |(forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001] ,"if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])|if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])|if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])",,,,,,,,,,,,,,,,,,,,,BFO:0000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000001,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,continuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C50678,Occlusion,Occlusive|Occlusal|Occlusion,"Obstruction or a closure of hollow organ, passageway or vessel; also the transient approximation of the edges of a natural opening; imperforation.",false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,"The act of closure or the state of being closed; an obstruction; the relationship between all of the components of the masticatory system in normal function, dysfunction, and parafunction; momentary complete closure of some area in the vocal tract, causing stoppage of the breath and accumulation of pressure.",,,,,,,,,C50678,,,FDA,,,,,,,"Obstruction or a closure of hollow organ, passageway or vessel; also the transient approximation of the edges of a natural opening; imperforation.",,,,,,,,,,,,,,,,Patient Code (Appendix B),,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C3284,,Occlusive|Occlusal|Occlusion,,,,,,,,,,,,,NCIT:C50678,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C54450|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C62596,,,,,,,,,,Occlusion,Occlusion,,,,,,,,,,,,,,,,,,Occlusion,,,,Finding,,,,,,,,C1947917,
http://purl.obolibrary.org/obo/OGG_3000084868,HAVCR2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,KIM-3|HAVcr-2|TIM3|Tim-3|TIMD3|TIMD-3,,,,,,,5,,,,,,,,,,Vega:OTTHUMG00000130249|HPRD:16227|HGNC:18437|Ensembl:ENSG00000135077|MIM:606652,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,hepatitis A virus cellular receptor 2,,5q33.3,,,,GO_0016021 (EC: IEA),PMID: 11725301; 11823861; 12477932; 14556005; 14556006; 14702039; 15153541; 15325803; 15342556; 15489334; 15603868; 15867855; 16159638; 16286920; 16344560; 16456792; 16685421; 16754722; 16940744; 17069754; 17096021; 17207965; 17430399; 17665973; 17703412; 18006747; 18052965; 18294362; 18354161; 18401547; 18485114; 18785518; 19001139; 19005181; 19100864; 19104436; 19258923; 19332093; 19395088; 19414817; 19480659; 19494522; 19566956; 19587053; 19676072; 19768575; 19789190; 19913121; 20083673; 20133006; 20176801; 20331378; 20503287; 20574007; 20628086; 20656318; 20805041; 20811886; 20819923; 21048031; 21084749; 21263071; 21367814; 21382414; 21392402; 21402546; 21446887; 21519864; 21565238; 21621846; 21637332; 21717191; 21807895; 21832049; 21844165; 21989170; 22172823; 22177036; 22294262; 22323453; 22363469; 22371007; 22383801; 22387059; 22426209; 22469568; 22472081; 22505239; 22539292; 22587604; 22733499; 22738814; 22792231; 22842346; 22863785; 22875804; 22968087; 23029209; 23117395; 23144609; 23161469; 23180819; 23291409; 23314411; 23334427; 23335978; 23359271; 23365080; 23385979; 23388728; 23505323; 23526963; 23555248; 23665438; 23773130; 23791624; 23837986; 23866914; 23886204; 23967307; 24007284; 24121505; 24195506,,,,,,,,,,,,,,,,,,OGG:3000084868,,,,,,,,,,,,,,,,,,,hepatitis A virus cellular receptor 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.medrxiv.org/content/10.1101/2020.02.18.20024364v1,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HAVCR2,,,20140408,84868,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,HAVCR2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_292360,SARS Coronavirus CDC#200301157,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:292360,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS Coronavirus CDC#200301157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072006,nephron development,nephrogenesis,"The process whose specific outcome is the progression of the nephron over time, from its formation to the mature structure. A nephron is the functional unit of the kidney.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,midori,2010-01-25T01:37:16Z,,,,"The process whose specific outcome is the progression of the nephron over time, from its formation to the mature structure. A nephron is the functional unit of the kidney.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,nephrogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0072006,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072006,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nephron development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1903364,positive regulation of cellular protein catabolic process,upregulation of cellular protein degradation|upregulation of cellular protein catabolism|upregulation of cellular protein catabolic process|upregulation of cellular protein breakdown|up regulation of cellular protein catabolism|up-regulation of cellular protein catabolism|up-regulation of cellular protein degradation|positive regulation of cellular protein degradation|up regulation of cellular protein breakdown|up regulation of cellular protein degradation|up-regulation of cellular protein breakdown|positive regulation of cellular protein breakdown|up-regulation of cellular protein catabolic process|up regulation of cellular protein catabolic process|positive regulation of cellular protein catabolism|positive regulation of cyclin breakdown|activation of cellular protein breakdown|positive regulation of cyclin degradation|positive regulation of cyclin catabolic process|activation of cellular protein catabolic process|activation of cellular protein catabolism|positive regulation of cyclin catabolism|positive regulation of degradation of cyclin|activation of cellular protein degradation,"Any process that activates or increases the frequency, rate or extent of cellular protein catabolic process.",false,,,http://purl.obolibrary.org/obo/GO_1903362|http://purl.obolibrary.org/obo/GO_0031331|http://purl.obolibrary.org/obo/GO_0045732,,,,,,,,,,,,,,,,kmv,2014-08-21T15:06:01Z,,,,"Any process that activates or increases the frequency, rate or extent of cellular protein catabolic process.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:2000600,,,,upregulation of cellular protein degradation|upregulation of cellular protein catabolism|upregulation of cellular protein catabolic process|upregulation of cellular protein breakdown|up regulation of cellular protein catabolism|up-regulation of cellular protein catabolism|up-regulation of cellular protein degradation|positive regulation of cellular protein degradation|up regulation of cellular protein breakdown|up regulation of cellular protein degradation|up-regulation of cellular protein breakdown|positive regulation of cellular protein breakdown|up-regulation of cellular protein catabolic process|up regulation of cellular protein catabolic process|positive regulation of cellular protein catabolism,,,positive regulation of cyclin breakdown|activation of cellular protein breakdown|positive regulation of cyclin degradation|positive regulation of cyclin catabolic process|activation of cellular protein catabolic process|activation of cellular protein catabolism|positive regulation of cyclin catabolism|positive regulation of degradation of cyclin|activation of cellular protein degradation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1903362|http://purl.obolibrary.org/obo/GO_0031331|http://purl.obolibrary.org/obo/GO_0045732,,,,GO:1903364,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903364,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cellular protein catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012418,Hypoxemia,Low blood oxygen level|Hypoxia,An abnormally low level of blood oxygen.|Note that hypoxemia is defined as a condition where arterial oxygen tension is below normal (80-100mmHg). Hypoxia is defined as the failure of oxygenation at the tissue level. Hypoxia is not measured directly by a standard laboratory value.,false,,,http://purl.obolibrary.org/obo/HP_0500165,,,,,,,,,,,,,,,,peter,2013-11-10T05:07:07Z,,,SNOMEDCT_US:389087006|MSH:D000860|UMLS:C0700292,An abnormally low level of blood oxygen.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Low blood oxygen level,,,,,human_phenotype,,Hypoxia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that hypoxemia is defined as a condition where arterial oxygen tension is below normal (80-100mmHg). Hypoxia is defined as the failure of oxygenation at the tissue level. Hypoxia is not measured directly by a standard laboratory value.,,http://purl.obolibrary.org/obo/HP_0500165,,,,HP:0012418,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32172669,,,,HP:0012418,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Hypoxemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000777,condensed chromosome kinetochore,,A multisubunit complex that is located at the centromeric region of a condensed chromosome and provides an attachment point for the spindle microtubules.,false,,,http://purl.obolibrary.org/obo/GO_0000776,,,,,,,,,,,,,,,,,,,,,A multisubunit complex that is located at the centromeric region of a condensed chromosome and provides an attachment point for the spindle microtubules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000776,,,,GO:0000777,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000777,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,condensed chromosome kinetochore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_5364,pulmonary coin lesion,Coin lesion of lung|Coin lesion lung,,false,,,http://purl.obolibrary.org/obo/DOID_3683,,,,,,,,,,,,,,,,,,,,MESH:D003074|ICD10CM:R91.1|SNOMEDCT_US_2019_09_01:308689002|UMLS_CUI:C0009250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Coin lesion of lung|Coin lesion lung,,,,,disease_ontology,,,,,,,,,"A single lung lesion that is characterized by a small round mass of tissue, usually less than 1 cm in diameter, and can be detected by chest radiography. A solitary pulmonary nodule can be associated with neoplasm, tuberculosis, cyst, or other anomalies in the lung, the chest wall, or the pleura.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_3683,,,,DOID:5364,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216961/,,,,DOID:5364,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,pulmonary coin lesion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006090,pyruvate metabolic process,pyruvate metabolism|pyruvate dehydrogenase bypass,"The chemical reactions and pathways involving pyruvate, 2-oxopropanoate.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Pyruvic_acid|MetaCyc:P41-PWY,"The chemical reactions and pathways involving pyruvate, 2-oxopropanoate.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0006087,,,,pyruvate metabolism,,,,,biological_process,,pyruvate dehydrogenase bypass,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006090,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006090,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pyruvate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043648,dicarboxylic acid metabolic process,dicarboxylate metabolic process|dicarboxylate metabolism|dicarboxylic acid metabolism,"The chemical reactions and pathways involving dicarboxylic acids, any organic acid containing two carboxyl (COOH) groups or anions (COO-).",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving dicarboxylic acids, any organic acid containing two carboxyl (COOH) groups or anions (COO-).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,dicarboxylate metabolic process|dicarboxylate metabolism|dicarboxylic acid metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0043648,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043648,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,dicarboxylic acid metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_87211,fluoroquinolone antibiotic,fluoroquinolone antibiotics,An organonitrogen heterocyclic antibiotic containing a quinolone (or quinolone-like) moiety and which have a fluorine atom attached to the central ring system.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:25226071|PMID:8386356|PMID:24947193,An organonitrogen heterocyclic antibiotic containing a quinolone (or quinolone-like) moiety and which have a fluorine atom attached to the central ring system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,fluoroquinolone antibiotics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:87211,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,fluoroquinolones,,CHEBI:87211,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,fluoroquinolone antibiotic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0033048,negative regulation of mitotic sister chromatid segregation,,"Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid segregation during mitosis.",false,,,http://purl.obolibrary.org/obo/GO_0033046|http://purl.obolibrary.org/obo/GO_0045839|http://purl.obolibrary.org/obo/GO_0033047,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid segregation during mitosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033046|http://purl.obolibrary.org/obo/GO_0045839|http://purl.obolibrary.org/obo/GO_0033047,,,,GO:0033048,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033048,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of mitotic sister chromatid segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00837844,Baloxavir marboxil,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2099995,,,,DRON:00837844,"An orally bioavailable prodrug and influenza cap-dependent endonuclease (CEN) inhibitor, with antiviral activity. Upon administration of baloxavir marboxil, the agent is converted by hydrolysis to its active metabolite baloxavir. Baloxavir targets, binds to and inhibits the CEN activity of the influenza polymerase acidic (PA) protein, an influenza virus-specific enzyme in the viral RNA polymerase complex required for the initiation of influenza gene transcription.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32205870,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,Baloxavir marboxil,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0040133,Abnormal serum ferritin,Abnormal plasma ferritin|Abnormal serum ferritin,"A deviation from the normal circulating concentration of ferritin. Ferritin concentration can be measured in serum or plasma.|Ferritin is an iron storage protein present in all cells of the organism. A small amount is found in plasma and serum, which is a reflection of iron stores in healthy individuals. A low serum ferritin concentration is usually regarded as an indicator of iron depletion, although the interpretation of normal or high serum ferritin values is challenging in the presence of acute or chronic inflammatory processes, as ferritin is increased in iron overload states and inflammation.",false,,,http://purl.obolibrary.org/obo/HP_0010876,,,,,,,,,,,,,,,,HPO:skoehler,,,,UMLS:C0853228,A deviation from the normal circulating concentration of ferritin. Ferritin concentration can be measured in serum or plasma.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal plasma ferritin|Abnormal serum ferritin,,,,,,,,,,,,,HP:0040133,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Ferritin is an iron storage protein present in all cells of the organism. A small amount is found in plasma and serum, which is a reflection of iron stores in healthy individuals. A low serum ferritin concentration is usually regarded as an indicator of iron depletion, although the interpretation of normal or high serum ferritin values is challenging in the presence of acute or chronic inflammatory processes, as ferritin is increased in iron overload states and inflammation.",,http://purl.obolibrary.org/obo/HP_0010876,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal serum ferritin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000010220,GDF11,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,BMP-11|BMP11,,,,,,,12,,,,,,,,,,MIM:603936|Ensembl:ENSG00000135414|HPRD:04895|Vega:OTTHUMG00000170188|HGNC:4216,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,growth differentiation factor 11,,12q13.2,,,,"GO_0001501 (EC: TAS, PMID: 10391213); GO_0001656 (EC: IEA); GO_0001657 (EC: IEA); GO_0005125 (EC: IEA); GO_0005575 (EC: ND); GO_0005615 (EC: IEA); GO_0007399 (EC: TAS, PMID: 10075854); GO_0007498 (EC: TAS, PMID: 10075854); GO_0008083 (EC: IEA); GO_0008285 (EC: IEA); GO_0021512 (EC: IEA); GO_0031016 (EC: IEA); GO_0040007 (EC: IEA); GO_0045596 (EC: IEA); GO_0048469 (EC: IEA); GO_0048593 (EC: IEA)",PMID: 8889549; 10075854; 10391213; 10508689; 15988002; 16845371; 17912435; 17997109; 18519639; 18535106; 18596030; 19751112; 20734064,,,,,,,,,,,,,,,,,,OGG:3000010220,,,,,,,,,,,,,,,,,,,growth differentiation factor 11,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GDF11,,,20140408,10220,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,GDF11,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_9635,toremifene,"2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine|toremifene|toremifenum|toremifeno",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:EP95875|CAS:89778-26-7|Drug_Central:2709|DrugBank:DB00539|KEGG:C08166|KEGG:D08620|Patent:US4696949|Wikipedia:Toremifene,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine",,,,,chebi_ontology,,toremifene|toremifenum|toremifeno,,,,,,,,,0,C26H28ClNO,"InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-",XFCLJVABOIYOMF-QPLCGJKRSA-N,405.95936,405.18594,CN(C)CCOc1ccc(cc1)C(c1ccccc1)=C(\CCCl)c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9635,,,,,,true,,,,,,,,,CHEBI:9635,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,toremifene,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003538,IGLC2,,,false,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,IGLC,,,,,,,22,,,,,,,,,,IMGT/GENE-DB:IGLC2|HGNC:5856,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,immunoglobulin lambda constant 2 (Kern-Oz- marker),,22q11.2,,,,"GO_0003823 (EC: IEA); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005886 (EC: TAS); GO_0006956 (EC: TAS); GO_0006958 (EC: TAS); GO_0038095 (EC: TAS); GO_0038096 (EC: TAS); GO_0045087 (EC: TAS); GO_0050776 (EC: TAS); GO_0070062 (EC: IDA, PMID: 19199708); GO_0072562 (EC: IDA)",PMID: 814163; 1249422; 2115572; 2515285; 3122211; 4215080; 4415202; 4814727; 4883841; 4909564; 5549568; 6273747; 6404900; 7737190; 9074928; 11955599; 12077254; 12477932; 19199708; 20637260,,,,,,,,,,,,,,,,,,OGG:3000003538,,,,,,,,,,,,,,,,,,,immunoglobulin lambda constant 2 (Kern-Oz- marker),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IGLC2,,,20140408,3538,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,IGLC2,,"Bin Zhao, Yue Liu, Oliver He",,other,,
http://purl.obolibrary.org/obo/GO_0006733,oxidoreduction coenzyme metabolic process,oxidoreduction coenzyme metabolism,"The chemical reactions and pathways involving coenzymes that are required, in addition to an enzyme and a substrate, for an oxidoreductase reaction to proceed.",false,,,http://purl.obolibrary.org/obo/GO_0006732,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving coenzymes that are required, in addition to an enzyme and a substrate, for an oxidoreductase reaction to proceed.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,oxidoreduction coenzyme metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006732,,,,GO:0006733,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006733,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,oxidoreduction coenzyme metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006260,DNA replication,,"The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA.|DNA biosynthesis is only part of this process. See also the biological process terms 'DNA-dependent DNA replication ; GO:0006261' and 'RNA-dependent DNA replication ; GO:0006278'.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:DNA_replication,"The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0055133,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,DNA biosynthesis is only part of this process. See also the biological process terms 'DNA-dependent DNA replication ; GO:0006261' and 'RNA-dependent DNA replication ; GO:0006278'.,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006260,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006260,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,DNA replication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000051,N-terminal domain (SARS-CoV-2),,,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N-terminal domain (NTD) of SARS Cov2 is part of spike protein which functions as a receptor-binding entity.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,modified definition,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://pubmed.ncbi.nlm.nih.gov/32275855/|https://www.ncbi.nlm.nih.gov/pubmed/32231345,,,,,,,,,,,,,,,,,N-terminal domain (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305408,SARS coronavirus B029,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305408,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus B029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0031695,Severe parainfluenza infection,,An unusually severe infection by a parainfluenza virus.,false,,,http://purl.obolibrary.org/obo/HP_0031691,,,,,,,,,,,,,,,,peter,,,,,An unusually severe infection by a parainfluenza virus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0031695,,,,,,,,,,,,,,,,,,2017-12-17T22:38:29Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0031691,,,,,,,,,,,,true,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,parainfluenza,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Severe parainfluenza infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2501931,Orthocoronavirinae,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_11118,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_subfamily,,,,,,,NCBITaxon:2501931,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_11118,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Orthocoronavirinae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0099572,postsynaptic specialization,,"A network of proteins within and adjacent to the postsynaptic membrane. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"A network of proteins within and adjacent to the postsynaptic membrane. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0099572,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0099572,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_synapse,,,,,,,,,,postsynaptic specialization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0090307,mitotic spindle assembly,spindle assembly involved in mitosis,"Mitotic bipolar spindle assembly begins with spindle microtubule nucleation from the separated spindle pole body, includes spindle elongation during prometaphase, and is complete when all kinetochores are stably attached the spindle, and the spindle assembly checkpoint is satisfied.",false,,,http://purl.obolibrary.org/obo/GO_0007052|http://purl.obolibrary.org/obo/GO_0051225,,,,,,,,,,,,,,,,tanyaberardini,2010-04-09T11:31:28Z,,,,"Mitotic bipolar spindle assembly begins with spindle microtubule nucleation from the separated spindle pole body, includes spindle elongation during prometaphase, and is complete when all kinetochores are stably attached the spindle, and the spindle assembly checkpoint is satisfied.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,spindle assembly involved in mitosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007052|http://purl.obolibrary.org/obo/GO_0051225,,,,GO:0090307,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0090307,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic spindle assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_90926,tenofovir alafenamide,propan-2-yl N-[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl]-L-alaninate|GS 7340|tenofovir alafenamide|GS-7340|TAF,"An L-alanine derivative that is isopropyl L-alaninate in which one of the amino hydrogens is replaced by an (S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl group. A prodrug for tenofovir, it is used (as the fumarate salt) in combination therapy for the treatment of HIV-1 infection.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:8948831|CAS:379270-37-8|Wikipedia:Tenofovir_alafenamide|Drug_Central:4944|KEGG:D10428|DrugBank:DB09299,"An L-alanine derivative that is isopropyl L-alaninate in which one of the amino hydrogens is replaced by an (S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl group. A prodrug for tenofovir, it is used (as the fumarate salt) in combination therapy for the treatment of HIV-1 infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,propan-2-yl N-[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)(phenoxy)phosphoryl]-L-alaninate,,,,,chebi_ontology,,GS 7340|tenofovir alafenamide|GS-7340|TAF,,,,,,,,,0,C21H29N6O5P,"InChI=1S/C21H29N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24)/t15-,16+,33+/m1/s1",LDEKQSIMHVQZJK-CAQYMETFSA-N,476.467,476.19371,N1=CN=C2C(=C1N)N=CN2C[C@H](OC[P@](N[C@H](C(OC(C)C)=O)C)(=O)OC3=CC=CC=C3)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:90926,,,,,,,,,,,,,,,CHEBI:90926,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tenofovir alafenamide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2042697,SARS-related bat coronavirus RsSHC014,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:2042697,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS-related bat coronavirus RsSHC014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258965,SARS coronavirus TW2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258965,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C78251,Cytokine Release Syndrome,Cytokine Release Syndrome|Cytokine release syndrome,"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.",false,,,http://purl.obolibrary.org/obo/DOID_225,,"A systemic inflammatory reaction caused by the release of an excessive amount of cytokines into the circulation by activated T-cells.|A disorder characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath; it is caused by the release of cytokines from the cells.",,,,,,,,,C78251,,,MedDRA|NICHD,,,,,,,"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cytokine Release Syndrome|Cytokine release syndrome,,,,http://purl.obolibrary.org/obo/NCIT_C3507,,,,,,,,,NCIT:C78251,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_225,,,,,,,,,,true,,,,,,,cytokine storm syndrome,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118464,,,,,,,,,,Cytokine Release Syndrome,Cytokine_Release_Syndrome,Cytokine release syndrome,,,,,,Cytokine Release Syndrome,,,,,,,,,,,Cytokine Release Syndrome,,,https://doi.org/10.1016/S0140-6736(20)30628-0,Disease or Syndrome,,,,,,,,C0948245,
http://purl.obolibrary.org/obo/NCIT_C17456,Experimental Model,"Experimental Model|Experimental Models, Other",,false,,,http://purl.obolibrary.org/obo/NCIT_C80519,,,,,,,,,,,C17456,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Experimental Model|Experimental Models, Other",,,,,,,,,,,,,NCIT:C17456,"Animals that are employed to model the development and progression of diseases, and to test new treatments before they are given to humans",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C80519,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Experimental Model,Experimental_Model,,,,,,,,,,,,,,,,,,Experimental Model,,,,Intellectual Product,,,,,,,,C0086272,
http://purl.obolibrary.org/obo/TRANS_0000008,droplet spread,,"Droplet spread transmission is a direct transmission process during which the pathogen is transmitted from a reservoir, source or host to another host by spray of aerosols over a short distance, spray from sneezing, coughing or talking.",false,,,http://purl.obolibrary.org/obo/TRANS_0000001,,,,,,,,,,,,,,,,,,,,,"Droplet spread transmission is a direct transmission process during which the pathogen is transmitted from a reservoir, source or host to another host by spray of aerosols over a short distance, spray from sneezing, coughing or talking.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,transmission_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/TRANS_0000001,,,,TRANS:0000008,,,,,,true,,,,,,,,,TRANS:0000008,,http://purl.obolibrary.org/obo/trans.owl,,,,,,,,,,,droplet spread,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000009241,NOG,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SYM1|SYNS1,,,,,,,17,,,,,,,,,,HGNC:7866|Ensembl:ENSG00000183691|MIM:602991|HPRD:04291|Vega:OTTHUMG00000151770,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,noggin,,17q22,,,,"GO_0000122 (EC: IEA); GO_0001501 (EC: TAS, PMID: 10080184); GO_0001649 (EC: ISS); GO_0001701 (EC: IEA); GO_0001706 (EC: IEA); GO_0001707 (EC: IEA); GO_0001837 (EC: ISS); GO_0001839 (EC: IEA); GO_0001843 (EC: IEA); GO_0005515 (EC: IPI, PMID: 19804412); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 11562478); GO_0007399 (EC: TAS, PMID: 7666191); GO_0008045 (EC: IEA); GO_0009953 (EC: IDA, PMID: 7666191); GO_0019955 (EC: IPI, PMID: 8752214); GO_0021510 (EC: IEA); GO_0021533 (EC: IMP, PMID: 8582276); GO_0021983 (EC: IEA); GO_0030336 (EC: IDA); GO_0030509 (EC: TAS); GO_0030514 (EC: IDA, PMID: 10780858); GO_0030514 (EC: ISS); GO_0035019 (EC: IMP, PMID: 17889703); GO_0042060 (EC: ISS); GO_0042474 (EC: IMP, PMID: 10080184); GO_0042733 (EC: IMP, PMID: 10080184); GO_0042803 (EC: IDA, PMID: 11562478); GO_0045668 (EC: IDA); GO_0045944 (EC: IEA); GO_0048318 (EC: IEA); GO_0048570 (EC: IEA); GO_0048706 (EC: IMP, PMID: 10080184); GO_0048712 (EC: ISS); GO_0050679 (EC: IEA); GO_0051216 (EC: IEA); GO_0060044 (EC: ISS); GO_0060173 (EC: IMP, PMID: 10080184); GO_0060272 (EC: IMP, PMID: 16151340); GO_0060302 (EC: IPI, PMID: 8752214); GO_0060325 (EC: IEA); GO_0060394 (EC: IDA, PMID: 15539560); GO_0060425 (EC: IEA); GO_0060513 (EC: IEA); GO_0060676 (EC: IEA); GO_0060825 (EC: IMP, PMID: 8582276); GO_0061037 (EC: IEA); GO_0061053 (EC: IEA); GO_0071773 (EC: IEA); GO_0090090 (EC: IDA, PMID: 15539560); GO_0090190 (EC: ISS); GO_0090193 (EC: ISS); GO_2000313 (EC: IMP, PMID: 8582276); GO_2001234 (EC: IEA)",PMID: 7557985; 7666191; 8582276; 8752214; 9585504; 9603738; 9634519; 10080184; 10087923; 10657699; 10780858; 11545688; 11562478; 11580864; 11706034; 11846737; 11857750; 12089654; 12115893; 12404109; 12477932; 12478285; 12621334; 14999064; 15064755; 15264296; 15489334; 15539560; 15621726; 15756420; 16126463; 16151340; 16532400; 17029022; 17138967; 17200191; 17218603; 17668388; 17696196; 17889703; 18019378; 18204269; 18391951; 18537141; 18560367; 18931653; 19023570; 19058174; 19167531; 19400542; 19453261; 19597895; 19692649; 19700758; 19804412; 20023658; 20048150; 20503332; 20546612; 20645637; 20734064; 20881960; 21111488; 21249149; 22083168; 22288654; 22364398; 22503063; 22529972; 22547073; 22621191; 22628200; 22740073; 23483047; 23732071; 23826422; 23936387; 24170657,,,,,,,,,,,,,,,,,,OGG:3000009241,,,,,,,,,,,,,,,,,,,noggin,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,NOG,,,20140408,9241,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,NOG,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_1503296,BtRf-BetaCoV/HeB2013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1503296,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,BtRf-BetaCoV/HeB2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0040085,bacterial sepsis,,A bacterial infectious disease has_material_basis_in Bacteria.,false,,,http://purl.obolibrary.org/obo/DOID_104,,,,,,,,,,,,,,,,,,,,ICD9CM:995.91|SNOMEDCT_US_2020_03_01:10001005,A bacterial infectious disease has_material_basis_in Bacteria.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_104,,,,DOID:0040085,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,,,,DOID:0040085,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_IEDB_slim,,,,,,,,,,bacterial sepsis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_25805,oxygen atom,oxygen|oxygen|oxygene|Sauerstoff|O|oxigeno|8O,,false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,KEGG:C00007|WebElements:O,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,oxygen,,,,,chebi_ontology,,oxygen|oxygene|Sauerstoff|O|oxigeno|8O,,,,,,,,,0,O,InChI=1S/O,QVGXLLKOCUKJST-UHFFFAOYSA-N,15.99940,15.99491,[O],,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,CHEBI:25805,,,,,,true,,,,,,,oxygen,,CHEBI:25805,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,oxygen atom,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011111,Abnormality of immune serum protein physiology,,An abnormality of the concentration or function of circulating immune proteins.,false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,peter,2011-06-12T08:58:47Z,,,UMLS:C4023536,An abnormality of the concentration or function of circulating immune proteins.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,HP:0011111,,,,,,,,,,,,,,,HP:0011111,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of immune serum protein physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000023,role,,,false,,,http://purl.obolibrary.org/obo/BFO_0000017,,,,,Role,role,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: One major family of examples of non-rigid universals involves roles, and ontologies developed for corresponding administrative purposes may consist entirely of representatives of entities of this sort. Thus ‘professor’, defined as follows,b instance_of professor at t =Def. there is some c, c instance_of professor role & c inheres_in b at t.denotes a non-rigid universal and so also do ‘nurse’, ‘student’, ‘colonel’, ‘taxpayer’, and so forth. (These terms are all, in the jargon of philosophy, phase sortals.) By using role terms in definitions, we can create a BFO conformant treatment of such entities drawing on the fact that, while an instance of professor may be simultaneously an instance of trade union member, no instance of the type professor role is also (at any time) an instance of the type trade union member role (any more than any instance of the type color is at any time an instance of the type length).If an ontology of employment positions should be defined in terms of roles following the above pattern, this enables the ontology to do justice to the fact that individuals instantiate the corresponding universals –  professor, sergeant, nurse – only during certain phases in their lives.",,,"b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])",,"the student role|the role of a building in serving as a military target|the priest role|John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married.|the role of subject in a clinical trial|the role of a stone in marking a property boundary|the role of a boundary to demarcate two neighboring administrative territories",,,,,,,,,(forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000023,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000017,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,role,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000020,COVID-19 suppression,,,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,Modified definition,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32245346,Strategies for mitigation and suppression of COVID -19.,Suppression of COVID-19,,,,,,,,,,,,,,,COVID-19 suppression,,,,,,,,,,,,,,,,,,,,,,https://www.preventionweb.net/publications/view/71077,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_228407,SARS coronavirus BJ01,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:228407,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/15629030,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264370,SARS coronavirus TW,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264370,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000049,severe acute respiratory syndrome coronavirus 2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,The coronavirus (Severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus) that is the causative agent of COVID-19,2019-nCoV|SARS-CoV-2,,,,,,,,,,,,,,,severe acute respiratory syndrome coronavirus 2,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_2697049,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003110,Abnormality of urine homeostasis,Pee issues|Urine issues,An abnormality of the composition of urine or the levels of its components.,false,,,http://purl.obolibrary.org/obo/HP_0001939|http://purl.obolibrary.org/obo/HP_0011277,,,,,,,,,,,,,,,,,,,,UMLS:C4025655,An abnormality of the composition of urine or the levels of its components.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0011865|HP:0011866,,,,Pee issues|Urine issues,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001939|http://purl.obolibrary.org/obo/HP_0011277,,,,HP:0003110,,,,,,,,,,,,,,,HP:0003110,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of urine homeostasis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002243,FGA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,Fib2,,,,,,,4,,,,,,,,,,HGNC:3661|Vega:OTTHUMG00000150330|Ensembl:ENSG00000171560|MIM:134820|HPRD:00619,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,fibrinogen alpha chain,,4q28,,,,"GO_0002576 (EC: TAS); GO_0005102 (EC: IEA); GO_0005515 (EC: IPI, PMID: 10954706); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0005577 (EC: IEA); GO_0005615 (EC: IDA, PMID: 6777381); GO_0005886 (EC: TAS); GO_0005938 (EC: IEA); GO_0007165 (EC: IEA); GO_0007596 (EC: TAS); GO_0009897 (EC: IDA, PMID: 6777381); GO_0009986 (EC: IDA, PMID: 6777381); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0030674 (EC: IEA); GO_0031091 (EC: IDA, PMID: 6777381); GO_0031093 (EC: TAS); GO_0051258 (EC: IEA); GO_0051592 (EC: IDA, PMID: 6777381); GO_0070062 (EC: IDA, PMID: 19056867); GO_0072562 (EC: IDA)",PMID: 518845; 518846; 632262; 936108; 1391954; 1457396; 1560020; 1587268; 1634621; 1675636; 1680863; 1912564; 2070049; 2102623; 2133223; 2133234; 2367530; 2738154; 2742826; 2877981; 3088041; 3345340; 3590111; 3618591; 4052020; 4084461; 4250289; 5084810; 5645286; 6165239; 6266066; 6318767; 6383194; 6500566; 6575389; 6575700; 6688355; 6689067; 6719396; 6777381; 7298640; 7356959; 8097946; 8140431; 8384496; 8400261; 8461606; 8473507; 8589203; 8636415; 8639778; 8675656; 8939956; 8944230; 9276466; 9333233; 9389696; 9485375; 9628725; 9689040; 9867861; 10074346; 10391209; 10467729; 10602365; 10605720; 10891444; 10913112; 10954706; 10956659; 10963790; 11054085; 11159525; 11170397; 11435303; 11460491; 11460506; 11546832; 11562340; 11583334; 11739173; 11776317; 11833854; 11858505; 11900554; 11914657; 12009908; 12050338; 12117709; 12119191; 12193970; 12356313; 12358944; 12406899; 12430881; 12477932; 12617173; 12665801; 12707238; 12729597; 12871600; 12878203; 14615374; 14667819; 14718574; 14746139; 14751930; 15166913; 15174051; 15203218; 15217804; 15311936; 15346842; 15637140; 15735812; 15795540; 15795809; 15831156; 15865460; 15968394; 16005629; 16086292; 16144795; 16210568; 16263253; 16324093; 16335952; 16362348; 16466010; 16468976; 16525568; 16581250; 16614319; 16698114; 16706972; 16712791; 16807684; 16881935; 16894470; 16928957; 16939214; 16940416; 17241179; 17263791; 17264959; 17275949; 17295221; 17303222; 17408411; 17408725; 17414213; 17433418; 17565234; 17568659; 17591786; 17596138; 17630702; 17643375; 17650077; 17688324; 17701467; 17849064; 17849175; 17951283; 17982313; 17994314; 18057060; 18202324; 18208536; 18227259; 18278190; 18294856; 18331453; 18500534; 18676163; 18690352; 18772067; 18842294; 18848323; 18974842; 19056867; 19136375; 19143925; 19190816; 19350124; 19412134; 19420105; 19429776; 19468208; 19471022; 19507189; 19515723; 19572064; 19631771; 19696023; 19698251; 19718467; 19729601; 19750100; 19899640; 19913121; 19923982; 19928926; 19948975; 19967163; 20019599; 20031577; 20051841; 20059469; 20128871; 20167083; 20217997; 20218626; 20237496; 20360068; 20416077; 20533267; 20628086; 20677013; 20709368; 20806111; 20829681; 21063468; 21190511; 21190668; 21192254; 21224475; 21245743; 21248064; 21258858; 21459789; 21464904; 21502573; 21694469; 21757653; 21800001; 21806028; 21891970; 21932842; 21980494; 22342352; 22397628; 22407772; 22489912; 22552295; 22639050; 22642105; 22705885; 22713578; 22795623; 22819533; 22836683; 23020230; 23056168; 23061815; 23224113; 23238100; 23303819; 23314748; 23551149; 23612884; 23639427; 23725126; 23750785; 23852822; 23877568; 23894515; 23958299; 23969696,,,,,,,,,,,,,,,,,,OGG:3000002243,,,,,,,,,,,,,,,,,,,fibrinogen alpha chain,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,fibrinogen,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FGA,,,20140408,2243,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,FGA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0000778,condensed nuclear chromosome kinetochore,,A multisubunit complex that is located at the centromeric region of a condensed nuclear chromosome and provides an attachment point for the spindle microtubules.,false,,,http://purl.obolibrary.org/obo/GO_0000777,,,,,,,,,,,,,,,,,,,,,A multisubunit complex that is located at the centromeric region of a condensed nuclear chromosome and provides an attachment point for the spindle microtubules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000777,,,,GO:0000778,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000778,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,condensed nuclear chromosome kinetochore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002532,production of molecular mediator involved in inflammatory response,production of molecular mediator involved in acute inflammatory response|production of cellular mediator of acute inflammation,"The synthesis or release of any molecular mediator of the inflammatory response following an inflammatory stimulus, resulting in an increase in its intracellular or extracellular levels.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The synthesis or release of any molecular mediator of the inflammatory response following an inflammatory stimulus, resulting in an increase in its intracellular or extracellular levels.",,,,,,,,,,,,,,,,,,,,,,,,,,,,production of molecular mediator involved in acute inflammatory response,,,,,,,,biological_process,,production of cellular mediator of acute inflammation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0002532,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002532,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,production of molecular mediator involved in inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_28775,hesperidin,"hesperidin|Hesperidin|(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside|Cirantin|Hesperetin 7-O-rutinoside|Ciratin|Hesperidoside|(S)-(-)-hesperidin",A disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,MetaCyc:CPD-7075|Beilstein:75140|DrugBank:DB04703|KEGG:C09755|HMDB:HMDB0003265|Reaxys:75140|Wikipedia:Hesperidin|KEGG:D01038|KNApSAcK:C00000970|LINCS:LSM-2858|CAS:520-26-3,A disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:24530|CHEBI:5682,,,,"hesperidin|Hesperidin|(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside",,,,,chebi_ontology,,Cirantin|Hesperetin 7-O-rutinoside|Ciratin|Hesperidoside|(S)-(-)-hesperidin,,,,,,,,,0,C28H34O15,"InChI=1S/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7,10,17,19,21-30,32-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1",QUQPHWDTPGMPEX-QJBIFVCTSA-N,610.56056,610.18977,COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:28775,,,,,true,true,,,,,,,,,CHEBI:28775,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,hesperidin,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000001,entity,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,Entity,entity,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: In all areas of empirical inquiry we encounter general terms of two sorts. First are general terms which refer to universals or types:animaltuberculosissurgical procedurediseaseSecond, are general terms used to refer to groups of entities which instantiate a given universal but do not correspond to the extension of any subuniversal of that universal because there is nothing intrinsic to the entities in question by virtue of which they – and only they – are counted as belonging to the given group. Examples are: animal purchased by the Emperortuberculosis diagnosed on a Wednesdaysurgical procedure performed on a patient from Stockholmperson identified as candidate for clinical trial #2056-555person who is signatory of Form 656-PPVpainting by Leonardo da VinciSuch terms, which represent what are called ‘specializations’ in [81|Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf",,,An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001]),,the Second World War|Julius Caesar|Verdi’s Requiem|your body mass index,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BFO:0000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ogg.owl|http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,entity|entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000124,seizure,seizure,,false,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,seizure,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,SYMP:0000124,,,,,,true,,,,,,"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.",,,SYMP:0000124,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,seizure,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C82254,Maribavir,NTBC|maribavir|MARIBAVIR|BW 1263W94|Maribavir|Benzimidazol-2-amine,"An orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,A substance that blocks the ability of viruses to make new viruses and infect cells. It is being studied in the prevention of cytomegalovirus infection in cancer patients who have had a donor stem cell transplant. It is a type of antiviral agent.,,,,,176161-24-3,,C15H19Cl2N3O4,,C82254,,,CTRP|FDA,,,,,,,"An orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.",,,,,,Maribavir,,,,,,,,,,,PTB4X93HE1,,,,,,,,,,,,,,NTBC|maribavir|MARIBAVIR|BW 1263W94|Maribavir|Benzimidazol-2-amine,,,,,,,,,,,,,NCIT:C82254,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Maribavir,Maribavir,,,,,,,,,,,,,,,429563,429563,,Maribavir,,,,Pharmacologic Substance,,,,,,,,C1508759,
http://purl.obolibrary.org/obo/OGG_3000003576,IL8,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LECT|GCP1|MDNCF|NAP-1|NAP1|MONAP|LUCT|NAF|LYNAP|CXCL8|GCP-1,,,,,,,4,,,,,,,,,,MIM:146930|HPRD:00909|HGNC:6025|Vega:OTTHUMG00000151316|Ensembl:ENSG00000169429,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 8,,4q13-q21,,,,"GO_0001525 (EC: TAS, PMID: 11483765); GO_0002237 (EC: IDA, PMID: 19912257); GO_0005153 (EC: IPI, PMID: 1840701); GO_0005515 (EC: IPI, PMID: 10880251); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006928 (EC: TAS, PMID: 10820279); GO_0006935 (EC: TAS, PMID: 12782716); GO_0006954 (EC: TAS, PMID: 11483765); GO_0006955 (EC: IEA); GO_0006987 (EC: TAS); GO_0007050 (EC: IDA, PMID: 11564821); GO_0007165 (EC: TAS, PMID: 10820279); GO_0007186 (EC: TAS, PMID: 8381837); GO_0008009 (EC: TAS, PMID: 12782716); GO_0008285 (EC: TAS, PMID: 9551928); GO_0019722 (EC: TAS, PMID: 11877327); GO_0030155 (EC: IDA, PMID: 2007144); GO_0030593 (EC: IGI, PMID: 11564821); GO_0030968 (EC: TAS); GO_0031623 (EC: IDA, PMID: 10734056); GO_0034976 (EC: IDA); GO_0035556 (EC: IDA, PMID: 10734056); GO_0042119 (EC: TAS, PMID: 11483765); GO_0044267 (EC: TAS); GO_0044344 (EC: IEP, PMID: 9407497); GO_0045091 (EC: IDA, PMID: 11483765); GO_0045744 (EC: IDA, PMID: 10734056); GO_0048566 (EC: IEP); GO_0050930 (EC: IGI, PMID: 11564821); GO_0071222 (EC: IDA, PMID: 19912257); GO_0071347 (EC: IEP, PMID: 9407497); GO_0071356 (EC: IEP, PMID: 9407497); GO_0090023 (EC: TAS, PMID: 1699135)",PMID: 1281554; 1391327; 1639201; 1673289; 1699135; 1840701; 1895676; 1988949; 2005614; 2007144; 2145175; 2170450; 2182630; 2184886; 2200751; 2212672; 2456256; 2523801; 2555418; 2648135; 2648569; 2655583; 2659722; 2663993; 2664463; 2681204; 2834384; 2953813; 3057503; 3223947; 3260265; 3279957; 3322281; 3480540; 7673721; 7695626; 8077676; 8081002; 8381837; 8626516; 8631339; 8662698; 8663179; 8702798; 8995686; 9141135; 9323208; 9363947; 9378998; 9407497; 9464567; 9510190; 9551928; 9659156; 9828130; 9921412; 10343098; 10361232; 10368283; 10376933; 10491366; 10620615; 10707023; 10734056; 10764593; 10775602; 10820279; 10823949; 10880251; 10881932; 10929056; 10982368; 10985244; 10985253; 11023497; 11069235; 11083887; 11160671; 11226151; 11328384; 11483765; 11509627; 11564821; 11756416; 11784713; 11814358; 11854210; 11855786; 11868823; 11876744; 11877327; 11884401; 11884459; 11888846; 11896938; 11910304; 11911801; 11940655; 11950481; 11956621; 11960393; 11964077; 11966578; 11973337; 11978786; 11989790; 11999552; 12021366; 12027404; 12033786; 12034575; 12039947; 12055238; 12055326; 12056817; 12060853; 12067976; 12081586; 12089333; 12090473; 12091490; 12093676; 12096924; 12096927; 12100025; 12101072; 12115500; 12117737; 12117926; 12117969; 12117995; 12123753; 12126643; 12133438; 12139952; 12149127; 12150710; 12151316; 12151344; 12163591; 12164325; 12165085; 12169092; 12169272; 12186702; 12186913; 12187073; 12195386; 12223528; 12225945; 12239630; 12359770; 12364441; 12366401; 12370346; 12382118; 12384994; 12388718; 12388959; 12391099; 12393171; 12410798; 12415593; 12453441; 12477932; 12480084; 12485855; 12496258; 12502445; 12513912; 12520365; 12524080; 12529421; 12530093; 12533683; 12543081; 12547728; 12548717; 12565901; 12573991; 12576442; 12584113; 12586630; 12594001; 12594058; 12615831; 12626597; 12628493; 12632066; 12633940; 12634636; 12637525; 12646250; 12653788; 12654635; 12654834; 12660426; 12662377; 12702497; 12707271; 12720537; 12727029; 12729795; 12738388; 12744776; 12748056; 12748173; 12777373; 12782302; 12782716; 12792476; 12797546; 12802400; 12818188; 12820969; 12839933; 12839942; 12849706; 12850808; 12855659; 12857601; 12870115; 12871882; 12876073; 12898436; 12898448; 12901801; 12902511; 12909591; 12919697; 12933891; 12952969; 12960242; 13129857; 14500465; 14500470; 14500479; 14530367; 14550286; 14578856; 14604894; 14623984; 14625302; 14630611; 14634582; 14634584; 14641180; 14645117; 14657869; 14669337; 14672330; 14675394; 14676125; 14688120; 14711052; 14714557; 14718619; 14725568; 14729508; 14730209; 14756945; 14767470; 14977935; 15001458; 15021975; 15022458; 15039334; 15047831; 15057743; 15063730; 15069060; 15072962; 15077296; 15079071; 15085176; 15096327; 15102084; 15120188; 15133028; 15143062; 15146413; 15152368; 15158775; 15169673; 15178568; 15178703; 15181190; 15194816; 15196572; 15203561; 15203565; 15208657; 15208668; 15209388; 15214047; 15218164; 15220553; 15222686; 15265021; 15271933; 15273081; 15280021; 15280372; 15292066; 15297389; 15300588; 15302608; 15321994; 15321998; 15331599; 15337758; 15342208; 15356171; 15356575; 15358661; 15364108; 15379213; 15385484; 15453805; 15454487; 15469436; 15481145; 15489227; 15489334; 15494311; 15496610; 15498828; 15514971; 15521010; 15528384; 15529362; 15531763; 15534087; 15541716; 15542429; 15556942; 15564333; 15569594; 15579374; 15579377; 15579481; 15583145; 15585560; 15585673; 15591054; 15598788; 15607204; 15607368; 15609321; 15613411; 15615716; 15627645; 15630185; 15630732; 15641067; 15650393; 15650394; 15652404; 15652492; 15659384; 15661856; 15664665; 15667946; 15679580; 15701651; 15708897; 15710978; 15731050; 15746434; 15760459; 15760676; 15784717; 15803062; 15805227; 15828019; 15831558; 15845475; 15845476; 15845864; 15854776; 15862344; 15866212; 15894298; 15897801; 15902922; 15914533; 15917409; 15945132; 15962221; 15972644; 15976103; 15976326; 15979992; 15987860; 15989802; 16004996; 16007706; 16029496; 16038881; 16038986; 16039610; 16052590; 16085794; 16088182; 16096323; 16098041; 16098254; 16101867; 16107255; 16107886; 16110031; 16125276; 16134994; 16164755; 16166417; 16168518; 16185356; 16195477; 16195815; 16197369; 16202743; 16204411; 16207434; 16220540; 16240219; 16251188; 16251427; 16270354; 16273337; 16280123; 16284368; 16289597; 16293628; 16293707; 16299055; 16313297; 16317381; 16322472; 16365152; 16373669; 16375755; 16387844; 16394009; 16403098; 16406804; 16411061; 16429233; 16487026; 16491014; 16498082; 16499908; 16503988; 16525644; 16541418; 16545602; 16547413; 16547804; 16552338; 16552751; 16554734; 16573784; 16581825; 16618781; 16620395; 16632517; 16635219; 16679868; 16679918; 16687414; 16697675; 16698420; 16702372; 16719905; 16720107; 16757060; 16769764; 16775170; 16777061; 16788380; 16793206; 16794530; 16795034; 16797773; 16806015; 16820307; 16824064; 16825597; 16846747; 16862120; 16864907; 16864908; 16873245; 16890267; 16897191; 16926411; 16927373; 16928771; 16929824; 16934308; 16937502; 16937534; 16939660; 16959787; 16973972; 16978071; 16990258; 16996240; 17008880; 17020755; 17020928; 17022986; 17024463; 17035306; 17061983; 17075576; 17077296; 17078003; 17115422; 17124436; 17141217; 17141246; 17174061; 17189320; 17197385; 17202379; 17203209; 17204468; 17207568; 17207890; 17211588; 17215524; 17220369; 17222831; 17240051; 17244794; 17257314; 17268170; 17277102; 17285966; 17296422; 17304101; 17307163; 17307204; 17309748; 17314689; 17327408; 17336597; 17346315; 17351514; 17355643; 17356794; 17380888; 17388919; 17400536; 17416748; 17420005; 17433258; 17444864; 17456336; 17458901; 17462092; 17466952; 17471497; 17488320; 17494793; 17498253; 17498309; 17498967; 17513150; 17513455; 17517062; 17538964; 17540779; 17543146; 17550933; 17565687; 17581194; 17581316; 17592301; 17599774; 17617741; 17618838; 17620090; 17621625; 17624583; 17630697; 17638896; 17639289; 17667842; 17671691; 17671716; 17680645; 17681858; 17703412; 17707405; 17709521; 17709599; 17710424; 17716703; 17720627; 17725646; 17761179; 17761353; 17767856; 17786963; 17802898; 17805211; 17845205; 17848618; 17850672; 17854143; 17854923; 17869651; 17883593; 17908769; 17908789; 17914409; 17918746; 17931612; 17936667; 17944600; 17947704; 17949231; 17953379; 17974147; 17997161; 18019737; 18023202; 18025101; 18028768; 18031543; 18051367; 18054497; 18057554; 18060802; 18065201; 18070438; 18073500; 18074095; 18079209; 18080864; 18086557; 18086782; 18086816; 18090907; 18156286; 18164040; 18182303; 18184679; 18190463; 18191274; 18192685; 18206243; 18211687; 18226242; 18234802; 18235016; 18240029; 18249366; 18251157; 18252714; 18252863; 18258920; 18259970; 18260266; 18264801; 18266131; 18273643; 18274637; 18275043; 18276095; 18282421; 18283335; 18284424; 18299272; 18301299; 18305316; 18307536; 18309649; 18310311; 18314120; 18314475; 18315921; 18322253; 18363812; 18370868; 18380907; 18380966; 18385984; 18391721; 18391842; 18395088; 18397859; 18406509; 18413205; 18416756; 18424663; 18426885; 18441098; 18448485; 18457043; 18458115; 18463682; 18467491; 18469140; 18474653; 18479302; 18486623; 18487223; 18487355; 18501560; 18502145; 18502748; 18506929; 18511707; 18512730; 18515987; 18523031; 18523665; 18524891; 18536738; 18542040; 18545091; 18547996; 18549840; 18550579; 18563170; 18566434; 18568476; 18571457; 18574677; 18577758; 18593988; 18599499; 18607537; 18609140; 18615482; 18617617; 18623207; 18628242; 18628251; 18633131; 18635170; 18635816; 18637012; 18644894; 18646527; 18650551; 18657231; 18662984; 18665932; 18667484; 18671849; 18673463; 18676680; 18676870; 18678243; 18678662; 18679168; 18689272; 18690522; 18691435; 18692776; 18703508; 18710930; 18763295; 18772138; 18780829; 18785913; 18786178; 18789871; 18796448; 18799095; 18799285; 18800145; 18818748; 18824549; 18827892; 18830271; 18837094; 18850010; 18854173; 18926718; 18936229; 18942752; 18953959; 18953964; 18974369; 18977990; 18983460; 18985541; 18990769; 18992148; 19009622; 19010917; 19012493; 19013323; 19013427; 19013788; 19015376; 19019335; 19021203; 19026125; 19028451; 19029276; 19035451; 19046427; 19047751; 19053024; 19055487; 19064995; 19066394; 19074641; 19074885; 19077731; 19086264; 19086996; 19096229; 19103522; 19109168; 19109405; 19112107; 19118103; 19120897; 19136823; 19147919; 19156359; 19157552; 19158563; 19162161; 19170075; 19170196; 19176759; 19180796; 19184985; 19185507; 19189859; 19201759; 19203362; 19229069; 19232500; 19233564; 19234105; 19238009; 19238444; 19239421; 19246914; 19246943; 19247692; 19254160; 19258923; 19267370; 19272692; 19275586; 19275588; 19285667; 19286927; 19300393; 19303321; 19325234; 19328242; 19333684; 19336370; 19338485; 19339032; 19343203; 19345795; 19346317; 19347053; 19348790; 19349617; 19350238; 19357230; 19357773; 19358850; 19359602; 19360326; 19363120; 19364277; 19369450; 19372628; 19376162; 19376732; 19377236; 19379593; 19383348; 19390575; 19393580; 19401270; 19404719; 19410569; 19423540; 19426598; 19427781; 19436689; 19446037; 19448676; 19454705; 19460731; 19460789; 19467703; 19470239; 19474090; 19484147; 19494510; 19496969; 19505916; 19506726; 19506876; 19514335; 19526283; 19527294; 19527514; 19535567; 19556613; 19561378; 19567187; 19570208; 19570915; 19573080; 19578117; 19588509; 19591568; 19596978; 19597126; 19597830; 19608678; 19608729; 19617600; 19622587; 19625176; 19646263; 19661010; 19661014; 19667085; 19668110; 19668231; 19674346; 19681642; 19688109; 19692168; 19692203; 19694638; 19699525; 19714766; 19719901; 19720161; 19726162; 19726280; 19732956; 19733855; 19734226; 19734969; 19747898; 19751561; 19755917; 19760027; 19773182; 19773279; 19773451; 19777350; 19786303; 19787256; 19789190; 19794965; 19799797; 19801670; 19805069; 19816813; 19819266; 19819989; 19834107; 19835476; 19837667; 19838218; 19840968; 19842025; 19852851; 19855073; 19858310; 19874800; 19887538; 19890050; 19898747; 19904283; 19906815; 19912257; 19913121; 19914270; 19929572; 19932683; 19948975; 19950606; 19956874; 19994728; 19995941; 19996617; 19996656; 20004360; 20005738; 20008399; 20012528; 20015396; 20026745; 20037740; 20038977; 20039880; 20044268; 20047188; 20056178; 20061995; 20084405; 20102417; 20103651; 20106902; 20107186; 20118277; 20127012; 20148189; 20150959; 20162422; 20166885; 20172018; 20174873; 20181930; 20185670; 20187772; 20190550; 20194723; 20194818; 20198307; 20206550; 20207250; 20217044; 20218918; 20220108; 20222161; 20227257; 20237496; 20298300; 20300863; 20306660; 20363151; 20363644; 20369436; 20378727; 20379392; 20380014; 20384861; 20384872; 20398511; 20399512; 20400187; 20400292; 20405297; 20406964; 20410302; 20418110; 20431935; 20437058; 20438785; 20441409; 20444155; 20448351; 20452482; 20453000; 20454998; 20463618; 20465445; 20470938; 20473875; 20483454; 20483667; 20485444; 20486195; 20487506; 20488171; 20501448; 20503287; 20506652; 20510674; 20512787; 20518825; 20523065; 20540789; 20540853; 20540976; 20546607; 20556966; 20562101; 20564140; 20568250; 20571236; 20574123; 20591742; 20592029; 20595617; 20595649; 20598369; 20607798; 20618343; 20621718; 20626862; 20628086; 20628624; 20630874; 20631636; 20634942; 20636397; 20644561; 20648559; 20670689; 20673868; 20698984; 20704821; 20709566; 20711410; 20715983; 20731692; 20733339; 20799037; 20803037; 20811626; 20817073; 20826776; 20839488; 20872800; 20884746; 20886283; 20887801; 20889674; 20934961; 20942272; 20952496; 21033124; 21037509; 21041296; 21042230; 21046243; 21048114; 21048327; 21058913; 21060150; 21061265; 21082280; 21091348; 21091908; 21130993; 21176887; 21179067; 21179282; 21188496; 21190575; 21191670; 21193404; 21196908; 21219446; 21225224; 21240497; 21266580; 21266854; 21268001; 21282106; 21297080; 21299226; 21300928; 21310414; 21316925; 21316985; 21330456; 21333631; 21336628; 21336718; 21336735; 21343296; 21348591; 21356375; 21368236; 21376140; 21398406; 21401388; 21411730; 21413027; 21417823; 21419646; 21423807; 21443923; 21454676; 21468596; 21468699; 21471847; 21477645; 21493783; 21524887; 21537542; 21544811; 21546588; 21554996; 21555999; 21570865; 21573018; 21590707; 21591973; 21593445; 21601196; 21603907; 21610567; 21619709; 21620438; 21640118; 21640702; 21645924; 21649887; 21649933; 21653678; 21660963; 21666788; 21670316; 21670847; 21681427; 21684758; 21697472; 21702700; 21711965; 21731723; 21745629; 21749879; 21750647; 21763153; 21765616; 21780129; 21782870; 21802960; 21820916; 21831204; 21831449; 21840299; 21848410; 21851175; 21854541; 21862577; 21873556; 21873605; 21876747; 21882260; 21882633; 21895606; 21904597; 21923858; 21925169; 21925926; 21932060; 21938724; 21952587; 21957142; 21959016; 21961038; 21961943; 21964883; 21968713; 21988832; 21989944; 21994122; 21995333; 21996014; 22003289; 22015631; 22019593; 22028792; 22030312; 22031506; 22037460; 22037980; 22043704; 22048642; 22052387; 22056994; 22059352; 22064657; 22068677; 22072831; 22079264; 22080750; 22092715; 22093783; 22094458; 22108905; 22126705; 22129622; 22132892; 22140266; 22151543; 22168600; 22171160; 22192353; 22197408; 22214159; 22215047; 22216191; 22223513; 22224945; 22226472; 22229891; 22242662; 22244449; 22248188; 22257833; 22262769; 22268119; 22274300; 22279522; 22287022; 22292036; 22293189; 22301094; 22303451; 22325052; 22326254; 22332739; 22335768; 22346248; 22348317; 22354777; 22366438; 22367386; 22389383; 22394598; 22403723; 22407782; 22408359; 22411631; 22416189; 22427564; 22441735; 22452847; 22454194; 22466961; 22475215; 22479352; 22482416; 22513191; 22531917; 22537067; 22553989; 22563025; 22579115; 22580394; 22590978; 22609211; 22617157; 22626465; 22626766; 22645023; 22664113; 22675954; 22685373; 22690076; 22695075; 22696056; 22710869; 22726456; 22727020; 22732298; 22740130; 22741617; 22748467; 22751949; 22762377; 22763041; 22763101; 22766852; 22775568; 22783581; 22786753; 22788685; 22815748; 22819245; 22819246; 22819248; 22821380; 22840453; 22848630; 22849850; 22869038; 22876745; 22877792; 22891614; 22897124; 22902391; 22904195; 22921153; 22923190; 22923236; 22924768; 22935637; 22939387; 22964303; 22983351; 23000201; 23002445; 23007230; 23029099; 23029125; 23042271; 23043537; 23058014; 23070988; 23072563; 23091318; 23092711; 23110185; 23118425; 23124693; 23125416; 23128233; 23145117; 23149083; 23160385; 23160800; 23165450; 23168996; 23197259; 23198942; 23204162; 23207068; 23221335; 23225384; 23242124; 23244113; 23247723; 23251686; 23259986; 23268406; 23269580; 23269842; 23276701; 23297014; 23321310; 23325853; 23325889; 23327592; 23334651; 23342280; 23347173; 23389820; 23392805; 23403077; 23405070; 23409168; 23418512; 23418647; 23425997; 23434371; 23441821; 23444260; 23456515; 23463699; 23478175; 23490412; 23498057; 23519334; 23526216; 23545310; 23546865; 23546898; 23576566; 23577098; 23584701; 23597430; 23603048; 23610962; 23615914; 23624000; 23632023; 23633491; 23680697; 23688054; 23704827; 23712703; 23714383; 23762476; 23770363; 23773024; 23779254; 23782136; 23785756; 23821953; 23831257; 23831464; 23867456; 23870461; 23887394; 23888551; 23890815; 23894194; 23912333; 23924923; 23972657; 23992011; 24032673; 24076166; 24080022; 24099766; 24121485; 24161763; 24186266; 24260304; 24273918; 24284797; 24313836; 24344010,,,,,,,,,,,,,,,,,,OGG:3000003576,,,,,,,,,,,,,,,,,,,interleukin 8,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL8,,,20140408,3576,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL8,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0031968,organelle outer membrane,,"The outer, i.e. cytoplasm-facing in a cellular organelle, lipid bilayer of an organelle envelope.",false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0019867,,,,,,,,,,,,,,,,,,,,,"The outer, i.e. cytoplasm-facing in a cellular organelle, lipid bilayer of an organelle envelope.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0019867,,,,GO:0031968,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031968,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,organelle outer membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098677,virion maturation,viral particle maturation|virus particle maturation,"Maturation of a virion after separation from the host cell. Not all viruses mature after separation.  In those that do, maturation typically involves rearangement and/or cleavage of viral proteins, resulting in the virion becoming competent for reinfection.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,dos,2017-01-19T12:49:22Z,,,UniProtKB-KW:KW-0917|VZ:1946,"Maturation of a virion after separation from the host cell. Not all viruses mature after separation.  In those that do, maturation typically involves rearangement and/or cleavage of viral proteins, resulting in the virion becoming competent for reinfection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral particle maturation,,,,,biological_process,,virus particle maturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0098677,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/31133031,,,,GO:0098677,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,virion maturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_9397,Chiroptera,bats|bats,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_314145,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,bats,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_order,bats,,,,,,NCBITaxon:9397,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_314145,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Chiroptera,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000053,triazavirin,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Triazavirin is a guanine nucleotide analog antiviral drug originally developed in Russia that has shown efficacy against influenza A and B, including the H5N1 strain.It appears that Triazavirin has shown promise in reducing influenza disease severity and associated complications",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,true,,,,,,,,,,,,,,,,,,,,,,triazavirin,,,,,,,,,,,,,,,,,,,,,,https://www.drugbank.ca/drugs/DB15622|https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002697,regulation of immune effector process,,"Any process that modulates the frequency, rate, or extent of an immune effector process.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate, or extent of an immune effector process.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0002697,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002697,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of immune effector process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006754,ATP biosynthetic process,ATP anabolism|ATP biosynthesis|ATP synthesis|ATP formation|ATP regeneration,"The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.",false,,,http://purl.obolibrary.org/obo/GO_0046034|http://purl.obolibrary.org/obo/GO_0009152|http://purl.obolibrary.org/obo/GO_0009206,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0006759|GO:0006758,,,,ATP anabolism|ATP biosynthesis|ATP synthesis|ATP formation,,,ATP regeneration,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046034|http://purl.obolibrary.org/obo/GO_0009152|http://purl.obolibrary.org/obo/GO_0009206,,,,GO:0006754,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006754,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ATP biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249065,SARS coronavirus GZ-D,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249065,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ-D,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0038061,NIK/NF-kappaB signaling,noncanonical NF-kappaB signaling|non-canonical NF-KB signaling|noncanonical nuclear factor kappaB (NF-kappaB) pathway|NIK/NF-kappaB signal transduction|p52-dependent NF-kappaB signaling|NIK/NF-kappaB cascade,"The process in which a signal is passed on to downstream components within the cell through the NIK-dependent processing and activation of NF-KappaB. Begins with activation of the NF-KappaB-inducing kinase (NIK), which in turn phosphorylates and activates IkappaB kinase alpha (IKKalpha). IKKalpha phosphorylates the NF-Kappa B2 protein (p100) leading to p100 processing and release of an active NF-KappaB (p52).",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,rfoulger,2012-01-16T05:44:46Z,,,,"The process in which a signal is passed on to downstream components within the cell through the NIK-dependent processing and activation of NF-KappaB. Begins with activation of the NF-KappaB-inducing kinase (NIK), which in turn phosphorylates and activates IkappaB kinase alpha (IKKalpha). IKKalpha phosphorylates the NF-Kappa B2 protein (p100) leading to p100 processing and release of an active NF-KappaB (p52).",,,,,,,,,,,,,,,,,,,,,,,,,,,,noncanonical NF-kappaB signaling|non-canonical NF-KB signaling|noncanonical nuclear factor kappaB (NF-kappaB) pathway,,,NIK/NF-kappaB signal transduction,,,p52-dependent NF-kappaB signaling,,biological_process,,NIK/NF-kappaB cascade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0038061,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,GO:0038061,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,NIK/NF-kappaB signaling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/FMA_62871,Immunoglobulin,Antibody,,false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Antibody,,,,,fma,,,,,,,,,http://purl.obolibrary.org/obo/IDOMAL_0000764|Immunoglobulins are gamma globulin proteins consisting of heavy and light chains connected by disulfide bonds. They are synthesized in response to stimulation by an antigen.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,FMA:62871,,,,,,,,,,,,,,,FMA:62871,,http://purl.obolibrary.org/obo/fma.owl,,,,,,,,,,,Immunoglobulin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000128,conjunctivitis,,doid/symp duplicate,false,,,http://purl.obolibrary.org/obo/SYMP_0019163,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,doid/symp duplicate,,http://purl.obolibrary.org/obo/SYMP_0019163,,,,SYMP:0000128,,,,,,true,,,,,,Conjunctivitis is an inflammation or swelling of the conjunctiva.,,,SYMP:0000128,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,conjunctivitis,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042470,melanosome,,"A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.",false,,,http://purl.obolibrary.org/obo/GO_0048770,,,,,,,,,,,,,,,,,,,,Wikipedia:Melanosome,"A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_4895|http://purl.obolibrary.org/obo/NCBITaxon_6237,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0048770,,,,GO:0042470,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042470,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,melanosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1904666,regulation of ubiquitin protein ligase activity,regulation of ubiquitin ligase activity|regulation of protein ubiquitination activity|regulation of APC-fizzy related complex activity|regulation of E3,"Any process that modulates the frequency, rate or extent of ubiquitin protein ligase activity.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,dph,2015-09-08T15:26:59Z,,,,"Any process that modulates the frequency, rate or extent of ubiquitin protein ligase activity.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:1903834,,,,regulation of ubiquitin ligase activity|regulation of protein ubiquitination activity,,,regulation of APC-fizzy related complex activity,,biological_process,,regulation of E3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1904666,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1904666,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of ubiquitin protein ligase activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005759,mitochondrial matrix,mitochondrial lumen|mitochondrial stroma,"The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Mitochondrial_matrix|NIF_Subcellular:sao1804523077,"The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0031980,,,,mitochondrial lumen,,,mitochondrial stroma,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005759,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005759,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitochondrial matrix,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003579,CXCR2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL8R2|CMKAR2|CDw128b|IL8RA|IL8RB|CD182,,,,,,,2,,,,,,,,,,HPRD:00907|Vega:OTTHUMG00000133107|MIM:146928|HGNC:6027|Ensembl:ENSG00000180871,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) receptor 2,,2q35,,,,"GO_0002407 (EC: TAS, PMID: 16621978); GO_0002438 (EC: IEA); GO_0004871 (EC: IDA, PMID: 10438939); GO_0004918 (EC: IDA, PMID: 10820279); GO_0005515 (EC: IPI); GO_0005622 (EC: IDA, PMID: 10878382); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 10438939); GO_0006935 (EC: IDA, PMID: 10725748); GO_0006954 (EC: TAS, PMID: 9725262); GO_0006968 (EC: IDA, PMID: 10725748); GO_0007165 (EC: IDA, PMID: 10820279); GO_0007166 (EC: IDA, PMID: 10734056); GO_0007200 (EC: IDA, PMID: 10438939); GO_0007204 (EC: IEA); GO_0008284 (EC: IDA, PMID: 10438939); GO_0009986 (EC: IDA, PMID: 10878382); GO_0010666 (EC: IEA); GO_0016020 (EC: IDA, PMID: 10725748); GO_0016494 (EC: IDA, PMID: 10878382); GO_0019959 (EC: IPI, PMID: 1840701); GO_0030593 (EC: IDA, PMID: 10820279); GO_0030901 (EC: IEA); GO_0031623 (EC: IDA, PMID: 10734056); GO_0033030 (EC: IEA); GO_0038112 (EC: IDA, PMID: 10820279); GO_0042119 (EC: IDA, PMID: 10878382); GO_0042629 (EC: IDA, PMID: 9725262); GO_0043117 (EC: IEA); GO_0045766 (EC: IEA); GO_0070098 (EC: IDA, PMID: 10878382); GO_0072173 (EC: IEA); GO_0090023 (EC: IEA)",PMID: 1303245; 1379593; 1427896; 1840701; 1891716; 2834384; 7512557; 7829970; 7929358; 8036519; 8194768; 8195702; 8294449; 8316840; 8384312; 8550564; 8626516; 8662698; 8702798; 8940121; 9058825; 9079638; 9260277; 9464567; 9651375; 9692902; 9725262; 9843397; 10438939; 10593335; 10688807; 10725748; 10734056; 10820279; 10878382; 10881932; 10943863; 11007922; 11023990; 11138777; 11170396; 11196695; 11278485; 11397869; 11435493; 11524231; 11751889; 11818437; 12164325; 12176324; 12239185; 12442335; 12453441; 12477932; 12496258; 12606476; 12620646; 12628493; 12633567; 12870115; 12888558; 12975484; 14713106; 14967163; 15004234; 15028716; 15063762; 15265017; 15358660; 15364949; 15452121; 15454487; 15479720; 15489334; 15545821; 15598788; 15618253; 15626158; 15630732; 15772681; 15793866; 15946947; 16086366; 16098254; 16260092; 16272353; 16344560; 16406804; 16411061; 16621978; 16679868; 16702372; 16793206; 16897191; 16987681; 16990258; 17003486; 17142783; 17204468; 17272812; 17295203; 17360650; 17435771; 17604950; 17630697; 17672867; 17703412; 17709521; 17939034; 17949231; 17996233; 18025257; 18199703; 18208820; 18240029; 18244953; 18292390; 18307412; 18462836; 18555777; 18577758; 18633131; 18676870; 18755694; 18780829; 18852457; 19010874; 19012493; 19026125; 19035451; 19057948; 19067586; 19118103; 19147552; 19151925; 19155217; 19170196; 19258923; 19401689; 19423540; 19435808; 19435811; 19549892; 19573080; 19585580; 19634663; 19750480; 19773279; 19887480; 19890050; 19904283; 19913121; 20005738; 20016196; 20016852; 20018298; 20044480; 20056178; 20070156; 20089160; 20140262; 20237496; 20406964; 20419088; 20429924; 20438785; 20452482; 20453000; 20468071; 20485444; 20503287; 20505188; 20519647; 20540789; 20568250; 20580690; 20628086; 20630874; 20635912; 20673868; 20802378; 21036625; 21042230; 21106938; 21297633; 21343381; 21441140; 21555225; 21670971; 21749879; 21876773; 21915051; 21948388; 21989491; 22076427; 22088968; 22117410; 22152684; 22171941; 22203670; 22231733; 22242662; 22274915; 22325052; 22389383; 22482416; 22617157; 22626766; 22763041; 22763101; 22850671; 22885102; 22893608; 22904195; 22986777; 23023221; 23029099; 23128233; 23204236; 23293110; 23389772; 23403077; 23470693; 23479735; 23548249; 23615182; 23758411; 23912333; 23972657; 24161763,,,,,,,,,,,,,,,,,,OGG:3000003579,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) receptor 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCR2,,,20140408,3579,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CXCR2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCIT_C90548,Sapanisertib,INK128|Sapanisertib|MLN0128|TAK-228|MLN-0128|SAPANISERTIB|INK-128,"An orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. Sapanisertib binds to and inhibits both TORC1 and TORC2 complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some tumors and play an important role in the PI3K/Akt/mTOR signaling pathway, which is frequently dysregulated in human cancers.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,1224844-38-5,,,,C90548,,,CTRP|FDA,,,,,,,"An orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. Sapanisertib binds to and inhibits both TORC1 and TORC2 complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some tumors and play an important role in the PI3K/Akt/mTOR signaling pathway, which is frequently dysregulated in human cancers.",,,,,,Sapanisertib,,,,,,,,,,,JGH0DF1U03,,,,,,,,,,,,,,INK128|Sapanisertib|MLN0128|TAK-228|MLN-0128|SAPANISERTIB|INK-128,,,,,,,,,,,,,NCIT:C90548,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Sapanisertib,,,,,,,,,,,,,,,,665687,665687,,Sapanisertib,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,Pharmacologic Substance,,,,,,,,C2983747,
http://purl.obolibrary.org/obo/NCIT_C102865,Diammonium Glycyrrhizinate,"Diammonium Glycyrrhizinate|alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-Glucopyranuronosyl-, Diammonium Salt (9CI)|18beta-Glycyrrhizic Acid Diammoniumsalt","The diammonium salt of glycyrrhizin and the active constituent in the traditional Chinese medicinal herb Glycyrrhiza uralensis (Chinese liquorice or Gan-Cao) with anti-inflammatory, antioxidant and hepatoprotective properties. Diammonium glycyrrhizinate (DG) is slowly metabolized within the cells into glycyrrhetic acid, which inhibits enzymes that control cortisol metabolism and contributes to this agent's anti-inflammatory effect. Although the exact mechanism of action remains to be fully elucidated, DG may prevent or reduce hepatotoxicity via the scavenging of free radicals. This agent also upregulates the expression of transcription coactivator PGC-1alpha and modulates hepatic enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), superoxide dismutase and glutathion peroxidase.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,79165-06-3,,C42H62O16.2H3N,,C102865,,,,,,,,,,"The diammonium salt of glycyrrhizin and the active constituent in the traditional Chinese medicinal herb Glycyrrhiza uralensis (Chinese liquorice or Gan-Cao) with anti-inflammatory, antioxidant and hepatoprotective properties. Diammonium glycyrrhizinate (DG) is slowly metabolized within the cells into glycyrrhetic acid, which inhibits enzymes that control cortisol metabolism and contributes to this agent's anti-inflammatory effect. Although the exact mechanism of action remains to be fully elucidated, DG may prevent or reduce hepatotoxicity via the scavenging of free radicals. This agent also upregulates the expression of transcription coactivator PGC-1alpha and modulates hepatic enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), superoxide dismutase and glutathion peroxidase.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Diammonium Glycyrrhizinate|alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-Glucopyranuronosyl-, Diammonium Salt (9CI)|18beta-Glycyrrhizic Acid Diammoniumsalt",,,,,,,,,,,,,NCIT:C102865,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Diammonium Glycyrrhizinate,,,,,,,,,,,,,,,,737610,737610,,Diammonium Glycyrrhizinate,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,Pharmacologic Substance,,,,,,,,C1956193,
http://purl.obolibrary.org/obo/OGG_3000004142,MAS1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MAS|MGRA,,,,,,,6,,,,,,,,,,HGNC:6899|MIM:165180|HPRD:01306|Vega:OTTHUMG00000015944|Ensembl:ENSG00000130368,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,MAS1 oncogene,,6q25.3-q26,,,,"GO_0001595 (EC: ISS); GO_0001933 (EC: IEA); GO_0004930 (EC: IDA, PMID: 16611642); GO_0004945 (EC: TAS, PMID: 3419518); GO_0005886 (EC: IDA, PMID: 16611642); GO_0005887 (EC: TAS, PMID: 3419518); GO_0007186 (EC: TAS, PMID: 3419518); GO_0007250 (EC: IEA); GO_0007283 (EC: IEA); GO_0008283 (EC: TAS, PMID: 3419518); GO_0008284 (EC: IEA); GO_0008584 (EC: IEA); GO_0009653 (EC: TAS, PMID: 8661154); GO_0009986 (EC: IEA); GO_0014823 (EC: IEA); GO_0017046 (EC: IEA); GO_0021766 (EC: IEA); GO_0034698 (EC: IEA); GO_0042277 (EC: ISS); GO_0042493 (EC: IEA); GO_0045740 (EC: IEA); GO_0050727 (EC: IEA); GO_0060732 (EC: IEA); GO_0070528 (EC: IMP, PMID: 16611642); GO_0071375 (EC: IEA)",PMID: 1725048; 2197067; 3329713; 3419518; 3708691; 8661154; 10785460; 11967280; 12477932; 12829792; 14574404; 15123239; 15489334; 16611642; 17207965; 18636314; 19164480; 19240061; 19461648; 20361351; 20592051; 20674894; 21316680; 22003054; 22048948; 22164327; 22319643; 22510001; 22518283; 22518286; 23459756; 23592774; 24128372; 24583173,,,,,,,,,,,,,,,,,,OGG:3000004142,,,,,,,,,,,,,,,,,,,MAS1 oncogene,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,MAS1,,,20140408,4142,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,MAS1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0014074,response to purine-containing compound,response to purine,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purine-containing compound stimulus.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purine-containing compound stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,response to purine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0014074,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0014074,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to purine-containing compound,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000035,process boundary,,p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001]),false,,,http://purl.obolibrary.org/obo/BFO_0000003,,,,,ProcessBoundary,p-boundary,,,,,,,,,,,,,,,p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001]),,,,,,,,,,,,,the boundary between the 2nd and 3rd year of your life.,,,,,,,,,(forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002] |(iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001] ,Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002]),,,,,,,,,,,,,,,,,,,,,BFO:0000035,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000003,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,process boundary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MONDO_0005111,Epstein-Barr virus infection,"Human gammaherpesvirus 4 caused disease or disorder|Human gammaherpesvirus 4 infectious disease|Epstein-Barr Virus infection|Human gammaherpesvirus 4 disease or disorder|EBV infection|Epstein Barr Virus infections|Human Herpes Virus 4 infections|infections, Epstein-Barr Virus|Human Herpesvirus 4 infections|infections, EBV|EBV infections|Herpesvirus 4 infections, Human|Virus infections, Epstein-Barr",An infection that is caused by Epstein-Barr virus.,false,,,http://purl.obolibrary.org/obo/MONDO_0005794,,,,,,,,,,,,,,,,,,,,EFO:0000769|NCIT:C38759|MESH:D020031|UMLS:C0149678,An infection that is caused by Epstein-Barr virus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Human gammaherpesvirus 4 caused disease or disorder|Human gammaherpesvirus 4 infectious disease|Epstein-Barr Virus infection|Human gammaherpesvirus 4 disease or disorder|EBV infection,,,,,,,"Epstein Barr Virus infections|Human Herpes Virus 4 infections|infections, Epstein-Barr Virus|Human Herpesvirus 4 infections|infections, EBV|EBV infections|Herpesvirus 4 infections, Human|Virus infections, Epstein-Barr",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/MONDO_0005794,,http://identifiers.org/mesh/D014412,http://linkedlifedata.com/resource/umls/id/C0149678|http://identifiers.org/mesh/D020031|http://purl.obolibrary.org/obo/NCIT_C38759,MONDO:0005111,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,MONDO:0005111,,http://purl.obolibrary.org/obo/mondo.owl,,,,,,,,,,,Epstein-Barr virus infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048285,organelle fission,,The creation of two or more organelles by division of one organelle.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The creation of two or more organelles by division of one organelle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0048285,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048285,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,organelle fission,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_63628,tipranavir,"N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide|tipranavir|3'-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide",A pyridine-2-sulfonamide substituted at C-5 by a trifluoromethyl group and at the sulfonamide nitrogen by a dihydropyrone-containing m-tolyl substituent. It is an HIV-1 protease inhibitor.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:21871444|CAS:174484-41-4|PMID:17620375|DrugBank:DB00932|PMID:21571982|PMID:22258921|Reaxys:7698323|KEGG:D08605|PMID:21041916|PMID:25017682|PMID:21825300|PMID:22007990|PMID:21576452|PMID:22096044|PMID:20368406,A pyridine-2-sulfonamide substituted at C-5 by a trifluoromethyl group and at the sulfonamide nitrogen by a dihydropyrone-containing m-tolyl substituent. It is an HIV-1 protease inhibitor.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide",,,,,chebi_ontology,,"tipranavir|3'-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide",,,,,,,,,0,C31H33F3N2O5S,"InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1",SUJUHGSWHZTSEU-FYBSXPHGSA-N,602.66400,602.20623,CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:63628,,,,,true,true,,,,,,,,,CHEBI:63628,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tipranavir,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258967,SARS coronavirus TW4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258967,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_1273,respiratory syncytial virus infectious disease,,"A viral infectious disease that results_in infection located_in upper respiratory tract or located_in lower respiratory tract, has_material_basis_in Human respiratory syncytial virus, which is transmitted_by droplet spread of nasal secretions from an infected person while coughing or sneezing, or transmitted_by contaminated fomites. The infection has_symptom runny nose, has_symptom fever, has_symptom cough, has_symptom wheezing, and has_symptom respiratory distress.",false,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,,,,,,,,,NCI:C3354|SNOMEDCT_US_2019_09_01:55735004|MESH:D018357|UMLS_CUI:C0035235,"A viral infectious disease that results_in infection located_in upper respiratory tract or located_in lower respiratory tract, has_material_basis_in Human respiratory syncytial virus, which is transmitted_by droplet spread of nasal secretions from an infected person while coughing or sneezing, or transmitted_by contaminated fomites. The infection has_symptom runny nose, has_symptom fever, has_symptom cough, has_symptom wheezing, and has_symptom respiratory distress.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934,,,,DOID:1273,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,respiratory syncytial virus infection,,DOID:1273,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,respiratory syncytial virus infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249079,SARS coronavirus HSZ-Bc,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249079,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HSZ-Bc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0101002,ficolin-1-rich granule,ficolin-1 rich granule|ficolin granule,"Highly exocytosable gelatinase-poor granules found in neutrophils and rich in ficolin-1.  Ficolin-1 is released from neutrophil granules by stimulation with fMLP or PMA, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"Highly exocytosable gelatinase-poor granules found in neutrophils and rich in ficolin-1.  Ficolin-1 is released from neutrophil granules by stimulation with fMLP or PMA, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ficolin-1 rich granule,,,,,cellular_component,,ficolin granule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0101002,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0101002,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ficolin-1-rich granule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002478,antigen processing and presentation of exogenous peptide antigen,exogenous peptide antigen processing and presentation,The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.,false,,,http://purl.obolibrary.org/obo/GO_0019884,,,,,,,,,,,,,,,,,,,,,The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,exogenous peptide antigen processing and presentation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019884,,,,GO:0002478,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002478,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antigen processing and presentation of exogenous peptide antigen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2583,agammaglobulinemia,hypogammaglobulinemia|mu heavy chain deficiency|IGHM,A B cell deficiency that is caused by a reduction in all types of gamma globulins.|OMIM mapping confirmed by DO. [SN].,false,,,http://purl.obolibrary.org/obo/DOID_2115,,,,,,,,,,,,,,,,,,,,OMIM:613502|OMIM:PS601495|SNOMEDCT_US_2019_09_01:119250001|ICD10CM:D80.1|UMLS_CUI:C0086438|SNOMEDCT_US_2019_09_01:119249001|OMIM:601495|MESH:D000361|OMIM:613500|UMLS_CUI:C0001768|OMIM:615214|OMIM:613501|NCI:C26931|OMIM:612692|ICD9CM:279.00,A B cell deficiency that is caused by a reduction in all types of gamma globulins.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:618,,,,hypogammaglobulinemia|mu heavy chain deficiency|IGHM,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,OMIM mapping confirmed by DO. [SN].,,http://purl.obolibrary.org/obo/DOID_2115,,,,DOID:2583,,,,,,,,,,,,,,,DOID:2583,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,agammaglobulinemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_742003,Bat SARS coronavirus HKU3-6,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:742003,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IAO_0000109,measurement datum,,A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device.,false,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,,,,,,,,,,,,A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device.,,group:OBI|OBI_0000305,,,,,,2/2/2009 is_specified_output of some assay?,measurement datum,,,,"Examples of measurement data are the recoding of the weight of a mouse as {40,mass,""grams""}, the recording of an observation of the behavior of the mouse {,process,""agitated""}, the recording of the expression level of a gene as measured through the process of microarray experiment {3.4,luminosity,}.",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000125,,,,,,,,,,,,,,,,,,,,IAO:0000109,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/iao.owl,,,,,,,,,,,measurement datum,,,,,,,,,,,,,,,,,,,,,,,,,,,,person:Chris Stoeckert,,,,
http://purl.obolibrary.org/obo/OGG_3000000718,C3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,AHUS5|C3b|C3a|HEL-S-62p|ARMD9|ASP|CPAMD1,,,,,,,19,,,,,,,,,,Ensembl:ENSG00000125730|HGNC:1318|Vega:OTTHUMG00000150335|HPRD:00400|MIM:120700,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,complement component 3,,19p13.3-p13.2,,,,"GO_0001798 (EC: IEA); GO_0001934 (EC: IDA, PMID: 15833747); GO_0001970 (EC: IEA); GO_0004866 (EC: IEA); GO_0005102 (EC: TAS, PMID: 9164946); GO_0005515 (EC: IPI, PMID: 11705926); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005886 (EC: TAS); GO_0006631 (EC: IEA); GO_0006954 (EC: IEA); GO_0006955 (EC: TAS, PMID: 4097977); GO_0006956 (EC: TAS); GO_0006957 (EC: TAS); GO_0006958 (EC: IEA); GO_0007165 (EC: TAS, PMID: 10085065); GO_0007186 (EC: TAS, PMID: 9164946); GO_0010575 (EC: IDA, PMID: 16452172); GO_0010828 (EC: IDA, PMID: 15833747); GO_0010866 (EC: IDA, PMID: 10432298); GO_0010884 (EC: IDA, PMID: 9555951); GO_0030449 (EC: TAS); GO_0031715 (EC: IDA, PMID: 15833747); GO_0045087 (EC: TAS); GO_0045745 (EC: IDA, PMID: 15833747); GO_0045766 (EC: IEA); GO_0050766 (EC: IEA); GO_0050776 (EC: TAS); GO_0070062 (EC: IDA); GO_0072562 (EC: IDA)",PMID: 162484; 279011; 695691; 1238393; 1323007; 1350678; 1401896; 1531292; 1577777; 1703437; 1717583; 1830068; 1861080; 1976733; 2387584; 2473125; 2579379; 2584723; 2824652; 3052276; 3260670; 3279119; 3421908; 3488995; 3546307; 3871945; 4062888; 4097977; 6175959; 6203109; 6912277; 7512600; 7535292; 7539791; 7590866; 7642209; 7893437; 7911492; 7961791; 8406564; 8416818; 8471312; 8630395; 8648130; 8702752; 8845016; 8943712; 9059512; 9164946; 9291131; 9544576; 9555951; 9596584; 9605165; 9719152; 9988761; 10078261; 10079271; 10085065; 10358196; 10382758; 10432298; 10608878; 10610782; 10622723; 10882776; 10946275; 11058592; 11073102; 11086104; 11342658; 11367533; 11387479; 11513971; 11684127; 11705926; 11773063; 11785295; 11803045; 11813855; 11854358; 11884542; 11896391; 11939578; 11979403; 12006395; 12165538; 12477932; 12511407; 12540846; 12645945; 12679444; 12754519; 12761187; 12816955; 12878586; 12893820; 12942785; 12967641; 14527961; 14563826; 14639503; 14662858; 14702039; 14760718; 15033778; 15090635; 15187133; 15199963; 15241561; 15278436; 15342556; 15381670; 15383607; 15489226; 15590640; 15648851; 15713467; 15713468; 15749882; 15810889; 15833747; 15872081; 16148107; 16148115; 16177781; 16199891; 16263699; 16301317; 16335952; 16339538; 16355111; 16449793; 16452172; 16516157; 16530040; 16570073; 16627066; 16670774; 16809564; 16823297; 16889542; 16893076; 17051150; 17051152; 17051160; 17060630; 17172439; 17322907; 17372315; 17482181; 17498719; 17502296; 17520688; 17634448; 17684013; 17703412; 17762737; 17767156; 17984207; 18039528; 18039777; 18054386; 18061265; 18174230; 18206145; 18247123; 18253759; 18325906; 18356838; 18383369; 18434316; 18456336; 18562232; 18562603; 18566738; 18572187; 18585783; 18596911; 18631248; 18671285; 18682851; 18694577; 18702682; 18755462; 18760301; 18796626; 18802120; 18805911; 18854167; 18936151; 18974840; 19005416; 19015224; 19017934; 19022911; 19028820; 19028829; 19048105; 19112495; 19117936; 19131662; 19164292; 19168221; 19179465; 19196712; 19202148; 19225544; 19234341; 19246358; 19247692; 19258923; 19259132; 19263529; 19265162; 19328844; 19336475; 19344414; 19387462; 19399715; 19407382; 19423540; 19454698; 19457998; 19503104; 19505474; 19549636; 19559392; 19590060; 19661236; 19665237; 19670317; 19680263; 19694644; 19703145; 19767107; 19773279; 19797206; 19823576; 19825847; 19828715; 19834535; 19843088; 19850835; 19861685; 19878567; 19899988; 19913121; 19913840; 19939777; 19948975; 20089077; 20091675; 20104494; 20105190; 20105310; 20109314; 20139276; 20139773; 20157618; 20173020; 20188594; 20237496; 20238042; 20301541; 20378178; 20379614; 20381870; 20385819; 20385826; 20395963; 20406964; 20438785; 20453728; 20498262; 20503287; 20513133; 20523265; 20576771; 20603037; 20628086; 20628624; 20639865; 20644161; 20664795; 20706769; 20807366; 20817881; 20837143; 20841369; 20852386; 20861866; 20862287; 20888482; 20926033; 20926148; 20951140; 21055811; 21085669; 21163532; 21205667; 21270401; 21308746; 21402993; 21404895; 21414106; 21415311; 21435440; 21462136; 21464960; 21501302; 21527715; 21555552; 21566112; 21642543; 21658310; 21664558; 21665990; 21706294; 21733505; 21788512; 21801245; 21813769; 21816153; 21953030; 21966368; 21988832; 22007489; 22089112; 22132894; 22138144; 22145905; 22153860; 22171262; 22174912; 22176838; 22194611; 22228414; 22234447; 22246034; 22250080; 22253322; 22258234; 22264230; 22273503; 22324951; 22361228; 22390383; 22393059; 22415003; 22456601; 22518841; 22542119; 22553783; 22565852; 22635230; 22669319; 22673887; 22705344; 22718507; 22792353; 22851413; 22863782; 22878256; 22909298; 22930722; 22996269; 23028341; 23031360; 23056509; 23068452; 23071281; 23098807; 23134230; 23206327; 23209669; 23233260; 23235567; 23285141; 23337555; 23356914; 23365660; 23385359; 23390291; 23427180; 23455636; 23537682; 23619360; 23628799; 23639844; 23661701; 23719603; 23750785; 23833239; 23878142; 23956345; 23982842; 24239583; 24287422; 24367091,,,,,,,,,,,,,,,,,,OGG:3000000718,,,,,,,,,,,,,,,,,,,complement component 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,C3,,,20140408,718,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,C3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0032309,Abnormal granulocyte count,,"Any deviation from the normal cell count per volume of granulocytes in the blood circulation.|Granulocytes belong to the innate immune system and make up the largest proportion of white blood cells. They are myeloid cells and can be classified as neutrophil granulocytes (neutrophils), eosinophils, basophils, monocytes, and mast cells.",false,,,http://purl.obolibrary.org/obo/HP_0011893|http://purl.obolibrary.org/obo/HP_0001911,,,,,,,,,,,,,,,,peter,,,,,Any deviation from the normal cell count per volume of granulocytes in the blood circulation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0032309,,,,,,,,,,,,,,,,,,2019-02-14T10:54:57Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Granulocytes belong to the innate immune system and make up the largest proportion of white blood cells. They are myeloid cells and can be classified as neutrophil granulocytes (neutrophils), eosinophils, basophils, monocytes, and mast cells.",,http://purl.obolibrary.org/obo/HP_0011893|http://purl.obolibrary.org/obo/HP_0001911,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal granulocyte count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_296839,SARS coronavirus PC4-145,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:296839,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-145,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042110,T cell activation,T-cell activation|T-lymphocyte activation|T lymphocyte activation,"The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,T-cell activation|T-lymphocyte activation|T lymphocyte activation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042110,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32178593,,,,GO:0042110,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,T cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C86570,Mask,Mask,"A protective covering worn over the face, or an apparatus for administering anesthesia or oxygen through the nose or mouth.",false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,C86570,,,,,,,,,,"A protective covering worn over the face, or an apparatus for administering anesthesia or oxygen through the nose or mouth.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mask,,,,,,,,,,,,,NCIT:C86570,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203710,,surgical mask,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Mask,,,,,,,,,,,,,,,,,,,Mask,,,,Manufactured Object,,,,,,,,C0024861,
http://purl.obolibrary.org/obo/PR_000036197,viral protein,virus protein,A protein that is encoded in the genome of some virus.,false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,,,,,,,,,,,A protein that is encoded in the genome of some virus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,virus protein,,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,PR:000036197,,,,,,,,,,,,,,,PR:000036197,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,viral protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_741998,Bat SARS coronavirus HKU3-11,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:741998,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_7496,nelfinavir,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide|nelfinavir",An aryl sulfide that is used (as its mesylate salt) for treatment of HIV and also exhibits some anticancer properties.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,HMDB:HMDB0014365|PMID:23109184|PMID:24596143|PMID:23916134|PDBeChem:1UN|PMID:24574416|Reaxys:7419619|Wikipedia:Nelfinavir|PMID:24719428|PMID:24194293|PMID:23386514|PMID:24498124|KEGG:D08259|PMID:23454896|PMID:23647753|DrugBank:DB00220|PMID:24418752|CAS:159989-64-7|Drug_Central:1893|KEGG:C07257|PMID:23872785|LINCS:LSM-5819|PMID:24483157,An aryl sulfide that is used (as its mesylate salt) for treatment of HIV and also exhibits some anticancer properties.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide",,,,,chebi_ontology,,nelfinavir,,,,,,,,,0,C32H45N3O4S,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,567.78200,567.31308,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:7496,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:7496,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,nelfinavir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000016,exhaustion of CD8+ T cell,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,Modified definition,,,biological process,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186,"Excessive amount of persistent antigen and/or inflammatory signals often leads CD8+ T cells to gradual deterioration of T cell function, a state called “exhaustion.” Exhausted T cells are characterized by progressive loss of effector functions (cytokine production and killing function), expression of multiple inhibitory receptors (such as PD-1 and LAG3), dysregulated metabolism, poor memory recall response, and homeostatic proliferation.",CD8+ T cell exhaustion,,,,,,,,,,,,,,,exhaustion of CD8+ T cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000064386,MMP25,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MT-MMP6|MMP20A|MMPL1|MT6-MMP|MMP-25|MT-MMP 6|MMP20|MTMMP6|MT6MMP,,,,,,,16,,,,,,,,,,HGNC:14246|Vega:OTTHUMG00000177475|HPRD:07090|MIM:608482|Ensembl:ENSG00000008516|HPRD:07492,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,matrix metallopeptidase 25,,16p13.3,,,,"GO_0004222 (EC: IEA); GO_0005509 (EC: IEA); GO_0005578 (EC: NAS, PMID: 10628838); GO_0005886 (EC: IEA); GO_0006508 (EC: NAS, PMID: 10706098); GO_0006954 (EC: NAS, PMID: 10628838); GO_0008270 (EC: IEA); GO_0016020 (EC: NAS, PMID: 11034316); GO_0031225 (EC: IEA); GO_0060022 (EC: IEA)",PMID: 8663332; 9653642; 10419448; 10628838; 10706098; 11034316; 11226436; 11282999; 12477932; 12860995; 14583471; 14755462; 15149845; 17513868; 18936094; 19726693; 19834535; 19913121; 20237496; 20308072; 20337648; 20501611; 20587546; 20628086; 20672350; 22367194; 23851692; 24250222,,,,,,,,,,,,,,,,,,OGG:3000064386,,,,,,,,,,,,,,,,,,,matrix metallopeptidase 25,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,MMP25,,,20140408,64386,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,MMP25,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000001509,CTSD,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CLN10|CPSD|HEL-S-130P,,,,,,,11,,,,,,,,,,HGNC:2529|MIM:116840|Vega:OTTHUMG00000044760|Ensembl:ENSG00000117984|HPRD:00291,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,cathepsin D,,11p15.5,,,,"GO_0000045 (EC: IEA); GO_0004190 (EC: IEA); GO_0005515 (EC: IPI, PMID: 17112520); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005615 (EC: ISS); GO_0005739 (EC: IEA); GO_0005764 (EC: IDA, PMID: 1837142); GO_0008219 (EC: IEA); GO_0019886 (EC: TAS); GO_0022617 (EC: TAS); GO_0030198 (EC: TAS); GO_0030574 (EC: TAS); GO_0031012 (EC: IDA, Qualifier: colocalizes_with); GO_0042470 (EC: IEA); GO_0043202 (EC: TAS); GO_0070062 (EC: IDA, PMID: 19056867)",PMID: 938470; 1522590; 1734961; 1837142; 1883350; 1939080; 2013314; 2069717; 2180427; 2736531; 3261170; 3588310; 3665421; 3927292; 3988746; 6236213; 7523115; 7547509; 7657720; 7935485; 8106429; 8262386; 8393577; 8419924; 8467789; 8671230; 8889548; 8930981; 8943232; 9076588; 9275067; 9731700; 10504270; 10508159; 10605825; 10623764; 10716266; 10748089; 10849758; 10876156; 10931940; 10986284; 11095076; 11198280; 11258665; 11264868; 11304834; 11341921; 11436125; 11581410; 11687971; 11779865; 11780226; 11786931; 11840502; 11906282; 12011767; 12083803; 12140763; 12147324; 12151789; 12185597; 12477932; 12556904; 12643545; 12651610; 12754519; 12782337; 12782632; 12811635; 12826741; 12970159; 14702039; 14718574; 14767531; 15003956; 15081423; 15158911; 15168727; 15192082; 15211064; 15211070; 15258139; 15318816; 15489334; 15668295; 15739123; 15843343; 15862967; 15896324; 15989967; 16046058; 16081416; 16127101; 16263699; 16263712; 16331270; 16335952; 16341674; 16354654; 16396496; 16417614; 16543533; 16608402; 16652347; 16685649; 16709808; 16784755; 16850161; 17032648; 17081065; 17112520; 17176069; 17188016; 17284061; 17289576; 17340625; 17395004; 17532541; 17601350; 17670831; 17875703; 18177262; 18202773; 18248894; 18296260; 18307033; 18367545; 18387691; 18396902; 18426579; 18431031; 18494001; 18559512; 18566016; 18566385; 18624398; 18702517; 18830724; 18977241; 19056867; 19061927; 19109932; 19115690; 19203374; 19221643; 19383337; 19487283; 19494521; 19571726; 19723497; 19802014; 19828951; 19854241; 19913121; 19919557; 19926167; 19939935; 19950226; 20000738; 20071328; 20083556; 20125193; 20301601; 20385381; 20399529; 20430722; 20597865; 20628086; 20666480; 20666745; 20826454; 20855565; 20926008; 21139048; 21145461; 21148553; 21298030; 21311773; 21315176; 21470957; 21533003; 21632707; 21674799; 21709160; 21789704; 21800051; 21890473; 21906983; 21909273; 21948970; 22081071; 22118674; 22190034; 22244896; 22268729; 22302483; 22388353; 22399610; 22439866; 22476353; 22528489; 22542809; 22623531; 22627201; 22816225; 22824147; 22898924; 22939629; 22949512; 22964611; 22990118; 22996917; 23042275; 23065739; 23107604; 23219593; 23250759; 23415546; 23455922; 23466190; 23483898; 23499937; 23840360; 23868063; 24198402; 24250222; 24511668,,,,,,,,,,,,,,,,,,OGG:3000001509,,,,,,,,,,,,,,,,,,,cathepsin D,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CTSD,,,20140408,1509,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CTSD,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0035578,azurophil granule lumen,primary granule lumen,"The volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.",false,,,http://purl.obolibrary.org/obo/GO_0034774|http://purl.obolibrary.org/obo/GO_0005775,,,,,,,,,,,,,,,,rfoulger,2010-10-05T01:30:33Z,,,,"The volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,primary granule lumen,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0034774|http://purl.obolibrary.org/obo/GO_0005775,,,,GO:0035578,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035578,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,azurophil granule lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1905819,negative regulation of chromosome separation,down regulation of chromosome separation|down-regulation of chromosome separation|downregulation of chromosome separation|downregulation of rDNA separation|inhibition of rDNA separation|negative regulation of rDNA separation|down-regulation of rDNA separation|inhibition of chromosome separation|down regulation of rDNA separation|down-regulation of chromatid release|downregulation of chromatid release|inhibition of chromatid release|down regulation of chromatid release|negative regulation of chromatid release,"Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.",false,,,http://purl.obolibrary.org/obo/GO_1905818|http://purl.obolibrary.org/obo/GO_0010948|http://purl.obolibrary.org/obo/GO_0051985,,,,,,,,,,,,,,,,bmeldal,2017-01-13T13:55:27Z,,,,"Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,down regulation of chromosome separation|down-regulation of chromosome separation|downregulation of chromosome separation,,,downregulation of rDNA separation|inhibition of rDNA separation|negative regulation of rDNA separation|down-regulation of rDNA separation|inhibition of chromosome separation|down regulation of rDNA separation,,biological_process,,down-regulation of chromatid release|downregulation of chromatid release|inhibition of chromatid release|down regulation of chromatid release|negative regulation of chromatid release,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1905818|http://purl.obolibrary.org/obo/GO_0010948|http://purl.obolibrary.org/obo/GO_0051985,,,,GO:1905819,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1905819,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of chromosome separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051187,cofactor catabolic process,cofactor breakdown|cofactor degradation|cofactor catabolism,"The chemical reactions and pathways resulting in the breakdown of a cofactor, a substance that is required for the activity of an enzyme or other protein.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of a cofactor, a substance that is required for the activity of an enzyme or other protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cofactor breakdown|cofactor degradation|cofactor catabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0051187,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051187,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cofactor catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_7864,oxymetholone,"17beta-hydroxy-2-(hydroxymethylidene)-17-methyl-5alpha-androstan-3-one|Anapolon|17alpha-methyl-2-hydroxymethylene-17-hydroxy-5alpha-androstan-3-one|Protanabol|17beta-hydroxy-2-(hydroxymethylene)-17-methyl-5alpha-androstan-3-one|Synasteron|oxymetholone|Nastenon|4,5alpha-dihydro-2-hydroxymethylene-17alpha-methyltestosterone|2-hydroxymethylene-17alpha-methyl-17beta-hydroxy-5alpha-androstan-3-one|2-hydroxymethylene-17alpha-methyl-5alpha-androstan-17beta-ol-3-one|Plenastril|(5alpha,17beta)-17-hydroxy-2-(hydroxymethylidene)-17-methylandrostan-3-one|2-hydroxymethylene-17alpha-methyldihydrotestosterone|Anadrol-50|oxymetholonum|oximetolona|Adroyd|Pardroyd","A 3-oxo-5alpha- steroid that is 4,5alpha-dihydrotestosterone which is substituted by a hydroxymethylidene group at position 2 and by a methyl group at the 17alpha position. A synthetic androgen, it was mainly used for the treatment of anaemias until being replaced by treatments with fewer side effects.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D00490|PMID:1125426|PMID:11071398|KEGG:C07393|PMID:21860526|CAS:434-07-1|Wikipedia:Oxymetholone|Reaxys:2623806|Patent:DE1070632|PMID:11440282,"A 3-oxo-5alpha- steroid that is 4,5alpha-dihydrotestosterone which is substituted by a hydroxymethylidene group at position 2 and by a methyl group at the 17alpha position. A synthetic androgen, it was mainly used for the treatment of anaemias until being replaced by treatments with fewer side effects.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17beta-hydroxy-2-(hydroxymethylidene)-17-methyl-5alpha-androstan-3-one,,,,,chebi_ontology,,"Anapolon|17alpha-methyl-2-hydroxymethylene-17-hydroxy-5alpha-androstan-3-one|Protanabol|17beta-hydroxy-2-(hydroxymethylene)-17-methyl-5alpha-androstan-3-one|Synasteron|oxymetholone|Nastenon|4,5alpha-dihydro-2-hydroxymethylene-17alpha-methyltestosterone|2-hydroxymethylene-17alpha-methyl-17beta-hydroxy-5alpha-androstan-3-one|2-hydroxymethylene-17alpha-methyl-5alpha-androstan-17beta-ol-3-one|Plenastril|(5alpha,17beta)-17-hydroxy-2-(hydroxymethylidene)-17-methylandrostan-3-one|2-hydroxymethylene-17alpha-methyldihydrotestosterone|Anadrol-50|oxymetholonum|oximetolona|Adroyd|Pardroyd",,,,,,,,,0,C21H32O3,"InChI=1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/t14-,15+,16-,17-,19-,20-,21-/m0/s1",ICMWWNHDUZJFDW-IYRCEVNGSA-N,332.47700,332.23514,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C(C[C@]4(C)[C@H]3CC[C@]12C)=CO,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:7864,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:7864,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,oxymetholone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051783,regulation of nuclear division,,"Any process that modulates the frequency, rate or extent of nuclear division, the partitioning of the nucleus and its genetic information.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of nuclear division, the partitioning of the nucleus and its genetic information.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0051783,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051783,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045292,"mRNA cis splicing, via spliceosome","splicing|nuclear mRNA cis splicing, via spliceosome|nuclear mRNA cis splicing, via U2-type spliceosome","The joining together, after removal of an intervening sequence composed of one or more introns, of two segments of the same RNA molecule via spliceosomal catalysis to produce an mRNA composed only of exon sequences that all came from the same primary transcript.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The joining together, after removal of an intervening sequence composed of one or more introns, of two segments of the same RNA molecule via spliceosomal catalysis to produce an mRNA composed only of exon sequences that all came from the same primary transcript.",,,,,,,,,,,,,,,,,,,,,,,,,,,,splicing,,,"nuclear mRNA cis splicing, via spliceosome",,,"nuclear mRNA cis splicing, via U2-type spliceosome",,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0045292,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045292,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"mRNA cis splicing, via spliceosome",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000024,fiat object part,,,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,FiatObjectPart,fiat-object-part,,,,,,,,,,,,,,,,,,,,,,,BFO 2 Reference: Most examples of fiat object parts are associated with theoretically drawn divisions,,,"b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of  c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004])",,"the FMA:regional parts of an intact human body.|the Western hemisphere of the Earth|the division of the planet into hemispheres|the dorsal and ventral surfaces of the body|the upper and lower lobes of the left lung|the division of the brain into regions|or with divisions drawn by cognitive subjects for practical reasons, such as the division of a cake (before slicing) into (what will become) slices (and thus member parts of an object aggregate). However, this does not mean that fiat object parts are dependent for their existence on divisions or delineations effected by cognitive subjects. If, for example, it is correct to conceive geological layers of the Earth as fiat object parts of the Earth, then even though these layers were first delineated in recent times, still existed long before such delineation and what holds of these layers (for example that the oldest layers are also the lowest layers) did not begin to hold because of our acts of delineation.Treatment of material entity in BFOExamples viewed by some as problematic cases for the trichotomy of fiat object part, object, and object aggregate include: a mussel on (and attached to) a rock, a slime mold, a pizza, a cloud, a galaxy, a railway train with engine and multiple carriages, a clonal stand of quaking aspen, a bacterial community (biofilm), a broken femur. Note that, as Aristotle already clearly recognized, such problematic cases – which lie at or near the penumbra of instances defined by the categories in question – need not invalidate these categories. The existence of grey objects does not prove that there are not objects which are black and objects which are white; the existence of mules does not prove that there are not objects which are donkeys and objects which are horses. It does, however, show that the examples in question need to be addressed carefully in order to show how they can be fitted into the proposed scheme, for example by recognizing additional subdivisions [29",,,,,,,,,(forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000024,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,fiat object part,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003117,Abnormal circulating hormone level,Abnormality of circulating hormone level,An abnormal concentration of a hormone in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0000818,,,,,,,,,,,,,,,,,,,,UMLS:C4025652,An abnormal concentration of a hormone in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of circulating hormone level,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000818,,,,HP:0003117,,,,,,,,,,,,,,,HP:0003117,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal circulating hormone level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000395,mRNA 5'-splice site recognition,nuclear mRNA 5' splice site recognition|nuclear mRNA 5'-splice site recognition|spliceosomal commitment complex formation|U12-type nuclear mRNA 5'-splice site recognition|U12-type nuclear mRNA 5' splice site recognition|U2-type nuclear mRNA 5'-splice site recognition|spliceosomal CC complex formation|spliceosomal CC complex biosynthesis|U2-type nuclear mRNA 5' splice site recognition|spliceosomal E complex formation|spliceosomal E complex biosynthesis|spliceosomal commitment complex biosynthesis,"Recognition of the intron 5'-splice site by components of the assembling spliceosome.|Note that this step represents formation of the Commitment Complex (CC, in yeast) or the E complex (mammalian).",false,,,http://purl.obolibrary.org/obo/GO_0006376,,,,,,,,,,,,,,,,,,,,,Recognition of the intron 5'-splice site by components of the assembling spliceosome.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000368|GO:0000369,,,,nuclear mRNA 5' splice site recognition|nuclear mRNA 5'-splice site recognition,,,spliceosomal commitment complex formation|U12-type nuclear mRNA 5'-splice site recognition|U12-type nuclear mRNA 5' splice site recognition|U2-type nuclear mRNA 5'-splice site recognition|spliceosomal CC complex formation|spliceosomal CC complex biosynthesis|U2-type nuclear mRNA 5' splice site recognition|spliceosomal E complex formation|spliceosomal E complex biosynthesis|spliceosomal commitment complex biosynthesis,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this step represents formation of the Commitment Complex (CC, in yeast) or the E complex (mammalian).",,http://purl.obolibrary.org/obo/GO_0006376,,,,GO:0000395,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000395,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mRNA 5'-splice site recognition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000001,nonstructural protein,,,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Proteins encoded by a viral genome that are produced in the organisms they infect, but not packaged into the virus particles. Some of these proteins may play roles within the infected cell during virus relpication or act in regulation of virus replication or virus assembly.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,,,,,,,,,,,,,,nonstructural protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249086,SARS coronavirus LC4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249086,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus LC4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000011,planned process,,A processual entity that realizes a plan which is the concretization of a plan specification.,false,,,http://purl.obolibrary.org/obo/BFO_0000015,,,,,,,,,,,,,,,,,,,"6/11/9: Edited at workshop. Used to include: is initiated by an agent|This class merges the previously separated objective driven process and planned process, as they the separation proved hard to maintain. (1/22/09, branch call)",,A processual entity that realizes a plan which is the concretization of a plan specification.,,branch derived,,,,,,"We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some
objectives is a planned process.|'Plan' includes a future direction sense. That can be problematic if plans are changed during their execution. There are however implicit contingencies for protocols that an agent has in his mind that can be considered part of the plan, even if the agent didn't have them in mind before. Therefore, a planned process can diverge from what the agent would have said the plan was before executing it, by adjusting to problems encountered during execution (e.g. choosing another reagent with equivalent properties, if the originally planned one has run out.)|We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some 
objectives is a planned process.",planned process|planned process,,,,Injecting mice with a vaccine in order to test its efficacy,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,OBI:0000011,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000015,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl|http://purl.obolibrary.org/obo/ogms.owl|http://purl.obolibrary.org/obo/cto.owl|http://purl.obolibrary.org/obo/vo.owl|http://purl.obolibrary.org/obo/dron.owl|http://purl.obolibrary.org/obo/omrse.owl|http://purl.obolibrary.org/obo/opmi.owl|http://purl.obolibrary.org/obo/ico.owl|http://purl.obolibrary.org/obo/envo.owl|http://purl.obolibrary.org/obo/obi.owl|http://purl.obolibrary.org/obo/ero.owl|http://purl.obolibrary.org/obo/oae.owl,,,,,,,,,,,planned process|planned process,,,,,,,,,,,,,,,,,,,,,,,,,,,,Bjoern Peters,,,,
http://purl.obolibrary.org/obo/HP_0011947,Respiratory tract infection,Respiratory tract infection|Respiratory infection|Respiratory infections,An infection of the upper or lower respiratory tract.,false,,,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,peter,2012-06-21T08:26:36Z,,,MSH:D012141|UMLS:C0035243|SNOMEDCT_US:275498002,An infection of the upper or lower respiratory tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Respiratory tract infection|Respiratory infection,,,,,human_phenotype,,Respiratory infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002088,,,,HP:0011947,,,,,,,,,,,,,,,HP:0011947,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Respiratory tract infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032388,positive regulation of intracellular transport,up regulation of intracellular transport|up-regulation of intracellular transport|upregulation of intracellular transport|stimulation of intracellular transport|activation of intracellular transport,"Any process that activates or increases the frequency, rate or extent of the directed movement of substances within cells.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of the directed movement of substances within cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,up regulation of intracellular transport|up-regulation of intracellular transport|upregulation of intracellular transport,,,stimulation of intracellular transport|activation of intracellular transport,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0032388,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032388,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of intracellular transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003439,IFNA1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IFNA@|IFN-alphaD|IFN|IFN-ALPHA|IFL|IFNA13,,,,,,,9,,,,,,,,,,HPRD:00974|Vega:OTTHUMG00000019673|HGNC:5417|Ensembl:ENSG00000197919|MIM:147660,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interferon, alpha 1",,9p22,,,,,PMID: 1381203; 1385305; 1708818; 1849076; 1905933; 2014240; 2552026; 2985969; 3262520; 4057246; 6157095; 6157600; 6159536; 6163083; 6310510; 6479148; 7511078; 7526537; 7532202; 7583919; 7815507; 7904170; 7913356; 7932753; 8345204; 8438572; 8454630; 8661419; 8668211; 8764000; 9108403; 9181467; 9225992; 9271440; 9343822; 9425112; 9520456; 9658081; 9865497; 11032395; 11315919; 11744801; 11986939; 11991671; 12070711; 12089333; 12091360; 12097384; 12162875; 12242445; 12323007; 12393722; 12410802; 12435568; 12477932; 12530117; 12538683; 12543882; 12581491; 12620797; 12682235; 12749388; 12759354; 12761564; 12804771; 12817009; 12967644; 14500632; 14734746; 15056668; 15087447; 15164053; 15188363; 15233997; 15240148; 15481145; 15489334; 15571260; 15585849; 15621727; 15634924; 15674657; 15699120; 15790787; 15795269; 15883164; 15941912; 15989801; 16005433; 16160188; 16175599; 16253303; 16278001; 16375755; 16418394; 16426578; 16785534; 16797201; 16859998; 16948893; 17180012; 17360657; 17517919; 17572490; 17597478; 17703412; 17785816; 17911607; 17933493; 17956986; 17968925; 17968926; 18005734; 18050196; 18071879; 18184042; 18200009; 18200012; 18218993; 18272764; 18283629; 18311820; 18318750; 18405996; 18414664; 18576315; 18606657; 18633131; 18672082; 18708672; 18771758; 18926293; 19000144; 19004943; 19050236; 19095736; 19124763; 19158240; 19203249; 19258923; 19339987; 19401392; 19434718; 19559726; 19651532; 19657094; 19706714; 19754307; 19796531; 19796549; 19817985; 19857525; 19913121; 20018632; 20065083; 20096141; 20112359; 20149251; 20164424; 20174557; 20182777; 20237496; 20299058; 20303780; 20331378; 20465564; 20473322; 20503287; 20506305; 20554782; 20565368; 20574843; 20588103; 20588308; 20592282; 20628086; 20628092; 20810735; 20817881; 20857263; 20860222; 20875078; 20959405; 20964804; 20980519; 21120500; 21177291; 21213104; 21263073; 21268015; 21276246; 21317915; 21320124; 21339641; 21361792; 21376046; 21525212; 21645334; 21705624; 21772053; 21821707; 21918813; 21923413; 22149411; 22156987; 22192711; 22195005; 22222875; 22226324; 22242767; 22249201; 22264514; 22315404; 22396599; 22661095; 22684144; 22685561; 22693567; 22706089; 22739040; 22814248; 22925929; 23026954; 23042723; 23224365; 23237992; 23303061; 23382558; 23434493; 23462180; 23479228; 23649622; 23724117; 23814052; 23890815; 23910645; 24049170; 24269682,,,,,,,,,,,,,,,,,,OGG:3000003439,,,,,,,,,,,,,,,,,,,"interferon, alpha 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IFNA1,,,20140408,3439,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,doi:10.20944/preprints202003.0206.v1,,,,IFNA1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_633137,SARS coronavirus MA15,Urbani derived|SARS coronavirus strain MA15,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:627441,,,,Urbani derived,,,,,ncbi_taxonomy,,SARS coronavirus strain MA15,,,,,,NCBITaxon:633137,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus MA15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002293,alpha-beta T cell differentiation involved in immune response,alpha-beta T cell development involved in immune response|alpha-beta T cell differentiation during immune response|alpha-beta T-cell differentiation during immune response|alpha-beta T-lymphocyte differentiation during immune response|alpha-beta T lymphocyte differentiation during immune response,"The process in which an antigenically naive alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell during an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells.|Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.",false,,,http://purl.obolibrary.org/obo/GO_0002287|http://purl.obolibrary.org/obo/GO_0042110|http://purl.obolibrary.org/obo/GO_0046631|http://purl.obolibrary.org/obo/GO_0002292,,,,,,,,,,,,,,,,,,,,,"The process in which an antigenically naive alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell during an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,alpha-beta T cell development involved in immune response|alpha-beta T cell differentiation during immune response|alpha-beta T-cell differentiation during immune response|alpha-beta T-lymphocyte differentiation during immune response|alpha-beta T lymphocyte differentiation during immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.,,http://purl.obolibrary.org/obo/GO_0002287|http://purl.obolibrary.org/obo/GO_0042110|http://purl.obolibrary.org/obo/GO_0046631|http://purl.obolibrary.org/obo/GO_0002292,,,,GO:0002293,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002293,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,alpha-beta T cell differentiation involved in immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048146,positive regulation of fibroblast proliferation,upregulation of fibroblast proliferation|up-regulation of fibroblast proliferation|up regulation of fibroblast proliferation|activation of fibroblast proliferation|stimulation of fibroblast proliferation,"Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.",false,,,http://purl.obolibrary.org/obo/GO_0048145,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of fibroblast proliferation|up-regulation of fibroblast proliferation|up regulation of fibroblast proliferation,,,activation of fibroblast proliferation|stimulation of fibroblast proliferation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0048145,,,,GO:0048146,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048146,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of fibroblast proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C13292,Open Reading Frame,ORF|Open Reading Frame,A sequence of nucleotides in that contains no termination codons and so can potentially translate as a polypeptide chain.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,C13292,,,,,,,,,,A sequence of nucleotides in that contains no termination codons and so can potentially translate as a polypeptide chain.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ORF|Open Reading Frame,,,,,,,,,,,,,NCIT:C13292,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32083328,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Open Reading Frame,Open_Reading_Frame,,,,,,,,,,,,,,,,,,Open Reading Frame,,,,Nucleotide Sequence,,,,,,,,C0079941,
http://purl.obolibrary.org/obo/CHEBI_41879,dexamethasone,"dexamethasone|9-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione|Dexamethasone|dexamethasonum|dexametasona|dexamethasone|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|9alpha-Fluoro-16alpha-methylprednisolone|Decadron","A fluorinated steroid that is 9-fluoropregna-1,4-diene substituted by hydroxy groups at positions 11, 17 and 21, a methyl group at position 16 and oxo groups at positions 3 and 20. It is a synthetic member of the class of  glucocorticoids.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:DE1113690|Patent:US3007923|PMID:11508649|Beilstein:2066652|PMID:18524938|Patent:GB869511|PMID:18272184|Reaxys:2066652|VSDB:1769|KEGG:D00292|CAS:50-02-2|HMDB:HMDB0015364|DrugBank:DB01234|Wikipedia:Dexamethasone|KEGG:C15643|Drug_Central:824,"A fluorinated steroid that is 9-fluoropregna-1,4-diene substituted by hydroxy groups at positions 11, 17 and 21, a methyl group at position 16 and oxo groups at positions 3 and 20. It is a synthetic member of the class of  glucocorticoids.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:41873|CHEBI:4461,,,,"dexamethasone|9-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione|Dexamethasone",,,,,chebi_ontology,,dexamethasonum|dexametasona|dexamethasone|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|9alpha-Fluoro-16alpha-methylprednisolone|Decadron,,,,,,,,,0,C22H29FO5,"InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",UREBDLICKHMUKA-CXSFZGCWSA-N,392.46106,392.19990,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:41879,,,,,,,,,,,,,,,CHEBI:41879,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,dexamethasone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002719,Recurrent infections,"infections, recurrent|Susceptibility to infection|Frequent, severe infections|Frequent infections|Recurrent infections|Increased frequency of infection|Predisposition to infections",Increased susceptibility to infections.,false,,,http://purl.obolibrary.org/obo/HP_0032101,,,,,,,,,,,,,,,,,,,,UMLS:C0239998,Increased susceptibility to infections.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0002957|HP:0005405|HP:0002964,,,,"infections, recurrent|Susceptibility to infection|Frequent, severe infections|Frequent infections|Recurrent infections|Increased frequency of infection|Predisposition to infections",,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0032101,,,,HP:0002719,,,,,,,,,,,,,,,HP:0002719,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Recurrent infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,IgG-mediated phagocytosis|Fc gamma receptor-dependent phagocytosis|Fcgamma receptor-mediated phagocytosis|Fc-gamma receptor signalling pathway involved in phagocytosis,An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.,false,,,http://purl.obolibrary.org/obo/GO_0038094|http://purl.obolibrary.org/obo/GO_0002433|http://purl.obolibrary.org/obo/GO_0002431,,,,,,,,,,,,,,,,rfoulger,2012-02-16T05:26:25Z,,,,An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IgG-mediated phagocytosis|Fc gamma receptor-dependent phagocytosis|Fcgamma receptor-mediated phagocytosis|Fc-gamma receptor signalling pathway involved in phagocytosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0038094|http://purl.obolibrary.org/obo/GO_0002433|http://purl.obolibrary.org/obo/GO_0002431,,,,GO:0038096,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0038096,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,Fc-gamma receptor signaling pathway involved in phagocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_9779,bowel dysfunction,,,false,,,http://purl.obolibrary.org/obo/DOID_5295,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0016807|ICD9CM:564.9|SNOMEDCT_US_2019_09_01:81120009|ICD10CM:K59.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,Any disease in which the causes of the disease is a perturbation of the lower digestive tract leading to its dysfunction.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_5295,,,,DOID:9779,,,,,,,,,,,,,,,DOID:9779,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,bowel dysfunction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249088,SARS coronavirus ZS-C,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249088,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ZS-C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2497570,Haploviricotina,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2497569,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_subphylum,,,,,,,NCBITaxon:2497570,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2497569,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Haploviricotina,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_61016,angiotensin receptor antagonist,angiotensin receptor antagonists,A hormone antagonist that blocks angiotensin receptors.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,A hormone antagonist that blocks angiotensin receptors.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,angiotensin receptor antagonists,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:61016,,,,,,true,,,,,,,,,CHEBI:61016,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,angiotensin receptor antagonist,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0010000,multicellular anatomical structure,multicellular structure,An anatomical structure that has more than one cell as a part.,false,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,,,,,,,,,,,,,,,,,CARO:0010000|FBbt:00100313,An anatomical structure that has more than one cell as a part.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,multicellular structure,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,UBERON:0010000,,,,,,,,,,,,,,,UBERON:0010000,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,multicellular anatomical structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000018,cytosolic part,,,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,"Any constituent part of cytosol, that part of the cytoplasm that does not contain membranous or particulate subcellular components.",,,,,,,,,,,,,,,,cytosolic part,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249077,SARS coronavirus HZS2-C,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249077,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HZS2-C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0010876,Abnormal circulating protein level,Abnormality of circulating protein level|Blood protein disease|Serum protein abnormality,An abnormal level of a circulating protein in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0032180,,,,,,,,,,,,,,,,peter,2010-09-07T01:51:12Z,,,UMLS:C4023679|UMLS:C4020763|UMLS:C4020764,An abnormal level of a circulating protein in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of circulating protein level,,,,,human_phenotype,,Blood protein disease|Serum protein abnormality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0032180,,,,HP:0010876,,,,,,,,,,,,,,,HP:0010876,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal circulating protein level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000083,danoprevir,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Danoprevir (ITMN-191, R-7227) is a promising and potent NS3/4A protease inhibitor for the oral treatment of HCV infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32309623,,,,,,,,,,,,,,,,,danoprevir,,,,,,,,,,,,,,,,,,,,,,https://www.sciencedirect.com/topics/medicine-and-dentistry/danoprevir,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,,Any process that regulates transcription such that the target genes are involved in the transition between G1 and S phase of the mitotic cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,Any process that regulates transcription such that the target genes are involved in the transition between G1 and S phase of the mitotic cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0000083,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000083,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of transcription involved in G1/S transition of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC3,protein 3a (SARS-CoV-2),protein U274 (SARS2)|ORF3a (SARS2)|PRO_0000449650|protein X1 (SARS2)|accessory protein 3a (SARS2)|ORF3a|GU280_gp03,A protein that is a translation product of the ORF3a gene in SARS-CoV-2.|Category=organism-gene. Note: 275 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,UniProtKB:P0DTC3|GenPept:YP_009724391,A protein that is a translation product of the ORF3a gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein U274 (SARS2)|ORF3a (SARS2)|PRO_0000449650|protein X1 (SARS2)|accessory protein 3a (SARS2),,,,,protein,,ORF3a|GU280_gp03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 275 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC3,,,,,,true,,,,,,,,,PR:P0DTC3,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,protein 3a (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_5959,irbesartan,"2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|irbesartan|BMS 186295|Avapro",A  biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LINCS:LSM-3338|CAS:138402-11-6|KEGG:C07469|PMID:15101793|Beilstein:6620400|Patent:US5270317|DrugBank:DB01029|Drug_Central:1481|Patent:WO9114679|Reaxys:6620400|PMID:15526904|PMID:15210574|KEGG:D00523|Wikipedia:Irbesartan,A  biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan",,,,,chebi_ontology,,"2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|irbesartan|BMS 186295|Avapro",,,,,,,,,0,C25H28N6O,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",YOSHYTLCDANDAN-UHFFFAOYSA-N,428.52966,428.23246,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:5959,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:5959,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,irbesartan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030139,endocytic vesicle,endocytotic vesicle|endocytotic transport vesicle,A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1362520468,A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,endocytotic vesicle|endocytotic transport vesicle,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030139,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030139,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endocytic vesicle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006517,protein deglycosylation,glycoprotein deglycosylation,The removal of sugar residues from a glycosylated protein.,false,,,http://purl.obolibrary.org/obo/GO_0009100,,,,,,,,,,,,,,,,,,,,,The removal of sugar residues from a glycosylated protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,glycoprotein deglycosylation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009100,,,,GO:0006517,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006517,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein deglycosylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050673,epithelial cell proliferation,,"The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0050673,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050673,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,epithelial cell proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006279,S100A8,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CFAG|MIF|MRP8|MA387|CAGA|60B8AG|CP-10|NIF|L1Ag|CGLA|P8,,,,,,,1,,,,,,,,,,HPRD:00471|Ensembl:ENSG00000143546|MIM:123885|HGNC:10498|Vega:OTTHUMG00000013124,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,S100 calcium binding protein A8,,1q21,,,,"GO_0001816 (EC: TAS); GO_0002523 (EC: IDA, PMID: 12626582); GO_0002526 (EC: IEA); GO_0002544 (EC: IEA); GO_0005509 (EC: TAS); GO_0005515 (EC: IPI); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005829 (EC: TAS); GO_0005856 (EC: TAS); GO_0005886 (EC: TAS); GO_0006914 (EC: IDA, PMID: 19935772); GO_0006919 (EC: IDA, PMID: 19935772); GO_0006954 (EC: TAS, PMID: 3313057); GO_0008017 (EC: TAS); GO_0008270 (EC: TAS); GO_0010043 (EC: IEA); GO_0030307 (EC: TAS); GO_0030593 (EC: IDA, PMID: 12626582); GO_0032119 (EC: TAS); GO_0032496 (EC: IEA); GO_0032602 (EC: TAS); GO_0035662 (EC: TAS); GO_0042060 (EC: IEA); GO_0042742 (EC: TAS); GO_0045087 (EC: IEA); GO_0045471 (EC: IEA); GO_0050544 (EC: TAS); GO_0050729 (EC: IDA, PMID: 12626582); GO_0050786 (EC: TAS); GO_0050832 (EC: TAS); GO_0051092 (EC: TAS); GO_0051493 (EC: TAS); GO_0070062 (EC: IDA, PMID: 19056867); GO_0070488 (EC: IDA, PMID: 12626582); GO_2001244 (EC: IDA, PMID: 19935772)",PMID: 1286667; 1326551; 2039599; 2149559; 3267695; 3313057; 3405210; 3561500; 7759097; 7849642; 8341667; 8400238; 8423249; 8619876; 8701470; 9867828; 9920411; 10571075; 10771424; 10837826; 11058579; 11141076; 11435486; 11564187; 11708798; 11867565; 11895856; 12137245; 12218151; 12477932; 12480428; 12489193; 12553726; 12626582; 12645005; 12697438; 12704215; 12710851; 12719414; 12748257; 12833525; 12937135; 13130482; 15069705; 15331440; 15489334; 15598812; 15642721; 15816004; 16033829; 16169070; 16216873; 16297907; 16573830; 16613612; 16690079; 16710414; 16806487; 16979015; 17050004; 17069562; 17090475; 17197440; 17353931; 17429438; 17469085; 17557234; 17636430; 17644317; 17787039; 17852869; 17895549; 17936757; 18030206; 18044712; 18060880; 18339893; 18374411; 18537548; 18588753; 18689872; 18786929; 18832721; 18922970; 19056867; 19079333; 19087201; 19186948; 19201880; 19210342; 19232095; 19248102; 19284577; 19380743; 19440546; 19466434; 19505873; 19530996; 19596235; 19601998; 19608587; 19615732; 19670424; 19695969; 19752232; 19755614; 19823685; 19898558; 19935772; 19957061; 20096140; 20172281; 20219570; 20391533; 20555353; 20594128; 20717964; 20811636; 20819668; 20833513; 20936779; 21067798; 21072048; 21139048; 21145461; 21182205; 21192933; 21228116; 21239714; 21319273; 21334078; 21434523; 21463326; 21472666; 21492422; 21592353; 21766173; 21791097; 21799753; 21832049; 21900206; 21912088; 21961943; 21971985; 22127564; 22139384; 22209981; 22282267; 22318783; 22363402; 22381691; 22420238; 22446997; 22505354; 22555971; 22586326; 22622474; 22634002; 22660800; 22683330; 22728165; 22806545; 22808130; 22990118; 23018243; 23165982; 23248262; 23299480; 23320892; 23378728; 23423260; 23426492; 23431180; 23455922; 23456298; 23483999; 23626736; 23637971; 23800059; 23824909; 23850136; 23874958; 23907944; 23915068; 23942785; 23954397; 24122301; 24202303,,,,,,,,,,,,,,,,,,OGG:3000006279,,,,,,,,,,,,,,,,,,,S100 calcium binding protein A8,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,S100A8,,,20140408,6279,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,S100A8,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000125,A1a haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A1a haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,A1a haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_17698,chloramphenicol,"chloramphenicol|2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide|CHLORAMPHENICOL|Chloramphenicol|Chloramex|chloramphenicol|levomicetina|cloramfenicol|D-(-)-threo-1-p-nitrophenyl-2-dichloroacetylamino-1,3-propanediol|chloramphenicolum|Halomycetin|Chlorocid|D-(-)-2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenylethyl)acetamide|Sificetina|Chloromycetin|Fenicol|Chlorocol|Oleomycetin|laevomycetinum|chlornitromycin|levomycetin|Globenicol","An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:16659995|Patent:US2483892|PMID:6653106|PMID:23494278|PMID:17217404|Drug_Central:589|PMID:18794387|VSDB:1835|PMID:23395526|PMID:23317719|LINCS:LSM-5256|PDBeChem:CLM|PMID:18657290|PMID:23512826|KEGG:D00104|KEGG:C00918|Wikipedia:Chloramphenicol|Patent:US2483884|PMID:12217690|Patent:US2483871|Beilstein:2225532|PMID:16897441|Patent:GB795131|PMID:11468347|DrugBank:DB00446|PMID:18559535|Patent:GB796901|Patent:US2839577|PMID:657786|PMID:17692887|PMID:23142491|CAS:56-75-7,"An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:23106|CHEBI:13965|CHEBI:47327|CHEBI:23108|CHEBI:3603,,,,"chloramphenicol|2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide|CHLORAMPHENICOL|Chloramphenicol",,,,,chebi_ontology,,"Chloramex|chloramphenicol|levomicetina|cloramfenicol|D-(-)-threo-1-p-nitrophenyl-2-dichloroacetylamino-1,3-propanediol|chloramphenicolum|Halomycetin|Chlorocid|D-(-)-2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenylethyl)acetamide|Sificetina|Chloromycetin|Fenicol|Chlorocol|Oleomycetin|laevomycetinum|chlornitromycin|levomycetin|Globenicol",,,,,,,,,0,C11H12Cl2N2O5,"InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1",WIIZWVCIJKGZOK-RKDXNWHRSA-N,323.130,322.01233,C1=C([C@H]([C@H](NC(C(Cl)Cl)=O)CO)O)C=CC(=C1)[N+]([O-])=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:17698,,,,,,true,,,,,,,,,CHEBI:17698,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,chloramphenicol,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1990777,lipoprotein particle,,A spherical particle containing non-covalently associated proteins and lipids. Examples are plasma lipoprotein particles which transport lipids in the blood or lymph.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,pr,2015-06-18T08:42:53Z,,,,A spherical particle containing non-covalently associated proteins and lipids. Examples are plasma lipoprotein particles which transport lipids in the blood or lymph.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:1990777,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1990777,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lipoprotein particle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/TRANS_0000007,contact,,"Contact transmission is a direct transmission process during which the pathogen is transmitted   from a reservoir, source or host to another host by kissing, skin-to-skin contact, sexual intercourse, or by contact with soil or vegetation containing the pathogen.",false,,,http://purl.obolibrary.org/obo/TRANS_0000001,,,,,,,,,,,,,,,,,,,,,"Contact transmission is a direct transmission process during which the pathogen is transmitted   from a reservoir, source or host to another host by kissing, skin-to-skin contact, sexual intercourse, or by contact with soil or vegetation containing the pathogen.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,transmission_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/TRANS_0000001,,,,TRANS:0000007,,,,,,true,,,,,,,direct contact,,TRANS:0000007,,http://purl.obolibrary.org/obo/trans.owl,,,,,,,,,,,contact,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000200315,APOBEC3A,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,bK150C2.1|ARP3|A3A|PHRBN,,,,,,,22,,,,,,,,,,MIM:607109|HGNC:17343|Ensembl:ENSG00000128383|Vega:OTTHUMG00000151004|HPRD:06168,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A",,22q13.1-q13.2,,,,"GO_0004126 (EC: IDA, PMID: 16527742); GO_0004126 (EC: IMP); GO_0005515 (EC: IPI); GO_0005634 (EC: IDA); GO_0005730 (EC: IDA, Qualifier: NOT); GO_0005737 (EC: IDA); GO_0008270 (EC: IEA); GO_0009972 (EC: IDA, PMID: 16527742); GO_0009972 (EC: IMP); GO_0010529 (EC: IDA, PMID: 16527742); GO_0044356 (EC: IDA); GO_0045071 (EC: IDA, PMID: 16527742); GO_0045087 (EC: IDA); GO_0047844 (EC: IMP); GO_0051607 (EC: IDA); GO_0070383 (EC: IDA, PMID: 16527742); GO_0070383 (EC: IMP); GO_0071466 (EC: IDA); GO_0080111 (EC: IDA)",PMID: 1286667; 10469298; 10591208; 10737800; 11863358; 12477932; 12539042; 12683974; 12859895; 15461802; 15489334; 16344560; 16407327; 16527742; 17447845; 17727729; 17977970; 18403710; 19008196; 19038776; 19461882; 19788695; 19911124; 20012521; 20062055; 20178977; 20615867; 20972438; 21123384; 21279453; 21460793; 21906983; 21957290; 21963094; 21995620; 22272271; 22457529; 22798497; 22822074; 22948384; 22977230; 23000965; 23640892; 23695684; 23840298; 23979356; 24163103,,,,,,,,,,,,,,,,,,OGG:3000200315,,,,,,,,,,,,,,,,,,,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,APOBEC3A,,,20140408,200315,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,APOBEC3A,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0046753,non-lytic viral release,,The exit of a viral particle from a cell that does not involve cell lysis.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,The exit of a viral particle from a cell that does not involve cell lysis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0046753,,,,,,true,,,,true,,,,,GO:0046753,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,non-lytic viral release,,,,,,,,,,,,,,,,,,,,,,https://www.nature.com/articles/s41591-020-0869-5,,,,,,,https://github.com/geneontology/go-ontology/issues/18852,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000003,"abnormal respiratory finding
",,,false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal breathing patterns that suggest the possibility of an underlying injury or metabolic derangements. Early recognition of abnormal respiratory patterns can aid the clinician in early intervention to prevent further deterioration of the patient's condition.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/books/NBK470309/|https://www.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,,,,,,,,,,,,"abnormal respiratory finding
",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_145535,pevonedistat,"[(1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate|MLN 4924|[(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxy-cyclopentyl]methyl sulfamate|MLN-4924|pevonedistatum|pevonedistat|MLN4924","A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine which is substituted by a (1S)-2,3-dihydro-1H-inden-1-ylnitrilo group at position 4 and by a (1S,3S,4S)-3-hydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl group at position 7. It is a potent and selective NEDD8-activating enzyme inhibitor with an IC50 of 4.7 nM, and currently under clinical investigation for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:30545630|PMID:30020196|PMID:28578874|PMID:25733005|PMID:26561559|Wikipedia:Pevonedistat|PMID:29348128|PDBeChem:B39|LINCS:LSM-6263|PMID:30850948|PMID:31355467|PMID:29667067|PMID:20129059|CAS:905579-51-3|PMID:27901050|PMID:30845347|PMID:31665821|PMID:31528694|PMID:28838998|PMID:26292710|PMID:19360080|PMID:30341788|PMID:28717191|KEGG:D10413|PMID:27783255|PMID:30556867|PMID:31002342|DrugBank:DB11759|PMID:27551465,"A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine which is substituted by a (1S)-2,3-dihydro-1H-inden-1-ylnitrilo group at position 4 and by a (1S,3S,4S)-3-hydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl group at position 7. It is a potent and selective NEDD8-activating enzyme inhibitor with an IC50 of 4.7 nM, and currently under clinical investigation for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[(1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate",,,,,chebi_ontology,,"MLN 4924|[(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxy-cyclopentyl]methyl sulfamate|MLN-4924|pevonedistatum|pevonedistat|MLN4924",,,,,,,,,0,C21H25N5O4S,"InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1",MPUQHZXIXSTTDU-QXGSTGNESA-N,443.520,443.16273,C1=CC2=C(C=C1)[C@H](CC2)NC3=C4C(=NC=N3)N(C=C4)[C@@H]5C[C@H]([C@H](C5)O)COS(N)(=O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:145535,,,,,,true,,,,,,,,,CHEBI:145535,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,pevonedistat,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051784,negative regulation of nuclear division,down-regulation of nuclear division|downregulation of nuclear division|down regulation of nuclear division|inhibition of nuclear division,"Any process that stops, prevents, or reduces the frequency, rate or extent of nuclear division, the partitioning of the nucleus and its genetic information.",false,,,http://purl.obolibrary.org/obo/GO_0051783,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate or extent of nuclear division, the partitioning of the nucleus and its genetic information.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,down-regulation of nuclear division|downregulation of nuclear division|down regulation of nuclear division,,,inhibition of nuclear division,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051783,,,,GO:0051784,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051784,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044282,small molecule catabolic process,small molecule catabolism,"The chemical reactions and pathways resulting in the breakdown of small molecules, any low molecular weight, monomeric, non-encoded molecule.|Small molecules in GO include monosaccharides but exclude disaccharides and polysaccharides.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,jane,2010-01-26T12:06:10Z,,,,"The chemical reactions and pathways resulting in the breakdown of small molecules, any low molecular weight, monomeric, non-encoded molecule.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,small molecule catabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Small molecules in GO include monosaccharides but exclude disaccharides and polysaccharides.,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0044282,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044282,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,small molecule catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003138,Increased blood urea nitrogen,Increased blood urea nitrogen|Increased BUN,An increased amount of nitrogen in the form of urea in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0002157|http://purl.obolibrary.org/obo/HP_0031970,,,,,,,,,,,,,,,,,,,,UMLS:C0151539,An increased amount of nitrogen in the form of urea in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Increased blood urea nitrogen|Increased BUN,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002157|http://purl.obolibrary.org/obo/HP_0031970,,,,HP:0003138,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,HP:0003138,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Increased blood urea nitrogen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042788,polysomal ribosome,active ribosome,A ribosome bound to mRNA that forms part of a polysome.,false,,,http://purl.obolibrary.org/obo/GO_0005840,,,,,,,,,,,,,,,,,,,,,A ribosome bound to mRNA that forms part of a polysome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,active ribosome,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005840,,,,GO:0042788,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042788,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,polysomal ribosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000051512,GTSE1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,B99,,,,,,,22,,,,,,,,,,Ensembl:ENSG00000075218|HPRD:09593|HGNC:13698|Vega:OTTHUMG00000150486|MIM:607477,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,G-2 and S-phase expressed 1,,22q13.2-q13.3,,,,"GO_0000085 (EC: NAS, PMID: 10974554); GO_0003674 (EC: ND); GO_0005515 (EC: IPI); GO_0005881 (EC: NAS, PMID: 10974554); GO_0006977 (EC: NAS, PMID: 10974554); GO_0007017 (EC: NAS, PMID: 10974554)",PMID: 8125298; 8889548; 10591208; 10974554; 10984615; 12477932; 12750368; 14702039; 14707141; 15146197; 15231747; 15302935; 15461802; 15489334; 15790807; 15998911; 16344560; 16964243; 19531213; 19615732; 19913121; 20018861; 20577264; 20628086; 20800603; 21139048; 21693764; 21890473; 22292647; 22990118; 23236459; 24250222,,,,,,,,,,,,,,,,,,OGG:3000051512,,,,,,,,,,,,,,,,,,,G-2 and S-phase expressed 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GTSE1,,,20140408,51512,RP5-1163J1.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,GTSE1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0016323,basolateral plasma membrane,,"The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0016323,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016323,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,basolateral plasma membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_2042698,SARS-related betacoronavirus Rp3/2004,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:2042698,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS-related betacoronavirus Rp3/2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_296840,SARS coronavirus PC4-199,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:296840,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C71164,Animal Model,"Animal Model, Generic|Animal Model|Research Model, Animal",An animal that is amenable to experimentation and whose physiological or pathologic mechanisms are sufficiently similar to those of a human for the animal to serve as a model.,false,,,http://purl.obolibrary.org/obo/NCIT_C19148,,,,,,,,,,,C71164,,,,,,,,,,An animal that is amenable to experimentation and whose physiological or pathologic mechanisms are sufficiently similar to those of a human for the animal to serve as a model.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Animal Model, Generic|Animal Model|Research Model, Animal",,,,,,,,,,,,,NCIT:C71164,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C19148,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Animal Model,Animal_Model_Generic,,,,,,,,,,,,,,,,,,Animal Model,,,,Research Activity,,,,,,,,C0599779,
https://bscantology/COVID_0000107,gamma-glutamyltransferase,,,false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,Gamma glutamyl transferases (GGT) are highly conserved enzymes that occur from bacteria to humans. They remove terminal γ-glutamyl residue from peptides and amides.,Gamma-glutamyltransferases,,,,,,,,,,,,,,,gamma-glutamyltransferase,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_231513,Civet SARS CoV SZ3/2003,SARS coronavirus SZ3|Civet SARS-CoV/SZ3/2003,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus SZ3|Civet SARS-CoV/SZ3/2003,,,,,,NCBITaxon:231513,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Civet SARS CoV SZ3/2003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006954,inflammatory response,inflammation,"The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Inflammation,"The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.",,,,,,,,,,,,,,,,,,,,,,,,,,,,inflammation,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0006954,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215613,,,,GO:0006954,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_22907,bleomycin,,"A glycopeptide produced by the bacterium Streptomyces verticillus. The term, 'bleomycin' refers to a family of structurally related compounds. When used as an anti-cancer agent, the chemotherapeutical forms are primarily bleomycin A2 and B2.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,DrugBank:DB00290|Wikipedia:Bleomycin,"A glycopeptide produced by the bacterium Streptomyces verticillus. The term, 'bleomycin' refers to a family of structurally related compounds. When used as an anti-cancer agent, the chemotherapeutical forms are primarily bleomycin A2 and B2.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:584977,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:22907,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32205856,,,,CHEBI:22907,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,bleomycin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031639,plasminogen activation,cleavage of plasminogen to plasmin,"The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.",false,,,http://purl.obolibrary.org/obo/GO_0016485,,,,,,,,,,,,,,,,,,,,,"The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cleavage of plasminogen to plasmin,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016485,,,,GO:0031639,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031639,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,plasminogen activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002244,FGB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HEL-S-78p,,,,,,,4,,,,,,,,,,HGNC:3662|MIM:134830|HPRD:00620,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,fibrinogen beta chain,,4q28,,,,"GO_0002576 (EC: TAS); GO_0005102 (EC: IEA); GO_0005515 (EC: IPI); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0005577 (EC: IEA); GO_0005615 (EC: IDA, PMID: 19996109); GO_0005886 (EC: TAS); GO_0005938 (EC: IEA); GO_0007165 (EC: IEA); GO_0007596 (EC: TAS); GO_0009897 (EC: IDA, PMID: 6777381); GO_0009986 (EC: IDA, PMID: 6777381); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0030674 (EC: IEA); GO_0031091 (EC: IDA, PMID: 6777381); GO_0031093 (EC: TAS); GO_0044320 (EC: IEA); GO_0051087 (EC: IPI, PMID: 19996109); GO_0051258 (EC: IEA); GO_0051592 (EC: IDA, PMID: 6777381); GO_0071347 (EC: IEA); GO_0072562 (EC: IDA)",PMID: 156564; 420779; 891553; 936108; 1565641; 1634610; 1680863; 2018836; 2102623; 2322576; 2572363; 2742826; 3029722; 3156856; 3194892; 5084810; 6165239; 6383194; 6575389; 6575689; 6575700; 6688356; 6777381; 7356959; 7583541; 7592883; 7642629; 8148485; 8384496; 8666148; 8889549; 8910396; 8979138; 9028318; 9224210; 9333233; 9351824; 9628725; 9787167; 10074346; 10391209; 10467729; 10605720; 10666208; 10766195; 10980194; 11027931; 11054085; 11293402; 11296154; 11460506; 11460528; 11468164; 11546832; 11588042; 11714857; 11728146; 11798781; 11833854; 11836675; 11858186; 11877019; 11940334; 12048138; 12082590; 12082592; 12122980; 12141403; 12151156; 12161363; 12356313; 12393540; 12406024; 12477932; 12511408; 12514663; 12518110; 12578626; 12615788; 12616980; 12617173; 12624729; 12637691; 12665801; 12710752; 12716802; 12747593; 12871600; 12878203; 12893758; 12899665; 14618197; 14629463; 14629469; 14652632; 14669221; 14691567; 14706682; 14718574; 14746139; 14963283; 15076187; 15091001; 15104216; 15170397; 15192836; 15213870; 15217804; 15300640; 15346842; 15489334; 15575509; 15583729; 15608011; 15631828; 15671034; 15709716; 15723073; 15735811; 15735812; 15737987; 15793786; 15795538; 15795540; 15842357; 15857159; 15939070; 15968394; 15983960; 16005629; 16049588; 16080811; 16086292; 16144795; 16157382; 16195396; 16215953; 16263699; 16324093; 16335952; 16353042; 16409729; 16420563; 16443328; 16466010; 16489740; 16525568; 16525569; 16567932; 16581250; 16601848; 16604498; 16611940; 16614319; 16635210; 16697386; 16706972; 16750002; 16767673; 16776623; 16899909; 16928957; 16938111; 16940416; 16953282; 17003923; 17111197; 17115186; 17116333; 17126309; 17160939; 17230042; 17263791; 17264952; 17414213; 17469143; 17497226; 17582472; 17591786; 17637253; 17643375; 17688324; 17849064; 17925485; 17951283; 17994314; 18000621; 18029348; 18057060; 18173921; 18188987; 18202324; 18253477; 18278190; 18284606; 18331453; 18334738; 18434720; 18503143; 18511872; 18513389; 18683729; 18685811; 18726528; 18772067; 18803625; 18818200; 18836720; 18841297; 18842294; 18848323; 18853456; 18927546; 18930220; 18936436; 18974842; 18977990; 18982866; 19056482; 19072566; 19131662; 19136375; 19143925; 19190816; 19227305; 19229055; 19238444; 19264644; 19272152; 19332210; 19352213; 19395327; 19404555; 19409601; 19420105; 19420351; 19431272; 19479237; 19508823; 19559392; 19560472; 19578796; 19593947; 19682239; 19750100; 19811441; 19860767; 19892918; 19899640; 19906129; 19913121; 19923980; 19948975; 19954614; 19956635; 19996109; 20031576; 20031577; 20036902; 20051843; 20059469; 20064497; 20075509; 20078877; 20079495; 20082208; 20128871; 20135074; 20162731; 20167083; 20237496; 20360068; 20376805; 20425806; 20452482; 20533267; 20535834; 20536507; 20538554; 20619835; 20628086; 20637145; 20673868; 20709368; 20873219; 20978265; 21034162; 21054877; 21098282; 21122273; 21160146; 21241403; 21258858; 21296900; 21316837; 21420681; 21499712; 21713329; 21725578; 21757653; 21800007; 21900206; 21988832; 22053176; 22273812; 22293628; 22386478; 22489912; 22552295; 22575419; 22642105; 22836683; 22889670; 23056168; 23061815; 23129316; 23144326; 23238100; 23650004; 23750785; 23852822; 23877568; 23958299; 23969696,,,,,,,,,,,,,,,,,,OGG:3000002244,,,,,,,,,,,,,,,,,,,fibrinogen beta chain,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,fibrinogen,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FGB,,,20140408,2244,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,FGB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/SYMP_0019174,chills,rigors,,false,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,rigors,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,SYMP:0019174,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32213337,Shivering or moderate tremors of the body often accompanied by a cold sensation.,,,SYMP:0019174,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,chills,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002896,GRN,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PEPI|PCDGF|GEP|PGRN|CLN11|GP88,,,,,,,17,,,,,,,,,,Vega:OTTHUMG00000181816|MIM:138945|HGNC:4601|HPRD:00733|Ensembl:ENSG00000030582,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,granulin,,17q21.32,,,,"GO_0001835 (EC: IEA); GO_0005125 (EC: IEA); GO_0005515 (EC: IPI); GO_0005615 (EC: IEA); GO_0005739 (EC: IEA); GO_0007165 (EC: NAS, PMID: 1542665); GO_0007566 (EC: IEA); GO_0008083 (EC: TAS, PMID: 1542665); GO_0008219 (EC: IEA); GO_0043231 (EC: IDA); GO_0044822 (EC: IDA); GO_0050679 (EC: IEA)",PMID: 1417868; 1542665; 1618805; 2268320; 8125298; 8471244; 8471426; 8496151; 8619474; 8912679; 9110174; 9826678; 10079180; 10397269; 10477733; 10715107; 10728698; 11068878; 11549288; 11846389; 12031912; 12477932; 12526812; 12538450; 12588988; 12900424; 12914763; 12931033; 14652816; 14702039; 14977833; 15231748; 15489334; 15569995; 15653695; 16189514; 16533762; 16713569; 16857791; 16862115; 16862116; 16950801; 16983677; 16983685; 17110338; 17157414; 17166276; 17202431; 17210807; 17228326; 17261172; 17266030; 17278999; 17291356; 17345602; 17353379; 17371905; 17383054; 17417739; 17436289; 17439980; 17458552; 17522386; 17572900; 17620546; 17698705; 17826340; 17949857; 17950702; 17984093; 18029348; 18157829; 18166610; 18183624; 18184915; 18192287; 18223198; 18234697; 18245784; 18276110; 18314228; 18322394; 18359860; 18378771; 18392865; 18413467; 18413474; 18442119; 18464284; 18479928; 18543312; 18551524; 18565828; 18593276; 18654987; 18706200; 18723384; 18723524; 18752597; 18768919; 18771956; 18838661; 18848708; 18855025; 18955727; 19012866; 19016491; 19020205; 19049508; 19056610; 19091059; 19101631; 19133655; 19158106; 19179604; 19237611; 19255408; 19321167; 19343720; 19446372; 19473366; 19487464; 19618231; 19625741; 19632744; 19649643; 19730170; 19730171; 19795409; 19847305; 19858458; 19863344; 19864668; 19913121; 19938685; 19940479; 19963041; 20020531; 20028451; 20045477; 20054825; 20061636; 20087814; 20142524; 20142525; 20154673; 20171924; 20197700; 20215705; 20237496; 20301545; 20301601; 20387302; 20463744; 20479936; 20489155; 20570546; 20628086; 20682318; 20711061; 20798611; 20858962; 20884628; 20930269; 20930271; 20933034; 20947212; 20975516; 21047645; 21078624; 21085476; 21087763; 21107132; 21123963; 21178100; 21204008; 21212639; 21224065; 21232819; 21258152; 21263192; 21289198; 21319273; 21393509; 21454553; 21482928; 21645364; 21677378; 21707777; 21753165; 21800185; 21802097; 21813674; 21891865; 21891869; 21892962; 21942715; 21988832; 22032330; 22045426; 22068162; 22088468; 22127750; 22130207; 22176685; 22194816; 22204653; 22268729; 22280948; 22316048; 22338605; 22348647; 22366795; 22397762; 22491866; 22504418; 22505994; 22509390; 22608501; 22623979; 22647257; 22665040; 22761921; 22787763; 22792281; 22797721; 22802426; 22819134; 22859297; 22890097; 22890101; 22945272; 22986778; 23088713; 23158232; 23218900; 23236149; 23317568; 23338682; 23342160; 23364791; 23396349; 23402259; 23409033; 23419701; 23455922; 23476101; 23478307; 23596077; 23609919; 23684369; 23702100; 24005336; 24070898; 24081456; 24163370; 24186875; 24457600,,,,,,,,,,,,,,,,,,OGG:3000002896,,,,,,,,,,,,,,,,,,,granulin,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GRN,,,20140408,2896,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,GRN,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000096,A2a3a haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A2a3a haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,A2a3a haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_231515,Civet SARS CoV SZ16/2003,SARS coronavirus SZ16|Civet SARS-CoV/SZ16/2003,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus SZ16|Civet SARS-CoV/SZ16/2003,,,,,,NCBITaxon:231515,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Civet SARS CoV SZ16/2003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1902850,microtubule cytoskeleton organization involved in mitosis,microtubule cytoskeleton organisation involved in mitosis|microtubule dynamics involved in mitosis|microtubule cytoskeleton organization and biogenesis involved in mitosis,Any microtubule cytoskeleton organization that is involved in mitosis.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,vw,2014-04-02T14:19:38Z,,,,Any microtubule cytoskeleton organization that is involved in mitosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,microtubule cytoskeleton organisation involved in mitosis|microtubule dynamics involved in mitosis,,,,,biological_process,,microtubule cytoskeleton organization and biogenesis involved in mitosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:1902850,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902850,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,microtubule cytoskeleton organization involved in mitosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_285267,SARS coronavirus HHS-2004,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:285267,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HHS-2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003612,IMPA1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IMPA|IMP,,,,,,,8,,,,,,,,,,HGNC:6050|Ensembl:ENSG00000133731|MIM:602064|HPRD:03641|Vega:OTTHUMG00000164682,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,inositol(myo)-1(or 4)-monophosphatase 1,,8q21.13-q21.3,,,,"GO_0005737 (EC: IDA, PMID: 1377913); GO_0005829 (EC: TAS); GO_0006021 (EC: IEA); GO_0006661 (EC: IMP, PMID: 1377913); GO_0006796 (EC: IMP, PMID: 1377913); GO_0007165 (EC: IMP, PMID: 1377913); GO_0008934 (EC: IDA, PMID: 17068342); GO_0008934 (EC: IMP, PMID: 1377913); GO_0042802 (EC: IPI, PMID: 16189514); GO_0042803 (EC: IPI, PMID: 17068342); GO_0043647 (EC: TAS); GO_0044281 (EC: TAS); GO_0046854 (EC: IEA); GO_0046855 (EC: IDA, PMID: 17068342); GO_0046872 (EC: IEA); GO_0052832 (EC: IEA); GO_0052833 (EC: IEA)",PMID: 1332026; 1377913; 6253491; 8068620; 8068621; 8718889; 9210592; 9339367; 11281967; 11911470; 11959401; 12176979; 12477932; 14699425; 15342556; 15489334; 16189514; 16344560; 17068342; 17207965; 18029348; 19322201; 19447967; 19593677; 20153384; 21139048; 21890473; 21906983; 21963094; 21965294; 23027737; 23535730,,,,,,,,,,,,,,,,,,OGG:3000003612,,,,,,,,,,,,,,,,,,,inositol(myo)-1(or 4)-monophosphatase 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129059/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IMPA1,,,20140408,3612,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IMPA1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OMIT_0004723,Cross Infection,,,false,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0004723,"A cross infection is the transfer of harmful microorganisms, usually bacteria and viruses. The spread of infections can occur between people, pieces of equipment, or within the body.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Cross Infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_41774,tamoxifen,"2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine|Tamoxifen|Diemon|tamoxifen|Crisafeno|trans-Tamoxifen|tamoxifene|Apo-Tamox|tamoxifeno|(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine|tamoxifenum|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:7688593|HMDB:HMDB0014813|KEGG:D08559|Beilstein:2062020|PMID:14681337|DrugBank:DB00675|Drug_Central:2561|Wikipedia:Tamoxifen|Patent:BE678807|Patent:US4536516|CAS:10540-29-1|PMID:14709804|KEGG:C07108|Patent:BE637389|PMID:18348622,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:41767|CHEBI:9396,,,,"2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine|Tamoxifen",,,,,chebi_ontology,,"Diemon|tamoxifen|Crisafeno|trans-Tamoxifen|tamoxifene|Apo-Tamox|tamoxifeno|(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine|tamoxifenum|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene",,,,,,,,,0,C26H29NO,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",NKANXQFJJICGDU-QPLCGJKRSA-N,371.51460,371.22491,CCC(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:41774,,,,,,yes,,,,,,,,,CHEBI:41774,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,DOI: 10.4103/bbrj.bbrj_53_20,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000104,gene ontology enrichment analysis,,,false,,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,,,,Assay,,true,,,,,,"A ranked list of Gene Ontology concepts, each associated with a p-value, concerning or derived from the analysis of e.g. a set of genes or proteins.",,,,,,,,,,,,,,,,gene ontology enrichment analysis,,,,,,,,,,,,,,,,,,,,,,http://geneontology.org/covid-19.html,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_296838,SARS coronavirus PC4-137,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:296838,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-137,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C12611,Antibody-Producing Cell,Antibody-Producing Cell|Antibody Producing Cell|Immunoglobulin-Producing Cells|Immunoglobulin-Producing Cell|Antibody-Producing Cells,A type of B lymphocyte that reacts with antigens to produce immune proteins called antibodies.,false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,C12611,,,,,,,,,,A type of B lymphocyte that reacts with antigens to produce immune proteins called antibodies.,,,,,,Antibody-Producing Cell,,,,,,,,,,,,,,,,,,,,,,,,,Antibody-Producing Cell|Antibody Producing Cell|Immunoglobulin-Producing Cells|Immunoglobulin-Producing Cell|Antibody-Producing Cells,,,,,,,,,,,,,NCIT:C12611,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32284614,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Antibody-Producing Cell,Antibody_Producing_Cell,,,,,,,,,,,,,,,,,,Antibody-Producing Cell,,,,Cell,,,,,,,,C0003273,
http://purl.obolibrary.org/obo/CMO_0000002,heart rate,,The number of contractions of the cardiac ventricles per unit of time.,false,,,http://purl.obolibrary.org/obo/CMO_0000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000002,,,,,,,,,,,,The number of contractions of the cardiac ventricles per unit of time.,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000001,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32189136/,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,heart rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0008608,attachment of spindle microtubules to kinetochore,microtubule and chromosome interaction|kinetochore microtubule interaction|kinetochore-microtubule interaction|spindle-chromosome interaction|spindle chromosome attachment|attachment of spindle microtubules to chromosome|spindle kinetochore attachment|microtubule anchoring at kinetochore|kinetochore-microtubule attachment|microtubule capture|amphotelic attachment|microtubule and kinetochore interaction|bipolar attachment,"The process in which spindle microtubules become physically associated with the proteins making up the kinetochore complex.|This class covers all attachments of spindle microtubules to the kinetochore, including the many incorrect attachments which initially form and are later corrected to stable attachments with the correct orientation for segregation to proceed (sister chromatid biorientation).",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The process in which spindle microtubules become physically associated with the proteins making up the kinetochore complex.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0051313,microtubule and chromosome interaction|kinetochore microtubule interaction|kinetochore-microtubule interaction|spindle-chromosome interaction,,,spindle chromosome attachment|attachment of spindle microtubules to chromosome|spindle kinetochore attachment|microtubule anchoring at kinetochore|kinetochore-microtubule attachment,,,microtubule capture,,biological_process,,amphotelic attachment|microtubule and kinetochore interaction|bipolar attachment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"This class covers all attachments of spindle microtubules to the kinetochore, including the many incorrect attachments which initially form and are later corrected to stable attachments with the correct orientation for segregation to proceed (sister chromatid biorientation).",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0008608,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0008608,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,attachment of spindle microtubules to kinetochore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039665,permeabilization of host organelle membrane involved in viral entry into host cell,viral penetration via host endosomal membrane disruption by virus|viral penetration via perforation of host organellar membrane by virus|viral penetration via permeabilization of host organellar membrane|viral membrane-penetration protein|viral entry into host cell via permeabilization of host organelle membrane,Induction of organellar membrane permeabilization triggered by an interaction between the host membrane and a membrane-penetration protein associated with a viral capsid. Results in release of the virus contents from an organelle into the host cell cytoplasm.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-08-29T11:57:21Z,,,VZ:985,Induction of organellar membrane permeabilization triggered by an interaction between the host membrane and a membrane-penetration protein associated with a viral capsid. Results in release of the virus contents from an organelle into the host cell cytoplasm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral penetration via host endosomal membrane disruption by virus|viral penetration via perforation of host organellar membrane by virus|viral penetration via permeabilization of host organellar membrane,,,,,biological_process,,viral membrane-penetration protein|viral entry into host cell via permeabilization of host organelle membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039665,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,GO:0039665,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,permeabilization of host organelle membrane involved in viral entry into host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C32055,Alveolar Cell Type II,Type II Pneumocyte|Alveolar Cell Type II,A pleomorphic cell of the pulmonary alveolar epithelium that secretes surfactant and is distinguished by abundant cytoplasm containing numerous lipid-rich multilamellar bodies.,false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,C32055,,,,,,,,,,A pleomorphic cell of the pulmonary alveolar epithelium that secretes surfactant and is distinguished by abundant cytoplasm containing numerous lipid-rich multilamellar bodies.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Type II Pneumocyte|Alveolar Cell Type II,,,,,,,,,,,,,NCIT:C32055,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32125455,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Alveolar Cell Type II,Alveolar_Cell_Type_II,,,,,,,,,,,,,,,,,,Alveolar Cell Type II,,,,Cell,,,,,,,,C0225700,
http://purl.obolibrary.org/obo/CHEBI_135876,valrubicin,AD-32|N-Trifluoroacetyldoxorubicin 14-valerate|N-Trifluoroacetyladriamycin 14-valerate|valstar,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:2805|CAS:56124-62-0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,AD-32|N-Trifluoroacetyldoxorubicin 14-valerate|N-Trifluoroacetyladriamycin 14-valerate|valstar,,,,,,,,,0,C34H36F3NO13,"InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1",ZOCKGBMQLCSHFP-KQRAQHLDSA-N,723.651,723.21387,O([C@H]1C[C@H](NC(C(F)(F)F)=O)[C@@H]([C@@H](O1)C)O)[C@@H]2C3=C(C(O)=C4C(=C3O)C(=O)C=5C(C4=O)=CC=CC5OC)C[C@](C2)(C(COC(CCCC)=O)=O)O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:135876,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:135876,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,valrubicin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_331,central nervous system disease,,A nervous system disease that affects either the spinal cord (myelopathy) or brain (encephalopathy) of the central nervous system.,false,,,http://purl.obolibrary.org/obo/DOID_863,,,,,,,,,,,,,,,,,,,,MESH:D002493|UMLS_CUI:C0007682|NCI:C2934|SNOMEDCT_US_2019_09_01:23853001|ICD10CM:G96.9,A nervous system disease that affects either the spinal cord (myelopathy) or brain (encephalopathy) of the central nervous system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_863,,,,DOID:331,,,,,,,,,,,,,,,DOID:331,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,central nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C100098,Ademetionine,"ADEMETIONINE|(+-)-5'-((R*)-((R*)-3-Amino-3-carboxypropyl)methylsulfonio)-5'-deoxyadenosine Hydroxide, Inner Salt|S-Adenosyl-DL-methionine|Ademetionine|Methionine, S-adenosyl-, DL-",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,17176-17-9,,C15H22N6O5S,,C100098,,,FDA,,,,,,,,,,,,,,,,,,,,,,,,7LP2MPO46S,,,,,,,,,,,,,,"ADEMETIONINE|(+-)-5'-((R*)-((R*)-3-Amino-3-carboxypropyl)methylsulfonio)-5'-deoxyadenosine Hydroxide, Inner Salt|S-Adenosyl-DL-methionine|Ademetionine|Methionine, S-adenosyl-, DL-",,,,,,,,,,,,,NCIT:C100098,Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Ademetionine,,,,,,,CL434401,,,,,,,,,,,,Ademetionine,,,https://www.preprints.org/manuscript/202003.0239/v1,"Amino Acid, Peptide, or Protein",,,,,,,,,
http://purl.obolibrary.org/obo/DOID_9500,leukocyte disease,,A hematopoietic system disease that is located_in white blood cells.,false,,,http://purl.obolibrary.org/obo/DOID_74,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0023510|ICD9CM:288|ICD10CM:D72.9|SNOMEDCT_US_2019_09_01:54097007|MESH:D007960,A hematopoietic system disease that is located_in white blood cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_74,,,,DOID:9500,,,,,,,,,,,,,,,DOID:9500,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,leukocyte disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061008,hepaticobiliary system development,hepatobiliary system development,"The progression of the hepaticobiliary system over time, from its formation to the mature structure. The hepaticobiliary system is responsible for metabolic and catabolic processing of small molecules absorbed from the blood or gut, hormones and serum proteins, detoxification, storage of glycogen, triglycerides, metals and lipid soluble vitamins and excretion of bile. Included are the synthesis of albumin, blood coagulation factors, complement, and specific binding proteins.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,dph,2010-01-22T09:11:59Z,,,,"The progression of the hepaticobiliary system over time, from its formation to the mature structure. The hepaticobiliary system is responsible for metabolic and catabolic processing of small molecules absorbed from the blood or gut, hormones and serum proteins, detoxification, storage of glycogen, triglycerides, metals and lipid soluble vitamins and excretion of bile. Included are the synthesis of albumin, blood coagulation factors, complement, and specific binding proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hepatobiliary system development,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0061008,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061008,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,hepaticobiliary system development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000077,Abnormality of the kidney,Abnormal kidney|Abnormality of the kidney|Renal anomaly|Renal anomalies,An abnormality of the kidney.|The kidney is a paired organ whose primary function is the production of urine.,false,,,http://purl.obolibrary.org/obo/HP_0010935,,,,,,,,,,,,,,,,,,,,MSH:D007674|SNOMEDCT_US:44513007|SNOMEDCT_US:90708001|UMLS:C0022658|UMLS:C0266292,An abnormality of the kidney.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal kidney|Abnormality of the kidney|Renal anomaly|Renal anomalies,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,The kidney is a paired organ whose primary function is the production of urine.,,http://purl.obolibrary.org/obo/HP_0010935,,,,HP:0000077,,,,,,,,,,,,,,,HP:0000077,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the kidney,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_2000816,negative regulation of mitotic sister chromatid separation,negative regulation of sister chromatid separation during mitosis|negative regulation of mitotic sister chromatid resolution|negative regulation of chromosome separation during mitosis|negative regulation of mitotic chromosome separation,"Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid separation.",false,,,http://purl.obolibrary.org/obo/GO_0033048|http://purl.obolibrary.org/obo/GO_1905819|http://purl.obolibrary.org/obo/GO_0010965,,,,,,,,,,,,,,,,midori,2011-07-11T04:45:06Z,,,,"Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid separation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,negative regulation of sister chromatid separation during mitosis|negative regulation of mitotic sister chromatid resolution,,,,,biological_process,,negative regulation of chromosome separation during mitosis|negative regulation of mitotic chromosome separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033048|http://purl.obolibrary.org/obo/GO_1905819|http://purl.obolibrary.org/obo/GO_0010965,,,,GO:2000816,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:2000816,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of mitotic sister chromatid separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061620,glycolytic process through glucose-6-phosphate,,"The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, occurring through a glucose-6-phosphate intermediate, with the concomitant production of a small amount of ATP.",false,,,http://purl.obolibrary.org/obo/GO_0061615,,,,,,,,,,,,,,,,dph,2014-04-14T09:17:48Z,,,MetaCyc:GLYCOLYSIS,"The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, occurring through a glucose-6-phosphate intermediate, with the concomitant production of a small amount of ATP.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0061615,,,,GO:0061620,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061620,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,glycolytic process through glucose-6-phosphate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000004360,MRC1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MMR|CLEC13DL|MRC1L1|CD206|CLEC13D|bA541I19.1,,,,,,,10,,,,,,,,,,HGNC:7228|Vega:OTTHUMG00000017757|HPRD:01089|Ensembl:ENSG00000183748|MIM:153618|Ensembl:ENSG00000120586|Vega:OTTHUMG00000017754,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"mannose receptor, C type 1",,10p12.33,,,,"GO_0004872 (EC: IDA); GO_0005515 (EC: IPI, PMID: 11222859); GO_0005537 (EC: TAS, PMID: 2373685); GO_0005886 (EC: IDA); GO_0005887 (EC: TAS, PMID: 1294118); GO_0006898 (EC: IDA); GO_0010008 (EC: IDA)",PMID: 1294118; 1730714; 2258707; 2373685; 3611070; 8001982; 8940052; 9038177; 9677318; 10779515; 11120831; 11222859; 11715017; 11752456; 11841552; 12368450; 12477932; 14568928; 15042510; 15047828; 15155616; 15190005; 15637102; 15767290; 15955449; 16000387; 16203868; 16385451; 16547227; 16615932; 16672549; 17020928; 17077296; 17255364; 17360361; 17502612; 18029348; 18279703; 18353434; 19196802; 19197942; 19224860; 19403625; 19460752; 19683778; 19772890; 19902202; 20035344; 20139978; 20554962; 20610655; 21029423; 21331365; 21416197; 21628571; 21922073; 21943158; 22132194; 22289891; 22314623; 22392581; 22393309; 22842622; 22967244; 23148569; 23345393; 23603511; 23653008; 23734186; 23951013; 24184555,,,,,,,,,,,,,,,,,,OGG:3000004360,,,,,,,,,,,,,,,,,,,"mannose receptor, C type 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,MRC1,,,20140408,4360,RP11-457D2.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,MRC1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0051225,spindle assembly,bipolar spindle formation|spindle formation|bipolar spindle biosynthesis|spindle biosynthesis,"The aggregation, arrangement and bonding together of a set of components to form the spindle, the array of microtubules and associated molecules that serves to move duplicated chromosomes apart.",false,,,http://purl.obolibrary.org/obo/GO_0007051,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of a set of components to form the spindle, the array of microtubules and associated molecules that serves to move duplicated chromosomes apart.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0051227|GO:0051226,,,,bipolar spindle formation|spindle formation|bipolar spindle biosynthesis|spindle biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007051,,,,GO:0051225,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051225,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spindle assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00015413,nitazoxanide,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31819,,,,DRON:00015413,"A synthetic benzamide with antiprotozoal activity. Nitazoxanide exerts its antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction, which is essential to anaerobic energy metabolism. PFOR enzyme reduces nitazoxanide, thereby impairing the energy metabolism.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32293834,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,nitazoxanide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000146,feces and droppings symptom,fecal,,false,,,http://purl.obolibrary.org/obo/SYMP_0000459,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,fecal,,,,,symptoms,,,,,,,,,"Symptoms that accompany with the changes in the color, shape and texture of stool revealing any kind of digestive health problems.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000459,,,,SYMP:0000146,,modified definition,,,,,,,,,,,,,SYMP:0000146,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,feces and droppings symptom,,,,,,,,,,,,,,,,,,,,,,"https://www.piedmont.org/living-better/what-your-stool-says-about-your-health#:~:text=Your%20bowel%20habits%20are%20a,health%20problems%2C%20such%20as%20cancer.",,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043149,stress fiber assembly,actin cable assembly|stress fibre biosynthesis|actin cable formation|stress fibre formation,"The aggregation, arrangement and bonding together of a set of components to form a stress fiber. A stress fiber is a contractile actin filament bundle that consists of short actin filaments with alternating polarity.",false,,,http://purl.obolibrary.org/obo/GO_0030038,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of a set of components to form a stress fiber. A stress fiber is a contractile actin filament bundle that consists of short actin filaments with alternating polarity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,actin cable assembly|stress fibre biosynthesis|actin cable formation|stress fibre formation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030038,,,,GO:0043149,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043149,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,stress fiber assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006413,translational initiation,biopolymerization|biopolymerisation|protein synthesis initiation|translation initiation,"The process preceding formation of the peptide bond between the first two amino acids of a protein. This includes the formation of a complex of the ribosome, mRNA or circRNA, and an initiation complex that contains the first aminoacyl-tRNA.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The process preceding formation of the peptide bond between the first two amino acids of a protein. This includes the formation of a complex of the ribosome, mRNA or circRNA, and an initiation complex that contains the first aminoacyl-tRNA.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0006454|GO:0006440,biopolymerization|biopolymerisation|protein synthesis initiation,,,translation initiation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006413,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006413,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,translational initiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C1429,Vapreotide,vapreotide|VAPREOTIDE|Vapreotide|RC-160|BMY-41606|Docrised,"A synthetic cyclic octapeptide analogue of somatostatin with direct and indirect antitumor effects. Vapreotide binds to somatostatin receptors (SSTR), specifically SSTR-2 and to SSTR-5 with a lesser affinity, in the similar behaviors as other octapeptide somatostatin analogues. Like octreotide, this agent has direct and indirect antitumor effects via inhibiting the release of growth hormone and other peptides that regulate release of insulin, gastrointestinal hormones. Furthermore, vapreotide may also be useful for inducing hemostasis in cases of acute hemorrhage of the upper gastrointestinal tract.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called somatostatin analogs.,,,,,103222-11-3,,C57H70N12O9S2,,C1429,,,FDA,,,,,,,"A synthetic cyclic octapeptide analogue of somatostatin with direct and indirect antitumor effects. Vapreotide binds to somatostatin receptors (SSTR), specifically SSTR-2 and to SSTR-5 with a lesser affinity, in the similar behaviors as other octapeptide somatostatin analogues. Like octreotide, this agent has direct and indirect antitumor effects via inhibiting the release of growth hormone and other peptides that regulate release of insulin, gastrointestinal hormones. Furthermore, vapreotide may also be useful for inducing hemostasis in cases of acute hemorrhage of the upper gastrointestinal tract.",,,,,,,,,,,,,,,,,2PK59M9GFF,,,,,,,,,,,,,,vapreotide|VAPREOTIDE|Vapreotide|RC-160|BMY-41606|Docrised,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C95320,,,NCIT:C1429,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Vapreotide,Vapreotide,,,,,,,,,,,,,,,38258,38258,,Vapreotide,,16917205,,"Pharmacologic Substance|Amino Acid, Peptide, or Protein",,,,,,,,C0164678,
http://purl.obolibrary.org/obo/CHEBI_6827,methicillin,"6beta-(2,6-dimethoxybenzamido)-2,2-dimethylpenam-3alpha-carboxylic acid|Methicillin|meticillinum|(2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|meticillin|6beta-(2,6-dimethoxybenzamido)penicillanic acid|meticilline|meticilina","A penicillin that is 6-aminopenicillanic acid in which one of the amino hydrogens is replaced by a 2,6-dimethoxybenzoyl group.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,DrugBank:DB01603|Drug_Central:1744|KEGG:C07177|PMID:24405901|PMID:11969119|PMID:26962156|CAS:61-32-5|PMID:24433925|Reaxys:966227|Wikipedia:Meticillin|Beilstein:966227|PMID:12569987,"A penicillin that is 6-aminopenicillanic acid in which one of the amino hydrogens is replaced by a 2,6-dimethoxybenzoyl group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6beta-(2,6-dimethoxybenzamido)-2,2-dimethylpenam-3alpha-carboxylic acid|Methicillin",,,,,chebi_ontology,,"meticillinum|(2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|meticillin|6beta-(2,6-dimethoxybenzamido)penicillanic acid|meticilline|meticilina",,,,,,,,,0,C17H20N2O6S,"InChI=1S/C17H20N2O6S/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23)/t11-,12+,15-/m1/s1",RJQXTJLFIWVMTO-TYNCELHUSA-N,380.41500,380.10421,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)c1c(OC)cccc1OC)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6827,,,,,true,true,,,,,,,,,CHEBI:6827,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,methicillin,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016324,apical plasma membrane,,The region of the plasma membrane located at the apical end of the cell.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The region of the plasma membrane located at the apical end of the cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0016324,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016324,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,apical plasma membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_147411,TDZD-8,"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione|NP 01139|thiadiazolidinone-8","A member of the class of thiadiazolidines that is 1,2,4-thiadiazolidine-3,5-dione which is substituted by a methyl group at position 2 and by a benzyl group at position 4. It is a non-ATP competitive inhibitor of glycogen synthase kinase 3beta (GSK3beta). An experimental compound which was being developed for the potential treatment of Alzheimer's disease.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:32181909|Patent:NZ574619|PMID:17785584|PMID:25453207|PMID:25394244|PMID:30392874|PMID:21079728|PMID:28962480|PMID:25735991|PMID:28624830|CAS:327036-89-5|PMID:28256059|PMID:11881998|PMID:21966423|PMID:31399185|PMID:28965119|PMID:32188325|PMID:18323734|PMID:32141492,"A member of the class of thiadiazolidines that is 1,2,4-thiadiazolidine-3,5-dione which is substituted by a methyl group at position 2 and by a benzyl group at position 4. It is a non-ATP competitive inhibitor of glycogen synthase kinase 3beta (GSK3beta). An experimental compound which was being developed for the potential treatment of Alzheimer's disease.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione",,,,,chebi_ontology,,NP 01139|thiadiazolidinone-8,,,,,,,,,0,C10H10N2O2S,"InChI=1S/C10H10N2O2S/c1-11-9(13)12(10(14)15-11)7-8-5-3-2-4-6-8/h2-6H,7H2,1H3",JDSJDASOXWCHPN-UHFFFAOYSA-N,222.260,222.04630,N1(C(N(C(S1)=O)CC=2C=CC=CC2)=O)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:147411,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:147411,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,TDZD-8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019054,modulation by virus of host cellular process,modulation by virus of host process|regulation of cellular process in host by virus|modification by virus of host cellular process|regulation by virus of host cellular process|regulation of host cellular process by virus|viral host cell process manipulation|modulation of cellular process in host by virus,The process in which a virus effects a change in the processes and activities of its host organism.,false,,,http://purl.obolibrary.org/obo/GO_0019048,,,,,,,,,,,,,,,,,,,,,The process in which a virus effects a change in the processes and activities of its host organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,modulation by virus of host process,,,regulation of cellular process in host by virus|modification by virus of host cellular process|regulation by virus of host cellular process|regulation of host cellular process by virus|viral host cell process manipulation,,,,,biological_process,,modulation of cellular process in host by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019048,,,,GO:0019054,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32105090,,,,GO:0019054,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host cellular process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0013522,subdivision of tube,,,false,,,http://purl.obolibrary.org/obo/UBERON_0000064,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,Tube subdivisions that can eventually develop into distinct regions various organ systems,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000064,,,,UBERON:0013522,,modified definition,,,,,,,,,,,,,UBERON:0013522,,http://purl.obolibrary.org/obo/uberon.owl,,,,,,,,,,,subdivision of tube,,,,,,,,,,,,,,,,,,,,,,http://www.ifc.unam.mx/Brain/devel.htm,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_228406,SARS coronavirus BJ02,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:228406,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/15629030,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0100763,Abnormality of the lymphatic system,Lymphatic disease,"An anomaly of the lymphatic system, a network of lymphatic vessels that carry a clear fluid called lymph unidirectionally towards either the right lymphatic duct or the thoracic duct, which in turn drain into the right and left subclavian veins respectively.",false,,,http://purl.obolibrary.org/obo/HP_0002715|http://purl.obolibrary.org/obo/HP_0002597,,,,,,,,,,,,,,,,doelkens,2011-06-07T10:40:36Z,,,UMLS:C4021976|SNOMEDCT_US:3305006|SNOMEDCT_US:234087005|SNOMEDCT_US:111590001|MSH:D008206|SNOMEDCT_US:362971004|UMLS:C0024228,"An anomaly of the lymphatic system, a network of lymphatic vessels that carry a clear fluid called lymph unidirectionally towards either the right lymphatic duct or the thoracic duct, which in turn drain into the right and left subclavian veins respectively.",,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0003012,,,,,,,,,human_phenotype,,Lymphatic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002715|http://purl.obolibrary.org/obo/HP_0002597,,,,HP:0100763,,,,,,,,,,,,,,,HP:0100763,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the lymphatic system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_50366,6-methylprednisolone,"11beta,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|(11beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888|http://purl.obolibrary.org/obo/CHEBI_35341,,,,,,,,,,,,,,,,,,,,Beilstein:7113955,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"11beta,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione",,,,,chebi_ontology,,"(11beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione",,,,,,,,,0,C22H30O5,"InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12?,14-,15-,17-,19+,20-,21-,22-/m0/s1",VHRSUDSXCMQTMA-UWKORSIYSA-N,374.47060,374.20932,CC1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888|http://purl.obolibrary.org/obo/CHEBI_35341,,,,CHEBI:50366,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,CHEBI:50366,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,6-methylprednisolone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075526,cap snatching,cap snatching involved in viral mRNA transcription,"A transcription initiation process during which a nucleotide sequence between 10 and 20 nucleotides in size is cleaved from the 5' end of host mRNAs by a viral RNA-dependent polymerase. The capped leader sequence obtained is subsequently used to prime transcription on the viral genome, which ultimately leads to the synthesis of capped, translatable viral mRNAs.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,janelomax,2011-08-04T01:19:00Z,,,VZ:839,"A transcription initiation process during which a nucleotide sequence between 10 and 20 nucleotides in size is cleaved from the 5' end of host mRNAs by a viral RNA-dependent polymerase. The capped leader sequence obtained is subsequently used to prime transcription on the viral genome, which ultimately leads to the synthesis of capped, translatable viral mRNAs.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cap snatching involved in viral mRNA transcription,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0075526,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/20421945,,,,GO:0075526,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cap snatching,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000106,preprocalcitonin,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Preprocalcitonin is a precursor of procalcitionin hormone which is cleaved by endopeptidase. The procalcitonin forms a precursor of hormone calcitonin which is involved in calcium homeostasis.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,,,,true,,https://pubmed.ncbi.nlm.nih.gov/6546550/|https://www.ncbi.nlm.nih.gov/pubmed/32193831/,,,,,,,,,,,,,,,,,preprocalcitonin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901136,carbohydrate derivative catabolic process,carbohydrate derivative degradation|carbohydrate derivative catabolism|carbohydrate derivative breakdown,The chemical reactions and pathways resulting in the breakdown of carbohydrate derivative.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,bf,2012-07-12T04:05:31Z,,,,The chemical reactions and pathways resulting in the breakdown of carbohydrate derivative.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,carbohydrate derivative degradation|carbohydrate derivative catabolism|carbohydrate derivative breakdown,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:1901136,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901136,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,carbohydrate derivative catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000679,average value,,A  data item that is produced as the output of an averaging data transformation and represents the average value of the input data.,false,,,http://purl.obolibrary.org/obo/IAO_0000027,,,arithmetic mean,,,,,,,,,,,,,,,,,,A  data item that is produced as the output of an averaging data transformation and represents the average value of the input data.,,,,,,,,,average value,,A  data item that is produced as the output of an averaging data transformation and represents the average value of the input data.,,,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000125,,,,,,,,,,,,,,,,,,,,OBI:0000679,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl|http://purl.obolibrary.org/obo/apollo_sv.owl,,,,,,,,,,,average value,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: James Malone|PERSON: Monnie McGee,,,,mean
http://purl.obolibrary.org/obo/GO_0007077,mitotic nuclear envelope disassembly,mitotic nuclear envelope degradation|mitotic nuclear envelope breakdown|mitotic nuclear envelope catabolism,The cell cycle process in which the controlled breakdown of the nuclear envelope during mitotic cell division occurs.,false,,,http://purl.obolibrary.org/obo/GO_0051081,,,,,,,,,,,,,,,,,,,,,The cell cycle process in which the controlled breakdown of the nuclear envelope during mitotic cell division occurs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mitotic nuclear envelope degradation|mitotic nuclear envelope breakdown|mitotic nuclear envelope catabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051081,,,,GO:0007077,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007077,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic nuclear envelope disassembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000790,Hematuria,High urine occult blood|Blood in urine,The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine).,false,,,http://purl.obolibrary.org/obo/HP_0012211|http://purl.obolibrary.org/obo/HP_0012614,,,,,,,,,,,,,,,,,,,,UMLS:C0018965|SNOMEDCT_US:34436003|SNOMEDCT_US:53298000|MSH:D006417,The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine).,,,,,,,,,,,,,,,,,,,,,,,,,,,,High urine occult blood,,,Blood in urine,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012211|http://purl.obolibrary.org/obo/HP_0012614,,,,HP:0000790,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,HP:0000790,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Hematuria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0009582,"Medicine, Chinese Traditional",,,false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0009582,,,,,,,,,,,,,,,,,,,,,,,Chinese herbal medicine,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32193831/,A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,"Medicine, Chinese Traditional",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_23066,cephalosporin,Cephalosporin|cephalosporins|cephalosphorin|cephalosphorins,"A class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring.  Although cephalosporins are among the most commonly used antibiotics in the treatment of routine infections, and their use is increasing over time, they can cause a range of hypersensitivity reactions, from mild, delayed-onset cutaneous reactions to life-threatening anaphylaxis in patients with immunoglobulin E (IgE)-mediated allergy.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:11936371|PMID:3320614|PMID:6762896|PMID:8426246|Wikipedia:Cephalosporin|PMID:12833570|KEGG:C00875|PMID:10069359|PMID:24269048,"A class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring.  Although cephalosporins are among the most commonly used antibiotics in the treatment of routine infections, and their use is increasing over time, they can cause a range of hypersensitivity reactions, from mild, delayed-onset cutaneous reactions to life-threatening anaphylaxis in patients with immunoglobulin E (IgE)-mediated allergy.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:3538,,,,Cephalosporin,,,,,chebi_ontology,,cephalosporins|cephalosphorin|cephalosphorins,,,,,,,,,0,C7H5NO3SR2,,,183.18500,182.99901,[H][C@]12SCC([*])=C(N1C(=O)[C@H]2[*])C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:23066,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,CHEBI:23066,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,cephalosporin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046631,alpha-beta T cell activation,alpha-beta T-lymphocyte activation|alpha-beta T-cell activation|alpha-beta T lymphocyte activation,"The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",false,,,http://purl.obolibrary.org/obo/GO_0042110,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,alpha-beta T-lymphocyte activation|alpha-beta T-cell activation|alpha-beta T lymphocyte activation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0042110,,,,GO:0046631,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046631,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,alpha-beta T cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0100302,graph-based analysis operation,,Placeholder for EDAM operation class.,false,,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ERO:0100302,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Placeholder for EDAM operation class.,,http://purl.obolibrary.org/obo/ERO_0100288,,,,,,,,,,,,,,,,A graph-based model is a model based on graph theory. Testing an application can be viewed as traversing a path through the graph of the model.,graph-based models,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,graph-based analysis operation,,,,,,,,,,,,,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S2468042720300087,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000036,blood cell measurement,,"A value resulting from the quantification of a morphological or physiological parameter of blood cells, i.e. cells native to the circulation, including those of erythroid, lymphoid, myeloid and monocytic lineages. A cell is a membrane-enclosed protoplasmic mass constituting the smallest structural unit of an organism that is capable of independent functioning.",false,,,http://purl.obolibrary.org/obo/CMO_0000227|http://purl.obolibrary.org/obo/CMO_0000035,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000036,,,,,,,,,,,,"A value resulting from the quantification of a morphological or physiological parameter of blood cells, i.e. cells native to the circulation, including those of erythroid, lymphoid, myeloid and monocytic lineages. A cell is a membrane-enclosed protoplasmic mass constituting the smallest structural unit of an organism that is capable of independent functioning.",,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000227|http://purl.obolibrary.org/obo/CMO_0000035,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,blood cell measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1415851,Bat SARS-like coronavirus RsSHC014,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1415851,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS-like coronavirus RsSHC014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MONDO_0015118,rare pulmonary disease,,"Editor note: TODO merge with parent, distinction in ORDO not clear",false,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,,,,,,,,,,Orphanet:101944,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Rare lung diseases may involve the lung only or multiple organs and those which are not widely researched, where specific treatment is not available, and which may only be of limited interest to scientists and doctors.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Editor note: TODO merge with parent, distinction in ORDO not clear",,http://purl.obolibrary.org/obo/DOID_1579,,http://linkedlifedata.com/resource/umls/id/C0024115,http://www.orpha.net/ORDO/Orphanet_101944,MONDO:0015118,,,,,,,,,,,,,,,MONDO:0015118,,http://purl.obolibrary.org/obo/mondo.owl,http://purl.oboInOwllibrary.org/oboInOwl/mondo#obsoletion_candidate|http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders,,,,,,,,,,rare pulmonary disease,,,,,,,,,,,,,,,,,,,,,,https://github.com/monarch-initiative/mondo/issues/254,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0099045,viral extrusion,,"The process whereby a filamentous phage particle is released from a bacterial host cell via a concerted mechanism of assembly and secretion. Neosynthesized virions are coordinately exported as they are assembled at the cell surface in a secretory process that leaves the host cell fully viable.  Non-capsid proteins form structures that facilitate translocation through the inner membrane and outer membranes. A viral single-stranded DNA binding protein coats progeny viral DNA molecules to generate the intracellular precursor for assembly of phage particles as they are extruded through the membranes of the bacterial host. The structural proteins of the virus are anchored in the inner membrane before their incorporation into the phage particle. As assembly proceeds, the phage genome traverses the inner and outer membranes until the entire DNA molecule has been coated and extruded.",false,,,http://purl.obolibrary.org/obo/GO_0046753,,,,,,,,,,,,,,,,,,,,VZ:3951,"The process whereby a filamentous phage particle is released from a bacterial host cell via a concerted mechanism of assembly and secretion. Neosynthesized virions are coordinately exported as they are assembled at the cell surface in a secretory process that leaves the host cell fully viable.  Non-capsid proteins form structures that facilitate translocation through the inner membrane and outer membranes. A viral single-stranded DNA binding protein coats progeny viral DNA molecules to generate the intracellular precursor for assembly of phage particles as they are extruded through the membranes of the bacterial host. The structural proteins of the virus are anchored in the inner membrane before their incorporation into the phage particle. As assembly proceeds, the phage genome traverses the inner and outer membranes until the entire DNA molecule has been coated and extruded.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046753,,,,GO:0099045,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/15550199,,,,GO:0099045,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral extrusion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003586,IL10,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL-10|GVHDS|IL10A|CSIF|TGIF,,,,,,,1,,,,,,,,,,HGNC:5962|MIM:124092|Vega:OTTHUMG00000036386|HPRD:00495|Ensembl:ENSG00000136634,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 10,,1q31-q32,,,,"GO_0002237 (EC: IDA, PMID: 17449476); GO_0002740 (EC: IDA, PMID: 10443688); GO_0002875 (EC: IEA); GO_0002904 (EC: IDA, PMID: 9184696); GO_0005125 (EC: NAS, PMID: 10443688); GO_0005141 (EC: NAS, PMID: 1847510); GO_0005615 (EC: IDA, PMID: 10443688); GO_0006954 (EC: IDA, PMID: 10443688); GO_0007253 (EC: NAS, PMID: 10975994); GO_0007267 (EC: IC, PMID: 1847510); GO_0008083 (EC: NAS, PMID: 1371884); GO_0010468 (EC: IDA, PMID: 9184696); GO_0014823 (EC: IEA); GO_0014854 (EC: IEA); GO_0030097 (EC: TAS, PMID: 11244051); GO_0030183 (EC: NAS, PMID: 8228801); GO_0030595 (EC: TAS, PMID: 9405662); GO_0030886 (EC: IEA); GO_0030889 (EC: IDA, PMID: 9184696); GO_0032689 (EC: IEA); GO_0032695 (EC: IEA); GO_0032715 (EC: IDA, PMID: 10443688); GO_0032720 (EC: IEA); GO_0032800 (EC: IDA, PMID: 10443688); GO_0032868 (EC: IEA); GO_0034465 (EC: IEA); GO_0042092 (EC: TAS, PMID: 11244051); GO_0042100 (EC: NAS, PMID: 8228801); GO_0042130 (EC: NAS, PMID: 14971032); GO_0042493 (EC: IEA); GO_0042536 (EC: IEA); GO_0042742 (EC: IEA); GO_0043066 (EC: NAS, PMID: 8312229); GO_0044130 (EC: IEA); GO_0045019 (EC: IEA); GO_0045191 (EC: NAS, PMID: 8228801); GO_0045347 (EC: TAS, PMID: 11244051); GO_0045348 (EC: IEA); GO_0045355 (EC: NAS, PMID: 9637497); GO_0045893 (EC: IDA, PMID: 7749983); GO_0045944 (EC: IEA); GO_0050715 (EC: IDA, PMID: 10443688); GO_0051045 (EC: IDA, PMID: 18383040); GO_0051091 (EC: IDA, PMID: 7749983); GO_0051384 (EC: IDA, PMID: 10443688); GO_0051930 (EC: IEA); GO_0060670 (EC: IEA); GO_0071222 (EC: NAS, PMID: 14971032); GO_0071392 (EC: IEA)",PMID: 1121048; 1350294; 1371884; 1847510; 2173142; 7511078; 7527834; 7547951; 7553888; 7590988; 7591871; 7695626; 7749063; 7749983; 7759550; 7815507; 8037735; 8228801; 8248239; 8312229; 8364028; 8402911; 8499633; 8590020; 8764000; 8881045; 8897595; 8898665; 8910398; 9043871; 9096366; 9108403; 9143942; 9162098; 9184696; 9225992; 9234486; 9312047; 9334723; 9405662; 9463379; 9534962; 9637497; 9658081; 9689103; 9743208; 9788463; 10064624; 10089566; 10231374; 10443688; 10542212; 10714547; 10775602; 10807185; 10975994; 10985253; 11023480; 11023665; 11044099; 11087201; 11121048; 11137132; 11160847; 11163082; 11168433; 11192323; 11196656; 11196688; 11196718; 11212157; 11223972; 11230752; 11233912; 11238636; 11244051; 11260510; 11266927; 11266928; 11267084; 11271474; 11292301; 11294564; 11298547; 11307152; 11315919; 11316066; 11316069; 11354638; 11391238; 11404167; 11436536; 11441115; 11477472; 11478505; 11485736; 11493351; 11496247; 11517440; 11528523; 11544427; 11544434; 11544437; 11640949; 11689215; 11715070; 11717514; 11737614; 11740730; 11745479; 11758730; 11777537; 11792123; 11805149; 11820460; 11821159; 11828010; 11829538; 11833470; 11838849; 11852287; 11857058; 11869683; 11881827; 11883743; 11896938; 11906646; 11908705; 11919157; 11920312; 11922883; 11928840; 11929132; 11943322; 11952921; 11953141; 11953994; 11956022; 11960393; 11964134; 11964300; 11970958; 11986609; 11991675; 11994432; 12011375; 12020266; 12028020; 12039409; 12042661; 12047360; 12050565; 12060853; 12067976; 12069178; 12069391; 12078789; 12089333; 12089714; 12093676; 12095061; 12095128; 12097418; 12100571; 12100575; 12101075; 12104048; 12115622; 12117955; 12119553; 12121678; 12121679; 12124654; 12133353; 12133517; 12145682; 12151439; 12160736; 12164325; 12164877; 12165551; 12170266; 12189567; 12190181; 12197884; 12202153; 12203138; 12207099; 12207325; 12207353; 12209037; 12215823; 12219016; 12220553; 12220699; 12223518; 12232842; 12233881; 12239181; 12270545; 12370394; 12377950; 12389080; 12390476; 12392859; 12393426; 12393603; 12393699; 12394188; 12404162; 12420205; 12423294; 12438341; 12438348; 12438424; 12438965; 12444143; 12447749; 12451269; 12458048; 12477767; 12477932; 12486603; 12493739; 12495723; 12496396; 12496489; 12507818; 12509628; 12525572; 12526950; 12531774; 12534553; 12535204; 12538698; 12540792; 12544990; 12548511; 12554901; 12558814; 12578333; 12581488; 12590978; 12591385; 12594817; 12595905; 12595908; 12599058; 12609526; 12615834; 12616343; 12618859; 12626585; 12627487; 12631183; 12633940; 12640314; 12651071; 12654092; 12662377; 12663757; 12667161; 12668613; 12671741; 12676754; 12687213; 12687247; 12688341; 12700072; 12700599; 12705485; 12707018; 12709682; 12714267; 12714269; 12727335; 12727482; 12730860; 12738388; 12738467; 12743452; 12746253; 12746914; 12756345; 12761561; 12761564; 12765479; 12778475; 12782719; 12787424; 12788307; 12788980; 12791310; 12791313; 12791314; 12792880; 12799024; 12799207; 12802400; 12813360; 12818128; 12823999; 12824008; 12825869; 12826153; 12826369; 12828754; 12847677; 12847896; 12850811; 12851716; 12861049; 12864989; 12867583; 12909463; 12925485; 12926133; 12934185; 12938145; 12938195; 12940515; 12942209; 12944981; 12944983; 12945076; 12946990; 12959221; 12967650; 12971465; 13129651; 14512909; 14514772; 14522096; 14523823; 14550257; 14551598; 14562641; 14563376; 14566095; 14567558; 14572794; 14583474; 14585195; 14592815; 14597210; 14616291; 14625191; 14629328; 14630401; 14631168; 14638775; 14642153; 14646574; 14647192; 14657427; 14669219; 14675398; 14679088; 14682393; 14697748; 14697935; 14698136; 14701701; 14701704; 14722888; 14730222; 14742283; 14744383; 14746814; 14746878; 14748015; 14756669; 14872501; 14959851; 14969768; 14971032; 14978075; 14994383; 14999688; 15001471; 15007355; 15016829; 15021309; 15036247; 15039132; 15041164; 15042002; 15057267; 15057902; 15066699; 15070757; 15072702; 15078471; 15084933; 15085177; 15086488; 15100460; 15102771; 15104679; 15116066; 15120189; 15122773; 15122797; 15127646; 15129234; 15131577; 15135368; 15142213; 15144570; 15152368; 15155645; 15161508; 15170937; 15179129; 15180472; 15187110; 15188059; 15189946; 15191519; 15194284; 15194285; 15200436; 15200452; 15207246; 15212825; 15214940; 15221281; 15223609; 15223612; 15225432; 15235132; 15246967; 15247007; 15247172; 15265021; 15271933; 15288631; 15292002; 15292362; 15295621; 15304673; 15306847; 15316224; 15316663; 15325405; 15325406; 15340161; 15345120; 15345504; 15346339; 15351436; 15361124; 15361128; 15367225; 15368517; 15374585; 15381182; 15388260; 15452323; 15458467; 15462469; 15465816; 15466015; 15481145; 15485815; 15488737; 15497451; 15527169; 15530917; 15534100; 15547296; 15551142; 15561982; 15562761; 15566952; 15573087; 15579372; 15579481; 15581980; 15592292; 15596839; 15599305; 15599664; 15602175; 15603866; 15603899; 15607028; 15611648; 15621151; 15622443; 15643599; 15644127; 15650893; 15652446; 15659329; 15661939; 15663746; 15663966; 15674653; 15678510; 15682481; 15686588; 15690532; 15693804; 15694997; 15709194; 15711248; 15714121; 15718915; 15723707; 15728515; 15733644; 15747244; 15748779; 15749884; 15755291; 15761493; 15763337; 15772682; 15773449; 15780075; 15780879; 15784411; 15787640; 15800006; 15803357; 15809210; 15810889; 15811521; 15814696; 15814743; 15815688; 15815689; 15818327; 15837194; 15838798; 15841043; 15842590; 15843082; 15845862; 15848524; 15857508; 15863393; 15871134; 15884119; 15886526; 15894515; 15900488; 15901906; 15907845; 15910294; 15914210; 15915323; 15918171; 15919371; 15919456; 15925543; 15927351; 15927856; 15931634; 15932621; 15933064; 15933743; 15937090; 15940038; 15941525; 15951665; 15956545; 15964392; 15978325; 15979955; 15985167; 15990800; 15993715; 16008678; 16014616; 16024856; 16030091; 16030322; 16034145; 16038043; 16043753; 16043936; 16043989; 16051275; 16059673; 16076299; 16078336; 16083174; 16084491; 16091126; 16098562; 16100774; 16109775; 16114018; 16120761; 16122836; 16133175; 16148556; 16160188; 16162776; 16163478; 16164695; 16165702; 16171432; 16173237; 16182624; 16183136; 16184405; 16193177; 16202743; 16226734; 16230423; 16232344; 16243534; 16247433; 16249504; 16256199; 16259956; 16276011; 16279907; 16284379; 16287542; 16287924; 16305644; 16313808; 16323127; 16323614; 16331571; 16341266; 16343245; 16361810; 16362796; 16364177; 16375755; 16378074; 16378687; 16380445; 16389181; 16396704; 16403098; 16411061; 16412052; 16413199; 16424284; 16425360; 16429138; 16433832; 16435103; 16441483; 16449530; 16460885; 16461080; 16464746; 16481285; 16489646; 16493441; 16507146; 16522370; 16523426; 16525502; 16537004; 16537707; 16540751; 16547227; 16551363; 16566641; 16567828; 16570020; 16573560; 16573780; 16579847; 16584395; 16585075; 16600026; 16611358; 16618781; 16635219; 16638698; 16644716; 16672066; 16672072; 16672419; 16681592; 16690414; 16690518; 16698276; 16698426; 16699450; 16699452; 16702372; 16702858; 16707559; 16712948; 16720107; 16720211; 16722148; 16723241; 16730575; 16759385; 16762155; 16780675; 16781761; 16785496; 16803619; 16803995; 16803996; 16804000; 16807647; 16809636; 16815316; 16820326; 16820919; 16824070; 16824159; 16826368; 16842617; 16850164; 16859503; 16859504; 16861661; 16861684; 16863661; 16867043; 16872712; 16883528; 16889540; 16895750; 16905295; 16907941; 16908746; 16911685; 16920714; 16924108; 16930778; 16931134; 16933851; 16938461; 16940525; 16943796; 16945026; 16949747; 16959027; 16961803; 16962335; 16971956; 16973274; 16978071; 16984283; 16987066; 17003778; 17005410; 17006334; 17006724; 17015714; 17015751; 17041236; 17049666; 17051272; 17052299; 17052682; 17070109; 17083041; 17092253; 17097497; 17103073; 17107380; 17113632; 17122782; 17132891; 17133531; 17138053; 17138064; 17141301; 17145371; 17145373; 17152005; 17163451; 17173255; 17178344; 17178764; 17182240; 17188628; 17198275; 17202341; 17204399; 17207568; 17208210; 17209781; 17213232; 17215337; 17215862; 17220333; 17225142; 17230494; 17237407; 17237722; 17238853; 17241871; 17257312; 17261758; 17261759; 17263806; 17304105; 17307204; 17310845; 17314689; 17321603; 17321902; 17326156; 17331973; 17335372; 17336597; 17338374; 17351514; 17353161; 17355643; 17369174; 17373677; 17376198; 17380193; 17380888; 17388919; 17389013; 17389235; 17393023; 17407084; 17408400; 17412916; 17413867; 17420099; 17428673; 17431682; 17438520; 17444587; 17444864; 17448042; 17449476; 17454884; 17460178; 17463301; 17470530; 17483704; 17487426; 17490670; 17496310; 17498265; 17509455; 17510437; 17511783; 17522354; 17524861; 17530721; 17537769; 17543146; 17544514; 17544674; 17544800; 17546224; 17548183; 17552041; 17553352; 17559370; 17559576; 17565648; 17568575; 17572155; 17574964; 17576577; 17587429; 17587715; 17592300; 17597660; 17605296; 17607501; 17612762; 17617027; 17618436; 17627763; 17634568; 17640058; 17640324; 17645476; 17645589; 17652887; 17653830; 17654453; 17656331; 17665434; 17674321; 17678726; 17684137; 17686006; 17688234; 17689273; 17690160; 17690329; 17700165; 17703177; 17703412; 17704111; 17706223; 17711410; 17714919; 17716348; 17716608; 17717744; 17724799; 17761309; 17762971; 17763324; 17763336; 17804501; 17825889; 17845635; 17846855; 17869646; 17875118; 17875573; 17884957; 17889143; 17903648; 17908769; 17916230; 17917921; 17919702; 17923267; 17929139; 17932439; 17938902; 17945537; 17947295; 17960405; 17961177; 17965799; 17968299; 17974504; 17979488; 17980158; 17981284; 17983270; 17988266; 17990180; 17999153; 18023359; 18023521; 18024395; 18039196; 18041006; 18042256; 18049335; 18054497; 18056366; 18056971; 18057536; 18071035; 18071881; 18080762; 18086767; 18090276; 18093240; 18093541; 18093884; 18158121; 18163209; 18164040; 18165865; 18171291; 18173702; 18174230; 18174250; 18184461; 18191118; 18192685; 18199828; 18200504; 18201362; 18208460; 18212693; 18216090; 18218037; 18221542; 18230105; 18234565; 18234854; 18235016; 18239807; 18242340; 18249038; 18267346; 18271063; 18273643; 18283248; 18284424; 18286551; 18292506; 18299793; 18303205; 18304876; 18307517; 18310311; 18311435; 18312596; 18315435; 18318911; 18325328; 18337305; 18341210; 18347814; 18353715; 18361934; 18362084; 18362887; 18363812; 18366487; 18375254; 18382869; 18383040; 18383862; 18384906; 18387831; 18391721; 18391751; 18392953; 18393655; 18397303; 18400189; 18405249; 18408074; 18414898; 18416756; 18424735; 18424756; 18427872; 18430198; 18436572; 18436829; 18439592; 18440625; 18444945; 18447856; 18448485; 18456270; 18457043; 18479293; 18479302; 18485518; 18490728; 18490762; 18493769; 18502564; 18510721; 18512809; 18522869; 18523359; 18534084; 18538381; 18539537; 18541226; 18551071; 18554409; 18559596; 18560870; 18569989; 18576303; 18579697; 18582197; 18583979; 18589089; 18593434; 18597405; 18609361; 18612930; 18614592; 18616700; 18619701; 18627514; 18628242; 18628251; 18632425; 18633131; 18633332; 18633768; 18636124; 18638093; 18640487; 18641355; 18651178; 18665050; 18665932; 18668392; 18674658; 18676680; 18676870; 18680515; 18683035; 18687423; 18692180; 18703108; 18705845; 18707865; 18725394; 18753053; 18760861; 18781131; 18792803; 18793860; 18794066; 18796448; 18797896; 18798072; 18805892; 18815552; 18818748; 18819899; 18826950; 18832862; 18836448; 18843277; 18845324; 18923248; 18924213; 18930197; 18931463; 18936436; 18937577; 18945465; 18950592; 18952289; 18953879; 18956675; 18962896; 18972133; 18972297; 18974840; 18974842; 18976327; 18996999; 18997484; 18997828; 19001136; 19004675; 19005292; 19009622; 19011628; 19012493; 19013323; 19013788; 19019335; 19021042; 19026560; 19027043; 19028820; 19031431; 19034880; 19038787; 19039953; 19050632; 19055487; 19056482; 19058854; 19058987; 19064572; 19065724; 19066394; 19071030; 19074885; 19077731; 19082598; 19084429; 19086955; 19087313; 19089920; 19097982; 19099482; 19109192; 19110537; 19111610; 19117745; 19118909; 19124156; 19124506; 19126646; 19127455; 19131662; 19132772; 19145440; 19153889; 19157224; 19164257; 19170196; 19176318; 19183122; 19184348; 19196047; 19200845; 19201467; 19201880; 19208551; 19210299; 19210338; 19222424; 19225544; 19228651; 19237018; 19237638; 19238444; 19239428; 19244371; 19246943; 19247692; 19249119; 19258635; 19258923; 19259799; 19264973; 19267370; 19272082; 19272636; 19274101; 19275586; 19276283; 19279357; 19282863; 19284443; 19290853; 19295315; 19295440; 19295541; 19299022; 19300393; 19307576; 19308651; 19319950; 19321591; 19332120; 19334424; 19336263; 19336370; 19336475; 19337556; 19341387; 19347053; 19348329; 19349988; 19358670; 19365081; 19372622; 19375306; 19375805; 19376105; 19383027; 19383626; 19385959; 19386798; 19389111; 19401389; 19401395; 19401628; 19407822; 19408823; 19409109; 19412539; 19413695; 19415548; 19419334; 19420105; 19427781; 19430480; 19437115; 19437232; 19450147; 19458621; 19470040; 19474090; 19477525; 19478959; 19479237; 19480854; 19481774; 19481975; 19488421; 19495883; 19497711; 19501525; 19505916; 19505919; 19508433; 19527514; 19528258; 19534595; 19541591; 19543506; 19544559; 19552724; 19552919; 19555400; 19559392; 19561105; 19562463; 19565483; 19570392; 19573080; 19576194; 19578796; 19578817; 19579695; 19581835; 19585232; 19586841; 19591971; 19594368; 19596995; 19604093; 19608017; 19608431; 19614971; 19617629; 19620304; 19621425; 19621989; 19625176; 19625651; 19644155; 19652739; 19656776; 19658300; 19661010; 19661089; 19667950; 19669876; 19673019; 19683555; 19692168; 19692203; 19698128; 19698145; 19700159; 19700502; 19700864; 19706920; 19711225; 19733878; 19737632; 19738620; 19740314; 19744138; 19748989; 19753334; 19758163; 19758192; 19759281; 19760027; 19762082; 19762555; 19766898; 19771178; 19773279; 19773451; 19778488; 19779724; 19781301; 19782084; 19786281; 19796538; 19798061; 19802007; 19805095; 19811408; 19813110; 19817985; 19819209; 19821803; 19822020; 19823053; 19838195; 19852851; 19856416; 19860911; 19861958; 19882211; 19889024; 19889076; 19889475; 19890236; 19892918; 19895848; 19907653; 19908064; 19908237; 19912737; 19913121; 19915572; 19917162; 19934104; 19936625; 19938203; 19939284; 19948975; 19956635; 19957794; 19958312; 19996617; 19996656; 20001857; 20010527; 20012528; 20014019; 20015215; 20016407; 20016783; 20017308; 20018615; 20030788; 20032313; 20037209; 20042578; 20042580; 20044609; 20047977; 20051670; 20052801; 20059417; 20061995; 20070620; 20070836; 20072143; 20080912; 20082482; 20082647; 20083555; 20087644; 20087693; 20087947; 20089329; 20097948; 20102414; 20107186; 20138641; 20144201; 20145925; 20148913; 20150436; 20150742; 20163933; 20171114; 20176734; 20177758; 20178529; 20181890; 20184663; 20188863; 20189706; 20190550; 20191326; 20191386; 20195402; 20195716; 20196868; 20200511; 20202139; 20204402; 20207250; 20207982; 20213229; 20217044; 20227257; 20227772; 20228669; 20228798; 20228799; 20232770; 20233508; 20236506; 20236616; 20237496; 20299965; 20302034; 20305143; 20306684; 20335604; 20337945; 20339193; 20339966; 20349753; 20356901; 20359252; 20363151; 20367137; 20369436; 20370995; 20371920; 20378550; 20378664; 20381257; 20384861; 20385468; 20388088; 20388104; 20393813; 20395963; 20399512; 20404426; 20410487; 20413987; 20416077; 20418110; 20419805; 20421626; 20424473; 20424554; 20424918; 20430716; 20431935; 20438703; 20445748; 20447254; 20448110; 20452482; 20453000; 20454933; 20457266; 20459687; 20463618; 20470442; 20471133; 20472930; 20473875; 20477882; 20482524; 20484443; 20484876; 20485362; 20485444; 20486195; 20490277; 20490891; 20503287; 20509889; 20518833; 20518842; 20519163; 20523065; 20525402; 20527514; 20529592; 20530519; 20531015; 20536507; 20536548; 20551628; 20553628; 20558465; 20561040; 20564140; 20565774; 20567520; 20568250; 20570082; 20571871; 20576226; 20578820; 20587610; 20588103; 20588308; 20589076; 20591588; 20592893; 20595152; 20602615; 20603037; 20603050; 20617924; 20618176; 20622753; 20622878; 20622879; 20625422; 20628086; 20628373; 20638860; 20640364; 20644561; 20646924; 20650298; 20659236; 20661303; 20661604; 20662694; 20671651; 20673868; 20711808; 20714960; 20716621; 20720222; 20722024; 20723894; 20725607; 20732366; 20735825; 20737205; 20798845; 20804371; 20805562; 20807264; 20809522; 20809684; 20811626; 20825427; 20825636; 20830806; 20835611; 20838432; 20839488; 20860222; 20861424; 20863526; 20879862; 20880001; 20880267; 20880745; 20881642; 20883321; 20884746; 20889146; 20889800; 20922456; 20927126; 20934598; 20934961; 20942272; 20952070; 20953818; 20957732; 20970781; 20976276; 21030268; 21037509; 21040915; 21048327; 21052690; 21054877; 21055074; 21055733; 21057561; 21057730; 21061265; 21067483; 21067752; 21068755; 21076061; 21086908; 21088899; 21090240; 21098222; 21102463; 21107607; 21107665; 21123382; 21131395; 21135123; 21138342; 21160051; 21168854; 21183270; 21191065; 21205466; 21211963; 21215074; 21215285; 21216474; 21223691; 21227406; 21238445; 21239715; 21240493; 21254836; 21255795; 21267581; 21281983; 21297633; 21300911; 21303362; 21309719; 21314735; 21316985; 21317876; 21323660; 21328800; 21332458; 21339768; 21354456; 21357266; 21357402; 21358669; 21359250; 21372199; 21398611; 21398617; 21402594; 21406270; 21413929; 21424183; 21426411; 21439624; 21440743; 21455338; 21463487; 21466366; 21467695; 21468030; 21468579; 21478113; 21481602; 21508509; 21518800; 21519827; 21526166; 21527907; 21532858; 21549291; 21553228; 21558138; 21560494; 21567173; 21595995; 21609779; 21621860; 21624746; 21626471; 21641950; 21642542; 21658228; 21658363; 21669226; 21688665; 21689404; 21699407; 21721376; 21724486; 21725623; 21729106; 21730023; 21744325; 21756510; 21757655; 21764596; 21767236; 21777343; 21779975; 21786452; 21791113; 21792878; 21808111; 21812905; 21816135; 21829393; 21830424; 21839042; 21858117; 21861711; 21862302; 21863566; 21863628; 21869490; 21873118; 21876975; 21878338; 21901441; 21902578; 21909800; 21910858; 21917128; 21918473; 21923667; 21925952; 21926547; 21931651; 21936714; 21940055; 21968303; 21972680; 21986577; 21998459; 22010076; 22019000; 22032897; 22033829; 22038351; 22048455; 22050548; 22057691; 22057973; 22058059; 22070668; 22075762; 22077544; 22079540; 22081333; 22082370; 22092594; 22095765; 22100578; 22105495; 22116520; 22122951; 22123389; 22129927; 22140263; 22140472; 22144535; 22156547; 22157213; 22158873; 22160576; 22168225; 22172723; 22174866; 22176654; 22182686; 22184725; 22187388; 22189417; 22189756; 22205204; 22205395; 22213066; 22219323; 22225835; 22235320; 22239992; 22263663; 22279662; 22287022; 22288916; 22298356; 22307790; 22311038; 22323454; 22325340; 22335769; 22347492; 22350281; 22356904; 22358381; 22366404; 22371646; 22378604; 22387064; 22390924; 22393278; 22410761; 22416256; 22424164; 22425021; 22425265; 22427230; 22436502; 22442690; 22445549; 22466287; 22475179; 22484198; 22484241; 22487811; 22494514; 22503116; 22507621; 22520513; 22529524; 22535664; 22537067; 22537751; 22544931; 22547702; 22547705; 22549091; 22556042; 22565155; 22566507; 22572643; 22575708; 22578382; 22580886; 22582500; 22586040; 22592039; 22592860; 22594912; 22595646; 22628023; 22634719; 22644143; 22653776; 22655468; 22664006; 22673037; 22677268; 22678905; 22681958; 22682876; 22685028; 22687336; 22698805; 22710869; 22711892; 22715992; 22732092; 22740130; 22749664; 22753934; 22753938; 22763734; 22768144; 22784413; 22788775; 22795294; 22796266; 22805022; 22812212; 22812241; 22818022; 22825546; 22835429; 22835835; 22848356; 22850906; 22851691; 22859398; 22859944; 22880107; 22886309; 22897390; 22902304; 22911481; 22924705; 22931953; 22932817; 22940633; 22966128; 22972930; 22981868; 22986179; 22989497; 23013217; 23013641; 23017230; 23020144; 23021880; 23027536; 23028907; 23029361; 23034167; 23046616; 23046617; 23053983; 23062006; 23062580; 23069299; 23071313; 23073467; 23075771; 23079832; 23086275; 23088578; 23094074; 23095823; 23096091; 23118878; 23125413; 23128233; 23143946; 23149083; 23152883; 23159283; 23166328; 23168096; 23185315; 23192326; 23207823; 23209731; 23210681; 23220432; 23225254; 23232337; 23235789; 23237063; 23237776; 23251077; 23265747; 23272193; 23273903; 23273955; 23276701; 23294711; 23299779; 23300021; 23300769; 23325892; 23326478; 23334981; 23335974; 23343479; 23349310; 23355741; 23357299; 23363891; 23376084; 23379624; 23380741; 23415626; 23416458; 23430974; 23432860; 23438682; 23444260; 23449984; 23450495; 23453286; 23460834; 23485354; 23485538; 23485736; 23488731; 23498167; 23525950; 23541976; 23544075; 23556339; 23562725; 23570798; 23574339; 23582441; 23583365; 23591975; 23595519; 23602200; 23602201; 23607333; 23613317; 23623844; 23638863; 23640160; 23640982; 23645090; 23654353; 23663047; 23663500; 23668806; 23679256; 23690289; 23711712; 23712703; 23716201; 23720844; 23723980; 23725154; 23725178; 23733877; 23743567; 23749933; 23752129; 23752604; 23762097; 23768819; 23772925; 23777202; 23797738; 23798430; 23814099; 23818986; 23834952; 23838435; 23846686; 23875023; 23880295; 23880623; 23886125; 23897063; 23898109; 23901045; 23910644; 23936042; 23990628; 24015034; 24042116; 24043893; 24067460; 24077340; 24130510; 24174668; 24216477; 24327156; 24340926; 24379064,,,,,,,,,,,,,,,,,,OGG:3000003586,,,,,,,,,,,,,,,,,,,interleukin 10,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217834,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL10,,,20140408,3586,RP11-262N9.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL10,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_71415,nitrofurantoin,"1-{[(5-nitro-2-furyl)methylene]amino}imidazolidine-2,4-dione|nitrofurantoina|nitrofurantoinum|1-((5-Nitrofurfurylidene)amino)hydantoin|1-(5-Nitro-2-furfurylidenamino)hydantoin|nitrofurantoin|5-Nitrofurantoin|1-(5-Nitro-2-furfurylideneamino)hydantoin|nitrofurantoine|N-(5-Nitrofurfurylidene)-1-aminohydantoin|1-[(5-Nitrofurfurylidene)amino]hydantoin","An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA.",false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,PMID:22535452|Drug_Central:1949|Patent:US2898335|PMID:22876623|PMID:22285235|Reaxys:8132135|CAS:67-20-9|Patent:US2927110|PMID:22857139|PMID:22252808|PMID:22552451|PMID:22779302|PMID:22332195|PMID:22869929|PMID:21567157|PMID:22836745|Patent:US2610181|PMID:22508296|PMID:22787489|PMID:22252772|Patent:WO2006019844|PMID:22929632|PMID:22977056|PMID:22240115|KEGG:D00439|DrugBank:DB00698|Patent:WO2010065110|KEGG:C07268|Wikipedia:Nitrofurantoin|PMID:23016316|PMID:23113731|PMID:22722224|Patent:WO2008103673|PMID:22923965|PMID:23109011|PMID:23114172,"An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:7591,,,,"1-{[(5-nitro-2-furyl)methylene]amino}imidazolidine-2,4-dione",,,,,chebi_ontology,,nitrofurantoina|nitrofurantoinum|1-((5-Nitrofurfurylidene)amino)hydantoin|1-(5-Nitro-2-furfurylidenamino)hydantoin|nitrofurantoin|5-Nitrofurantoin|1-(5-Nitro-2-furfurylideneamino)hydantoin|nitrofurantoine|N-(5-Nitrofurfurylidene)-1-aminohydantoin|1-[(5-Nitrofurfurylidene)amino]hydantoin,,,,,,,,,0,C8H6N4O5,"InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+",NXFQHRVNIOXGAQ-YCRREMRBSA-N,238.157,238.03382,C1(N(/N=C/C=2OC(=CC2)[N+]([O-])=O)CC(N1)=O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:71415,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:71415,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,nitrofurantoin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000970,eye,light-detecting organ|visual apparatus,An organ that detects light.,false,,,http://purl.obolibrary.org/obo/UBERON_0000020,,,,,,,,,,,,,,,,,,,"This class encompasses a variety of light-detecting structures from different phyla with no implication of homology, from the compound insect eye to the vertebrate camera-type eye (distinct classes are provided for each)",FBbt:00005162|GAID:69|EV:0100336|OpenCyc:Mx4rvViTvpwpEbGdrcN5Y29ycA|MESH:D005123|EFO:0000827|MAT:0000140|MIAA:0000140|BTO:0000439|BILA:0000017|CALOHA:TS-0309|http://en.wikipedia.org/wiki/Eye,An organ that detects light.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,light-detecting organ|visual apparatus,optic|ocular,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000020,,,,UBERON:0000970,,,,,,true,,,,,,,,,UBERON:0000970,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#functional_classification|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#major_organ|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,eye,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,"Note that whilst this is classified as an organ, it is in fact more of a unit composed of different structures: in Drosophila, it includes the interommatidial bristle as a part; we consider here the vertebrate eye to include the eyeball/eye proper as a part, with the eye having as parts (when present): eyelids, conjuctiva,",,,,,,,
http://purl.obolibrary.org/obo/HP_0011025,Abnormal cardiovascular system physiology,Abnormality of cardiovascular system physiology,Abnormal functionality of the cardiovascular system.,false,,,http://purl.obolibrary.org/obo/HP_0001626,,,,,,,,,,,,,,,,peter,2011-03-03T10:23:19Z,,,UMLS:C4023587,Abnormal functionality of the cardiovascular system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of cardiovascular system physiology,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001626,,,,HP:0011025,,,,,,,,,,,,,,,HP:0011025,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal cardiovascular system physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030216,keratinocyte differentiation,keratinocyte cell differentiation,The process in which a relatively unspecialized cell acquires specialized features of a keratinocyte.,false,,,http://purl.obolibrary.org/obo/GO_0009913,,,,,,,,,,,,,,,,,,,,,The process in which a relatively unspecialized cell acquires specialized features of a keratinocyte.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,keratinocyte cell differentiation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009913,,,,GO:0030216,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030216,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,keratinocyte differentiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_4653,dipyridamole,"2,2',2'',2'''-[(4,8-dipiperidin-1-ylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol|Dipyudamine|dipyridamolum|Curantyl|Cardoxin|Persantin|dipiridamol|Cleridium 150|Dypyridamol|dipyridamole|Dipyridamine","A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:924|LINCS:LSM-3927|KEGG:D00302|Patent:US3031450|Patent:GB807826|Reaxys:68373|DrugBank:DB00975|PMID:11709364|CAS:58-32-2|Wikipedia:Dipyridamole|Beilstein:0068373|PMID:11098344,"A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2,2',2'',2'''-[(4,8-dipiperidin-1-ylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol",,,,,chebi_ontology,,Dipyudamine|dipyridamolum|Curantyl|Cardoxin|Persantin|dipiridamol|Cleridium 150|Dypyridamol|dipyridamole|Dipyridamine,,,,,,,,,0,C24H40N8O4,"InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2",IZEKFCXSFNUWAM-UHFFFAOYSA-N,504.62592,504.31725,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:4653,,,,,,true,,,,,,,,,CHEBI:4653,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,dipyridamole,,,,,,,,,,,,,,,,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.27.20027557v1,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000734,stroke,apoplexy|cerebral accident|brain attack|cerebrovascular accident,"Stroke is a nervous system symptom characterized by a sudden diminution or loss of consciousness, sensation, and voluntary motion caused by rupture or obstruction (as by a clot) of a blood vessel of the brain.",false,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,,,,,,,,,,,,,,,,,,"Stroke is a nervous system symptom characterized by a sudden diminution or loss of consciousness, sensation, and voluntary motion caused by rupture or obstruction (as by a clot) of a blood vessel of the brain.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,apoplexy|cerebral accident|brain attack|cerebrovascular accident,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,SYMP:0000734,,,,,,true,,,,,,,,,SYMP:0000734,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,stroke,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_37887,adrenergic antagonist,adrenergic blockaders|adrenergic blocker|adrenergic antagonists|adrenoceptor antagonists|adrenergic blockers|adrenergic receptor blockaders,An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,adrenergic blockaders|adrenergic blocker|adrenergic antagonists|adrenoceptor antagonists|adrenergic blockers|adrenergic receptor blockaders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:37887,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32220710,,,,CHEBI:37887,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,adrenergic antagonist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000001,cardiovascular measurement,,Any value resulting from the quantification of a morphological or physiological parameter pertaining to the heart and/or blood vessels.,false,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000001,,,,,,,,,,,,Any value resulting from the quantification of a morphological or physiological parameter pertaining to the heart and/or blood vessels.,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,cardiovascular measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006066,alcohol metabolic process,alcohol metabolism,"The chemical reactions and pathways involving alcohols, any of a class of compounds containing one or more hydroxyl groups attached to a saturated carbon atom.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving alcohols, any of a class of compounds containing one or more hydroxyl groups attached to a saturated carbon atom.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,alcohol metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006066,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006066,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila,,,,,,,,,,alcohol metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042310,vasoconstriction,negative regulation of blood vessel size,"A decrease in the diameter of blood vessels, especially arteries, due to constriction of smooth muscle cells that line the vessels, and usually causing an increase in blood pressure.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Vasoconstriction,"A decrease in the diameter of blood vessels, especially arteries, due to constriction of smooth muscle cells that line the vessels, and usually causing an increase in blood pressure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,negative regulation of blood vessel size,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0042310,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,GO:0042310,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,vasoconstriction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305418,SARS coronavirus C029,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305418,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C029,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000119,Abnormality of the genitourinary system,Genitourinary abnormality|Genitourinary tract malformation|Urogenital anomalies|Urogenital abnormalities|Abnormality of the GU system|Genitourinary tract anomalies|Genitourinary disease|Genitourinary dysplasia,The presence of any abnormality of the genitourinary system.,false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:287085006|UMLS:C0042063|UMLS:C4020895|MSH:D014564|SNOMEDCT_US:42030000|UMLS:C0080276,The presence of any abnormality of the genitourinary system.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0008704|HP:0008688|HP:0008658|HP:0008713,,,,Genitourinary abnormality|Genitourinary tract malformation|Urogenital anomalies|Urogenital abnormalities|Abnormality of the GU system|Genitourinary tract anomalies,,,,,human_phenotype,,Genitourinary disease|Genitourinary dysplasia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0000119,,,,,,,,,,,,,,,HP:0000119,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the genitourinary system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0033314,mitotic DNA replication checkpoint,S-phase checkpoint|S-M DNA replication checkpoint|mitotic cell cycle DNA replication checkpoint|S-M checkpoint,"A cell cycle checkpoint that acts during a mitotic cell cycle and prevents the initiation of mitosis until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.",false,,,http://purl.obolibrary.org/obo/GO_0000076|http://purl.obolibrary.org/obo/GO_0044818|http://purl.obolibrary.org/obo/GO_0044774,,,,,,,,,,,,,,,,,,,,,"A cell cycle checkpoint that acts during a mitotic cell cycle and prevents the initiation of mitosis until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0031574,S-phase checkpoint,,,S-M DNA replication checkpoint|mitotic cell cycle DNA replication checkpoint|S-M checkpoint,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000076|http://purl.obolibrary.org/obo/GO_0044818|http://purl.obolibrary.org/obo/GO_0044774,,,,GO:0033314,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033314,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic DNA replication checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044818,mitotic G2/M transition checkpoint,,A cell cycle checkpoint that detects and negatively regulates progression from G2 to M phase as part of a mitotic cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_1902750|http://purl.obolibrary.org/obo/GO_1901991|http://purl.obolibrary.org/obo/GO_0007093|http://purl.obolibrary.org/obo/GO_0010389,,,,,,,,,,,,,,,,janelomax,2013-11-19T14:20:00Z,,,,A cell cycle checkpoint that detects and negatively regulates progression from G2 to M phase as part of a mitotic cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1902750|http://purl.obolibrary.org/obo/GO_1901991|http://purl.obolibrary.org/obo/GO_0007093|http://purl.obolibrary.org/obo/GO_0010389,,,,GO:0044818,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044818,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic G2/M transition checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032263,Increased blood pressure,Increased BP,"Abnormal increase in blood pressure. An individual measurement of increased blood pressure does not necessarily imply hypertension. In practical terms, multiple measurements are recommended to diagnose the presence of hypertension.",false,,,http://purl.obolibrary.org/obo/HP_0030972,,,,,,,,,,,,,,,,peter,,,,,"Abnormal increase in blood pressure. An individual measurement of increased blood pressure does not necessarily imply hypertension. In practical terms, multiple measurements are recommended to diagnose the presence of hypertension.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Increased BP,,,,,,,,,,,,,HP:0032263,,,,,,,,,,,,,,,,,,2019-01-27T20:07:59Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0030972,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Increased blood pressure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012211,Abnormal renal physiology,Renal functional abnormality|Abnormal kidney function|Kidney function issue|Abnormal renal function|Abnormality of renal physiology,An abnormal functionality of the kidney.,false,,,http://purl.obolibrary.org/obo/HP_0000077|http://purl.obolibrary.org/obo/HP_0011277,,,,,,,,,,,,,,,,peter,2013-03-14T07:43:34Z,,,UMLS:C0151746|SNOMEDCT_US:39539005,An abnormal functionality of the kidney.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0000087|HP:0005566|HP:0000082|HP:0008646,,,,Renal functional abnormality|Abnormal kidney function|Kidney function issue|Abnormal renal function|Abnormality of renal physiology,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000077|http://purl.obolibrary.org/obo/HP_0011277,,,,HP:0012211,,,,,,,,,,,,,,,HP:0012211,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal renal physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305407,SARS coronavirus B024,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305407,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus B024,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0050700,cardiomyopathy,Cardiomyopathies,A heart disease and a myopathy that is characterized by deterioration of the function of the heart muscle.|MESH:D009202 added from NeuroDevNet [WAK].,false,,,http://purl.obolibrary.org/obo/DOID_114,,,,,,,,,,,,,,,,lschriml,2012-01-03T02:54:11Z,,,UMLS_CUI:C0036529|UMLS_CUI:C0033141|ICD9CM:425|NCI:C53654|SNOMEDCT_US_2019_09_01:89461002|SNOMEDCT_US_2019_09_01:85898001|UMLS_CUI:C0878544|NCI:C34830|MESH:D009202|ICD10CM:I42|ICD9CM:425.9,A heart disease and a myopathy that is characterized by deterioration of the function of the heart muscle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cardiomyopathies,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,MESH:D009202 added from NeuroDevNet [WAK].,,http://purl.obolibrary.org/obo/DOID_114,,,,DOID:0050700,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215613,,,,DOID:0050700,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,cardiomyopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000035,heptad repeat 2 (SARS-CoV-2),,,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,modified definition,,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32231345,"Heptad repeat 2 (HR2) is a fragment of spike protien of SARS COV-2, forms a  six-helical bundle interacting with HR1 , plays a key role during the viral membrane fusion process.",,,,,,,,,,,,,,,,heptad repeat 2 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249076,SARS coronavirus HZS2-Fc,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249076,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HZS2-Fc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1283332,Bat coronavirus Rp/Shaanxi2011,Bat Rp-coronavirus/Shaanxi2011,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat Rp-coronavirus/Shaanxi2011,,,,,,NCBITaxon:1283332,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat coronavirus Rp/Shaanxi2011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032527,protein exit from endoplasmic reticulum,protein exit from ER|protein export from endoplasmic reticulum|protein export from ER,The directed movement of proteins from the endoplasmic reticulum.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The directed movement of proteins from the endoplasmic reticulum.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein exit from ER|protein export from endoplasmic reticulum|protein export from ER,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0032527,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032527,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein exit from endoplasmic reticulum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072672,neutrophil extravasation,,The migration of a neutrophil from the blood vessels into the surrounding tissue.,false,,,http://purl.obolibrary.org/obo/GO_0050900,,,,,,,,,,,,,,,,midori,2011-02-21T03:03:52Z,,,,The migration of a neutrophil from the blood vessels into the surrounding tissue.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050900,,,,GO:0072672,,,,,,,true,,true,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,GO:0072672,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neutrophil extravasation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2043,hepatitis B,chronic hepatitis B|hepatitis B infection|Serum hepatitis,"A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis B virus, which is transmitted_by sexual contact, transmitted_by blood transfusions, and transmitted_by fomites like needles or syringes. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",false,,,http://purl.obolibrary.org/obo/DOID_934,,,,,,,,,,,,,,,,,,,,NCI:C3097|MESH:D006509|UMLS_CUI:C0019163|EFO:0004197|SNOMEDCT_US_2019_09_01:66071002,"A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis B virus, which is transmitted_by sexual contact, transmitted_by blood transfusions, and transmitted_by fomites like needles or syringes. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:12592|DOID:2042|DOID:12591,,,,chronic hepatitis B|hepatitis B infection,,,,,disease_ontology,,Serum hepatitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934,,,,DOID:2043,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217650/,,,,DOID:2043,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#sexually_transmitted_infectious_disease|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,hepatitis B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_37943,colistin,Colistin|polymyxin E|colistine|colistinum|colistina,"A multi-component mixture comprising mostly of colistin A (R = Me) and B (R = H), with small amounts of colistin C and other polymyxins, produced by certain strains of Bacillus polymyxa var. colistinus. An antibiotic, it is used as its sulfate salt (for oral or topical use) or as the sodium salt of the N-methylsulfonic acid derivative (the injectable form) in the treatment of severe Gram-negative infections, partiularly those due to Pseudomonas aeruginosa.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:26252512|PMID:28018876|PMID:17620384|PMID:27160031|PMID:28029008|PMID:28315729|PMID:27411324|PMID:26488563|PMID:16931410|PMID:27684296|PMID:26730548|PMID:25322351|PMID:17576842|DrugBank:DB00803|PMID:15825037|PMID:27793510|PMID:17876007|PMID:17646423|PMID:28267779|PMID:26415906|PMID:27524102|CAS:1264-72-8|PMID:27790432|PMID:17145797|PMID:18625681|PMID:27480806|PMID:17606684|KEGG:D02138|PMID:17846127|PMID:27743779|PMID:28321410|PMID:27552304|PMID:28300674|KEGG:C13768|PMID:27891118|PMID:28257552|PMID:17562800|PMID:28267594|PMID:27917926|CAS:1066-17-7|PMID:28215823,"A multi-component mixture comprising mostly of colistin A (R = Me) and B (R = H), with small amounts of colistin C and other polymyxins, produced by certain strains of Bacillus polymyxa var. colistinus. An antibiotic, it is used as its sulfate salt (for oral or topical use) or as the sodium salt of the N-methylsulfonic acid derivative (the injectable form) in the treatment of severe Gram-negative infections, partiularly those due to Pseudomonas aeruginosa.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:560465|CHEBI:659853|CHEBI:600596|CHEBI:472593|CHEBI:34651|CHEBI:566816|CHEBI:597111|CHEBI:596826,,,,Colistin,,,,,chebi_ontology,,polymyxin E|colistine|colistinum|colistina,,,,,,,,,0,C52H97N16O13R,,,1154.428,1153.74210,C(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H]1C(N[C@H](C(N[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)NCC1)[C@@H](C)O)=O)CCN)=O)CCN)=O)CC(C)C)=O)CC(C)C)=O)CCN)=O)=O)CCN)=O)[C@@H](C)O)=O)CCN)=O)CCC[C@@H](C*)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:37943,,,,,true,true,,,,,,,,,CHEBI:37943,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,colistin,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001822,kidney development,nephrogenesis,"The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Kidney_development,"The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,nephrogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0001822,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001822,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,kidney development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_8378,prednisolone,"11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione|1,4-pregnadiene-3,20-dione-11beta,17alpha,21-triol|1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione|3,20-dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene|(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione|Delta(1)-dehydrohydrocortisone|prednisolonum|prednisolone|Delta(1)-dehydrocortisol|prednisolona|metacortandralone|hydroretrocortine|Delta(1)-hydrocortisone",A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23625982|KEGG:D00472|KEGG:C07369|Wikipedia:Prednisolone|CAS:50-24-8|DrugBank:DB00860|VSDB:1848|Reaxys:1354103|PMID:24392764|Beilstein:1354103|Drug_Central:2245|HMDB:HMDB0014998|PMID:11294518,A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione",,,,,chebi_ontology,,"1,4-pregnadiene-3,20-dione-11beta,17alpha,21-triol|1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione|3,20-dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene|(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione|Delta(1)-dehydrohydrocortisone|prednisolonum|prednisolone|Delta(1)-dehydrocortisol|prednisolona|metacortandralone|hydroretrocortine|Delta(1)-hydrocortisone",,,,,,,,,0,C21H28O5,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",OIGNJSKKLXVSLS-VWUMJDOOSA-N,360.44400,360.19367,[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])CC[C@]1(O)C(=O)CO,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:8378,,,,,,,,,,,,,,,CHEBI:8378,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,prednisolone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_741999,Bat SARS coronavirus HKU3-12,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:741999,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002377,immunoglobulin production,antibody production,"The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.",false,,,http://purl.obolibrary.org/obo/GO_0002440,,,,,,,,,,,,,,,,,,,,,"The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,antibody production,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002440,,,,GO:0002377,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002377,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,immunoglobulin production,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000141,immaterial entity,,,false,,,http://purl.obolibrary.org/obo/BFO_0000004,,,,,ImmaterialEntity,immaterial,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: Immaterial entities are divided into two subgroups:boundaries and sites, which bound, or are demarcated in relation, to material entities, and which can thus change location, shape and size and as their material hosts move or change shape or size (for example: your nasal passage; the hold of a ship; the boundary of Wales (which moves with the rotation of the Earth) [38, 7, 10",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BFO:0000141,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000004,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,immaterial entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019075,virus maturation,viral maturation|bacteriophage maturation,The refolding and structural rearrangements of virion parts to transition from the intermediate virion to the more mature virion. Maturation usually involves proteolysis events and changes in the folding of the virion proteins. Can occur inside the host cell or after release.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,The refolding and structural rearrangements of virion parts to transition from the intermediate virion to the more mature virion. Maturation usually involves proteolysis events and changes in the folding of the virion proteins. Can occur inside the host cell or after release.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral maturation,,,bacteriophage maturation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019075,,,,,,true,,,,true,,,,,GO:0019075,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,virus maturation,,,,,,,,,,,,,,,,,,,,,,https://prosite.expasy.org/sars-cov-2.html,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0070098,chemokine-mediated signaling pathway,chemokine-mediated signalling pathway,"A series of molecular signals initiated by the binding of a chemokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,,"A series of molecular signals initiated by the binding of a chemokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chemokine-mediated signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0070098,,,,,,true,true,,,,,,,,GO:0070098,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,chemokine-mediated signaling pathway,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_321147,SARS coronavirus BJ162,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:321147,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003126,HLA-DRB4,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,DRB4|DR4|HLA-DR4B|DR-4,,,,,,,6,,,,,,,,,,HPRD:09986|HGNC:4952,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"major histocompatibility complex, class II, DR beta 4",,6p21.3,,,,"GO_0000139 (EC: TAS); GO_0002381 (EC: ISS); GO_0002437 (EC: IDA, PMID: 15795121); GO_0002455 (EC: ISS); GO_0002862 (EC: IDA, PMID: 18039812); GO_0005515 (EC: IPI, PMID: 15795121); GO_0005765 (EC: IDA, PMID: 18305173); GO_0005765 (EC: TAS); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 10425186); GO_0006955 (EC: ISS); GO_0007165 (EC: NAS, PMID: 8775462); GO_0009897 (EC: ISS); GO_0012507 (EC: TAS); GO_0016045 (EC: ISS); GO_0019221 (EC: TAS); GO_0019886 (EC: TAS); GO_0030658 (EC: TAS); GO_0030666 (EC: TAS); GO_0030669 (EC: TAS); GO_0031295 (EC: TAS); GO_0031902 (EC: IDA, PMID: 18305173); GO_0032395 (EC: TAS, PMID: 10425186); GO_0032588 (EC: TAS); GO_0032673 (EC: ISS); GO_0032689 (EC: ISS); GO_0035774 (EC: ISS); GO_0042088 (EC: ISS); GO_0042130 (EC: ISS); GO_0042605 (EC: ISS); GO_0042613 (EC: IEA); GO_0050852 (EC: TAS); GO_0051262 (EC: ISS); GO_0060333 (EC: TAS); GO_0071556 (EC: TAS); GO_2001179 (EC: ISS)",PMID: 1358866; 1428007; 1612646; 1869305; 1905983; 1967269; 1970352; 1978941; 2023919; 2212675; 2466818; 2511168; 2543930; 2592019; 2846691; 3015788; 3020127; 3036826; 3099214; 3110774; 3174462; 3372263; 3458223; 3467350; 3476943; 3489470; 3596674; 3860851; 3875800; 7512597; 7528725; 7541827; 7602119; 7645219; 7652736; 7734415; 7792759; 8084338; 8085262; 8125298; 8168144; 8344726; 8376762; 8450224; 8775462; 9027964; 9062971; 9079699; 9098937; 9162096; 9223324; 9234493; 9243754; 9354468; 9500545; 9952022; 10425186; 10551425; 10661406; 10703621; 10717810; 10729169; 11034566; 11048639; 11082517; 11118314; 11237011; 11532019; 11751963; 11782380; 11827988; 11972878; 11997714; 12008082; 12121280; 12144077; 12144632; 12202216; 12209103; 12230470; 12296785; 12358860; 12391221; 12392858; 12427289; 12477932; 12541760; 12631591; 12859598; 12956878; 14508706; 14558083; 14574404; 14677183; 15046556; 15055474; 15140072; 15188377; 15191532; 15496913; 15513680; 15721314; 15730527; 15784911; 15795121; 15896200; 15902698; 15908298; 15982264; 16405603; 16441501; 16629714; 16634878; 16690413; 16815190; 16973583; 17002906; 17021767; 17052889; 17106278; 17153701; 17174751; 17182961; 17237562; 17310371; 17411376; 17431094; 17491100; 17507489; 17763415; 17893434; 17910142; 17959659; 18039812; 18053473; 18193213; 18223493; 18305173; 18520346; 18523312; 18569076; 18672082; 18846964; 18945465; 19035513; 19052923; 19223392; 19233472; 19235017; 19449444; 19487610; 19620308; 19770068; 19811438; 19922436; 20012522; 20164547; 20193583; 20307907; 20371654; 20458337; 20606439; 21085635; 21282506; 21410658; 21556773; 21666788; 21778700; 21922073; 21988832; 22041925; 22531795; 22671039; 22808111; 22860026; 23454623; 23537298,,,,,,,,,,,,,,,,,,OGG:3000003126,,,,,,,,,,,,,,,,,,,"major histocompatibility complex, class II, DR beta 4",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HLA-DRB4,,,20140408,3126,DAMC-146E17.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,HLA-DRB4,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0002286,T cell activation involved in immune response,T-lymphocyte activation during immune response|T-cell activation during immune response|T lymphocyte activation during immune response|T cell activation during immune response,"The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.",false,,,http://purl.obolibrary.org/obo/GO_0002285|http://purl.obolibrary.org/obo/GO_0042110,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,T-lymphocyte activation during immune response|T-cell activation during immune response|T lymphocyte activation during immune response|T cell activation during immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002285|http://purl.obolibrary.org/obo/GO_0042110,,,,GO:0002286,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002286,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,T cell activation involved in immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_863,nervous system disease,,A disease of anatomical entity that is located_in the central nervous system or located_in the peripheral nervous system.,false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,ICD10CM:G98|NCI:C26835|ICD10CM:G00-G99|ICD9CM:349.9|ICD10CM:G98.8|SNOMEDCT_US_2019_09_01:118940003|MESH:D009422|UMLS_CUI:C0027765,A disease of anatomical entity that is located_in the central nervous system or located_in the peripheral nervous system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:863,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,DOID:863,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,nervous system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000142,signal peptide (SARS-CoV-2),,,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32075877,Signal peptide (amino acids 1–12) located at the N terminus of S protein.,,signal sequence,,,,,,,,,,,,,,signal peptide (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/TXPO_0000540,inflammatory cell  infiltration,,Inflammatory cell infiltration is a subtype of moving A to the inside of B: A process that moves the outside inflammatory cell to the inside in response to an inflammatory reaction.,false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,Inflammatory cell infiltration is a subtype of moving A to the inside of B: A process that moves the outside inflammatory cell to the inside in response to an inflammatory reaction.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TXPO:0000540,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/txpo.owl,,,,,,,,,,,inflammatory cell  infiltration,,,,,,,,,,,,,,,,,,,,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.13.990226,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010971,positive regulation of G2/M transition of mitotic cell cycle,positive regulation of mitotic entry|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,Any signalling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the mitotic cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_0010389|http://purl.obolibrary.org/obo/GO_1901992|http://purl.obolibrary.org/obo/GO_1902751,,,,,,,,,,,,,,,,tanyaberardini,2009-06-01T10:16:34Z,,,,Any signalling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the mitotic cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0031662,,,,positive regulation of mitotic entry,,,,,biological_process,,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0010389|http://purl.obolibrary.org/obo/GO_1901992|http://purl.obolibrary.org/obo/GO_1902751,,,,GO:0010971,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010971,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of G2/M transition of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_240552,SARS coronavirus TWS,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:240552,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011458,Abdominal symptom,,,false,,,http://purl.obolibrary.org/obo/HP_0025032,,,,,,,,,,,,,,,,peter,2012-03-25T05:35:45Z,,,UMLS:C0740651,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,"Symptoms that accompany abdominal pain ,nausea, vomiting, abdominal distention, diarrhea, constipation, obstipation, tarry stools, chills, fever, urinary frequency, hematuria, and jaundice.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0025032,,,,HP:0011458,,,,,,,,,,,,,,,HP:0011458,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abdominal symptom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0000347,intervention,,"A planned process used to influence one or more factors in a research study, and the independent variable in an interventional study wherein the influence is measured or evaluated.",false,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,,,"A planned process used to influence one or more factors in a research study, and the independent variable in an interventional study wherein the influence is measured or evaluated.",,PERSON: Melissa Haendel,,,,,,,,,,,An drug intervention for cancer.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,ERO:0000347,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,intervention,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Melanie Wilson,,,,
http://purl.obolibrary.org/obo/OMIT_0026579,Viral Tropism,,,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0026579,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,The specificity of a virus for infecting a particular type of cell or tissue.,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Viral Tropism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_239241,SARS coronavirus CUHK-AG01,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:239241,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CUHK-AG01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_17,musculoskeletal system disease,,A disease of anatomical entity that occurs in the muscular and/or skeletal system.,false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,NCI:C107377|UMLS_CUI:C0026857|SNOMEDCT_US_2019_09_01:928000|SNOMEDCT_US_2018_03_01:928000|MESH:D009140,A disease of anatomical entity that occurs in the muscular and/or skeletal system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:17,,,,,,,,,,,,,,,DOID:17,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,musculoskeletal system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C12535,Lymphocyte,Lymph Cell|lymphocyte|Lymphocyte|Lymphocytes,"White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each); those with characteristics of neither major class are called null cells.",false,,,http://purl.obolibrary.org/obo/CL_0000000,,"A type of immune cell that is made in the bone marrow and is found in the blood and in lymph tissue. The two main types of lymphocytes are B lymphocytes and T lymphocytes. B lymphocytes make antibodies, and T lymphocytes help kill tumor cells and help control immune responses. A lymphocyte is a type of white blood cell.",,,,,,,,,C12535,,,CTRP,,,,,,,"White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each); those with characteristics of neither major class are called null cells.",,,,,,Lymphocyte,,,,,,,,,,,,,,,,,,,,,,,,,Lymph Cell|lymphocyte|Lymphocyte|Lymphocytes,,,,,,,,,,,,,NCIT:C12535,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142773,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799,,,,,,,,,,Lymphocyte,Lymphocyte,Lymphocytes,,,,,,,,,,,,,,,,,Lymphocyte,,,,Cell,,,,,,,,C0024264,
http://purl.obolibrary.org/obo/SYMP_0000514,respiratory system and chest symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,UMLS_ICD9CM_2005_AUI:A0284200|SyOID:5868|UMLS_CUI:C0476271|ICD9CM_2005:786,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms of respiratory diseases.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000514,,,,,,,,,,,,,,,SYMP:0000514,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,respiratory system and chest symptom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000012,posterior distribution,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,common CT patterns,,true,,,,,,Ground-glass opacities with a posterior predominance.,,,,,,,,,,,,,,,,posterior distribution,,,,,,,,,,,,,,,,,,,,,,https://www.ajronline.org/doi/full/10.2214/AJR.20.22975,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002446,neutrophil mediated immunity,,Any process involved in the carrying out of an immune response by a neutrophil.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,Any process involved in the carrying out of an immune response by a neutrophil.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0002446,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002446,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neutrophil mediated immunity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC1-1,replicase polyprotein 1a (SARS-CoV-2),pp1a (SARS2)|ORF1a polyprotein (SARS2)|PRO_0000449634|rep/iso:ORF1a (SARS2),A rep gene translation product (SARS-CoV-2) that is a translation product of some mRNA giving rise to a protein with the amino acid sequence represented by UniProtKB:P0DTC1-1.|Category=organism-sequence. Note: 4405 aa protein. Undergoes additional processing by proteolytic cleavage.,false,,,http://purl.obolibrary.org/obo/PR_000050263,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725295|UniProtKB:P0DTC1,A rep gene translation product (SARS-CoV-2) that is a translation product of some mRNA giving rise to a protein with the amino acid sequence represented by UniProtKB:P0DTC1-1.,,,,,,,,,,,,,,,,,,,,,,,,,,,PR:P0DTC1,,,,pp1a (SARS2)|ORF1a polyprotein (SARS2)|PRO_0000449634|rep/iso:ORF1a (SARS2),,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-sequence. Note: 4405 aa protein. Undergoes additional processing by proteolytic cleavage.,,http://purl.obolibrary.org/obo/PR_000050263,,,,PR:P0DTC1-1,,,,,,true,,,,,,,,,PR:P0DTC1-1,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,replicase polyprotein 1a (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0027404,Pandemics,,,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0027404,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32203710,"Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people.",pandemic,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Pandemics,,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039595,induction by virus of catabolism of host mRNA,viral induction of host mRNA decay|virus-mediated mRNA decay|induction by virus of host mRNA catabolic process|promotion of host mRNA degradation|induction of host mRNA decay,"The process in which a virus increases the frequency, rate or extent of the breakdown of host messenger RNA (mRNA).",false,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2012-07-04T03:14:04Z,,,VZ:901,"The process in which a virus increases the frequency, rate or extent of the breakdown of host messenger RNA (mRNA).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral induction of host mRNA decay|virus-mediated mRNA decay|induction by virus of host mRNA catabolic process|promotion of host mRNA degradation|induction of host mRNA decay,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039595,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32292689,,,,GO:0039595,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,induction by virus of catabolism of host mRNA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045132,meiotic chromosome segregation,,"The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets during M phase of the meiotic cell cycle.",false,,,http://purl.obolibrary.org/obo/GO_0098813|http://purl.obolibrary.org/obo/GO_1903046,,,,,,,,,,,,,,,,,,,,,"The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets during M phase of the meiotic cell cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0098813|http://purl.obolibrary.org/obo/GO_1903046,,,,GO:0045132,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045132,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,meiotic chromosome segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_4781,emetine,"Emetine|6',7',10,11-tetramethoxyemetan|Emetan|cephaeline methyl ether|methyl cephaeline|Emetin","A pyridoisoquinoline comprising emetam having methoxy substituents at the 6'-, 7'-, 10- and 11-positions.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:100834|Drug_Central:1001|LINCS:LSM-2041|PMID:16109351|KNApSAcK:C00001849|Wikipedia:Emetine|Beilstein:6253162|PMID:17094176|Beilstein:100834|CAS:483-18-1|MetaCyc:CPD-14817|KEGG:C09421,"A pyridoisoquinoline comprising emetam having methoxy substituents at the 6'-, 7'-, 10- and 11-positions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Emetine|6',7',10,11-tetramethoxyemetan",,,,,chebi_ontology,,Emetan|cephaeline methyl ether|methyl cephaeline|Emetin,,,,,,,,,0,C29H40N2O4,"InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1",AUVVAXYIELKVAI-CKBKHPSWSA-N,480.63898,480.29881,[H][C@]1(C[C@@]2([H])NCCc3cc(OC)c(OC)cc23)C[C@]2([H])N(CCc3cc(OC)c(OC)cc23)C[C@@H]1CC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:4781,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32251767,,,,CHEBI:4781,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,emetine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MP_0010210,abnormal circulating cytokine level,,deviation from the normal levels in the blood of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells,false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,csmith,2010-07-05T10:02:09Z,,,,deviation from the normal levels in the blood of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,MP:0010210,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113714,,significantly high blood levels of chemokines,,MP:0010210,,http://purl.obolibrary.org/obo/mp.owl,,,,,,,,,,,abnormal circulating cytokine level,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MPATH_11,hemorrhagic necrosis,,Necrosis associated with local hemorrhage.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,Necrosis associated with local hemorrhage.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mouse_pathology.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,MPATH:11,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,MPATH:11,,http://purl.obolibrary.org/obo/mpath.owl,,,,,,,,,,,hemorrhagic necrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005844,polysome,polyribosome,A multiribosomal structure representing a linear array of ribosomes held together by messenger RNA. They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Polysome|NIF_Subcellular:sao1038025871,A multiribosomal structure representing a linear array of ribosomes held together by messenger RNA. They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,polyribosome,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005844,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005844,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,polysome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030970,"retrograde protein transport, ER to cytosol","protein retrotranslocation, ER to cytosol|protein dislocation from ER|retrograde protein transport, endoplasmic reticulum to cytosol",The directed movement of unfolded or misfolded proteins from the endoplasmic reticulum to the cytosol through the translocon.,false,,,http://purl.obolibrary.org/obo/GO_0032527|http://purl.obolibrary.org/obo/GO_1903513,,,,,,,,,,,,,,,,,,,,,The directed movement of unfolded or misfolded proteins from the endoplasmic reticulum to the cytosol through the translocon.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"protein retrotranslocation, ER to cytosol|protein dislocation from ER|retrograde protein transport, endoplasmic reticulum to cytosol",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0032527|http://purl.obolibrary.org/obo/GO_1903513,,,,GO:0030970,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030970,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"retrograde protein transport, ER to cytosol",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_81567,thyroid stimulating hormone,,,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:138153,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:81567,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,CHEBI:81567,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,thyroid stimulating hormone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002920,CXCL2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MIP-2a|SCYB2|MGSA-b|GRO2|MIP2|CINC-2a|GROb|MIP2A,,,,,,,4,,,,,,,,,,Ensembl:ENSG00000081041|HGNC:4603|MIM:139110|Vega:OTTHUMG00000160865|HPRD:00741,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 2,,4q21,,,,"GO_0002237 (EC: IDA, PMID: 19912257); GO_0005515 (EC: IPI, PMID: 18275857); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006935 (EC: TAS, PMID: 2643119); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0008009 (EC: IEA); GO_0060326 (EC: TAS, PMID: 9873037)",PMID: 1906501; 2078213; 2129556; 2201751; 2217207; 2341726; 2643119; 2834384; 7864661; 8702798; 9260277; 9277410; 9843467; 9873037; 10600366; 10725737; 10928473; 11134351; 11559650; 12419803; 12477932; 12508094; 12556377; 12892904; 15489334; 15614130; 16421598; 16697212; 17466952; 17703412; 17944017; 17999991; 18191274; 18240029; 18275857; 18322244; 18577758; 18624398; 18835392; 19258923; 19369450; 19435811; 19912257; 20056178; 20162422; 20185584; 20237496; 21145461; 21220697; 21630055; 21677836; 21738478; 21738479; 21988832; 22056994; 22615136; 22770218; 22771802; 23021568; 23128233; 23225384; 23372021; 23554905; 23904157,,,,,,,,,,,,,,,,,,OGG:3000002920,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCL2,,,20140408,2920,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CXCL2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0039648,modulation by virus of host protein ubiquitination,modulation of host ubiquitin pathway by virus,"Any process in which a virus modulates the frequency, rate or extent of protein ubiquitination in the host organism. Ubiquitination is the process in which one or more ubiquitin groups are added to a protein.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2012-10-09T15:20:47Z,,,,"Any process in which a virus modulates the frequency, rate or extent of protein ubiquitination in the host organism. Ubiquitination is the process in which one or more ubiquitin groups are added to a protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,modulation of host ubiquitin pathway by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039648,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/20020050,,,,GO:0039648,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host protein ubiquitination,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034383,low-density lipoprotein particle clearance,LDL clearance,The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.,false,,,http://purl.obolibrary.org/obo/GO_0034381,,,,,,,,,,,,,,,,,,,,,The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,LDL clearance,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0034381,,,,GO:0034383,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034383,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,low-density lipoprotein particle clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0028187,Noninvasive Ventilation,,,false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0028187,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169372/,Techniques for administering artificial respiration without the need for INTRATRACHEAL INTUBATION.,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Noninvasive Ventilation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C18908,Older Population,Older Population|Older Populations,"The population of retired people, generally over 62",false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,C18908,,,,,,,,,,"The population of retired people, generally over 62",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Older Population|Older Populations,,,,,,,,,,,,,NCIT:C18908,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,true,,,,,,,,older age,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Older Population,Older_Population,,,,,,,,,,,,,,,,,,Older Population,,,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext,Population Group,,,,,,,,C1518563,
http://purl.obolibrary.org/obo/GO_0070268,cornification,,"A type of programmed cell death that occurs in the epidermis, morphologically and biochemically distinct from apoptosis. It leads to the formation of corneocytes, i.e. dead keratinocytes containing an amalgam of specific proteins (e.g., keratin, loricrin, SPR and involucrin) and lipids (e.g., fatty acids and ceramides), which are necessary for the function of the cornified skin layer (mechanical resistance, elasticity, water repellence and structural stability).",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A type of programmed cell death that occurs in the epidermis, morphologically and biochemically distinct from apoptosis. It leads to the formation of corneocytes, i.e. dead keratinocytes containing an amalgam of specific proteins (e.g., keratin, loricrin, SPR and involucrin) and lipids (e.g., fatty acids and ceramides), which are necessary for the function of the cornified skin layer (mechanical resistance, elasticity, water repellence and structural stability).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0070268,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0070268,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cornification,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051156,glucose 6-phosphate metabolic process,glucose 6-phosphate metabolism|glucose 6-phosphate utilization,"The chemical reactions and pathways involving glucose 6-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-6.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving glucose 6-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-6.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0006010,,,,glucose 6-phosphate metabolism,,,,,biological_process,,glucose 6-phosphate utilization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0051156,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051156,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,glucose 6-phosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_77736,(S)-verapamil,"(2S)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile|(S)-(-)-verapamil|(-)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile|(-)-verapamil|(-)-(S)-verapamil","A 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile that has S configuration.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:5314473,"A 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile that has S configuration.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(2S)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile",,,,,chebi_ontology,,"(S)-(-)-verapamil|(-)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile|(-)-verapamil|(-)-(S)-verapamil",,,,,,,,,0,C27H38N2O4,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3/t27-/m0/s1",SGTNSNPWRIOYBX-MHZLTWQESA-N,454.60160,454.28316,COc1ccc(CCN(C)CCC[C@](C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:77736,,,,,,true,,,,,,,,,CHEBI:77736,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,(S)-verapamil,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C13457,Cytoplasmic Domain,Cytosolic Domain|Cytoplasmic Tail|Cytoplasmic Domain,The part of a transmembrane protein which projects into the cytoplasm.,false,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,C13457,,,,,,,,,,The part of a transmembrane protein which projects into the cytoplasm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cytosolic Domain|Cytoplasmic Tail|Cytoplasmic Domain,,,,,,,,,,,,,NCIT:C13457,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PR_000000001,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Cytoplasmic Domain,Cytoplasmic_Tail,,,,,,,,,,,,,,,,,,Cytoplasmic Domain,,,,Spatial Concept,,,,,,,,C1511625,
http://purl.obolibrary.org/obo/NCBITaxon_293321,SARS coronavirus GZ0403,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:293321,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ0403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000028,ribosomal small subunit assembly,40S ribosomal subunit assembly|30S ribosomal subunit assembly,"The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the small ribosomal subunit.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the small ribosomal subunit.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,40S ribosomal subunit assembly|30S ribosomal subunit assembly,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0000028,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000028,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribosomal small subunit assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000793,condensed chromosome,mitotic chromosome|cytoplasmic mitotic chromosome|metaphase chromosome,A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure.|Note that this term can be used to annotate gene products that localize to a mitotic chromosome in an organism that undergoes an 'open mitosis' in which the nuclear envelope breaks down during mitosis.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,mitotic chromosome|cytoplasmic mitotic chromosome|metaphase chromosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term can be used to annotate gene products that localize to a mitotic chromosome in an organism that undergoes an 'open mitosis' in which the nuclear envelope breaks down during mitosis.,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0000793,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000793,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,condensed chromosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_321149,SARS coronavirus BJ202,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:321149,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000050,"
frequently washing hands with soap and water for 20 seconds",,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,Modified definition,,,intervention,,true,,,,,,Scrubbing  hands frequently for at least 20 seconds  to prevent the spread of germs.,,,,,,,,,,,,,,,,"
frequently washing hands with soap and water for 20 seconds",,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/handwashing/when-how-handwashing.html|https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000815,regulatory T cell,suppressor T-cell|suppressor T cell|suppressor T lymphocyte|suppressor T-lymphocyte|regulatory T-lymphocyte|regulatory T-cell|regulatory T lymphocyte|Treg,A T cell which regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.|This cell type may express FoxP3 and CD25 and secretes IL-10 and TGF-beta.,false,,,http://purl.obolibrary.org/obo/CL_0002419,,,,,,,,,,,,,,,,,,,,BTO:0004520|FMA:84070,A T cell which regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.,,,,,,,,,,,,,,,,,,,,,,,,,,,,suppressor T-cell|suppressor T cell|suppressor T lymphocyte|suppressor T-lymphocyte,,,regulatory T-lymphocyte|regulatory T-cell|regulatory T lymphocyte|Treg,,,,,cell,,,,,,,,CL:0000815,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This cell type may express FoxP3 and CD25 and secretes IL-10 and TGF-beta.,,http://purl.obolibrary.org/obo/CL_0002419,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,regulatory T cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000146225,CMTM2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CKLFSF2,,,,,,,16,,,,,,,,,,MIM:607885|Vega:OTTHUMG00000137501|HGNC:19173|HPRD:07434|Ensembl:ENSG00000140932,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,CKLF-like MARVEL transmembrane domain containing 2,,16q21,,,,"GO_0005125 (EC: IEA); GO_0005615 (EC: IEA); GO_0005634 (EC: IDA); GO_0005730 (EC: IDA, Qualifier: NOT); GO_0006935 (EC: IEA); GO_0016021 (EC: IEA)",PMID: 12477932; 12782130; 14702039; 15489334; 15778092; 15896670; 17334588; 18029348; 21034562; 21832049; 22901147,,,,,,,,,,,,,,,,,,OGG:3000146225,,,,,,,,,,,,,,,,,,,CKLF-like MARVEL transmembrane domain containing 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CMTM2,,,20140408,146225,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CMTM2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/DOID_0060051,autoimmune disease of cardiovascular system,,An autoimmune hypersensitivity disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the cardiovascular system.,false,,,http://purl.obolibrary.org/obo/DOID_1287|http://purl.obolibrary.org/obo/DOID_417,,,,,,,,,,,,,,,,,,,,,An autoimmune hypersensitivity disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the cardiovascular system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287|http://purl.obolibrary.org/obo/DOID_417,,,,DOID:0060051,,,,,,,,,,,,,,,DOID:0060051,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,autoimmune disease of cardiovascular system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000410,neurological and physiological symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Physical Symptoms of Neurological Problems,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000410,,,,,,,,,,,,,,,SYMP:0000410,,http://purl.obolibrary.org/obo/doid.owl|http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,neurological and physiological symptom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_442736,Bat SARS coronavirus HKU3,Bat coronavirus HKU3|SARS-related bat coronavirus HKU3,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat coronavirus HKU3|SARS-related bat coronavirus HKU3,,,,,,NCBITaxon:442736,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708621/,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1904724,tertiary granule lumen,membrane-enclosed lumen of tertiary granule|membrane-enclosed lumen of gelatinase granule|tertiary granule membrane-enclosed lumen|gelatinase granule membrane-enclosed lumen,Any membrane-enclosed lumen that is part of a tertiary granule.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,mec,2015-10-12T12:53:10Z,,,,Any membrane-enclosed lumen that is part of a tertiary granule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,membrane-enclosed lumen of tertiary granule|membrane-enclosed lumen of gelatinase granule|tertiary granule membrane-enclosed lumen,,,,,cellular_component,,gelatinase granule membrane-enclosed lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:1904724,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1904724,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,tertiary granule lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007267,cell-cell signaling,cell-cell signalling,"Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell.  Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell.  Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cell-cell signalling,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007267,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0007267,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant,,,,,,,,,,cell-cell signaling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,ER-Golgi intermediate compartment membrane,The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ER-Golgi intermediate compartment membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0033116,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033116,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endoplasmic reticulum-Golgi intermediate compartment membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003559,IL2RA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IDDM10|TCGFR|CD25|IL2R,,,,,,,10,,,,,,,,,,Ensembl:ENSG00000134460|HGNC:6008|MIM:147730|HPRD:00986|Vega:OTTHUMG00000017616,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interleukin 2 receptor, alpha",,10p15-p14,,,,"GO_0002437 (EC: IEA); GO_0004911 (EC: IEA); GO_0005886 (EC: TAS); GO_0006915 (EC: TAS, PMID: 9096364); GO_0006924 (EC: IEA); GO_0006955 (EC: TAS, PMID: 9096364); GO_0007166 (EC: TAS, PMID: 2983318); GO_0007219 (EC: IEA); GO_0008144 (EC: IEA); GO_0008283 (EC: TAS, PMID: 2983318); GO_0009897 (EC: IEA); GO_0016021 (EC: IEA); GO_0019976 (EC: IEA); GO_0042104 (EC: IEA); GO_0042130 (EC: IEA); GO_0045582 (EC: IEA); GO_0046013 (EC: IEA); GO_0050687 (EC: IEA); GO_0050728 (EC: IEA); GO_0050777 (EC: IEA)",PMID: 1394441; 1511461; 1685671; 1693645; 1832084; 1976256; 1993646; 2016116; 2083254; 2153927; 2303462; 2308942; 2315327; 2467293; 2497520; 2785715; 2843775; 2901720; 2941417; 2983318; 2990220; 2996141; 2999698; 3030566; 3097520; 3134887; 3135323; 3925551; 6090948; 6090949; 6096720; 7529123; 7539755; 7588634; 7734194; 7853525; 7862168; 7903128; 8098618; 8125298; 8364583; 8493579; 8530186; 8752938; 8896456; 8943338; 9096364; 9203962; 9223324; 9268307; 9341758; 9637477; 10602027; 10815800; 10825200; 10848593; 11416131; 11485747; 11856346; 11886175; 11960393; 11986281; 12171778; 12200381; 12230826; 12374985; 12486319; 12525482; 12581498; 12698200; 12970897; 14680494; 15123239; 15197226; 15263076; 15328201; 15353339; 15365604; 15503821; 15617342; 15619904; 15649306; 15713622; 15714205; 15731180; 15776395; 15784911; 15885081; 15964425; 15972448; 15985167; 16003241; 16034095; 16060678; 16087671; 16126178; 16226465; 16293754; 16339919; 16380476; 16385451; 16410445; 16477002; 16491350; 16690518; 16698664; 16750991; 16758122; 16889540; 16911870; 16920911; 16955142; 17062437; 17074352; 17152005; 17175221; 17205058; 17237241; 17275508; 17294624; 17302593; 17304105; 17313446; 17371467; 17372588; 17389235; 17395754; 17420929; 17431094; 17462597; 17523134; 17543960; 17591854; 17604883; 17615291; 17645467; 17660530; 17661330; 17676041; 17703412; 17712998; 17878392; 17944116; 17975141; 17981806; 17985312; 18021968; 18059223; 18089681; 18162781; 18174382; 18204854; 18261176; 18287585; 18354419; 18376303; 18390743; 18451325; 18556337; 18593762; 18641303; 18641304; 18650830; 18715339; 18780166; 18818748; 18978792; 19019335; 19034005; 19073967; 19077408; 19106270; 19116909; 19119414; 19125193; 19139102; 19141347; 19155502; 19155519; 19192224; 19231135; 19240061; 19258923; 19264985; 19265545; 19289595; 19303058; 19327240; 19375175; 19375249; 19377213; 19430480; 19447046; 19471255; 19499289; 19505389; 19506219; 19522766; 19523791; 19525953; 19525955; 19527514; 19565500; 19637754; 19664391; 19667946; 19667950; 19701192; 19715524; 19734224; 19794070; 19798683; 19822714; 19833889; 19834503; 19849846; 19865102; 19879194; 19913121; 19923221; 19951265; 19956099; 19956753; 20032294; 20033399; 20063526; 20140262; 20164820; 20179739; 20203524; 20213609; 20219786; 20224778; 20237496; 20346270; 20362271; 20368992; 20378605; 20388015; 20403730; 20410501; 20424473; 20448211; 20450971; 20452482; 20453842; 20483636; 20484297; 20498205; 20503287; 20518821; 20539016; 20545784; 20562654; 20595929; 20596022; 20599261; 20615141; 20628086; 20673868; 20716621; 20716663; 20729906; 20810507; 20849903; 20930173; 21048031; 21094786; 21102463; 21131424; 21132303; 21157146; 21179414; 21180073; 21211217; 21239413; 21249500; 21278348; 21300823; 21376048; 21437244; 21525574; 21533205; 21557210; 21557772; 21571262; 21651772; 21722762; 21744325; 21757642; 21815908; 21829393; 21833088; 21839272; 21911588; 21941578; 21949691; 21980389; 22012429; 22032685; 22117963; 22158072; 22190364; 22195034; 22211793; 22213266; 22222639; 22228203; 22266274; 22293688; 22294642; 22309031; 22310634; 22313865; 22419479; 22436290; 22446965; 22447883; 22461703; 22466163; 22479496; 22516956; 22537764; 22554193; 22558434; 22564647; 22576476; 22623161; 22672991; 22824721; 22897480; 23103669; 23116454; 23121673; 23128233; 23129754; 23170961; 23217119; 23282736; 23320892; 23340699; 23345407; 23383287; 23416241; 23418630; 23508266; 23510625; 23512675; 23529819; 23665204; 23676143; 23715268; 23758320; 23817569; 23870656; 23874506; 23904478; 24134837; 24159173; 24163352; 24449572,,,,,,,,,,,,,,,,,,OGG:3000003559,,,,,,,,,,,,,,,,,,,"interleukin 2 receptor, alpha",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL2RA,,,20140408,3559,RP11-536K7.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL2RA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0031970,Abnormal blood urea nitrogen concentration,Abnormal BUN concentration,Any deviation from the normal concentration of urea nitrogen in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0004364,,,,,,,,,,,,,,,,peter,,,,,Any deviation from the normal concentration of urea nitrogen in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal BUN concentration,,,,,,,,,,,,,HP:0031970,,,,,,,,,,,,,,,,,,2018-07-07T23:29:10Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0004364,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal blood urea nitrogen concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002431,Fc receptor mediated stimulatory signaling pathway,Fc-receptor mediated stimulatory signaling pathway|Fc receptor mediated stimulatory signalling pathway,A series of molecular signals generated as a consequence of a the binding of the Fc portion of an immunoglobulin by an Fc receptor capable of activating or perpetuating an immune response. The Fc portion of an immunoglobulin is its C-terminal constant region.,false,,,http://purl.obolibrary.org/obo/GO_0002429,,,,,,,,,,,,,,,,,,,,,A series of molecular signals generated as a consequence of a the binding of the Fc portion of an immunoglobulin by an Fc receptor capable of activating or perpetuating an immune response. The Fc portion of an immunoglobulin is its C-terminal constant region.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fc-receptor mediated stimulatory signaling pathway|Fc receptor mediated stimulatory signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002429,,,,GO:0002431,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002431,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,Fc receptor mediated stimulatory signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007059,chromosome segregation,chromosome division|chromosome transmission,"The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Chromosome_segregation,"The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chromosome division,,,,,biological_process,,chromosome transmission,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007059,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007059,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,chromosome segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000404,COVID signs and symptoms,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The 'COVID signs and symptoms' concept enables a compilation of diverse concepts that are related to signs and symptoms of Covid-19  via the Axiome 'isSignsAndSymptomsFor some COVID-19'. Thus enables the adaptation of the ontology for text mining purposes for Covid-19 related information retrieval and information extraction.,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID signs and symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039671,evasion by virus of host natural killer cell activity,protection by virus against host NK cell cytotoxicity|evasion by virus of host natural killer cell response|evasion by virus of host NK cell killing|suppression by virus of host natural killer cell function|viral immunoevasion of host NK cell|modulation of host NK-cell activity by virus,Any process by which a virus avoids the effects mediated by the host organism's natural killer (NK) cells.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-09-25T11:04:53Z,,,,Any process by which a virus avoids the effects mediated by the host organism's natural killer (NK) cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protection by virus against host NK cell cytotoxicity|evasion by virus of host natural killer cell response|evasion by virus of host NK cell killing|suppression by virus of host natural killer cell function|viral immunoevasion of host NK cell,,,,,biological_process,,modulation of host NK-cell activity by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039671,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32203188,,,,GO:0039671,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,evasion by virus of host natural killer cell activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044839,cell cycle G2/M phase transition,,The cell cycle process by which a cell in G2 phase commits to M phase.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,janelomax,2014-03-05T14:56:45Z,,,,The cell cycle process by which a cell in G2 phase commits to M phase.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0044839,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044839,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cell cycle G2/M phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000185,AGTR1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,AT2R1|AT1B|AT1|HAT1R|AT1AR|AG2S|AGTR1B|AT1BR|AT1R,,,,,,,3,,,,,,,,,,MIM:106165|HPRD:00107|Vega:OTTHUMG00000159503|HGNC:336|Ensembl:ENSG00000144891,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"angiotensin II receptor, type 1",,3q24,,,,"GO_0001558 (EC: NAS, PMID: 17159080); GO_0001596 (EC: IDA, PMID: 10993080); GO_0001596 (EC: IPI, PMID: 1378723); GO_0001822 (EC: IMP, PMID: 16116425); GO_0002018 (EC: NAS, PMID: 17159080); GO_0002034 (EC: IC, PMID: 10993080); GO_0003081 (EC: IC, PMID: 1378723); GO_0004945 (EC: IDA, PMID: 15611106); GO_0005515 (EC: IPI, PMID: 1378723); GO_0005886 (EC: IDA, PMID: 19023134); GO_0005886 (EC: TAS); GO_0005887 (EC: IC, PMID: 1378723); GO_0007186 (EC: IDA, PMID: 1378723); GO_0007200 (EC: NAS, PMID: 17159080); GO_0007204 (EC: IDA, PMID: 1567413); GO_0007266 (EC: IDA, PMID: 15611106); GO_0010744 (EC: IC, PMID: 18971559); GO_0010873 (EC: IMP, PMID: 18971559); GO_0016021 (EC: NAS, PMID: 8135787); GO_0019229 (EC: IC, PMID: 1378723); GO_0019229 (EC: IDA, PMID: 15117835); GO_0019229 (EC: NAS, PMID: 17159080); GO_0019722 (EC: IDA, PMID: 1567413); GO_0031711 (EC: IPI, PMID: 10993080); GO_0032270 (EC: IMP, PMID: 18971559); GO_0032430 (EC: IMP, PMID: 17069818); GO_0033864 (EC: TAS, PMID: 17159080); GO_0034374 (EC: NAS, PMID: 17069818); GO_0035813 (EC: NAS, PMID: 17159080); GO_0038166 (EC: IDA, PMID: 15611106); GO_0042127 (EC: NAS, PMID: 17159080); GO_0042312 (EC: IC, PMID: 1378723); GO_0046982 (EC: IPI, PMID: 10993080); GO_0050727 (EC: IC, PMID: 1378723); GO_0050729 (EC: TAS, PMID: 17159080); GO_0051482 (EC: IDA, PMID: 1567413); GO_0060326 (EC: IDA, PMID: 15635042); GO_0086097 (EC: IDA, PMID: 10993080); GO_0086097 (EC: IPI, PMID: 1378723); GO_2000379 (EC: TAS, PMID: 17159080)",PMID: 1378723; 1508224; 1543512; 1550596; 1567413; 1683828; 7491117; 7746328; 7792812; 7980575; 8021009; 8135787; 8166699; 8185574; 8662816; 8753867; 9074770; 9211925; 9468203; 9516477; 9606715; 9766385; 10510297; 10972591; 10993080; 11079515; 11081769; 11082147; 11085286; 11106322; 11110972; 11122322; 11136175; 11137090; 11152457; 11158334; 11208365; 11213892; 11226259; 11246471; 11250978; 11279203; 11288810; 11289708; 11317203; 11324803; 11330506; 11336183; 11341749; 11354780; 11355019; 11359462; 11444146; 11484170; 11531970; 11575217; 11577832; 11579203; 11593098; 11682489; 11687736; 11688760; 11689223; 11692158; 11696658; 11696688; 11707217; 11707686; 11709400; 11709801; 11711524; 11733189; 11752456; 11774217; 11775887; 11776100; 11793101; 11793845; 11798574; 11799082; 11852019; 11865575; 11881039; 11882570; 11903322; 11909563; 11910300; 11910301; 11913624; 11923700; 11924723; 11926202; 11938025; 11967817; 11999641; 12006574; 12031955; 12034692; 12045255; 12048678; 12095411; 12117739; 12127057; 12133421; 12133518; 12187084; 12358135; 12390711; 12394950; 12425365; 12436935; 12446192; 12446598; 12450401; 12454231; 12460700; 12473660; 12476891; 12477932; 12482634; 12511523; 12513040; 12514663; 12522132; 12522467; 12534336; 12544439; 12544508; 12556231; 12579398; 12579405; 12591176; 12593997; 12597535; 12624609; 12627871; 12627873; 12631360; 12660887; 12694873; 12694874; 12695419; 12716844; 12728975; 12747597; 12778448; 12832734; 12842881; 12860335; 12865608; 12891302; 12897464; 12898858; 12904590; 12925562; 12932862; 12950120; 12960024; 14502296; 14508191; 14521778; 14529856; 14530292; 14569094; 14597852; 14610337; 14627489; 14654250; 14657020; 14730619; 14749533; 14764974; 14765837; 14767013; 14987254; 14997233; 15013293; 15013322; 15013333; 15017542; 15031629; 15042429; 15045574; 15062885; 15080371; 15097234; 15108186; 15117835; 15126556; 15130920; 15153745; 15193870; 15193960; 15196067; 15212666; 15221785; 15238568; 15269283; 15295089; 15326089; 15332573; 15353577; 15355986; 15364762; 15376229; 15385810; 15452107; 15452121; 15454732; 15458433; 15480097; 15480098; 15492474; 15496309; 15498133; 15498791; 15498833; 15504143; 15505642; 15543360; 15545271; 15545843; 15563875; 15580058; 15590451; 15611106; 15612584; 15628301; 15635042; 15662219; 15673342; 15676177; 15683714; 15694792; 15718424; 15718497; 15743363; 15775779; 15785027; 15797649; 15824464; 15848528; 15863668; 15890659; 15905345; 15914614; 15923814; 15930094; 15934435; 15946912; 15949885; 16006956; 16012192; 16047641; 16061119; 16076618; 16088850; 16105049; 16108768; 16109085; 16109807; 16109907; 16112405; 16116425; 16152821; 16188060; 16189286; 16231503; 16271939; 16274774; 16276415; 16294326; 16314886; 16339777; 16344560; 16364240; 16369102; 16384824; 16395664; 16396964; 16398146; 16434990; 16468060; 16492203; 16498788; 16504375; 16519598; 16521052; 16522324; 16525943; 16525944; 16530863; 16550310; 16565729; 16603315; 16609364; 16611642; 16615274; 16636899; 16651460; 16672053; 16684954; 16685579; 16691016; 16736244; 16741369; 16741935; 16754659; 16775386; 16787961; 16790149; 16805920; 16823505; 16831865; 16876684; 16893516; 16911325; 16923768; 16954165; 16998258; 17008309; 17024648; 17051401; 17069818; 17097490; 17118372; 17118790; 17118791; 17143591; 17146658; 17159080; 17160213; 17165166; 17166941; 17173513; 17190732; 17207964; 17211247; 17211857; 17220293; 17223428; 17227479; 17229913; 17256744; 17261659; 17270098; 17274465; 17285438; 17293603; 17298481; 17299793; 17325239; 17326392; 17327458; 17334527; 17336987; 17375465; 17378368; 17393691; 17399955; 17429042; 17433630; 17446269; 17446655; 17486447; 17487826; 17499413; 17519002; 17520398; 17522061; 17524880; 17541127; 17546276; 17557241; 17569300; 17586411; 17586781; 17595257; 17617024; 17668390; 17702963; 17703434; 17710578; 17719203; 17725712; 17726226; 17728799; 17785770; 17851694; 17903694; 17914507; 17921131; 17921431; 17921816; 17984617; 17988266; 17992634; 17993594; 18006496; 18026817; 18059164; 18069999; 18088317; 18091746; 18158351; 18172057; 18188697; 18202720; 18205094; 18231736; 18239157; 18239384; 18240029; 18245065; 18260840; 18261537; 18296263; 18308844; 18328310; 18331441; 18347611; 18348177; 18364271; 18413189; 18413222; 18413308; 18414380; 18417209; 18432064; 18434621; 18446309; 18464745; 18464932; 18475152; 18488444; 18491423; 18497458; 18513389; 18534055; 18550062; 18550936; 18551012; 18563171; 18565507; 18575418; 18577758; 18594050; 18594540; 18612202; 18622242; 18633425; 18637188; 18641512; 18660489; 18676046; 18679149; 18698212; 18700314; 18703536; 18719072; 18767410; 18787507; 18787943; 18800139; 18830250; 18855530; 18856058; 18927546; 18953568; 18971559; 18974842; 18985387; 19014923; 19017652; 19021695; 19023134; 19023273; 19026696; 19040540; 19056482; 19057513; 19059460; 19064815; 19067809; 19082699; 19086053; 19102886; 19108684; 19110485; 19112833; 19131662; 19145770; 19162241; 19162259; 19166692; 19178574; 19185300; 19218102; 19236533; 19238444; 19242491; 19245071; 19247266; 19253715; 19254215; 19263529; 19274051; 19274077; 19276075; 19282863; 19286758; 19286759; 19288324; 19302184; 19304510; 19308748; 19309260; 19327134; 19330904; 19332265; 19341158; 19397700; 19408837; 19418628; 19420105; 19424575; 19461648; 19463113; 19479237; 19487683; 19503013; 19509012; 19520069; 19524223; 19546528; 19559392; 19578796; 19587357; 19593696; 19620885; 19635801; 19680137; 19681973; 19696781; 19706169; 19713412; 19716087; 19729965; 19752885; 19755917; 19779016; 19779330; 19779464; 19782519; 19811349; 19833117; 19853701; 19913121; 19929134; 19940150; 19948975; 19954723; 19956635; 19997001; 20026870; 20027122; 20066125; 20080265; 20108069; 20118823; 20137558; 20142115; 20161734; 20181817; 20223791; 20223792; 20300066; 20302034; 20304486; 20308035; 20351714; 20361261; 20452482; 20458733; 20465154; 20478903; 20486282; 20525211; 20536507; 20537417; 20537563; 20558762; 20559404; 20560294; 20563831; 20565774; 20570668; 20577119; 20580725; 20594303; 20602615; 20606419; 20628086; 20659024; 20667857; 20673868; 20703234; 20708651; 20714875; 20731749; 20732682; 20816596; 20824505; 20837730; 20838438; 20851291; 20854100; 20854388; 20856803; 20861505; 20864943; 20943774; 20945417; 20966899; 20975235; 20978160; 21052031; 21086617; 21152433; 21162207; 21163122; 21173159; 21176342; 21223556; 21234519; 21234654; 21316998; 21319597; 21330421; 21332426; 21412239; 21436209; 21449976; 21463477; 21502318; 21525005; 21570644; 21596033; 21600887; 21607620; 21628354; 21633717; 21636204; 21638051; 21641389; 21670585; 21671168; 21740964; 21771600; 21791198; 21808598; 21846682; 21856918; 21937042; 21970881; 21986569; 22021115; 22147663; 22237156; 22282354; 22291018; 22297600; 22323719; 22362742; 22387727; 22392878; 22407459; 22433249; 22475523; 22484478; 22555639; 22561363; 22569962; 22581182; 22590832; 22613986; 22645060; 22647632; 22703619; 22719026; 22758920; 22782431; 22939041; 23081748; 23145508; 23176211; 23210602; 23223579; 23273598; 23326349; 23386604; 23389452; 23451270; 23480300; 23480670; 23484035; 23505107; 23536940; 23564192; 23567951; 23585396; 23592774; 23603059; 23615648; 23681235; 23694962; 23700157; 23745680; 23755207; 23828384; 23880184; 23942655; 24015270; 24055489; 24202179; 24218433; 24400721,,,,,,,,,,,,,,,,,,OGG:3000000185,,,,,,,,,,,,,,,,,,,"angiotensin II receptor, type 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,AGTR1,,,20140408,185,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,AGTR1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0046760,viral budding from Golgi membrane,Golgi membrane viral budding|virus budding from Golgi membrane|Golgi membrane viral budding during viral capsid envelopment|viral budding from Golgi membrane during viral capsid envelopment|viral budding from Golgi membrane by viral capsid envelopment|virus budding from Golgi membrane by viral capsid envelopment|virus budding from Golgi membrane during viral capsid envelopment,A viral budding that starts with formation of a membrane curvature in the host Golgi membrane.,false,,,http://purl.obolibrary.org/obo/GO_0046755,,,,,,,,,,,,,,,,,,,,,A viral budding that starts with formation of a membrane curvature in the host Golgi membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046750|GO:0046763,,,,Golgi membrane viral budding|virus budding from Golgi membrane,,,,,biological_process,,Golgi membrane viral budding during viral capsid envelopment|viral budding from Golgi membrane during viral capsid envelopment|viral budding from Golgi membrane by viral capsid envelopment|virus budding from Golgi membrane by viral capsid envelopment|virus budding from Golgi membrane during viral capsid envelopment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046755,,,,GO:0046760,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32236561,,,,GO:0046760,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral budding from Golgi membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000121,RNA viral genome,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,Modified definition,,,,,true,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/figure/article-52171.image.f5/,"Viral genomes consisting of  ribonucleic acid  that can be either circular, linear, or fragmented.",,,,,,,,,,,,,,,,RNA viral genome,,,,,,,,,,,,,,,,,,,,,,https://www.sciencedirect.com/topics/immunology-and-microbiology/virus-genome,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10029,Cricetulus griseus,Chinese hamsters|Chinese hamster|Cricetulus aureus|Cricetulus barabensis griseus,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_314146,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:143285,,,,Chinese hamsters|Chinese hamster|Cricetulus aureus,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Cricetulus barabensis griseus,,,,,,NCBITaxon:10029,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_314146,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215622,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Cricetulus griseus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000065,online-interview,,,false,,,http://purl.obolibrary.org/obo/NCIT_C16751,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C16751,,,,,,,,interview,,true,,,,,,"An online interview is an online research method conducted using computer-mediated communication (CMC), such as instant messaging, email, or video.",Online Survey,,,,,,,,,,,,,,,online-interview,,,,,,,,,,,,,,,,,,,,,,https://www.mdmag.com/medical-news/survey-reveals-knowledge-misperceptions-covid-19,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012614,Abnormal urine cytology,,An anomalous finding in the examination of the urine for cells.,false,,,http://purl.obolibrary.org/obo/HP_0003110,,,,,,,,,,,,,,,,peter,2014-01-17T12:01:16Z,,,SNOMEDCT_US:310439007|UMLS:C0587955,An anomalous finding in the examination of the urine for cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0003110,,,,HP:0012614,,,,,,,,,,,,,,,HP:0012614,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal urine cytology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000597,head and neck symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,ICD9CM_2005:784|UMLS_ICD9CM_2005_AUI:A0284173|SyOID:7123|UMLS_CUI:C0476247,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms that manifest in any of the part of head and neck,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000597,,modified definition,,,,,,,,,,,,,SYMP:0000597,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,head and neck symptom,,,,,,,,,,,,,,,,,,,,,,https://www.macmillan.org.uk/cancer-information-and-support/head-and-neck-cancer/signs-and-symptoms-of-head-and-neck-cancer,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000926,CD8B,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LYT3|LY3|LEU2|CD8B1|P37,,,,,,,2,,,,,,,,,,HPRD:01725|Vega:OTTHUMG00000130264|MIM:186730|Ensembl:ENSG00000172116|HGNC:1707,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,CD8b molecule,,2p12,,,,"GO_0005515 (EC: IPI, PMID: 2493728); GO_0005576 (EC: IEA); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 3145195); GO_0006955 (EC: NAS, PMID: 11131152); GO_0007169 (EC: NAS, PMID: 9830036); GO_0009897 (EC: IEA); GO_0015026 (EC: NAS, PMID: 11131152); GO_0016032 (EC: TAS); GO_0031901 (EC: TAS); GO_0042101 (EC: NAS, PMID: 11131152); GO_0042110 (EC: NAS, PMID: 9830036); GO_0042288 (EC: NAS, PMID: 11131152); GO_0050690 (EC: TAS); GO_0050776 (EC: TAS)",PMID: 1541829; 2111591; 2493728; 2536941; 3114136; 3145195; 3145196; 3264320; 3860845; 8436166; 9550407; 9830036; 10623829; 10809759; 11131152; 11937547; 12215456; 12459555; 12477932; 12702212; 15980863; 16103193; 16344560; 18473783; 18490743; 19149577; 19322201; 19768696; 20379614; 21543478; 21685912; 21922073; 21936714; 21954283; 22013062; 22844345; 24047902; 24297179,,,,,,,,,,,,,,,,,,OGG:3000000926,,,,,,,,,,,,,,,,,,,CD8b molecule,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD8B,,,20140408,926,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CD8B,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0035371,microtubule plus-end,growing microtubule plus end|microtubule plus end,"The growing (plus) end of a microtubule. In vitro, microtubules polymerize more quickly at the plus end than at the minus end. In vivo, microtubule growth occurs only at the plus end, and the plus end switches between periods of growth and shortening, a behavior known as dynamic instability.",false,,,http://purl.obolibrary.org/obo/GO_1990752,,,,,,,,,,,,,,,,rfoulger,2010-03-11T10:55:00Z,,,,"The growing (plus) end of a microtubule. In vitro, microtubules polymerize more quickly at the plus end than at the minus end. In vivo, microtubule growth occurs only at the plus end, and the plus end switches between periods of growth and shortening, a behavior known as dynamic instability.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,growing microtubule plus end|microtubule plus end,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1990752,,,,GO:0035371,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035371,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,microtubule plus-end,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1,root,all,,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,all,,,,,,NCBITaxon:1,A root refers to a concept that is considered as the top node for a specific purpose in a hierarchy.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,modified definition,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,root,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C45800,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007229,integrin-mediated signaling pathway,integrin-mediated signalling pathway,"A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,,"A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,integrin-mediated signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0007229,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007229,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,integrin-mediated signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000098,patchy consolidation,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,common CT patterns,,true,,,,,,Patchy pulmonary opacity.,,lung consolidation,,,,,,,,,,,,,,patchy consolidation,,,,,,,,,,,,,,,,,,,,,,https://www.ajronline.org/doi/full/10.2214/AJR.20.22975,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000004283,CXCL9,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,crg-10|MIG|CMK|SCYB9|Humig,,,,,,,4,,,,,,,,,,MIM:601704|HGNC:7098|Vega:OTTHUMG00000160889|Ensembl:ENSG00000138755|HPRD:03416,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 9,,4q21,,,,"GO_0005125 (EC: TAS, PMID: 2115167); GO_0005515 (EC: IPI, PMID: 18275857); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006935 (EC: IDA, PMID: 12782716); GO_0006952 (EC: TAS, PMID: 2115167); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0006968 (EC: TAS, PMID: 10570316); GO_0007165 (EC: TAS, PMID: 10201891); GO_0007186 (EC: TAS, PMID: 10903763); GO_0007267 (EC: TAS, PMID: 8476424); GO_0008009 (EC: IDA, PMID: 12782716); GO_0009897 (EC: IEA); GO_0030816 (EC: IDA, PMID: 12782716); GO_0042127 (EC: IDA, PMID: 12782716); GO_0043950 (EC: IDA, PMID: 12782716); GO_0048248 (EC: IDA, PMID: 12782716); GO_0051281 (EC: IDA, PMID: 12782716); GO_0051607 (EC: IEA); GO_0060326 (EC: IDA, PMID: 12782716); GO_0060326 (EC: TAS, PMID: 10903763)",PMID: 2115167; 2834384; 7595201; 8476424; 8976378; 9660793; 9730616; 10201891; 10201901; 10233762; 10570316; 10903763; 11110785; 11157474; 11208713; 11390394; 11422029; 11423172; 11449350; 11523044; 12107104; 12162873; 12185171; 12270371; 12384933; 12477932; 12539042; 12782716; 12847282; 12856973; 12884299; 12946268; 14507644; 14550288; 15081261; 15113590; 15150261; 15489334; 16200621; 16210647; 16243485; 16583210; 17207965; 17255201; 17262710; 17490641; 17703315; 17703412; 17875534; 17892861; 17975089; 18240029; 18275857; 18292502; 18338951; 18413205; 18415893; 18930766; 19087608; 19134328; 19157479; 19258635; 19258923; 19274094; 19340290; 19344719; 19410617; 19459809; 19565490; 19639049; 19800124; 19898927; 19929857; 20038462; 20137825; 20237496; 20299237; 20456109; 20485444; 20503287; 20626297; 20628624; 20810571; 20838432; 20942936; 21167783; 21179030; 21303517; 21470996; 21475065; 21601475; 21645215; 21812928; 21962843; 21988832; 22037980; 22333315; 22367045; 22401175; 22467521; 22580676; 22586042; 22689822; 22766105; 22889476; 22905138; 23012327; 23150742; 23179902; 23352833; 23417848; 23527708; 23600831; 23769451; 24063316; 24363401; 24600982,,,,,,,,,,,,,,,,,,OGG:3000004283,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 9,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCL9,,,20140408,4283,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,CXCL9,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCIT_C15747,Supportive Care,"Therapy, Supportive|Supportive Care|supportive care|Supportive Therapy|Symptom Management","Supportive care is that which helps the patient and their family to cope with cancer and treatment of it from pre-diagnosis, through the process of diagnosis and treatment, to cure, continuing illness or death and into bereavement. It helps the patient to maximize the benefits of treatment and to live as well as possible with the effects of the disease. Supportive therapy may provide a patient with friendship, encouragement, practical advice such as access to community resources or how to develop a more active social life, vocational counseling, suggestions for minimizing friction with family members, and, above all, hope that the life of the patient may be improved. In all situations, supportive therapy involves the teaching of such life skills as managing medication, learning to socialize, handling finances, and getting a job.",false,,,http://purl.obolibrary.org/obo/OGMS_0000096,,"Any action or process to maximize comfort, minimize side effects, or mitigate against a decline in the participant's health or function. (clinicaltrials.gov)",,,,,,,,,C15747,,,CDISC|CTRP,,,,,,,"Supportive care is that which helps the patient and their family to cope with cancer and treatment of it from pre-diagnosis, through the process of diagnosis and treatment, to cure, continuing illness or death and into bereavement. It helps the patient to maximize the benefits of treatment and to live as well as possible with the effects of the disease. Supportive therapy may provide a patient with friendship, encouragement, practical advice such as access to community resources or how to develop a more active social life, vocational counseling, suggestions for minimizing friction with family members, and, above all, hope that the life of the patient may be improved. In all situations, supportive therapy involves the teaching of such life skills as managing medication, learning to socialize, handling finances, and getting a job.",,,,,,Supportive Care,,,,,,,,,,,,,,,,,,,,,,,,,"Therapy, Supportive|Supportive Care|supportive care|Supportive Therapy|Symptom Management",,,,,,,,,,,,,NCIT:C15747,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000096,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32297723,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C147067,,,,,,,,,,Supportive Care,Supportive_Care,,,,,,,,,,,,,,,,,,Supportive Care,,,,Therapeutic or Preventive Procedure,,,,,,,,C0344211,
http://purl.obolibrary.org/obo/GO_0061572,actin filament bundle organization,actin filament cable organization,"A process that results in the assembly, arrangement of constituent parts, or disassembly of an actin filament bundle.",false,,,http://purl.obolibrary.org/obo/GO_0007015,,,,,,,,,,,,,,,,dph,2013-08-02T11:24:11Z,,,,"A process that results in the assembly, arrangement of constituent parts, or disassembly of an actin filament bundle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,actin filament cable organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007015,,,,GO:0061572,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061572,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,actin filament bundle organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000025848,type I interferon,interferon type I|IFN type I,"A protein that consists solely of an Interferon alpha/beta domain (Pfam:PF00143) and which binds to a specific cell surface receptor complex known as the IFN-alpha receptor (IFNAR), a heterodimer of IFNAR1 and IFNAR2 chains.|Category=family.",false,,,http://purl.obolibrary.org/obo/NCIT_C20493,,,,,,,,,,,,,,,,,,,,,"A protein that consists solely of an Interferon alpha/beta domain (Pfam:PF00143) and which binds to a specific cell surface receptor complex known as the IFN-alpha receptor (IFNAR), a heterodimer of IFNAR1 and IFNAR2 chains.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,interferon type I|IFN type I,,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=family.,,http://purl.obolibrary.org/obo/NCIT_C20493,,,,PR:000025848,,,,,,,true,,true,,http://biorxiv.org/lookup/doi/10.1101/2020.03.07.982264,,,,PR:000025848,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,type I interferon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019061,uncoating of virus,viral uncoating,The process by which an incoming virus is disassembled in the host cell to release a replication-competent viral genome.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,The process by which an incoming virus is disassembled in the host cell to release a replication-competent viral genome.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral uncoating,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019061,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,GO:0019061,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,uncoating of virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000235,macrophage,histiocyte,"A mononuclear phagocyte present in variety of tissues, typically differentiated from monocytes, capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells.|Morphology: Diameter 30_M-80 _M, abundant cytoplasm, low N/C ratio, eccentric nucleus. Irregular shape with pseudopods, highly adhesive. Contain vacuoles and phagosomes, may contain azurophilic granules; markers: Mouse & Human: CD68, in most cases CD11b. Mouse: in most cases F4/80+; role or process: immune, antigen presentation, & tissue remodelling; lineage: hematopoietic, myeloid.",false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,,,,,,,,,,BTO:0000801|CALOHA:TS-0587|FMA:83585|FMA:63261,"A mononuclear phagocyte present in variety of tissues, typically differentiated from monocytes, capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,histiocyte,,,,,cell,,,,,,,,CL:0000235,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Morphology: Diameter 30_M-80 _M, abundant cytoplasm, low N/C ratio, eccentric nucleus. Irregular shape with pseudopods, highly adhesive. Contain vacuoles and phagosomes, may contain azurophilic granules; markers: Mouse & Human: CD68, in most cases CD11b. Mouse: in most cases F4/80+; role or process: immune, antigen presentation, & tissue remodelling; lineage: hematopoietic, myeloid.",,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,macrophage,,,,,,,,,,,,,,,,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010389,regulation of G2/M transition of mitotic cell cycle,regulation of mitotic entry,Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the mitotic cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_1902749|http://purl.obolibrary.org/obo/GO_1901990,,,,,,,,,,,,,,,,,,,,,Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the mitotic cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of mitotic entry,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1902749|http://purl.obolibrary.org/obo/GO_1901990,,,,GO:0010389,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010389,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of G2/M transition of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030496,midbody,,"A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Midbody_(cell_biology),"A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030496,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030496,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,midbody,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016572,histone phosphorylation,,The modification of histones by addition of phosphate groups.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The modification of histones by addition of phosphate groups.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0016572,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016572,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,histone phosphorylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032177,Parenchymal consolidation,,"Consolidation refers to an exudate or other product of disease that replaces alveolar air, rendering the lung solid (as in infective pneumonia).|In radiographs and CT scans, consolidation appears as a homogeneous increase in pulmonary parenchymal attenuation that obscures the margins of vessels and airway walls (See Figure 19 of PMID:18195376). An air bronchogram may be present. The attenuation characteristics of consolidated lung are only rarely helpful in differential diagnosis (eg, decreased attenuation in lipoid pneumonia and increased in amiodarone toxicity).",false,,,http://purl.obolibrary.org/obo/HP_0031983,,,,,,,,,,,,,,,,peter,,,,,"Consolidation refers to an exudate or other product of disease that replaces alveolar air, rendering the lung solid (as in infective pneumonia).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0032177,,,,,,,,,,,,,,,,,,2019-01-06T11:25:27Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"In radiographs and CT scans, consolidation appears as a homogeneous increase in pulmonary parenchymal attenuation that obscures the margins of vessels and airway walls (See Figure 19 of PMID:18195376). An air bronchogram may be present. The attenuation characteristics of consolidated lung are only rarely helpful in differential diagnosis (eg, decreased attenuation in lipoid pneumonia and increased in amiodarone toxicity).",,http://purl.obolibrary.org/obo/HP_0031983,,,,,,,,,,,,,,,,,pulmonary parenchymal consolidation,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Parenchymal consolidation,,,,,,,,,,,,,,,,,,,,,,https://www.ajronline.org/doi/full/10.2214/AJR.20.22975,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010965,regulation of mitotic sister chromatid separation,,"Any process that modulates the frequency, rate or extent of mitotic sister chromatid separation. Mitotic sister chromatid separation is the process in which sister chromatids are physically detached from each other during mitosis.",false,,,http://purl.obolibrary.org/obo/GO_0033047|http://purl.obolibrary.org/obo/GO_1905818,,,,,,,,,,,,,,,,tanyaberardini,2009-05-20T11:39:07Z,,,,"Any process that modulates the frequency, rate or extent of mitotic sister chromatid separation. Mitotic sister chromatid separation is the process in which sister chromatids are physically detached from each other during mitosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033047|http://purl.obolibrary.org/obo/GO_1905818,,,,GO:0010965,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010965,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of mitotic sister chromatid separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002167,FABP4,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,ALBP|A-FABP|AFABP|aP2|HEL-S-104,,,,,,,8,,,,,,,,,,Ensembl:ENSG00000170323|HPRD:02698|MIM:600434|HGNC:3559|Vega:OTTHUMG00000164602,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"fatty acid binding protein 4, adipocyte",,8q21,,,,"GO_0001816 (EC: IEA); GO_0005215 (EC: IEA); GO_0005504 (EC: TAS, PMID: 2481498); GO_0005634 (EC: IEA); GO_0005737 (EC: IDA); GO_0005737 (EC: TAS, PMID: 16130169); GO_0005811 (EC: TAS); GO_0006469 (EC: IEA); GO_0019433 (EC: TAS); GO_0042632 (EC: IEA); GO_0044281 (EC: TAS); GO_0045892 (EC: IEA); GO_0050729 (EC: IEA); GO_0050872 (EC: IEA); GO_0050873 (EC: IEA); GO_0071285 (EC: IEA)",PMID: 1304913; 1648089; 2481498; 7784447; 8463311; 9070383; 9204877; 10318917; 12417276; 12477932; 15015141; 15168018; 15456755; 15489334; 15734831; 16130169; 16169070; 16313911; 16641093; 16750515; 16952017; 17322100; 17353931; 17396233; 17425064; 17428383; 17535427; 17553506; 17826730; 18024526; 18029348; 18051367; 18417367; 18421072; 18437151; 18535557; 18564921; 18657008; 18660489; 18710473; 18820256; 18835952; 18931100; 18996102; 19001529; 19115207; 19144635; 19181913; 19197257; 19368945; 19421706; 19573524; 19608978; 19615732; 19625659; 19842034; 19844814; 19911253; 19913121; 20009357; 20111020; 20156355; 20193950; 20231079; 20388924; 20413122; 20452069; 20579864; 20587710; 20628086; 20723896; 20870707; 21063874; 21073559; 21106915; 21159847; 21167393; 21176857; 21257725; 21376375; 21407103; 21421494; 21492859; 21552513; 21562251; 21600061; 21664182; 21720879; 21775757; 21900206; 21966368; 22102888; 22174896; 22188744; 22396741; 22476608; 22562362; 22584136; 22589738; 22617714; 22679309; 22706792; 22709426; 22717543; 22855337; 22918198; 23013043; 23052058; 23068962; 23139800; 23183502; 23183506; 23357154; 23372061; 23387955; 23391391; 23480783; 23525430; 23535730; 23598540; 23642261; 23805908; 23866022,,,,,,,,,,,,,,,,,,OGG:3000002167,,,,,,,,,,,,,,,,,,,"fatty acid binding protein 4, adipocyte",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FABP4,,,20140408,2167,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,FABP4,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0060541,respiratory system development,,The progression of the respiratory system over time from its formation to its mature structure. The respiratory system carries out respiratory gaseous exchange.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,dph,2009-04-10T08:55:42Z,,,,The progression of the respiratory system over time from its formation to its mature structure. The respiratory system carries out respiratory gaseous exchange.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0060541,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0060541,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila,,,,,,,,,,respiratory system development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000024939,interferon beta,IFNB,Category=family.,false,,,http://purl.obolibrary.org/obo/NCIT_C20493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IFNB,,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=family.,,http://purl.obolibrary.org/obo/NCIT_C20493,,,,PR:000024939,,,,,,true,true,,,,,A class of interferon elaborated by fibroblasts.,,,PR:000024939,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,interferon beta,,,,,,,,,,,,,,,,,,,,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.07.982264,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000827,ventricular tachycardia,V-tach|VT,"A tachycardia that is associated with the generation of improper electrical impulses within the ventricles, characterized by an electrocardiogram showing a rate of greater than 120 BPM and three or more wide QRS complexes in a row.",false,,,http://purl.obolibrary.org/obo/SYMP_0000529,,,,,,,,,,,,,,,,,,,,,"A tachycardia that is associated with the generation of improper electrical impulses within the ventricles, characterized by an electrocardiogram showing a rate of greater than 120 BPM and three or more wide QRS complexes in a row.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,V-tach|VT,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000529,,,,SYMP:0000827,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/3221830,,,,SYMP:0000827,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,ventricular tachycardia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249087,SARS coronavirus LC5,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249087,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus LC5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_240551,SARS coronavirus TWK,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:240551,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030055,cell-substrate junction,cell-matrix junction,A cell junction that forms a connection between a cell and the extracellular matrix.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,A cell junction that forms a connection between a cell and the extracellular matrix.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cell-matrix junction,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030055,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030055,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cell-substrate junction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000008480,RAE1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,dJ481F12.3|Mnrp41|dJ800J21.1|MRNP41|MIG14,,,,,,,20,,,,,,,,,,HGNC:9828|MIM:603343|HPRD:11939,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,ribonucleic acid export 1,,20q13.31,,,,"GO_0000278 (EC: TAS); GO_0003723 (EC: TAS, PMID: 9256445); GO_0005634 (EC: IDA); GO_0005635 (EC: TAS); GO_0005640 (EC: TAS, PMID: 9256445); GO_0005643 (EC: TAS, PMID: 10209021); GO_0005730 (EC: IDA); GO_0005737 (EC: IEA); GO_0005856 (EC: TAS, PMID: 9256445); GO_0005975 (EC: TAS); GO_0006406 (EC: TAS, PMID: 10209021); GO_0007077 (EC: TAS); GO_0008017 (EC: ISS, PMID: 15851029); GO_0008645 (EC: TAS); GO_0010827 (EC: TAS); GO_0015758 (EC: TAS); GO_0016032 (EC: TAS); GO_0019221 (EC: TAS); GO_0044281 (EC: TAS); GO_0055085 (EC: TAS); GO_0071407 (EC: IEA)",PMID: 8982867; 9256445; 9370289; 9918853; 10209021; 10601273; 10668806; 11352911; 11520456; 11780052; 11831386; 12228227; 12477932; 14702039; 15489334; 15629720; 15778465; 15851029; 16169070; 16196087; 16479161; 17172455; 18212744; 18832153; 19615732; 19738201; 19745842; 20016259; 20360068; 20498086; 20530257; 20946988; 21139048; 21145461; 21467841; 21799930; 21890473; 21906983; 21963094; 22118674; 22357847; 22505724; 22797925; 22939629; 23000965; 23028327; 23169621; 23444366; 23455922; 23667531; 24250222; 24255178,,,,,,,,,,,,,,,,,,OGG:3000008480,,,,,,,,,,,,,,,,,,,ribonucleic acid export 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,RAE1,,,20140408,8480,RP4-800J21.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,RAE1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0045259,proton-transporting ATP synthase complex,hydrogen-transporting ATP synthase complex|F1-F0 complex|hydrogen-translocating F-type ATPase complex|proton-transporting F-type ATPase complex,"A proton-transporting two-sector ATPase complex that catalyzes the phosphorylation of ADP to ATP during oxidative phosphorylation. The complex comprises a membrane sector (F0) that carries out proton transport and a cytoplasmic compartment sector (F1) that catalyzes ATP synthesis by a rotational mechanism; the extramembrane sector (containing 3 a and 3 b subunits) is connected via the d-subunit to the membrane sector by several smaller subunits. Within this complex, the g and e subunits and the 9-12 c subunits rotate by consecutive 120 degree angles and perform parts of ATP synthesis. This movement is driven by the hydrogen ion electrochemical potential gradient.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"A proton-transporting two-sector ATPase complex that catalyzes the phosphorylation of ADP to ATP during oxidative phosphorylation. The complex comprises a membrane sector (F0) that carries out proton transport and a cytoplasmic compartment sector (F1) that catalyzes ATP synthesis by a rotational mechanism; the extramembrane sector (containing 3 a and 3 b subunits) is connected via the d-subunit to the membrane sector by several smaller subunits. Within this complex, the g and e subunits and the 9-12 c subunits rotate by consecutive 120 degree angles and perform parts of ATP synthesis. This movement is driven by the hydrogen ion electrochemical potential gradient.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045255,,,,hydrogen-transporting ATP synthase complex|F1-F0 complex|hydrogen-translocating F-type ATPase complex,,,,,cellular_component,,proton-transporting F-type ATPase complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0045259,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045259,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,proton-transporting ATP synthase complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C25305,Medical Examination,Examination|Medical Inspection|Medical Exam|Medical Examination|Exam|Medical Assessment,"An appraisal or evaluation of a patient's condition by a clinician that is based on a physical exam, medical history, and the patient's account of symptoms.",false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,C25305,,,CTRP,,,,,,,"An appraisal or evaluation of a patient's condition by a clinician that is based on a physical exam, medical history, and the patient's account of symptoms.",,,,,,Medical Examination,,,,,,,,,,,,,,,,,,,,,,,,,Examination|Medical Inspection|Medical Exam|Medical Examination|Exam|Medical Assessment,,,,,,,,,,,,,NCIT:C25305,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977,,,,,,,,,,Medical Examination,Examination,General examination and investigation of persons without complaint and reported diagnosis|Encounter for general adult medical examination without abnormal findings|Examination for normal comparison and control in clinical research programme|Routine child health examination,,,,,,,,,,,,,,,,,Medical Examination,,,https://emedicine.medscape.com/article/2500114-clinical,Diagnostic Procedure,,,,,,,,C0582103,
https://bio.scai.fraunhofer.de/ontology/COVID_0000067,convalescent plasma,,,false,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32186952/,"Convalescent plasma is the term used for plasma that is removed from the blood of a person who has recovered from a disease, then transfused into a patient still battling it.",,,,,,,,,,,,,,,,convalescent plasma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267389,SARS coronavirus Sin3725V,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267389,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin3725V,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_11247,disseminated intravascular coagulation,Defibrination syndrome|Diffuse or disseminated intravascular coagulation|DIC,,false,,,http://purl.obolibrary.org/obo/DOID_2452,,,,,,,,,,,,,,,,,,,,MESH:D004211|ICD9CM:286.6|UMLS_CUI:C0012739|SNOMEDCT_US_2019_09_01:67406007|ICD10CM:D65|NCI:C2992,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Defibrination syndrome|Diffuse or disseminated intravascular coagulation|DIC,,,,,disease_ontology,,,,,,,,,"Disseminated intravascular coagulation is characterized by the widespread activation of coagulation, which results in the intravascular formation of fibrin and ultimately thrombotic occlusion of small and midsize vessels.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_2452,,,,DOID:11247,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/|https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,DOID:11247,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,disseminated intravascular coagulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000406,COVID model,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The 'COVID model' concept enables a compilation of diverse concepts that are related to biological models used in Covid-19 related research via the Axiome 'isModelFor some COIVID-19'.  Thus enables the adaptation of the ontology for text mining purposes for Covid-19 related information retrieval and information extraction.,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0018573,"T-Lymphocytopenia, Idiopathic CD4-Positive",,,false,,,http://purl.obolibrary.org/obo/DOID_74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0018573,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_74,,,,,,,,,,true,true,,,,,"Reproducible depletion of CD4+ lymphocytes below 300 per cubic millimeter in the absence of HIV infection or other known causes of immunodeficiency. This is a rare, heterogeneous syndrome and does not appear to be caused by a transmissible agent.",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,"T-Lymphocytopenia, Idiopathic CD4-Positive",,,,,,,,,,,,,,,,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0004921,subdivision of digestive tract,alimentary system subdivision|subdivision of alimentary system|segment of intestinal tract|intestinal tract,A proximal-distal subdivision of the digestive tract.,false,,,http://purl.obolibrary.org/obo/UBERON_0013522,,,,,,,,,,,,,,,,,,,intended to denote both embryonic and adult structures. Note the FMA grouping here is not quite correct.,FBbt:00100315|FMA:71131,A proximal-distal subdivision of the digestive tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,alimentary system subdivision|subdivision of alimentary system|segment of intestinal tract|intestinal tract,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0013522,,,,UBERON:0004921,,,,,,,,,,,,,,,UBERON:0004921,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,subdivision of digestive tract,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039672,suppression by virus of host natural killer cell activation,suppression by virus of host NK-cell activation,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of natural killer cell activation in the host.",false,,,http://purl.obolibrary.org/obo/GO_0039671|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-09-25T11:08:19Z,,,,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of natural killer cell activation in the host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,suppression by virus of host NK-cell activation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039671|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039672,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32203188,,,,GO:0039672,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host natural killer cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075509,endocytosis involved in viral entry into host cell,virus endocytosis by host|viral penetration via endocytosis followed by endosome disruption|viral entry into host cell via endocytosis,Any endocytosis that is involved in the uptake of a virus into a host cell.,false,,,http://purl.obolibrary.org/obo/GO_0046794|http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,janelomax,2011-07-27T11:06:34Z,,,VZ:977,Any endocytosis that is involved in the uptake of a virus into a host cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,virus endocytosis by host|viral penetration via endocytosis followed by endosome disruption,,,,,biological_process,,viral entry into host cell via endocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046794|http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0075509,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/18227861,,,,GO:0075509,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endocytosis involved in viral entry into host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005774,vacuolar membrane,,The lipid bilayer surrounding the vacuole and separating its contents from the cytoplasm of the cell.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The lipid bilayer surrounding the vacuole and separating its contents from the cytoplasm of the cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005774,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005774,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,vacuolar membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264380,SARS coronavirus TW-GD3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264380,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-GD3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0022627,cytosolic small ribosomal subunit,40S ribosomal subunit|30S ribosomal subunit|prokaryotic small ribosomal subunit|eukaryotic ribosomal SSU,The small subunit of a ribosome located in the cytosol.,false,,,http://purl.obolibrary.org/obo/GO_0015935,,,,,,,,,,,,,,,,,,,,,The small subunit of a ribosome located in the cytosol.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030873|GO:0005843|GO:0009283|GO:0030499,,,,,,,40S ribosomal subunit|30S ribosomal subunit|prokaryotic small ribosomal subunit|eukaryotic ribosomal SSU,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0015935,,,,GO:0022627,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0022627,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytosolic small ribosomal subunit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000041,hemorrhage,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,SYMP:0000041,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/|https://www.ncbi.nlm.nih.gov/pubmed/32222466,Hemorrhage is an acute loss of blood from a damaged blood vessel.,,,SYMP:0000041,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,hemorrhage,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1415852,Bat SARS-like coronavirus WIV1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1415852,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS-like coronavirus WIV1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_37296,Human gammaherpesvirus 8,KSHV|HHV8|Kaposi's sarcoma-associated herpesvirus|Kaposi's sarcoma herpesvirus|Karposi's sarcoma-associated herpes-like virus|Kaposi's sarcoma-associated herpesvirus - Human herpesvirus 8|Human herpesvirus 8 type P|Kaposi's sarcoma-associated herpes-like virus|Human herpesvirus 8,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10379,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:435896,KSHV|HHV8,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Kaposi's sarcoma-associated herpesvirus|Kaposi's sarcoma herpesvirus|Karposi's sarcoma-associated herpes-like virus|Kaposi's sarcoma-associated herpesvirus - Human herpesvirus 8|Human herpesvirus 8 type P|Kaposi's sarcoma-associated herpes-like virus|Human herpesvirus 8,,,,,,NCBITaxon:37296,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10379,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human gammaherpesvirus 8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000004869,NPM1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,B23|NPM,,,,,,,5,,,,,,,,,,MIM:164040|HGNC:7910|HPRD:01246|Ensembl:ENSG00000181163|Vega:OTTHUMG00000130465,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",,5q35.1,,,,"GO_0003713 (EC: IDA, PMID: 15087454); GO_0003723 (EC: IDA, PMID: 12058066); GO_0004860 (EC: IDA, PMID: 12882984); GO_0005515 (EC: IPI, PMID: 12080348); GO_0005634 (EC: IDA); GO_0005634 (EC: ISS); GO_0005654 (EC: IDA, PMID: 12058066); GO_0005654 (EC: TAS); GO_0005730 (EC: IDA); GO_0005737 (EC: IDA, PMID: 9121481); GO_0005737 (EC: ISS); GO_0005813 (EC: IDA, PMID: 11051553); GO_0005813 (EC: ISS); GO_0005829 (EC: TAS); GO_0006281 (EC: IDA, PMID: 19188445); GO_0006334 (EC: IDA, PMID: 11602260); GO_0006334 (EC: TAS); GO_0006886 (EC: TAS, PMID: 12080348); GO_0006913 (EC: IDA, PMID: 16041368); GO_0006913 (EC: TAS, PMID: 12080348); GO_0006950 (EC: IMP, PMID: 12080348); GO_0007098 (EC: IMP, PMID: 11051553); GO_0007098 (EC: ISS); GO_0007165 (EC: NAS, PMID: 16130169); GO_0007569 (EC: IMP, PMID: 12080348); GO_0007569 (EC: ISS); GO_0008104 (EC: IDA, PMID: 18420587); GO_0008285 (EC: IMP, PMID: 12080348); GO_0008285 (EC: ISS); GO_0010826 (EC: IMP, PMID: 16041368); GO_0016032 (EC: TAS); GO_0019901 (EC: IPI); GO_0030529 (EC: IDA, PMID: 18809582); GO_0030957 (EC: IDA, PMID: 9094689); GO_0031616 (EC: IDA, PMID: 16041368); GO_0032071 (EC: IDA, PMID: 19188445); GO_0034080 (EC: TAS); GO_0042255 (EC: TAS, PMID: 12080348); GO_0042393 (EC: IDA, PMID: 11602260); GO_0042803 (EC: IDA, PMID: 9121481); GO_0043023 (EC: IDA, PMID: 18809582); GO_0043024 (EC: IDA, PMID: 18809582); GO_0043066 (EC: IDA, PMID: 12882984); GO_0043066 (EC: NAS, PMID: 16130169); GO_0044387 (EC: IDA, PMID: 12882984); GO_0044822 (EC: IDA); GO_0045727 (EC: IDA, PMID: 12882984); GO_0046599 (EC: IMP); GO_0046982 (EC: IMP, PMID: 12080348); GO_0051059 (EC: IDA, PMID: 15087454); GO_0051059 (EC: ISS); GO_0051082 (EC: IDA, PMID: 10211837); GO_0051082 (EC: ISS); GO_0051092 (EC: IMP, PMID: 15087454); GO_0051259 (EC: IDA, PMID: 18809582); GO_0060699 (EC: IDA, PMID: 19188445); GO_0060735 (EC: IDA, PMID: 12882984)",PMID: 2017166; 2109912; 2404140; 2429957; 2478125; 2602120; 2713355; 2775293; 3944116; 7542384; 7593322; 7628555; 7794916; 7821789; 7826206; 8089149; 8122112; 8224012; 8471164; 8562957; 8570204; 8620867; 8633037; 8778315; 9092633; 9092824; 9094689; 9121481; 9150888; 9150948; 9548374; 9642267; 9763551; 9819383; 10211837; 10503877; 11051553; 11215285; 11278991; 11420665; 11602260; 11790298; 11812799; 11888936; 12031912; 12039952; 12057857; 12058066; 12080348; 12209603; 12374805; 12429849; 12450141; 12477932; 12511551; 12748172; 12777385; 12882984; 14506644; 14519847; 14559993; 14563642; 14636574; 14656879; 14730621; 14759373; 14968112; 15047060; 15082766; 15087454; 15144954; 15161933; 15184379; 15190079; 15310764; 15342556; 15456888; 15489334; 15514966; 15576338; 15589822; 15615785; 15635413; 15644315; 15659725; 15665273; 15684379; 15772089; 15831697; 15848144; 15870172; 15872011; 15944709; 15964625; 15973451; 15989956; 15994285; 16041368; 16046528; 16076867; 16107701; 16130169; 16170350; 16196087; 16205118; 16293633; 16354571; 16376875; 16376884; 16415342; 16455950; 16455956; 16522924; 16541144; 16547420; 16565220; 16574551; 16622419; 16645213; 16648475; 16678898; 16679321; 16709933; 16720834; 16725311; 16740634; 16766651; 16825495; 16835382; 16855788; 16857742; 16870548; 16912078; 16916647; 16926303; 16957780; 17076533; 17081983; 17147251; 17151698; 17215513; 17277230; 17306368; 17315018; 17318229; 17353931; 17361185; 17410190; 17438371; 17440048; 17475909; 17488663; 17504301; 17535915; 17537995; 17546053; 17549383; 17569113; 17597811; 17598835; 17602943; 17616680; 17620599; 17637812; 17637816; 17639390; 17674968; 17690253; 17690700; 17715399; 17768124; 17875528; 17877154; 17879352; 17920239; 17922009; 17943167; 17951246; 17957027; 17968318; 17972951; 17990177; 17998938; 18029348; 18037965; 18059485; 18081718; 18162579; 18165222; 18172692; 18180033; 18192111; 18200037; 18212063; 18214681; 18259216; 18261272; 18268276; 18273044; 18298902; 18308931; 18316603; 18319061; 18332108; 18367491; 18371977; 18420587; 18448670; 18454140; 18478020; 18511415; 18559874; 18590714; 18596743; 18603563; 18639523; 18641025; 18726096; 18729828; 18775548; 18809582; 18845790; 18850631; 18931307; 18948745; 18951898; 18954305; 19005479; 19015314; 19020547; 19052985; 19055671; 19059939; 19066330; 19103589; 19131589; 19149558; 19151774; 19160485; 19188445; 19221506; 19242062; 19279329; 19286999; 19287380; 19289604; 19309322; 19339032; 19351769; 19365794; 19369962; 19379554; 19410544; 19410545; 19423729; 19429869; 19454010; 19471022; 19484332; 19522705; 19531656; 19535344; 19536888; 19540590; 19557552; 19569254; 19581289; 19587375; 19596686; 19637342; 19638589; 19642896; 19672946; 19679565; 19679658; 19694479; 19710015; 19725029; 19734942; 19738201; 19770764; 19775300; 19805454; 19824900; 19843866; 19865112; 19887368; 19901261; 19928837; 19946338; 19965647; 20001230; 20011973; 20020773; 20023256; 20026798; 20027629; 20073075; 20080577; 20127469; 20137111; 20145123; 20164180; 20172040; 20203266; 20212148; 20237420; 20306250; 20308430; 20308691; 20333249; 20338617; 20352051; 20368469; 20368538; 20393185; 20404347; 20424160; 20428199; 20431927; 20439648; 20460684; 20462248; 20464055; 20471513; 20473970; 20494930; 20506166; 20508983; 20513120; 20515654; 20520634; 20533335; 20542566; 20546020; 20554525; 20592250; 20606168; 20616361; 20618440; 20634376; 20651067; 20673208; 20678218; 20684989; 20713446; 20713529; 20724983; 20802533; 20803351; 20807181; 20849383; 20855646; 20858903; 20864535; 20872983; 20875872; 20877721; 20880116; 20924036; 20962268; 20979630; 20981679; 21030560; 21030982; 21045017; 21081666; 21084279; 21102525; 21110914; 21122805; 21139048; 21145461; 21173125; 21182205; 21182834; 21183700; 21233837; 21245151; 21245599; 21258971; 21278791; 21282530; 21310483; 21316727; 21331074; 21338238; 21385873; 21393327; 21418451; 21425800; 21441929; 21492127; 21516736; 21518927; 21537333; 21537492; 21555683; 21577323; 21606167; 21621842; 21660047; 21666141; 21689627; 21693764; 21703420; 21705779; 21719597; 21744003; 21763502; 21765024; 21784052; 21789382; 21809990; 21822216; 21832049; 21852383; 21853274; 21860418; 21875946; 21880628; 21890473; 21904378; 21906983; 21933585; 21963094; 21979956; 21986840; 21987572; 21988832; 22002061; 22099964; 22104247; 22113938; 22126574; 22174271; 22174317; 22178446; 22193965; 22268729; 22337638; 22362118; 22362753; 22374696; 22397365; 22451695; 22454318; 22467873; 22475129; 22481022; 22487825; 22494415; 22505724; 22528486; 22561347; 22573554; 22586326; 22592607; 22623428; 22631075; 22665062; 22707729; 22717133; 22733614; 22745010; 22761710; 22791379; 22810585; 22833565; 22851180; 22863883; 22906848; 22911473; 22914610; 22926011; 22939629; 22968966; 22996295; 23000965; 23019224; 23020761; 23027902; 23039052; 23064464; 23065518; 23154527; 23182705; 23183427; 23232117; 23238897; 23246001; 23271972; 23285058; 23301224; 23328624; 23338972; 23377436; 23393136; 23398456; 23402259; 23403313; 23435463; 23436734; 23438482; 23455922; 23463506; 23483572; 23489260; 23496932; 23511494; 23536448; 23544830; 23590662; 23591014; 23601747; 23618861; 23656730; 23666693; 23704090; 23730215; 23742937; 23814019; 23874639; 23877794; 23907410; 23929838; 24183235; 24244333; 24250222,,,,,,,,,,,,,,,,,,OGG:3000004869,,,,,,,,,,,,,,,,,,,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,NPM1,,,20140408,4869,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,NPM1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0071600,otic vesicle morphogenesis,,The process in which the anatomical structures of the otic vesicle are generated and organized. The otic vesicle is a transient embryonic structure formed during development of the vertebrate inner ear.,false,,,http://purl.obolibrary.org/obo/GO_0042472,,,,,,,,,,,,,,,,midori,2010-02-04T04:07:27Z,,,,The process in which the anatomical structures of the otic vesicle are generated and organized. The otic vesicle is a transient embryonic structure formed during development of the vertebrate inner ear.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0042472,,,,GO:0071600,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0071600,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,otic vesicle morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_135890,pralmorelin,pralmorelin HCl|pralmorelin dihydrochloride|GHRP|pralmorelin hydrochloride|KP-102D|KP-102|GHRP-2,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:158861-67-7|Drug_Central:2232,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,pralmorelin HCl|pralmorelin dihydrochloride|GHRP|pralmorelin hydrochloride|KP-102D|KP-102|GHRP-2,,,,,,,,,0,C45H55N9O6,"InChI=1S/C45H55N9O6/c1-27(47)41(56)52-38(24-30-19-20-31-14-6-7-15-32(31)22-30)43(58)50-28(2)42(57)53-39(25-33-26-49-35-17-9-8-16-34(33)35)45(60)54-37(23-29-12-4-3-5-13-29)44(59)51-36(40(48)55)18-10-11-21-46/h3-9,12-17,19-20,22,26-28,36-39,49H,10-11,18,21,23-25,46-47H2,1-2H3,(H2,48,55)(H,50,58)(H,51,59)(H,52,56)(H,53,57)(H,54,60)/t27-,28+,36+,37-,38-,39+/m1/s1",HRNLPPBUBKMZMT-RDRUQFPZSA-N,817.977,817.42753,C[C@@H](N)C(N[C@H](CC=1C=C2C(=CC1)C=CC=C2)C(N[C@@H](C)C(N[C@@H](CC3=CNC4=C3C=CC=C4)C(N[C@H](CC5=CC=CC=C5)C(N[C@@H](CCCCN)C(N)=O)=O)=O)=O)=O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:135890,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:135890,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,pralmorelin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C114983,Beclabuvir,"BECLABUVIR|(4bS,5aR)-12-Cyclohexyl-N-(dimethylsulfamoyl)-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-4b,5,5a,6-tetrahydrocyclopropa(d)indolo(2,1-a)(2)benzazepine-9-carboxamide|BMS-791325|Beclabuvir","A non-nucleoside, polymerase inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (NS5B), a RNA-dependent RNA polymerase, with potential activity against HCV. Upon administration and after intracellular uptake, beclabuvir allosterically binds to the non-catalytic Thumb 1 site of viral HCV NS5B polymerase and causes a decrease in viral RNA synthesis and replication. The HCV NS5B protein is essential for the replication of the viral HCV RNA genome. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,958002-33-0,,,,C114983,,,FDA,,,,,,,"A non-nucleoside, polymerase inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (NS5B), a RNA-dependent RNA polymerase, with potential activity against HCV. Upon administration and after intracellular uptake, beclabuvir allosterically binds to the non-catalytic Thumb 1 site of viral HCV NS5B polymerase and causes a decrease in viral RNA synthesis and replication. The HCV NS5B protein is essential for the replication of the viral HCV RNA genome. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.",,,,,,,,,,,,,,,,,MYW1X5CO9S,,,,,,,,,,,,,,"BECLABUVIR|(4bS,5aR)-12-Cyclohexyl-N-(dimethylsulfamoyl)-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-4b,5,5a,6-tetrahydrocyclopropa(d)indolo(2,1-a)(2)benzazepine-9-carboxamide|BMS-791325|Beclabuvir",,,,,,,,,,,,,NCIT:C114983,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Beclabuvir,,,,,,,,,,,,,,,,759585,759585,,Beclabuvir,,,,Pharmacologic Substance,,,,,,,,C3852614,
http://purl.obolibrary.org/obo/CHEBI_21241,vitamin C,Vitamin C|vitamina C|vitamine C|vitaminum C,,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,PMID:21885436,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Vitamin C,,,,,chebi_ontology,,vitamina C|vitamine C|vitaminum C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:21241,,,,,,true,,,,,,,,,CHEBI:21241,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,vitamin C,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035577,azurophil granule membrane,primary granule membrane,"The lipid bilayer surrounding an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.",false,,,http://purl.obolibrary.org/obo/GO_0005765|http://purl.obolibrary.org/obo/GO_0030667,,,,,,,,,,,,,,,,rfoulger,2010-10-05T01:29:10Z,,,,"The lipid bilayer surrounding an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,primary granule membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005765|http://purl.obolibrary.org/obo/GO_0030667,,,,GO:0035577,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035577,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,azurophil granule membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039634,killing by virus of host cell during superinfection exclusion,killing by virus of host cells during superinfection exclusion|killing by virus of host cells involved in superinfection exclusion|Rex exclusion,The viral-killing of a host cell by a pre-existing virus in response to a subsequent infection of the host cell by second virus.,false,,,http://purl.obolibrary.org/obo/GO_0039633,,,,,,,,,,,,,,,,rfoulger,2012-08-10T14:46:03Z,,,,The viral-killing of a host cell by a pre-existing virus in response to a subsequent infection of the host cell by second virus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,killing by virus of host cells during superinfection exclusion|killing by virus of host cells involved in superinfection exclusion,,,Rex exclusion,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039633,,,,GO:0039634,,,,,,true,,,,true,,,,,GO:0039634,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,killing by virus of host cell during superinfection exclusion,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0310/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1903050,regulation of proteolysis involved in cellular protein catabolic process,regulation of peptidolysis involved in cellular protein catabolism|regulation of peptidolysis involved in cellular protein catabolic process|regulation of peptidolysis during cellular protein catabolism|regulation of peptidolysis during cellular protein catabolic process|regulation of proteolysis during cellular protein catabolic process|regulation of proteolysis during cellular protein catabolism,"Any process that modulates the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.|overexpression of cathepsin C propeptide significantly increased the degradation of of intestinal alkaline phosphatase (IAP)",false,,,http://purl.obolibrary.org/obo/GO_1903362,,,,,,,,,,,,,,,,rl,2014-05-22T18:00:45Z,,,,"Any process that modulates the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of peptidolysis involved in cellular protein catabolism|regulation of peptidolysis involved in cellular protein catabolic process,,,,,biological_process,,regulation of peptidolysis during cellular protein catabolism|regulation of peptidolysis during cellular protein catabolic process|regulation of proteolysis during cellular protein catabolic process|regulation of proteolysis during cellular protein catabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,overexpression of cathepsin C propeptide significantly increased the degradation of of intestinal alkaline phosphatase (IAP),,http://purl.obolibrary.org/obo/GO_1903362,,,,GO:1903050,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903050,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of proteolysis involved in cellular protein catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016052,carbohydrate catabolic process,carbohydrate degradation|catabolic carbohydrate metabolism|catabolic carbohydrate metabolic process|carbohydrate catabolism|carbohydrate breakdown|multicellular organismal carbohydrate catabolic process|single-organism carbohydrate catabolic process,"The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,janelomax,2012-10-23T16:34:39Z,,,,"The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0044724|GO:0044276|GO:0006095,,,,carbohydrate degradation|catabolic carbohydrate metabolism|catabolic carbohydrate metabolic process|carbohydrate catabolism|carbohydrate breakdown,,,multicellular organismal carbohydrate catabolic process,,biological_process,,single-organism carbohydrate catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0016052,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016052,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,carbohydrate catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_101381,aloxistatin,"ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate|Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate|aloxistatin|aloxistatina|E 64d|E64d|aloxistatinum|Loxistatin|aloxistatine|E-64d","An L-leucine derivative that is the amide obtained by formal condensation of the carboxy group of (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylic acid with the amino group of N-(3-methylbutyl)-L-leucinamide.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:5354546|PMID:26388830|Beilstein:5354546|CAS:88321-09-9,"An L-leucine derivative that is the amide obtained by formal condensation of the carboxy group of (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylic acid with the amino group of N-(3-methylbutyl)-L-leucinamide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate",,,,,chebi_ontology,,"Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate|aloxistatin|aloxistatina|E 64d|E64d|aloxistatinum|Loxistatin|aloxistatine|E-64d",,,,,,,,,0,C17H30N2O5,"InChI=1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1",SRVFFFJZQVENJC-IHRRRGAJSA-N,342.431,342.21547,O1[C@@H]([C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C)C(=O)OCC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:101381,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142650,,,,CHEBI:101381,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,aloxistatin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_68556,icatibant,"(2S)-2-({[(2S,3aS,7aS)-1-({(3R)-2-[(2S)-2-{[(2S)-2-[2-({[(2S,4R)-1-({(2S)-1-[(2S)-2-{[(2R)-2-amino-5-carbamimidamidopentanoyl]amino}-5-carbamimidamidopentanoyl]pyrrolidin-2-yl}carbonyl)-4-hydroxypyrrolidin-2-yl]carbonyl}amino)acetamido]-3-(thiophen-2-yl)propanoyl]amino}-3-hydroxypropanoyl]-1,2,3,4-tetrahydroisoquinolin-3-yl}carbonyl)octahydro-1H-indol-2-yl]carbonyl}amino)-5-carbamimidamidopentanoic acid|icatibant|H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH|D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2alpha,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl-L-arginine|icatibantum|icatibanto","A ten-membered synthetic oligopeptide consisting of D-Arg, Arg, Pro, Hyp, Gly, Thi, Ser, D-Tic, Oic, and Arg residues joined in sequrence. A bradykinin receptor antagonist used as its acetate salt for the treatment of acute attacks of hereditary angioedema in adult patients.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22577920|PMID:22904641|CAS:130308-48-4|PMID:22691903|PMID:22584193|PMID:22797560|PMID:22522852|PMID:21959973|PMID:22830287|PMID:22686628|PMID:22970904|PMID:22507340|DrugBank:DB06196|PMID:22386830|Wikipedia:Icatibant|PMID:22577166|PMID:22936825|PMID:22434085|PMID:22958093|PMID:22142018|PMID:22552531|PMID:22435954|Reaxys:8185933|PMID:22519593,"A ten-membered synthetic oligopeptide consisting of D-Arg, Arg, Pro, Hyp, Gly, Thi, Ser, D-Tic, Oic, and Arg residues joined in sequrence. A bradykinin receptor antagonist used as its acetate salt for the treatment of acute attacks of hereditary angioedema in adult patients.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(2S)-2-({[(2S,3aS,7aS)-1-({(3R)-2-[(2S)-2-{[(2S)-2-[2-({[(2S,4R)-1-({(2S)-1-[(2S)-2-{[(2R)-2-amino-5-carbamimidamidopentanoyl]amino}-5-carbamimidamidopentanoyl]pyrrolidin-2-yl}carbonyl)-4-hydroxypyrrolidin-2-yl]carbonyl}amino)acetamido]-3-(thiophen-2-yl)propanoyl]amino}-3-hydroxypropanoyl]-1,2,3,4-tetrahydroisoquinolin-3-yl}carbonyl)octahydro-1H-indol-2-yl]carbonyl}amino)-5-carbamimidamidopentanoic acid",,,,,chebi_ontology,,"icatibant|H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH|D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2alpha,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl-L-arginine|icatibantum|icatibanto",,,,,,,,,0,C59H89N19O13S,"InChI=1S/C59H89N19O13S/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,35+,37+,38-,39-,40-,41-,42-,43-,44-,45-,46+/m0/s1",QURWXBZNHXJZBE-SKXRKSCCSA-N,1304.526,1303.66080,N1(C([C@@H](NC([C@@H](CCCNC(=N)N)N)=O)CCCNC(N)=N)=O)[C@@H](CCC1)C(N2C[C@@H](C[C@H]2C(NCC(N[C@H](C(N[C@H](C(N3CC=4C(C[C@@H]3C(N5[C@@H](C[C@]6([C@@]5(CCCC6)[H])[H])C(N[C@H](C(O)=O)CCCNC(N)=N)=O)=O)=CC=CC4)=O)CO)=O)CC7=CC=CS7)=O)=O)O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:68556,,,,,true,true,,,,,,,,,CHEBI:68556,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,icatibant,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1905818,regulation of chromosome separation,regulation of rDNA separation|regulation of chromatid release,"Any process that modulates the frequency, rate or extent of chromosome separation.",false,,,http://purl.obolibrary.org/obo/GO_0051983,,,,,,,,,,,,,,,,bmeldal,2017-01-13T13:55:18Z,,,,"Any process that modulates the frequency, rate or extent of chromosome separation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of rDNA separation,,biological_process,,regulation of chromatid release,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051983,,,,GO:1905818,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1905818,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of chromosome separation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0008544,epidermis development,hypodermis development,"The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,hypodermis development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0008544,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0008544,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,epidermis development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000059272,ACE2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,ACEH,,,,,,,X,,,,,,,,,,HGNC:13557|Ensembl:ENSG00000130234|Vega:OTTHUMG00000021177|MIM:300335|HPRD:02274,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,angiotensin I converting enzyme 2,,Xp22,,,,"GO_0001618 (EC: IDA, PMID: 18343844); GO_0001817 (EC: IC, PMID: 15380922); GO_0001948 (EC: IPI, PMID: 18343844); GO_0002003 (EC: TAS); GO_0002005 (EC: IC, PMID: 10924499); GO_0003051 (EC: IMP, PMID: 18258853); GO_0003081 (EC: IC, PMID: 10924499); GO_0003081 (EC: IMP, PMID: 18258853); GO_0004175 (EC: IDA, PMID: 15283675); GO_0004180 (EC: IDA, PMID: 10924499); GO_0005576 (EC: IDA, PMID: 10969042); GO_0005615 (EC: IDA, PMID: 18258853); GO_0005886 (EC: TAS); GO_0008237 (EC: IDA, Qualifier: NOT, PMID: 10924499); GO_0008241 (EC: IDA, Qualifier: NOT, PMID: 10924499); GO_0008270 (EC: TAS, PMID: 10924499); GO_0009615 (EC: IDA, PMID: 18343844); GO_0009986 (EC: IDA, PMID: 18343844); GO_0016021 (EC: IEA); GO_0017046 (EC: IEA); GO_0019229 (EC: IC, PMID: 15380922); GO_0032800 (EC: IMP, PMID: 18258853); GO_0042127 (EC: TAS, PMID: 17703127); GO_0042312 (EC: IC, PMID: 15380922); GO_0044267 (EC: TAS); GO_0045121 (EC: TAS, PMID: 18279660); GO_0046718 (EC: TAS, PMID: 15165741); GO_0046813 (EC: IDA, PMID: 18343844); GO_0050727 (EC: IC, PMID: 15380922); GO_0070062 (EC: IDA, PMID: 19056867); GO_2000379 (EC: IC, PMID: 15380922)",PMID: 10924499; 10969042; 11815627; 12025971; 12075344; 12459472; 12477932; 12967627; 12975309; 14647384; 14670965; 14754895; 15084671; 15141377; 15151696; 15165741; 15231706; 15233982; 15276642; 15283675; 15361769; 15380922; 15452268; 15489334; 15640278; 15671045; 15769906; 15791205; 15897467; 15937940; 15979045; 15983030; 16001071; 16006956; 16055515; 16088128; 16166094; 16166518; 16211375; 16215952; 16283142; 16315782; 16338465; 16459167; 16510163; 16574921; 16647014; 16690935; 16866021; 16912312; 16962475; 17037534; 17037543; 17037544; 17037581; 17079315; 17303661; 17473847; 17504232; 17703127; 17897017; 17906677; 18022600; 18029348; 18070603; 18164957; 18208662; 18223023; 18223027; 18223028; 18258853; 18279660; 18310257; 18343844; 18389211; 18441099; 18448527; 18490652; 18496132; 18502721; 18554741; 18560893; 18660448; 18753062; 18814896; 18926157; 18931070; 19020433; 19021774; 19034303; 19051693; 19056867; 19067252; 19077419; 19077694; 19136547; 19141296; 19164471; 19164480; 19212105; 19286756; 19286757; 19289653; 19297479; 19411314; 19461648; 19684612; 19700132; 19716087; 19864379; 19901337; 19913121; 19924243; 19926873; 19934006; 20060185; 20117248; 20117991; 20134095; 20142028; 20160196; 20204277; 20224560; 20349406; 20484496; 20541774; 20559404; 20592051; 20628086; 20660625; 20674894; 20679547; 20692300; 20703229; 20798044; 20813695; 20831027; 20854388; 21052031; 21068237; 21072744; 21115782; 21189404; 21265092; 21316680; 21346373; 21411533; 21457402; 21490025; 21670585; 21814048; 21864606; 21880865; 21946695; 21952934; 21963832; 21993363; 22025374; 22033511; 22048948; 22179088; 22291007; 22297693; 22475818; 22523556; 22629438; 22647782; 22718567; 22749485; 22750422; 23091417; 23144053; 23230080; 23328447; 23545945; 23630610; 23893738; 24014829; 24100303; 24147777; 24172901; 24191856; 24227843,,,,,,,,,,,,,,,,,,OGG:3000059272,,,,,,,,,,,,,,,,,,,angiotensin I converting enzyme 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167153,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ACE2,,,20140408,59272,UNQ868/PRO1885,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,ACE2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_231514,SARS coronavirus SZ13,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231514,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SZ13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C80519,Biological Model,Biological Models|Model|Model System|Biological Model,"Systems designed to elucidate facts about complex biological phenomena, usually in a less complex or theoretical test environment.",false,,,http://purl.obolibrary.org/obo/NCIT_C16866,,,,,,,,,,,C80519,,,,,,,,,,"Systems designed to elucidate facts about complex biological phenomena, usually in a less complex or theoretical test environment.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Biological Models|Model|Model System|Biological Model,,,,,,,,,,,,,NCIT:C80519,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C16866,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Biological Model,Biological_Model,,,,,,,,,,,,,,,,,,Biological Model,,,,Intellectual Product,,,,,,,,C0026339,
http://purl.obolibrary.org/obo/GO_0045047,protein targeting to ER,protein-endoplasmic reticulum targeting|protein targeting to endoplasmic reticulum|protein-ER targeting,"The process of directing proteins towards the endoplasmic reticulum (ER) using signals contained within the protein. One common mechanism uses a 16- to 30-residue signal sequence, typically located at the N-terminus of the protein and containing positively charged amino acids followed by a continuous stretch of hydrophobic residues, which directs the ribosome to the ER membrane and initiates transport of the growing polypeptide across the ER membrane.",false,,,http://purl.obolibrary.org/obo/GO_0072599|http://purl.obolibrary.org/obo/GO_0006605,,,,,,,,,,,,,,,,,,,,,"The process of directing proteins towards the endoplasmic reticulum (ER) using signals contained within the protein. One common mechanism uses a 16- to 30-residue signal sequence, typically located at the N-terminus of the protein and containing positively charged amino acids followed by a continuous stretch of hydrophobic residues, which directs the ribosome to the ER membrane and initiates transport of the growing polypeptide across the ER membrane.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein-endoplasmic reticulum targeting|protein targeting to endoplasmic reticulum|protein-ER targeting,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072599|http://purl.obolibrary.org/obo/GO_0006605,,,,GO:0045047,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045047,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein targeting to ER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10376,Human gammaherpesvirus 4,EPV|HHV-4|Epstein-Barr virus|Epstein Barr virus|Epstein-Barr virus EBV|Human herpesvirus 4|Human herpesvirus type 4,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10375,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:47902,EPV|HHV-4,,,Epstein-Barr virus|Epstein Barr virus,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Epstein-Barr virus EBV|Human herpesvirus 4|Human herpesvirus type 4,,,,,,NCBITaxon:10376,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10375,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human gammaherpesvirus 4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000037,non-segmented viral genome,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165108/,A viral genome that consists of one continuous nucleic acid molecule.,,,,,,,,,,,,,,,,non-segmented viral genome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000624,"CD4-positive, alpha-beta T cell","CD4-positive, alpha-beta T lymphocyte|CD4-positive, alpha-beta T-cell|CD4-positive, alpha-beta T-lymphocyte",A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.,false,,,http://purl.obolibrary.org/obo/CL_0000791,,,,,,,,,,,,,,,,,,,,,A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"CD4-positive, alpha-beta T lymphocyte|CD4-positive, alpha-beta T-cell|CD4-positive, alpha-beta T-lymphocyte",,,,,cell,,,,,,,,CL:0000624,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000791,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,"CD4-positive, alpha-beta T cell",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006959,humoral immune response,,An immune response mediated through a body fluid.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Humoral_immunity,An immune response mediated through a body fluid.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0006959,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006959,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,humoral immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000003,occurrent,,,false,,,http://purl.obolibrary.org/obo/BFO_0000001,,,,,Occurrent,occurrent,,,,,,,,,,,,,,,,,,,,,,,"BFO 2 Reference: every occurrent that is not a temporal or spatiotemporal region is s-dependent on some independent continuant that is not a spatial region|BFO 2 Reference: s-dependence obtains between every process and its participants in the sense that, as a matter of necessity, this process could not have existed unless these or those participants existed also. A process may have a succession of participants at different phases of its unfolding. Thus there may be different players on the field at different times during the course of a football game; but the process which is the entire game s-depends_on all of these players nonetheless. Some temporal parts of this process will s-depend_on on only some of the players.|Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process.|Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame.",,,An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002]),,,,,,,,,,,(forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001] |(forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001] ,b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001])|Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001]),,,,,,,,,,,,,,,,,,,,,BFO:0000003,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000001,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,occurrent|occurrent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_6713,cerebrovascular disease,cerebrovascular disorder|stroke|cerebrovascular accident|Cerebrovascular accident|CVA,An vascular disease that is characterized by dysfunction of the blood vessels supplying the brain.|OMIM mapping confirmed by DO. [SN].,false,,,http://purl.obolibrary.org/obo/DOID_178|http://purl.obolibrary.org/obo/DOID_936,,,,,,,,,,,,,,,,,,,,ICD9CM:437.9|ICD10CM:I67.9|NCI:C2938|SNOMEDCT_US_2019_09_01:62914000|UMLS_CUI:C0007820|MESH:D002561|EFO:0000712,An vascular disease that is characterized by dysfunction of the blood vessels supplying the brain.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:12214|DOID:3455|DOID:8231,,,,cerebrovascular disorder|stroke|cerebrovascular accident|Cerebrovascular accident|CVA,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,OMIM mapping confirmed by DO. [SN].,,http://purl.obolibrary.org/obo/DOID_178|http://purl.obolibrary.org/obo/DOID_936,,,,DOID:6713,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,DOID:6713,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,cerebrovascular disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0006524,alveolar system,pulmonary alveolar system|bronchoalveolar system,System pertaining to a bronchus and alveoli.,false,,,http://purl.obolibrary.org/obo/UBERON_0011216|http://purl.obolibrary.org/obo/UBERON_0004119,,,,,,,,,,,,,,,,,,,,CALOHA:TS-1296|EMAPA:32692|MA:0000416|BTO:0000136,System pertaining to a bronchus and alveoli.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pulmonary alveolar system,,,,,uberon,,bronchoalveolar system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0011216|http://purl.obolibrary.org/obo/UBERON_0004119,,,,UBERON:0006524,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32189136/,,,,UBERON:0006524,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim,,,,,,,,,,alveolar system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048145,regulation of fibroblast proliferation,,"Any process that modulates the frequency, rate or extent of multiplication or reproduction of fibroblast cells.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of multiplication or reproduction of fibroblast cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0048145,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048145,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of fibroblast proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000004879,NPPB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,BNP,,,,,,,1,,,,,,,,,,MIM:600295|Vega:OTTHUMG00000002389|Ensembl:ENSG00000120937|HGNC:7940|HPRD:08974,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,natriuretic peptide B,,1p36.2,,,,"GO_0005102 (EC: IDA, PMID: 1672777); GO_0005102 (EC: IPI, PMID: 12727915); GO_0005179 (EC: NAS, PMID: 7601467); GO_0005576 (EC: TAS, PMID: 14960748); GO_0005615 (EC: NAS, PMID: 7601467); GO_0006182 (EC: IDA, PMID: 1672777); GO_0007166 (EC: NAS, PMID: 12727915); GO_0007168 (EC: IDA, PMID: 1672777); GO_0007589 (EC: TAS, PMID: 14960748); GO_0008217 (EC: NAS, PMID: 12727915); GO_0008613 (EC: TAS, PMID: 14960748); GO_0016525 (EC: TAS, PMID: 14737067); GO_0030308 (EC: NAS, PMID: 12727915); GO_0035810 (EC: TAS, PMID: 14737067); GO_0035815 (EC: TAS, PMID: 14960748); GO_0042312 (EC: NAS, PMID: 7601467); GO_0043114 (EC: TAS, PMID: 14737067); GO_0043234 (EC: IDA); GO_0050880 (EC: IEA)",PMID: 1309330; 1660465; 1672777; 2136732; 2138890; 2522777; 2597152; 7601467; 7901875; 8837222; 8890728; 9832489; 11120697; 11750283; 11999635; 12015190; 12084525; 12477932; 12601551; 12612980; 12727915; 12742987; 12771003; 12832317; 12861161; 12890912; 14645255; 14726474; 14737067; 14960748; 14967157; 15118286; 15277419; 15489334; 15525883; 15604421; 15616804; 15619076; 15644628; 15686715; 15689309; 15732251; 15735222; 15875778; 15911064; 15947264; 16037399; 16061439; 16117728; 16179421; 16185779; 16189514; 16203929; 16236896; 16236924; 16236931; 16293687; 16298451; 16338248; 16338261; 16338262; 16338263; 16338268; 16377932; 16386619; 16446217; 16495466; 16546444; 16594987; 16600203; 16624649; 16644347; 16648193; 16697117; 16710414; 16716660; 16722030; 16733597; 16733598; 16754798; 16801175; 16829184; 16831981; 16870210; 16875975; 16937127; 16940194; 16962475; 16962477; 17086116; 17097992; 17099013; 17112494; 17149558; 17175893; 17186137; 17289171; 17323015; 17340039; 17343213; 17365940; 17381357; 17412758; 17478552; 17482153; 17490778; 17517347; 17519779; 17554401; 17567649; 17607499; 17607502; 17643631; 17662495; 17669797; 17690842; 17719005; 17721754; 17785934; 17822384; 17855407; 17879024; 17881654; 17891611; 17899307; 17900714; 17901852; 17943627; 17959862; 17972161; 17996240; 18037101; 18037739; 18037753; 18049439; 18054808; 18055041; 18077013; 18160811; 18163013; 18177956; 18191909; 18194671; 18219371; 18243818; 18252905; 18255169; 18256871; 18258801; 18298592; 18309461; 18319268; 18322550; 18326895; 18328262; 18335382; 18347270; 18353715; 18353850; 18362234; 18374882; 18375252; 18378336; 18388105; 18394002; 18394456; 18418236; 18440296; 18443568; 18450924; 18484161; 18495276; 18513509; 18513528; 18528966; 18537757; 18562472; 18573197; 18602177; 18609042; 18609050; 18632168; 18632852; 18649054; 18649955; 18654020; 18660489; 18701924; 18703243; 18706401; 18712036; 18721456; 18728335; 18729306; 18759301; 18762474; 18774614; 18786480; 18789145; 18794210; 18816264; 18823968; 18824845; 18835219; 18855222; 18923244; 18948614; 18957868; 18971547; 18971552; 18971785; 19008326; 19032759; 19042041; 19077418; 19086053; 19103499; 19116708; 19127569; 19130415; 19155075; 19157602; 19157978; 19166616; 19168558; 19172697; 19183435; 19189316; 19194108; 19194564; 19210529; 19214022; 19219041; 19221295; 19237086; 19247872; 19262210; 19263527; 19275472; 19293713; 19298805; 19299763; 19322079; 19326473; 19327104; 19327608; 19329198; 19339274; 19356487; 19356514; 19356808; 19359532; 19359811; 19377085; 19386989; 19387249; 19387960; 19391062; 19394710; 19398076; 19407818; 19413180; 19424098; 19430483; 19444135; 19455566; 19477027; 19487972; 19492165; 19494782; 19497572; 19505208; 19523464; 19542490; 19546389; 19560452; 19568166; 19581836; 19584071; 19606057; 19615861; 19615987; 19635983; 19638709; 19642911; 19643359; 19653574; 19662018; 19667278; 19670155; 19685518; 19690080; 19708225; 19712988; 19719987; 19719993; 19729213; 19729800; 19740358; 19755761; 19808368; 19809305; 19815210; 19816874; 19830720; 19838110; 19843778; 19844734; 19845751; 19860001; 19897258; 19900726; 19913121; 19919978; 19920165; 19929142; 19929271; 19932518; 19944367; 19945451; 19968983; 20002300; 20023254; 20024643; 20034689; 20038279; 20051875; 20083731; 20087954; 20090534; 20102554; 20113292; 20140438; 20142019; 20142024; 20142028; 20142114; 20173383; 20187770; 20214692; 20216395; 20223915; 20228511; 20234137; 20346360; 20350538; 20364046; 20368210; 20370326; 20373129; 20378998; 20407391; 20441480; 20470220; 20470299; 20485180; 20492497; 20505308; 20505514; 20506274; 20507952; 20519808; 20528912; 20536328; 20539839; 20539843; 20553977; 20562693; 20575653; 20576043; 20576050; 20581772; 20598759; 20610233; 20628086; 20636229; 20655247; 20660094; 20674395; 20690091; 20700369; 20701470; 20709045; 20713912; 20726994; 20727348; 20729741; 20731986; 20804651; 20805692; 20807228; 20812386; 20829070; 20835904; 20846963; 20849244; 20883932; 20887619; 20930495; 20947817; 20956023; 20978564; 20979755; 21041973; 21067752; 21070664; 21086902; 21108561; 21110196; 21110214; 21111985; 21127887; 21131173; 21131684; 21152016; 21162718; 21173540; 21178638; 21188387; 21194766; 21199206; 21200085; 21214096; 21215559; 21217075; 21225672; 21234705; 21261781; 21273288; 21297144; 21304210; 21333352; 21343155; 21364112; 21367474; 21371160; 21376713; 21387129; 21394710; 21396728; 21397374; 21397962; 21413834; 21435188; 21450621; 21450626; 21464097; 21464227; 21470289; 21473725; 21480001; 21486579; 21498911; 21514286; 21516440; 21526421; 21538234; 21543459; 21558448; 21567460; 21584749; 21600847; 21604967; 21617607; 21620395; 21624043; 21629202; 21663466; 21689859; 21696613; 21697610; 21700090; 21701385; 21714421; 21763278; 21779816; 21792022; 21795086; 21798425; 21807382; 21807423; 21824924; 21838836; 21857933; 21858735; 21872142; 21884743; 21891968; 21892902; 21900689; 21909110; 21939835; 21952518; 21955499; 21955828; 21960417; 21993227; 22000971; 22018780; 22072300; 22087311; 22105112; 22113444; 22116811; 22137497; 22138041; 22143056; 22154198; 22160408; 22166506; 22209994; 22222353; 22234370; 22234513; 22242262; 22251274; 22286795; 22307842; 22310189; 22313067; 22316276; 22322531; 22325151; 22327025; 22349089; 22368903; 22374183; 22384001; 22386698; 22390472; 22396190; 22397400; 22412224; 22421508; 22439818; 22459392; 22459404; 22532404; 22536076; 22541282; 22543574; 22545649; 22546865; 22547689; 22581254; 22592287; 22608896; 22629130; 22645408; 22658561; 22664008; 22670496; 22676431; 22685586; 22691215; 22695938; 22740123; 22748606; 22753861; 22773432; 22785411; 22797925; 22825646; 22834778; 22841166; 22847152; 22878353; 22878801; 22914252; 22926410; 22938543; 22973461; 22989031; 22997250; 22998064; 23006812; 23012317; 23019395; 23033840; 23042311; 23047817; 23051933; 23058722; 23064562; 23071500; 23084819; 23114906; 23119023; 23132698; 23149248; 23152754; 23152884; 23183321; 23192919; 23217478; 23228375; 23289011; 23293174; 23315043; 23318845; 23341901; 23349346; 23357662; 23373852; 23377871; 23391507; 23422348; 23471272; 23477424; 23516493; 23518421; 23542086; 23552626; 23568644; 23574011; 23585345; 23602778; 23615024; 23639511; 23643288; 23645505; 23653297; 23656924; 23667500; 23668272; 23669527; 23725445; 23747879; 23789447; 23792241; 23801020; 23803318; 23831167; 23852911; 23876603; 23916937; 24015598; 24030529; 24036936; 24065415; 24186915; 24340744,,,,,,,,,,,,,,,,,,OGG:3000004879,,,,,,,,,,,,,,,,,,,natriuretic peptide B,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/3221830,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,NPPB,,,20140408,4879,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,NPPB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0000075,cell cycle checkpoint,G1/S transition checkpoint|G2/M transition checkpoint|G2/M checkpoint|G1/S checkpoint,"A cell cycle process that controls cell cycle progression by monitoring the integrity of specific cell cycle events. A cell cycle checkpoint begins with detection of deficiencies or defects and ends with signal transduction.|This term should not be used in direct manual annotation as it should always be possible to minimally designate mitotic or meiotic checkpoint, and usually to additionally specify the checkpoint (i.e mitotic spindle assembly checkpoint, mitotic DNA damage checkpoint etc). Note also that the effector processes are not part of the checkpoint but are positively regulated by the checkpoint signaling and should not be annotated here.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Cell_cycle_checkpoint,A cell cycle process that controls cell cycle progression by monitoring the integrity of specific cell cycle events. A cell cycle checkpoint begins with detection of deficiencies or defects and ends with signal transduction.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0071779|GO:0031576,,,,,,,G1/S transition checkpoint|G2/M transition checkpoint|G2/M checkpoint|G1/S checkpoint,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"This term should not be used in direct manual annotation as it should always be possible to minimally designate mitotic or meiotic checkpoint, and usually to additionally specify the checkpoint (i.e mitotic spindle assembly checkpoint, mitotic DNA damage checkpoint etc). Note also that the effector processes are not part of the checkpoint but are positively regulated by the checkpoint signaling and should not be annotated here.",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0000075,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000075,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_manually_annotate,,,,,,,,,,cell cycle checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MP_0010922,alveolitis,alveolus inflammation|alveolar inflammation,inflammation of the small sac-like dilations of the distal airspace of the lung; acute pulmonary alveolitis involves exudate into the pulmonary alveoli and impaired gas exchange,false,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,,,,,,csmith,2011-03-10T04:01:31Z,,,,inflammation of the small sac-like dilations of the distal airspace of the lung; acute pulmonary alveolitis involves exudate into the pulmonary alveoli and impaired gas exchange,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,alveolus inflammation|alveolar inflammation,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002086,,,,MP:0010922,,,,,,,,,,,,,,,MP:0010922,,http://purl.obolibrary.org/obo/mp.owl,,,,,,,,,,,alveolitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249089,SARS coronavirus HZS2-Bb,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249089,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HZS2-Bb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039526,modulation by virus of host apoptotic process,modulation of host cell apoptosis by virus|regulation by virus of host apoptosis|modulation by virus of host apoptosis,"Any process in which a virus modulates the frequency, rate or extent of apoptosis of infected host cells.",false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2011-06-22T05:22:53Z,,,VZ:1581,"Any process in which a virus modulates the frequency, rate or extent of apoptosis of infected host cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,modulation of host cell apoptosis by virus|regulation by virus of host apoptosis|modulation by virus of host apoptosis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039526,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226,,,,GO:0039526,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host apoptotic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034501,protein localization to kinetochore,protein localisation to kinetochore|condensin localization to kinetochore,"Any process in which a protein is transported to, or maintained at, the kinetochore.",false,,,http://purl.obolibrary.org/obo/GO_0034502,,,,,,,,,,,,,,,,,,,,,"Any process in which a protein is transported to, or maintained at, the kinetochore.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein localisation to kinetochore,,,condensin localization to kinetochore,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0034502,,,,GO:0034501,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034501,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein localization to kinetochore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000070,assay,,"A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.|A planned process with the objective to produce information about some evaluant",false,,,http://purl.obolibrary.org/obo/ERO_0000007,,,scientific observation|measuring,,,,,,,,,,,,,,,,,,"A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.|A planned process with the objective to produce information about some evaluant",,OBI branch derived,,,,,,"12/3/12: BP: the reference to the 'physical examination' is included to point out that a prediction is not an assay, as that does not require physical examiniation. ",assay,,,,Assay the wavelength of light emitted by excited Neon atoms. Count of geese flying over a house.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,OBI:0000070,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000007,,,,,,,,,,,,,,,,,,,,any method,http://purl.obolibrary.org/obo/obi.owl|http://purl.obolibrary.org/obo/ero.owl,,study assay,,,,,,,,,assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,PlanAndPlannedProcess Branch,,,,
http://purl.obolibrary.org/obo/OGG_2060009606,protein-coding gene of Homo sapiens,,A gene of Homo sapiens that has a protein-coding gene disposition,false,,,http://purl.obolibrary.org/obo/OGG_2000009606,,,,,,,,,,,,,,,,,,,,,A gene of Homo sapiens that has a protein-coding gene disposition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGG:2060009606,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2000009606,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,protein-coding gene of Homo sapiens,,,,,,,,,,,,,,,9606,,,,,,,,,,,,,"Bin Zhao, Oliver He",,,,
http://purl.obolibrary.org/obo/GO_0031589,cell-substrate adhesion,,The attachment of a cell to the underlying substrate via adhesion molecules.,false,,,http://purl.obolibrary.org/obo/GO_0007155,,,,,,,,,,,,,,,,,,,,,The attachment of a cell to the underlying substrate via adhesion molecules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007155,,,,GO:0031589,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031589,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cell-substrate adhesion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MONDO_0005570,hematologic disease,blood disease|hematological disease|hematologic disorder|hematopoietic disease|disease of the blood and blood-forming organs|hematologic and lymphocytic disorder|blood disorder|disorder of hematopoietic system|hematopoietic system disease|hematological disorder|hematopoietic system disease or disorder|disease of hematopoietic system|disease or disorder of hematopoietic system|blood dyscrasia|hematological system disease|blood dyscrasia NOS|disorder of hematopoietic system|hematological disorders and malignancies,A disease involving the hematopoietic system.|placeholder for lymphoid disease,false,,,http://purl.obolibrary.org/obo/DOID_74,,,,,,,,,,,,,,,,,,,,ICD9:289.9|MESH:D006402|DOID:74|ICD9:280-289.99|ICD10:D75.9|ICD9:289.8|UMLS:C0018939|EFO:0005803|SCTID:414022008|GTR:AN1320635|UMLS:CN882913|NCIT:C26323,A disease involving the hematopoietic system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood disease|hematological disease|hematologic disorder|hematopoietic disease|disease of the blood and blood-forming organs|hematologic and lymphocytic disorder|blood disorder|disorder of hematopoietic system|hematopoietic system disease|hematological disorder|hematopoietic system disease or disorder|disease of hematopoietic system|disease or disorder of hematopoietic system|blood dyscrasia|hematological system disease,,,,,,,blood dyscrasia NOS|disorder of hematopoietic system|hematological disorders and malignancies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,placeholder for lymphoid disease,,http://purl.obolibrary.org/obo/DOID_74,,http://identifiers.org/snomedct/267573000|http://identifiers.org/snomedct/34093004|http://identifiers.org/snomedct/191402006|http://identifiers.org/snomedct/191446003|http://identifiers.org/snomedct/154842002|http://identifiers.org/snomedct/191124002|http://identifiers.org/snomedct/154785002|http://identifiers.org/snomedct/267552000,http://linkedlifedata.com/resource/umls/id/CN882913|http://purl.obolibrary.org/obo/DOID_74|http://identifiers.org/snomedct/414022008|http://identifiers.org/mesh/D006402|http://linkedlifedata.com/resource/umls/id/C0018939|http://purl.obolibrary.org/obo/NCIT_C26323,MONDO:0005570,,,,,,,,,,,,,,,MONDO:0005570,,http://purl.obolibrary.org/obo/mondo.owl,,,,,,,,,,,hematologic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019068,virion assembly,virus particle assembly|viral particle assembly|virion organization|virus assembly|virion assembly and maintenance|viral assembly|phage assembly|bacteriophage assembly,A late phase of the viral life cycle during which all the components necessary for the formation of a mature virion collect at a particular site in the cell and the basic structure of the virus particle is formed.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,A late phase of the viral life cycle during which all the components necessary for the formation of a mature virion collect at a particular site in the cell and the basic structure of the virus particle is formed.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042963,,,,virus particle assembly|viral particle assembly|virion organization|virus assembly|virion assembly and maintenance|viral assembly,,,phage assembly|bacteriophage assembly,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019068,,,,,,,,true,,true,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,GO:0019068,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,virion assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_63115,fingolimod,"2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol|FTY720|fingolimod|fingolimodum","An aminodiol that consists of propane-1,3-diol having amino and 2-(4-octylphenyl)ethyl substituents at the 2-position. It is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis. A prodrug, fingolimod is phosphorylated by sphingosine kinase to active metabolite fingolimod-phosphate, a structural analogue of sphingosine 1-phosphate.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23531349|PMID:23211038|PMID:21669553|Wikipedia:Fingolimod|Reaxys:7811195|PMID:23261767|PMID:21790210|PMID:21045201|PMID:23167788|PMID:21280229|PMID:17203219|PMID:23518370|Drug_Central:4167|DrugBank:DB08868|PMID:21045200|PMID:21789537|PMID:16571654|PMID:21652609|PMID:21459808|PMID:23508350|KEGG:D10001|PMID:23073075|PMID:21955849|PMID:23223539|PMID:21425262|PMID:21906625|PMID:21456524|PMID:11888913|PMID:23471662|CAS:162359-55-9|PMID:23183172|PMID:21838759|PMID:23541049|PMID:21845450|PMID:21394595|PMID:19940275,"An aminodiol that consists of propane-1,3-diol having amino and 2-(4-octylphenyl)ethyl substituents at the 2-position. It is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis. A prodrug, fingolimod is phosphorylated by sphingosine kinase to active metabolite fingolimod-phosphate, a structural analogue of sphingosine 1-phosphate.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol",,,,,chebi_ontology,,FTY720|fingolimod|fingolimodum,,,,,,,,,0,C19H33NO2,"InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3",KKGQTZUTZRNORY-UHFFFAOYSA-N,307.47080,307.25113,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:63115,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138156/,,,,CHEBI:63115,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,fingolimod,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_11396,pulmonary edema,,,false,,,http://purl.obolibrary.org/obo/DOID_11162,,,,,,,,,,,,,,,,,,,,ICD10CM:J81|SNOMEDCT_US_2019_09_01:19242006|UMLS_CUI:C0034063|NCI:C26868|MESH:D011654,,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:13472,,,,,,,,,disease_ontology,,,,,,,,,Pulmonary edema is a respiratory failure characterized by an abnormal accumulation of fluid in the lungs.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_11162,,,,DOID:11396,,modified definition,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32189136/,,,,DOID:11396,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,pulmonary edema,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/SYMP_0019151,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_2000758,positive regulation of peptidyl-lysine acetylation,,"Any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,yaf,2011-06-16T09:51:35Z,,,,"Any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:2000758,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:2000758,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of peptidyl-lysine acetylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_389167,Bat CoV 279/2005,Bat coronavirus (BtCoV/279/2005),,false,,,http://purl.obolibrary.org/obo/NCBITaxon_347536,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat coronavirus (BtCoV/279/2005),,,,,,NCBITaxon:389167,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_347536,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat CoV 279/2005,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/TRANS_0000001,direct,,"Direct transmission is a transmission process that is the means during which the pathogen is transmitted immediately from a reservoir, source or host to another host.",false,,,http://purl.obolibrary.org/obo/TRANS_0000000,,,,,,,,,,,,,,,,,,,,,"Direct transmission is a transmission process that is the means during which the pathogen is transmitted immediately from a reservoir, source or host to another host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,transmission_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/TRANS_0000000,,,,TRANS:0000001,,,,,,,,,,,,,,,TRANS:0000001,,http://purl.obolibrary.org/obo/trans.owl,,,,,,,,,,,direct,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0008037,cell recognition,recognition of surroundings by cell,The process in which a cell in an organism interprets its surroundings.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The process in which a cell in an organism interprets its surroundings.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,recognition of surroundings by cell,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0008037,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0008037,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,cell recognition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_7742,Vertebrata <vertebrates>,vertebrates|Vertebrata|vertebrates,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2759,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,vertebrates|Vertebrata,,,,,ncbi_taxonomy,,vertebrates,,,,,,NCBITaxon:7742,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2759,,,,,,,,,,,,,,,,"Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.",,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Vertebrata <vertebrates>,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC2,spike glycoprotein (SARS-CoV-2),surface glycoprotein (SARS2)|S (SARS2)|peplomer protein (SARS2)|S glycoprotein (SARS2)|E2 (SARS2)|GU280_gp02|S,A protein that is a translation product of the S gene in SARS-CoV-2.|Category=organism-gene. Note: 1273 aa protein. Undergoes additional processing by proteolytic cleavage.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,UniProtKB:P0DTC2|GenPept:YP_009724390,A protein that is a translation product of the S gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,surface glycoprotein (SARS2)|S (SARS2)|peplomer protein (SARS2)|S glycoprotein (SARS2)|E2 (SARS2),,,,,protein,,GU280_gp02|S,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 1273 aa protein. Undergoes additional processing by proteolytic cleavage.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC2,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,PR:P0DTC2,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,spike glycoprotein (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_417,autoimmune hypersensitivity disease,autoimmune disease|hypersensitivity reaction type II disease,An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.|Xref MGI.,false,,,http://purl.obolibrary.org/obo/DOID_0060056,,,,,,,,,,,,,,,,,,,,OMIM:109100|UMLS_CUI:C0003089|ICD9CM:720,An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,autoimmune disease|hypersensitivity reaction type II disease,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Xref MGI.,,http://purl.obolibrary.org/obo/DOID_0060056,,,,DOID:417,,,,,,,,,,,,,,,DOID:417,autoimmune disease,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,autoimmune hypersensitivity disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009897,external side of plasma membrane,juxtamembrane|external leaflet of plasma membrane|outer surface of cytoplasmic membrane,The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.,,,,,,,,,,,,,,,,,,,,,,,,,,,,juxtamembrane,,,external leaflet of plasma membrane|outer surface of cytoplasmic membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0009897,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009897,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,external side of plasma membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000119,nose nerve ending cell damage,,,false,,,http://purl.obolibrary.org/obo/HP_0004408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Damage to the terminal branches of the ophthalmic and maxillary divisions of the trigeminal nerve of nose.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0004408,,,,,,modified definition,,phenotypic abnormality,,true,,,,,https://pubmed.ncbi.nlm.nih.gov/32116984/,,,,,,,,,,,,,,,,,nose nerve ending cell damage,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019724,B cell mediated immunity,B-cell mediated immune effector process|B-lymphocyte mediated immune effector process|B-lymphocyte mediated immunity|B-cell mediated immunity|B lymphocyte mediated immunity|B lymphocyte mediated immune effector process,"Any process involved with the carrying out of an immune response by a B cell, through, for instance, the production of antibodies or cytokines, or antigen presentation to T cells.",false,,,http://purl.obolibrary.org/obo/GO_0002460|http://purl.obolibrary.org/obo/GO_0002449,,,,,,,,,,,,,,,,,,,,,"Any process involved with the carrying out of an immune response by a B cell, through, for instance, the production of antibodies or cytokines, or antigen presentation to T cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B-cell mediated immune effector process|B-lymphocyte mediated immune effector process|B-lymphocyte mediated immunity|B-cell mediated immunity|B lymphocyte mediated immunity|B lymphocyte mediated immune effector process,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002460|http://purl.obolibrary.org/obo/GO_0002449,,,,GO:0019724,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019724,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,B cell mediated immunity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039599,cleavage by virus of host mRNA,host mRNA cleavage by viral endoribonuclease|viral endoribonuclease activity involved in degradation of host mRNA,Any process in which a host pre-mRNA or mRNA molecule is cleaved at specific sites or in a regulated manner by a viral endoribonuclease.,false,,,http://purl.obolibrary.org/obo/GO_0019048,,,,,,,,,,,,,,,,rfoulger,2012-07-04T05:09:08Z,,,,Any process in which a host pre-mRNA or mRNA molecule is cleaved at specific sites or in a regulated manner by a viral endoribonuclease.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,host mRNA cleavage by viral endoribonuclease,,,,,biological_process,,viral endoribonuclease activity involved in degradation of host mRNA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019048,,,,GO:0039599,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/27712623,,,,GO:0039599,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cleavage by virus of host mRNA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_35620,vasodilator agent,vasodilator|vasodilator agents,A drug used to cause dilation of the blood vessels.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,A drug used to cause dilation of the blood vessels.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,vasodilator|vasodilator agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:35620,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32220710,,,,CHEBI:35620,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,vasodilator agent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_2000514,"regulation of CD4-positive, alpha-beta T cell activation",,"Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.",false,,,http://purl.obolibrary.org/obo/GO_0046634,,,,,,,,,,,,,,,,ebc,2011-03-22T10:36:56Z,,,,"Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046634,,,,GO:2000514,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:2000514,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"regulation of CD4-positive, alpha-beta T cell activation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_367163,darunavir,"Darunavir|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate|darunavirum|TMC114|N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE|(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|darunavir|(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|{(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester","An N,N-disubstituted benzenesulfonamide bearing an unsubstituted amino group at the 4-position, used for the treatment of HIV infection. A second-generation HIV protease inhibitor, darunavir was designed to form robust interactions with the protease  enzyme from many strains of HIV, including those from treatment-experienced patients with multiple resistance mutations to other protease inhibitors.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Wikipedia:Darunavir|PDBeChem:017|KEGG:D03656|DrugBank:DB01264|CAS:206361-99-1|Drug_Central:4143|Reaxys:7960555|PMID:16480273|PMID:25017682|Beilstein:7960555|PMID:15771427,"An N,N-disubstituted benzenesulfonamide bearing an unsubstituted amino group at the 4-position, used for the treatment of HIV infection. A second-generation HIV protease inhibitor, darunavir was designed to form robust interactions with the protease  enzyme from many strains of HIV, including those from treatment-experienced patients with multiple resistance mutations to other protease inhibitors.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:39487|CHEBI:589942,,,,"Darunavir|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate",,,,,chebi_ontology,,"darunavirum|TMC114|N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE|(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|darunavir|(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|{(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester",,,,,,,,,0,C27H37N3O7S,"InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1",CJBJHOAVZSMMDJ-HEXNFIEUSA-N,547.66400,547.23522,[H][C@]12OCC[C@@]1([H])[C@H](CO2)OC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)C)S(=O)(=O)c1ccc(N)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:367163,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32297571,,,,CHEBI:367163,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,darunavir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000776,kinetochore,,"A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules.|Note that the kinetochore overlaps the centromeric DNA, but centromeric DNA is not part of the kinetochore.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Kinetochore,A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005699,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that the kinetochore overlaps the centromeric DNA, but centromeric DNA is not part of the kinetochore.",,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0000776,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000776,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,kinetochore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000048,lumen stenosis,,,false,,,http://purl.obolibrary.org/obo/HP_0001871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001871,,,,,Modified definition,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,"Narrowing of the lumen, the inside diameter of a blood vessel or hollow organ.",,,,,,,,,,,,,,,,lumen stenosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046629,gamma-delta T cell activation,gamma-delta T-lymphocyte activation|gamma-delta T-cell activation|gamma-delta T lymphocyte activation,"The change in morphology and behavior of a gamma-delta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",false,,,http://purl.obolibrary.org/obo/GO_0042110,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of a gamma-delta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,gamma-delta T-lymphocyte activation|gamma-delta T-cell activation|gamma-delta T lymphocyte activation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0042110,,,,GO:0046629,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046629,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,gamma-delta T cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_240273,SARS coronavirus ZMY 1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:240273,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ZMY 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_32146,sodium hypochlorite,"sodium hypochlorite|Hypochlorous acid, sodium salt|Sodium oxychloride|NaClO|NaOCl|Hypochlorite sodium",An inorganic sodium salt in which hypochlorite is the counterion.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D01711|PMID:23355285|PMID:23011474|CAS:7681-52-9|PMID:24701613|PMID:19707590|PMID:24331991|PMID:24554854|PMID:24308707|PMID:24862721|PMID:24417739|PMID:23892500|PMID:23710836|Wikipedia:Sodium_hypochlorite|PMID:23701220|PMID:24784510|Reaxys:11342986|PPDB:1493|PMID:24554863|PMID:24717113,An inorganic sodium salt in which hypochlorite is the counterion.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,sodium hypochlorite,,,,,chebi_ontology,,"Hypochlorous acid, sodium salt|Sodium oxychloride|NaClO|NaOCl|Hypochlorite sodium",,,,,,,,,0,ClNaO,InChI=1S/ClO.Na/c1-2;/q-1;+1,SUKJFIGYRHOWBL-UHFFFAOYSA-N,74.44200,73.95354,[Na+].[O-]Cl,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:32146,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,,,CHEBI:32146,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,sodium hypochlorite,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002113,Pulmonary infiltrates,Pulmonic infiltration|Lung infiltrates,,false,,,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,,,,,UMLS:C0235896,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pulmonic infiltration|Lung infiltrates,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002088,,,,HP:0002113,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217650/,"An infiltrate is the filling of airspaces with fluid (pulmonary oedema), inflammatory exudates (white cells or pus, protein and immunological substances), or cells (malignant cells, red cells or haemorrhage) that fill a region of lung and increase the visual impression of increased soft tissue density.",,,HP:0002113,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Pulmonary infiltrates,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039554,suppression by virus of host MDA-5 activity,Inhibition of host MDA5 by virus|inhibition of host IFIH1/MDA5 by virus,"Any process in which a virus stops, prevents, or reduces the activity of MDA-5 (also known as IFIH1). The cytoplasmic pattern recognition receptor MDA-5 detects dsRNA synthesized during active viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.",false,,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048,,,,,,,,,,,,,,,,rfoulger,2012-03-09T03:03:49Z,,,VZ:603,"Any process in which a virus stops, prevents, or reduces the activity of MDA-5 (also known as IFIH1). The cytoplasmic pattern recognition receptor MDA-5 detects dsRNA synthesized during active viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Inhibition of host MDA5 by virus,,,,,biological_process,,inhibition of host IFIH1/MDA5 by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048,,,,GO:0039554,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/24509444,,,,GO:0039554,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host MDA-5 activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_119486,efavirenz,"(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one|Efavirenz|(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE|(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one|(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one|6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one","1,4-Dihydro-2H-3,1-benzoxazin-2-one substituted at the 4 position by cyclopropylethynyl and trifluoromethyl groups (S configuration) and at the 6 position by chlorine. A non-nucleoside reverse transcriptase inhibitor with activity against HIV, it is used with other antiretrovirals for combination therapy of HIV infection.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,DrugBank:DB00625|PMID:10673109|Wikipedia:Efavirenz|HMDB:HMDB0014763|PDBeChem:EFZ|Patent:US5519021|Beilstein:7387333|Reaxys:7387333|PMID:25017682|PMID:10576692|KEGG:D00896|KEGG:C08088|LINCS:LSM-5526|Drug_Central:989|Patent:EP582455|CAS:154598-52-4,"1,4-Dihydro-2H-3,1-benzoxazin-2-one substituted at the 4 position by cyclopropylethynyl and trifluoromethyl groups (S configuration) and at the 6 position by chlorine. A non-nucleoside reverse transcriptase inhibitor with activity against HIV, it is used with other antiretrovirals for combination therapy of HIV infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:190461|CHEBI:47396|CHEBI:4760,,,,"(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one|Efavirenz",,,,,chebi_ontology,,"(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE|(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one|(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one|6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one",,,,,,,,,0,C14H9ClF3NO2,"InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1",XPOQHMRABVBWPR-ZDUSSCGKSA-N,315.67500,315.02739,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:119486,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:119486,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,efavirenz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030038,contractile actin filament bundle assembly,,Assembly of actin filament bundles in which the filaments are loosely packed (approximately 30-60 nm apart) and arranged with opposing polarities; the loose packing allows myosin (usually myosin-II) to enter the bundle.,false,,,http://purl.obolibrary.org/obo/GO_0051017,,,,,,,,,,,,,,,,,,,,,Assembly of actin filament bundles in which the filaments are loosely packed (approximately 30-60 nm apart) and arranged with opposing polarities; the loose packing allows myosin (usually myosin-II) to enter the bundle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051017,,,,GO:0030038,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030038,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,contractile actin filament bundle assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000134,"cytokine dysregulation
",,,false,,,http://purl.obolibrary.org/obo/HP_0002715,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002715,,,,,Modified defintion,,,,,true,,,,,https://www.ncbi.nlm.nih.gov/pubmed/16166805, Cytokine dysregulation is characterized by a dysregulation of the pro- versus anti-inflammatory and T helper (Th)1 versus Th2 cytokine balance.,,,,,,,,,,,,,,,,"cytokine dysregulation
",,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_18,urinary system disease,urinary tract disease|Non-neoplastic urinary tract disease,"A disease of anatomical entity that is located_in kidney, ureter, bladder and urethra.",false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C1335051|NCI:C27599,"A disease of anatomical entity that is located_in kidney, ureter, bladder and urethra.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:579,,,,urinary tract disease|Non-neoplastic urinary tract disease,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:18,,,,,,,,,,,,,,,DOID:18,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,urinary system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010948,negative regulation of cell cycle process,,"Any process that decreases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,tanyaberardini,2009-04-27T09:53:22Z,,,,"Any process that decreases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0010948,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010948,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of cell cycle process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000916,CD3E,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IMD18|TCRE|T3E,,,,,,,11,,,,,,,,,,Ensembl:ENSG00000198851|HPRD:08923|HGNC:1674|MIM:186830|Vega:OTTHUMG00000166968,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"CD3e molecule, epsilon (CD3-TCR complex)",,11q23,,,,"GO_0001772 (EC: IEA); GO_0002669 (EC: IEA); GO_0004888 (EC: NAS, PMID: 9485181); GO_0005057 (EC: TAS, PMID: 1370449); GO_0005515 (EC: IPI, PMID: 11855827); GO_0005886 (EC: IDA, PMID: 11390434); GO_0005886 (EC: TAS); GO_0005887 (EC: NAS, PMID: 9485181); GO_0006461 (EC: NAS, PMID: 9886373); GO_0007166 (EC: NAS, PMID: 12110186); GO_0007169 (EC: TAS, PMID: 8530500); GO_0007172 (EC: TAS, PMID: 8490660); GO_0007186 (EC: TAS, PMID: 8530500); GO_0007584 (EC: IEA); GO_0009897 (EC: IDA, PMID: 11390434); GO_0017124 (EC: IPI, PMID: 12110186); GO_0019901 (EC: NAS, PMID: 12110186); GO_0030159 (EC: NAS, PMID: 9886373); GO_0031295 (EC: TAS); GO_0032729 (EC: IEA); GO_0032753 (EC: IEA); GO_0035556 (EC: TAS, PMID: 1370449); GO_0042101 (EC: IDA, PMID: 8176201); GO_0042101 (EC: NAS, PMID: 9485181); GO_0042102 (EC: IMP, PMID: 12110186); GO_0042105 (EC: IEA); GO_0042110 (EC: NAS, PMID: 12110186); GO_0042608 (EC: NAS, PMID: 11186279); GO_0042981 (EC: NAS, PMID: 12567487); GO_0045060 (EC: IEA); GO_0045086 (EC: IEA); GO_0045879 (EC: IEA); GO_0046641 (EC: IEA); GO_0046982 (EC: IPI, PMID: 9485181); GO_0050731 (EC: IEA); GO_0050776 (EC: TAS); GO_0050850 (EC: IEA); GO_0050852 (EC: TAS); GO_0097190 (EC: IEA)",PMID: 1370449; 1385321; 1387664; 1671006; 1832084; 1979339; 2111780; 2138083; 2859526; 3012357; 3267235; 3478717; 7499176; 7500045; 7506554; 7514106; 7517794; 7539755; 7541024; 7699329; 7761456; 7774645; 8125527; 8145026; 8176201; 8366117; 8490660; 8530500; 8621646; 8626450; 8809126; 8906806; 8920877; 9045614; 9120393; 9263011; 9312149; 9378960; 9485181; 9510190; 9582308; 9687533; 9698567; 9743208; 9780176; 9886373; 10373416; 10722370; 11048639; 11115514; 11186279; 11349123; 11390434; 11439187; 11689561; 11827988; 11855827; 12110186; 12410792; 12477932; 12499387; 12522270; 12567487; 12626537; 12734335; 12812314; 14523017; 14757743; 15123239; 15144186; 15342556; 15489334; 15489916; 15534202; 15546002; 15592455; 16094384; 16308105; 16412509; 16461343; 16777597; 17001685; 17023417; 17176095; 17213291; 17507663; 17630354; 17632570; 17652306; 17668204; 17928336; 18473783; 18504423; 18541215; 18555270; 18555888; 18667496; 18808677; 19190244; 19616027; 19724882; 19726522; 19759518; 19913121; 20012528; 20179761; 20237496; 20478055; 20594957; 20628086; 20824090; 21203507; 21669053; 21669059; 21980389; 22401598; 22505724; 22911005; 23166358; 23216707,,,,,,,,,,,,,,,,,,OGG:3000000916,,,,,,,,,,,,,,,,,,,"CD3e molecule, epsilon (CD3-TCR complex)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD3E,,,20140408,916,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CD3E,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000002495,FTH1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PIG15|FHC|PLIF|FTH|HFE5|FTHL6,,,,,,,11,,,,,,,,,,Ensembl:ENSG00000167996|Vega:OTTHUMG00000166217|HPRD:00615|HGNC:3976|MIM:134770,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"ferritin, heavy polypeptide 1",,11q13,,,,"GO_0004322 (EC: IEA); GO_0005506 (EC: TAS, PMID: 3020541); GO_0005515 (EC: IPI, PMID: 16169070); GO_0005829 (EC: TAS); GO_0006826 (EC: IEA); GO_0006879 (EC: TAS); GO_0006880 (EC: IDA, PMID: 9924025); GO_0006892 (EC: TAS); GO_0006955 (EC: ISS); GO_0008043 (EC: TAS, PMID: 6589621); GO_0008199 (EC: IEA); GO_0008285 (EC: ISS); GO_0048147 (EC: IDA, PMID: 9924025); GO_0055085 (EC: TAS); GO_0061024 (EC: TAS); GO_0070062 (EC: IDA, PMID: 19056867)",PMID: 659425; 1992356; 3003694; 3020541; 3023856; 3685996; 3840162; 3857215; 3858810; 6323167; 6589621; 6653779; 7504084; 7616228; 7821789; 7916709; 7931301; 8630420; 8889548; 8915895; 9159481; 9581019; 9924025; 10833524; 10855793; 11031247; 11252894; 11389486; 11591653; 11783942; 11821435; 11903046; 11964300; 11988076; 12387819; 12435735; 12477932; 14615048; 14702039; 14998975; 15123426; 15302935; 15388255; 15489334; 15604093; 15607035; 15727900; 15755449; 15967798; 16169070; 16189514; 16964243; 16969126; 17070541; 17081983; 17116749; 17702748; 17761032; 17970701; 18160403; 18621011; 18985028; 19023418; 19056867; 19126685; 19471022; 19539693; 19821764; 19855093; 19910193; 20088381; 20110920; 20133674; 20195357; 20360068; 20390345; 20705053; 20877624; 20936779; 21029774; 21139048; 21385903; 21413929; 21555518; 21573799; 21674799; 21800051; 21829377; 21890473; 21988832; 22020807; 22043922; 22117997; 22212821; 22426960; 22443280; 22675492; 22676252; 22760008; 22768652; 22779921; 22843505; 22863883; 22939629; 23079089; 23079850; 23119080; 23324584; 23344859; 23463506; 23602568; 23611361,,,,,,,,,,,,,,,,,,OGG:3000002495,,,,,,,,,,,,,,,,,,,"ferritin, heavy polypeptide 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,Ferritin,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FTH1,,,20140408,2495,OK/SW-cl.84,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,FTH1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000005133,PDCD1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,hPD-1|CD279|SLEB2|PD1|hSLE1|PD-1|hPD-l,,,,,,,2,,,,,,,,,,HGNC:8760|Ensembl:ENSG00000188389|Vega:OTTHUMG00000151342|HPRD:02590|MIM:600244,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,programmed cell death 1,,2q37.3,,,,"GO_0004871 (EC: TAS, PMID: 1396582); GO_0005515 (EC: IPI); GO_0005886 (EC: TAS); GO_0006915 (EC: IEA); GO_0006959 (EC: TAS, PMID: 9332365); GO_0007165 (EC: TAS, PMID: 1396582); GO_0007275 (EC: TAS, PMID: 9332365); GO_0009897 (EC: IEA); GO_0016021 (EC: IEA); GO_0031295 (EC: TAS)",PMID: 1396582; 7851902; 9141617; 9332365; 9843982; 9843983; 10677248; 10677315; 11224527; 12095712; 12402038; 12477932; 12517932; 12719480; 12893276; 14617032; 14730631; 15022318; 15188352; 15322919; 15334473; 15352422; 15818672; 15883854; 15912506; 15934088; 15959535; 16171790; 16227604; 16265694; 16278812; 16471222; 16493037; 16917489; 16921384; 16954372; 16956940; 16988698; 17002900; 17024563; 17064404; 17130567; 17136123; 17203303; 17228327; 17272504; 17311651; 17344889; 17468813; 17490403; 17535987; 17567698; 17570250; 17603844; 17610472; 17641065; 17721918; 17868872; 17885290; 17942371; 17963598; 17968013; 17999073; 18037500; 18041714; 18042085; 18056444; 18067228; 18069935; 18096476; 18160439; 18171281; 18173375; 18174230; 18203952; 18250483; 18294387; 18322304; 18337305; 18401354; 18440040; 18448390; 18455515; 18490780; 18494554; 18510628; 18549878; 18550794; 18566376; 18578969; 18594468; 18676751; 18680238; 18707923; 18756934; 18768824; 18771758; 18799583; 18822202; 18830259; 18925909; 18981091; 19035512; 19050238; 19056397; 19058313; 19074163; 19095563; 19116915; 19141860; 19147248; 19160029; 19197939; 19202444; 19220647; 19224853; 19234630; 19263877; 19332785; 19380770; 19395117; 19420358; 19423728; 19439344; 19449188; 19468750; 19500502; 19505258; 19539220; 19564339; 19581275; 19651643; 19695683; 19739236; 19759858; 19794071; 19800335; 19811417; 19811426; 19828602; 19900372; 19949078; 19959217; 19998245; 20012629; 20066438; 20070620; 20087161; 20113370; 20128032; 20185964; 20381020; 20388336; 20445553; 20447384; 20473887; 20506224; 20514052; 20518841; 20587542; 20617899; 20636820; 20657553; 20661763; 20668808; 20677149; 20693422; 20700634; 20709947; 20738778; 20819923; 20825974; 20826917; 20837075; 20848568; 20881011; 20883163; 20886079; 20890291; 20943073; 20959405; 20975732; 21064032; 21084749; 21091911; 21110433; 21113674; 21148500; 21161353; 21237493; 21263070; 21268005; 21269571; 21276005; 21291295; 21328438; 21346771; 21376795; 21383382; 21408177; 21442435; 21481848; 21487727; 21514692; 21547439; 21562156; 21645441; 21651862; 21652684; 21659460; 21712100; 21717461; 21791547; 21795591; 21851845; 21856939; 21868077; 21876620; 21907333; 21908482; 21912640; 21914188; 21927903; 21943489; 21961966; 21982860; 21989349; 22039410; 22042085; 22105417; 22133721; 22152383; 22153879; 22205715; 22246361; 22274654; 22322668; 22342451; 22397719; 22430646; 22441249; 22466343; 22503210; 22532845; 22549384; 22635166; 22722467; 22740686; 22742708; 22797302; 22892379; 22894700; 22895698; 22900886; 22916009; 22956035; 23041554; 23101188; 23189845; 23209326; 23220495; 23267208; 23288508; 23291409; 23297127; 23300177; 23331211; 23383287; 23398844; 23403273; 23417675; 23458521; 23504559; 23521696; 23610399; 23620109; 23628397; 23661793; 23732914; 23772031; 23773130; 23792703; 23907003; 23918986; 24035365; 24127452; 24138884; 24240160,,,,,,,,,,,,,,,,,,OGG:3000005133,,,,,,,,,,,,,,,,,,,programmed cell death 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PDCD1,,,20140408,5133,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,PDCD1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000052,cytoplasmic budding,,,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Cytoplasmic budding is a key step in vesicular transport, multivesicular body and exosome biogenesis, and enveloped virus release. Budding of cytosol involves the formation of coated vesicle for intracellular protein sorting.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,modified definition,,biological process,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138183/|https://pubmed.ncbi.nlm.nih.gov/21145455/,,,,,,,,,,,,,,,,,cytoplasmic budding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039516,modulation by virus of host catalytic activity,regulation by virus of host catalytic activity|regulation of host catalytic activity by virus|modulation of catalytic activity of host by virus,The process in which a virus effects a change in host enzyme activity.,false,,,http://purl.obolibrary.org/obo/GO_0019048,,,,,,,,,,,,,,,,rfoulger,2011-06-16T02:59:35Z,,,,The process in which a virus effects a change in host enzyme activity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation by virus of host catalytic activity|regulation of host catalytic activity by virus|modulation of catalytic activity of host by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019048,,,,GO:0039516,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/19052324,,,,GO:0039516,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host catalytic activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000092304,SCGB3A1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PnSP-2|HIN1|HIN-1|LU105|UGRP2,,,,,,,5,,,,,,,,,,Ensembl:ENSG00000161055|MIM:606500|HPRD:05932|Vega:OTTHUMG00000130936|HGNC:18384,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"secretoglobin, family 3A, member 1",,5q35.3,,,,"GO_0005125 (EC: NAS, PMID: 11481438); GO_0005576 (EC: NAS, PMID: 11481438); GO_0005615 (EC: IEA); GO_0030308 (EC: NAS, PMID: 11481438); GO_0042127 (EC: NAS, PMID: 11481438); GO_0070062 (EC: IDA, PMID: 19199708)",PMID: 11481438; 12175512; 12406855; 12438750; 12477932; 12727813; 12847263; 12975309; 14601057; 14614327; 14977834; 15340161; 15383627; 15472908; 15489334; 16266985; 17545522; 17623056; 18483325; 18950845; 19098448; 19199708; 19258476; 19470737; 19509163; 20496080; 20505321; 20642860; 21274384; 21812955; 22048254; 22095135; 22155607; 22695491; 22871047,,,,,,,,,,,,,,,,,,OGG:3000092304,,,,,,,,,,,,,,,,,,,"secretoglobin, family 3A, member 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,SCGB3A1,,,20140408,92304,UNQ629/PRO1245,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,SCGB3A1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0046653,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,"The chemical reactions and pathways involving tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.",false,,,http://purl.obolibrary.org/obo/GO_0006760,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving tetrahydrofolate, 5,6,7,8-tetrahydrofolic acid, a folate derivative bearing additional hydrogens on the pterin group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tetrahydrofolate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006760,,,,GO:0046653,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046653,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,tetrahydrofolate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0025179,Ground-glass opacification on pulmonary HRCT,,"A descriptive term that is applied to computer tomography imaging and that refers to a hazy area of increased attenuation in the lung with preserved bronchial and vascular markings.|Ground-glass opacification is a non-specific sign and can be observed with many conditions including infection, chronic interstitial disease and acute alveolar disease.",false,,,http://purl.obolibrary.org/obo/HP_0031457|http://purl.obolibrary.org/obo/HP_0025389,,,,,,,,,,,,,,,,HPO:probinson,,,,,A descriptive term that is applied to computer tomography imaging and that refers to a hazy area of increased attenuation in the lung with preserved bronchial and vascular markings.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0025179,,,,,,,,,,,,,,,,,,2016-12-04T19:55:32Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Ground-glass opacification is a non-specific sign and can be observed with many conditions including infection, chronic interstitial disease and acute alveolar disease.",,http://purl.obolibrary.org/obo/HP_0031457|http://purl.obolibrary.org/obo/HP_0025389,,,,,,,,,,,,,,,,,,Ground glass opacification,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Ground-glass opacification on pulmonary HRCT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_3082,interstitial lung disease,ILD,"A lung disease that is characterized by inflammation and altered lung interstitium compromising pulmonary function and often has_symptom shortness of breath, dyspnea, and/or cough.",false,,,http://purl.obolibrary.org/obo/DOID_850|http://purl.obolibrary.org/obo/DOID_65,,,,,,,,,,,,,,,,,,,,ICD10CM:J84.9|GARD:13336|UMLS_CUI:C0206062|MESH:D017563|SNOMEDCT_US_2019_09_01:233703007,"A lung disease that is characterized by inflammation and altered lung interstitium compromising pulmonary function and often has_symptom shortness of breath, dyspnea, and/or cough.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ILD,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_850|http://purl.obolibrary.org/obo/DOID_65,,,,DOID:3082,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,DOID:3082,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,interstitial lung disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0097191,extrinsic apoptotic signaling pathway,extrinsic apoptotic pathway|extrinsic apoptotic signalling pathway|extrinsic apoptotic signaling pathway in presence of ligand|extrinsic apoptosis|death receptor-mediated apoptosis,"A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.|Fas acts as a death receptor with a role in apoptosis, but can also act as a non-apoptotic signal transducer.",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,paola,2011-11-23T09:34:28Z,,,,"A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,extrinsic apoptotic pathway|extrinsic apoptotic signalling pathway,,,extrinsic apoptotic signaling pathway in presence of ligand|extrinsic apoptosis|death receptor-mediated apoptosis,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Fas acts as a death receptor with a role in apoptosis, but can also act as a non-apoptotic signal transducer.",,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0097191,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0097191,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,extrinsic apoptotic signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001772,immunological synapse,supramolecular activation cluster|c-SMAC,"An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Immunological_synapse,"An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,supramolecular activation cluster,,,c-SMAC,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0001772,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001772,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,immunological synapse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_241183,SARS coronavirus BJ2232,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:241183,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ2232,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000123,zoonotic viral transmission,,,false,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32092483,The transmission of an infectious agent from an animal to a human being.,,,,,,,,,,,,,,,,zoonotic viral transmission,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000165,MAPK cascade,MAP kinase kinase kinase cascade|MAPK signal transduction|MAPKKK cascade|mitogen-activated protein kinase cascade|MAP kinase cascade|MAPKKK cascade during sporulation|ERK/MAPK cascade|MAPK signaling|MAPK signalling,"An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.|MAPK cascades lie downstream of many cell surface receptors and cooperate in transmitting various extracellular signals to the nucleus. One way by which the specificity of each cascade is regulated is through the existence of several distinct components in each tier of the different cascades. The cascades are typically named according to the component in the MAPK tier.",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,Wikipedia:MAPK_cascade|Wikipedia:Mitogen-activated_protein_kinase,"An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,MAP kinase kinase kinase cascade|MAPK signal transduction|MAPKKK cascade|mitogen-activated protein kinase cascade|MAP kinase cascade,,,MAPKKK cascade during sporulation|ERK/MAPK cascade,,biological_process,,MAPK signaling|MAPK signalling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,MAPK cascades lie downstream of many cell surface receptors and cooperate in transmitting various extracellular signals to the nucleus. One way by which the specificity of each cascade is regulated is through the existence of several distinct components in each tier of the different cascades. The cascades are typically named according to the component in the MAPK tier.,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0000165,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0000165,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,MAPK cascade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048144,fibroblast proliferation,,"The multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0048144,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048144,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,fibroblast proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007139,TNNT2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,cTnT|CMH2|CMPD2|TnTC|RCM3|CMD1D|LVNC6,,,,,,,1,,,,,,,,,,HPRD:01844|Vega:OTTHUMG00000035733|Ensembl:ENSG00000118194|MIM:191045|HGNC:11949,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,troponin T type 2 (cardiac),,1q32,,,,"GO_0003779 (EC: IDA, PMID: 8205619); GO_0005200 (EC: IEA); GO_0005523 (EC: IDA, PMID: 10850966); GO_0005829 (EC: TAS); GO_0005861 (EC: IDA, PMID: 12093807); GO_0005865 (EC: IDA, PMID: 12186860); GO_0006200 (EC: IDA, PMID: 12093807); GO_0006937 (EC: IEA); GO_0008016 (EC: IMP, PMID: 15542288); GO_0016887 (EC: IDA, Qualifier: contributes_to, PMID: 12093807); GO_0030017 (EC: TAS, PMID: 16754800); GO_0030049 (EC: IDA, PMID: 12186860); GO_0030049 (EC: TAS); GO_0030172 (EC: IPI, PMID: 15542288); GO_0031013 (EC: IPI, PMID: 15542288); GO_0032780 (EC: IDA, PMID: 10850966); GO_0032781 (EC: IDA, PMID: 10850966); GO_0045214 (EC: IEA); GO_0051592 (EC: IDA, PMID: 2530435); GO_0051592 (EC: IMP, PMID: 8205619); GO_0055009 (EC: IEA); GO_0055010 (EC: IMP, PMID: 16754800)",PMID: 2530435; 2584239; 3581171; 6205765; 6746613; 7498159; 7534662; 7895342; 7898523; 7981753; 8088824; 8205619; 8344420; 8521556; 8576938; 8798526; 8989109; 9060892; 9140840; 9219516; 9482583; 9560191; 9689598; 9714088; 10405326; 10451243; 10525521; 10529204; 10610467; 10850966; 10978365; 11034944; 11106718; 11262409; 11684629; 11857753; 11904166; 11931771; 12084606; 12087140; 12093807; 12186860; 12206807; 12473556; 12477932; 12707239; 12732643; 12760310; 12819028; 12832403; 12840750; 12881443; 12923187; 12974739; 14636924; 14702039; 14722098; 14736877; 14986170; 15226628; 15387941; 15524170; 15524172; 15542288; 15563892; 15568820; 15604421; 15673967; 15759546; 15769782; 15923195; 15950076; 16115869; 16199542; 16338248; 16651346; 16716613; 16754800; 16776629; 16789403; 16882671; 17101185; 17207965; 17289431; 17512511; 17612745; 17672918; 17848144; 17891611; 18029407; 18032382; 18032444; 18037101; 18063145; 18065785; 18174208; 18322550; 18403758; 18460953; 18506004; 18513529; 18645057; 18651846; 18719346; 18780659; 18785956; 19016149; 19035361; 19061534; 19149795; 19150014; 19253838; 19275886; 19293840; 19324435; 19330751; 19356187; 19359536; 19359810; 19412328; 19454539; 19459818; 19615100; 19666196; 19736474; 19808368; 19833747; 19853701; 19875404; 19880069; 19887861; 19913121; 19920153; 20031601; 20031618; 20031650; 20035047; 20038417; 20083571; 20093942; 20101793; 20201937; 20299689; 20301486; 20301725; 20359594; 20378771; 20414521; 20472389; 20474083; 20512449; 20624503; 20628086; 20661138; 20677290; 20800588; 20805692; 20884259; 20975235; 21056973; 21276572; 21422391; 21448080; 21502316; 21565741; 21574239; 21632491; 21639091; 21779191; 21792561; 21807382; 21832049; 21864916; 22017532; 22078394; 22144547; 22264874; 22277685; 22326514; 22334656; 22396190; 22525447; 22545649; 22558116; 22579624; 22623715; 22675533; 22681487; 22685114; 22685586; 22694299; 22713569; 22734916; 22808179; 22822013; 22914904; 22982904; 23021597; 23084110; 23114876; 23141854; 23184341; 23228375; 23247143; 23274882; 23315610; 23328564; 23355808; 23393062; 23455924; 23469039; 23471272; 23586019; 23604180; 23628072; 23667500; 23684676; 23688568; 23702074; 23711808; 23788249; 23803255; 24015599; 24036936; 24093860; 24148285; 24333560,,,,,,,,,,,,,,,,,,OGG:3000007139,,,,,,,,,,,,,,,,,,,troponin T type 2 (cardiac),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/3221830,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TNNT2,,,20140408,7139,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TNNT2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_267391,SARS coronavirus SinP2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267391,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SinP2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0150034,distal axon,distal part of axon|distal part of the axon,That part of an axon close to and including the growth cone or the axon terminus.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,BarbaraCzub,2018-02-19T15:04:24Z,,,,That part of an axon close to and including the growth cone or the axon terminus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,distal part of axon|distal part of the axon,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0150034,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0150034,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,distal axon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000031,self-assessment application,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000087,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000087,,,,,,,,medical device,,true,,,,,,Self Evaluation mobile apps.,,,,,,,,,,,,,,,,self-assessment application,,,,,,,,,,,,,,,,,,,,,,https://www.cma.ca/covid-19-self-assessment-tool-and-app,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030176,integral component of endoplasmic reticulum membrane,integral to ER membrane|ER integral membrane protein|integral to endoplasmic reticulum membrane,The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.,false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0031227,,,,,,,,,,,,,,,,,,,,,The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,integral to ER membrane|ER integral membrane protein,,,integral to endoplasmic reticulum membrane,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0031227,,,,GO:0030176,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030176,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,integral component of endoplasmic reticulum membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0140267,viral entry via permeabilization of host membrane,,"The entry of a virus into the cytoplasm of a host cell, triggered by an interaction between the bilayer of a host membrane and a membrane-penetration capsid protein. Results in release of the virus contents into the host cell cytoplasm.",false,,,http://purl.obolibrary.org/obo/GO_0046718,,,,,,,,,,,,,,,,pg,2018-09-25T14:33:03Z,,,,"The entry of a virus into the cytoplasm of a host cell, triggered by an interaction between the bilayer of a host membrane and a membrane-penetration capsid protein. Results in release of the virus contents into the host cell cytoplasm.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046718,,,,GO:0140267,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32142651,,,,GO:0140267,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_annotate,,,,,,,,,,viral entry via permeabilization of host membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002696,positive regulation of leukocyte activation,up-regulation of leukocyte activation|upregulation of leukocyte activation|positive regulation of immune cell activation|positive regulation of leucocyte activation|up regulation of leukocyte activation|stimulation of leukocyte activation|activation of leukocyte activation,"Any process that activates or increases the frequency, rate, or extent of leukocyte activation.",false,,,http://purl.obolibrary.org/obo/GO_0050867,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate, or extent of leukocyte activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,up-regulation of leukocyte activation|upregulation of leukocyte activation|positive regulation of immune cell activation|positive regulation of leucocyte activation|up regulation of leukocyte activation,,,stimulation of leukocyte activation|activation of leukocyte activation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050867,,,,GO:0002696,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002696,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of leukocyte activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0097084,vascular smooth muscle cell development,,"The process aimed at the progression of a vascular smooth muscle cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. A vascular smooth muscle cell is a non-striated, elongated, spindle-shaped cell found lining the blood vessels.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,paola,2011-06-20T04:03:08Z,,,,"The process aimed at the progression of a vascular smooth muscle cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. A vascular smooth muscle cell is a non-striated, elongated, spindle-shaped cell found lining the blood vessels.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0097084,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,GO:0097084,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,vascular smooth muscle cell development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1503299,BtRf-BetaCoV/JL2012,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1503299,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,BtRf-BetaCoV/JL2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061517,macrophage proliferation,,The expansion of a macrophage population by cell division.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,dph,2013-04-18T13:17:56Z,,,,The expansion of a macrophage population by cell division.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0061517,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,GO:0061517,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,macrophage proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006401,RNA catabolic process,RNA degradation|RNA catabolism|RNA breakdown,"The chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,RNA degradation|RNA catabolism|RNA breakdown,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006401,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006401,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila,,,,,,,,,,RNA catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039517,modulation by virus of host protein serine/threonine phosphatase activity,regulation by virus of host protein serine/threonine phosphatase activity|modulation by virus of protein serine/threonine phosphatase activity in host,The process in which a virus effects a change in host protein serine/threonine phosphatase activity.,false,,,http://purl.obolibrary.org/obo/GO_0019054|http://purl.obolibrary.org/obo/GO_0039516,,,,,,,,,,,,,,,,rfoulger,2011-06-16T03:04:14Z,,,,The process in which a virus effects a change in host protein serine/threonine phosphatase activity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation by virus of host protein serine/threonine phosphatase activity|modulation by virus of protein serine/threonine phosphatase activity in host,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054|http://purl.obolibrary.org/obo/GO_0039516,,,,GO:0039517,,,,,,true,,,,true,,,,,GO:0039517,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host protein serine/threonine phosphatase activity,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.04.01.020941v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002920,regulation of humoral immune response,,"Any process that modulates the frequency, rate, or extent of a humoral immune response.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate, or extent of a humoral immune response.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0002920,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002920,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of humoral immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000028639,TRBC1,,,false,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,BV05S1J2.2|TCRB|TCRBC1,,,,,,,7,,,,,,,,,,MIM:186930|IMGT/GENE-DB:TRBC1|HGNC:12156,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,T cell receptor beta constant 1,,7q34,,,,"GO_0005886 (EC: TAS); GO_0006955 (EC: NAS, PMID: 6336315); GO_0016020 (EC: NAS, PMID: 6336315); GO_0016021 (EC: IEA); GO_0031295 (EC: TAS); GO_0050776 (EC: TAS); GO_0050852 (EC: TAS)",PMID: 3860845; 6336315; 8650574; 11048639; 11827988; 12429093; 12477932; 15480765; 15489916; 17652306; 22190034,,,,,,,,,,,,,,,,,,OGG:3000028639,,,,,,,,,,,,,,,,,,,T cell receptor beta constant 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TRBC1,,,20140408,28639,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,TRBC1,,"Bin Zhao, Yue Liu, Oliver He",,other,,
http://purl.obolibrary.org/obo/OGG_3000004088,SMAD3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HsT17436|LDS1C|JV15-2|HSPC193|MADH3|LDS3,,,,,,,15,,,,,,,,,,Ensembl:ENSG00000166949|Vega:OTTHUMG00000133230|MIM:603109|HPRD:04380|HGNC:6769|HPRD:08533,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,SMAD family member 3,,15q22.33,,,,"GO_0000122 (EC: IDA, PMID: 8774881); GO_0000122 (EC: IMP, PMID: 14555988); GO_0000122 (EC: TAS); GO_0000987 (EC: IDA, PMID: 18832382); GO_0000988 (EC: IDA, Qualifier: contributes_to, PMID: 18832382); GO_0001102 (EC: IPI, PMID: 17251190); GO_0001657 (EC: IEA); GO_0001666 (EC: IMP, PMID: 12411310); GO_0001701 (EC: IEA); GO_0001707 (EC: IEA); GO_0001756 (EC: IEA); GO_0001889 (EC: IEA); GO_0001933 (EC: IMP); GO_0001947 (EC: IEA); GO_0002076 (EC: IEA); GO_0002520 (EC: IEA); GO_0003690 (EC: IEA); GO_0003700 (EC: IDA, PMID: 10823886); GO_0003700 (EC: IDA, Qualifier: contributes_to, PMID: 9111321); GO_0005160 (EC: IPI, PMID: 9311995); GO_0005515 (EC: IPI, PMID: 10681527); GO_0005518 (EC: IEA); GO_0005634 (EC: IDA, PMID: 12446380); GO_0005637 (EC: IDA, PMID: 15647271); GO_0005654 (EC: TAS); GO_0005667 (EC: IDA); GO_0005737 (EC: IDA, PMID: 12446380); GO_0005829 (EC: TAS); GO_0005886 (EC: IEA); GO_0006351 (EC: TAS); GO_0006367 (EC: TAS); GO_0006810 (EC: IDA, PMID: 15799969); GO_0006919 (EC: IMP, PMID: 15107418); GO_0006955 (EC: IMP, PMID: 16886151); GO_0007050 (EC: IMP, PMID: 14555988); GO_0007179 (EC: IDA); GO_0007179 (EC: TAS); GO_0007183 (EC: IDA, PMID: 10823886); GO_0007492 (EC: IEA); GO_0008013 (EC: IPI); GO_0008134 (EC: IPI, PMID: 9732876); GO_0008270 (EC: IDA, PMID: 12686552); GO_0009880 (EC: IEA); GO_0010467 (EC: TAS); GO_0010694 (EC: IEA); GO_0010718 (EC: IDA); GO_0010718 (EC: IMP, PMID: 18505915); GO_0016202 (EC: IEA); GO_0017015 (EC: IMP, PMID: 8774881); GO_0019049 (EC: IDA, PMID: 15334054); GO_0019901 (EC: IPI, PMID: 12874272); GO_0019902 (EC: IPI, PMID: 16751101); GO_0023019 (EC: IEA); GO_0030308 (EC: IDA, PMID: 8774881); GO_0030335 (EC: IEA); GO_0030501 (EC: IEA); GO_0030512 (EC: TAS); GO_0030618 (EC: IDA, PMID: 9111321); GO_0030878 (EC: IEA); GO_0031053 (EC: TAS, PMID: 19018011); GO_0031490 (EC: IEA); GO_0031625 (EC: IPI, PMID: 11278251); GO_0032332 (EC: IEA); GO_0032731 (EC: IEA); GO_0032909 (EC: IMP, PMID: 12411310); GO_0032916 (EC: IEA); GO_0032924 (EC: IMP, PMID: 15150278); GO_0033689 (EC: IEA); GO_0035413 (EC: IMP); GO_0035556 (EC: IDA, PMID: 9111321); GO_0038092 (EC: IMP, PMID: 15150278); GO_0042060 (EC: TAS, PMID: 19018011); GO_0042110 (EC: IEA); GO_0042177 (EC: IMP); GO_0042803 (EC: IPI, PMID: 8774881); GO_0042993 (EC: IDA, PMID: 15799969); GO_0043066 (EC: IEA); GO_0043130 (EC: IDA, PMID: 18794808); GO_0043235 (EC: IMP, PMID: 8774881); GO_0043565 (EC: IDA, PMID: 10823886); GO_0044212 (EC: IDA, PMID: 9732876); GO_0045216 (EC: IMP, PMID: 18505915); GO_0045668 (EC: IEA); GO_0045893 (EC: IDA, PMID: 9111321); GO_0045930 (EC: IMP, PMID: 14555988); GO_0045944 (EC: IDA, PMID: 18832382); GO_0045944 (EC: IMP, PMID: 14555988); GO_0045944 (EC: TAS); GO_0048340 (EC: IEA); GO_0048589 (EC: IEA); GO_0048617 (EC: IEA); GO_0048701 (EC: IEA); GO_0050678 (EC: IEA); GO_0050728 (EC: IEA); GO_0050776 (EC: IEA); GO_0050821 (EC: IMP); GO_0050927 (EC: IEA); GO_0051098 (EC: IEA); GO_0051496 (EC: IEA); GO_0051894 (EC: IEA); GO_0060039 (EC: IEA); GO_0060290 (EC: IEA); GO_0061045 (EC: IEA); GO_0070306 (EC: IEA); GO_0070410 (EC: IPI, PMID: 8774881); GO_0070412 (EC: IPI, PMID: 9311995); GO_0071141 (EC: IDA, PMID: 18832382); GO_0090263 (EC: IMP); GO_0097191 (EC: IMP, PMID: 15334054); GO_0097296 (EC: IEA); GO_1901313 (EC: IMP)",PMID: 7958924; 7958925; 8673135; 8774881; 8889548; 9111321; 9311995; 9380693; 9464505; 9665135; 9679056; 9732876; 9741623; 9753318; 9759503; 9843199; 9858566; 9865696; 9892009; 10037600; 10085140; 10092624; 10197981; 10220381; 10400677; 10497242; 10518526; 10531062; 10531362; 10549282; 10557285; 10575014; 10587642; 10601313; 10647776; 10681527; 10708948; 10708949; 10757800; 10823886; 10846168; 10878024; 10890911; 10903323; 10942775; 10962029; 10973944; 10995777; 11016919; 11027280; 11042152; 11058129; 11094085; 11100470; 11114293; 11118211; 11158580; 11163184; 11274402; 11278251; 11278756; 11280774; 11306568; 11359933; 11387212; 11387330; 11389444; 11427533; 11432852; 11438668; 11486006; 11555647; 11590145; 11691834; 11707452; 11711431; 11804592; 12000714; 12023901; 12097320; 12099698; 12150994; 12154125; 12161428; 12161532; 12165866; 12167862; 12191474; 12202226; 12202987; 12226080; 12228247; 12270924; 12370310; 12393416; 12393612; 12411310; 12419246; 12426322; 12446380; 12477932; 12483531; 12524424; 12531695; 12543979; 12551947; 12615364; 12618756; 12631740; 12650946; 12686552; 12700238; 12714599; 12718878; 12732139; 12732634; 12743038; 12758167; 12759229; 12760775; 12764135; 12794086; 12808092; 12815042; 12847691; 12857746; 12874272; 12902338; 12904571; 12917407; 12917425; 12939660; 12963786; 14512875; 14525983; 14531804; 14555988; 14557482; 14603262; 14612439; 14623893; 14630914; 14633126; 14638857; 14647420; 14651998; 14657019; 14691252; 14699069; 14701756; 14727154; 14729983; 14966294; 14988407; 15001984; 15009097; 15044214; 15051726; 15066998; 15084259; 15107418; 15133024; 15138260; 15144564; 15150273; 15150278; 15166010; 15198928; 15221015; 15231748; 15240101; 15241418; 15247277; 15308665; 15326485; 15334054; 15350224; 15356634; 15359284; 15464984; 15467747; 15489334; 15494412; 15496141; 15520018; 15527767; 15561701; 15623506; 15629128; 15647271; 15665291; 15688032; 15735739; 15750622; 15761153; 15781469; 15798217; 15799969; 15845540; 15849193; 15881652; 15897867; 15907489; 15917296; 15922743; 15990875; 15994459; 16007227; 16027725; 16061479; 16156666; 16187293; 16200078; 16223572; 16224064; 16247473; 16253118; 16285943; 16344560; 16362038; 16403803; 16413503; 16423881; 16449645; 16528675; 16543220; 16556868; 16619037; 16636667; 16714330; 16750572; 16751101; 16751102; 16754688; 16777850; 16785237; 16806069; 16828225; 16849317; 16876108; 16886151; 16890162; 16924420; 16959829; 17035229; 17053951; 17074765; 17099224; 17142261; 17197157; 17230494; 17251190; 17264880; 17279001; 17283070; 17292623; 17341133; 17469184; 17471513; 17474147; 17476473; 17591695; 17591701; 17623674; 17634449; 17638910; 17653079; 17657819; 17786540; 17875924; 17908958; 17920062; 17927854; 17934056; 17994767; 18003620; 18055455; 18078810; 18082619; 18095113; 18095154; 18166170; 18172167; 18174158; 18174246; 18203713; 18210139; 18215124; 18223258; 18245174; 18250161; 18263591; 18268325; 18333754; 18339718; 18384750; 18393632; 18417583; 18445023; 18482992; 18495657; 18505915; 18568018; 18729074; 18768831; 18776948; 18791848; 18794808; 18826955; 18832382; 18950738; 18955504; 18974875; 19013433; 19018011; 19032343; 19041414; 19049980; 19064572; 19066393; 19101551; 19106105; 19122240; 19129849; 19135894; 19139564; 19211612; 19218245; 19247629; 19252133; 19255064; 19263472; 19265200; 19289081; 19336575; 19345189; 19351817; 19375841; 19394554; 19419955; 19420158; 19421146; 19453261; 19458083; 19461048; 19468687; 19589780; 19595713; 19616922; 19620243; 19693466; 19751112; 19758997; 19768112; 19819941; 19822523; 19875456; 19914168; 19917253; 19920136; 19951945; 19953087; 19959123; 20010874; 20037158; 20070253; 20093492; 20097766; 20102559; 20142324; 20207742; 20211142; 20222112; 20301299; 20301312; 20346360; 20360068; 20379614; 20427289; 20463300; 20506137; 20547485; 20553715; 20564330; 20571128; 20599907; 20602465; 20607798; 20634891; 20694560; 20734064; 20736297; 20738937; 20739403; 20819778; 20860503; 20930144; 20945383; 21042764; 21057546; 21068203; 21081648; 21095583; 21102463; 21114847; 21139048; 21150326; 21159608; 21217753; 21258410; 21307346; 21310903; 21345218; 21377836; 21532621; 21624123; 21625455; 21646355; 21685363; 21749466; 21778426; 21798735; 21828274; 21829441; 21832049; 21835029; 21862595; 21883378; 21896644; 21924870; 21947082; 21960005; 21965288; 21986102; 21988832; 21990365; 22020340; 22034170; 22045334; 22110135; 22161558; 22167769; 22195013; 22196728; 22227581; 22228025; 22232600; 22241478; 22251470; 22278155; 22310290; 22344298; 22382019; 22385658; 22576977; 22615489; 22617150; 22633655; 22710166; 22740248; 22778267; 22782721; 22803640; 22820497; 22878587; 22921829; 22927430; 22927969; 22966790; 23000965; 23022526; 23056222; 23128233; 23139211; 23179147; 23291589; 23292212; 23305226; 23362262; 23384547; 23419524; 23468994; 23474366; 23530056; 23554019; 23576639; 23585475; 23668999; 23685151; 23687300; 23741351; 23747528; 23779087; 23781096; 23788249; 23788427; 23804438; 23817569; 23824909; 23838884; 23913824; 23937428; 23996929; 24071738; 24183998; 24257415; 24324267; 24330518; 24370825,,,,,,,,,,,,,,,,,,OGG:3000004088,,,,,,,,,,,,,,,,,,,SMAD family member 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/18055455,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,SMAD3,,,20140408,4088,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,SMAD3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000207,COVID risk factor,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The 'COVID risk factor' concept enables a compilation of diverse concepts that are related to risk factor of Covid-19  via the Axiome 'isRiskFactorFor some COVID-19'. Thus enables the adaptation of the ontology for text mining purposes for Covid-19 related information retrieval and information extraction.,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID risk factor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6402,leflunomide,"Leflunomide|5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide|Arava|leflunomidum|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|leflunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|leflunomida","A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:19169882|PMID:18413415|PMID:10890256|PMID:11067959|Drug_Central:1552|PMID:15030575|PMID:16106593|PMID:16142756|PMID:16769661|PMID:12833393|PMID:11391470|PMID:11707749|PMID:19715969|Patent:DE2854439|PMID:11718154|PMID:11876141|PMID:11333342|PMID:17604599|PMID:16645972|PMID:15385935|Patent:US4284786|PMID:10702725|PMID:10515382|PMID:15934905|PMID:18034546|Wikipedia:Leflunomide|DrugBank:DB01097|PMID:16202258|PMID:14622739|PMID:15489872|PMID:9123314|PMID:15214907|KEGG:D00749|PMID:11340750|PMID:19190124|PMID:16688677|PMID:18496682|PMID:11994686|HMDB:HMDB0015229|PMID:16638062|PMID:17646975|PMID:11884931|KEGG:C07905|PMID:11522581|PMID:16638420|PMID:18173611|PMID:7676489|PMID:9777697|PMID:11475244|LINCS:LSM-3771|PMID:18663553|PMID:15652966|PMID:17366662|PMID:15665760|PMID:15188371|Reaxys:4323174|PMID:19344337|PMID:12017890|PMID:7496341|PMID:11043056|PMID:9625011|PMID:9075844|PMID:19581389|PMID:11271257|PMID:19770782|PMID:15789891|PMID:18688040|PMID:15899055|PMID:15127974|PMID:17854740|PMID:11053058|PMID:19751817|CAS:75706-12-6|PMID:16778342|PMID:15537652|Beilstein:4323174|PMID:8610393|PMID:12074690|PMID:15127968|PMID:16284916,"A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Leflunomide|5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide",,,,,chebi_ontology,,"Arava|leflunomidum|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|leflunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|leflunomida",,,,,,,,,0,C12H9F3N2O2,"InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)",VHOGYURTWQBHIL-UHFFFAOYSA-N,270.20730,270.06161,Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6402,,,,,,true,,,,,,,,,CHEBI:6402,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,leflunomide,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006402,SELL,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LECAM1|TQ1|LNHR|LAM1|LYAM1|LSEL|PLNHR|CD62L|LEU8,,,,,,,1,,,,,,,,,,Vega:OTTHUMG00000034809|MIM:153240|HGNC:10720|Ensembl:ENSG00000188404,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,selectin L,,1q23-q25,,,,"GO_0002020 (EC: IPI, PMID: 17548643); GO_0005515 (EC: IPI, PMID: 18606703); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 1692315); GO_0007155 (EC: IEA); GO_0007596 (EC: TAS); GO_0008201 (EC: TAS, PMID: 7680663); GO_0009897 (EC: IEA); GO_0030246 (EC: IEA); GO_0033198 (EC: IEA); GO_0043208 (EC: TAS, PMID: 7680663); GO_0050776 (EC: TAS); GO_0050839 (EC: IEA); GO_0050900 (EC: TAS)",PMID: 1375831; 1376638; 1692315; 1717161; 2473156; 2509939; 2663882; 2664786; 7488174; 7539755; 7680663; 8125298; 8986819; 9024699; 9538010; 9625756; 10377245; 10449768; 10725346; 10747985; 10882119; 10950950; 11064106; 11466384; 11706008; 11821431; 11828340; 11907045; 12036888; 12042326; 12063026; 12144128; 12147693; 12165498; 12186696; 12200076; 12200386; 12202158; 12370391; 12431911; 12477932; 12496379; 12532021; 12588680; 12595908; 12609846; 12736247; 12738381; 12844406; 12871600; 12874338; 12889478; 12918706; 14533031; 14576059; 14585903; 14592723; 14597772; 14615387; 14737745; 15093751; 15178693; 15192100; 15249540; 15470072; 15506984; 15776384; 15831305; 16270299; 16335952; 16344560; 16352650; 16357481; 16565092; 16585636; 16690519; 16712791; 16738933; 16740600; 16916660; 16974056; 16982492; 17028146; 17055225; 17056762; 17407075; 17465998; 17515951; 17525255; 17548643; 17698668; 17703412; 17706337; 17765649; 17890399; 17954174; 18028430; 18032547; 18089680; 18182036; 18191640; 18250165; 18375392; 18385135; 18496641; 18582506; 18606703; 18619508; 18665829; 18713749; 18713968; 18829897; 18973547; 18974842; 19052753; 19064610; 19074885; 19088176; 19118161; 19129194; 19212205; 19240957; 19258923; 19419934; 19451621; 19462221; 19536175; 19654311; 19670701; 19837408; 19913121; 19954409; 20065025; 20193033; 20212041; 20220571; 20306662; 20469932; 20485444; 20503287; 20507883; 20580062; 20628086; 20708610; 20925194; 21197561; 21237580; 21316337; 21465128; 21484243; 21521525; 21546114; 21584225; 21664913; 21869829; 22068558; 22119815; 22159147; 22505724; 22627390; 22836626; 22842622; 22921892; 22941246; 22977256; 23028631; 23319734; 23442851; 23487023; 23573259; 23658780; 23796515; 23925765; 24127491,,,,,,,,,,,,,,,,,,OGG:3000006402,,,,,,,,,,,,,,,,,,,selectin L,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,SELL,,,20140408,6402,RP1-117P20.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,SELL,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_264379,SARS coronavirus TW-GD2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264379,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-GD2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000280,nuclear division,karyokinesis,"The division of a cell nucleus into two nuclei, with DNA and other nuclear contents distributed between the daughter nuclei.",false,,,http://purl.obolibrary.org/obo/GO_0048285,,,,,,,,,,,,,,,,,,,,,"The division of a cell nucleus into two nuclei, with DNA and other nuclear contents distributed between the daughter nuclei.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,karyokinesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0048285,,,,GO:0000280,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000280,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,nuclear division,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CTO_0000220,clinical trial,,"a clinical trial is a medical interventional study where participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the safety and efficacy of the intervention(s) on biomedical or other health related outcomes. The Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc.",false,,,http://purl.obolibrary.org/obo/OBI_0000011,,,interventional trial,,,,,,,,,,,,,,,,,,"a clinical trial is a medical interventional study where participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the safety and efficacy of the intervention(s) on biomedical or other health related outcomes. The Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc.",,https://prsinfo.clinicaltrials.gov/definitions.html|https://www.who.int/ictrp/en/|https://clinicaltrials.gov/ct2/search/map|https://en.wikipedia.org/wiki/Clinical_trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CTO:0000220,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cto.owl,,,,,,,,,,,clinical trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Oliver He, Asiyah Yu Lin, Qingliang Li",,,,
http://purl.obolibrary.org/obo/OGG_3000007040,TGFB1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,DPD1|LAP|TGFbeta|CED|TGFB,,,,,,,19,,,,,,,,,,HPRD:01821|MIM:190180|HGNC:11766,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"transforming growth factor, beta 1",,19q13.1,,,,"GO_0000060 (EC: IDA); GO_0000122 (EC: IEA); GO_0000165 (EC: IMP); GO_0001657 (EC: IEA); GO_0001666 (EC: IEA); GO_0001837 (EC: IEA); GO_0001933 (EC: IDA, PMID: 8053900); GO_0001934 (EC: IDA, PMID: 18625725); GO_0002028 (EC: IEA); GO_0002062 (EC: IDA, PMID: 15040835); GO_0002244 (EC: IDA, PMID: 15451575); GO_0002248 (EC: TAS, PMID: 9639571); GO_0002460 (EC: IEA); GO_0002513 (EC: IEA); GO_0002576 (EC: TAS); GO_0003823 (EC: IPI, PMID: 16754747); GO_0005114 (EC: IDA, PMID: 11157754); GO_0005114 (EC: IPI, PMID: 1333888); GO_0005515 (EC: IPI, PMID: 10092230); GO_0005576 (EC: TAS); GO_0005578 (EC: ISS); GO_0005615 (EC: IDA, PMID: 19734317); GO_0005634 (EC: IDA, PMID: 18040277); GO_0005737 (EC: IDA, PMID: 18040277); GO_0005796 (EC: TAS); GO_0005886 (EC: TAS); GO_0005902 (EC: IDA, Qualifier: colocalizes_with, PMID: 19366691); GO_0006468 (EC: ISS); GO_0006611 (EC: IDA, PMID: 17438144); GO_0006754 (EC: IDA, PMID: 10513816); GO_0006796 (EC: IDA, PMID: 10513816); GO_0006874 (EC: IEA); GO_0006954 (EC: IDA); GO_0007050 (EC: IDA, PMID: 14555988); GO_0007093 (EC: IDA, PMID: 15334054); GO_0007173 (EC: IDA, PMID: 18625725); GO_0007179 (EC: IDA, PMID: 11157754); GO_0007179 (EC: TAS); GO_0007182 (EC: IDA); GO_0007183 (EC: IDA, PMID: 17438144); GO_0007184 (EC: IDA, PMID: 15334054); GO_0007406 (EC: IEA); GO_0007435 (EC: IEP, PMID: 18080134); GO_0007492 (EC: IEA); GO_0007565 (EC: IEA); GO_0007568 (EC: IEA); GO_0007596 (EC: TAS); GO_0008083 (EC: IEA); GO_0008156 (EC: IMP, PMID: 11158066); GO_0008284 (EC: IDA, PMID: 10513816); GO_0008285 (EC: IDA, PMID: 15334054); GO_0008354 (EC: IEA); GO_0009314 (EC: IEA); GO_0009611 (EC: IEP, PMID: 18040277); GO_0009749 (EC: IEA); GO_0009790 (EC: IEA); GO_0009817 (EC: IEA); GO_0009986 (EC: IMP, PMID: 19366691); GO_0010575 (EC: TAS, PMID: 19506300); GO_0010628 (EC: IDA, PMID: 18625725); GO_0010718 (EC: IDA, PMID: 17999987); GO_0010718 (EC: NAS); GO_0010742 (EC: IC, PMID: 15219857); GO_0010763 (EC: IDA, PMID: 18555217); GO_0010800 (EC: IDA, PMID: 18625725); GO_0010862 (EC: IDA, PMID: 19736306); GO_0010936 (EC: IDA); GO_0016049 (EC: IEA); GO_0016202 (EC: ISS); GO_0017015 (EC: IDA, PMID: 15334054); GO_0019048 (EC: TAS); GO_0019049 (EC: IDA, PMID: 15334054); GO_0019058 (EC: TAS); GO_0019899 (EC: IPI, PMID: 19366691); GO_0022408 (EC: IDA, PMID: 18593713); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0030214 (EC: IDA, PMID: 17324121); GO_0030279 (EC: IEA); GO_0030308 (EC: IDA, PMID: 15334054); GO_0030334 (EC: TAS, PMID: 19018011); GO_0030335 (EC: IDA, PMID: 19736306); GO_0030424 (EC: IEA); GO_0030501 (EC: IEP, PMID: 17401695); GO_0030512 (EC: TAS); GO_0031065 (EC: IEA); GO_0031093 (EC: TAS); GO_0031100 (EC: IEA); GO_0031334 (EC: IDA, PMID: 19366691); GO_0031536 (EC: IEA); GO_0031663 (EC: IDA); GO_0032270 (EC: IDA, PMID: 15219857); GO_0032355 (EC: IDA, PMID: 18039789); GO_0032570 (EC: IDA, PMID: 18039789); GO_0032740 (EC: IDA, PMID: 18453574); GO_0032801 (EC: IDA, PMID: 17878231); GO_0032930 (EC: IDA); GO_0032943 (EC: IEA); GO_0032967 (EC: IDA, PMID: 19734317); GO_0032967 (EC: IMP, PMID: 11158066); GO_0033138 (EC: IDA, PMID: 18625725); GO_0033280 (EC: IEA); GO_0034616 (EC: IEA); GO_0035066 (EC: IEA); GO_0035307 (EC: IDA, PMID: 14555988); GO_0042130 (EC: IEA); GO_0042306 (EC: ISS); GO_0042307 (EC: IDA, PMID: 19366691); GO_0042482 (EC: IEA); GO_0042493 (EC: IEA); GO_0042552 (EC: IEA); GO_0042803 (EC: IEA); GO_0043011 (EC: IEA); GO_0043025 (EC: IEA); GO_0043029 (EC: IEA); GO_0043065 (EC: IEA); GO_0043406 (EC: IDA, PMID: 18625725); GO_0043491 (EC: IMP); GO_0043536 (EC: IDA, PMID: 18555217); GO_0043537 (EC: IDA, PMID: 18555217); GO_0043552 (EC: IDA, PMID: 18625725); GO_0043932 (EC: IEP, PMID: 17401695); GO_0045066 (EC: IEA); GO_0045216 (EC: IDA, PMID: 18505915); GO_0045599 (EC: IDA, PMID: 15040835); GO_0045662 (EC: IDA, PMID: 9770491); GO_0045786 (EC: IDA, PMID: 11502704); GO_0045892 (EC: IDA, PMID: 15702480); GO_0045893 (EC: IDA, PMID: 14517293); GO_0045893 (EC: ISS); GO_0045930 (EC: IDA, PMID: 14555988); GO_0045944 (EC: IDA, PMID: 18832382); GO_0046732 (EC: TAS); GO_0046982 (EC: IEA); GO_0047485 (EC: IEA); GO_0048298 (EC: IDA, PMID: 14988498); GO_0048535 (EC: ISS); GO_0048565 (EC: IEA); GO_0048642 (EC: IDA, PMID: 9770491); GO_0048839 (EC: IEA); GO_0050679 (EC: IEA); GO_0050680 (EC: IDA, PMID: 9950587); GO_0050680 (EC: IMP, PMID: 16943770); GO_0050714 (EC: IDA, PMID: 18505915); GO_0050765 (EC: IEA); GO_0050777 (EC: IEA); GO_0050921 (EC: IDA, PMID: 18555217); GO_0051092 (EC: IEA); GO_0051098 (EC: ISS); GO_0051101 (EC: ISS); GO_0051152 (EC: IEA); GO_0051280 (EC: IEA); GO_0051781 (EC: IEA); GO_0051897 (EC: IDA, PMID: 18625725); GO_0060325 (EC: IEA); GO_0060364 (EC: IEA); GO_0060389 (EC: IDA, PMID: 11157754); GO_0060391 (EC: IDA, PMID: 19366691); GO_0060744 (EC: IEA); GO_0060751 (EC: IEA); GO_0060762 (EC: IEA); GO_0061035 (EC: IEA); GO_0070306 (EC: IEA); GO_0070723 (EC: IDA, PMID: 17878231); GO_0071158 (EC: IEA); GO_0071407 (EC: IDA); GO_0071549 (EC: IEA); GO_0072562 (EC: IDA); GO_0085029 (EC: IDA, PMID: 19734317); GO_0090190 (EC: IEA); GO_0097191 (EC: IDA, PMID: 15334054); GO_1900126 (EC: IDA, PMID: 17324121); GO_1901666 (EC: IDA); GO_2000679 (EC: IDA)",PMID: 1281686; 1326540; 1333888; 1550960; 2119582; 2909528; 2982829; 3162913; 3457014; 3459257; 3470709; 3487831; 3861940; 7495302; 7513640; 7638106; 7686157; 7695626; 7798269; 7803268; 7852346; 7935686; 8053900; 8093006; 8106553; 8235612; 8242742; 8264131; 8294518; 8336945; 8370410; 8424942; 8424943; 8471846; 8551249; 8568261; 8599089; 8617200; 8679613; 8811049; 9150447; 9383706; 9389648; 9434787; 9521216; 9639571; 9660815; 9670843; 9675033; 9770491; 9783545; 9813058; 9865696; 9895299; 9918798; 9934696; 9950587; 9987082; 10025398; 10085302; 10092230; 10376933; 10383378; 10431160; 10457363; 10513816; 10631145; 10652271; 10716993; 10746731; 10843814; 10887155; 10930463; 10973241; 11008076; 11062463; 11100470; 11157754; 11158066; 11172812; 11176807; 11192323; 11233912; 11266927; 11266928; 11267084; 11267423; 11278302; 11316069; 11345594; 11357939; 11374867; 11389394; 11391236; 11391238; 11401606; 11404167; 11436536; 11453244; 11456401; 11483955; 11496247; 11502704; 11528523; 11557193; 11568166; 11576951; 11604083; 11694328; 11715070; 11740340; 11746498; 11750277; 11769974; 11771728; 11776328; 11784716; 11796824; 11800227; 11803605; 11810274; 11824477; 11826761; 11830340; 11836565; 11839086; 11867550; 11876742; 11876761; 11906036; 11906646; 11908736; 11911944; 11912197; 11924651; 11925630; 11928807; 11934870; 11960000; 11966931; 11970960; 11981433; 11991670; 11991675; 11992481; 11998866; 12000722; 12009575; 12015308; 12020803; 12021923; 12032592; 12036913; 12041672; 12046078; 12050565; 12055267; 12057905; 12060054; 12061838; 12062452; 12068984; 12081893; 12081894; 12082048; 12085100; 12089714; 12095061; 12097320; 12099698; 12101112; 12107734; 12117671; 12133353; 12140283; 12150293; 12151385; 12160532; 12161098; 12161428; 12163012; 12163055; 12164325; 12168782; 12170265; 12171249; 12172787; 12174377; 12175481; 12176809; 12182464; 12186868; 12189134; 12202226; 12202478; 12202987; 12207584; 12209716; 12219028; 12223346; 12232842; 12234017; 12352892; 12358597; 12358852; 12366695; 12370400; 12370804; 12374793; 12376363; 12379307; 12382579; 12393416; 12393612; 12397374; 12410804; 12411321; 12413771; 12420205; 12421823; 12431651; 12431652; 12432546; 12438348; 12441075; 12451269; 12453980; 12454225; 12457461; 12477932; 12478192; 12479636; 12485831; 12485877; 12489179; 12489185; 12491092; 12493411; 12493741; 12500218; 12507818; 12514788; 12515830; 12525765; 12529270; 12531695; 12531696; 12531888; 12540377; 12547711; 12548199; 12559970; 12560323; 12560674; 12569017; 12572925; 12579267; 12579348; 12589095; 12590978; 12591385; 12595498; 12595908; 12598898; 12601022; 12607775; 12615364; 12626500; 12630751; 12637138; 12649573; 12654639; 12667558; 12669309; 12675860; 12682078; 12700666; 12707335; 12723985; 12727482; 12743121; 12746254; 12747448; 12751024; 12753290; 12754205; 12758167; 12772773; 12775566; 12787424; 12794244; 12795790; 12802498; 12810668; 12815042; 12817760; 12821938; 12824005; 12838101; 12843182; 12850832; 12857600; 12858019; 12858451; 12859695; 12867422; 12874450; 12875973; 12879019; 12879228; 12893825; 12894997; 12898374; 12902338; 12909463; 12911534; 12911563; 12917425; 12938093; 12938195; 12943995; 12944979; 12953061; 12960355; 12974899; 13678774; 13679381; 14504277; 14504444; 14507446; 14510802; 14514699; 14514772; 14517293; 14525983; 14529885; 14531781; 14531804; 14532743; 14555988; 14557872; 14566095; 14576166; 14576954; 14583433; 14585325; 14595120; 14596813; 14597484; 14600158; 14604900; 14607332; 14607563; 14607699; 14608199; 14612292; 14612931; 14614718; 14625191; 14633126; 14633628; 14633705; 14634021; 14635011; 14636845; 14637150; 14641541; 14642613; 14643949; 14644155; 14648590; 14667198; 14672557; 14675189; 14675394; 14676209; 14679171; 14697238; 14697748; 14699019; 14704634; 14707053; 14712482; 14720431; 14722617; 14725686; 14726452; 14727154; 14732719; 14737114; 14751563; 14755254; 14756669; 14757763; 14760152; 14767644; 14871809; 14872501; 14969768; 14976204; 14978126; 14988407; 14988498; 14991065; 14993265; 14999526; 15000149; 15001984; 15003992; 15006917; 15009097; 15009106; 15009180; 15018667; 15020570; 15030461; 15033015; 15033492; 15034041; 15034927; 15040835; 15041164; 15041717; 15044465; 15044491; 15049387; 15057277; 15063762; 15066699; 15068691; 15084245; 15086490; 15100259; 15100460; 15102678; 15102771; 15104684; 15113633; 15114294; 15120189; 15132952; 15133024; 15133032; 15135368; 15159307; 15161830; 15166495; 15170816; 15170937; 15175276; 15178409; 15180953; 15184872; 15187087; 15187109; 15189946; 15191521; 15192047; 15192088; 15194285; 15200451; 15200452; 15203191; 15207246; 15212689; 15214940; 15215809; 15219857; 15220111; 15221033; 15225617; 15231647; 15240008; 15247230; 15247411; 15248227; 15257453; 15269821; 15271980; 15284289; 15288191; 15294900; 15297631; 15305380; 15308875; 15316224; 15334054; 15337504; 15342556; 15342643; 15351436; 15353478; 15354859; 15359164; 15361124; 15361128; 15361357; 15365652; 15367225; 15368517; 15372625; 15373772; 15377500; 15387373; 15450129; 15451575; 15458467; 15467747; 15479754; 15488704; 15489334; 15494412; 15498571; 15498766; 15522940; 15529502; 15536170; 15539010; 15546338; 15552843; 15569360; 15574511; 15592292; 15593052; 15593053; 15596839; 15598443; 15599305; 15599395; 15599946; 15603866; 15604209; 15606694; 15609398; 15613484; 15621151; 15622443; 15623538; 15623763; 15632190; 15637079; 15641096; 15650893; 15654963; 15661045; 15663966; 15665522; 15671065; 15690532; 15694998; 15698546; 15702480; 15703175; 15705190; 15708894; 15712349; 15716278; 15718915; 15721312; 15723707; 15730046; 15732863; 15735739; 15738684; 15750822; 15753900; 15754021; 15761148; 15763337; 15767424; 15769917; 15770661; 15773449; 15777850; 15778389; 15778431; 15784411; 15787639; 15788474; 15790343; 15794197; 15799969; 15800982; 15802940; 15803361; 15811853; 15818397; 15824172; 15833881; 15834029; 15837559; 15838283; 15838328; 15841043; 15842590; 15843517; 15845540; 15848524; 15848527; 15854667; 15856020; 15857508; 15860935; 15878096; 15879087; 15880049; 15881652; 15895394; 15896309; 15901906; 15905358; 15910294; 15913806; 15913903; 15916738; 15917409; 15917723; 15925543; 15927846; 15932621; 15935652; 15935832; 15938776; 15941661; 15941974; 15942255; 15943594; 15944607; 15945506; 15946939; 15951295; 15951665; 15955247; 15957132; 15982639; 16003239; 16014625; 16023325; 16029542; 16030091; 16044414; 16046050; 16046504; 16055706; 16082716; 16086840; 16095497; 16098131; 16100012; 16100774; 16111879; 16113310; 16133992; 16135802; 16135988; 16144297; 16144346; 16146757; 16148664; 16158060; 16162149; 16179583; 16179614; 16179804; 16179826; 16183136; 16184401; 16187293; 16187311; 16193177; 16207846; 16209640; 16210002; 16219695; 16222707; 16223572; 16223775; 16236363; 16243534; 16245329; 16251192; 16253118; 16253647; 16258727; 16258965; 16259606; 16260615; 16263699; 16270194; 16272332; 16277007; 16285938; 16287542; 16289860; 16292494; 16297654; 16298544; 16301119; 16307809; 16310402; 16323703; 16324212; 16327802; 16330131; 16335952; 16336267; 16343799; 16344560; 16350816; 16367920; 16369764; 16378061; 16378062; 16378074; 16387180; 16387590; 16400883; 16403803; 16407286; 16412560; 16413503; 16414983; 16423881; 16423922; 16424284; 16425360; 16428771; 16433832; 16456143; 16461080; 16463783; 16467160; 16482098; 16484622; 16488890; 16493441; 16495290; 16496359; 16499994; 16504679; 16521228; 16524740; 16540751; 16541418; 16543220; 16543493; 16549165; 16552334; 16554035; 16563223; 16563228; 16564125; 16567828; 16570020; 16571622; 16609882; 16617095; 16619041; 16619184; 16620985; 16621788; 16622033; 16622736; 16635219; 16635548; 16637060; 16638864; 16641085; 16646981; 16671880; 16675485; 16675963; 16677601; 16685022; 16690986; 16698802; 16702209; 16704031; 16704689; 16712948; 16718633; 16720864; 16722148; 16730575; 16730947; 16732186; 16733295; 16734133; 16754688; 16754747; 16778279; 16780585; 16785237; 16792132; 16798416; 16799085; 16803995; 16804000; 16807529; 16815840; 16816361; 16820791; 16820871; 16824159; 16824504; 16828225; 16828470; 16835828; 16837650; 16843825; 16849317; 16872485; 16873204; 16875935; 16877343; 16896935; 16904244; 16916603; 16916659; 16920945; 16921482; 16931622; 16933058; 16934609; 16938461; 16941960; 16943770; 16951150; 16962335; 16962935; 16966185; 16969385; 16971953; 16980081; 16987065; 16987066; 16989156; 16990280; 16990569; 16998703; 17003485; 17014924; 17017182; 17018615; 17018616; 17018785; 17021946; 17023672; 17023741; 17032917; 17035001; 17035229; 17044077; 17047091; 17052957; 17059371; 17067743; 17071067; 17072955; 17074098; 17074765; 17076676; 17080483; 17088559; 17097497; 17100549; 17114344; 17137775; 17138053; 17139467; 17145161; 17145371; 17146441; 17151785; 17157157; 17157217; 17164348; 17173255; 17184296; 17187359; 17192829; 17194537; 17198270; 17198275; 17203972; 17205957; 17209781; 17213232; 17214746; 17217620; 17217840; 17220333; 17230494; 17234915; 17237561; 17242066; 17257312; 17261758; 17261759; 17264880; 17268554; 17277740; 17285762; 17288590; 17290010; 17292826; 17293864; 17303584; 17305717; 17312920; 17314099; 17319955; 17324121; 17325209; 17327236; 17332318; 17333284; 17338374; 17341608; 17341610; 17341683; 17346099; 17347580; 17348207; 17359969; 17360530; 17360654; 17361195; 17365852; 17367219; 17368597; 17369174; 17369289; 17371954; 17373677; 17374177; 17376051; 17376924; 17381064; 17382930; 17392271; 17394006; 17400536; 17401617; 17401695; 17404043; 17405902; 17409139; 17415413; 17417945; 17418380; 17418594; 17424886; 17428349; 17433803; 17438144; 17456311; 17459720; 17468136; 17469184; 17471240; 17471513; 17476473; 17483238; 17485238; 17486072; 17498265; 17515815; 17520266; 17522998; 17524861; 17530715; 17540773; 17544674; 17545053; 17548703; 17554369; 17557241; 17557799; 17560118; 17562261; 17567933; 17570736; 17574548; 17579118; 17579298; 17580335; 17587163; 17588962; 17591977; 17594488; 17596875; 17597658; 17598964; 17601559; 17605296; 17612762; 17615257; 17620406; 17621264; 17622752; 17623674; 17624411; 17625450; 17626784; 17627086; 17627763; 17635914; 17637743; 17637750; 17638910; 17640324; 17641021; 17644809; 17649947; 17651146; 17653872; 17654453; 17654516; 17656362; 17656680; 17657504; 17657819; 17662305; 17664003; 17664181; 17669238; 17671518; 17673695; 17680270; 17680535; 17687390; 17689884; 17690184; 17690329; 17692120; 17692821; 17700165; 17703412; 17704440; 17707032; 17711410; 17713555; 17714959; 17720884; 17766609; 17768235; 17768377; 17785866; 17802821; 17823083; 17827158; 17848193; 17848599; 17875052; 17875924; 17876891; 17878231; 17882904; 17884818; 17889117; 17889143; 17889927; 17892594; 17906455; 17911416; 17915216; 17916352; 17920062; 17922404; 17924060; 17927862; 17928287; 17938236; 17947678; 17953753; 17961177; 17965799; 17967972; 17974160; 17974504; 17975134; 17975199; 17982242; 17986101; 17988266; 17989584; 17989610; 17990985; 17999987; 18001570; 18003620; 18024258; 18024394; 18028462; 18029191; 18036644; 18039529; 18039789; 18040277; 18041006; 18055455; 18058229; 18058470; 18058603; 18060582; 18065769; 18070591; 18075785; 18076044; 18078367; 18079410; 18080134; 18081437; 18082198; 18082619; 18082740; 18091351; 18097622; 18155753; 18156442; 18158121; 18160707; 18163430; 18165865; 18174158; 18174230; 18174246; 18186562; 18190611; 18191107; 18197538; 18199825; 18199828; 18202754; 18203080; 18206261; 18208460; 18214641; 18216320; 18217413; 18219106; 18234825; 18243286; 18245174; 18245894; 18250161; 18252865; 18256755; 18264937; 18266005; 18268354; 18275506; 18281501; 18284942; 18287089; 18292811; 18293167; 18294958; 18298657; 18299279; 18299321; 18300111; 18300128; 18303197; 18307173; 18310076; 18312614; 18314484; 18315703; 18316594; 18316602; 18321307; 18321309; 18325189; 18325348; 18325393; 18326816; 18328430; 18332228; 18334149; 18334740; 18335503; 18337117; 18337305; 18339576; 18341540; 18344931; 18349127; 18354237; 18355347; 18355371; 18356176; 18359288; 18375250; 18375254; 18379050; 18381592; 18385519; 18395486; 18398939; 18403781; 18404666; 18408074; 18417583; 18418730; 18421026; 18424453; 18425216; 18425817; 18426913; 18430198; 18431743; 18434375; 18435790; 18438339; 18451140; 18451154; 18453574; 18456797; 18457660; 18457978; 18467449; 18467512; 18467597; 18469800; 18469808; 18471524; 18473105; 18483277; 18484655; 18487557; 18490728; 18492692; 18496036; 18498721; 18499657; 18499753; 18502564; 18505915; 18506886; 18506891; 18510217; 18515987; 18519684; 18522884; 18523885; 18538673; 18541723; 18545091; 18546940; 18547814; 18550614; 18551993; 18555217; 18559281; 18563170; 18564632; 18571008; 18575776; 18579759; 18580607; 18582803; 18587729; 18588859; 18589089; 18591668; 18593713; 18593877; 18600473; 18600500; 18602101; 18614962; 18615206; 18619701; 18621908; 18625725; 18627514; 18632425; 18640487; 18644234; 18651288; 18651839; 18665940; 18670143; 18674744; 18675921; 18676351; 18676680; 18676771; 18676870; 18677119; 18677313; 18680515; 18683731; 18685869; 18693126; 18702109; 18704924; 18711258; 18718051; 18752744; 18756605; 18757300; 18761817; 18769113; 18774639; 18776948; 18780763; 18787533; 18790176; 18790234; 18793775; 18797412; 18801363; 18802103; 18804384; 18809335; 18813784; 18813854; 18818748; 18821144; 18827819; 18829510; 18832382; 18834524; 18842317; 18843049; 18845534; 18848540; 18922939; 18923419; 18924213; 18925687; 18931463; 18932017; 18936038; 18936436; 18940717; 18952601; 18952846; 18953895; 18955504; 18972297; 18974840; 18974971; 18975137; 18975778; 18978303; 18981143; 18981148; 18983975; 18985362; 18988918; 18996102; 19004027; 19005292; 19009622; 19011936; 19012493; 19014341; 19017876; 19018011; 19019335; 19020727; 19020994; 19021063; 19027918; 19028605; 19028820; 19030200; 19032343; 19036501; 19036873; 19038040; 19039592; 19043669; 19046298; 19048627; 19054515; 19058987; 19060265; 19062040; 19062536; 19064572; 19071013; 19079344; 19082463; 19086032; 19087310; 19091788; 19094228; 19096005; 19106168; 19109251; 19111454; 19113055; 19115199; 19115689; 19117745; 19124506; 19130583; 19131662; 19136038; 19136278; 19138248; 19138653; 19142800; 19144335; 19147499; 19147994; 19153535; 19161338; 19169878; 19170196; 19173720; 19176688; 19179799; 19182256; 19183122; 19186046; 19192227; 19193641; 19193648; 19193655; 19201832; 19207109; 19208517; 19209241; 19210273; 19212830; 19218245; 19221447; 19221482; 19222424; 19223381; 19224638; 19224917; 19229971; 19231972; 19235591; 19236751; 19246311; 19247692; 19249027; 19252942; 19253281; 19253312; 19258388; 19258923; 19259356; 19259799; 19260117; 19261809; 19263472; 19263529; 19264229; 19264973; 19269255; 19270180; 19277688; 19279557; 19281856; 19284383; 19285572; 19289081; 19299112; 19299629; 19301310; 19302374; 19304546; 19307427; 19317336; 19317620; 19319146; 19319950; 19331718; 19332120; 19336370; 19336475; 19339270; 19339796; 19345189; 19345330; 19349911; 19351925; 19352540; 19353247; 19357773; 19358670; 19360357; 19363708; 19365037; 19366691; 19368689; 19370415; 19371798; 19379560; 19380441; 19383239; 19383262; 19383287; 19383344; 19385047; 19389097; 19389474; 19392797; 19394095; 19400903; 19401628; 19406989; 19407153; 19407822; 19408823; 19411308; 19414763; 19419264; 19419955; 19420105; 19422573; 19424634; 19426152; 19432813; 19435800; 19442892; 19447876; 19451693; 19453261; 19458083; 19461048; 19461075; 19462508; 19465936; 19466271; 19467929; 19470040; 19478074; 19479237; 19481774; 19481975; 19485899; 19487690; 19488063; 19488421; 19489682; 19491338; 19493496; 19494111; 19494553; 19495883; 19497711; 19497778; 19498318; 19505401; 19505916; 19506017; 19506300; 19506792; 19520754; 19522188; 19527514; 19528989; 19529863; 19531477; 19533439; 19536281; 19538467; 19538865; 19543397; 19546837; 19550366; 19551451; 19553350; 19559392; 19566948; 19572226; 19574221; 19578796; 19579695; 19582455; 19582787; 19584867; 19589780; 19594368; 19608867; 19614955; 19616542; 19622397; 19625176; 19626999; 19636272; 19639490; 19644155; 19645615; 19649705; 19651619; 19657147; 19657566; 19657898; 19661148; 19665058; 19667198; 19672706; 19683555; 19684017; 19690403; 19692168; 19693466; 19700647; 19703231; 19707465; 19710458; 19710682; 19713222; 19723045; 19724928; 19727403; 19728040; 19733294; 19733878; 19734317; 19736306; 19738092; 19745160; 19747910; 19749460; 19750484; 19751964; 19753334; 19759128; 19760097; 19766114; 19768112; 19768163; 19768696; 19778283; 19781301; 19782287; 19786738; 19786804; 19789190; 19796538; 19796969; 19812599; 19816956; 19817957; 19822523; 19825523; 19829006; 19829035; 19830740; 19834456; 19835575; 19845895; 19847669; 19852794; 19854106; 19857272; 19858036; 19858184; 19860911; 19861314; 19863607; 19863608; 19864245; 19864455; 19878580; 19879772; 19882211; 19885568; 19885573; 19886734; 19888474; 19889475; 19890996; 19892918; 19893244; 19894308; 19897194; 19898961; 19901516; 19908229; 19910030; 19911703; 19913121; 19925479; 19933216; 19937272; 19937589; 19940030; 19940507; 19943923; 19950605; 19951597; 19955655; 19958642; 19961777; 19963138; 19967654; 19969188; 19997821; 19998449; 20012233; 20016783; 20019669; 20019772; 20021864; 20021962; 20023176; 20034688; 20036843; 20037158; 20037209; 20038274; 20039825; 20041033; 20045909; 20047981; 20052600; 20053797; 20055790; 20056178; 20057170; 20059631; 20061380; 20061511; 20061995; 20067105; 20081262; 20082482; 20082658; 20083094; 20085599; 20086175; 20096948; 20097948; 20100616; 20102559; 20128678; 20130485; 20130650; 20142324; 20142847; 20143152; 20144876; 20145137; 20145925; 20146266; 20150362; 20154716; 20157775; 20165854; 20170971; 20172396; 20172853; 20173430; 20177758; 20178607; 20179236; 20182440; 20183799; 20184663; 20185928; 20188863; 20191437; 20193458; 20193474; 20196115; 20198308; 20204402; 20207161; 20207982; 20209104; 20212457; 20213229; 20219075; 20219685; 20219718; 20228065; 20228669; 20232138; 20232305; 20233420; 20237496; 20301335; 20301428; 20304823; 20306668; 20308003; 20308061; 20308542; 20309626; 20332216; 20334523; 20335639; 20339548; 20346216; 20346360; 20349130; 20349216; 20352126; 20354825; 20356380; 20357204; 20357999; 20359293; 20359544; 20360039; 20361250; 20368328; 20368424; 20369484; 20370995; 20382885; 20388015; 20389311; 20393141; 20395963; 20399617; 20404275; 20404426; 20407224; 20409029; 20410122; 20416076; 20416077; 20418110; 20419805; 20424473; 20428185; 20428796; 20432436; 20435362; 20435363; 20446778; 20447046; 20449615; 20452036; 20452482; 20453000; 20457266; 20458825; 20459371; 20467172; 20473875; 20479942; 20485444; 20486867; 20489148; 20497023; 20498357; 20503287; 20504320; 20505824; 20506050; 20506163; 20506678; 20511186; 20514018; 20514447; 20517696; 20517890; 20518656; 20519498; 20521251; 20522558; 20525719; 20534926; 20536507; 20540115; 20540853; 20542332; 20543463; 20544801; 20545903; 20548127; 20559120; 20561440; 20565368; 20565774; 20571834; 20571871; 20576680; 20577838; 20581097; 20583212; 20584638; 20587546; 20587610; 20592450; 20592473; 20595396; 20599261; 20599907; 20602615; 20603037; 20603050; 20604712; 20605201; 20608170; 20622901; 20628086; 20628268; 20630504; 20631156; 20634891; 20640597; 20644561; 20650890; 20650904; 20652825; 20654748; 20660732; 20664575; 20667562; 20673868; 20677160; 20686866; 20693403; 20693406; 20697017; 20701096; 20704113; 20712005; 20716621; 20717921; 20720212; 20727350; 20730440; 20731800; 20732366; 20732850; 20734064; 20736227; 20801055; 20809419; 20818498; 20819124; 20832885; 20833210; 20837351; 20838432; 20843298; 20845106; 20847078; 20854793; 20861221; 20862427; 20865036; 20874259; 20876581; 20878063; 20883286; 20885978; 20926009; 20930355; 20931341; 20934403; 20936779; 20944123; 20944558; 20945347; 20945375; 20945379; 20945383; 20945401; 20945437; 20949074; 20951096; 20953611; 20960015; 20965173; 20970781; 20977504; 20981300; 21030067; 21033130; 21034459; 21036908; 21039988; 21041659; 21041994; 21044893; 21047210; 21048327; 21054221; 21054789; 21054877; 21055322; 21056681; 21057545; 21057546; 21059542; 21067483; 21067752; 21068203; 21084277; 21087804; 21093933; 21102523; 21106222; 21113716; 21129244; 21131394; 21131601; 21148227; 21156726; 21161310; 21163049; 21165571; 21167485; 21169032; 21170088; 21170261; 21176193; 21176535; 21177849; 21179414; 21179807; 21183289; 21186301; 21193909; 21205231; 21205989; 21209102; 21216973; 21217013; 21217753; 21219858; 21222048; 21224050; 21228704; 21233699; 21236710; 21249319; 21251657; 21257318; 21258411; 21264231; 21264234; 21268543; 21278057; 21278244; 21278795; 21280981; 21282066; 21288887; 21289011; 21296375; 21297662; 21303979; 21305699; 21306480; 21308777; 21311742; 21317396; 21320324; 21320870; 21324108; 21334453; 21345218; 21353594; 21358594; 21360509; 21368882; 21376140; 21382126; 21384510; 21385594; 21385933; 21390241; 21390541; 21402698; 21403861; 21406171; 21406405; 21410631; 21411626; 21411746; 21422801; 21423726; 21424084; 21427239; 21429769; 21440420; 21440743; 21444670; 21447988; 21448509; 21454519; 21455587; 21462125; 21462384; 21466889; 21468608; 21470928; 21471441; 21478096; 21478191; 21478266; 21479366; 21482686; 21494076; 21503873; 21507959; 21507981; 21514423; 21515455; 21515830; 21521695; 21524276; 21527583; 21539622; 21540640; 21546388; 21547849; 21555587; 21556788; 21559296; 21562160; 21566131; 21567395; 21573718; 21576833; 21591983; 21591998; 21593157; 21605940; 21611193; 21613448; 21613981; 21623988; 21624123; 21625229; 21625455; 21629186; 21630266; 21632881; 21640045; 21643654; 21644048; 21658938; 21673106; 21677668; 21679448; 21679949; 21683954; 21685787; 21689159; 21689549; 21695462; 21697762; 21701776; 21708430; 21712382; 21712700; 21713404; 21718734; 21721104; 21724537; 21725704; 21726930; 21739671; 21740305; 21740541; 21740629; 21744325; 21747928; 21756862; 21757750; 21761116; 21773949; 21777208; 21782795; 21782870; 21789015; 21798735; 21803306; 21803524; 21806346; 21807564; 21816829; 21821041; 21826055; 21826657; 21829601; 21832838; 21833528; 21839042; 21840566; 21843649; 21849067; 21850315; 21853110; 21858035; 21862019; 21862631; 21865076; 21880709; 21885147; 21887843; 21890473; 21897371; 21898545; 21903280; 21906983; 21910069; 21913799; 21914811; 21921666; 21923032; 21924870; 21925532; 21931165; 21935711; 21937134; 21937873; 21940632; 21948779; 21949130; 21963094; 21963846; 21964026; 21965722; 21968601; 21968712; 21980489; 21985798; 21991303; 21998741; 22000747; 22002724; 22003087; 22007481; 22013113; 22015003; 22025551; 22028892; 22030425; 22033267; 22034170; 22036565; 22037216; 22037217; 22039050; 22041457; 22041558; 22049790; 22053598; 22068323; 22072025; 22072289; 22074128; 22079734; 22079987; 22095517; 22103462; 22113713; 22116522; 22118314; 22126761; 22127241; 22133666; 22135187; 22138668; 22140658; 22161860; 22169532; 22206775; 22209986; 22211842; 22213299; 22214163; 22215279; 22217516; 22240154; 22262853; 22264233; 22268139; 22268729; 22269108; 22269311; 22275377; 22278155; 22278742; 22279205; 22282866; 22284668; 22284809; 22287592; 22290469; 22290546; 22292774; 22293501; 22306319; 22310280; 22334695; 22349829; 22350281; 22353043; 22355187; 22357622; 22366990; 22371403; 22374302; 22377751; 22378783; 22379029; 22385796; 22389764; 22391565; 22393057; 22393371; 22395513; 22396040; 22406175; 22412222; 22412921; 22414880; 22415826; 22421944; 22425021; 22429842; 22429882; 22430847; 22433249; 22434388; 22435331; 22447164; 22451656; 22453918; 22458981; 22461896; 22464821; 22465044; 22465760; 22466340; 22479366; 22490392; 22491319; 22496449; 22503347; 22508498; 22512703; 22513132; 22516997; 22528667; 22532183; 22537351; 22542711; 22544614; 22552294; 22566144; 22571197; 22573330; 22573806; 22583901; 22584294; 22592044; 22593181; 22605926; 22607024; 22609357; 22610072; 22615019; 22615489; 22617150; 22617683; 22622138; 22633168; 22637579; 22641039; 22641218; 22647687; 22651914; 22653756; 22658438; 22659134; 22659181; 22662243; 22664874; 22667130; 22667340; 22674574; 22677269; 22678103; 22682513; 22689943; 22692760; 22694813; 22695319; 22699080; 22705563; 22706080; 22707713; 22710166; 22710170; 22710171; 22710176; 22724518; 22730691; 22732125; 22732936; 22739178; 22740248; 22752005; 22753928; 22766682; 22768115; 22771320; 22771387; 22773947; 22782721; 22787119; 22788736; 22789125; 22791552; 22791812; 22803051; 22805880; 22808268; 22812212; 22815997; 22819827; 22824789; 22825972; 22829018; 22833091; 22835453; 22835454; 22835455; 22835456; 22835458; 22841502; 22859956; 22874531; 22878343; 22896337; 22901921; 22902304; 22905131; 22906243; 22906289; 22915806; 22918238; 22918885; 22926010; 22931704; 22935165; 22936401; 22940691; 22941282; 22942286; 22946048; 22949934; 22958403; 22960426; 22965824; 22966790; 22970254; 22971480; 22974591; 22975373; 22977658; 22984076; 22988034; 22990108; 22996328; 23001908; 23018556; 23020627; 23022171; 23023332; 23031257; 23041062; 23049541; 23050851; 23051628; 23056251; 23056332; 23059779; 23060149; 23063511; 23064636; 23078766; 23084539; 23088218; 23104471; 23108401; 23118848; 23119075; 23126427; 23127773; 23129177; 23154409; 23167402; 23175152; 23176363; 23179798; 23183523; 23185371; 23192429; 23199655; 23201680; 23204521; 23207623; 23208491; 23209731; 23220173; 23222298; 23223528; 23226264; 23232296; 23239467; 23242839; 23243310; 23245944; 23249950; 23258796; 23260996; 23275154; 23277357; 23280075; 23284751; 23285029; 23291965; 23295196; 23298711; 23306609; 23319603; 23322881; 23325483; 23333936; 23334061; 23344525; 23352789; 23352795; 23357697; 23358854; 23359369; 23361571; 23362262; 23363776; 23378223; 23382382; 23390194; 23393376; 23399816; 23403314; 23416372; 23416968; 23419524; 23420368; 23421960; 23424236; 23426367; 23428182; 23434344; 23435990; 23437118; 23437179; 23447672; 23459932; 23463512; 23464518; 23466425; 23467611; 23468994; 23479725; 23481710; 23483604; 23486522; 23500081; 23503840; 23515048; 23536722; 23546898; 23548068; 23548835; 23554457; 23555036; 23567513; 23576639; 23581259; 23583521; 23589287; 23614931; 23618868; 23619257; 23623844; 23631855; 23638863; 23640911; 23645040; 23651239; 23653379; 23657067; 23657402; 23668958; 23684116; 23685151; 23690936; 23704908; 23705641; 23717436; 23727026; 23731614; 23741351; 23747893; 23748363; 23762097; 23762330; 23764028; 23770288; 23770290; 23779087; 23781096; 23783250; 23792459; 23792503; 23792529; 23793025; 23801826; 23804438; 23824844; 23824952; 23828577; 23830915; 23831640; 23839959; 23861796; 23872147; 23873179; 23884197; 23892434; 23904169; 23904263; 23911408; 23921128; 23923066; 23926107; 23936495; 23937428; 23940283; 23946447; 23951322; 23958565; 23965869; 23975370; 23990681; 23996684; 24005672; 24014274; 24015303; 24026183; 24049142; 24056369; 24067469; 24080022; 24106276; 24123012; 24129188; 24129565; 24133214; 24145170; 24162774; 24170657; 24183998; 24195511; 24240172; 24305876; 24316888; 24324267; 24511106; 24597264; 24597398,,,,,,,,,,,,,,,,,,OGG:3000007040,,,,,,,,,,,,,,,,,,,"transforming growth factor, beta 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TGFB1,,,20140408,7040,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,TGFB1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000069,low-flow nasal cannula oxygenation,,,false,,,http://purl.obolibrary.org/obo/NCIT_C94624,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C94624,,,,,,,,oxygen therapy,,true,,,,,,The low-flow nasal cannula is an open system of supplementation with high levels of leaking air around the oxygen source.,,,,,,,,,,,,,,,,low-flow nasal cannula oxygenation,,,,,,,,,,,,,,,,,,,,,,https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-critical-care-issues,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000408,COVID prevention and control,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The 'COVID prevention and control' concept enables a compilation of diverse concepts that are related to prevention and control of Covid-19  via the Axiome 'isPreventionAndControlFor some COVID-19'.  Thus enables the adaptation of the ontology for text mining purposes for Covid-19 related information retrieval and information extraction.,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID prevention and control,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0018995,host cellular component,host organism,"Any organism in which another organism, especially a parasite or symbiont, spends part or all of its life cycle and from which it obtains nourishment and/or protection.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Host_(biology),"Any organism in which another organism, especially a parasite or symbiont, spends part or all of its life cycle and from which it obtains nourishment and/or protection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,host organism,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0018995,,,,,,,,true,,,https://www.ncbi.nlm.nih.gov/books/NBK7782/,,host,,GO:0018995,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,host cellular component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0002113,kidney,reniculate kidney,A paired organ of the urinary tract which has the production of urine as its primary function.,false,,,http://purl.obolibrary.org/obo/UBERON_0000489|http://purl.obolibrary.org/obo/UBERON_0005172|http://purl.obolibrary.org/obo/UBERON_0015212,,,,,,,,,,,,,,,,,,,,MA:0000368|UMLS:C0022646|AAO:0000250|MIAA:0000119|BTO:0000671|XAO:0003267|OpenCyc:Mx4rvVjlYpwpEbGdrcN5Y29ycA|FMA:7203|GAID:423|CALOHA:TS-0510|NCIT:C12415|EMAPA:17373|MESH:D007668|EV:0100096|galen:Kidney|MAT:0000119|EFO:0000929|http://linkedlifedata.com/resource/umls/id/C0022646|http://en.wikipedia.org/wiki/Kidney|http://www.snomedbrowser.com/Codes/Details/181414000,A paired organ of the urinary tract which has the production of urine as its primary function.,,,,,,,,,,,,,,One of either of a pair of structures lying on either side of the dorsal aorta in which fluid balance is regulated and waste is excreted out in the form of urine.[AAO],,,,http://purl.obolibrary.org/obo/FMA_264815,,,,,,,,,,,,,,,,reniculate kidney,,uberon,,,renal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000489|http://purl.obolibrary.org/obo/UBERON_0005172|http://purl.obolibrary.org/obo/UBERON_0015212,,,,UBERON:0002113,,,,,,true,,,,,,,,,UBERON:0002113,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#major_organ|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,kidney,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0025180,Centrilobular ground-glass opacification on pulmonary HRCT,Centrilobular groundglass opacification|Centrilobular groundglass opacity,A hazy area of increased attenuation in centrilobular areas of the lung with preserved bronchial and vascular markings seen on a computer tomography scan. Centrilobular refers to a location that is central within secondary pulmonary lobules.,false,,,http://purl.obolibrary.org/obo/HP_0025179,,,,,,,,,,,,,,,,HPO:probinson,,,,,A hazy area of increased attenuation in centrilobular areas of the lung with preserved bronchial and vascular markings seen on a computer tomography scan. Centrilobular refers to a location that is central within secondary pulmonary lobules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Centrilobular groundglass opacification|Centrilobular groundglass opacity,,,,,,,,,,,,,HP:0025180,,,,,,,,,,,,,,,,,,2016-12-04T19:57:32Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0025179,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32294504,,ground-glass opacity,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Centrilobular ground-glass opacification on pulmonary HRCT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_5147,formoterol,"rac-N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide|formoterolum|(R*,R*)-(+-)-N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide|formoterol|(+-)-2'-hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|(+-)-formoterol|N-{2-hydroxy-5-[(1RS)-1-hydroxy-2-{[(2RS)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide","A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:DE2305092|Reaxys:6741801|Patent:US3994974|KEGG:D07990|CAS:73573-87-2|KEGG:C07805|Wikipedia:Formoterol|DrugBank:DB00983,"A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,rac-N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide,,,,,chebi_ontology,,"formoterolum|(R*,R*)-(+-)-N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide|formoterol|(+-)-2'-hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|(+-)-formoterol|N-{2-hydroxy-5-[(1RS)-1-hydroxy-2-{[(2RS)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide",,,,,,,,,0,C19H24N2O4,,,344.40490,344.17361,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:5147,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:5147,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,formoterol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000922,spindle pole,,"Either of the ends of a spindle, where spindle microtubules are organized; usually contains a microtubule organizing center and accessory molecules, spindle microtubules and astral microtubules.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"Either of the ends of a spindle, where spindle microtubules are organized; usually contains a microtubule organizing center and accessory molecules, spindle microtubules and astral microtubules.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030615,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0000922,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000922,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spindle pole,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0017203,"Immunoglobulins, Intravenous",,,false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0017203,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32218340,"Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,"Immunoglobulins, Intravenous",,,,,,,,,,,,,,,,,,,,,,https://www.contagionlive.com/news/highdose-ivig-reversed-worsening-covid19-in-case-reports,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_235088,SARS coronavirus HSR 1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:235088,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HSR 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_389166,Bat CoV 273/2005,BtCoV/273/2005|Bat coronavirus (BtCoV/273/2005),,false,,,http://purl.obolibrary.org/obo/NCBITaxon_347537,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,BtCoV/273/2005|Bat coronavirus (BtCoV/273/2005),,,,,,NCBITaxon:389166,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_347537,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat CoV 273/2005,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_29687,teicoplanin,antibiotic 8327A|teicoplanin|Targocid|teicoplaninum|teicoplanina|teicoplanine,"A complex mixture of related natural products isolated from the fermentation broth of a strain of Actinoplanes teichomyceticus comprising five major components (teicoplanin A2-1 through A2-5), a hydrolysis component (teicoplanin A3-1), and four minor components (teicoplanin RS-1 through RS-4). An antibiotic with a similar spectrum of activity to vancomycin, it is used to treat serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:C15820|Reaxys:8196734|PMID:25218156|Wikipedia:Teicoplanin|DrugBank:DB06149|CAS:61036-62-2|PMID:1416858|PMID:24506456|PMID:25358800|KEGG:D02142|PMID:25224001|PMID:25616054|PMID:24693468|PMID:25726436|PMID:25190719,"A complex mixture of related natural products isolated from the fermentation broth of a strain of Actinoplanes teichomyceticus comprising five major components (teicoplanin A2-1 through A2-5), a hydrolysis component (teicoplanin A3-1), and four minor components (teicoplanin RS-1 through RS-4). An antibiotic with a similar spectrum of activity to vancomycin, it is used to treat serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,antibiotic 8327A|teicoplanin|Targocid|teicoplaninum|teicoplanina|teicoplanine,,,,,,,,,0,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:29687,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32307245,,,,CHEBI:29687,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,teicoplanin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000102,touching contaminated surfaces,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,behaviour process,,true,,,,,,Touch contaminated objects or surfaces.,,,,,,,,,,,,,,,,touching contaminated surfaces,,,,,,,,,,,,,,,,,,,,,,https://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000029,platelet count,,"The number of platelets (thrombocytes) in a specified volume of blood, usually expressed as platelets per cubic millimeter of whole blood.",false,,,http://purl.obolibrary.org/obo/CMO_0000036,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000029,,,,,,,,,,,,"The number of platelets (thrombocytes) in a specified volume of blood, usually expressed as platelets per cubic millimeter of whole blood.",,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000036,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,platelet count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1904380,endoplasmic reticulum mannose trimming,"ER protein alpha-1,2-demannosylation|protein alpha-1,2-demannosylation in endoplasmic reticulum|protein alpha-1,2-demannosylation in ER|protein alpha-1,2-demannosylation in ER quality control compartment|protein alpha-1,2-demannosylation in ERQC|ER mannose trimming|protein alpha-1,2-demannosylation in endoplasmic reticulum quality control compartment|glycoprotein mannose trimming in ER quality control compartment|glycoprotein mannose trimming in ERQC|glycoprotein mannose trimming in endoplasmic reticulum quality control compartment|glycoprotein mannose trimming in ER-derived quality control compartment|protein alpha-1,2-demannosylation in ER-derived quality control compartment","Any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC).",false,,,http://purl.obolibrary.org/obo/GO_0036508,,,,,,,,,,,,,,,,bf,2015-06-23T09:35:41Z,,,,"Any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"ER protein alpha-1,2-demannosylation|protein alpha-1,2-demannosylation in endoplasmic reticulum|protein alpha-1,2-demannosylation in ER|protein alpha-1,2-demannosylation in ER quality control compartment|protein alpha-1,2-demannosylation in ERQC|ER mannose trimming|protein alpha-1,2-demannosylation in endoplasmic reticulum quality control compartment",,,,,biological_process,,"glycoprotein mannose trimming in ER quality control compartment|glycoprotein mannose trimming in ERQC|glycoprotein mannose trimming in endoplasmic reticulum quality control compartment|glycoprotein mannose trimming in ER-derived quality control compartment|protein alpha-1,2-demannosylation in ER-derived quality control compartment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0036508,,,,GO:1904380,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1904380,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endoplasmic reticulum mannose trimming,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002292,T cell differentiation involved in immune response,T-cell differentiation during immune response|T-lymphocyte differentiation during immune response|T cell development involved in immune response|T cell differentiation during immune response|T lymphocyte differentiation during immune response,"The process in which an antigenically naive T cell acquires the specialized features of an effector, regulatory, or memory T cell as part of an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells.|Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.",false,,,http://purl.obolibrary.org/obo/GO_0042110|http://purl.obolibrary.org/obo/GO_0002286,,,,,,,,,,,,,,,,,,,,,"The process in which an antigenically naive T cell acquires the specialized features of an effector, regulatory, or memory T cell as part of an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,T-cell differentiation during immune response|T-lymphocyte differentiation during immune response|T cell development involved in immune response|T cell differentiation during immune response|T lymphocyte differentiation during immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.,,http://purl.obolibrary.org/obo/GO_0042110|http://purl.obolibrary.org/obo/GO_0002286,,,,GO:0002292,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002292,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,T cell differentiation involved in immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_741997,Bat SARS coronavirus HKU3-10,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:741997,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042558,pteridine-containing compound metabolic process,pteridine and derivative metabolic process|pteridine-containing compound metabolism|pteridine and derivative metabolism|pterin metabolism|pterin metabolic process,"The chemical reactions and pathways involving any compound containing pteridine (pyrazino(2,3-dipyrimidine)), e.g. pteroic acid, xanthopterin and folic acid.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving any compound containing pteridine (pyrazino(2,3-dipyrimidine)), e.g. pteroic acid, xanthopterin and folic acid.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019721,,,,pteridine and derivative metabolic process|pteridine-containing compound metabolism|pteridine and derivative metabolism,,,pterin metabolism|pterin metabolic process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042558,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042558,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pteridine-containing compound metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000062,organ,element|anatomical unit|body organ,Anatomical structure that performs a specific function or group of functions [WP].,false,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,,,,,,,,,,,,,,,,,UMLS:C0178784|BIRNLEX:4|WBbt:0003760|OpenCyc:Mx4rwP3iWpwpEbGdrcN5Y29ycA|CARO:0020004|OpenCyc:Mx4rv5XMb5wpEbGdrcN5Y29ycA|EMAPA:35949|EFO:0000634|NCIT:C13018|FMA:67498|MA:0003001|ENVO:01000162|http://www.snomedbrowser.com/Codes/Details/272625005|http://linkedlifedata.com/resource/umls/id/C0178784|http://en.wikipedia.org/wiki/Organ_(anatomy),Anatomical structure that performs a specific function or group of functions [WP].,,,,,,,,,,,,,,"Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.","CARO v1 does not include a generic 'organ' class, only simple and compound organ. CARO v2 may include organ, see https://github.com/obophenotype/caro/issues/4",,,,,,,,,,,,,,,,,,,,,uberon,,element|anatomical unit|body organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,UBERON:0000062,,,,,,,,,,,,,,,UBERON:0000062,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000136,social distancing,,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,,"Social distancing, also called “physical distancing,” means keeping space between yourself and other people outside of your home.",Physical Distancing,,,,,,,,,,,,,,,social distancing,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/social-distancing.html,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061458,reproductive system development,,The progression of the reproductive system over time from its formation to the mature structure. The reproductive system consists of the organs that function in reproduction.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,dph,2012-08-22T17:47:53Z,,,,The progression of the reproductive system over time from its formation to the mature structure. The reproductive system consists of the organs that function in reproduction.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0061458,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061458,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,reproductive system development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007165,signal transduction,signalling cascade|signaling cascade|signalling pathway|signaling pathway,"The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.|Note that signal transduction is defined broadly to include a ligand interacting with a receptor, downstream signaling steps and a response being triggered. A change in form of the signal in every step is not necessary. Note that in many cases the end of this process is regulation of the initiation of transcription. Note that specific transcription factors may be annotated to this term, but core/general transcription machinery such as RNA polymerase should not.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Signal_transduction|MIPS_funcat:30,"The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0023033,,,,,,,signalling cascade|signaling cascade,,biological_process,,signalling pathway|signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that signal transduction is defined broadly to include a ligand interacting with a receptor, downstream signaling steps and a response being triggered. A change in form of the signal in every step is not necessary. Note that in many cases the end of this process is regulation of the initiation of transcription. Note that specific transcription factors may be annotated to this term, but core/general transcription machinery such as RNA polymerase should not.",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007165,,,,,,,,,,,,,,,GO:0007165,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus,,,,,,,,,,signal transduction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0017795,hemic and immune system symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,"Symptoms manifested in organs involved in the production of blood, including the cellular and the molecular components essential in providing defense against foreign organisms or substances",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0017795,,modified definition,,,,,,,,,,,,,SYMP:0017795,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,hemic and immune system symptom,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/mesh/68006424,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061718,glucose catabolic process to pyruvate,glucose catabolism to pyruvate,"The chemical reactions and pathways resulting in the breakdown of glucose, with the production of pyruvate.",false,,,http://purl.obolibrary.org/obo/GO_0006090|http://purl.obolibrary.org/obo/GO_0019320|http://purl.obolibrary.org/obo/GO_0006006,,,,,,,,,,,,,,,,dph,2015-06-30T13:17:26Z,,,,"The chemical reactions and pathways resulting in the breakdown of glucose, with the production of pyruvate.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,glucose catabolism to pyruvate,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006090|http://purl.obolibrary.org/obo/GO_0019320|http://purl.obolibrary.org/obo/GO_0006006,,,,GO:0061718,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061718,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,glucose catabolic process to pyruvate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005788,endoplasmic reticulum lumen,ER lumen|ER cisterna|cisternal lumen|endoplasmic reticulum cisterna,The volume enclosed by the membranes of the endoplasmic reticulum.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The volume enclosed by the membranes of the endoplasmic reticulum.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016022,,,,ER lumen|ER cisterna|cisternal lumen|endoplasmic reticulum cisterna,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005788,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005788,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endoplasmic reticulum lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/VO_0000001,vaccine,,"A vaccine is a processed material with the function that when administered, it prevents or ameliorates a disorder in a target organism by inducing or modifying adaptive immune responses specific to the antigens in the vaccine.",false,,,http://purl.obolibrary.org/obo/OBI_0000047,,,,,,,,,,,,,,,,,,,,,"A vaccine is a processed material with the function that when administered, it prevents or ameliorates a disorder in a target organism by inducing or modifying adaptive immune responses specific to the antigens in the vaccine.",,,,,,,,"Many vaccines are developed to protect against infectious pathogens that causes infectious diseases. Many vaccines are also being developed against other diseases such as cancer, allergy, and autoimmune diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,VO:0000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0000047,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32273591,,,,,,http://purl.obolibrary.org/obo/vo.owl,,,,,,,,,,,vaccine,,,,,,,,,,,,,,,,,,,,,,MeSH: D014612,,,,,,"YH, BP, BS, MC, LC, XZ, RS|a role that inheres in a prepared material entity that is designed to induce protection or treament for a diease or infection in vivo.",,,,
http://purl.obolibrary.org/obo/NCBITaxon_255194,SARS coronavirus SoD,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:255194,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SoD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048565,digestive tract development,gut development|intestinal development|intestine development,"The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.",,,,,,,,,,,,,,,,,,,,,,,,,,,,gut development,,,,,,intestinal development|intestine development,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0048565,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048565,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,digestive tract development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000142,one-dimensional continuant fiat boundary,,,false,,,http://purl.obolibrary.org/obo/BFO_0000140,,,,,OneDimensionalContinuantFiatBoundary,1d-cf-boundary,,,,,,,,,,,,,,,,,,,,,,,,,,a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001]),,The Equator|all geopolitical boundaries|the median sulcus of your tongue|the line separating the outer surface of the mucosa of the lower lip from the outer surface of the skin of the chin.|all lines of latitude and longitude,,,,,,,,,(iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000142,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000140,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,one-dimensional continuant fiat boundary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006402,mRNA catabolic process,mRNA degradation|mRNA catabolism|mRNA breakdown|mRNA decay,"The chemical reactions and pathways resulting in the breakdown of mRNA, messenger RNA, which is responsible for carrying the coded genetic 'message', transcribed from DNA, to sites of protein assembly at the ribosomes.",false,,,http://purl.obolibrary.org/obo/GO_0006401,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of mRNA, messenger RNA, which is responsible for carrying the coded genetic 'message', transcribed from DNA, to sites of protein assembly at the ribosomes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mRNA degradation|mRNA catabolism|mRNA breakdown,,,,,biological_process,,mRNA decay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006401,,,,GO:0006402,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006402,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mRNA catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267390,SARS coronavirus SinP1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267390,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SinP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000084,transmission of virus,,,false,,,http://purl.obolibrary.org/obo/TRANS_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/TRANS_0000000,,,,,,,,,,,,true,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,Viral transmission is the process by which viruses spread between hosts. It includes spread to members of the same host species or spread to different species in the case of viruses that can cross species barriers.,Transmission Cycle of SARS CoV 2,,,,,,,,,,,,,,,transmission of virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C2284,Thymosin,Thymosin,A hormone secreted by the thymus gland and effects T-lymphocyte differentiation and activation.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,61512-21-8,,,,C2284,,,,,,,,,,A hormone secreted by the thymus gland and effects T-lymphocyte differentiation and activation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Thymosin,,,,,,,,,,,,,NCIT:C2284,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Thymosin,Thymosin,,,,,,,,,,,,,,,,,,Thymosin,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,Hormone,,,,,,,,C0040106,
http://purl.obolibrary.org/obo/GO_0005635,nuclear envelope,,"The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space).",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Nuclear_envelope,"The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space).",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005636,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005635,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005635,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant,,,,,,,,,,nuclear envelope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0010930,Abnormal blood monovalent inorganic cation concentration,Abnormality of monovalent inorganic cation homeostasis,An abnormality of monovalent inorganic cation homeostasis.,false,,,http://purl.obolibrary.org/obo/HP_0010929,,,,,,,,,,,,,,,,peter,2011-01-06T10:38:38Z,,,UMLS:C4023645,An abnormality of monovalent inorganic cation homeostasis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of monovalent inorganic cation homeostasis,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010929,,,,HP:0010930,,,,,,,,,,,,,,,HP:0010930,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal blood monovalent inorganic cation concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000140,"drive-thru testing
",,,false,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,Modified definition,,,,,true,,,,,,"In drive thru testing residents drive up in their cars, and medical staff (clad in full protective gear) comes to administer the swab test—the entire procedure takes about 15 minutes. |https://www.health.com/condition/infectious-diseases/coronavirus/drive-through-coronavirus-testing",,,,,,,,,,,,,,,,"drive-thru testing
",,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6343,labetalol,Labetalol|2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|kabetalol|labetalol|labetalolum,A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,HMDB:HMDB0014736|DrugBank:DB00598|Beilstein:2948416|Patent:DE2032642|KEGG:D08106|KEGG:C07063|Patent:US4012444|PMID:22300487|PMID:28166217|CAS:36894-69-6|PMID:21908132|PMID:22528277|Wikipedia:Labetalol|Drug_Central:1531|PMID:23055089|Reaxys:2948416|LINCS:LSM-1282,A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Labetalol|2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide,,,,,chebi_ontology,,5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|kabetalol|labetalol|labetalolum,,,,,,,,,0,C19H24N2O3,"InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)",SGUAFYQXFOLMHL-UHFFFAOYSA-N,328.40554,328.17869,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6343,,,,,,true,,,,,,,,,CHEBI:6343,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,labetalol,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000082,G1/S transition of mitotic cell cycle,,"The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.",false,,,http://purl.obolibrary.org/obo/GO_0044843,,,,,,,,,,,,,,,,,,,,,"The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044843,,,,GO:0000082,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000082,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,G1/S transition of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTD2,protein 9b (SARS-CoV-2),ORF9b (SARS2)|accessory protein 9b (SARS2)|PRO_0000449657|ORF-9b (SARS2)|ORF9b,A protein that is a translation product of the ORF9b gene in SARS-CoV-2.|Category=organism-gene. Note: 97 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,UniProtKB:P0DTD2,A protein that is a translation product of the ORF9b gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ORF9b (SARS2)|accessory protein 9b (SARS2)|PRO_0000449657|ORF-9b (SARS2),,,,,protein,,ORF9b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 97 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTD2,,,,,,true,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32218151,,,,PR:P0DTD2,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,protein 9b (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/FMA_62873,Immunoglobulin M,IgM,,false,,,http://purl.obolibrary.org/obo/FMA_62871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IgM,,,,,fma,,,,,,,,,"It is a pentameric gamma globulin protein consisting of five monomers joined by disulfide bonds and the J chain. Each monomer consists of two mu heave chains and either two kappa light chains or two lambda light chains, connected by disulfide bonds.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/FMA_62871,,,,FMA:62873,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32284614,,,,FMA:62873,,http://purl.obolibrary.org/obo/fma.owl,,,,,,,,,,,Immunoglobulin M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005743,mitochondrial inner membrane,inner mitochondrial membrane,"The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Inner_mitochondrial_membrane|NIF_Subcellular:sao1371347282,"The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,inner mitochondrial membrane,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005743,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005743,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitochondrial inner membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1901992,positive regulation of mitotic cell cycle phase transition,upregulation of mitotic cell cycle phase transition|up regulation of mitotic cell cycle phase transition|up-regulation of mitotic cell cycle phase transition|activation of mitotic cell cycle phase transition,"Any process that activates or increases the frequency, rate or extent of mitotic cell cycle phase transition.",false,,,http://purl.obolibrary.org/obo/GO_1901990|http://purl.obolibrary.org/obo/GO_1901989|http://purl.obolibrary.org/obo/GO_0045931,,,,,,,,,,,,,,,,jl,2013-03-19T16:14:51Z,,,,"Any process that activates or increases the frequency, rate or extent of mitotic cell cycle phase transition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of mitotic cell cycle phase transition|up regulation of mitotic cell cycle phase transition|up-regulation of mitotic cell cycle phase transition,,,activation of mitotic cell cycle phase transition,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1901990|http://purl.obolibrary.org/obo/GO_1901989|http://purl.obolibrary.org/obo/GO_0045931,,,,GO:1901992,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1901992,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of mitotic cell cycle phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IAO_0000033,directive information entity,,An information content entity whose concretizations indicate to their bearer how to realize them in a process.,false,,,http://purl.obolibrary.org/obo/IAO_0000030,,,,,,,,,,,,,,,,,,,,,An information content entity whose concretizations indicate to their bearer how to realize them in a process.,,,,,,,,"Werner pushed back on calling it realizable information entity as it isn't realizable. However this name isn't right either. An example would be a recipe. The realizable entity would be a plan, but the information entity isn't about the plan, it, once concretized, *is* the plan. -Alan|8/6/2009 Alan Ruttenberg: Changed label from ""information entity about a realizable"" after discussions at ICBO|2009-03-16: provenance: a term realizable information entity was proposed for OBI (OBI_0000337) , edited by the PlanAndPlannedProcess branch. Original definition was  ""is the specification of a process that can be
concretized and realized by an actor"" with alternative term  ""instruction"".It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.|2013-05-30 Alan Ruttenberg: What differentiates a directive information entity from an information concretization is that it can have concretizations that are either qualities or realizable entities. The concretizations that are realizable entities are created when an individual chooses to take up the direction, i.e. has the intention to (try to) realize it.|2009-03-16: provenance: a term realizable information entity was proposed for OBI (OBI_0000337) , edited by the PlanAndPlannedProcess branch. Original definition was  ""is the specification of a process that can be concretized and realized by an actor"" with alternative term  ""instruction"".It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.",,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122|http://purl.obolibrary.org/obo/IAO_0000123,,,,,,,,,,,,,,,,,,,,IAO:0000033,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000030,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/apollo_sv.owl|http://purl.obolibrary.org/obo/ero.owl|http://purl.obolibrary.org/obo/iao.owl,,,,,,,,,,,directive information entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Bjoern Peters|PERSON: Alan Ruttenberg,,,,
http://purl.obolibrary.org/obo/NCIT_C1452,Enoxaparin,Enoxaparin|ENOXAPARIN|enoxaparin,"A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells.  Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. (NCI04)",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,A drug used to prevent blood clots.  It belongs to the family of drugs called anticoagulants.,,,,,9005-49-6,CHEBI:28304,(C14H18NO11)n.C14H18NO11.C12H17NO12S.(C12H16NO13S)n.C12H15NO13S.Na.H.5HO3S,,C1452,,,CTRP|FDA,,,,,,,"A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells.  Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. (NCI04)",,,,,,Enoxaparin,,,,,,,,,,,E47C0NF7LV,,,,,,,,,,,,,,Enoxaparin|ENOXAPARIN|enoxaparin,,,,,,,,,,,,,NCIT:C1452,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Enoxaparin,Enoxaparin,,,,,,,,,728167,,,,,,37880,37880,,Enoxaparin,,,,Pharmacologic Substance|Organic Chemical,,,,,,,,C0206460,
http://purl.obolibrary.org/obo/DOID_0050117,disease by infectious agent,infectious disease,"A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions.|DO:wk",false,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0001485|ICD9CM:079.0,"A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:2288|DOID:95|DOID:9696|DOID:2040|DOID:11078|DOID:945|DOID:4120|DOID:5256|DOID:1321|DOID:9532|DOID:10115|DOID:4620|DOID:3099|DOID:1304,,,,infectious disease,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,DO:wk,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,DOID:0050117,,,,,,,,,,,,,,,DOID:0050117,infectious disease,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,disease by infectious agent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_43755,lisinopril,N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline|(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline|lisinopril anhydrous|[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:76547-98-3|Wikipedia:Lisinopril|Drug_Central:1587|Beilstein:4276619|LINCS:LSM-5756|PDBeChem:LPR|DrugBank:DB00722,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:43750,,,,N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline,,,,,chebi_ontology,,(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline|lisinopril anhydrous|[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE,,,,,,,,,0,C21H31N3O5,"InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1",RLAWWYSOJDYHDC-BZSNNMDCSA-N,405.48790,405.22637,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:43755,,,,,,true,,,,,,,,,CHEBI:43755,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,lisinopril,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003123,HLA-DRB1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,DRw10|HLA-DR1B|SS1|DRB1|HLA-DRB,,,,,,,6,,,,,,,,,,Vega:OTTHUMG00000031196|HPRD:08349|HGNC:4948|Ensembl:ENSG00000196126|MIM:142857,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"major histocompatibility complex, class II, DR beta 1",,6p21.3,,,,"GO_0000139 (EC: TAS); GO_0002381 (EC: IDA, PMID: 17050030); GO_0002381 (EC: ISS); GO_0002437 (EC: ISS); GO_0002455 (EC: IDA, PMID: 17050030); GO_0002455 (EC: ISS); GO_0005765 (EC: IDA, PMID: 18305173); GO_0005765 (EC: TAS); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 3456344); GO_0006955 (EC: ISS); GO_0006955 (EC: NAS, PMID: 3129499); GO_0009897 (EC: ISS); GO_0012507 (EC: TAS); GO_0016020 (EC: NAS, PMID: 3129499); GO_0016045 (EC: ISS); GO_0019221 (EC: TAS); GO_0019886 (EC: TAS); GO_0023026 (EC: IDA); GO_0030658 (EC: TAS); GO_0030666 (EC: TAS); GO_0030669 (EC: TAS); GO_0031295 (EC: TAS); GO_0031902 (EC: IDA, PMID: 18305173); GO_0032395 (EC: NAS, PMID: 3129499); GO_0032395 (EC: TAS, PMID: 3456344); GO_0032588 (EC: TAS); GO_0032673 (EC: ISS); GO_0032689 (EC: ISS); GO_0035774 (EC: ISS); GO_0042088 (EC: ISS); GO_0042130 (EC: ISS); GO_0042605 (EC: ISS); GO_0042613 (EC: IEA); GO_0050852 (EC: TAS); GO_0051262 (EC: ISS); GO_0060333 (EC: TAS); GO_0070062 (EC: IDA, PMID: 12519789); GO_0071556 (EC: TAS); GO_2001179 (EC: ISS)",PMID: 1370621; 1399719; 1428007; 1481205; 1541486; 1602009; 1688595; 1869305; 1905983; 1967269; 1970352; 1975801; 1978941; 1979063; 2003917; 2010223; 2023919; 2311644; 2342492; 2450924; 2453563; 2466818; 2471740; 2493052; 2497068; 2511168; 2541120; 2543930; 2592019; 2846691; 2884201; 2885840; 2998758; 3020127; 3099214; 3129499; 3137159; 3174462; 3259543; 3372263; 3456344; 3458223; 3466180; 3476943; 3489470; 3571980; 3858829; 3860851; 3875800; 6415003; 6589154; 6600932; 6947956; 6955026; 7512597; 7519244; 7541827; 7602119; 7642208; 7645219; 7652736; 7734415; 7878660; 7940503; 8016840; 8023844; 8084338; 8086129; 8106268; 8119741; 8145819; 8152483; 8168144; 8300408; 8316295; 8376762; 8406622; 8436426; 8450224; 8462990; 8550105; 8560457; 8612229; 8838355; 8883301; 8889548; 9062971; 9062980; 9079699; 9174151; 9223324; 9234492; 9354468; 9371817; 9500545; 9777332; 9782128; 9802612; 10203026; 10321590; 10425186; 10609818; 10661406; 10716924; 10729169; 10958361; 11014350; 11019926; 11027344; 11034591; 11045836; 11048639; 11053637; 11069565; 11070170; 11082516; 11082517; 11093435; 11093441; 11095018; 11097225; 11098934; 11113070; 11115839; 11118029; 11118314; 11120931; 11121169; 11124840; 11144299; 11146462; 11157139; 11163081; 11165717; 11165718; 11167958; 11168337; 11169240; 11169241; 11169242; 11169247; 11169267; 11171832; 11179016; 11181188; 11181995; 11182227; 11196513; 11202431; 11222331; 11229460; 11229461; 11246532; 11246655; 11250044; 11250046; 11251689; 11257148; 11260506; 11260508; 11261326; 11263477; 11263767; 11266078; 11267248; 11272094; 11285127; 11285131; 11288988; 11289148; 11290778; 11291046; 11294566; 11318984; 11320565; 11334675; 11334677; 11349219; 11359453; 11374095; 11378822; 11390038; 11391541; 11393660; 11409118; 11409121; 11423176; 11423179; 11423504; 11424637; 11436079; 11454644; 11469465; 11474249; 11476905; 11476906; 11477477; 11480844; 11482129; 11495087; 11500439; 11502807; 11507979; 11519010; 11543892; 11543893; 11555411; 11558319; 11574100; 11580849; 11588129; 11672906; 11678027; 11678832; 11679920; 11704283; 11704285; 11704803; 11724419; 11742191; 11744483; 11751963; 11751969; 11756990; 11776098; 11780465; 11782272; 11782273; 11782380; 11782575; 11791643; 11797339; 11799174; 11802942; 11802982; 11812768; 11819862; 11821160; 11824952; 11827988; 11836687; 11839711; 11841366; 11841481; 11841486; 11841488; 11841495; 11842822; 11857064; 11857065; 11860796; 11860824; 11865153; 11868921; 11870103; 11872237; 11872240; 11873625; 11877480; 11881821; 11886480; 11888582; 11894970; 11895223; 11903620; 11904677; 11911111; 11914753; 11916167; 11920855; 11923913; 11927549; 11929589; 11929590; 11935333; 11950806; 11953976; 11961170; 11972875; 11972877; 11972881; 11972886; 11978563; 11979305; 11984513; 11985790; 11994765; 11997714; 12008082; 12010826; 12021129; 12021131; 12021137; 12021139; 12021152; 12022354; 12022360; 12028537; 12028548; 12028549; 12030733; 12039413; 12047361; 12047362; 12048293; 12058255; 12070003; 12071546; 12072187; 12073071; 12075003; 12077712; 12083823; 12089669; 12095976; 12098513; 12100571; 12100686; 12109964; 12115177; 12121274; 12121280; 12121676; 12124858; 12124873; 12125959; 12126569; 12134251; 12135442; 12136889; 12137324; 12139680; 12144077; 12144619; 12144621; 12144622; 12144623; 12144625; 12144632; 12145745; 12145797; 12149602; 12150008; 12150055; 12166499; 12169181; 12170464; 12188437; 12195370; 12196893; 12198621; 12202216; 12208877; 12209103; 12209487; 12211723; 12212234; 12230470; 12233873; 12235085; 12235090; 12244309; 12270547; 12296785; 12351419; 12355479; 12358152; 12358854; 12358860; 12362498; 12364641; 12366783; 12373032; 12375325; 12376743; 12390851; 12392510; 12392614; 12392856; 12392857; 12392858; 12393675; 12411009; 12415586; 12415587; 12418392; 12427289; 12443029; 12445309; 12445315; 12445316; 12445319; 12447731; 12455817; 12455867; 12464650; 12472657; 12477229; 12477932; 12482190; 12482357; 12486606; 12486608; 12506649; 12507821; 12507822; 12507825; 12508396; 12508774; 12508775; 12519789; 12525627; 12526952; 12528108; 12541760; 12542740; 12543794; 12559632; 12559635; 12574360; 12579512; 12581796; 12590981; 12594107; 12595908; 12604316; 12605834; 12610047; 12618858; 12620968; 12622778; 12622783; 12632487; 12635863; 12635936; 12648281; 12649403; 12651073; 12651074; 12651075; 12654235; 12656131; 12658812; 12660263; 12663229; 12665835; 12671736; 12687213; 12687342; 12687511; 12694574; 12694577; 12694583; 12694584; 12694585; 12694587; 12694588; 12716485; 12717273; 12721936; 12729048; 12734793; 12753657; 12753667; 12765483; 12770791; 12770797; 12771724; 12774051; 12778456; 12786999; 12787001; 12793199; 12794545; 12794845; 12798452; 12811505; 12820921; 12823766; 12823767; 12823769; 12825172; 12826377; 12835080; 12841565; 12845430; 12845730; 12846065; 12858445; 12858454; 12859593; 12867584; 12870731; 12873589; 12878355; 12878360; 12878361; 12878363; 12887819; 12888330; 12889993; 12903044; 12903056; 12903490; 12905660; 12911663; 12917840; 12917841; 12919753; 12921878; 12934467; 12939427; 12941076; 12941545; 12941546; 12941547; 12941548; 12942703; 12956878; 12960752; 12974796; 14504973; 14508706; 14510801; 14522089; 14522093; 14527201; 14530370; 14551034; 14562382; 14567462; 14570623; 14571756; 14572343; 14574404; 14578453; 14581545; 14581671; 14582328; 14592217; 14602216; 14617033; 14617034; 14617035; 14617036; 14630402; 14641517; 14648147; 14651137; 14651518; 14651526; 14656748; 14662898; 14669136; 14673570; 14675393; 14677183; 14679080; 14680508; 14686115; 14690140; 14693734; 14694619; 14700595; 14700596; 14700597; 14700598; 14700599; 14705987; 14714495; 14718045; 14719586; 14730600; 14740435; 14745491; 14748996; 14749980; 14752708; 14760938; 14769517; 14872482; 14872499; 14964841; 14976194; 14976605; 14995006; 15000695; 15003812; 15009177; 15009181; 15009432; 15009808; 15013978; 15014429; 15016191; 15016308; 15018649; 15019280; 15019597; 15022316; 15029234; 15030582; 15037989; 15041159; 15041166; 15041167; 15046222; 15049049; 15057268; 15057902; 15061705; 15065436; 15070884; 15075536; 15077289; 15081263; 15083289; 15086350; 15089899; 15089901; 15096192; 15102786; 15104683; 15116308; 15120191; 15120192; 15121303; 15122136; 15124939; 15128924; 15140072; 15142265; 15144462; 15144476; 15157381; 15158329; 15158619; 15164528; 15175643; 15175852; 15182324; 15185301; 15188377; 15191519; 15191529; 15191530; 15191952; 15192840; 15194283; 15194331; 15199166; 15202948; 15203870; 15218339; 15219382; 15219383; 15227724; 15228651; 15228652; 15231205; 15237447; 15239092; 15242955; 15243926; 15245369; 15245379; 15245541; 15248208; 15248209; 15250035; 15251317; 15256073; 15256088; 15257408; 15265024; 15269854; 15275783; 15300424; 15301864; 15304010; 15304011; 15304012; 15304013; 15304014; 15304015; 15305234; 15305244; 15305487; 15307871; 15310011; 15311520; 15321756; 15323271; 15325795; 15331395; 15334474; 15336778; 15336779; 15336786; 15338498; 15338511; 15343265; 15350494; 15357778; 15361127; 15361134; 15361135; 15372502; 15388265; 15448101; 15449022; 15452304; 15457442; 15462607; 15468351; 15471368; 15471889; 15476187; 15476204; 15476205; 15479890; 15489334; 15489916; 15492185; 15496200; 15496201; 15496209; 15496210; 15505772; 15507397; 15522921; 15529352; 15529361; 15529363; 15529553; 15530631; 15531903; 15533584; 15535834; 15546341; 15548263; 15554365; 15555263; 15556690; 15561961; 15565951; 15570643; 15572392; 15585555; 15602199; 15603874; 15603876; 15613143; 15620466; 15621102; 15625617; 15626888; 15627041; 15629656; 15640103; 15640334; 15640608; 15641099; 15642902; 15643010; 15645749; 15650879; 15655774; 15660729; 15663743; 15664787; 15665016; 15666025; 15683420; 15688398; 15690658; 15696102; 15699400; 15699512; 15703453; 15703957; 15712014; 15713215; 15713222; 15719619; 15728986; 15730527; 15730926; 15734871; 15735647; 15735807; 15743917; 15747244; 15750822; 15763345; 15770496; 15780746; 15784113; 15784468; 15784911; 15785242; 15786423; 15789899; 15821740; 15825968; 15833172; 15834022; 15846589; 15849775; 15851575; 15853898; 15853900; 15853901; 15853903; 15853910; 15854278; 15856071; 15858601; 15863864; 15881283; 15885635; 15896200; 15896210; 15898419; 15901902; 15902698; 15906352; 15908298; 15929613; 15932622; 15934994; 15935893; 15941540; 15941914; 15943829; 15952133; 15958261; 15969672; 15975271; 15982254; 15982255; 15982256; 15982264; 15982265; 15985473; 15993714; 15993720; 16005081; 16005098; 16005527; 16007032; 16011982; 16014635; 16014670; 16019679; 16025255; 16026587; 16029431; 16029441; 16042197; 16049290; 16053028; 16086294; 16086295; 16094724; 16095006; 16095118; 16096810; 16096857; 16098233; 16101833; 16101838; 16101839; 16103458; 16107511; 16107953; 16112029; 16112030; 16116311; 16118124; 16122986; 16126967; 16130422; 16133177; 16140993; 16142706; 16142711; 16143070; 16148166; 16155070; 16157380; 16158194; 16173256; 16174649; 16180280; 16185329; 16185333; 16186814; 16188098; 16188937; 16198136; 16200610; 16201295; 16208405; 16215732; 16215957; 16226480; 16237774; 16245224; 16249228; 16254435; 16255019; 16255021; 16258157; 16261886; 16263823; 16267409; 16267776; 16269080; 16276008; 16277691; 16277843; 16277897; 16279844; 16282347; 16286957; 16292086; 16297186; 16303674; 16314951; 16320082; 16320316; 16321988; 16337001; 16343061; 16352685; 16356649; 16358956; 16361713; 16362659; 16365741; 16366416; 16385499; 16386646; 16386648; 16386650; 16386651; 16390390; 16390391; 16405603; 16409303; 16417614; 16420246; 16426240; 16426241; 16426242; 16430717; 16433795; 16437632; 16438485; 16441486; 16441488; 16441489; 16441501; 16441502; 16447236; 16451199; 16451208; 16453260; 16456797; 16456799; 16456803; 16463424; 16467040; 16473309; 16481299; 16490755; 16495319; 16496287; 16507114; 16518608; 16530511; 16532100; 16533342; 16537577; 16540751; 16555323; 16566202; 16572445; 16572446; 16573562; 16584643; 16604510; 16606409; 16609350; 16611256; 16611259; 16629714; 16646680; 16646982; 16671949; 16673133; 16689106; 16698432; 16700999; 16704757; 16709874; 16712649; 16714073; 16720210; 16720213; 16720214; 16731854; 16733891; 16756466; 16767683; 16769963; 16773677; 16774552; 16778420; 16785530; 16786764; 16792590; 16793843; 16796128; 16799707; 16802776; 16815190; 16826237; 16829307; 16829309; 16829512; 16846526; 16849401; 16855521; 16855621; 16857416; 16866883; 16866885; 16872485; 16875346; 16879301; 16879749; 16883532; 16884876; 16887863; 16890179; 16905561; 16916662; 16923796; 16935351; 16935791; 16941709; 16948649; 16960929; 16964961; 16966600; 16972006; 16973583; 16988007; 17002902; 17002906; 17003171; 17003176; 17016821; 17021767; 17026463; 17026464; 17026471; 17028803; 17047287; 17050030; 17054449; 17055527; 17056584; 17060025; 17074598; 17075818; 17075829; 17086601; 17092866; 17105585; 17106278; 17106689; 17113829; 17116345; 17119950; 17124999; 17126830; 17130528; 17130566; 17130569; 17133612; 17143607; 17144392; 17153701; 17174751; 17180363; 17182961; 17186951; 17198869; 17207378; 17207713; 17207714; 17207965; 17212706; 17212707; 17212710; 17215337; 17223660; 17227111; 17234427; 17237562; 17252545; 17256150; 17257318; 17257319; 17257320; 17265477; 17266100; 17284220; 17284224; 17285554; 17285557; 17287608; 17288808; 17294607; 17299710; 17301827; 17304884; 17305280; 17306585; 17309132; 17309450; 17310371; 17311253; 17311339; 17318773; 17324966; 17325942; 17328818; 17329717; 17334650; 17341285; 17341507; 17345114; 17349874; 17350686; 17364902; 17376212; 17378697; 17383044; 17384941; 17387388; 17388766; 17389012; 17389014; 17389015; 17392350; 17392574; 17396103; 17401504; 17406641; 17406941; 17407088; 17411376; 17412364; 17428358; 17431094; 17433060; 17436241; 17437273; 17445172; 17445173; 17453717; 17455230; 17458393; 17460569; 17462511; 17463066; 17469097; 17469103; 17488703; 17489060; 17489940; 17493158; 17493347; 17498269; 17505501; 17507489; 17509453; 17510796; 17513705; 17516530; 17531857; 17534404; 17537386; 17538887; 17541908; 17543145; 17546694; 17554059; 17554300; 17554341; 17559577; 17559688; 17561243; 17573956; 17578051; 17578052; 17583734; 17584581; 17584585; 17584771; 17588142; 17589850; 17592398; 17603847; 17604825; 17610416; 17610417; 17622942; 17629023; 17631742; 17632545; 17652306; 17652848; 17652849; 17653284; 17653770; 17658488; 17660221; 17661908; 17661909; 17661910; 17662002; 17662350; 17662890; 17665209; 17666451; 17672065; 17673320; 17673491; 17680546; 17681614; 17686102; 17714903; 17715334; 17722299; 17722421; 17726164; 17728335; 17761456; 17763415; 17763436; 17767551; 17785583; 17785916; 17804836; 17825227; 17826339; 17845076; 17845310; 17869653; 17875181; 17876645; 17878210; 17891921; 17893434; 17895416; 17900288; 17901090; 17907045; 17910142; 17911417; 17911430; 17922429; 17927716; 17928868; 17935228; 17936227; 17941906; 17947711; 17956579; 17959659; 17961775; 17961971; 17964196; 17971048; 17971052; 17971177; 17972102; 17977208; 17982455; 17987563; 17989341; 17989838; 17992468; 17997607; 18000641; 18001297; 18001300; 18003662; 18007983; 18022570; 18022694; 18022727; 18028350; 18032542; 18036100; 18036860; 18038917; 18039812; 18053473; 18057318; 18057383; 18057683; 18058064; 18064508; 18065518; 18069933; 18070207; 18070287; 18070336; 18071880; 18077428; 18082572; 18084828; 18085741; 18085998; 18086264; 18086267; 18087043; 18088468; 18088469; 18093280; 18156150; 18162709; 18163478; 18164964; 18167262; 18176993; 18177450; 18186801; 18196245; 18203322; 18222012; 18223493; 18236804; 18240241; 18240242; 18240960; 18241227; 18244920; 18248305; 18252895; 18256425; 18257894; 18258695; 18259107; 18267980; 18270855; 18272668; 18272866; 18273034; 18275683; 18277084; 18279373; 18289678; 18292987; 18295677; 18295738; 18300568; 18301070; 18301962; 18305173; 18307784; 18309376; 18312478; 18312480; 18316396; 18320121; 18331414; 18332066; 18332098; 18334870; 18338763; 18345414; 18347100; 18351579; 18352820; 18356404; 18367833; 18370845; 18371160; 18372357; 18378005; 18381784; 18381799; 18385790; 18390988; 18395261; 18395773; 18396213; 18397187; 18398946; 18399156; 18401352; 18408250; 18408266; 18412308; 18413431; 18416774; 18433881; 18438843; 18449200; 18449568; 18450852; 18451182; 18463715; 18465452; 18466466; 18466483; 18466515; 18466541; 18481581; 18482373; 18487476; 18489735; 18501999; 18504544; 18513341; 18520158; 18520346; 18521924; 18523354; 18535809; 18537178; 18544086; 18554163; 18561316; 18565246; 18565258; 18565729; 18569076; 18571007; 18576341; 18580885; 18582515; 18583252; 18588574; 18589099; 18593440; 18599937; 18613417; 18615093; 18623133; 18635594; 18656179; 18672082; 18683155; 18684745; 18684978; 18689790; 18694972; 18706091; 18713991; 18716994; 18718089; 18721271; 18721277; 18721466; 18722491; 18726686; 18761557; 18764812; 18765817; 18768435; 18778327; 18779568; 18780165; 18789688; 18791284; 18794605; 18794853; 18797890; 18799094; 18801688; 18812394; 18820539; 18821214; 18822201; 18824733; 18827882; 18832704; 18835879; 18838388; 18846964; 18854880; 18922348; 18930994; 18932050; 18939942; 18941528; 18945361; 18945465; 18952831; 18955791; 18955792; 18958335; 18976432; 18976433; 18976440; 18978792; 18987644; 18996998; 18998014; 19000139; 19000140; 19000142; 19000143; 19002558; 19003916; 19005023; 19022862; 19023492; 19024262; 19030725; 19031816; 19032829; 19041429; 19046300; 19046302; 19046304; 19047245; 19052350; 19052351; 19055605; 19058789; 19070257; 19096254; 19098025; 19104471; 19116921; 19116923; 19117368; 19117726; 19120272; 19120278; 19122664; 19124916; 19127112; 19140826; 19140832; 19143810; 19143811; 19143812; 19143813; 19143814; 19143818; 19143821; 19144284; 19151010; 19153174; 19154326; 19155468; 19156166; 19159415; 19165231; 19167759; 19180512; 19188433; 19193207; 19196481; 19197344; 19199253; 19199259; 19200828; 19201236; 19204159; 19204171; 19208355; 19210322; 19210888; 19214504; 19219503; 19221531; 19223392; 19227412; 19230187; 19232439; 19233472; 19235017; 19235869; 19243543; 19246116; 19247821; 19248090; 19251712; 19254248; 19254255; 19254257; 19262578; 19272325; 19286445; 19287509; 19290000; 19295542; 19299434; 19327239; 19327846; 19332095; 19332633; 19333928; 19333936; 19333951; 19337647; 19348686; 19349081; 19350523; 19364369; 19364514; 19374512; 19380721; 19382529; 19382531; 19387463; 19390203; 19392788; 19392836; 19401421; 19404393; 19405864; 19407364; 19409091; 19411391; 19411392; 19416238; 19421224; 19429597; 19433080; 19439981; 19445991; 19449444; 19473214; 19473559; 19474744; 19479859; 19479873; 19480851; 19481774; 19482865; 19482867; 19486004; 19487610; 19487887; 19490211; 19490212; 19493233; 19493234; 19493426; 19495996; 19500315; 19502265; 19516267; 19523767; 19525953; 19525955; 19539218; 19543371; 19544559; 19553558; 19565552; 19571811; 19585166; 19585495; 19587357; 19589487; 19592628; 19593744; 19596691; 19597292; 19597844; 19616314; 19620308; 19624613; 19625333; 19629136; 19630074; 19648126; 19648278; 19653987; 19654074; 19654407; 19654554; 19654877; 19655145; 19659809; 19663932; 19664674; 19668019; 19674013; 19674023; 19683555; 19690132; 19692729; 19698125; 19700393; 19702653; 19703234; 19703245; 19714482; 19714585; 19718441; 19720533; 19722042; 19728932; 19733917; 19738989; 19740903; 19741008; 19741715; 19744147; 19756183; 19758197; 19758198; 19758199; 19758202; 19758204; 19758311; 19761839; 19769302; 19770068; 19811436; 19811437; 19811438; 19812988; 19817985; 19819281; 19820007; 19820376; 19822091; 19833889; 19834793; 19837788; 19838193; 19845915; 19847191; 19851445; 19854714; 19858318; 19860590; 19860744; 19861144; 19865101; 19865102; 19874322; 19879194; 19879597; 19879913; 19884265; 19884273; 19886988; 19890026; 19894308; 19895570; 19896518; 19896562; 19898480; 19906105; 19908388; 19920092; 19922436; 19924143; 19925877; 19927159; 19931565; 19937591; 19949652; 19956544; 19956635; 19965521; 19995845; 19995849; 20002609; 20003135; 20003137; 20003324; 20003377; 20006387; 20008659; 20012522; 20017299; 20018638; 20018961; 20028711; 20030936; 20031464; 20038641; 20051322; 20054547; 20062572; 20070603; 20073143; 20073992; 20075704; 20082482; 20083660; 20090103; 20095337; 20101097; 20105138; 20108780; 20112396; 20141578; 20145915; 20147981; 20150397; 20154067; 20164547; 20169624; 20170930; 20173784; 20179740; 20187937; 20191587; 20191588; 20193235; 20193456; 20193583; 20196825; 20196826; 20196860; 20205319; 20207784; 20209134; 20210922; 20211854; 20214848; 20216938; 20221424; 20224785; 20225292; 20230522; 20230525; 20233754; 20235791; 20237121; 20298583; 20301492; 20303356; 20307907; 20309863; 20331476; 20335219; 20335276; 20345872; 20345929; 20346252; 20347497; 20352225; 20353580; 20353806; 20370905; 20371654; 20374297; 20375311; 20380521; 20380523; 20383728; 20385791; 20387488; 20392899; 20394989; 20395221; 20403136; 20403137; 20405713; 20417641; 20424860; 20426625; 20437569; 20438789; 20439292; 20444266; 20448347; 20449807; 20453840; 20453841; 20453842; 20458337; 20462405; 20462916; 20463743; 20466734; 20476860; 20478772; 20486920; 20492596; 20492599; 20493227; 20497637; 20502044; 20507388; 20510319; 20518845; 20518846; 20522201; 20522202; 20522537; 20533289; 20536911; 20536993; 20537173; 20537664; 20541027; 20542071; 20547426; 20549830; 20550778; 20559009; 20560812; 20561992; 20569042; 20580654; 20580995; 20584722; 20586801; 20591987; 20592276; 20593013; 20594918; 20595243; 20595679; 20600444; 20603341; 20603497; 20606439; 20617178; 20627832; 20629714; 20631027; 20634196; 20637045; 20639266; 20639878; 20666704; 20668555; 20670332; 20670354; 20671941; 20678810; 20684489; 20685690; 20685768; 20686866; 20691532; 20692483; 20694011; 20711174; 20719952; 20722010; 20723328; 20725783; 20735759; 20736246; 20739684; 20797713; 20798335; 20800921; 20810130; 20825955; 20837527; 20842443; 20843162; 20849588; 20850383; 20851016; 20854863; 20858521; 20861181; 20876154; 20884011; 20888281; 20919945; 20923326; 20923327; 20931685; 20933106; 20937338; 20966625; 20970669; 20972469; 20974205; 20977916; 21029659; 21031025; 21033293; 21040492; 21049023; 21059595; 21059899; 21062236; 21063024; 21067287; 21067577; 21072187; 21074862; 21075156; 21079793; 21085635; 21087485; 21087494; 21091360; 21149397; 21172035; 21179106; 21186201; 21241376; 21246357; 21251479; 21270202; 21276381; 21280007; 21288988; 21292329; 21297633; 21299892; 21303861; 21316924; 21325036; 21340025; 21342137; 21354458; 21358010; 21360493; 21373184; 21388356; 21388361; 21395562; 21396892; 21399633; 21411354; 21413052; 21417892; 21418440; 21422625; 21422655; 21429451; 21431378; 21447263; 21452313; 21484216; 21497601; 21501120; 21502966; 21535077; 21554253; 21557256; 21569485; 21593777; 21598828; 21599852; 21614018; 21617122; 21621859; 21644227; 21646624; 21652028; 21653833; 21659045; 21676191; 21699788; 21709571; 21712058; 21716163; 21720852; 21726205; 21732917; 21739420; 21741664; 21744463; 21748712; 21751159; 21762745; 21778700; 21779181; 21796887; 21806423; 21809595; 21816002; 21816760; 21820153; 21833018; 21833019; 21841780; 21851420; 21873689; 21881596; 21888287; 21891926; 21898163; 21900604; 21902584; 21906983; 21908482; 21911185; 21922073; 21924912; 21929573; 21952999; 21955839; 21964432; 21978430; 21982422; 22028790; 22042692; 22057263; 22068554; 22074998; 22074999; 22084083; 22094856; 22096508; 22106694; 22112985; 22119882; 22121859; 22122841; 22127897; 22156484; 22170232; 22186711; 22190364; 22196942; 22197929; 22204478; 22219324; 22224635; 22233603; 22234791; 22244918; 22284614; 22286218; 22286648; 22289117; 22289814; 22307773; 22308705; 22310063; 22310618; 22311500; 22339947; 22349877; 22357454; 22363536; 22367481; 22370504; 22391763; 22404765; 22448298; 22461888; 22487840; 22493691; 22494469; 22499074; 22504415; 22509268; 22521184; 22523259; 22537824; 22554526; 22564118; 22572536; 22573116; 22578019; 22580214; 22588649; 22590574; 22594481; 22595829; 22633068; 22649493; 22658931; 22661643; 22701553; 22731780; 22733780; 22781039; 22803655; 22807207; 22807686; 22808111; 22848563; 22860026; 22862152; 22863772; 22868506; 22886382; 22889831; 22892251; 22893315; 22898764; 22912672; 22913598; 22935200; 22938381; 22991420; 22991974; 23028341; 23053058; 23090223; 23110937; 23119005; 23128233; 23130884; 23139797; 23171011; 23176610; 23177929; 23180817; 23183775; 23184486; 23186557; 23200758; 23212062; 23218978; 23225889; 23232601; 23243276; 23246582; 23253237; 23257407; 23260142; 23264739; 23266558; 23273568; 23278646; 23283466; 23291585; 23302880; 23303446; 23312038; 23317308; 23318129; 23321172; 23321320; 23326239; 23328091; 23331206; 23349640; 23376085; 23378606; 23380141; 23380142; 23391249; 23392276; 23398374; 23404077; 23407388; 23413297; 23421483; 23472185; 23477965; 23482656; 23485854; 23507476; 23511034; 23535732; 23543758; 23555757; 23555798; 23556450; 23577190; 23588515; 23590002; 23593151; 23628399; 23636221; 23637323; 23638805; 23674880; 23737967; 23739956; 23742216; 23791106; 23793098; 23793423; 23834030; 23837503; 23850713; 23951151; 23992015; 24046013; 24097066; 24190431; 24295149; 24449572,,,,,,,,,,,,,,,,,,OGG:3000003123,,,,,,,,,,,,,,,,,,,"major histocompatibility complex, class II, DR beta 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HLA-DRB1,,,20140408,3123,XXbac-BPG161M6.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,HLA-DRB1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0004408,Abnormality of the sense of smell,Smell defect|Abnormal sense of smell|Abnormality of the sense of smell|Abnormality of olfaction,An anomaly in the ability to perceive and distinguish scents (odors).,false,,,http://purl.obolibrary.org/obo/HP_0012638|http://purl.obolibrary.org/obo/HP_0000366,,,,,,,,,,,,,,,,peter,2008-03-18T09:21:00Z,,,UMLS:C4021655,An anomaly in the ability to perceive and distinguish scents (odors).,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0004410,,,,Smell defect|Abnormal sense of smell|Abnormality of the sense of smell|Abnormality of olfaction,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012638|http://purl.obolibrary.org/obo/HP_0000366,,,,HP:0004408,,,,,,,,,,,,,,,HP:0004408,,http://purl.obolibrary.org/obo/hp.owl,http://purl.oboInOwllibrary.org/oboInOwl/hp#hposlim_core,,,,,,,,,,Abnormality of the sense of smell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002205,Recurrent respiratory infections,"Recurrent respiratory infections|Frequent respiratory infections|Multiple respiratory infections|Susceptibility to respiratory infections|respiratory infections, recurrent",An increased susceptibility to respiratory infections as manifested by a history of recurrent respiratory infections.,false,,,http://purl.obolibrary.org/obo/HP_0011947|http://purl.obolibrary.org/obo/HP_0002719,,,,,,,,,,,,,,,,,,,,UMLS:C3806482,An increased susceptibility to respiratory infections as manifested by a history of recurrent respiratory infections.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0002782|HP:0002873,,,,"Recurrent respiratory infections|Frequent respiratory infections|Multiple respiratory infections|Susceptibility to respiratory infections|respiratory infections, recurrent",,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011947|http://purl.obolibrary.org/obo/HP_0002719,,,,HP:0002205,,,,,,,,,,,,,,,HP:0002205,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Recurrent respiratory infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003309,HSPA5,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,BIP|MIF2|HEL-S-89n|GRP78,,,,,,,9,,,,,,,,,,Ensembl:ENSG00000044574|HPRD:00682|Vega:OTTHUMG00000020672|MIM:138120|HGNC:5238,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",,9q33.3,,,,"GO_0002576 (EC: TAS); GO_0005509 (EC: TAS, PMID: 16130169); GO_0005515 (EC: IPI, PMID: 11907036); GO_0005524 (EC: IEA); GO_0005634 (EC: IMP, PMID: 11943137); GO_0005783 (EC: IDA, PMID: 16223484); GO_0005783 (EC: IMP, PMID: 11943137); GO_0005783 (EC: TAS, PMID: 16130169); GO_0005788 (EC: TAS); GO_0005789 (EC: TAS); GO_0005793 (EC: IDA, PMID: 15308636); GO_0006200 (EC: ISS); GO_0006983 (EC: IEA); GO_0006987 (EC: TAS); GO_0007596 (EC: TAS); GO_0008180 (EC: IDA, Qualifier: colocalizes_with, PMID: 18850735); GO_0009986 (EC: IEA); GO_0016887 (EC: ISS); GO_0019904 (EC: IPI, PMID: 12411443); GO_0021589 (EC: IEA); GO_0021680 (EC: IEA); GO_0021762 (EC: IEP); GO_0030168 (EC: TAS); GO_0030176 (EC: IDA, PMID: 11181571); GO_0030335 (EC: IMP); GO_0030433 (EC: TAS, PMID: 19816510); GO_0030496 (EC: IDA, PMID: 15166316); GO_0030512 (EC: IEA); GO_0030968 (EC: TAS, PMID: 19816510); GO_0031398 (EC: IEA); GO_0031625 (EC: IPI, PMID: 8666824); GO_0034663 (EC: IDA, PMID: 18400946); GO_0035437 (EC: IMP); GO_0042149 (EC: IDA, PMID: 10085239); GO_0042470 (EC: IEA); GO_0043022 (EC: IEA); GO_0043066 (EC: IMP, PMID: 10760948); GO_0043066 (EC: TAS, PMID: 16130169); GO_0044267 (EC: TAS); GO_0051082 (EC: TAS, PMID: 16130169); GO_0051087 (EC: TAS, PMID: 19816510); GO_0051787 (EC: IDA, PMID: 18400946); GO_0060904 (EC: TAS, PMID: 19816510); GO_0070062 (EC: IDA, PMID: 19056867); GO_0071236 (EC: IEA); GO_0071353 (EC: IEA)",PMID: 1480470; 1602151; 1649196; 1900540; 2294010; 2840249; 3087629; 3122216; 7724523; 7878056; 7906708; 7957306; 8020977; 8666824; 9006956; 9150946; 9150948; 9305856; 9409741; 9492298; 9885241; 10049727; 10085239; 10197448; 10397760; 10461883; 10514465; 10588643; 10617616; 10708769; 10760948; 10777498; 10887119; 10906332; 10964507; 10964928; 10970892; 11013075; 11160188; 11162507; 11162551; 11181571; 11294872; 11476899; 11719466; 11751874; 11752154; 11765911; 11790298; 11907036; 11932435; 11943137; 12076252; 12097557; 12194978; 12356756; 12359150; 12383251; 12397072; 12411443; 12471035; 12475965; 12477932; 12480769; 12493773; 12514190; 12516782; 12552023; 12621026; 12637535; 12643545; 12665508; 12713871; 12832005; 12840015; 15009096; 15077298; 15146195; 15150263; 15166316; 15280358; 15308636; 15324660; 15456888; 15489334; 15514946; 15525676; 15618547; 15635413; 15657421; 15664986; 15778089; 15817150; 15899857; 15908432; 15949590; 15952740; 16027165; 16051665; 16130169; 16168956; 16169070; 16182273; 16196087; 16212417; 16223484; 16236267; 16257961; 16282978; 16329989; 16344560; 16400691; 16428306; 16472112; 16488447; 16497268; 16522924; 16543232; 16731524; 16912156; 16912197; 17002502; 17062670; 17081065; 17139257; 17184779; 17215244; 17220478; 17337485; 17380188; 17431395; 17601350; 17620599; 17640713; 17643375; 17670764; 17683050; 17721549; 17725712; 17728248; 17765891; 17805346; 17848573; 17906960; 17931354; 17932454; 17936241; 17942541; 17979178; 17991893; 18022401; 18064632; 18083346; 18192872; 18264092; 18268478; 18278507; 18331622; 18343577; 18400946; 18403493; 18411300; 18457437; 18482745; 18502753; 18556570; 18654987; 18708056; 18708359; 18720263; 18757373; 18776923; 18781276; 18781797; 18790759; 18840615; 18842681; 18850735; 18977241; 19014922; 19017364; 19056867; 19097122; 19103594; 19107326; 19128512; 19135240; 19151922; 19164805; 19165527; 19167051; 19188365; 19193609; 19212831; 19228285; 19236758; 19275587; 19287380; 19296942; 19309398; 19343720; 19380743; 19386345; 19411306; 19421146; 19470730; 19471022; 19482905; 19533686; 19546472; 19596686; 19616278; 19626590; 19632185; 19659607; 19671925; 19674193; 19713465; 19718440; 19722195; 19738201; 19741001; 19765186; 19776128; 19786088; 19815544; 19815549; 19816510; 19823030; 19838160; 19838163; 19842229; 19845896; 19850743; 19875381; 19950238; 20017148; 20020773; 20028516; 20072656; 20082722; 20085233; 20145413; 20171186; 20176102; 20204278; 20208072; 20213805; 20360535; 20371724; 20457808; 20473863; 20473970; 20484513; 20492754; 20497865; 20506407; 20508642; 20525207; 20605795; 20628775; 20651985; 20664690; 20672702; 20720212; 20735358; 20739513; 20936779; 20979610; 21056970; 21080038; 21081666; 21112319; 21118962; 21137052; 21139048; 21145461; 21156321; 21189163; 21199322; 21203488; 21221131; 21252943; 21319273; 21343306; 21374734; 21382870; 21389343; 21418596; 21467168; 21472681; 21479362; 21503958; 21516372; 21565611; 21597391; 21622563; 21642380; 21673190; 21738476; 21745816; 21763498; 21779363; 21800051; 21825151; 21840908; 21853274; 21890413; 21890473; 21903092; 21906983; 21940774; 21947079; 21947694; 21963094; 21965664; 21987572; 21988832; 22004425; 22076227; 22079093; 22146569; 22178446; 22215138; 22234250; 22268729; 22297694; 22306319; 22425662; 22427667; 22430489; 22438978; 22446326; 22460328; 22472071; 22495374; 22505724; 22527697; 22528773; 22536838; 22543280; 22546345; 22564965; 22581315; 22613557; 22627132; 22689054; 22735594; 22751133; 22752300; 22796945; 22801219; 22810585; 22851173; 22855534; 22863883; 22889453; 22912664; 22939629; 22945507; 22963397; 22996014; 23000965; 23056589; 23085757; 23089287; 23097496; 23123197; 23161089; 23182705; 23184937; 23200913; 23220234; 23233672; 23246001; 23277564; 23280503; 23314748; 23318453; 23322163; 23349634; 23363602; 23378021; 23383273; 23398456; 23402259; 23402331; 23416888; 23428871; 23438482; 23455922; 23456958; 23457489; 23470966; 23485528; 23544152; 23569248; 23575540; 23578665; 23703321; 23721263; 23759331; 23760505; 23798571; 23818965; 23862649; 23922175; 23956138; 24030972; 24080088; 24113185; 24113381; 24155957; 24239288; 24244333; 24457600,,,,,,,,,,,,,,,,,,OGG:3000003309,,,,,,,,,,,,,,,,,,,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32169481,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HSPA5,,,20140408,3309,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,HSPA5,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_240550,SARS coronavirus TWJ,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:240550,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWJ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C152860,Verdinexor,VERDINEXOR|Verdinexor,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C152860,,,FDA,,,,,,,,,,,,,,,,,,,,,,,,85Q03215IW,,,,,,,,,,,,,,VERDINEXOR|Verdinexor,,,,,,,,,,,,,NCIT:C152860,"Verdinexor (KPT-335) is a novel, oral Selective Inhibitor of Nuclear Export (SINE) compound being evaluated in a variety of viral indications as well as in autoimmune / inflammatory diseases. Additionally, it is being studied for the treatment of canine cancers, including lymphoma.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Verdinexor,,,,,,,CL554064,,,,,,,,,,,,Verdinexor,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,Pharmacologic Substance,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009127,purine nucleoside monophosphate biosynthetic process,purine nucleoside monophosphate anabolism|purine nucleoside monophosphate formation|purine nucleoside monophosphate synthesis|purine nucleoside monophosphate biosynthesis,"The chemical reactions and pathways resulting in the formation of purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009126|http://purl.obolibrary.org/obo/GO_0009124,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine nucleoside monophosphate anabolism|purine nucleoside monophosphate formation|purine nucleoside monophosphate synthesis|purine nucleoside monophosphate biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009126|http://purl.obolibrary.org/obo/GO_0009124,,,,GO:0009127,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009127,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine nucleoside monophosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046683,response to organophosphorus,organophosphorus susceptibility/resistance|organophosphorus resistance,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organophosphorus stimulus. Organophosphorus is a compound containing phosphorus bound to an organic molecule; several organophosphorus compounds are used as insecticides, and they are highly toxic cholinesterase inhibitors.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organophosphorus stimulus. Organophosphorus is a compound containing phosphorus bound to an organic molecule; several organophosphorus compounds are used as insecticides, and they are highly toxic cholinesterase inhibitors.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,organophosphorus susceptibility/resistance|organophosphorus resistance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0046683,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046683,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to organophosphorus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000033,ssRNA viral genome,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/books/NBK554776/figure/article-52171.image.f5/,Single-stranded RNA viruses are classified as positive or negative strand according to the way in which coding information is stored in the viral genome.,,,,,,,,,,,,,,,,ssRNA viral genome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0100288,data analysis operation,,Placeholder for EDAM operation class.,false,,,http://purl.obolibrary.org/obo/ERO_0100287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ERO:0100288,"Data analysis is a process of inspecting, cleaning, transforming, and modeling data with the goal of highlighting useful information, suggesting conclusions, and supporting decision making.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Placeholder for EDAM operation class.,,http://purl.obolibrary.org/obo/ERO_0100287,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,data analysis operation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0071474,cellular hyperosmotic response,cellular response to hypertonicity|cellular hypertonic response|cellular HOG response,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell.",false,,,http://purl.obolibrary.org/obo/GO_0033554|http://purl.obolibrary.org/obo/GO_0006970,,,,,,,,,,,,,,,,midori,2009-12-18T11:51:36Z,,,,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular response to hypertonicity|cellular hypertonic response|cellular HOG response,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033554|http://purl.obolibrary.org/obo/GO_0006970,,,,GO:0071474,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0071474,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cellular hyperosmotic response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://identifiers.org/mamo/MAMO_0000023,computational model,,"mathematical model that requires computer simulations to study the behavior of a complex system. The system under study is often a complex nonlinear system for which simple, intuitive analytical solutions are not readily available. Rather than deriving a mathematical analytical solution to the problem, experimentation with the model is done by adjusting the parameters of the system in the computer, and studying the differences in the outcome of the experiments. ",false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000412,,,,,,,,,,,,,,,,,,,,,"mathematical model that requires computer simulations to study the behavior of a complex system. The system under study is often a complex nonlinear system for which simple, intuitive analytical solutions are not readily available. Rather than deriving a mathematical analytical solution to the problem, experimentation with the model is done by adjusting the parameters of the system in the computer, and studying the differences in the outcome of the experiments. ",,,,,,,,,,,,"weather forecasting models, earth simulator models, flight simulator models, molecular protein folding models, neural network models.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000412,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mamo.owl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,computational model,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0032251,Abnormal immune system morphology,,,false,,,http://purl.obolibrary.org/obo/HP_0002715,,,,,,,,,,,,,,,,peter,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0032251,"Any unspecified morphological anomaly of the immune system, such as, for example, abnormal shape or colour.",,,,,,,,,,,,,,,,,2019-01-27T16:44:33Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002715,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal immune system morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000123,clinical data item,,a data item that is about a patient and is the specified output of a health care process assay or diagnostic process,false,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,,,,,,,,,,creation date: 2018-11-27,,a data item that is about a patient and is the specified output of a health care process assay or diagnostic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000123,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl|http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,clinical data item,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009925,basal plasma membrane,,"The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0009925,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009925,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,basal plasma membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0060139,positive regulation of apoptotic process by virus,positive regulation of apoptosis by virus,"Any viral process that activates or increases the frequency, rate or extent of cell death by apoptotic process.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"Any viral process that activates or increases the frequency, rate or extent of cell death by apoptotic process.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,positive regulation of apoptosis by virus,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0060139,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226,,,,GO:0060139,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of apoptotic process by virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_91231,piperaquine,"7-chloro-4-(4-{3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl}piperazin-1-yl)quinoline|1,3-bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane|piperaquinoline","An aminoquinoline that is 1,3-di(piperazin-1-yl)propane in which the nitrogen at position 4 of each of the piperazine moieties is replaced by a 7-chloroquinolin-4-yl group.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:21914092|PMID:15610051|PMID:22515619|Reaxys:905079|Drug_Central:4193|PMID:25221689|PMID:25748707|PMID:25975936|PMID:26821381|Wikipedia:Piperaquine|PMID:18378269|CAS:4085-31-8|PMID:19773652|PMID:26695060,"An aminoquinoline that is 1,3-di(piperazin-1-yl)propane in which the nitrogen at position 4 of each of the piperazine moieties is replaced by a 7-chloroquinolin-4-yl group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7-chloro-4-(4-{3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl}piperazin-1-yl)quinoline,,,,,chebi_ontology,,"1,3-bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane|piperaquinoline",,,,,,,,,0,C29H32Cl2N6,"InChI=1S/C29H32Cl2N6/c30-22-2-4-24-26(20-22)32-8-6-28(24)36-16-12-34(13-17-36)10-1-11-35-14-18-37(19-15-35)29-7-9-33-27-21-23(31)3-5-25(27)29/h2-9,20-21H,1,10-19H2",UCRHFBCYFMIWHC-UHFFFAOYSA-N,535.512,534.20655,C12=CC=C(C=C1N=CC=C2N3CCN(CC3)CCCN4CCN(CC4)C=5C=CN=C6C5C=CC(=C6)Cl)Cl,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:91231,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32291112,,,,CHEBI:91231,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,piperaquine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000061,haplotype of Severe acute respiratory syndrome coronavirus 2 infection,,,false,,,http://purl.obolibrary.org/obo/OGI_0000043,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Haplotype associated with SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGI_0000043,,,,,,modified definition,,"Haplotype is classified under material entity , so as 'haplotype of Severe acute respiratory syndrome coronavirus 2 infection.'
Refer : https://www.ebi.ac.uk/ols/ontologies/ogi/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FOGI_0000043",,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,haplotype of Severe acute respiratory syndrome coronavirus 2 infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C17103,Risk Factor,Risk Factor|risk factor,"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.",false,,,http://purl.obolibrary.org/obo/BFO_0000016,,"Something that increases the chance of developing a disease. Some examples of risk factors for cancer are age, a family history of certain cancers, use of tobacco products, being exposed to radiation or certain chemicals, infection with certain viruses or bacteria, and certain genetic changes.",,,,,,,,,C17103,,,,,,,,,,"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Risk Factor|risk factor,,,,,,,,,,,,,NCIT:C17103,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000016,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Risk Factor,Risk_Factor,,,,,,,,,,,,,,,,,,Risk Factor,,,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext,Clinical Attribute,,,,,,,,C0035648,
http://purl.obolibrary.org/obo/DRON_00019607,tocilizumab,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,612865,,,,DRON:00019607,"A recombinant, humanized IgG1 monoclonal antibody directed against the interleukin-6 receptor (IL-6R) with immunosuppressant activity. Tocilizumab targets and binds to both the soluble form of IL-6R (sIL-6R) and the membrane-bound form (mIL-6R), thereby blocking the binding of IL-6 to its receptor. This prevents IL-6-mediated signaling. Il-6, a pro-inflammatory cytokine that plays an important role in the regulation of the immune response, is overproduced in autoimmune disorders, certain types of cancers and possibly various other inflammatory conditions.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32290839,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,tocilizumab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_16737,creatinine,"2-imino-1-methylimidazolidin-4-one|creatinine|Creatinine|1-Methylglycocyamidine|1-methylglycocyamidine|2-amino-1,5-dihydro-1-methyl-4H-Imidazol-4-one|Creatine anhydride|Kreatinin|creatinina|1-Methylhydantoin-2-imide|2-Amino-1-methylimidazolin-4-one",A lactam obtained by formal cyclocondensation of creatine. It is a metabolite of creatine.,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,Reaxys:112064|PMID:21775764|PMID:17190852|PMID:22459582|PMID:22390548|PMID:19236048|KEGG:D03600|KEGG:C00791|PMID:22498455|PMID:18182718|PMID:22349552|PMID:22166252|HMDB:HMDB0000562|Wikipedia:Creatinine|CAS:60-27-5|PMID:22331238|PMID:19968328|PMID:22432114|PMID:22207347|PMID:22338083|PMID:22441184|PMID:11981083|PMID:17422601|PMID:22047975|PMID:22212624|MetaCyc:CREATININE|PMID:22223530|PMID:19715855|PMID:11256540|PMID:22121923,A lactam obtained by formal cyclocondensation of creatine. It is a metabolite of creatine.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:14029|CHEBI:3910|CHEBI:23406,,,,2-imino-1-methylimidazolidin-4-one|creatinine|Creatinine,,,,,chebi_ontology,,"1-Methylglycocyamidine|1-methylglycocyamidine|2-amino-1,5-dihydro-1-methyl-4H-Imidazol-4-one|Creatine anhydride|Kreatinin|creatinina|1-Methylhydantoin-2-imide|2-Amino-1-methylimidazolin-4-one",,,,,,,,,0,C4H7N3O,"InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)",DDRJAANPRJIHGJ-UHFFFAOYSA-N,113.11800,113.05891,CN1CC(=O)NC1=N,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:16737,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,CHEBI:16737,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,creatinine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012252,Abnormal respiratory system morphology,,A structural anomaly of the respiratory system.,false,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,,,,,,peter,2013-04-07T09:11:09Z,,,Fyler:4235|UMLS:C4022992,A structural anomaly of the respiratory system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002086,,,,HP:0012252,,,,,,,,,,,,,,,HP:0012252,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal respiratory system morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_511433,SARS coronavirus BJ182b,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:511433,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ182b,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003939,LDHA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,GSD11|HEL-S-133P|LDH1|LDHM,,,,,,,11,,,,,,,,,,MIM:150000|Vega:OTTHUMG00000167721|HPRD:01025|Ensembl:ENSG00000134333|HGNC:6535,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,lactate dehydrogenase A,,11p15.4,,,,"GO_0004459 (EC: NAS, PMID: 1953713); GO_0005515 (EC: IPI); GO_0005739 (EC: IEA); GO_0005829 (EC: TAS); GO_0005929 (EC: IEA); GO_0006090 (EC: TAS); GO_0006096 (EC: NAS, PMID: 1953713); GO_0021762 (EC: IEP); GO_0031668 (EC: IEA); GO_0044237 (EC: TAS); GO_0044262 (EC: IEA); GO_0044281 (EC: TAS); GO_0070062 (EC: IDA, PMID: 11487543)",PMID: 1297552; 1445373; 1953713; 1959923; 2315312; 2334430; 2434947; 3000353; 3838278; 5014440; 7273846; 7908613; 8125298; 8327147; 10508479; 10897012; 11125887; 11276087; 11487543; 11582518; 12107167; 12145195; 12160330; 12477932; 12555229; 12629811; 12712614; 14702039; 14760703; 15161933; 15231747; 15240094; 15489334; 15592455; 15635413; 15710247; 16009940; 16027165; 16132575; 16196087; 16263121; 16344560; 16766262; 17178662; 17220478; 17483170; 18039033; 18160415; 18521687; 18534967; 18781797; 18814027; 18821170; 19021062; 19135240; 19276158; 19668225; 19738201; 19838163; 19847924; 19923867; 20385008; 20639865; 20677014; 20828817; 20849852; 20877624; 20946988; 20951115; 21044950; 21081666; 21124955; 21139048; 21145461; 21249322; 21252943; 21319273; 21452021; 21632858; 21726808; 21853274; 21858537; 21890473; 21906983; 21963094; 21969607; 21987572; 21988832; 22053931; 22079093; 22127970; 22268729; 22304920; 22360420; 22429998; 22505724; 22536838; 22593701; 22623428; 22863883; 22897481; 22923663; 22939629; 22948140; 22961700; 22990118; 23000965; 23166385; 23184277; 23266049; 23318563; 23349634; 23404405; 23467744; 23516535; 23722553; 23797802; 23859015; 24250222; 24457600,,,,,,,,,,,,,,,,,,OGG:3000003939,,,,,,,,,,,,,,,,,,,lactate dehydrogenase A,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,LDHA,,,20140408,3939,PIG19,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,LDHA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0098687,chromosomal region,chromosome region,Any subdivision of a chromosome along its length.|Chromosomal regions include parts that are not part of the chromatin.  Examples include the kinetochore.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,Any subdivision of a chromosome along its length.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chromosome region,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Chromosomal regions include parts that are not part of the chromatin.  Examples include the kinetochore.,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0098687,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098687,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,chromosomal region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006270,DNA replication initiation,DNA-dependent DNA replication initiation|DNA endoreduplication initiation|DNA re-replication initiation,"The process in which DNA-dependent DNA replication is started; this begins with the ATP dependent loading of an initiator complex onto the DNA, this is followed by DNA melting and helicase activity. In bacteria, the gene products that enable the helicase activity are loaded after the initial melting and in archaea and eukaryotes, the gene products that enable the helicase activity are inactive when they are loaded and subsequently activate.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The process in which DNA-dependent DNA replication is started; this begins with the ATP dependent loading of an initiator complex onto the DNA, this is followed by DNA melting and helicase activity. In bacteria, the gene products that enable the helicase activity are loaded after the initial melting and in archaea and eukaryotes, the gene products that enable the helicase activity are inactive when they are loaded and subsequently activate.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042024,,,,DNA-dependent DNA replication initiation,,,DNA endoreduplication initiation|DNA re-replication initiation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006270,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006270,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,DNA replication initiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267384,SARS coronavirus Sin852,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267384,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin852,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00862672,Fedratinib,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2197490,,,,DRON:00862672,"An orally bioavailable, small-molecule, ATP-competitive inhibitor of Janus-associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2), with potential antineoplastic activity. Upon oral administration, fedratinib competes with wild-type JAK2 as well as mutated forms for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, inhibition of tumor cell proliferation and induction of tumor cell apoptosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113509/,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,Fedratinib,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002886,regulation of myeloid leukocyte mediated immunity,,"Any process that modulates the frequency, rate, or extent of myeloid leukocyte mediated immunity.",false,,,http://purl.obolibrary.org/obo/GO_0002697,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate, or extent of myeloid leukocyte mediated immunity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002697,,,,GO:0002886,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002886,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of myeloid leukocyte mediated immunity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000661,enzyme-linked immunosorbent assay,,"An analyte assay where binding of an enzyme linked antibody to a material entity that is immobilized on solid support is detected utilizing a chemiluminescent reaction. Depending on the setup, the enzyme-linked antibody could be binding directly to the analyte, or it serves as a secondary antibody detecting binding of the primary antibody to the analyte.",false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,ELISA,,,,,,,,,,,,,,,,,,"An analyte assay where binding of an enzyme linked antibody to a material entity that is immobilized on solid support is detected utilizing a chemiluminescent reaction. Depending on the setup, the enzyme-linked antibody could be binding directly to the analyte, or it serves as a secondary antibody detecting binding of the primary antibody to the analyte.",,IEDB,,,,,,,enzyme-linked immunosorbent assay,,,,"1) Detection of IL-2 (analyte) in a cell supernatant (evaluant), using plate bound anti IL-2 antibodies, and a reporter enzyme-linked reporter antibody. 2) Measurement of IgG antibody (analyte) titer in a serum sample (evaluant) using plate bound antigen and a reporter anti-IgG antibody.",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,OBI:0000661,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,enzyme-linked immunosorbent assay,,,,,,,,,,,,,,,,,,,,,,http://www.epitopediagnostics.com/covid-19-elisa,,,,,,IEDB,,,,
http://purl.obolibrary.org/obo/NCIT_C25549,Isolation,isolation|Isolation|Isolated,A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements.,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,State of being separated from others. Isolation is sometimes used to prevent disease from spreading.,,,,,,,,,C25549,,,,,,,,,,A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,isolation|Isolation|Isolated,,,,,,,,,,,,,NCIT:C25549,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Isolation,Isolated,,,,,,,,,,,,,,,,,,Isolation,,,https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/social-distancing.html,Qualitative Concept,,,,,,,,C0205409,
https://bio.scai.fraunhofer.de/ontology/COVID_0000095,enzaplatovir,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Enzaplatovir (BTA-C585) is an orally bioavailable fusion inhibitor for respiratory syncytial virus (RSV) infection[1].,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,,,,,,,,,,,,,,enzaplatovir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006735,NADH regeneration,reduced NAD regeneration|reduced nicotinamide adenine dinucleotide regeneration|NAD (reduced) regeneration,A metabolic process that generates a pool of NADH by the reduction of NAD+.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,A metabolic process that generates a pool of NADH by the reduction of NAD+.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,reduced NAD regeneration|reduced nicotinamide adenine dinucleotide regeneration|NAD (reduced) regeneration,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006735,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006735,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,NADH regeneration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0035966,response to topologically incorrect protein,response to misfolded or unfolded protein,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,rfoulger,2011-08-03T11:43:12Z,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,response to misfolded or unfolded protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0035966,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0035966,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to topologically incorrect protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OAE_0000001,adverse event,,"a pathological bodily process that occurs after a medical intervention. An adverse event is likely caused by the medical intervention; however, such a causal association is not required to be an adverse event.|The OAE official website is: http://www.oae-ontology.org/.",false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,adverse reaction|AE,,,,,,,,,,,,,,,,,,"a pathological bodily process that occurs after a medical intervention. An adverse event is likely caused by the medical intervention; however, such a causal association is not required to be an adverse event.",,WEB: http://en.wikipedia.org/wiki/Adverse_event|WEB: http://www.ncbi.nlm.nih.gov/pubmed/25093068|WEB: http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm,,,,,,"YH: In development of OAE, we initially use vaccine adverse event as our use case. A vaccine adverse event is associated with a vaccination (i.e. a medical intervention), regardless of whether it is considered vaccine-related, and includes any side effect, injury, toxicity, or sensitivity reaction or significant failure of immunization (i.e., a pharmacologic action).
Ref: Baylor NW and Midthum K. Regulation and testing of vaccines. In: Vaccines (Editors: Plotkin S, Orenstein W, and Offit P). 2008.  p1623.|YH: There has been discussion regarding whether the term 'side effect' is an alternative term for 'adverse event'. In AERO, the term 'AERO:adverse event' represents a subset of those adverse events for which causality has been established. In OAE, an adverse event for which causality has been established is called 'causal adverse event'.|YH: The current term 'adverse event' is different from the term definition shown in our paper: He Y, Xiang Z, Sarntivijai S, Toldo L, Ceusters W. OAE: a realism-based biomedical ontology for the representation of adverse events. Adverse Event Representation Workshop, International Conference on Biomedical Ontologies (ICBO), University at Buffalo, NY, July 26-30, 2011. Full lenghth conference proceeding paper.  

We  made the name changing in order to make OAE cover the broader sense of the 'adverse event' which does not assume definite causal effect between an adverse event and a medical intervention. In current definition, the adverse event emphasizes the time association and assumes a likelihood of such a causal association. This term 'adverse event' is stil under the OGMS:pathological bodily process.

The 'adverse event' defined in the above paper has now been changed to a new term: 'causal adverse event'. See more information in the new publication: Yongqun He Y, Sirarat Sarntivijai, Yu Lin, Zuoshuang Xiang, Abra Guo, Shelley Zhang, Desikan Jagannathan, Luca Toldo, Cui Tao and Barry Smith. OAE: The Ontology of Adverse Events. Journal of Biomedical Semantics. 2014, 5:29  doi:10.1186/2041-1480-5-29. PMID: 25093068.PMCID: PMC4120740.|YH: An adverse event is a process that has specified output of some adverse medical outcome (e.g., symptom, sign or accident) after a medical intervention (or process) (e.g., administration of drug or vaccine). The medical intervention can be an administration of a drug, a vaccine (i.e., vaccination), or a special nutritional product (for example, dietary supplement, infant formula, medical food), surgery, or usage of a medical device.|YH: The main scope of OAE includes: (1) represent terms and relations in the area of adverse events, (2) assess possible associations between an adverse event and a medical intervention, particularly, identify any causal effect of a medical intervention to an adverse event; and (2) understand the mechanism (including molecular mechanisms) of causal adverse events.|YH: An adverse event is possibly induced by the medical intervention. It can be caused by the medical intervention, or may not be caused by the medical intervention. One ultimate goal (or the goal in clinics) of study adverse events is to assess if the adverse event outcome is due to the medical intervention.|Melanie Courtot and YH: More work is needed on how to restrict the scope of a term to be an 'adverse event', notably regarding temporal association. When is an appropirate time interval between a medical intervention and an adverse event observed? One week, one month, one year, or a lifetime? For some well-studied medical interventions (e.g., administration of many vaccines or drugs), we probably have a general idea. For many new interventions, we don't know much. In OAE, this issue is associated with defining the 'adverse event incubation time'.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OAE:0000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,The OAE official website is: http://www.oae-ontology.org/.,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/oae.owl,,,,,,,,,,,adverse event,,,,,,,,,,,,,,,,,,,,,,,,,,,,Yongqun He,,,,
http://purl.obolibrary.org/obo/CHEBI_39548,atorvastatin,"Atorvastatin|(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid|atorvastatina|atorvastatinum|Atorlip|(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid|7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID|atorvastatin|atorvastatine","A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D07474|Reaxys:8373630|KEGG:C06834|PMID:15012735|PDBeChem:117|PMID:11693468|Patent:US5273995|Drug_Central:257|Wikipedia:Atorvastatin|CAS:134523-00-5|Patent:EP409281|DrugBank:DB01076|Beilstein:8373630|HMDB:HMDB0005006|LINCS:LSM-5771|PMID:18720283,"A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:39538|CHEBI:2910,,,,"Atorvastatin|(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid",,,,,chebi_ontology,,"atorvastatina|atorvastatinum|Atorlip|(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid|7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]-3,5-DIHYDROXY-HEPTANOIC ACID|atorvastatin|atorvastatine",,,,,,,,,0,C33H35FN2O5,"InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1",XUKUURHRXDUEBC-KAYWLYCHSA-N,558.63988,558.25300,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:39548,,,,,true,true,,,,,,,,,CHEBI:39548,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,atorvastatin,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044774,mitotic DNA integrity checkpoint,mitotic cell cycle G2/M transition decatenation checkpoint|topoisomerase II checkpoint|topo II checkpoint,"A mitotic cell cycle process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and ends with signal transduction.",false,,,http://purl.obolibrary.org/obo/GO_0031570|http://purl.obolibrary.org/obo/GO_0007093,,,,,,,,,,,,,,,,janelomax,2013-02-28T16:07:26Z,,,,"A mitotic cell cycle process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA. The DNA integrity checkpoint begins with detection of DNA damage, defects in DNA structure or DNA replication, and ends with signal transduction.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0070683,,,,mitotic cell cycle G2/M transition decatenation checkpoint|topoisomerase II checkpoint|topo II checkpoint,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0031570|http://purl.obolibrary.org/obo/GO_0007093,,,,GO:0044774,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044774,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mitotic DNA integrity checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1902100,negative regulation of metaphase/anaphase transition of cell cycle,down-regulation of metaphase/anaphase transition of cell cycle|down regulation of metaphase/anaphase transition of cell cycle|downregulation of metaphase/anaphase transition of cell cycle|inhibition of metaphase/anaphase transition of cell cycle,"Any process that stops, prevents or reduces the frequency, rate or extent of metaphase/anaphase transition of cell cycle.",false,,,http://purl.obolibrary.org/obo/GO_1902099|http://purl.obolibrary.org/obo/GO_1901988,,,,,,,,,,,,,,,,jl,2013-05-02T12:45:20Z,,,,"Any process that stops, prevents or reduces the frequency, rate or extent of metaphase/anaphase transition of cell cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,down-regulation of metaphase/anaphase transition of cell cycle|down regulation of metaphase/anaphase transition of cell cycle|downregulation of metaphase/anaphase transition of cell cycle,,,inhibition of metaphase/anaphase transition of cell cycle,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1902099|http://purl.obolibrary.org/obo/GO_1901988,,,,GO:1902100,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902100,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of metaphase/anaphase transition of cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043202,lysosomal lumen,,The volume enclosed within the lysosomal membrane.,false,,,http://purl.obolibrary.org/obo/GO_0005775,,,,,,,,,,,,,,,,,,,,,The volume enclosed within the lysosomal membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005775,,,,GO:0043202,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043202,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lysosomal lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2452,thrombophilia,hypercoagulability state,OMIM mapping confirmed by DO. [LS].,false,,,http://purl.obolibrary.org/obo/DOID_1247,,,,,,,,,,,,,,,,,,,,NCI:C84479|UMLS_CUI:C0398623|SNOMEDCT_US_2019_09_01:234467004|ICD10CM:D68.59|OMIM:188050|MESH:D019851|OMIM:614486,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hypercoagulability state,,,,,disease_ontology,,,,,,,,,"A condition characterized by an abnormally high level of thrombi. Causes include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, bone marrow disorders, and antiphospholipid antibody syndrome.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,OMIM mapping confirmed by DO. [LS].,,http://purl.obolibrary.org/obo/DOID_1247,,,,DOID:2452,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,DOID:2452,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,thrombophilia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000450,shock,,"A cardiovascular system symptom that is characterized as a state of profound depression of the vital processes of the body that is characterized by pallor, rapid but weak pulse, rapid and shallow respiration, reduced total blood volume, and low blood pressure and that is caused usually by severe especially crushing injuries, hemorrhage, burns, or major surgery.",false,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,,,,,,,,,,,,,,,,,ICD9CM_2005:785.5|UMLS_CUI:C0159051|UMLS_ICD9CM_2005_AUI:A0284197,"A cardiovascular system symptom that is characterized as a state of profound depression of the vital processes of the body that is characterized by pallor, rapid but weak pulse, rapid and shallow respiration, reduced total blood volume, and low blood pressure and that is caused usually by severe especially crushing injuries, hemorrhage, burns, or major surgery.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000528,,,,SYMP:0000450,,,,,,,,,,,,,,,SYMP:0000450,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,shock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_168396,mycophenolic acid,"(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid|acide mycophenolique|acido micofenolico|Micofenolico acido|Mycophenolsaeure|Mycophenolate|mycophenolic acid|(E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|acidum mycophenolicum","A member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PDBeChem:MOA|Reaxys:318158|PMID:11272311|Patent:US4753935|KEGG:D05096|Wikipedia:Mycophenolic_acid|PMID:17498396|PMID:19689217|PMID:18194117|CAS:24280-93-1|PMID:15470161|PMID:17482154|PMID:18996104|DrugBank:DB01024|PMID:16640327|PMID:16629948|Drug_Central:1860|PMID:18611107|Beilstein:318158,"A member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:43973,,,,"(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid",,,,,chebi_ontology,,acide mycophenolique|acido micofenolico|Micofenolico acido|Mycophenolsaeure|Mycophenolate|mycophenolic acid|(E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|acidum mycophenolicum,,,,,,,,,0,C17H20O6,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",HPNSFSBZBAHARI-RUDMXATFSA-N,320.33710,320.12599,COc1c(C)c2COC(=O)c2c(O)c1CC=C(/C)CCC(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:168396,,,,,,true,,,,,,,,,CHEBI:168396,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,mycophenolic acid,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050263,rep gene translation product (SARS-CoV-2),rep (SARS2)|ORF1a-1b|rep|GU280_gp01|ORF1ab,"A protein that is a translation product of the rep gene in SARS-CoV-2.|Category=organism-gene. Note: The rep gene produces two translation products, one with (ORF1ab) and one without (ORF1a) -1 ribosomal frameshifting. Both products are further processed by proteolytic cleavage to yield 10 identical chains, while 1 additional chain is unique to ORF1a and 5 additional chains are unique to ORF1ab.",false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,,A protein that is a translation product of the rep gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,rep (SARS2),,,,,protein,,ORF1a-1b|rep|GU280_gp01|ORF1ab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Category=organism-gene. Note: The rep gene produces two translation products, one with (ORF1ab) and one without (ORF1a) -1 ribosomal frameshifting. Both products are further processed by proteolytic cleavage to yield 10 identical chains, while 1 additional chain is unique to ORF1a and 5 additional chains are unique to ORF1ab.",,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:000050263,,,,,,,,,,,,,,,PR:000050263,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,rep gene translation product (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005871,kinesin complex,,"Any complex that includes a dimer of molecules from the kinesin superfamily, a group of related proteins that contain an extended region of predicted alpha-helical coiled coil in the main chain that likely produces dimerization. The native complexes of several kinesin family members have also been shown to contain additional peptides, often designated light chains as all of the noncatalytic subunits that are currently known are smaller than the chain that contains the motor unit. Kinesin complexes generally possess a force-generating enzymatic activity, or motor, which converts the free energy of the gamma phosphate bond of ATP into mechanical work.",false,,,http://purl.obolibrary.org/obo/GO_0005875,,,,,,,,,,,,,,,,,,,,,"Any complex that includes a dimer of molecules from the kinesin superfamily, a group of related proteins that contain an extended region of predicted alpha-helical coiled coil in the main chain that likely produces dimerization. The native complexes of several kinesin family members have also been shown to contain additional peptides, often designated light chains as all of the noncatalytic subunits that are currently known are smaller than the chain that contains the motor unit. Kinesin complexes generally possess a force-generating enzymatic activity, or motor, which converts the free energy of the gamma phosphate bond of ATP into mechanical work.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005875,,,,GO:0005871,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005871,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,kinesin complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050853,B cell receptor signaling pathway,B-lymphocyte receptor signaling pathway|B-cell receptor signalling pathway|B lymphocyte receptor signaling pathway|B-lymphocyte receptor signalling pathway|B-cell receptor signaling pathway|B cell receptor signalling pathway|B lymphocyte receptor signalling pathway,A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.,false,,,http://purl.obolibrary.org/obo/GO_0050851,,,,,,,,,,,,,,,,,,,,,A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B-lymphocyte receptor signaling pathway|B-cell receptor signalling pathway|B lymphocyte receptor signaling pathway|B-lymphocyte receptor signalling pathway|B-cell receptor signaling pathway|B cell receptor signalling pathway|B lymphocyte receptor signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050851,,,,GO:0050853,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050853,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,B cell receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://www.ebi.ac.uk/efo/EFO_0010106,CD3-positive T-lymphocyte count,,A quantification of CD3-positive T-lymphocytes in blood.,false,,,http://purl.obolibrary.org/obo/CMO_0000031,,,,,,,,,,,,,,,,,,,,PMID:20045101,A quantification of CD3-positive T-lymphocytes in blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,efo:EFO_0010106,,,,,,,,,,,,,,,,,,,,,,YES,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000031,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32193831/,,,,,,http://www.ebi.ac.uk/efo/efo.owl,,,,,,,,,,,CD3-positive T-lymphocyte count,,,,,,,,,,,,,,,,,,,,,,,,,,,,Annalisa Buniello,,,,
http://purl.obolibrary.org/obo/BFO_0000008,temporal region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000003,,,,,TemporalRegion,t-region,,,,,,,,,,,,,,,,,,,,,,,Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional,,,A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001]),,,,,,,,,,,(forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001] |(forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001] |(forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002] ,All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001])|Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002]),,,,,,,,,,,,,,,,,,,,,BFO:0000008,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000003,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/ido.owl,,,,,,,,,,,temporal region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039548,suppression by virus of host IRF3 activity,Inhibition of IRF3-dependent antiviral response|inhibition of host IRF3 by virus|suppression by virus of host interferon regulatory factor 3,"Any process in which a virus stops, prevents, or reduces the activity of host IRF3 (interferon regulatory factor-3), a transcription factor in the RIG-I/MDA-5 signaling pathway. Viral infection triggers phosphorylation of cytoplasmic IRF3, which allows IRF3 to form a homodimer, migrate to the nucleus, and activate transcription of IFN-alpha and IFN-beta genes.|This term is for annotation of viral proteins that counteract the host anti-viral innate immune response.",false,,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2012-01-19T04:04:26Z,,,VZ:757,"Any process in which a virus stops, prevents, or reduces the activity of host IRF3 (interferon regulatory factor-3), a transcription factor in the RIG-I/MDA-5 signaling pathway. Viral infection triggers phosphorylation of cytoplasmic IRF3, which allows IRF3 to form a homodimer, migrate to the nucleus, and activate transcription of IFN-alpha and IFN-beta genes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,Inhibition of IRF3-dependent antiviral response,,,inhibition of host IRF3 by virus|suppression by virus of host interferon regulatory factor 3,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This term is for annotation of viral proteins that counteract the host anti-viral innate immune response.,,http://purl.obolibrary.org/obo/GO_0039503|http://purl.obolibrary.org/obo/GO_0019048|http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039548,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272517/,,,,GO:0039548,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host IRF3 activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_207229,dihydroartemisinin,"(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol|1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)",A sesquiterpenoid compound which is used as a drug for treatment of malaria.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:3669021|PMID:10893313|Beilstein:4185848,A sesquiterpenoid compound which is used as a drug for treatment of malaria.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol",,,,,chebi_ontology,,"1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)",,,,,,,,,0,C15H24O5,"InChI=1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11+,12?,13-,14-,15-/m1/s1",BJDCWCLMFKKGEE-HVDUHBCDSA-N,284.34810,284.16237,[H][C@@]12CC[C@@]3(C)OO[C@]11[C@]([H])(OC(O)[C@H](C)[C@]1([H])CC[C@H]2C)O3,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:207229,,,,,,true,,,,,,,,,CHEBI:207229,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,dihydroartemisinin,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_255729,SARS coronavirus Sino3-11,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:255729,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sino3-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000402,COVID clinical aspect,,,false,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The 'COVID clinical aspect' concept enables a compilation of diverse concepts that are related to clincal aspects in Covid-19 related research via the Axiome 'isClinicalAspectFor some COIVID-19'.  Thus enables the adaptation of the ontology for text mining purposes for Covid-19 related information retrieval and information extraction.,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://www.w3.org/2002/07/owl#Thing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COVID clinical aspect,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C3890,Hypoxia,Hypoxic|Hypoxia|hypoxic|hypoxia,"A decrease in the amount of oxygen in the body. Symptoms range from mild (impaired judgment, memory loss, impaired motor coordination) to severe (seizures and coma).",false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,"A condition in which there is low oxygen in the tissues.|A condition in which there is a decrease in the oxygen supply to a tissue. In cancer treatment, the level of hypoxia in a tumor may help predict the response of the tumor to the treatment.|A disorder characterized by a decrease in the level of oxygen in the body.",,,,,,,,,C3890,,,MedDRA|NICHD|FDA|CTCAE,,,,,,,"A decrease in the amount of oxygen in the body. Symptoms range from mild (impaired judgment, memory loss, impaired motor coordination) to severe (seizures and coma).",,,,,,,,,,,,,,,,Patient Code (Appendix B),,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C54450,,Hypoxic|Hypoxia|hypoxic|hypoxia,,,,http://purl.obolibrary.org/obo/NCIT_C45233,,,,,,,,,NCIT:C3890,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32203186,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C54450|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99147|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118464|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C89506|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C62596,,,,,,,,,,Hypoxia,Hypoxia,Hypoxia,,,,,,Hypoxia,,,,,,,,,,,Hypoxia,,,,Finding,,,,,,,,C0242184,
http://purl.obolibrary.org/obo/NCBITaxon_33154,Opisthokonta,opisthokonts|Fungi/Metazoa group,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2759,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,opisthokonts|Fungi/Metazoa group,,,,,,NCBITaxon:33154,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2759,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Opisthokonta,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000721,C4B,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,C4B1|CPAMD3|C4F|CO4|C4B5|C4B_2|CH|C4B2|C4B3|C4BD|C4B12,,,,,,,6,,,,,,,,,,HPRD:00402|MIM:120820|Ensembl:ENSG00000224389|Vega:OTTHUMG00000031187|HPRD:18631|HGNC:1324,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,complement component 4B (Chido blood group),,6p21.3,,,,GO_0004866 (EC: IEA); GO_0005576 (EC: TAS); GO_0005886 (EC: TAS); GO_0006954 (EC: IEA); GO_0006956 (EC: TAS); GO_0006958 (EC: IEA); GO_0030449 (EC: TAS); GO_0045087 (EC: TAS); GO_0072562 (EC: IDA),PMID: 1088823; 1699796; 1717583; 1988494; 2295627; 2431902; 2883116; 3542363; 3696167; 3840370; 3944109; 6167582; 6546707; 6559257; 6832377; 6881182; 6950384; 6978711; 7391573; 7525470; 7545960; 7590866; 7642209; 7893437; 7911492; 8132574; 8575831; 8630395; 8660986; 8889548; 9759862; 10072631; 10207042; 10383431; 10528211; 10851272; 10946278; 11062289; 11168010; 11341920; 11367523; 11803045; 12224044; 12226794; 12477932; 12480675; 12754519; 12878586; 12893820; 12907438; 14574404; 14760718; 14989716; 15033778; 15096498; 15203218; 15456488; 15665772; 15787745; 15816885; 15998580; 16098595; 16344560; 16386506; 16504674; 16740002; 16889542; 16893076; 16908004; 16980082; 17015733; 17202363; 17212707; 17257223; 17318071; 17425651; 17503323; 17728371; 17915330; 17921792; 17971360; 17984207; 18032375; 18065805; 18085389; 18091514; 18179706; 18315707; 18347532; 18360261; 18365397; 18645500; 18682851; 18927458; 18929826; 19062096; 19135723; 19137635; 19150565; 19167759; 19505723; 19900552; 19913121; 20022265; 20139276; 20452682; 20506482; 20580617; 20628086; 20795316; 21085669; 21345967; 21620080; 21642539; 21857912; 21967755; 22076784; 22132894; 22151770; 22169613; 22387014; 22393059; 22737222; 22785613; 22841245; 22878256; 23006730; 23026593; 23199209; 23274969; 23447068; 23535732; 23698598; 23911397; 23918728,,,,,,,,,,,,,,,,,,OGG:3000000721,,,,,,,,,,,,,,,,,,,complement component 4B (Chido blood group),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,C4B,,,20140408,721,DADB-112B14.11-001,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,C4B,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGMS_0000018,laboratory finding,,A representation of a quality of a specimen that is the output of a laboratory test and that can support an inference to an assertion about some quality of the patient.,false,,,http://purl.obolibrary.org/obo/OGMS_0000014,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T10:21:58Z,,A representation of a quality of a specimen that is the output of a laboratory test and that can support an inference to an assertion about some quality of the patient.,,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000014,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl,,,,,,,,,,,laboratory finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/GO_0097205,renal filtration,,A renal system process in which fluid circulating through the body is filtered through a barrier system.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,paola,2012-01-03T03:10:17Z,,,,A renal system process in which fluid circulating through the body is filtered through a barrier system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0097205,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0097205,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,renal filtration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000063,gold immunochromatographic assay,,,false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221133,"The gold immunochromatographic assay (GICA), a technique based on the specific antigen–antibody immunoreactions, is a highly useful tool in diagnostics that can be completed within 30 min, without specialized equipment or complicated handling procedures, providing convenience for rapid testing.",,,,,,,,,,,,,,,,gold immunochromatographic assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0060140,modulation by virus of syncytium formation via plasma membrane fusion,,"The formation in a cell that has been targeted by a virus of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"The formation in a cell that has been targeted by a virus of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0060140,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32165541,,,,GO:0060140,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of syncytium formation via plasma membrane fusion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGI_0000043,haplotype,,,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGI:0000043,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,"The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the major histocompatibility complex.",haplotype of SARS-CoV-2 infection,,,,http://purl.obolibrary.org/obo/ogi.owl,,,,,,,,,,,haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006846,XCL2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SCM-1b|SCYC2|SCM1B,,,,,,,1,,,,,,,,,,HGNC:10646|MIM:604828|Ensembl:ENSG00000143185|HPRD:05317|Vega:OTTHUMG00000034549,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C motif) ligand 2,,1q24.2,,,,"GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 7875320); GO_0008009 (EC: IEA); GO_0008015 (EC: TAS, PMID: 7875320); GO_0060326 (EC: TAS, PMID: 7875320)",PMID: 7875320; 8849694; 9632725; 11181995; 12477932; 15340161; 15489334; 16710414; 16754659; 17763208; 18618175,,,,,,,,,,,,,,,,,,OGG:3000006846,,,,,,,,,,,,,,,,,,,chemokine (C motif) ligand 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,XCL2,,,20140408,6846,hCG_1729916,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,XCL2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/SYMP_0000551,disturbances of sensation of smell and taste,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000480,,,,SYMP:0000551,,,,,,,,,,,,"Reduced ability to smell or taste specific things that are sweet, sour, bitter or salty. In some cases, normally pleasant tastes or smells may become unpleasant",decreased sence of smell and taste,,SYMP:0000551,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,disturbances of sensation of smell and taste,,,,,,,,,,,,,,,,,,,,,,https://www.contagionlive.com/news/does-loss-of-smell-require-covid19-precautions,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000105,Jakotinib hydrochloride,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Jakotinib hydrochloride is a presumed inhibitor of Janus-associated kinases. It is an investigational drug used against single-stranded RNA virus (SARS-CoV2).,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,true,,,,,,,,,,,,,,,,,,,,,,Jakotinib hydrochloride,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0010314,structure with developmental contribution from neural crest,,An anatomical structure that has some part that develops from the neural crest.,false,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,,,,,,,,,,,,,,,,Grouping term for query purposes,,An anatomical structure that has some part that develops from the neural crest.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,UBERON:0010314,,,,,,,,,,,,,,,UBERON:0010314,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,structure with developmental contribution from neural crest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000031,generically dependent continuant,,b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001]),false,,,http://purl.obolibrary.org/obo/BFO_0000002,,,,,GenericallyDependentContinuant,gdc,,,,,,,,,,,,,,,b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001]),,,,,,,,,,,,,"The entries in your database are patterns instantiated as quality instances in your hard drive. The database itself is an aggregate of such patterns. When you create the database you create a particular instance of the generically dependent continuant type database. Each entry in the database is an instance of the generically dependent continuant type IAO: information content entity.|the pdf file on your laptop, the pdf file that is a copy thereof on my laptop|the sequence of this protein molecule; the sequence that is a copy thereof in that protein molecule.",,,,,,,,,(iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000031,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000002,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,generically dependent continuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC5,membrane protein (SARS-CoV-2),matrix glycoprotein (SARS2)|membrane glycoprotein (SARS2)|M protein (SARS2)|E1 glycoprotein (SARS2)|M (SARS2)|PRO_0000449652|ORF5|GU280_gp05|M,A protein that is a translation product of the M gene in SARS-CoV-2.|Category=organism-gene. Note: 222 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,UniProtKB:P0DTC5|GenPept:YP_009724393,A protein that is a translation product of the M gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,matrix glycoprotein (SARS2)|membrane glycoprotein (SARS2)|M protein (SARS2)|E1 glycoprotein (SARS2)|M (SARS2)|PRO_0000449652,,,,,protein,,ORF5|GU280_gp05|M,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 222 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC5,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,PR:P0DTC5,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,membrane protein (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098857,membrane microdomain,,A membrane region with a lipid composition that is distinct from that of the membrane regions that surround it.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,A membrane region with a lipid composition that is distinct from that of the membrane regions that surround it.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0098857,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098857,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,membrane microdomain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0004421,Elevated systolic blood pressure,Elevated systolic BP,Abnormal increase in systolic blood pressure.|Normal systolic blood pressure is less than 120 mmHg in adults.,false,,,http://purl.obolibrary.org/obo/HP_0032263,,,,,,,,,,,,,,,,peter,2008-03-18T09:33:00Z,,,UMLS:C1840374,Abnormal increase in systolic blood pressure.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0004956,,,,Elevated systolic BP,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Normal systolic blood pressure is less than 120 mmHg in adults.,,http://purl.obolibrary.org/obo/HP_0032263,,,,HP:0004421,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,HP:0004421,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Elevated systolic blood pressure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_242743,SARS coronavirus FRA,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:242743,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus FRA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6541,losartan,"Losartan|(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol|(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|losartan|2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole","A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:114798-26-4|Reaxys:4770867|Drug_Central:1610|KEGG:C07072|Patent:US5138069|LINCS:LSM-3701|Wikipedia:Losartan|Patent:EP253310|KEGG:D08146|DrugBank:DB00678|PMID:15703421|Beilstein:4770867,"A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Losartan|(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol",,,,,chebi_ontology,,(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|losartan|2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole,,,,,,,,,0,C22H23ClN6O,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",PSIFNNKUMBGKDQ-UHFFFAOYSA-N,422.91100,422.16219,CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6541,,,,,,true,,,,,,,,,CHEBI:6541,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,losartan,,,,,,,,,,,,,,,,,,,,,,https://bestpractice.bmj.com/topics/en-gb/3000168/emergingtxs,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000029,local transmission,,,false,,,http://purl.obolibrary.org/obo/TRANS_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/TRANS_0000000,,,,,,,,transmission of infection(biological process),,true,,,,,,"Limited local confirmed transmission is defined as a single, locally acquired case, or cases clustered in a single household or nearby houses.",,,,,,,,,,,,,,,,local transmission,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1903332,regulation of protein folding,"regulation of beta-tubulin folding|regulation of alpha-tubulin folding|regulation of chaperonin-mediated tubulin folding|regulation of co-chaperone activity|regulation of protein complex assembly, multichaperone pathway|regulation of chaperone activity|regulation of co-chaperonin activity|regulation of chaperonin ATPase activity|regulation of non-chaperonin molecular chaperone ATPase activity|regulation of glycoprotein-specific chaperone activity","Any process that modulates the frequency, rate or extent of protein folding.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,vw,2014-08-18T13:14:34Z,,,,"Any process that modulates the frequency, rate or extent of protein folding.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of beta-tubulin folding|regulation of alpha-tubulin folding|regulation of chaperonin-mediated tubulin folding,,biological_process,,"regulation of co-chaperone activity|regulation of protein complex assembly, multichaperone pathway|regulation of chaperone activity|regulation of co-chaperonin activity|regulation of chaperonin ATPase activity|regulation of non-chaperonin molecular chaperone ATPase activity|regulation of glycoprotein-specific chaperone activity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1903332,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903332,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of protein folding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0020854,Cyclophilins,,,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0020854,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32178593,A family of peptidyl-prolyl cis-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Cyclophilins,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_6801,metformin,"N,N-dimethylimidodicarbonimidic diamide|Metformin|1,1-Dimethylbiguanide",A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D04966|CAS:657-24-9|Reaxys:606492|PMID:11772907|PMID:18212742|PMID:18608522|LINCS:LSM-4730|DrugBank:DB00331|PMID:24428821|Wikipedia:Metformin|Drug_Central:1725|KEGG:C07151|PMID:17062558|HMDB:HMDB0001921,A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"N,N-dimethylimidodicarbonimidic diamide|Metformin",,,,,chebi_ontology,,"1,1-Dimethylbiguanide",,,,,,,,,0,C4H11N5,"InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)",XZWYZXLIPXDOLR-UHFFFAOYSA-N,129.16384,129.10145,CN(C)C(=N)NC(N)=N,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6801,,,,,,true,,,,,,,,,CHEBI:6801,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,metformin,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000170,tryptanthrin,,,false,,,http://purl.obolibrary.org/obo/OMIT_0009582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Tryptanthrin is Chinese herbal medicine,  extracted from Strobilanthes cusia leaf, with diverse biological activities.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OMIT_0009582,,,,,,,,,,,,,yes,,https://pubmed.ncbi.nlm.nih.gov/32120929/,,,,,,,,,,,,,,,,,tryptanthrin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000057817,HAMP,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HEPC|HFE2B|LEAP1|PLTR,,,,,,,19,,,,,,,,,,MIM:606464|HPRD:05925|HGNC:15598,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,hepcidin antimicrobial peptide,,19q13.1,,,,"GO_0005179 (EC: IEA); GO_0005576 (EC: NAS, PMID: 11034317); GO_0006879 (EC: IEA); GO_0006955 (EC: TAS, PMID: 11113131); GO_0031640 (EC: IEA); GO_0042742 (EC: IEA); GO_0045179 (EC: IEA); GO_0050832 (EC: IEA)",PMID: 11034317; 11113131; 11113132; 11836175; 12010514; 12138110; 12393428; 12433676; 12469120; 12477932; 12637325; 12663437; 12915468; 12975309; 14630809; 14670915; 14702039; 15057824; 15124013; 15124018; 15178582; 15198949; 15489334; 15514116; 15671438; 15685557; 15725899; 15797999; 15831700; 15933050; 15998830; 16103673; 16204153; 16315135; 16460831; 16737972; 16769573; 16769583; 16835372; 16929540; 16937259; 16946298; 16952548; 16962038; 17112858; 17229646; 17229647; 17331161; 17488680; 17559363; 17577979; 17613866; 17721544; 17766053; 17768112; 17847004; 17905608; 17905609; 17951471; 17962361; 18023212; 18073346; 18278547; 18304682; 18322945; 18326817; 18333366; 18421430; 18462824; 18495462; 18541040; 18544472; 18556388; 18603562; 18641032; 18671304; 18676162; 18680715; 18694648; 18758412; 18762941; 18775801; 18809758; 18827264; 18970934; 19032104; 19059216; 19070948; 19093740; 19099655; 19150361; 19214511; 19231148; 19252486; 19254567; 19287179; 19291818; 19292870; 19346972; 19387685; 19414861; 19423366; 19454498; 19478464; 19483160; 19541813; 19553669; 19589941; 19610021; 19652026; 19652645; 19656379; 19679815; 19681654; 19711434; 19715836; 19729219; 19734422; 19740974; 19787796; 19816411; 19850683; 19882752; 19890342; 19907144; 19924283; 20007134; 20019408; 20026331; 20102409; 20113314; 20124516; 20191031; 20299375; 20301349; 20502037; 20526394; 20587610; 20620527; 20634490; 20653062; 20655381; 20660052; 20679527; 20721554; 20800515; 20801192; 20863724; 20888657; 20924211; 20937842; 21031015; 21039223; 21075282; 21088809; 21095135; 21103663; 21126372; 21143009; 21143959; 21145254; 21149632; 21150441; 21183736; 21199652; 21209031; 21219868; 21283681; 21285884; 21289291; 21333642; 21346250; 21401300; 21499082; 21508121; 21518494; 21535154; 21593278; 21609320; 21654163; 21733041; 21810240; 21818622; 21873546; 21873547; 21876117; 21882342; 21885789; 21886780; 21971825; 21988832; 22023767; 22118000; 22125467; 22227182; 22228627; 22248501; 22249207; 22365732; 22398782; 22525500; 22609894; 22611157; 22676252; 22682226; 22682227; 22689680; 22768976; 22776295; 22792339; 22815544; 22819549; 22844726; 22851866; 22869521; 22932892; 22951294; 23012398; 23041085; 23062413; 23065424; 23065507; 23065513; 23088733; 23110054; 23148308; 23154866; 23179904; 23293962; 23300182; 23335357; 23375327; 23379486; 23380741; 23390091; 23390933; 23438894; 23460869; 23531037; 23536837; 23580428; 23618075; 23656728; 23665668; 23700338; 23760782; 23798368; 23836842; 23842708; 23846698; 23852902; 24157792; 24334869,,,,,,,,,,,,,,,,,,OGG:3000057817,,,,,,,,,,,,,,,,,,,hepcidin antimicrobial peptide,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,Hepcidin,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HAMP,,,20140408,57817,UNQ487/PRO1003,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,HAMP,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_499361,aprepitant,"5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one|aprepitant|aprepitantum|3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one","A morpholine-based antiemetic, which is or the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:170729-80-3|PMID:22141732|PMID:23191934|Wikipedia:Aprepitant|Beilstein:8096869|PMID:21415280|Reaxys:8096869|LINCS:LSM-5637|Drug_Central:230|PMID:23062719|PMID:23370141|KEGG:D02968|PMID:22187110|PMID:23560185|HMDB:HMDB0014811|PMID:22260216|DrugBank:DB00673|PMID:22995650,"A morpholine-based antiemetic, which is or the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one",,,,,chebi_ontology,,"aprepitant|aprepitantum|3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one",,,,,,,,,0,C23H21F7N4O3,"InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1",ATALOFNDEOCMKK-OITMNORJSA-N,534.42670,534.15019,C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:499361,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:499361,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,aprepitant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039708,nuclear capsid assembly,,The assembly of a virus capsid that occurs in the nucleus. The assembly of large icosahedral shells for herpesviridae and adenoviridae requires structural proteins that act as chaperones for assembly.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-11-28T15:08:41Z,,,VZ:1516,The assembly of a virus capsid that occurs in the nucleus. The assembly of large icosahedral shells for herpesviridae and adenoviridae requires structural proteins that act as chaperones for assembly.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039708,,,,,,true,,,,true,,,,,GO:0039708,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nuclear capsid assembly,,,,,,,,,,,,,,,,,,,,,,https://www.researchsquare.com/article/rs-21833/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000055240,STEAP3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,STMP3|dudlin-2|AHMIO2|TSAP6,,,,,,,2,,,,,,,,,,Ensembl:ENSG00000115107|HPRD:10285|Vega:OTTHUMG00000131402|MIM:609671|HGNC:24592,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"STEAP family member 3, metalloreductase",,2q14.2,,,,"GO_0000293 (EC: IEA); GO_0005515 (EC: IPI); GO_0005771 (EC: IDA, PMID: 15319436); GO_0005886 (EC: IEA); GO_0006879 (EC: TAS); GO_0006915 (EC: IEA); GO_0007049 (EC: IEA); GO_0009306 (EC: IDA, PMID: 15319436); GO_0009306 (EC: IMP); GO_0010008 (EC: TAS); GO_0016021 (EC: IEA); GO_0033572 (EC: TAS); GO_0043065 (EC: IEA); GO_0046872 (EC: IEA); GO_0055085 (EC: TAS)",PMID: 2874839; 11076863; 11230166; 12095985; 12477932; 12606722; 14702039; 15319436; 15489336; 16381901; 18495927; 19236508; 20379614; 20587610; 21139048; 21871451; 21890473; 21906983; 21963094; 21987572; 21988832; 22624035; 23000965; 23958962,,,,,,,,,,,,,,,,,,OGG:3000055240,,,,,,,,,,,,,,,,,,,"STEAP family member 3, metalloreductase",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,STEAP3,,,20140408,55240,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,STEAP3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000001514,CTSL,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MEP|CTSL1|CATL,,,,,,,9,,,,,,,,,,Vega:OTTHUMG00000020149|HGNC:2537|MIM:116880|HPRD:00293|Ensembl:ENSG00000135047,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,cathepsin L,,9q21.33,,,,"GO_0001968 (EC: IPI); GO_0002224 (EC: TAS); GO_0002250 (EC: IEP, PMID: 15196205); GO_0004197 (EC: IDA, PMID: 14511383); GO_0005515 (EC: IPI, PMID: 17889653); GO_0005518 (EC: IDA); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005634 (EC: TAS); GO_0005764 (EC: IDA, PMID: 15196205); GO_0006508 (EC: IDA); GO_0008234 (EC: IDA, PMID: 8811434); GO_0019882 (EC: TAS, PMID: 15196205); GO_0019886 (EC: TAS); GO_0022617 (EC: TAS); GO_0030198 (EC: TAS); GO_0030574 (EC: IDA); GO_0030574 (EC: TAS); GO_0036021 (EC: TAS); GO_0042393 (EC: IDA); GO_0043202 (EC: TAS); GO_0043394 (EC: IPI); GO_0045087 (EC: TAS); GO_0051603 (EC: IDA); GO_0071888 (EC: NAS, PMID: 18495127); GO_0097067 (EC: IEP)",PMID: 116880; 1551416; 1837142; 1939080; 2275556; 2835398; 3342889; 3421948; 3490478; 3545185; 3550705; 7340337; 8419312; 8666891; 8811434; 8889548; 8896443; 9076588; 9141479; 9468501; 9548757; 9585570; 9632704; 9733783; 9837884; 9918848; 10022822; 10218831; 10395917; 10428479; 10716919; 10849756; 11278902; 11327826; 11435427; 11514663; 11517935; 11767948; 11771045; 11777924; 11801256; 11978977; 12137950; 12437117; 12437119; 12477932; 12492488; 12504904; 12748383; 12754519; 12809493; 12818188; 12921779; 12926111; 12941783; 12949073; 14511383; 14702039; 14718574; 15099520; 15100281; 15174051; 15196205; 15255544; 15318816; 15454886; 15489334; 15498563; 15512772; 15665831; 15816632; 15832773; 15982660; 16303743; 16335952; 16354158; 16433682; 16565075; 16740135; 16913838; 16918298; 17192395; 17227755; 17519890; 17561110; 17574778; 17643114; 17889653; 17928356; 18163891; 18221013; 18366346; 18450756; 18495127; 18616803; 18619973; 18624398; 18658137; 18971274; 19005484; 19096818; 19270352; 19291794; 19550400; 19663777; 19915865; 19924101; 19939935; 19958782; 19959474; 20075068; 20302512; 20347002; 20497254; 20524145; 20567828; 20837372; 20881085; 20926012; 21029616; 21134415; 21226994; 21308479; 21382349; 21395501; 21484410; 21496199; 21501115; 21555518; 21562164; 21585286; 21700710; 21715684; 21742978; 21750527; 21756348; 21769426; 21775114; 21880013; 21896479; 21898833; 21900206; 21906983; 21925292; 21965756; 21967108; 21988832; 22031933; 22222211; 22281037; 22365146; 22451661; 22571763; 22674323; 22695494; 22871890; 22963824; 23009386; 23063511; 23229094; 23337117; 23536651; 23603447; 23677785; 23915070,,,,,,,,,,,,,,,,,,OGG:3000001514,,,,,,,,,,,,,,,,,,,cathepsin L,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142651,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CTSL,,,20140408,1514,RP11-65B23.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CTSL,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0031145,anaphase-promoting complex-dependent catabolic process,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein degradation|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|APC-dependent proteasomal ubiquitin-dependent protein catabolic process|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolism|APC-dependent proteasomal ubiquitin-dependent protein catabolism|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein breakdown|cyclin catabolism|cyclin breakdown|degradation of cyclin|cyclin catabolic process|negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation|cyclin degradation,"The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by the anaphase-promoting complex, and mediated by the proteasome.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by the anaphase-promoting complex, and mediated by the proteasome.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008054,,,,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein degradation|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|APC-dependent proteasomal ubiquitin-dependent protein catabolic process|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolism|APC-dependent proteasomal ubiquitin-dependent protein catabolism|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein breakdown,,,cyclin catabolism|cyclin breakdown|degradation of cyclin|cyclin catabolic process|negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation|cyclin degradation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0031145,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031145,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,anaphase-promoting complex-dependent catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0003565,Elevated erythrocyte sedimentation rate,Raised erythrocyte sedimentation rate|Elevated sedimentation rate|Increased erythrocyte sedimentation rate|High erythrocyte sedimentation rate|High ESR|Elevated ESR,An increased erythrocyte sedimentation rate (ESR). The ESR a test that measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The ESR is a nonspecific finding. An elevation may indicate inflammation or may be caused by any condition that elevates fibrinogen.,false,,,http://purl.obolibrary.org/obo/HP_0025021,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:165468009|UMLS:C0151632,An increased erythrocyte sedimentation rate (ESR). The ESR a test that measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The ESR is a nonspecific finding. An elevation may indicate inflammation or may be caused by any condition that elevates fibrinogen.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Raised erythrocyte sedimentation rate|Elevated sedimentation rate|Increased erythrocyte sedimentation rate|High erythrocyte sedimentation rate|High ESR|Elevated ESR,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0025021,,,,HP:0003565,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678|https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,HP:0003565,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Elevated erythrocyte sedimentation rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042176,regulation of protein catabolic process,regulation of protein catabolism|regulation of protein breakdown|regulation of protein degradation,"Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of protein catabolism|regulation of protein breakdown|regulation of protein degradation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0042176,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042176,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of protein catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_7711,Chordata,chordates|chordates,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_33208,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chordates,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_phylum,chordates,,,,,,NCBITaxon:7711,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_33208,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Chordata,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_52717,bortezomib,[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-N(alpha)-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|Velcade|bortezomib|PS-341|PS 341|N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,L-Phenylalaninamide substituted at the amide nitrogen by a 1-(dihydroxyboranyl)-3-methylbutyl group and at N(alpha) by a pyrazin-2-ylcarbonyl group. It is a dipeptidyl boronic acid that reversibly inhibits the 26S proteasome.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:21504411|DrugBank:DB00188|Reaxys:8723817|PMID:21865767|PMID:18980173|KEGG:D03150|Wikipedia:Bortezomib|CAS:179324-69-7|PDBeChem:BO2|Drug_Central:391|LINCS:LSM-6281|PMID:18484921,L-Phenylalaninamide substituted at the amide nitrogen by a 1-(dihydroxyboranyl)-3-methylbutyl group and at N(alpha) by a pyrazin-2-ylcarbonyl group. It is a dipeptidyl boronic acid that reversibly inhibits the 26S proteasome.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:41143,,,,[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-N(alpha)-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide,,,,,chebi_ontology,,Velcade|bortezomib|PS-341|PS 341|N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,,,,,,,,0,C19H25BN4O4,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",GXJABQQUPOEUTA-RDJZCZTQSA-N,384.23700,384.19689,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:52717,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:52717,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,bortezomib,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042472,inner ear morphogenesis,,"The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0042472,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042472,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,inner ear morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0005177,trunk region element,trunk organ,An organ or element that part of the trunk region. The trunk region can be further subdividied into thoracic (including chest and thoracic cavity) and abdominal (including abdomen and pelbis) regions.,false,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,,,,,,,,,,,,,,,,,EMAPA:37270|MA:0000516,An organ or element that part of the trunk region. The trunk region can be further subdividied into thoracic (including chest and thoracic cavity) and abdominal (including abdomen and pelbis) regions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,trunk organ,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,UBERON:0005177,,,,,,,,,,,,,,,UBERON:0005177,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,trunk region element,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MMO_0000128,computed tomography,computerized axial tomography (CAT)|CAT scan|CT scan|computed axial tomography|X-ray computed tomography,"Tomography, that is, method that produces images of single tissue planes, in which the emergent X-ray beam is measured by a scintillation counter and the electronic impulses are recorded on a magnetic disk and processed by a mini-computer for reconstruction display of the body in cross-section on a cathode ray tube.",false,,,http://purl.obolibrary.org/obo/ERO_0001312,,,,,,,,,,,,,,,,mshimoyama,2010-08-05T02:24:12Z,,,,"Tomography, that is, method that produces images of single tissue planes, in which the emergent X-ray beam is measured by a scintillation counter and the electronic impulses are recorded on a magnetic disk and processed by a mini-computer for reconstruction display of the body in cross-section on a cathode ray tube.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,measurement_method_ontology,,computerized axial tomography (CAT)|CAT scan|CT scan|computed axial tomography|X-ray computed tomography,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0001312,,,,MMO:0000128,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32294504,,,,MMO:0000128,,http://purl.obolibrary.org/obo/mmo.owl,,,,,,,,,,,computed tomography,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000538,edema,dropsy,A skin and integumentary tissue symptom characterized as an abnormal excess accumulation of serous fluid in connective tissue or in a serous cavity.,false,,,http://purl.obolibrary.org/obo/SYMP_0000488,,,,,,,,,,,,,,,,,,,,SyOID:17347|UMLS_CUI:C0013604|ICD9CM_2005:782.3|UMLS_ICD9CM_2005_AUI:A0052720,A skin and integumentary tissue symptom characterized as an abnormal excess accumulation of serous fluid in connective tissue or in a serous cavity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,dropsy,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000488,,,,SYMP:0000538,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,SYMP:0000538,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,edema,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002772,inhibitory C-type lectin receptor signaling pathway,inhibitory C-type lectin receptor signalling pathway|Ly49 inhibitory receptor signaling pathway,A series of molecular signals initiated by the binding of an extracellular ligand to an inhibitory C-type lectin receptor capable of inhibiting an immune effector process contributing to an immune response.,false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,,A series of molecular signals initiated by the binding of an extracellular ligand to an inhibitory C-type lectin receptor capable of inhibiting an immune effector process contributing to an immune response.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,inhibitory C-type lectin receptor signalling pathway,,,,,biological_process,,Ly49 inhibitory receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0002772,,,,,,true,true,,,,,,,,GO:0002772,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,inhibitory C-type lectin receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_694009,Severe acute respiratory syndrome-related coronavirus,SARSr-CoV|HCoV-SARS|SARS|Severe acute respiratory syndrome coronavirus|Human coronavirus (strain SARS)|SARS virus|SARS-like coronavirus|SARS-related coronavirus|SARS coronavirus,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2509511,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:227859|NCBITaxon:311178,SARSr-CoV|HCoV-SARS|SARS,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Severe acute respiratory syndrome coronavirus|Human coronavirus (strain SARS)|SARS virus|SARS-like coronavirus|SARS-related coronavirus|SARS coronavirus,,,,,,NCBITaxon:694009,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2509511,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/32123347,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Severe acute respiratory syndrome-related coronavirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000018,zero-dimensional spatial region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000006,,,,,ZeroDimensionalSpatialRegion,0d-s-region,,,,,,,,,,,,,,,,,,,,,,,,,,A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001]),,,,,,,,,,,(forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000006,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,zero-dimensional spatial region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000044,positive COVID-19 test,,,false,,,http://purl.obolibrary.org/obo/NCIT_C35682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C35682,,,,,,,,clinical finding,,true,,,,,,"A positive test result shows you have antibodies that likely resulted from an infection with SARS-CoV-2, or possibly a related coronavirus.",Confirmed positive case,,,,,,,,,,,,,,,positive COVID-19 test,,,,,,,,,,,,,,,,,,,,,,"https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-glossary-of-terms/|https://www.georgetown.edu/coronavirus/glossary-of-terms/
",,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000029,site,,,false,,,http://purl.obolibrary.org/obo/BFO_0000141,,,,,Site,site,,,,,,,,,,,,,,,,,,,,,,,,,,b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002]),,the Grand Canyon|the interior of your office|the interior of your bedroom|the Piazza San Marco|the interior of the trunk of your car|a rabbit hole|your left nostril (a fiat part – the opening – of your left nasal cavity)|an air traffic control region defined in the airspace above an airport|the hold of a ship|Manhattan Canyon)|a hole in the interior of a portion of cheese|the lumen of your gut|the cockpit of an aircraft|the interior of a kangaroo pouch|the interior of your refrigerator,,,,,,,,,(forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000029,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000141,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,site,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051985,negative regulation of chromosome segregation,downregulation of chromosome segregation|down regulation of chromosome segregation|down-regulation of chromosome segregation|inhibition of chromosome segregation,"Any process that stops, prevents, or reduces the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets.",false,,,http://purl.obolibrary.org/obo/GO_0051983,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents, or reduces the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,downregulation of chromosome segregation|down regulation of chromosome segregation|down-regulation of chromosome segregation,,,inhibition of chromosome segregation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051983,,,,GO:0051985,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051985,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of chromosome segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0060141,positive regulation of syncytium formation by virus,syncytium formation induced by viral infection,"The process in which a virus increases the frequency, rate or extent of the formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.",false,,,http://purl.obolibrary.org/obo/GO_0060140|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"The process in which a virus increases the frequency, rate or extent of the formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,syncytium formation induced by viral infection,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0060140|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0060141,,,,,,true,,,,true,,,,,GO:0060141,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of syncytium formation by virus,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.05.979260v1,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIABIS_0001008,comorbidity,,"A diagnosis that is the outcome of a diagnostic process targeting a second or additional health problem.|It is argued that Comorbidity occurs due to a disposition established by a prior infection with a pathogenic organism of a different kind.
",false,,,http://purl.obolibrary.org/obo/OGMS_0000073,,,"secondary infection, nosocomial infection",,,,,,,,,,,,,,,,,,A diagnosis that is the outcome of a diagnostic process targeting a second or additional health problem.,,amended from http://en.wikipedia.org/wiki/Comorbidity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIABIS:0001008,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"It is argued that Comorbidity occurs due to a disposition established by a prior infection with a pathogenic organism of a different kind.
",,http://purl.obolibrary.org/obo/OGMS_0000073,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/omiabis.owl,,,,,,,,,,,comorbidity,,,,,,,,,,,,,,,,,,,,,,,,,,,,Alice Nzinga|Mathias Brochhausen,,,,
http://purl.obolibrary.org/obo/GO_0036503,ERAD pathway,protein degradation by ERAD|endoplasmic reticulum-associated degradation|ER-associated degradation pathway|endoplasmic reticulum-associated protein degradation pathway,"The protein catabolic pathway which targets endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. It begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein modifications necessary for correct substrate transfer (e.g. ubiquitination), transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.|ER-associated protein degradation (ERAD) pathways target misfolded ER lumenal proteins (ERAD-L), ER membrane proteins (ERAD-M), and ER proteins with misfolded cytosolic domains (ERAD-C) by recognizing aberrant proteins, retrotranslocating these substrates to the cytosol, followed by substrate ubiquitination and proteosomal-mediated degradation. In contrast the stress-induced homeostatically regulated protein degradation (SHRED) pathway (GO:0120174), although inducible by stress, targets diverse ER membrane, and cytosolic proteins as well as numerous other native proteins in the absence of stress. Stress results in the protease-mediated (Nma111p) generation of a Roq1p cleavage product that then binds to the type-1 active site of Ubr1p, altering its substrate specificity, and leading to the proteasome-mediated degradation of both misfolded and native proteins. Although the SHRED pathway may contain some components in common with ERAD pathways (GO:0036503), such as UBR1, RAD6 and CDC48, other ERAD components, such as HRD1 and DOA10, do not appear to be involved, and as such these pathways are currently considered to be distinct.",false,,,http://purl.obolibrary.org/obo/GO_0034976,,,,,,,,,,,,,,,,rebeccafoulger,2015-05-14T11:43:06Z,,,,"The protein catabolic pathway which targets endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. It begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein modifications necessary for correct substrate transfer (e.g. ubiquitination), transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein degradation by ERAD|endoplasmic reticulum-associated degradation,,,,,biological_process,,ER-associated degradation pathway|endoplasmic reticulum-associated protein degradation pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"ER-associated protein degradation (ERAD) pathways target misfolded ER lumenal proteins (ERAD-L), ER membrane proteins (ERAD-M), and ER proteins with misfolded cytosolic domains (ERAD-C) by recognizing aberrant proteins, retrotranslocating these substrates to the cytosol, followed by substrate ubiquitination and proteosomal-mediated degradation. In contrast the stress-induced homeostatically regulated protein degradation (SHRED) pathway (GO:0120174), although inducible by stress, targets diverse ER membrane, and cytosolic proteins as well as numerous other native proteins in the absence of stress. Stress results in the protease-mediated (Nma111p) generation of a Roq1p cleavage product that then binds to the type-1 active site of Ubr1p, altering its substrate specificity, and leading to the proteasome-mediated degradation of both misfolded and native proteins. Although the SHRED pathway may contain some components in common with ERAD pathways (GO:0036503), such as UBR1, RAD6 and CDC48, other ERAD components, such as HRD1 and DOA10, do not appear to be involved, and as such these pathways are currently considered to be distinct.",,http://purl.obolibrary.org/obo/GO_0034976,,,,GO:0036503,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0036503,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ERAD pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042581,specific granule,secondary granule,"Granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Specific_granule,"Granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,secondary granule,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0042581,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042581,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,specific granule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000634,leukocytosis,,,false,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,SYMP:0000634,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,Leukocytosis refers to an increase in the total number of white blood cells (WBCs) due to any cause.,,,SYMP:0000634,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,leukocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_36773,camphor,"camphor|Camphor|bornan-2-one|1,7,7-trimethylbicyclo[2.2.1]heptan-2-one|Japan camphor|2-keto-1,7,7-trimethylnorcamphane|2-camphanone|spirit of camphor|gum camphor|Formosa camphor|Kampfer|root bark oil|laurel camphor|2-bornanone",A cyclic monoterpene ketone that is bornane bearing an oxo substituent at position 2. A naturally occurring monoterpenoid.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Gmelin:83275|DrugBank:DB01744|PMID:19384733|PMID:21620923|PMID:21562741|Beilstein:6475830|CAS:464-48-2|PMID:21906366|Beilstein:3196099|PMID:21777420|MetaCyc:Camphor|Beilstein:1907611|KEGG:C00809|Drug_Central:470|PMID:17488023|LIPID_MAPS_instance:LMPR0102120001|Wikipedia:Camphor|KEGG:D00098|PMID:20950270|CAS:76-22-2|KEGG:C18369|KNApSAcK:C00000135|Reaxys:3196099,A cyclic monoterpene ketone that is bornane bearing an oxo substituent at position 2. A naturally occurring monoterpenoid.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"camphor|Camphor|bornan-2-one|1,7,7-trimethylbicyclo[2.2.1]heptan-2-one",,,,,chebi_ontology,,"Japan camphor|2-keto-1,7,7-trimethylnorcamphane|2-camphanone|spirit of camphor|gum camphor|Formosa camphor|Kampfer|root bark oil|laurel camphor|2-bornanone",,,,,,,,,0,C10H16O,"InChI=1S/C10H16O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7H,4-6H2,1-3H3",DSSYKIVIOFKYAU-UHFFFAOYSA-N,152.23340,152.12012,CC1(C)C2CCC1(C)C(=O)C2,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:36773,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:36773,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,camphor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_465284,ganciclovir,"Ganciclovir|2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|gancyclovir|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|ganciclovir|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one|ganciclovirum|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|GA2|9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine","An oxopurine that is  guanine substituted by a [(1,3-dihydroxypropan-2-yl)oxy]methyl group at position 9. Ganciclovir is an antiviral drug used to treat or prevent AIDS-related cytomegalovirus infections.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:17622128|PMID:17672445|PMID:9216836|PMID:8176714|PMID:2840500|PMID:16480257|PMID:17948980|PMID:14643358|PMID:2157013|PMID:9934470|PMID:10966740|PMID:9925738|PMID:8784444|PMID:2822928|PMID:7562929|PMID:15745823|PMID:15081019|PMID:11454465|PMID:7562946|PMID:2163454|PMID:1849998|PMID:17434304|PMID:18082410|PMID:15509173|PMID:15689173|PMID:7932543|PMID:1323678|PMID:16759112|Drug_Central:1277|PMID:15509175|PDBeChem:GA2|PMID:11472207|PMID:15509174|PMID:8941388|PMID:17188402|PMID:12459010|PMID:17004726|PMID:2848125|PMID:17513108|PMID:11985471|PMID:17239594|PMID:2544723|PMID:8765514|PMID:17043128|PMID:10560739|PMID:10882375|PMID:17298047|PMID:11677126|HMDB:HMDB0015139|PMID:15658873|PMID:11708929|PMID:16392824|PMID:10447945|PMID:8254613|PMID:11858989|PMID:2989523|PMID:14521407|Wikipedia:Ganciclovir|PMID:8632412|PMID:2993615|PMID:9057866|PMID:2846837|Reaxys:3654487|PMID:17181162|Patent:US4355032|PMID:17161946|PMID:1310744|PMID:2163453|PMID:15615545|PMID:15509176|PMID:10882374|PMID:11495586|PMID:9575044|PMID:2842505|PMID:10377226|PMID:11412988|PMID:15658861|PMID:9046339|PMID:8071942|PMID:9836626|PMID:16134946|PMID:2500527|PMID:2913300|PMID:16814545|PMID:10966745|PMID:17181158|PMID:17438061|PMID:9057868|Beilstein:3654487|PMID:14643328|PMID:9057867|PMID:8709116|PMID:8784445|PMID:2329561|PMID:17329103|PMID:8394933|PMID:14736238|PMID:1319491|PMID:9871553|PMID:11262090|PMID:11229780|PMID:12723951|PMID:14584954|KEGG:D00333|PMID:2329551|PMID:9548814|PMID:17402726|PMID:11814776|PMID:10197958|PMID:2391689|PMID:11708924|PMID:16420056|PMID:3871860|PMID:7562947|PMID:16392791|PMID:9934471|PMID:7877148|CAS:82410-32-0|PMID:2160539|PMID:2826784|PMID:17960926|PMID:1652016|PMID:12408716|PMID:2165163|LINCS:LSM-5382|PMID:2175356|PMID:15801851|DrugBank:DB01004|PMID:11585457|PMID:3009811|PMID:10882370|PMID:15634003|PMID:10411487|PMID:15027877|PMID:9836613|PMID:9438017|PMID:17518459|PMID:10882372|PMID:11754587|PMID:15481985|PMID:10691698|PMID:10999475|PMID:10888336|PMID:15658858|PMID:17092728|PMID:17869124|PMID:3016263|PMID:17539622|PMID:7752205,"An oxopurine that is  guanine substituted by a [(1,3-dihydroxypropan-2-yl)oxy]methyl group at position 9. Ganciclovir is an antiviral drug used to treat or prevent AIDS-related cytomegalovirus infections.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:42659|CHEBI:5273,,,,"Ganciclovir|2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one",,,,,chebi_ontology,,"2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|gancyclovir|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|ganciclovir|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one|ganciclovirum|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|GA2|9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine",,,,,,,,,0,C9H13N5O4,"InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)",IRSCQMHQWWYFCW-UHFFFAOYSA-N,255.23060,255.09675,Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:465284,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32178711/,,,,CHEBI:465284,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ganciclovir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0062023,collagen-containing extracellular matrix,,"An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,dph,2018-04-13T12:47:21Z,,,,"An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0062023,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0062023,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,collagen-containing extracellular matrix,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_45409,ritonavir,"N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N(2)-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide|ritonavir","An L-valine derivative that is L-valinamide in which alpha-amino group has been acylated by a [(2-isopropyl-1,3-thiazol-4-yl)methyl]methylcarbamoyl group and in which a hydrogen of the carboxamide amino group has been replaced by a (2R,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl group. A CYP3A inhibitor and antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS, it is often used as a fixed-dose combination with another protease inhibitor, lopinavir. Also used in combination with dasabuvir sodium hydrate, ombitasvir and paritaprevir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:768009|PMID:9585800|PMID:24202050|LINCS:LSM-5623|PMID:11363517|PMID:11363086|PMID:9140265|Wikipedia:Ritonavir|PMID:8568292|PMID:9278209|KEGG:D00427|CAS:155213-67-5|PMID:11996889|PMID:11363397|KEGG:C07240|PMID:11363184|PMID:11363329|PMID:11363300|Drug_Central:2391|PDBeChem:RIT|HMDB:HMDB0014646,"An L-valine derivative that is L-valinamide in which alpha-amino group has been acylated by a [(2-isopropyl-1,3-thiazol-4-yl)methyl]methylcarbamoyl group and in which a hydrogen of the carboxamide amino group has been replaced by a (2R,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl group. A CYP3A inhibitor and antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS, it is often used as a fixed-dose combination with another protease inhibitor, lopinavir. Also used in combination with dasabuvir sodium hydrate, ombitasvir and paritaprevir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:8873,,,,"N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N(2)-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide",,,,,chebi_ontology,,ritonavir,,,,,,,,,0,C37H48N6O5S2,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,720.94400,720.31276,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:45409,,,,,,,,,,,,,,,CHEBI:45409,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ritonavir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C15760,Drug Development,Drug Development,"Design, identification, synthesis, extraction, purification, modification, or characterization of potential anticancer agents; studies of their metabolism, distribution, excretion, physiological effects, molecular interactions, structural analysis, toxicity, mechanism of action, antitumor effects in vivo (nonhuman species) or in vitro (human or nonhuman), and phase I and phase II clinical trials.",false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,C15760,,,,,,,,,,"Design, identification, synthesis, extraction, purification, modification, or characterization of potential anticancer agents; studies of their metabolism, distribution, excretion, physiological effects, molecular interactions, structural analysis, toxicity, mechanism of action, antitumor effects in vivo (nonhuman species) or in vitro (human or nonhuman), and phase I and phase II clinical trials.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Drug Development,,,,,,,,,,,,,NCIT:C15760,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32306822%20,,drug discovery,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Drug Development,Drug_Development,,,,,,,,,,,,,,,,,,Drug Development,,,,Research Activity,,,,,,,,C0872152,
http://purl.obolibrary.org/obo/NCIT_C17741,Oxidative Stress,oxidative stress|Oxidative Stress,"A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products.  The damage to biological tissues is caused by superoxide and other free radicals generated by many factors, including exposure to alcohol, medications, trauma, cold, toxins, and radiation or by antimicrobial cellular immunity, metabolic abnormality, or ""normal"" aging; not synonymous with hypoxia or hyperoxia.  Oxidative stress promotes a range of degenerative disorders, including cancer, diabetes, premature aging, Alzheimer's, and many others.",false,,,http://purl.obolibrary.org/obo/OGMS_0000061,,A condition in which antioxidant levels are lower than normal. Antioxidant levels are usually measured in blood plasma.,,,,,,,,,C17741,,,,,,,,,,"A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products.  The damage to biological tissues is caused by superoxide and other free radicals generated by many factors, including exposure to alcohol, medications, trauma, cold, toxins, and radiation or by antimicrobial cellular immunity, metabolic abnormality, or ""normal"" aging; not synonymous with hypoxia or hyperoxia.  Oxidative stress promotes a range of degenerative disorders, including cancer, diabetes, premature aging, Alzheimer's, and many others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,oxidative stress|Oxidative Stress,,,,,,,,,,,,,NCIT:C17741,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000061,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Oxidative Stress,Oxidative_Stress,,,,,,,,,,,,,,,,,,Oxidative Stress,,,,Phenomenon or Process,,,,,,,,C0242606,
http://purl.obolibrary.org/obo/OGG_3000007422,VEGFA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,VEGF|MVCD1|VPF,,,,,,,6,,,,,,,,,,MIM:192240|Ensembl:ENSG00000112715|Vega:OTTHUMG00000014745|HGNC:12680|HPRD:01889,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,vascular endothelial growth factor A,,6p12,,,,"GO_0000122 (EC: IDA, PMID: 18093989); GO_0001525 (EC: IDA, PMID: 11427521); GO_0001541 (EC: ISS); GO_0001569 (EC: ISS); GO_0001570 (EC: TAS, PMID: 15015550); GO_0001666 (EC: IDA, PMID: 16490744); GO_0001701 (EC: ISS); GO_0001822 (EC: ISS); GO_0001934 (EC: IDA, PMID: 18386220); GO_0001938 (EC: IDA, PMID: 10022831); GO_0001938 (EC: ISS); GO_0001968 (EC: IDA, PMID: 14570917); GO_0002042 (EC: IDA, PMID: 18059339); GO_0002052 (EC: ISS); GO_0002053 (EC: ISS); GO_0002092 (EC: IDA); GO_0002575 (EC: IDA, PMID: 17082651); GO_0002576 (EC: TAS); GO_0002687 (EC: TAS, PMID: 1312256); GO_0003007 (EC: ISS); GO_0003151 (EC: ISS); GO_0003169 (EC: ISS); GO_0005125 (EC: IDA, PMID: 18440775); GO_0005125 (EC: ISS); GO_0005161 (EC: IPI, PMID: 17470632); GO_0005172 (EC: IPI, PMID: 10471394); GO_0005515 (EC: IPI, PMID: 10543948); GO_0005576 (EC: TAS); GO_0005578 (EC: NAS, PMID: 14570917); GO_0005615 (EC: IDA, PMID: 16490744); GO_0005615 (EC: ISS); GO_0005737 (EC: IDA, PMID: 17082651); GO_0006357 (EC: IMP, PMID: 18093989); GO_0007399 (EC: TAS, PMID: 15351965); GO_0007498 (EC: ISS); GO_0007595 (EC: ISS); GO_0007596 (EC: TAS); GO_0008083 (EC: IDA); GO_0008083 (EC: ISS); GO_0008201 (EC: IDA, PMID: 15001987); GO_0008201 (EC: IMP, PMID: 14570917); GO_0008284 (EC: IDA, PMID: 7929439); GO_0008360 (EC: IDA, PMID: 10527820); GO_0009986 (EC: IDA, PMID: 17470632); GO_0010595 (EC: IDA, PMID: 10022831); GO_0010628 (EC: IDA, PMID: 18386220); GO_0016020 (EC: IEA); GO_0030141 (EC: IDA, PMID: 17082651); GO_0030168 (EC: TAS); GO_0030224 (EC: IDA); GO_0030225 (EC: IDA); GO_0030324 (EC: ISS); GO_0030335 (EC: IDA, PMID: 17470632); GO_0030855 (EC: ISS); GO_0030949 (EC: IDA, PMID: 1312256); GO_0031077 (EC: ISS); GO_0031093 (EC: TAS); GO_0031334 (EC: IDA, PMID: 16489009); GO_0031954 (EC: IDA, PMID: 17470632); GO_0032147 (EC: IDA, PMID: 18059339); GO_0032793 (EC: IDA); GO_0033138 (EC: IDA, PMID: 18440775); GO_0035148 (EC: IDA, PMID: 19033661); GO_0035767 (EC: IDA, PMID: 18440775); GO_0035924 (EC: IDA, PMID: 18440775); GO_0036303 (EC: ISS); GO_0038033 (EC: IDA, PMID: 18440775); GO_0038091 (EC: IDA, PMID: 17470632); GO_0038190 (EC: ISS); GO_0040007 (EC: ISS); GO_0042056 (EC: IDA, PMID: 17082651); GO_0042462 (EC: ISS); GO_0042802 (EC: IPI, PMID: 12207021); GO_0042803 (EC: ISS); GO_0043066 (EC: IMP, PMID: 10066377); GO_0043117 (EC: IDA, PMID: 16109918); GO_0043129 (EC: ISS); GO_0043154 (EC: IDA, PMID: 18386220); GO_0043183 (EC: IPI, PMID: 1312256); GO_0043184 (EC: IPI, PMID: 10022831); GO_0043406 (EC: IDA, PMID: 18440775); GO_0043536 (EC: IDA, PMID: 18440775); GO_0045766 (EC: IDA, PMID: 18440775); GO_0045766 (EC: IMP, PMID: 18275976); GO_0045785 (EC: IDA, PMID: 19674970); GO_0045944 (EC: IDA, PMID: 18059339); GO_0045944 (EC: IMP, PMID: 18093989); GO_0046982 (EC: IDA, PMID: 8702615); GO_0048010 (EC: IDA); GO_0048010 (EC: TAS); GO_0048018 (EC: IPI, PMID: 17470632); GO_0048469 (EC: ISS); GO_0048593 (EC: ISS); GO_0048739 (EC: ISS); GO_0048754 (EC: ISS); GO_0048842 (EC: ISS); GO_0048844 (EC: ISS); GO_0050679 (EC: ISS); GO_0050731 (EC: IDA, PMID: 10022831); GO_0050840 (EC: IC, PMID: 14570917); GO_0050918 (EC: IDA, PMID: 19275959); GO_0050927 (EC: IDA, PMID: 12744932); GO_0050930 (EC: IDA, PMID: 19275959); GO_0050930 (EC: NAS, PMID: 12744932); GO_0051272 (EC: IDA, PMID: 10527820); GO_0051781 (EC: IEA); GO_0051894 (EC: IDA, PMID: 16489009); GO_0060319 (EC: ISS); GO_0060749 (EC: ISS); GO_0060754 (EC: IDA, PMID: 19275959); GO_0060948 (EC: ISS); GO_0060982 (EC: ISS); GO_0061418 (EC: TAS); GO_0061419 (EC: IMP, PMID: 19652095); GO_0071456 (EC: IDA, PMID: 10575000); GO_0071456 (EC: TAS); GO_0071542 (EC: ISS); GO_0071679 (EC: ISS); GO_0090037 (EC: IDA, PMID: 18059339); GO_0090050 (EC: IDA); GO_0090190 (EC: ISS); GO_0090259 (EC: ISS); GO_1900086 (EC: IDA); GO_1900745 (EC: IDA, PMID: 18386220); GO_1901727 (EC: IDA); GO_1902336 (EC: ISS); GO_1902533 (EC: IDA)",PMID: 1312256; 1417831; 1550962; 1567395; 1711045; 1791831; 2479986; 2479987; 2584205; 7518352; 7525053; 7678805; 7681362; 7759509; 7829517; 7929439; 8621427; 8631822; 8641698; 8702615; 8786112; 8889548; 9012504; 9012841; 9054410; 9202027; 9207067; 9323936; 9336848; 9351807; 9393862; 9450968; 9529250; 9634701; 9674707; 9684805; 9716565; 9792673; 9878851; 9922142; 10022831; 10066377; 10067980; 10196157; 10409677; 10464055; 10471394; 10527820; 10543948; 10575000; 10585578; 10626738; 10748121; 10873597; 11016853; 11032698; 11069235; 11115828; 11122379; 11133233; 11146397; 11196464; 11352659; 11427521; 11461089; 11563986; 11642726; 11686329; 11705851; 11705867; 11731620; 11741977; 11742492; 11744618; 11748975; 11751905; 11783119; 11784713; 11784722; 11796824; 11806247; 11809675; 11809713; 11815711; 11819817; 11824377; 11831981; 11832343; 11834731; 11836562; 11839635; 11847008; 11866530; 11866538; 11867956; 11875709; 11877311; 11877669; 11882460; 11891801; 11908876; 11912213; 11912219; 11920479; 11921018; 11930687; 11930688; 11940485; 11956584; 11956638; 11957147; 11959648; 11960372; 11961297; 11961303; 11964077; 11964307; 11972026; 11978184; 11978667; 11980898; 11986311; 11986954; 11999550; 12012273; 12014632; 12016145; 12023772; 12038454; 12039075; 12042276; 12058259; 12062186; 12067896; 12067976; 12085210; 12086892; 12089333; 12102661; 12105188; 12114504; 12117969; 12119553; 12124351; 12127077; 12133473; 12133520; 12133521; 12141529; 12149254; 12151344; 12151391; 12163680; 12168088; 12168808; 12168898; 12174362; 12174901; 12187074; 12197476; 12207021; 12208766; 12209585; 12209725; 12213806; 12213874; 12213878; 12215337; 12232762; 12235106; 12239588; 12358602; 12391145; 12391545; 12393542; 12400015; 12406876; 12407018; 12413884; 12425822; 12427739; 12427750; 12428103; 12429966; 12430738; 12439912; 12445161; 12446667; 12451991; 12452000; 12453880; 12453985; 12456629; 12474525; 12477932; 12481883; 12482858; 12482957; 12493399; 12496364; 12499259; 12505748; 12509426; 12509854; 12517803; 12545153; 12546587; 12548213; 12551914; 12553038; 12558813; 12563064; 12568850; 12574959; 12579315; 12581744; 12590639; 12591230; 12591731; 12593846; 12594002; 12594815; 12597245; 12604407; 12607595; 12607599; 12615701; 12629515; 12631341; 12637571; 12646239; 12651930; 12654193; 12654197; 12660426; 12666706; 12667326; 12668280; 12668286; 12670505; 12684660; 12684689; 12687277; 12696078; 12700666; 12708473; 12710853; 12711260; 12714610; 12716475; 12716911; 12719950; 12727858; 12740269; 12742981; 12744932; 12756808; 12763746; 12767510; 12788875; 12796773; 12800229; 12810642; 12810677; 12810700; 12827055; 12839933; 12844492; 12845559; 12845630; 12845639; 12847526; 12850503; 12855698; 12860293; 12865814; 12871382; 12871881; 12883661; 12883688; 12883692; 12888890; 12890905; 12893367; 12901801; 12918061; 12926153; 12937141; 12949011; 12957716; 14500349; 14507446; 14507641; 14512169; 14512791; 14513045; 14513053; 14514674; 14530810; 14532971; 14555767; 14559444; 14570917; 14572781; 14574404; 14585871; 14593238; 14600159; 14602779; 14604996; 14607580; 14607712; 14609725; 14610338; 14633511; 14633819; 14634801; 14644752; 14644771; 14647449; 14648803; 14654077; 14655184; 14656735; 14656883; 14659975; 14660505; 14667896; 14669345; 14670179; 14672622; 14674128; 14675094; 14676217; 14676843; 14681237; 14691147; 14694016; 14699103; 14702039; 14704231; 14708636; 14712484; 14714296; 14715242; 14719060; 14719080; 14726393; 14728692; 14729621; 14729679; 14735189; 14741347; 14747470; 14747750; 14749705; 14753452; 14759416; 14762365; 14764537; 14764596; 14767538; 14767569; 14871830; 14959852; 14962110; 14977835; 14981918; 14983012; 14988276; 14997002; 15001987; 15009103; 15014023; 15015550; 15015562; 15040022; 15047611; 15050452; 15051508; 15052220; 15059159; 15063730; 15067085; 15073116; 15081313; 15086939; 15090854; 15093699; 15112337; 15117722; 15118294; 15120936; 15122338; 15126502; 15126581; 15127326; 15135240; 15135259; 15140509; 15140761; 15146197; 15149853; 15153787; 15160911; 15161630; 15161709; 15161830; 15168728; 15173661; 15175342; 15180964; 15184633; 15188178; 15191350; 15191555; 15201500; 15213335; 15217829; 15217947; 15217952; 15239258; 15244100; 15246970; 15247002; 15254682; 15254962; 15256791; 15263820; 15265021; 15273288; 15274325; 15283056; 15284224; 15292252; 15298982; 15302276; 15309707; 15329326; 15331549; 15334691; 15338501; 15339792; 15340161; 15342781; 15345585; 15347673; 15347840; 15351862; 15351965; 15358155; 15374700; 15374715; 15374730; 15375582; 15388333; 15453096; 15453394; 15453815; 15457582; 15458440; 15458509; 15470196; 15474072; 15474081; 15474452; 15475194; 15477409; 15477421; 15489334; 15492846; 15492987; 15494412; 15500293; 15503824; 15503825; 15515423; 15515495; 15516835; 15522212; 15532726; 15540202; 15541813; 15542434; 15548611; 15556999; 15562207; 15568021; 15569051; 15569052; 15580293; 15583754; 15583822; 15583829; 15588162; 15607642; 15609122; 15609132; 15610240; 15610528; 15613104; 15614129; 15621731; 15629128; 15631865; 15633213; 15635051; 15638384; 15640157; 15646833; 15649874; 15653207; 15661835; 15661856; 15664512; 15665295; 15667531; 15667866; 15668894; 15669079; 15671530; 15674338; 15674425; 15682485; 15701844; 15704107; 15705187; 15705790; 15708566; 15714497; 15726914; 15731179; 15732116; 15733833; 15735682; 15741444; 15742396; 15745839; 15746194; 15754021; 15754412; 15756443; 15763997; 15767331; 15770733; 15776280; 15777969; 15788677; 15788755; 15809749; 15820807; 15826815; 15838334; 15838884; 15845615; 15847702; 15864753; 15871723; 15878754; 15880052; 15880074; 15880336; 15886312; 15892598; 15896327; 15897560; 15897913; 15905202; 15916974; 15917409; 15920019; 15935515; 15937083; 15940042; 15945504; 15949234; 15951295; 15956982; 15958542; 15963467; 15970595; 15973775; 15979997; 15996656; 16002046; 16005848; 16007189; 16014410; 16019439; 16024519; 16026585; 16036113; 16046504; 16049137; 16049374; 16054650; 16084492; 16086118; 16088182; 16095053; 16109918; 16116481; 16124648; 16130099; 16132039; 16142870; 16152587; 16154235; 16163059; 16166239; 16169405; 16170370; 16170373; 16171822; 16176284; 16179809; 16184401; 16186493; 16198352; 16202150; 16202216; 16216669; 16222693; 16226108; 16229182; 16239224; 16239639; 16243805; 16254334; 16260429; 16263579; 16269156; 16271941; 16278385; 16283008; 16299233; 16301496; 16301860; 16318581; 16320826; 16322068; 16328781; 16339827; 16343055; 16344560; 16357200; 16359995; 16375117; 16375118; 16384981; 16385345; 16386649; 16388189; 16388758; 16395752; 16396768; 16398404; 16403913; 16409998; 16410078; 16410746; 16412381; 16421229; 16423422; 16432214; 16434047; 16441660; 16456664; 16461129; 16465407; 16467091; 16482425; 16482999; 16484238; 16488441; 16489009; 16489641; 16490744; 16496302; 16499871; 16507781; 16508738; 16513643; 16514669; 16515588; 16516166; 16516857; 16517614; 16521228; 16526314; 16528367; 16530326; 16538528; 16543242; 16543245; 16543500; 16545694; 16569480; 16569553; 16570043; 16581961; 16583410; 16585124; 16596190; 16601840; 16608813; 16611402; 16612574; 16613616; 16616080; 16620970; 16627366; 16630077; 16636650; 16638750; 16643910; 16645174; 16645995; 16647384; 16648151; 16650817; 16675573; 16682007; 16684540; 16685110; 16702519; 16702604; 16707486; 16728464; 16730575; 16739374; 16740682; 16753977; 16759016; 16761623; 16763549; 16769575; 16773219; 16775174; 16775835; 16778084; 16778129; 16784838; 16786118; 16787408; 16788380; 16801663; 16804907; 16806288; 16816119; 16816927; 16820871; 16826426; 16830384; 16835467; 16835828; 16839256; 16856151; 16867277; 16870555; 16874958; 16877277; 16880208; 16883594; 16891801; 16894118; 16906455; 16908180; 16909109; 16911686; 16914267; 16916647; 16916659; 16920734; 16924371; 16930552; 16932349; 16937522; 16940309; 16941962; 16949073; 16954806; 16961715; 16962110; 16972327; 16979977; 16982461; 16984727; 16990600; 16999951; 17001321; 17008323; 17013089; 17015762; 17016437; 17023682; 17051153; 17058024; 17068288; 17082651; 17083617; 17084400; 17085437; 17088559; 17103175; 17105389; 17109192; 17111394; 17112680; 17113198; 17119993; 17121786; 17141247; 17141472; 17144494; 17148604; 17167981; 17168735; 17169805; 17178724; 17183639; 17189520; 17198275; 17203162; 17203176; 17204151; 17205120; 17210097; 17210106; 17215390; 17216542; 17222790; 17225860; 17227294; 17227476; 17237399; 17237427; 17255303; 17255526; 17256873; 17257729; 17259494; 17264508; 17276402; 17277913; 17279364; 17283531; 17283532; 17285972; 17285974; 17287067; 17287073; 17289129; 17289863; 17289872; 17289883; 17289903; 17293873; 17296185; 17297559; 17298206; 17310988; 17318185; 17319747; 17334712; 17334879; 17336974; 17348020; 17349182; 17353160; 17353919; 17367506; 17374440; 17379761; 17392174; 17392976; 17393106; 17393111; 17400419; 17409493; 17419711; 17426061; 17434451; 17442277; 17444036; 17445799; 17453634; 17454603; 17461470; 17470563; 17470632; 17471570; 17475821; 17477366; 17482348; 17482599; 17483438; 17487399; 17487982; 17488794; 17490619; 17495954; 17505039; 17505511; 17509958; 17511025; 17512973; 17513698; 17521372; 17525262; 17530707; 17536453; 17538775; 17543159; 17549360; 17550303; 17556598; 17558601; 17559806; 17562275; 17564725; 17570036; 17574386; 17574707; 17575273; 17577783; 17584582; 17588334; 17591953; 17597103; 17597658; 17601350; 17602688; 17604022; 17605857; 17611605; 17616354; 17618600; 17622743; 17625068; 17625508; 17626014; 17626017; 17626901; 17630849; 17631682; 17633444; 17633783; 17636397; 17638880; 17640598; 17640983; 17650671; 17651148; 17659575; 17661837; 17661998; 17664148; 17666321; 17671399; 17671679; 17671690; 17671709; 17672245; 17676480; 17678892; 17683807; 17685428; 17686471; 17693148; 17695550; 17698375; 17702963; 17707181; 17714861; 17716775; 17717293; 17726104; 17760549; 17762899; 17765237; 17784864; 17785433; 17786144; 17826416; 17828495; 17849138; 17852434; 17854909; 17855506; 17868952; 17874221; 17881084; 17884919; 17886678; 17889387; 17891484; 17893268; 17895817; 17897552; 17901362; 17904522; 17908694; 17908800; 17909169; 17914566; 17914573; 17916562; 17917789; 17919877; 17920582; 17931612; 17934147; 17934516; 17938959; 17947829; 17948123; 17949520; 17949784; 17951537; 17953946; 17959544; 17961496; 17961532; 17963063; 17972505; 17972522; 17974148; 17977866; 17978056; 17982650; 17983459; 17989695; 17991885; 18006432; 18006774; 18006812; 18006827; 18006829; 18024322; 18025258; 18025626; 18026817; 18031381; 18032824; 18035072; 18037256; 18039346; 18039850; 18043973; 18046016; 18047936; 18048970; 18051571; 18053608; 18053993; 18054203; 18056764; 18057235; 18059339; 18060622; 18060642; 18069627; 18069633; 18075302; 18078864; 18079407; 18079435; 18079689; 18080800; 18081234; 18086921; 18087285; 18093816; 18093986; 18093989; 18094062; 18094433; 18094712; 18094729; 18097541; 18158186; 18164591; 18164965; 18167313; 18171482; 18171601; 18172253; 18172321; 18172354; 18180305; 18181047; 18186798; 18188715; 18190463; 18200665; 18203080; 18204875; 18210198; 18211808; 18223238; 18225684; 18231921; 18239970; 18240292; 18242763; 18250044; 18250065; 18250616; 18251679; 18256065; 18256925; 18261579; 18261732; 18261985; 18264090; 18270456; 18272814; 18273500; 18275976; 18278068; 18280482; 18281657; 18282597; 18284215; 18285708; 18294357; 18295763; 18297377; 18298425; 18299215; 18300052; 18304943; 18307536; 18307947; 18307948; 18314110; 18317076; 18317686; 18317782; 18317954; 18321491; 18325345; 18326231; 18330257; 18330749; 18332870; 18337445; 18343373; 18344025; 18347025; 18349828; 18350569; 18350635; 18358555; 18359110; 18363112; 18363167; 18364383; 18366667; 18372903; 18373164; 18373940; 18374641; 18376140; 18378209; 18382903; 18383582; 18384433; 18386220; 18394773; 18396391; 18398039; 18413200; 18413368; 18414651; 18419602; 18425331; 18430064; 18430730; 18434853; 18437586; 18438338; 18438343; 18440775; 18441306; 18443354; 18449811; 18450321; 18450769; 18450951; 18451308; 18452581; 18452596; 18455421; 18459027; 18461364; 18476562; 18480385; 18483368; 18486981; 18489763; 18492378; 18494554; 18497527; 18498284; 18499616; 18504050; 18505065; 18509004; 18509061; 18513850; 18514506; 18514790; 18515987; 18516298; 18528739; 18534064; 18535271; 18546007; 18550579; 18551071; 18554246; 18554449; 18554584; 18556049; 18568888; 18569020; 18570923; 18574502; 18577655; 18581593; 18583877; 18588866; 18595517; 18595528; 18597093; 18598002; 18599607; 18609713; 18613756; 18614607; 18614759; 18614962; 18615482; 18617766; 18626660; 18628999; 18632621; 18636124; 18639520; 18641541; 18642643; 18644116; 18645275; 18646041; 18655183; 18655767; 18656381; 18665074; 18668138; 18669887; 18671849; 18671974; 18674955; 18676680; 18676870; 18682813; 18689794; 18691078; 18691902; 18692491; 18698224; 18701503; 18702899; 18704312; 18707678; 18708255; 18709380; 18709948; 18713823; 18714373; 18714564; 18718055; 18718059; 18719373; 18720901; 18724005; 18729809; 18752579; 18758126; 18758633; 18771509; 18780185; 18780663; 18780893; 18785001; 18787186; 18787502; 18788631; 18789115; 18789802; 18797821; 18800145; 18800249; 18802921; 18806748; 18813854; 18818406; 18818673; 18818748; 18821062; 18821695; 18824714; 18826376; 18826631; 18827607; 18829023; 18829111; 18830612; 18834676; 18835104; 18835464; 18835792; 18837095; 18842317; 18843117; 18845336; 18852899; 18922344; 18926648; 18927085; 18930211; 18936974; 18937791; 18940803; 18948156; 18949376; 18950958; 18952601; 18972599; 18974274; 18974372; 18976721; 18977241; 18978955; 18980821; 18983460; 18987249; 18987561; 18987662; 18987982; 18988927; 18991188; 18996083; 18996102; 18997771; 18998201; 19009560; 19010534; 19010874; 19011936; 19013462; 19014499; 19014781; 19014892; 19015224; 19016764; 19017033; 19017672; 19018001; 19018553; 19019335; 19020323; 19020709; 19020737; 19023980; 19027922; 19028605; 19031130; 19033661; 19034659; 19035465; 19036703; 19037583; 19039941; 19041000; 19041064; 19047116; 19048366; 19053834; 19054372; 19056482; 19058305; 19060000; 19060482; 19062717; 19064572; 19066962; 19071013; 19074885; 19080330; 19082594; 19086654; 19089753; 19089921; 19091459; 19094228; 19098893; 19102938; 19105269; 19107931; 19112107; 19115062; 19118564; 19119604; 19120886; 19121088; 19124506; 19127540; 19129951; 19131057; 19135668; 19139726; 19141347; 19141396; 19141403; 19141860; 19144048; 19144909; 19147754; 19148342; 19148469; 19148513; 19151604; 19152186; 19157636; 19167769; 19169051; 19170196; 19173907; 19174516; 19176759; 19179443; 19180920; 19181962; 19182495; 19188818; 19192227; 19192642; 19196101; 19196430; 19196819; 19197986; 19204726; 19209155; 19214813; 19215683; 19218116; 19219655; 19223316; 19223463; 19233472; 19234131; 19236408; 19236744; 19236756; 19236760; 19240722; 19244479; 19246299; 19246491; 19246638; 19249761; 19250552; 19253105; 19260469; 19260835; 19261502; 19263526; 19267183; 19270265; 19272614; 19275959; 19277666; 19278477; 19278589; 19281453; 19281856; 19284623; 19287200; 19291182; 19292043; 19295501; 19296249; 19302703; 19303319; 19307105; 19308252; 19309490; 19317804; 19324337; 19324447; 19324448; 19325137; 19330612; 19331191; 19332363; 19332989; 19336370; 19336661; 19340604; 19347725; 19349383; 19350273; 19350508; 19351507; 19351908; 19352513; 19358726; 19360850; 19364969; 19366059; 19369471; 19376222; 19376511; 19386985; 19389474; 19394248; 19398483; 19402151; 19404567; 19407245; 19409555; 19419943; 19420105; 19423615; 19424629; 19426547; 19429179; 19429439; 19434817; 19436948; 19437103; 19446005; 19452726; 19453261; 19462903; 19473053; 19474288; 19477063; 19477952; 19478092; 19478386; 19479188; 19479364; 19480853; 19483196; 19483288; 19483467; 19485983; 19487287; 19492417; 19493574; 19495422; 19496079; 19500509; 19506300; 19508152; 19508309; 19509297; 19515220; 19520980; 19521712; 19526316; 19527514; 19527632; 19528353; 19529993; 19531502; 19541645; 19542190; 19543148; 19544222; 19548138; 19548265; 19549711; 19550130; 19551141; 19553068; 19553626; 19553815; 19558170; 19558547; 19558800; 19559675; 19561538; 19563076; 19564559; 19565133; 19565930; 19566948; 19567589; 19573080; 19575912; 19575963; 19576015; 19576729; 19576799; 19576877; 19577260; 19578796; 19581046; 19582455; 19584152; 19587357; 19589268; 19589380; 19592043; 19594543; 19595210; 19595531; 19597830; 19598235; 19602472; 19614919; 19616847; 19624906; 19625176; 19626992; 19628492; 19631445; 19633358; 19633424; 19636272; 19638429; 19644155; 19649652; 19651147; 19652095; 19653005; 19654314; 19655095; 19659863; 19661350; 19662363; 19663127; 19663672; 19666581; 19670153; 19670620; 19673440; 19674970; 19676106; 19685443; 19692168; 19693769; 19697322; 19700204; 19701853; 19706811; 19707156; 19707198; 19707816; 19713864; 19715477; 19718476; 19720844; 19723043; 19724847; 19729488; 19734318; 19741061; 19747727; 19749460; 19754224; 19755511; 19761764; 19762163; 19763724; 19768695; 19773279; 19775068; 19779269; 19779281; 19783962; 19784389; 19787256; 19790065; 19794965; 19796028; 19797898; 19800880; 19801654; 19801785; 19804771; 19805546; 19813243; 19816237; 19816815; 19818105; 19819950; 19821158; 19828679; 19833888; 19834107; 19834490; 19835575; 19837381; 19837659; 19837976; 19842071; 19850021; 19855435; 19860625; 19861268; 19861314; 19874715; 19875757; 19877526; 19883500; 19884647; 19885588; 19885594; 19888861; 19889554; 19890661; 19890996; 19892399; 19893619; 19895315; 19896188; 19899407; 19904558; 19906640; 19908168; 19908237; 19910455; 19913121; 19914243; 19919523; 19920796; 19922608; 19931423; 19934363; 19940550; 19944696; 19948975; 19956867; 19957608; 19958548; 19961885; 20001221; 20003271; 20008399; 20011081; 20011601; 20015329; 20015661; 20019880; 20021822; 20021862; 20021866; 20026801; 20029166; 20029173; 20030927; 20031017; 20036815; 20036889; 20038274; 20039880; 20041256; 20044268; 20044875; 20045916; 20052595; 20056267; 20061392; 20063989; 20066538; 20066901; 20069330; 20072657; 20074475; 20075150; 20082870; 20084021; 20084057; 20085644; 20089932; 20093283; 20096741; 20098841; 20102314; 20103650; 20106729; 20107934; 20117921; 20117988; 20125120; 20127012; 20127022; 20127137; 20132989; 20133349; 20134268; 20137109; 20137122; 20137269; 20137346; 20138124; 20140301; 20142849; 20143643; 20144626; 20159686; 20164467; 20164848; 20166898; 20169144; 20173307; 20174965; 20176809; 20176926; 20177148; 20179233; 20182908; 20183799; 20184549; 20184663; 20185790; 20186105; 20187681; 20193458; 20196627; 20202860; 20204302; 20204402; 20205278; 20209496; 20210775; 20211058; 20218294; 20221394; 20222950; 20223440; 20228934; 20229258; 20232316; 20233927; 20237090; 20237496; 20299690; 20302942; 20303008; 20306656; 20306691; 20307196; 20308035; 20308631; 20331634; 20335639; 20346360; 20349215; 20349288; 20352346; 20356362; 20357617; 20358425; 20359293; 20360594; 20363638; 20364320; 20364398; 20369584; 20369693; 20370579; 20374513; 20381197; 20382120; 20382636; 20383146; 20388088; 20388222; 20388348; 20388479; 20389299; 20395257; 20395351; 20396703; 20396759; 20396799; 20398057; 20400478; 20406100; 20413783; 20413880; 20414936; 20416077; 20417690; 20420808; 20422320; 20422487; 20424473; 20430742; 20430845; 20442584; 20443868; 20444917; 20446021; 20449668; 20452482; 20453000; 20453883; 20465445; 20465852; 20470445; 20471067; 20471686; 20471768; 20473646; 20477880; 20482220; 20485168; 20485444; 20489156; 20489684; 20492336; 20497701; 20501856; 20502414; 20502715; 20504760; 20510681; 20514415; 20522805; 20529820; 20531372; 20532559; 20538805; 20540786; 20543462; 20545903; 20546613; 20549300; 20551700; 20552269; 20552697; 20554972; 20555002; 20556584; 20561442; 20562294; 20563637; 20566589; 20568250; 20571438; 20571754; 20571871; 20580871; 20587967; 20591524; 20592375; 20592377; 20593045; 20593288; 20599538; 20602615; 20615131; 20618614; 20619094; 20621071; 20621078; 20628086; 20628624; 20629312; 20631454; 20631636; 20632925; 20635170; 20640910; 20644561; 20646480; 20652396; 20659485; 20660327; 20660740; 20664058; 20666680; 20666936; 20669661; 20670331; 20671396; 20673503; 20673868; 20674013; 20677014; 20677158; 20678803; 20682175; 20683431; 20685027; 20686603; 20690032; 20690185; 20695190; 20697987; 20702774; 20705519; 20706192; 20709463; 20712888; 20713592; 20717925; 20723915; 20724477; 20725676; 20725807; 20736307; 20736792; 20797778; 20799939; 20801867; 20802176; 20810734; 20813696; 20819778; 20830305; 20832104; 20838751; 20840814; 20842453; 20847577; 20849862; 20850693; 20851810; 20854187; 20855282; 20857215; 20860536; 20860824; 20863203; 20864099; 20864667; 20868598; 20872175; 20873541; 20873967; 20883786; 20889853; 20927120; 20927579; 20932296; 20935629; 20939477; 20939988; 20940716; 20941554; 20950367; 20953377; 20956022; 20959293; 20959405; 20973260; 20974861; 20977975; 20978160; 20979864; 20980160; 20981515; 20981743; 21031415; 21034500; 21036706; 21041183; 21041381; 21047416; 21047768; 21048041; 21056306; 21056681; 21057529; 21057546; 21062896; 21067446; 21071025; 21071450; 21080079; 21081932; 21091242; 21093207; 21097568; 21103625; 21107201; 21110424; 21115961; 21117958; 21118571; 21118974; 21119072; 21121979; 21126911; 21127992; 21128597; 21138680; 21158586; 21161264; 21161943; 21162194; 21163075; 21165437; 21172937; 21173077; 21174212; 21174216; 21175804; 21175812; 21179282; 21179479; 21191630; 21194429; 21196048; 21196926; 21211657; 21212275; 21213129; 21219538; 21221762; 21222176; 21233846; 21236558; 21239704; 21242666; 21245770; 21245995; 21247755; 21248670; 21249429; 21251073; 21254648; 21257617; 21264844; 21269615; 21269972; 21275514; 21278683; 21282065; 21282580; 21285868; 21292509; 21293011; 21295294; 21300047; 21302448; 21302807; 21306819; 21309690; 21309701; 21316969; 21318419; 21319995; 21323573; 21331989; 21334418; 21343907; 21344505; 21345805; 21347390; 21349629; 21357506; 21362301; 21362767; 21365932; 21367627; 21371321; 21374591; 21376261; 21378341; 21382274; 21382277; 21385874; 21388351; 21389676; 21390493; 21395178; 21398142; 21400522; 21411409; 21412269; 21414893; 21416580; 21424032; 21424698; 21426646; 21426843; 21436157; 21441136; 21442180; 21445972; 21447743; 21450501; 21451433; 21455573; 21458805; 21466159; 21468688; 21474827; 21480261; 21481963; 21482134; 21491998; 21495021; 21498704; 21509530; 21515330; 21515455; 21517260; 21519633; 21525162; 21535601; 21543926; 21544626; 21546870; 21556933; 21558292; 21558971; 21562766; 21566137; 21568945; 21569455; 21570413; 21572114; 21573104; 21574155; 21575227; 21575493; 21576240; 21596454; 21597001; 21603628; 21605336; 21609392; 21610314; 21612402; 21616486; 21616551; 21617191; 21619628; 21623273; 21636803; 21637343; 21637825; 21643812; 21646367; 21650061; 21651424; 21653826; 21655646; 21661398; 21664646; 21665940; 21665990; 21666711; 21667015; 21669490; 21671140; 21672190; 21672207; 21673370; 21677035; 21683519; 21684758; 21685944; 21698469; 21699503; 21706043; 21706269; 21708009; 21710234; 21710604; 21711965; 21712445; 21724588; 21726930; 21730794; 21734015; 21737794; 21740084; 21743435; 21744122; 21757152; 21757650; 21757917; 21761115; 21761458; 21763962; 21763969; 21763972; 21766497; 21769478; 21771176; 21773953; 21774929; 21782227; 21782870; 21782909; 21797753; 21798757; 21799753; 21802218; 21809353; 21809368; 21813166; 21814723; 21826315; 21830391; 21831507; 21832278; 21832283; 21837996; 21845872; 21845875; 21851000; 21851923; 21853312; 21854110; 21856421; 21866460; 21867616; 21872252; 21873429; 21876459; 21881842; 21882634; 21886838; 21897119; 21902756; 21905000; 21905955; 21906274; 21912077; 21913973; 21917937; 21918901; 21918972; 21923031; 21935869; 21938405; 21939655; 21939755; 21944175; 21948244; 21950586; 21953277; 21959110; 21959987; 21964530; 21965736; 21968684; 21978756; 21979585; 21982816; 21983449; 21984182; 21985298; 21986500; 21986923; 21987221; 21988832; 21994955; 21998580; 22004076; 22009797; 22012426; 22014666; 22016416; 22020326; 22020917; 22024063; 22028446; 22030397; 22034877; 22040304; 22051188; 22051879; 22053594; 22053610; 22058001; 22064697; 22067973; 22073279; 22082308; 22084166; 22086907; 22094096; 22095559; 22095586; 22097317; 22098148; 22098246; 22098296; 22103490; 22104143; 22105769; 22111836; 22116346; 22120617; 22124604; 22125641; 22125837; 22126484; 22128293; 22128802; 22129133; 22139971; 22147251; 22147779; 22158497; 22159356; 22161247; 22162628; 22167330; 22170854; 22171127; 22174163; 22174934; 22178239; 22178822; 22183311; 22184869; 22185591; 22186244; 22189703; 22194599; 22197408; 22198599; 22199270; 22199311; 22203927; 22203935; 22206010; 22209065; 22209952; 22210436; 22222630; 22227235; 22227305; 22227643; 22230112; 22230399; 22230402; 22231433; 22233184; 22251524; 22257487; 22259987; 22260074; 22268049; 22270366; 22270936; 22274866; 22275161; 22287745; 22289522; 22292637; 22296200; 22307775; 22307787; 22308085; 22311631; 22314268; 22315135; 22318385; 22318724; 22319020; 22320189; 22321253; 22328776; 22337942; 22344539; 22350794; 22355348; 22363824; 22368191; 22370607; 22380724; 22382924; 22385323; 22385934; 22386962; 22392094; 22392487; 22392726; 22395988; 22397762; 22399811; 22402207; 22402885; 22402934; 22407444; 22409847; 22417860; 22429695; 22431315; 22433249; 22437209; 22452999; 22455137; 22460086; 22461367; 22471664; 22472004; 22475441; 22475893; 22479202; 22489699; 22493900; 22494072; 22497886; 22506349; 22510875; 22511716; 22513751; 22517242; 22521084; 22527851; 22528855; 22534113; 22541785; 22542989; 22547925; 22548401; 22552325; 22553402; 22558473; 22558480; 22564870; 22568177; 22569438; 22573202; 22577248; 22580375; 22581182; 22581719; 22587628; 22590832; 22594508; 22609636; 22612323; 22612467; 22613408; 22622799; 22635523; 22640261; 22643235; 22644871; 22645074; 22652447; 22652457; 22659165; 22659470; 22659681; 22670172; 22674805; 22675957; 22677927; 22685266; 22689615; 22689881; 22690749; 22692760; 22694909; 22696064; 22697069; 22699049; 22699054; 22699060; 22699782; 22699808; 22705563; 22711306; 22729570; 22729710; 22730813; 22733742; 22735262; 22740248; 22762535; 22763125; 22768249; 22771446; 22773844; 22776467; 22781068; 22786655; 22789536; 22790437; 22791116; 22795057; 22796052; 22800355; 22813402; 22818823; 22819906; 22833169; 22836100; 22840423; 22848663; 22849380; 22850906; 22853925; 22854047; 22855059; 22855159; 22864531; 22864925; 22865486; 22869459; 22872519; 22872931; 22875307; 22876972; 22877565; 22882209; 22899753; 22901144; 22901561; 22906062; 22915033; 22915086; 22925497; 22926658; 22927437; 22930318; 22931643; 22935455; 22942646; 22944463; 22948895; 22951014; 22956610; 22957090; 22961433; 22962287; 22963269; 22965144; 22992725; 22993129; 22993299; 22994042; 22994764; 23005896; 23015149; 23020605; 23025904; 23029477; 23038639; 23039092; 23040494; 23053181; 23058011; 23059773; 23060442; 23061744; 23062326; 23062640; 23064377; 23065156; 23065202; 23065534; 23068100; 23073296; 23077562; 23086295; 23086340; 23086933; 23093658; 23094709; 23098361; 23098453; 23102786; 23104639; 23104894; 23108136; 23114032; 23117246; 23118492; 23128854; 23129289; 23137522; 23145112; 23151382; 23155231; 23155236; 23155356; 23160675; 23161411; 23166713; 23167810; 23168996; 23169005; 23169435; 23172303; 23176363; 23177780; 23181555; 23182805; 23192572; 23201159; 23204297; 23206462; 23211130; 23212515; 23213275; 23217559; 23220088; 23221067; 23222716; 23224211; 23225320; 23227881; 23232696; 23236677; 23236888; 23239744; 23243026; 23250775; 23254909; 23254958; 23257745; 23263486; 23264084; 23264219; 23265127; 23269488; 23269798; 23272057; 23272609; 23279742; 23280079; 23285958; 23288726; 23290762; 23293030; 23293323; 23295255; 23302311; 23313225; 23315815; 23317892; 23321169; 23321170; 23326384; 23326500; 23328414; 23329570; 23332132; 23332617; 23334331; 23335070; 23335846; 23339636; 23340303; 23346798; 23350126; 23350655; 23352645; 23353010; 23359195; 23364276; 23367565; 23369005; 23370341; 23374220; 23374253; 23383089; 23384557; 23390884; 23398358; 23401860; 23403511; 23404377; 23405237; 23408906; 23413901; 23421785; 23421942; 23428182; 23429328; 23429999; 23430447; 23435217; 23444216; 23449351; 23454149; 23454747; 23455636; 23459872; 23462604; 23465821; 23467576; 23470436; 23475388; 23481572; 23485997; 23499421; 23511629; 23522390; 23542734; 23545315; 23548900; 23552871; 23553563; 23554900; 23555666; 23559636; 23569009; 23572336; 23586368; 23588859; 23589053; 23592000; 23599627; 23602531; 23605255; 23608225; 23613250; 23613251; 23613412; 23618468; 23620752; 23625573; 23639731; 23644986; 23648010; 23649946; 23650550; 23651239; 23656623; 23661335; 23667446; 23673188; 23679262; 23679318; 23687977; 23688054; 23690937; 23695013; 23698113; 23699597; 23711375; 23714383; 23719599; 23722461; 23725153; 23725155; 23728502; 23737289; 23737650; 23745581; 23748230; 23749886; 23754270; 23754948; 23756256; 23759331; 23761723; 23765166; 23767832; 23780896; 23790363; 23794239; 23831623; 23831629; 23838139; 23838428; 23840094; 23848209; 23851330; 23860526; 23861821; 23867510; 23870474; 23877020; 23884416; 23884772; 23884891; 23886195; 23886210; 23904001; 23906304; 23907576; 23913375; 23922493; 23926105; 23929745; 23933698; 23950980; 23953100; 23953866; 23976881; 23982876; 23992143; 23998120; 24005038; 24016866; 24021340; 24021586; 24024441; 24043765; 24048796; 24052076; 24067461; 24120473; 24123039; 24222145; 24225154; 24254563; 24263190; 24274376; 24284961; 24321896; 24341227; 24400721; 24403492; 24510998; 24511001,,,,,,,,,,,,,,,,,,OGG:3000007422,,,,,,,,,,,,,,,,,,,vascular endothelial growth factor A,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,VEGFA,,,20140408,7422,RP1-261G23.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,VEGFA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0001533,cornified envelope,,"A type of plasma membrane that has been modified through addition of distinct intracellular and extracellular components, including ceramide, found in cornifying epithelial cells (corneocytes).",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"A type of plasma membrane that has been modified through addition of distinct intracellular and extracellular components, including ceramide, found in cornifying epithelial cells (corneocytes).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_50557,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0001533,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001533,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cornified envelope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046794,transport of virus,viral transport|virion transport,"The directed movement of a virus, or part of a virus, into, out of, or within a host cell.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"The directed movement of a virus, or part of a virus, into, out of, or within a host cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral transport,,,virion transport,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0046794,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0046794,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,transport of virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0410042,Abnormal liver morphology,,"Any structural anomaly of the bile-secreting organ that is important for detoxification, for fat, carbohydrate, and protein metabolism, and for glycogen storage.",false,,,http://purl.obolibrary.org/obo/HP_0001392,,,,,,,,,,,,,,,,ORCID:0000-0001-5208-3432,,,,Fyler:4447,"Any structural anomaly of the bile-secreting organ that is important for detoxification, for fat, carbohydrate, and protein metabolism, and for glycogen storage.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0410042,,,,,,,,,,,,,,,,,,2017-09-20T00:22:53Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001392,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal liver morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_255730,SARS coronavirus Sino1-11,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:255730,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sino1-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000138,alpha-ketoamide inhibitor,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A broad-spectrum antiviral drugs that targets coronaviruses and enteroviruses replication.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,,,,true,,https://pubmed.ncbi.nlm.nih.gov/32045235/|https://www.ncbi.nlm.nih.gov/pubmed/32198291/,,,,,,,,,,,,,,,,,alpha-ketoamide inhibitor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_3441,carvedilol,1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol|Carvedilol|carvedilol|SKF 105517|(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol|carvedilolum,A member of the class of carbazoles that is an adrenergic antagonist with non-selective beta- and alpha-1 receptor blocking properties which helps in the management of congestive heart failure.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D00255|PMID:17383596|Drug_Central:522|Patent:US4503067|DrugBank:DB01136|LINCS:LSM-1310|Beilstein:1514452|CAS:72956-09-3|PMID:15184840|PMID:18992766|Patent:DE2815926|KEGG:C06875|HMDB:HMDB0015267|Reaxys:1514452|PMID:11389884|Wikipedia:Carvedilol,A member of the class of carbazoles that is an adrenergic antagonist with non-selective beta- and alpha-1 receptor blocking properties which helps in the management of congestive heart failure.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol|Carvedilol,,,,,chebi_ontology,,carvedilol|SKF 105517|(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol|carvedilolum,,,,,,,,,0,C24H26N2O4,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",OGHNVEJMJSYVRP-UHFFFAOYSA-N,406.47432,406.18926,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:3441,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:3441,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,carvedilol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001505,regulation of neurotransmitter levels,,Any process that modulates levels of neurotransmitter.,false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,Any process that modulates levels of neurotransmitter.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0001505,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001505,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of neurotransmitter levels,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_4031,cyclosporin A,"30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone|Cyclosporin A|1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine]|Ciclosporin|Cyclosporine|(R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)|Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)|30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone|ciclosporina|ciclosporine|Sandimmune|ciclosporin|Antibiotic S 7481F1|ciclosporinum|Neoral|Gengraf","A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:15811524|PMID:18818682|KEGG:D00184|PMID:11426833|PMID:18299432|VSDB:1765|PMID:11493684|PMID:11870366|Beilstein:3647785|PMID:11529914|PMID:17220244|PMID:11557554|PMID:15030555|PMID:11315347|KEGG:C05086|PMID:17265451|PMID:11238591|PMID:11676831|Wikipedia:Ciclosporin|PMID:12950728|PMID:11406057|CAS:59865-13-3|PMID:11079273|PMID:1566062|PMID:15210365|PMID:12603598|PMID:19282398|PMID:14621732|KNApSAcK:C00001517|PMID:14521916|PMID:15626898|PMID:16801218|PMID:19589783|LINCS:LSM-1703|PMID:18583716|PMID:18975184|PMID:17446460|PMID:16724420|PMID:15711594|PMID:14672695|PMID:11278005|Patent:US4117118|PMID:14638917|PMID:16372476|Drug_Central:760|PMID:16404634|PMID:17083576|PMID:11481617|PMID:15613074|PMID:18171316|PMID:12761440|PMID:15175101|PMID:17229932|PMID:15383526|PMID:18790203|PMID:17192032|PMID:11080188|PMID:16898534|PMID:17603747|PMID:17117422|PMID:18076075|PMID:12021257|PMID:18259730|PMID:14682659|PMID:11370709|PMID:11442023|PMID:18359899|PMID:15306697|DrugBank:DB00091|PMID:12050171|PMID:17032751|PMID:18931077|PMID:11256490|PMID:11058832|PMID:18217899|PMID:12929192|PMID:18597363|PMID:11069928|PMID:15657176|PMID:14743390|PMID:18191430|Reaxys:3647785|PMID:15541012|PMID:15962181|PMID:11564166,"A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:63586|CHEBI:91802,,,,"30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone|Cyclosporin A",,,,,chebi_ontology,,"1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine]|Ciclosporin|Cyclosporine|(R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl)|Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl)|30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone|ciclosporina|ciclosporine|Sandimmune|ciclosporin|Antibiotic S 7481F1|ciclosporinum|Neoral|Gengraf",,,,,,,,,0,C62H111N11O12,"InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1",PMATZTZNYRCHOR-CGLBZJNRSA-N,1202.61120,1201.84137,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:4031,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:4031,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,cyclosporin A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249069,SARS coronavirus HSZ-A,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249069,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HSZ-A,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061640,cytoskeleton-dependent cytokinesis,,A cytokinesis that involves the function of a set of proteins that are part of the microfilament or microtubule cytoskeleton.,false,,,http://purl.obolibrary.org/obo/GO_0000910,,,,,,,,,,,,,,,,dph,2014-08-22T14:21:35Z,,,,A cytokinesis that involves the function of a set of proteins that are part of the microfilament or microtubule cytoskeleton.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000910,,,,GO:0061640,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061640,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytoskeleton-dependent cytokinesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019074,viral RNA genome packaging,,The packaging of viral RNA (single-stranded or double-stranded) into a nucleocapsid.,false,,,http://purl.obolibrary.org/obo/GO_0019072,,,,,,,,,,,,,,,,,,,,,The packaging of viral RNA (single-stranded or double-stranded) into a nucleocapsid.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019072,,,,GO:0019074,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32282268,,,,GO:0019074,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral RNA genome packaging,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007051,spindle organization,spindle organisation|spindle organization and biogenesis|spindle stabilization,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the spindle, the array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during DNA segregation and serves to move the duplicated chromosomes apart.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the spindle, the array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during DNA segregation and serves to move the duplicated chromosomes apart.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043146,,,,spindle organisation,,,,,biological_process,,spindle organization and biogenesis|spindle stabilization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007051,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007051,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spindle organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002900,Hypokalemia,Low blood potassium levels,An abnormally decreased potassium concentration in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0011042,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:166690008|UMLS:C0020621|MSH:D007008|SNOMEDCT_US:43339004,An abnormally decreased potassium concentration in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Low blood potassium levels,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011042,,,,HP:0002900,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32173576,,,,HP:0002900,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Hypokalemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_391355,SARS coronavirus Frankfurt1-v01,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_229992,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:391355,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_229992,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Frankfurt1-v01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003178,HNRNPA1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HNRPA1L3|ALS19|HNRPA1|ALS20|hnRNP-A1|IBMPFD3|hnRNP A1,,,,,,,12,,,,,,,,,,Ensembl:ENSG00000135486|HPRD:01242|Vega:OTTHUMG00000169702|HGNC:5031|MIM:164017,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,heterogeneous nuclear ribonucleoprotein A1,,12q13.1,,,,"GO_0000166 (EC: IEA); GO_0000380 (EC: IEA); GO_0000398 (EC: IC, PMID: 11991638); GO_0000398 (EC: TAS); GO_0003697 (EC: IDA, PMID: 8521471); GO_0003723 (EC: TAS, PMID: 8521471); GO_0003727 (EC: IC, PMID: 8521471); GO_0005515 (EC: IPI); GO_0005634 (EC: IDA); GO_0005654 (EC: IDA); GO_0005654 (EC: TAS); GO_0005681 (EC: IDA, PMID: 9731529); GO_0005730 (EC: IDA, Qualifier: NOT); GO_0005737 (EC: IDA); GO_0006397 (EC: TAS, PMID: 8521471); GO_0006405 (EC: IC, PMID: 8521471); GO_0008219 (EC: IEA); GO_0008380 (EC: TAS); GO_0010467 (EC: TAS); GO_0016032 (EC: IEA); GO_0030529 (EC: IDA, PMID: 17289661); GO_0044822 (EC: IDA); GO_0045111 (EC: IDA); GO_0051028 (EC: IEA); GO_0051168 (EC: IDA, PMID: 8521471); GO_0051170 (EC: IDA, PMID: 8521471); GO_0070062 (EC: IDA); GO_0071013 (EC: IDA, PMID: 11991638)",PMID: 1691095; 1733858; 2176620; 2760922; 2836799; 3023065; 7505766; 7730395; 7769000; 8288564; 8473331; 8521471; 8663146; 8883365; 8889548; 9115444; 9144189; 9164463; 9731529; 9891755; 9925777; 10212141; 10323862; 10383403; 10772858; 10843177; 10913197; 11003644; 11313474; 11546873; 11779509; 11790298; 11825891; 11884611; 11893730; 11991638; 12060656; 12212851; 12226669; 12419255; 12458794; 12477932; 12565831; 12612063; 12665590; 12777385; 12799433; 12927788; 12945950; 14559993; 14611647; 14633690; 14645369; 14667819; 14690413; 14703516; 14704337; 14729942; 15047060; 15161933; 15161980; 15208309; 15210956; 15231747; 15342234; 15489334; 15492215; 15525641; 15592455; 15604093; 15635413; 15671034; 15703079; 15703818; 15782174; 15848144; 15861128; 16000324; 16097034; 16159877; 16169070; 16177791; 16196087; 16230076; 16449650; 16600502; 16603717; 16916647; 16990281; 17081983; 17110431; 17229681; 17264152; 17287399; 17289661; 17332742; 17353911; 17558416; 17611602; 17620599; 17643375; 17803295; 17884807; 17898077; 17950949; 18029348; 18391021; 18457437; 18483487; 18562319; 18809582; 18846111; 18850631; 19004954; 19101556; 19135240; 19282454; 19322201; 19339352; 19349988; 19430204; 19596686; 19667073; 19710015; 19715280; 19737937; 19738201; 19808671; 19913121; 19926721; 19928837; 20000738; 20010808; 20020773; 20133837; 20301623; 20628086; 20639865; 20639884; 20716340; 20872967; 20974848; 20978194; 21081666; 21110914; 21120954; 21139048; 21145461; 21182205; 21319273; 21398516; 21399625; 21424008; 21454539; 21548758; 21627027; 21642987; 21832049; 21853274; 21858080; 21890473; 21906983; 21942715; 21963094; 21987572; 21988832; 22053931; 22079093; 22132154; 22174317; 22178446; 22187150; 22227431; 22268729; 22285803; 22325350; 22365833; 22412018; 22446626; 22505724; 22536838; 22623428; 22628224; 22751105; 22810585; 22821376; 22863883; 22939629; 22944692; 22983828; 22990118; 23000965; 23035981; 23106379; 23184937; 23383273; 23394998; 23398456; 23430061; 23438482; 23455423; 23455922; 23463506; 23602568; 23658645; 23827524; 24244333; 24250222; 24457600,,,,,,,,,,,,,,,,,,OGG:3000003178,,,,,,,,,,,,,,,,,,,heterogeneous nuclear ribonucleoprotein A1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HNRNPA1,,,20140408,3178,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,HNRNPA1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000003929,LBP,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,BPIFD2,,,,,,,20,,,,,,,,,,HGNC:6517|HPRD:07175|Ensembl:ENSG00000129988|Vega:OTTHUMG00000032447|MIM:151990,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,lipopolysaccharide binding protein,,20q11.23,,,,"GO_0001530 (EC: IDA, PMID: 12594207); GO_0001530 (EC: ISS, PMID: 2477488); GO_0002224 (EC: TAS); GO_0002232 (EC: IEA); GO_0002281 (EC: ISS, PMID: 2402637); GO_0005102 (EC: ISS, PMID: 2477488); GO_0005515 (EC: IPI); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 11528597); GO_0005615 (EC: ISS, PMID: 2477488); GO_0006953 (EC: IEP, PMID: 12932360); GO_0006953 (EC: ISS, PMID: 2477488); GO_0006968 (EC: ISS, PMID: 2402637); GO_0008228 (EC: IC, PMID: 12932360); GO_0008228 (EC: ISS, PMID: 2477488); GO_0009986 (EC: IDA, PMID: 11528597); GO_0015920 (EC: IDA, PMID: 8985160); GO_0031663 (EC: IDA, PMID: 11739189); GO_0032490 (EC: IDA, PMID: 11528597); GO_0032496 (EC: IDA, PMID: 11739189); GO_0032720 (EC: IDA, PMID: 11739189); GO_0032722 (EC: IEA); GO_0032755 (EC: IDA, PMID: 8409400); GO_0032757 (EC: IDA, PMID: 8409400); GO_0032760 (EC: IDA, PMID: 12594207); GO_0032760 (EC: ISS, PMID: 2402637); GO_0034142 (EC: TAS); GO_0034145 (EC: IDA, PMID: 11528597); GO_0042535 (EC: IEA); GO_0043032 (EC: IDA, PMID: 8409400); GO_0044130 (EC: IEA); GO_0045087 (EC: IC, PMID: 12932360); GO_0045087 (EC: ISS, PMID: 2477488); GO_0045087 (EC: TAS); GO_0050829 (EC: IDA, PMID: 11528597); GO_0050829 (EC: ISS, PMID: 2402637); GO_0050830 (EC: IDA, PMID: 12932360); GO_0060265 (EC: ISS); GO_0070062 (EC: IDA, PMID: 19056867); GO_0070891 (EC: IDA, PMID: 12594207); GO_0071222 (EC: IDA, PMID: 12594207); GO_0071223 (EC: IDA, PMID: 12594207); GO_0090023 (EC: IEA)",PMID: 2402637; 2477488; 7517398; 7583357; 8409400; 8432532; 8663389; 8985160; 9179291; 9240454; 9338787; 9441745; 9568897; 9665271; 10079194; 10453023; 10768924; 10811873; 10919979; 11373419; 11528597; 11544322; 11598069; 11739189; 11773072; 11780052; 11976738; 11991204; 12117913; 12417309; 12477932; 12521224; 12538700; 12594207; 12615620; 12754215; 12831460; 12932360; 14718574; 15127192; 15618154; 15932345; 16303759; 16493079; 16512634; 16907704; 16928689; 18029348; 18056482; 18056918; 18288274; 18397383; 18559343; 18783308; 18987746; 19010986; 19056867; 19200604; 19423540; 19522765; 19560454; 19707138; 19718443; 19913121; 20346360; 20379614; 20381257; 20406964; 20438785; 20530747; 20628086; 20800603; 20865702; 21353369; 21633598; 21702700; 21722015; 21740312; 21901123; 21988832; 22476641; 22552880; 22736337; 22960476; 23349936; 23382691; 23430250; 23463341; 24024966; 24120359,,,,,,,,,,,,,,,,,,OGG:3000003929,,,,,,,,,,,,,,,,,,,lipopolysaccharide binding protein,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,LBP,,,20140408,3929,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,LBP,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0007044,cell-substrate junction assembly,cell-substrate adherens junction assembly,"The aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate.|The primary label for merged term was 'cell-substrate adherens junction assembly' GO:0007045. The term was merged into the parent 'cell-substrate junction assembly', because, based on the most recent litarature, 'adherens junction' is always a 'cell-cell junction' (PMID:20571587, PMID:17854762, PMID:21422226, PMID:28096264, PMID:28401269, PMID:26923917).",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007045,,,,,,,,,biological_process,,cell-substrate adherens junction assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The primary label for merged term was 'cell-substrate adherens junction assembly' GO:0007045. The term was merged into the parent 'cell-substrate junction assembly', because, based on the most recent litarature, 'adherens junction' is always a 'cell-cell junction' (PMID:20571587, PMID:17854762, PMID:21422226, PMID:28096264, PMID:28401269, PMID:26923917).",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007044,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007044,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cell-substrate junction assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_229993,SARS coronavirus TW1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:229993,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_253433,SARS coronavirus PUMC01,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:253433,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PUMC01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258971,SARS coronavirus TW8,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258971,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098995,disruption by virus of host envelope lipopolysaccharide during virus entry,degradation of host lipopolysaccharide during virus entry|degradation of host cell envelope lipopolysaccharide during viral entry|disassembly by virus of outer membrane lipopolysaccharide during viral entry,The breakdown of lipopolysaccharides in a host cell envelope during virus entry into a host cell.  For example a phage entering a gram-negative bacterium may actively break down outer membrane lipopolysaccharides.,false,,,http://purl.obolibrary.org/obo/GO_0098994|http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,VZ:3939,The breakdown of lipopolysaccharides in a host cell envelope during virus entry into a host cell.  For example a phage entering a gram-negative bacterium may actively break down outer membrane lipopolysaccharides.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,degradation of host lipopolysaccharide during virus entry|degradation of host cell envelope lipopolysaccharide during viral entry,,,disassembly by virus of outer membrane lipopolysaccharide during viral entry,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0098994|http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0098995,,,,,,true,,,,true,,,,,GO:0098995,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,disruption by virus of host envelope lipopolysaccharide during virus entry,,,,,,,,,,,,,,,,,,,,,,https://www.macrophi.co.jp/english/lps/2-9.html,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000027,ribosomal large subunit assembly,60S ribosomal subunit assembly|50S ribosomal subunit assembly,"The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the large ribosomal subunit.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the large ribosomal subunit.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60S ribosomal subunit assembly|50S ribosomal subunit assembly,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0000027,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000027,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribosomal large subunit assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_228607,SARS coronavirus BJ04,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:228607,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,https://www.ncbi.nlm.nih.gov/pubmed/15629030,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0000097,participant under investigation role,,A role that is realized through the execution of a study design in which the bearer of the role participates and in which data about that bearer is collected.,false,,,http://purl.obolibrary.org/obo/BFO_0000023,,,,,,,,,,,,,,,,,,,"Following OBI call November 2012,26th:
 
1. it was decided there was no need for moving the children class and making them siblings of study subject role.
2. it also settles the disambiguation about 'study subject'. This is about the individual participating in the investigation/study, Not the 'topic' (as in 'toxicity study') of the investigation/study

This note closes the issue and validates the class definition to be part of the OBI core
editor = PRS
",,A role that is realized through the execution of a study design in which the bearer of the role participates and in which data about that bearer is collected.,,OBI,,,,,,"A participant can realize both ""specimen role"" and ""participant under investigation role"" at the same time. However ""participant under investigation role"" is distinct from ""specimen role"", since a specimen could somehow be involved in an investigation without being the thing that is under investigation.",study subject role,,,,"Human subjects in a clinical trial, rats in a toxicogenomics study, tissue cutlures subjected to drug tests, fish observed in an ecotoxicology study. 
Parasite example: people are infected with a parasite which is then extracted; the particpant under investigation could be the parasite, the people, or a population of which the people are members, depending on the nature of the study.
Lake example: a lake could realize this role in an investigation that assays pollution levels in samples of water taken from the lake.",,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000122,,,,,,,,,,,,,,,,,,,,OBI:0000097,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000023,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,participant under investigation role,,,,,,,,,,,,,,,,,,,,,,,,,,,,GROUP:  Role Branch,,,,
http://purl.obolibrary.org/obo/OGMS_0000031,disease,,A disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.,false,,,http://purl.obolibrary.org/obo/BFO_0000016,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T11:21:20Z,,A disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.,,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000031,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000016,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/OGMS_0000014,clinical finding,,"A representation that is either the output of a clinical history taking or a physical examination or an image finding, or some combination thereof.",false,,,http://purl.obolibrary.org/obo/OGMS_0000123,,,,,,,,,,,,,,,,,,,creation date: 2010-07-19T10:18:02Z,,"A representation that is either the output of a clinical history taking or a physical examination or an image finding, or some combination thereof.",,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000014,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000123,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl|http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,clinical finding,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/GO_0039633,killing by virus of host cell,killing by virus of host cells|killing by phage of host cells,Any process mediated by a virus that results in the death of a cell in the host organism.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2012-08-10T14:44:40Z,,,,Any process mediated by a virus that results in the death of a cell in the host organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,killing by virus of host cells,,,killing by phage of host cells,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039633,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32311318,,,,GO:0039633,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,killing by virus of host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000290,ANPEP,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,APN|PEPN|LAP1|GP150|CD13|P150,,,,,,,15,,,,,,,,,,HPRD:01055|Vega:OTTHUMG00000149814|HGNC:500|Ensembl:ENSG00000166825|MIM:151530,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,alanyl (membrane) aminopeptidase,,15q25-q26,,,,"GO_0001525 (EC: IEA); GO_0001618 (EC: IEA); GO_0002003 (EC: TAS); GO_0004177 (EC: IEA); GO_0004872 (EC: TAS, PMID: 1350662); GO_0005765 (EC: IDA, PMID: 17897319); GO_0005793 (EC: IDA, PMID: 15308636); GO_0005829 (EC: IEA); GO_0005887 (EC: TAS, PMID: 2564851); GO_0008237 (EC: IEA); GO_0008270 (EC: IEA); GO_0009897 (EC: IEA); GO_0016032 (EC: IEA); GO_0030154 (EC: IEA); GO_0044267 (EC: TAS); GO_0070062 (EC: IDA, PMID: 15326289)",PMID: 1350662; 1675638; 1705556; 1977688; 2428842; 2564851; 2901990; 2903074; 6149934; 7576235; 7902291; 8102610; 8105105; 8887485; 9056417; 9367365; 9634079; 10605003; 10676659; 10734069; 11140838; 11384645; 11559807; 11774469; 11999577; 12406907; 12443882; 12473585; 12477932; 12551991; 12634402; 12675232; 14507917; 14767532; 15084671; 15166647; 15234325; 15280478; 15308636; 15326289; 15489334; 15758076; 15812828; 15840518; 15883031; 15916720; 16216591; 16335952; 16466852; 16469741; 16533817; 16572171; 16685268; 16778789; 16818694; 17192395; 17329256; 17363734; 17363739; 17636545; 17655775; 17662271; 17888402; 17897319; 17897790; 17953966; 17999179; 18008160; 18085638; 18366676; 18431797; 18495788; 18605079; 18677709; 18794057; 19236378; 19330903; 19373777; 19562339; 19597336; 19908113; 20064928; 20360068; 20379614; 20689807; 21048031; 21376765; 21611838; 21879266; 21881118; 22040956; 22065384; 22079983; 22307972; 22544935; 22932899; 23206754; 23322201; 23488598; 23500679; 23643324; 23677132,,,,,,,,,,,,,,,,,,OGG:3000000290,,,,,,,,,,,,,,,,,,,alanyl (membrane) aminopeptidase,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142651,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ANPEP,,,20140408,290,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,ANPEP,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0061326,renal tubule development,,"The progression of the renal tubule over time from its formation to the mature form. A renal tubule is a tube that filters, re-absorbs and secretes substances to rid an organism of waste and to play a role in fluid homeostasis.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,dph,2010-09-28T12:50:43Z,,,,"The progression of the renal tubule over time from its formation to the mature form. A renal tubule is a tube that filters, re-absorbs and secretes substances to rid an organism of waste and to play a role in fluid homeostasis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0061326,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061326,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,renal tubule development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0002419,mature T cell,mature T-cell|CD3e-positive T cell|CD3epsilon T cell,A T cell that expresses a T cell receptor complex and has completed T cell selection.,false,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,,,,,,tmeehan,2010-10-12T01:56:15Z,,,,A T cell that expresses a T cell receptor complex and has completed T cell selection.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mature T-cell|CD3e-positive T cell,,,,,cell,,CD3epsilon T cell,,,,,,CL:0002419,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,mature T cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001803,DPP4,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CD26|DPPIV|ADABP|ADCP2|TP103,,,,,,,2,,,,,,,,,,Ensembl:ENSG00000197635|Vega:OTTHUMG00000132056|HGNC:3009|HPRD:02187|MIM:102720,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,dipeptidyl-peptidase 4,,2q24.3,,,,"GO_0001666 (EC: IDA, PMID: 16670267); GO_0002020 (EC: IPI, PMID: 16651416); GO_0004177 (EC: IEA); GO_0004252 (EC: IEA); GO_0005102 (EC: IPI, PMID: 10900005); GO_0005515 (EC: IPI, PMID: 14684150); GO_0005765 (EC: IDA, PMID: 17897319); GO_0005886 (EC: IDA, PMID: 16670267); GO_0007155 (EC: IEA); GO_0008236 (EC: IDA, PMID: 14684150); GO_0008239 (EC: IDA, PMID: 14684150); GO_0008284 (EC: IDA, PMID: 17549790); GO_0009986 (EC: IDA, PMID: 10900005); GO_0010716 (EC: IDA, PMID: 16651416); GO_0016021 (EC: IEA); GO_0016324 (EC: IDA, PMID: 15052268); GO_0030027 (EC: IDA, PMID: 16651416); GO_0030139 (EC: IDA, PMID: 10900005); GO_0031258 (EC: IEA); GO_0031295 (EC: IDA, PMID: 10900005); GO_0033632 (EC: IDA, PMID: 11772392); GO_0042110 (EC: IDA, PMID: 7594462); GO_0042802 (EC: IPI); GO_0042803 (EC: IPI, PMID: 14684150); GO_0043542 (EC: IDA, PMID: 16651416); GO_0045121 (EC: IEA); GO_0046581 (EC: IEA); GO_0070062 (EC: IDA, PMID: 11487543); GO_0071438 (EC: IDA, PMID: 16651416)",PMID: 1347043; 1352530; 1352704; 1362202; 1677636; 1680916; 1975616; 1977364; 7487939; 7522442; 7539755; 7585218; 7594462; 7833626; 7903479; 7911242; 7912830; 7927537; 8094732; 8095514; 8096237; 8101391; 8635502; 8763423; 8806567; 8852605; 8925885; 9103436; 9185130; 9252108; 9263011; 9330689; 9330696; 9330699; 9374514; 9516414; 9537773; 9645485; 9671214; 9685737; 9710254; 9933589; 10880264; 10899322; 10900005; 10961862; 11278278; 11390394; 11487543; 11549856; 11696365; 11739156; 11739489; 11772392; 11773049; 11831694; 11882590; 11901152; 12023964; 12031601; 12047913; 12095981; 12112826; 12175726; 12176563; 12213886; 12239451; 12437097; 12471135; 12477932; 12483204; 12529175; 12579300; 12595736; 12634639; 12646248; 12675218; 12675220; 12675229; 12675231; 12675232; 12675233; 12675238; 12675243; 12675245; 12675246; 12675247; 12675248; 12675253; 12675254; 12690074; 12727530; 12752434; 12767062; 12790770; 12820316; 12832764; 12906826; 14525771; 14630704; 14684150; 14684825; 14691230; 14718659; 15002062; 15016824; 15027119; 15052268; 15146553; 15175333; 15213224; 15215186; 15292258; 15323360; 15353589; 15375776; 15448155; 15489334; 15490304; 15540901; 15681827; 15695814; 15797249; 15819895; 15864535; 15866709; 15911629; 15985311; 16335952; 16611738; 16621928; 16651416; 16670267; 16700508; 16700520; 16700525; 16704418; 16778789; 16781669; 16829852; 17071493; 17091451; 17244786; 17270095; 17287217; 17492130; 17525828; 17549790; 17610364; 17786309; 17846797; 17897319; 17904681; 17944883; 17949241; 18007554; 18189200; 18496701; 18520029; 18538760; 18563594; 18595667; 18606664; 18682883; 18708048; 18820218; 18940185; 18976975; 18983807; 19024603; 19061927; 19153055; 19247978; 19327104; 19358731; 19459926; 19469710; 19632987; 19654580; 19687096; 19734982; 19762327; 19811413; 19817894; 19913121; 19917055; 20008019; 20043068; 20075514; 20155839; 20185737; 20198559; 20361950; 20455069; 20459800; 20468064; 20495958; 20520837; 20534982; 20569697; 20572019; 20584285; 20628086; 20628624; 20805868; 20828536; 20841351; 20847730; 20878214; 20942971; 21108831; 21198750; 21281985; 21284881; 21334743; 21526345; 21558160; 21593202; 21614532; 21656024; 21672052; 21674250; 21785903; 21856036; 21894438; 21917073; 21951552; 21988832; 22001206; 22062893; 22086610; 22153807; 22167343; 22179204; 22185679; 22261805; 22369943; 22382050; 22388283; 22406180; 22504421; 22539793; 22561447; 22648548; 22674411; 22806538; 22846168; 22908963; 22949266; 22982114; 23035207; 23113658; 23122333; 23160239; 23184393; 23197976; 23219738; 23327927; 23382843; 23437290; 23486063; 23544270; 23548652; 23575259; 23586735; 23603488; 23608773; 23638030; 23654079; 23677473; 23894014; 24067970,,,,,,,,,,,,,,,,,,OGG:3000001803,,,,,,,,,,,,,,,,,,,dipeptidyl-peptidase 4,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32142651,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,DPP4,,,20140408,1803,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,DPP4,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_16480,nitric oxide,Nitric oxide|oxidonitrogen(.)|oxoazanyl|nitric oxide|endothelium-derived relaxing factor|Nitrogen monoxide|oxido nitrico|Stickstoffmonoxid|(.)NO|(NO)(.)|nitrosyl|Stickstoff(II)-oxid|oxyde nitrique|[NO]|nitrogen monooxide|oxyde azotique|NO|nitrogen monoxide|EDRF|monoxyde d'azote|oxido de nitrogeno(II)|monoxido de nitrogeno|NO(.)|mononitrogen monoxide,"A nitrogen oxide which is a free radical, each molecule of which consists of one nitrogen and one oxygen atom.",false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,DrugBank:DB00435|Gmelin:451|KEGG:D00074|KEGG:C00533|CAS:10102-43-9|PDBeChem:NO|MolBase:943|Reaxys:3587257|Wikipedia:Nitric_oxide,"A nitrogen oxide which is a free radical, each molecule of which consists of one nitrogen and one oxygen atom.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:14657|CHEBI:25546|CHEBI:44452|CHEBI:7583,,,,Nitric oxide|oxidonitrogen(.)|oxoazanyl|nitric oxide,,,,,chebi_ontology,,endothelium-derived relaxing factor|Nitrogen monoxide|oxido nitrico|Stickstoffmonoxid|(.)NO|(NO)(.)|nitrosyl|Stickstoff(II)-oxid|oxyde nitrique|[NO]|nitrogen monooxide|oxyde azotique|NO|nitrogen monoxide|EDRF|monoxyde d'azote|oxido de nitrogeno(II)|monoxido de nitrogeno|NO(.)|mononitrogen monoxide,,,,,,,,,0,NO,InChI=1S/NO/c1-2,MWUXSHHQAYIFBG-UHFFFAOYSA-N,30.00614,29.99799,[N]=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,CHEBI:16480,,,,,,,,,,,,,,,CHEBI:16480,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,nitric oxide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006614,SRP-dependent cotranslational protein targeting to membrane,ER translocation|SRP-dependent cotranslational protein-membrane targeting|SRP-dependent cotranslational membrane targeting,"The targeting of proteins to a membrane that occurs during translation and is dependent upon two key components, the signal-recognition particle (SRP) and the SRP receptor. SRP is a cytosolic particle that transiently binds to the endoplasmic reticulum (ER) signal sequence in a nascent protein, to the large ribosomal unit, and to the SRP receptor in the ER membrane.",false,,,http://purl.obolibrary.org/obo/GO_0045047|http://purl.obolibrary.org/obo/GO_0006613,,,,,,,,,,,,,,,,,,,,,"The targeting of proteins to a membrane that occurs during translation and is dependent upon two key components, the signal-recognition particle (SRP) and the SRP receptor. SRP is a cytosolic particle that transiently binds to the endoplasmic reticulum (ER) signal sequence in a nascent protein, to the large ribosomal unit, and to the SRP receptor in the ER membrane.",,,,,,,,,,,,,,,,,,,,,,,,,,,,ER translocation,,,SRP-dependent cotranslational protein-membrane targeting|SRP-dependent cotranslational membrane targeting,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0045047|http://purl.obolibrary.org/obo/GO_0006613,,,,GO:0006614,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006614,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,SRP-dependent cotranslational protein targeting to membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_27732,caffeine,"caffeine|1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione|Caffeine|CAFFEINE|1-methyltheobromine|Thein|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|theine|1,3,7-trimethylxanthine|mateina|Koffein|guaranine|7-methyltheophylline|1,3,7-trimethylpurine-2,6-dione|1,3,7-Trimethylxanthine|cafeina|cafeine|1,3,7-trimethyl-2,6-dioxopurine|anhydrous caffeine|teina|methyltheobromine|Coffein","A trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee.",false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,PMID:10796597|PMID:16143823|PMID:10822912|Reaxys:17705|PMID:11410911|PMID:12574990|PMID:16644114|Drug_Central:463|PMID:17387608|PMID:11312039|PMID:18258404|PMID:15840517|PMID:17508167|PMID:19088793|PMID:10983026|PMID:16391865|PMID:19879252|PMID:11209966|PDBeChem:CFF|PMID:18421070|PMID:9067318|PMID:19007524|PMID:11022879|PMID:11014293|PMID:10510174|PMID:10884512|PMID:15681408|Gmelin:103040|PMID:22770225|PMID:17724925|PMID:7689104|PMID:20164568|PMID:12915014|KEGG:C07481|Beilstein:17705|PMID:18625110|PMID:15257305|PMID:12397877|PMID:19084078|PMID:11815511|PMID:8679661|PMID:11431501|PMID:11949272|PMID:12457274|PMID:18647558|CAS:58-08-2|PMID:9132918|PMID:9063686|PMID:16709440|MetaCyc:1-3-7-TRIMETHYLXANTHINE|PMID:17932622|PMID:20470411|PMID:15280431|Wikipedia:Caffeine|PMID:15718055|PMID:7441110|PMID:17957400|PMID:18068204|PMID:19418355|DrugBank:DB00201|PMID:8332255|PMID:14607010|PMID:10924888|PMID:16528931|PMID:14521986|PMID:8347173|PMID:17132260|HMDB:HMDB0001847|PMID:9218278|LINCS:LSM-2026|PMID:16856769|KNApSAcK:C00001492|KEGG:D00528|PMID:19047957|PMID:10803761|PMID:12943586|PMID:16805851,"A trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:3295|CHEBI:41472|CHEBI:22982,,,,"caffeine|1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione|Caffeine|CAFFEINE",,,,,chebi_ontology,,"1-methyltheobromine|Thein|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|theine|1,3,7-trimethylxanthine|mateina|Koffein|guaranine|7-methyltheophylline|1,3,7-trimethylpurine-2,6-dione|1,3,7-Trimethylxanthine|cafeina|cafeine|1,3,7-trimethyl-2,6-dioxopurine|anhydrous caffeine|teina|methyltheobromine|Coffein",,,,,,,,,0,C8H10N4O2,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",RYYVLZVUVIJVGH-UHFFFAOYSA-N,194.19076,194.08038,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,CHEBI:27732,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,,,,CHEBI:27732,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,caffeine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000117,lianhuaqingwen,,,false,,,http://purl.obolibrary.org/obo/OMIT_0009582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lianhuaqingwen (LH) is a Chinese patent medicine composed of 13 herbs that has been used to treat influenza and exerted broad-spectrum antiviral effects on a series of influenza viruses.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OMIT_0009582,,,,,,modified definition,,,,,,,true,,https://pubmed.ncbi.nlm.nih.gov/32205232/|https://www.ncbi.nlm.nih.gov/pubmed/32186952/,,,,,,,,,,,,,,,,,lianhuaqingwen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000080,desoxyrhaponticin,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Desoxyrhaponticin is an agent that is potentially effective in controlling postprandial hyperglycemia in diabetes. Desoxyrhaponticin could be considered as a promising fatty acid synthase(FAS) inhibitor, it could inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,,,,,,,,,,,,,,desoxyrhaponticin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002247,FGF2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,BFGF|HBGF-2|FGF-2|FGFB,,,,,,,4,,,,,,,,,,Ensembl:ENSG00000138685|MIM:134920|HGNC:3676|Vega:OTTHUMG00000039506|HPRD:00622,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,fibroblast growth factor 2 (basic),,4q26,,,,"GO_0000186 (EC: IEA); GO_0000187 (EC: TAS, PMID: 9712850); GO_0000189 (EC: IEA); GO_0001658 (EC: IDA, PMID: 12631064); GO_0001759 (EC: IEA); GO_0001938 (EC: IMP, PMID: 18059339); GO_0002042 (EC: IDA, PMID: 18059339); GO_0002042 (EC: IGI, PMID: 19351956); GO_0005104 (EC: IPI, PMID: 10830168); GO_0005125 (EC: IDA, PMID: 18059339); GO_0005515 (EC: IPI, PMID: 10490103); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0005634 (EC: IEA); GO_0005829 (EC: IEA); GO_0006661 (EC: IDA); GO_0006700 (EC: IEA); GO_0006935 (EC: TAS, PMID: 10848592); GO_0007165 (EC: NAS, PMID: 9712850); GO_0007173 (EC: TAS); GO_0007265 (EC: TAS, PMID: 10848592); GO_0007399 (EC: TAS, PMID: 9576942); GO_0008083 (EC: IDA, PMID: 18059339); GO_0008201 (EC: IEA); GO_0008284 (EC: IGI, PMID: 8663044); GO_0008285 (EC: IEA); GO_0008286 (EC: TAS); GO_0008543 (EC: IDA, PMID: 17500071); GO_0008543 (EC: IGI, PMID: 8663044); GO_0008543 (EC: IPI, PMID: 10830168); GO_0008543 (EC: TAS); GO_0009887 (EC: TAS, PMID: 10903182); GO_0010001 (EC: IEA); GO_0010764 (EC: IDA, PMID: 19577615); GO_0010863 (EC: IDA); GO_0017134 (EC: IEA); GO_0021762 (EC: IEA); GO_0021940 (EC: IEA); GO_0030198 (EC: TAS); GO_0030214 (EC: IDA, PMID: 19577615); GO_0030308 (EC: IEA); GO_0030324 (EC: IEA); GO_0030374 (EC: IDA, PMID: 17500071); GO_0032958 (EC: IDA); GO_0038095 (EC: TAS); GO_0042056 (EC: IDA, PMID: 18059339); GO_0042060 (EC: TAS); GO_0042660 (EC: IDA, PMID: 18635606); GO_0043536 (EC: IDA, PMID: 18555217); GO_0043537 (EC: IDA, PMID: 18555217); GO_0043552 (EC: IDA); GO_0045087 (EC: TAS); GO_0045669 (EC: IEA); GO_0045765 (EC: TAS); GO_0045766 (EC: IDA); GO_0045892 (EC: IEA); GO_0045893 (EC: IDA, PMID: 17500071); GO_0045944 (EC: IDA, PMID: 18059339); GO_0046668 (EC: IEA); GO_0048011 (EC: TAS); GO_0048015 (EC: TAS); GO_0048598 (EC: TAS); GO_0048678 (EC: IEA); GO_0048864 (EC: IEA); GO_0050918 (EC: IDA, PMID: 18059339); GO_0051209 (EC: IDA); GO_0051726 (EC: IEA); GO_0051781 (EC: IEA); GO_0060045 (EC: IDA, PMID: 9553078); GO_0060128 (EC: IEA); GO_0060129 (EC: IEA); GO_0060548 (EC: IDA, PMID: 12631064); GO_0060591 (EC: IDA, PMID: 17167778); GO_0060644 (EC: IEA); GO_0061045 (EC: IDA, PMID: 19577615); GO_0070374 (EC: IDA, PMID: 17167778)",PMID: 1417798; 1697263; 1702556; 1707542; 1769963; 1785797; 1849658; 1885605; 2265560; 2320377; 2435284; 2435575; 2538817; 2726761; 3472745; 3579930; 3732516; 3780670; 3964259; 7532176; 7691311; 7735329; 7935812; 7999082; 8344959; 8530375; 8622701; 8663044; 8885834; 9139660; 9266968; 9342064; 9553078; 9558385; 9576942; 9712850; 9826564; 9858574; 9925931; 10358027; 10397733; 10438928; 10490103; 10574949; 10579907; 10652299; 10830168; 10848592; 10903182; 10950949; 11030354; 11053263; 11066092; 11075807; 11141237; 11276432; 11294897; 11390973; 11418238; 11509569; 11598182; 11708770; 11716516; 11742492; 11796824; 11815602; 11847221; 11864711; 11891198; 11891801; 11928807; 11940567; 11960370; 11964307; 11976347; 11985797; 11986954; 11999550; 12000311; 12006402; 12008951; 12020352; 12032827; 12054499; 12057924; 12080186; 12087465; 12145206; 12168799; 12172783; 12209593; 12235165; 12369790; 12393937; 12403780; 12428103; 12477932; 12478660; 12496364; 12509902; 12517814; 12538477; 12545206; 12571252; 12574959; 12590983; 12607599; 12623787; 12631064; 12631070; 12651930; 12659634; 12660731; 12676798; 12682649; 12717444; 12727994; 12746216; 12755687; 12799459; 12815619; 12823444; 12857600; 12857733; 12871330; 12871334; 12872165; 13680247; 14523006; 14630795; 14669345; 14672345; 14680499; 14699503; 14706681; 15033176; 15096041; 15117822; 15120936; 15146197; 15166228; 15199049; 15208265; 15243127; 15247002; 15247275; 15249224; 15293454; 15297314; 15302993; 15316024; 15342556; 15464234; 15481452; 15496150; 15525641; 15573376; 15603823; 15610530; 15631865; 15680705; 15689238; 15695515; 15703886; 15713745; 15725477; 15726914; 15731686; 15737206; 15756443; 15769511; 15769981; 15780951; 15809086; 15817123; 15825079; 15875316; 15875782; 15879597; 15906377; 15924676; 15942693; 15947088; 15985216; 15996482; 16020751; 16077964; 16077988; 16080018; 16095497; 16103882; 16135988; 16160009; 16210019; 16222707; 16227592; 16257968; 16278388; 16304044; 16320338; 16436505; 16463783; 16490198; 16495214; 16521228; 16597610; 16597617; 16631837; 16638370; 16685268; 16709186; 16723715; 16739027; 16769728; 16807244; 16816927; 16820871; 16822883; 16840552; 16867222; 16876430; 16905765; 16949906; 16982797; 16996573; 17133345; 17157157; 17166351; 17167778; 17169545; 17204151; 17217840; 17234579; 17285972; 17298206; 17381064; 17466952; 17478553; 17487982; 17497037; 17500071; 17503459; 17505261; 17522998; 17532297; 17537644; 17537668; 17543283; 17556598; 17562265; 17578349; 17605857; 17637743; 17651425; 17653045; 17676480; 17699594; 17706726; 17724016; 17726742; 17762899; 17825301; 17929017; 17942638; 17949478; 17968311; 17968943; 17981115; 17996481; 17997184; 18006148; 18025790; 18031768; 18036796; 18042549; 18051571; 18052595; 18055262; 18059339; 18088275; 18093228; 18094712; 18164591; 18164704; 18171671; 18179408; 18187129; 18253936; 18258238; 18279437; 18281281; 18298475; 18329368; 18332228; 18347025; 18364383; 18419755; 18420995; 18438927; 18452581; 18476630; 18481005; 18511454; 18519946; 18549879; 18555217; 18570917; 18592007; 18635606; 18639416; 18680389; 18698254; 18705695; 18773427; 18783914; 18802039; 18803285; 18819464; 18829480; 18930044; 18974971; 18979395; 19056764; 19059221; 19061884; 19086919; 19096229; 19096867; 19100714; 19107653; 19147956; 19160106; 19196427; 19197140; 19217457; 19235591; 19245795; 19279131; 19287993; 19301256; 19308772; 19318994; 19319189; 19351956; 19386985; 19423540; 19453261; 19456219; 19477940; 19478386; 19489096; 19495899; 19533745; 19541589; 19556344; 19577615; 19586755; 19587357; 19608737; 19614919; 19617559; 19631775; 19631914; 19651147; 19670348; 19696444; 19710942; 19713533; 19781633; 19802384; 19822079; 19828453; 19885553; 19890880; 19892399; 19913121; 19919531; 19930868; 19933269; 19950605; 19952401; 20001221; 20016498; 20053757; 20056600; 20116383; 20122687; 20127022; 20128380; 20150555; 20197313; 20202860; 20206949; 20224347; 20230531; 20335309; 20339243; 20362567; 20363749; 20371606; 20406964; 20438785; 20452482; 20504760; 20504870; 20514456; 20526813; 20571834; 20628086; 20628269; 20628624; 20634891; 20641033; 20644561; 20645833; 20646480; 20672350; 20673868; 20681019; 20713592; 20817637; 20819778; 20850693; 20857427; 20886037; 20926602; 20945415; 21029699; 21037114; 21041608; 21041986; 21048031; 21139048; 21161264; 21209880; 21224050; 21266348; 21350328; 21381082; 21382096; 21460777; 21471211; 21501244; 21506108; 21506113; 21515689; 21528671; 21539890; 21572099; 21678127; 21695795; 21699503; 21720547; 21733164; 21761458; 21766497; 21771176; 21830216; 21832283; 21835001; 21855631; 21894939; 21919032; 21923031; 21942441; 21996542; 21997191; 21998584; 22009965; 22016523; 22102278; 22125837; 22158871; 22174424; 22193058; 22228819; 22233184; 22237711; 22260074; 22267482; 22335910; 22393273; 22493287; 22506349; 22508498; 22542539; 22546563; 22577248; 22599586; 22680042; 22730382; 22732006; 22804708; 22836867; 22895562; 22927437; 22932066; 22962037; 22967508; 23053181; 23071632; 23086340; 23122986; 23154434; 23236888; 23239497; 23243019; 23264596; 23265436; 23290762; 23322705; 23331079; 23335070; 23352645; 23385422; 23435034; 23448571; 23457216; 23485603; 23620752; 23630597; 23677479; 23861152; 23869761; 23998120; 24014875; 24063890; 24089521; 24216509,,,,,,,,,,,,,,,,,,OGG:3000002247,,,,,,,,,,,,,,,,,,,fibroblast growth factor 2 (basic),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FGF2,,,20140408,2247,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,FGF2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0030665,clathrin-coated vesicle membrane,clathrin coated vesicle membrane,The lipid bilayer surrounding a clathrin-coated vesicle.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The lipid bilayer surrounding a clathrin-coated vesicle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,clathrin coated vesicle membrane,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030665,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030665,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,clathrin-coated vesicle membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_48219,disinfectant,disinfecting agent|desinfectant|disinfectants|Desinfektionsmittel,An antimicrobial agent that is applied to non-living objects to destroy harmful microorganisms or to inhibit their activity.,false,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,,,,,,,,,,,,,,,,,,An antimicrobial agent that is applied to non-living objects to destroy harmful microorganisms or to inhibit their activity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,disinfecting agent|desinfectant|disinfectants|Desinfektionsmittel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_24431,,,,CHEBI:48219,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,,,CHEBI:48219,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,disinfectant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012176,Abnormal natural killer cell morphology,Abnormality of natural killer cells|Abnormal NK cells,"An anomaly of the natural killer cell, which is a lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors. It also regulates immune responses via cytokine release and direct contact with other cells.",false,,,http://purl.obolibrary.org/obo/HP_0004332,,,,,,,,,,,,,,,,peter,2013-02-23T10:02:16Z,,,UMLS:C4021098,"An anomaly of the natural killer cell, which is a lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors. It also regulates immune responses via cytokine release and direct contact with other cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of natural killer cells|Abnormal NK cells,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0004332,,,,HP:0012176,,,,,,,,,,,,,,,HP:0012176,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal natural killer cell morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0004120,mesoderm-derived structure,mesodermal derivative,An anatomical structure that develops (entirely or partially) from the mesoderm.,false,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,,,,,,,,,,,,,,,,Grouping term for query purposes,FBbt:00025998,An anatomical structure that develops (entirely or partially) from the mesoderm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mesodermal derivative,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,UBERON:0004120,,,,,,,,,,,,,,,UBERON:0004120,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,mesoderm-derived structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_233872,SARS coronavirus TWC,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:233872,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TWC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001874,Abnormality of neutrophils,Abnormality of neutrophil|Abnormality of polymorphonuclear neutrophils|Abnormality of neutrophils,A neutrophil abnormality.|Neutrophils are the most abundant leukocytes in blood and are considered to be the first line of defense during inflammation and infections. They are myeloid granulocytes and their names is derived from the fact that their cytoplasm contains granules that stain with acidic dye as well as granules that stain with basic dye. Their nuclei consist of three to five lobes connected by slender threads of chromatin. Mature neutrophils live for approximately one day.,false,,,http://purl.obolibrary.org/obo/HP_0001911,,,,,,,,,,,,,,,,,,,,UMLS:C0427515|SNOMEDCT_US:250274006,A neutrophil abnormality.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of neutrophil|Abnormality of polymorphonuclear neutrophils|Abnormality of neutrophils,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Neutrophils are the most abundant leukocytes in blood and are considered to be the first line of defense during inflammation and infections. They are myeloid granulocytes and their names is derived from the fact that their cytoplasm contains granules that stain with acidic dye as well as granules that stain with basic dye. Their nuclei consist of three to five lobes connected by slender threads of chromatin. Mature neutrophils live for approximately one day.,,http://purl.obolibrary.org/obo/HP_0001911,,,,HP:0001874,,,,,,,,,,,,,,,HP:0001874,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of neutrophils,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012649,Increased inflammatory response,,A abnormal increase in the inflammatory response to injury or infection.,false,,,http://purl.obolibrary.org/obo/HP_0012647,,,,,,,,,,,,,,,,peter,2014-02-01T01:29:58Z,,,UMLS:C4022803,A abnormal increase in the inflammatory response to injury or infection.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012647,,,,HP:0012649,,,,,,,,,,,,,,,HP:0012649,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Increased inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MP_0000266,abnormal heart morphology,cardiac abnormalities|heart defects|heart abnormalities|cardiac defects|abnormal heart|cardiac dysplasia|abnormal cardiac morphology,"any structural anomaly of the hollow, muscular organ that maintains the circulation of the blood",false,,,http://purl.obolibrary.org/obo/HP_0001626,,,,,,,,,,,,,,,,,,,,GO:0007505,"any structural anomaly of the hollow, muscular organ that maintains the circulation of the blood",,,,,,,,,,,,,,,,,,,,,,,,,,,MP:0000271,cardiac abnormalities|heart defects|heart abnormalities|cardiac defects|abnormal heart,,,cardiac dysplasia|abnormal cardiac morphology,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001626,,,,MP:0000266,,,,,,,,,,,,,,,MP:0000266,,http://purl.obolibrary.org/obo/mp.owl,http://purl.oboInOwllibrary.org/oboInOwl/mp-edit#IMPC_Prenatal|http://purl.oboInOwllibrary.org/oboInOwl/mp-edit#CvDC_Terms|http://purl.oboInOwllibrary.org/oboInOwl/mp-edit#Europhenome_Terms,,,,,,,,,,abnormal heart morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000046,B1a1 haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B1a1 haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,B1a1 haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0012200,Abnormality of prothrombin,,"An anomaly of clotting factor II, which is known as prothrombin, a vitamin K-dependent proenzyme that functions in the blood coagulation cascade.",false,,,http://purl.obolibrary.org/obo/HP_0003256,,,,,,,,,,,,,,,,peter,2013-03-12T11:48:06Z,,,UMLS:C4023005,"An anomaly of clotting factor II, which is known as prothrombin, a vitamin K-dependent proenzyme that functions in the blood coagulation cascade.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0003256,,,,HP:0012200,,,,,,,,,,,,,,,HP:0012200,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of prothrombin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_51209,pseudoephedrine,"Pseudoephedrine|(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol|d-psi-Ephedrine|Psi-ephedrine|d-Isoephedrine|L(+)-psi-Ephedrine|pseudoephedrinum|Pseudoephedrine D-form|psi-ephedrine|pseudoefedrina|d-Pseudoephedrine|(1S,2S)-(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|Isoephedrine|(+)-(1S,2S)-Pseudoephedrine|L-(+)-Pseudoephedrine|(+)-psi-Ephedrine|Psi-ephedrin|(+)-threo-Ephedrine|(+)-Pseudoephedrine|2-(Methylamino)-1-phenyl-1-propanol|pseudoephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|trans-Ephedrine|(1S,2S)-Pseudoephedrine",A member of the class of the class of phenylethanolamines that is (1S)-2-(methylamino)-1-phenylethan-1-ol in which the pro-S hydrogen at position 2 is replaced by a methyl group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Wikipedia:Pseudoephedrine|PMID:17230461|PMID:16410207|KEGG:C02765|LINCS:LSM-3885|PMID:17316256|PMID:27168748|Beilstein:2414132|PMID:27179610|Reaxys:2414132|PMID:15532139|PMID:12199969|HMDB:HMDB0001943|CAS:90-82-4|Drug_Central:2326|DrugBank:DB00852|PMID:26708626|MetaCyc:CPD-9954|PMID:11153535|KEGG:D08449|KNApSAcK:C00031097|PMID:26762956|PMID:16531903|PMID:16965375|PMID:26888635,A member of the class of the class of phenylethanolamines that is (1S)-2-(methylamino)-1-phenylethan-1-ol in which the pro-S hydrogen at position 2 is replaced by a methyl group.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:44,,,,"Pseudoephedrine|(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol",,,,,chebi_ontology,,"d-psi-Ephedrine|Psi-ephedrine|d-Isoephedrine|L(+)-psi-Ephedrine|pseudoephedrinum|Pseudoephedrine D-form|psi-ephedrine|pseudoefedrina|d-Pseudoephedrine|(1S,2S)-(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|Isoephedrine|(+)-(1S,2S)-Pseudoephedrine|L-(+)-Pseudoephedrine|(+)-psi-Ephedrine|Psi-ephedrin|(+)-threo-Ephedrine|(+)-Pseudoephedrine|2-(Methylamino)-1-phenyl-1-propanol|pseudoephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|trans-Ephedrine|(1S,2S)-Pseudoephedrine",,,,,,,,,0,C10H15NO,"InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1",KWGRBVOPPLSCSI-WCBMZHEXSA-N,165.23224,165.11536,CN[C@@H](C)[C@@H](O)c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:51209,,,,,,true,,,,,,,,,CHEBI:51209,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,pseudoephedrine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_304858,SARS coronavirus A022,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:304858,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus A022,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050281,rep gene proteolytic cleavage product (SARS-CoV-2),rep/ClvPrd (SARS2),A rep gene translation product (SARS-CoV-2) that has been processed by proteolytic cleavage.|Category=organism-modification.,false,,,http://purl.obolibrary.org/obo/PR_000050263,,,,,,,,,,,,,,,,,,,,,A rep gene translation product (SARS-CoV-2) that has been processed by proteolytic cleavage.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,rep/ClvPrd (SARS2),,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification.,,http://purl.obolibrary.org/obo/PR_000050263,,,,PR:000050281,,,,,,,,,,,,,,,PR:000050281,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,rep gene proteolytic cleavage product (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0025021,Abnormal erythrocyte sedimentation rate,Abnormal Westergren sedimentation rate|Abnormal ESR,"A deviation from normal range of the erythrocyte sedimentation rate (ESR), a test that measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The ESR is a nonspecific finding. An elevation may indicate inflammation or may be caused by any condition that elevates fibrinogen. A decreased ESR may be seen in polycythemia or in certain blood diseases in which red blood cells have an irregular or smaller shape that causes slower settling.",false,,,http://purl.obolibrary.org/obo/HP_0001939,,,,,,,,,,,,,,,,HPO:probinson,,,,,"A deviation from normal range of the erythrocyte sedimentation rate (ESR), a test that measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The ESR is a nonspecific finding. An elevation may indicate inflammation or may be caused by any condition that elevates fibrinogen. A decreased ESR may be seen in polycythemia or in certain blood diseases in which red blood cells have an irregular or smaller shape that causes slower settling.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal Westergren sedimentation rate|Abnormal ESR,,,,,,,,,,,,,HP:0025021,,,,,,,,,,,,,,,,,,2016-08-22T10:26:22Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0001939,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal erythrocyte sedimentation rate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000019,quality,,,false,,,http://purl.obolibrary.org/obo/BFO_0000020,,,,,Quality,quality,,,,,,,,,,,,,,,,,,,,,,,,,,"a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001])",,the length of the circumference of your waist|the mass of this piece of gold.|the color of a tomato|the ambient temperature of this portion of air|the shape of your nose|the shape of your nostril,,,,,,,,,(forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001] |(forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001] ,"If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001])",,,,,,,,,,,,,,,,,,,,,BFO:0000019,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000020,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl|http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,quality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_31528,Ebastine,Ebastine|ebastin|ebastel|bastel|erostin|Kestine (TN)|kestine,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:90729-43-4|KEGG:D01478|HMDB:HMDB0060159|Drug_Central:977,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Ebastine,,,,,chebi_ontology,,ebastin|ebastel|bastel|erostin|Kestine (TN)|kestine,,,,,,,,,0,C32H39NO2,"InChI=1S/C32H39NO2/c1-32(2,3)28-18-16-25(17-19-28)30(34)15-10-22-33-23-20-29(21-24-33)35-31(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-9,11-14,16-19,29,31H,10,15,20-24H2,1-3H3",MJJALKDDGIKVBE-UHFFFAOYSA-N,469.659,469.29808,C(OC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)C(C)(C)C)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31528,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32291112,,,,CHEBI:31528,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Ebastine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_627440,SARS coronavirus ExoN1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:627440,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ExoN1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_698419,SARS coronavirus wtic-MB,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:698419,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_698398,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus wtic-MB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046496,nicotinamide nucleotide metabolic process,nicotinamide nucleotide metabolism,"The chemical reactions and pathways involving nicotinamide nucleotides, any nucleotide that contains combined nicotinamide.",false,,,http://purl.obolibrary.org/obo/GO_0019362,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving nicotinamide nucleotides, any nucleotide that contains combined nicotinamide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nicotinamide nucleotide metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019362,,,,GO:0046496,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046496,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nicotinamide nucleotide metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258969,SARS coronavirus TW6,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258969,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006911,"phagocytosis, engulfment",phagosome biosynthesis|phagosome formation,"The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.",false,,,http://purl.obolibrary.org/obo/GO_0099024,,,,,,,,,,,,,,,,,,,,,"The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,phagosome biosynthesis|phagosome formation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0099024,,,,GO:0006911,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006911,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"phagocytosis, engulfment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002958,Immune dysregulation,Immune dysregulation|Unregulated immune response,"Altered immune function characterized by lymphoid proliferation, immune activation, and excessive autoreactivity often leading to autoimmune/inflammatory complications.",false,,,http://purl.obolibrary.org/obo/HP_0010978,,,,,,,,,,,,,,,,,,,,UMLS:C1844666,"Altered immune function characterized by lymphoid proliferation, immune activation, and excessive autoreactivity often leading to autoimmune/inflammatory complications.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Immune dysregulation|Unregulated immune response,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010978,,,,HP:0002958,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175425/,,,,HP:0002958,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Immune dysregulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_68606,rilpivirine,"4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile|TMC 278|4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile|rilpivirine|TMC278","An aminopyrimidine that is pyrimidine-2,4-diamine in which the amino groups at positions 2 and 4 are substituted by 4-cyanophenyl and 4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl groups respectively. Used for treatment of HIV.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22067667|PMID:22504027|PMID:21902621|Patent:WO2006035069|PMID:19249947|PMID:22567823|KEGG:D09720|Patent:WO2006035067|PMID:22356290|PMID:21308448|PMID:22951490|Patent:US2008280849|PMID:22343174|PMID:22024527|Patent:WO2004016581|PMID:21997204|PMID:21763920|PMID:20160045|PDBeChem:T27|PMID:22209291|CAS:500287-72-9|PMID:22878339|PMID:22406117|PMID:22842995|PMID:21763936|PMID:21860365|Reaxys:9952270|PMID:25017682|PMID:22955279|PMID:19548857|PMID:22555080|Patent:WO2007113254|Wikipedia:Rilpivirine|PMID:22096405|PMID:19048650|Patent:WO2006035068|PMID:15771441|PMID:22293086|PMID:22430974|PMID:22729755|PMID:21373646|PMID:21763935|PMID:22257626|PMID:19678794|Patent:WO2007082922|PMID:22664973|PMID:22921088|PMID:22519768|Patent:WO2009007441|PMID:20438081|PMID:15771449|Patent:WO2004069812|PMID:19328850|PMID:22570576,"An aminopyrimidine that is pyrimidine-2,4-diamine in which the amino groups at positions 2 and 4 are substituted by 4-cyanophenyl and 4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl groups respectively. Used for treatment of HIV.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile",,,,,chebi_ontology,,"TMC 278|4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile|rilpivirine|TMC278",,,,,,,,,0,C22H18N6,"InChI=1S/C22H18N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3,(H2,25,26,27,28)/b4-3+",YIBOMRUWOWDFLG-ONEGZZNKSA-N,366.41850,366.15929,Cc1cc(C=C\C#N)cc(C)c1Nc1ccnc(Nc2ccc(cc2)C#N)n1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:68606,,,,,true,true,,,,,,,,,CHEBI:68606,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,rilpivirine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002181,cytoplasmic translation,,"The chemical reactions and pathways resulting in the formation of a protein in the cytoplasm. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein.|Note that this term applies to translation performed by cytoplasmic ribosomes, which is distinct from translation performed by organellar ribosomes. For mitochondrial translation, consider GO:0032543 'mitochondrial translation' or its child terms.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,hjd,2011-06-09T03:11:53Z,,,,The chemical reactions and pathways resulting in the formation of a protein in the cytoplasm. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term applies to translation performed by cytoplasmic ribosomes, which is distinct from translation performed by organellar ribosomes. For mitochondrial translation, consider GO:0032543 'mitochondrial translation' or its child terms.",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0002181,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002181,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,cytoplasmic translation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264374,SARS coronavirus TW-HP4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264374,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-HP4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0060158,acquired metabolic disease,,"A disease of metabolism that has _material_basis_in enzyme deficiency or accumulation of enzymes or toxins which interfere with normal function due to an endocrine organ disease, organ malfunction, inadequate intake, dietary deficiency, or malabsorption.",false,,,http://purl.obolibrary.org/obo/DOID_0014667,,,,,,,,,,,,,,,,lschriml,2011-08-24T02:53:03Z,,,,"A disease of metabolism that has _material_basis_in enzyme deficiency or accumulation of enzymes or toxins which interfere with normal function due to an endocrine organ disease, organ malfunction, inadequate intake, dietary deficiency, or malabsorption.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0014667,,,,DOID:0060158,,,,,,,,,,,,,,,DOID:0060158,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim,,,,,,,,,,acquired metabolic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000097,ternatin 4,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Ternatin is a cyclic heptapeptide isolated from the mushroom C. versicolor that has been shown to have cytotoxic and anti-adipogenic effects.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,,true,,,,,,,,,,,,,,,,,,,,,,ternatin 4,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full|https://www.caymanchem.com/product/20691,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305411,SARS coronavirus C013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305411,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0008305,integrin complex,laminin receptor protein,"A protein complex that is composed of one alpha subunit and one beta subunit, both of which are members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands.",false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0098636,,,,,,,,,,,,,,,,,,,,,"A protein complex that is composed of one alpha subunit and one beta subunit, both of which are members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,laminin receptor protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0098636,,,,GO:0008305,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0008305,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,integrin complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001931,uropod,uropodium|distal pole complex|retractile pole,"A membrane projection with related cytoskeletal components at the trailing edge of a cell in the process of migrating or being activated, found on the opposite side of the cell from the leading edge or immunological synapse, respectively.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"A membrane projection with related cytoskeletal components at the trailing edge of a cell in the process of migrating or being activated, found on the opposite side of the cell from the leading edge or immunological synapse, respectively.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uropodium,,,,,cellular_component,,distal pole complex|retractile pole,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0001931,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001931,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,uropod,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010755,regulation of plasminogen activation,,"Any process that modulates the rate, frequency or extent of plasminogen activation. Plasminogen activation is the process in which plasminogen is processed to plasmin.",false,,,http://purl.obolibrary.org/obo/GO_0070613,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the rate, frequency or extent of plasminogen activation. Plasminogen activation is the process in which plasminogen is processed to plasmin.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0070613,,,,GO:0010755,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010755,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of plasminogen activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0006044,Eosinophils,,,false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0006044,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32173576,"Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Eosinophils,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030433,ubiquitin-dependent ERAD pathway,ERAD|ubiquitin-dependent proteasomal protein catabolism of ER proteins|ER-associated ubiquitin-dependent protein catabolic process|ER-associated ubiquitin-dependent protein breakdown|endoplasmic reticulum-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum-associated ubiqutin-dependent protein catabolism|ER-associated ubiquitin-dependent protein catabolism|ER-associated ubiquitin-dependent protein degradation,"The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein ubiquitination necessary for correct substrate transfer, transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.|See also the biological process terms 'ERAD pathway ; GO:0036503', 'unfolded protein response ; GO:0030968' and 'retrograde protein transport, ER to cytosol ; GO:0030970'.",false,,,http://purl.obolibrary.org/obo/GO_0036503,,,,,,,,,,,,,,,,,,,,,"The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein ubiquitination necessary for correct substrate transfer, transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,ERAD,,,ubiquitin-dependent proteasomal protein catabolism of ER proteins|ER-associated ubiquitin-dependent protein catabolic process|ER-associated ubiquitin-dependent protein breakdown|endoplasmic reticulum-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum-associated ubiqutin-dependent protein catabolism|ER-associated ubiquitin-dependent protein catabolism|ER-associated ubiquitin-dependent protein degradation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"See also the biological process terms 'ERAD pathway ; GO:0036503', 'unfolded protein response ; GO:0030968' and 'retrograde protein transport, ER to cytosol ; GO:0030970'.",,http://purl.obolibrary.org/obo/GO_0036503,,,,GO:0030433,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030433,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ubiquitin-dependent ERAD pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006002,fructose 6-phosphate metabolic process,fructose 6-phosphate metabolism,"The chemical reactions and pathways involving fructose 6-phosphate, also known as F6P. The D-enantiomer is an important intermediate in glycolysis, gluconeogenesis, and fructose metabolism.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving fructose 6-phosphate, also known as F6P. The D-enantiomer is an important intermediate in glycolysis, gluconeogenesis, and fructose metabolism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,fructose 6-phosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006002,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006002,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,fructose 6-phosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/FLU_0001035,neuraminidase inhibitor drug,,"A drug targeted at the influenza virus, which work by blocking the function of the viral neuraminidase protein, thus preventing the virus from reproducing by budding from the host cell.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,"A drug targeted at the influenza virus, which work by blocking the function of the viral neuraminidase protein, thus preventing the virus from reproducing by budding from the host cell.",,WEB: http://en.wikipedia.org/wiki/Neuraminidase_inhibitor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,FLU:0001035,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/flu.owl,,,,,,,,,,,neuraminidase inhibitor drug,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Melanie Courtot,,,,
http://purl.obolibrary.org/obo/OGG_3000009133,CCNB2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HsT17299,,,,,,,15,,,,,,,,,,HPRD:04131|Vega:OTTHUMG00000132715|MIM:602755|HGNC:1580|Ensembl:ENSG00000157456,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,cyclin B2,,15q22.2,,,,"GO_0000079 (EC: IEA); GO_0000086 (EC: TAS); GO_0000278 (EC: TAS); GO_0001701 (EC: IEA); GO_0005515 (EC: IPI, PMID: 15232106); GO_0005654 (EC: TAS); GO_0005813 (EC: IDA); GO_0005829 (EC: TAS); GO_0007067 (EC: IEA); GO_0007077 (EC: TAS); GO_0015630 (EC: IDA); GO_0016020 (EC: IEA); GO_0019901 (EC: IEA); GO_0040007 (EC: IEA); GO_0043029 (EC: IEA); GO_0048538 (EC: IEA); GO_0051726 (EC: TAS)",PMID: 1717476; 7474080; 7474100; 7494303; 7666531; 7737117; 8070405; 8125298; 9094673; 9356466; 9520381; 9539739; 9560267; 9926943; 10958988; 11076863; 11230166; 11256614; 11531413; 11878934; 11960377; 12477932; 12482752; 12727876; 14702039; 14718574; 15232106; 15489334; 15489336; 16381901; 17289878; 17388661; 17533373; 17549666; 18591933; 18692784; 19223528; 19454010; 19664331; 19738611; 19786724; 20360068; 20660152; 20972266; 21139048; 21161946; 21890473; 22916037; 22939629; 23282137; 23455922; 23602568,,,,,,,,,,,,,,,,,,OGG:3000009133,,,,,,,,,,,,,,,,,,,cyclin B2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCNB2,,,20140408,9133,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CCNB2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0002013,Vomiting,Emesis|Vomiting|Throwing up,Forceful ejection of the contents of the stomach through the mouth by means of a series of involuntary spasmic contractions.,false,,,http://purl.obolibrary.org/obo/HP_0002017,,,,,,,,,,,,,,,,,,,,UMLS:C0042963|SNOMEDCT_US:422400008|SNOMEDCT_US:300359004|MEDDRA:10047700|SNOMEDCT_US:249497008|MSH:D014839,Forceful ejection of the contents of the stomach through the mouth by means of a series of involuntary spasmic contractions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Emesis|Vomiting|Throwing up,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002017,,,,HP:0002013,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32109013|https://www.ncbi.nlm.nih.gov/pubmed/32215613,,,,HP:0002013,,http://purl.obolibrary.org/obo/hp.owl,http://purl.oboInOwllibrary.org/oboInOwl/hp#hposlim_core,,,,,,,,,,Vomiting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_421444,SARS coronavirus TJ01,SARS coronavirus strain TJ01,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus strain TJ01,,,,,,NCBITaxon:421444,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TJ01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C15324,Self Care,Self-care|Selfcare|Self Care,Personal performance of activities or tasks traditionally performed by professional health care providers.,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,C15324,,,,,,,,,,Personal performance of activities or tasks traditionally performed by professional health care providers.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Self-care|Selfcare|Self Care,,,,,,,,,,,,,NCIT:C15324,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Self Care,Self_Care,,,,,,,,,,,,,,,,,,Self Care,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,Health Care Activity,,,,,,,,C0036592,
http://purl.obolibrary.org/obo/OGG_3000002875,GPT,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,ALT1|GPT1|AAT1,,,,,,,8,,,,,,,,,,Ensembl:ENSG00000167701|HGNC:4552|MIM:138200|HPRD:00689|Vega:OTTHUMG00000165176,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,glutamic-pyruvate transaminase (alanine aminotransferase),,8q24.3,,,,"GO_0004021 (EC: EXP); GO_0004021 (EC: NAS, PMID: 1931970); GO_0005829 (EC: TAS); GO_0008652 (EC: TAS); GO_0030170 (EC: IEA); GO_0034641 (EC: TAS); GO_0042853 (EC: IEA); GO_0044281 (EC: TAS); GO_0070062 (EC: IDA, PMID: 19056867)",PMID: 49232; 1931970; 3192219; 5581908; 7114790; 7114791; 7361762; 8125298; 9119391; 11863375; 12358155; 12477932; 12480555; 12774006; 14506613; 15306699; 15342556; 15489334; 16652026; 17134955; 17378732; 17405346; 17570354; 17764776; 17766001; 17877759; 17907292; 17907318; 17934148; 18090161; 18178283; 18242760; 18315552; 18432999; 18473412; 18508279; 18708042; 18763311; 18774966; 19012630; 19056867; 19065605; 19100265; 19159884; 19217453; 19232448; 19303161; 19360321; 19370784; 19393479; 19687577; 19938201; 20032584; 20190678; 20205615; 20387481; 20433554; 20872970; 20961180; 20972737; 21040936; 21199427; 21692932; 21715038; 21720553; 21987480; 21988832; 22132177; 22140488; 22158663; 22177542; 22242166; 22293393; 22352690; 22357454; 22389715; 22954960; 22975640; 23119080; 23384374; 23403445; 23667618; 23794308; 23880909,,,,,,,,,,,,,,,,,,OGG:3000002875,,,,,,,,,,,,,,,,,,,glutamic-pyruvate transaminase (alanine aminotransferase),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GPT,,,20140408,2875,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,GPT,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/PR_000050268,spike protein S2 (SARS-CoV-2),"PRO_0000449648|UniProtKB:P0DTC2, 686-1273|S2 (SARS2)","A spike glycoprotein, signal peptide removed form (SARS-CoV-2) that has been processed by proteolytic cleavage to yield the C-terminal portion. UniProtKB:P0DTC2, 686-1273.|Category=organism-modification.",false,,,http://purl.obolibrary.org/obo/PR_000050266,,,,,,,,,,,,,,,,,,,,,"A spike glycoprotein, signal peptide removed form (SARS-CoV-2) that has been processed by proteolytic cleavage to yield the C-terminal portion. UniProtKB:P0DTC2, 686-1273.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"PRO_0000449648|UniProtKB:P0DTC2, 686-1273|S2 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification.,,http://purl.obolibrary.org/obo/PR_000050266,,,,PR:000050268,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/%2032075877,,,,PR:000050268,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,spike protein S2 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039696,RNA-templated viral transcription,,A transcription process that uses viral RNA as a template.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-10-28T13:28:01Z,,,,A transcription process that uses viral RNA as a template.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039696,,,,,,,,true,,true,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,GO:0039696,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,RNA-templated viral transcription,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_22198,acetylcysteine,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:22198,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32291112,,,,CHEBI:22198,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,acetylcysteine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C118505,Presatovir,"Respiratory Syncytial Virus Fusion Inhibitor GS-5806|Presatovir|GS 5806|PRESATOVIR|Methanesulfonamide, N-(2-(((2S)-2-(5-((3S)-3-amino-1-pyrrolidinyl)-6-methylpyrazolo(1,5-a)pyrimidin-2-yl)-1-piperidinyl)carbonyl)-4-chlorophenyl)-|GS-5806","An orally available inhibitor of human respiratory syncytial virus (RSV) fusion protein (F protein), with potential antiviral activity. Upon oral administration of GS-5806, this agent specifically binds to F protein on the viral surface, which inhibits RSV F protein-mediated fusion with the host cell membrane and prevents viral entry. This blocks RSV replication, reduces viral load, and decreases the severity of the disease. RSV F protein, a viral surface glycoprotein, plays a key role in RSV fusion with and entry into target cells.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,1353625-73-6,,,,C118505,,,CTRP|FDA,,,,,,,"An orally available inhibitor of human respiratory syncytial virus (RSV) fusion protein (F protein), with potential antiviral activity. Upon oral administration of GS-5806, this agent specifically binds to F protein on the viral surface, which inhibits RSV F protein-mediated fusion with the host cell membrane and prevents viral entry. This blocks RSV replication, reduces viral load, and decreases the severity of the disease. RSV F protein, a viral surface glycoprotein, plays a key role in RSV fusion with and entry into target cells.",,,,,,Presatovir,,,,,,,,,,,9628AJ27JA,,,,,,,,,,,,,,"Respiratory Syncytial Virus Fusion Inhibitor GS-5806|Presatovir|GS 5806|PRESATOVIR|Methanesulfonamide, N-(2-(((2S)-2-(5-((3S)-3-amino-1-pyrrolidinyl)-6-methylpyrazolo(1,5-a)pyrimidin-2-yl)-1-piperidinyl)carbonyl)-4-chlorophenyl)-|GS-5806",,,,,,,,,,,,,NCIT:C118505,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Presatovir,,,,,,,,,,,,,,,,773674,773674,,Presatovir,,,,Pharmacologic Substance,,,,,,,,C3885071,
http://purl.obolibrary.org/obo/NCIT_C148534,Polyinosinic-polycytidylic Acid/Inactivated Rabies Virus Vaccine YS-ON-001,Poly IC/Inactivated RV-V YS-ON-001|YS-ON-001|YS ON 001|Polyinosinic-polycytidylic Acid/Inactivated Rabies Virus Vaccine YS-ON-001,"A cancer vaccine composed of inactivated rabies vaccine (RV-V) and polyinosinic-polycytidylic acid (poly IC; poly I-C), an immunostimulant and Toll-like receptor 3 (TLR3) agonist, with potential immunostimulating and antineoplastic activities. Upon administration of the poly IC/inactivated RV-V YS-ON-001, the RV-V stimulates the immune system in various ways, such as promoting the activation and proliferation of T helper type 1 (Th1) cells, dendritic cells (DCs), B cells and natural killer cells (NKs), promoting macrophage M1 polarization, downregulating regulatory T-cells (Tregs), and inducing the production of anti-tumor cytokines. This re-activates immune responses in the suppressed tumor microenvironment (TME), leading to an induction of cytotoxic T-lymphocyte (CTL)-mediated immune response against the tumor cells, which cause tumor cell apoptosis and a reduction of tumor cell proliferation. Poly IC, a synthetic double-stranded RNA with one strand composed of a inosinic acid polymer and the other strand a cytidylic acid polymer, binds to TLR3 and stimulates the release of cytotoxic cytokines, such as interferon-gamma (IFNg). This may boost the immune response against the tumor cells.",false,,,http://purl.obolibrary.org/obo/VO_0000001,,,,,,,,,,,C148534,,,,,,,,,,"A cancer vaccine composed of inactivated rabies vaccine (RV-V) and polyinosinic-polycytidylic acid (poly IC; poly I-C), an immunostimulant and Toll-like receptor 3 (TLR3) agonist, with potential immunostimulating and antineoplastic activities. Upon administration of the poly IC/inactivated RV-V YS-ON-001, the RV-V stimulates the immune system in various ways, such as promoting the activation and proliferation of T helper type 1 (Th1) cells, dendritic cells (DCs), B cells and natural killer cells (NKs), promoting macrophage M1 polarization, downregulating regulatory T-cells (Tregs), and inducing the production of anti-tumor cytokines. This re-activates immune responses in the suppressed tumor microenvironment (TME), leading to an induction of cytotoxic T-lymphocyte (CTL)-mediated immune response against the tumor cells, which cause tumor cell apoptosis and a reduction of tumor cell proliferation. Poly IC, a synthetic double-stranded RNA with one strand composed of a inosinic acid polymer and the other strand a cytidylic acid polymer, binds to TLR3 and stimulates the release of cytotoxic cytokines, such as interferon-gamma (IFNg). This may boost the immune response against the tumor cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poly IC/Inactivated RV-V YS-ON-001|YS-ON-001|YS ON 001|Polyinosinic-polycytidylic Acid/Inactivated Rabies Virus Vaccine YS-ON-001,,,,,,,,,,,,,NCIT:C148534,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/VO_0000001,,,,,,,,,,true,,,,,,,Polyinosinic- polycytidylic acid,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Polyinosinic-polycytidylic Acid/Inactivated Rabies Virus Vaccine YS-ON-001,,,,,,,CL551131,,,,,,,,,792708,792708,,Polyinosinic-polycytidylic Acid/Inactivated Rabies Virus Vaccine YS-ON-001,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,Pharmacologic Substance,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045785,positive regulation of cell adhesion,up regulation of cell adhesion|upregulation of cell adhesion|up-regulation of cell adhesion|stimulation of cell adhesion|activation of cell adhesion,"Any process that activates or increases the frequency, rate or extent of cell adhesion.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of cell adhesion.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,up regulation of cell adhesion|upregulation of cell adhesion|up-regulation of cell adhesion,,,stimulation of cell adhesion|activation of cell adhesion,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0045785,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045785,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cell adhesion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0022626,cytosolic ribosome,70S ribosome|80S ribosome,A ribosome located in the cytosol.,false,,,http://purl.obolibrary.org/obo/GO_0005840,,,,,,,,,,,,,,,,,,,,,A ribosome located in the cytosol.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030871|GO:0005830|GO:0009281,,,,,,,70S ribosome|80S ribosome,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005840,,,,GO:0022626,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0022626,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cytosolic ribosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000076,"person-to-person transmission
",,,false,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C128376,,,,,Modified definition,,,,,true,,,,,,Transmission from person to person by direct or indirect contact.,human-to-human viral transmission,,,,,,,,,,,,,,,"person-to-person transmission
",,,,,,,,,,,,,,,,,,,,,,https://www.healthline.com/health/disease-transmission|https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2914,immune system disease,,A disease of anatomical entity that is located_in the immune system.,false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,ICD10CM:D89.9|EFO:0000540|UMLS_CUI:C0041806|ICD9CM:279.9,A disease of anatomical entity that is located_in the immune system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:2914,,,,,,,,,,,,,,,DOID:2914,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,immune system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1903513,endoplasmic reticulum to cytosol transport,ER to cytosol transport,The directed movement of substances from endoplasmic reticulum to cytosol.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,rl,2014-10-02T11:24:34Z,,,,The directed movement of substances from endoplasmic reticulum to cytosol.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ER to cytosol transport,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:1903513,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903513,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endoplasmic reticulum to cytosol transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006948,induction by virus of host cell-cell fusion,viral-induced cell-cell fusion|viral-induced host cell-cell fusion|induction by virus of cell-cell fusion in host|viral-induced membrane fusion,"The process of syncytia-forming cell-cell fusion, caused by a virus.|Where syncytium formation results in the spread of virus in the host, also consider annotating to the term 'spread of virus in multicellular host ; GO:0046739'.",false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,,,,,,"The process of syncytia-forming cell-cell fusion, caused by a virus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral-induced cell-cell fusion|viral-induced host cell-cell fusion|induction by virus of cell-cell fusion in host,,,viral-induced membrane fusion,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Where syncytium formation results in the spread of virus in the host, also consider annotating to the term 'spread of virus in multicellular host ; GO:0046739'.",,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0006948,,,,,,true,,,,true,,,,,GO:0006948,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,induction by virus of host cell-cell fusion,,,,,,,,,,,,,,,,,,,,,,https://www.nature.com/articles/s41422-020-0305-x,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002223,stimulatory C-type lectin receptor signaling pathway,stimulatory C-type lectin receptor signalling pathway|stimulatory Ly49 family receptor signaling pathway,Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation.,false,,,http://purl.obolibrary.org/obo/GO_0002429,,,,,,,,,,,,,,,,,,,,,Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,stimulatory C-type lectin receptor signalling pathway,,,stimulatory Ly49 family receptor signaling pathway,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002429,,,,GO:0002223,,,,,,true,true,,,,,,,,GO:0002223,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,stimulatory C-type lectin receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_50858,corticosteroid,corticoides|corticosteroids|corticosteroides,A natural or synthetic analogue of the hormones secreted by the adrenal gland.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,A natural or synthetic analogue of the hormones secreted by the adrenal gland.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,corticoides|corticosteroids|corticosteroides,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50858,,,,,,true,,,,,,,,,CHEBI:50858,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,corticosteroid,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031069,hair follicle morphogenesis,,The process in which the anatomical structures of the hair follicle are generated and organized.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,The process in which the anatomical structures of the hair follicle are generated and organized.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0031069,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031069,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,hair follicle morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003127,HLA-DRB5,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,HLA-DRB,,,,,,,6,,,,,,,,,,MIM:604776|HGNC:4953|HPRD:09209|Vega:OTTHUMG00000031027|Ensembl:ENSG00000198502,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"major histocompatibility complex, class II, DR beta 5",,6p21.3,,,,"GO_0000139 (EC: TAS); GO_0002381 (EC: ISS); GO_0002437 (EC: ISS); GO_0002455 (EC: ISS); GO_0005765 (EC: IDA, PMID: 18305173); GO_0005765 (EC: TAS); GO_0005886 (EC: TAS); GO_0006955 (EC: ISS); GO_0009897 (EC: ISS); GO_0012507 (EC: TAS); GO_0016045 (EC: ISS); GO_0019221 (EC: TAS); GO_0019886 (EC: TAS); GO_0030658 (EC: TAS); GO_0030666 (EC: TAS); GO_0030669 (EC: TAS); GO_0031295 (EC: TAS); GO_0031902 (EC: IDA, PMID: 18305173); GO_0032588 (EC: TAS); GO_0032673 (EC: ISS); GO_0032689 (EC: ISS); GO_0035774 (EC: ISS); GO_0042088 (EC: ISS); GO_0042130 (EC: ISS); GO_0042605 (EC: ISS); GO_0042613 (EC: IEA); GO_0050852 (EC: TAS); GO_0051262 (EC: ISS); GO_0060333 (EC: TAS); GO_0070062 (EC: IDA, PMID: 12519789); GO_0071556 (EC: TAS); GO_2001179 (EC: ISS)",PMID: 1428007; 1612646; 1869305; 1905983; 1967269; 1970352; 1975801; 1978941; 2023919; 2212675; 2471740; 2511168; 2543930; 2565895; 2846691; 2884201; 2885840; 3015788; 3020127; 3099214; 3129499; 3137159; 3259543; 3371836; 3456344; 3466180; 3476943; 3489470; 3571980; 7512597; 7541827; 7547576; 7602119; 7645219; 7652736; 7734415; 7974469; 8016840; 8026992; 8084338; 8168144; 8168862; 8362413; 8376762; 8450224; 8462990; 8655358; 8864175; 8988548; 9027973; 9079699; 9162096; 9223324; 9226128; 9349614; 9500545; 9777332; 9820607; 9864034; 10551425; 10609818; 10661406; 10703621; 10729169; 11034591; 11048639; 11082515; 11082517; 11118314; 11144300; 11169266; 11181188; 11181995; 11260517; 11380955; 11469465; 11555411; 11704801; 11751963; 11782380; 11798795; 11827988; 11934390; 11972886; 11997714; 12028548; 12121280; 12133402; 12144077; 12144632; 12202216; 12209103; 12230470; 12244309; 12296785; 12358860; 12392858; 12427289; 12477932; 12519789; 12652907; 12694574; 12694577; 12956878; 14508706; 14617041; 14752708; 14989721; 15191532; 15191533; 15245378; 15489916; 15730527; 15784911; 15896200; 15902698; 15982265; 16140993; 16305688; 16405603; 16426242; 16441501; 16566202; 16916662; 16973583; 17106278; 17153701; 17182961; 17207965; 17411376; 17431094; 17507489; 17559577; 17652306; 17910142; 17959659; 18305173; 18520346; 18569076; 18672082; 18713991; 18832704; 18846964; 18945465; 19116923; 19122664; 19223392; 19235017; 19380721; 19449444; 19620308; 19663932; 19770068; 19811438; 20012522; 20193235; 20193583; 20307907; 20394989; 20458337; 20606439; 20639878; 21085635; 21131588; 21297633; 21299892; 21778700; 21906983; 21922073; 22033527; 22493691; 22531795; 22723597; 22808111; 22860026; 22862923; 22888134; 23349640; 23535732; 23850713,,,,,,,,,,,,,,,,,,OGG:3000003127,,,,,,,,,,,,,,,,,,,"major histocompatibility complex, class II, DR beta 5",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HLA-DRB5,,,20140408,3127,hCG_1998957,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,HLA-DRB5,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0011991,Abnormal neutrophil count,Abnormal neutrophil cell number,A deviation from the normal range of neutrophil cell counts in the circulation.,false,,,http://purl.obolibrary.org/obo/HP_0032309|http://purl.obolibrary.org/obo/HP_0001874,,,,,,,,,,,,,,,,peter,2012-07-19T10:59:14Z,,,UMLS:C4023092,A deviation from the normal range of neutrophil cell counts in the circulation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormal neutrophil cell number,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0032309|http://purl.obolibrary.org/obo/HP_0001874,,,,HP:0011991,,,,,,,,,,,,,,,HP:0011991,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal neutrophil count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C12542,CD8-Positive T-Lymphocyte,CD8-Positive T-Lymphocyte|CD8+ T Lymphocytes|CD8 Cell|CD8-Positive Lymphocyte|CD8 Lymphocyte|T8 Lymphocyte|CD8 Lymphocytes|T8 Cells|CD8-Positive T-Lymphocytes|CD8+ T Lymphocyte|CD8-Positive Lymphocytes|CD8+ T-Lymphocyte|T8 Cell|T8 Lymphocytes|CD8+ T Cell,A subset of T-lymphocytes that express the CD8 surface glycoprotein and bind epitopes that are part of class I histocompatibility molecules. CD8-positive T-lymphocytes include cytotoxic T-lymphocytes and CD8+ suppressor T-lymphocytes.,false,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,,C12542,,,CTRP,,,,,,,A subset of T-lymphocytes that express the CD8 surface glycoprotein and bind epitopes that are part of class I histocompatibility molecules. CD8-positive T-lymphocytes include cytotoxic T-lymphocytes and CD8+ suppressor T-lymphocytes.,,,,,,CD8-Positive T-Lymphocyte,,,,,,,,,,,,,,,,,,,,,,,,,CD8-Positive T-Lymphocyte|CD8+ T Lymphocytes|CD8 Cell|CD8-Positive Lymphocyte|CD8 Lymphocyte|T8 Lymphocyte|CD8 Lymphocytes|T8 Cells|CD8-Positive T-Lymphocytes|CD8+ T Lymphocyte|CD8-Positive Lymphocytes|CD8+ T-Lymphocyte|T8 Cell|T8 Lymphocytes|CD8+ T Cell,,,,,,,,,,,,,NCIT:C12542,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000084,,,,,,,,,,true,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32167524,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142800|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799,,,,,,,,,,CD8-Positive T-Lymphocyte,CD8_Plus_T-Lymphocyte,,,,,,,,,,,,,,,,,,CD8-Positive T-Lymphocyte,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,Cell,,,,,,,,C0242629,
http://purl.obolibrary.org/obo/GO_0003094,glomerular filtration,,"The process in which plasma is filtered through the glomerular membrane which consists of capillary endothelial cells, the basement membrane, and epithelial cells. The glomerular filtrate is the same as plasma except it has no significant amount of protein.",false,,,http://purl.obolibrary.org/obo/GO_0097205,,,,,,,,,,,,,,,,,,,,,"The process in which plasma is filtered through the glomerular membrane which consists of capillary endothelial cells, the basement membrane, and epithelial cells. The glomerular filtrate is the same as plasma except it has no significant amount of protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0097205,,,,GO:0003094,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0003094,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,glomerular filtration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046741,"transport of virus in host, tissue to tissue","viral spread within host, tissue to tissue|tissue to tissue spread of virus within host|spread of virus within host, tissue to tissue|spread of virus in host, tissue to tissue",The transport of a virus between tissues in a multicellular organism.,false,,,http://purl.obolibrary.org/obo/GO_0046794,,,,,,,,,,,,,,,,,,,,,The transport of a virus between tissues in a multicellular organism.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"viral spread within host, tissue to tissue|tissue to tissue spread of virus within host|spread of virus within host, tissue to tissue",,,,,biological_process,,"spread of virus in host, tissue to tissue",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046794,,,,GO:0046741,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,GO:0046741,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"transport of virus in host, tissue to tissue",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000099,emergency Warning Sign,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,data item,,true,,,,,,Warning signs that indicate a medical emergency.,,,,,,,,,,,,,,,,emergency Warning Sign,,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0001655,urogenital system development,,"The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0001655,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0001655,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,urogenital system development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019320,hexose catabolic process,hexose degradation|hexose breakdown|hexose catabolism,"The chemical reactions and pathways resulting in the breakdown of hexose, any monosaccharide with a chain of six carbon atoms in the molecule.",false,,,http://purl.obolibrary.org/obo/GO_0044282|http://purl.obolibrary.org/obo/GO_0016052|http://purl.obolibrary.org/obo/GO_0019318|http://purl.obolibrary.org/obo/GO_0005996,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of hexose, any monosaccharide with a chain of six carbon atoms in the molecule.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hexose degradation|hexose breakdown|hexose catabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044282|http://purl.obolibrary.org/obo/GO_0016052|http://purl.obolibrary.org/obo/GO_0019318|http://purl.obolibrary.org/obo/GO_0005996,,,,GO:0019320,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019320,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,hexose catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0028469,Hand Sanitizers,,,false,,,http://purl.obolibrary.org/obo/OMIT_0008054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0028469,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OMIT_0008054,,,,,,,,,,,,,,,,"Preparations used as alternatives or supplements to hand washing with soap and water to destroy microorganisms and prevent transmission of pathogens. The active ingredient may be ETHANOL; 1-PROPANOL; or POVIDONE-IODINE in a gel, foam, or liquid solution.",,using alcohol based rub frequently,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Hand Sanitizers,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/selection_medicines/committees/expert/20/applications/abhr/en/,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000132,higher sequential organ failure assessment score,,,false,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000000,,,,,Modified definition,,,Risk,,true,,,,,https://www.ncbi.nlm.nih.gov/pubmed/19325482,Higher sequential organ failure assessment score,,,,,,,,,,,,,,,,higher sequential organ failure assessment score,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10374,Gammaherpesvirinae,lymphoproliferative virus group|Gammaherpesviruses,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10292,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,lymphoproliferative virus group|Gammaherpesviruses,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_subfamily,,,,,,,NCBITaxon:10374,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10292,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Gammaherpesvirinae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/IDO_0000567,secondary infection,,An infection bearing the secondary infection role.,false,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,,,,,,,,,,,,,,,,,,An infection bearing the secondary infection role.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IDO:0000567,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,,,,,,http://purl.obolibrary.org/obo/ido.owl,,,,,,,,,,,secondary infection,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain|Alexander Diehl|Lindsay Cowell,,,,
http://purl.obolibrary.org/obo/OGG_3000003557,IL1RN,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL1F3|IL-1ra|IL-1ra3|IL-1RN|IRAP|DIRA|IL1RA|MVCD4|ICIL-1RA,,,,,,,2,,,,,,,,,,Vega:OTTHUMG00000131341|HPRD:00978|Ensembl:ENSG00000136689|HGNC:6000|MIM:147679,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 1 receptor antagonist,,2q14.2,,,,"GO_0001660 (EC: IEA); GO_0001960 (EC: IDA, PMID: 2137200); GO_0002439 (EC: IEA); GO_0005149 (EC: IDA, PMID: 2137200); GO_0005150 (EC: IPI, PMID: 1828071); GO_0005151 (EC: IPI, PMID: 1830582); GO_0005152 (EC: IDA, PMID: 2137200); GO_0005152 (EC: TAS, PMID: 7629520); GO_0005615 (EC: IDA, PMID: 10443688); GO_0005622 (EC: NAS, PMID: 7629520); GO_0005737 (EC: IEA); GO_0005886 (EC: TAS); GO_0006629 (EC: IEA); GO_0006953 (EC: IDA, PMID: 9185517); GO_0006955 (EC: NAS, PMID: 7629520); GO_0007565 (EC: IEA); GO_0007613 (EC: IEA); GO_0010243 (EC: IEA); GO_0014050 (EC: IEA); GO_0019752 (EC: IEA); GO_0030073 (EC: IEA); GO_0030336 (EC: IEA); GO_0032496 (EC: IEA); GO_0034115 (EC: IDA, PMID: 2139180); GO_0042493 (EC: IEA); GO_0043066 (EC: IEA); GO_0043507 (EC: IEA); GO_0045352 (EC: IDA, PMID: 1828071); GO_0045353 (EC: IDA, PMID: 1830582); GO_0045837 (EC: IEA); GO_0051384 (EC: IDA, PMID: 10443688); GO_0070062 (EC: IDA, PMID: 19056867); GO_0070670 (EC: IEA); GO_2000660 (EC: IDA, PMID: 2137200)",PMID: 1385987; 1386337; 1479000; 1534997; 1827201; 1828071; 1828896; 1830582; 1834644; 2137200; 2137201; 2139180; 2143761; 2147937; 7629520; 7867645; 8045306; 8175703; 8188271; 8432529; 8726668; 8852605; 8992991; 9062194; 9169134; 9185517; 9514884; 9597123; 9710237; 9933103; 10443688; 10512743; 10625660; 10673296; 10744718; 10786823; 10860666; 10948677; 10988299; 11023482; 11027520; 11033452; 11045853; 11093146; 11127488; 11138328; 11145836; 11171832; 11233912; 11247888; 11264025; 11278614; 11423389; 11448121; 11466363; 11531943; 11574262; 11600466; 11606494; 11606496; 11640949; 11641511; 11665981; 11686217; 11762793; 11770040; 11784248; 11793861; 11802774; 11803448; 11816697; 11840488; 11841485; 11841553; 11846196; 11858187; 11876744; 11876758; 11991722; 12044341; 12070246; 12082590; 12082592; 12095061; 12102486; 12105837; 12111633; 12114904; 12115161; 12115182; 12133467; 12136897; 12140751; 12160520; 12161036; 12161099; 12164325; 12165808; 12220547; 12239970; 12240899; 12355453; 12441323; 12445219; 12445604; 12452470; 12453918; 12454835; 12468823; 12472674; 12477932; 12483741; 12496176; 12519748; 12530098; 12547728; 12551827; 12568735; 12578333; 12593203; 12595908; 12609525; 12618859; 12624309; 12626603; 12645941; 12667023; 12667286; 12679428; 12686792; 12694213; 12714264; 12718576; 12722027; 12729191; 12730545; 12730860; 12746420; 12746914; 12764021; 12768436; 12775358; 12788304; 12794527; 12801479; 12820354; 12824054; 12828754; 12847695; 12854083; 12891537; 12901853; 12913327; 12919285; 12930389; 12938145; 12958619; 14504049; 14514232; 14521725; 14522096; 14533660; 14566095; 14568678; 14585879; 14586324; 14611908; 14632761; 14633943; 14634579; 14634582; 14644395; 14647192; 14652282; 14656692; 14657427; 14664464; 14669220; 14672899; 14673228; 14734209; 14735144; 14750640; 14753487; 14758530; 14982742; 14984963; 14986816; 14997019; 15020290; 15030461; 15036245; 15036607; 15056081; 15077300; 15082121; 15127646; 15141093; 15144571; 15170937; 15171792; 15181037; 15184943; 15188516; 15190266; 15201366; 15205567; 15223609; 15231136; 15233701; 15235132; 15236174; 15241561; 15247172; 15250242; 15266130; 15270852; 15286433; 15292002; 15305821; 15318032; 15325407; 15338333; 15339690; 15379752; 15457475; 15476179; 15485792; 15489334; 15507960; 15507961; 15512788; 15530901; 15535834; 15539764; 15540224; 15551344; 15562761; 15566952; 15570075; 15574426; 15579481; 15602586; 15610073; 15644653; 15670034; 15672946; 15679582; 15694997; 15704154; 15717635; 15723707; 15727567; 15730917; 15733644; 15766560; 15797878; 15800325; 15803022; 15830637; 15836820; 15851404; 15866604; 15878285; 15884119; 15885804; 15900570; 15923123; 15927855; 15931231; 15943888; 15954918; 15986200; 16019127; 16019233; 16025481; 16026159; 16043936; 16053468; 16078996; 16088107; 16096333; 16098232; 16100774; 16106254; 16109659; 16114018; 16115908; 16126303; 16128937; 16142351; 16159520; 16164697; 16172101; 16174285; 16183821; 16195370; 16200608; 16202742; 16217062; 16226351; 16244470; 16246569; 16263000; 16268484; 16284368; 16284379; 16301842; 16318998; 16319982; 16335952; 16361275; 16361815; 16362796; 16369899; 16389181; 16403098; 16405550; 16409203; 16414081; 16423338; 16436009; 16454826; 16456536; 16510430; 16519819; 16538639; 16540751; 16549749; 16550552; 16553947; 16573560; 16579840; 16595248; 16596202; 16635219; 16635751; 16636119; 16637265; 16638698; 16698387; 16699452; 16741227; 16764597; 16766392; 16769128; 16777324; 16804398; 16815316; 16817913; 16820326; 16820919; 16824064; 16839849; 16842617; 16856121; 16873708; 16879054; 16885604; 16886894; 16900886; 16905295; 16906455; 16907768; 16911569; 16921503; 16937503; 16938461; 16980335; 16984283; 16985030; 17002905; 17005410; 17026469; 17034724; 17035400; 17068065; 17069782; 17074546; 17083033; 17096351; 17107994; 17113632; 17114844; 17115419; 17174563; 17176440; 17177339; 17182583; 17207379; 17222831; 17224277; 17235630; 17256873; 17257312; 17258699; 17286233; 17290743; 17292896; 17295877; 17309751; 17314118; 17324969; 17327408; 17332449; 17335371; 17348243; 17351514; 17359523; 17373677; 17380888; 17388919; 17391700; 17413037; 17443229; 17444587; 17444864; 17446060; 17448214; 17453104; 17454884; 17459217; 17482260; 17483707; 17532232; 17548705; 17572155; 17584583; 17592300; 17593860; 17596285; 17607501; 17607547; 17610660; 17611547; 17611673; 17618436; 17627763; 17640324; 17645476; 17656565; 17703412; 17716546; 17760842; 17846855; 17847930; 17867984; 17899305; 17900737; 17903994; 17907045; 17914732; 17926179; 17948066; 17959519; 17963170; 17964974; 17993728; 18008080; 18029348; 18038187; 18047563; 18052703; 18052726; 18063673; 18069935; 18086767; 18165865; 18180150; 18186699; 18239554; 18243027; 18271063; 18272394; 18278133; 18288276; 18288454; 18299273; 18321309; 18322311; 18329282; 18332090; 18333945; 18336824; 18354254; 18361937; 18364273; 18385937; 18386294; 18389618; 18396210; 18416755; 18423886; 18451331; 18455629; 18464913; 18468936; 18471873; 18484169; 18484691; 18494930; 18496214; 18545091; 18551993; 18565646; 18572364; 18579366; 18581280; 18583979; 18589098; 18597398; 18624935; 18632425; 18633131; 18665932; 18666137; 18676680; 18688110; 18702109; 18703194; 18715339; 18723088; 18728809; 18754838; 18761558; 18763028; 18771989; 18773331; 18779738; 18782283; 18805892; 18807132; 18808736; 18810365; 18814951; 18815552; 18818748; 18821666; 18832862; 18838927; 18853133; 18926055; 18940468; 18942754; 18987561; 19004046; 19009622; 19012493; 19013788; 19019335; 19026124; 19026700; 19030199; 19031173; 19046297; 19053923; 19056867; 19058789; 19066720; 19073760; 19074885; 19076825; 19086955; 19102413; 19111743; 19117745; 19125864; 19127455; 19129082; 19132772; 19134476; 19135625; 19141860; 19142372; 19151976; 19170196; 19191798; 19203086; 19247692; 19258032; 19258923; 19267917; 19269948; 19272615; 19280228; 19290009; 19290417; 19295440; 19322919; 19332120; 19334424; 19336370; 19336475; 19338208; 19347053; 19375283; 19399323; 19408823; 19418669; 19419456; 19427781; 19431193; 19453261; 19470040; 19489682; 19494218; 19495883; 19497711; 19505916; 19505919; 19506726; 19527514; 19544559; 19544973; 19550417; 19573080; 19574724; 19594368; 19603010; 19607807; 19618316; 19625176; 19638314; 19643686; 19644155; 19664671; 19683555; 19684156; 19692168; 19701653; 19702713; 19706048; 19711225; 19729601; 19733643; 19733878; 19764937; 19773279; 19804405; 19811432; 19811433; 19811434; 19818512; 19820020; 19822419; 19822442; 19839644; 19844779; 19850242; 19860911; 19876593; 19889076; 19892918; 19900796; 19904560; 19909950; 19913121; 19925477; 19930406; 19934104; 19948975; 20002810; 20005085; 20012999; 20032313; 20034444; 20056442; 20070880; 20080142; 20087638; 20092400; 20113413; 20131253; 20140262; 20141484; 20169140; 20175886; 20178882; 20185814; 20188863; 20192980; 20193596; 20196868; 20200422; 20207250; 20213229; 20213597; 20237151; 20237496; 20301318; 20305143; 20334849; 20335539; 20347268; 20353565; 20364673; 20378664; 20379614; 20399384; 20400062; 20412719; 20427258; 20450372; 20452482; 20453000; 20463618; 20467172; 20472930; 20482626; 20484876; 20485444; 20486195; 20495422; 20503287; 20536609; 20538031; 20551628; 20564140; 20568250; 20581747; 20592454; 20595916; 20603050; 20621920; 20626741; 20628086; 20630038; 20631624; 20650788; 20654748; 20673868; 20709104; 20734064; 20800651; 20802378; 20837746; 20839488; 20863445; 20880168; 20880945; 20934174; 20940514; 20942594; 20975573; 21035110; 21037510; 21044950; 21048327; 21049406; 21054807; 21086908; 21111725; 21174170; 21182747; 21235388; 21241861; 21243433; 21248262; 21265111; 21278303; 21357189; 21394384; 21455057; 21523343; 21558284; 21575667; 21591983; 21621860; 21655939; 21671260; 21768915; 21848462; 21968104; 21980458; 22027586; 22032624; 22035161; 22059992; 22127713; 22205395; 22267087; 22285242; 22286731; 22312160; 22322675; 22327782; 22370044; 22431772; 22455686; 22498095; 22537067; 22744645; 22753384; 22795294; 22829643; 22882323; 22909148; 22939635; 22948742; 23009887; 23013217; 23014359; 23028694; 23049596; 23049925; 23053980; 23122308; 23168096; 23192617; 23195019; 23212299; 23251650; 23251661; 23308180; 23323013; 23388595; 23406623; 23449693; 23462747; 23472661; 23499887; 23554905; 23562526; 23577098; 23592003; 23602199; 23602982; 23609451; 23633206; 23743874; 23765978; 23800434; 23818854; 23969696; 24611340,,,,,,,,,,,,,,,,,,OGG:3000003557,,,,,,,,,,,,,,,,,,,interleukin 1 receptor antagonist,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/31986264,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL1RN,,,20140408,3557,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL1RN,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_338606,Bat SARS coronavirus HKU3-3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:338606,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007411,axon guidance,axon pathfinding|axon growth cone guidance|axon chemotaxis,The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.,false,,,http://purl.obolibrary.org/obo/GO_0097485,,,,,,,,,,,,,,,,,,,,Wikipedia:Axon_guidance,The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008040,,,,axon pathfinding,,,axon growth cone guidance,,biological_process,,axon chemotaxis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0097485,,,,GO:0007411,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007411,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,axon guidance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0030879,Interlobular septal thickening on pulmonary HRCT,,"Presence of thickening of the interlobular septa of the lungs as seen on a CT scan.|Interlobular septa are 10-20nm long structures at the border of the secondary pulmonary lobules and which are usually perpendicular to the pleura in the periphery of the lung. Interlobular septa are composed of connective tisues and contain pulmonary venules and lymphatics. Diseases that affect one of the components of the interlobular septa may lead to thickeninig of the septa, which makes the visible on computed tomography (CT) scans. Some of the diseases that may be associated with this phenotypic feature are pulmonary edema, pulmonary lymphangitis carcinomatosis, leukemic or lymphomic involvement of the lung, diffuse alveolar hemorrhage, Nieman-Pick disease, and pneumonia. The terms septal lines or septal thickening may also be used to describe interlobular septal thickening. Earlier descriptions include the terms peripheral lines, short lines, and interlobular lines.",false,,,http://purl.obolibrary.org/obo/HP_0025389,,,,,,,,,,,,,,,,,,,,UMLS:C4280727,Presence of thickening of the interlobular septa of the lungs as seen on a CT scan.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0030879,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Interlobular septa are 10-20nm long structures at the border of the secondary pulmonary lobules and which are usually perpendicular to the pleura in the periphery of the lung. Interlobular septa are composed of connective tisues and contain pulmonary venules and lymphatics. Diseases that affect one of the components of the interlobular septa may lead to thickeninig of the septa, which makes the visible on computed tomography (CT) scans. Some of the diseases that may be associated with this phenotypic feature are pulmonary edema, pulmonary lymphangitis carcinomatosis, leukemic or lymphomic involvement of the lung, diffuse alveolar hemorrhage, Nieman-Pick disease, and pneumonia. The terms septal lines or septal thickening may also be used to describe interlobular septal thickening. Earlier descriptions include the terms peripheral lines, short lines, and interlobular lines.",,http://purl.obolibrary.org/obo/HP_0025389,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156903/,,,interlobular involvement,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Interlobular septal thickening on pulmonary HRCT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/MP_0003141,cardiac fibrosis,,formation of fibrous tissue within the heart often resulting from inflammation or injury,false,,,http://purl.obolibrary.org/obo/MP_0000266,,,,,,,,,,,,,,,,,,,,,formation of fibrous tissue within the heart often resulting from inflammation or injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,MPheno.ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/MP_0000266,,,,MP:0003141,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,MP:0003141,,http://purl.obolibrary.org/obo/mp.owl,,,,,,,,,,,cardiac fibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_26214,porphyrins,porphyrins,Natural pigments containing a fundamental skeleton of four pyrrole nuclei united through the alpha-positions by four methine groups to form a macrocyclic structure.,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,Wikipedia:Porphyrin,Natural pigments containing a fundamental skeleton of four pyrrole nuclei united through the alpha-positions by four methine groups to form a macrocyclic structure.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,porphyrins,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:26214,,,,,,true,,,,,,,,,CHEBI:26214,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,porphyrins,,,,,,,,,,,,,,,,,,,,,,https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173/5,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016363,nuclear matrix,nucleoskeleton,The dense fibrillar network lying on the inner side of the nuclear membrane.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Nuclear_matrix,The dense fibrillar network lying on the inner side of the nuclear membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nucleoskeleton,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0016363,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016363,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nuclear matrix,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034976,response to endoplasmic reticulum stress,cellular response to endoplasmic reticulum stress|response to ER stress|ER stress response,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.",false,,,http://purl.obolibrary.org/obo/GO_0033554,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular response to endoplasmic reticulum stress|response to ER stress|ER stress response,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0033554,,,,GO:0034976,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034976,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to endoplasmic reticulum stress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_627442,SARS coronavirus P2,SARS coronavirus strain P2,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,NCBITaxon:633141,,,,,,,,,ncbi_taxonomy,,SARS coronavirus strain P2,,,,,,NCBITaxon:627442,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus P2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000152,Abnormality of head or neck,Abnormality of head or neck|Head and neck abnormality,An abnormality of head and neck.,false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,UMLS:C4021817,An abnormality of head and neck.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of head or neck|Head and neck abnormality,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0000152,,,,,,,,,,,,,,,HP:0000152,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of head or neck,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305413,SARS coronavirus C017,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305413,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C017,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_260550,SARS coronavirus CUHK-L2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:260550,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus CUHK-L2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_511432,SARS coronavirus BJ182a,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:511432,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus BJ182a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305402,SARS coronavirus A013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305402,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus A013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1487703,Rhinolophus affinis coronavirus,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1487703,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Rhinolophus affinis coronavirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258970,SARS coronavirus TW7,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258970,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000083,Renal insufficiency,Renal failure in adulthood|Renal failure,"A reduction in the level of performance of the kidneys in areas of function comprising the concentration of urine, removal of wastes, the maintenance of electrolyte balance, homeostasis of blood pressure, and calcium metabolism.",false,,,http://purl.obolibrary.org/obo/HP_0012211,,,,,,,,,,,,,,,,,,,,UMLS:C0035078|UMLS:C1839604|MSH:D051437|SNOMEDCT_US:42399005|UMLS:C1565489|SNOMEDCT_US:236423003,"A reduction in the level of performance of the kidneys in areas of function comprising the concentration of urine, removal of wastes, the maintenance of electrolyte balance, homeostasis of blood pressure, and calcium metabolism.",,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0000084|HP:0004723,,,,Renal failure in adulthood|Renal failure,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0012211,,,,HP:0000083,,,,,,,,,,,,,,,HP:0000083,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Renal insufficiency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0005952,Decreased pulmonary function,Decreased lung function|Impaired lung function|Impaired pulmonary function,,false,,,http://purl.obolibrary.org/obo/HP_0002795,,,,,,,,,,,,,,,,,,,,UMLS:C0235063|MSH:D012131|SNOMEDCT_US:80954004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Decreased lung function|Impaired lung function|Impaired pulmonary function,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002795,,,,HP:0005952,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,Decreased lung function is associated with reduced ventilation and oxygen intake and reported to affect body functions.,,,HP:0005952,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Decreased pulmonary function,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249071,SARS coronavirus HSZ-Cb,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249071,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HSZ-Cb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0013045,Pulmonary Ventilation,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0013045,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32189136/,"The total volume of gas inspired or expired per unit of time, usually measured in liters per minute.",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Pulmonary Ventilation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_82960,raltegravir,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:82960,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:82960,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#1_STAR,,,,,,,,,,raltegravir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000078,"shelter-in-place order
",,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,true,,,,,, An emergency measure or condition in which people are temporarily prevented from entering or leaving a restricted area or building (such as a school) during a threat of danger.,Lockdown,,,,,,,,,,,,,,,"shelter-in-place order
",,,,,,,,,,,,,,,,,,,,,,"https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-glossary-of-terms/|https://www.yalemedicine.org/stories/covid-19-glossary/
",,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_77543,ebselen,"2-phenyl-1,2-benzoselenazol-3(2H)-one|2-phenyl-1,2-benzoselenazol-3-one|PZ 51|DR3305|ebseleno|ebselen|ebselenum|ebselene","A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:11060699|PMID:23499840|PMID:24231787|Reaxys:164926|PMID:2563645|PMID:24131109|PMID:23496767|Wikipedia:Ebselen|PMID:23795780|PMID:17030476|PMID:21822642|PMID:22181350|PMID:23933410|PMID:23649643|CAS:60940-34-3|PMID:22491720|PMID:19747949|PMID:16962325|PMID:24470283|PMID:17976864|PMID:23299882|PMID:24134695|PMID:24350274|PMID:24012716|PMID:24490132|PMID:7590103|PMID:16239596|PMID:24587987|PMID:9445321|PMID:14588151|PMID:24635113|LINCS:LSM-2644|PMID:24405262|PMID:23801580,"A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2-phenyl-1,2-benzoselenazol-3(2H)-one",,,,,chebi_ontology,,"2-phenyl-1,2-benzoselenazol-3-one|PZ 51|DR3305|ebseleno|ebselen|ebselenum|ebselene",,,,,,,,,0,C13H9NOSe,InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H,DYEFUKCXAQOFHX-UHFFFAOYSA-N,274.18000,274.98494,O=c1n([se]c2ccccc12)-c1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:77543,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:77543,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ebselen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000299,hyperemia,hyperaemia|hyperemic,Hyperemia is a hemic system symptom consisting of an excess of blood in a body part as from an increased flow of blood due to vasodilation.,false,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,,,,,,,,,,,,,,,,,,Hyperemia is a hemic system symptom consisting of an excess of blood in a body part as from an increased flow of blood due to vasodilation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hyperaemia|hyperemic,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,SYMP:0000299,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,SYMP:0000299,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,hyperemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000031,blood lymphocyte count,,The number of lymphocytes in a specified volume of blood.,false,,,http://purl.obolibrary.org/obo/CMO_0000027,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000031,,,,,,,,,,,,The number of lymphocytes in a specified volume of blood.,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000027,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,blood lymphocyte count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000075,lethargy,,Lethargy is a fatigue characterized as abnormal drowsiness.,false,,,http://purl.obolibrary.org/obo/SYMP_0019177,,,,,,,,,,,,,,,,,,,,,Lethargy is a fatigue characterized as abnormal drowsiness.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0019177,,,,SYMP:0000075,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,,,,SYMP:0000075,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,lethargy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009987,cellular process,cellular physiological process|cell physiology|cell growth and/or maintenance|single-organism cellular process,"Any process that is carried out at the cellular level, but not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.",false,,,http://purl.obolibrary.org/obo/GO_0008150,,,,,,,,,,,,,,,,janelomax,2012-12-11T16:56:55Z,,,,"Any process that is carried out at the cellular level, but not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0050875|GO:0044763|GO:0008151,,,,cellular physiological process|cell physiology,,,cell growth and/or maintenance,,biological_process,,single-organism cellular process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0008150,,,,GO:0009987,,,,,,,,,,,,,,,GO:0009987,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant,,,,,,,,,,cellular process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019081,viral translation,viral protein synthesis|viral protein biosynthetic process|viral protein formation|viral protein biosynthesis|viral protein anabolism,"A process by which viral mRNA is translated into viral protein, using the host cellular machinery.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"A process by which viral mRNA is translated into viral protein, using the host cellular machinery.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral protein synthesis|viral protein biosynthetic process|viral protein formation|viral protein biosynthesis|viral protein anabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019081,,,,,,true,,,,true,,,,,GO:0019081,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral translation,,,,,,,,,,,,,,,,,,,,,,https://www.antibodies-online.com/resources/18/5410/sars-cov-2-life-cycle-stages-and-inhibition-targets/,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000458,Anosmia,Loss of smell|Lost smell,"An inability to perceive odors. This is a general term describing inability to smell arising in any part of the process of smelling from absorption of odorants into the nasal mucous overlying the olfactory epithelium, diffusion to the cilia, binding to olfactory receptor sites, generation of action potentials in olfactory neurons, and perception of a smell.",false,,,http://purl.obolibrary.org/obo/HP_0004408,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:44169009|MSH:D000857|UMLS:C0003126,"An inability to perceive odors. This is a general term describing inability to smell arising in any part of the process of smelling from absorption of odorants into the nasal mucous overlying the olfactory epithelium, diffusion to the cilia, binding to olfactory receptor sites, generation of action potentials in olfactory neurons, and perception of a smell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Loss of smell|Lost smell,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0004408,,,,HP:0000458,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32237238,,,,HP:0000458,,http://purl.obolibrary.org/obo/hp.owl,http://purl.oboInOwllibrary.org/oboInOwl/hp#hposlim_core,,,,,,,,,,Anosmia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002429,immune response-activating cell surface receptor signaling pathway,activation of immune response by cell surface receptor signaling pathway|immune response-activating cell surface receptor signalling pathway,A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of a cell capable of activating or perpetuating an immune response.,false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,,A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of a cell capable of activating or perpetuating an immune response.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,activation of immune response by cell surface receptor signaling pathway|immune response-activating cell surface receptor signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0002429,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002429,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,immune response-activating cell surface receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019814,immunoglobulin complex,antibody,"A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.|Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,antibody,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available.,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0019814,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019814,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,immunoglobulin complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_28285,Human adenovirus 5,Human mastadenovirus 5|Mastadenovirus h5|adenovirus Ad5|Human adenovirus type 5|Mastadenovirus 5|Human adenovirus C5|Adenovirus type 5|adenovirus type 5 AD5|Adenovirus 5,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_129951,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Human mastadenovirus 5|Mastadenovirus h5|adenovirus Ad5|Human adenovirus type 5|Mastadenovirus 5|Human adenovirus C5|Adenovirus type 5|adenovirus type 5 AD5|Adenovirus 5,,,,,,NCBITaxon:28285,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_129951,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human adenovirus 5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072331,signal transduction by p53 class mediator,,An intracellular signaling process that is induced by the cell cycle regulator phosphoprotein p53 or an equivalent protein.,false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,midori,2010-11-03T01:32:59Z,,,,An intracellular signaling process that is induced by the cell cycle regulator phosphoprotein p53 or an equivalent protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0072331,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072331,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,signal transduction by p53 class mediator,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_299335,SARS coronavirus B039,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:299335,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus B039,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C90808,Apilimod,"Apilimod|APILIMOD|N-(3-Methyl-Benzylidene)-N'-(6-Morpholin-4-Yl-2-(2-Pyridin-2-Yl-Ethoxy)-Pyrimidin-4-Yl)-Hydrazine|Benzaldehyde, 3-Methyl-, (6-(4-Morpholinyl)-2-(2-(2-Pyridinyl)Ethoxy)-4-Pyrimidinyl)Hydrazone|STA 5326",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,541550-19-0,,C23H26N6O2,,C90808,,,FDA,,,,,,,,,,,,,,,,,,,,,,,,GFW2K84S4L,,,,,,,,,,,,,,"Apilimod|APILIMOD|N-(3-Methyl-Benzylidene)-N'-(6-Morpholin-4-Yl-2-(2-Pyridin-2-Yl-Ethoxy)-Pyrimidin-4-Yl)-Hydrazine|Benzaldehyde, 3-Methyl-, (6-(4-Morpholinyl)-2-(2-(2-Pyridinyl)Ethoxy)-4-Pyrimidinyl)Hydrazone|STA 5326",,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C90809,,,NCIT:C90808,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,"Apilimod is a small molecule inhibitor of interleukin-12 and interleukin-23 synthesis thereby preventing IL-12/IL-23 mediated immune responses. Apilimod is also observed to inhibit the nuclear accumulation of NF-kappB protein family, and viral infections dependent on phosphatidylinositol-3-phosphate 5-kinase (PIKfyve). Apilimod has been investigated as a potential treatment for a number of autoimmune conditions.",,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Apilimod,,,,,,,,,,,,,,,,,,,Apilimod,,,,Pharmacologic Substance|Organic Chemical,,,,,,,,C1610483,
http://purl.obolibrary.org/obo/GO_0005938,cell cortex,cell periphery|peripheral cytoplasm,"The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Cell_cortex,"The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,cell periphery|peripheral cytoplasm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005938,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005938,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus,,,,,,,,,,cell cortex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050282,ORF1a proteolytic cleavage product (SARS-CoV-2),ORF1a/ClvPrd (SARS2),A replicase polyprotein 1a (SARS-CoV-2) that has been processed by proteolytic cleavage.|Category=organism-modification.,false,,,http://purl.obolibrary.org/obo/PR_P0DTC1-1|http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,,A replicase polyprotein 1a (SARS-CoV-2) that has been processed by proteolytic cleavage.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ORF1a/ClvPrd (SARS2),,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification.,,http://purl.obolibrary.org/obo/PR_P0DTC1-1|http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050282,,,,,,,,,,,,,,,PR:000050282,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,ORF1a proteolytic cleavage product (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019058,viral life cycle,"viral assembly, maturation, egress, and release|viral infectious cycle|lytic viral life cycle|viral replication","A set of processes which all viruses follow to ensure survival; includes attachment and entry of the virus particle, decoding of genome information, translation of viral mRNA by host ribosomes, genome replication, and assembly and release of viral particles containing the genome.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"A set of processes which all viruses follow to ensure survival; includes attachment and entry of the virus particle, decoding of genome information, translation of viral mRNA by host ribosomes, genome replication, and assembly and release of viral particles containing the genome.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019067,,,,,,,"viral assembly, maturation, egress, and release",,biological_process,,viral infectious cycle|lytic viral life cycle|viral replication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019058,,,,,,,true,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226/|https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0019058,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral life cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045334,clathrin-coated endocytic vesicle,,"A clathrin-coated, membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance.",false,,,http://purl.obolibrary.org/obo/GO_0030136|http://purl.obolibrary.org/obo/GO_0030139,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1243595998,"A clathrin-coated, membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030136|http://purl.obolibrary.org/obo/GO_0030139,,,,GO:0045334,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045334,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,clathrin-coated endocytic vesicle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019318,hexose metabolic process,hexose metabolism,"The chemical reactions and pathways involving a hexose, any monosaccharide with a chain of six carbon atoms in the molecule.",false,,,http://purl.obolibrary.org/obo/GO_0005996,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a hexose, any monosaccharide with a chain of six carbon atoms in the molecule.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hexose metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005996,,,,GO:0019318,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019318,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,hexose metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048569,post-embryonic animal organ development,post-embryonic animal organogenesis,"Development, taking place during the post-embryonic phase of an animal tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"Development, taking place during the post-embryonic phase of an animal tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,post-embryonic animal organogenesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0048569,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048569,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,post-embryonic animal organ development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0061384,heart trabecula morphogenesis,,"The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,dph,2010-12-02T08:54:20Z,,,,"The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0061384,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0061384,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,heart trabecula morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_78543,ponatinib,"3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide|AP 24534|ponatinibum|ponatinib|AP24534","A benzamide obtained by the formal condensation of the carboxy group of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzoic acid with the anilino group of 4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)aniline.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Wikipedia:Ponatinib|KEGG:D09950|PMID:24481648|PMID:24408322|PMID:24602068|Reaxys:12923700|PMID:24552773|PMID:24729118|PMID:24596204|PMID:24550512|PMID:24402926|PMID:24766374|LINCS:LSM-1151|PMID:24768818|PMID:24807266|PMID:24934866|CAS:943319-70-8|PMID:24695735|PMID:24407160|PMID:24756787|Drug_Central:4716|PMID:24297701|PMID:24472312|Patent:US2014038920|PMID:24586514,"A benzamide obtained by the formal condensation of the carboxy group of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzoic acid with the anilino group of 4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)aniline.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide",,,,,chebi_ontology,,AP 24534|ponatinibum|ponatinib|AP24534,,,,,,,,,0,C29H27F3N6O,"InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)",PHXJVRSECIGDHY-UHFFFAOYSA-N,532.55950,532.21984,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:78543,,,,,,true,,,,,,,,,CHEBI:78543,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ponatinib,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000529,tachycardia,,Tachycardia is a cardiovascular system symptom consisting of a relatively rapid heart action whether physiological (as after exercise) or pathological.,false,,,http://purl.obolibrary.org/obo/SYMP_0000287,,,,,,,,,,,,,,,,,,,,UMLS_ICD9CM_2005_AUI:A0804597|UMLS_CUI:C0039231|SyOID:16496|ICD9CM_2005:785.0,Tachycardia is a cardiovascular system symptom consisting of a relatively rapid heart action whether physiological (as after exercise) or pathological.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000287,,,,SYMP:0000529,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,SYMP:0000529,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,tachycardia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009161,ribonucleoside monophosphate metabolic process,ribonucleoside monophosphate metabolism,"The chemical reactions and pathways involving a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009123,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribonucleoside monophosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009123,,,,GO:0009161,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009161,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribonucleoside monophosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002783,Recurrent lower respiratory tract infections,Recurrent chest infections|Lower respiratory tract infections|Chronic lung infections,An increased susceptibility to lower respiratory tract infections as manifested by a history of recurrent lower respiratory tract infections.,false,,,http://purl.obolibrary.org/obo/HP_0002205,,,,,,,,,,,,,,,,,,,,UMLS:C0149725|UMLS:C0585953|SNOMEDCT_US:50417007|UMLS:C3163798|SNOMEDCT_US:448739000,An increased susceptibility to lower respiratory tract infections as manifested by a history of recurrent lower respiratory tract infections.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0004884|HP:0005955,,,,Recurrent chest infections|Lower respiratory tract infections|Chronic lung infections,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002205,,,,HP:0002783,,,,,,,,,,,,,,,HP:0002783,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Recurrent lower respiratory tract infections,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000015,fulminant myocarditis,,,false,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1287,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215613,"Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe diffuse cardiac inflammation often leading to death resulting from cardiogenic shock, ventricular arrhythmias, or multiorgan system failure.",,,,,,,,,,,,,,,,fulminant myocarditis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_333387,Bat SARS coronavirus HKU3-1,SARS-CoV HKU3-1,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS-CoV HKU3-1,,,,,,NCBITaxon:333387,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007409,axonogenesis,neuron long process generation|axon morphogenesis|axon growth,"De novo generation of a long process of a neuron, including the terminal branched region. Refers to the morphogenesis or creation of shape or form of the developing axon, which carries efferent (outgoing) action potentials from the cell body towards target cells.|Note that 'axonogenesis' differs from 'axon development' in that the latter also covers other processes, such as axon regeneration (regrowth after loss or damage, not necessarily of the whole axon).",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"De novo generation of a long process of a neuron, including the terminal branched region. Refers to the morphogenesis or creation of shape or form of the developing axon, which carries efferent (outgoing) action potentials from the cell body towards target cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007410,,,,neuron long process generation|axon morphogenesis,,,axon growth,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that 'axonogenesis' differs from 'axon development' in that the latter also covers other processes, such as axon regeneration (regrowth after loss or damage, not necessarily of the whole axon).",,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007409,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007409,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,axonogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000182,history,,,false,,,http://purl.obolibrary.org/obo/BFO_0000015,,,,,History,history,,,,,,,,,,,,,,,,,,,,,,,,,,"A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001])",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BFO:0000182,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000015,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,history,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000032,homeostasis,,,false,,,http://purl.obolibrary.org/obo/BFO_0000016,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T11:22:01Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000032,The body's maintenance of a consistent internal environment within a narrow range of variation. It is important to the continuation of life.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000016,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,homeostasis,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/MAXO_0000607,D-dimer measurement,D dimer level test,A quantification of a fibrinogen degradation product in blood used in the diagnosis of thrombosis.,false,,,http://purl.obolibrary.org/obo/CMO_0000023,,,,,,,,,,,,,,,,http://orcid.org/0000-0001-7941-2961,,,,NCIT:C82621|EFO:0004507,A quantification of a fibrinogen degradation product in blood used in the diagnosis of thrombosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,D dimer level test,,,,,,,,,,,,,MAXO:0000607,,,,,,,,,,,,,,,,,,2020-04-07T21:37:45Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000023,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/maxo.owl,,,,,,,,,,,D-dimer measurement,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0033157,regulation of intracellular protein transport,,"Any process that modulates the frequency, rate or extent of the directed movement of proteins within cells.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the directed movement of proteins within cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0033157,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0033157,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of intracellular protein transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000058191,CXCL16,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SR-PSOX|CXCLG16|SRPSOX,,,,,,,17,,,,,,,,,,MIM:605398|HPRD:16103|HGNC:16642|Ensembl:ENSG00000161921|Vega:OTTHUMG00000090761,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 16,,17p13,,,,"GO_0005041 (EC: ISS); GO_0005044 (EC: TAS, PMID: 11060282); GO_0005102 (EC: NAS, PMID: 11017100); GO_0005576 (EC: NAS, PMID: 11017100); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 18373975); GO_0005886 (EC: IEA); GO_0006898 (EC: NAS, PMID: 11060282); GO_0006935 (EC: NAS, PMID: 11290797); GO_0008009 (EC: IDA, PMID: 18373975); GO_0008009 (EC: ISS); GO_0016020 (EC: TAS, PMID: 11060282); GO_0016021 (EC: NAS, PMID: 11017100); GO_0030307 (EC: IMP, PMID: 18373975); GO_0030335 (EC: IMP, PMID: 18373975); GO_0034097 (EC: IDA, PMID: 18373975); GO_0034341 (EC: IDA, PMID: 18373975); GO_0034612 (EC: IDA, PMID: 18373975); GO_0048247 (EC: NAS, PMID: 11017100)",PMID: 11017100; 11060282; 11290797; 12477932; 12902461; 12975309; 14625285; 14634054; 14699018; 14702039; 14988089; 15128827; 15489334; 15555552; 15634930; 15836657; 15883016; 15934948; 16142401; 16200580; 16431903; 16849465; 17207965; 17300746; 17363916; 17703412; 17803654; 17855433; 18194461; 18195710; 18240029; 18248772; 18250446; 18279707; 18293410; 18339644; 18344492; 18373975; 18480749; 18514099; 18565283; 18577758; 18636150; 18760678; 19070478; 19258923; 19322201; 19415545; 19426159; 19435795; 19494317; 19528340; 19575365; 19578796; 19605674; 19674076; 19690611; 19729872; 19913121; 19919988; 19954776; 20334513; 20503287; 20621591; 20628086; 20646641; 20848509; 20960183; 21233446; 21303517; 21467783; 21468586; 21471570; 21492481; 21505717; 21527066; 21612780; 21638128; 21773780; 21832049; 21845497; 22055341; 22113484; 22278019; 22378888; 22454615; 22627199; 22863086; 23009930; 23229614; 23428418; 23628207; 23633118; 23743627; 24064021; 24284794,,,,,,,,,,,,,,,,,,OGG:3000058191,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 16,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCL16,,,20140408,58191,UNQ2759/PRO6714,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CXCL16,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0006958,"complement activation, classical pathway","complement cascade, classical pathway","Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes.",false,,,http://purl.obolibrary.org/obo/GO_0006956,,,,,,,,,,,,,,,,,,,,,"Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"complement cascade, classical pathway",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006956,,,,GO:0006958,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006958,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"complement activation, classical pathway",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000002806,GOT2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,KATIV|KAT4|mitAAT,,,,,,,16,,,,,,,,,,MIM:138150|Ensembl:ENSG00000125166|HPRD:00684|HGNC:4433|Vega:OTTHUMG00000133769,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"glutamic-oxaloacetic transaminase 2, mitochondrial",,16q21,,,,"GO_0004069 (EC: EXP); GO_0004069 (EC: IDA, PMID: 2182221); GO_0004069 (EC: ISS); GO_0005739 (EC: IDA); GO_0005739 (EC: ISS); GO_0005743 (EC: IEA); GO_0005759 (EC: TAS); GO_0005886 (EC: IDA, PMID: 9537447); GO_0005975 (EC: TAS); GO_0006006 (EC: TAS); GO_0006094 (EC: TAS); GO_0006103 (EC: ISS); GO_0006107 (EC: IEA); GO_0006531 (EC: ISS); GO_0006532 (EC: IEA); GO_0006533 (EC: IDA, PMID: 2567216); GO_0006536 (EC: ISS); GO_0008652 (EC: TAS); GO_0015908 (EC: IEP, PMID: 9537447); GO_0016212 (EC: IEA); GO_0019470 (EC: TAS); GO_0019550 (EC: IEA); GO_0019551 (EC: IEA); GO_0030170 (EC: IEA); GO_0034641 (EC: TAS); GO_0044281 (EC: TAS); GO_0044822 (EC: IDA); GO_0045471 (EC: IDA, PMID: 9537447); GO_0070062 (EC: IDA); GO_0080130 (EC: IEA)",PMID: 376500; 752471; 2182221; 2567216; 2731362; 2777255; 2899080; 3207426; 3997814; 4052435; 5450376; 6397370; 6930651; 7114792; 7225087; 7559589; 8125298; 8349677; 9537447; 12477932; 12601813; 14702039; 15489334; 16169070; 16212419; 17353931; 17442055; 17728674; 17877759; 18781797; 19305408; 19834535; 20360068; 20877624; 21081666; 21139048; 21223598; 21319273; 21890473; 21900206; 21906983; 21963094; 22713574; 23000965,,,,,,,,,,,,,,,,,,OGG:3000002806,,,,,,,,,,,,,,,,,,,"glutamic-oxaloacetic transaminase 2, mitochondrial",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GOT2,,,20140408,2806,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://doi.org/10.1101/2020.02.06.20020974/,,,,GOT2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_239758,SARS coronavirus Taiwan TC3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:239758,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Taiwan TC3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000623,natural killer cell,null cell|large granular lymphocyte|NK cell,A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.,false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,,,,,,,,,,FMA:83601|CALOHA:TS-0664|FMA:63147|VHOG:0001697|BTO:0000914|BTO:0004716,A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,null cell|large granular lymphocyte,,,NK cell,,,,,cell,,,,,,,,CL:0000623,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,natural killer cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_934,viral infectious disease,Viral disease|Viral Infection|virus infection,"A disease by infectious agent that results in infection, has_material_basis_in Viruses.",false,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:40610006|UMLS_CUI:C0042769|SNOMEDCT_US_2019_09_01:34014006|ICD10CM:B34.9|NCI:C34396|NCI:C3439|ICD9CM:060-066.99|MESH:D001102|MESH:D014777|UMLS_CUI:C0003723|ICD10CM:A94,"A disease by infectious agent that results in infection, has_material_basis_in Viruses.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:1329,,,,Viral disease|Viral Infection|virus infection,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,DOID:934,,,,,,,,,,,,,,,DOID:934,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,viral infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042542,response to hydrogen peroxide,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.",false,,,http://purl.obolibrary.org/obo/GO_0000302,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000302,,,,GO:0042542,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042542,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to hydrogen peroxide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046635,positive regulation of alpha-beta T cell activation,positive regulation of alpha-beta T-lymphocyte activation|positive regulation of alpha-beta T lymphocyte activation|upregulation of alpha-beta T cell activation|up regulation of alpha-beta T cell activation|positive regulation of alpha-beta T-cell activation|up-regulation of alpha-beta T cell activation|stimulation of alpha-beta T cell activation|activation of alpha-beta T cell activation,"Any process that activates or increases the frequency, rate or extent of alpha-beta T cell activation.",false,,,http://purl.obolibrary.org/obo/GO_0045785|http://purl.obolibrary.org/obo/GO_0046634|http://purl.obolibrary.org/obo/GO_0051251|http://purl.obolibrary.org/obo/GO_0051249,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of alpha-beta T cell activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,positive regulation of alpha-beta T-lymphocyte activation|positive regulation of alpha-beta T lymphocyte activation|upregulation of alpha-beta T cell activation|up regulation of alpha-beta T cell activation|positive regulation of alpha-beta T-cell activation|up-regulation of alpha-beta T cell activation,,,stimulation of alpha-beta T cell activation|activation of alpha-beta T cell activation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0045785|http://purl.obolibrary.org/obo/GO_0046634|http://purl.obolibrary.org/obo/GO_0051251|http://purl.obolibrary.org/obo/GO_0051249,,,,GO:0046635,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046635,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of alpha-beta T cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C98054,Silmitasertib,"CX 4945|5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic Acid|CX-4945|SILMITASERTIB|CX4945|Silmitasertib",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,1009820-21-6,,C19H12ClN3O2,,C98054,,,FDA,,,,,,,,,,,,,,,,,,,,,,,,C6RWP0N0L2,,,,,,,,,,,,,,"CX 4945|5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic Acid|CX-4945|SILMITASERTIB|CX4945|Silmitasertib",,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C85460,,,NCIT:C98054,"Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Silmitasertib,,,,,,,CL430602,,,,,,,,,,,,Silmitasertib,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,Pharmacologic Substance,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003037,HAS2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,8,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,hyaluronan synthase 2,,8q24.12,,,,"GO_0001570 (EC: ISS); GO_0001822 (EC: ISS); GO_0005887 (EC: IDA); GO_0008284 (EC: IMP); GO_0030213 (EC: IDA, PMID: 17324121); GO_0030213 (EC: IEA); GO_0030213 (EC: IMP); GO_0030213 (EC: ISS); GO_0030335 (EC: IMP); GO_0035810 (EC: ISS); GO_0036120 (EC: IDA, PMID: 17324121); GO_0036302 (EC: ISS); GO_0045226 (EC: ISS); GO_0050501 (EC: IMP); GO_0050501 (EC: ISS); GO_0060349 (EC: IEA); GO_0070295 (EC: ISS); GO_0071347 (EC: IEP); GO_0071356 (EC: IEP); GO_0071498 (EC: IEP); GO_0085029 (EC: ISS); GO_0090500 (EC: ISS); GO_1900625 (EC: IMP)",PMID: 8798477; 9169154; 10093717; 11790779; 12477932; 14636845; 14752026; 14988410; 15489334; 15642402; 15677552; 15722343; 15843373; 15922739; 16564133; 16603733; 16687630; 16786194; 16807238; 17307735; 17315194; 17324121; 17611197; 17872502; 18587729; 19231585; 19416972; 19435493; 19577615; 20072653; 20379614; 20507985; 20522558; 20875124; 20960509; 21228273; 21357421; 21546767; 21551265; 21743962; 21795679; 22016393; 22113945; 22162480; 22298898; 22404213; 22473523; 22529214; 22695958; 22742591; 22887999; 22960332; 23251661; 23303191; 23397370; 23452080; 23560496; 23806178; 23979132; 24314882; 24333416,,,,,,,,,,,,,,,,,,OGG:3000003037,,,,,,,,,,,,,,,,,,,hyaluronan synthase 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32205856,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HAS2,,,20140408,3037,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,HAS2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/UBERON_0004119,endoderm-derived structure,,An anatomical structure that develops (entirely or partially) from the endoderm.,false,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,,,,,,,,,,,,,,,,Grouping term for query purposes,,An anatomical structure that develops (entirely or partially) from the endoderm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,UBERON:0004119,,,,,,,,,,,,,,,UBERON:0004119,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,endoderm-derived structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0022612,gland morphogenesis,,The process in which the anatomical structures of a gland are generated and organized.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,The process in which the anatomical structures of a gland are generated and organized.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0022612,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0022612,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,gland morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/TRANS_0000000,transmission process,,"A process that is the means during which the pathogen is transmitted directly or indirectly from its natural reservoir, a susceptible host or source to a new host.",false,,,http://purl.obolibrary.org/obo/GO_0008150,,,,,,,,,,,,,,,,,,,,,"A process that is the means during which the pathogen is transmitted directly or indirectly from its natural reservoir, a susceptible host or source to a new host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,transmission_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0008150,,,,TRANS:0000000,,,,,,true,,,,,,,transmission route,,TRANS:0000000,,http://purl.obolibrary.org/obo/trans.owl,,,,,,,,,,,transmission process,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039654,fusion of virus membrane with host endosome membrane,fusion of virus membrane with host endosomal membrane|viral penetration via endocytosis followed by caveolae-mediated membrane fusion with the endosome membrane|viral entry into host cell via caveolae-mediated endocytosis followed by membrane fusion with the endosome membrane|viral penetration via endocytosis followed by clathrin-mediated membrane fusion with the endosome membrane|viral entry into host cell via clathrin-mediated endocytosis followed by membrane fusion with the endosome membrane|viral entry into host cell via caveolin-mediated endocytosis followed by membrane fusion with the endosome membrane|viral entry into host cell via endocytosis followed by membrane fusion with the endosome membrane|viral entry into host cell via endocytosis followed by membrane fusion with host endosome,"Fusion of a virus membrane with a host endosome membrane. Occurs after internalization of the virus through the endosomal pathway, and results in release of the virus contents into the cell.",false,,,http://purl.obolibrary.org/obo/GO_0039663,,,,,,,,,,,,,,,,rfoulger,2013-06-20T14:24:05Z,,,VZ:992,"Fusion of a virus membrane with a host endosome membrane. Occurs after internalization of the virus through the endosomal pathway, and results in release of the virus contents into the cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0075501|GO:0075517,,,,fusion of virus membrane with host endosomal membrane,,,viral penetration via endocytosis followed by caveolae-mediated membrane fusion with the endosome membrane|viral entry into host cell via caveolae-mediated endocytosis followed by membrane fusion with the endosome membrane|viral penetration via endocytosis followed by clathrin-mediated membrane fusion with the endosome membrane|viral entry into host cell via clathrin-mediated endocytosis followed by membrane fusion with the endosome membrane|viral entry into host cell via caveolin-mediated endocytosis followed by membrane fusion with the endosome membrane,,biological_process,,viral entry into host cell via endocytosis followed by membrane fusion with the endosome membrane|viral entry into host cell via endocytosis followed by membrane fusion with host endosome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039663,,,,GO:0039654,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32142651,,,,GO:0039654,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,fusion of virus membrane with host endosome membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016485,protein processing,protein maturation by peptide bond cleavage|protein maturation by peptide bond hydrolysis|protein maturation by proteolysis|peptidolysis during protein maturation,Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein.,false,,,http://purl.obolibrary.org/obo/GO_0051604,,,,,,,,,,,,,,,,,,,,,Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0051605,,,,protein maturation by peptide bond cleavage|protein maturation by peptide bond hydrolysis,,,,,biological_process,,protein maturation by proteolysis|peptidolysis during protein maturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051604,,,,GO:0016485,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016485,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,protein processing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003606,IL18,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL1F4|IL-18|IGIF|IL-1g,,,,,,,11,,,,,,,,,,HGNC:5986|HPRD:02976|Ensembl:ENSG00000150782|Vega:OTTHUMG00000167006|MIM:600953,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 18,,11q22.2-q22.3,,,,"GO_0000165 (EC: IMP); GO_0001525 (EC: IDA, PMID: 11466388); GO_0005125 (EC: TAS, PMID: 11598150); GO_0005576 (EC: TAS, PMID: 11598150); GO_0005615 (EC: IEA); GO_0005829 (EC: TAS); GO_0006954 (EC: IDA); GO_0006955 (EC: TAS, PMID: 8999896); GO_0007267 (EC: TAS, PMID: 9792649); GO_0010628 (EC: IEA); GO_0030101 (EC: IEA); GO_0030155 (EC: IDA, PMID: 11477102); GO_0030431 (EC: ISS, PMID: 11506998); GO_0031663 (EC: IDA); GO_0032725 (EC: IDA); GO_0032729 (EC: IDA, PMID: 19088061); GO_0032740 (EC: IDA, PMID: 16482511); GO_0032819 (EC: IDA, PMID: 19088061); GO_0034105 (EC: IC, PMID: 16482511); GO_0042033 (EC: TAS, PMID: 11598150); GO_0042088 (EC: IDA, PMID: 8766574); GO_0042092 (EC: TAS, PMID: 11905033); GO_0042094 (EC: TAS, PMID: 10653850); GO_0042095 (EC: TAS, PMID: 10227975); GO_0042104 (EC: IDA, PMID: 10000000); GO_0042231 (EC: TAS, PMID: 10227975); GO_0042253 (EC: TAS, PMID: 10653850); GO_0042346 (EC: IEA); GO_0050729 (EC: IC, PMID: 16482511); GO_0051142 (EC: IDA, PMID: 19088061); GO_0071407 (EC: IDA)",PMID: 7477296; 8666798; 8766574; 8999548; 8999896; 9108085; 9325300; 9334240; 9693051; 9792649; 10000000; 10227975; 10460493; 10639148; 10653850; 10681439; 11466388; 11477102; 11506998; 11598150; 11714750; 11714826; 11770036; 11781190; 11790772; 11798931; 11805151; 11855785; 11888846; 11894141; 11895335; 11905033; 11907126; 11920321; 11936774; 11958300; 11960649; 12096920; 12105209; 12149432; 12172382; 12207348; 12366781; 12377944; 12381835; 12387830; 12390326; 12401730; 12424620; 12438388; 12456593; 12472176; 12472673; 12477932; 12482935; 12517977; 12527894; 12571842; 12572878; 12594843; 12616343; 12654091; 12679613; 12738632; 12748489; 12759422; 12788305; 12794718; 12796418; 12819633; 12847274; 12857602; 12858406; 12874316; 12911784; 12938205; 12941729; 12947340; 14504095; 14556808; 14561165; 14581397; 14584052; 14605444; 14617033; 14630085; 14640907; 14660053; 14662834; 14679107; 14697936; 14709415; 14718574; 14725568; 14734463; 14738910; 14764217; 14960579; 14991611; 14998974; 15005726; 15104599; 15140035; 15212675; 15225625; 15230817; 15277983; 15302292; 15308504; 15326478; 15327523; 15358638; 15371332; 15463896; 15471361; 15489334; 15555533; 15581980; 15585330; 15643599; 15644127; 15645140; 15646011; 15663745; 15674367; 15710458; 15728489; 15731584; 15753257; 15760905; 15786533; 15789055; 15802534; 15806006; 15816833; 15826815; 15842270; 15860738; 15860756; 15863395; 15894108; 15896202; 15927856; 15932380; 15955098; 15963597; 16024007; 16043644; 16049975; 16051062; 16052331; 16053025; 16059673; 16061751; 16078996; 16084898; 16186395; 16215941; 16243298; 16260350; 16266857; 16273766; 16306550; 16306764; 16306765; 16315783; 16316892; 16325763; 16339124; 16358956; 16373926; 16405895; 16406079; 16406656; 16420594; 16424284; 16428475; 16433722; 16433859; 16443795; 16482511; 16492204; 16493047; 16514436; 16516851; 16556702; 16563174; 16571086; 16584830; 16621994; 16635219; 16647017; 16650813; 16671950; 16738942; 16759385; 16767839; 16772281; 16780720; 16806233; 16820919; 16827865; 16839849; 16842597; 16883062; 16903774; 16909454; 16943580; 16948912; 16971411; 16979683; 17001321; 17016692; 17027359; 17055358; 17072982; 17075246; 17077020; 17117487; 17142727; 17192354; 17222831; 17225121; 17225924; 17235324; 17237446; 17252172; 17262717; 17299019; 17301041; 17336309; 17343316; 17355643; 17361200; 17364073; 17373930; 17396252; 17399992; 17445542; 17461482; 17487222; 17517100; 17517876; 17530707; 17586702; 17597334; 17597823; 17605864; 17610422; 17611614; 17611643; 17611971; 17625598; 17626902; 17658666; 17666338; 17671745; 17674327; 17683383; 17687255; 17688413; 17691022; 17703412; 17708609; 17765248; 17767553; 17845300; 17851127; 17851835; 17854431; 17893261; 17907957; 17919265; 17922692; 17948066; 17951325; 17959666; 17962365; 17964972; 17965486; 17981284; 17984243; 17988833; 18024284; 18043444; 18050195; 18050226; 18064631; 18092318; 18093181; 18160214; 18160936; 18163476; 18165223; 18178861; 18200581; 18225542; 18225563; 18235016; 18237555; 18250135; 18279187; 18286551; 18287807; 18295214; 18295340; 18297714; 18307517; 18336908; 18359638; 18386818; 18391570; 18399311; 18433937; 18442334; 18464913; 18484687; 18504197; 18514203; 18514661; 18520705; 18523012; 18538088; 18555694; 18562922; 18566306; 18594952; 18599493; 18628791; 18632660; 18662786; 18678419; 18683145; 18684981; 18685607; 18706445; 18773860; 18777510; 18780764; 18781864; 18803662; 18818748; 18818761; 18819819; 18821674; 18835036; 18853133; 18922682; 18930181; 18937548; 18940019; 18949051; 18983635; 19016763; 19019335; 19031096; 19036565; 19064572; 19073159; 19074166; 19074885; 19077897; 19088061; 19091595; 19092166; 19097518; 19102398; 19110334; 19126646; 19131059; 19138654; 19152241; 19176284; 19178691; 19200605; 19208460; 19229765; 19230467; 19236760; 19247692; 19258923; 19263242; 19265133; 19265174; 19285156; 19288449; 19309308; 19339355; 19342689; 19347053; 19387647; 19390575; 19394601; 19403407; 19420105; 19443970; 19453784; 19455410; 19466545; 19469892; 19470251; 19473509; 19508433; 19509137; 19527514; 19538326; 19550095; 19553661; 19573080; 19581111; 19584085; 19593889; 19605669; 19622039; 19633236; 19637196; 19638090; 19638429; 19639049; 19642044; 19657406; 19669125; 19669363; 19684151; 19687159; 19692203; 19699611; 19712260; 19740312; 19745201; 19757044; 19758166; 19773279; 19789190; 19796548; 19811440; 19816189; 19817957; 19865096; 19879772; 19900154; 19907017; 19913121; 19954659; 19961286; 19961892; 20003764; 20017708; 20056178; 20060272; 20061784; 20083555; 20096599; 20097272; 20137369; 20140262; 20140691; 20150558; 20169140; 20186552; 20216908; 20227257; 20227263; 20233133; 20237496; 20304021; 20306652; 20306665; 20331838; 20331879; 20339966; 20340055; 20349123; 20350254; 20374388; 20399512; 20412718; 20414054; 20416077; 20418295; 20423837; 20424918; 20441695; 20452482; 20478055; 20482998; 20485444; 20490717; 20490891; 20522205; 20525402; 20530519; 20538124; 20545903; 20558561; 20565717; 20568250; 20586818; 20617584; 20627039; 20628086; 20673868; 20689079; 20725807; 20735470; 20797704; 20818961; 20824296; 20885390; 20960175; 20964873; 20971720; 21035858; 21061265; 21118329; 21120501; 21126942; 21139048; 21145535; 21149337; 21149398; 21224476; 21225442; 21239711; 21241672; 21249128; 21264805; 21273776; 21288140; 21321938; 21323571; 21323573; 21334074; 21336086; 21356600; 21382268; 21393015; 21394384; 21395662; 21398142; 21418456; 21418867; 21421008; 21437204; 21440322; 21448661; 21464751; 21470492; 21481392; 21484426; 21487696; 21510800; 21526496; 21532063; 21538928; 21571262; 21611751; 21636628; 21656327; 21661419; 21672342; 21681500; 21710494; 21723753; 21733366; 21742406; 21742843; 21802664; 21832842; 21836143; 21836147; 21840518; 21842238; 21864160; 21867627; 21876975; 21906983; 21922295; 21943853; 21963094; 21965503; 21969001; 21988832; 22008665; 22015107; 22058412; 22125454; 22135309; 22136483; 22141572; 22149501; 22226490; 22228436; 22289535; 22307326; 22325058; 22347372; 22364914; 22373801; 22386125; 22462419; 22468101; 22484385; 22489883; 22493490; 22515481; 22518072; 22531046; 22537138; 22537218; 22587568; 22595646; 22596175; 22613414; 22639237; 22664470; 22678894; 22686311; 22723447; 22749533; 22811364; 22825306; 22837141; 22840759; 22863216; 22883217; 22900713; 22913567; 22945280; 22980562; 22996386; 23000965; 23018032; 23023653; 23027874; 23028054; 23056251; 23073298; 23075512; 23085113; 23121308; 23132931; 23137633; 23153245; 23171362; 23178856; 23207179; 23214284; 23232703; 23238919; 23242610; 23257837; 23269628; 23276493; 23298491; 23302036; 23327592; 23403235; 23419721; 23433789; 23459183; 23499732; 23522322; 23526823; 23546966; 23557801; 23587914; 23603311; 23632060; 23656272; 23675517; 23702484; 23702978; 23707237; 23723976; 23741523; 23746337; 23793845; 23794112; 23883285; 23885403; 23888552; 23901078; 23904224; 23938462; 24331389,,,,,,,,,,,,,,,,,,OGG:3000003606,,,,,,,,,,,,,,,,,,,interleukin 18,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL18,,,20140409,3606,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL18,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_305401,SARS coronavirus A001,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305401,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus A001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_162145,Human metapneumovirus,HMPV,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_162387,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HMPV,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,,,,,,,NCBITaxon:162145,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_162387,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human metapneumovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000082,A2a3 haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A2a3 haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,A2a3 haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_68558,ticagrelor,"(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|ticagrelor|AZD-6140|Brilinta|(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|AZD 6140|AZD6140","A triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:274693-27-5|KEGG:D09017|Patent:WO2012085665|Drug_Central:4184|PMID:22991347|HMDB:HMDB0015702|Reaxys:15468079,"A triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol",,,,,chebi_ontology,,"ticagrelor|AZD-6140|Brilinta|(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|AZD 6140|AZD6140",,,,,,,,,0,C23H28F2N6O4S,"InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1",OEKWJQXRCDYSHL-FNOIDJSQSA-N,522.56800,522.18608,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:68558,,,,,true,true,,,,,,,,,CHEBI:68558,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ticagrelor,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_35498,diuretic,diuretics,An agent that promotes the excretion of urine through its effects on kidney function.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,An agent that promotes the excretion of urine through its effects on kidney function.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,diuretics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:35498,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32220710,,,,CHEBI:35498,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,diuretic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050272,non-structural protein 3 (SARS-CoV-2),"papain-like proteinase (SARS2)|main proteinase (SARS2)|PRO_0000449637|PLpro (SARS2)|UniProtKB:P0DTD1, 819-2763|rep/Clv:nsp3 (SARS2)|nsp3 (SARS2)|UniProtKB:P0DTC1, 819-2763|PRO_0000449621|PL2-PRO (SARS2)","A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the autocatalytic action of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 818-819 and 2763-2764.|Category=organism-modification. Note: 1945 aa protein. Unlike some other coronaviruses, SARS coronaviruses only encode a single papain-like proteinase, PLpro. [PMID:15564471]",false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725299,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the autocatalytic action of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 818-819 and 2763-2764.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"papain-like proteinase (SARS2)|main proteinase (SARS2)|PRO_0000449637|PLpro (SARS2)|UniProtKB:P0DTD1, 819-2763|rep/Clv:nsp3 (SARS2)|nsp3 (SARS2)|UniProtKB:P0DTC1, 819-2763|PRO_0000449621",,,,,protein,,PL2-PRO (SARS2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Category=organism-modification. Note: 1945 aa protein. Unlike some other coronaviruses, SARS coronaviruses only encode a single papain-like proteinase, PLpro. [PMID:15564471]",,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050272,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32083328,,,,PR:000050272,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 3 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000017,B1a haplotype,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B1a haplotype of SARS CoV2,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000061,,,,,,modified definition,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,,,,,,,,,,,,,,,,B1a haplotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031331,positive regulation of cellular catabolic process,up regulation of cellular catabolic process|positive regulation of cellular degradation|upregulation of cellular catabolic process|up-regulation of cellular catabolic process|positive regulation of cellular catabolism|positive regulation of cellular breakdown|stimulation of cellular catabolic process|activation of cellular catabolic process,"Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.",false,,,http://purl.obolibrary.org/obo/GO_0009896,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,up regulation of cellular catabolic process|positive regulation of cellular degradation|upregulation of cellular catabolic process|up-regulation of cellular catabolic process|positive regulation of cellular catabolism|positive regulation of cellular breakdown,,,stimulation of cellular catabolic process|activation of cellular catabolic process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009896,,,,GO:0031331,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031331,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cellular catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019079,viral genome replication,viral replication|sigma virus replication,"Any process involved directly in viral genome replication, including viral nucleotide metabolism.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"Any process involved directly in viral genome replication, including viral nucleotide metabolism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,viral replication,,,,,,sigma virus replication,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019079,,,,,,true,,,,true,,,,,GO:0019079,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral genome replication,,,,,,,,,,,,,,,,,,,,,,https://www.antibodies-online.com/resources/18/5410/sars-cov-2-life-cycle-stages-and-inhibition-targets/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009168,purine ribonucleoside monophosphate biosynthetic process,purine ribonucleoside monophosphate anabolism|purine ribonucleoside monophosphate formation|purine ribonucleoside monophosphate biosynthesis|purine ribonucleoside monophosphate synthesis,"The chemical reactions and pathways resulting in the formation of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009124|http://purl.obolibrary.org/obo/GO_0009167|http://purl.obolibrary.org/obo/GO_0009127|http://purl.obolibrary.org/obo/GO_0009161,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine ribonucleoside monophosphate anabolism|purine ribonucleoside monophosphate formation|purine ribonucleoside monophosphate biosynthesis|purine ribonucleoside monophosphate synthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009124|http://purl.obolibrary.org/obo/GO_0009167|http://purl.obolibrary.org/obo/GO_0009127|http://purl.obolibrary.org/obo/GO_0009161,,,,GO:0009168,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009168,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine ribonucleoside monophosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039501,suppression by virus of host type I interferon production,suppression by virus of host interferon type I production|suppression by virus of host type I IFN production|negative regulation by virus of host type I interferon production,"Any viral process that results in the inhibition of host cell type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.",false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2011-05-11T03:53:20Z,,,VZ:875,"Any viral process that results in the inhibition of host cell type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,suppression by virus of host interferon type I production|suppression by virus of host type I IFN production|negative regulation by virus of host type I interferon production,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039501,,,,,,true,,,,true,,,,,GO:0039501,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host type I interferon production,,,,,,,,,,,,,,,,,,,,,,https://jvi.asm.org/content/91/8/e02143-16,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000847,Abnormality of renin-angiotensin system,Abnormality of the renin-aldosterone axis,An abnormality of the renin-angiotensin system.|The renin-angiotensin system is a hormone system that regulates blood pressure and water (fluid) balance.,false,,,http://purl.obolibrary.org/obo/HP_0000818,,,,,,,,,,,,,,,,,,,,UMLS:C4021793,An abnormality of the renin-angiotensin system.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0003350,,,,Abnormality of the renin-aldosterone axis,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,The renin-angiotensin system is a hormone system that regulates blood pressure and water (fluid) balance.,,http://purl.obolibrary.org/obo/HP_0000818,,,,HP:0000847,,,,,,,,,,,,,,,HP:0000847,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of renin-angiotensin system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_742006,Bat SARS coronavirus HKU3-9,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:742006,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_227984,SARS coronavirus Tor2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:227984,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Tor2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C137824,Leronlimab,PRO140|LERONLIMAB|PRO 140|PRO-140|PA14|Leronlimab|WHO 10751,"A humanized immunoglobulin (Ig) G4 monoclonal antibody against CC chemokine receptor 5 (CCR5; CD195), with potential activity as a human immunodeficiency virus (HIV) entry blocker and potential protective activity against graft-versus-host disease (GvHD). Upon administration, leronlimab targets and binds to CCR5 expressed on T-cells. This blocks HIV cell entry, which prevents HIV infection and/or reduces HIV viral load. In addition, blocking CCR5 by PRO 140 decreases CCR5-mediated signaling and the CCR5-induced migration of donor cells into tissues after an allogeneic hematopoietic cell transplantation (HCT). Blocking CCR5 may therefore prevent or reduce GvHD. CCR5, a co-receptor needed for HIV cell entry, plays a key role in immunomodulation. Expressed on monocytes, activated T-cells and dendritic cells (DCs), CCR5 can regulate chemotaxis. Lymphocyte trafficking via chemokine receptors, such as CCR5, and recruitment to target organs, plays a critical role in alloreactive responses.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,674782-26-4,,,,C137824,,,FDA,,,,,,,"A humanized immunoglobulin (Ig) G4 monoclonal antibody against CC chemokine receptor 5 (CCR5; CD195), with potential activity as a human immunodeficiency virus (HIV) entry blocker and potential protective activity against graft-versus-host disease (GvHD). Upon administration, leronlimab targets and binds to CCR5 expressed on T-cells. This blocks HIV cell entry, which prevents HIV infection and/or reduces HIV viral load. In addition, blocking CCR5 by PRO 140 decreases CCR5-mediated signaling and the CCR5-induced migration of donor cells into tissues after an allogeneic hematopoietic cell transplantation (HCT). Blocking CCR5 may therefore prevent or reduce GvHD. CCR5, a co-receptor needed for HIV cell entry, plays a key role in immunomodulation. Expressed on monocytes, activated T-cells and dendritic cells (DCs), CCR5 can regulate chemotaxis. Lymphocyte trafficking via chemokine receptors, such as CCR5, and recruitment to target organs, plays a critical role in alloreactive responses.",,,,,,Leronlimab,,,,,,,,,,,Y1J4NP8FF0,,,,,,,,,,,,,,PRO140|LERONLIMAB|PRO 140|PRO-140|PA14|Leronlimab|WHO 10751,,,,,,,,,,,,,NCIT:C137824,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Leronlimab,,,,,,,,,,,,,,,,790146,790146,,Leronlimab,,,https://www.onclive.com/web-exclusives/leronlimab-covid19-trial-treats-first-patients,"Pharmacologic Substance|Amino Acid, Peptide, or Protein",,,,,,,,C3179326,
http://purl.obolibrary.org/obo/CHEBI_6888,6alpha-methylprednisolone,"11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Delta(1)-6alpha-methylhydrocortisone|Medrate|1-dehydro-6alpha-methylhydrocortisone|metilprednisolona|Methylprednisolon|Solomet|Urbason|methylprednisolone|(6alpha,11beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Medrone|methylprednisolonum|Medrol|6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione",The 6alpha-stereoisomer of  6-methylprednisolone.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:25232411|Reaxys:2340300|Wikipedia:Methylprednisolone|DrugBank:DB00959|HMDB:HMDB0015094|KEGG:D00407|Patent:US2897218|VSDB:1936|Drug_Central:1768|Beilstein:2340300|CAS:83-43-2|Patent:US3053832,The 6alpha-stereoisomer of  6-methylprednisolone.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione",,,,,chebi_ontology,,"Delta(1)-6alpha-methylhydrocortisone|Medrate|1-dehydro-6alpha-methylhydrocortisone|metilprednisolona|Methylprednisolon|Solomet|Urbason|methylprednisolone|(6alpha,11beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Medrone|methylprednisolonum|Medrol|6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione",,,,,,,,,0,C22H30O5,"InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1",VHRSUDSXCMQTMA-PJHHCJLFSA-N,374.47060,374.20932,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:6888,,,,,,,,,,,,,,,CHEBI:6888,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,6alpha-methylprednisolone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_3770,pulmonary fibrosis,Fibrosis of lung,"An interstitial lung disease that is characterized by destruction, scarring, and thickening of the interstitial lung tissues and progressive pulmonary function loss in a restrictive pattern, has_symptom progressive shortness of breath, fatigue, and chronic cough, possibly has_material_basis_in exposure to certain chemicals, autoimmune conditions, and radiation.",false,,,http://purl.obolibrary.org/obo/DOID_3082,,,,,,,,,,,,,,,,,,,,NCI:C26869|UMLS_CUI:C0034069|SNOMEDCT_US_2019_09_01:51615001|MESH:D011658,"An interstitial lung disease that is characterized by destruction, scarring, and thickening of the interstitial lung tissues and progressive pulmonary function loss in a restrictive pattern, has_symptom progressive shortness of breath, fatigue, and chronic cough, possibly has_material_basis_in exposure to certain chemicals, autoimmune conditions, and radiation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Fibrosis of lung,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_3082,,,,DOID:3770,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171193,,,,DOID:3770,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,pulmonary fibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034358,plasma lipoprotein particle,,"A spherical particle with a hydrophobic core of triglycerides and/or cholesterol esters, surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Plasma lipoprotein particles transport lipids, which are non-covalently associated with the particles, in the blood or lymph.",false,,,http://purl.obolibrary.org/obo/GO_1990777,,,,,,,,,,,,,,,,,,,,,"A spherical particle with a hydrophobic core of triglycerides and/or cholesterol esters, surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Plasma lipoprotein particles transport lipids, which are non-covalently associated with the particles, in the blood or lymph.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1990777,,,,GO:0034358,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034358,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,plasma lipoprotein particle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000570,diarrhea,diarrhoea|bacterial gastroenteritis|loose bowel|loose bowels|the runs|fecal incontinence|incontinence of feces,Diarrhea is a feces and droppng symptom involving the abnormally frequent intestinal evacuations with more or less fluid stools.|doid/symp duplicate,false,,,http://purl.obolibrary.org/obo/SYMP_0000146,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0011991|UMLS_ICD9CM_2005_AUI:A0048148|SyOID:3517|ICD9CM_2005:787.91,Diarrhea is a feces and droppng symptom involving the abnormally frequent intestinal evacuations with more or less fluid stools.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,diarrhoea|bacterial gastroenteritis|loose bowel|loose bowels|the runs|fecal incontinence|incontinence of feces,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,doid/symp duplicate,,http://purl.obolibrary.org/obo/SYMP_0000146,,,,SYMP:0000570,,,,,,true,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32278065,,diarrhoea,,SYMP:0000570,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,diarrhea,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C74082,Thioredoxin-1 Inhibitor PX-12,Thioredoxin-1 Inhibitor PX-12|1-Methylpropyl 2-Imidazolyl Disulfide|PX-12,"An orally bioavailable small molecule with potential antineoplastic activity. Thioredoxin-1 inhibitor PX-12 irreversibly binds to thioredoxin-1 (Trx-1) and inhibits its activity, which may result in growth inhibition and the induction of apoptosis. Overexpressed in many cancer cell types, the low molecular weight redox protein Trx-1 regulates transcription factor activity and inhibits apoptosis, promoting cell growth and survival; it also interacts with growth factors extracellularly to stimulate cell growth.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C74082,,,CTRP,,,,,,,"An orally bioavailable small molecule with potential antineoplastic activity. Thioredoxin-1 inhibitor PX-12 irreversibly binds to thioredoxin-1 (Trx-1) and inhibits its activity, which may result in growth inhibition and the induction of apoptosis. Overexpressed in many cancer cell types, the low molecular weight redox protein Trx-1 regulates transcription factor activity and inhibits apoptosis, promoting cell growth and survival; it also interacts with growth factors extracellularly to stimulate cell growth.",,,,,,Thioredoxin-1 Inhibitor PX-12,,,,,,,,,,,,,,,,,,,,,,,,,Thioredoxin-1 Inhibitor PX-12|1-Methylpropyl 2-Imidazolyl Disulfide|PX-12,,,,,,,,,,,,,NCIT:C74082,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784,,,,,,,,,,Thioredoxin-1 Inhibitor PX-12,Thioredoxin-1_Inhibitor_PX-12,,,,,,,,,,,,,,,590656,590656,,Thioredoxin-1 Inhibitor PX-12,,,,Pharmacologic Substance,,,,,,,,C0960559,
http://purl.obolibrary.org/obo/OGG_3000005155,PDGFB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IBGC5|PDGF-2|c-sis|PDGF2|SIS|SSV,,,,,,,22,,,,,,,,,,HPRD:01815|Ensembl:ENSG00000100311|HGNC:8800|MIM:190040|Vega:OTTHUMG00000151029,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,platelet-derived growth factor beta polypeptide,,22q13.1,,,,"GO_0000139 (EC: TAS); GO_0001666 (EC: IEA); GO_0001892 (EC: ISS); GO_0001938 (EC: IDA, PMID: 9685360); GO_0002548 (EC: IDA, PMID: 17991872); GO_0002576 (EC: TAS); GO_0003104 (EC: ISS); GO_0005161 (EC: IDA, PMID: 2836953); GO_0005161 (EC: IDA, Qualifier: contributes_to, PMID: 2439522); GO_0005161 (EC: IPI, PMID: 2536956); GO_0005161 (EC: NAS, PMID: 1661670); GO_0005515 (EC: IPI, PMID: 10806482); GO_0005518 (EC: IDA, PMID: 8900172); GO_0005576 (EC: NAS, PMID: 1661670); GO_0005576 (EC: TAS); GO_0005615 (EC: IBA); GO_0005737 (EC: ISS); GO_0005788 (EC: TAS); GO_0006260 (EC: IEA); GO_0006468 (EC: IDA, PMID: 17942966); GO_0006929 (EC: IEA); GO_0007173 (EC: TAS); GO_0007179 (EC: ISS); GO_0007507 (EC: ISS); GO_0007596 (EC: TAS); GO_0008083 (EC: IDA, PMID: 12070119); GO_0008284 (EC: IDA, PMID: 2836953); GO_0008543 (EC: TAS); GO_0009611 (EC: IDA, PMID: 2538439); GO_0009611 (EC: NAS, PMID: 1661670); GO_0009986 (EC: IDA, PMID: 2538439); GO_0010512 (EC: IDA, PMID: 2538439); GO_0010544 (EC: IDA, PMID: 2538439); GO_0014068 (EC: IDA, PMID: 10734101); GO_0014911 (EC: IDA, PMID: 12070119); GO_0016049 (EC: IEA); GO_0016176 (EC: IDA, PMID: 17942966); GO_0016323 (EC: ISS); GO_0018105 (EC: IDA, PMID: 16530387); GO_0018108 (EC: IDA, PMID: 10734101); GO_0030031 (EC: IEA); GO_0030036 (EC: IEA); GO_0030097 (EC: IMP, Qualifier: NOT, PMID: 11264163); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0030335 (EC: IDA, PMID: 11788434); GO_0030336 (EC: IEA); GO_0031093 (EC: TAS); GO_0031954 (EC: IDA, PMID: 12070119); GO_0032147 (EC: IDA, PMID: 16530387); GO_0032148 (EC: IDA, PMID: 16530387); GO_0032355 (EC: IEA); GO_0032868 (EC: IEA); GO_0035793 (EC: IDA, PMID: 19019919); GO_0038001 (EC: ISS); GO_0038095 (EC: TAS); GO_0042056 (EC: IDA); GO_0042493 (EC: IEA); GO_0042802 (EC: IPI, PMID: 1396586); GO_0042803 (EC: IDA, PMID: 2836953); GO_0043406 (EC: IDA, PMID: 11788434); GO_0043410 (EC: IMP, PMID: 11788434); GO_0043536 (EC: IDA, PMID: 9685360); GO_0043552 (EC: IDA, PMID: 16530387); GO_0045087 (EC: TAS); GO_0045737 (EC: IDA, PMID: 16530387); GO_0045740 (EC: IDA, PMID: 2439522); GO_0045743 (EC: IEA); GO_0045840 (EC: IDA, PMID: 10644978); GO_0045892 (EC: IDA, PMID: 16530387); GO_0045893 (EC: IDA, PMID: 16530387); GO_0046982 (EC: IPI, PMID: 7073684); GO_0048008 (EC: IDA); GO_0048011 (EC: TAS); GO_0048015 (EC: TAS); GO_0048146 (EC: IDA, PMID: 10644978); GO_0048407 (EC: IPI, PMID: 7073684); GO_0048514 (EC: IEA); GO_0048661 (EC: IDA, PMID: 12070119); GO_0050731 (EC: IDA); GO_0050918 (EC: IDA); GO_0050921 (EC: IDA, PMID: 19019919); GO_0051781 (EC: IEA); GO_0060326 (EC: IDA, PMID: 16014047); GO_0060445 (EC: IEA); GO_0060664 (EC: IEA); GO_0061098 (EC: IDA, PMID: 16530387); GO_0070374 (EC: IDA, PMID: 11788434); GO_0071363 (EC: IDA); GO_0071506 (EC: ISS); GO_0072126 (EC: IDA, PMID: 11788434); GO_0072255 (EC: ISS); GO_0072262 (EC: IEA); GO_0072264 (EC: IEA); GO_0072593 (EC: IMP, PMID: 17942966); GO_0090280 (EC: IDA, PMID: 19019919); GO_1900127 (EC: IDA, PMID: 17324121); GO_2000379 (EC: IDA, PMID: 19019919); GO_2000573 (EC: IDA, PMID: 10644978); GO_2000591 (EC: IDA, PMID: 10734101)",PMID: 287022; 291037; 1311092; 1317862; 1396586; 1661670; 1906887; 2212004; 2439522; 2536956; 2538439; 2544881; 2836953; 2845420; 2991848; 3023958; 3275870; 3456904; 3472769; 3517869; 3969118; 4033772; 6091919; 6297002; 6306471; 6318322; 6327048; 6329745; 6336312; 6740330; 6844921; 7073684; 7659502; 7829517; 7896901; 8174076; 8647855; 8697155; 8780057; 8889548; 8900172; 8988177; 9057949; 9334164; 9409235; 9685360; 9692901; 9739761; 10409733; 10446987; 10485711; 10591208; 10644978; 10681572; 10734101; 10806482; 11264163; 11331882; 11498506; 11788434; 11811779; 11854294; 11903042; 11994382; 12023768; 12034531; 12070119; 12127408; 12176024; 12411321; 12477932; 12576295; 12615918; 12660034; 12850807; 12850832; 12960151; 14595114; 14643521; 14702039; 14705808; 14760763; 14997209; 15081117; 15461802; 15489334; 15496150; 15522237; 15695519; 15826941; 15897913; 15915457; 15919668; 15956925; 16007151; 16014047; 16081426; 16149045; 16227675; 16477226; 16530387; 16596190; 16641085; 16709185; 16777970; 16843106; 16847823; 16893901; 17074267; 17157157; 17227125; 17229887; 17292826; 17324121; 17338425; 17341683; 17395886; 17431412; 17518657; 17545544; 17608589; 17626901; 17671690; 17724602; 17942966; 17944929; 17950782; 17958740; 17981115; 17991872; 17998143; 18069662; 18075302; 18239136; 18300076; 18310286; 18325189; 18326546; 18420995; 18456732; 18471357; 18478301; 18570917; 18573259; 18700164; 18758297; 18772331; 18819098; 18973553; 19019919; 19060904; 19091791; 19219070; 19447872; 19451595; 19498003; 19576918; 19584075; 19628565; 19635106; 19696027; 19728062; 19890351; 19913121; 19956642; 20019669; 20036421; 20042679; 20061935; 20083221; 20224347; 20233927; 20406730; 20452482; 20485444; 20624165; 20628086; 20628624; 20673868; 20681813; 20694560; 20717068; 20739660; 20822908; 20950212; 21102276; 21111450; 21118571; 21124835; 21129745; 21171016; 21175804; 21211989; 21321954; 21368226; 21429937; 21483469; 21618276; 21750433; 21754979; 21764712; 21766497; 21769672; 21819559; 21919032; 21921666; 21956466; 22021110; 22038837; 22104124; 22133064; 22174424; 22200892; 22279551; 22619279; 22688015; 22689130; 22711911; 22805337; 22908324; 22922228; 23042547; 23199263; 23207290; 23302418; 23537647; 23633549; 23906294; 23913003; 23934686; 24331325,,,,,,,,,,,,,,,,,,OGG:3000005155,,,,,,,,,,,,,,,,,,,platelet-derived growth factor beta polypeptide,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.st-va.ncbi.nlm.nih.gov/pubmed/32113704,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PDGFB,,,20140408,5155,LL22NC03-10C3.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,PDGFB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGMS_0000060,bodily process,,A process in which at least one bodily component of an organsim participates.|From OGMS: http://purl.obolibrary.org/obo/OGMS_0000060,false,,,http://purl.obolibrary.org/obo/BFO_0000015,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T11:53:49Z,,A process in which at least one bodily component of an organsim participates.,,http://www.jbiomedsem.com/content/1/1/10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000060,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,From OGMS: http://purl.obolibrary.org/obo/OGMS_0000060,,http://purl.obolibrary.org/obo/BFO_0000015,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/mfomd.owl|http://purl.obolibrary.org/obo/ogms.owl|http://purl.obolibrary.org/obo/oae.owl,,,,,,,,,,,bodily process,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/CHEBI_45081,pentamidine,"Pentamidine|4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide|4,4'-(1,5-pentanediylbis(oxy))bis-benzenecarboximidamide|pentamidine|1,5-bis(4-amidinophenoxy)pentane|p,p'-(pentamethylenedioxy)dibenzamidine|4,4'-(pentamethylenedioxy)dibenzamidine|pentamidin|4,4'-Diamidinodiphenoxypentane","A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A  trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:27297108|Patent:US7115665|PMID:15711592|PMID:18971316|Reaxys:3159790|PMID:14603035|Wikipedia:Pentamidine|PMID:26938448|LINCS:LSM-4540|PDBeChem:PNT|Patent:US2008167296|PMID:26117647|PMID:18346045|PMID:26606757|PMID:10917591|PMID:26052915|Patent:US2008214569|PMID:11438428|PMID:26418240|PMID:26824946|HMDB:HMDB0014876|Patent:GB507565|PMID:26903605|Patent:US2394003|PMID:11584934|PMID:27357655|PMID:7690919|Beilstein:3159790|PMID:27011917|PMID:22327112|PMID:20144237|PMID:28167598|Patent:EP975608|PMID:10415905|PMID:22200378|DrugBank:DB00738|Drug_Central:2090|PMID:27600039|PMID:26648589|PMID:26882015|PMID:27214074|PMID:22093811|PMID:26734860|PMID:27353022|PMID:19966562|KEGG:D08333|PMID:28074607|PMID:28263303|PMID:27729250|PMID:20599360|CAS:100-33-4|Patent:US2006235001|PMID:26295040|PMID:26515653|PMID:22046004|PMID:27164533|PMID:26828608|PMID:7542607|KEGG:C07420|PMID:27135970|PMID:26344166|PMID:26431253|PMID:8841838,"A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A  trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:7976|CHEBI:45077,,,,"Pentamidine|4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide",,,,,chebi_ontology,,"4,4'-(1,5-pentanediylbis(oxy))bis-benzenecarboximidamide|pentamidine|1,5-bis(4-amidinophenoxy)pentane|p,p'-(pentamethylenedioxy)dibenzamidine|4,4'-(pentamethylenedioxy)dibenzamidine|pentamidin|4,4'-Diamidinodiphenoxypentane",,,,,,,,,0,C19H24N4O2,"InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)",XDRYMKDFEDOLFX-UHFFFAOYSA-N,340.420,340.18993,C(CCCOC1=CC=C(C=C1)C(N)=N)COC2=CC=C(C=C2)C(N)=N,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:45081,,,,,true,true,,,,,,,,,CHEBI:45081,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,pentamidine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075519,microtubule-dependent intracellular transport of viral material,,The directed movement of the viral genome or viral particle within the host cell cytoplasm along host microtubules. Microtubule-dependent transport involves motor proteins like dynein and kinesin and is mostly used by viruses that target their genomes to the nucleus.,false,,,http://purl.obolibrary.org/obo/GO_0075733,,,,,,,,,,,,,,,,janelomax,2011-08-03T01:45:25Z,,,,The directed movement of the viral genome or viral particle within the host cell cytoplasm along host microtubules. Microtubule-dependent transport involves motor proteins like dynein and kinesin and is mostly used by viruses that target their genomes to the nucleus.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0075733,,,,GO:0075519,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/25375324,,,,GO:0075519,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,microtubule-dependent intracellular transport of viral material,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000135,openEHR-Suspected Covid-19 assessment.v0,,,false,,,http://purl.obolibrary.org/obo/ERO_0000722,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000722,,,,,Modified definition,,,Medical device,,true,,,,,,"openEHR-Suspected Covid-19 assessment.v0 is to record the information required to evaluate the potential risk of Covid-19 infection, as part of professional screening or self-assessment.",,,,,,,,,,,,,,,,openEHR-Suspected Covid-19 assessment.v0,,,,,,,,,,,,,,,,,,,,,,https://openehr.org/ckm/templates/1013.26.267,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C133344,Recovered Plasma,Recovered Plasma,"Plasma derived from single units of whole blood, plasma, or as a by-product in the preparation of blood components from whole blood, for use in the manufacturing of licensed or unlicensed products.",false,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,C133344,,,FDA,,,,,,,"Plasma derived from single units of whole blood, plasma, or as a by-product in the preparation of blood components from whole blood, for use in the manufacturing of licensed or unlicensed products.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Recovered Plasma,,,,,,,,,,,,,NCIT:C133344,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OBI_0100051,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32253318,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C133243|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C54452|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C133239,,,,,,,,,,Recovered Plasma,,,,,,,CL520220,,,,,,,,,,,,Recovered Plasma,,,,Pharmacologic Substance,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0004121,ectoderm-derived structure,ectodermal deriviative,An anatomical structure that develops (entirely or partially) from the ectoderm.,false,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,,,,,,,,,,,,,,,,Grouping term for query purposes,FBbt:00025990,An anatomical structure that develops (entirely or partially) from the ectoderm.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ectodermal deriviative,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,UBERON:0004121,,,,,,,,,,,,,,,UBERON:0004121,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,ectoderm-derived structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_15552,prostaglandin I2,"(5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid|Prostaglandin I2|(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|prostaglandin X|Flolan|(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|PGX|Vasocyclin|Epoprostenol|PGI2|Prostacyclin",,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,KEGG:C01312|DrugBank:DB01240|Beilstein:1690090|KEGG:D00106|CAS:35121-78-9|Drug_Central:1034|LIPID_MAPS_instance:LMFA03010087,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:245|CHEBI:10912|CHEBI:26331,,,,"(5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid|Prostaglandin I2",,,,,chebi_ontology,,"(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|prostaglandin X|Flolan|(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|PGX|Vasocyclin|Epoprostenol|PGI2|Prostacyclin",,,,,,,,,0,C20H32O5,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1",KAQKFAOMNZTLHT-OZUDYXHBSA-N,352.46508,352.22497,[H][C@]12C[C@@H](O)[C@H](C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:15552,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:15552,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,prostaglandin I2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010463,mesenchymal cell proliferation,,"The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0010463,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010463,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,mesenchymal cell proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_72289,elvitegravir,"6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|GS 9137|elvitegravir|GS-9137|elvitegravirum","A quinolinemonocarboxylic acid that is 7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid substited at position 1 by a 1-hydroxy-3-methylbutan-2-yl group and at position 6 by a 3-chloro-2-fluorobenzyl group (the S-enantiomer). It is used in combination therapy for the treatment of HIV-1 infection.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22015077|PMID:23123342|PMID:23114768|KEGG:D06677|PMID:20040702|PMID:21044030|Patent:WO2010137032|Drug_Central:4300|PMID:21505303|PMID:23253887|PMID:22197635|PMID:22256860|PMID:22571404|PMID:22886031|LINCS:LSM-5647|PMID:23372110|PMID:23337366|Patent:WO2011004389|Patent:WO2009089263|PMID:22766666|PMID:23341902|PMID:23136357|Wikipedia:Elvitegravir|PMID:23028968|PMID:23231029|PMID:22992351|Reaxys:10609264|PMID:22321026|CAS:697761-98-1|PMID:22347806|PMID:22789987,"A quinolinemonocarboxylic acid that is 7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid substited at position 1 by a 1-hydroxy-3-methylbutan-2-yl group and at position 6 by a 3-chloro-2-fluorobenzyl group (the S-enantiomer). It is used in combination therapy for the treatment of HIV-1 infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",,,,,chebi_ontology,,GS 9137|elvitegravir|GS-9137|elvitegravirum,,,,,,,,,0,C23H23ClFNO5,"InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1",JUZYLCPPVHEVSV-LJQANCHMSA-N,447.88400,447.12488,COc1cc2n(cc(C(O)=O)c(=O)c2cc1Cc1cccc(Cl)c1F)[C@H](CO)C(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:72289,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:72289,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,elvitegravir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0032956,regulation of actin cytoskeleton organization,regulation of actin cytoskeleton organisation|regulation of actin cytoskeleton organization and biogenesis,"Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.",false,,,http://purl.obolibrary.org/obo/GO_0032970,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of actin cytoskeleton organisation,,,,,biological_process,,regulation of actin cytoskeleton organization and biogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0032970,,,,GO:0032956,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032956,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of actin cytoskeleton organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1699361,Bat SARS-like coronavirus YNLF_34C,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1699361,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS-like coronavirus YNLF_34C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0001911,Abnormal granulocyte morphology,Abnormality of granulocytes,Any structural abnormality or abnormal count of granulocytes.,false,,,http://purl.obolibrary.org/obo/HP_0010974,,,,,,,,,,,,,,,,,,,,UMLS:C0427515|SNOMEDCT_US:250274006,Any structural abnormality or abnormal count of granulocytes.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0005438,,,,Abnormality of granulocytes,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010974,,,,HP:0001911,,,,,,,,,,,,,,,HP:0001911,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal granulocyte morphology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_2000257,regulation of protein activation cascade,regulation of protein activation pathway|regulation of protein activitory cascade,"Any process that modulates the frequency, rate or extent of protein activation cascade.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,midori,2010-11-23T11:33:46Z,,,,"Any process that modulates the frequency, rate or extent of protein activation cascade.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of protein activation pathway|regulation of protein activitory cascade,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:2000257,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:2000257,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of protein activation cascade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0002048,lung,pulmo,"Respiration organ that develops as an oupocketing of the esophagus.|Snakes and limbless lizards typically possess only the right lung as a major respiratory organ; the left lung is greatly reduced, or even absent. Amphisbaenians, however, have the opposite arrangement, with a major left lung, and a reduced or absent right lung [WP]",false,,,http://purl.obolibrary.org/obo/UBERON_0000171|http://purl.obolibrary.org/obo/UBERON_0004119|http://purl.obolibrary.org/obo/UBERON_0005178|http://purl.obolibrary.org/obo/UBERON_0015212,,,,,,,,,,,,,,,,,,,,EHDAA2:0001042|UMLS:C0024109|MESH:D008168|EHDAA:1554|VHOG:0000310|OpenCyc:Mx4rvVjKy5wpEbGdrcN5Y29ycA|BTO:0000763|EMAPA:16728|NCIT:C12468|EFO:0000934|MIAA:0000135|XAO:0000119|MA:0000415|AAO:0000275|EHDAA:2205|AAO:0010567|EV:0100042|GAID:345|FMA:7195|CALOHA:TS-0568|MAT:0000135|galen:Lung|http://www.snomedbrowser.com/Codes/Details/181216001|http://linkedlifedata.com/resource/umls/id/C0024109|http://en.wikipedia.org/wiki/Lung,Respiration organ that develops as an oupocketing of the esophagus.,,,,,,,,,,,,,,Either of two organs which allow gas exchange absorbing oxygen from inhaled air and releasing carbon dioxide with exhaled air.[AAO],,,,,,,,,,,,,,,,,pulmo,,,,,uberon,,,pulmonary,,,,"Lungs had already developed as paired ventral pockets from the intestine in the ancestor of Osteognathostomata. (...) In actinopterygian fishes, apart from Cladistia, the ventral intestinal pocket migrates dorsally and becomes the swim-bladder, a mainly hydrostatical organ (reference 1); Comparative transcriptome analyses indicate molecular homology of zebrafish swimbladder and Mammalian lung (reference 2).[well established][VHOG]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Snakes and limbless lizards typically possess only the right lung as a major respiratory organ; the left lung is greatly reduced, or even absent. Amphisbaenians, however, have the opposite arrangement, with a major left lung, and a reduced or absent right lung [WP]",,http://purl.obolibrary.org/obo/UBERON_0000171|http://purl.obolibrary.org/obo/UBERON_0004119|http://purl.obolibrary.org/obo/UBERON_0005178|http://purl.obolibrary.org/obo/UBERON_0015212,,,,UBERON:0002048,,,,,,true,,,,,,,,,UBERON:0002048,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#organ_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#major_organ|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,lung,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes|https://github.com/obophenotype/uberon/issues/701,,,,,"respiration organ in all air-breathing animals, including most tetrapods, a few fish and a few snails. In mammals and the more complex life forms, the two lungs are located in the chest on either side of the heart. Their principal function is to transport oxygen from the atmosphere into the bloodstream, and to release carbon dioxide from the bloodstream into the atmosphere. This exchange of gases is accomplished in the mosaic of specialized cells that form millions of tiny, exceptionally thin-walled air sacs called alveoli. // Avian lungs do not have alveoli as mammalian lungs do, they have Faveolar lungs. They contain millions of tiny passages known as para-bronchi, connected at both ends by the dorsobronchi",,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000030,meplazumab,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,"Meplazumab (Ketantin®) is a lyophilized powder for injection of small volume. The main active ingredient of the product, meplazumab, is a humanized immunoglobulin (Ig) G2 monoclonal antibody, consisting of the complementary-determining regions of anti CD147 murine antibody and the human framework region. It acts as an erythrocytic stage-macromolecular antibody drug that has the potential to mediate both treatment and prophylaxis of falciparum malaria.",,,,,,,,,,,,,,,,meplazumab,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002017,Nausea and vomiting,Nausea and vomiting,,false,,,http://purl.obolibrary.org/obo/HP_0011458,,,,,,,,,,,,,,,,,,,,UMLS:C0027498|SNOMEDCT_US:16932000,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Nausea and vomiting,,,,,human_phenotype,,,,,,,,,Expelling the contents of the stomach and the sensations associated with it. They are symptoms of an underlying disease or condition and not a specific illness,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011458,,,,HP:0002017,,,,,,,,,,,,,,,HP:0002017,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Nausea and vomiting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0048730,epidermis morphogenesis,hypodermis morphogenesis,"The process in which the anatomical structures of the epidermis are generated and organized. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process in which the anatomical structures of the epidermis are generated and organized. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,hypodermis morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0048730,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0048730,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,epidermis morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000147,zero-dimensional continuant fiat boundary,,,false,,,http://purl.obolibrary.org/obo/BFO_0000140,,,,,ZeroDimensionalContinuantFiatBoundary,0d-cf-boundary,,,,,,,,,,,,,,,,,,,,,,,"zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona.",,,a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001]),,"the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet|the point of origin of some spatial coordinate system.|the geographic North Pole",,,,,,,,,(iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000147,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000140,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,zero-dimensional continuant fiat boundary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_82721,dalbavancin,dalbavancin B0|dalbavancin|BI 397|BI397,A semisynthetic glycopeptide used for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22951648|PMID:24341387|PMID:25118105|Reaxys:9839185|PMID:25211361|PMID:25136251|PMID:24608916|KEGG:D03640|PMID:24972854|PMID:24939490|Drug_Central:777|CAS:171500-79-1|PMID:25229923|PMID:24897082|PMID:25229922|PMID:23880168|PMID:25229924|PMID:25229925|Wikipedia:Dalbavancin|PMID:24343828|PMID:25243251|PMID:23414746|PMID:23357293,A semisynthetic glycopeptide used for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,dalbavancin B0|dalbavancin|BI 397|BI397,,,,,,,,,0,C88H100Cl2N10O28,"InChI=1S/C88H100Cl2N10O28/c1-38(2)13-10-8-6-7-9-11-14-61(106)94-70-73(109)75(111)78(86(120)121)128-87(70)127-77-58-31-43-32-59(77)124-55-24-19-42(29-50(55)89)71(107)69-85(119)98-67(80(114)92-25-12-26-100(4)5)48-33-44(102)34-57(125-88-76(112)74(110)72(108)60(37-101)126-88)62(48)47-28-40(17-22-52(47)103)65(82(116)99-69)95-83(117)66(43)96-84(118)68-49-35-46(36-54(105)63(49)90)123-56-30-41(18-23-53(56)104)64(91-3)81(115)93-51(79(113)97-68)27-39-15-20-45(122-58)21-16-39/h15-24,28-36,38,51,60,64-76,78,87-88,91,101-105,107-112H,6-14,25-27,37H2,1-5H3,(H,92,114)(H,93,115)(H,94,106)(H,95,117)(H,96,118)(H,97,113)(H,98,119)(H,99,116)(H,120,121)/t51-,60-,64-,65-,66-,67+,68+,69+,70-,71-,72-,73-,74+,75+,76+,78+,87-,88+/m1/s1",KGPGQDLTDHGEGT-SZUNQUCBSA-N,1816.69200,1814.60856,CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3ccc(O)c(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(=O)NCCCN(C)C)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)C(O)=O)cc4)NC1=O)c2,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:82721,,,,,,true,,,,,,,,,CHEBI:82721,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,dalbavancin,,,,,,,,,,,,,,,,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.27.20027557v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_7936,paroxetine,"Paroxetine|(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine|(-)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|paroxetinum|paroxetina","A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for alpha1-, alpha2- or beta-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:19687003|Reaxys:7467879|PMID:11565622|PMID:16426087|PMID:17612590|PMID:21908494|PMID:21922171|KEGG:D02362|PMID:11271409|PMID:17874333|PMID:17122538|PMID:22198456|PMID:16397315|PMID:12820211|PMID:16395417|PMID:11910269|PMID:14566200|PMID:15963219|PMID:15992089|PMID:22153922|PMID:12088162|PMID:22263916|PMID:16822276|PMID:11169163|PMID:21739267|PMID:14673053|PMID:21452176|PMID:15199661|CAS:61869-08-7|PMID:11893234|Wikipedia:Paroxetine|PMID:11281965|PMID:21909633|PMID:15903129|Beilstein:7467879|KEGG:C07415|PMID:22212003|PMID:12421645|PMID:14689334|PMID:11324355|PMID:21404089|PMID:21939725|PMID:15544025|PMID:22353759|Drug_Central:2068|DrugBank:DB00715|PMID:14619895|PMID:17219219|PMID:22283559|PMID:15845695|PMID:18273418|PMID:12369443|PMID:15853570|PMID:15374134|PMID:14566196|PMID:16765127|LINCS:LSM-2843|PMID:11819027|PMID:15264994|PMID:14978354|PMID:11563413|PMID:12818234|PMID:18345955|PMID:12920419|PMID:11360029|PMID:16913391|PMID:22377745|PMID:12906023|PMID:11513198|PMID:14521492|PMID:14624192|PMID:14516531|PMID:22240860|PMID:15376524|PMID:17162096|PMID:18808757|PMID:17452166|PMID:17652957|PMID:15613191|PMID:17559097|PMID:19851065|PMID:17286545|PMID:18983224|PMID:15048901|PMID:15241233|PMID:11009210|PMID:12027788,"A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for alpha1-, alpha2- or beta-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Paroxetine|(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine",,,,,chebi_ontology,,"(-)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|paroxetinum|paroxetina",,,,,,,,,0,C19H20FNO3,"InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1",AHOUBRCZNHFOSL-YOEHRIQHSA-N,329.36540,329.14272,[H][C@]1(CCNC[C@H]1COc1ccc2OCOc2c1)c1ccc(F)cc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:7936,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:7936,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,paroxetine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045120,pronucleus,,"The nucleus of either the ovum or the spermatozoon following fertilization. Thus, in the fertilized ovum, there are two pronuclei, one originating from the ovum, the other from the spermatozoon that brought about fertilization; they approach each other, but do not fuse until just before the first cleavage, when each pronucleus loses its membrane to release its contents.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Pronucleus,"The nucleus of either the ovum or the spermatozoon following fertilization. Thus, in the fertilized ovum, there are two pronuclei, one originating from the ovum, the other from the spermatozoon that brought about fertilization; they approach each other, but do not fuse until just before the first cleavage, when each pronucleus loses its membrane to release its contents.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0045120,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045120,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pronucleus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006909,phagocytosis,,"A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Phagocytosis,"A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_4751,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006909,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006909,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,phagocytosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098883,synapse pruning,synapse disassembly|synapse clearance|synapse removal|synapse elimination,A cellular process that results in the controlled breakdown of synapse. After it starts the process is continuous until the synapse has disappeared.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,A cellular process that results in the controlled breakdown of synapse. After it starts the process is continuous until the synapse has disappeared.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,synapse disassembly|synapse clearance|synapse removal|synapse elimination,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0098883,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098883,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_synapse,,,,,,,,,,synapse pruning,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_1074,kidney failure,renal failure,A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood.|PRISM.,false,,,http://purl.obolibrary.org/obo/DOID_557,,,,,,,,,,,,,,,,,,,,ICD10CM:N19|UMLS_CUI:C0035078|ICD9CM:586|MESH:D051437|SNOMEDCT_US_2019_09_01:42399005|NCI:C4376,A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,renal failure,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,PRISM.,,http://purl.obolibrary.org/obo/DOID_557,,,,DOID:1074,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,DOID:1074,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,kidney failure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000160,intestine,bowel|intestinal tract,"Segment of the alimentary canal extending from the stomach to the anus and, in humans and other mammals, consists of two segments, the small intestine and the large intestine.",false,,,http://purl.obolibrary.org/obo/UBERON_0004921,,,,,,,,,,,,,,,,,,,,TAO:0001338|XAO:0000129|galen:Intestine|MA:0000328|BTO:0000648|EMAPA:32874|VHOG:0000056|MA:0001524|UMLS:C0021853|MESH:A03.492.411|BSA:0000093|WBbt:0005772|GAID:295|NCIT:C12736|ANISEED:1235303|AAO:0000246|EV:0100071|FMA:7199|EFO:0000834|ZFA:0001338|MIAA:0000043|CALOHA:TS-0490|http://en.wikipedia.org/wiki/Intestine|http://www.snomedbrowser.com/Codes/Details/256876008|http://linkedlifedata.com/resource/umls/id/C0021853,"Segment of the alimentary canal extending from the stomach to the anus and, in humans and other mammals, consists of two segments, the small intestine and the large intestine.",,,,,,,,This class is probably too inclusive,,,,,,"Portion of the alimentary canal bounded anteriorly by the pyloric sphincter and posteriorly by the cloacal sphincter.[AAO]|The tract of the alimentary canal. [Dorian_AF, Elsevier's_encyclopaedic_dictionary_of_medicine, Part_B:_Anatomy_(1988)_Amsterdam_etc.:_Elsevier][VHOG]",,,,,,,,,,,,,,,,,bowel,,,,,uberon,,intestinal tract,intestinal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0004921,,,,UBERON:0000160,,,,,,true,,,,,,,,,UBERON:0000160,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,intestine,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,"In zebrafish, No stomach, small intestine, or large intestine can be distinguished. However, differences can be found in the morphology of the mucosa columnar epithelial cells and the number of goblet cells, suggesting functional differentiation. The intestine has numerous folds that become progressively shorter in a rostral-to-caudal direction. Proportionally, these folds are significantly larger than the finger-like intestinal villi of mammals and other amniotes (Wallace et al. 2005). Columnar-shaped absorptive enterocytes are the most numerous in the zebrafish intestinal epithelium. Goblet cells are the second most populous epithelial cell type.",,,,,
http://purl.obolibrary.org/obo/OGG_3000005045,FURIN,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PACE|PCSK3|SPC1|FUR,,,,,,,15,,,,,,,,,,MIM:136950|Ensembl:ENSG00000140564|HPRD:00653|HGNC:8568|Vega:OTTHUMG00000149831,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,furin (paired basic amino acid cleaving enzyme),,15q26.1,,,,"GO_0000139 (EC: TAS); GO_0002020 (EC: IPI, PMID: 14744861); GO_0004175 (EC: IDA, PMID: 17010968); GO_0004252 (EC: IDA, PMID: 10567353); GO_0004867 (EC: IDA, PMID: 10567353); GO_0005615 (EC: IDA, Qualifier: NOT, PMID: 10567353); GO_0005796 (EC: TAS); GO_0005802 (EC: IDA, PMID: 14744861); GO_0005886 (EC: TAS); GO_0006465 (EC: IDA, PMID: 16912035); GO_0006508 (EC: TAS); GO_0007179 (EC: TAS); GO_0007219 (EC: TAS); GO_0008233 (EC: IDA, PMID: 10526337); GO_0008283 (EC: IMP, PMID: 15899807); GO_0009966 (EC: IEA); GO_0009986 (EC: IDA, PMID: 16537537); GO_0010951 (EC: IDA, PMID: 10567353); GO_0016021 (EC: IEA); GO_0016032 (EC: TAS); GO_0016485 (EC: IDA, PMID: 10526337); GO_0016485 (EC: IMP, PMID: 15899807); GO_0016486 (EC: IDA, PMID: 9242664); GO_0017187 (EC: TAS); GO_0019058 (EC: IEP, PMID: 8940009); GO_0019068 (EC: TAS); GO_0019082 (EC: TAS); GO_0022617 (EC: TAS); GO_0030140 (EC: IDA, PMID: 15078902); GO_0030198 (EC: TAS); GO_0030574 (EC: TAS); GO_0032455 (EC: TAS); GO_0032804 (EC: IDA, PMID: 16912035); GO_0032902 (EC: IDA, PMID: 8615794); GO_0032904 (EC: IDA, Qualifier: NOT, PMID: 10567353); GO_0032911 (EC: IMP, PMID: 15899807); GO_0032940 (EC: IDA, PMID: 8615794); GO_0042176 (EC: IMP, PMID: 15899807); GO_0042277 (EC: IDA, PMID: 8940009); GO_0043043 (EC: IDA, PMID: 8262946); GO_0043687 (EC: TAS); GO_0044267 (EC: TAS); GO_0045121 (EC: IDA, PMID: 17010968); GO_0046872 (EC: IEA); GO_0048011 (EC: TAS); GO_0048406 (EC: IDA, PMID: 8615794); GO_0051044 (EC: IC, PMID: 17010968); GO_0052548 (EC: IDA, PMID: 14744861); GO_0070062 (EC: IDA, PMID: 19199708)",PMID: 1360148; 1571548; 1629222; 1713771; 1741956; 2112085; 2251280; 2408021; 2674906; 3023061; 7508380; 7639757; 7690548; 7721880; 7737999; 7774724; 7781597; 7782070; 8020465; 8163529; 8174106; 8189547; 8262946; 8546712; 8615794; 8670066; 8846780; 8940009; 8995623; 9094426; 9166946; 9242664; 9412467; 9442015; 9521771; 9599222; 9642263; 9653148; 9695949; 9827567; 9927419; 10037747; 10050053; 10225274; 10373500; 10409610; 10452538; 10526337; 10567353; 10593987; 10887202; 10888676; 10900462; 11071887; 11237874; 11294867; 11323410; 11331585; 11380615; 11416205; 11422372; 11571266; 11723118; 11804956; 11861638; 11861826; 11921231; 12006600; 12058031; 12058067; 12071862; 12220680; 12354117; 12411321; 12460941; 12477932; 12482870; 12547702; 12584323; 12586364; 12644459; 12670890; 12736257; 12787574; 14596804; 14644155; 14739277; 14741044; 14744861; 15078902; 15082773; 15135058; 15240540; 15247425; 15371436; 15489334; 15564468; 15584904; 15606899; 15611046; 15637056; 15659365; 15899807; 15911696; 16407210; 16537537; 16600625; 16627761; 16648485; 16912035; 16942750; 17010968; 17283058; 17301129; 17360815; 17477394; 17525470; 17641413; 17905608; 17905609; 17909005; 17938254; 17948127; 18037384; 18064302; 18174282; 18245819; 18323532; 18343183; 18353966; 18467449; 18544638; 18546152; 18665212; 18826955; 19056739; 19152512; 19193799; 19199708; 19322201; 19477160; 19492430; 19541935; 19913121; 19998449; 20055586; 20062797; 20101215; 20605791; 20608975; 20628086; 20634490; 20635860; 20707915; 20811902; 20945401; 21147780; 21296375; 21406565; 21503879; 21550985; 21805236; 21805237; 21880759; 21889147; 21890473; 21909115; 21988832; 22038627; 22247010; 22479394; 22505724; 22577343; 22679642; 22808247; 22995191; 23000965; 23135270; 23302673; 23390091; 23558288; 23568742; 23598405; 23653353; 23661674; 23686857; 23744066; 23775089; 23936445,,,,,,,,,,,,,,,,,,OGG:3000005045,,,,,,,,,,,,,,,,,,,furin (paired basic amino acid cleaving enzyme),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32198713,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,FURIN,,,20140408,5045,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,FURIN,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_235410,SARS coronavirus Sin2774,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:235410,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin2774,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075528,modulation by virus of host immune response,regulation by virus of host immune system process,The process in which a virus effects a change in the host immune response.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,janelomax,2011-08-04T02:47:57Z,,,,The process in which a virus effects a change in the host immune response.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation by virus of host immune system process,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0075528,,,,,,true,,,,true,,,,,GO:0075528,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host immune response,,,,,,,,,,,,,,,,,,,,,,https://sph.nus.edu.sg/wp-content/uploads/2020/03/COVID-19-Science-Report-Pathogenesis-and-Host-Immune-Response-to-SARS-CoV-2.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2115,B cell deficiency,B cell (antibody) deficiencies|Immunoglobulin heavy chain deficiency|immunoglobulin heavy chain deletion,A primary immunnodeficiency disease that is caused by a lack of infection-fighting antibody producing B cells (immunoglobulins) or B cells that are not functioning properly.,false,,,http://purl.obolibrary.org/obo/DOID_612,,,,,,,,,,,,,,,,,,,,ICD9CM:279.03|UMLS_CUI:C0154276,A primary immunnodeficiency disease that is caused by a lack of infection-fighting antibody producing B cells (immunoglobulins) or B cells that are not functioning properly.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:6026,,,,B cell (antibody) deficiencies|Immunoglobulin heavy chain deficiency|immunoglobulin heavy chain deletion,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_612,,,,DOID:2115,,,,,,,,,,,,,,,DOID:2115,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,B cell deficiency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000101,air bronchogram,,,false,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002086,,,,,,,,assay,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216961/,Air bronchogram refers to the phenomenon of air-filled bronchi (dark) being made visible by the opacification of surrounding alveoli (grey/white).,,,,,,,,,,,,,,,,air bronchogram,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_85089,ledipasvir,"methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate|GS-5885|GS5885|WHO 9796|GS 5885",A benzimidazole derivative that is used in combination with sofosbuvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:25553890|PMID:25591505|Wikipedia:Ledipasvir|Reaxys:23926149|PMID:25619871|CAS:1256388-51-8|PMID:25674658|Drug_Central:4899|PMID:25627448|PMID:25706754|KEGG:D10442|PMID:25676581|PMID:25706232|PMID:25674516,A benzimidazole derivative that is used in combination with sofosbuvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate",,,,,chebi_ontology,,GS-5885|GS5885|WHO 9796|GS 5885,,,,,,,,,0,C49H54F2N8O6,"InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1",VRTWBAAJJOHBQU-KMWAZVGDSA-N,888.99990,888.41344,COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c1nc(c[nH]1)-c1ccc2-c3ccc(cc3C(F)(F)c2c1)-c1ccc2[nH]c(nc2c1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:85089,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:85089,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ledipasvir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000093,positive sense viral genome,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,true,,,https://www.ncbi.nlm.nih.gov/books/NBK554776/,"Also known as a sense-strand RNA virus, a virus whose genetic information consists of a single strand of RNA that is the positive (or sense) strand which encodes mRNA (messenger RNA) and protein. Replication in positive-strand RNA viruses is via a negative-strand intermediate.",,,,,,,,,,,,,,,,positive sense viral genome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050900,leukocyte migration,immune cell migration|leucocyte migration|leukocyte trafficking|immune cell trafficking|leucocyte trafficking,The movement of a leukocyte within or between different tissues and organs of the body.,false,,,http://purl.obolibrary.org/obo/GO_0016477,,,,,,,,,,,,,,,,,,,,,The movement of a leukocyte within or between different tissues and organs of the body.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,immune cell migration|leucocyte migration|leukocyte trafficking|immune cell trafficking|leucocyte trafficking,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016477,,,,GO:0050900,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050900,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,leukocyte migration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009260,ribonucleotide biosynthetic process,ribonucleotide formation|ribonucleotide synthesis|ribonucleotide anabolism|ribonucleotide biosynthesis,"The chemical reactions and pathways resulting in the formation of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009165,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribonucleotide formation|ribonucleotide synthesis|ribonucleotide anabolism|ribonucleotide biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009165,,,,GO:0009260,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009260,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ribonucleotide biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000009,mean arterial blood pressure,,"The average blood pressure within an artery over a specified period of time. It is often calculated using the formula of one third systolic pressure plus two thirds diastolic pressure, or alternatively, using the formula diastolic pressure plus 1/3 of the difference between systolic pressure and  diastolic pressure (i.e. 1/3 pulse pressure).",false,,,http://purl.obolibrary.org/obo/CMO_0000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000009,,,,,,,,,,,,"The average blood pressure within an artery over a specified period of time. It is often calculated using the formula of one third systolic pressure plus two thirds diastolic pressure, or alternatively, using the formula diastolic pressure plus 1/3 of the difference between systolic pressure and  diastolic pressure (i.e. 1/3 pulse pressure).",,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000001,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,systolic blood pressure,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,mean arterial blood pressure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_82977,daclatasvir,"methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate|BMS-790052|BMS790052|Dimethyl N,N'-(biphenyl-4,4'-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate|BMS 790052",A member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23089758|PMID:23684844|PMID:23177287|PMID:25117173|PMID:24623983|PMID:25117197|PMID:24451151|CAS:1009119-64-5|PMID:24169581|PMID:23403428|PMID:24343001|PMID:24451122|PMID:24372205|PMID:23931586|PMID:24612030|PMID:25311593|KEGG:D10065|Drug_Central:4875|PMID:25365735|PMID:25080450|Reaxys:13077731|PMID:24448487|Wikipedia:Daclatasvir|PMID:23431163,A member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate,,,,,chebi_ontology,,"BMS-790052|BMS790052|Dimethyl N,N'-(biphenyl-4,4'-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate|BMS 790052",,,,,,,,,0,C40H50N8O6,"InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1",FKRSSPOQAMALKA-CUPIEXAXSA-N,738.87500,738.38533,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:82977,,,,,true,true,,,,,,,,,CHEBI:82977,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,daclatasvir,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,peptide or polysaccharide antigen processing and presentation of via MHC class II,The process in which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex.,false,,,http://purl.obolibrary.org/obo/GO_0019882,,,,,,,,,,,,,,,,,,,,,The process in which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,peptide or polysaccharide antigen processing and presentation of via MHC class II,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019882,,,,GO:0002504,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002504,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C647,Methylprednisolone,"Metysolon|Veriderm Medrol|Wyacort|Medrate|Caberdelta M|Prednilen|Medrol Veriderm|Mega-Star|Radilem|Medlone 21|6Alpha-Methylprednisolone|Sieropresol|METHYLPREDNISOLONE|Methylprednisolone|Urbason|methylprednisolone|Emmetipi|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Metypresol|Solpredone|Depo-Nisolone|Adlone|Medrone|Methylprednisolonum|Duralone|Metilbetasone Solubile|Meprolone|Esametone|Firmacort|Medrol|DepMedalone|Summicort|Depo Moderin|Predni-M-Tablinen|Metrocort","A synthetic corticosteroid with anti-inflammatory and immunomodulating properties.  Methylprednisolone binds to and activates specific nuclear receptors, resulting in altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,Adrenocortical insufficiency; Conditions requiring immunosuppression; Inflammatory conditions; Multiple Sclerosis; Nephrotic syndrome,A corticosteroid hormone replacement.,,,,,83-43-2,CHEBI:6888,C22H30O5,,C647,,,CTRP|FDA,,,,,,,"A synthetic corticosteroid with anti-inflammatory and immunomodulating properties.  Methylprednisolone binds to and activates specific nuclear receptors, resulting in altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.",,,,,,Methylprednisolone,,,,,,,,,,,X4W7ZR7023,,,,,,,,,,,,,,"Metysolon|Veriderm Medrol|Wyacort|Medrate|Caberdelta M|Prednilen|Medrol Veriderm|Mega-Star|Radilem|Medlone 21|6Alpha-Methylprednisolone|Sieropresol|METHYLPREDNISOLONE|Methylprednisolone|Urbason|methylprednisolone|Emmetipi|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Metypresol|Solpredone|Depo-Nisolone|Adlone|Medrone|Methylprednisolonum|Duralone|Metilbetasone Solubile|Meprolone|Esametone|Firmacort|Medrol|DepMedalone|Summicort|Depo Moderin|Predni-M-Tablinen|Metrocort",,,,,,,,,,,,,NCIT:C647,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Methylprednisolone,Methylprednisolone,,,,,,,,,19987,,,,,,41528,41528,,Methylprednisolone,,,,Pharmacologic Substance|Organic Chemical,,,,,,,,C0025815,
http://purl.obolibrary.org/obo/OMIT_0027103,Endophenotypes,,,false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0027103,"Measurable biological (physiological, biochemical, and anatomical features), behavioral (psychometric pattern) or cognitive markers that are found more often in individuals with a disease than in the general population. Because many endophenotypes are present before the disease onset and in individuals with heritable risk for disease such as unaffected family members, they can be used to help diagnose and search for causative genes.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Endophenotypes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002679,respiratory burst involved in defense response,,"A phase of elevated metabolic activity, during which oxygen consumption increases made as part of a defense response ; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.",false,,,http://purl.obolibrary.org/obo/GO_0045730,,,,,,,,,,,,,,,,,,,,,"A phase of elevated metabolic activity, during which oxygen consumption increases made as part of a defense response ; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0045730,,,,GO:0002679,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002679,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,respiratory burst involved in defense response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0028258,Hand Hygiene,,,false,,,http://purl.obolibrary.org/obo/OMIT_0008054,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0028258,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OMIT_0008054,,,,,,,,,,,,,,,,Practices involved in preventing the transmission of diseases by hand.,hand washing,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Hand Hygiene,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/docs/default-source/inaugural-who-partners-forum/who-interim-recommendation-on-obligatory-hand-hygiene-against-transmission-of-covid-19.pdf,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000032,mild symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,symptom,,true,,,,,,Mild or moderate cases were generally defined based on less severe clinical symptoms.,,,,,,,,,,,,,,,,mild symptom,,,,,,,,,,,,,,,,,,,,,,https://www.healthline.com/health-news/mild-covid-19-symptoms-can-quickly-turn-serious,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003821,KLRC1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,NKG2|NKG2A|CD159A,,,,,,,12,,,,,,,,,,Vega:OTTHUMG00000168584|HPRD:01192|MIM:161555|Ensembl:ENSG00000134545|HGNC:6374,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"killer cell lectin-like receptor subfamily C, member 1",,12p13,,,,"GO_0004888 (EC: TAS, PMID: 2007850); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 2007850); GO_0007166 (EC: TAS, PMID: 2007850); GO_0030246 (EC: IEA); GO_0050776 (EC: TAS)",PMID: 2007850; 8436421; 8753859; 8943374; 9034158; 9218532; 9485206; 9486650; 9598306; 9842883; 10320637; 10488737; 11238637; 11513152; 12165520; 12387742; 12444112; 12461076; 12477932; 12618865; 15489334; 15528343; 15550116; 15561299; 15687235; 16434388; 16690409; 16951318; 17545086; 17706207; 17767552; 17927829; 17976318; 18056444; 18083576; 18172398; 18332182; 18448674; 18500933; 18700876; 18941190; 18981088; 19002424; 19124726; 19395088; 19615756; 19694640; 19782712; 20012119; 20139023; 20237496; 20379614; 20550548; 20587610; 20648603; 20654155; 20696944; 20700504; 20952657; 21212510; 21518478; 21538351; 22486170,,,,,,,,,,,,,,,,,,OGG:3000003821,,,,,,,,,,,,,,,,,,,"killer cell lectin-like receptor subfamily C, member 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,KLRC1,,,20140408,3821,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,KLRC1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000003627,CXCL10,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,crg-2|IP-10|INP10|IFI10|C7|gIP-10|mob-1|SCYB10,,,,,,,4,,,,,,,,,,HPRD:00930|HGNC:10637|MIM:147310|Ensembl:ENSG00000169245|Vega:OTTHUMG00000160887,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 10,,4q21,,,,"GO_0002690 (EC: IEA); GO_0005102 (EC: TAS, PMID: 10201891); GO_0005515 (EC: IPI, PMID: 18275857); GO_0005576 (EC: IDA); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0006935 (EC: IDA, PMID: 12782716); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 10201891); GO_0007166 (EC: TAS, PMID: 10903763); GO_0007186 (EC: IMP, PMID: 12782716); GO_0007267 (EC: TAS, PMID: 3925348); GO_0007517 (EC: TAS, PMID: 8798675); GO_0008009 (EC: IDA, PMID: 12782716); GO_0008015 (EC: TAS, PMID: 8798675); GO_0008201 (EC: IMP, PMID: 18645041); GO_0008284 (EC: IEA); GO_0008603 (EC: TAS, PMID: 10903763); GO_0009306 (EC: IEA); GO_0009409 (EC: IEA); GO_0009897 (EC: IEA); GO_0010332 (EC: IEA); GO_0010818 (EC: IMP, PMID: 18645041); GO_0010996 (EC: IEA); GO_0016525 (EC: IEA); GO_0030816 (EC: IDA, PMID: 12782716); GO_0032496 (EC: IEA); GO_0033280 (EC: IEA); GO_0034605 (EC: IEA); GO_0042127 (EC: IDA, PMID: 12782716); GO_0043950 (EC: IDA, PMID: 12782716); GO_0045859 (EC: TAS, PMID: 10903763); GO_0045944 (EC: TAS, PMID: 12782716); GO_0048248 (EC: IDA, PMID: 12782716); GO_0051281 (EC: IDA, PMID: 12782716); GO_0051607 (EC: IEA); GO_0070098 (EC: IMP, PMID: 18645041)",PMID: 2437586; 3925348; 7566098; 8145049; 8423327; 8798675; 9022006; 9060447; 9462486; 9705166; 10201891; 10201901; 10233762; 10903763; 10982368; 11083865; 11110785; 11390394; 11401991; 11418676; 11467655; 11559369; 11818520; 11867072; 11878903; 11897701; 12016104; 12089333; 12117914; 12117926; 12126650; 12162873; 12173928; 12189440; 12270371; 12356205; 12384933; 12393716; 12441140; 12445801; 12477932; 12539042; 12571234; 12584353; 12603854; 12663757; 12667820; 12668159; 12698106; 12718750; 12737818; 12782716; 12794718; 12819030; 12819903; 12847218; 12847282; 12856973; 12884299; 12930373; 12946268; 14507644; 14550288; 14578618; 14600836; 14630801; 14739277; 15063730; 15081247; 15081261; 15150261; 15307834; 15315758; 15489334; 15518810; 15644410; 15725351; 15745922; 15814716; 15843529; 15879427; 15880073; 15885315; 15919935; 15944327; 15988033; 16181055; 16195357; 16200621; 16210647; 16243485; 16490936; 16507178; 16581825; 16645011; 16697675; 16709871; 16733654; 16825597; 16864907; 16867276; 16920957; 16931519; 16934957; 16969644; 17018607; 17052298; 17052299; 17085967; 17211148; 17244787; 17250724; 17255201; 17360657; 17364892; 17467667; 17505511; 17541284; 17628646; 17652371; 17668902; 17763275; 17763328; 17766680; 17875534; 17912012; 17943641; 17957030; 17963704; 17996064; 18037659; 18046562; 18085351; 18234638; 18240029; 18259970; 18275857; 18281042; 18282714; 18325387; 18379127; 18415893; 18424889; 18538864; 18569454; 18645041; 18647352; 18682747; 18684849; 18702954; 18729739; 18798334; 18855195; 18973545; 18985732; 18986693; 19031697; 19065267; 19070948; 19088500; 19105984; 19134328; 19155980; 19175890; 19181310; 19187771; 19195322; 19203362; 19223260; 19258635; 19274094; 19281798; 19327225; 19342252; 19342664; 19410617; 19441886; 19447045; 19459809; 19472212; 19479051; 19506876; 19508602; 19523460; 19558503; 19565490; 19590927; 19639049; 19641142; 19694638; 19756997; 19800124; 19817957; 19821051; 19827943; 19880820; 19887486; 19901067; 19918044; 19939453; 19941336; 19969087; 20041963; 20056178; 20059481; 20137269; 20137825; 20144041; 20153790; 20164184; 20186422; 20186843; 20187787; 20299237; 20302596; 20404089; 20473322; 20485145; 20485444; 20523065; 20525556; 20592450; 20626297; 20648615; 20680966; 20833730; 20856926; 20929277; 20942936; 20943047; 20948191; 20980518; 21045270; 21054674; 21062959; 21099280; 21106778; 21167783; 21183794; 21191639; 21219680; 21254158; 21270681; 21274647; 21303425; 21303517; 21390311; 21454254; 21457060; 21475065; 21489350; 21497908; 21508508; 21531038; 21601475; 21613464; 21645215; 21649525; 21708014; 21725974; 21802343; 21811993; 21812928; 21849907; 21897004; 21906079; 21912394; 21962843; 21966356; 22004287; 22008312; 22022583; 22037980; 22038159; 22053613; 22058116; 22117591; 22136974; 22160826; 22168752; 22178859; 22192885; 22367045; 22390571; 22393386; 22401175; 22471703; 22472061; 22491449; 22496888; 22562465; 22564606; 22621182; 22634718; 22652417; 22675025; 22685032; 22697070; 22738089; 22746298; 22800603; 22809599; 22814248; 22892369; 22896023; 22905138; 22975476; 22989785; 22996399; 23011799; 23012327; 23024806; 23034049; 23056251; 23065240; 23092582; 23118425; 23118858; 23144331; 23150742; 23213058; 23265968; 23272100; 23288171; 23291247; 23291435; 23306067; 23312578; 23322900; 23333920; 23352833; 23437705; 23458521; 23505918; 23542734; 23559389; 23589576; 23600831; 23614810; 23629827; 23630573; 23684765; 23740952; 23743311; 23762283; 23873303; 23905710; 23998932; 24023775; 24025324; 24063316; 24273934; 24600982,,,,,,,,,,,,,,,,,,OGG:3000003627,,,,,,,,,,,,,,,,,,,chemokine (C-X-C motif) ligand 10,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CXCL10,,,20140408,3627,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.nature.com/articles/s41577-020-0305-6,,,,CXCL10,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0032957,inositol trisphosphate metabolic process,IP3 metabolism|inositol trisphosphate metabolism|IP3 metabolic process|myo-inositol trisphosphate metabolic process,"The chemical reactions and pathways involving myo-inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached.",false,,,http://purl.obolibrary.org/obo/GO_0006066,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving myo-inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IP3 metabolism|inositol trisphosphate metabolism|IP3 metabolic process,,,myo-inositol trisphosphate metabolic process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006066,,,,GO:0032957,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0032957,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,inositol trisphosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264384,SARS coronavirus TW-YM2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264384,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-YM2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072001,renal system development,urinary tract development|urinary system development,"The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,midori,2010-01-25T10:31:00Z,,,,"The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels.",,,,,,,,,,,,,,,,,,,,,,,,,,,,urinary tract development|urinary system development,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0072001,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072001,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_annotate,,,,,,,,,,renal system development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0010464,regulation of mesenchymal cell proliferation,,"Any process that modulates the frequency, rate or extent of mesenchymal cell proliferation. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of mesenchymal cell proliferation. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0010464,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0010464,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of mesenchymal cell proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000009908,G3BP2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,4,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,GTPase activating protein (SH3 domain) binding protein 2,,4q21.1,,,,"GO_0000166 (EC: IEA); GO_0005737 (EC: IDA); GO_0005737 (EC: NAS, PMID: 10969074); GO_0007253 (EC: NAS, PMID: 10969074); GO_0007265 (EC: NAS, PMID: 9575347); GO_0030159 (EC: NAS, PMID: 10969074); GO_0044822 (EC: IDA); GO_0051028 (EC: IEA)",PMID: 8619474; 9110174; 9575347; 9734811; 10969074; 12477932; 15345747; 15489334; 15717329; 15782174; 16055720; 16196087; 16341674; 16344560; 16973615; 17081983; 17297477; 17353931; 17361185; 17474147; 17620599; 18029348; 18781797; 19322201; 19471022; 19615732; 20020773; 20811636; 21139048; 21145461; 21182205; 21319273; 21890473; 21906983; 21963094; 21985131; 22190034; 22505724; 22536444; 23000965; 23087212; 23181366; 23279204; 23383273; 23455922; 24250222; 24457600,,,,,,,,,,,,,,,,,,OGG:3000009908,,,,,,,,,,,,,,,,,,,GTPase activating protein (SH3 domain) binding protein 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,G3BP2,,,20140408,9908,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,G3BP2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/UBERON_0000475,organism subdivision,anatomic region|body part|cardinal body part|body region,"Anatomical structure which is a subdivision of a whole organism, consisting of components of multiple anatomical systems, largely surrounded by a contiguous region of integument.",false,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,,,,,,,,,,,,,,,,,UMLS:C0229962|BIRNLEX:7|EFO:0000808|XAO:0003013|MA:0002433|MAT:0000293|MIAA:0000293|TAO:0001308|AAO:0010053|CARO:0000032|TGMA:0001840|EHDAA2:0003032|CALOHA:TS-2084|BILA:0000032|AEO:0000032|EMAPA:36031|galen:BodyPart|FMA:7153|VHOG:0001758|HAO:0000032|MESH:D001829|ZFA:0001308|OpenCyc:Mx4rvViAHJwpEbGdrcN5Y29ycA|NCIT:C32221|FBbt:00007009|http://en.wikipedia.org/wiki/Body_part|http://linkedlifedata.com/resource/umls/id/C0229962,"Anatomical structure which is a subdivision of a whole organism, consisting of components of multiple anatomical systems, largely surrounded by a contiguous region of integument.",,,,,,,,"Reflects CARO2. todo - check the inclusion of FMA 'cardinal body part here', and check child terms for consistency",,,,,,,,,,,,,,,,,,,,,,,anatomic region,,,,,uberon,,body part|cardinal body part|body region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,UBERON:0000475,,,,,,,,,,,,,,,UBERON:0000475,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,organism subdivision,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0097485,neuron projection guidance,neuronal cell projection guidance|neuron process guidance|neuron protrusion guidance|neurite guidance,The process in which the migration of a neuron projection is directed to a specific target site in response to a combination of attractive and repulsive cues.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,paola,2013-07-08T13:32:37Z,,,,The process in which the migration of a neuron projection is directed to a specific target site in response to a combination of attractive and repulsive cues.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,neuronal cell projection guidance|neuron process guidance|neuron protrusion guidance,,,neurite guidance,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0097485,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0097485,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neuron projection guidance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_132975,grazoprevir,"(1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide|MK 5172|grazoprevir",An azamacrocyclic compound that is a hepatitis C protease inhibitor used in combination with elbasvir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:26938699|PMID:27291249|PMID:26423374|PMID:26818134|PMID:27091555|PMID:26849059|PMID:26933896|PMID:26353843|Reaxys:19999739|PMID:26926625|PMCID:PMC4135988|PMID:27403342|PMID:26532861|PMID:25467591|PMID:24666106|PMID:25266288|PMID:27123552|PMID:24727022|Wikipedia:Grazoprevir|PMID:26682473|PMID:26943930|PMID:27418810|CAS:1350514-68-9|Drug_Central:5081|PMID:25467560,An azamacrocyclic compound that is a hepatitis C protease inhibitor used in combination with elbasvir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide",,,,,chebi_ontology,,MK 5172|grazoprevir,,,,,,,,,0,C38H50N6O9S,"InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1",OBMNJSNZOWALQB-NCQNOWPTSA-N,766.906,766.33600,[C@@]1(C(NS(C2CC2)(=O)=O)=O)(C[C@H]1C=C)NC(=O)[C@H]3N4C[C@@H](C3)OC5=C(CCCCC[C@H]6[C@@H](C6)OC(N[C@H](C4=O)C(C)(C)C)=O)N=C7C(=N5)C=C(C=C7)OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:132975,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:132975,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,grazoprevir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C1311,Tacrolimus,"TACROLIMUS|Fujimycin|Prograf|FK 506|tacrolimus|Hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone|Protopic|Hecoria|Tacrolimus","A macrolide isolated from Streptomyces tsukubaensis. Tacrolimus binds to the FKBP-12 protein and forms a complex with calcium-dependent proteins, thereby inhibiting calcineurin phosphatase activity and resulting in decreased cytokine production. This agent exhibits potent immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation. Tacrolimus possesses similar immunosuppressive properties to cyclosporine, but is more potent.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,"Atopic dermatitis; Kidney transplant rejection, prophylaxis; Liver transplant rejection, prophylaxis",A drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.,,,,,109581-93-3,CHEBI:61057,C44H69NO12.H2O,,C1311,,,CTRP|FDA,,,,,,,"A macrolide isolated from Streptomyces tsukubaensis. Tacrolimus binds to the FKBP-12 protein and forms a complex with calcium-dependent proteins, thereby inhibiting calcineurin phosphatase activity and resulting in decreased cytokine production. This agent exhibits potent immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation. Tacrolimus possesses similar immunosuppressive properties to cyclosporine, but is more potent.",,,,,,Tacrolimus,,,,,,,,,,,WM0HAQ4WNM,,,,,,,,,,,,,,"TACROLIMUS|Fujimycin|Prograf|FK 506|tacrolimus|Hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone|Protopic|Hecoria|Tacrolimus",,,,,,,,,,,,,NCIT:C1311,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32256705,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Tacrolimus,Tacrolimus,,,,,,,,,717865,,,,,,42009,42009,,Tacrolimus,,,,Pharmacologic Substance|Organic Chemical,,,,,,,,C0085149,
http://purl.obolibrary.org/obo/NCBITaxon_2499399,Cornidovirineae,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_76804,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_suborder,,,,,,,NCBITaxon:2499399,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_76804,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Cornidovirineae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305410,SARS coronavirus B040,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305410,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus B040,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045930,negative regulation of mitotic cell cycle,downregulation of progression through mitotic cell cycle|negative regulation of progression through mitotic cell cycle|down regulation of progression through mitotic cell cycle|down-regulation of progression through mitotic cell cycle|negative regulation of mitotic cell cycle progression|inhibition of progression through mitotic cell cycle,"Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,downregulation of progression through mitotic cell cycle|negative regulation of progression through mitotic cell cycle|down regulation of progression through mitotic cell cycle|down-regulation of progression through mitotic cell cycle|negative regulation of mitotic cell cycle progression,,,inhibition of progression through mitotic cell cycle,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0045930,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045930,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,negative regulation of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0000007,technique,,"A technique is a planned process used to accomplish a specific activity or task.|Protocol is added to eagle-i temporarily until a relationship between the informatio entity ""protocol"" and these planned processes is created. This class refers to the axtual process not the document",false,,,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,,,A technique is a planned process used to accomplish a specific activity or task.,,http://en.wikipedia.org/wiki/Technique,,,,,,,,,,,Flow cytometry is a technique.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,ERO:0000007,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Protocol is added to eagle-i temporarily until a relationship between the informatio entity ""protocol"" and these planned processes is created. This class refers to the axtual process not the document",,http://purl.obolibrary.org/obo/OBI_0000011,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,technique,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Melissa Haendel,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000103,medical aspect,,,false,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,quality,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32259130,The medical aspects of environmental health problems in emergencies involve taking care of the affected people.,Clinical Aspects|clinical aspect,,,,,,,,,,,,,,,medical aspect,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0072522,purine-containing compound biosynthetic process,purine-containing compound synthesis|purine-containing compound anabolism|purine-containing compound formation|purine and derivative biosynthetic process|purine-containing compound biosynthesis,"The chemical reactions and pathways resulting in the formation of a purine-containing compound, i.e. any compound that contains purine or a formal derivative thereof.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,midori,2011-01-04T03:15:29Z,,,,"The chemical reactions and pathways resulting in the formation of a purine-containing compound, i.e. any compound that contains purine or a formal derivative thereof.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine-containing compound synthesis|purine-containing compound anabolism|purine-containing compound formation|purine and derivative biosynthetic process|purine-containing compound biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0072522,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0072522,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine-containing compound biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045121,membrane raft,lipid raft|glycolipid-enriched membrane domain|GEM domain,"Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.",false,,,http://purl.obolibrary.org/obo/GO_0098857,,,,,,,,,,,,,,,,,,,,Wikipedia:Lipid_raft,"Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,lipid raft,,,,,cellular_component,,glycolipid-enriched membrane domain|GEM domain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0098857,,,,GO:0045121,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045121,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,membrane raft,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C79748,Atrophy,Atrophy|ATROPHY,"Any weakening or degeneration, especially through lack of use.",false,,,http://purl.obolibrary.org/obo/SYMP_0000567,,"A decrease in size of organ, tissue or cell. (INHAND)",,,,,,,,,C79748,,,CDISC,,,,,,,"Any weakening or degeneration, especially through lack of use.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Atrophy|ATROPHY,,,,,,,,,,,,,NCIT:C79748,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000567,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C120531|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526,,,,,,,,,,Atrophy,Atrophy,,,,,,,,,,,,,,,,,,Atrophy,,,,Pathologic Function,,,,,,,,C0333641,
http://purl.obolibrary.org/obo/GO_0007568,aging,ageing,"A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).",false,,,http://purl.obolibrary.org/obo/GO_0008150,,,,,,,,,,,,,,,,,,,,Wikipedia:Aging,"A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016280,,,,ageing,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0008150,,,,GO:0007568,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,,,,GO:0007568,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,aging,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019064,fusion of virus membrane with host plasma membrane,viral penetration via membrane fusion|viral envelope fusion|viral envelope fusion with host plasma membrane|viral envelope fusion with host membrane|viral envelope fusion with host cell membrane|viral-cell fusion molecule activity|viral entry into host cell via membrane fusion with the plasma membrane,Fusion of a viral membrane with the host cell membrane during viral entry. Results in release of the virion contents into the cytoplasm.,false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,VZ:987,Fusion of a viral membrane with the host cell membrane during viral entry. Results in release of the virion contents into the cytoplasm.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0075706,viral penetration via membrane fusion|viral envelope fusion,,,viral envelope fusion with host plasma membrane|viral envelope fusion with host membrane|viral envelope fusion with host cell membrane,,,,,biological_process,,viral-cell fusion molecule activity|viral entry into host cell via membrane fusion with the plasma membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019064,,,,,,true,,,,true,,,,,GO:0019064,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,fusion of virus membrane with host plasma membrane,,,,,,,,,,,,,,,,,,,,,,https://www.sciencedaily.com/releases/2020/04/200407150816.htm,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0097440,apical dendrite,,"A dendrite that emerges near the apical pole of a neuron. In bipolar neurons, apical dendrites are located on the opposite side of the soma from the axon.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,paola,2012-12-06T13:45:18Z,,,NIF_Subcellular:sao273773228,"A dendrite that emerges near the apical pole of a neuron. In bipolar neurons, apical dendrites are located on the opposite side of the soma from the axon.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0097440,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0097440,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,apical dendrite,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043588,skin development,animal skin development,"The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,animal skin development,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_50557,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0043588,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043588,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,skin development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002835,Aspiration,Pulmonary aspiration,Inspiration of a foreign object into the airway.,false,,,http://purl.obolibrary.org/obo/HP_0002795,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US:413585005|UMLS:C2712334|UMLS:C0700198|SNOMEDCT_US:68052005,Inspiration of a foreign object into the airway.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,Pulmonary aspiration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002795,,,,HP:0002835,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,HP:0002835,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Aspiration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007155,cell adhesion,cell adhesion molecule activity|single organism cell adhesion,"The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,davidos,2014-04-15T15:59:10Z,,,Wikipedia:Cell_adhesion,"The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0098602,,,,,,,,,biological_process,,cell adhesion molecule activity|single organism cell adhesion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0007155,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,GO:0007155,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,cell adhesion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000114,"oxygen uptake diminishment
",,,false,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0019139,,,,,Modified definition,,,,,true,,,,,,Diminished oxygen uptake.,,,,,,,,,,,,,,,,"oxygen uptake diminishment
",,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098984,neuron to neuron synapse,,A synapse in which pre and post-synaptic cells are neurons.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,A synapse in which pre and post-synaptic cells are neurons.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0098984,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098984,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,neuron to neuron synapse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046634,regulation of alpha-beta T cell activation,regulation of alpha-beta T lymphocyte activation|regulation of alpha-beta T-cell activation|regulation of alpha-beta T-lymphocyte activation,"Any process that modulates the frequency, rate or extent of alpha-beta T cell activation.",false,,,http://purl.obolibrary.org/obo/GO_0051249,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of alpha-beta T cell activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of alpha-beta T lymphocyte activation|regulation of alpha-beta T-cell activation|regulation of alpha-beta T-lymphocyte activation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051249,,,,GO:0046634,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0046634,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of alpha-beta T cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_11244,Pneumoviridae,Pneumovirinae,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_11157,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_family,Pneumovirinae,,,,,,NCBITaxon:11244,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_11157,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Pneumoviridae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_65,connective tissue disease,connective tissue disorder|disorder of connective tissue,"A musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage.",false,,,http://purl.obolibrary.org/obo/DOID_17,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:105969002|UMLS_CUI:C0009782|MESH:D003240|NCI:C26729,"A musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,connective tissue disorder|disorder of connective tissue,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_17,,,,DOID:65,,,,,,,,,,,,,,,DOID:65,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,connective tissue disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_305412,SARS coronavirus C014,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:305412,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus C014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_344702,SARS coronavirus ZJ0301,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:344702,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ZJ0301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_248485,SARS coronavirus AS,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:248485,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus AS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249081,SARS coronavirus ZS-B,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249081,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ZS-B,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019882,antigen processing and presentation,antigen presentation|antigen processing,The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Antigen_presentation,The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030333,,,,antigen presentation|antigen processing,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0019882,,,,,,true,true,,,,,,,,GO:0019882,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antigen processing and presentation,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0060337,type I interferon signaling pathway,type I interferon-mediated signalling pathway|type I interferon-activated signaling pathway|type I interferon-mediated signaling pathway,"A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.",false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,,"A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,type I interferon-mediated signalling pathway|type I interferon-activated signaling pathway,,,,,biological_process,,type I interferon-mediated signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0060337,,,,,,,true,,true,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1|https://www.ncbi.nlm.nih.gov/pubmed/32142938,,,,GO:0060337,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,type I interferon signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006241,RRM2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,R2|RR2M|RR2,,,,,,,2,,,,,,,,,,Ensembl:ENSG00000171848|Vega:OTTHUMG00000090449|MIM:180390|HPRD:01587|HGNC:10452,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,ribonucleotide reductase M2,,2p25-p24,,,,"GO_0000082 (EC: TAS); GO_0000083 (EC: TAS); GO_0000278 (EC: TAS); GO_0004748 (EC: ISS); GO_0004748 (EC: NAS, PMID: 1627826); GO_0005515 (EC: IPI); GO_0005634 (EC: IDA); GO_0005654 (EC: TAS); GO_0005737 (EC: IDA); GO_0005829 (EC: TAS); GO_0006260 (EC: IEA); GO_0009186 (EC: IEA); GO_0009263 (EC: ISS); GO_0015949 (EC: TAS); GO_0044281 (EC: TAS); GO_0046872 (EC: IEA); GO_0051290 (EC: IEA); GO_0055086 (EC: TAS)",PMID: 1627826; 3311968; 7937751; 9990288; 10631117; 11517226; 11781084; 11978967; 11978970; 12477932; 12615712; 12655059; 12694192; 14583450; 14661056; 14702039; 14729598; 15096505; 15489334; 15815621; 16344560; 16376858; 16964243; 17222798; 17486094; 18278438; 18414411; 18820369; 18941749; 19002265; 19082948; 19250552; 19322201; 19416980; 19568409; 19639316; 20056645; 20155784; 20159953; 20484015; 20587610; 20825972; 20927319; 21139048; 21166702; 21628579; 21844567; 21873171; 21875941; 21890473; 21906983; 21963094; 21965764; 22166006; 22190034; 22505724; 22569992; 22632967; 22670179; 22797925; 22884145; 22939629; 23002339; 23249808; 23335963; 23466567; 23519412; 23535732; 23719266; 24082141,,,,,,,,,,,,,,,,,,OGG:3000006241,,,,,,,,,,,,,,,,,,,ribonucleotide reductase M2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,RRM2,,,20140408,6241,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,RRM2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_267383,SARS coronavirus Sin842,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267383,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin842,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249070,SARS coronavirus HSZ-Bb,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249070,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HSZ-Bb,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000796,CALCA,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CALC1|CGRP|KC|CGRP-I|CT|CGRP1,,,,,,,11,,,,,,,,,,MIM:114130|HGNC:1437|HPRD:00238|Vega:OTTHUMG00000159731|Ensembl:ENSG00000110680,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,calcitonin-related polypeptide alpha,,11p15.2,,,,"GO_0001935 (EC: IDA, PMID: 17267696); GO_0001944 (EC: IDA, PMID: 17267696); GO_0001976 (EC: IDA, PMID: 10642343); GO_0001984 (EC: IEA); GO_0002027 (EC: IEA); GO_0002031 (EC: IDA, PMID: 10882736); GO_0002548 (EC: IDA, PMID: 15248232); GO_0005102 (EC: IDA, PMID: 16014619); GO_0005179 (EC: IEA); GO_0005515 (EC: IPI, PMID: 17689535); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 18057382); GO_0005634 (EC: IEA); GO_0005737 (EC: IDA, PMID: 17267696); GO_0005737 (EC: IEA); GO_0006468 (EC: IDA); GO_0006954 (EC: IEA); GO_0007159 (EC: IDA, PMID: 1326102); GO_0007189 (EC: IEA); GO_0007190 (EC: IDA, PMID: 10822112); GO_0007204 (EC: IDA, PMID: 17983652); GO_0007218 (EC: IEA); GO_0007267 (EC: TAS, PMID: 2408883); GO_0007566 (EC: IDA, PMID: 17983652); GO_0007568 (EC: IEA); GO_0007631 (EC: IEA); GO_0008217 (EC: NAS, PMID: 1318039); GO_0009408 (EC: IEA); GO_0010523 (EC: IDA, PMID: 16014619); GO_0030279 (EC: IEA); GO_0030819 (EC: IDA, PMID: 10882736); GO_0031623 (EC: IDA, PMID: 10882736); GO_0031645 (EC: IEA); GO_0031716 (EC: IPI, PMID: 8078488); GO_0032147 (EC: IDA, PMID: 17983652); GO_0032403 (EC: IDA, PMID: 14722252); GO_0032730 (EC: IDA, PMID: 16904178); GO_0032757 (EC: IDA, PMID: 16904178); GO_0042802 (EC: IPI); GO_0043025 (EC: IEA); GO_0043195 (EC: IEA); GO_0043542 (EC: IDA, PMID: 17267696); GO_0045651 (EC: IDA, PMID: 10822112); GO_0045671 (EC: IDA, PMID: 10822112); GO_0045762 (EC: IDA, PMID: 11014233); GO_0045776 (EC: IDA, PMID: 10642343); GO_0045778 (EC: IEA); GO_0045779 (EC: IDA, PMID: 17241109); GO_0045892 (EC: IDA, PMID: 11014233); GO_0045909 (EC: IDA, PMID: 3266556); GO_0045986 (EC: IEA); GO_0048265 (EC: IEA); GO_0050727 (EC: IEA); GO_0050965 (EC: IEA); GO_0051480 (EC: IDA, PMID: 9685362); GO_0051482 (EC: IDA, PMID: 8078488)",PMID: 1318039; 1326102; 1761559; 1988044; 2001366; 2039456; 2408883; 2571128; 2578663; 2983422; 3001670; 3034287; 3259294; 3266556; 3485540; 3492492; 3549095; 3872459; 5760861; 6132180; 6148938; 6327497; 6546550; 6609312; 6610687; 8078488; 8405394; 8468047; 8626685; 8940110; 9620797; 9685362; 10642343; 10754330; 10822112; 10882736; 11014233; 11185743; 11317366; 11337490; 11389975; 11803621; 12036966; 12063634; 12198603; 12213903; 12220731; 12231407; 12234182; 12359227; 12369791; 12446725; 12477932; 12517415; 12529288; 12540523; 12590613; 12594852; 12728303; 12871824; 12917321; 14586070; 14627864; 14654229; 14668209; 14684361; 14722252; 14745805; 14759258; 14984255; 15155765; 15168342; 15203218; 15248232; 15300632; 15319367; 15449935; 15489334; 15621724; 15696922; 15761041; 15761654; 15784626; 15880427; 16014619; 16236878; 16386179; 16439457; 16511394; 16531504; 16574742; 16597919; 16611736; 16710309; 16712930; 16720289; 16840549; 16890288; 16904178; 16996466; 17026622; 17038199; 17087112; 17101796; 17123735; 17149558; 17207965; 17241109; 17251226; 17267696; 17381353; 17441790; 17481780; 17485015; 17535749; 17552872; 17558349; 17669797; 17676478; 17689535; 17710246; 17785463; 17934713; 17941085; 17983652; 18000879; 18039931; 18057382; 18167349; 18180663; 18197882; 18211417; 18240029; 18295515; 18384419; 18403669; 18525431; 18556380; 18574663; 18577758; 18626012; 18779512; 18784182; 18941191; 18953261; 18959118; 19078972; 19086053; 19236383; 19282810; 19299090; 19440016; 19447044; 19453261; 19484659; 19485922; 19541012; 19541585; 19543500; 19589278; 19623026; 19685709; 19715516; 19736013; 19797133; 19829249; 19909213; 19913121; 20010500; 20046084; 20131075; 20143189; 20146868; 20146986; 20173430; 20214413; 20233513; 20375903; 20441469; 20530033; 20595156; 20628086; 20654671; 20654748; 20699253; 20803037; 20805714; 20832068; 20890583; 20929576; 20930646; 20959432; 21078153; 21083886; 21195698; 21211657; 21216873; 21219690; 21289592; 21352816; 21391919; 21423046; 21457239; 21541027; 21550738; 21658317; 21703310; 21778801; 21843355; 21937947; 21996233; 22019953; 22074408; 22079264; 22149667; 22200484; 22207498; 22208649; 22233274; 22371911; 22399852; 22429353; 22550867; 22561677; 22573121; 22607374; 22631226; 22652631; 22677443; 22685586; 22819536; 22898635; 22960196; 22961239; 23010746; 23086568; 23118979; 23123709; 23128457; 23214280; 23237777; 23313519; 23327335; 23356193; 23436675; 23461295; 23490535; 23510625; 23552643; 23580106; 23702052; 23722301; 23731651; 23799041; 23813138; 23835994; 23968948; 23975872; 24065474; 24081951; 24379064,,,,,,,,,,,,,,,,,,OGG:3000000796,,,,,,,,,,,,,,,,,,,calcitonin-related polypeptide alpha,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CALCA,,,20140408,796,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CALCA,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000006357,CCL13,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MCP-4|NCC1|NCC-1|SCYL1|CKb10|SCYA13,,,,,,,17,,,,,,,,,,Vega:OTTHUMG00000132890|HGNC:10611|MIM:601391|Ensembl:ENSG00000181374|HPRD:03230,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 13,,17q11.2,,,,"GO_0005102 (EC: TAS, PMID: 9195948); GO_0005615 (EC: IEA); GO_0006874 (EC: TAS, PMID: 9195948); GO_0006935 (EC: TAS, PMID: 9195948); GO_0006954 (EC: IEA); GO_0006955 (EC: IEA); GO_0007010 (EC: IDA, PMID: 10072545); GO_0007165 (EC: TAS, PMID: 9195948); GO_0007267 (EC: TAS, PMID: 9195948); GO_0008009 (EC: IDA, PMID: 10072545); GO_0008360 (EC: IDA, PMID: 10072545); GO_0048245 (EC: IDA, PMID: 10072545)",PMID: 8642349; 8661057; 8955214; 9060459; 9195948; 9405404; 9558100; 10049733; 10072545; 10477718; 10734104; 11342433; 11400154; 11597922; 12149192; 12477932; 12731055; 12805085; 12915769; 14560935; 15489334; 16169070; 16625196; 16855189; 17181634; 17541284; 17703412; 17824960; 17851891; 18219197; 18660381; 19258923; 19423540; 19565514; 19865101; 20056178; 20139115; 20237496; 20406964; 20438785; 20503287; 20628624; 21327296; 21832049; 22393877; 22412388; 23128233; 23375121,,,,,,,,,,,,,,,,,,OGG:3000006357,,,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 13,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCL13,,,20140408,6357,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,CCL13,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000000917,CD3G,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IMD17|T3G|CD3-GAMMA,,,,,,,11,,,,,,,,,,HGNC:1675|HPRD:07037|MIM:186740,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"CD3g molecule, gamma (CD3-TCR complex)",,11q23,,,,"GO_0004888 (EC: IMP, PMID: 12794121); GO_0005886 (EC: TAS); GO_0005887 (EC: NAS, PMID: 9485181); GO_0006461 (EC: NAS, PMID: 12794121); GO_0007163 (EC: IMP, PMID: 12407027); GO_0007166 (EC: IMP, PMID: 12407027); GO_0015031 (EC: IMP, PMID: 12794121); GO_0030159 (EC: NAS, PMID: 12794121); GO_0031295 (EC: TAS); GO_0038096 (EC: TAS); GO_0042101 (EC: NAS, PMID: 9485181); GO_0042105 (EC: IEA); GO_0042110 (EC: NAS, PMID: 12407027); GO_0042608 (EC: NAS, PMID: 11186279); GO_0045087 (EC: TAS); GO_0046982 (EC: IPI, PMID: 9485181); GO_0050776 (EC: TAS); GO_0050852 (EC: TAS); GO_0070228 (EC: IMP, PMID: 12407027)",PMID: 1385321; 1387664; 1535555; 1635567; 1709425; 1826255; 1832084; 1979339; 2111780; 2138083; 2139676; 2540970; 2547833; 2826124; 2944745; 3112151; 3478717; 7506554; 7517794; 7533164; 7539755; 7774645; 8125298; 8125527; 8145026; 8636209; 8809126; 9045614; 9263011; 9485181; 9510190; 9582308; 9743208; 10722370; 11048639; 11186279; 11298321; 11827988; 12374807; 12407027; 12410792; 12477932; 12794121; 15459203; 15489334; 15489916; 15638726; 15778375; 15879122; 16094384; 16344560; 16777597; 16888097; 16888650; 16916653; 17001685; 17023417; 17176095; 17632570; 17652306; 17822534; 17923503; 17928336; 18051367; 18473783; 18541215; 18808677; 18815285; 19056690; 19536290; 19724882; 19726522; 19759518; 19860678; 19898481; 20012528; 20179761; 20237496; 20478055; 20511557; 20594957; 20660709; 20824090; 21669053; 21669059; 21670311; 21764047; 21984702; 22401598; 22482414; 22505724; 22731821; 22911005; 23336327; 23348211; 23590417,,,,,,,,,,,,,,,,,,OGG:3000000917,,,,,,,,,,,,,,,,,,,"CD3g molecule, gamma (CD3-TCR complex)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CD3G,,,20140408,917,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,CD3G,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/PR_000050287,uridylate-specific endoribonuclease (SARS-CoV-2),"UniProtKB:P0DTD1, 6453-6798|PRO_0000449632|ORF1ab/Clv:nsp15 (SARS2)|NendoU (SARS2)|endoRNAse (SARS2)|nsp15 (SARS2)",An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 6452-6453 and 6798-6799.|Category=organism-modification. Note: 346 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050283,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725310,An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 6452-6453 and 6798-6799.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"UniProtKB:P0DTD1, 6453-6798|PRO_0000449632|ORF1ab/Clv:nsp15 (SARS2)|NendoU (SARS2)|endoRNAse (SARS2)|nsp15 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 346 aa protein.,,http://purl.obolibrary.org/obo/PR_000050283,,,,PR:000050287,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32218151,,,,PR:000050287,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,uridylate-specific endoribonuclease (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043296,apical junction complex,apical junction|apical cell junction complex,"A functional unit located near the cell apex at the points of contact between epithelial cells, which in vertebrates is composed of the tight junction, the zonula adherens, and desmosomes and in some invertebrates, such as Drosophila, is composed of the subapical complex (SAC), the zonula adherens and the septate junction. Functions in the regulation of cell polarity, tissue integrity and intercellular adhesion and permeability.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"A functional unit located near the cell apex at the points of contact between epithelial cells, which in vertebrates is composed of the tight junction, the zonula adherens, and desmosomes and in some invertebrates, such as Drosophila, is composed of the subapical complex (SAC), the zonula adherens and the septate junction. Functions in the regulation of cell polarity, tissue integrity and intercellular adhesion and permeability.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,apical junction|apical cell junction complex,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0043296,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0043296,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,apical junction complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051017,actin filament bundle assembly,actin cable assembly|actin bundling activity|actin cable formation,The assembly of actin filament bundles; actin filaments are on the same axis but may be oriented with the same or opposite polarities and may be packed with different levels of tightness.,false,,,http://purl.obolibrary.org/obo/GO_0061572,,,,,,,,,,,,,,,,,,,,,The assembly of actin filament bundles; actin filaments are on the same axis but may be oriented with the same or opposite polarities and may be packed with different levels of tightness.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045011,,,,,,,,,biological_process,,actin cable assembly|actin bundling activity|actin cable formation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0061572,,,,GO:0051017,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051017,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,actin filament bundle assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007292,female gamete generation,,Generation of the female gamete; specialised haploid cells produced by meiosis and along with a male gamete takes part in sexual reproduction.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,Generation of the female gamete; specialised haploid cells produced by meiosis and along with a male gamete takes part in sexual reproduction.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0007292,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007292,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,female gamete generation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_12177,common variable immunodeficiency,sporadic hypogammaglobulinemia|acquired hypogammaglobulinemia|acquired agammaglobulinemia|CVID|common variable agammaglobulinemia,"An agammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells.|Xref MGI.
OMIM mapping confirmed by DO. [SN].",false,,,http://purl.obolibrary.org/obo/DOID_2583,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:23238000|ICD9CM:279.06|MESH:D017074|OMIM:613495|OMIM:614699|ICD10CM:D83|OMIM:613493|OMIM:613496|OMIM:607594|OMIM:614700|OMIM:615577|OMIM:613494|OMIM:615767|ORDO:1572|GARD:6140|UMLS_CUI:C0009447|OMIM:240500,An agammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,sporadic hypogammaglobulinemia|acquired hypogammaglobulinemia|acquired agammaglobulinemia|CVID|common variable agammaglobulinemia,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Xref MGI.
OMIM mapping confirmed by DO. [SN].",,http://purl.obolibrary.org/obo/DOID_2583,,,,DOID:12177,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217650/,,,,DOID:12177,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_rare_slim,,,,,,,,,,common variable immunodeficiency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_16796,melatonin,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide|melatonin|Melatonin|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide|N-Acetyl-5-methoxytryptamine|5-methoxy-N-acetyltryptamine|melatonine,A member of the class of  acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:205542|MetaCyc:N-ACETYL-5-METHOXY-TRYPTAMINE|HMDB:HMDB0001389|PMID:18212404|PDBeChem:ML1|KEGG:C01598|LINCS:LSM-4779|CAS:73-31-4|Wikipedia:Melatonin|PMID:16678784|Drug_Central:1672|KEGG:D08170|DrugBank:DB01065|Beilstein:205542|PMID:18485664,A member of the class of  acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:6730|CHEBI:14577|CHEBI:25180,,,,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide|melatonin|Melatonin,,,,,chebi_ontology,,N-[2-(5-methoxyindol-3-yl)ethyl]acetamide|N-Acetyl-5-methoxytryptamine|5-methoxy-N-acetyltryptamine|melatonine,,,,,,,,,0,C13H16N2O2,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",DRLFMBDRBRZALE-UHFFFAOYSA-N,232.283,232.12118,C=1C=C(C=C2C(=CNC12)CCNC(=O)C)OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:16796,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:16796,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,melatonin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000020,specifically dependent continuant,,b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003]),false,,,http://purl.obolibrary.org/obo/BFO_0000002,,,,,SpecificallyDependentContinuant,sdc,,,,,,,,,,,,,,,b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003]),,,,,,,,"Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc.",,,,,"the role of being a doctor|of one-sided specifically dependent continuants: the mass of this tomato|of relational dependent continuants (multiple bearers): John’s love for Mary, the ownership relation between John and this statue, the relation of authority between John and his subordinates.|the shape of this hole.|the disposition of this fish to decay|the pink color of a medium rare piece of grilled filet mignon at its center|the mutual dependence of proton donors and acceptors in chemical reactions [79|Reciprocal specifically dependent continuants: the function of this key to open this lock and the mutually dependent disposition of this lock: to be opened by this key|the smell of this portion of mozzarella|the function of this heart: to pump blood|the mutual dependence of the role predator and the role prey as played by two organisms in a given interaction",,,,,,,,,(iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000020,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000002,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,specifically dependent continuant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_35718,antifungal agent,antifungal agents|antifungal|antifungal drug|antifungal drugs|antifungals,An  antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,An  antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,antifungal agents|antifungal|antifungal drug|antifungal drugs|antifungals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:35718,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32166607,,,,CHEBI:35718,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,antifungal agent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000037,abnormal homeostasis,,Homeostasis that is clinically abnormal for an organism of a given type and age in a given environment.,false,,,http://purl.obolibrary.org/obo/OGMS_0000032,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T11:26:44Z,,Homeostasis that is clinically abnormal for an organism of a given type and age in a given environment.,,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000037,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000032,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,abnormal homeostasis,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/NCBITaxon_131567,cellular organisms,biota,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_1,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,biota,,,,,,NCBITaxon:131567,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_1,,,,,,,,,,,,,,,,A cellular organism is an organism that contains one or more cells.,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,cellular organisms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10375,Lymphocryptovirus,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10374,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,,,,,,,NCBITaxon:10375,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10374,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Lymphocryptovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031099,regeneration,,"The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Regeneration_(biology),"The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0031099,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031099,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regeneration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003824,KLRD1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CD94,,,,,,,12,,,,,,,,,,Ensembl:ENSG00000134539|HPRD:04204|HGNC:6378|MIM:602894,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"killer cell lectin-like receptor subfamily D, member 1",,12p13,,,,"GO_0004888 (EC: TAS, PMID: 7589107); GO_0005886 (EC: TAS); GO_0007166 (EC: TAS, PMID: 7589107); GO_0009897 (EC: IEA); GO_0016021 (EC: IEA); GO_0030246 (EC: IEA); GO_0045087 (EC: TAS); GO_0050776 (EC: TAS)",PMID: 7589107; 8046333; 8769479; 8943374; 9034158; 9405670; 9472066; 9485206; 9486650; 9598306; 9601951; 9655483; 9815261; 9886400; 10023772; 10201920; 10320637; 11493613; 11513152; 11751968; 12149421; 12165520; 12387742; 12444112; 12461076; 12477932; 12618865; 14607929; 14734748; 15489334; 15528343; 15561299; 15940674; 16237464; 16378079; 17706207; 17767552; 17976318; 18083576; 18323797; 18332182; 18363778; 18448674; 19124726; 19303396; 19555665; 19782712; 19811464; 19897577; 20132973; 20237496; 20648603; 20654155; 21212510; 22102879; 22384114; 22486170; 22576308; 24030638; 24082146,,,,,,,,,,,,,,,,,,OGG:3000003824,,,,,,,,,,,,,,,,,,,"killer cell lectin-like receptor subfamily D, member 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,KLRD1,,,20140408,3824,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,KLRD1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_31781,lopinavir,"Lopinavir|(2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide","A dicarboxylic acid diamide that is amphetamine is substituted on nitrogen by a (2,6-dimethylphenoxy)acetyl group and on the carbon alpha- to nitrogen by a (1S,3S)-1-hydroxy-3-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1-yl)butanoyl]amino}-4-phenylbutyl group. An antiretroviral of the protease inhibitor class, it is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LINCS:LSM-6027|PMID:24566184|KEGG:D01425|KEGG:C12871|PMID:24805184|PMID:24518130|Drug_Central:1601|CAS:192725-17-0|PMID:25120613|PDBeChem:AB1|HMDB:HMDB0015539|PMID:24014186|Reaxys:9309881|DrugBank:DB01601|PMID:24906762|PMID:24958908,"A dicarboxylic acid diamide that is amphetamine is substituted on nitrogen by a (2,6-dimethylphenoxy)acetyl group and on the carbon alpha- to nitrogen by a (1S,3S)-1-hydroxy-3-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1-yl)butanoyl]amino}-4-phenylbutyl group. An antiretroviral of the protease inhibitor class, it is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Lopinavir|(2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide",,,,,chebi_ontology,,,,,,,,,,,0,C37H48N4O5,"InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1",KJHKTHWMRKYKJE-SUGCFTRWSA-N,628.80080,628.36247,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc1ccccc1)NC(=O)COc1c(C)cccc1C)Cc1ccccc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31781,,,,,,,,,,,,,,,CHEBI:31781,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,lopinavir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030968,endoplasmic reticulum unfolded protein response,ER unfolded protein response|erUPR|SREBP-mediated signalling pathway,"The series of molecular signals generated as a consequence of the presence of unfolded proteins in the endoplasmic reticulum (ER) or other ER-related stress; results in changes in the regulation of transcription and translation.|Note that this term should not be confused with 'response to unfolded protein ; GO:0006986', which refers to any response to the presence of unfolded proteins anywhere in the cell or in multicellular organism. Also see 'ER-associated protein catabolic process ; GO:0030433'.",false,,,http://purl.obolibrary.org/obo/GO_0050789|http://purl.obolibrary.org/obo/GO_0034976,,,,,,,,,,,,,,,,,,,,,The series of molecular signals generated as a consequence of the presence of unfolded proteins in the endoplasmic reticulum (ER) or other ER-related stress; results in changes in the regulation of transcription and translation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ER unfolded protein response|erUPR,,,,,biological_process,,SREBP-mediated signalling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term should not be confused with 'response to unfolded protein ; GO:0006986', which refers to any response to the presence of unfolded proteins anywhere in the cell or in multicellular organism. Also see 'ER-associated protein catabolic process ; GO:0030433'.",,http://purl.obolibrary.org/obo/GO_0050789|http://purl.obolibrary.org/obo/GO_0034976,,,,GO:0030968,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030968,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endoplasmic reticulum unfolded protein response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_253634,SARS coronavirus HB,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:253634,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050867,positive regulation of cell activation,upregulation of cell activation|up regulation of cell activation|up-regulation of cell activation|activation of cell activation|stimulation of cell activation,"Any process that activates or increases the frequency, rate or extent of activation.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of cell activation|up regulation of cell activation|up-regulation of cell activation,,,activation of cell activation|stimulation of cell activation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0050867,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050867,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000011,secondary bacterial infection,,,false,,,http://purl.obolibrary.org/obo/IDO_0000567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IDO_0000567,,,,,,,,Disease,,true,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32292265,"Secondary bacterial infection, as the name suggests, is a bacterial infection that occurs during or after an infection from another pathogen, commonly viruses.",,,,,,,,,,,,,,,,secondary bacterial infection,,,,,,,,,,,,,,,,,,,,,,https://www.reactgroup.org/news-and-views/news-and-opinions/year-2020/covid-19-and-amr-what-do-we-know-so-far/,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_16335,adenosine,"adenosine|ADENOSINE|Adenosine|Adenosin|Adenocor|Adenoscan|6-Amino-9-beta-D-ribofuranosyl-9H-purine|beta-D-Adenosine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adenyldeoxyriboside|Adenocard|Desoxyadenosine|Ade-Rib|9-beta-D-Ribofuranosidoadenine|Deoxyadenosine|(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Ado|Adenine Deoxyribonucleoside|9-beta-D-ribofuranosyl-9H-purin-6-amine",A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond.,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,LINCS:LSM-28568|PMID:11820865|KEGG:C00212|PMID:17190852|ECMDB:ECMDB00050|PMID:11213237|PMID:18000974|HMDB:HMDB0000050|Gmelin:53385|CAS:58-61-7|PMID:16917093|Reaxys:93029|DrugBank:DB00640|Drug_Central:90|KEGG:D00045|KNApSAcK:C00007444|MetaCyc:ADENOSINE|PMID:323854|Wikipedia:Adenosine|PMID:11978011|YMDB:YMDB00058|PDBeChem:ADN|Beilstein:93029|PMID:16183671,A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:13734|CHEBI:40825|CHEBI:22237|CHEBI:40906|CHEBI:40558|CHEBI:2472,,,,adenosine|ADENOSINE|Adenosine,,,,,chebi_ontology,,"Adenosin|Adenocor|Adenoscan|6-Amino-9-beta-D-ribofuranosyl-9H-purine|beta-D-Adenosine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adenyldeoxyriboside|Adenocard|Desoxyadenosine|Ade-Rib|9-beta-D-Ribofuranosidoadenine|Deoxyadenosine|(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Ado|Adenine Deoxyribonucleoside|9-beta-D-ribofuranosyl-9H-purin-6-amine",,,,,,,,,0,C10H13N5O4,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",OIRDTQYFTABQOQ-KQYNXXCUSA-N,267.24152,267.09675,Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:16335,,,,,true,true,,,,,,,,,CHEBI:16335,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,adenosine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_44032,indinavir,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide|Indinavir|2-benzyl-5-[(2S)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylmethyl)piperazin-1-yl]-2,3,5-trideoxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-D-erythro-pentonamide|(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:C07051|CAS:150378-17-9|DrugBank:DB00224|Wikipedia:Indinavir|LINCS:LSM-5471|Drug_Central:1437,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:44029|CHEBI:5898,,,,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide|Indinavir|2-benzyl-5-[(2S)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylmethyl)piperazin-1-yl]-2,3,5-trideoxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-D-erythro-pentonamide",,,,,chebi_ontology,,"(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide",,,,,,,,,0,C36H47N5O4,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,613.78968,613.36281,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12)Cc1cccnc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:44032,,,,,true,true,,,,,,,,,CHEBI:44032,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,indinavir,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050273,non-structural protein 4 (SARS-CoV-2),"PRO_0000449638|nsp4 (SARS2)|rep/Clv:nsp4 (SARS2)|PRO_0000449622|UniProtKB:P0DTD1, 2764-3263|UniProtKB:P0DTC1, 2764-3263","A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the combined actions of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 2763-2764, and 3CL-PRO (nsp5) when it cleaves the precursor between residues 3263-3264.|Category=organism-modification. Note: 500 aa protein.",false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725300,"A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the combined actions of PL-PRO proteinase (nsp3) when it cleaves the precursor between residues 2763-2764, and 3CL-PRO (nsp5) when it cleaves the precursor between residues 3263-3264.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"PRO_0000449638|nsp4 (SARS2)|rep/Clv:nsp4 (SARS2)|PRO_0000449622|UniProtKB:P0DTD1, 2764-3263|UniProtKB:P0DTC1, 2764-3263",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 500 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050273,,,,,,,,,true,,https://www.who.int/bulletin/online_first/20-253591.pdf,,,,PR:000050273,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 4 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000005644,PRSS1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TRYP1|TRY1|TRP1|TRY4,,,,,,,7,,,,,,,,,,Ensembl:ENSG00000204983|MIM:276000|HPRD:02039|HGNC:9475|Vega:OTTHUMG00000158923,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"protease, serine, 1 (trypsin 1)",,7q34,,,,"GO_0004252 (EC: TAS, PMID: 8841182); GO_0005576 (EC: NAS, PMID: 14718574); GO_0005576 (EC: TAS); GO_0006766 (EC: TAS); GO_0006767 (EC: TAS); GO_0007586 (EC: IEA); GO_0009235 (EC: TAS); GO_0022617 (EC: TAS); GO_0030198 (EC: TAS); GO_0044281 (EC: TAS); GO_0046872 (EC: IEA); GO_0072562 (EC: IDA)",PMID: 1370825; 1763044; 2437112; 2598466; 3011602; 6589790; 8340386; 8650574; 8683601; 8841182; 8910369; 9169621; 9322498; 9402754; 9633818; 9732462; 10204851; 10381903; 10419450; 10512713; 10835640; 10909845; 10930381; 11057674; 11073545; 11073713; 11260229; 11278730; 11549837; 11702203; 11708864; 11719509; 11734061; 11788572; 11866271; 11932257; 11938439; 12021776; 12120220; 12120234; 12189145; 12360463; 12395893; 12477932; 12529713; 12543931; 12690205; 12765848; 12792776; 12832630; 12939655; 14526128; 14695529; 14718574; 15017610; 15082592; 15174051; 15329520; 15342556; 15651064; 15678497; 15725718; 15749231; 15776435; 15786540; 15952740; 16327984; 16534247; 16685108; 16764792; 16954950; 17003641; 17069643; 17087724; 17474147; 17480209; 17489851; 17613931; 17641559; 17981921; 18063422; 18076731; 18184119; 18272034; 18428024; 18461367; 18511571; 18522894; 18580441; 18702646; 18755888; 18781797; 18852684; 18946221; 18953248; 18986377; 19077465; 19096130; 19433603; 19454815; 19550412; 19593166; 19654461; 19657220; 19690177; 19801634; 19951905; 20001681; 20198321; 20452997; 20484960; 20502448; 20676769; 20950468; 21139048; 21415673; 21499207; 21792085; 21922221; 21952138; 22088471; 22094894; 22109105; 22379635; 22427236; 22539344; 22699143; 22722260; 22939629; 23143602; 23455922; 23474566; 23601753; 23745029; 23745036; 23751316; 23801884; 23864476; 23882137; 24146905; 24624459,,,,,,,,,,,,,,,,,,OGG:3000005644,,,,,,,,,,,,,,,,,,,"protease, serine, 1 (trypsin 1)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PRSS1,,,20140408,5644,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,PRSS1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/BFO_0000009,two-dimensional spatial region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000006,,,,,TwoDimensionalSpatialRegion,2d-s-region,,,,,,,,,,,,,,,,,,,,,,,,,,A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001]),,the surface of a sphere-shaped part of space|an infinitely thin plane in space.,,,,,,,,,(forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000009,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000006,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,two-dimensional spatial region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000383,ARG1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,6,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,arginase 1,,6q23,,,,"GO_0000050 (EC: IEA); GO_0000050 (EC: TAS); GO_0001889 (EC: IEA); GO_0001938 (EC: IEA); GO_0004053 (EC: EXP); GO_0005615 (EC: IEA); GO_0005737 (EC: TAS, PMID: 3540966); GO_0005829 (EC: TAS); GO_0006527 (EC: TAS, PMID: 3540966); GO_0009635 (EC: IEA); GO_0010042 (EC: IEA); GO_0010043 (EC: IEA); GO_0010269 (EC: IEA); GO_0010963 (EC: IEA); GO_0014075 (EC: IEA); GO_0030145 (EC: IEA); GO_0030324 (EC: IEA); GO_0032964 (EC: IEA); GO_0033189 (EC: IEA); GO_0033197 (EC: IEA); GO_0034641 (EC: TAS); GO_0042493 (EC: IEA); GO_0043005 (EC: IEA); GO_0043025 (EC: IEA); GO_0043200 (EC: IEA); GO_0044281 (EC: TAS); GO_0046686 (EC: IEA); GO_0048678 (EC: IEA); GO_0051597 (EC: IEA); GO_0060056 (EC: IEA); GO_0060135 (EC: IEA); GO_0070207 (EC: IEA); GO_0070301 (EC: IEA); GO_0071222 (EC: IEA); GO_0071353 (EC: IEA); GO_0071377 (EC: IEA); GO_0071549 (EC: IEA); GO_0071560 (EC: IEA)",PMID: 1463019; 1598908; 2241902; 2365823; 2913054; 3174433; 3540966; 3658675; 3752085; 7649538; 9686347; 10502833; 10542097; 11224628; 11329013; 11750286; 11849441; 12083807; 12115381; 12139964; 12477932; 14574404; 14702039; 15489334; 15998894; 16387594; 16709958; 16720041; 17113085; 17119118; 17255300; 17347269; 17369504; 17469833; 17703412; 17934065; 18478052; 18617639; 18957279; 19052914; 19101531; 19253371; 19258923; 19281908; 19282757; 19286931; 19293328; 19303401; 19431148; 19508396; 19615732; 19636440; 19684035; 19687346; 19713467; 19789190; 19801451; 19896478; 19913121; 19936428; 20032293; 20124949; 20153713; 20200399; 20301338; 20473875; 20503287; 20562859; 20628086; 20661013; 20711410; 20851928; 20942574; 21039601; 21139048; 21182205; 21206033; 21217072; 21330347; 21533769; 21552555; 21704615; 21800051; 21870783; 21945700; 21988832; 22118674; 22145905; 22189190; 22298472; 22582175; 22827286; 22869115; 22959135; 23061982; 23111165; 23327293; 23348905; 23454751; 23505904; 23740519; 23859858; 24281232; 24457600,,,,,,,,,,,,,,,,,,OGG:3000000383,,,,,,,,,,,,,,,,,,,arginase 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32224164,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ARG1,,,20140408,383,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,ARG1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/DOID_628,combined T cell and B cell immunodeficiency,Congenital Combined Immunodeficiency|combined immunodeficiency,"A primary immunodeficiency disease that involves multiple components of the immune system, including both humoral immunity and cell-mediated immunity.|Xref MGI.",false,,,http://purl.obolibrary.org/obo/DOID_612,,,,,,,,,,,,,,,,,,,,OMIM:312863|ORDO:101972|NCI:C27871|ICD9CM:279.2|ICD10CM:D81|UMLS_CUI:C0494261,"A primary immunodeficiency disease that involves multiple components of the immune system, including both humoral immunity and cell-mediated immunity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Congenital Combined Immunodeficiency|combined immunodeficiency,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Xref MGI.,,http://purl.obolibrary.org/obo/DOID_612,,,,DOID:628,,,,,,,,,,,,,,,DOID:628,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_rare_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,combined T cell and B cell immunodeficiency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000064,peripheral distribution,,,false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,common CT patterns,,true,,,,,,Peripheral ground-glass and consolidative pulmonary opacities.,,,,,,,,,,,,,,,,peripheral distribution,,,,,,,,,,,,,,,,,,,,,,https://www.ajronline.org/doi/full/10.2214/AJR.20.23034,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0040236,Hyperfibrinolysis,,"Increased degradation of fibrin, associated with clot instability and bleeding|This term has been requested and created by members of the BRIDGE consortium",false,,,http://purl.obolibrary.org/obo/HP_0040224,,,,,,,,,,,,,,,,,,,,UMLS:C3805089,"Increased degradation of fibrin, associated with clot instability and bleeding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0040236,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This term has been requested and created by members of the BRIDGE consortium,,http://purl.obolibrary.org/obo/HP_0040224,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Hyperfibrinolysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000622,BDH1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,BDH|SDR9C1,,,,,,,3,,,,,,,,,,Vega:OTTHUMG00000155478|MIM:603063|HGNC:1027|HPRD:04344|Ensembl:ENSG00000161267,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"3-hydroxybutyrate dehydrogenase, type 1",,3q29,,,,"GO_0001889 (EC: IEA); GO_0003858 (EC: IDA, PMID: 8679568); GO_0003858 (EC: TAS); GO_0005543 (EC: IEA); GO_0005634 (EC: IDA); GO_0005730 (EC: IDA, Qualifier: NOT); GO_0005739 (EC: IDA); GO_0005743 (EC: IEA); GO_0005759 (EC: TAS); GO_0007420 (EC: IEA); GO_0007584 (EC: IEA); GO_0009636 (EC: IEA); GO_0032355 (EC: IEA); GO_0032868 (EC: IEA); GO_0042493 (EC: IEA); GO_0042594 (EC: IEA); GO_0044255 (EC: TAS); GO_0044281 (EC: TAS); GO_0045471 (EC: IEA); GO_0046686 (EC: IEA); GO_0046950 (EC: TAS); GO_0046951 (EC: TAS); GO_0046952 (EC: TAS); GO_0051412 (EC: IEA); GO_0060416 (EC: IEA); GO_0060612 (EC: IEA)",PMID: 1639787; 7686368; 8615695; 8679568; 8889549; 10933785; 11009606; 11752456; 12477932; 15489334; 17207965; 18029348; 19027726; 20877624; 21791085; 21832049; 23752268,,,,,,,,,,,,,,,,,,OGG:3000000622,,,,,,,,,,,,,,,,,,,"3-hydroxybutyrate dehydrogenase, type 1",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216803/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,BDH1,,,20140408,622,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,BDH1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_50924,sorafenib,4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide|sorafenibum|N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide|sorafenib,"A member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LINCS:LSM-1008|DrugBank:DB00398|CAS:284461-73-0|KEGG:D08524|Drug_Central:2459|Wikipedia:Sorafenib|PDBeChem:BAX,"A member of the class of phenylureas that is urea in which one of the nitrogens is substituted by a 4-chloro-3-trifluorophenyl group while the other is substituted by a phenyl group which, in turn, is substituted at the para position by a [2-(methylcarbamoyl)pyridin-4-yl]oxy group.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:47228,,,,4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide,,,,,chebi_ontology,,sorafenibum|N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide|sorafenib,,,,,,,,,0,C21H16ClF3N4O3,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",MLDQJTXFUGDVEO-UHFFFAOYSA-N,464.826,464.08630,C1(=C(C=C(C=C1)NC(NC2=CC=C(C=C2)OC3=CC=NC(=C3)C(NC)=O)=O)C(F)(F)F)Cl,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50924,,,,,true,true,,,,,,,,,CHEBI:50924,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,sorafenib,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0045732,positive regulation of protein catabolic process,upregulation of protein catabolic process|up-regulation of protein catabolic process|positive regulation of protein breakdown|positive regulation of protein degradation|up regulation of protein catabolic process|positive regulation of protein catabolism|stimulation of protein catabolic process|activation of protein catabolic process,"Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.",false,,,http://purl.obolibrary.org/obo/GO_0009896|http://purl.obolibrary.org/obo/GO_0042176,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of protein catabolic process|up-regulation of protein catabolic process|positive regulation of protein breakdown|positive regulation of protein degradation|up regulation of protein catabolic process|positive regulation of protein catabolism,,,stimulation of protein catabolic process|activation of protein catabolic process,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009896|http://purl.obolibrary.org/obo/GO_0042176,,,,GO:0045732,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0045732,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of protein catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_35660,HIV protease inhibitor,HIV protease inhibitors,"An inhibitor of HIV protease, an enzyme required for production of proteins needed for viral assembly.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Wikipedia:Protease_inhibitor_(pharmacology),"An inhibitor of HIV protease, an enzyme required for production of proteins needed for viral assembly.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,HIV protease inhibitors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:35660,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32187463,,,,CHEBI:35660,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,HIV protease inhibitor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000120,"RNAaemia
",,,false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,Modified definition,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113704,RNAemia is defined as the detection of viral RNA in samples taken.,,,,,,,,,,,,,,,,"RNAaemia
",,,,,,,,,,,,,,,,,,,,,,https://www.fda.gov/media/101367/download,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000045,disorder,,A material entity which is clinically abnormal and part of an extended organism. Disorders are the physical basis of disease.,false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T11:39:44Z,,A material entity which is clinically abnormal and part of an extended organism. Disorders are the physical basis of disease.,,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000045,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,disorder,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/GO_0005923,bicellular tight junction,zonula occludens,An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.,false,,,http://purl.obolibrary.org/obo/GO_0070160,,,,,,,,,,,,,,,,,,,,Wikipedia:Tight_junction|NIF_Subcellular:sao1939999134,An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,zonula occludens,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0070160,,,,GO:0005923,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005923,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,bicellular tight junction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034381,plasma lipoprotein particle clearance,lipoprotein particle clearance,The process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,lipoprotein particle clearance,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0034381,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034381,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,plasma lipoprotein particle clearance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019730,antimicrobial humoral response,,An immune response against microbes mediated through a body fluid. Examples of this process are seen in the antimicrobial humoral response of Drosophila melanogaster and Mus musculus.,false,,,http://purl.obolibrary.org/obo/GO_0006959,,,,,,,,,,,,,,,,,,,,,An immune response against microbes mediated through a body fluid. Examples of this process are seen in the antimicrobial humoral response of Drosophila melanogaster and Mus musculus.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019735|GO:0006960,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006959,,,,GO:0019730,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019730,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antimicrobial humoral response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_49442,Rhinolophus,horseshoe bats,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_314145,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,horseshoe bats,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,,,,,,,NCBITaxon:49442,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_314145,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32106852,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Rhinolophus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_28412,eriodictyol,"(2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one|Eriodictyol|Eriodictiol|(S)-eriodictyol|(S)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4-benzopyrone","A tetrahydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7, 3' and 4' respectively.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,LIPID_MAPS_instance:LMPK12140432|CAS:552-58-9|KEGG:C05631|LIPID_MAPS_instance:LMPK12140002|Beilstein:92358|KNApSAcK:C00000960,"A tetrahydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7, 3' and 4' respectively.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:4832|CHEBI:49606|CHEBI:23945,,,,"(2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one|Eriodictyol",,,,,chebi_ontology,,"Eriodictiol|(S)-eriodictyol|(S)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4-benzopyrone",,,,,,,,,0,C15H12O6,"InChI=1S/C15H12O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-5,13,16-19H,6H2/t13-/m0/s1",SBHXYTNGIZCORC-ZDUSSCGKSA-N,288.25220,288.06339,Oc1cc(O)c2C(=O)C[C@H](Oc2c1)c1ccc(O)c(O)c1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:28412,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:28412,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,eriodictyol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000451,septic shock,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000450,,,,,,,,,,,,,,,,,,,,UMLS_ICD9CM_2005_AUI:A2797434|UMLS_CUI:C0036983|SyOID:10220|ICD9CM_2005:785.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000450,,,,SYMP:0000451,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076,A state of acute circulatory failure characterized by persistent arterial hypotension despite adequate fluid resuscitation or by tissue hypoperfusion unexplained by other causes.,"Shock, Septic",,SYMP:0000451,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,septic shock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050277,non-structural protein 8 (SARS-CoV-2),"PRO_0000449642|UniProtKB:P0DTD1, 3943-4140|UniProtKB:P0DTC1, 3943-4140|PRO_0000449626|rep/Clv:nsp8 (SARS2)|nsp8 (SARS2)",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3942-3943 and 4140-4141.|Category=organism-modification. Note: 198 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725304,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 3942-3943 and 4140-4141.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"PRO_0000449642|UniProtKB:P0DTD1, 3943-4140|UniProtKB:P0DTC1, 3943-4140|PRO_0000449626|rep/Clv:nsp8 (SARS2)|nsp8 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 198 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050277,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32218151,,,,PR:000050277,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 8 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075514,endosome lysis involved in viral entry into host cell,viral entry into host cell via caveolae-mediated endocytosis followed by endosome lysis,"Viral-induced lysis of the endosome involved in uptake of a virus into a host cell. Occurs after internalization of the virus through the endosomal pathway, and results in release of the viral contents from the endosome into the host cell cytoplasm.",false,,,http://purl.obolibrary.org/obo/GO_0039664,,,,,,,,,,,,,,,,janelomax,2011-07-27T02:56:15Z,,,,"Viral-induced lysis of the endosome involved in uptake of a virus into a host cell. Occurs after internalization of the virus through the endosomal pathway, and results in release of the viral contents from the endosome into the host cell cytoplasm.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral entry into host cell via caveolae-mediated endocytosis followed by endosome lysis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0039664,,,,GO:0075514,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/16115318,,,,GO:0075514,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endosome lysis involved in viral entry into host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0011277,Abnormality of the urinary system physiology,,,false,,,http://purl.obolibrary.org/obo/HP_0000079,,,,,,,,,,,,,,,,peter,2011-12-30T02:51:16Z,,,UMLS:C4023437,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,"Any functional anomaly of any of the organs or tissues responsible for fluid volume regulation, regulating electrolytes, maintaining acid-base homeostasis, and elimination of water and water soluble waste products in an organism",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000079,,,,HP:0011277,,,,,,,,,,,,,,,HP:0011277,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the urinary system physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_247149,SARS coronavirus WHU,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:247149,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus WHU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/FMA_62875,Immunoglobulin E,IgE,,false,,,http://purl.obolibrary.org/obo/FMA_62871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IgE,,,,,fma,,,,,,,,,"It is a monomeric immunoglobulin consisting of two epsilon heavy chains and either two kappa light chains or two lambda light chains, connected by disulfide bonds.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/FMA_62871,,,,FMA:62875,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,FMA:62875,,http://purl.obolibrary.org/obo/fma.owl,,,,,,,,,,,Immunoglobulin E,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_A0A663DJA2,ORF10 protein (SARS-CoV-2),ORF10 (SARS2)|ORF10|GU280_gp11,A protein that is a translation product of the ORF10 gene in SARS-CoV-2.|Category=organism-gene. Note: 38 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725255|UniProtKB:A0A663DJA2,A protein that is a translation product of the ORF10 gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ORF10 (SARS2),,,,,protein,,ORF10|GU280_gp11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 38 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:A0A663DJA2,,,,,,true,,,,,,,,,PR:A0A663DJA2,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,ORF10 protein (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,regulation of cyclin-dependent protein kinase activity|regulation of CDK activity,"Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.",false,,,http://purl.obolibrary.org/obo/GO_1904029,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of cyclin-dependent protein kinase activity,,,regulation of CDK activity,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1904029,,,,GO:0000079,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000079,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of cyclin-dependent protein serine/threonine kinase activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0015934,large ribosomal subunit,ribosomal large subunit,"The larger of the two subunits of a ribosome. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site).",false,,,http://purl.obolibrary.org/obo/GO_0044391,,,,,,,,,,,,,,,,,,,,,"The larger of the two subunits of a ribosome. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ribosomal large subunit,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044391,,,,GO:0015934,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0015934,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,large ribosomal subunit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0097066,response to thyroid hormone,response to thyroid hormone stimulus,"A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,paola,2011-06-14T05:01:18Z,,,,"A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,response to thyroid hormone stimulus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0097066,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0097066,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,response to thyroid hormone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_627,severe combined immunodeficiency,SCID|combined T and B cell inborn immunodeficiency,A combined T cell and B cell immunodeficiency that is caused by a defect in infection-fighting immune cells resulting in individuals with non-functional immune systems.,false,,,http://purl.obolibrary.org/obo/DOID_628,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0085110|NCI:C3472|MESH:D016511|SNOMEDCT_US_2019_09_01:31323000|GARD:7628,A combined T cell and B cell immunodeficiency that is caused by a defect in infection-fighting immune cells resulting in individuals with non-functional immune systems.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SCID|combined T and B cell inborn immunodeficiency,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_628,,,,DOID:627,,,,,,,,,,,,,,,DOID:627,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,severe combined immunodeficiency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002012,Abnormality of the abdominal organs,Abnormality of the abdominal organs|Gastrointestinal tract defects,"An abnormality of the viscera of the abdomen.|The abdominal organs comprise the stomach, small and large intestines, liver, pancreas, bile tract, and spleen.",false,,,http://purl.obolibrary.org/obo/HP_0025031,,,,,,,,,,,,,,,,,,,,UMLS:C4021764,An abnormality of the viscera of the abdomen.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abnormality of the abdominal organs|Gastrointestinal tract defects,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The abdominal organs comprise the stomach, small and large intestines, liver, pancreas, bile tract, and spleen.",,http://purl.obolibrary.org/obo/HP_0025031,,,,HP:0002012,,,,,,,,,,,,,,,HP:0002012,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the abdominal organs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1905897,regulation of response to endoplasmic reticulum stress,regulation of ER stress response|regulation of response to ER stress|regulation of cellular response to endoplasmic reticulum stress,"Any process that modulates the frequency, rate or extent of response to endoplasmic reticulum stress.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,BarbaraCzub,2017-02-01T11:42:55Z,,,,"Any process that modulates the frequency, rate or extent of response to endoplasmic reticulum stress.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation of ER stress response|regulation of response to ER stress|regulation of cellular response to endoplasmic reticulum stress,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1905897,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1905897,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of response to endoplasmic reticulum stress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_349344,Bat SARS CoV Rp3/2004,Bat SARS coronavirus Rp3|Bat SARS-CoV/Rp3/2004,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat SARS coronavirus Rp3|Bat SARS-CoV/Rp3/2004,,,,,,NCBITaxon:349344,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS CoV Rp3/2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_2089,constipation,,A bowel dysfunction that is characterized by infrequent or difficult evacuation of feces.,false,,,http://purl.obolibrary.org/obo/DOID_9779,,,,,,,,,,,,,,,,,,,,ICD9CM:564.0|MESH:D003248|UMLS_CUI:C0009806|SNOMEDCT_US_2019_09_01:14760008|ICD10CM:K59.0|NCI:C37930,A bowel dysfunction that is characterized by infrequent or difficult evacuation of feces.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_9779,,,,DOID:2089,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32193831/,,,,DOID:2089,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,constipation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_45783,imatinib,4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide|4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE|STI 571|imatinib|alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide,"A benzamide obtained by formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine. Used (as its mesylate salt) for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:19052981|PMID:19077095|PMID:15966213|KEGG:D08066|PMID:23580311|PMID:16122278|PMID:18376233|PMID:23075630|PMID:18548219|PMID:15722647|Wikipedia:Imatinib|PMID:19810774|PMID:17457302|PMID:19749465|PMID:15170967|PMID:18407734|Beilstein:7671333|PMID:23536338|Reaxys:7671333|PMID:23574742|PMID:23394269|PDBeChem:STI|PMID:23183914|PMID:19920908|PMID:18423008|PMID:23503753|PMID:19853594|PMID:19097599|PMID:19020005|HMDB:HMDB0014757|PMID:19182535|PMID:18780518|Patent:EP564409|PMID:17717205|Drug_Central:1423|PMID:16826359|PMID:18193246|PMID:18337118|PMID:17410337|PMID:19415889|PMID:15073101|PMID:14715630|PMID:22891806|PMID:15794712|PMID:18344535|PMID:18216472|DrugBank:DB00619|PMID:19591692|PMID:16983347|LINCS:LSM-1023|CAS:152459-95-5|Patent:US5521184|PMID:19242505|PMID:18623899|PMID:19527930|PMID:18809244|PMID:19693287|PMID:23313020|PMID:18420270|PMID:23480638|PMID:17190842|PMID:23587588|PMID:14660054,"A benzamide obtained by formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine. Used (as its mesylate salt) for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:45781|CHEBI:305376|CHEBI:38918,,,,4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide,,,,,chebi_ontology,,4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE|STI 571|imatinib|alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide,,,,,,,,,0,C29H31N7O,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",KTUFNOKKBVMGRW-UHFFFAOYSA-N,493.60270,493.25901,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:45783,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:45783,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,imatinib,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042113,B cell activation,B-lymphocyte activation|B lymphocyte activation|B-cell activation,"The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B-lymphocyte activation|B lymphocyte activation|B-cell activation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042113,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042113,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,B cell activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_66919,ruxolitinib,"(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile|ruxolitinib|INCB018424","A pyrazole substituted at position 1 by a 2-cyano-1-cyclopentylethyl group and at position 3 by a pyrrolo[2,3-d]pyrimidin-4-yl group. Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Wikipedia:Ruxolitinib|Drug_Central:4190|PMID:21926964|Patent:US2008312258|PMID:22227528|PMID:22281165|PMID:22830345|PMID:22279053|PMID:22034658|CAS:941678-49-5|Patent:US2010190981|PMID:22544377|LINCS:LSM-1139|PMID:22422826|PMID:21602517|PMID:22375971|PMID:22375970|KEGG:D09959|PMID:22474318|Reaxys:18703668|PMID:21919691|PMID:22718840|PMID:22399854,"A pyrazole substituted at position 1 by a 2-cyano-1-cyclopentylethyl group and at position 3 by a pyrrolo[2,3-d]pyrimidin-4-yl group. Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile",,,,,chebi_ontology,,ruxolitinib|INCB018424,,,,,,,,,0,C17H18N6,"InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1",HFNKQEVNSGCOJV-OAHLLOKOSA-N,306.36500,306.15929,N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:66919,,,,,,true,,,,,,,,,CHEBI:66919,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ruxolitinib,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC4,envelope small membrane protein (SARS-CoV-2),E protein (SARS2)|PRO_0000449651|E (SARS2)|envelope protein (SARS2)|sM protein (SARS2)|E|GU280_gp04|ORF4,A protein that is a translation product of the E gene in SARS-CoV-2.|Category=organism-gene. Note: 75 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,GenPept:YP_009724392|UniProtKB:P0DTC4,A protein that is a translation product of the E gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,E protein (SARS2)|PRO_0000449651|E (SARS2)|envelope protein (SARS2)|sM protein (SARS2),,,,,protein,,E|GU280_gp04|ORF4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 75 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC4,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,PR:P0DTC4,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,envelope small membrane protein (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264988,SARS coronavirus sf099,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264988,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus sf099,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_50131,5-aza-2'-deoxycytidine,"4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one|4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one|5-azadeoxycytidine|decitabine",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Beilstein:617982|LINCS:LSM-5855|DrugBank:DB01262|Wikipedia:Decitabine|CAS:2353-33-5|Drug_Central:790,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one",,,,,chebi_ontology,,4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one|5-azadeoxycytidine|decitabine,,,,,,,,,0,C8H12N4O4,"InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1",XAUDJQYHKZQPEU-KVQBGUIXSA-N,228.20544,228.08585,Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:50131,,,,,true,true,,,,,,,,,CHEBI:50131,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,5-aza-2'-deoxycytidine,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019362,pyridine nucleotide metabolic process,pyridine nucleotide metabolism,"The chemical reactions and pathways involving a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.",false,,,http://purl.obolibrary.org/obo/GO_0072524|http://purl.obolibrary.org/obo/GO_0006733,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,pyridine nucleotide metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0072524|http://purl.obolibrary.org/obo/GO_0006733,,,,GO:0019362,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019362,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pyridine nucleotide metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0031891,Decreased eosinophil count,,Abnormal reduction in the count of eosinophils in the blood per volume.,false,,,http://purl.obolibrary.org/obo/HP_0020064,,,,,,,,,,,,,,,,peter,,,,,Abnormal reduction in the count of eosinophils in the blood per volume.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0031891,,,,,,,,,,,,,,,,,,2018-05-13T20:35:28Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0020064,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Decreased eosinophil count,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0001981,blood vessel,vascular element|region of vascular tree organ|vascular tree organ region|vas sanguineum,A vessel through which blood circulates in the body.,false,,,http://purl.obolibrary.org/obo/UBERON_0000055|http://purl.obolibrary.org/obo/UBERON_0004120,,,,,,,,,,,,,,,,,,,,FMA:50722|TAO:0002137|VHOG:0001250|NLXANAT:090901|ZFA:0005314|XAO:0001011|CALOHA:TS-0080|EHDAA2:0003252|EMAPA:35993|NCIT:C12679|EFO:0000817|AAO:0011004|MESH:D001808|EHDAA:240|AEO:0000207|OpenCyc:Mx4rvVjxlpwpEbGdrcN5Y29ycA|GAID:169|UMLS:C0005847|EMAPA:32743|FMA:63183|MA:0000060|MAT:0000393|BTO:0001102|http://en.wikipedia.org/wiki/Blood_vessel|http://www.snomedbrowser.com/Codes/Details/361097006|http://linkedlifedata.com/resource/umls/id/C0005847,A vessel through which blood circulates in the body.,,,,http://upload.wikimedia.org/wikipedia/commons/2/29/Circulatory_System_en.svg,,,,"consider adopting the EMAPA superclass 'vascular element', which includes microvasculature (e.g. capillaries), vascular plexus",,,,,,Any of the vessels through which blood circulates in the body.[AAO]|Any of the vessels through which blood circulates in the body. [XAO:0001011_][VHOG],FMA:63183 Blood vessel is categorized as 'general anatomical term'. Suggestion to map to region of vascular tree from Terry H at JAX,,,,,,,,,,,,,vascular element,,,region of vascular tree organ|vascular tree organ region,,,,,uberon,,vas sanguineum,,,,,"The appearance of Chordata and subsequently the vertebrates is accompanied by a rapid structural diversification of this primitive linear heart: looping, unidirectional circulation, an enclosed vasculature, and the conduction system.[well established][VHOG]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000055|http://purl.obolibrary.org/obo/UBERON_0004120,,,,UBERON:0001981,,,,,,true,,,,,,,,,UBERON:0001981,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim,,,,,,,,,,blood vessel,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,"annelids have blood vessels, but this class is not applicable to annelids.",,,,,
http://purl.obolibrary.org/obo/OAE_0001525,mechanical ventilation,,A medical intervention that is a life-support system designed to replace or support normal ventilatory lung function,false,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,,,,,,,,,A medical intervention that is a life-support system designed to replace or support normal ventilatory lung function,,WEB: www.medscape.com/resource/mechanical-ventilation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10067221,,,,,,,,,,,OAE:0001525,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OAE_0000002,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32209544,,,,,,http://purl.obolibrary.org/obo/oae.owl,,,,,,,,,,,mechanical ventilation,,,,,,,,,,,,,,,,,,,,,,,,,,,,"YH, SS",,,,
http://purl.obolibrary.org/obo/GO_0039638,lipopolysaccharide-mediated virion attachment to host cell,"LPS binding involved in viral attachment to host cell|lipopolysaccharide binding involved in viral attachment to host cell|virion attachment, binding to host lipopolysaccharide",The process by which a virion attaches to a host cell by binding to a lipopolysaccharide (LPS) on the host cell surface.,false,,,http://purl.obolibrary.org/obo/GO_0019062,,,,,,,,,,,,,,,,rfoulger,2012-08-17T10:13:06Z,,,,The process by which a virion attaches to a host cell by binding to a lipopolysaccharide (LPS) on the host cell surface.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"LPS binding involved in viral attachment to host cell|lipopolysaccharide binding involved in viral attachment to host cell|virion attachment, binding to host lipopolysaccharide",,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019062,,,,GO:0039638,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32167747,,,,GO:0039638,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lipopolysaccharide-mediated virion attachment to host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000137,C-19 COVID symptom tracker,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000087,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000087,,,,,Modified definition,,,Mobile apps,,true,,,,,,"A new COVID-19 symptom research app is recruiting millions of Americans, including healthcare professionals, cancer patients and survivors, to beat the disease.The app will help identify those at risk sooner, and help slow the outbreak of the disease. Information about those who remain symptom-free will also support better understanding of COVID-19.",,,,,,,,,,,,,,,,C-19 COVID symptom tracker,,,,,,,,,,,,,,,,,,,,,,https://covid.joinzoe.com/?ref=producthunt|https://www.massgeneral.org/cancer-center/news/covid-symptom-tracker-app,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_231517,SARS coronavirus GZ43,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231517,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0071754,"IgM immunoglobulin complex, circulating",IgM antibody,"A polymer of five or six IgM core units each composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds; the individual IgM core units are held together via disulfide bonds with a single J chain polypeptide acting as a bridge between two of the polymeric units. Circulating IgM is present in the extracellular space, in mucosal areas or other tissues, or in the blood or lymph.|Note that an IgM immunoglobulin complex has the function of antigen binding if a suitable antigen is available.",false,,,http://purl.obolibrary.org/obo/GO_0042571|http://purl.obolibrary.org/obo/GO_0019814,,,,,,,,,,,,,,,,midori,2010-03-24T01:44:53Z,,,,"A polymer of five or six IgM core units each composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds; the individual IgM core units are held together via disulfide bonds with a single J chain polypeptide acting as a bridge between two of the polymeric units. Circulating IgM is present in the extracellular space, in mucosal areas or other tissues, or in the blood or lymph.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IgM antibody,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that an IgM immunoglobulin complex has the function of antigen binding if a suitable antigen is available.,,http://purl.obolibrary.org/obo/GO_0042571|http://purl.obolibrary.org/obo/GO_0019814,,,,GO:0071754,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221133,,,,GO:0071754,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"IgM immunoglobulin complex, circulating",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000463,organism substance,body fluid or substance|organism substance|body substance|portion of organism substance|portion of body substance,"Material anatomical entity in a gaseous, liquid, semisolid or solid state; produced by anatomical structures or derived from inhaled and ingested substances that have been modified by anatomical structures as they pass through the body.",false,,,http://purl.obolibrary.org/obo/UBERON_0000465,,,,,,,,,,,,,,,,,,,,FBbt:00007019|FMA:9669|VHOG:0001726|CARO:0000004|galen:BodySubstance|EHDAA2:0003004|MA:0002450|BILA:0000004|TAO:0001487|HAO:0000004|ZFA:0001487|NCIT:C13236|AEO:0000004|TGMA:0001824|EMAPA:35178|XAO:0004001|SPD:0000008|CALOHA:TS-2101|AAO:0010839,"Material anatomical entity in a gaseous, liquid, semisolid or solid state; produced by anatomical structures or derived from inhaled and ingested substances that have been modified by anatomical structures as they pass through the body.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,body fluid or substance|organism substance|body substance|portion of organism substance|portion of body substance,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000465,,,,UBERON:0000463,,,,,,,,,,,,,,,UBERON:0000463,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,organism substance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050852,T cell receptor signaling pathway,T-cell receptor signalling pathway|TCR signaling pathway|T-lymphocyte receptor signaling pathway|T-lymphocyte receptor signalling pathway|T lymphocyte receptor signalling pathway|T-cell receptor signaling pathway|T lymphocyte receptor signaling pathway,A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.,false,,,http://purl.obolibrary.org/obo/GO_0050851,,,,,,,,,,,,,,,,,,,,,A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,T-cell receptor signalling pathway|TCR signaling pathway|T-lymphocyte receptor signaling pathway|T-lymphocyte receptor signalling pathway|T lymphocyte receptor signalling pathway|T-cell receptor signaling pathway|T lymphocyte receptor signaling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050851,,,,GO:0050852,,,,,,true,true,,,,,,,,GO:0050852,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,T cell receptor signaling pathway,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/MONDO_0008651,vertebral hypoplasia with lumbar kyphosis,vertebral hypoplasia with lumbar kyphosis,,false,,,http://purl.obolibrary.org/obo/DOID_17,,,,,,,,,,,,,,,,,,,,MESH:C566002|OMIM:192900|UMLS:C1860463,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,vertebral hypoplasia with lumbar kyphosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_17,,,http://linkedlifedata.com/resource/umls/id/C1860463|http://identifiers.org/mesh/C566002|http://identifiers.org/omim/192900,MONDO:0008651,,,,,,true,true,,,,,Vertebral hypoplasia leading to kyphosis in the upper lumbar area.,,,MONDO:0008651,,http://purl.obolibrary.org/obo/mondo.owl,,,,,,,,,,,vertebral hypoplasia with lumbar kyphosis,,,,,,,,,,,,,,,,,,,,,,http://biorxiv.org/lookup/doi/10.1101/2020.03.13.990226,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_293934,SARS coronavirus PC4-13,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:293934,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000465,material anatomical entity,,Anatomical entity that has mass.,false,,,http://purl.obolibrary.org/obo/UBERON_0001062,,,,,,,,,,,,,,,,,,,,BILA:0000006|AAO:0010264|CARO:0000006|FBbt:00007016|VHOG:0001721|EHDAA2:0003006|TGMA:0001826|TAO:0001836|HAO:0000006|FMA:67165|AEO:0000006,Anatomical entity that has mass.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0001062,,,,UBERON:0000465,,,,,,,,,,,,,,,UBERON:0000465,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,material anatomical entity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_42309,equilin,"EQUILIN|Equilin|3-hydroxyestra-1,3,5(10),7-tetraen-17-one|Dihydroequilenin|7-Dehydroestrone|1,3,5,7-Estratetraen-3-ol-17-one",,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:474-86-2|PDBeChem:EQI|Beilstein:2624302|LINCS:LSM-2063|KEGG:D04041|KEGG:C14392|DrugBank:DB02187|LIPID_MAPS_instance:LMST02010026,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:34740|CHEBI:42304,,,,"EQUILIN|Equilin|3-hydroxyestra-1,3,5(10),7-tetraen-17-one",,,,,chebi_ontology,,"Dihydroequilenin|7-Dehydroestrone|1,3,5,7-Estratetraen-3-ol-17-one",,,,,,,,,0,C18H20O2,"InChI=1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1",WKRLQDKEXYKHJB-HFTRVMKXSA-N,268.35020,268.14633,[H][C@]12CC[C@]3(C)C(=O)CC[C@@]3([H])C1=CCc1cc(O)ccc21,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:42309,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:42309,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,equilin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051983,regulation of chromosome segregation,,"Any process that modulates the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0051983,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051983,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of chromosome segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003501,IGHG2,,,false,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,14,,,,,,,,,,,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,immunoglobulin heavy constant gamma 2 (G2m marker),,14q32.33,,,,"GO_0003823 (EC: IEA); GO_0005515 (EC: IPI, PMID: 16457820); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0006956 (EC: TAS); GO_0006958 (EC: TAS); GO_0038096 (EC: TAS); GO_0045087 (EC: TAS); GO_0072562 (EC: IDA)",PMID: 113060; 118920; 4940472; 5782707; 6299662; 6327276; 6329676; 6407005; 6421489; 6774012; 6804948; 6811139; 7737190; 11257305; 12477932; 15084671; 15174051; 16457820; 16785571; 16944158; 18821675; 18974198; 23225573; 23398456,,,,,,,,,,,,,,,,,,OGG:3000003501,,,,,,,,,,,,,,,,,,,immunoglobulin heavy constant gamma 2 (G2m marker),,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2250009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IGHG2,,,20140408,3501,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,IGHG2,,"Bin Zhao, Yue Liu, Oliver He",,other,,
http://purl.obolibrary.org/obo/GO_0002526,acute inflammatory response,,"Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.",false,,,http://purl.obolibrary.org/obo/GO_0006954,,,,,,,,,,,,,,,,,,,,,"Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006954,,,,GO:0002526,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002526,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,acute inflammatory response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098671,adhesion receptor-mediated virion attachment to host cell,viral attachment to host adhesion receptor,"The process by which a virion attaches to a host cell by binding to a receptor on the host cell surface that does not mediate or trigger entry into the host cell. This binding is typically reversible and enhances significantly infectivity by concentrating the virus in the vicinity of its entry receptors, or bringing it to an organ in which its target cells are located.",false,,,http://purl.obolibrary.org/obo/GO_0046813,,,,,,,,,,,,,,,,dos,2017-01-16T13:22:54Z,,,VZ:3943,"The process by which a virion attaches to a host cell by binding to a receptor on the host cell surface that does not mediate or trigger entry into the host cell. This binding is typically reversible and enhances significantly infectivity by concentrating the virus in the vicinity of its entry receptors, or bringing it to an organ in which its target cells are located.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral attachment to host adhesion receptor,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046813,,,,GO:0098671,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32178593,,,,GO:0098671,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,adhesion receptor-mediated virion attachment to host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267395,SARS coronavirus Sin845,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267395,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin845,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0004396,Poor appetite,Poor appetite|Decreased appetite|No appetite,,false,,,http://purl.obolibrary.org/obo/HP_0011458,,,,,,,,,,,,,,,,peter,2008-03-18T09:12:00Z,,,SNOMEDCT_US:64379006|UMLS:C0232462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poor appetite|Decreased appetite,,,,,human_phenotype,,No appetite,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0011458,,,,HP:0004396,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,Loss of appetite (anorexia) implies that hunger is absent—a person with anorexia has no desire to eat.,Loss of appetite,,HP:0004396,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Poor appetite,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_68621,boceprevir,"(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide|SCH 503034|boceprevir|Victrelis","A synthetic tripeptide consisting of N-(tert-butylcarbamoyl)-3-methyl-L-valyl, a cyclopropyl-fused prolyl and 3-amino-4-cyclobutyl-2-oxobutanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22222799|Patent:WO2006130688|Patent:US2006276406|KEGG:D08876|Patent:US2006276404|Patent:WO2010117936|CAS:394730-60-0|PMID:22570678|PMID:20945949|PMID:23016967|PMID:22239501|Patent:WO2007092616|Reaxys:10502086|Patent:WO2008079216|PMID:22169996|PMID:21828346|Patent:WO2006130553|PMID:22392426|PMID:18201776|Patent:US2005249702|Patent:US2007021351|PMID:22383557|Patent:US2007010431|PMID:22515132|Patent:US2006281688|PDBeChem:HU5|Wikipedia:Boceprevir|Drug_Central:4172|PMID:22397560|PMID:22404758|Patent:WO2008076316|Patent:US2007287664|Patent:US2006281689|PMID:20004570|PMID:22537438|PMID:22506260|PMID:22770811|Patent:US2006276407|PMID:22095516|Patent:WO2008073282|PMID:21123164|PMID:23001704|PMID:22349607|Patent:US2007149459|PMID:22799589|Patent:US2006275366|PMID:22975763|PMID:19456105|PMID:22576324,"A synthetic tripeptide consisting of N-(tert-butylcarbamoyl)-3-methyl-L-valyl, a cyclopropyl-fused prolyl and 3-amino-4-cyclobutyl-2-oxobutanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",,,,,chebi_ontology,,SCH 503034|boceprevir|Victrelis,,,,,,,,,0,C27H45N5O5,"InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1",LHHCSNFAOIFYRV-DOVBMPENSA-N,519.67670,519.34207,[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:68621,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:68621,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,boceprevir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_265124,SARS coronavirus cw037,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:265124,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus cw037,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039522,suppression by virus of host mRNA export from nucleus,negative regulation by virus of host mRNA nuclear export|inhibition of host mRNA nuclear export by virus|inhibition by virus of host mRNA nuclear export|suppression of host mRNA nuclear export by virus,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of movement of mRNA from the nucleus to the cytoplasm in the host organism.",false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2011-06-22T04:34:14Z,,,VZ:902,"Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of movement of mRNA from the nucleus to the cytoplasm in the host organism.",,,,,,,,,,,,,,,,,,,,,,,,,,,,negative regulation by virus of host mRNA nuclear export,,,inhibition of host mRNA nuclear export by virus|inhibition by virus of host mRNA nuclear export|suppression of host mRNA nuclear export by virus,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039522,,,,,,true,,,,,,,,,GO:0039522,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,suppression by virus of host mRNA export from nucleus,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9398,tamsulosin,Tamsulosin|5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide|tamsulosine|(R)-(-)-tamsulosin|tamsulosina|tamsulosin|(-)-tamsulosin|(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|tamsulosinum,"A 5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide that has (R)-configuration. A specific alpha1 adrenoceptor antagonist used (generally as its hydrochloride salt, tamsulosin hydrochloride) in the treatment of prostatic hyperplasia, chronic prostatitis, urinary retention, and help with the passage of kidney stones.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:US4703063|PMID:30174141|Reaxys:6896059|DrugBank:DB00706|KEGG:C07124|Drug_Central:2562|PMID:29737501|PMID:29971698|PMID:29728928|Beilstein:6896059|KEGG:D08560|PMID:29913020|PMID:29974124|PMID:30360332|Patent:EP34432|Wikipedia:Tamsulosin|PMID:2891044|CAS:106133-20-4,"A 5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide that has (R)-configuration. A specific alpha1 adrenoceptor antagonist used (generally as its hydrochloride salt, tamsulosin hydrochloride) in the treatment of prostatic hyperplasia, chronic prostatitis, urinary retention, and help with the passage of kidney stones.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Tamsulosin|5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide,,,,,chebi_ontology,,tamsulosine|(R)-(-)-tamsulosin|tamsulosina|tamsulosin|(-)-tamsulosin|(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|tamsulosinum,,,,,,,,,0,C20H28N2O5S,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",DRHKJLXJIQTDTD-OAHLLOKOSA-N,408.514,408.17189,C=1C=C(OCCN[C@@H](CC2=CC=C(C(=C2)S(N)(=O)=O)OC)C)C(=CC1)OCC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9398,,,,,true,true,,,,,,,,,CHEBI:9398,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tamsulosin,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005996,monosaccharide metabolic process,monosaccharide metabolism,"The chemical reactions and pathways involving monosaccharides, the simplest carbohydrates. They are polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving monosaccharides, the simplest carbohydrates. They are polyhydric alcohols containing either an aldehyde or a keto group and between three to ten or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,monosaccharide metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0005996,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005996,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,monosaccharide metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031577,spindle checkpoint,,A cell cycle checkpoint that originates from the mitotic or meiotic spindle.|Note that this term should not be used for direct manual annotation as it should always be possible to choose either a mitotic or meiotic child term.,false,,,http://purl.obolibrary.org/obo/GO_0000075,,,,,,,,,,,,,,,,,,,,Wikipedia:Spindle_checkpoint,A cell cycle checkpoint that originates from the mitotic or meiotic spindle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term should not be used for direct manual annotation as it should always be possible to choose either a mitotic or meiotic child term.,,http://purl.obolibrary.org/obo/GO_0000075,,,,GO:0031577,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031577,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_manually_annotate,,,,,,,,,,spindle checkpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OBI_0001170,reverse transcription polymerase chain reaction assay,,"An assay that determines the concentration of RNA in a sample in which an RNA strand is first reverse transcribed into its DNA complement (complementary DNA, or cDNA) using the enzyme reverse transcriptase, and the resulting cDNA is amplified using traditional or real-time PCR.",false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,,,,,,,,,,,"An assay that determines the concentration of RNA in a sample in which an RNA strand is first reverse transcribed into its DNA complement (complementary DNA, or cDNA) using the enzyme reverse transcriptase, and the resulting cDNA is amplified using traditional or real-time PCR.",,Penn Group,,,,,,,reverse transcription polymerase chain reaction assay,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,OBI:0001170,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32132196,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,reverse transcription polymerase chain reaction assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,Chris Stoeckert|Jie Zheng,,,,
http://purl.obolibrary.org/obo/NCIT_C85859,Expectorate,EXPECTORATION|Expectorate,To clear material from the throat or lungs by coughing it up and spitting it out.,false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,A technique in which material is cleared from the throat or lungs by coughing it up and spitting it out.,,,,,,,,,C85859,,,CDISC,,,,,,,To clear material from the throat or lungs by coughing it up and spitting it out.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,EXPECTORATION|Expectorate,,,,,,,,,,,,,NCIT:C85859,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32186952/|https://www.ncbi.nlm.nih.gov/pubmed/32193831/,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132314|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830,,,,,,,,,,Expectorate,,,,,,,,,,,,,,,,,,,Expectorate,,,,Activity,,,,,,,,C0566528,
http://purl.obolibrary.org/obo/GO_0051251,positive regulation of lymphocyte activation,upregulation of lymphocyte activation|up-regulation of lymphocyte activation|up regulation of lymphocyte activation|activation of lymphocyte activation|stimulation of lymphocyte activation,"Any process that activates or increases the frequency, rate or extent of lymphocyte activation.",false,,,http://purl.obolibrary.org/obo/GO_0002696|http://purl.obolibrary.org/obo/GO_0051249,,,,,,,,,,,,,,,,,,,,,"Any process that activates or increases the frequency, rate or extent of lymphocyte activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of lymphocyte activation|up-regulation of lymphocyte activation|up regulation of lymphocyte activation,,,activation of lymphocyte activation|stimulation of lymphocyte activation,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002696|http://purl.obolibrary.org/obo/GO_0051249,,,,GO:0051251,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051251,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of lymphocyte activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_55438,Ile(5)-angiotensin II (1-7),L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline|Angiotensin I (1-7)|Angiotensin (1-7)|8-Des-phe-angiotensin II|Angiotensin II (1-7) heptapeptide|Angiotensin II (1-7),An angiotensin compound consisting of the linear heptapeptide sequence L-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:51833-78-4|CAS:39386-80-6|KEGG:C15850|Beilstein:8753045,An angiotensin compound consisting of the linear heptapeptide sequence L-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline,,,,,chebi_ontology,,Angiotensin I (1-7)|Angiotensin (1-7)|8-Des-phe-angiotensin II|Angiotensin II (1-7) heptapeptide|Angiotensin II (1-7),,,,,,,,,0,C41H62N12O11,"InChI=1S/C41H62N12O11/c1-5-22(4)33(38(61)50-29(17-24-19-45-20-47-24)39(62)53-15-7-9-30(53)40(63)64)52-36(59)28(16-23-10-12-25(54)13-11-23)49-37(60)32(21(2)3)51-35(58)27(8-6-14-46-41(43)44)48-34(57)26(42)18-31(55)56/h10-13,19-22,26-30,32-33,54H,5-9,14-18,42H2,1-4H3,(H,45,47)(H,48,57)(H,49,60)(H,50,61)(H,51,58)(H,52,59)(H,55,56)(H,63,64)(H4,43,44,46)/t22-,26-,27-,28-,29-,30-,32-,33-/m0/s1",PVHLMTREZMEJCG-GDTLVBQBSA-N,899.00480,898.46610,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:55438,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32129518,,,,CHEBI:55438,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,Ile(5)-angiotensin II (1-7),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_548681,Herpesvirales,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10239,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_order,,,,,,,NCBITaxon:548681,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10239,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Herpesvirales,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_28971,ampicillin,"6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid|Ampicillin|ampicillin anhydrous|D-(-)-6-(alpha-aminophenylacetamido)penicillanic acid|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|ampicilina|ampicilline|ampicillin acid|AP|ampicillin|ampicillinum|6-(D-(2-amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC|D-(-)-ampicillin|(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID|(2S,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|AMP|Anhydrous ampicillin|aminobenzylpenicillin",A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:GB902703|PMID:16033609|KEGG:C06574|Patent:US3157640|PMID:24474427|CAS:69-53-4|PDB:1H8S|PMID:24666465|VSDB:1849|PMID:18611716|LINCS:LSM-5761|PMID:29017833|DrugBank:DB00415|PMID:10930630|PMID:6176550|PMID:23861268|PMID:23568176|PMID:12833570|PMID:2083978|PMID:25998949|PMID:15768449|PMID:8020088|PMID:9433938|Wikipedia:Ampicillin|Beilstein:4300240|PMID:19967069|PDBeChem:AIC|Drug_Central:198|PMID:14455820|Reaxys:4300240|PMID:14139119|KEGG:D00204|PMID:12562703|PMID:28543395|Patent:US2985648|PMID:12569987|PDBeChem:PN1|HMDB:HMDB0014559,A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:2683|CHEBI:40648|CHEBI:45042|CHEBI:22536,,,,"6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid|Ampicillin",,,,,chebi_ontology,,"ampicillin anhydrous|D-(-)-6-(alpha-aminophenylacetamido)penicillanic acid|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|ampicilina|ampicilline|ampicillin acid|AP|ampicillin|ampicillinum|6-(D-(2-amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC|D-(-)-ampicillin|(2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID|(2S,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|AMP|Anhydrous ampicillin|aminobenzylpenicillin",,,,,,,,,0,C16H19N3O4S,"InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1",AVKUERGKIZMTKX-NJBDSQKTSA-N,349.40500,349.10963,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C(O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:28971,,,,,true,true,,,,,,,,,CHEBI:28971,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ampicillin,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051235,maintenance of location,maintenance of localization|retention|storage|sequestering,"Any process in which a cell, substance or cellular entity, such as a protein complex or organelle, is maintained in a location and prevented from moving elsewhere.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"Any process in which a cell, substance or cellular entity, such as a protein complex or organelle, is maintained in a location and prevented from moving elsewhere.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,maintenance of localization,,,retention|storage|sequestering,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0051235,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051235,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,maintenance of location,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039519,modulation by virus of host autophagy,regulation by virus of host autophagy,"Any process in which a virus effect a change in the frequency, rate or extent of autophagy in the host.",false,,,http://purl.obolibrary.org/obo/GO_0019054,,,,,,,,,,,,,,,,rfoulger,2011-06-22T04:19:19Z,,,,"Any process in which a virus effect a change in the frequency, rate or extent of autophagy in the host.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,regulation by virus of host autophagy,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019054,,,,GO:0039519,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226,,,,GO:0039519,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation by virus of host autophagy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000004599,MX1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MxA|MX|IFI78|IFI-78K,,,,,,,21,,,,,,,,,,HPRD:00919|HGNC:7532|Vega:OTTHUMG00000086755|Ensembl:ENSG00000157601|MIM:147150,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)",,21q22.3,,,,"GO_0003924 (EC: IEA); GO_0005515 (EC: IPI, PMID: 15047845); GO_0005525 (EC: IEA); GO_0005634 (EC: IEA); GO_0005737 (EC: IDA); GO_0005789 (EC: IEA); GO_0005829 (EC: IDA, PMID: 16780588); GO_0005829 (EC: TAS); GO_0006915 (EC: TAS, PMID: 9389754); GO_0006952 (EC: TAS, PMID: 2154602); GO_0007165 (EC: TAS, PMID: 9389754); GO_0009615 (EC: IMP, PMID: 15047845); GO_0019221 (EC: TAS); GO_0034340 (EC: TAS); GO_0045071 (EC: IDA, PMID: 14687945); GO_0045087 (EC: TAS, PMID: 16202617); GO_0048471 (EC: IDA, PMID: 15047845); GO_0051607 (EC: IEA); GO_0060337 (EC: TAS)",PMID: 1548781; 1629950; 1674496; 2154602; 2161946; 2481229; 2607176; 3162334; 8125298; 8411374; 8798556; 9060610; 9093949; 9389754; 9735310; 9933640; 10590150; 10830953; 10942113; 10971132; 11716541; 11805446; 11847228; 11880649; 11911186; 11916975; 12447867; 12477932; 12539042; 12595530; 12867637; 12944978; 14499622; 14687945; 14702039; 14752052; 14872030; 15047845; 15063762; 15117331; 15135736; 15163707; 15221897; 15355513; 15489334; 15602733; 15757897; 15766558; 15850793; 16009940; 16168514; 16202617; 16344560; 16390004; 16413306; 16459719; 16595158; 16704297; 16712791; 16769349; 16780588; 16792864; 16824203; 16843495; 16894313; 16978069; 17075576; 17126411; 17177148; 17307214; 17374778; 17407708; 17570575; 17845304; 17947524; 18549400; 18668195; 18676680; 18782441; 18843779; 19109387; 19170196; 19177264; 19236454; 19297326; 19434718; 19462904; 19625176; 19625466; 19635103; 19692168; 19744071; 19817957; 20019841; 20237496; 20309637; 20331378; 20428112; 20462354; 20494980; 20538602; 20588308; 20603636; 20628624; 20921509; 20959021; 21166595; 21645334; 21832049; 21859714; 21900240; 21906983; 21918813; 21935451; 21962493; 21992152; 22340769; 22507598; 22531919; 22647704; 22714910; 22950423; 22985419; 22998463; 23015724; 23084925; 23115279; 23152507; 23160781; 23232524; 23274784; 23382691; 23438650; 24049170; 24314641,,,,,,,,,,,,,,,,,,OGG:3000004599,,,,,,,,,,,,,,,,,,,"myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,MX1,,,20140408,4599,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,MX1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0009205,purine ribonucleoside triphosphate metabolic process,purine ribonucleoside triphosphate metabolism,"The chemical reactions and pathways involving purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009199|http://purl.obolibrary.org/obo/GO_0009144,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine ribonucleoside triphosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009199|http://purl.obolibrary.org/obo/GO_0009144,,,,GO:0009205,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009205,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine ribonucleoside triphosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042255,ribosome assembly,ribosomal subunit assembly,"The aggregation, arrangement and bonding together of the mature ribosome and of its subunits.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of the mature ribosome and of its subunits.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042257,,,,,,,ribosomal subunit assembly,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042255,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042255,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,ribosome assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001880,GPR183,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,EBI2,,,,,,,13,,,,,,,,,,HGNC:3128|Vega:OTTHUMG00000017263|MIM:605741|HPRD:12040|Ensembl:ENSG00000169508,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,G protein-coupled receptor 183,,13q32.3,,,,"GO_0002313 (EC: ISS); GO_0004930 (EC: IEA); GO_0005886 (EC: IDA); GO_0005887 (EC: TAS, PMID: 8383238); GO_0006955 (EC: TAS, PMID: 8383238); GO_0006959 (EC: ISS); GO_0007186 (EC: IDA); GO_0008142 (EC: IDA); GO_0030890 (EC: IDA); GO_0070374 (EC: IDA)",PMID: 8125298; 8383238; 12477932; 15489334; 16169070; 16540462; 18628402; 21139048; 21261596; 22875855; 22913878; 22930711; 23128233; 23473835,,,,,,,,,,,,,,,,,,OGG:3000001880,,,,,,,,,,,,,,,,,,,G protein-coupled receptor 183,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,GPR183,,,20140408,1880,RP11-461N23.2,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,GPR183,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OBI_0000435,genotyping assay,,An assay which generates data about a genotype from a specimen of genomic DNA. A variety of techniques and instruments can be used to produce information about sequence variation at particular genomic positions.,false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,SNP analysis|genotype profiling,,,,,,,,,,,,,,,,,,An assay which generates data about a genotype from a specimen of genomic DNA. A variety of techniques and instruments can be used to produce information about sequence variation at particular genomic positions.,,OBI Biomaterial,,,,,,,genotyping assay,,,,High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin Chem. 2008 Jan;54(1):86-92. Epub 2007 Nov 2.PMID: 17981923,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,OBI:0000435,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32265180,,,,,,http://purl.obolibrary.org/obo/obi.owl,,,,,,,,,,,genotyping assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,Philippe Rocca-Serra,,,,
http://purl.obolibrary.org/obo/GO_0002250,adaptive immune response,immune memory response|acquired immune response,"An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Adaptive_immune_system,"An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,immune memory response|acquired immune response,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0002250,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32205856,,,,GO:0002250,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,adaptive immune response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046718,viral entry into host cell,virus entry into host cell|entry of virus into host cell|phage translocation|virion penetration|viral penetration|virion penetration into host cell,"The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.|Viral attachment to the host cell is not part of viral entry in GO because virus attachment does not always lead to viral entry: attachment can also result in the virion being carried by the host cell to another location.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,VZ:936,"The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019063,,,,virus entry into host cell|entry of virus into host cell|phage translocation|virion penetration|viral penetration|virion penetration into host cell,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Viral attachment to the host cell is not part of viral entry in GO because virus attachment does not always lead to viral entry: attachment can also result in the virion being carried by the host cell to another location.,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0046718,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0046718,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics,,,,,,,,,,viral entry into host cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046677,response to antibiotic,antibiotic susceptibility/resistance,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,antibiotic susceptibility/resistance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0046677,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,,,,GO:0046677,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,response to antibiotic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000045,sneeze etiquette,,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,Intervention,,true,,,,,,Sneeze etiquette refers to simple hygiene practices everybody can take to prevent passing on respiratory infections like cold and flu to other people.,,,,,,,,,,,,,,,,sneeze etiquette,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/healthywater/hygiene/etiquette/coughing_sneezing.html,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_134722,favipiravir,avigan|T-705,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:4887|CAS:259793-96-9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,avigan|T-705,,,,,,,,,0,C5H4FN3O2,"InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)",ZCGNOVWYSGBHAU-UHFFFAOYSA-N,157.103,157.02875,N=1C(=CN=C(C1C(=O)N)O)F,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:134722,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32307245,,,,CHEBI:134722,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,favipiravir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0003206,cardiac chamber morphogenesis,heart chamber morphogenesis,The process in which a cardiac chamber is generated and organized. A cardiac chamber is an enclosed cavity within the heart.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,dph,2009-10-13T09:14:51Z,,,,The process in which a cardiac chamber is generated and organized. A cardiac chamber is an enclosed cavity within the heart.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,heart chamber morphogenesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0003206,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0003206,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cardiac chamber morphogenesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_49662,indomethacin,"INDOMETHACIN|[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid|Indomethacin|Indocin|Indometacin|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|C19H16ClNO4|COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1|InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)|InChIKey=CGIGDMFJXJATDK-UHFFFAOYSA-N",An indole-3-acetic acid that has formula C19H16ClNO4.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Gmelin:1446006|Beilstein:497341|ChemIDplus:53-86-1|KEGG COMPOUND:53-86-1|KEGG DRUG:D00141|KEGG COMPOUND:C01926|NIST Chemistry WebBook:53-86-1|Wikipedia:Indomethacin|PDBeChem:IMN,An indole-3-acetic acid that has formula C19H16ClNO4.,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:5918|CHEBI:49660,,,,INDOMETHACIN|[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid|Indomethacin,,,,,,,"Indocin|Indometacin|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|C19H16ClNO4|COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1|InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)|InChIKey=CGIGDMFJXJATDK-UHFFFAOYSA-N",,5781,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:49662,,,,,,true,,,,,,,,,CHEBI:49662,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,indomethacin|Indomethacin,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_231519,SARS coronavirus HKU-36871,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231519,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HKU-36871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0060085,organ system benign neoplasm,,A benign neoplasm that is classified by the organ system from which it is arising from.,false,,,http://purl.obolibrary.org/obo/DOID_0060072,,,,,,,,,,,,,,,,lschriml,2011-07-14T12:12:23Z,,,,A benign neoplasm that is classified by the organ system from which it is arising from.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0060072,,,,DOID:0060085,,,,,,,,,,,,,,,DOID:0060085,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim,,,,,,,,,,organ system benign neoplasm,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002086,Abnormality of the respiratory system,Respiratory abnormality,"An abnormality of the respiratory system, which include the airways, lungs, and the respiratory muscles.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,UMLS:C4018871,"An abnormality of the respiratory system, which include the airways, lungs, and the respiratory muscles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Respiratory abnormality,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0002086,,,,,,,,,,,,,,,HP:0002086,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the respiratory system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGMS_0000073,diagnosis,,The representation of a conclusion of a diagnostic process.,false,,,http://purl.obolibrary.org/obo/OGMS_0000123,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T12:42:23Z,,The representation of a conclusion of a diagnostic process.,,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000073,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000123,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,diagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/OGG_3000006347,CCL2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SMC-CF|MCP1|HSMCR30|MCP-1|MCAF|SCYA2|GDCF-2|HC11,,,,,,,17,,,,,,,,,,Ensembl:ENSG00000108691|HPRD:01149|Vega:OTTHUMG00000132887|HGNC:10618|MIM:158105,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 2,,17q11.2-q12,,,,"GO_0000165 (EC: IMP); GO_0001525 (EC: TAS, PMID: 18334747); GO_0001666 (EC: IEA); GO_0001938 (EC: IEA); GO_0002548 (EC: IDA, PMID: 12207323); GO_0004672 (EC: TAS, PMID: 9973507); GO_0005102 (EC: TAS, PMID: 10542238); GO_0005576 (EC: IDA); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0005737 (EC: IEA); GO_0006468 (EC: TAS, PMID: 9670957); GO_0006874 (EC: IEA); GO_0006935 (EC: TAS, PMID: 10623817); GO_0006954 (EC: IDA); GO_0006959 (EC: TAS, PMID: 9548499); GO_0006987 (EC: TAS); GO_0007010 (EC: IDA, PMID: 10072545); GO_0007155 (EC: TAS, PMID: 10198043); GO_0007165 (EC: NAS, PMID: 10770925); GO_0007166 (EC: TAS, PMID: 9548499); GO_0007179 (EC: IEA); GO_0007186 (EC: TAS, PMID: 10542238); GO_0007187 (EC: TAS, PMID: 10770925); GO_0007259 (EC: TAS, PMID: 9670957); GO_0007568 (EC: IEA); GO_0008009 (EC: IEA); GO_0008201 (EC: IEA); GO_0008360 (EC: IDA, PMID: 10072545); GO_0009408 (EC: IEA); GO_0009612 (EC: IEA); GO_0009617 (EC: IEP, PMID: 16034137); GO_0009887 (EC: TAS, PMID: 9364936); GO_0010332 (EC: IEA); GO_0010574 (EC: IEA); GO_0010759 (EC: IEA); GO_0014823 (EC: IEA); GO_0016525 (EC: IEA); GO_0019079 (EC: TAS, PMID: 10985244); GO_0019221 (EC: IDA, PMID: 12207323); GO_0019725 (EC: TAS, PMID: 18334747); GO_0030593 (EC: IEA); GO_0030968 (EC: TAS); GO_0031100 (EC: IEA); GO_0031663 (EC: IDA); GO_0031727 (EC: ISS); GO_0031727 (EC: TAS, PMID: 18021937); GO_0032570 (EC: IEA); GO_0033552 (EC: IEA); GO_0034351 (EC: IDA, PMID: 12753088); GO_0035684 (EC: ISS); GO_0042493 (EC: IEA); GO_0043025 (EC: IEA); GO_0043200 (EC: IEA); GO_0043491 (EC: IMP); GO_0043524 (EC: IDA, PMID: 12753088); GO_0043615 (EC: IDA, PMID: 12271471); GO_0044267 (EC: TAS); GO_0044344 (EC: IEP, PMID: 9407497); GO_0045471 (EC: IEA); GO_0046677 (EC: IEA); GO_0048010 (EC: IEA); GO_0048246 (EC: IDA, PMID: 12207323); GO_0048247 (EC: IEA); GO_0050806 (EC: IEA); GO_0050870 (EC: ISS); GO_0051384 (EC: IEA); GO_0051770 (EC: ISS); GO_0060137 (EC: IEA); GO_0070098 (EC: IEA); GO_0071222 (EC: ISS); GO_0071346 (EC: IEP, PMID: 9407497); GO_0071346 (EC: ISS); GO_0071347 (EC: IEP, PMID: 9407497); GO_0071347 (EC: ISS); GO_0071356 (EC: IEP, PMID: 9407497); GO_0071356 (EC: ISS); GO_0071407 (EC: IDA); GO_0090265 (EC: IEA); GO_2000427 (EC: ISS); GO_2000502 (EC: IDA, PMID: 7545673)",PMID: 1661560; 1857712; 2004761; 2071154; 2322286; 2357211; 2465924; 2501656; 2513477; 2518726; 2648385; 2923622; 7545673; 7651403; 8051410; 8107690; 8195247; 8627182; 8631787; 8639605; 8642344; 8898111; 8989326; 9287323; 9364936; 9405404; 9407497; 9501225; 9548499; 9558113; 9670957; 9789057; 9792375; 9792674; 9837883; 9973507; 10068657; 10072545; 10198043; 10453044; 10477718; 10529171; 10542238; 10587439; 10623817; 10644332; 10706668; 10734104; 10751368; 10770925; 10918580; 10982368; 10985244; 11083865; 11145723; 11154208; 11313374; 11350939; 11500196; 11544456; 11750041; 11751881; 11776402; 11844145; 11878903; 11912219; 11929421; 11989790; 11999660; 12009356; 12022754; 12067898; 12078856; 12082252; 12089333; 12093796; 12117737; 12127997; 12149192; 12183528; 12186702; 12195705; 12204371; 12207323; 12234797; 12239249; 12271471; 12351486; 12358851; 12372466; 12374865; 12391099; 12391196; 12393171; 12397639; 12399623; 12408680; 12410798; 12413001; 12419245; 12443832; 12460032; 12462338; 12470469; 12473373; 12477932; 12485413; 12488502; 12505750; 12520153; 12520365; 12540965; 12632067; 12651071; 12665582; 12724308; 12753088; 12758167; 12787135; 12805068; 12826189; 12826377; 12846738; 12904997; 12944979; 12946945; 12957789; 12960255; 13679391; 14517168; 14517792; 14550782; 14571188; 14576080; 14597108; 14602575; 14620921; 14647058; 14651522; 14660607; 14687706; 14733721; 14767014; 15005768; 15016614; 15022320; 15033992; 15034225; 15041705; 15067078; 15077296; 15081318; 15082170; 15110609; 15115316; 15123743; 15135805; 15167690; 15188361; 15191525; 15191888; 15191916; 15194470; 15203564; 15226634; 15257681; 15280531; 15288699; 15296827; 15302103; 15308783; 15312962; 15349727; 15389752; 15466648; 15468376; 15481145; 15488313; 15489334; 15492853; 15529362; 15545821; 15579297; 15599324; 15602730; 15607028; 15611878; 15627719; 15630704; 15654958; 15677312; 15722361; 15740484; 15745922; 15780578; 15832427; 15848524; 15866653; 15880317; 15883814; 15900302; 15919935; 15976326; 15979992; 16003740; 16004967; 16009177; 16009638; 16020745; 16034137; 16050950; 16078996; 16095529; 16105652; 16116069; 16129702; 16160188; 16164699; 16195477; 16204411; 16206161; 16206198; 16213182; 16214031; 16230097; 16249002; 16278381; 16280328; 16280979; 16307829; 16309586; 16318581; 16351713; 16352737; 16356504; 16358960; 16359995; 16362156; 16397773; 16415174; 16427785; 16436595; 16439461; 16439481; 16439891; 16445900; 16474202; 16479072; 16504689; 16516290; 16518346; 16524739; 16597919; 16609683; 16631114; 16636247; 16636603; 16672419; 16697212; 16697654; 16697675; 16705739; 16712788; 16719905; 16730843; 16733654; 16741188; 16750572; 16751386; 16781696; 16795034; 16802342; 16804844; 16814297; 16825597; 16828028; 16835702; 16867220; 16872505; 16873204; 16903979; 16934270; 16939660; 16980310; 16988194; 16997300; 17008880; 17032917; 17046994; 17052731; 17062130; 17065190; 17082648; 17091019; 17098977; 17138827; 17169533; 17187019; 17202846; 17207568; 17218539; 17262819; 17280738; 17283105; 17284607; 17307163; 17322498; 17364892; 17376903; 17379849; 17384985; 17390372; 17395051; 17404035; 17407231; 17416748; 17417600; 17424890; 17426779; 17431224; 17458901; 17465499; 17485071; 17486299; 17490777; 17495598; 17522215; 17525255; 17530707; 17582674; 17596666; 17625600; 17694504; 17700210; 17703277; 17703412; 17704101; 17706208; 17707134; 17728497; 17763208; 17767550; 17804911; 17822317; 17884268; 17886678; 17917677; 17920586; 17922439; 17928143; 17934860; 17940904; 17943082; 17949278; 17968528; 17968796; 17975143; 17977907; 17982227; 18021937; 18022660; 18032547; 18040846; 18042260; 18055544; 18060801; 18061474; 18069114; 18069417; 18070228; 18074388; 18089573; 18093183; 18093816; 18158188; 18164957; 18172114; 18186797; 18190912; 18191726; 18203956; 18205260; 18208975; 18230355; 18242157; 18266131; 18266972; 18270300; 18271757; 18272603; 18274642; 18276775; 18284633; 18310503; 18314120; 18334747; 18347511; 18371304; 18373164; 18381789; 18395486; 18395775; 18402383; 18436581; 18439751; 18443042; 18458846; 18469140; 18495743; 18506929; 18508485; 18515987; 18521742; 18522702; 18525219; 18528529; 18570214; 18611860; 18615095; 18619701; 18623207; 18636124; 18637012; 18646053; 18651322; 18656701; 18660381; 18660489; 18665050; 18678243; 18684531; 18690522; 18702087; 18702954; 18710415; 18718072; 18758234; 18762729; 18784079; 18790652; 18804983; 18808740; 18818748; 18824549; 18829011; 18837094; 18855195; 18937353; 18940815; 18953909; 18954908; 18962899; 18976655; 18976766; 18977211; 18996102; 18996288; 19001328; 19002595; 19009499; 19014891; 19017462; 19019335; 19020833; 19032843; 19032844; 19032966; 19034671; 19048368; 19055601; 19072670; 19074885; 19092169; 19099590; 19099689; 19100389; 19115220; 19132243; 19136823; 19147409; 19148342; 19152916; 19154405; 19155472; 19156168; 19166999; 19167353; 19168721; 19170716; 19176388; 19185603; 19187096; 19211266; 19215923; 19218821; 19228389; 19233564; 19234509; 19242604; 19247692; 19247801; 19258635; 19258923; 19267279; 19277984; 19281798; 19287949; 19288202; 19298002; 19317061; 19327225; 19328242; 19332042; 19347053; 19357773; 19360344; 19361458; 19364494; 19371341; 19373627; 19376162; 19379593; 19392835; 19409809; 19411748; 19420105; 19423540; 19426980; 19439012; 19441883; 19441886; 19443842; 19446037; 19450143; 19458908; 19465691; 19479998; 19494437; 19496969; 19506371; 19524871; 19525388; 19525846; 19526283; 19527514; 19555664; 19558503; 19565503; 19573434; 19576791; 19587356; 19587833; 19625220; 19628738; 19632522; 19639050; 19641159; 19642141; 19642908; 19644155; 19646633; 19658300; 19664934; 19668598; 19706805; 19711822; 19720836; 19726280; 19729601; 19736361; 19755790; 19755933; 19760754; 19773451; 19777601; 19781192; 19781803; 19782713; 19819989; 19822078; 19828696; 19833726; 19844201; 19851831; 19864434; 19865101; 19866475; 19881959; 19885629; 19893256; 19902472; 19904283; 19906815; 19913121; 19923858; 19926874; 19929093; 19938194; 19941075; 19942750; 19948975; 19957783; 19995900; 20000039; 20004457; 20016208; 20029197; 20029451; 20031554; 20038977; 20040767; 20041183; 20056091; 20056178; 20087947; 20097750; 20100200; 20102417; 20111728; 20121167; 20125127; 20137666; 20138641; 20140679; 20177146; 20179890; 20187772; 20193755; 20196868; 20221866; 20228199; 20231199; 20237358; 20237496; 20299238; 20299783; 20339010; 20339966; 20349326; 20351714; 20364004; 20368224; 20370601; 20374368; 20389059; 20406462; 20406964; 20414371; 20416077; 20423879; 20430117; 20431065; 20432237; 20437404; 20438785; 20442634; 20446021; 20449800; 20449809; 20451256; 20452482; 20484496; 20485444; 20488574; 20497022; 20503287; 20504881; 20523065; 20526368; 20531015; 20540976; 20546673; 20563852; 20570966; 20573518; 20576301; 20602615; 20605053; 20607592; 20610178; 20617559; 20625355; 20628086; 20634732; 20637631; 20650649; 20673868; 20677014; 20681057; 20692455; 20725607; 20726788; 20737475; 20811626; 20818133; 20825374; 20859200; 20861640; 20880493; 20934684; 20947712; 20950459; 20960176; 20962626; 20965747; 21033620; 21037509; 21072187; 21073393; 21087336; 21097527; 21102463; 21107756; 21114970; 21134984; 21135144; 21148795; 21181544; 21183736; 21187454; 21190865; 21199725; 21220697; 21224075; 21247529; 21251883; 21264298; 21264360; 21327296; 21328336; 21354997; 21361908; 21368227; 21376205; 21383955; 21384169; 21385934; 21397653; 21401388; 21413027; 21423810; 21447688; 21450101; 21486440; 21486949; 21504590; 21527853; 21529268; 21529952; 21532752; 21551367; 21556333; 21569455; 21574823; 21610567; 21615418; 21620438; 21627744; 21654748; 21691937; 21701898; 21726903; 21734368; 21744268; 21760952; 21774078; 21787749; 21799302; 21851000; 21855541; 21858104; 21859809; 21868018; 21868706; 21883707; 21890375; 21898402; 21900689; 21906274; 21910857; 21920519; 21924076; 21930770; 21951843; 21951854; 21961038; 21975431; 21991356; 21992868; 22026334; 22037282; 22037980; 22059352; 22081934; 22117412; 22117820; 22125641; 22131127; 22132892; 22138288; 22142522; 22147846; 22152380; 22159219; 22183310; 22197827; 22203484; 22210436; 22226505; 22240432; 22265030; 22276574; 22288595; 22300682; 22301094; 22303443; 22319587; 22319627; 22321225; 22362506; 22377751; 22378888; 22381103; 22384203; 22396538; 22412388; 22420243; 22422499; 22425139; 22427564; 22448134; 22466290; 22472119; 22476561; 22484917; 22487967; 22490648; 22493691; 22541401; 22543850; 22554651; 22558273; 22612293; 22617682; 22619484; 22641100; 22664781; 22669976; 22691208; 22694757; 22697070; 22707193; 22711527; 22721162; 22729037; 22733495; 22739041; 22750227; 22752804; 22759858; 22762377; 22763298; 22766373; 22815949; 22823210; 22848642; 22857869; 22859936; 22861370; 22868806; 22927430; 22942263; 22961048; 22980664; 22981148; 22985557; 22989614; 22992722; 23007133; 23017229; 23037589; 23039889; 23069648; 23090289; 23128233; 23135705; 23143679; 23151275; 23154550; 23160182; 23161207; 23166687; 23180368; 23185481; 23185512; 23192155; 23206327; 23211090; 23224211; 23255244; 23274856; 23300810; 23303452; 23349788; 23350010; 23352833; 23375122; 23383162; 23402987; 23408426; 23416968; 23418647; 23429817; 23434371; 23454776; 23474119; 23490412; 23529020; 23542734; 23548612; 23549806; 23555755; 23557387; 23559389; 23583295; 23629827; 23657965; 23686489; 23704830; 23712703; 23762283; 23770363; 23782302; 23816715; 23831464; 23845726; 23886148; 23887394; 23890452; 23939977; 23954399; 23982944; 23999007; 24058270; 24077340; 24078580; 24260304; 24273921,,,,,,,,,,,,,,,,,,OGG:3000006347,,,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 2,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217117,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCL2,,,20140408,6347,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CCL2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0031647,regulation of protein stability,,"Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0031647,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031647,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,regulation of protein stability,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTC7,protein 7a (SARS-CoV-2),accessory protein 7a (SARS2)|protein U122 (SARS2)|ORF7a (SARS2)|protein X4 (SARS2)|ORF7a|GU280_gp07,A protein that is a translation product of the ORF7a gene in SARS-CoV-2.|Category=organism-gene. Note: 121 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,GenPept:YP_009724395|UniProtKB:P0DTC7,A protein that is a translation product of the ORF7a gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,accessory protein 7a (SARS2)|protein U122 (SARS2)|ORF7a (SARS2)|protein X4 (SARS2),,,,,protein,,ORF7a|GU280_gp07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 121 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTC7,,,,,,true,,,,,,,,,PR:P0DTC7,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,protein 7a (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000010394,PRG3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MBPH|MBP2,,,,,,,11,,,,,,,,,,HGNC:9363|HPRD:08434|Ensembl:ENSG00000156575|MIM:606814|Vega:OTTHUMG00000167026,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,proteoglycan 3,,11q12,,,,"GO_0001694 (EC: IDA, PMID: 10318872); GO_0006955 (EC: IEA); GO_0017148 (EC: IDA, PMID: 10318872); GO_0019370 (EC: IDA, PMID: 10318872); GO_0030246 (EC: IEA); GO_0042119 (EC: IDA, PMID: 10318872); GO_0042554 (EC: IDA, PMID: 10318872); GO_0045416 (EC: IDA, PMID: 10318872); GO_0045575 (EC: IDA, PMID: 10318872)",PMID: 10318872; 11170744; 12477932; 12975309; 15489334; 17136616; 17308074; 20379614; 21048031; 22412388,,,,,,,,,,,,,,,,,,OGG:3000010394,,,,,,,,,,,,,,,,,,,proteoglycan 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PRG3,,,20140408,10394,UNQ486/PRO1002,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.31.019216v1,,,,PRG3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_264371,SARS coronavirus TW-HP1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264371,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-HP1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_77,gastrointestinal system disease,GIT disease|Gastroenteropathy|gastrointestinal disease|alimentary system disease|gastrointestinal disorder|digestive system disorder,A disease of anatomical entity that is located_in the gastrointestinal tract.,false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,MESH:D004066|ICD9CM:520-579.99|SNOMEDCT_US_2019_09_01:53619000|UMLS_CUI:C0012242|ICD10CM:K92.9,A disease of anatomical entity that is located_in the gastrointestinal tract.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:27|DOID:944,,,,GIT disease|Gastroenteropathy|gastrointestinal disease|alimentary system disease|gastrointestinal disorder|digestive system disorder,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:77,,,,,,,,,,,,,,,DOID:77,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,gastrointestinal system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1902554,serine/threonine protein kinase complex,PDR16 complex homodimer|PDR16 complex dimer,A protein complex which is capable of protein serine/threonine kinase activity.|An example is IRE1 in S. cerevisiae (UniProt ID P32361) in PMID:18191223 (inferred from direct assay).,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,bhm,2013-12-06T16:06:12Z,,,,A protein complex which is capable of protein serine/threonine kinase activity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,PDR16 complex homodimer|PDR16 complex dimer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,An example is IRE1 in S. cerevisiae (UniProt ID P32361) in PMID:18191223 (inferred from direct assay).,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:1902554,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902554,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,serine/threonine protein kinase complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050288,2'-O-methyltransferase (SARS-CoV-2),"ORF1ab/Clv:nsp16 (SARS2)|2'-O-ribose methyltransferase (SARS2)|UniProtKB:P0DTD1, 6799-7096|nsp16 (SARS2)|PRO_0000449633",An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 6798-6799.|Category=organism-modification. Note: 298 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050283,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725311,An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 6798-6799.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"ORF1ab/Clv:nsp16 (SARS2)|2'-O-ribose methyltransferase (SARS2)|UniProtKB:P0DTD1, 6799-7096|nsp16 (SARS2)|PRO_0000449633",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 298 aa protein.,,http://purl.obolibrary.org/obo/PR_000050283,,,,PR:000050288,,,,,,true,,,,,,,,,PR:000050288,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,2'-O-methyltransferase (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.who.int/bulletin/online_first/20-255943.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_11157,Mononegavirales,negative-sense genome single-stranded RNA viruses,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_2497574,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,negative-sense genome single-stranded RNA viruses,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_order,,,,,,,NCBITaxon:11157,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_2497574,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Mononegavirales,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000116,azvudine,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32291112,,,,,,,,,,,,,,,,,azvudine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_228330,SARS coronavirus Urbani,SARS coronavirus strain Urbani|SARS-CoV (Urbani strain),,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,SARS coronavirus strain Urbani|SARS-CoV (Urbani strain),,,,,,NCBITaxon:228330,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Urbani,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009206,purine ribonucleoside triphosphate biosynthetic process,purine ribonucleoside triphosphate synthesis|purine ribonucleoside triphosphate biosynthesis|purine ribonucleoside triphosphate anabolism|purine ribonucleoside triphosphate formation,"The chemical reactions and pathways resulting in the formation of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009145|http://purl.obolibrary.org/obo/GO_0009201|http://purl.obolibrary.org/obo/GO_0009205,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,purine ribonucleoside triphosphate synthesis|purine ribonucleoside triphosphate biosynthesis|purine ribonucleoside triphosphate anabolism|purine ribonucleoside triphosphate formation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009145|http://purl.obolibrary.org/obo/GO_0009201|http://purl.obolibrary.org/obo/GO_0009205,,,,GO:0009206,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009206,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,purine ribonucleoside triphosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_227860,SARS coronavirus Vietnam,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:227860,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Vietnam,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044423,virion part,,"Any constituent part of a virion, a complete fully infectious extracellular virus particle.|Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,"Any constituent part of a virion, a complete fully infectious extracellular virus particle.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_131567,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.",,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0044423,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32226285,,,,GO:0044423,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_annotate,,,,,,,,,,virion part,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000047,"clusters of COVID-19
",,,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,Modified definition,,,,,true,,,,,,A collection of COVID-19 cases occurring in the same place at the same time. ,,,,,,,,,,,,,,,,"clusters of COVID-19
",,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000024,bipartite viral genome,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,A segmented viral genome consisting of two sub-genomic nucleic acids but each nucleic acid is packaged into a different virion.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,true,,,,,,,,,,,,,,,,,,,,,,bipartite viral genome,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.04.05.026450v1.full.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0019161,muscle pain,,Muscle pain is a pain characterized by pain in one or more muscles.,false,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,,,,,,,,,,,,,,,,,,Muscle pain is a pain characterized by pain in one or more muscles.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,SYMP:0019161,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32226295,,,,SYMP:0019161,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,muscle pain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264373,SARS coronavirus TW-HP3,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264373,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-HP3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000020,sense organ,organ of sensory system|organ of sense organ system|sensory organ system organ|organ of sensory organ system|sensory organ|sensory system organ|sense organ system organ|sensillum|Sinnesorgan|sensor,An organ that is capable of transducing sensory stimulus to the nervous system.,false,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,,,,,,,,,,,,https://github.com/cmungall,,,,,BTO:0000202|CALOHA:TS-2043|NCIT:C33224|EHDAA2:0001824|HAO:0000930|WBbt:0006929|FBbt:00005155|UMLS:C0935626|GAID:63|VHOG:0001407|AEO:0000094|BSA:0000121|MA:0000017|MESH:D012679|EMAPA:35955|EHDAA:500|http://www.snomedbrowser.com/Codes/Details/244485009|http://linkedlifedata.com/resource/umls/id/C0935626,An organ that is capable of transducing sensory stimulus to the nervous system.,,,,http://upload.wikimedia.org/wikipedia/commons/c/c0/Gray722.png,,,,,,,,,,,,,,,,,,,,,,,,,,,organ of sensory system|organ of sense organ system|sensory organ system organ|organ of sensory organ system|sensory organ|sensory system organ|sense organ system organ,,,sensillum,,uberon,,Sinnesorgan|sensor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,UBERON:0000020,,,,,,,,,,,,,,,UBERON:0000020,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim,,,,,,,,,,sense organ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030135,coated vesicle,,"Small membrane-bounded organelle formed by pinching off of a coated region of membrane. Some coats are made of clathrin, whereas others are made from other proteins.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1985096626,"Small membrane-bounded organelle formed by pinching off of a coated region of membrane. Some coats are made of clathrin, whereas others are made from other proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005909,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030135,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030135,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila,,,,,,,,,,coated vesicle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10379,Rhadinovirus,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10374,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,,,,,,,NCBITaxon:10379,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10374,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Rhadinovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000005245,PHB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,PHB1|HEL-S-54e|HEL-215,,,,,,,17,,,,,,,,,,Vega:OTTHUMG00000134271|HPRD:01454|MIM:176705|HGNC:8912|Ensembl:ENSG00000167085,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,prohibitin,,17q21,,,,"GO_0000122 (EC: IDA, PMID: 16964284); GO_0000981 (EC: IEA); GO_0005515 (EC: IPI, PMID: 11302691); GO_0005634 (EC: IDA, PMID: 16964284); GO_0005634 (EC: TAS, PMID: 16130169); GO_0005654 (EC: IDA, PMID: 12466959); GO_0005737 (EC: IDA, PMID: 16964284); GO_0005739 (EC: IDA); GO_0005743 (EC: TAS, PMID: 14500729); GO_0005887 (EC: IDA, PMID: 15274632); GO_0006260 (EC: IEA); GO_0006355 (EC: IDA, PMID: 14500729); GO_0007165 (EC: TAS, PMID: 16130169); GO_0008285 (EC: IMP, PMID: 18487222); GO_0010944 (EC: IDA, PMID: 18487222); GO_0016575 (EC: IDA, PMID: 12466959); GO_0030308 (EC: IMP, PMID: 12065415); GO_0042826 (EC: IPI, PMID: 16964284); GO_0042981 (EC: TAS, PMID: 16130169); GO_0044212 (EC: IDA, PMID: 18487222); GO_0045892 (EC: IDA, PMID: 12065415); GO_0045892 (EC: IMP, PMID: 18487222); GO_0045893 (EC: IDA, PMID: 14500729); GO_0050847 (EC: IDA, PMID: 16964284); GO_0060766 (EC: IDA, PMID: 16964284); GO_0060766 (EC: IMP, PMID: 18487222); GO_0070062 (EC: IDA); GO_0071354 (EC: IDA, PMID: 17324931); GO_0071897 (EC: IEA); GO_2000323 (EC: IDA, PMID: 16964284)",PMID: 1540973; 1602151; 1684951; 7607556; 7796893; 7843414; 8125298; 8244394; 8401585; 8591812; 8612677; 8706794; 8889548; 9629920; 10376528; 10523633; 11076863; 11256614; 11302691; 11377649; 11517187; 11790298; 12065415; 12085232; 12354477; 12466959; 12477932; 12566959; 12628297; 12821355; 14500355; 14500729; 14637159; 15047060; 15141164; 15250827; 15274632; 15342556; 15378209; 15489334; 15489336; 15614618; 15823758; 16041367; 16130169; 16196087; 16226712; 16236267; 16294014; 16319068; 16381901; 16426920; 16705168; 16918502; 16951178; 16964284; 17004108; 17043753; 17081983; 17203973; 17284347; 17324931; 17544200; 17676665; 17873902; 17932104; 18029348; 18086671; 18183577; 18258228; 18397521; 18487222; 18494604; 18676680; 18709484; 18763282; 18781797; 18789835; 19034380; 19071013; 19170196; 19207009; 19238206; 19327358; 19430483; 19454010; 19591124; 19615732; 19625176; 19640993; 19655254; 19664078; 19692168; 19710421; 19725029; 19725052; 19738201; 19805454; 19854158; 19906925; 20069396; 20133800; 20134482; 20186120; 20186755; 20195357; 20195544; 20301425; 20360068; 20391533; 20462248; 20516557; 20562859; 20596663; 20638487; 20830747; 20856874; 20877624; 21061155; 21081666; 21139048; 21145461; 21152868; 21155232; 21209023; 21275458; 21296110; 21318481; 21319273; 21783252; 21853274; 21879722; 21890473; 21896168; 21903368; 21906983; 21963094; 22124450; 22179832; 22190034; 22212092; 22238093; 22268729; 22304787; 22304920; 22324369; 22363587; 22410782; 22505583; 22536838; 22537547; 22623428; 22669161; 22711522; 22728421; 22904065; 22939629; 22994754; 22997079; 23000965; 23098474; 23244120; 23246001; 23275444; 23327602; 23455922; 23535732; 23587357; 23752268; 23798571; 23870455; 24133204; 24140708; 24380853; 24457600,,,,,,,,,,,,,,,,,,OGG:3000005245,,,,,,,,,,,,,,,,,,,prohibitin,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/19640993,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,PHB,,,20140408,5245,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,PHB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/UBERON_0004923,organ component layer,,A part of a wall of an organ that forms a layer.,false,,,http://purl.obolibrary.org/obo/UBERON_0000064,,,,,,,,,,,,,,,,,,,,FMA:82485,A part of a wall of an organ that forms a layer.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000064,,,,UBERON:0004923,,,,,,,,,,,,,,,UBERON:0004923,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#upper_level,,,,,,,,,,organ component layer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019080,viral gene expression,viral genome expression,"A process by which a viral gene is converted into a mature gene product or products (proteins or RNA). This includes viral transcription, processing to produce a mature RNA product, and viral translation.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"A process by which a viral gene is converted into a mature gene product or products (proteins or RNA). This includes viral transcription, processing to produce a mature RNA product, and viral translation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral genome expression,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019080,,,,,,,true,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32228226/|https://www.ncbi.nlm.nih.gov/pubmed/32221306,,,,GO:0019080,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral gene expression,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHMO_0001592,magnetic bead extraction,magnetic-bead extraction|magnetic separation|MS,A method for extracting biological molecules from a biological sample by functionalising a magnetic bead (0.001–200 μm diameter) with a molecule specific to the target molecule (e.g. complementary DNA or a specific antibody) and placing it in the sample solution. The bead is removed from the solution using a magnetized source.,false,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,,,,,,,,,,,,,,,,,,A method for extracting biological molecules from a biological sample by functionalising a magnetic bead (0.001–200 μm diameter) with a molecule specific to the target molecule (e.g. complementary DNA or a specific antibody) and placing it in the sample solution. The bead is removed from the solution using a magnetized source.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,magnetic-bead extraction|magnetic separation,,,,,,,MS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000833,,,,CHMO:0001592,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32289214,,automated magnetic bead-purification procedure,,CHMO:0001592,,http://purl.obolibrary.org/obo/chmo.owl,,,,,,,,,,,magnetic bead extraction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000245,spliceosomal complex assembly,spliceosome assembly,"The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,spliceosome assembly,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0000245,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000245,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,spliceosomal complex assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019722,calcium-mediated signaling,calcium ion signaling|calcium signaling|calcium signalling|calcium-mediated signalling,Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.,false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,Wikipedia:Calcium_signaling,Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,calcium ion signaling|calcium signaling|calcium signalling|calcium-mediated signalling,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0019722,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019722,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,calcium-mediated signaling,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0025031,Abnormality of the digestive system,,"Any anomaly of the digestive system, a collection of organs that is made up of the gastrointestinal tract and the liver, pancreas, and gallbladder. The gastrointestinal tract is a series of hollow organs joined in a long, twisting tube from the mouth to the anus, including the mouth, esophagus, stomach, small intestine, large intestine and anus.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,HPO:probinson,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0025031,"Any anomaly of the digestive system, a collection of organs that is made up of the gastrointestinal tract and the liver, pancreas, and gallbladder. The gastrointestinal tract is a series of hollow organs joined in a long, twisting tube from the mouth to the anus, including the mouth, esophagus, stomach, small intestine, large intestine and anus.",,,,,,,,,,,,,,,,,2016-08-27T13:44:32Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Any anomaly of the digestive system, a collection of organs that is made up of the gastrointestinal tract and the liver, pancreas, and gallbladder. The gastrointestinal tract is a series of hollow organs joined in a long, twisting tube from the mouth to the anus, including the mouth, esophagus, stomach, small intestine, large intestine and anus.",,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the digestive system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000576,chest pain,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,,,,,,,,,,,,,,,,,SyOID:4705|UMLS_CUI:C0008031|UMLS_ICD9CM_2005_AUI:A0400627|ICD9CM_2005:786.5|ICD9CM_2005:786.50|UMLS_ICD9CM_2005_AUI:A0243830,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000099,,,,SYMP:0000576,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32178547/,"An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the chest.",,,SYMP:0000576,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,chest pain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_135626,gemeprost,cervageme|cergem|cervagem|carprost,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:64318-79-2|Drug_Central:1284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,cervageme|cergem|cervagem|carprost,,,,,,,,,0,C23H38O5,"InChI=1S/C23H38O5/c1-5-6-15-23(2,3)21(26)14-13-18-17(19(24)16-20(18)25)11-9-7-8-10-12-22(27)28-4/h10,12-14,17-18,20-21,25-26H,5-9,11,15-16H2,1-4H3/b12-10+,14-13+/t17-,18-,20-,21-/m1/s1",KYBOHGVERHWSSV-VNIVIJDLSA-N,394.546,394.27192,C(=C/[C@H](C(CCCC)(C)C)O)[C@@H]1[C@@H](CCCC/C=C/C(OC)=O)C(C[C@H]1O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:135626,,,,,true,true,,,,,,,,,CHEBI:135626,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,gemeprost,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9588,ticlopidine,"5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine|ticlopidinum|ticlopidina|ticlopidine","A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Patent:US4127580|Wikipedia:Ticlopidine|CAS:55142-85-3|LINCS:LSM-1986|PMID:19180126|Patent:US4051141|Reaxys:1216802|KEGG:D08594|KEGG:C07140|Patent:DE2404308|DrugBank:DB00208|Drug_Central:2657,"A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine",,,,,chebi_ontology,,ticlopidinum|ticlopidina|ticlopidine,,,,,,,,,0,C14H14ClNS,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",PHWBOXQYWZNQIN-UHFFFAOYSA-N,263.78600,263.05355,Clc1ccccc1CN1CCc2sccc2C1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9588,,,,,true,true,,,,,,,,,CHEBI:9588,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ticlopidine,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_7798,oseltamivir,"ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate|Oseltamivir|Tamiflu|(-)-oseltamivir|oseltamivirum|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|Agucort|oseltamivir|GS-4104|Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|HSDB 7433","A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D08306|PMID:19884755|Reaxys:8003908|DrugBank:DB00198|PMID:17912363|PMID:18559644|CAS:196618-13-0|Wikipedia:Oseltamivir|PMID:11270942|HMDB:HMDB0014343|KEGG:C08092|Patent:US5763483|Beilstein:8003908|PMID:19557131|PMID:18936828|PMID:19355841|PMID:19439487|Drug_Central:2001|PMID:11825310|PMID:11075941,"A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:42582,,,,"ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate|Oseltamivir",,,,,chebi_ontology,,"Tamiflu|(-)-oseltamivir|oseltamivirum|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|Agucort|oseltamivir|GS-4104|Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|HSDB 7433",,,,,,,,,0,C16H28N2O4,"InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1",VSZGPKBBMSAYNT-RRFJBIMHSA-N,312.40450,312.20491,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:7798,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32256547|https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,CHEBI:7798,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,oseltamivir,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,"antigen presentation, exogenous antigen via MHC class II|antigen processing, exogenous antigen via major histocompatibility complex class II|antigen presentation, exogenous peptide antigen|exogenous peptide antigen processing and presentation via MHC class II","The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.",false,,,http://purl.obolibrary.org/obo/GO_0002495|http://purl.obolibrary.org/obo/GO_0002478,,,,,,,,,,,,,,,,,,,,,"The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042591|GO:0048005,"antigen presentation, exogenous antigen via MHC class II|antigen processing, exogenous antigen via major histocompatibility complex class II|antigen presentation, exogenous peptide antigen",,,exogenous peptide antigen processing and presentation via MHC class II,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002495|http://purl.obolibrary.org/obo/GO_0002478,,,,GO:0019886,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019886,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antigen processing and presentation of exogenous peptide antigen via MHC class II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000006348,CCL3,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,G0S19-1|SCYA3|MIP1A|MIP-1-alpha|LD78ALPHA,,,,,,,17,,,,,,,,,,Ensembl:ENSG00000006075|MIM:182283|HPRD:01656|Vega:OTTHUMG00000133000|HGNC:10627,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 3,,17q12,,,,"GO_0000165 (EC: IEP, PMID: 12032188); GO_0000165 (EC: IMP); GO_0001649 (EC: IEP); GO_0001775 (EC: IDA, PMID: 10706735); GO_0002548 (EC: IC, PMID: 10660125); GO_0002548 (EC: IDA, PMID: 10706735); GO_0004672 (EC: IDA, PMID: 10734056); GO_0004698 (EC: IDA, PMID: 15764707); GO_0005515 (EC: IPI); GO_0005576 (EC: IDA); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA); GO_0005622 (EC: IDA, PMID: 10072545); GO_0005737 (EC: IDA); GO_0005829 (EC: IDA, PMID: 19523456); GO_0006468 (EC: IDA, PMID: 10734056); GO_0006816 (EC: IDA, PMID: 10734056); GO_0006874 (EC: IDA, PMID: 10072545); GO_0006887 (EC: IDA, PMID: 10734056); GO_0006935 (EC: IDA, PMID: 10679098); GO_0006954 (EC: IDA, PMID: 10679098); GO_0007010 (EC: IDA, PMID: 10072545); GO_0007267 (EC: IDA, PMID: 10679098); GO_0007610 (EC: IDA); GO_0008009 (EC: IDA, PMID: 10072545); GO_0008360 (EC: IDA, PMID: 10072545); GO_0009636 (EC: IDA, PMID: 10841574); GO_0010628 (EC: IDA, PMID: 10706735); GO_0010629 (EC: IDA); GO_0010818 (EC: IDA, PMID: 10706735); GO_0014808 (EC: IDA, PMID: 19523456); GO_0016004 (EC: IDA, PMID: 10734056); GO_0016301 (EC: IDA); GO_0019722 (EC: IDA, PMID: 10072545); GO_0023052 (EC: IEP, PMID: 12032188); GO_0030335 (EC: IDA, PMID: 10706735); GO_0030502 (EC: IDA); GO_0030593 (EC: IDA, PMID: 10706735); GO_0031663 (EC: IDA); GO_0031726 (EC: IPI, PMID: 10660125); GO_0031730 (EC: IPI, PMID: 10679098); GO_0032760 (EC: ISS); GO_0042056 (EC: IDA, PMID: 10072545); GO_0042802 (EC: IPI); GO_0043085 (EC: IDA, PMID: 10734056); GO_0043308 (EC: IDA, PMID: 10706735); GO_0043491 (EC: IMP); GO_0043525 (EC: ISS); GO_0043615 (EC: ISS); GO_0043922 (EC: IDA, PMID: 10841574); GO_0045671 (EC: IDA); GO_0048245 (EC: IDA, PMID: 10072545); GO_0048246 (EC: ISS); GO_0048247 (EC: IDA, PMID: 10706735); GO_0050718 (EC: ISS); GO_0050729 (EC: ISS); GO_0050850 (EC: IMP, PMID: 10679098); GO_0050918 (EC: IDA, PMID: 10072545); GO_0051897 (EC: IEP); GO_0051928 (EC: IDA, PMID: 15764707); GO_0051930 (EC: IDA, PMID: 15764707); GO_0070374 (EC: IDA); GO_0070723 (EC: IDA, PMID: 19523456); GO_0071346 (EC: IEP, PMID: 9407497); GO_0071347 (EC: IEP, PMID: 9407497); GO_0071356 (EC: IEP, PMID: 9407497); GO_0071407 (EC: IDA); GO_0071621 (EC: IDA, PMID: 10706735); GO_2000503 (EC: IDA, PMID: 7545673)",PMID: 1004873; 1296815; 1694014; 1972563; 2271120; 2521882; 3058856; 3086300; 3279154; 7537510; 7545673; 7594543; 7695626; 8077676; 8460127; 8525373; 8541527; 8568261; 8573157; 8613703; 8687429; 8699119; 8898753; 8906795; 9092555; 9175116; 9207199; 9359702; 9366434; 9405404; 9407497; 9420238; 9520456; 9576751; 9653130; 9658081; 9885903; 9973507; 10072545; 10089882; 10198043; 10201982; 10202040; 10347159; 10446313; 10470075; 10477718; 10490959; 10602409; 10644351; 10660125; 10679098; 10706735; 10734056; 10751368; 10820198; 10841574; 10843431; 10857861; 10964543; 10985253; 11023526; 11086082; 11278300; 11461120; 11602715; 11700073; 11751963; 11861262; 12032188; 12070155; 12089333; 12186702; 12200385; 12218153; 12370346; 12370381; 12377943; 12393595; 12393716; 12401480; 12408680; 12413001; 12445801; 12447751; 12477932; 12506012; 12543931; 12560229; 12574335; 12603824; 12651610; 12651617; 12771199; 12960275; 14680814; 14733721; 15001559; 15067078; 15077296; 15142381; 15481145; 15489334; 15531890; 15585099; 15588341; 15602730; 15638726; 15728180; 15764707; 15780175; 15817944; 16160188; 16234357; 16354571; 16379602; 16393999; 16427155; 16439481; 16507178; 16697675; 16712957; 16849642; 17005260; 17270460; 17330138; 17357337; 17572013; 17625600; 17656823; 17765942; 17914560; 18070228; 18076643; 18164590; 18196935; 18242850; 18346864; 18559339; 18619972; 18678243; 18689282; 18762952; 18802359; 18818748; 18945465; 18991615; 19019335; 19055602; 19074730; 19234184; 19436054; 19463769; 19494336; 19523456; 19527514; 19587705; 19841187; 19917679; 20015995; 20041127; 20042585; 20056178; 20124101; 20368576; 20380698; 20403075; 20420712; 20482449; 20518837; 20650649; 20702408; 20725607; 20817073; 20959807; 21030011; 21082024; 21115978; 21118814; 21368236; 21403648; 21756796; 21784977; 21890375; 22042700; 22085486; 22118025; 22146622; 22156348; 22187158; 22295852; 22307528; 22407921; 22691208; 22727097; 22987449; 23029252; 23151487; 23152559; 23223135; 23233369; 23295355; 23334651; 23711864; 23760235; 23818986; 24047437; 24116893; 24370436,,,,,,,,,,,,,,,,,,OGG:3000006348,,,,,,,,,,,,,,,,,,,chemokine (C-C motif) ligand 3,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217117,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CCL3,,,20140408,6348,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CCL3,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGMS_0000029,vital sign,,A physical sign in which a non-zero value is standardly considered to be an indication that the organism is alive.,false,,,http://purl.obolibrary.org/obo/OGMS_0000024,,,,,,,,,,,,,,,,,,,creation date: 2009-06-23T11:19:17Z,,A physical sign in which a non-zero value is standardly considered to be an indication that the organism is alive.,,http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OGMS:0000029,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000024,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ogms.owl,,,,,,,,,,,vital sign,,,,,,,,,,,,,,,,,,,,,,,,,,,,Albert Goldfain,,,,
http://purl.obolibrary.org/obo/OGG_3000008743,TNFSF10,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TRAIL|TL2|CD253|APO2L|Apo-2L,,,,,,,3,,,,,,,,,,HPRD:04670|HGNC:11925|Vega:OTTHUMG00000156917|Ensembl:ENSG00000121858|MIM:603598,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"tumor necrosis factor (ligand) superfamily, member 10",,3q26,,,,"GO_0005102 (EC: TAS, PMID: 8663110); GO_0005125 (EC: IEA); GO_0005164 (EC: IEA); GO_0005515 (EC: IPI, PMID: 10549288); GO_0005576 (EC: TAS); GO_0005615 (EC: IEA); GO_0005887 (EC: TAS, PMID: 8663110); GO_0006915 (EC: TAS); GO_0006919 (EC: TAS); GO_0006955 (EC: IEA); GO_0007165 (EC: TAS, PMID: 8663110); GO_0007267 (EC: TAS, PMID: 8777713); GO_0008584 (EC: IEA); GO_0032868 (EC: IEA); GO_0043065 (EC: IDA); GO_0043123 (EC: IEP, PMID: 12761501); GO_0043280 (EC: IDA); GO_0046872 (EC: IEA); GO_0070062 (EC: IDA, PMID: 19199708); GO_0090200 (EC: IDA); GO_0097190 (EC: TAS); GO_2001238 (EC: IDA); GO_2001239 (EC: TAS)",PMID: 8663110; 8777713; 8793301; 9082980; 9242610; 9311998; 9314565; 9325248; 9430226; 9520411; 9613612; 9754559; 9830064; 10485660; 10542098; 10549288; 10651627; 10894160; 10960444; 11022932; 11027498; 11059770; 11094155; 11095979; 11243698; 11385301; 11466352; 11553609; 11568006; 11677236; 11739488; 11781716; 11830480; 11844843; 11852102; 11877293; 11936954; 11940602; 11956660; 11964312; 11994437; 12029096; 12036888; 12082620; 12082629; 12097384; 12097388; 12118245; 12140294; 12198154; 12221720; 12351634; 12359235; 12398939; 12407100; 12414956; 12421926; 12421985; 12421989; 12429913; 12439929; 12445619; 12447876; 12477932; 12488957; 12496482; 12517970; 12532461; 12539042; 12556488; 12574346; 12576447; 12592338; 12604406; 12642868; 12663665; 12707267; 12715915; 12738989; 12761501; 12761581; 12767990; 12787570; 12808117; 12813457; 12839575; 12874246; 12907654; 12915532; 12915677; 12920112; 12927928; 12934102; 12969966; 14534533; 14601052; 14637151; 14644197; 14645705; 14647456; 14670183; 14675194; 14691451; 14715264; 14726404; 14729397; 14742697; 15030996; 15033706; 15041704; 15064358; 15077162; 15093732; 15094456; 15110168; 15137068; 15201983; 15205263; 15241475; 15251327; 15256058; 15257094; 15285015; 15286701; 15292354; 15308561; 15326479; 15339846; 15361826; 15451437; 15459016; 15459191; 15475369; 15489334; 15498932; 15509531; 15511228; 15520016; 15531913; 15539085; 15557763; 15558024; 15569667; 15607733; 15615731; 15619633; 15634757; 15637055; 15653751; 15655781; 15671071; 15681838; 15688023; 15757891; 15760909; 15767553; 15774464; 15792357; 15806163; 15809718; 15828026; 15884050; 15887227; 15916713; 15962328; 15990565; 15996036; 16007425; 16026644; 16037944; 16040132; 16041267; 16046522; 16082383; 16116625; 16166346; 16169070; 16174727; 16178278; 16180223; 16199534; 16206163; 16215673; 16226105; 16229016; 16245299; 16288714; 16289694; 16344560; 16368536; 16382051; 16436464; 16449964; 16455983; 16459719; 16478725; 16514644; 16518756; 16574768; 16607283; 16627981; 16645643; 16731632; 16751802; 16785986; 16807984; 16820090; 16831934; 16857810; 16863850; 16887991; 16941746; 16950202; 16951203; 17012835; 17070520; 17079165; 17110373; 17187253; 17195089; 17278883; 17314102; 17352408; 17356300; 17384675; 17420249; 17431115; 17431792; 17479107; 17495957; 17513605; 17525260; 17540725; 17544413; 17548900; 17553352; 17554866; 17558561; 17571163; 17579120; 17583676; 17617740; 17638906; 17683987; 17686764; 17697742; 17701086; 17702740; 17703232; 17765202; 17767167; 17803681; 17881904; 17884184; 17895594; 17900262; 17907960; 17913827; 17932312; 17938258; 17940338; 17947462; 17956986; 17982483; 17983809; 18006822; 18006832; 18006836; 18031928; 18057577; 18063697; 18089811; 18174230; 18178561; 18187663; 18202704; 18220834; 18233993; 18243765; 18266928; 18266968; 18284918; 18287563; 18314443; 18330721; 18338379; 18339897; 18341587; 18343496; 18348311; 18362888; 18362891; 18375389; 18385934; 18413764; 18424742; 18430896; 18451172; 18474604; 18483205; 18491232; 18502726; 18519235; 18522940; 18566412; 18599181; 18599488; 18640940; 18644981; 18723061; 18726983; 18772312; 18780288; 18802096; 18814951; 18834856; 18838202; 18922903; 18942021; 19050264; 19058836; 19074436; 19074831; 19106633; 19147771; 19197243; 19199708; 19203346; 19212626; 19221598; 19223770; 19236007; 19261616; 19265041; 19270498; 19281785; 19289465; 19294332; 19305384; 19309556; 19349211; 19361506; 19379558; 19385057; 19398149; 19404407; 19406930; 19407827; 19412666; 19418484; 19427028; 19435900; 19449143; 19453261; 19470406; 19476940; 19481529; 19519609; 19533303; 19540229; 19573080; 19587531; 19597472; 19629467; 19632771; 19671825; 19674787; 19690337; 19724854; 19749795; 19767219; 19773279; 19782681; 19802013; 19812265; 19854352; 19890662; 19896469; 19948942; 19954364; 19954896; 19956887; 19962668; 19962958; 19967427; 20007807; 20042498; 20119620; 20123409; 20150555; 20154087; 20189551; 20204286; 20237496; 20308427; 20334827; 20339295; 20354842; 20372797; 20379197; 20393185; 20394499; 20400979; 20417200; 20424169; 20430391; 20443055; 20560677; 20568250; 20580220; 20580868; 20628624; 20638129; 20638385; 20671119; 20734142; 20802294; 20811726; 20819778; 20838376; 20839416; 20852190; 20862322; 20961336; 20977779; 21047948; 21059290; 21064084; 21086019; 21107885; 21120579; 21125311; 21156789; 21160038; 21167276; 21183948; 21209944; 21211989; 21248767; 21255088; 21279373; 21291526; 21305500; 21308719; 21317160; 21368892; 21381010; 21426505; 21435442; 21437625; 21437722; 21454681; 21465464; 21480222; 21482133; 21483669; 21485546; 21525012; 21538027; 21554547; 21603612; 21622121; 21670755; 21695716; 21697087; 21706325; 21732015; 21760914; 21769428; 21769834; 21802664; 21822306; 21824395; 21846721; 21859711; 21864851; 21926463; 21941373; 21952139; 21988644; 21993926; 22023762; 22034880; 22072062; 22110611; 22159760; 22194780; 22202560; 22266862; 22310286; 22320196; 22322844; 22328338; 22345097; 22354145; 22384114; 22392486; 22398750; 22408249; 22449797; 22462553; 22471587; 22496450; 22542907; 22554587; 22585859; 22698523; 22719861; 22729471; 22783581; 22883061; 22898820; 22899350; 22914768; 22922789; 22948392; 23014529; 23018355; 23053497; 23071256; 23085529; 23096115; 23142077; 23228130; 23247197; 23258590; 23277172; 23290504; 23306613; 23319802; 23375756; 23384657; 23392805; 23408429; 23426404; 23428290; 23437333; 23441146; 23456625; 23457619; 23468057; 23472162; 23481489; 23492767; 23579274; 23615398; 23636231; 23667901; 23674352; 23686163; 23699397; 23699656; 23703388; 23732517; 23774624; 23792015; 23932896; 23937794; 23959437; 23974204; 23981753; 24019170; 24078627; 24100030; 24167941; 24184557; 24223304; 24299309; 24344047,,,,,,,,,,,,,,,,,,OGG:3000008743,,,,,,,,,,,,,,,,,,,"tumor necrosis factor (ligand) superfamily, member 10",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TNFSF10,,,20140408,8743,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TNFSF10,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/CHEBI_71019,omacetaxine mepesuccinate,"(2'R,3S,4S,5R)-(-)-homoharringtonine|Synribo|omacetaxine mepesuccinate|omacetaxini mepesuccinas|mepesuccinato de omacetaxina|Homoharringtonine|(-)-homoharringtonine|CGX-635|mepesuccinate d'omacetaxine",A cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23059828|Drug_Central:4677|PMID:22714632|PMID:22898909|PMID:22391162|Wikipedia:Omacetaxine_mepesuccinate|PMID:22040954|Patent:WO2007089878|Beilstein:5687925|KEGG:D08956|PMID:21152934|CAS:26833-87-4|PMID:21468038|LINCS:LSM-3716|PMID:21294709|PMID:22054289|PMID:22967374|PMID:22580751|Reaxys:5687925|PMID:23053254|PMID:22289991|PMID:22075327|PMID:23086639|PMID:20971952|PMID:23456623|PMID:21258877|PMID:21415308|PMID:22917222|PMID:21509439|Patent:US2010240887|PMID:21916787|PMID:22896000|PDBeChem:HMT|PMID:23109844|PMID:21845438|PMID:21418889,A cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,"(2'R,3S,4S,5R)-(-)-homoharringtonine|Synribo|omacetaxine mepesuccinate|omacetaxini mepesuccinas|mepesuccinato de omacetaxina|Homoharringtonine|(-)-homoharringtonine|CGX-635|mepesuccinate d'omacetaxine",,,,,,,,,0,C29H39NO9,"InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1",HYFHYPWGAURHIV-JFIAXGOJSA-N,545.62130,545.26248,[H][C@@]12[C@H](OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@@]11CCCN1CCc1cc3OCOc3cc21,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:71019,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32251767,,,,CHEBI:71019,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,omacetaxine mepesuccinate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1904813,ficolin-1-rich granule lumen,ficolin-1-rich granule membrane-enclosed lumen|membrane-enclosed lumen of ficolin-1-rich granule|membrane-enclosed lumen of ficolin-1 rich granule|membrane-enclosed lumen of ficolin granule,Any membrane-enclosed lumen that is part of a ficolin-1-rich granule.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,mec,2015-11-13T11:58:20Z,,,,Any membrane-enclosed lumen that is part of a ficolin-1-rich granule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ficolin-1-rich granule membrane-enclosed lumen|membrane-enclosed lumen of ficolin-1-rich granule|membrane-enclosed lumen of ficolin-1 rich granule,,,,,cellular_component,,membrane-enclosed lumen of ficolin granule,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:1904813,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1904813,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,ficolin-1-rich granule lumen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006613,cotranslational protein targeting to membrane,cotranslational protein membrane targeting|cotranslational protein-membrane targeting|cotranslational membrane targeting,"The targeting of proteins to a membrane that occurs during translation. The transport of most secretory proteins, particularly those with more than 100 amino acids, into the endoplasmic reticulum lumen occurs in this manner, as does the import of some proteins into mitochondria.",false,,,http://purl.obolibrary.org/obo/GO_0006612,,,,,,,,,,,,,,,,,,,,,"The targeting of proteins to a membrane that occurs during translation. The transport of most secretory proteins, particularly those with more than 100 amino acids, into the endoplasmic reticulum lumen occurs in this manner, as does the import of some proteins into mitochondria.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cotranslational protein membrane targeting|cotranslational protein-membrane targeting|cotranslational membrane targeting,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006612,,,,GO:0006613,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006613,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cotranslational protein targeting to membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000118,not touching face,,,false,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0000605,,,,,,,,Intervention,,true,,,,,,Not touch your face.,,,,,,,,,,,,,,,,not touching face,,,,,,,,,,,,,,,,,,,,,,https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_576,proteinuria,,A kidney disease that is characterized by the presence of excess proteins in the urine.,false,,,http://purl.obolibrary.org/obo/DOID_557,,,,,,,,,,,,,,,,,,,,ICD10CM:R80|UMLS_CUI:C0033687|MESH:D011507|ICD9CM:791.0|SNOMEDCT_US_2019_09_01:29738008|NCI:C38012,A kidney disease that is characterized by the presence of excess proteins in the urine.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_557,,,,DOID:576,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,DOID:576,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,proteinuria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0031227,intrinsic component of endoplasmic reticulum membrane,intrinsic to endoplasmic reticulum membrane,The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,intrinsic to endoplasmic reticulum membrane,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0031227,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0031227,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,intrinsic component of endoplasmic reticulum membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0028047,Molecular Docking Simulation,,,false,,,http://identifiers.org/mamo/MAMO_0000023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0028047,A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://identifiers.org/mamo/MAMO_0000023,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32169481,,Molecular docking,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Molecular Docking Simulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0075520,actin-dependent intracellular transport of virus,actin-dependent intracellular transport of viral material,"The directed movement of a virus, or part of a virus, within the host cell cytoplasm via the host's actin filaments. Actin-dependent transport is induced by viral proteins that interact with actin and/or host cell motor proteins like myosins or that promotes actin polymerization/depolymerization reactions.",false,,,http://purl.obolibrary.org/obo/GO_0075733,,,,,,,,,,,,,,,,janelomax,2011-08-03T01:45:55Z,,,VZ:991,"The directed movement of a virus, or part of a virus, within the host cell cytoplasm via the host's actin filaments. Actin-dependent transport is induced by viral proteins that interact with actin and/or host cell motor proteins like myosins or that promotes actin polymerization/depolymerization reactions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,actin-dependent intracellular transport of viral material,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0075733,,,,GO:0075520,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/25375324,,,,GO:0075520,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,actin-dependent intracellular transport of virus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1503301,BtRs-BetaCoV/GX2013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1503301,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,BtRs-BetaCoV/GX2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000013,presumptive positive COVID-19 test,,,false,,,http://purl.obolibrary.org/obo/NCIT_C35682,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C35682,,,,,,,,clinical finding,,true,,,,,," Anyone who has tested positive for the virus, but testing was conducted at the local or state level. Currently, presumptive positive cases must have sample undergo confirmatory testing at the CDC.",,,,,,,,,,,,,,,,presumptive positive COVID-19 test,,,,,,,,,,,,,,,,,,,,,,https://www.georgetown.edu/coronavirus/glossary-of-terms/,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_1579,respiratory system disease,,A disease of anatomical entity that located_in the respiratory system which extends from the nasal sinuses to the diaphragm.,false,,,http://purl.obolibrary.org/obo/DOID_7,,,,,,,,,,,,,,,,,,,,ICD9CM:519|UMLS_CUI:C0029582|ICD10CM:J98,A disease of anatomical entity that located_in the respiratory system which extends from the nasal sinuses to the diaphragm.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:3226,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_7,,,,DOID:1579,,,,,,,,,,,,,,,DOID:1579,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_MGI_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,respiratory system disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_9351,diabetes mellitus,,"A glucose metabolism disease characterized  by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both.",false,,,http://purl.obolibrary.org/obo/DOID_4194,,,,,,,,,,,,,,,,,,,,NCI:C2985|SNOMEDCT_US_2019_09_01:73211009|MESH:D003920|UMLS_CUI:C0011849|ICD10CM:E08-E13|ICD9CM:250,"A glucose metabolism disease characterized  by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_4194,,,,DOID:9351,,,,,,,,,,,,,,diabetes,DOID:9351,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,diabetes mellitus,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30116-8/fulltext,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030027,lamellipodium,,A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments.,false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,Wikipedia:Lamellipodia,A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0030027,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030027,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lamellipodium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050278,non-structural protein 9 (SARS-CoV-2),"UniProtKB:P0DTD1, 4141-4253|UniProtKB:P0DTC1, 4141-4253|PRO_0000449627|PRO_0000449643|rep/Clv:nsp9 (SARS2)|nsp9 (SARS2)",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4140-4141 and 4253-4254.|Category=organism-modification. Note: 113 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725305,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4140-4141 and 4253-4254.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"UniProtKB:P0DTD1, 4141-4253|UniProtKB:P0DTC1, 4141-4253|PRO_0000449627|PRO_0000449643|rep/Clv:nsp9 (SARS2)|nsp9 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 113 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050278,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32218151,,,,PR:000050278,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 9 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_31360,Carmofur,Carmofur|mifurol|yamaful|1-hexylcarbamoyl-5-fluorouracil,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D01784|Drug_Central:511|LINCS:LSM-5293|CAS:61422-45-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:94505,,,,Carmofur,,,,,chebi_ontology,,mifurol|yamaful|1-hexylcarbamoyl-5-fluorouracil,,,,,,,,,0,C11H16FN3O3,"InChI=1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18)",AOCCBINRVIKJHY-UHFFFAOYSA-N,257.262,257.11757,CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31360,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32147628,,,,CHEBI:31360,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Carmofur,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_10100,zafirlukast,cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate|4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide|cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|zafirlukast|Accolate,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:3641829|LINCS:LSM-5792|PMID:19331987|Beilstein:3641829|Wikipedia:Zafirlukast|PMID:22159431|Drug_Central:2855|PMID:11888331|KEGG:D00411|PMID:25798389|CAS:107753-78-6|DrugBank:DB00549|HMDB:HMDB0014689|PMID:25834030|KEGG:C07206|PMID:22614107|PMID:24258705,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate,,,,,chebi_ontology,,4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide|cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|zafirlukast|Accolate,,,,,,,,,0,C31H33N3O6S,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",YEEZWCHGZNKEEK-UHFFFAOYSA-N,575.677,575.20901,C1=CC=2N(C=C(C2C=C1NC(OC3CCCC3)=O)CC4=CC=C(C(NS(C5=CC=CC=C5C)(=O)=O)=O)C=C4OC)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:10100,,,,,true,true,,,,,,,,,CHEBI:10100,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,zafirlukast,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000107,pleural effusion,,A skin and integumentary tissue symptom characterized as an exudation of fluid from the blood or lymph into a pleural cavity.,false,,,http://purl.obolibrary.org/obo/SYMP_0000488,,,,,,,,,,,,,,,,,,,,,A skin and integumentary tissue symptom characterized as an exudation of fluid from the blood or lymph into a pleural cavity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000488,,,,SYMP:0000107,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32173576,,,,SYMP:0000107,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,pleural effusion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051321,meiotic cell cycle,meiosis,"Progression through the phases of the meiotic cell cycle, in which canonically a cell replicates to produce four offspring with half the chromosomal content of the progenitor cell via two nuclear divisions.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,Wikipedia:Meiosis,"Progression through the phases of the meiotic cell cycle, in which canonically a cell replicates to produce four offspring with half the chromosomal content of the progenitor cell via two nuclear divisions.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007126,,,,,,,,,biological_process,,meiosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0051321,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051321,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila,,,,,,,,,,meiotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_338605,Bat SARS coronavirus HKU3-2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:338605,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_442736,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS coronavirus HKU3-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000084,T cell,T-cell|T lymphocyte|T-lymphocyte|mature T cell|immature T cell,A type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.,false,,,http://purl.obolibrary.org/obo/NCIT_C12535,,,,,,,,,,,,,,,,,,,,CALOHA:TS-1001|VHOG:0001479|FMA:62870|BTO:0000782,A type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.,,,,,,,,,,,,,,,,,,,,,,,,,,,CL:0000804|CL:0000812,,,,T-cell|T lymphocyte|T-lymphocyte,,,,,cell,,mature T cell|immature T cell,,,,,,CL:0000084,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C12535,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217835/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,T cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0016049,cell growth,growth of cell|cellular growth|metabolic process resulting in cell growth|cell expansion|non-developmental cell growth|metabolism resulting in cell growth|non-developmental growth of a unicellular organism,The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0048591,,,,growth of cell|cellular growth,,,,,biological_process,,metabolic process resulting in cell growth|cell expansion|non-developmental cell growth|metabolism resulting in cell growth|non-developmental growth of a unicellular organism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0016049,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0016049,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_drosophila|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant|http://purl.oboInOwllibrary.org/oboInOwl/go#gocheck_do_not_annotate,,,,,,,,,,cell growth,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006739,NADP metabolic process,reduced nicotinamide adenine dinucleotide phosphate metabolic process|nicotinamide adenine dinucleotide phosphate metabolic process|oxidized nicotinamide adenine dinucleotide phosphate metabolic process|reduced NADP metabolism|NADP (oxidized) metabolism|NADP (reduced) metabolism|NADPH metabolism|NADP (reduced) metabolic process|oxidized NADP metabolism|NADP (oxidized) metabolic process|oxidized nicotinamide adenine dinucleotide phosphate metabolism|oxidized NADP metabolic process|nicotinamide adenine dinucleotide phosphate metabolism|reduced NADP metabolic process|NADPH metabolic process|NADP metabolism|reduced nicotinamide adenine dinucleotide phosphate metabolism|NAD phosphorylation and dephosphorylation,"The chemical reactions and pathways involving nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; metabolism may be of either the oxidized form, NADP, or the reduced form, NADPH.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; metabolism may be of either the oxidized form, NADP, or the reduced form, NADPH.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,reduced nicotinamide adenine dinucleotide phosphate metabolic process|nicotinamide adenine dinucleotide phosphate metabolic process|oxidized nicotinamide adenine dinucleotide phosphate metabolic process|reduced NADP metabolism|NADP (oxidized) metabolism|NADP (reduced) metabolism|NADPH metabolism|NADP (reduced) metabolic process|oxidized NADP metabolism|NADP (oxidized) metabolic process|oxidized nicotinamide adenine dinucleotide phosphate metabolism|oxidized NADP metabolic process|nicotinamide adenine dinucleotide phosphate metabolism|reduced NADP metabolic process|NADPH metabolic process|NADP metabolism|reduced nicotinamide adenine dinucleotide phosphate metabolism,,,,,biological_process,,NAD phosphorylation and dephosphorylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0006739,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006739,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,NADP metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C116537,Fluid Therapy,Fluid Therapy,"The administration of fluids, most commonly via an intravenous route, to restore intravascular volume.",false,,,http://purl.obolibrary.org/obo/OGMS_0000112,,,,,,,,,,,C116537,,,CTRP,,,,,,,"The administration of fluids, most commonly via an intravenous route, to restore intravascular volume.",,,,,,Fluid Therapy,,,,,,,,,,,,,,,,,,,,,,,,,Fluid Therapy,,,,,,,,,,,,,NCIT:C116537,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000112,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32186952/,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977,,,,,,,,,,Fluid Therapy,,,,,,,,,,,,,,,,,,,Fluid Therapy,,,,Therapeutic or Preventive Procedure,,,,,,,,C0016286,
http://purl.obolibrary.org/obo/CHEBI_4798,entacapone,"Entacapone|(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide|entacapone|N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide|(E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|entacaponum|Comtan|entacapona|Comtess","A monocarboxylic acid amide that is N,N-diethylprop-2-enamide in which the hydrogen at position 2 is substituted by a cyano group and the hydrogen at the 3E position is substituted by a 3,4-dihydroxy-5-nitrophenyl group.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:8158723|PMID:15878587|Wikipedia:Entacapone|Drug_Central:1018|KEGG:D00781|PMID:11244274|PMID:15875340|CAS:130929-57-6|Patent:WO2005063693|PMID:15698633|PMID:19879254|DrugBank:DB00494|PMID:19578428|KEGG:C07943|Patent:US6599530|PMID:12952501|PMID:15992091|PMID:11732751|Patent:US5135950|PMID:11586115|Patent:EP426468,"A monocarboxylic acid amide that is N,N-diethylprop-2-enamide in which the hydrogen at position 2 is substituted by a cyano group and the hydrogen at the 3E position is substituted by a 3,4-dihydroxy-5-nitrophenyl group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Entacapone|(2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",,,,,chebi_ontology,,"entacapone|N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide|(E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|entacaponum|Comtan|entacapona|Comtess",,,,,,,,,0,C14H15N3O5,"InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+",JRURYQJSLYLRLN-BJMVGYQFSA-N,305.28612,305.10117,CCN(CC)C(=O)C(C#N)=C\c1cc(O)c(O)c(c1)[N+]([O-])=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:4798,,,,,,true,,,,,,,,,CHEBI:4798,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,entacapone,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10292,Herpesviridae,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_548681,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_family,,,,,,,NCBITaxon:10292,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_548681,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Herpesviridae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249080,SARS coronavirus HSZ-Cc,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249080,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus HSZ-Cc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000148,zero-dimensional temporal region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000008,,,temporal instant.,,ZeroDimensionalTemporalRegion,0d-t-region,,,,,,,,,,,,,,,,,,,,,,,,,,A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001]),,the moment at which a child is born|a temporal region that is occupied by a process boundary|right now|the moment at which a finger is detached in an industrial accident|the moment of death.,,,,,,,,,(forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001] ,,,,,,,,,,,,,,,,,,,,,,BFO:0000148,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000008,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,zero-dimensional temporal region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050269,spike protein S2' (SARS-CoV-2),"UniProtKB:P0DTC2, 816-1273|S2' (SARS2)|PRO_0000449649","A spike protein S2 (SARS-CoV-2) that has been further processed by proteolytic cleavage to yield the C-terminal portion. UniProtKB:P0DTC2, 816-1273.|Category=organism-modification.",false,,,http://purl.obolibrary.org/obo/PR_000050268,,,,,,,,,,,,,,,,,,,,,"A spike protein S2 (SARS-CoV-2) that has been further processed by proteolytic cleavage to yield the C-terminal portion. UniProtKB:P0DTC2, 816-1273.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"UniProtKB:P0DTC2, 816-1273|S2' (SARS2)|PRO_0000449649",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification.,,http://purl.obolibrary.org/obo/PR_000050268,,,,PR:000050269,,,,,,true,,,,,,,,,PR:000050269,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,spike protein S2' (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.04.17.046185v1,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0005178,thoracic cavity element,thoracic cavity organ,"An organ or element that is in the thoracic cavity. Examples: lung, heart, longus colli.",false,,,http://purl.obolibrary.org/obo/UBERON_0005181,,,,,,,,,,,,,,,,,,,,EMAPA:37273|MA:0000557,"An organ or element that is in the thoracic cavity. Examples: lung, heart, longus colli.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,thoracic cavity organ,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0005181,,,,UBERON:0005178,,,,,,,,,,,,,,,UBERON:0005178,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,thoracic cavity element,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_000050286,bifunctional exonuclease/methyltransferase (SARS-CoV-2),"ORF1ab/Clv:nsp14 (SARS2)|UniProtKB:P0DTD1, 5926-6452|ExoN (SARS2)|nsp14 (SARS2)|PRO_0000449631|guanine-N7 methyltransferase (SARS2)|3'-to-5' exonuclease (SARS2)",An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 5925-5926 and 6452-6453.|Category=organism-modification. Note: 527 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050283,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725309,An ORF1ab proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 5925-5926 and 6452-6453.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"ORF1ab/Clv:nsp14 (SARS2)|UniProtKB:P0DTD1, 5926-6452|ExoN (SARS2)|nsp14 (SARS2)|PRO_0000449631",,,guanine-N7 methyltransferase (SARS2)|3'-to-5' exonuclease (SARS2),,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 527 aa protein.,,http://purl.obolibrary.org/obo/PR_000050283,,,,PR:000050286,,,,,,true,,,,,,,,,PR:000050286,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,bifunctional exonuclease/methyltransferase (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0025032,Abnormality of digestive system physiology,,A functional anomaly of the digestive system.,false,,,http://purl.obolibrary.org/obo/HP_0025031,,,,,,,,,,,,,,,,HPO:probinson,,,,,A functional anomaly of the digestive system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0025032,,,,,,,,,,,,,,,,,,2016-08-27T13:58:05Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0025031,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of digestive system physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009123,nucleoside monophosphate metabolic process,nucleoside monophosphate metabolism,"The chemical reactions and pathways involving a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nucleoside monophosphate metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0009123,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009123,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nucleoside monophosphate metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_265125,SARS coronavirus xw002,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:265125,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus xw002,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10357,Betaherpesvirinae,Betaherpesviruses,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10292,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Betaherpesviruses,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_subfamily,,,,,,,NCBITaxon:10357,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10292,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Betaherpesvirinae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GENEPIO_0000120,travel history item,,A datetime measurement related to a person's travel with respect to potential epidemilogical implications.,false,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,,,,,,,,,,,,A datetime measurement related to a person's travel with respect to potential epidemilogical implications.,,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000428,,,,,,,,,,,,,,,,,,,,GENEPIO:0000120,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000027,,,,,,,,,,true,,,,,,,travel history evaluation,,,,http://purl.obolibrary.org/obo/genepio.owl,,,,,,,,,,,travel history item,,,,,,,,,,,,,,,,,,,,,,https://www.cdc.gov/coronavirus/2019-ncov/travelers/after-travel-precautions.html,,,,,,Damion Dooley,,,,
http://purl.obolibrary.org/obo/CHEBI_31347,camostat methanesulfonate,Camostat mesilate|Camostat monomethanesulfonate,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:59721-29-8|KEGG:D01766,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,Camostat mesilate|Camostat monomethanesulfonate,,,,,,,,,0,C20H23N4O5.CH3O3S|C21H26N4O8S,"InChI=1S/C20H22N4O5.CH4O3S/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22;1-5(2,3)4/h3-10H,11-12H2,1-2H3,(H4,21,22,23);1H3,(H,2,3,4)",FSEKIHNIDBATFG-UHFFFAOYSA-N,494.520,494.14713,C1(=CC=C(C=C1)NC(=N)N)C(OC2=CC=C(C=C2)CC(OCC(N(C)C)=O)=O)=O.S(C)(O)(=O)=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31347,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32125455,,,,CHEBI:31347,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,camostat methanesulfonate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C1661,Nucleic Acid Synthesis Inhibitor,"Nucleic Acid Synthesis Inhibitor|Inhibitors, Nucleic Acid Synthesis",A pharmacological agent that inhibits DNA replication or RNA synthesis.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C1661,,,,,,,,,,A pharmacological agent that inhibits DNA replication or RNA synthesis.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Nucleic Acid Synthesis Inhibitor|Inhibitors, Nucleic Acid Synthesis",,,,,,,,,,,,,NCIT:C1661,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127067/,,,RNA synthesis inhibitor,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Nucleic Acid Synthesis Inhibitor,Nucleic_Acid_Synthesis_Inhibitor,,,,,,,,,,,,,,,,,,Nucleic Acid Synthesis Inhibitor,,,,Chemical Viewed Functionally,,,,,,,,C0376568,
http://purl.obolibrary.org/obo/OGG_3000003570,IL6R,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,IL-6R-1|IL6RA|IL6RQ|CD126|gp80|IL6Q|IL-6RA,,,,,,,1,,,,,,,,,,HGNC:6019|HPRD:01000|Vega:OTTHUMG00000036073|Ensembl:ENSG00000160712|MIM:147880,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interleukin 6 receptor,,1q21,,,,"GO_0002384 (EC: TAS, PMID: 12832423); GO_0002446 (EC: IC, PMID: 16034137); GO_0002548 (EC: IC, PMID: 10510402); GO_0002690 (EC: IC, PMID: 16034137); GO_0002690 (EC: TAS, PMID: 15100312); GO_0004897 (EC: IMP, Qualifier: contributes_to, PMID: 12643274); GO_0004915 (EC: IDA, Qualifier: contributes_to, PMID: 2261637); GO_0005138 (EC: IPI, Qualifier: contributes_to, PMID: 12829785); GO_0005515 (EC: IPI, PMID: 11238858); GO_0005576 (EC: IDA, PMID: 12748171); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 12419823); GO_0005886 (EC: TAS); GO_0005896 (EC: IDA, PMID: 12829785); GO_0006953 (EC: TAS, PMID: 12832423); GO_0008284 (EC: IDA, PMID: 2261637); GO_0008284 (EC: IMP, PMID: 18719127); GO_0009986 (EC: IEA); GO_0010536 (EC: IDA, PMID: 12419823); GO_0016323 (EC: IEA); GO_0016324 (EC: IDA, PMID: 16034137); GO_0019221 (EC: IDA, PMID: 2261637); GO_0019899 (EC: IPI, PMID: 12748171); GO_0019981 (EC: IPI, PMID: 12829785); GO_0031018 (EC: IC, PMID: 18719127); GO_0031018 (EC: IMP, PMID: 18719127); GO_0032717 (EC: IEP, PMID: 16034137); GO_0032722 (EC: IDA, PMID: 10510402); GO_0032755 (EC: IDA, PMID: 10510402); GO_0032966 (EC: IDA, PMID: 12419823); GO_0034097 (EC: IDA, PMID: 2261637); GO_0042517 (EC: IMP, PMID: 12643274); GO_0042803 (EC: IPI, PMID: 12633863); GO_0043410 (EC: IDA, PMID: 12419823); GO_0045669 (EC: TAS, PMID: 12372336); GO_0048661 (EC: IDA, PMID: 10510402); GO_0050731 (EC: IDA, PMID: 11884403); GO_0050829 (EC: IEP, PMID: 16034137); GO_0050830 (EC: IEP, PMID: 16034137); GO_0051092 (EC: IDA, Qualifier: NOT, PMID: 12419823); GO_0070102 (EC: IMP, PMID: 12643274); GO_0070119 (EC: IPI, PMID: 12643274); GO_0070120 (EC: IMP, PMID: 12643274); GO_0097191 (EC: TAS, PMID: 15100312)",PMID: 1281789; 1381187; 1872801; 1889804; 2112585; 2157217; 2261637; 2529343; 2788034; 3136546; 8056053; 8125298; 8265649; 8428753; 8450224; 8467812; 8889549; 9169421; 9927325; 10066782; 10462375; 10510402; 10777583; 10785334; 10982829; 11017875; 11238858; 11884403; 12002769; 12008038; 12079407; 12372336; 12412787; 12414855; 12419823; 12445803; 12461182; 12472176; 12477932; 12553038; 12553555; 12574959; 12633863; 12643274; 12748171; 12748876; 12789531; 12829785; 12832423; 12857602; 12917504; 14557255; 14592826; 14718574; 15041717; 15063602; 15100312; 15166129; 15213442; 15284182; 15297310; 15306846; 15456942; 15489334; 15561970; 15562008; 15579373; 15625895; 15641051; 15816827; 15837717; 15857508; 15895091; 16034137; 16127269; 16270750; 16372246; 16557588; 16710414; 16731080; 16794539; 16817825; 16899024; 16912152; 16973585; 17151125; 17160948; 17310346; 17313958; 17346257; 17357077; 17519976; 17570254; 17619842; 17652155; 17671508; 17703412; 17898129; 17903307; 17908769; 17984249; 18065760; 18276608; 18320358; 18439548; 18464913; 18490707; 18508242; 18538149; 18543249; 18676680; 18719127; 18781131; 18784373; 18818748; 18852330; 18853133; 18971377; 18980999; 19019335; 19026125; 19088723; 19124510; 19170196; 19258923; 19277666; 19280716; 19336475; 19396608; 19406470; 19420002; 19422646; 19453261; 19495883; 19503017; 19505916; 19527514; 19567438; 19573080; 19625176; 19633828; 19665805; 19671870; 19692168; 19713205; 19733878; 19773279; 19773451; 19790045; 19877065; 19913121; 19914334; 19926672; 19966016; 20017315; 20026129; 20031577; 20083667; 20140262; 20145925; 20157327; 20159251; 20186139; 20197062; 20237496; 20379614; 20438838; 20452482; 20453000; 20463041; 20484876; 20503287; 20551110; 20568250; 20599261; 20600579; 20628086; 20661738; 20673868; 20698883; 20727736; 20800603; 20811626; 20823887; 20839491; 20856253; 20951753; 20974296; 21159831; 21173340; 21196890; 21220034; 21229891; 21255427; 21282511; 21295508; 21300955; 21401300; 21490132; 21496483; 21515913; 21700295; 21748280; 21813064; 21835044; 21846873; 21851175; 21879314; 21907864; 21968316; 21981268; 21989726; 22072558; 22079540; 22128229; 22133618; 22209080; 22295972; 22319020; 22421339; 22449275; 22552503; 22554704; 22642608; 22742541; 22761857; 22911828; 22984080; 23073775; 23078005; 23094986; 23242610; 23375120; 23428306; 23564454; 23582566; 23582716; 23593036; 23648090; 23658720; 23677452; 23902164; 23935104; 23969696; 24032723; 24152848,,,,,,,,,,,,,,,,,,OGG:3000003570,,,,,,,,,,,,,,,,,,,interleukin 6 receptor,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL6R,,,20140408,3570,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://science.sciencemag.org/content/early/2020/04/16/science.abb8925/tab-pdf,,,,IL6R,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/MONDO_0005043,hyperplasia,hyperplasia|hyperplastic,An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.,false,,,http://purl.obolibrary.org/obo/DOID_14566,,,,,,,,,,,,,,,,,,,,MESH:D006965|NCIT:C3113|EFO:0000536,An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hyperplasia|hyperplastic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_14566,,http://identifiers.org/snomedct/76197007|http://linkedlifedata.com/resource/umls/id/C0020507,http://purl.obolibrary.org/obo/NCIT_C3113|http://identifiers.org/mesh/D006965,MONDO:0005043,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32222466,,,,MONDO:0005043,,http://purl.obolibrary.org/obo/mondo.owl,,,,,,,,,,,hyperplasia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0005172,abdomen element,abdomen organ,"An organ or element that is in the abdomen. Examples: spleen, intestine, kidney, abdominal mammary gland.",false,,,http://purl.obolibrary.org/obo/UBERON_0005173,,,,,,,,,,,,,,,,,,,,MA:0000522|http://www.snomedbrowser.com/Codes/Details/272631008,"An organ or element that is in the abdomen. Examples: spleen, intestine, kidney, abdominal mammary gland.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,abdomen organ,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0005173,,,,UBERON:0005172,,,,,,,,,,,,,,,UBERON:0005172,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,abdomen element,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0013765,digestive system element,digestive organ|digestive system organ,"Any of the organs or elements that are part of the digestive system. Examples: tongue, esophagus, spleen, crop, lunge feeding organ, tooth elements.",false,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,,,,,,,,,,,,,,,,,EMAPA:37843|http://www.snomedbrowser.com/Codes/Details/272627002,"Any of the organs or elements that are part of the digestive system. Examples: tongue, esophagus, spleen, crop, lunge feeding organ, tooth elements.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,digestive organ|digestive system organ,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000062,,,,UBERON:0013765,,,,,,,,,,,,,,,UBERON:0013765,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class,,,,,,,,,,digestive system element,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C26947,Aspartate Aminotransferase Increased,Aspartate aminotransferase increased|Aspartate Aminotransferase Increased,An increase in the level of aspartate aminotransferase in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0010876,,A finding based on laboratory test results that indicate an increase in the level of aspartate aminotransferase (AST or SGOT) in a blood specimen.,,,,,,,,,C26947,,,,,,,,,,An increase in the level of aspartate aminotransferase in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Aspartate aminotransferase increased|Aspartate Aminotransferase Increased,,,,,,,,,,,,,NCIT:C26947,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010876,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138655/,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Aspartate Aminotransferase Increased,Aspartate_Aminotransferase_Increased,,,,,,,,,,,,,,,,,,Aspartate Aminotransferase Increased,,,,Laboratory or Test Result,,,,,,,,C4076281,
http://purl.obolibrary.org/obo/GO_0019042,viral latency,latent virus infection|viral dormancy|phage lysogeny,"The process by which, after initial infection, a virus lies dormant within a cell and viral production ceases. The process ends when the virus switches from latency and starts to replicate.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,,,,,,"The process by which, after initial infection, a virus lies dormant within a cell and viral production ceases. The process ends when the virus switches from latency and starts to replicate.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030069|GO:0075710,,,,latent virus infection|viral dormancy|phage lysogeny,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0019042,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32234466,,,,GO:0019042,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral latency,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000819,sister chromatid segregation,,The cell cycle process in which sister chromatids are organized and then physically separated and apportioned to two or more sets.,false,,,http://purl.obolibrary.org/obo/GO_0098813,,,,,,,,,,,,,,,,,,,,,The cell cycle process in which sister chromatids are organized and then physically separated and apportioned to two or more sets.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0098813,,,,GO:0000819,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000819,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,sister chromatid segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000086,G2/M transition of mitotic cell cycle,mitotic G2/M transition,The mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex.,false,,,http://purl.obolibrary.org/obo/GO_0044839,,,,,,,,,,,,,,,,,,,,,The mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,mitotic G2/M transition,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0044839,,,,GO:0000086,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000086,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,G2/M transition of mitotic cell cycle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000091,SARS-CoV genome,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17253,,,,,,,,material entity,,true,,,,,,Genome of the SARS-associated coronavirus (SARS-CoV).,,,,,,,,,,,,,,,,SARS-CoV genome,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)13444-7/fulltext,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000054541,DDIT4,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,Dig2|REDD-1|REDD1,,,,,,,10,,,,,,,,,,HGNC:24944|HPRD:09662|Vega:OTTHUMG00000183961|MIM:607729|Ensembl:ENSG00000168209,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,DNA-damage-inducible transcript 4,,10q22.1,,,,"GO_0001666 (EC: IDA); GO_0001764 (EC: ISS); GO_0005622 (EC: IDA); GO_0005737 (EC: IDA, PMID: 12453409); GO_0005739 (EC: IEA); GO_0005829 (EC: IEA); GO_0007420 (EC: ISS); GO_0008283 (EC: ISS); GO_0010801 (EC: ISS); GO_0030182 (EC: ISS); GO_0032007 (EC: IMP); GO_0033137 (EC: ISS); GO_0042771 (EC: ISS); GO_0043241 (EC: IEA); GO_0045820 (EC: IEA); GO_0048011 (EC: ISS); GO_0051607 (EC: IEA); GO_0071889 (EC: IEA); GO_0072593 (EC: IEA); GO_1901216 (EC: ISS); GO_1902532 (EC: ISS)",PMID: 11076863; 11230166; 11256614; 11884613; 12453409; 12477932; 14646594; 15146197; 15180327; 15489336; 15592522; 15632201; 15988001; 16169070; 16196087; 16258273; 16341674; 16381901; 16713569; 17005863; 17307335; 18029348; 18781797; 18796435; 18953439; 19114033; 19127203; 19210572; 19221489; 19557001; 19996311; 20166753; 20354178; 20374513; 20473305; 20639865; 20972266; 21123297; 21139048; 21258409; 21266827; 21414293; 21460850; 21540236; 21798997; 21890473; 21900206; 21906983; 21909097; 21963094; 21987572; 22053931; 22505724; 23000965; 23193052; 23528835,,,,,,,,,,,,,,,,,,OGG:3000054541,,,,,,,,,,,,,,,,,,,DNA-damage-inducible transcript 4,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,DDIT4,,,20140408,54541,RP11-442H21.1,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,DDIT4,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000084525,HOPX,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,LAGY|NECC1|SMAP31|CAMEO|HOP|OB1|HOD|TOTO,,,,,,,4,,,,,,,,,,HGNC:24961|MIM:607275|Ensembl:ENSG00000171476|HPRD:06280|Vega:OTTHUMG00000128768,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,HOP homeobox,,4q12,,,,"GO_0000122 (EC: IEA); GO_0001829 (EC: IDA, PMID: 17576768); GO_0003700 (EC: IEA); GO_0005634 (EC: IDA, PMID: 17192267); GO_0006351 (EC: IEA); GO_0007507 (EC: IEA); GO_0008016 (EC: IEA); GO_0016575 (EC: IEA); GO_0043393 (EC: IEA); GO_0043415 (EC: IEA); GO_0043565 (EC: IEA); GO_0045596 (EC: IDA, PMID: 17576768); GO_0048286 (EC: IEA); GO_0051155 (EC: IEA)",PMID: 11076863; 12297045; 12477932; 12573257; 12759545; 12975471; 14516659; 14522464; 14532270; 14702039; 15213722; 15307938; 15381369; 15457851; 15489334; 15489336; 16344560; 16381901; 16939210; 17192267; 17498662; 17576768; 18052042; 18234960; 18507846; 19173292; 20211142; 20226564; 20228841; 21061432; 21256618; 21382376; 21700222; 22824801; 22904674; 23036489; 23707782,,,,,,,,,,,,,,,,,,OGG:3000084525,,,,,,,,,,,,,,,,,,,HOP homeobox,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,HOPX,,,20140408,84525,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,HOPX,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000026,touching nose,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,Modified definition,,,behaviour process,,true,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25637115,A face-touching behavior involving nose touches.,,,,,,,,,,,,,,,,touching nose,,,,,,,,,,,,,,,,,,,,,,https://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_249064,SARS coronavirus GZ-C,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:249064,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ-C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019031,viral envelope,viral outside membrane|viral glycoprotein,The lipid bilayer of a virion that surrounds the protein capsid. May also contain glycoproteins.,false,,,http://purl.obolibrary.org/obo/GO_0036338,,,,,,,,,,,,,,,,,,,,Wikipedia:Viral_envelope,The lipid bilayer of a virion that surrounds the protein capsid. May also contain glycoproteins.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral outside membrane,,,,,cellular_component,,viral glycoprotein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0036338,,,,GO:0019031,,,,,,,,true,,true,https://www.ncbi.nlm.nih.gov/books/NBK554776/,,,,GO:0019031,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl,,,,,,,,,,viral envelope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000724,multiple organ failure,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000724,,,,,,true,,,,,,Complete impairment of two or more organs or organ systems.,multiorgan dysfunction,,SYMP:0000724,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,multiple organ failure,,,,,,,,,,,,,,,,,,,,,,https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30558-4.pdf,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000007042,TGFB2,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,TGF-beta2|LDS4,,,,,,,1,,,,,,,,,,MIM:190220|HPRD:01828|Vega:OTTHUMG00000039521|Ensembl:ENSG00000092969|HGNC:11768,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"transforming growth factor, beta 2",,1q41,,,,"GO_0000902 (EC: IDA, PMID: 15896309); GO_0001502 (EC: IEA); GO_0001525 (EC: TAS, PMID: 9611771); GO_0001540 (EC: IDA, PMID: 16227582); GO_0001654 (EC: IDA, PMID: 15944186); GO_0001666 (EC: IMP, PMID: 12411310); GO_0001837 (EC: IDA, PMID: 10092230); GO_0001837 (EC: TAS, PMID: 14679171); GO_0001942 (EC: IDA, PMID: 10433821); GO_0001942 (EC: ISS); GO_0001974 (EC: IEA); GO_0002576 (EC: TAS); GO_0003007 (EC: IDA, PMID: 10092230); GO_0004702 (EC: IDA, PMID: 12958365); GO_0005102 (EC: IMP, PMID: 16227582); GO_0005114 (EC: IDA, PMID: 11157754); GO_0005114 (EC: IPI, PMID: 1333888); GO_0005125 (EC: TAS, PMID: 9611771); GO_0005160 (EC: IDA, PMID: 10092230); GO_0005515 (EC: IPI, PMID: 10930463); GO_0005515 (EC: IPI, Qualifier: contributes_to, PMID: 11157754); GO_0005576 (EC: IDA, PMID: 16227582); GO_0005576 (EC: TAS, PMID: 2119582); GO_0005615 (EC: IEA); GO_0006468 (EC: IDA, PMID: 18358889); GO_0007050 (EC: IDA, PMID: 18223299); GO_0007179 (EC: IDA, PMID: 11157754); GO_0007184 (EC: IDA, PMID: 17192487); GO_0007267 (EC: TAS, PMID: 3322813); GO_0007411 (EC: IEA); GO_0007435 (EC: IEP, PMID: 18080134); GO_0007507 (EC: IDA, PMID: 15896309); GO_0007596 (EC: TAS); GO_0008083 (EC: IEA); GO_0008219 (EC: IDA, PMID: 16227582); GO_0008283 (EC: TAS, PMID: 3322813); GO_0008284 (EC: IDA, PMID: 15896309); GO_0008285 (EC: IDA, PMID: 15944186); GO_0008347 (EC: IDA, PMID: 18431253); GO_0009611 (EC: IEP, PMID: 16891397); GO_0009790 (EC: TAS, PMID: 2119582); GO_0010002 (EC: IDA, PMID: 15896309); GO_0010628 (EC: IEA); GO_0010634 (EC: IDA, PMID: 17960115); GO_0010693 (EC: IDA, PMID: 18358889); GO_0010718 (EC: IDA, PMID: 17999987); GO_0010936 (EC: IDA); GO_0014068 (EC: IDA, PMID: 18223299); GO_0016049 (EC: IEA); GO_0016477 (EC: IDA, PMID: 10092230); GO_0022601 (EC: IEP, PMID: 18039789); GO_0023014 (EC: IDA, PMID: 12958365); GO_0030097 (EC: ISS); GO_0030168 (EC: TAS); GO_0030198 (EC: TAS); GO_0030199 (EC: IDA, PMID: 16891397); GO_0030307 (EC: IDA, PMID: 15896309); GO_0030308 (EC: IDA, PMID: 18358889); GO_0030424 (EC: ISS); GO_0030593 (EC: ISS); GO_0030593 (EC: TAS, PMID: 9611771); GO_0031012 (EC: IDA, PMID: 18049952); GO_0031069 (EC: ISS); GO_0031093 (EC: TAS); GO_0032147 (EC: IDA, PMID: 17192487); GO_0032570 (EC: IDA, PMID: 18039789); GO_0032874 (EC: IDA, PMID: 17192487); GO_0032909 (EC: IMP, PMID: 12411310); GO_0033630 (EC: IDA, PMID: 17960115); GO_0042060 (EC: ISS); GO_0042416 (EC: ISS); GO_0042476 (EC: NAS, PMID: 18078367); GO_0042493 (EC: IDA); GO_0042637 (EC: IDA, PMID: 15955085); GO_0042803 (EC: IDA, PMID: 2119582); GO_0043025 (EC: ISS); GO_0043525 (EC: IDA, PMID: 16227582); GO_0045216 (EC: IDA, PMID: 18505915); GO_0045726 (EC: IDA, PMID: 17960115); GO_0045778 (EC: IEP, PMID: 17401695); GO_0045787 (EC: ISS); GO_0045823 (EC: IDA, PMID: 15896309); GO_0046982 (EC: TAS, PMID: 9611771); GO_0048103 (EC: ISS); GO_0048566 (EC: IEP); GO_0048663 (EC: IEA); GO_0048666 (EC: ISS); GO_0048699 (EC: TAS, PMID: 15944186); GO_0050680 (EC: IDA, PMID: 17217916); GO_0050680 (EC: IMP, PMID: 16943770); GO_0050714 (EC: IDA, PMID: 18505915); GO_0050777 (EC: TAS, PMID: 9611771); GO_0050778 (EC: ISS); GO_0051781 (EC: IEA); GO_0051795 (EC: IDA, PMID: 15955085); GO_0051891 (EC: IDA, PMID: 15896309); GO_0060038 (EC: IDA, PMID: 15896309); GO_0060317 (EC: IDA, PMID: 10092230); GO_0060325 (EC: IEA); GO_0060389 (EC: IDA, PMID: 11157754); GO_0070237 (EC: IEA); GO_0097191 (EC: IDA, PMID: 17217916); GO_2001241 (EC: IEA)",PMID: 1333888; 1631557; 1641027; 1764261; 2119582; 2850146; 3162414; 3226728; 3322813; 3457014; 3476488; 7513640; 7852346; 8093006; 8106553; 9493905; 9611771; 9675033; 10092230; 10433821; 10457363; 10861501; 10930463; 11157754; 11241554; 11278302; 11483955; 11488419; 11528528; 11716069; 11795478; 11796824; 11895345; 11991670; 12011061; 12015308; 12021923; 12060054; 12060393; 12062452; 12064833; 12411310; 12420205; 12477932; 12489185; 12545247; 12607775; 12706107; 12772773; 12802400; 12867422; 12911534; 12958365; 14507446; 14510802; 14679171; 14702039; 15009106; 15113633; 15247411; 15290353; 15389580; 15489334; 15695166; 15816823; 15857508; 15896309; 15944186; 15955085; 16210002; 16227582; 16260601; 16463680; 16467496; 16608413; 16778279; 16885354; 16891397; 16943770; 16998703; 17192487; 17201588; 17217916; 17401695; 17431704; 17453002; 17532297; 17611697; 17651146; 17679942; 17703412; 17827158; 17960115; 17999987; 18039789; 18040277; 18043895; 18049952; 18078367; 18080134; 18174230; 18223299; 18239623; 18292822; 18348727; 18358889; 18384390; 18431253; 18457978; 18498721; 18505915; 18563556; 18694919; 19031438; 19062040; 19161338; 19212830; 19249525; 19258923; 19438810; 19444386; 19453261; 19472023; 19572226; 19651985; 19710942; 19834535; 19913121; 19937272; 19959123; 19965872; 20059631; 20134268; 20142847; 20201926; 20237496; 20301312; 20485444; 20503287; 20543478; 20585394; 20587546; 20628086; 20628624; 20630504; 20634891; 20734064; 20875417; 20881960; 21034224; 21087804; 21087928; 21088899; 21106846; 21139048; 21161068; 21207416; 21212630; 21305699; 21360509; 21411746; 21446058; 21585337; 21642622; 21693611; 21738403; 21917933; 21946350; 22180604; 22464821; 22487836; 22504005; 22582395; 22653295; 22706080; 22736943; 22739237; 22772368; 22772371; 22786655; 22823397; 22955109; 23099432; 23102774; 23249391; 23257207; 23297089; 23306609; 23322721; 23387555; 23651239; 23668958; 23687438; 24045946; 24314882,,,,,,,,,,,,,,,,,,OGG:3000007042,,,,,,,,,,,,,,,,,,,"transforming growth factor, beta 2",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,TGFB2,,,20140408,7042,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,TGFB2,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_385685,SARS coronavirus ES191,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:385685,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus ES191,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000000,cell,,"A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.|The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one).",false,,,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,VHOG:0001533|XAO:0003012|FMA:68646|CALOHA:TS-2035|WBbt:0004017|KUPO:0000002|GO:0005623,A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cell,,,,,,,,CL:0000000,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one).",,http://purl.obolibrary.org/obo/BFO_0000040,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cl.owl,http://purl.oboInOwllibrary.org/oboInOwl/ubprop#_upper_level,,,,,,,,,,cell|cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0006530,Interstitial pulmonary abnormality,Interstitial pulmonary disease|Abnormality in area between air sacs in lung|Interstitial lung disease,Abnormality of the lung parenchyma extending to the pulmonary interstitium and leading to diffuse pulmonary fibrosis.,false,,,http://purl.obolibrary.org/obo/HP_0002088,,,,,,,,,,,,,,,,,,,,MSH:D017563|UMLS:C0206062|SNOMEDCT_US:233703007,Abnormality of the lung parenchyma extending to the pulmonary interstitium and leading to diffuse pulmonary fibrosis.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0006513|HP:0006547,,,,Interstitial pulmonary disease|Abnormality in area between air sacs in lung|Interstitial lung disease,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002088,,,,HP:0006530,,,,,,,,,,,,,,,HP:0006530,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Interstitial pulmonary abnormality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0031352,Chest tightness,Tightness in chest,An unpleasant sensation of tightness or pressure in the chest.,false,,,http://purl.obolibrary.org/obo/HP_0025142,,,,,,,,,,,,,,,,peter,,,,,An unpleasant sensation of tightness or pressure in the chest.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Tightness in chest,,,,,,,,,,,,,HP:0031352,,,,,,,,,,,,,,,,,,2017-08-27T14:49:28Z,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0025142,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Chest tightness,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000077,virus contact,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,Process,,true,,,,,,Contact with someone who has the same infection.,,,,,,,,,,,,,,,,virus contact,,,,,,,,,,,,,,,,,,,,,,https://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0000000,clinical measurement,,"A quantitative or qualitative value which is the result of an act of assessing a morphological or physiological state or property in a single individual or sample or a group of individuals or samples, based on direct observation or experimental manipulation.",false,,,http://purl.obolibrary.org/obo/IAO_0000109,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0000000,,,,,,,,,,,,"A quantitative or qualitative value which is the result of an act of assessing a morphological or physiological state or property in a single individual or sample or a group of individuals or samples, based on direct observation or experimental manipulation.",,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/IAO_0000109,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,clinical measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10509,Mastadenovirus,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10508,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,,,,,,,NCBITaxon:10509,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10508,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Mastadenovirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_5801,hydroxychloroquine,2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol|7-chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|hydroxychloroquine|2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol|NSC4375|7-chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|(+-)-hydroxychloroquine|2-(N-(4-(7-chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|oxichlorochine|Polirreumin|7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|hidroxicloroquina|oxichloroquine|hydroxychloroquinum|7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline,"An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23887202|LINCS:LSM-5193|Patent:US2546658|Reaxys:253894|PMID:23481418|PMID:23581274|PMID:23218706|KEGG:D08050|PMID:23902281|PMID:23485647|CAS:118-42-3|HMDB:HMDB0015549|PMID:23778483|DrugBank:DB01611|Drug_Central:1395|KEGG:C07043|PMID:23216212|Wikipedia:Hydroxychloroquine,"An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol,,,,,chebi_ontology,,7-chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|hydroxychloroquine|2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol|NSC4375|7-chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|(+-)-hydroxychloroquine|2-(N-(4-(7-chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|oxichlorochine|Polirreumin|7-chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|hidroxicloroquina|oxichloroquine|hydroxychloroquinum|7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline,,,,,,,,,0,C18H26ClN3O,"InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)",XXSMGPRMXLTPCZ-UHFFFAOYSA-N,335.87200,335.17644,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:5801,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32205204,,,,CHEBI:5801,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,hydroxychloroquine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_0014667,disease of metabolism,metabolic disease,A disease that involving errors in metabolic processes of building or degradation of molecules.,false,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,,,,,,,,,,,,,,,,,ICD9CM:277.9|ICD10CM:E88.9|UMLS_CUI:C0025517|SNOMEDCT_US_2019_09_01:75934005|MESH:D008659|NCI:C3235,A disease that involving errors in metabolic processes of building or degradation of molecules.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,metabolic disease,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000031,,,,DOID:0014667,,,,,,,,,,,,,,,DOID:0014667,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,disease of metabolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000133,nsp7 and nsp8 primase complex,,,false,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000001,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,The SARS-CoV-2 putative primase  is a nonstructural viral proteins that is composed of the nsp7 and nsp8 proteins and fold with a helical core of the heterotetramer formed by both nsp7 and nsp8 that is flanked with two symmetry-related nsp8 β-sheet subdomains.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,https://bio.scai.fraunhofer.de/ontology/COVID_0000001,,,,,,modified definition,,"Since Proteins are classified under material entity, so as all the viral proteins.
Refer : https://www.ebi.ac.uk/ols/ontologies/pr/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FPR_000000001",,,,,true,,https://pubmed.ncbi.nlm.nih.gov/32535228/|https://www.ncbi.nlm.nih.gov/pubmed/31138817,,nsp7-nsp8 heterodimer,,,,,,,,,,,,,,,nsp7 and nsp8 primase complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000079,Abnormality of the urinary system,Urinary tract abnormalities|Urinary tract anomalies|Urinary tract abnormality,An abnormality of the urinary system.,false,,,http://purl.obolibrary.org/obo/HP_0000119,,,,,,,,,,,,,,,,,,,,UMLS:C4021821,An abnormality of the urinary system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Urinary tract abnormalities|Urinary tract anomalies|Urinary tract abnormality,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0000119,,,,HP:0000079,,,,,,,,,,,,,,,HP:0000079,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the urinary system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000955,brain,encephalon|suprasegmental structures|synganglion|the brain|suprasegmental levels of nervous system,"The brain is the center of the nervous system in all vertebrate, and most invertebrate, animals. Some primitive animals such as jellyfish and starfish have a decentralized nervous system without a brain, while sponges lack any nervous system at all. In vertebrates, the brain is located in the head, protected by the skull and close to the primary sensory apparatus of vision, hearing, balance, taste, and smell[WP].",false,,,http://purl.obolibrary.org/obo/UBERON_0000062|http://purl.obolibrary.org/obo/UBERON_0004121,,,,,,,,,,,,,,,https://github.com/cmungall,,,,,MIAA:0000098|MBA:997|EV:0100164|EMAPA:16894|EHDAA:6485|BAMS:Br|EFO:0000302|OpenCyc:Mx4rvVjT65wpEbGdrcN5Y29ycA|EHDAA:2641|MAT:0000098|PBA:3999|MA:0000168|FMA:50801|GAID:571|BTO:0000142|http://braininfo.rprc.washington.edu/centraldirectory.aspx?ID=21|ABA:Brain|BILA:0000135|AAO:0010478|ZFA:0000008|NCIT:C12439|FBbt:00005095|DHBA:10155|MBA:8|BAMS:Brain|VHOG:0000157|BIRNLEX:796|EHDAA2:0000183|XAO:0000010|UMLS:C1269537|HBA:4005|MESH:D001921|TAO:0000008|CALOHA:TS-0095|galen:Brain|UMLS:C0006104|http://linkedlifedata.com/resource/umls/id/C0006104|http://linkedlifedata.com/resource/umls/id/C1269537|http://braininfo.rprc.washington.edu/centraldirectory.aspx?ID=21|http://en.wikipedia.org/wiki/Brain|http://www.snomedbrowser.com/Codes/Details/258335003,"The brain is the center of the nervous system in all vertebrate, and most invertebrate, animals. Some primitive animals such as jellyfish and starfish have a decentralized nervous system without a brain, while sponges lack any nervous system at all. In vertebrates, the brain is located in the head, protected by the skull and close to the primary sensory apparatus of vision, hearing, balance, taste, and smell[WP].",,,,,,,,"requires review for applicability to invertebrate structures, e.g. synganglion",,,,,,"Part of the central nervous system situated within the cranium and composed of both nerve cell bodies and nerve fibers.[AAO]|The part of the central nervous system contained within the cranium, comprising the forebrain, midbrain, hindbrain, and metencephalon. It is derived from the anterior part of the embryonic neural tube (or the encephalon). Does not include retina. (CUMBO)|Cavitated compound organ which is comprised of gray and white matter and surrounds the cerebral ventricular system.[TAO]",,,,,,,,,,,,,,,,,,,,,,uberon,,encephalon|suprasegmental structures|synganglion|the brain|suprasegmental levels of nervous system,,,,,"(...) at some stage of its development, every chordate exhibits five uniquely derived characters or synapomorphies of the group: (...) (4) a single, tubular nerve cord that is located dorsal to the notochord (...) (reference 1); The neural tube is destined to differentiate into the brain and spinal cord (the central nervous system) (reference 2).[well established][VHOG]",,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000062|http://purl.obolibrary.org/obo/UBERON_0004121,,,,UBERON:0000955,,,,,,true,,,,,,,,,UBERON:0000955,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#uberon_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#vertebrate_core|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#major_organ|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#efo_slim|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#cumbo,,,,,,,,,,brain,,,,,,,,,,,,,,,,,,,,,,https://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264382,SARS coronavirus TW-GD5,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264382,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-GD5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0019139,hemic system symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0017795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms manifested in organs involved in the production and circulation of blood,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0017795,,,,SYMP:0019139,,modified definition,,,,,,,,,,,,,SYMP:0019139,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,hemic system symptom,,,,,,,,,,,,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/mesh/68006424,,,,,,,,,,
http://purl.obolibrary.org/obo/PATO_0002003,population quality,,A quality that inheres in an entire population or part of a population.,false,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,,,,,,,,,,,,,,A quality that inheres in an entire population or part of a population.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,quality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,PATO:0002003,,,,,,,,,,,,,,,PATO:0002003,,http://purl.obolibrary.org/obo/pato.owl,http://purl.oboInOwllibrary.org/oboInOwl/pato#attribute_slim,,,,,,,,,,population quality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_80618,Isoniazid pyruvate,,,false,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,,,,,,,,,,,,,,,,,CAS:1081-50-1|KEGG:C16624|HMDB:HMDB0060664,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,,,,,,,,,,0,C9H9N3O3,"InChI=1S/C9H9N3O3/c1-6(9(14)15)11-12-8(13)7-2-4-10-5-3-7/h2-5H,1H3,(H,12,13)(H,14,15)/b11-6+",ZGGPNDKKJIWQJU-IZZDOVSWSA-N,207.18610,207.06439,CC(C(O)=O)=N/NC(=O)c1ccncc1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_25212,,,,CHEBI:80618,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:80618,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Isoniazid pyruvate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0006314,bodily fluid,fluid|body fluid,Liquid components of living organisms. includes fluids that are excreted or secreted from the body as well as body water that normally is not.,false,,,http://purl.obolibrary.org/obo/UBERON_0000463,,,,,,,,,,,,,,,,,,,,FMA:280556|galen:BodyFluid|GAID:266|EMAPA:37441|MESH:D001826|BIRNLEX:20|http://en.wikipedia.org/wiki/Body_fluid,Liquid components of living organisms. includes fluids that are excreted or secreted from the body as well as body water that normally is not.,,,,,,,,,,,,,,,,,,,,,,,,,,,,fluid,,,body fluid,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000463,,,,UBERON:0006314,,,,,,,,,,,,,,,UBERON:0006314,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#pheno_slim,,,,,,,,,,bodily fluid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_134719,ceftolozane,"7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-[ (5-amino-4-{[(2-aminoethyl)carbamoyl]amino}-1-methyl-1H-pyrazol-2-ium-2-yl)methyl]-3,4-didehydrocepham-4-carboxylate|ceftolozano|CXA-101|(6R,7R)-3-[(5-amino-4-{[(2-aminoethyl)carbamoyl]amino}-1-methyl-1H-pyrazol-2-ium-2-yl)methyl]-7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|ceftolozane|ceftolozanum","A fifth-generation cephalosporin antibiotic having (5-amino-4-{[(2-aminoethyl)carbamoyl]amino}-1-methyl-1H-pyrazol-2-ium-2-yl)methyl and [(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino side groups located at positions 3 and 7 respectively; developed for the treatment of infections with gram-negative bacteria that have become resistant to conventional antibiotics.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:29517862|Wikipedia:Ceftolozane|PMID:28980834|PMID:29017833|PMID:29493397|Reaxys:24720344|PMID:29521242|Patent:US2017233408|PMID:28923865|Patent:WO2016028670|PMID:28993338|PMID:28689923|PMID:29167294|CAS:689293-68-3,"A fifth-generation cephalosporin antibiotic having (5-amino-4-{[(2-aminoethyl)carbamoyl]amino}-1-methyl-1H-pyrazol-2-ium-2-yl)methyl and [(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino side groups located at positions 3 and 7 respectively; developed for the treatment of infections with gram-negative bacteria that have become resistant to conventional antibiotics.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-[ (5-amino-4-{[(2-aminoethyl)carbamoyl]amino}-1-methyl-1H-pyrazol-2-ium-2-yl)methyl]-3,4-didehydrocepham-4-carboxylate",,,,,chebi_ontology,,"ceftolozano|CXA-101|(6R,7R)-3-[(5-amino-4-{[(2-aminoethyl)carbamoyl]amino}-1-methyl-1H-pyrazol-2-ium-2-yl)methyl]-7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|ceftolozane|ceftolozanum",,,,,,,,,0,C23H30N12O8S2,"InChI=1S/C23H30N12O8S2/c1-23(2,20(40)41)43-31-11(15-30-21(26)45-32-15)16(36)29-12-17(37)35-13(19(38)39)9(8-44-18(12)35)6-34-7-10(14(25)33(34)3)28-22(42)27-5-4-24/h7,12,18,25H,4-6,8,24H2,1-3H3,(H7,26,27,28,29,30,32,36,38,39,40,41,42)/b31-11-/t12-,18-/m1/s1",JHFNIHVVXRKLEF-DCZLAGFPSA-N,666.693,666.17510,C=1(N2[C@](SCC1C[N+]=3N(C(=C(C3)NC(NCCN)=O)N)C)([C@@H](C2=O)NC(/C(/C4=NSC(=N4)N)=NOC(C(=O)O)(C)C)=O)[H])C([O-])=O,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:134719,,,,,true,true,,,,,,,,,CHEBI:134719,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,ceftolozane,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_31303,bromhexine hydrochloride,"2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline hydrochloride|N-(2-amino-3,5-dibromobenzyl)-N-methyl-cyclohexylammonium chloride|Quentan|bromhexine chloride|Broncokin|bromohexine monohydrochloride|3,5-dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha,2-diamine monohydrochloride|bromhexine HCl|N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexanaminium chloride|Viscolyt|Auxit|2-amino-N-cyclohexyl-3,5-dibromo-N-methylbenzylamine hydrochloride|Ophtolsol|N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)ammonium chloride",A hydrochloride resulting from the reaction of equimolar amounts of bromhexine and hydrogen chloride. It is used as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:4848376|VSDB:1786|CAS:611-75-6|PMID:16385235|PMID:9260207|PMID:2365032|KEGG:D01778|Patent:CN101817754,A hydrochloride resulting from the reaction of equimolar amounts of bromhexine and hydrogen chloride. It is used as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline hydrochloride",,,,,chebi_ontology,,"N-(2-amino-3,5-dibromobenzyl)-N-methyl-cyclohexylammonium chloride|Quentan|bromhexine chloride|Broncokin|bromohexine monohydrochloride|3,5-dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha,2-diamine monohydrochloride|bromhexine HCl|N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexanaminium chloride|Viscolyt|Auxit|2-amino-N-cyclohexyl-3,5-dibromo-N-methylbenzylamine hydrochloride|Ophtolsol|N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)ammonium chloride",,,,,,,,,0,C14H21Br2ClN2,"InChI=1S/C14H20Br2N2.ClH/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17;/h7-8,12H,2-6,9,17H2,1H3;1H",UCDKONUHZNTQPY-UHFFFAOYSA-N,412.59100,409.97600,Cl.CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:31303,,,,,,true,,,,,,,,,CHEBI:31303,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,bromhexine hydrochloride,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0043542,endothelial cell migration,,The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.,false,,,http://purl.obolibrary.org/obo/GO_0016477,,,,,,,,,,,,,,,,,,,,,The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016477,,,,GO:0043542,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32221983,,,,GO:0043542,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endothelial cell migration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0005905,clathrin-coated pit,coated pit,"A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,NIF_Subcellular:sao1969557946,"A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,coated pit,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0005905,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0005905,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,clathrin-coated pit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_72291,cobicistat,"1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate|GS 9350|cobicistatum|GS-9350|cobicistat","A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoic acid with the amino group of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate. Acts as a pharmacoenhancer in treatment of HIV-1 by inhibiting P450 enzymes that metabolise other medications..",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:22732469|Patent:WO2008010921|PMID:22833060|CAS:1004316-88-4|PMID:22886031|Drug_Central:4299|PMID:22766666|Reaxys:13088386|PMID:23136357|Patent:WO2012151165|PMID:22850510|PMID:20683270|Wikipedia:Cobicistat|Patent:US2010256366|PMID:20043009|PMID:21348537|PMID:23243633,"A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoic acid with the amino group of 1,3-thiazol-5-ylmethyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate. Acts as a pharmacoenhancer in treatment of HIV-1 by inhibiting P450 enzymes that metabolise other medications..",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate",,,,,chebi_ontology,,GS 9350|cobicistatum|GS-9350|cobicistat,,,,,,,,,0,C40H53N7O5S2,"InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1",ZCIGNRJZKPOIKD-CQXVEOKZSA-N,776.02300,775.35496,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:72291,,,,,,true,,,,,,,,,CHEBI:72291,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,cobicistat,,,,,,,,,,,,,,,,,,,,,,https://clinicaltrials.gov/ct2/show/NCT04252274,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C19148,In Vivo Model,In Vivo Model,,false,,,http://purl.obolibrary.org/obo/NCIT_C17456,,,,,,,,,,,C19148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,In Vivo Model,,,,,,,,,,,,,NCIT:C19148,"In vivo (Latin for “within the living”) refers to experimentation using a whole, living organism as opposed to a partial or dead organism.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17456,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,In Vivo Model,in_vivo_Model,,,,,,,,,,,,,,,,,,In Vivo Model,,,,Research Activity,,,,,,,,C1515657,
http://purl.obolibrary.org/obo/DOID_1227,neutropenia,,,false,,,http://purl.obolibrary.org/obo/DOID_12987,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0027947|ICD9CM:288.0|SNOMEDCT_US_2019_09_01:303011007|ICD10CM:D70|MESH:D009503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,A decrease in the number of neutrophils in the peripheral blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_12987,,,,DOID:1227,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32196678,,,,DOID:1227,,http://purl.obolibrary.org/obo/doid.owl,,,,,,,,,,,neutropenia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000956,nuclear-transcribed mRNA catabolic process,nuclear mRNA catabolism|nuclear mRNA degradation|nuclear mRNA breakdown,The chemical reactions and pathways resulting in the breakdown of nuclear-transcribed mRNAs in eukaryotic cells.,false,,,http://purl.obolibrary.org/obo/GO_0006402,,,,,,,,,,,,,,,,,,,,,The chemical reactions and pathways resulting in the breakdown of nuclear-transcribed mRNAs in eukaryotic cells.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nuclear mRNA catabolism|nuclear mRNA degradation|nuclear mRNA breakdown,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0006402,,,,GO:0000956,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000956,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nuclear-transcribed mRNA catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_296841,SARS coronavirus PC4-241,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:296841,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-241,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0044843,cell cycle G1/S phase transition,,The cell cycle process by which a cell in G1 phase commits to S phase.,false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,janelomax,2014-03-25T16:33:47Z,,,,The cell cycle process by which a cell in G1 phase commits to S phase.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0044843,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044843,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,cell cycle G1/S phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_22689,bafilomycin A1,"(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-{(2S,3R,4S)-4-[(2R,4R,5S,6R)-2,4-dihydroxy-6-isopropyl-5-methyltetrahydro-2H-pyran-2-yl]-3-hydroxypentan-2-yl}-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one","The most used of the bafilomycins, a family of toxic macrolide antibiotics derived from Streptomyces griseus.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:8446034|PMID:22943412|PMID:22344969|PMID:11533151|PMID:24977403|PMID:17917797|PMID:19289106|PMID:19067440|PMID:26242265|PMID:23038011|PMID:23480984|PMID:24890793|PMID:20820851|PMID:7817803|Reaxys:4730700|PMID:26156798|PMID:25512644|Beilstein:3640011|CAS:88899-55-2|PMID:10519916|Beilstein:4730699|Beilstein:4730700,"The most used of the bafilomycins, a family of toxic macrolide antibiotics derived from Streptomyces griseus.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-{(2S,3R,4S)-4-[(2R,4R,5S,6R)-2,4-dihydroxy-6-isopropyl-5-methyltetrahydro-2H-pyran-2-yl]-3-hydroxypentan-2-yl}-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one",,,,,chebi_ontology,,,,,,,,,,,0,C35H58O9,"InChI=1S/C35H58O9/c1-19(2)32-24(7)27(36)18-35(40,44-32)26(9)31(38)25(8)33-28(41-10)14-12-13-20(3)15-22(5)30(37)23(6)16-21(4)17-29(42-11)34(39)43-33/h12-14,16-17,19,22-28,30-33,36-38,40H,15,18H2,1-11H3/b14-12+,20-13+,21-16+,29-17-/t22-,23+,24-,25-,26-,27+,28-,30-,31+,32+,33+,35+/m0/s1",XDHNQDDQEHDUTM-JQWOJBOSSA-N,622.82960,622.40808,CO[C@H]1C=C\C=C(C)\C[C@H](C)[C@H](O)[C@H](C)\C=C(C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O)[C@H](C)[C@H](O1)C(C)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:22689,,,,,,true,,,,,,,,,CHEBI:22689,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,bafilomycin A1,,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.full,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0042737,drug catabolic process,drug degradation|drug catabolism|drug breakdown,"The chemical reactions and pathways resulting in the breakdown of a drug, a substance used in the diagnosis, treatment or prevention of a disease.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of a drug, a substance used in the diagnosis, treatment or prevention of a disease.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,drug degradation|drug catabolism|drug breakdown,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0042737,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0042737,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,drug catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_347537,Bat SARS CoV Rf1/2004,Bat SARS-CoV/Rf1/2004|Bat SARS coronavirus Rf1,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,Bat SARS-CoV/Rf1/2004|Bat SARS coronavirus Rf1,,,,,,NCBITaxon:347537,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Bat SARS CoV Rf1/2004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_104,bacterial infectious disease,,"A disease by infectious agent that results_in infection, has_material_basis_in Bacteria.",false,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,,,,,,,,,,,,,,,,,SNOMEDCT_US_2019_09_01:301811001|UMLS_CUI:C0004623|MESH:D001424|NCI:C2890|ICD10CM:A49.9,"A disease by infectious agent that results_in infection, has_material_basis_in Bacteria.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_0050117,,,,DOID:104,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32220278,,,,DOID:104,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,bacterial infectious disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CL_0000647,multinucleated giant cell,Langerhans giant cell|multinucleate giant cell|foreign body giant cell|syncytial giant cell|macrophage polykaryon,"A phagocytic cell formed by the fusion of macrophages, occurs in chronic inflammatory responses to persistent microorganism such as M.tuberculosis, component of granulomas. Sometimes used to refer to megakaryocytes.|Role or process: Chronic infection, granulomatous inflammation. Consider also megakaryocyte (CL:0000556) as sometimes multinucleated giant cell is used to refer to this.",false,,,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,,,,,,,,,,FMA:83035|BTO:0003107,"A phagocytic cell formed by the fusion of macrophages, occurs in chronic inflammatory responses to persistent microorganism such as M.tuberculosis, component of granulomas. Sometimes used to refer to megakaryocytes.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Langerhans giant cell|multinucleate giant cell|foreign body giant cell|syncytial giant cell|macrophage polykaryon,,,,,cell,,,,,,,,CL:0000647,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Role or process: Chronic infection, granulomatous inflammation. Consider also megakaryocyte (CL:0000556) as sometimes multinucleated giant cell is used to refer to this.",,http://purl.obolibrary.org/obo/CL_0000000,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,,,http://purl.obolibrary.org/obo/cl.owl,,,,,,,,,,,multinucleated giant cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098676,modulation of host virulence by virus,,"Any process by which a virus modulates the ability of its host to infect and/or damage an organism for which it is a host.  Typically this involves a phage modulating the virulence of a bacterium.  Mechanisms include the expression of factors that modulate a bacterial adhesion to a host cell, spread through host tissues, production exotoxins or provide protection against host immune defenses.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,dos,2017-01-19T11:59:46Z,,,VZ:3965,"Any process by which a virus modulates the ability of its host to infect and/or damage an organism for which it is a host.  Typically this involves a phage modulating the virulence of a bacterium.  Mechanisms include the expression of factors that modulate a bacterial adhesion to a host cell, spread through host tissues, production exotoxins or provide protection against host immune defenses.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0098676,,,,,,true,,,,true,,,,,GO:0098676,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,modulation of host virulence by virus,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202004.0077/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C50747,Sore Throat,"Throat, Sore|Sore Throat|Sore throat","Any kind of inflammatory process of the tonsils, pharynx, or/and larynx characterized by pain in swallowing.",false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,A disorder characterized by of marked discomfort in the throat,,,,,,,,,C50747,,,FDA|CTCAE,,,,,,,"Any kind of inflammatory process of the tonsils, pharynx, or/and larynx characterized by pain in swallowing.",,,,,,,,,,,,,,,,Patient Code (Appendix B),,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C54450,,"Throat, Sore|Sore Throat|Sore throat",,,,,,,,,,,,,NCIT:C50747,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,,true,true,,https://www.ncbi.nlm.nih.gov/books/NBK554776/|https://www.ncbi.nlm.nih.gov/pubmed/32106852,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C54450|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C62596,,,,,,,,,,Sore Throat,Sore_Throat,,,,,,,,,,,,,,,,,,Sore Throat,,,,Finding,,,,,,,,C0242429,
https://bio.scai.fraunhofer.de/ontology/COVID_0000112,early symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Signs or symptoms that appear at an early stage of disease,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,modified definition,,,,true,,,,,,,,,,,,,,,,,,,,,,early symptom,,,,,,,,,,,,,,,,,,,,,,https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963|https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-symptoms-frequently-asked-questions,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C82255,Rupintrivir,"Rupintrivir|AG7088|Ethyl (2E,4S)-4-(((2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-(((5-methylisoxazol-3-yl)carbonyl)amino)-4-oxoheptanoyl)amino)-5-((3S)-2-oxopyrrolidin-3-yl)pent-2-enoate|RUPINTRIVIR|Ruprintrivir","A peptidomimetic inhibitor with activity against human rhinoviruses. Rupintrivir is an irreversible 3C protease inhibitor which blocks processing of viral proteins, thus blocking viral replication.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,223537-30-2,,C31H39FN4O7,,C82255,,,FDA,,,,,,,"A peptidomimetic inhibitor with activity against human rhinoviruses. Rupintrivir is an irreversible 3C protease inhibitor which blocks processing of viral proteins, thus blocking viral replication.",,,,,,,,,,,,,,,,,RGE5K1Q5QW,,,,,,,,,,,,,,"Rupintrivir|AG7088|Ethyl (2E,4S)-4-(((2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-(((5-methylisoxazol-3-yl)carbonyl)amino)-4-oxoheptanoyl)amino)-5-((3S)-2-oxopyrrolidin-3-yl)pent-2-enoate|RUPINTRIVIR|Ruprintrivir",,,,,,,,,,,,,NCIT:C82255,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Rupintrivir,Rupintrivir,,,,,,,,,,,,,,,,,,Rupintrivir,,,,Pharmacologic Substance,,,,,,,,C2350739,
http://purl.obolibrary.org/obo/OGG_3000007514,XPO1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CRM1|exp1|emb,,,,,,,2,,,,,,,,,,Ensembl:ENSG00000082898|MIM:602559|Vega:OTTHUMG00000152316|HPRD:03975|HGNC:12825,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,exportin 1,,2p15,,,,"GO_0000122 (EC: IEA); GO_0000278 (EC: TAS); GO_0000776 (EC: IDA, PMID: 17363900); GO_0003723 (EC: IEA); GO_0005215 (EC: TAS); GO_0005515 (EC: IPI, PMID: 11545741); GO_0005634 (EC: IDA); GO_0005635 (EC: TAS, PMID: 9368044); GO_0005642 (EC: IDA, PMID: 12210765); GO_0005654 (EC: TAS); GO_0005730 (EC: IEA); GO_0005737 (EC: IDA); GO_0005829 (EC: TAS); GO_0006611 (EC: IEA); GO_0007179 (EC: TAS); GO_0008536 (EC: IEA); GO_0008565 (EC: IEA); GO_0010467 (EC: TAS); GO_0010824 (EC: IEA); GO_0015030 (EC: IEA); GO_0016032 (EC: TAS); GO_0016070 (EC: TAS); GO_0016071 (EC: TAS); GO_0019058 (EC: TAS); GO_0019904 (EC: IEA); GO_0030512 (EC: TAS); GO_0030529 (EC: IDA, PMID: 18809582); GO_0031965 (EC: IDA); GO_0034504 (EC: IEA); GO_0042176 (EC: IEA); GO_0042493 (EC: IEA); GO_0043231 (EC: IDA); GO_0046825 (EC: IEA); GO_0051028 (EC: IEA); GO_0075733 (EC: TAS)",PMID: 1648487; 7543368; 7634337; 7637788; 7745679; 7878053; 8633082; 9049309; 9070945; 9111043; 9205132; 9311922; 9323132; 9323133; 9368044; 9368759; 9837918; 10202161; 10209022; 10330396; 10347184; 10358091; 10381392; 10430904; 10518602; 10601307; 10604476; 10611974; 10668806; 10779340; 10786834; 10835362; 10875611; 10882110; 10891499; 10944119; 11118210; 11119609; 11149927; 11152524; 11238447; 11309306; 11313479; 11425870; 11545741; 11551912; 11571268; 11604520; 11716535; 11779848; 11782423; 11836381; 11839808; 11884594; 11889117; 11932251; 12065584; 12070164; 12089160; 12134013; 12134041; 12176322; 12196506; 12210765; 12217955; 12239324; 12477932; 12493914; 12517958; 12519765; 12529437; 12676962; 12724356; 12805458; 12821127; 12860972; 12861014; 12915405; 14554087; 14612415; 14617633; 14630927; 14702039; 14729966; 15117971; 15126627; 15175654; 15189895; 15239126; 15302935; 15364930; 15489334; 15507209; 15513923; 15556946; 15574331; 15574332; 15574333; 15632073; 15635413; 15790592; 15814838; 15815621; 15908946; 16041368; 16140268; 16196087; 16263121; 16294017; 16314522; 16319068; 16354571; 16449650; 16484227; 16504563; 16511568; 16552725; 16580684; 16675447; 16707848; 16895915; 16943420; 17053781; 17064665; 17099693; 17110338; 17141982; 17142760; 17148452; 17314511; 17363900; 17405816; 17616652; 17643375; 17661632; 17711849; 17715235; 17726064; 17764157; 17869244; 18059333; 18245089; 18246793; 18256292; 18306389; 18316374; 18508616; 18606808; 18624354; 18641393; 18687685; 18715912; 18781797; 18809582; 18923137; 18976462; 18976975; 19020832; 19082467; 19117056; 19149558; 19149559; 19322201; 19339969; 19339972; 19342232; 19412186; 19435492; 19454010; 19471022; 19522705; 19535902; 19536614; 19545931; 19574837; 19591226; 19738201; 19812309; 19828735; 19858290; 20003838; 20012529; 20018238; 20018851; 20026644; 20085707; 20127713; 20151187; 20233715; 20360068; 20473970; 20562859; 20712566; 20805509; 20857263; 20935510; 20953181; 20972448; 21044950; 21048991; 21064154; 21081666; 21139048; 21251165; 21252943; 21268017; 21358275; 21364925; 21364984; 21378169; 21518760; 21522132; 21613532; 21683812; 21708948; 21750575; 21799930; 21888622; 21890473; 21906983; 21909257; 21953454; 21963094; 21988832; 22053931; 22111374; 22114565; 22171254; 22174317; 22190034; 22250199; 22262852; 22266855; 22284678; 22289179; 22318151; 22334690; 22348310; 22355797; 22421880; 22500989; 22505724; 22555597; 22586326; 22623428; 22675540; 22677130; 22678362; 22783232; 22832492; 22833565; 22846997; 22863883; 22933280; 22939629; 22965172; 23000965; 23034282; 23079374; 23115280; 23175358; 23181366; 23242554; 23251541; 23264634; 23275444; 23455922; 23464991; 23471078; 23564911; 23588715; 23752175; 23825024; 23850451; 23850454; 23956138; 24018641; 24113472; 24457600,,,,,,,,,,,,,,,,,,OGG:3000007514,,,,,,,,,,,,,,,,,,,exportin 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,XPO1,,,20140408,7514,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,XPO1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/OGG_3000003084,NRG1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,SMDF|NDF|HRG1|HRGA|HRG|ARIA|MST131|GGF2|HGL|GGF,,,,,,,8,,,,,,,,,,MIM:142445|HGNC:7997|Ensembl:ENSG00000157168|HPRD:00802|Vega:OTTHUMG00000163918,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,neuregulin 1,,8p12,,,,"GO_0000165 (EC: IEA); GO_0000902 (EC: IEA); GO_0003161 (EC: IEA); GO_0003222 (EC: IDA, PMID: 17336907); GO_0003712 (EC: IDA, PMID: 15073182); GO_0005102 (EC: IPI, PMID: 7514177); GO_0005125 (EC: TAS, PMID: 10372964); GO_0005176 (EC: IEA); GO_0005515 (EC: IPI, PMID: 7592681); GO_0005576 (EC: NAS, PMID: 1348215); GO_0005576 (EC: TAS); GO_0005615 (EC: IDA, PMID: 11389077); GO_0005634 (EC: IEA); GO_0005737 (EC: IEA); GO_0005887 (EC: IEA); GO_0007154 (EC: TAS, PMID: 17432114); GO_0007169 (EC: IDA, PMID: 7514177); GO_0007171 (EC: IDA, PMID: 9553078); GO_0007171 (EC: NAS, PMID: 1348215); GO_0007173 (EC: TAS); GO_0007399 (EC: TAS, PMID: 17432114); GO_0007416 (EC: IEA); GO_0007422 (EC: IEA); GO_0007626 (EC: IEA); GO_0008083 (EC: IDA, PMID: 11389077); GO_0008083 (EC: NAS, PMID: 8096067); GO_0008283 (EC: IDA, PMID: 11389077); GO_0008543 (EC: TAS); GO_0009790 (EC: IEA); GO_0010667 (EC: IDA, PMID: 9553078); GO_0014032 (EC: TAS, PMID: 17432114); GO_0016020 (EC: NAS, PMID: 8096067); GO_0016324 (EC: IDA, PMID: 12646923); GO_0016477 (EC: IEA); GO_0021781 (EC: IEA); GO_0030296 (EC: IDA, PMID: 7556068); GO_0030297 (EC: IC, PMID: 9553078); GO_0030297 (EC: NAS, PMID: 1348215); GO_0030307 (EC: IDA, PMID: 9553078); GO_0030424 (EC: IEA); GO_0030879 (EC: TAS, PMID: 17432114); GO_0030971 (EC: NAS, PMID: 1348215); GO_0031594 (EC: IEA); GO_0038095 (EC: TAS); GO_0038127 (EC: IDA, PMID: 11389077); GO_0042060 (EC: IDA, PMID: 12646923); GO_0042060 (EC: TAS, PMID: 16412517); GO_0042177 (EC: IEA); GO_0043125 (EC: IDA, PMID: 7556068); GO_0043125 (EC: IPI, PMID: 11389077); GO_0043496 (EC: TAS, PMID: 16412517); GO_0043497 (EC: IDA, PMID: 10559227); GO_0043624 (EC: IGI, PMID: 15155732); GO_0045087 (EC: TAS); GO_0045213 (EC: IEA); GO_0045785 (EC: IDA, PMID: 7556068); GO_0045892 (EC: IDA, PMID: 15073182); GO_0046579 (EC: IEA); GO_0048011 (EC: TAS); GO_0048015 (EC: TAS); GO_0048663 (EC: IEA); GO_0051048 (EC: IDA, PMID: 10559227); GO_0051155 (EC: ISS); GO_0051897 (EC: IEA); GO_0055007 (EC: ISS); GO_0055012 (EC: IDA, PMID: 9553078); GO_0060045 (EC: IDA, PMID: 9553078); GO_0060379 (EC: IDA, PMID: 17336907); GO_0060956 (EC: IDA, PMID: 17336907); GO_0061098 (EC: IDA, PMID: 7556068); GO_2001240 (EC: IDA, PMID: 9553078)",PMID: 1348215; 1350381; 7509448; 7514177; 7556068; 7592681; 7689552; 7721889; 7730382; 7782315; 7876250; 7903175; 8062828; 8095334; 8096067; 8125298; 8325659; 8702572; 9168114; 9168115; 9333014; 9342050; 9553078; 9565587; 9685409; 10372964; 10523851; 10537356; 10559227; 10585499; 10597312; 11116142; 11389077; 11555649; 11896060; 12082616; 12145742; 12204892; 12471041; 12477932; 12478479; 12509456; 12528817; 12556556; 12600989; 12646923; 12768307; 12800145; 12808428; 12874607; 14569272; 14632199; 14647391; 14699424; 14702039; 14729827; 14966480; 15007393; 15073182; 15155732; 15159416; 15162166; 15197397; 15219675; 15248869; 15276238; 15303101; 15326116; 15466169; 15489334; 15494726; 15498868; 15527969; 15538186; 15545978; 15584912; 15609326; 15645137; 15703820; 15897877; 15939841; 16082692; 16155362; 16158055; 16189508; 16219117; 16219118; 16249994; 16287046; 16326006; 16344560; 16412517; 16428439; 16442083; 16446404; 16470843; 16483744; 16520822; 16526041; 16618933; 16638076; 16687441; 16690615; 16730337; 16767099; 16825199; 16867224; 16868568; 16891421; 16940976; 17033632; 17072305; 17214955; 17275115; 17300918; 17336907; 17336946; 17366345; 17405926; 17408693; 17432114; 17447867; 17499242; 17503451; 17519028; 17562386; 17565985; 17598910; 17602072; 17631867; 17652086; 17884806; 17901998; 17903296; 17925794; 17941827; 17962208; 18032396; 18159252; 18180429; 18193072; 18198266; 18234478; 18255317; 18282690; 18286587; 18291420; 18395550; 18455303; 18455369; 18466879; 18466881; 18470533; 18494263; 18494554; 18497096; 18516516; 18543275; 18571900; 18583979; 18584117; 18585932; 18606232; 18668031; 18704261; 18714568; 18728681; 18798975; 18799465; 18806920; 19054571; 19058791; 19086053; 19127563; 19148499; 19150438; 19156152; 19184335; 19196962; 19199244; 19229203; 19269083; 19306381; 19328558; 19339916; 19350564; 19367581; 19367584; 19394386; 19439994; 19448847; 19449332; 19497323; 19521112; 19545856; 19556605; 19569180; 19573260; 19575259; 19594860; 19597049; 19626024; 19644050; 19652122; 19659570; 19733651; 19736351; 19782967; 19797898; 19801490; 19802002; 19913121; 19913623; 19937977; 19965935; 19967439; 20036336; 20061032; 20102668; 20182055; 20215529; 20218976; 20227043; 20371257; 20374152; 20379614; 20427670; 20435087; 20472376; 20497232; 20520724; 20526724; 20580130; 20582876; 20625696; 20628086; 20638435; 20671236; 20682778; 20736300; 20800603; 20921115; 20926259; 20927045; 20978455; 21035784; 21041608; 21057508; 21127983; 21234898; 21239627; 21246584; 21247898; 21283760; 21368034; 21371516; 21437657; 21467033; 21512575; 21546767; 21555713; 21576249; 21653853; 21706185; 21716252; 21745728; 21792199; 21840482; 21858616; 21865659; 21965611; 22019858; 22027878; 22042562; 22052506; 22158511; 22183611; 22200588; 22209534; 22216327; 22226049; 22226548; 22249266; 22249457; 22267200; 22350758; 22377709; 22378022; 22378872; 22414959; 22425775; 22467496; 22494484; 22504067; 22520967; 22563075; 22574178; 22590542; 22613991; 22739235; 22790889; 22832904; 22886427; 22891299; 22944276; 22968213; 22974608; 22999558; 23032943; 23035098; 23104879; 23148218; 23213231; 23247143; 23253390; 23301017; 23308187; 23328545; 23360725; 23399902; 23400839; 23408906; 23468880; 23480537; 23489597; 23524320; 23572145; 23590603; 23625463; 23632455; 23739962; 23870195; 23934736; 23937725; 24097984; 24112719,,,,,,,,,,,,,,,,,,OGG:3000003084,,,,,,,,,,,,,,,,,,,neuregulin 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,NRG1,,,20140408,3084,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,NRG1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_1903829,positive regulation of cellular protein localization,upregulation of cellular protein localization|up regulation of cellular protein localization|upregulation of cellular protein localisation|up-regulation of cellular protein localisation|positive regulation of cellular protein localisation|up-regulation of cellular protein localization|up regulation of cellular protein localisation|activation of cellular protein localisation|activation of cellular protein localization|up regulation of channel localizer activity|upregulation of channel localizer activity|up-regulation of channel localizer activity|positive regulation of channel localizer activity|activation of channel localizer activity,"Any process that activates or increases the frequency, rate or extent of cellular protein localization. Cellular protein localization is any process in which a protein is transported to, and/or maintained in, a specific location and encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,jl,2015-01-20T14:32:33Z,,,,"Any process that activates or increases the frequency, rate or extent of cellular protein localization. Cellular protein localization is any process in which a protein is transported to, and/or maintained in, a specific location and encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of cellular protein localization|up regulation of cellular protein localization|upregulation of cellular protein localisation|up-regulation of cellular protein localisation|positive regulation of cellular protein localisation|up-regulation of cellular protein localization|up regulation of cellular protein localisation,,,activation of cellular protein localisation|activation of cellular protein localization|up regulation of channel localizer activity|upregulation of channel localizer activity|up-regulation of channel localizer activity|positive regulation of channel localizer activity|activation of channel localizer activity,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1903829,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1903829,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cellular protein localization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_291613,SARS coronavirus GD322,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:291613,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GD322,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_231516,SARS coronavirus SZ1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231516,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SZ1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C47445,Chloroquine Phosphate,"Tanakan|CHLOROQUINE PHOSPHATE|1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, Phosphate (1:2)|Chloroquine Phosphate|7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline Phosphate (1:2)|Aralen Phosphate|Avloclor","The phosphate salt of chloroquine, a quinoline compound with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,50-63-5,,C18H26ClN3.2H3O4P,,C47445,,,FDA,,,,,,,"The phosphate salt of chloroquine, a quinoline compound with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids.",,,,,,,,,,,,,,,,,6E17K3343P,,,,,,,,,,,,,,"Tanakan|CHLOROQUINE PHOSPHATE|1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, Phosphate (1:2)|Chloroquine Phosphate|7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline Phosphate (1:2)|Aralen Phosphate|Avloclor",http://purl.obolibrary.org/obo/NCIT_C61671,,,,,,,,,,,,NCIT:C47445,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32291112,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Chloroquine Phosphate,Chloroquine_Phosphate,,,,,,,,,14050,,,,,,,,,Chloroquine Phosphate,,,,Pharmacologic Substance,,,,,,,,C0055447,
http://purl.obolibrary.org/obo/PR_000050279,non-structural protein 10 (SARS-CoV-2),"PRO_0000449644|UniProtKB:P0DTD1, 4254-4392|PRO_0000449628|GFL (SARS2)|UniProtKB:P0DTC1, 4254-4392|rep/Clv:nsp10 (SARS2)|growth factor-like peptide (SARS2)|nsp10 (SARS2)",A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4253-4254 and 4392-4393.|Category=organism-modification. Note: 139 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050281,,,,,,,,,,,,,,,,,,,,GenPept:YP_009725306,A rep gene proteolytic cleavage product (SARS-CoV-2) that is the portion produced by the enzymatic action of 3CL-PRO proteinase (nsp5) when it cleaves the precursor between residues 4253-4254 and 4392-4393.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"PRO_0000449644|UniProtKB:P0DTD1, 4254-4392|PRO_0000449628|GFL (SARS2)|UniProtKB:P0DTC1, 4254-4392|rep/Clv:nsp10 (SARS2)|growth factor-like peptide (SARS2)|nsp10 (SARS2)",,,,,protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-modification. Note: 139 aa protein.,,http://purl.obolibrary.org/obo/PR_000050281,,,,PR:000050279,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32201449,,,,PR:000050279,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,non-structural protein 10 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0071599,otic vesicle development,,"The process whose specific outcome is the progression of the otic vesicle over time, from its formation to the mature structure. The otic vesicle is a transient embryonic structure formed during development of the vertebrate inner ear.",false,,,http://purl.obolibrary.org/obo/GO_0048839,,,,,,,,,,,,,,,,midori,2010-02-04T04:07:17Z,,,,"The process whose specific outcome is the progression of the otic vesicle over time, from its formation to the mature structure. The otic vesicle is a transient embryonic structure formed during development of the vertebrate inner ear.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0048839,,,,GO:0071599,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0071599,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,otic vesicle development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007431,salivary gland development,,"The process whose specific outcome is the progression of the salivary gland over time, from its formation to the mature structure. Salivary glands include any of the saliva-secreting exocrine glands of the oral cavity.",false,,,http://purl.obolibrary.org/obo/GO_0048732,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the salivary gland over time, from its formation to the mature structure. Salivary glands include any of the saliva-secreting exocrine glands of the oral cavity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0048732,,,,GO:0007431,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0007431,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,salivary gland development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002035,brain renin-angiotensin system,,The process in which an angiotensin-mediated signaling system present in the brain regulates the force with which blood passes through the circulatory system.,false,,,http://purl.obolibrary.org/obo/UBERON_0000467,,,,,,,,,,,,,,,,,,,,,The process in which an angiotensin-mediated signaling system present in the brain regulates the force with which blood passes through the circulatory system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000467,,,,GO:0002035,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32125455,,,,GO:0002035,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,brain renin-angiotensin system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_293319,SARS coronavirus PC4-127,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:293319,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus PC4-127,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_266148,SARS coronavirus Sin_WNV,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:266148,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus Sin_WNV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046761,viral budding from plasma membrane,virus budding from plasma membrane by viral capsid envelopment|plasma membrane viral budding|virus budding from plasma membrane|virus budding from plasma membrane during viral capsid envelopment|viral budding from plasma membrane during viral capsid envelopment|plasma membrane viral budding during viral capsid envelopment|viral budding from plasma membrane by viral capsid envelopment,A viral budding that starts with formation of a membrane curvature in the host plasma membrane.,false,,,http://purl.obolibrary.org/obo/GO_0046755|http://purl.obolibrary.org/obo/GO_0046753,,,,,,,,,,,,,,,,,,,,,A viral budding that starts with formation of a membrane curvature in the host plasma membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046766|GO:0046767,,,,virus budding from plasma membrane by viral capsid envelopment|plasma membrane viral budding|virus budding from plasma membrane,,,,,biological_process,,virus budding from plasma membrane during viral capsid envelopment|viral budding from plasma membrane during viral capsid envelopment|plasma membrane viral budding during viral capsid envelopment|viral budding from plasma membrane by viral capsid envelopment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046755|http://purl.obolibrary.org/obo/GO_0046753,,,,GO:0046761,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32236561,,,,GO:0046761,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral budding from plasma membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OMIT_0026254,Lung Injury,,,false,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,OMIT:0026254,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,"Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.",,,,,http://purl.obolibrary.org/obo/omit.owl,,,,,,,,,,,Lung Injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_1503302,BtRs-BetaCoV/HuB2013,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:1503302,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,BtRs-BetaCoV/HuB2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0002643,Neonatal respiratory distress,"Neonatal respiratory distress|Newborn respiratory distress|Infantile respiratory distress|Respiratory distress, neonatal",Respiratory difficulty as newborn.,false,,,http://purl.obolibrary.org/obo/HP_0002093,,,,,,,,,,,,,,,,,,,,UMLS:C0852283,Respiratory difficulty as newborn.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Neonatal respiratory distress|Newborn respiratory distress|Infantile respiratory distress|Respiratory distress, neonatal",,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002093,,,,HP:0002643,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32215598,,,,HP:0002643,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Neonatal respiratory distress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007259,receptor signaling pathway via JAK-STAT,JAK-STAT signal transduction|JAK-STAT cascade,Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The receptor signaling pathway via JAK-STAT begins with activation of a receptor and proceeeds through STAT protein activation by members of the JAK family of tyrosine kinases. STAT proteins dimerize and subsequently translocate to the nucleus. The pathway ends with regulation of target gene expression by STAT proteins.,false,,,http://purl.obolibrary.org/obo/GO_0007165,,,,,,,,,,,,,,,,,,,,Wikipedia:JAK-STAT_signaling_pathway,Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The receptor signaling pathway via JAK-STAT begins with activation of a receptor and proceeeds through STAT protein activation by members of the JAK family of tyrosine kinases. STAT proteins dimerize and subsequently translocate to the nucleus. The pathway ends with regulation of target gene expression by STAT proteins.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,JAK-STAT signal transduction,,,JAK-STAT cascade,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0007165,,,,GO:0007259,,,,,,true,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32113509/|https://www.ncbi.nlm.nih.gov/pubmed/32220278,,,,GO:0007259,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,receptor signaling pathway via JAK-STAT,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0286/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0098800,inner mitochondrial membrane protein complex,,Any protein complex that is part of the inner mitochondrial membrane.,false,,,http://purl.obolibrary.org/obo/GO_0098798|http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,,,,,,Any protein complex that is part of the inner mitochondrial membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0098798|http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0098800,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0098800,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,inner mitochondrial membrane protein complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_267394,SARS coronavirus SinP5,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:267394,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus SinP5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DRON_00789755,sarilumab,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1923319,,,,DRON:00789755,"A recombinant, human immunoglobulin (IgG) monoclonal antibody targeting the interleukin 6 receptor (IL-6R), with potential anti-inflammatory activity. Upon intravenous administration of sarilumab, this agent targets and binds to both soluble IL-6 receptor (sIL-6R) and membrane-bound IL-6 receptor (mIL-6R). This inhibits the binding of the pro-inﬂammatory cytokine IL-6 to the IL-6 receptor (IL-6R), which results in the blockade of the IL-6/IL-6R-mediated signal transduction pathway. This may inhibit IL-6/IL-6R-mediated inflammation.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/dron.owl,,,,,,,,,,,sarilumab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1904029,regulation of cyclin-dependent protein kinase activity,,"Any process that modulates the frequency, rate or extent of cyclin-dependent protein kinase activity.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,als,2015-03-13T15:43:38Z,,,,"Any process that modulates the frequency, rate or extent of cyclin-dependent protein kinase activity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:1904029,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1904029,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of cyclin-dependent protein kinase activity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_293933,SARS coronavirus GZ0402,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:293933,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ0402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C26948,Alanine Aminotransferase Increased,Alanine Aminotransferase Increased|Alanine aminotransferase increased,An increase in the level of alanine aminotransferase in the blood.,false,,,http://purl.obolibrary.org/obo/HP_0010876,,A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen.,,,,,,,,,C26948,,,,,,,,,,An increase in the level of alanine aminotransferase in the blood.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Alanine Aminotransferase Increased|Alanine aminotransferase increased,,,,,,,,,,,,,NCIT:C26948,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0010876,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138655/,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Alanine Aminotransferase Increased,Alanine_Aminotransferase_Increased,,,,,,,,,,,,,,,,,,Alanine Aminotransferase Increased,,,,Laboratory or Test Result,,,,,,,,C0151905,
http://purl.obolibrary.org/obo/OGG_3000009636,ISG15,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,G1P2|IFI15|IP17|hUCRP|UCRP,,,,,,,1,,,,,,,,,,Ensembl:ENSG00000187608|Vega:OTTHUMG00000040777|HGNC:4053|HPRD:00958|MIM:147571,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,ISG15 ubiquitin-like modifier,,1p36.33,,,,"GO_0005515 (EC: IPI, PMID: 16872604); GO_0005576 (EC: IDA); GO_0005829 (EC: TAS); GO_0016032 (EC: IEA); GO_0019221 (EC: TAS); GO_0019941 (EC: IEA); GO_0031386 (EC: IEA); GO_0031397 (EC: IDA, PMID: 18305167); GO_0032020 (EC: IDA, PMID: 16122702); GO_0032020 (EC: IMP); GO_0032480 (EC: TAS); GO_0032649 (EC: IMP); GO_0034340 (EC: IDA); GO_0042742 (EC: IMP); GO_0045071 (EC: IMP, PMID: 19357168); GO_0045087 (EC: TAS); GO_0045648 (EC: IEA); GO_0051607 (EC: IMP, PMID: 19357168); GO_0060337 (EC: TAS)",PMID: 1373138; 1695131; 2005397; 2440890; 2477469; 3087979; 3350799; 3476954; 7490683; 7526157; 8550581; 8889548; 8892645; 10476939; 10508226; 10866800; 11157743; 11788588; 12055236; 12067988; 12477932; 12539042; 14976209; 15131269; 15489334; 15670748; 15684817; 15917233; 16009940; 16112642; 16122702; 16139798; 16169070; 16189514; 16254333; 16424026; 16428300; 16434471; 16641915; 16815975; 16872604; 16884686; 17069755; 17097911; 17222803; 17289916; 17353931; 17653289; 17692280; 17719635; 18057259; 18287095; 18305167; 18356159; 18566215; 18583345; 18597038; 18606809; 18627608; 18953482; 19043203; 19073728; 19074853; 19357168; 19378789; 19430494; 19656964; 19694548; 19846672; 19913121; 19956859; 19959962; 20035788; 20093371; 20133869; 20157543; 20164219; 20219937; 20308324; 20542004; 20581239; 20628086; 20628624; 20639253; 20946978; 20975683; 21139048; 21245344; 21298066; 21399617; 21544738; 21757684; 21808041; 21906983; 21994560; 22093708; 22100648; 22185919; 22405323; 22647704; 22693631; 22706304; 22729740; 22740306; 22762019; 22859821; 22939629; 23212917; 23229543; 23588721; 23824909; 24386835,,,,,,,,,,,,,,,,,,OGG:3000009636,,,,,,,,,,,,,,,,,,,ISG15 ubiquitin-like modifier,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,true,true,,,,,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,ISG15,,,20140408,9636,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,https://www.medrxiv.org/content/10.1101/2020.02.23.20026690v1,,,,ISG15,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_10912,Rotavirus,Rotaviruses,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_689832,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_genus,Rotaviruses,,,,,,NCBITaxon:10912,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_689832,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Rotavirus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003659,IRF1,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,MAR|IRF-1,,,,,,,5,,,,,,,,,,Vega:OTTHUMG00000059497|HPRD:00961|MIM:147575|HGNC:6116|Ensembl:ENSG00000125347,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,interferon regulatory factor 1,,5q31.1,,,,"GO_0000790 (EC: IDA, PMID: 18035482); GO_0000978 (EC: IDA, PMID: 18035482); GO_0002819 (EC: TAS, PMID: 11846971); GO_0003677 (EC: TAS, PMID: 11846971); GO_0003700 (EC: IEA); GO_0005515 (EC: IPI, PMID: 10702232); GO_0005634 (EC: TAS, PMID: 11846971); GO_0005654 (EC: TAS); GO_0005737 (EC: ISS); GO_0005829 (EC: TAS); GO_0006366 (EC: TAS, PMID: 2475256); GO_0006915 (EC: IDA, PMID: 19851330); GO_0007050 (EC: IDA); GO_0007596 (EC: TAS); GO_0008285 (EC: TAS, PMID: 11846974); GO_0019221 (EC: TAS); GO_0032481 (EC: ISS); GO_0032728 (EC: IMP); GO_0034124 (EC: ISS); GO_0035458 (EC: IDA, PMID: 18035482); GO_0043374 (EC: IEA); GO_0045084 (EC: IEA); GO_0045088 (EC: TAS, PMID: 11846971); GO_0045590 (EC: ISS); GO_0045892 (EC: IMP, PMID: 18084608); GO_0045893 (EC: IDA); GO_0045893 (EC: IMP, PMID: 15509808); GO_0045944 (EC: IEA); GO_0051607 (EC: IDA); GO_0051726 (EC: TAS, PMID: 11846974); GO_0060333 (EC: ISS); GO_0060333 (EC: TAS); GO_0060337 (EC: TAS); GO_0071260 (EC: IEP, PMID: 19593445); GO_2000564 (EC: ISS)",PMID: 1382447; 1680796; 2475256; 2726461; 3409321; 7507207; 7768900; 8438156; 8746784; 9593745; 9649509; 9659924; 9679752; 9742224; 9865486; 9865487; 10022868; 10094406; 10357819; 10438822; 10702232; 10764778; 11069564; 11240951; 11304541; 11315919; 11483597; 11559933; 11675348; 11716756; 11721695; 11804954; 11846971; 11846972; 11846974; 11909852; 11948194; 11970993; 12021315; 12067985; 12105194; 12115600; 12162881; 12191570; 12420205; 12420214; 12433281; 12477932; 12479817; 12482935; 12545159; 12677441; 12711307; 12732645; 12759449; 12788988; 12799427; 14599866; 14662860; 14675396; 14764039; 14993214; 15078941; 15173018; 15226432; 15241475; 15265939; 15331704; 15489234; 15489334; 15509808; 15511228; 15548708; 15560761; 15576464; 15710386; 15778351; 15863386; 15878912; 15893730; 15907481; 16085646; 16195385; 16195814; 16223733; 16483648; 16512786; 16636311; 16679314; 16703666; 16857162; 16894313; 16914093; 16944293; 16961714; 17016442; 17121613; 17177148; 17213842; 17255955; 17328074; 17498560; 17516545; 17617740; 17703412; 17852336; 17869652; 17918184; 17924060; 17942705; 17947510; 17970693; 17985330; 18035482; 18079498; 18084608; 18200030; 18216101; 18316378; 18338947; 18381204; 18401423; 18454680; 18641303; 18655181; 18676680; 18678606; 18688264; 18694960; 18986693; 19012493; 19028144; 19056926; 19129219; 19131452; 19145247; 19170196; 19247692; 19258923; 19295429; 19345417; 19404407; 19426920; 19428110; 19433065; 19450680; 19463200; 19482358; 19502235; 19536153; 19548631; 19574175; 19593445; 19625176; 19642896; 19692168; 19697121; 19805480; 19845895; 19851330; 19858727; 19880820; 20031576; 20031577; 20177805; 20177960; 20211142; 20435892; 20457620; 20459687; 20485362; 20503287; 20525893; 20533260; 20588308; 20817723; 20846942; 20861350; 20947504; 20980339; 21102463; 21200019; 21245151; 21257209; 21288140; 21300955; 21389130; 21411754; 21586271; 21683060; 21725055; 21740303; 21790247; 21803131; 21834067; 21903422; 21988832; 22096509; 22139419; 22213332; 22345458; 22367195; 22401175; 22874466; 22879909; 23040881; 23046934; 23071666; 23128233; 23134341; 23226549; 23255602; 23378427; 23487038; 23554911; 23729439; 23746807; 23799084; 23807161; 23811275; 23934855; 23969696,,,,,,,,,,,,,,,,,,OGG:3000003659,,,,,,,,,,,,,,,,,,,interferon regulatory factor 1,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,doi:10.20944/preprints202003.0206.v1,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IRF1,,,20140408,3659,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IRF1,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0044322,endoplasmic reticulum quality control compartment,ER quality control compartment|ERQC|ER-derived quality control compartment,"A subcompartment of the endoplasmic reticulum in which proteins with improper or incorrect folding accumulate. Enzymes in this compartment direct proteins with major folding problems to translocation to the cytosol and degradation, and proteins with minor folding problems to the ER, to interact with chaperon proteins.",false,,,http://purl.obolibrary.org/obo/GO_0005575,,,,,,,,,,,,,,,,janelomax,2010-08-03T01:12:59Z,,,,"A subcompartment of the endoplasmic reticulum in which proteins with improper or incorrect folding accumulate. Enzymes in this compartment direct proteins with major folding problems to translocation to the cytosol and degradation, and proteins with minor folding problems to the ER, to interact with chaperon proteins.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ER quality control compartment|ERQC,,,,,cellular_component,,ER-derived quality control compartment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575,,,,GO:0044322,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0044322,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,endoplasmic reticulum quality control compartment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_258445,SARS coronavirus GD69,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:258445,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GD69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0010978,Abnormality of immune system physiology,,A functional abnormality of the immune system.,false,,,http://purl.obolibrary.org/obo/HP_0002715,,,,,,,,,,,,,,,,peter,2011-02-07T04:28:55Z,,,UMLS:C4023616,A functional abnormality of the immune system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/HP_0002715,,,,HP:0010978,,,,,,,,,,,,,,,HP:0010978,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of immune system physiology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000001522,CTSZ,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CTSX,,,,,,,20,,,,,,,,,,Ensembl:ENSG00000101160|MIM:603169|Vega:OTTHUMG00000032858|HPRD:04410|HGNC:2547,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,cathepsin Z,,20q13.32,,,,"GO_0002003 (EC: TAS); GO_0005615 (EC: IDA); GO_0005764 (EC: IEA); GO_0005783 (EC: IDA); GO_0005886 (EC: TAS); GO_0006508 (EC: TAS, PMID: 9642240); GO_0008234 (EC: IEA); GO_0043231 (EC: IDA); GO_0044267 (EC: TAS); GO_0060441 (EC: IEA)",PMID: 9642240; 9738465; 10653162; 10653163; 10656802; 10745011; 10760573; 11030415; 11076863; 11256614; 11780052; 12477932; 15489334; 15489336; 15680921; 16381901; 17065156; 17601350; 18420963; 18976975; 18977241; 21139048; 21310951; 21354459; 21368909; 21454358; 21616554; 21963094; 21966391; 22139419; 22268729; 22451661; 22632162; 23128233; 23827504; 24026423,,,,,,,,,,,,,,,,,,OGG:3000001522,,,,,,,,,,,,,,,,,,,cathepsin Z,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,CTSZ,,,20140408,1522,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,CTSZ,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/NCBITaxon_233044,SARS coronavirus GD01,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:233044,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GD01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0009142,nucleoside triphosphate biosynthetic process,nucleoside triphosphate formation|nucleoside triphosphate synthesis|nucleoside triphosphate anabolism|nucleoside triphosphate biosynthesis,"The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.",false,,,http://purl.obolibrary.org/obo/GO_0009141|http://purl.obolibrary.org/obo/GO_1901293,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nucleoside triphosphate formation|nucleoside triphosphate synthesis|nucleoside triphosphate anabolism|nucleoside triphosphate biosynthesis,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009141|http://purl.obolibrary.org/obo/GO_1901293,,,,GO:0009142,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0009142,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nucleoside triphosphate biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/PR_P0DTD3,uncharacterized protein 14 (SARS-CoV-2),PRO_0000449658|ORF14 (SARS2)|ORF14,A protein that is a translation product of the ORF14 gene in SARS-CoV-2.|Category=organism-gene. Note: 73 aa protein.,false,,,http://purl.obolibrary.org/obo/PR_000050262,,,,,,,,,,,,,,,,,,,,UniProtKB:P0DTD3,A protein that is a translation product of the ORF14 gene in SARS-CoV-2.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PRO_0000449658|ORF14 (SARS2),,,,,protein,,ORF14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Category=organism-gene. Note: 73 aa protein.,,http://purl.obolibrary.org/obo/PR_000050262,,,,PR:P0DTD3,,,,,,true,,,,,,,,,PR:P0DTD3,,http://purl.obolibrary.org/obo/pr.owl,,,,,,,,,,,uncharacterized protein 14 (SARS-CoV-2),,,,,,,,,,,,,,,,,,,,,,https://www.biorxiv.org/content/10.1101/2020.03.21.001586v1,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_8469,influenza,Influenza with other manifestations|Influenza with non-respiratory manifestation|influenza with non-respiratory manifestation|flu,"A viral infectious disease that results in infection, located in respiratory tract, has_material_basis_in Influenzavirus A, has_material_basis_in Influenzavirus B, or has_material_basis_in Influenzavirus C, which are transmitted by droplet spread of oronasal secretions during coughing, sneezing, or talking from an infected person. It is a highly contagious disease that affects birds and mammals and has symptom chills, has symptom fever, has symptom sore throat, has symptom runny nose, has symptom muscle pains, has symptom severe headache, has symptom cough, and has symptom weakness.",false,,,http://purl.obolibrary.org/obo/DOID_934|http://purl.obolibrary.org/obo/DOID_1579,,,,,,,,,,,,,,,,,,,,NCI:C53482|ICD9CM:487|SNOMEDCT_US_2019_09_01:6142004|UMLS_CUI:C0021400|ICD10CM:J11.1|MESH:D007251,"A viral infectious disease that results in infection, located in respiratory tract, has_material_basis_in Influenzavirus A, has_material_basis_in Influenzavirus B, or has_material_basis_in Influenzavirus C, which are transmitted by droplet spread of oronasal secretions during coughing, sneezing, or talking from an infected person. It is a highly contagious disease that affects birds and mammals and has symptom chills, has symptom fever, has symptom sore throat, has symptom runny nose, has symptom muscle pains, has symptom severe headache, has symptom cough, and has symptom weakness.",,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:8468,,,,Influenza with other manifestations|Influenza with non-respiratory manifestation|influenza with non-respiratory manifestation|flu,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_934|http://purl.obolibrary.org/obo/DOID_1579,,,,DOID:8469,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/books/NBK554776/|https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/,,,,DOID:8469,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,influenza,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000000374,AREG,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,CRDGF|AR|SDGF,,,,,,,4,,,,,,,,,,Ensembl:ENSG00000109321|Vega:OTTHUMG00000130006|HGNC:651|MIM:104640|HPRD:00093,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,amphiregulin,,4q13.3,,,,,PMID: 1333777; 2017164; 2234093; 2325643; 2466334; 3413110; 7698025; 9410906; 10085134; 10389762; 10424781; 10490105; 11038170; 11469683; 11494130; 11507076; 11719440; 11859273; 11942969; 12356750; 12370739; 12477932; 12568494; 12711607; 12743035; 14633617; 15186320; 15254267; 15284208; 15474502; 15489334; 15685553; 15696081; 15696083; 15735670; 15767261; 15955087; 16088955; 16207795; 16213893; 16336275; 16470170; 16641105; 16713569; 16888076; 17035230; 17525275; 17548638; 17942395; 17960400; 17962208; 18045238; 18325497; 18560449; 18811692; 18835871; 18946024; 18955794; 19003995; 19070973; 19337692; 19344731; 19494503; 19587163; 19609315; 19735466; 19825997; 19895983; 19915156; 19935651; 20103632; 20237496; 20428186; 20567134; 20628624; 20651071; 20651357; 20719813; 20726858; 20811902; 20856199; 21036386; 21161326; 21245963; 21258428; 21298020; 21302279; 21377153; 21439861; 21454516; 21514161; 21653755; 21742971; 21832049; 21906983; 21917092; 22395988; 22425981; 22438584; 22445895; 22570239; 22581387; 22641668; 22747683; 22825057; 22967896; 23263765; 23285165; 23430747; 23624749; 23625463; 23844004; 23885463,,,,,,,,,,,,,,,,,,OGG:3000000374,,,,,,,,,,,,,,,,,,,amphiregulin,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,AREG,,,20140408,374,,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,AREG,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/GO_0070821,tertiary granule membrane,,The lipid bilayer surrounding a tertiary granule.,false,,,http://purl.obolibrary.org/obo/GO_0030667,,,,,,,,,,,,,,,,midori,2009-07-20T03:59:41Z,,,,The lipid bilayer surrounding a tertiary granule.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0030667,,,,GO:0070821,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0070821,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,tertiary granule membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CMO_0001324,oxygen saturation,,The amount of oxygen bound to hemoglobin in the blood expressed as a percentage of the maximal binding capacity.,false,,,http://purl.obolibrary.org/obo/CMO_0000035,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CMO:0001324,,,,,,,,,,JSmith,2013-01-09T16:37:31Z,The amount of oxygen bound to hemoglobin in the blood expressed as a percentage of the maximal binding capacity.,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CMO_0000035,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216961/,,,,,,http://purl.obolibrary.org/obo/cmo.owl,,,,,,,,,,,oxygen saturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_35341,steroid,steroids|Steroid|a steroid,"Any of naturally occurring compounds and synthetic analogues, based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred. Natural steroids are derived biogenetically from squalene, so may be considered as triterpenoids.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,MetaCyc:Steroids|KEGG:C00377,"Any of naturally occurring compounds and synthetic analogues, based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred. Natural steroids are derived biogenetically from squalene, so may be considered as triterpenoids.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:13687|CHEBI:9263|CHEBI:26768,,,,steroids|Steroid,,,,,chebi_ontology,,a steroid,,,,,,,,,0,C19H31R,,,259.450,259.24258,C12C(C3C(C(CC3)*)(C)CC1)CCC4C2(CCCC4)C,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:35341,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32190290,,,,CHEBI:35341,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,steroid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0002449,lymphocyte mediated immunity,cellular immune response|cell-mediated immunity,Any process involved in the carrying out of an immune response by a lymphocyte.,false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,Any process involved in the carrying out of an immune response by a lymphocyte.,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular immune response|cell-mediated immunity,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0002449,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0002449,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lymphocyte mediated immunity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0015212,lateral structure,,Any structure that is placed on one side of the left-right axis of a bilaterian.,false,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,,,,,,,,,,,,,,,,This class is primarily to implement taxon constraints. It may be removed in the future.,,Any structure that is placed on one side of the left-right axis of a bilaterian.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000061,,,,UBERON:0015212,,,,,,,,,,,,,,,UBERON:0015212,,http://purl.obolibrary.org/obo/uberon.owl,http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#grouping_class|http://purl.oboInOwllibrary.org/oboInOwl/uberon/core#non_informative,,,,,,,,,,lateral structure,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046762,viral budding from endoplasmic reticulum membrane,virus budding from ER membrane by viral capsid envelopment|ER membrane viral budding|endoplasmic reticulum membrane viral budding|virus budding from ER membrane|viral budding from ER membrane|virus budding from ER membrane during viral capsid envelopment|ER membrane viral budding during viral capsid envelopment|endoplasmic reticulum membrane viral budding during viral capsid envelopment|viral budding from ER membrane during viral capsid envelopment|viral budding from ER membrane by viral capsid envelopment,A viral budding that starts with formation of a membrane curvature in the host ER membrane.,false,,,http://purl.obolibrary.org/obo/GO_0046755,,,,,,,,,,,,,,,,,,,,,A viral budding that starts with formation of a membrane curvature in the host ER membrane.,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0046764|GO:0046751,,,,virus budding from ER membrane by viral capsid envelopment|ER membrane viral budding|endoplasmic reticulum membrane viral budding|virus budding from ER membrane|viral budding from ER membrane,,,,,biological_process,,virus budding from ER membrane during viral capsid envelopment|ER membrane viral budding during viral capsid envelopment|endoplasmic reticulum membrane viral budding during viral capsid envelopment|viral budding from ER membrane during viral capsid envelopment|viral budding from ER membrane by viral capsid envelopment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0046755,,,,GO:0046762,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/32257431,,,,GO:0046762,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,viral budding from endoplasmic reticulum membrane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000488,skin and integumentary tissue symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0159037|SyOID:2103|UMLS_ICD9CM_2005_AUI:A0284161|ICD9CM_2005:782.9|UMLS_ICD9CM_2005_AUI:A0284146|ICD9CM_2005:782,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Symptoms involving skin and other integumentary tissue,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000488,,,,,,,,,,,,,,,SYMP:0000488,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,skin and integumentary tissue symptom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000598,respiratory abnormality,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,,,,,,,,,,,,,,,,,SyOID:7239|UMLS_CUI:C0159053|ICD9CM_2005:786.0|UMLS_ICD9CM_2005_AUI:A0284202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,"An abnormality of the respiratory system, which include the airways, lungs, and the respiratory muscles.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000514,,,,SYMP:0000598,,,,,,,,,,,,,,,SYMP:0000598,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,respiratory abnormality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_698398,recombinant SARSr-CoV,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:698398,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,recombinant SARSr-CoV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000912,mucus,,Mucus is a bodily fluid consisting of a slippery secretion of the lining of the mucous membranes in the body. It is a viscous colloid containing antiseptic enzymes (such as lysozyme) and immunoglobulins. Mucus is produced by goblet cells in the mucous membranes that cover the surfaces of the membranes. It is made up of mucins and inorganic salts suspended in water.,false,,,http://purl.obolibrary.org/obo/UBERON_0006314|http://purl.obolibrary.org/obo/UBERON_0000456,,,,,,,,,,,,,,,,,,,,UMLS:C0026727|CALOHA:TS-2144|NCIT:C13259|GAID:1164|MESH:D009093|ENVO:02000040|OpenCyc:Mx4rvVjHq5wpEbGdrcN5Y29ycA|FMA:66938|galen:Mucus|http://en.wikipedia.org/wiki/Mucus|http://linkedlifedata.com/resource/umls/id/C0026727,Mucus is a bodily fluid consisting of a slippery secretion of the lining of the mucous membranes in the body. It is a viscous colloid containing antiseptic enzymes (such as lysozyme) and immunoglobulins. Mucus is produced by goblet cells in the mucous membranes that cover the surfaces of the membranes. It is made up of mucins and inorganic salts suspended in water.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,uberon,,,mucoid|mucous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0006314|http://purl.obolibrary.org/obo/UBERON_0000456,,,,UBERON:0000912,,,,,,,,,,,,,,,UBERON:0000912,,http://purl.obolibrary.org/obo/uberon.owl,,,,,,,,,,,mucus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000060,outbreak,,,false,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/PATO_0002003,,,,,Process,,,,,true,,,,,,"Outbreak is a classification used in epidemiology to describe a small, localized group of people or organisms infected with a disease. ",,COVID-19  outbreak,,,,,,,,,,,,,,outbreak,,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_48432,angiotensin II,angiotensina II|angiotensinum II|ang II|1-8-angiotensin I,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,CAS:11128-99-7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,angiotensina II|angiotensinum II|ang II|1-8-angiotensin I,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:48432,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32125455,,,,CHEBI:48432,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,angiotensin II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0060037,pharyngeal system development,,"The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0060037,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0060037,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,pharyngeal system development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_231518,SARS coronavirus GZ60,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:231518,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_694009,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus GZ60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0051249,regulation of lymphocyte activation,,"Any process that modulates the frequency, rate or extent of lymphocyte activation.",false,,,http://purl.obolibrary.org/obo/GO_0050789,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of lymphocyte activation.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0050789,,,,GO:0051249,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0051249,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of lymphocyte activation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/OGG_3000003560,IL2RB,,,false,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,P70-75|CD122|IL15RB,,,,,,,22,,,,,,,,,,MIM:146710|HGNC:6009|Ensembl:ENSG00000100385|Vega:OTTHUMG00000150534|HPRD:00896,,,WEB: http://www.ncbi.nlm.nih.gov/gene,,,,,,,,,,,,,,,,,"interleukin 2 receptor, beta",,22q13.1,,,,"GO_0004911 (EC: IDA, PMID: 7736574); GO_0004911 (EC: TAS, Qualifier: contributes_to, PMID: 2467293); GO_0005886 (EC: TAS); GO_0005887 (EC: TAS, PMID: 8514792); GO_0006461 (EC: TAS, PMID: 2467293); GO_0007165 (EC: TAS, PMID: 2785715); GO_0009897 (EC: ISS); GO_0016032 (EC: IEA); GO_0019221 (EC: IDA, PMID: 7736574); GO_0019976 (EC: ISS); GO_0038110 (EC: IDA, PMID: 7736574); GO_0038110 (EC: TAS, PMID: 2467293); GO_0043066 (EC: IDA, PMID: 7736574)",PMID: 1394441; 1557373; 1639773; 1915291; 1973832; 2047859; 2303462; 2315327; 2333293; 2467293; 2785715; 2843775; 3925551; 7529123; 7600304; 7641685; 7693677; 7734194; 7736574; 7973658; 7973659; 8026467; 8041779; 8049354; 8294403; 8483935; 8493579; 8514792; 8648694; 8700888; 9176231; 9341758; 9520455; 9553136; 9637477; 9774657; 10214954; 10373548; 10514520; 10591208; 10602027; 10825200; 11035066; 11133764; 11238664; 11359922; 11463390; 11750878; 11856346; 11886175; 12133952; 12200137; 12230826; 12477932; 12676936; 12960323; 14680494; 15063762; 15191519; 15350462; 15461802; 15489334; 16084898; 16284400; 16293754; 16380905; 16477002; 17108990; 17115417; 17152005; 17703412; 18299274; 18445679; 18490721; 18589435; 18592269; 18715339; 18774388; 18791162; 18818748; 18829468; 19019335; 19240061; 19258923; 19471255; 19527514; 19602517; 19615332; 19773451; 19817957; 19822714; 19913121; 19923221; 20049410; 20140262; 20179739; 20219786; 20237496; 20379614; 20424473; 20495002; 20498205; 20503287; 20585888; 20628086; 20728947; 20811626; 20860503; 21345943; 21362618; 21653640; 21674833; 21829393; 21834013; 21839273; 21865161; 21984699; 22558434; 22573796; 23341462; 23418630; 23512675; 23628622; 23676143,,,,,,,,,,,,,,,,,,OGG:3000003560,,,,,,,,,,,,,,,,,,,"interleukin 2 receptor, beta",,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGG_2060009606,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217556,,,,,,http://purl.obolibrary.org/obo/ogg.owl,,,,,,,,,,,IL2RB,,,20140408,3560,RP5-1170K4.6,,,,Official from a nomenclature committee,,,,,,9606,,,,,,,,,,,IL2RB,,"Bin Zhao, Yue Liu, Oliver He",,protein-coding,,
http://purl.obolibrary.org/obo/HP_0000707,Abnormality of the nervous system,Brain and/or spinal cord issue|Neurological abnormality|Neurologic abnormalities|Abnormality of the nervous system,"An abnormality of the nervous system.|The nervous system comprises the neuraxis (brain, spinal cord, and ventricles), the autonomic nervous system, the enteric nervous system, and the peripheral nervous system.",false,,,http://purl.obolibrary.org/obo/HP_0000118,,,,,,,,,,,,,,,,,,,,MSH:D009421|SNOMEDCT_US:88425004|UMLS:C0497552,An abnormality of the nervous system.,,,,,,,,,,,,,,,,,,,,,,,,,,,HP:0006987|HP:0001333,Brain and/or spinal cord issue,,,Neurological abnormality|Neurologic abnormalities|Abnormality of the nervous system,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"The nervous system comprises the neuraxis (brain, spinal cord, and ventricles), the autonomic nervous system, the enteric nervous system, and the peripheral nervous system.",,http://purl.obolibrary.org/obo/HP_0000118,,,,HP:0000707,,,,,,,,,,,,,,,HP:0000707,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormality of the nervous system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0039664,lysis of host organelle involved in viral entry into host cell,viral penetration via lysis of host organellar membrane|viral entry into host cell via endosome membrane lysis|viral entry into host cell via lysis of host organelle membrane|viral membrane-lytic protein,"The viral-induced lysis of an organelle (endosome, lysosome, or caveosome) that is involved in the uptake of a virus into a host cell. Occurs once the virus is within the organelle, and results in transfer of the viral contents from the organelle compartment into the cytoplasm.",false,,,http://purl.obolibrary.org/obo/GO_0016032,,,,,,,,,,,,,,,,rfoulger,2013-08-29T11:30:18Z,,,VZ:984,"The viral-induced lysis of an organelle (endosome, lysosome, or caveosome) that is involved in the uptake of a virus into a host cell. Occurs once the virus is within the organelle, and results in transfer of the viral contents from the organelle compartment into the cytoplasm.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,viral penetration via lysis of host organellar membrane,,,viral entry into host cell via endosome membrane lysis,,biological_process,,viral entry into host cell via lysis of host organelle membrane|viral membrane-lytic protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016032,,,,GO:0039664,,,,,,true,,,,true,,,,,GO:0039664,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,lysis of host organelle involved in viral entry into host cell,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202004.0285/v1,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_9168,sirolimus,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone|Sirolimus|sirolimusum|Rapamune|(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone|sirolimus|(-)-Rapamycin|rapamycin|Antibiotic AY 22989","A macrolide lactam isolated from Streptomyces hygroscopicus consisting of a 29-membered ring containing 4 trans double bonds, three of which are conjugated. It is an antibiotic, immunosupressive and antineoplastic agent.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Reaxys:5848501|PDBeChem:RAP|Drug_Central:2446|LIPID_MAPS_instance:LMPK06000003|DrugBank:DB00877|PMID:22960739|CAS:53123-88-9|KEGG:C07909|PMID:22984623|Wikipedia:Rapamycin|KNApSAcK:C00018055|KEGG:D00753|PMID:22981852|HMDB:HMDB0015015,"A macrolide lactam isolated from Streptomyces hygroscopicus consisting of a 29-membered ring containing 4 trans double bonds, three of which are conjugated. It is an antibiotic, immunosupressive and antineoplastic agent.",,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:67812|CHEBI:45276,,,,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone|Sirolimus",,,,,chebi_ontology,,"sirolimusum|Rapamune|(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone|sirolimus|(-)-Rapamycin|rapamycin|Antibiotic AY 22989",,,,,,,,,0,C51H79NO13,"InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1",QFJCIRLUMZQUOT-HPLJOQBZSA-N,914.17190,913.55514,[H][C@]1(CC[C@@H](O)[C@@H](C1)OC)C[C@@H](C)[C@]1([H])CC(=O)[C@H](C)C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]2([H])CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:9168,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32194980,,,,CHEBI:9168,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,sirolimus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030532,small nuclear ribonucleoprotein complex,snRNP|small nuclear ribonucleoprotein,"A complex composed of RNA of the small nuclear RNA (snRNA) class and protein, found in the nucleus of a eukaryotic cell. These are typically named after the snRNA(s) they contain, e.g. U1 snRNP or U4/U6 snRNP. Many, but not all, of these complexes are involved in splicing of nuclear mRNAs.",false,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0120114,,,,,,,,,,,,,,,,,,,,Wikipedia:SnRNP,"A complex composed of RNA of the small nuclear RNA (snRNA) class and protein, found in the nucleus of a eukaryotic cell. These are typically named after the snRNA(s) they contain, e.g. U1 snRNP or U4/U6 snRNP. Many, but not all, of these complexes are involved in splicing of nuclear mRNAs.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,snRNP|small nuclear ribonucleoprotein,,,,,cellular_component,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0005575|http://purl.obolibrary.org/obo/GO_0120114,,,,GO:0030532,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030532,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir,,,,,,,,,,small nuclear ribonucleoprotein complex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264381,SARS coronavirus TW-GD4,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264381,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-GD4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C124946,PD1 Inhibitor,PD-1 Inhibitor|Programmed Cell Death Protein 1 Inhibitor|PD1 Inhibitor|Protein PD-1 Inhibitor,An agent designed to interfere with the activity of programmed cell death protein 1 (PD1). PD1 inhibitors block T-cell apoptosis and act as non-specific activators of the immune system.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C124946,,,CTRP,,,,,,,An agent designed to interfere with the activity of programmed cell death protein 1 (PD1). PD1 inhibitors block T-cell apoptosis and act as non-specific activators of the immune system.,,,,,,PD1 Inhibitor,,,,,,,,,,,,,,,,,,,,,,,,,PD-1 Inhibitor|Programmed Cell Death Protein 1 Inhibitor|PD1 Inhibitor|Protein PD-1 Inhibitor,,,,,,,,,,,,,NCIT:C124946,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,PD-1 mAb,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978,,,,,,,,,,PD1 Inhibitor,,,,,,,,,,,,,,,,,,,PD1 Inhibitor,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,Chemical Viewed Functionally,,,,,,,,C4086713,
http://purl.obolibrary.org/obo/GO_0016032,viral process,virus process|virulence|viral infection,"A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.|See also the biological process terms 'viral infectious cycle ; GO:0019058' and 'lysogeny ; GO:0030069'.",false,,,http://purl.obolibrary.org/obo/GO_0008150,,,,,,,,,,,,,,,,,,,,Wikipedia:Viral_life_cycle,"A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0022415,,,,virus process,,,,,biological_process,,virulence|viral infection,,,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/NCBITaxon_4751,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,See also the biological process terms 'viral infectious cycle ; GO:0019058' and 'lysogeny ; GO:0030069'.,,http://purl.obolibrary.org/obo/GO_0008150,,,,GO:0016032,,,,,,,,,true,true,https://www.ncbi.nlm.nih.gov/pubmed/19430490,,,,GO:0016032,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics,,,,,,,,,,viral process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_3393,coronary artery disease,coronary heart disease|Coronary disease|coronary arteriosclerosis|CHD,An artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles.|Xref MGI.,false,,,http://purl.obolibrary.org/obo/DOID_0050828,,,,,,,,,,,,,,,,,,,,UMLS_CUI:C0010054|ICD10CM:I20-I25|SNOMEDCT_US_2019_09_01:414795007|SNOMEDCT_US_2019_09_01:413844008|UMLS_CUI:C0151744|UMLS_CUI:C0010068|NCI:C35505|OMIM:611139|MESH:D017202|OMIM:608316|MESH:D003324|ICD9CM:410-414.99|ICD9CM:414.9|UMLS_CUI:C0264694|OMIM:614293|OMIM:607339|ICD10CM:I25.10|OMIM:610947|EFO:0001645|OMIM:300464|SNOMEDCT_US_2019_09_01:53741008|OMIM:608318|NCI:C50625|ICD10CM:I25|OMIM:608320|MESH:D003327|ICD9CM:414.0|OMIM:612030|ICD10CM:I25.1,An artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles.,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:9420|DOID:3394|DOID:10506|DOID:3363,,,,coronary heart disease|Coronary disease|coronary arteriosclerosis|CHD,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Xref MGI.,,http://purl.obolibrary.org/obo/DOID_0050828,,,,DOID:3393,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32171076|https://www.ncbi.nlm.nih.gov/pubmed/32186711|https://www.ncbi.nlm.nih.gov/pubmed/3221830,,,,DOID:3393,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,coronary artery disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0007596,blood coagulation,blood clotting,"The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,Wikipedia:Coagulation,"The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,blood clotting,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0007596,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32216698/,,,,GO:0007596,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,blood coagulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000094,bis(N-pantothenylamidoethyl) disulfide,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"bis(N-pantothenylamidoethyl) disulfide also known as Bis-pantethine, can be used to treat acne and improve the blood-cholesterol profile.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,modified definition,,,true,true,,,,,,,pantethine,,,,,,,,,,,,,,,bis(N-pantothenylamidoethyl) disulfide,,,,,,,,,,,,,,,,,,,,,,https://www.preprints.org/manuscript/202003.0239/v1|https://www.spectrumchemical.com/OA_HTML/chemical-synonym_Bis-N-pantothenylamidoethyldisulfide.jsp?pSynonym=Bis-(N-pantothenylamidoethyl)disulfide,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0021536,diencephalon development,,"The process whose specific outcome is the progression of the diencephalon over time, from its formation to the mature structure. The diencephalon is the paired caudal parts of the prosencephalon from which the thalamus, hypothalamus, epithalamus and subthalamus are derived; these regions regulate autonomic, visceral and endocrine function, and process information directed to the cerebral cortex.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"The process whose specific outcome is the progression of the diencephalon over time, from its formation to the mature structure. The diencephalon is the paired caudal parts of the prosencephalon from which the thalamus, hypothalamus, epithalamus and subthalamus are derived; these regions regulate autonomic, visceral and endocrine function, and process information directed to the cerebral cortex.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0021536,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0021536,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,diencephalon development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C71683,Antibody Titer,Antibody Titer,Concentration in serum of the antibody that recognizes a particular epitope expressed as the reciprocal of the highest serum dilution that produces the specific positive immunologic reaction in an appropriate test system.,false,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,C71683,,,,,,,,,,Concentration in serum of the antibody that recognizes a particular epitope expressed as the reciprocal of the highest serum dilution that produces the specific positive immunologic reaction in an appropriate test system.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Antibody Titer,,,,,,,,,,,,,NCIT:C71683,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000018,,,,,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32256547,,,,,,http://purl.obolibrary.org/obo/ncit.owl,,,,,,,,,,,Antibody Titer,Antibody_Titer,,,,,,,,,,,,,,,,,,Antibody Titer,,,,Quantitative Concept,,,,,,,,C1287242,
http://purl.obolibrary.org/obo/GO_0036507,protein demannosylation,protein de-mannosylation,"The removal of one or more mannose residues from a mannosylated protein.|Consider also annotating to the term 'mannosyl-oligosaccharide 1,2-alpha-mannosidase activity ; GO:0004571'.",false,,,http://purl.obolibrary.org/obo/GO_0006517,,,,,,,,,,,,,,,,rebeccafoulger,2015-06-11T13:57:01Z,,,,The removal of one or more mannose residues from a mannosylated protein.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,protein de-mannosylation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Consider also annotating to the term 'mannosyl-oligosaccharide 1,2-alpha-mannosidase activity ; GO:0004571'.",,http://purl.obolibrary.org/obo/GO_0006517,,,,GO:0036507,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0036507,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,protein demannosylation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0008150,biological_process,biological process|physiological process|single-organism process|single organism process,"A biological process represents a specific objective that the organism is genetically programmed to achieve. Biological processes are often described by their outcome or ending state, e.g., the biological process of cell division results in the creation of two daughter cells (a divided cell) from a single parent cell. A biological process is accomplished by a particular set of molecular functions carried out by specific gene products (or macromolecular complexes), often in a highly regulated manner and in a particular temporal sequence.|Note that, in addition to forming the root of the biological process ontology, this term is recommended for use for the annotation of gene products whose biological process is unknown. When this term is used for annotation, it indicates that no information was available about the biological process of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this.|Note that, in addition to forming the root of the biological process ontology, this term is recommended for use for the annotation of gene products whose biological process is unknown. When this term is used for annotation, it indicates that no information was available about the biological process of the gene product annotated as of the date the annotation was made; the evidence code ""no data"" (ND), is used to indicate this.",false,,,http://purl.obolibrary.org/obo/BFO_0000015,,,,,,,,,,,,,,,,janelomax,2012-09-19T15:05:24Z,,,Wikipedia:Biological_process,"A biological process represents a specific objective that the organism is genetically programmed to achieve. Biological processes are often described by their outcome or ending state, e.g., the biological process of cell division results in the creation of two daughter cells (a divided cell) from a single parent cell. A biological process is accomplished by a particular set of molecular functions carried out by specific gene products (or macromolecular complexes), often in a highly regulated manner and in a particular temporal sequence.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0044699|GO:0000004|GO:0007582,,,,biological process|physiological process,,,,,biological_process,,single-organism process|single organism process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Note that, in addition to forming the root of the biological process ontology, this term is recommended for use for the annotation of gene products whose biological process is unknown. When this term is used for annotation, it indicates that no information was available about the biological process of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this.|Note that, in addition to forming the root of the biological process ontology, this term is recommended for use for the annotation of gene products whose biological process is unknown. When this term is used for annotation, it indicates that no information was available about the biological process of the gene product annotated as of the date the annotation was made; the evidence code ""no data"" (ND), is used to indicate this.",,http://purl.obolibrary.org/obo/BFO_0000015,,,,GO:0008150,,,,,,,,,,,,,,,GO:0008150,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_generic|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_chembl|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pir|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_plant|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_metagenomics|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_candida|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_aspergillus|http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/SYMP_0000567,general symptom,,,false,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,,,,,,,,,,,,,,,,,UMLS_ICD9CM_2005_AUI:A0284119|SyOID:777|UMLS_CUI:C0159028|ICD9CM_2005:780,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,symptoms,,,,,,,,,Constitutional or general symptoms are those related to the systemic effects of a disease,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/SYMP_0000462,,,,SYMP:0000567,,,,,,,,,,,,,,,SYMP:0000567,,http://purl.obolibrary.org/obo/symp.owl,,,,,,,,,,,general symptom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_10508,Adenoviridae,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10239,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_family,,,,,,,NCBITaxon:10508,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10239,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Adenoviridae,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0050851,antigen receptor-mediated signaling pathway,antigen receptor-mediated signalling pathway,A series of molecular signals initiated by the cross-linking of an antigen receptor on a B or T cell.,false,,,http://purl.obolibrary.org/obo/GO_0002429,,,,,,,,,,,,,,,,,,,,,A series of molecular signals initiated by the cross-linking of an antigen receptor on a B or T cell.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,antigen receptor-mediated signalling pathway,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0002429,,,,GO:0050851,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0050851,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,antigen receptor-mediated signaling pathway,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0046395,carboxylic acid catabolic process,carboxylic acid breakdown|carboxylic acid catabolism|carboxylic acid degradation,"The chemical reactions and pathways resulting in the breakdown of carboxylic acids, any organic acid containing one or more carboxyl (-COOH) groups.",false,,,http://purl.obolibrary.org/obo/GO_0016054,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the breakdown of carboxylic acids, any organic acid containing one or more carboxyl (-COOH) groups.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,carboxylic acid breakdown|carboxylic acid catabolism|carboxylic acid degradation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0016054,,,,GO:0046395,,,,,,,true,,true,,"",,,,GO:0046395,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,carboxylic acid catabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_3083,chronic obstructive pulmonary disease,COLD|chronic obstructive lung disease|COPD|chronic obstructive airway disease,,false,,,http://purl.obolibrary.org/obo/DOID_2320,,,,,,,,,,,,,,,,,,,,EFO:0000341|SNOMEDCT_US_2019_09_01:13645005|ICD10CM:J44.9|UMLS_CUI:C0024117|OMIM:606963|NCI:C3199|MESH:D029424,,,,,,,,,,,,,,,,,,,,,,,,,,,,DOID:6144|DOID:11500,,,,COLD|chronic obstructive lung disease|COPD|chronic obstructive airway disease,,,,,disease_ontology,,,,,,,,,"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways.",,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/DOID_2320,,,,DOID:3083,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32217650/,,,,DOID:3083,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,chronic obstructive pulmonary disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_129951,Human mastadenovirus C,HAdV-C|Human adenovirus C,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_10509,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HAdV-C,,,,,,,,ncbi_taxonomy,http://purl.obolibrary.org/obo/NCBITaxon_species,Human adenovirus C,,,,,,NCBITaxon:129951,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_10509,,,,,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32130973,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,Human mastadenovirus C,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264383,SARS coronavirus TW-YM1,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264383,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-YM1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_135074,ethoheptazine,aethoheptazin|ethoheptazine citrate|ethyl heptazine,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,Drug_Central:1085|CAS:77-15-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,aethoheptazin|ethoheptazine citrate|ethyl heptazine,,,,,,,,,0,C16H23NO2,"InChI=1S/C16H23NO2/c1-3-19-15(18)16(14-8-5-4-6-9-14)10-7-12-17(2)13-11-16/h4-6,8-9H,3,7,10-13H2,1-2H3",WGJHHMKQBWSQIY-UHFFFAOYSA-N,261.360,261.17288,C(OCC)(=O)C1(CCN(CCC1)C)C2=CC=CC=C2,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:135074,,,,,true,true,,,,,,,,,CHEBI:135074,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,ethoheptazine,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0004111,anatomical conduit,foramen|foramina|ostia|opening|ostium,"Any tube, opening or passage that connects two distinct anatomical spaces.",false,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,,,,,,,,,,,,,,,,,FMA:242873|AEO:0000080|EHDAA2:0003080|http://en.wikipedia.org/wiki/Foramen|http://www.snomedbrowser.com/Codes/Details/346902003,"Any tube, opening or passage that connects two distinct anatomical spaces.",,,,,,,,,,,,,,,FMA has both conduit and conduit space. In EHDAA2 this is a surface feature,,,,,,,,,,,,,,,,,,,foramen|foramina,,uberon,,ostia|opening|ostium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0010000,,,,UBERON:0004111,,,,,,,,,,,,,,,UBERON:0004111,,http://purl.obolibrary.org/obo/uberon.owl,,,,,,,,,,,anatomical conduit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006006,glucose metabolic process,cellular glucose metabolic process|glucose metabolism,"The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.",false,,,http://purl.obolibrary.org/obo/GO_0019318,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cellular glucose metabolic process|glucose metabolism,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019318,,,,GO:0006006,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006006,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,glucose metabolic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_612,primary immunodeficiency disease,immune deficiency disorder|hypoimmunity|immunodeficiency syndrome,An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation.|Xref MGI.,false,,,http://purl.obolibrary.org/obo/DOID_2914,,,,,,,,,,,,,,,,,,,,OMIM:242850|ICD9CM:279.3|KEGG:05340|SNOMEDCT_US_2019_09_01:234532001|UMLS_CUI:C0021051|ICD10CM:D84.9|MESH:D007153|NCI:C3131,An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,immune deficiency disorder|hypoimmunity|immunodeficiency syndrome,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Xref MGI.,,http://purl.obolibrary.org/obo/DOID_2914,,,,DOID:612,,,,,,,,,,,,,,,DOID:612,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus,,,,,,,,,,primary immunodeficiency disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/UBERON_0000456,secretion of exocrine gland,secretion|secreted substance|bodily secretion|exocrine gland fluid/secretion|exocrine gland fluid or secretion|exocrine gland fluid|exocrine gland secretion|external secretion,A portion of organism substance that is produced by exocrine glands.,false,,,http://purl.obolibrary.org/obo/UBERON_0000463,,,,,,,,,,,,,,,,,,,,NCIT:C34062|BTO:0002977|MA:0002504|EMAPA:36535|FMA:9675|UMLS:C1516992|BTO:0002979|AEO:0001005|MESH:D012634|galen:Secretion|http://linkedlifedata.com/resource/umls/id/C1516992,A portion of organism substance that is produced by exocrine glands.,,,,,,,,,,,,,,,"BTO has two distunct classes, with exocrine glandular secretion a subtype of secretion - however, all examples in BTO directly under secretion appear to be exocrine gland secretions",,,,,,,,,,,,UBERON:0006540,secretion,,,secreted substance|bodily secretion|exocrine gland fluid/secretion,,,,,uberon,,exocrine gland fluid or secretion|exocrine gland fluid|exocrine gland secretion|external secretion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/UBERON_0000463,,,,UBERON:0000456,,,,,,,,,,,,,,,UBERON:0000456,,http://purl.obolibrary.org/obo/uberon.owl,,,,,,,,,,,secretion of exocrine gland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000062,"super-spreader
",,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_131567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_131567,,,,,,,,,,true,,,,,,"A super-spreader is an unusually contagious organism infected with a disease. In context of a human-borne illness, a super-spreader is an individual who is more likely to infect others, compared with a typical infected person. Such super-spreaders are of particular concern in epidemiology.",,,,,,,,,,,,,,,,"super-spreader
",,,,,,,,,,,,,,,,,,,,,,https://www.yalemedicine.org/stories/covid-19-glossary/,,,,,,,,,,
http://purl.obolibrary.org/obo/NCBITaxon_264372,SARS coronavirus TW-HP2,,,false,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,,,,,,,GC_ID:1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ncbi_taxonomy,,,,,,,,NCBITaxon:264372,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCBITaxon_264370,,,,,,,,,,,,,,true,,,,,,,http://purl.obolibrary.org/obo/ncbitaxon.owl,,,,,,,,,,,SARS coronavirus TW-HP2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0030071,regulation of mitotic metaphase/anaphase transition,,"Any process that modulates the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.",false,,,http://purl.obolibrary.org/obo/GO_1902099|http://purl.obolibrary.org/obo/GO_1901990|http://purl.obolibrary.org/obo/GO_0010965,,,,,,,,,,,,,,,,,,,,,"Any process that modulates the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1902099|http://purl.obolibrary.org/obo/GO_1901990|http://purl.obolibrary.org/obo/GO_0010965,,,,GO:0030071,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0030071,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,regulation of mitotic metaphase/anaphase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0006970,response to osmotic stress,osmotic stress response|osmotic response,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.",false,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,,,,,,,,,,,,,,,,,,"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,osmotic stress response|osmotic response,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/OGMS_0000060,,,,GO:0006970,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0006970,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_yeast,,,,,,,,,,response to osmotic stress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/BFO_0000011,spatiotemporal region,,,false,,,http://purl.obolibrary.org/obo/BFO_0000003,,,,,SpatiotemporalRegion,st-region,,,,,,,,,,,,,,,,,,,,,,,,,,A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001]),,the spatiotemporal region occupied by a human life|the spatiotemporal region occupied by a process of cellular meiosis.|the spatiotemporal region occupied by the development of a cancer tumor,,,,,,,,,(forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001] |(forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001] |(forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001] |(forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002] |(forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001] ,Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001])|Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002])|All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001])|Every spatiotemporal region occupies_spatiotemporal_region itself.|Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001]),,,,,,,,,,,,,,,,,,,,,BFO:0000011,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,http://purl.obolibrary.org/obo/bfo.owl,http://purl.obolibrary.org/obo/BFO_0000003,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/bfo.owl,,,,,,,,,,,spatiotemporal region,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/DOID_162,cancer,malignant neoplasm|primary cancer|malignant tumor,"A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis.|Updating out dated UMLS CUI.",false,,,http://purl.obolibrary.org/obo/DOID_14566,,,,,,,,,,,,,,,,,,,,ICD10CM:C80.1|UMLS_CUI:C0006826|NCI:C9305|SNOMEDCT_US_2019_09_01:363346000|ICD9CM:199|MESH:D009369|ICDO:M8000/3,"A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,malignant neoplasm|primary cancer|malignant tumor,,,,,disease_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Updating out dated UMLS CUI.,,http://purl.obolibrary.org/obo/DOID_14566,,,,DOID:162,,,,,,,,,,,https://www.ncbi.nlm.nih.gov/pubmed/32311820,,,,DOID:162,,http://purl.obolibrary.org/obo/doid.owl,http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_AGR_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_FlyBase_slim|http://purl.oboInOwllibrary.org/oboInOwl/doid#NCIthesaurus|http://purl.oboInOwllibrary.org/oboInOwl/doid#DO_GXD_slim,,,,,,,,,,cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0034333,adherens junction assembly,adherens junction formation,"The aggregation, arrangement and bonding together of a set of components to form an adherens junction. An adherens junction is a cell-cell junction composed of the epithelial cadherin-catenin complex at which the cytoplasmic face of the plasma membrane is attached to actin filaments.",false,,,http://purl.obolibrary.org/obo/GO_0009987,,,,,,,,,,,,,,,,,,,,,"The aggregation, arrangement and bonding together of a set of components to form an adherens junction. An adherens junction is a cell-cell junction composed of the epithelial cadherin-catenin complex at which the cytoplasmic face of the plasma membrane is attached to actin filaments.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,adherens junction formation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0009987,,,,GO:0034333,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0034333,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,adherens junction assembly,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000779,"condensed chromosome, centromeric region","condensed chromosome, centric region|condensed chromosome, pericentric region|condensed chromosome, centromere","The region of a condensed chromosome that includes the centromere and associated proteins, including the kinetochore. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.|Note that this term can be used in place of the obsolete cellular component term 'centromere ; GO:0005698'. Use with caution because this term refers to a specific region of the chromosome and not a protein complex.",false,,,http://purl.obolibrary.org/obo/GO_0000775,,,,,,,,,,,,,,,,,,,,,"The region of a condensed chromosome that includes the centromere and associated proteins, including the kinetochore. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"condensed chromosome, centric region",,,,,cellular_component,,"condensed chromosome, pericentric region|condensed chromosome, centromere",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,Note that this term can be used in place of the obsolete cellular component term 'centromere ; GO:0005698'. Use with caution because this term refers to a specific region of the chromosome and not a protein complex.,,http://purl.obolibrary.org/obo/GO_0000775,,,,GO:0000779,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000779,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,"condensed chromosome, centromeric region",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0004364,Abnormal circulating nitrogen compound concentration,,"Any deviation from the normal concentration of a nitrogen compound in the blood circulation.|Ammonia (NH3), one of the most clinically important nitrogen compounds in human metabolism, is a substance containing nitrogen resulting from the catabolism of protein. It is converted to the less toxic substance urea prior to excretion in urine.",false,,,http://purl.obolibrary.org/obo/HP_0032180,,,,,,,,,,,,,,,,peter,2008-03-17T04:51:00Z,,,UMLS:C4025336,Any deviation from the normal concentration of a nitrogen compound in the blood circulation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,"Ammonia (NH3), one of the most clinically important nitrogen compounds in human metabolism, is a substance containing nitrogen resulting from the catabolism of protein. It is converted to the less toxic substance urea prior to excretion in urine.",,http://purl.obolibrary.org/obo/HP_0032180,,,,HP:0004364,,,,,,,,,,,,,,,HP:0004364,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Abnormal circulating nitrogen compound concentration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/NCIT_C123816,Camrelizumab,HR-301210|Camrelizumab|SHR-1210|CAMRELIZUMAB|SHR1210,"A monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1,) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, anti-PD-1 monoclonal antibody SHR-1210 binds to and blocks the binding of PD-1, expressed on activated T-lymphocytes, B-cells and natural killer (NK) cells, to its ligands programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen presenting cells (APCs). This prevents the activation of PD-1 and its downstream signaling pathways. This restores immune function through the activation of cytotoxic T-lymphocytes (CTLs) and cell-mediated immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,C123816,,,FDA,,,,,,,"A monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1,) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, anti-PD-1 monoclonal antibody SHR-1210 binds to and blocks the binding of PD-1, expressed on activated T-lymphocytes, B-cells and natural killer (NK) cells, to its ligands programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen presenting cells (APCs). This prevents the activation of PD-1 and its downstream signaling pathways. This restores immune function through the activation of cytotoxic T-lymphocytes (CTLs) and cell-mediated immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.",,,,,,,,,,,,,,,,,73096E137E,,,,,,,,,,,,,,HR-301210|Camrelizumab|SHR-1210|CAMRELIZUMAB|SHR1210,,,,,,,,,,,http://purl.obolibrary.org/obo/NCIT_C94697,,NCIT:C123816,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,true,,,,,,,,,,,http://purl.obolibrary.org/obo/ncit.owl,http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784|http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923,,,,,,,,,,Camrelizumab,,,,,,,CL498210,,,,,,,,,775449,775449,,Camrelizumab,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,"Immunologic Factor|Amino Acid, Peptide, or Protein",,,,,,,,,
https://bio.scai.fraunhofer.de/ontology/COVID_0000028,touching mouth,,,false,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/NCIT_C17103,,,,,Modified definition,,,behaviour process,,true,,,,,https://www.ncbi.nlm.nih.gov/pubmed/25637115,A face-touching behavior involving mouth touches.,,,,,,,,,,,,,,,,touching mouth,,,,,,,,,,,,,,,,,,,,,,https://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0000070,mitotic sister chromatid segregation,mitotic chromosome segregation|mitotic sister-chromatid adhesion release,"The cell cycle process in which replicated homologous chromosomes are organized and then physically separated and apportioned to two sets during the mitotic cell cycle. Each replicated chromosome, composed of two sister chromatids, aligns at the cell equator, paired with its homologous partner. One homolog of each morphologic type goes into each of the resulting chromosome sets.",false,,,http://purl.obolibrary.org/obo/GO_0000819,,,,,,,,,,,,,,,,,,,,,"The cell cycle process in which replicated homologous chromosomes are organized and then physically separated and apportioned to two sets during the mitotic cell cycle. Each replicated chromosome, composed of two sister chromatids, aligns at the cell equator, paired with its homologous partner. One homolog of each morphologic type goes into each of the resulting chromosome sets.",,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016359,,,,mitotic chromosome segregation,,,mitotic sister-chromatid adhesion release,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0000819,,,,GO:0000070,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0000070,,http://purl.obolibrary.org/obo/go.owl,http://purl.oboInOwllibrary.org/oboInOwl/go#goslim_pombe,,,,,,,,,,mitotic sister chromatid segregation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/ERO_0001288,clinical assay,,An organismal assay designed to capture information about clinical samples or specimens.,false,,,http://purl.obolibrary.org/obo/ERO_0001285,,,,,,,,,,,,,,,,,,,,,An organismal assay designed to capture information about clinical samples or specimens.,,PERSON: Nicole Vasilevsky,,,,,,,,,,,Clinical diagnosis of a disease.,,,,,,,,,,,http://purl.obolibrary.org/obo/IAO_0000120,,,,,,,,,,,,,,,,,,,,ERO:0001288,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/ERO_0001285,,,,,,,,,,,,,,,,,,,,,http://purl.obolibrary.org/obo/ero.owl,,,,,,,,,,,clinical assay,,,,,,,,,,,,,,,,,,,,,,,,,,,,PERSON: Nicole Vasilevsky,,,,
http://purl.obolibrary.org/obo/GO_0090316,positive regulation of intracellular protein transport,,"Any process that activates or increases the frequency, rate or extent of the directed movement of proteins within cells.",false,,,http://purl.obolibrary.org/obo/GO_0051222|http://purl.obolibrary.org/obo/GO_0032388|http://purl.obolibrary.org/obo/GO_0033157|http://purl.obolibrary.org/obo/GO_1903829,,,,,,,,,,,,,,,,tanyaberardini,2010-04-16T03:45:07Z,,,,"Any process that activates or increases the frequency, rate or extent of the directed movement of proteins within cells.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0051222|http://purl.obolibrary.org/obo/GO_0032388|http://purl.obolibrary.org/obo/GO_0033157|http://purl.obolibrary.org/obo/GO_1903829,,,,GO:0090316,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0090316,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of intracellular protein transport,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_0019359,nicotinamide nucleotide biosynthetic process,nicotinamide nucleotide anabolism|nicotinamide nucleotide synthesis|nicotinamide nucleotide biosynthesis|nicotinamide nucleotide formation,"The chemical reactions and pathways resulting in the formation of nicotinamide nucleotides, any nucleotide that contains combined nicotinamide.",false,,,http://purl.obolibrary.org/obo/GO_0019363|http://purl.obolibrary.org/obo/GO_0046496,,,,,,,,,,,,,,,,,,,,,"The chemical reactions and pathways resulting in the formation of nicotinamide nucleotides, any nucleotide that contains combined nicotinamide.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,nicotinamide nucleotide anabolism|nicotinamide nucleotide synthesis|nicotinamide nucleotide biosynthesis|nicotinamide nucleotide formation,,,,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_0019363|http://purl.obolibrary.org/obo/GO_0046496,,,,GO:0019359,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:0019359,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,nicotinamide nucleotide biosynthetic process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_77572,tranilast,"2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid|Rizaben|tranilast|tranilastum|MK 341|MK-341|N-(3,4-Dimethoxycinnamoyl)anthranilic acid","An amidobenzoic acid that is anthranilic acid in which one of the anilino hydrogens is replaced by a 3,4-dimethoxycinnamoyl group.",false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,PMID:23821545|PMID:24389817|PMID:24377619|PMID:24374452|KEGG:D02027|PMID:23977380|PMID:24389486|PMID:23273396|PMID:23679559|Wikipedia:Tranilast|PMID:23121382|PDBeChem:D27|PMID:24092987|Drug_Central:2714|PMID:23363021|PMID:24055688|PMID:24143895|PMID:24475260|Reaxys:3085768|PMID:23715805|PMID:23694807|PMID:22753703|PMID:24157455|CAS:53902-12-8|PMID:24476069|PMID:24448965|PMID:24384948|PMID:24420060,"An amidobenzoic acid that is anthranilic acid in which one of the anilino hydrogens is replaced by a 3,4-dimethoxycinnamoyl group.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid",,,,,chebi_ontology,,"Rizaben|tranilast|tranilastum|MK 341|MK-341|N-(3,4-Dimethoxycinnamoyl)anthranilic acid",,,,,,,,,0,C18H17NO5,"InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+",NZHGWWWHIYHZNX-CSKARUKUSA-N,327.33130,327.11067,COc1ccc(C=C\C(=O)Nc2ccccc2C(O)=O)cc1OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:77572,,,,,,true,,,,,,,,,CHEBI:77572,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,tranilast,,,,,,,,,,,,,,,,,,,,,,https://www.cebm.net/covid-19/registered-trials-and-analysis/,,,,,,,,,,
http://purl.obolibrary.org/obo/HP_0000118,Phenotypic abnormality,Organ abnormality,A phenotypic abnormality.|This is the root of the phenotypic abnormality subontology of the HPO.,false,,,http://purl.obolibrary.org/obo/BFO_0000019,,,,,,,,,,,,,,,,,,,,UMLS:C4021819,A phenotypic abnormality.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Organ abnormality,,,,,human_phenotype,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,This is the root of the phenotypic abnormality subontology of the HPO.,,http://purl.obolibrary.org/obo/BFO_0000019,,,,HP:0000118,,,,,,,,,,,,,,,HP:0000118,,http://purl.obolibrary.org/obo/hp.owl,,,,,,,,,,,Phenotypic abnormality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_3546,cepharanthine,"Cepharanthine|(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2(16,19).1(3,10).1(21,25).0(4,8).0(14,39).0(31,35)]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene|6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan|(+)-Cepharanthine",A bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation.,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D01035|CAS:481-49-2|KEGG:C09391|Beilstein:75231|Reaxys:75231|KNApSAcK:C00001836|PMID:26703475,A bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Cepharanthine|(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2(16,19).1(3,10).1(21,25).0(4,8).0(14,39).0(31,35)]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene",,,,,chebi_ontology,,"6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan|(+)-Cepharanthine",,,,,,,,,0,C37H38N2O6,"InChI=1S/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29+/m1/s1",YVPXVXANRNDGTA-WDYNHAJCSA-N,606.709,606.27299,C12=C3C=4[C@@H](N(CCC4C=C1OCO2)C)CC=5C=CC(=CC5)OC=6C(=CC=C(C6)C[C@H]7N(CCC8=C7C=C(C(=C8)OC)O3)C)OC,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:3546,,,,,,,,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32232214,,,,CHEBI:3546,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#3_STAR,,,,,,,,,,cepharanthine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/GO_1902751,positive regulation of cell cycle G2/M phase transition,upregulation of cell cycle G2/M phase transition|up regulation of cell cycle G2/M phase transition|up-regulation of cell cycle G2/M phase transition|activation of cell cycle G2/M phase transition,Any signalling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle.,false,,,http://purl.obolibrary.org/obo/GO_1902749|http://purl.obolibrary.org/obo/GO_1901989,,,,,,,,,,,,,,,,jl,2014-03-05T15:38:27Z,,,,Any signalling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the cell cycle.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,upregulation of cell cycle G2/M phase transition|up regulation of cell cycle G2/M phase transition|up-regulation of cell cycle G2/M phase transition,,,activation of cell cycle G2/M phase transition,,biological_process,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/GO_1902749|http://purl.obolibrary.org/obo/GO_1901989,,,,GO:1902751,,,,,,,true,,true,,https://www.ncbi.nlm.nih.gov/pubmed/32228226/,,,,GO:1902751,,http://purl.obolibrary.org/obo/go.owl,,,,,,,,,,,positive regulation of cell cycle G2/M phase transition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_45267,praziquantel,,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CHEBI:8363,,,,,,,,,chebi_ontology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:45267,,,,,true,true,,,,,,,,,CHEBI:45267,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#1_STAR,,,,,,,,,,praziquantel,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
http://purl.obolibrary.org/obo/CHEBI_7470,Naphazoline,Naphazoline hydrochloride,,false,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,,,,,,,,,,,,,,,,,KEGG:D00743|CAS:550-99-2|KEGG:C07898,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,chebi_ontology,,Naphazoline hydrochloride,,,,,,,,,0,C14H14N2.HCl,"InChI=1S/C14H14N2.ClH/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14;/h1-7H,8-10H2,(H,15,16);1H",DJDFFEBSKJCGHC-UHFFFAOYSA-N,246.740,246.09238,Cl.C(C1=NCCN1)c1cccc2ccccc12,,,,,,,,,,,,,,,,,,,http://www.w3.org/2002/07/owl#Class,,,http://purl.obolibrary.org/obo/CHEBI_23888,,,,CHEBI:7470,,,,,true,true,,,,,,,,,CHEBI:7470,,http://purl.obolibrary.org/obo/chebi.owl,http://purl.oboInOwllibrary.org/oboInOwl/chebi#2_STAR,,,,,,,,,,Naphazoline,,,,,,,,,,,,,,,,,,,,,,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25681,,,,,,,,,,
